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ABOUT THIS EDITION OF IFRS ACCOUNTING TRENDS
& TECHNIQUES
The new edition of IFRS Accounting Trends & Techniques (IFRS ATT) continues to add strength to the
series of Accounting Trends & Techniques publications. These AICPA bestsellers are the tools of choice
for financial reporting and have an unmatched legacy of innovation and practical application.
Similar to the other titles in the series, IFRS ATT includes helpful reporting guidance, compiles annual
reporting and disclosure data, and presents illustrative reporting examples from an extensive analysis
of annual reports of entities across the globe and across numerous industries. The financial statements
of those entities selected for this edition include a required statement of compliance confirming that
the financial statements were prepared in conformity with International Financial Reporting Standards
(IFRSs), as issued by the International Accounting Standards Board (IASB). This edition also includes
survey entities for which the national standards applicable to their jurisdiction are essentially equivalent
to IFRSs, as issued by the IASB (for example, Australia). All but one entity, which is a farm-owned
cooperative, are publicly traded.
To be included in the survey sample, entities domiciled in jurisdictions in which the required accounting
standards may not be in full conformity with IFRSs, such as the European Union, were required to include
either the phrase “as issued by the IASB” in the statement of compliance or a separate sentence that
confirms that the standards applied in the financial statements are not different from those issued by
the IASB. Entities domiciled in jurisdictions where the national standards are essentially equivalent to
IFRSs, as issued by the IASB, were not required to include this additional confirmation of compliance
with IFRSs, as issued by the IASB. Survey entities that are also Securities and Exchange Commission
(SEC) registrants are required by the SEC to add the phrase “as issued by the IASB” to their statement
of compliance.
IFRS ATT provides preparers, auditors, and other financial professionals with an invaluable resource
for incorporating new and existing accounting and reporting guidance into financial statements using
presentation techniques adopted by some of the most recognized entities in the world. IFRS ATT can
also be used internally by an entity’s management and externally by investors, analysts, and academics
to build their base of understanding and awareness of financial statement presentation under IFRSs and
the accounting policies prevalent across different industries around the world reporting under IFRSs.
ORGANIZATION AND CONTENT
This 2011 edition of IFRS ATT incorporates information from the annual reports of 170 carefully selected
entities generally having annual fiscal periods ending between January and December 2010.
The content of IFRS ATT addresses many of the common requirements most likely to be encountered
when reporting on the general purpose financial statements, including consolidated financial statements
of commercial, industrial, and business reporting entities, as defined in the Conceptual Framework for
Financial Reporting (IFRS Conceptual Framework) within the IASB’s IFRS 2011 bound volume. The
IFRS Conceptual Framework sets forth the concepts that underlie the preparation and presentation of
financial statements for external users and contains definitions of the elements of financial statements
(that is, assets, liabilities, equity, income, and expenses).
Among other purposes, the IFRS Conceptual Framework assists preparers of financial statements in
applying IFRSs and in dealing with topics that have yet to form the subject of a specific standard or
interpretation. Although the framework is not a standard, the requirements of International Accounting
Standard (IAS) 8, Accounting Policies, Changes in Accounting Estimates and Errors, essentially establish
the IFRS Conceptual Framework as part of the IFRSs hierarchy of accounting and reporting requirements.
To provide you with the most useful and comprehensive look at current financial reporting techniques
and methods, IFRS ATT is topically organized using familiar financial statement terminology and offers
the following:
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• Descriptive guidance that includes comparisons of the current reporting requirements under IFRSs
and U.S. generally accepted accounting principles (GAAP). U.S. GAAP is generally considered to
be the requirements of the Financial Accounting Standards Board (FASB) Accounting Standards
CodificationTM (ASC) and regulations of the SEC for those foreign private issuers that are SEC
registrants.
• Statistical tables that track reporting trends.
• Illustrative examples from the surveyed annual reports showing reporting techniques.
• Detailed indexes.
Different terms for the same underlying concepts within IFRSs and U.S. GAAP are identified to enhance
relevance and understanding.
Reporting Guidance
IFRS ATT offers discerning, plain English guidance covering the significant IFRSs and U.S. GAAP
accounting and financial statement reporting requirements in a narrative presentation consistently applied
throughout all the sections. You’ll find a strategic use of common headings (overview, recognition and
measurement, presentation, and disclosure) throughout all sections; under those common headings
appear subheadings for IFRSs and U.S. GAAP. Although not a substitute for the authoritative accounting
and reporting standards, the reporting guidance boils down the complex requirements, with a focus on the
reader’s clear understanding of the content. The related authoritative sources for each requirement are
cited within the narratives (for example, IFRS 3, Business Combinations; FASB ASC 310, Receivables;
or Regulation S-K).
In 2011, the IASB issued two editions of the 2011 bound volume of IFRSs. One edition, IFRS—
Consolidated without early application (referred to as the blue book) includes the latest consolidated
version of the entire authoritative body of IFRSs as of December 31, 2010, that are required for annual
reporting periods beginning on January 1, 2011. The other edition, IFRS (referred to as the red book)
includes newly issued or amended standards and interpretations as of December 31, 2010, with full early
application. The latter edition, for example, includes IFRS 9, Financial Instruments, which is effective for
annual reporting periods beginning on or after January 1, 2013. The IFRSs narratives and comparisons to
U.S. GAAP only refer to standards in the blue edition. Author’s notes provide information about standards
and interpretations included in the red edition, when applicable (for example, to accompany an excerpt
illustrating early application of IFRS 9).
Annually, FASB and the IASB either separately or jointly issue proposals for changes to existing
standards or for standards to address new issues. If finalized, these proposals would change recognition,
measurement, presentation, and disclosure requirements, some significantly. For example, in 2010, the
IASB issued exposure drafts proposing changes to IAS 17, Leases, and 18, Revenue. At the same
time, FASB issued comparable Accounting Standards Update exposure drafts: Leases (Topic 840) and
Revenue Recognition (Topic 605): Revenue from Contracts with Customers. In 2011, the IASB issued
an exposure draft on accounting for investments by investment entities. Brief summaries about proposed
changes are provided in author’s notes, when relevant.
For easy reference and to avoid potential confusion, comparisons of IFRSs to U.S. GAAP are confined
within the U.S. GAAP components of the narratives.
Reporting Trends
Statistical trends tables are easily identified by a shaded background, which distinguishes them from
content excerpted from a survey entity’s financial statements. These tables show reporting trends across
the available choices in recognition, measurement, and presentation in such diverse reporting matters
as financial statement format and terminology and the treatment of transactions and events reflected in
the financial statements. Additional trends of this nature will be added in future editions.
Illustrative Reporting Examples
IFRS ATT presents carefully selected reporting examples excerpted from the audited annual reports of
the survey entities to illustrate current reporting techniques and various presentation practices. Each
edition of IFRS ATT includes completely new reporting examples found to be particularly relevant and
useful to financial statement preparers and other users in illustrating current reporting practices.
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Indexes
Indexes in this edition include the “Company Index,” which alphabetically lists each of the 170 survey
entities included in the current edition and identifies where in the text excerpts from their annual reports
can be found. The “Pronouncements Index” provides for easy cross-referencing of the IFRSs framework,
standards, and interpretations (collectively, IFRSs) to the applicable descriptive narratives. A detailed
“Subject Index” directs the reader to all significant topics included throughout the narratives.
AUTHORITATIVE SOURCES
Unless otherwise indicated, references to IFRSs throughout this 2011 edition of IFRS ATT refer to the
version of those standards and interpretations included in IFRS 2011 bound volume (the blue book)
that are effective for annual reporting periods beginning on or after January 1, 2011. When necessary,
author’s notes provide information about newly issued standards and interpretations that are effective
for annual periods beginning on or after a later date.
Unless otherwise indicated, references to U.S. GAAP throughout this 2011 edition of IFRS ATT refer
to FASB ASC as of December 31, 2010.
Note that the AICPA Code of Professional Conduct has been revised to recognize the IASB in London
as an accounting body for purposes of establishing IFRSs, thus granting AICPA members the option to
use IFRSs as an alternative to U.S. GAAP.
Also note that the effective dates of recently released guidance affect the timing of its inclusion in
the financial statements of the survey entities, thereby affecting the availability of illustrative excerpts for
potential inclusion in each edition of IFRS ATT.
IFRSs
What Is IFRSs?
IFRSs are a set of accounting standards and interpretations developed and issued by the IASB, the
London-based independent accounting standard-setting body currently consisting of 15 full-time mem-
bers, which will be expanded to 16 members by 2012. Important elements of member selection include
technical competence; recent practical experience; and diversity, including diversity in terms of work
experience, such as one’s background as a financial statement preparer, auditor, and external user, and
in terms of a member’s country of origin.
The IASB began operations in 2001, when it succeeded the International Accounting Standards Com-
mittee (IASC). The IASC was formed in 1973, soon after the formation of FASB. In 2001, when the IASB
replaced the IASC, a new, independent oversight body, the IASC Foundation, was created to appoint the
members of the IASB and oversee its due process. The IASC Foundation’s oversight role is very similar
to that of the Financial Accounting Foundation in its capacity as the oversight body of FASB.
The term IFRSs has both a narrow and broad meaning. Narrowly, IFRSs refer to the new numbered
series of pronouncements issued by the IASB, as differentiated from IASs issued by its predecessor,
the IASC. More broadly, however, IFRSs refer to the entire body of authoritative IASB pronouncements,
including those issued by the IASC and their respective interpretive bodies. Therefore, the authoritative
IFRSs literature, in its broadest sense and as applied in IFRS ATT, includes the following:
• Standards, whether labeled IFRSs or IASs
• Interpretations, whether labeled International Financial Reporting Interpretations Committee
(IFRIC), the current interpretive body of the IASC Foundation, or Standing Interpretations Com-
mittee, the predecessor to IFRIC and former interpretive body of the IASC
• IFRS Conceptual Framework
The preface to the IFRS 2011 bound volume states that IFRSs are designed to apply to the general
purpose financial statements and other financial reporting of all profit-oriented entities, including com-
mercial, industrial, and financial entities, regardless of legal form or organization. Included within the
scope of profit-oriented entities are mutual insurance companies and other mutual cooperative entities
that provide dividends or other economic benefits to their owners, members, or participants. IFRSs are
not designed to apply to not-for-profit entities or those in the public sector, but these entities may find
IFRSs appropriate in accounting for their activities. In contrast, U.S. GAAP is designed to apply to all
nongovernmental entities, including not-for-profit entities, and includes specific guidance for not-for-profit
entities, development stage entities, limited liability entities, and personal financial statements.
The IASB’s approach to establishing standards and interpretations differs to some degree from that
of FASB. In developing an IFRS, the IASB strikes a different balance than FASB in developing U.S.
GAAP by expecting preparers to rely on core principles and more limited application guidance, with
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fewer prescriptive rules than found in U.S. GAAP. In contrast, FASB has traditionally leaned more toward
providing extensive prescriptive guidance and detailed rules.
The difference in the amount of industry-specific guidance is an example of the different approaches.
Currently, IFRSs include only three standards (for example, IAS 41, Agriculture)1 that might be regarded
as primarily industry-specific guidance. However, the scope of these standards includes all entities to
which the scope of IFRSs applies. In contrast, U.S. GAAP has considerable guidance for entities within
specific industries. For example, on liability recognition and measurement alone, U.S. GAAP contains
specific guidance for entities in the following industries:
• Agriculture
• Health care
• Contractors and construction
• Contractors and the federal government
• Entertainment, with separate guidance for casinos, films, and music
• Financial services, with separate guidance for brokers and dealers, depository and lending, insur-
ance, and investment companies
For nonmonetary transactions, U.S. GAAP provides specific guidance for the airline, software, and en-
tertainment industries. U.S. GAAP also addresses some specific transactions not currently addressed in
IFRSs, such as accounting for reorganizations, including quasireorganizations, troubled debt restructur-
ing, spinoffs, and reverse spinoffs.
Convergence of U.S. GAAP and IFRSs
Converging the standards of FASB and the IASB was the primary focus of both organizations’ boards
during 2010–11. The commitment for global convergence gained momentum in 2002 when FASB and
the IASB signed what is known as the Norwalk Agreement. At that meeting, FASB and the IASB pledged
to use their best efforts to (a) make their existing financial reporting standards fully compatible as soon as
practicable and (b) coordinate their future work programs to ensure that, once achieved, compatibility is
maintained. That agreement was reaffirmed in a February 2006 Memorandum of Understanding (MoU),
which was based on the following three principles:
• Convergence of accounting standards can best be achieved through the development of high
quality, common standards over time.
• Trying to eliminate differences between two standards that are in need of significant improvement
is not the best use of FASB’s and the IASB’s resources; instead, a new common standard should
be developed that improves the financial information reported to investors.
• Serving the needs of investors means that FASB and the IASB should seek convergence by
replacing standards in need of improvement with jointly developed new standards.
At their joint meeting in April 2008, FASB and the IASB again affirmed their commitment to developing
common, high quality standards and agreed on a path to completing the MoU projects, including projected
completion dates. In September 2008 and again in April 2011, the two boards jointly published an update
of their 2006 MoU to report the progress that they have made since 2006. During 2011, the boards
regularly updated project completion dates as difficulties in completing projects arose. Some projects (for
example, Income Taxes) were removed from the convergence schedules when the boards agreed that
convergence was unlikely to be achieved in the short time available, but other projects have reached the
exposure draft milestone. Each board believes that these standards, when completed, would improve the
quality, consistency, and comparability of financial information for investors and capital markets around
the world.
In February 2010, the SEC staff published a work plan that, together with FASB’s and the IASB’s
convergence projects, would position the SEC regarding incorporating IFRSs into the financial reporting
system for U.S. issuers. This work plan contained the following keys areas and factors relevant to
determining “whether, when, and how [the U.S.] financial reporting system for U.S. issuers should be
transitioned to a system that incorporates [IFRSs]:”2
• Development and application of IFRSs
• Independence of standard setting
• Investor understanding and education regarding IFRSs
1 In addition to International Accounting Standards 41, Agriculture, the other International Financial Reporting Standards
(IFRSs) that address issues specific to certain industries are IFRS 4, Insurance Contracts, and 6, Exploration for and
Evaluation of Mineral Resources.
2 Securities and Exchange Commission Release Nos. 33-9109; 34-61578, Commission Statement in Support of Con-
vergence and Global Accounting Standards and the appendix of the Work Plan for the Consideration of Incorporating
International Financial Reporting Standards into the Financial Reporting System for U.S. Issuers.
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• Examination of the U.S. regulatory environment that would be affected by a change in accounting
standards
• Impact on both large and small issuer
• Human capital considerations
In October 2010, the SEC staff issued a progress report on its work plan that addresses each of
these issues and describes how the staff is evaluating each of them. For example, with respect to
the development and application of IFRSs, the staff is monitoring the development of MoU and IFRSs
projects that are outside the scope of the MoU. The SEC staff is also seeking constituent perspectives
and researching the experiences of regulators in other jurisdictions, as well as reviewing the financial
statements of both SEC and non-SEC registrants to evaluate the application of IFRSs in practice.
In May 2011, the SEC staff published a staff paper, Work Plan for the Consideration of Incorporating
International Financial Reporting Standards into the Financial Reporting System for U.S. Issuers: Explor-
ing a Possible Method of Incorporation, that confirmed that the SEC had not yet made a decision about
whether or how to incorporate IFRSs into the U.S. financial reporting system. In this paper, the staff
proposed a “condorsement” approach, whereby FASB would endorse new IFRSs one at a time as part
of a continuing convergence process, rather than a “big bang” approach that would specify a mandatory,
certain date for adoption of IFRSs. Subsequent to issuing this paper, the SEC staff held a roundtable
where invited constituents would discuss the proposal. Many of the roundtable participants favored this
“condorsement” approach.
Both FASB and the IASB provide extensive information about convergence and other projects on their
respective websites, often with links to the relevant page on the opposite partner’s site. The SEC also has
a section on its website, “Spotlight on Work Plan for Global Accounting Standards,” where the previously
cited documents can be found, as well as comments from constituents on its proposals.
OTHER AICPA PUBLICATIONS
For the same reasons that you’ll find IFRS ATT to be the premier resource for financial reporting under
IFRSs, the other publications in the Accounting Trends & Techniques series are just as robust and
deserving to be your tool of choice for their respective types of financial reporting. A similar publication
in this series that focuses exclusively on U.S. GAAP is Accounting Trends & Techniques (product
code 0099011). Now in its 65th edition, this AICPA bestseller is filled with all new examples of current
reporting techniques and methods used by 500 of the top publicly traded U.S. companies across all
major industries. See www.cpa2biz.com for ordering information.
Further, launched in 2011, eXacct: Financial Reporting Tools & Techniques, is a powerful new Web-
based tool that holistically addresses accounting, financial reporting, and enhanced business reporting.
Built on the framework of the best-selling Accounting Trends & Techniques, it shows statistical reporting
trends and actual reporting examples from the AICPA’s survey of annual reports from 500 of the country’s
top public companies. Going beyond the print edition, the added XBRL functionality of the online version
empowers XBRL filers with the analytical tools to inform their own reporting by providing all available
XBRL filings from all 500 survey companies and providing full tag information, highlighting company
extensions with the click of a button. A subscription to this robust online tool allows you to search,
browse, filter, download, and use the data exactly as you need it and is available at www.cpa2biz.com.
NOTICE
IFRS ATT is a nonauthoritative practice aid and is not designed to provide a comprehensive under-
standing of all the requirements contained in U.S. GAAP and IFRSs and does not identify all possible
differences between those aforementioned bases of accounting. IFRS ATT does not include reporting
requirements relating to other matters, such as internal control or agreed-upon procedures.
Authoritative guidance on accounting treatments in accordance with IFRSs can only be made by
reference to the IFRSs themselves, which are copyright of the IASC Foundation and can be acquired
directly from the IASB.
IFRS ATT has not been reviewed, approved, disapproved, or otherwise acted on by any senior
technical committee of the AICPA and does not represent official positions or pronouncements of the
AICPA.
The use of this publication requires the exercise of individual professional judgment. It is not a substitute
for the original authoritative pronouncements. Users are urged to refer directly to applicable authoritative
pronouncements, when appropriate. As an additional resource, users may call the AICPA Technical
Hotline at 1-877-242-7212.
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FEEDBACK
We hope that you find this third edition of IFRS ATT to be informative and useful. Please let us know!
What features do you like? What do you think can be improved or added? We encourage you to give us
your comments and questions about all aspects of IFRS ATT. Please direct your feedback to Anjali Patel
using the following contact information. All feedback is greatly appreciated and kept strictly confidential.
Anjali Patel—Accounting & Auditing Publications
AMERICAN INSTITUTE OF CERTIFIED PUBLIC ACCOUNTANTS




You can also contact the Accounting and Auditing Publications team of the AICPA directly via e-mail at
A&Apublications@aicpa.org.
LIST OF ABBREVIATIONS
AICPA American Institute of Certified Public Accountants
ASC Accounting Standards Codification
TM
EU European Union
FASB Financial Accounting Standards Board
GAAP Generally Accepted Accounting Principles
IAS International Accounting Standards
IASB International Accounting Standards Board
IASC International Accounting Standards Committee
ICAEW Institute of Chartered Accountants in England and Wales
IFRIC International Financial Reporting Interpretations Committee
IFRSs International Financial Reporting Standards
SEC Securities and Exchange Commission
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SECTION 1: GENERAL TOPICS AND RELATED DISCLOSURES∗
STATISTICAL PROFILE INFORMATION
ON SURVEY ENTITIES USED IN THIS
EDITION





Exchange(1) Fiscal Year End
Presentation
Currency(2)
A.G. Barr plc .............................................. United Kingdom BAG LSE January 29 2011 GBP
A/S Dampskibsselskabet TORM............... Denmark TRMD NASDAQ December 31 2010 USD
Absa Group Limited................................... South Africa AMAGB JSE December 31 2010 ZAR
Abu Dhabi Aviation.................................... United Arab Emirates ADAVIATION ADX December 31 2010 AED
Abu Dhabi National Hotels PJSC.............. United Arab Emirates ADNH ADX December 31 2010 AED
Abu Dhabi Ship Building PJSC.................. United Arab Emirates ADSB ADX December 31 2010 AED
Adecoagro S.A........................................... Luxembourg AGRO NYSE December 31 2010 USD
AEGON N.V............................................... The Netherlands AEG NYSE December 31 2010 EUR
Aixtron SE (formally, Aixtron
Aktiengesellschaft)................................. Germany AIXG NASDAQ December 31 2010 EUR
Alcatel-Lucent............................................ France ALU NYSE December 31 2010 EUR(5)
Alesco Corporation Limited ....................... Australia ALS ASX May 31 2010 AUD
Allied Irish Bank plc ................................... Ireland AIB NYSE December 31 2010 EUR
Alumina Limited ......................................... Australia AWC NYSE December 31 2010 AUD
Anooraq Resources Corporation............... Canada ARQ TSX December 31 2010 CAD
Aquarius Platinum Limited......................... Australia AQP.1 LSE June 30 2010 USD
ArcelorMittal............................................... Luxembourg MT NYSE December 31 2010 USD
ARM Holdings plc ...................................... United Kingdom ARM LSE December 31 2010 GBP
ARYZTA AG............................................... Switzerland ARYB SIX July 31 2010 EUR
Ashtead Group plc..................................... United Kingdom AHT LSE April 30 2010 GBP
AstraZeneca plc......................................... United Kingdom AZN NYSE December 31 2010 USD
Autonomy Corporation plc......................... United Kingdom AU LSE December 31 2010 USD
Aviva plc..................................................... United Kingdom AV LSE December 31 2010 GBP
AXA SA...................................................... France AXA NYSE December 31 2010 EUR
Barclays plc................................................ United Kingdom BCS NYSE December 31 2010 GBP
Barloworld Limited..................................... South Africa BAW JSE September 30 2010 ZAR
Barry Callebaut AG.................................... Switzerland BARN SIX August 31 2010 CHF
BBA Aviation plc ........................................ United Kingdom BBA LSE December 31 2010 GBP
BHP Billiton plc and BHP Billiton
Limited(3) .................................................
United Kingdom and
Australia, respectively BHP/BBL NYSE June 30 2010 USD
BP plc......................................................... United Kingdom BP NYSE December 31 2010 USD
Brewin Dolphin Holdings plc...................... United Kingdom BRW LSE September 26(4) 2010 GBP
British Sky Broadcasting Group plc........... United Kingdom BSY LSE June 30 2010 GBP
Brookfield Office Properties Canada......... Canada BOX.UN TSX December 31 2010 CAD
Brookfield Asset Management, Inc. .......... Canada BAM NYSE December 31 2010 USD
BT Group plc.............................................. United Kingdom BT NYSE March 31 2010 GBP
Cellcom Israel Ltd...................................... Israel CEL NYSE December 31 2010 ILS
(continued)
∗
Unless otherwise indicated, references to International Accounting Stand-
ards Board (IASB) standards and interpretations throughout this 2011 edi-
tion of IFRS Accounting Trends & Techniques refer to the version of those
standards and interpretations included in the IFRS 2011 bound volume, the
official printed consolidated text of IASB standards and interpretations,
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Presentation
Currency(2)
Centum Investment Company Ltd....................... Kenya IIC NSE March 31 2010 KES
China Eastern Airlines Corporation Limited........ China CEA NYSE December 31 2010 CNY
China Gold International Resources Corp, Ltd.
(formerly, Jinshan Gold Mines Inc.)................. Canada CGG TSX December 31, 2010 USD
China Mobile Limited........................................... Hong Kong CHL NYSE December 31 2010 CNY
China Southern Airlines Company Limited ......... China ZNH NYSE December 31 2010 CNY
China Telecom Corporation Limited.................... China CHA NYSE December 31 2010 CNY
China Xiniya Fashion Limited.............................. China XNY NYSE December 31 2010 CNY
China Yuchai International Limited...................... China CYO NYSE December 31 2010 CNY
Chocoladefabriken Lindt & Sprüngli AG.............. Switzerland LISN SIX December 31 2010 CHF
City Telecom (H.K.) Limited................................. Hong Kong CTEL NASDAQ August 31 2010 HKD
Clariant Ltd........................................................... Switzerland CLN SIX December 31 2010 CHF
Clicks Group Limited............................................ South Africa CLS JSE August 31 2010 ZAR
CNOOC Limited................................................... Hong Kong CEO NYSE December 31 2010 CNY
Compagnie Financière Richemont SA................ Switzerland CFR SIX March 31 2010 EUR
Compagnie Générale de Géophysique-Veritas,
S.A.................................................................... France CGV NYSE December 31 2010 EUR
Companhia de Bebidas das Américas
(American Beverage Company) – Ambev....... Brazil ABV NYSE December 31 2010 BRL
Companhia de Saneamento Basico do Estado
de Sao Paolo - SABESP.................................. Brazil SBS NYSE December 31 2010 BRL
Compañia Cervecerı́as Unidas S.A..................... Chile CCU NYSE December 31 2010 CLP
Copa Holdings, S.A.............................................. Panama CPA NYSE December 31 2010 USD
Credicorp Ltd........................................................ Bermuda BAP NYSE December 31 2010 USD
CRH Public Limited Company............................. Ireland CRH NYSE December 31 2010 EUR
CSR plc................................................................ United Kingdom CSR LSE December 31(4) 2010 USD
Daimler AG........................................................... Germany DAI DAX December 31 2010 EUR
Delhaize Brothers and Co “The Lion” (Delhaize
Group) SA......................................................... Belgium DEG NYSE December 31 2010 EUR
Deutsche Bank Aktiengesellschaft...................... Germany DBK NYSE December 31 2010 EUR
Deutsche Telekom AG......................................... Germany DT NYSE December 31 2010 EUR
DHT Holdings, Inc................................................ Marshall Islands DHT NYSE December 31 2010 USD
Diageo plc............................................................ United Kingdom DGE LSE June 30 2010 DKK
Diploma Group Limited........................................ Australia DGX ASX June 30 2010 AUD
East Asiatic Company Ltd. A/S ........................... Denmark EAC NASDAQ December 31 2010 GBP
Eastern Platinum Limited..................................... Canada ELR.TO TSX December 31 2010 USD
Elbit Imaging Ltd.................................................. Israel EMIT NASDAQ December 31 2010 ILS
Embotelladora Andina S.A. ................................. Chile AKO.A NYSE December 31 2010 CLP
Empresa Nacional de Electricidad
S.A.(Endesa-Chile)........................................... Chile EOC NYSE December 31 2010 CLP
Enersis S.A. ......................................................... Chile ENI NYSE December 31 2010 CHP
Eni S.p.A.............................................................. Italy E NYSE December 31 2010 EUR
Flughafen Zürich AG............................................ Switzerland FHZN SIX December 31 2010 CHF
France Telecom................................................... France FTE NYSE December 31 2010 EUR
Galenica Ltd......................................................... Switzerland GALN SIX December 31 2010 CHF
Gerdau S.A. ......................................................... Brazil GGB NYSE December 31 2010 BRL
Givaudan SA........................................................ Switzerland GIVN SIX 2010 CHF
GlaxoSmithKline plc............................................. United Kingdom GSK NYSE December 31 2010 GBP
Gol Linhas Aéreas Inteligentes S.A..................... Brazil GOL BVMF December 31 2010 BRL
GrainCorp Limited................................................ Australia GNC ASX September 30 2010 CHF
Guangshen Railway Company Limited............... China GSH NYSE December 31 2010 CNY
Harmony Gold Mining Company Limited ............ Canada HMY NASDAQ June 30 2010 USD
Heatherdale Resources Ltd................................. Canada HTR TSX-V October 31 2010 USD
Helical Bar plc...................................................... United Kingdom HLCL LSE March 31 2010 GBP
HGL Limited......................................................... Australia HNG ASX September 30 2010 AUD
Hikma Pharmaceuticals PLC............................... United Kingdom HIK LSE December 31 2010 USD
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Exchange(1) Fiscal Year End
Presentation
Currency(2)
HSBC Holdings plc............................................ United Kingdom HBC NYSE December 31 2010 USD
Huaneng Power International, Inc..................... China HNP NYSE December 31 2010 CNY
InterContinental Hotels Group plc..................... United Kingdom IHG NYSE December 31 2010 USD
JSC BTA Bank................................................... Kazakhstan BTAS KASE December 31 2010 KZT
JSC Halyk Bank................................................. Kazakhstan HSBK KASE December 31 2010 KZT
Julius Baer Group Ltd........................................ Switzerland BAER SIX December 31 2010 CHF
Koninklijke Philips Electronics NV..................... The Netherlands PHG NYSE December 31 2010 EUR
Lan Airlines S.A................................................. Chile LFL NYSE December 31 2010 USD
Luxottica Group S.p.A....................................... Italy LUX NYSE December 31 2010 EUR
Magyar Telekom plc.......................................... Hungary MTA NYSE December 31 2010 HUF
Millicom International Cellular S.A.................... Luxembourg MICC NYSE December 31 2010 USD
Mondi Limited and Mondi plc(3) ......................... South Africa and
United Kingdom,
respectively MNDI LSE December 31 2010 EUR
N Brown Group plc............................................ United Kingdom BWNG LSE February 27(4) 2010 GBP
National Grid plc................................................ United Kingdom NGG NYSE March 31 2010 GBP
National Westminster Bank Plc......................... United Kingdom NW.C NYSE December 31 2010 GBP
Nestlé SA........................................................... Switzerland NESN SIX December 31 2010 CHF
Newcrest Mining Limited................................... Australia NCM ASX June 30 2010 AUD
Nobel Biocare Holding AG................................ Switzerland NOBN SIX December 31 2010 EUR
Nokia Corporation.............................................. Finland NOK NYSE December 31 2010 EUR
Nortel Inversora S.A.......................................... Argentina NTL NYSE December 31 2010 ARS
Northern Dynasty Minerals Ltd ......................... Canada NDM TSX-V December 31 2010 CAD
Novartis AG....................................................... Switzerland NVS NYSE December 31 2010 USD
Novo Nordisk A/S.............................................. Denmark NVO NYSE December 31 2010 DKK
OAO Gazprom................................................... Russia OGZPY NASDAQ December 31 2010 RUB
Panalpina World Transport (Holding) Ltd......... Switzerland PWTN SIX December 31 2010 CHF
Pargesa Holding AG.......................................... Switzerland PARG SIX December 31 2010 CHF
Partner Communications Company Ltd............ Israel PTNR NASDAQ December 31 2010 ILS
Pearson plc........................................................ United Kingdom PSO NYSE December 31 2010 GBP
Philippine Long Distance Telephone Company Philippines PHI NYSE December 31 2010 PHP
Portugal Telecom, SGPS, S.A.......................... Portugal PT NYSE December 31 2010 EUR
Prudential plc..................................................... United Kingdom PUK NYSE December 31 2010 GBP
PSP Swiss Property Ltd.................................... Switzerland PSPN SIX December 31 2010 CHF
Randgold Resources Limited............................ United Kingdom GOLD NASDAQ December 31 2010 USD
REA Vipingo Plantations Limited...................... Kenya RPVL NSE September 30 2010 KES
Reckitt Benckiser Group plc.............................. United Kingdom RB LSE December 31 2010 GBP
Reed Elsevier NV and Reed Elsevier PLC(3).... The Netherlands and
United Kingdom,
respectively ENL NYSE December 31 2010 GBP
Repsol YPF, S.A. .............................................. Spain REP NYSE December 31 2010 EUR
Rio Tinto Limited and Rio Tinto plc(3) ................ Australia and United
Kingdom, respectively RTP NYSE December 31 2010 USD
Roche Holding Ltd............................................. Switzerland ROG SIX December 31 2010 CHF
The Royal Bank of Scotland Group plc............. United Kingdom RBS NYSE December 31 2010 GBP
Royal Dutch Shell plc........................................ United Kingdom RDSB NYSE December 31 2010 USD
Ryanair Holdings plc ......................................... Ireland RYAAY NASDAQ March 31 2010 EUR
sanofi-aventis .................................................... France SNY NYSE December 31 2010 EUR
SAP AG............................................................. Germany SAP NYSE December 31 2010 EUR
Sappi Limited..................................................... South Africa SPP NYSE September 30 2010 USD
Sasini Limited.................................................... Kenya SNSI NSE September 30 2010 KES
Sasol Limited..................................................... South Africa SSL NYSE June 30 2010 ZAR(5)
Seven Arts Pictures Plc..................................... United Kingdom SAPX NASDAQ June 30 2010 USD
Siemens Aktiengesellschaft.............................. Germany SI NYSE September 30 2010 EUR
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Exchange(1) Fiscal Year End
Presentation
Currency(2)
Sims Metal Management Limited........................ Australia SMS NYSE June 30 2010 AUD
Smith & Nephew plc............................................. United Kingdom SNN NYSE December 31 2010 USD
SouthGobi Resources Ltd. .................................. Canada SGQ TSX-V December 31 2010 USD
Stagecoach Group plc......................................... United Kingdom SGC NYSE April 30 2010 GBP
Sterlite Industries (India) Limited......................... India SLT NYSE March 31 2010 INR
Straumann Holding AG........................................ Switzerland STMN SIX December 31 2010 CHF
Subsea 7 S.A. (formerly, Acergy S.A.)................ Luxembourg ACGY NASDAQ November 30 2010 USD
Swiss Life Holding Ltd ......................................... Switzerland SLHN SIX December 31 2010 CHF
Swisscom Ltd....................................................... Switzerland SCMN SIX December 31 2010 CHF
Syngenta AG........................................................ Switzerland SYT NYSE December 31 2010 USD
TAM S.A............................................................... Brazil TAM NYSE December 31 2010 BRL
Taylor Wimpey plc ............................................... United Kingdom TW LSE December 31 2010 GBP
Technicolor SA..................................................... France TCLRY Euronext December 31 2010 EUR
Telecom Corporation of New Zealand Limited.... New Zealand NZT NYSE June 30 2010 NZD
Telecom Italia S.p.A............................................. Italy TI NYSE December 31 2010 EUR
Telefónica S.A...................................................... Spain TEF NYSE December 31 2010 EUR
Tenaris S.A. ......................................................... Luxembourg TS NYSE December 31 2010 USD
Ternium S.A......................................................... Luxembourg TX NYSE December 31 2010 USD
Thomson Reuters Corporation............................ Canada TRI NYSE December 31 2010 USD
TOTAL S.A........................................................... France TOT NYSE December 31 2010 EUR
Tourism Holdings Limited.................................... New Zealand THL NZX June 30 2010 NZD
Travis Perkins plc................................................. United Kingdom TPK LSE December 31 2010 GBP
Trencor Limited.................................................... South Africa TRE JSE December 31 2010 ZAR
Trinity Biotech plc................................................. Ireland TRIB NASDAQ December 31 2010 USD
Turkcell Iletisim Hizmetleri AS............................. Turkey TKC NYSE December 31 2010 USD
U308 Corp............................................................ Canada UWE TSX-V December 31 2010 CAD
UBS AG................................................................ Switzerland UBS NYSE December 31 2010 CHF
Ultra Electronics Holdings plc.............................. United Kingdom ULE LSE December 31 2010 GBP
Unilever N.V. and Unilever plc(3) ......................... The Netherlands and
United Kingdom,
respectively UN/UL NYSE December 31 2010 EUR
Veolia Environnement.......................................... France VE NYSE December 31 2010 EUR
Vina Concha y Toro S.A...................................... Chile VCO NYSE December 31 2010 CLP
Vodafone Group plc............................................. United Kingdom VOD NASDAQ March 31 2010 GBP
WPP plc ............................................................... United Kingdom WPPGY NASDAQ December 31 2010 GBP
Yanzhou Coal Mining Company Limited............. China YZC NYSE December 31 2010 CNY
(1) All but one (1) of the survey entities are listed on stock exchanges. Silver Fern Farms is a cooperative owned by livestock producers. For
ease of use, this table uses a code to identify a stock exchange that is either the acronym used by that particular exchange on its website
or the common acronym in the International Standards Organization (ISO) market identifier code list. The name of the stock exchange
corresponding to the code in this table and the unique market identifier code assigned by the ISP is shown in Table 1-4.








CNY: Chinese Yuan Renminbi
(may also be denoted as RMB)
DKK: Danish Krone
EUR: Euro
GBP: British Pound Sterling
HKD: Hong Kong Dollar
HUF: Hungarian Forint
ILS: New Israeli Sheqel (or Shekel)




NZD: New Zealand Dollar
RUB: Russian Ruble
USD: US Dollar
ZAR: South African Rand
ZWL: Zimbabwe Dollar
(3) These entities are dual listed. A dual listed entity is a corporate structure in which two listed entities, each with its own shareholders, share
one set of assets and liabilities, results of operations, management and other governance structure. The risks and rewards are shared in
proportions laid out in an equalization agreement. These entities issued one set of financial statements applicable to shareholders of both
listed entities. See Table 1-5 below.
(4) 52- or 53-week annual fiscal period.
(5) These survey entities provide convenience translations of their financial statements into U.S. dollars.
IFRS ATT
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TABLE 1-2: CLASSIFICATION OF SURVEY ENTITIES BY
INDUSTRY(1)
Industry 2010 2009 2008
Aerospace & Defense......................................... 1 1 3
Agriculture........................................................... 5 3 0
Airline.................................................................. 7 6 3
Apparel & Accessories....................................... 1 0 0
Automotive.......................................................... 1 1 1
Banking............................................................... 13 13 6
Beverage............................................................. 6 4 2
Broadcasting & Cable TV................................... 1 1 1
Building Products................................................ 3 3 2
Business Services.............................................. 1 2 2
Candy.................................................................. 2 2 0
Chemicals........................................................... 4 6 2
Construction........................................................ 2 1 1
Consumer Electronics........................................ 2 2 1
Entertainment ..................................................... 1 1 0
Food.................................................................... 3 3 2
Forest Products.................................................. 0 1 1
Holding Company............................................... 1 2 0
Household Cleaners........................................... 0 1 1
Industrial Machinery ........................................... 6 4 2
Insurance............................................................ 5 5 5
Medical Devices & Diagnostics.......................... 4 5 2
Metals ................................................................. 5 4 2
Mining ................................................................. 17 15 8
Oil & Gas............................................................. 9 10 6
Online Services................................................... 1 1 1
Paper & Packaging............................................. 1 1 1
Pharmaceuticals................................................. 9 9 7
Portable Computers............................................ 1 1 1
Printing & Publishing .......................................... 3 3 2
Professional & Management Services............... 0 1 0
Railways.............................................................. 0 1 1
Real Estate......................................................... 5 4 2
Retailing – Non-Food.......................................... 2 2 1
Securities............................................................ 4 2 1
Semiconductors.................................................. 1 2 2
Software.............................................................. 2 2 1
Supermarkets ..................................................... 0 1 1
Telecom Equipment............................................ 1 2 2
Telecommunications........................................... 20 18 17
Transportation..................................................... 9 7 32
Travel & Leisure.................................................. 4 2 2
Utilities ................................................................ 7 4 3
Total ................................................................... 170 160 100
(1) The industry classification of the survey entities is determined
by the author based on a number of considerations, includ-
ing a review of the entities’ annual reports, regulatory filings
and company profiles available on www.alacrastore.com and
www.corporateinformation.com. AlacraStore.com is a service of
Alacra, Inc., a leading global provider of business and finan-
cial information and proprietary solutions that enable clients to
quickly find, analyze, package and present mission-critical busi-
ness information. CorporateInformation.com is a premier provider
of value-added corporate and industry information for competi-
tive analysis and research, and is a service of Wright Investors’
Service. Certain reclassifications have been made to the prior
year’s data for comparison purposes.
TABLE 1-3: SURVEY ENTITIES’ COUNTRY OF
INCORPORATION
2010 2009 2008
Bermuda............................................................. 3 1 0
Canada............................................................... 12 8 0
Cayman Islands(1) ............................................... 0 1 1
Commonwealth of Australia (Australia).............. 6 6 3
Federal Republic of Germany............................ 6 6 6
Federative Republic of Brazil ............................. 5 4 0
French Republic (France)................................... 8 8 8
Grand-Duchy of Luxembourg (Luxembourg)..... 6 5 4
Hong Kong, China.............................................. 3 2 1
Independent State of Papua New Guinea
(Papua New Guinea)....................................... 1 1 1
Italian Republic (Italy)......................................... 3 2 1
Kingdom of Belgium (Belgium)........................... 1 1 1
Kingdom of Denmark (Denmark) ....................... 3 2 2
Kingdom of Spain (Spain) .................................. 2 2 2
New Zealand....................................................... 3 3 1
Portuguese Republic (Portugal)......................... 1 1 1
Republic of Argentina......................................... 1 0 0
Republic of Chile................................................. 6 2 0
Republic of Finland (Finland) ............................. 1 1 1
Republic of Hungary (Hungary).......................... 1 1 1
Republic of India (India)...................................... 1 0 0
Republic of Ireland (Ireland)............................... 4 4 3
Republic of Kazakhstan (Kazakhstan)............... 3 2 0
Republic of Kenya (Kenya)................................. 3 1 0
Republic of South Africa (South Africa) ............. 6 9 3
Republic of the Marshall Islands........................ 1 1 0
Republic of Panama (Panama).......................... 1 0 0
Republic of the Philippines................................. 1 0 0
Republic of Turkey (Turkey)............................... 1 1 1
Republic of Zimbabwe........................................ 0 1 0
Romania.............................................................. 0 1 0
Russian Federation (Russia).............................. 1 1 1
State of Israel (Israel)......................................... 3 4 1
Swiss Confederation (Switzerland).................... 21 23 3
The Netherlands................................................. 2 3 6
The People’s Republic of China (China)............ 7 6 2
United Arab Emirates......................................... 3 2 0
United Kingdom of Great Britain and Northern
Ireland.............................................................. 36 39 42
Dual Listed Companies(2) ................................... 5 5 4
Total ................................................................... 170 160 100
(1) Cayman Islands is a non-self governing British overseas territory.
(2) The five (5) dual listed entities listings are as follows:
1. United Kingdom and Australia: BHP Billiton plc and BHP
Billiton Limited
2. United Kingdom and South Africa: Mondi plc and Mondi
Limited
3. United Kingdom and The Netherlands: Reed Elsevier plc and
Reed Elsevier N.V.
4. United Kingdom and Australia: Rio Tinto plc and Rio Tinto
Limited
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TABLE 1-4: STOCK EXCHANGES ON WHICH SURVEY ENTITIES WERE LISTED AS OF DECEMBER 31, 2010
Exchange
ISO Market
Identifier Code Country 2010 2009 2008
Abu Dhabi Securities Market (ADX)......................................................................... XASE United Arab Emirates 3 2 0
Australian Securities Exchange (ASX)..................................................................... XASX Australia 5 4 1
BM&FBOVESPA S.A. - Bolsa De Valores, Mercadorias E Futuros (BVMF).......... BVMF Brazil 1 1 0
NYSE Euronext – Euronext: Paris, Paris................................................................. XPAR France 1 1 0
Frankfurt Stock Exchange (DAX)............................................................................. XFRA Germany 2 0 0
JSE Securities Exchange Limited (JSE).................................................................. XJSE South Africa 4 6 0
Kazakhstan Stock Exchange (KASE)...................................................................... XKAZ Kazakhstan 2 2 0
London Stock Exchange (LSE)................................................................................ XLON United Kingdom 20 19 23
Nairobi Stock Exchange (NSE)................................................................................ XNAI Kenya 3 1 0
NASDAQ Stock Market (NASDAQ)......................................................................... XNMS United States 16 15 9
New York Stock Exchange (NYSE) ......................................................................... XNYS United States 84 78 67
New Zealand Exchange Limited (NZX).................................................................... XNZE New Zealand 1 1 0
SIX Swiss Exchange (SIX)....................................................................................... XVTX Switzerland 18 20 0
Toronto Stock Exchange (TSX)................................................................................ XTSE Canada 5 4 0
TSX Venture Exchange (TSX-V).............................................................................. XTSX Canada 4 3 0
Zimbabwe Stock Exchange (ZSE)........................................................................... XZIM Zimbabwe 0 1 0
Unlisted (See Table 1-1)........................................................................................... 1 2 0
Total.......................................................................................................................... 170 160 100
TABLE 1-5: SURVEY ENTITIES’ MONTH OF FISCAL
YEAR END
2010 2009 2008
January............................................................... 1 1 1
February.............................................................. 0 0 0
March.................................................................. 8 9 6
April..................................................................... 2 1 1
May..................................................................... 1 2 1
June.................................................................... 11 9 5
July...................................................................... 1 1 0
August................................................................. 4 5 0
September.......................................................... 5 3 2
October............................................................... 0 0 0
November........................................................... 1 1 0
December........................................................... 133 124 79
52–53 week annual fiscal period........................ 3 4 5
Total ................................................................... 170 160 100
TABLE 1-6: SURVEY ENTITIES’ AUDIT FIRMS
2010 2009 2008
KPMG................................................................. 37 37 16
Deloitte................................................................ 44 40 29
Ernst & Young..................................................... 27 20 14
PricewaterhouseCoopers................................... 44 44 27
Grant Thornton................................................... 3 3 3
BDO.................................................................... 1 1 0
Audited by two audit firms.................................. 8 11 9
Other audit firms................................................. 6 4 2
Total ................................................................... 170 160 100
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THE CONCEPTUAL FRAMEWORK
FOR FINANCIAL REPORTING
IAS 1, PRESENTATION OF FINANCIAL
STATEMENTS




The International Accounting Standards Board (IASB)
is currently in the process of updating its conceptual
framework in stages. As a chapter is finalized, revised
paragraphs will replace the relevant paragraphs in the
Framework for the Preparation and Presentation of
Financial Statements (1989). In September 2010, the
IASB issued The Conceptual Framework for Finan-
cial Reporting (IFRS Conceptual Framework), which
includes the first two chapters published as a result of
phase 1 of this project:
• Chapter 1 The Objective of Financial Reporting
• Chapter 3 Qualitative Characteristics of Useful
Financial Information
Chapter 2, which is not included the document pub-
lished in 2010, will address the reporting entity con-
cept and the IASB published an exposure draft on this
topic in March 2010 with a comment period ending July
2010. Chapter 4 contains the remaining text of the old
Framework (1989). However, references to the Frame-
work (1989) in individual standards have not been re-
vised except that footnotes are provided in individual
standards identifying changes. For example, paragraph
25 in IAS 8 was superseded by Chapter 3 of the IFRS
Conceptual Framework.
IFRSs Overview and Comparison
to U.S. GAAP
1.01 In September 2010, the IASB issued the IFRS Con-
ceptual Framework, which supersedes the Framework for the
Preparation and Presentation of Financial Statements. The
IFRS Conceptual Framework establishes the concepts that
underlie the preparation and presentation of financial state-
ments for external users. Together with the IFRS Concep-
tual Framework, International Accounting Standard (IAS) 1,
Presentation of Financial Statements, and IAS 8, Account-
ing Policies, Changes in Accounting Estimates and Errors,
describe the guidance of International Financial Reporting
Standards (IFRSs) with respect to the necessary characteris-
tics and elements of financial statements; definitions of as-
sets, liabilities, equity, revenue and income; expenses; and
the general criteria for their recognition.
1.02 The IFRS Conceptual Framework establishes the fol-
lowing objective of general purpose financial reporting in
accordance with IFRSs:
To provide financial information about the reporting
entity that is useful to existing and potential investors,
lenders, and other creditors (financial statement users)
in making decisions about providing resources to the
entity.
1.03 In making these decisions, such users need information
to help them assess the entity’s prospects for net cash inflows.
This information includes information about the entity’s re-
sources, claims against the entity, and how efficiently and
effectively the entity’s management and governing board of
the entity have discharged their responsibilities to use the en-
tity’s resources. The IFRS Conceptual Framework explains
that general purpose financial statements are not designed
to show the value of the entity, but to provide information
that permits financial statement users to estimate the value
of the entity. However, financial statement users would be
expected to incorporate information from other sources into
this process. Other parties, such as regulators and the general
public, may find general purpose financial statements use-
ful, but such statements are not primarily directed to these
parties. The IFRS Conceptual Framework identifies the fol-
lowing types of information as providing useful information
for decisions about providing resources to the entity:
• Economic resources and claims to help assess the en-
tity’s financial strengths and weaknesses
• Changes in economic resources and claims to help dis-
tinguish changes resulting from financial performance
and those from other transactions and events
• Financial performance reflected by accrual accounting
to provide a better basis for assessing an entity’s past
and future performance than only information about
cash receipts and payments during the period
• Financial performance reflected by past cash flows to
help assess the entity’s ability to generate future net cash
inflows
• Changes in economic resources and claims not resulting
from financial performance to help in understanding the
reasons for the change and implications for the entity’s
future financial performance
1.04 The IFRS Conceptual Framework distinguishes be-
tween fundamental and enhancing qualitative characteristics:
• The fundamental qualitative characteristics of useful fi-
nancial information are relevance and faithful represen-
tation. Information must have both characteristics to be
useful:
— Relevance. Relevant financial information is capa-
ble of making a difference in users’ decisions. This
capability is not dependent on whether users make
use of the information or whether they were aware of
the information from other sources. To make a differ-
ence in decisions, information should have predictive
value, confirmatory value, or both. Financial infor-
mation has predictive value if it can be used to pre-
dict future outcomes and has confirmatory value if
it provides feedback about previous evaluation. The
IFRS Conceptual Framework considers materiality
to be a component of relevance and is defined as in-
fluencing decisions about a specific reporting entity
if omitted or misstated. Therefore, an entity assesses
materiality based on the nature of the information,
IFRS ATT 1.04
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its magnitude, or both, in the context of the entity’s
financial report.
— Faithful representation. Useful financial information
not only represents relevant phenomena, but also
faithfully represents the phenomena it purports to
represent. A perfectly faithful representation would
be complete, neutral, and free from error. Although
the IFRS Conceptual Framework recognizes that per-
fection is rarely achieved, the objective is that an
entity should maximize these qualities to the extent
possible.
• The enhancing qualitative characteristics are compara-
bility, verifiability, timeliness, and understandability:
— Comparability helps users to identify and understand
similarities and differences among items. Consis-
tency in the use of the same methods for the same
items, either in the same period entities or across pe-
riods for a single entity, although related to compa-
rability, is not the same. Consistency helps an entity
to provide comparable information.
— Verifiability helps users assess whether information
faithfully represents the economic phenomena it pur-
ports to represent. Verification can be direct (for ex-
ample, through observation) or indirect (for example,
checking inputs to a model). Disclosures that allow
verification include underlying assumptions, meth-
ods of compiling information, and other factors and
circumstances that support the information.
— Timeliness means that the information is available in
time to be capable of influencing users’ decisions.
Some information may continue to be timely after
the end of a reporting period (for example, when it
helps identify trends).
— Understandability means that information is classi-
fied, characterized, and presented clearly and con-
cisely. Although some economic phenomena may
be complex and inherently difficult to understand,
omitting information about these phenomena would
make the financial report incomplete and, therefore,
potentially misleading.
1.05 In discussing these characteristics, however, the IFRS
Conceptual Framework recognizes a cost constraint on useful
financial reporting. Therefore, in seeking information about
whether the benefits of reporting particular information jus-
tify the costs incurred in providing and using it, the IASB
considers costs and benefits generally and not just in relation
to individual reporting entities.
1.06 The IFRS Conceptual Framework presumes that when
an entity applies the aforementioned qualitative characteris-
tics and the appropriate IFRSs, an entity’s financial state-
ments will convey a fair presentation, or true and fair view,
of its financial position and performance. Therefore, although
the IFRS Conceptual Framework is not an accounting stan-
dard and does not create recognition, measurement, or disclo-
sure requirements or override the requirements of any stan-
dard, an entity cannot ignore it. IAS 8 requires entities to
consider the IFRS Conceptual Framework when evaluating
an accounting issue not specifically addressed in IFRSs.
Author’s Note




1.07 The IFRS Conceptual Framework defines the elements
of financial position: assets, liabilities, and equity. An asset
is a resource controlled by the entity as a result of past events
from which future economic benefits are expected to flow
to the entity. A liability is a present obligation as a result of
past events, the settlement of which is expected to result in
an outflow from the entity of resources embodying economic
benefits. Equity is the residual interest in the assets of the
entity after deducting all liabilities (net assets).
1.08 The IFRS Conceptual Framework defines the elements
of performance: income and expenses. Income is increases in
economic benefits during the accounting period in the form of
inflows or enhancements of assets or decreases in liabilities
that result in increases in equity, other than those related to
contributions by equity participants. Expenses are decreases
in economic benefits during the accounting period in the form
of outflows or depletion of assets or incurrence of liabilities
that result in decreases in equity, other than those related to
distributions to equity participants. An entity should only use
the term revenue to refer to income from ordinary business
activities. An entity may use the terms income and expense to
refer to elements from both ordinary business activities and
other activities of the entity.
1.09 The IFRS Conceptual Framework also describes gen-
eral recognition criteria, which is frequently reiterated in
IFRSs, that prescribe the accounting for particular financial
statement elements. An entity should recognize an element
of the financial statements if the following two criteria are
met:
• It is probable (that is, more likely than not) that any
future economic benefit associated with the element will
flow to or from the entity (probability criteria).
• The cost or value of the item can be measured reliably
(measurement reliability criteria).
Even if an element fails the recognition criteria, an entity
may still need to disclose information about the element in
the notes.
1.10 IAS 1 establishes the basis for presentation by an entity
of general purpose financial statements to ensure compara-
bility with those of other entities and with its own statements
from period to period. IAS 1 requires an entity to include
the following statements and supplemental information in a
complete set of financial statements:
• Statement of financial position
• Statement of comprehensive income
• Statement of cash flows
• Statement of changes in equity
• Note disclosures
1.11 IAS 1 establishes acceptable formats for the financial
statements and their minimum content and line items, the
details of which are included among the various sections
herein. IAS 1 also requires that each financial statement be
presented with the same prominence in a complete set of
financial statements.
1.12 An entity should make an explicit, unreserved state-
ment of compliance with IFRSs. However, IAS 1 provides
that in extremely rare circumstances, an entity can rebut the
IFRS ATT 1.05
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presumption that compliance with every IFRS results in a fair
presentation and can deviate from an IFRS requirement only
when compliance would be so misleading that it would con-
flict with the objectives of financial statements in the IFRS
Conceptual Framework. In these circumstances only, an en-
tity should deviate from an IFRS requirement, unless prohib-
ited by its regulatory authority. This deviation is generally
referred to as the true and fair view override.
1.13 IAS 1 also requires management to assess whether the
entity is a going concern, to prepare its financial statements on
that basis, and to use the accrual basis of accounting, except
for cash flow information.
1.14 IAS 8 establishes the criteria for selecting and chang-
ing an accounting policy and the treatment and disclosure of
changes in policy (whether voluntary or mandatory), changes
in accounting estimates, and corrections of errors in the fi-
nancial statements of prior periods.
1.15 Among other definitions, IAS 8 includes the following:
Accounting policy. A specific principle, basis, convention,
rule, or practice that an entity applies in its financial
statements.
Change in accounting estimate. An adjustment of the car-
rying amount of an asset or liability or the amount of
the periodic consumption of an asset that results from
a current assessment about the present status or future
economic benefits of an asset. Because this change re-
sults from new information, it is not an error.
Prior period errors. Omissions or misstatements in the
entity’s financial statements in one or more prior peri-
ods from misuse or failure to use reliable information
that either was available or the entity could reasonably
have been expected to obtain and taken into account in
preparing the financial statements.
Material. Omissions or misstatements of items are mate-
rial if they could, individually or collectively, influence
the economic decisions that users make on the basis of
financial statements. An entity should judge materiality
based on the nature and size of the omission or mis-
statement and surrounding circumstances, either alone
or in combination.
Impracticable. When the entity cannot apply a require-
ment of a standard or interpretation even after mak-
ing every reasonable attempt to do so. IAS 8 provides
additional specific guidance for entities in determin-
ing whether retrospective application of a change in
accounting policy is impracticable.
1.16 IAS 8 requires an entity to determine its accounting
policy for a particular issue by applying all relevant IFRSs.
In the absence of a relevant IFRS, an entity should use its
judgment to develop and use an accounting policy that pro-
vides relevant and reliable information, as defined by the
qualitative characteristics described in the IFRS Conceptual
Framework. In making the judgment previously described,
IAS 1 requires an entity to refer to and consider the follow-
ing sources of guidance in IAS 8 in descending order:
• Requirements in IFRSs dealing with similar and related
issues
• The definitions, recognition criteria, and measurement
concepts for assets, income, and expenses in the IFRS
Conceptual Framework
An entity may also consider the most recent pronouncements
of other standard setters that have a similar conceptual frame-
work, other accounting literature, and accepted industry prac-
tices, but only to the extent that these do not conflict with
either IFRSs or the IFRS Conceptual Framework.
Author’s Note
The requirement previously described is generally re-
ferred to as the IFRS hierarchy.
1.17 IAS 8 requires an entity to apply accounting policies
consistently to similar events and circumstances unless a spe-
cific IFRS requires or permits categorization of items for
which different policies would be appropriate. In the latter
case, an entity should apply an accounting policy consistently
to each category. IAS 8 permits an entity that is not adopting
IFRSs for the first time to change its accounting policy only
in one of the following two circumstances:
• IFRSs require a change in policy.
• The new policy provides reliable and more relevant
information.
1.18 IAS 8 does not consider an entity’s application of a
different policy to be a change in accounting policy when
the new policy is applied to transactions or events that are
substantively different from those occurring before, that did
not occur before, or that are immaterial.
1.19 When permitted or required to change an accounting
policy, an entity should apply the new policy retrospectively
or in accordance with any applicable transitional provisions
of an IFRS, except to the extent that it is impracticable to
determine the period-specific or cumulative effects of the
change. Retrospective application requires the entity to re-
state its financial statements as if it had always applied the new
policy. In addition to restating the relevant assets or liabilities,
the entity should adjust the opening balance of each affected
component of equity for the earliest period presented. When
retrospective application is impracticable for period-specific
effects, the entity should apply the new policy retrospectively
to the earliest period practicable. When retrospective appli-
cation is impracticable for the cumulative effect, the entity
should apply the new policy prospectively from the earliest
period practicable.
1.20 Except to the extent that a change in accounting es-
timate affects the carrying amounts of assets or liabilities,
IAS 8 requires an entity to recognize a change in estimate
prospectively by recognizing it in profit or loss in the period
of change or future periods, to the extent the change relates to
those periods respectively. When the change affects the car-
rying amount of an asset or liability, the entity should adjust
the carrying amount in the period of change. For example,
when an entity determines there is a change in the expected
pattern of consumption of future benefits over an asset’s use-
ful life, it should change its depreciation method to reflect
that pattern and treat the change as a change in accounting
estimate. An entity will recognize the effects of this change
in the amount of depreciation expense recognized both in the
current period and in future periods.
1.21 IAS 8 considers a change in measurement basis to be
a change in accounting policy, not a change in accounting
estimate. However, IAS 8 requires an entity that initially ap-
plies a policy of revaluation to applicable assets, either in
accordance with IAS 16, Property, Plant and Equipment, or
IAS 38, Intangible Assets, to treat the change from cost to
revalued amount as a revaluation in accordance with those
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standards. When it is difficult to distinguish a change in pol-
icy from a change in estimate, an entity should account for
the change as a change in estimate.
1.22 With respect to prior period errors, an entity should cor-
rect any material errors by retrospective restatement, unless
impracticable, in the first set of financial statements autho-
rized for issue after it detects the error by restating
• the comparative amounts for the prior periods affected,
when the error occurred during the period covered by
the statements or
• the opening affected balance sheet line items of the ear-
liest period presented, when the error occurred prior to
the period covered by the statements.
1.23 Retrospective restatement corrects the amounts of fi-
nancial statement elements as if the error had not occurred.
Similar to the impracticability exception for retrospective ap-
plication, an impracticability exception can apply to an en-
tity’s ability to determine both period-specific and cumula-
tive effects. When retrospective restatement is impracticable
for period-specific effects, the entity should retrospectively
restate in the earliest period for which restatement is practica-
ble. For a cumulative effect, the entity should restate prospec-
tively from the earliest possible date.
U.S. GAAP
1.24 Financial Accounting Standards Board (FASB) Ac-
counting Standards Codification (ASC) 105-10-05 explains
that if the necessary guidance for a transaction or event is
not specified within a source of authoritative U.S. generally
accepted accounting principles (GAAP), an entity should
first consider accounting principles for similar transactions
or events within a source of authoritative U.S. GAAP for
that entity and then consider nonauthoritative guidance from
other sources. When those accounting principles either pro-
hibit the application of the accounting treatment to the par-
ticular transaction or event or indicate that the accounting
treatment should not be applied by analogy, an entity should
not follow those accounting principles. Unlike IFRSs, the
concept statements are not considered authoritative sources
of U.S. GAAP, and FASB ASC does not give preference to
the concept statements over other nonauthoritative sources.
FASB ASC does not state that consistency with the concept
statements in connection with an entity’s application of an
accounting treatment is necessary. The following items are
examples of sources of nonauthoritative accounting and fi-
nancial reporting practices identified in FASB ASC:
• Practices that are widely recognized and prevalent either
generally or in the industry
• FASB Concepts Statements
• AICPA issues papers
• IFRSs
• Pronouncements of professional associations or regula-
tory agencies
• Technical Information Service Inquiries and Replies in-
cluded in AICPA Technical Practice Aids
• Accounting textbooks, handbooks, and articles (such as
IFRS Accounting Trends & Techniques).
Author’s Note
The AICPA Code of Professional Conduct and Bylaws
has been revised to recognize the IASB in London as
an accounting body for purposes of establishing IFRSs,
thus granting AICPA members the option to use IFRSs,
including International Financial Reporting Standard
for Small and Medium-sized Entities (IFRS for SMEs),
as an alternative to FASB ASC, as applicable. As de-
fined in the standard, SMEs are entities that do not have
public accountability and publish general purpose fi-
nancial statements for external users. Therefore, IFRS
for SMEs is not applicable to Securities and Exchange
Commission (SEC) registrants.
1.25 As discussed in FASB ASC 105-10-05-1, unlike
IFRSs, U.S. GAAP, as codified in FASB ASC, includes the
rules and interpretive releases of the SEC as sources of au-
thoritative GAAP as a convenience to SEC registrants. In
addition to SEC rules and interpretive releases, the SEC staff
issues Staff Accounting Bulletins that represent practices that
the staff follows when administering SEC disclosure require-
ments. SEC staff announcements and observer comments
made at meetings of the Emerging Issues Task Force pub-
licly announce the staff’s views on certain accounting issues
for SEC registrants.
Author’s Note
SEC rules and interpretative releases may expand,
modify, or decrease accounting and disclosure require-
ments for foreign private issuers, regardless of whether
they file their annual financial statements with the SEC
in Form 10-K, Form 20-F, or Form 40-F (Canadian is-
suers). Therefore, it is critical to consider SEC require-
ments, as well as those of FASB ASC, when reviewing
the financial statements of SEC registrants. A general
reference to FASB ASC in this publication does not in-
clude the SEC materials. When requirements are taken
from an SEC rule or regulation, that rule or regula-
tion will be cited directly. A reference to U.S. GAAP
should be read to include both FASB ASC and SEC
requirements.
1.26 Like IFRSs, FASB ASC 250-10-45-1 includes the pre-
sumption that, once adopted, an entity should not change an
accounting principle (policy) to account for events and trans-
actions of a similar type. Like IFRSs, FASB ASC 250-10-
45-2 permits an entity to change an accounting principle in
certain circumstances, such as when required to do so by
new authoritative accounting guidance that mandates the use
of a new accounting principle, interprets an existing princi-
ple, expresses a preference for an accounting principle, or
rejects a specific principle. Similar to IFRSs, this paragraph
also permits an entity to change an accounting principle if
it can justify the use of an allowable alternative accounting
principle on the basis that it is preferable. However, unlike
IFRSs, FASB ASC does not define a preferable policy and,
therefore, does not constrain the choice to one that is more
relevant to the users of the financial statements.
1.27 Like IFRSs, FASB ASC 250-10-45-1 does not consider
the following to be changes in accounting principle:
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• Initial adoption of an accounting principle for new
events or transactions that previously were immaterial
in their effect
• Adoption or modification of an accounting principle for
substantively different transactions or events from those
occurring previously
1.28 Like IFRSs, FASB ASC 250-10-45-5 requires an entity
to apply a change in accounting principle retrospectively to all
prior periods, unless it is impracticable to do so. Like IFRSs,
retrospective application requires cumulative adjustments to
the carrying amounts of assets and liabilities at the beginning
of the earliest period presented; an adjustment, if any, to the
opening balance of retained earnings or other relevant equity
account; and adjusted financial statements for each individ-
ual prior period presented to reflect the period-specific effects
of applying the new accounting principle. FASB ASC 250-
10-45-7 provides similar guidance to that in IAS 8 when the
impracticability exception applies to period-specific effects
or to all periods. However, unlike IFRSs, FASB ASC 250-10-
45-8 permits only direct effects of the change to be included
in the retrospective adjustment and prohibits an entity from
including indirect effects that would have been recognized if
the newly adopted accounting principle had been followed
in prior periods. An entity should only report indirect ef-
fects in the period in which the accounting change is made.
In contrast, IFRSs require an entity to adjust the financial
statements as if it had always applied the new policy and do
not distinguish between the direct and indirect effects of the
change.
1.29 Like IFRSs, FASB ASC 250-10-45-17 requires an en-
tity to account for a change in accounting estimate prospec-
tively in the period of change if the change affects that period
only or in the period of change and future periods if the change
affects both.
1.30 Like IFRSs, paragraphs 18–19 of FASB ASC 250-10-
45 recognize that it may be difficult to distinguish between
a change in an accounting principle and a change in an ac-
counting estimate. Unlike IFRSs, FASB ASC 250-10-45-18
provides additional guidance for those circumstances when
an entity’s change in estimate is affected by a change in ac-
counting principle, recognizing that the effect of a change
in accounting principle or the method of applying it may
be inseparable from the effect of the change in accounting
estimate. An example of such change is a change in the
method of depreciation, amortization, or depletion for long-
lived nonfinancial assets. FASB ASC 250-10-45-19 permits
an entity to apply this change prospectively as a change in ac-
counting estimate. The paragraph further states that an entity
should only make a change in accounting estimate affected
by a change in accounting principle if the entity can justify
the new accounting principle on the basis that it is prefer-
able.
1.31 Like IFRSs, paragraphs 23–24 of FASB ASC 250-10-
45 require an entity to correct any error in the financial state-
ments of a prior period discovered after the financial state-
ments are issued or available to be issued by restating the
prior period financial statements. These paragraphs in FASB
ASC require such errors to be reported as an error correction
by restating the prior-period financial statements retrospec-
tively with adjustments to the financial statements similar to
those required by IFRSs. Unlike IFRSs, FASB ASC 250-10-
45 does not provide an impracticability exception related to a
correction of an error as FASB ASC 250-10-45-7 addresses
with a change in accounting principle.
Presentation
IFRSs
1.32 IAS 1 requires an entity to include, at a minimum, a
complete set of prior year comparative financial statements
with the financial statements of the current year. When apply-
ing a change in an accounting policy retrospectively or mak-
ing a retrospective restatement for an error correction, the
entity should also provide a statement of financial position as
of the beginning of the earliest period presented. Individual
IFRSs may also require comparative note disclosures.
1.33 IAS 1 requires an entity to present fairly its financial
position, financial performance, and cash flows and describes
fair presentation in terms of faithful representation in accor-
dance with the definitions and recognition criteria in the IFRS
Conceptual Framework. An entity should presume that ap-
plication of all requirements of IFRSs, with additional dis-
closure when necessary, provides a fair presentation.
1.34 IAS 1 requires an entity to separately present each ma-
terial class of similar items and to separately present items
that are dissimilar by nature or function, unless they are im-
material. An entity should not offset assets and liabilities
or income and expense items, unless specifically required
or permitted by an IFRS. However, when not material, IAS
1 permits an entity to display gains or losses from similar
transactions on a net basis in the statement of comprehensive
income.
1.35 IAS 1 requires an entity to present and classify finan-
cial statement items consistently, unless the entity finds it ap-
parent that a different presentation or classification is more
appropriate or IFRSs require a change in presentation.
U.S. GAAP
1.36 Unlike IFRSs, FASB ASC 205-10-45-2 states only that
it is ordinarily desirable for an entity to present the statement
of financial position; the income statement; and the statement
of changes in equity for one or more preceding years, in
addition to those of the current year.
1.37 Like IFRSs, however, Rule 3-01(a) of SEC Regulation
S-X requires SEC registrants to present one-year compara-
tive statements of financial position (that is, the current year
and prior year). Unlike IFRSs, Rule 3-02(a) of SEC Regula-
tion S-X requires an entity to present two-year comparative
income statements and cash flow statements (that is, the cur-
rent year and the two years immediately preceding the current
year). Like IFRSs, paragraphs 3–4 of FASB ASC 205-10-45
require these statements to be comparable and include spe-
cific guidance for various changes (for example, changes in
accounting principle). An entity is required to repeat, or at
least refer to, any notes to financial statements, other expla-
nations, or accountants’ reports that contain qualifications
for prior years that appeared in the comparative statements
when originally issued, to the extent this information remains
significant. Multiple rules set forth in SEC Regulation S-X
provide guidance to SEC registrants on the form and ordering
of financial statements, presentation of amounts, omission of
certain items, and requirements for supplemental schedules.
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1.38 Unlike IFRSs, FASB ASC 250-10 does not require an
entity to present an opening balance sheet of the earliest pe-
riod presented when an entity retrospectively applies a change
in accounting policy or restates to correct an error. FASB ASC
205-10-50-1 only requires an entity to provide an explanation
of changes due to reclassifications or for other reasons that
affect the manner of, or basis for, presenting corresponding
items for two or more periods.
1.39 Like IFRSs, FASB ASC 210-20 permits an entity to
offset a liability with an asset only when certain conditions are
met. These conditions are similar, but not identical, to those in
IFRSs. See section 8, “Financial Instruments and Related Dis-
closures,” for further discussion on offsetting arrangements.
Disclosure
IFRSs
1.40 When an entity applies the true and fair view override
in IAS 1, it should disclose the following information:
• Management concludes that the financial statements
provide a fair presentation of financial position, finan-
cial performance, and cash flows.
• Management has complied with all of the requirements
of IFRSs, except for the relevant IFRSs from which it
deviated to achieve fair presentation.
The entity should also disclose the title of the relevant IFRSs
from which it deviated, the nature of the deviation, an expla-
nation of why the financial statements would be so mislead-
ing as to conflict with the objectives in the IFRS Conceptual
Framework if it complied with the IFRS requirement, and
the treatment adopted. In addition, the entity should disclose
the financial effect of the deviation on each affected financial
statement line item that would have been reported if the entity
had complied with the IFRS. When the entity invoked the true
and fair view override in a prior period and the current period
statements are affected, it should make the same disclosures
as required in the period of the deviation.
1.41 When a regulatory authority prohibits an entity from
invoking the true and fair view override, it should, to the
extent possible, disclose the following information:
• The title of the IFRS in question, the nature of the re-
quirement, and the reason why management concludes
that applying the requirement is so misleading that the
financial statements conflict with the objectives in the
IFRS Conceptual Framework.
• For each period presented, the adjustments to each af-
fected financial statement line item that would be nec-
essary to achieve fair presentation.
1.42 When management is aware of material uncertainties
that cast doubt on the entity’s ability to continue as a going
concern, it should disclose those uncertainties. If the entity
has not prepared its financial statements on a going concern
basis, it should disclose that fact, the basis on which the state-
ments are prepared, and the reason it is not considered a going
concern.
1.43 When an entity changes its reporting year and presents
financial statements for a period longer or shorter than one
year, it should disclose the reason for the longer or shorter
period and the fact that the amounts in the financial statements
are not entirely comparable.
1.44 With respect to comparative information, an entity
should provide comparative note disclosures, unless IFRSs
permit or require otherwise. An entity should also include
comparative relevant narrative and descriptive information.
When an entity changes the classification of financial state-
ment line items, it should reclassify comparative amounts,
unless impracticable. The entity should also disclose the na-
ture of, amount of, and reason for each reclassification by
item or class of items. When it is impracticable to reclassify
comparative period amounts, it should disclose the reason it
was impracticable and the nature of the necessary reclassifi-
cation adjustments.
1.45 IAS 1 establishes a structure for the note disclosures
and requires an entity to provide notes that present informa-
tion about the basis for preparation of its financial statements
and disclose information not presented elsewhere in the fi-
nancial statements, either because the information is required
by another IFRS or is relevant to an understanding of its finan-
cial statements. An entity should present the note disclosures
in a systematic way and cross-reference each line item in the
financial statements to its related note(s). IAS 1 suggests that
a useful organization of the notes would be for the entity to
start with the required statement of compliance and account-
ing policies, followed by notes related to financial statement
line items, and ending with notes related to off-balance sheet
information (such as commitments and contingencies) and
any nonfinancial disclosures they provide.
1.46 IAS 1 permits an entity to disclose the basis of prepa-
ration and discuss its accounting policies in a section separate
from the other note disclosures.
Author’s Note
Several survey companies provide accounting policy
disclosures in a separate unnumbered section, which
are so noted when included in an excerpt.
1.47 In the accounting policy disclosure, IAS 1 requires an
entity to disclose the measurement basis (or bases) it uses and
any other policy relevant to an understanding of how transac-
tions, events, and conditions are reflected in its financial state-
ments. An entity should also disclose, either in its accounting
policy or another note, information about its judgments and
decisions that affected the financial statements. The required
disclosures take two forms:
• Judgments, other than those involving estimation, that
could significantly affect the amounts recognized in the
financial statements (for example, classification of fi-
nancial instruments or whether all risks and rewards
have been transferred when financial or leased assets
are transferred to another entity)
• Sources of estimation uncertainty that could signifi-
cantly affect the carrying amounts of assets and li-
abilities and result in a material adjustment to those
amounts within the next fiscal year (for example, fair
values of financial instruments and estimated uncol-
lectible receivables)
With respect to sources of estimation uncertainty, an entity
should disclose the nature of the uncertainty and the carrying
amount at the end of the reporting period of the related asset
or liability.
1.48 IAS 1 requires an entity to disclose qualitative and sum-
mary quantitative information about its objectives, policies,
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and processes for managing its capital. For example, an entity
should disclose a description of what constitutes its capital,
whether it is subject to externally imposed capital require-
ments, and how it is meeting its own and externally imposed
objectives for managing capital.
1.49 If not disclosed elsewhere, an entity should also dis-
close similar information about puttable financial instruments
that it classifies as equity, including summary quantitative in-
formation, its objectives and policies for managing the obliga-
tion to repurchase or redeem these instruments, the expected
cash outflow on repurchase or redemption, and information
about how it determined the expected cash outflow.
1.50 IAS 1 requires an entity to disclose any unrecognized
dividends, in total and per share, proposed or declared before
the financial statements were authorized for issuance and any
unrecognized cumulative preference share dividends.
1.51 If not disclosed elsewhere in the document that in-
cludes the financial statements, IAS 1 requires an entity to
disclose its domicile and legal form; country of incorporation;
and the address of its registered office or principal places of
business, if different. An entity should describe the nature of
its operations and principal activities, the name of its parent
and the ultimate parent of the group to which it belongs, and
information about the length of its life if it is an entity with a
limited life.
1.52 In the period of the change in accounting policy, IAS 8
requires the following disclosures for changes in accounting
policy:
• The nature of the change in accounting policy
• To the extent practicable and for all periods presented,
the amount of any adjustments to each affected financial
statement line item and, when earnings per share are
presented, the effect on basic and diluted earnings per
share
• To the extent practicable, the amount of the adjustment
related to periods prior to those presented
• If retrospective application was impracticable for a par-
ticular prior period or for periods prior to those pre-
sented, the circumstances leading to the impracticabil-
ity and a description of how and when the entity applied
the change in policy
1.53 When an IFRS requires an entity to change its ac-
counting policy, the entity should also disclose the title of
the relevant IFRS, a description of any available transitional
provisions, whether the transitional provisions were applied,
and whether there will be any effect from such provisions in
future periods. When an entity changes an accounting pol-
icy voluntarily, it should also disclose the reasons why the
change is reliable and more relevant than its previous policy.
1.54 When a new IFRS has been issued but is not yet effec-
tive, an entity should disclose this fact and include the title
of the IFRS, the effective date, and the nature of the pend-
ing change in policy. An entity should also disclose the date
it expects to apply the new IFRS and discuss any known or
reasonably estimable information about the expected impact
on its financial statements or provide a statement to the effect
that the impact is unknown.
1.55 With respect to a change in accounting estimate, an
entity should disclose the nature and amount of the change in
the current period and, unless impracticable, an estimate of
the effect of the change in future periods. In the latter case,
an entity should disclose that it was impracticable to estimate
the future effect.
1.56 With respect to a prior-period error correction, an entity
should disclose the nature of the error and the amount of the
correction in the earliest prior period presented. To the extent
practicable, an entity should disclose the amount of the error
attributable to each prior period presented for each affected
financial statement line item and, if earnings per share is pre-
sented, the effect on basic and diluted earnings per share.
When retrospective restatement is impracticable for particu-
lar prior periods or all periods prior to those presented, the
entity should disclose the circumstances leading to impracti-
cability and provide a description of how and when the entity
corrected the error. IAS 8 does not require these disclosures
to be included in subsequent financial statements.
U.S. GAAP
1.57 Unlike IFRSs, FASB ASC does not contain an excep-
tion to achieve fair presentation comparable to the true and
fair view override in IAS 1.
1.58 Unlike IFRSs, FASB ASC does not currently contain
disclosure requirements when there is uncertainty regarding
whether the entity will continue as a going concern.
Author’s Note
Based on the FASB technical plan as of January 2011,
the Going Concern project has now been renamed Dis-
closures about Risks and Uncertainties and the Liquida-
tion Basis of Accounting. FASB originally undertook
this project to determine what analysis management
should make and the required disclosures in financial
statements about risks and uncertainties that cast doubt
about an entity’s ability to continue as a going concern.
FASB decided to broaden the scope of this project to ad-
dress (a) concerns about the ability of users of financial
statements to understand such risks and uncertainties
and (b) the ability of the entity to meet its obligations
when they become due. In addition, FASB decided to
provide guidance on the liquidation basis of accounting
at the request of constituents.
FASB has not specified a timeline for the release of
exposure documents.
1.59 Like IFRSs, FASB ASC 205-10-50-1 requires an entity
to explain any changes in the manner or basis of presentation
of financial statement items, whether because of reclassifica-
tions or for other reasons.
1.60 Like IFRSs, FASB ASC 235-10-05 requires disclosure
of an entity’s accounting policies. Unlike IFRSs, guidance on
the specific nature of such disclosures is not contained in a
specific standard but dispersed throughout FASB ASC.
Author’s Note
Accounting policy disclosure requirements under
IFRSs are similar to disclosure requirements of crit-
ical accounting estimates or policies disclosed by SEC
registrants. However, unlike IFRSs, which requires en-
tities to present such information in note disclosures
within the financial statements, SEC registrants gen-
erally disclose such information outside the financial
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statements within management’s discussion and anal-
ysis (MD&A), in accordance with the SEC Interpreta-
tion Commission Guidance Regarding Management’s
Discussion and Analysis of Financial Condition and
Results of Operations issued in 2003. This guidance
was intended to elicit more meaningful disclosure in
MD&A in a number of areas, including the overall
presentation and focus of MD&A, with general em-
phasis on the discussion and analysis of known trends,
demands, commitments, events and uncertainties, and
specific guidance on disclosures about liquidity, capital
resources, and critical accounting estimates.
1.61 Like IFRSs, FASB ASC 275-10-05-2 requires an en-
tity to disclose information about the risks and uncertainties
existing as of the date of its financial statements. These re-
quirements are similar in some respects, but not identical,
to those required by IAS 1. In accordance with FASB ASC
275-10-50-1, an entity should disclose risks and uncertainties
existing as of the date of the financial statements related to the
nature of operations, the use of estimates in the preparation
of the financial statements, certain significant estimates, and
current vulnerability due to certain concentrations. Although
both FASB ASC and IFRSs require an entity to disclose risks
and uncertainties related to an entity’s nature of operations,
FASB ASC 275-10-50 provides a more detailed discussion
of the type of information that must be disclosed, includ-
ing an explicit explanation that the preparation of financial
statements in conformity with U.S. GAAP requires the use
of management’s estimates, and criteria for assessing vulner-
ability due to certain concentrations, as well as the types of
concentrations requiring disclosure and their specific disclo-
sure requirements. FASB ASC 275-10-50 also includes more
implementation guidance and illustrations than IFRSs.
1.62 Unlike IFRSs, FASB ASC does not include a specific
requirement to disclose cash dividends declared after the bal-
ance sheet date. Like IFRSs, FASB ASC 505-10-50-5 re-
quires disclosure of the aggregate or per-share amounts at
which preferred stock may be called or is subject to redemp-
tion through sinking-fund operations or otherwise and the
aggregate and per-share amounts of arrearages in cumulative
preferred dividends.
Author’s Note
See the discussion of adjustments to earnings per share
disclosures due to stock dividends and stock splits de-
clared after the balance sheet date in paragraph 1.124.
1.63 Like IFRSs, FASB ASC 505-10-50-11 requires an en-
tity that issues redeemable stock to disclose the amount of
redemption requirements, separately by issue or combined,
for all issues of capital stock that are redeemable at fixed or
determinable prices on fixed or determinable dates in each
of the five years following the date of the latest statement of
financial position presented.
1.64 With respect to a change in accounting principle, FASB
ASC 250-10-50-1 requires an entity to disclose similar infor-
mation to that required by IFRSs, such as the nature of the
change, the method of applying the change, and similar dis-
closure requirements when retrospective application is im-
practical. However, unlike IFRSs, FASB ASC does not make
a distinction between mandated and voluntary changes in ac-
counting policy. Like IFRSs, FASB ASC 250-10-50-1 does
not require an entity to repeat disclosures related to a change
in accounting principle in the financial statements of subse-
quent periods. However, unlike IFRSs, if the change has no
material effect in the period of change but is reasonably cer-
tain to have a material effect in later periods, an entity should
provide the required disclosures whenever the financial state-
ments of the period of change are presented.
Author’s Note
IFRSs only require an entity to explain why a voluntary
change in accounting policy provides reliable and more
relevant information, On the other hand, FASB ASC
250-10-50-1 requires the entity to provide an explana-
tion of why a change in accounting policy is preferable,
even when an Accounting Standards Update (ASU)
mandates the change.
1.65 Because FASB ASC 250-10-50-1 requires an entity to
account for indirect effects of a change in accounting princi-
ple differently than direct effects, when an entity recognizes
such effects, it should disclose a description of the indirect
effects, including the amounts that have been recognized in
the current period and the related per share amounts, if appli-
cable. Unless impracticable, the entity should also disclose
the amount of the total recognized indirect effects and the re-
lated per share amounts, if applicable, that are attributable to
each prior period presented. IFRSs make no such distinction
between disclosures required for direct or indirect effects of
a change in accounting policy.
1.66 Unlike IFRSs, FASB ASC does not require an entity
to identify and discuss updates to the authoritative literature
and the potential impact on the financial statements. How-
ever, SEC Codification of Staff Accounting Bulletins topic
11(M), “Miscellaneous Disclosure—Disclosure of the Im-
pact That Recently Issued Accounting Standards Will Have
on the Financial Statements of the Registrant When Adopted
in a Future Period,” states that registrants who have not yet
adopted a newly issued accounting standard should discuss
the potential effects of adoption in registration statements
and reports filed with the SEC. The SEC staff believes that
recently issued accounting standards may constitute mate-
rial matters; therefore, disclosure in the financial statements
should also be considered in situations in which the change
to the new accounting standard will be accounted for in fi-
nancial statements of future periods. This guidance does not
require disclosure of the new standard if the entity does not
expect the impact on the company’s financial position and
results of operations to be material. However, it is preferable
for the entity to make a statement that the impact of the new
standard is not material.
1.67 With respect to changes in accounting estimates and
changes in accounting estimates affected by a change in ac-
counting principle, FASB ASC 250-10-50-4 requires an en-
tity to disclose the effect on income from continuing opera-
tions, net income (or other performance indicator), and any
related per share amounts of the current period. However,
unlike IFRSs, FASB ASC does not require this disclosure
for estimates made each period in the ordinary course of
accounting for items such as uncollectible accounts or in-
ventory obsolescence, unless there has been a change in the
estimate and the effect of the change is material. FASB ASC
250-10-50-5 also does not require disclosure of changes in an
estimate resulting from a change in a valuation technique or
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its application. IFRSs do not include comparable exemptions
from disclosure.
1.68 Unlike IFRSs, FASB ASC 250-10-50 does not require
disclosure of a future effect of a change in accounting esti-
mate; hence, disclosure is not required when it is impractica-
ble to estimate it.
1.69 With respect to error corrections, like IFRSs, para-
graphs 7 and 10 of FASB ASC 250-10-50 require an entity
to disclose the nature of the error, the fact that the financial
statements have been restated, the effect of the correction on
each financial statement line item and any per share amounts
presented for each prior period presented, and the cumula-
tive effect of the change on the opening balances of retained
earnings or other equity accounts for the earliest period pre-
sented. Like IFRSs, FASB ASC does not require an entity to
include this disclosure in the financial statements of subse-
quent periods. Unlike IFRSs, FASB ASC does not include an
impracticability exemption from retrospective correction of
an error.
TABLE 1-7: MANAGEMENT JUDGMENTS AND
CRITICAL ACCOUNTING ESTIMATES
2010 2009
Allowance for uncollectible receivables............................ 49 42
Asset retirement obligations and other environmental
liabilities ......................................................................... 29 26
Biological assets............................................................... 6 4
Business combinations..................................................... 30 31
Capitalization of development costs................................. 13 12
Classification of financial instruments .............................. 8 8
Consolidations, including special purpose entities........... 10 9
Derecognition of financial assets...................................... 3 2
Derivatives and hedging................................................... 23 25
Liability and equity components of hybrid financial
instruments.................................................................... 3 3
Mineral and oil and gas resources and reserves............. 13 11
Functional currency........................................................... 6 3
Going concern................................................................... 6 5
Impairment of financial assets.......................................... 2 40
Impairment of goodwill and other intangible assets......... 81 119
Impairment of property, plant and equipment .................. 128 71
Income statement presentation........................................ 43 3
Insurance contracts and claims........................................ 14 14
Inventories......................................................................... 26 23
Operating segments.......................................................... 2 2
Post employment and other employee benefits............... 82 77
Provisions and contingent liabilities.................................. 70 67
Residual values and useful lives of property, plant and
equipment, intangibles, and natural resources............. 67 58
Revaluation of property, plant and equipment ................. 7 4
Revenue recognition......................................................... 48 45
Share-based payments..................................................... 33 33
Taxation............................................................................. 116 111
Valuation of financial instruments at fair value................. 39 35
Valuation of investment property at fair value.................. 22 20
Survey companies with additional judgments or
estimates ....................................................................... 70 60
Total.................................................................................. 1049 963
Presentation and Disclosure Excerpts
Author’s Note
Some disclosure requirements of IAS 1 and IAS 8 only
apply when an entity makes a change in the way it
presents its financial statements or otherwise is not in
compliance with the underlying principles of financial
reporting established by IAS 1 and the IFRS Concep-
tual Framework. Generally, these requirements are not
relevant for the survey companies. Therefore, this sec-
tion does not include excerpts of all items requiring
disclosure (for example, statements not prepared on a
going concern basis.)
Comprehensive IAS 1 and IAS 8 Disclosures
1.70
Author’s Note
The Thomson Reuters disclosure excerpt that follows
includes examples of the following disclosures:
• General information about the entity (name, legal
form)
• Statement of compliance with IFRSs
• Basis of preparation
• Measurement bases
• Principles of consolidation
• Accounting policies and any changes thereto
• Use of estimates and judgments, risks and
uncertainties
• Discussion of issued but not yet effective IFRSs
Thomson Reuters Corporation (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
(Unless otherwise stated, all amounts are in millions of U.S.
dollars)
Note 1: Summary of Business and Significant
Accounting Policies
General Business Description
Thomson Reuters Corporation (the “Company” or “Thomson
Reuters”) is an Ontario, Canada corporation with common
shares listed on the Toronto Stock Exchange (“TSX”) and the
New York Stock Exchange (“NYSE”) and Series II preference
shares listed on the TSX. The Company provides intelligent in-
formation to businesses and professionals. Its offerings com-
bine industry expertise with innovative technology to deliver
critical information to decision makers.
These financial statements were approved by the Com-
pany’s board of directors on March 2, 2011.
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Basis of Preparation
These consolidated financial statements were prepared in
accordance with International Financial Reporting Standards
(“IFRS”), as issued by the International Accounting Standards
Board (“IASB”), on a going concern basis, under the historical
cost convention, as modified by the revaluation of financial as-
sets and financial liabilities (including derivative instruments)
at fair value through the income statement.
The preparation of financial statements in accordance with
IFRS requires the use of certain critical accounting estimates.
It also requires management to exercise judgment in apply-
ing the Company’s accounting policies. The areas involving a
higher degree of judgment or complexity, or areas where as-
sumptions and estimates are significant to the financial state-
ments are disclosed in note 2.
Pronouncements Effective Prospectively From
January 1, 2010
IAS 21, The Effects of Changes in Foreign Exchange Rates
Effective January 1, 2010, the Company adopted an amend-
ment to International Accounting Standard (“IAS”) 21, The Ef-
fects of Changes in Foreign Exchange Rates as a consequen-
tial amendment of IAS 27 (2008), Consolidated and Separate
Financial Statements. The amendment requires that accumu-
lated foreign exchange differences are reclassified from equity
to the income statement upon loss of control, significant influ-
ence or joint control of an entity. Additionally, the amendment
provides guidance on the reclassification of accumulated for-
eign exchange differences to the income statement when a
partial disposal of an interest in a foreign entity occurs. As a
result of this new guidance, the Company no longer reclassi-
fies accumulated foreign exchange differences from equity to
the income statement upon settlement of intercompany loan
balances when there is no change in the Company’s owner-
ship interest in the subsidiary.
IFRS 3 (Revised), Business Combinations
Effective January 1, 2010, the Company adopted IFRS 3 (Re-
vised), Business Combinations. Most significantly, the revised
standard requires:
• directly attributable transaction costs be expensed
rather than included in the acquisition purchase price;
• contingent consideration accounted for as a financial
liability be measured at fair value on the acquisition
date, with subsequent changes in the fair value recorded
through the income statement; and
• that upon gaining control in a step acquisition, an entity
re-measures its existing ownership interest to fair value
through the income statement.
During 2010, the Company expensed $26 million of directly
attributable transaction costs related to various acquisitions
and recorded an $18 million gain in connection with gaining
control in a step acquisition. See note 28 for details of the
Tradeweb transaction.
Principles of Consolidation
The financial statements of the Company include the accounts
of all of its subsidiaries.
Subsidiaries
Subsidiaries are entities over which the Company has control,
where control is defined as the power to govern financial and
operating policies. Generally, the Company has a sharehold-
ing of more than 50% of the voting rights in its subsidiaries.
The effect of potential voting rights that are currently exercis-
able are considered when assessing whether control exists.
Subsidiaries are fully consolidated from the date control is
transferred to the Company, and are de-consolidated from
the date control ceases.
The acquisition method of accounting is used to account
for the acquisition of subsidiaries as follows:
• cost is measured as the fair value of the assets given,
equity instruments issued and liabilities incurred or as-
sumed at the date of exchange, excluding transaction
costs which are expensed as incurred;
• identifiable assets acquired and liabilities assumed are
measured at their fair values at the acquisition date;
• the excess of acquisition cost over the fair value of the
identifiable net assets acquired is recorded as goodwill;
• if the acquisition cost is less than the fair value of the
net assets acquired, the fair value of the net assets is
re-assessed and any remaining difference is recognized
directly in the income statement;
• contingent consideration is measured at fair value on
the acquisition date, with subsequent changes in the
fair value recorded through the income statement when
the contingent consideration is a financial liability. Con-
tingent consideration is not re-measured when it is an
equity instrument. For acquisitions completed prior to
January 1, 2010, subsequent changes in the fair value
of contingent consideration are adjusted against good-
will; and
• upon gaining control in a step acquisition, the existing
ownership interest is re-measured to fair value through
the income statement.
Intercompany transactions between subsidiaries are elimi-
nated in consolidation. Transactions with non-controlling in-
terests are treated as transactions with equity owners of the
Company. For purchases from non-controlling interests, the
difference between the consideration paid and the share of
the carrying value of net assets acquired is recorded in eq-
uity. Gains or losses on disposals to non-controlling interests
are similarly computed and also recorded in equity.
Equity Method Investees
Equity method investees are entities over which the Company
has significant influence, but not control. Generally, the Com-
pany has a shareholding of between 20% and 50% of the
voting rights in its equity method investees. Investments in
equity method investees are accounted for using the equity
method as follows:
• investments are initially recognized at cost;
• equity method investees include goodwill identified on
acquisition, net of any accumulated impairment loss;
• the Company’s share of post-acquisition profits or losses
is recognized in the income statement and is adjusted
against the carrying amount of the investments;
• when the Company’s share of losses equals or exceeds
its interest in the investee, including unsecured receiv-
ables, the Company does not recognize further losses,
unless it has incurred obligations or made payments on
behalf of the investee; and
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• gains on transactions between the Company and its eq-
uity method investees are eliminated to the extent of
the Company’s interest in these entities, and losses are
eliminated unless the transaction provides evidence of
an impairment of the asset transferred.
Joint Ventures
Joint ventures are entities over which the Company has
joint control with one or more unaffiliated entities. Joint ven-
tures are accounted for using the proportionate consolidation
method as follows:
• the statement of financial position includes the Com-
pany’s share of the assets that it controls jointly and the
liabilities for which it is jointly responsible;
• the income statement includes the Company’s share of
the income and expenses of the jointly controlled entity;
and
• gains on transactions between the Company and its joint
ventures are eliminated to the extent of the Company’s
interest in the joint ventures and losses are eliminated,
unless the transaction provides evidence of an impair-
ment of the asset transferred.
The accounting policies of subsidiaries, equity method in-
vestees and joint ventures were changed where necessary to
ensure consistency with the policies adopted by the Company.
Operating Segments
The Company’s operating segments are organized around
the markets it serves and are reported in a manner consis-
tent with the internal reporting provided to the chief operating
decision-maker (“CODM”). The Chief Executive Officer has
authority for resource allocation and assessment of the Com-
pany’s performance and is therefore the CODM.
Foreign Currency
The consolidated financial statements are presented in U.S.
dollars, which is the Company’s presentation currency.
The financial statements of each of the Company’s sub-
sidiaries are measured using the currency of the primary
economic environment in which the subsidiary operates
(the “functional currency”). Foreign currency transactions are
translated into the functional currency using the exchange
rates prevailing at the dates of the transaction. Foreign ex-
change gains and losses resulting from the settlement of such
transactions as well as from the translation of monetary as-
sets and liabilities not denominated in the functional currency
of the subsidiary, are recognized in the income statement,
except for qualifying cash flow hedges which are deferred in
accumulated other comprehensive income in shareholders’
equity.
Assets and liabilities of entities with functional currencies
other than U.S. dollars are translated to U.S. dollars at the pe-
riod end rates of exchange, and the results of their operations
are translated at average rates of exchange for the period. The
resulting translation adjustments are included in accumulated
other comprehensive income in shareholders’ equity. Addi-
tionally, foreign exchange gains and losses related to certain
intercompany loans that are permanent in nature are included
in accumulated other comprehensive income.
Foreign exchange gains and losses arising from the fol-
lowing are presented in the income statement within “finance
costs, net”:
• borrowings;
• cash and cash equivalents;
• intercompany loans that are not permanent in nature;
and
• settlement of intercompany loans previously considered
permanent in nature upon loss of control, significant in-
fluence or joint control of the applicable entity.
All other foreign exchange gains and losses are presented in
the income statement within “Operating expenses.”
References to “$” are to U.S. dollars, references to “C$”
are to Canadian dollars, and references to “£” are to British
pounds sterling.
Revenue Recognition
Revenue is measured at the fair value of the considera-
tion received or receivable, net of estimated returns and dis-
counts, and after eliminating intercompany sales. The Com-
pany bases its estimates on historical results, taking into
consideration the type of customer, the type of transaction
and the specifics of each arrangement.
Revenue from the rendering of services is recognized when
the following criteria are met:
• the amount of revenue can be measured reliably;
• the stage of completion can be measured reliably;
• the receipt of economic benefits is probable; and
• costs incurred and to be incurred can be measured
reliably.
Revenue from the sale of goods is recognized when the fol-
lowing criteria are met:
• the risks and rewards of ownership, including manage-
rial involvement, have transferred to the buyer;
• the amount of revenue can be measured reliably;
• the receipt of economic benefits is probable; and
• costs incurred or to be incurred can be measured
reliably.
In addition to the above general principles, the Company ap-
plies the following specific revenue recognition policies:
Subscription-Based Products, Including Software
Term Licenses
Subscription revenues from sales of products and services
that are delivered under a contract over a period of time are
recognized on a straight-line basis over the term of the sub-
scription. Where applicable, usage fees above a base period
fee are recognized as services are delivered. Subscription
revenue received or receivable in advance of the delivery of
services or publications is included in deferred revenue.
Multiple Component Arrangements
When a single sales transaction requires the delivery of
more than one product or service (multiple components),
the revenue recognition criteria are applied to the separately
identifiable components. A component is considered to be
separately identifiable if the product or service delivered has
stand-alone value to that customer and the fair value asso-
ciated with the product or service can be measured reliably.
The amount recognized as revenue for each component is
the fair value of the element in relation to the fair value of the
arrangement as a whole.
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Installation or Implementation Services
Certain arrangements include installation or implementation
services. Consulting revenues from these arrangements are
accounted for separately from software or subscription rev-
enue if the services have stand-alone value to that customer
and the amount attributed to the services can be measured
reliably. If the services do not qualify for separate account-
ing, they are recognized together with the related software or
subscription revenue.
Sales Involving Third Parties
Revenue from sales of third party vendor products or services
is recorded net of costs when the Company is acting as an
agent between the customer and vendor and recorded gross
when the Company is a principal to the transaction.
Other Service Contracts
For service or consulting arrangements, revenues are recog-
nized as services are performed, generally based on hours
incurred relative to total hours expected to be incurred.
Employee Future Benefits
For defined benefit pension plans and other post-employment
benefits, the net periodic pension expense is actuarially de-
termined on an annual basis by independent actuaries using
the projected unit credit method. The determination of benefit
expense requires assumptions such as the expected return
on assets available to fund pension obligations, the discount
rate to measure obligations, expected mortality, the expected
rate of future compensation and the expected healthcare cost
trend rate. For the purpose of calculating the expected return
on plan assets, the assets are valued at fair value. Actual
results will differ from results which are estimated based on
assumptions. The vested portion of past service cost aris-
ing from plan amendments is recognized immediately in the
income statement. The unvested portion is amortized on a
straight-line basis over the average remaining period until the
benefits become vested.
The asset or liability recognized in the statement of financial
position is the present value of the defined benefit obligation
at the end of the reporting period less the fair value of plan as-
sets, together with adjustments for unrecognized past service
costs. The present value of the defined benefit obligation is
determined by discounting the estimated future cash outflows
using interest rates of high-quality corporate bonds that are
denominated in the currency in which the benefits will be paid
and that have terms to maturity approximating the terms of
the related pension liability. All actuarial gains and losses that
arise in calculating the present value of the defined benefit
obligation and the fair value of plan assets are recognized im-
mediately in retained earnings and included in the statement
of comprehensive income. For funded plans, surpluses are
recognized only to the extent that the surplus is considered
recoverable. Recoverability is primarily based on the extent
to which the Company can unilaterally reduce future contri-
butions to the plan.
Payments to defined contribution plans are expensed as
incurred, which is as the related employee service is rendered.
Share-Based Compensation Plans
The Company operates a number of equity-settled and cash-
settled share-based compensation plans under which it re-
ceives services from employees as consideration for equity
instruments of the Company or cash payments.
For equity-settled share-based compensation, expense is
based on the grant date fair value of the awards expected
to vest over the vesting period. For cash-settled share-based
compensation, the expense is determined based on the fair
value of the liability at the end of the reporting period until the
award is settled. The expense is recognized over the vesting
period, which is the period over which all of the specified vest-
ing conditions are satisfied. For awards with graded vesting,
the fair value of each tranche is recognized over its respec-
tive vesting period. At the end of each reporting period, the
Company re-assesses its estimates of the number of awards
that are expected to vest and recognizes the impact of the
revisions in the income statement.
In 2010, the Company revised its accounting for withholding
taxes on share-based compensation plans, which the Com-
pany settles from its own cash. Previously, the entire value
of share-based awards related to time-based restricted share
units (TRSUs), performance restricted share units (PRSUs)
and stock options was accounted for as an equity-settled
award. Accordingly, compensation expense was recognized
over the vesting period based on the grant date fair value. Un-
der the revised accounting, the portion of the award relating
to withholding tax is treated as cash-settled, which results in
a liability which is marked to market through the income state-
ment each period. The Company assessed the materiality of
this change and concluded that the revision was not material
to the current period nor to any prior annual or interim period.
The cumulative effect of this change on the Company’s con-
solidated financial statements as at and for the year Decem-







(1) Comprised of an $18 million increase for fair value changes during
2010 and a $5 million decrease for periods prior to 2010.
Termination Benefits
Termination benefits are generally payable when employment
is terminated before the normal retirement date or whenever
an employee accepts voluntary redundancy in exchange for
these benefits. The Company recognizes termination benefits
when it is demonstrably committed to either terminating the
employment of current employees according to a detailed for-
mal plan without realistic possibility of withdrawal or providing
termination benefits as a result of an offer made to encourage
voluntary redundancy.
Profit Sharing and Bonus Plans
Liabilities for bonuses and profit-sharing are recognized
based on a formula that takes into consideration the profit
attributable to the Company’s shareholders after certain ad-
justments. The Company recognizes a provision where con-
tractually obliged or where there is a past practice that has
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created a constructive obligation to make such compensation
payments.
Cash and Cash Equivalents
Cash and cash equivalents comprise cash on hand, demand
deposits and investments with an original maturity at the date
of purchase of three months or less.
Trade Receivables
Trade receivables are amounts due from customers from pro-
viding services or sale of goods in the ordinary course of
business. Trade receivables are classified as current assets if
payment is due within one year or less. Trade receivables are
recognized initially at fair value and subsequently measured
at amortized cost, less impairment.
The Company maintains an allowance for doubtful accounts
and sales adjustments to provide for impairment of trade re-
ceivables. The expense relating to doubtful accounts is in-
cluded within “Operating expenses” in the income statement.
Revenues are recorded net of sales adjustments.
Computer Hardware and Other Property
Computer hardware and other property are recorded at cost
and depreciated on a straight-line basis over their estimated
useful lives as follows:
Computer hardware 3–5 years
Buildings and building improvements 5–40 years
Furniture, fixtures and equipment 3–10 years
Residual values and useful lives are reviewed at the end of
each reporting period and adjusted if appropriate.
Intangible Assets
Computer Software
Certain costs incurred in connection with the development of
software to be used internally or for providing services to cus-
tomers are capitalized once a project has progressed beyond
a conceptual, preliminary stage to that of application develop-
ment. Development costs that are directly attributable to the
design and testing of identifiable and unique software prod-
ucts controlled by the Company are recognized as intangible
assets when the following criteria are met:
• it is technically feasible to complete the software product
so that it will be available for use;
• management intends to complete the software product
and use or sell it;
• there is an ability to use or sell the software product;
• it can be demonstrated how the software product will
generate probable future economic benefits;
• adequate technical, financial and other resources to
complete the development and to use or sell the soft-
ware product are available; and
• the expenditure attributable to the software product dur-
ing its development can be reliably measured.
Costs that qualify for capitalization include both internal and
external costs, but are limited to those that are directly re-
lated to the specific project. The capitalized amounts, net of
accumulated amortization, are included in “Computer soft-
ware, net” in the statement of financial position. These costs
are amortized over their expected useful lives, which range
from 3 to 10 years. The amortization expense is included in
“Amortization of computer software” in the income statement.
Residual values and useful lives are reviewed at the end of
each reporting period and adjusted if appropriate.
Goodwill
Goodwill represents the excess of the cost of an acquisition
over the fair value of the Company’s share of the identifiable
net assets of the acquired subsidiary or equity method in-
vestee at the date of acquisition. Goodwill is tested annually
for impairment and carried at cost less accumulated impair-
ment losses. Gains and losses on the disposal of an entity
include the carrying amount of goodwill relating to the entity
sold.
Other Identifiable Intangible Assets
Upon acquisition, identifiable intangible assets are recorded
at fair value and are carried at cost less accumulated
amortization.
Identifiable intangible assets with finite lives are amortized
on a straight-line basis over their estimated useful lives as
follows:
Trade names 2–27 years
Customer relationships 2–40 years
Databases and content 2–30 years
Other 2–30 years
Residual values and useful lives are reviewed at the end of
each reporting period and adjusted if appropriate.
Impairment
Impairments are recorded when the recoverable amount of
assets are less than their carrying amounts. The recoverable
amount is the higher of an asset’s fair value less cost to sell or
its value in use. Impairment losses, other than those relating
to goodwill, are evaluated for potential reversals when events
or changes in circumstances warrant such consideration.
Intangible Assets
The carrying values of all intangible assets are reviewed for
impairment whenever events or changes in circumstances in-
dicate that their carrying amounts may not be recoverable.
Additionally, the carrying values of identifiable intangible as-
sets with indefinite lives and goodwill are tested annually for
impairment. Specifically:
• Trade names with indefinite useful lives are subject to
an annual impairment assessment. For purposes of im-
pairment testing, the fair value of trade names is deter-
mined using an income approach, specifically the relief
from royalties method.
• For the purpose of impairment testing, goodwill is allo-
cated to cash-generating units (“CGU”) based on the
level at which management monitors it, which is not
higher than an operating segment. Goodwill is allocated
to those CGUs that are expected to benefit from the
business combination in which the goodwill arose.
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Non-Financial Assets
The carrying values of non-financial assets with finite lives,
such as computer hardware and software, are assessed for
impairment whenever events or changes in circumstances in-
dicate that their carrying amounts may not be recoverable.
In addition, long-lived assets that are not amortized, such as
equity investments, are subject to annual or more frequent
impairment assessment. For the purposes of assessing im-
pairment, assets are grouped at the lowest levels for which
there are separately identifiable cash flows.
Disposal of Long-Lived Assets and Discontinued Operations
Long-lived assets are classified as held for sale if the carry-
ing amount will be recovered principally through a sale trans-
action rather than through continued use and such sale is
considered highly probable. The criteria for classification as
held for sale include a firm decision by management or the
board of directors to dispose of a business or a group of se-
lected assets and the expectation that such disposal will be
completed within a 12 month period. Assets held for sale are
measured at the lower of their carrying amounts or their fair
value less costs to sell and are no longer depreciated. Assets
held for sale are classified as discontinued operations if the
operations and cash flows can be clearly distinguished, oper-
ationally and for financial reporting purposes from the rest of
the Company and they:
• represent a separate major line of business or geograph-
ical area of operations;
• are part of a single coordinated plan to dispose of a
separate major line of business or geographical area of
operations; or
• are a subsidiary acquired exclusively with a view to
resale.
Trade Payables
Trade payables are obligations to pay for goods or services
that have been acquired in the ordinary course of business.
Trade payables are recognized initially at fair value and sub-
sequently measured at amortized cost, and are classified as
current liabilities if payment is due within one year or less.
Provisions
Provisions represent liabilities to the Company for which the
amount or timing is uncertain. Provisions are recognized
when the Company has a present legal or constructive obli-
gation as a result of past events, it is probable that an outflow
of resources will be required to settle the obligation, and the
amount can be reliably estimated. Provisions are not recog-
nized for future operating losses. Provisions are measured at
the present value of the expected expenditures to settle the
obligation using a discount rate that reflects current market
assessments of the time value of money and the risks spe-
cific to the obligation. The increase in the provision due to
passage of time is recognized as interest expense.
Indebtedness
Debt is recognized initially at fair value, net of transaction
costs incurred. Debt is subsequently stated at amortized cost
with any difference between the proceeds (net of transactions
costs) and the redemption value recognized in the income
statement over the term of the debt using the effective interest
method. Where a debt instrument is in a fair value hedging
relationship, a fair value adjustment is made to its carrying
value to reflect hedged risk. Interest on indebtedness is ex-
pensed as incurred unless capitalized for qualifying assets in
accordance with IAS 23, Borrowing Costs.
Debt is classified as a current liability unless the Company
has an unconditional right to defer settlement for at least 12
months after the end of the reporting period.
Leases
Leases are classified as either operating or finance, based
on the substance of the transaction at inception of the lease.
Classification is re-assessed if the terms of the lease are
changed.
Operating Lease
Leases in which a significant portion of the risks and rewards
of ownership are retained by the lessor are classified as oper-
ating leases. Payments under an operating lease (net of any
incentives received from the lessor) are recognized in the in-
come statement on a straight-line basis over the period of the
lease.
Finance Lease
Leases in which substantially all the risks and rewards of
ownership are transferred to the Company are classified as
finance leases. Assets meeting finance lease criteria are cap-
italized at the lower of the present value of the related lease
payments or the fair value of the leased asset at the inception
of the lease. Minimum lease payments are apportioned be-
tween the finance charge and the liability. The finance charge
is allocated to each period during the lease term so as to
produce a constant periodic rate of interest on the remaining
balance of the liability.
Financial Assets
Purchases and sales of financial assets are recognized on
the settlement date, which is the date on which the asset is
delivered to or by the Company. Financial assets are derec-
ognized when the rights to receive cash flows from the invest-
ments have expired or were transferred and the Company has
transferred substantially all risks and rewards of ownership.
Financial assets are classified in the following categories at
the time of initial recognition based on the purpose for which
the financial assets were acquired:
Financial Assets at Fair Value Through the Income
Statement
• Classification Financial assets are classified as fair
value through the income statement if acquired princi-
pally for the purpose of selling in the short-term, such
as financial assets held for trading, or if so designated
by management. Assets in this category principally in-
clude embedded derivatives and derivatives which do
not qualify for hedge accounting.
• Recognition and measurement Financial assets car-
ried at fair value through the income statement are
initially recognized, and subsequently carried, at fair
value, with changes recognized in the income state-
ment. Transaction costs are expensed.
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Loans and Receivables
• Classification Loans and receivables are non-
derivative financial assets with fixed or determinable
payments that are not quoted in an active market. They
are included in current assets, except for those with ma-
turities greater than 12 months after the end of the re-
porting period, which are classified as non-current as-
sets. Assets in this category include “trade and other
receivables” and “cash and cash equivalents” and are
classified as current assets in the statement of financial
position.
• Recognition and measurement Loans and receiv-
ables are initially recognized at fair value plus transac-
tion costs and subsequently carried at amortized cost
using the effective interest method.
Available-for-Sale Financial Assets
• Classification Available-for-sale financial assets are
non-derivatives that are either designated in this cat-
egory or not classified in any of the other categories.
They are included in other non-current financial assets
unless management intends to dispose of the invest-
ment within 12 months of the end of the reporting period.
Included within this category are investments in entities
over which the Company does not have control, joint
control or significant influence.
• Recognition and measurement Investments are ini-
tially recognized at fair value plus transaction costs and
are subsequently carried at fair value with changes rec-
ognized in other comprehensive income. Upon sale or
impairment, the accumulated fair value adjustments rec-
ognized in other comprehensive income are included in
the income statement.
Impairment of Financial Assets
At the end of each reporting period, the Company assesses
whether there is objective evidence that a financial asset is
impaired. Impairments are measured as the excess of the
carrying amount over the fair value and are recognized in the
income statement.
Derivative Financial Instruments and Hedging
Derivatives are initially recognized at fair value on the date a
contract is entered into and are subsequently re-measured at
their fair value. The method of recognizing the resulting gain
or loss depends on whether the derivative is designated as a
hedging instrument and the nature of the item being hedged.
The Company documents at the inception of the transaction
the relationship between hedging instruments and hedged
items, as well as its risk management objectives and strat-
egy for undertaking various hedging transactions. The Com-
pany also documents its assessment, both at hedge inception
and on an ongoing basis, of whether the derivatives that are
used in hedging transactions are highly effective in offsetting
changes in fair values or cash flows of hedged items.
Non-performance risk, including the Company’s own credit
risk, is considered when determining the fair value of financial
instruments.
The Company designates certain derivatives as either:
• Fair value hedges These are hedges of the fair value
of recognized assets, liabilities or a firm commitment.
Changes in the fair value of derivatives that are desig-
nated as fair value hedges are recorded in the income
statement together with any changes in the fair value of
the hedged asset or liability that are attributable to the
hedged risk.
• Cash flow hedges These are hedges of highly probable
forecast transactions. The effective portion of changes
in the fair value of derivatives that are designated as a
cash flow hedge is recognized in other comprehensive
income. The gain or loss relating to the ineffective por-
tion is recognized immediately in the income statement.
Additionally:
—amounts accumulated in other comprehensive in-
come are recycled to the income statement in the
period when the hedged item will affect profit and loss
(for instance, when the forecast sale that is hedged
takes place);
—when a hedging instrument expires or is sold, or
when a hedge no longer meets the criteria for hedge
accounting, any cumulative gain or loss in other com-
prehensive income remains in other comprehensive
income and is recognized when the forecast transac-
tion is ultimately recognized in the income statement;
and
—when a forecast transaction is no longer expected to
occur, the cumulative gain or loss that was reported
in other comprehensive income is immediately rec-
ognized in the income statement.
Derivatives That Do Not Qualify for Hedge Accounting
Certain derivative instruments, while providing effective eco-
nomic hedges, are not designated as hedges for accounting
purposes. Changes in the fair value of any derivatives that
are not designated as hedges for accounting purposes are
recognized within “Other finance costs” (see note 7) or “Oper-
ating expenses” (see note 5) in the income statement consis-
tent with the underlying nature and purpose of the derivative
instruments.
Embedded Derivatives
An embedded derivative is a feature within a contract, where
the cash flows associated with that feature behave in a similar
fashion to a stand-alone derivative. The Company has embed-
ded foreign currency derivatives in certain revenue and pur-
chase contracts where the currency of the contract is different
from the functional or local currencies of the parties involved.
These derivatives are accounted for as separate instruments
and are measured at fair value at the end of the reporting pe-
riod using forward exchange market rates. Changes in their
fair values are recognized within “Operating expenses” in the
income statement.
Taxation
Tax expense comprises current and deferred tax. Tax is rec-
ognized in the income statement except to the extent it relates
to items recognized in other comprehensive income or directly
in equity.
Current Tax
Current tax expense is based on the results for the period
as adjusted for items that are not taxable or not deductible.
Current tax is calculated using tax rates and laws that were
enacted or substantively enacted at the end of the reporting
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period. Management periodically evaluates positions taken in
tax returns with respect to situations in which applicable tax
regulation is subject to interpretation. Provisions are estab-
lished where appropriate on the basis of amounts expected
to be paid to the tax authorities.
Deferred Tax
Deferred tax is recognized, using the liability method, on tem-
porary differences arising between the tax bases of assets
and liabilities and their carrying amounts in the statement of
financial position. Deferred tax is calculated using tax rates
and laws that have been enacted or substantively enacted at
the end of the reporting period, and which are expected to
apply when the related deferred income tax asset is realized
or the deferred income tax liability is settled.
Deferred Tax Liabilities:
• are generally recognized for all taxable temporary
differences;
• are recognized for taxable temporary differences aris-
ing on investments in subsidiaries, associates and joint
ventures, except where the reversal of the temporary
difference can be controlled and it is probable that the
difference will not reverse in the foreseeable future; and
• are not recognized on temporary differences that arise
from goodwill which is not deductible for tax purposes.
Deferred Tax Assets:
• are recognized to the extent it is probable that taxable
profits will be available against which the deductible tem-
porary differences can be utilized; and
• are reviewed at the end of the reporting period and re-
duced to the extent that it is no longer probable that
sufficient taxable profits will be available to allow all or
part of the asset to be recovered.
Deferred tax assets and liabilities are not recognized in re-
spect of temporary differences that arise on initial recogni-
tion of assets and liabilities acquired other than in a business
combination.
Note 2: Critical Accounting Estimates and Judgments
The preparation of financial statements requires management
to make estimates and judgments about the future. Estimates
and judgments are continually evaluated and are based on
historical experience and other factors, including expectations
of future events that are believed to be reasonable under the
circumstances. Accounting estimates will, by definition, sel-
dom equal the actual results. The following discussion sets
forth management’s:
• most critical estimates and assumptions in determining
the value of assets and liabilities; and
• most critical judgments in applying accounting policies.
Critical Accounting Estimates and Assumptions
Allowance for Doubtful Accounts and Sales Adjustments
The Company must make an assessment of whether ac-
counts receivable are collectible from customers. Accordingly,
management establishes an allowance for estimated losses
arising from non-payment and other sales adjustments, tak-
ing into consideration customer creditworthiness, current eco-
nomic trends and past experience. If future collections differ
from estimates, future earnings would be affected. At Decem-
ber 31, 2010, the combined allowances were $134 million, or
7%, of the gross trade accounts receivable balance of approx-
imately $1.9 billion. An increase to the reserve based on 1% of
accounts receivable would have decreased pre-tax earnings
by approximately $19 million for the year ended December
31, 2010.
Computer Software
Computer software represented approximately $1.6 billion of
total assets on the consolidated statement of financial position
at December 31, 2010. A significant portion of ongoing expen-
ditures relate to software that is developed as part of electronic
databases, delivery systems and internal infrastructures, and,
to a lesser extent, software sold directly to customers. As part
of the software development process, management must es-
timate the expected period of benefit over which capitalized
costs should be amortized. The considerations which form
the basis of the assumptions for these estimated useful lives
include the timing of technological obsolescence and compet-
itive pressures, as well as historical experience and internal
business plans for the projected use of the software. Due to
rapidly changing technology and the uncertainty of the soft-
ware development process itself, future results could be af-
fected if management’s current assessment of its software
projects differs from actual performance.
Other Identifiable Intangible Assets and Goodwill
Other identifiable intangible assets and goodwill represented
approximately $27.6 billion of total assets on the consoli-
dated statement of financial position at December 31, 2010.
These assets arise out of business combinations. In 2010, the
Company spent $612 million in net cash consideration on ac-
quisitions. Additionally, acquisitions included an exchange of
equity interests involving the Company’s Tradeweb business
(see note 28). These transactions were accounted for under
the acquisition method of accounting, which involves the allo-
cation of the cost of an acquisition to the underlying net assets
acquired based on their respective estimated fair values. As
part of this allocation process, the Company must identify and
attribute values and estimated lives to the intangible assets
acquired. These determinations involve significant estimates
and assumptions regarding cash flow projections, economic
risk and weighted cost of capital.
These estimates and assumptions determine the amount
allocated to other identifiable intangible assets and goodwill,
as well as the amortization period for identifiable intangible as-
sets with finite lives. If future events or results differ adversely
from these estimates and assumptions, the Company could
record increased amortization or impairment charges in the
future.
See note 18 for a discussion of the annual impairment test-
ing of goodwill.
Employee Future Benefits
The Company sponsors defined benefit plans providing pen-
sion and other post-employment benefits to covered employ-
ees. The determination of expense and obligations associ-
ated with employee future benefits requires the use of as-
sumptions such as the expected return on assets available to
fund pension obligations, the discount rate to measure obli-
gations, the expected mortality, the expected rate of future
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compensation and the expected healthcare cost trend rate.
Because the determination of the cost and obligations asso-
ciated with employee future benefits requires the use of vari-
ous assumptions, there is measurement uncertainty inherent
in the actuarial valuation process. Actual results will differ from
results which are estimated based on assumptions.
See note 26 for further details including an estimate of the
impact on the financial statements from changes in the most
critical assumptions.
Income Taxes
The Company computes an income tax provision in each of
the jurisdictions in which it operates. However, actual amounts
of income tax expense only become final upon filing and ac-
ceptance of the tax return by the relevant authorities, which
occur subsequent to the issuance of the financial statements.
Additionally, estimation of income taxes includes evaluating
the recoverability of deferred tax assets based on an assess-
ment of the ability to use the underlying future tax deductions
before they expire against future taxable income. The assess-
ment is based upon existing tax laws and estimates of future
taxable income. To the extent estimates differ from the final
tax return, earnings would be affected in a subsequent period.
In interim periods, the income tax provision is based on esti-
mates of full-year earnings by jurisdiction. The average annual
effective income tax rates are re-estimated at each interim
reporting date. To the extent that forecasts differ from actual
results, adjustments are recorded in subsequent periods.
The Company’s 2010 effective tax rate was 13% of earn-
ings from continuing operations before tax. A 1% increase in
the effective tax rate would have increased 2010 income tax
expense by approximately $11 million.
Critical Judgments in Applying Accounting Policies
Revenue Recognition
As described in note 1, the Company assesses the criteria
for the recognition of revenue related to arrangements that
have multiple components. These assessments require judg-
ment by management to determine if there are separately
identifiable components as well as how to allocate the to-
tal price among the components. Deliverables are accounted
for as separately identifiable components if they can be un-
derstood without reference to the series of transactions as
a whole. In concluding whether components are separately
identifiable, management considers the transaction from the
customer’s perspective. Among other factors, management
assesses whether the service or good is sold separately by
the Company in the normal course of business or whether
the customer could purchase the service or good separately.
With respect to the allocation of price among components,
management uses its judgment to assign a fair value to each
component. As evidence of fair value, management looks to
such items as the price for the component when sold sepa-
rately, renewal rates for specific components and prices for a
similar product sold separately.
Uncertain Tax Positions
The Company is subject to taxation in numerous jurisdic-
tions. There are many transactions and calculations during
the course of business for which the ultimate tax determi-
nation is uncertain. The Company maintains provisions for
uncertain tax positions that it believes appropriately reflect its
risk. These provisions are made using the best estimate of
the amount expected to be paid based on a qualitative as-
sessment of all relevant factors. The Company reviews the
adequacy of these provisions at the end of the reporting pe-
riod. However, it is possible that at some future date, liabilities
in excess of the Company’s provisions could result from audits
by, or litigation with, the IRS or other relevant taxing authori-
ties. Where the final outcome of these tax-related matters is
different from the amounts that were initially recorded, such
differences will affect the tax provisions in the period in which
such determination is made.
Note 3: Recent Accounting Pronouncements
Certain new standards, interpretations, amendments and im-
provements to existing standards were issued by the IASB or
International Financial Reporting Interpretations Committee
(“IFRIC”) that are mandatory for accounting periods beginning
January 1, 2011 or later periods. The standards impacted that
are applicable to the Company are as follows:
• IFRS 3—Business Combinations;
• IFRS 7—Financial Instruments: Disclosures;
• IAS 1—Presentation of Financial Statements;
• IAS 24—Related Party Disclosures;
• IAS 27—Consolidated and Separate Financial State-
ments; and
• IAS 34—Interim Financial Reporting.
The Company does not anticipate that any of these changes
will have a material impact on its results of operations or fi-
nancial position.
In addition to the above, the IASB has issued IFRS 9—
Financial Instruments (Classification and Measurement),
which is mandatory for accounting periods beginning January
1, 2013. The Company is assessing the impact of IFRS 9 on
its results of operations and financial position.
General Information, Regulatory Environment
1.71
Companhia de Saneamento Basico de Estado do
Sao Paolo—SABESP (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Amounts in thousands of reais, unless otherwise indicated.
1. Operations
Companhia de Saneamento Básico do Estado de Săo Paulo
(“SABESP” or the “Company”) is a mixed-capital company
headquartered in Săo Paulo, controlled by the Săo Paulo
State Government. The Company is engaged in the provi-
sion of basic and environmental sanitation services, supplies
treated water on a wholesale basis and provides sewage
treatment services to six other municipalities in the Greater
Săo Paulo Metropolitan Area.
In addition to providing basic sanitation services in the
State of Săo Paulo, SABESP may perform these activities
in other states and countries, and can operate in drainage,
urban cleaning, solid waste handling and energy markets.
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The objective set in the new vision of SABESP is to be rec-
ognized as the company that ensured universal access to
water and sewage services in its marketplace, focused on the
customer, and in a sustainable and competitive manner, with
excellence in environmental solutions.
On December 31, 2010, the company operates water and
sewage services in 364 of municipalities of the State of Săo
Paulo, having temporarily discontinued operations in five of
these municipalities, Itapira, Araçoiaba da Serra, Iperó, Ca-
jobi and Tarumă, due to judicial orders under ongoing lawsuits.
Most of these municipalities operations are based on 30-year
concession agreements. As of December 31, 2010, 119 con-
cessions had expired and are being negotiated. From 2011
to 2030, 44 concessions will expire, and the remaining con-
cessions operate on rollover basis. These concessions with
indefinite terms and expired concessions under negotiation
are amortized over the useful lives of the underlying assets.
By December 31, 2010, 201 concession program contracts
were signed (2009-174 concession program contracts). In
February 2011 the Company restarted the operation in the
municipality of Tarumă by judicial order.
Management believes that all concessions expired and not
yet renewed will result in new contracts or contract extensions,
disregarding the risk of discontinuity in the provision of munic-
ipal water supply and sewage services. As of December 31,
2010, the carrying amount of the underlying assets used in
the 119 concessions of the municipalities under negotiation
totaled R$ 5,465 million and the related revenue for the year
then ended totaled R$ 2,591 million.
The Company’s operations are concentrated in the mu-
nicipality of Săo Paulo, which accounted for 54.66% of the
gross revenues in 2010. On June 23, 2010, the State of Săo
Paulo, the Municipality of Săo Paulo, the Company and the
regulatory agency “Agência Reguladora de Saneamento e
Energia—ARSESP” signed an agreement to share the re-
sponsibility for water supply and sewage services to the Mu-
nicipality of Săo Paulo based on a 30-year concession agree-
ment. This agreement is extendable for another 30 years.
This agreement sets forth SABESP as the exclusive service
provider and designates ARSESP as regulator, establishing
prices, controlling and monitoring services.
Also, on June 23, 2010, the State of Săo Paulo, the city
of Săo Paulo and SABESP signed the “Public service provi-
sion agreement of water supply and sewage services,” a 30-
year concession agreement which is extendable for another
30 years. This agreement involves the following activities:
(i) protection of the sources of water in collaboration with
other agencies of the State and the City;
(ii) capture, transport and treatment of water;
(iii) collect, transport, treatment and final disposal of sani-
tary sewage; and
(iv) adoption of other actions of basic and environmental
sanitation.
In the municipality of Santos, in the Baixada Santista region,
which has a significant population, the Company operates
under an authorization by public deed, a situation similar to
other municipalities in that region and in the Ribeira valley,
where the Company started to operate after the merger of
the companies that formed it.
On January 5, 2007, Law 11,445 was enacted, establish-
ing the basic sanitation regulatory framework, providing for
the nationwide guidelines and basic principles for the provi-
sion of such services, such as social control, transparency,
the integration authority of sanitation infrastructure, water re-
sources management, and the articulation between industry
policies and public policies for urban and regional develop-
ment, housing, suppression of poverty, promotion of health
and environmental protection, and other related issues.
The Company’s shares have been listed in the Novo Mer-
cado (New Market) segment of BM&FBOVESPA (the Săo
Paulo Stock Exchange) since April 2002 and on the New York
Stock Exchange (NYSE) as American Depositary Receipts
(“ADRs”) since May 2002.
These financial statements were approved by the Board of
Directors on June 2, 2011.
Basis of Presentation, Statement of
Compliance, Going Concern Assessment
1.72
Anooraq Resources Corporation (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Nature of Operations
Anooraq Resources Corporation (“Company” or “Anooraq”)
is incorporated in the Province of British Columbia, Canada.
The consolidated financial statements of the Company as at
31 December 2010 and 2009 and for the years ended 31 De-
cember 2010, 2009 and 2008 comprise the Company and its
subsidiaries (together referred to as the “Group” and individ-
ually as “Group entities”) and the Group’s interest in asso-
ciates, special purpose entities and jointly controlled entities.
Its principal business activity is the mining and exploration of
Platinum Group Metals (“PGM”) through its mineral property
interests. The Company focuses on mineral property interests
located in the Republic of South Africa in the Bushveld Com-
plex. Anooraq operates in South Africa through its wholly-
owned subsidiary Plateau Resources (Proprietary) Limited
(“Plateau”) which owns the Group’s various mineral property
interests and conducted the Group’s business in South Africa.
2. Going Concern
The consolidated financial statements are prepared on the
basis that the Group will continue as a going concern which
contemplates the realisation of assets and settlement of li-
abilities in the normal course of operations as they become
due.
As a result of the acquisition of the operating mine (re-
fer note 34) in 2009, the Group secured various funding ar-
rangements (refer note 19) in order to fund the purchase con-
sideration and to fund its planned business objectives. The
funding agreements included securing a long-term credit fa-
cility, the Operating Cash Flow Shortfall Facility (“OCSF”), with
Rustenburg Platinum Mines Limited (“RPM”) for an amount of
$222 million (ZAR 1,470 million). The facility is used to fund
operating cash and capital requirements for an initial period
of three years. As at 31 December 2010, the Group utilised
$112 million (ZAR 741.4 million) thereof to fund operating re-
quirements from 1 July 2009 as the mining operations are not
currently generating sufficient cash flows to fund operations
and operational projects. The Group has no significant obliga-
tion to repay interest and capital on its outstanding loans and
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borrowings during 2011 even though the Group did not meet
certain loan covenants at 31 December 2010 (refer note 19).
As a result of securing the financial resources and long-
term funding, management expects that cash flows from the
mining operations and the OCSF will be sufficient to meet
immediate ongoing operating and capital cash requirements
of the Group.
The Group is currently pursuing various alternative funding
structures to achieve a more affordable debt equity level as
management believes that the Group would not be able to
service the repayments on the loans and borrowings once it
becomes due in the medium to long term.
3. Basis of Presentation
3.1 Statement of Compliance
The consolidated financial statements have been prepared in
accordance with International Financial Reporting Standards
(“IFRS”) as issued by the International Accounting Standards
Board.
3.2 Basis of Measurement
The consolidated financial statements have been prepared
on the historical cost basis as set out in the accounting poli-
cies below. Certain items, including derivative financial instru-
ments, are stated at fair value.
3.3 Use of Estimates and Judgements
The preparation of the consolidated financial statements in
accordance with IFRS requires management to make judge-
ments, estimates and assumptions that affect the application
of accounting policies and the reported amounts of assets,
liabilities, income and expenses. Actual results may differ from
these estimates.
Estimates and underlying assumptions are reviewed on an
ongoing basis. Revisions to accounting estimates are recog-
nised in the period in which the estimates are revised and in
any future periods affected.
Information about critical judgements in applying account-
ing policies that have the most significant effect on the
amounts recognised in the consolidated financial statements





National Grid plc (Mar 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS
H. Taxation (in part)
Deferred Tax and Investment Tax Credits
Deferred tax is provided for using the balance sheet liability
method and is recognised on temporary differences between
the carrying amount of assets and liabilities in the financial
statements and the corresponding tax bases used in the com-
putation of taxable profit.
Deferred tax liabilities are generally recognised on all tax-
able temporary differences and deferred tax assets are recog-
nised to the extent that it is probable that taxable profits will
be available against which deductible temporary differences
can be utilised. Such assets and liabilities are not recognised
if the temporary difference arises from the initial recognition
of goodwill or from the initial recognition of other assets and
liabilities in a transaction (other than a business combination)
that affects neither the accounting nor taxable profit or loss.
Deferred tax liabilities are recognised on taxable temporary
differences arising on investments in subsidiaries and jointly
controlled entities, except where the Company is able to con-
trol the reversal of the temporary difference and it is probable
that the temporary difference will not reverse in the foresee-
able future.
Deferred tax is calculated at the tax rates that are expected
to apply in the period when the liability is settled or the asset is
realised, based on the tax rates and tax laws that have been
enacted or substantively enacted by the balance sheet date.
Deferred tax is charged or credited to the income statement,
except to the extent that it relates to items recognised in other
comprehensive income or directly in equity. In these cases
the tax is also recognised in other comprehensive income or
directly in equity, respectively.
The carrying amount of deferred tax assets is reviewed at
each balance sheet date and reduced to the extent that it is no
longer probable that sufficient taxable profits will be available
to allow all or part of the deferred tax asset to be recovered.
Unrecognised deferred tax assets are reassessed at each
balance sheet date and are recognised to the extent that it
has become probable that future taxable profits will allow the
deferred tax asset to be recovered.
Deferred tax assets and liabilities are offset when there is a
legally enforceable right to set off current tax assets against
current tax liabilities and when they relate to income taxes
levied by the same taxation authority and the Company and
its subsidiaries intend to settle their current tax assets and
liabilities on a net basis.
Investment tax credits are amortised over the economic life
of the assets that give rise to the credits.
Offsetting—Pension Obligtations
1.74
Givaudan SA (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
The significant accounting policies applied in the preparation
of these consolidated financial statements are set out below.
These policies have been consistently applied to all years
presented, unless otherwise stated.
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2.8 Employee Benefit Costs (in part)
Wages, salaries, social security contributions, annual leave
and paid sick leave, bonuses and non-monetary benefits are
expensed in the year in which the associated services are
rendered by the Group’s employees.
Pension Obligations
A defined benefit plan is a pension plan that defines an
amount of pension benefit that an employee will receive on
retirement, principally dependent on an employee’s years of
service and remuneration at retirement. Plans are usually
funded by payments from the Group and employees to fi-
nancially independent trusts. The liability recognised in the
statement of financial position is the aggregate of the present
value of the defined benefits obligation at the statement of
financial position date less the fair value of plan assets, to-
gether with adjustments for unrecognised actuarial gains and
losses, and past service costs not yet recognised. If the ag-
gregate is negative, the asset is measured at the lower of such
aggregate or the aggregate of cumulative unrecognised net
actuarial losses and past service costs and the present value
of any economic benefits available in the form of refunds from
the plan or reductions in the future contributions to the plan.
The present value of the defined benefits obligation and the
related current service cost are calculated annually by inde-
pendent actuaries using the projected unit credit method. This
reflects the discounted expected future payment required to
settle the obligation resulting from employee service in the
current and prior periods. The future cash outflows incorpo-
rate actuarial assumptions primarily regarding the projected
rates of remuneration growth, long-term expected rates of re-
turn on plan assets, and long-term indexation rates. Discount
rates, used to determine the present value of the defined ben-
efit obligation, are based on the market yields of high-quality
corporate bonds in the country concerned. A portion, repre-
senting 10% of the greater of the present value of the defined
benefit obligation and the fair value of plan assets, of the differ-
ences between assumptions and actual experiences, as well
as the effects of changes in actuarial assumptions are recog-
nised over the estimated average remaining working lives of
employees.
Where a plan is unfunded, a liability is recognised in the
statement of financial position. A portion, representing 10% of
the present value of the defined benefit obligation, of the differ-
ences between assumptions and actual experiences, as well
as the effects of changes in actuarial assumptions are recog-
nised over the estimated average remaining working lives of
employees. Past service costs are amortised over the aver-
age period until the benefits become vested. Pension assets
and liabilities in different defined benefit schemes are not off-
set unless the Group has a legally enforceable right to use
the surplus in one plan to settle obligations in the other plan.
A defined contribution plan is a pension plan under which
the Group pays fixed contributions into publicly or privately
administrated funds. The Group has no further payment obli-
gations once the contributions have been made. The contri-




Turkcell Iletisim Hizmetleri AS (Dec 2010)
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended 31 December 2010
(Amounts expressed in thousands of US Dollars unless oth-
erwise indicated except share amounts)
Note 2010 2009 2008
Cash Flows From Operating Activities
Profit for the year 1,126,961 1,104,804 1,755,062
Adjustments for:
Depreciation and impairment of fixed assets 12 515,515 384,257 433,942
Amortization of intangible assets 13 241,839 206,421 245,985
Net finance (income) 10 (237,628) (254,582) (393,671)
Income tax expense 11 320,799 340,093 549,758
Share of profit of equity accounted investees (154,457) (115,240) (151,629)
(Gain)/loss on sale of property, plant and equipment 101 25,150 (6,931)
Gain on sale of subsidiary — — (4,727)
Unrealized foreign exchange gain and loss on operating assets (5,847) 88,572 (228,033)
Impairment losses on goodwill 23,499 61,835 —
Provision for impairment of trade receivables 18 126,257 75,379 68,550
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Note 2010 2009 2008
Change in trade receivables 18 (204,403) (269,360) (214,220)
Change in due from related parties 33 28,752 (20,312) 2,124
Change in inventories 3,083 (8,662) (267)
Change in other current assets 19 (29,389) (37,099) (27,208)
Change in other non-current assets 16 (29,011) (21,272) (10,704)
Change in due to related parties 33 (3,775) (6,290) (6,541)
Change in trade and other payables 32,541 180,469 66,690
Change in other current liabilities (96,118) (115,306) 206,537
Change in other non-current liabilities 23 (14,051) (82,893) 52,452
Change in employee benefits 25 2,690 942 5,773
Change in provisions 27 (45,102) 123,644 29,704
1,524,402 1,657,584 2,369,353
Interest paid (38,829) (29,497) (25,050)
Income tax paid (322,754) (395,024) (687,292)
Dividends received 99,759 83,543 89,235
Net cash generated by operating activities 1,262,578 1,316,606 1,746,246
Cash Flows from Investing Activities
Acquisition of property, plant and equipment (912,097) (1,044,165) (603,568)
Acquisition of intangible assets 12 (132,827) (723,507) (193,219)
Proceeds from sale of property, plant and equipment 13 8,506 4,471 16,693
Proceeds from currency option contracts 12,147 10,549 14,655
Payment of currency option contracts premium (4,988) (1,150) (4,970)
Acquisition of available-for-sale securities (16,762) (83,951) (47,549)
Proceeds from sale of available-for-sale securities 70,528 32,015 78,542
Acquisition of subsidiary, net of cash acquired — — (309,967)
Interest received 270,602 320,697 354,211
Net cash used in investing activities (704,891) (1,485,041) (695,172)
Cash Flows From Financing Activities
Proceeds from issuance of loans and borrowings 1,071,777 1,692,866 601,000
Loan transaction costs (12,100) (14,357) —
Repayment of borrowings (772,892) (944,133) (487,999)
Change in non-controlling interest 89 — 72,199
Proceeds from capital contribution — 4,570 18,202
Dividends paid (590,541) (744,380) (556,973)
Net cash used in financing activities (303,667) (5,434) (353,571)
Net decrease/(increase) in cash and cash equivalents 254,020 (173,869) 697,503
Cash and cash equivalents at 1 January 3,090,242 3,255,420 3,093,175
Effects of foreign exchange rate fluctuations on cash and cash equivalents 20 (47,995) 8,691 (535,258)
Cash and cash equivalents at 31 December 20 3,296,267 3,090,242 3,255,420
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Basis of Preparation (in part)
Comparative Information and Revision of Prior Period
Financial Statements
The consolidated financial statements of the Group have been
prepared with the prior periods on a comparable basis in or-
der to give consistent information about the financial position
and performance. If the presentation or classification of the
financial statements is changed, in order to maintain consis-
tency, the financial statements of the prior periods are also
reclassified in line with the related changes.
The Company has for 2010 revised the manner in which it
accounts for the impact of changes in foreign exchange rates
in its statement of cash flows and has revised its presenta-
tion of prior periods, resulting in a change in the allocation of
the impact of foreign exchange rate changes among “Oper-
ating activities,” “Effects of foreign exchange on statement of
financial position items” and “Effect of foreign exchange rate
changes on cash” in the statement of cash flows. The change
relates to the impact of re-translation of the underlying func-
tional currency cash flows into the presentation currency, the
US Dollar. The Company believes that changes to prior peri-
ods are immaterial. The change in the statement of cash flows
will not impact the Company’s previously reported statement
of income, statement of comprehensive income, statement of
financial positions or “Cash and cash equivalents” at the end
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of any period. The effect of the change on the statement of
cash flows is as follows:
For the Year Ended 31 December 2009
As Previously
Reported Revisions As Revised
Net cash from operating activities 1,294,935 21,671 1,316,606
Effects of foreign exchange on statement of financial position items 30,938 (30,938) —
Effects of foreign exchange rate changes on cash (576) 9,267 8,691
Cash and cash equivalents 3,090,242 — 3,090,242
For the Year Ended 31 December 2008
As Previously
Reported Revisions As Revised
Net cash from operating activities 1,674,385 71,861 1,746,246
Effects of foreign exchange on statement of financial position items (418,945) 418,945 —
Effects of foreign exchange rate changes on cash (44,452) (490,806) (535,258)
Cash and cash equivalents 3,255,420 — 3,255,420
Reclassifications and Restatements
1.76
JSC BTA Bank (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION (in part)




Cash and cash equivalents 8 100,790 78,215
Obligatory reserves 9 40 145
Trading securities 10 82,257 115,784
Amounts due from credit institutions 11 25,177 31,444
Derivative financial assets 12 4,795 25,980
Investment securities:
—available-for-sale 13 21,110 19,019
—held-to-maturity 13 7,321 —
Loans to customers 14 787,618 1,040,773
Bonds of NWF Samruk-Kazyna 15 142,017 175,907
Bonds of NWF Samruk-Kazyna pledged under repurchase agreement 15 388,946 336,339
Investments in associates 16 90,326 85,088
Property and equipment 10,664 9,911
Goodwill 17 3,786 1,841
Current corporate income tax asset 19 5,366 5,708
Deferred corporate income tax assets 19 159,735 5,267
Other assets 65,762 37,238
Total assets 1,895,710 1,968,659
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Basis of Preparation (in part)
Statement of Compliance
These consolidated financial statements have been prepared
in accordance with International Financial Reporting Stan-
dards (“IFRS”).
General
These financial statements are presented in millions of
Kazakh tenge (“KZT” or “tenge”), except per share amounts
and unless otherwise indicated. The KZT is utilized as the
shareholders, the managers and the regulators measure the
Group’s performance in KZT. In addition, the KZT, being the
national currency of the Republic of Kazakhstan, is the cur-
rency that reflects the economic substance of the underlying
events and circumstances relevant to the Group. Significant
foreign currency positions are maintained as they are neces-
sary to meet customers’ requirements, manage foreign cur-
rency risks and achieve a proper assets and liabilities struc-
ture of the Group. Transactions in other currencies are treated
as transactions in foreign currencies.
The consolidated financial statements are prepared under
the historical cost convention modified for the measurement
at fair value of available-for-sale investment securities, trad-
ing securities and derivative contracts as required by IAS 39
“Financial Instruments: Recognition and Measurement.”
Reclassifications:
Reclassification of the 2009 amounts to comply with presen-
tation of 2010 was as follows:
31 December 2009
As Presented
Earlier Reclassification As Reclassified Comments
Statement of Financial Position
Bonds of NWF Samruk-Kazyna 512,246 (336,339) 175,907
Bonds of NWF Samruk-Kazyna pledged under
repurchase agreement — 336,339 336,339
Reclassification from bonds of
NWF Samruk-Kazyna to bonds




SAP AG (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION OF SAP GROUP (in part)
As at December 31,
(Unaudited)
2010(1) 2010 2009
Millions Note US$ € €
Issued capital 1,628 1,227 1,226
Share premium 447 337 317
Retained earnings 12,960 9,767 8,571
Other components of equity (188) (142) (317)
Treasury shares (1,834) (1,382) (1,320)
Equity attributable to owners of parent 13,013 9,807 8,477
Non-controlling interests 23 17 14
Total equity (21) 13,035 9,824 8,491
Equity and liabilities 27,654 20,841 13,374
(1) The 2010 figures have been translated solely for the convenience of the reader at an exchange rate of US$1.3269 to €1.00, the Noon Buying
Rate certified by the Federal Reserve Bank of New York on December 30, 2010.
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As at December 31, 2010, SAP AG had issued 1,226,822,697
no-par shares (December 31, 2009: 1,226,039,608) with a
calculated nominal value of €1 per share. All the shares
issued are fully paid. The following table shows the changes
in the number and the value of issued shares and treasury
shares in millions.
Number of Shares in Millions Value in € Millions
Issued Capital Treasury Shares Issued Capital Treasury Shares
January 1, 2008 1,246 -48 1,246 -1,734
Issuing shares under share-based payment programs 1 0 1 0
Purchase of treasury shares 0 -14 0 -487
Cancellation of treasury shares -21 21 -21 744
Reissuance of treasury shares under share-based payment programs 0 3 0 115
December 31, 2008 1,226 -38 1,226 -1,362
Issuing shares under share-based payment programs 0 0 0 0
Reissuance of treasury shares under share-based payment programs 0 1 0 42
December 31, 2009 1,226 -37 1,226 -1,320
Issuing shares under share-based payment programs 1 0 1 0
Purchase of treasury shares 0 -6 0 -220
Reissuance of treasury shares under share-based payment programs 0 4 0 158
December 31, 2010 1,227 -39 1,227 -1,382
The line item “Shares issued to service convertible bonds and
stock options exercised” relates to the exercise of awards
granted to employees under certain share-based payment
plans and the shares purchased by employees under the
Share Matching Plan 2010 (see Note 28).
Authorized Shares
The Articles of Incorporation authorize the Executive Board of
SAP AG (the Executive Board) to increase the issued capital:
• Up to a total amount of €250 million through the is-
suance of new common shares in return for contribu-
tions in cash until June 7, 2015 (Authorized Capital Ia).
The issuance is subject to the statutory subscription
rights of existing shareholders.
• Up to a total amount of €250 million through the is-
suance of new common shares in return for contribu-
tions in cash or in kind until June 7, 2015 (Authorized
Capital IIa). Subject to certain preconditions and the
consent of the Supervisory Board, the Executive Board
is authorized to exclude the shareholders’ statutory sub-
scription rights.
• Up to a total amount of €30 million through the issuance
of new common shares in return for contributions in cash
or in kind until June 7, 2015 (Authorized Capital III). The
new shares can only be used for share-based compen-
sation (as employee shares). Shareholders’ subscrip-
tion rights are excluded.
Contingent Shares
SAP AG’s issued capital is subject to a contingent increase
of common shares. The contingent increase may be effected
only to the extent that the holders of the convertible bonds
and stock options that were issued by SAP AG under cer-
tain share-based payment plans (see Note 28) exercise their
conversion or subscription rights. As at December 31, 2010,
€207 million, representing 207 million shares, is still available
for issuance (2009: €208 million).
Share Premium
Share premium represents all capital contributed to SAP with
the proceeds resulting from the issuance of issued capital
in excess of their calculated par value. Share premium arises
mainly from issuance of issued capital, treasury shares trans-
actions and share-based compensation transactions.
Retained Earnings
Retained earnings contain prior years’ undistributed profit af-
ter tax and unrecognized pension costs. Unrecognized pen-
sion costs comprise actuarial gains and losses relating to de-
fined benefit pension plans and similar obligations.
Treasury Shares
By resolution of SAP AG’s Annual General Meeting of Share-
holders held on June 8, 2010, the Executive Board of SAP
AG was authorized to acquire, on or before June 30, 2013,
up to 120 million shares in the Company on the condition that
such share purchases, together with any previously acquired
shares, do not account for more than 10% of SAP AG’s is-
sued capital. Although treasury shares are legally considered
outstanding, there are no dividend or voting rights associ-
ated with shares held in treasury. We may redeem or resell
shares held in treasury or we may use treasury shares for the
purpose of servicing subscription rights and conversion rights
under the Company’s share-based payment plans. Also, we
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may use the shares held in treasury as consideration in con-
nection with the acquisition of other companies.
The Company purchased no SAP American depository re-
ceipts (ADRs) in 2010, 2009, or 2008, (each ADR represents
one common share of SAP AG). The Company held no SAP
ADRs as at December 31, 2010, 2009, and 2008, respectively.
Miscellaneous
Under the German Stock Corporation Act (Aktiengesetz), the
total amount of dividends available for distribution to SAP AG’s
shareholders is based on the earnings of SAP AG as reported
in its statutory financial statements, which are determined un-
der the accounting rules stipulated by the German Commer-
cial Code (Handelsgesetzbuch). For the year ended Decem-
ber 31, 2010, the Executive Board and the Supervisory Board
of SAP AG intend to propose a dividend of €0.60 per share
(estimated to be €713 million).
Dividends per share for both 2009 and 2008 were €0.50
and were paid in the succeeding year.
(22) Additional Capital Disclosures
Capital Structure Management
The primary objective of our capital structure management
is to maintain a strong financial profile for investor, creditor,
and customer confidence, and to support the growth of our
business. We aim for a capital structure that gives us a high
degree of independence, security, and financial flexibility so
that we can, for example, access capital markets on reason-
able terms to satisfy funding requirements.
We currently do not have a credit rating with any agency.
We do not believe that a rating would have a substantial effect





% of Equity and
Liabilities € Millions
% of Equity and
Liabilities % Change
Total equity 9,824 47 8,491 63 16
Total current liabilities 5,149 25 3,416 26 51
Total noncurrent liabilities 5,868 28 1,467 11 300
Total liabilities 11,017 53 4,883 37 126
Equity and liabilities 20,841 100 13,374 100 56
Until 2010, we were mainly equity-financed, but our debt ratio
(defined as the ratio of total liabilities to equity and liabilities)
increased to 53% at the end of 2010 (as compared to 37% at
the end of 2009) mainly due to the issuance of bank loans,
bonds and private placements in connection with the Sybase
acquisition. For the same reason, the ratio of total financial
debt to equity and liabilities increased to 21% at the end of
2010 (as compared to 5% at the end of 2009). Total financial
debt consists of bank loans, bonds, and private placements.
While we monitor those ratios continuously, our main focus is
on the management of our net liquidity position as outlined in
the following table:





Cash and cash equivalents 3,518 1,884 1,634
Current investments 10 400 -390
Total group liquidity 3,528 2,284 1,244
Current bank loans 1 4 -3
Net liquidity 1 3,527 2,280 1,247
Non-current bank loans 1,106 2 1,104
Private placement
transactions 1,071 697 374
Bonds 2,200 0 2,200
Net liquidity 2 -850 1,581 -2,431
Our net liquidity position is defined as cash, cash equivalents,
and current investments, less financial debt, which consists
of bank loans, bonds, and private placements. Our goal is to
continuously maintain a positive net liquidity position. How-
ever, we might deviate from that goal for a limited period of
time due to large acquisitions that require us to enter into
financing instruments. For example, this is the case as of De-
cember 31, 2010, due to the acquisition of Sybase, which we
financed with cash on hand and significant financial debt. We
structured the maturity profile of the additional financial debt
in a balanced way, so that our target of a positive net liquidity
position could be reached as quickly as possible given our
underlying cash flow planning.
Our goal is to remain in a position to return excess liquid-
ity to our shareholders by distributing annual dividends and
repurchasing shares. The amount of future dividends and
the extent of future repurchases of shares will be balanced
with our effort to continue to maintain an adequate liquidity
position.
In each of 2010, 2009, and 2008, we were able to dis-
tribute €594 million in dividends from our 2009, 2008, and
2007 profit. Aside from the distributed dividend, in 2010 and
2008 we also returned €220 and €487 million respectively to
our shareholders by repurchasing our own shares (no share
repurchase occurred in 2009).
Commitments exist to reissue treasury shares or issue
common shares in connection with our equity-settled share-
based payment plans as described in Note (28). In all
years presented we have satisfied and we expect to con-
tinue to satisfy commitments resulting from our equity-settled
share-based payment plans through both reissuance of trea-
sury shares and capital increases.
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UBS AG’s capital disclosures are extensive. UBS in-
corporates many of the capital disclosures required by
IAS 1 by reference to the Treasury and Risk Manage-
ment section of the annual report. This excerpt includes
part of those referenced disclosures.
UBS AG (Dec 2010)
BALANCE SHEET (in part)
% Change
From
CHF Million Note 31.12.10 31.12.09 31.12.08 31.12.09
Equity
Share capital 383 356 293 8
Share premium 34,393 34,824 25,288 (1)
Cumulative net income recognized directly in equity, net of tax (6,534) (4,875) (4,335) (34)
Retained earnings 19,285 11,751 14,487 64
Equity classified as obligation to purchase own shares (54) (2) (46)
Treasury shares (654) (1,040) (3,156) 37
Equity attributable to UBS shareholders 46,820 41,013 32,531 14
Equity attributable to non-controlling interests 5,043 7,620 8,002 (34)
Total equity 51,863 48,633 40,533 7
Total liabilities and equity 1,317,247 1,340,538 2,014,815 (2)


































Balance at 31 December 2009 356 34,824 (1,040) (2) 11,751 (6,445) 364 1,206 41,013 7,620 48,633
Issuance of share capital 27 27 27
Acquisition of treasury shares (1,574) (1,574) (1,574)
Disposition of treasury shares 1,960 1,960 1,960
Net premium/(discount) on
treasury share and own equity
derivative activity (43) (43) (43)
Premium on shares issued and
warrants exercised (27) (27) (27)
Employee share and share option
plans (104) (104) (104)
Tax benefits from deferred
compensation awards (8) (8) (8)
Transaction costs related to share
issuances, net of tax (113) (113) (113)
Dividends(1) 0 (305) (305)
Equity classified as obligation to
purchase own
shares—movements (52) (52) (52)
Preferred securities 0 (1,529) (1,529)
New consolidations and other
increases (136) (136) 6 (130)
Deconsolidations and other
decreases 0 (264) (264)
Total comprehensive income for
the year recognized in equity 7,534 (909) (607) (143) 5,875 (484) 5,391
Balance at 31 December 2010 383 34,393 (654) (54) 19,285 (7,354) (243) 1,063 46,820 5,043 51,863
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Preferred Securities(1) For the Year Ended
CHF Million 31.12.10 31.12.09 31.12.08
Balance at the beginning of the year 7,254 7,381 6,381
Issuances 1,618
Redemptions (1,529) (7)
Foreign currency translation (818) (120) (618)
Balance at the end of the year 4,907 7,254 7,381
(1) Represents equity attributable to non-controlling interests. Increases and offsetting decreases of equity attributable to non-controlling
interests due to dividends are excluded from this table.
For the Year Ended % Change From
Number of Shares 31.12.10 31.12.09 31.12.08 31.12.09
Shares Issued
Balance at the beginning of the year 3,558,112,753 2,932,580,549 2,073,547,344 21
Issuance of shares 272,727,760 625,532,204 859,033,205 (56)
Balance at the end of the year 3,830,840,513 3,558,112,753 2,932,580,549 8
Treasury Shares
Balance at the beginning of the year 37,553,872 61,903,121 158,105,524 (39)
Acquisitions 105,824,816 33,566,097 13,398,118 215
Disposals (104,486,657) (57,915,346) (109,600,521) (80)
Balance at the end of the year 38,892,031 37,553,872 61,903,121 4
Shares Issued
On 5 March 2010, the mandatory convertible notes (MCNs)
with a notional value of CHF 13 billion issued in March 2008
to the Government of Singapore Investment Corporation Pte.
Ltd. and an investor from the Middle East were converted into
UBS shares. The notes were converted at a price of CHF
47.68 per share. As a result, UBS issued 272,651,005 new
shares with a nominal value of CHF 0.10 each from existing
conditional capital. The MCNs were treated as equity instru-
ments and recognized in Share premium. The conversion of
the MCNs resulted in a reclassification of CHF 27 million from
Share premium to Share capital.
Conditional Share Capital
On 31 December 2010, 149,920,712 shares were available
for issue to fund UBS’s employee share option programs. In
addition, conditional capital of up to 100,000,000 shares was
available in connection with the Swiss National Bank (SNB)
transaction. Furthermore, on 14 April 2010 the Annual Gen-
eral Meeting of UBS AG approved the creation of conditional
capital up to a maximum amount of 380,000,000 shares for
conversion rights/warrants granted in connection with the is-
suance of bonds or similar financial instruments. These posi-
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STATEMENT OF CASH FLOWS (in part)
For the Year Ended
CHF Million 31.12.10 31.12.09 31.12.08
Cash flow from/(used in) financing activities
Net money market papers issued/(repaid) 4,459 (60,040) (40,637)
Net movements in treasury shares and own equity derivative activity (1,456) 673 623
Capital issuance (113) 3,726 23,135
Issuance of long-term debt, including financial liabilities designated at fair value 78,418 67,062 103,087
Repayment of long-term debt, including financial liabilities designated at fair value (77,497) (65,024) (92,894)
Increase in non-controlling interests(1) 6 3 1,661
Dividends paid to/decrease in non-controlling interests (2,053) (583) (532)
Net cash flow from/(used in) financing activities 1,764 (54,183) (5,557)
Effects of exchange rate differences (12,181) 5,529 (39,186)
Net increase/(decrease) in cash and cash equivalents (24,151) (14,721) 30,588
Cash and cash equivalents at the beginning of the year 164,973 179,693 149,105
Cash and cash equivalents at the end of the year 140,822 164,973 179,693
Cash and cash equivalents comprise:
Cash and balances with central banks 26,939 20,899 32,744
Money market papers(2) 77,998 98,432 86,732
Due from banks with original maturity of less than three months(3) 35,885 45,642 60,217
Total 140,822 164,973 179,693
(1) Includes issuance of preferred securities of CHF 1,617 million for the year ended 31 December 2008.
(2) Money market papers are included in the balance sheet under Trading portfolio assets, Trading portfolio assets pledged as collateral and
Financial investments available-for-sale. CHF 39,768 million, CHF 57,116 million and CHF 19,912 million were pledged at 31 December
2010, 31 December 2009 and 31 December 2008, respectively.
(3) Includes positions recognized in the balance sheet under Due from banks and Cash collateral receivables on derivative instruments.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1. Summary of Significant Accounting Policies
(in part)
a) Significant Accounting Policies (in part)
The principal accounting policies applied in the preparation
of these consolidated financial statements are set out below.
These policies have been consistently applied to all the years
presented, unless otherwise stated.
1) Basis of Accounting
UBS AG and subsidiaries (“UBS” or the “Group”) provide a
broad range of financial services including: advisory services,
underwriting, financing, market making, asset management
and brokerage on a global level and retail banking in Switzer-
land. The Group was formed on 29 June 1998 when Swiss
Bank Corporation and Union Bank of Switzerland merged.
The merger was accounted for using the uniting of interests
method of accounting.
The consolidated financial statements of UBS (the “Finan-
cial Statements”) are prepared in accordance with Interna-
tional Financial Reporting Standards (IFRS), as issued by
the International Accounting Standards Board (IASB), and
are stated in Swiss francs (CHF), the currency of Switzer-
land where UBS AG is incorporated. On 3 March 2011, the
Board of Directors approved them for issue.
Disclosures under IFRS 7 Financial Instruments: Disclo-
sures about the nature and extent of risks and capital dis-
closures under IAS 1 Presentation of Financial Statements
have been included in the audited parts of the “Risk and trea-
sury management” section. Several IFRS 7 credit risk-related
disclosures are provided in Note 29c.
Note 26. Capital Increase and Mandatory Convertible
Notes
Conversion of the Mandatory Convertible Notes Issued in
March 2008
On 5 March 2010, the mandatory convertible notes (MCNs)
with a notional value of CHF 13 billion issued in March 2008
to the Government of Singapore Investment Corporation Pte.
Ltd. and an investor from the Middle East were converted into
UBS shares. The notes were converted at a price of CHF
47.68 per share. As a result, UBS issued 272,651,005 new
shares with a nominal value of CHF 0.10 each from existing
conditional capital. The MCNs were treated as equity instru-
ments and recognized in Share premium. The conversion of
the MCNs resulted in a reclassification of CHF 27 million from
Share premium to Share capital.
THE FOLLOWING EXCERPTS ARE
INCORPORATED IN THE FINANCIAL STATEMENTS
BY REFERENCE
Treasury Management (in part)
Group Treasury oversees the balance sheet and the usage of
our critical financial resources including capital, liquidity and
funding. Treasury manages key portions of these resources
including the interest rate and currency risks arising from bal-
ance sheet and capital management activities.
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Capital Ratios, Risk-Weighted Assets And Eligible Capital
On 31 December 2010, our BIS tier 1 ratio was 17.8% and
the total capital ratio was 20.4%, up from 15.4% and 19.8%,
respectively, on 31 December 2009. BIS risk-weighted assets
declined from CHF 206.5 billion at the end of December 2009
to CHF 198.9 billion at the end of December 2010, while eligi-
ble tier 1 capital increased from CHF 31.8 billion to CHF 35.3
billion over the same period.
Equity Attribution
Group Treasury uses our equity attribution framework to guide
our businesses in the allocation of resources to opportunities
that are expected to provide the best risk-adjusted profitability
contributions.
Shares
As of 31 December 2010, we had a total of 3,830,840,513
shares issued. In 2010, the issued shares were increased by
a total of 272,727,760 shares. This was mainly due to our cap-
ital raising as CHF 13 billion in convertible notes (MCN) issued
in 2008 expired on 5 March 2010. The notes were mandatorily
converted into 272,651,005 newly issued shares, which rep-
resented 7.7% of our issued share capital at the time. Addi-
tionally there were a small number of exercises of conditional
capital due to exercises of employee options (76,755 shares).
Financial Resource Governance
Our Group Asset and Liability Management Committee
(Group ALCO) promotes the usage of our assets and liabil-
ities in line with our overall UBS Group (Group) strategy as
defined by the Board of Directors (BoD) and the Group Exec-
utive Board (GEB), our regulatory commitments and the inter-
ests of our shareholders and other stakeholders. The Group
ALCO manages the balance sheet of the business divisions
through allocation and monitoring of targets. In addition, the
Group ALCO manages our liquidity, funding and capital by
taking into account their business performance, overall risk
profile as well as market conditions.
Group Treasury provides Group ALCO with monthly report-
ing of our financial resources (e.g. balance sheet, capital, liq-
uidity and funding) in order for them to oversee and monitor
our asset and liability management policies and processes to
ensure their effectiveness under prevailing and prospective
conditions.
Capital Management
Eligible capital must be available to support business activ-
ities, in accordance with both our own internal assessment
and the requirements of our regulators, in particular our lead
regulator FINMA.
We aim to maintain sound capital ratios at all times, and
we therefore consider not only the current situation but also
projected business and regulatory developments. The main
tools we employ to manage our capital ratios are: the active
management of own shares, capital instruments, dividends
and RWA.
Capital Adequacy Management
Ongoing compliance with regulatory capital requirements and
target capital ratios is central to our capital adequacy man-
agement. In this process, we manage towards tier 1 and total
capital target ratios. In the target setting process we take into
account the current and future minimum requirements set by
regulators as well as their “buffer” expectations. Furthermore,
we consider our own internal assessment of aggregate risk
exposure in terms of capital-at-risk, the views of rating agen-
cies and comparisons with peer institutions.
• Refer to the “Risk management and control” section of
this report for more information on earnings-at-risk and
capital-at-risk.
Regulatory Requirements
We are subject to FINMA regulatory capital requirements,
which result in higher RWA than under BIS guidelines.
• Refer to the additional capital management disclosure
in the “Basel II Pillar 3” section of this report.
To allow for comparability, published RWA are determined in
accordance with the BIS guidelines. For the determination of
the eligible capital, there were no differences between BIS
guidelines and FINMA regulations as of 31 December 2010.
During 2010, we complied with all externally imposed cap-
ital requirements.
The Basel III revisions will have a negative impact on capital
(mainly due to the exclusion of deferred tax assets, pension
assets and hybrid tier 1 capital instruments for the calculation
of common equity) and also mean significantly higher RWA.
As a result, our common equity ratio would be materially lower
than our current BIS tier 1 ratio, if Basel III requirements were
effective immediately. It is therefore important to also con-
sider the Basel III transitional arrangements, which effectively
phase in the impacts on capital over several years.
• Refer to the “Regulatory developments” section of this
report for more information.
BIS Capital Ratios
The BIS capital ratios compare eligible capital (tier 1 and total
capital) with total RWA.
On 31 December 2010, our BIS tier 1 capital ratio stood
at 17.8% (up from 15.4% on 31 December 2009), our BIS
core tier 1 capital ratio stood at 15.3% (up from 11.9% on 31
December 2009), while our BIS total capital ratio was 20.4%
(up from 19.8% on 31 December 2009). Our BIS tier 1 capital
increased by CHF 3.5 billion to CHF 35.3 billion, while RWA
decreased to CHF 198.9 billion from CHF 206.5 billion.
• Refer to the discussions on “Capital adequacy man-
agement” and “Eligible capital” in this section for more
information.
Capital Requirements
Our capital requirements are based on our consolidated fi-
nancial statements in accordance with International Financial
Reporting Standards (IFRS), adjusted for regulatory differ-
ences. Under IFRS, subsidiaries and special purpose entities
that are directly or indirectly controlled by UBS must be con-
solidated, whereas for regulatory capital purposes, different
consolidation principles apply. For example, subsidiaries that
are not active in the banking and finance business are not
consolidated.
• Refer to the additional capital management disclosure
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On 31 December 2010, BIS RWA were CHF 198.9 billion,
compared with CHF 206.5 billion at year-end 2009. The anal-
ysis by component is as follows:
Treasury Management (in part)
Credit Risk
RWA for credit risk amounted to CHF 119.9 billion on 31 De-
cember 2010, compared with CHF 140.5 billion on 31 De-
cember 2009. The reduction was primarily related to lower
derivatives RWA of CHF 7.9 billion and reduced drawn expo-
sure RWA of CHF 8.7 billion, as well as a reduction in resi-
dential mortgage RWA of CHF 2.6 billion. These decreases
occurred mainly in the Investment Bank and Wealth Manage-
ment & Swiss Bank. The weakening of several major curren-
cies against the Swiss franc has been a significant contributor
to most of these RWA reductions.
• Refer to the “Credit risk” section of this report for more
information.
Non-Counterparty Related Assets
RWA for non-counterparty related assets amounted to CHF
6.2 billion on 31 December 2010, compared with CHF 7.0
billion on 31 December 2009.
Market Risk
In 2010, RWA for market risk increased by CHF 7.9 billion
to CHF 20.8 billion on 31 December 2010. This was due to
an increase in average regulatory VaR exposures, primarily
resulting from increased credit spread risk.
• Refer to the “Market risk” section of this report for more
information.
Operational Risk
RWA for operational risk increased to CHF 51.9 billion on 31
December 2010 from CHF 46.1 billion on 31 December 2009,
as agreed with FINMA.
• Refer to the “Operational risk” section of this report for
more information.
Eligible Capital
Eligible capital, the capital available to support RWA, consists
of tier 1 and tier 2 capital. To determine eligible tier 1 and
total capital, specific adjustments must be made to equity
attributable to our shareholders as defined by IFRS and as
shown on our balance sheet. The most notable adjustments
are the deductions for goodwill, intangible assets, investments
in unconsolidated entities engaged in banking and financial
activities and own credit effects on liabilities designated at fair
value.
Tier 1 Capital
Tier 1 capital amounted to CHF 35.3 billion on 31 December
2010, compared with CHF 31.8 billion on 31 December 2009,
an increase of CHF 3.5 billion. The positive contributors to
this increase were the CHF 7.5 billion net profit attributable
to UBS shareholders and the reversals of own credit losses
of CHF 0.5 billion. These effects were partially offset by a
redemption of hybrid tier 1 capital of CHF 1.5 billion, increased
tier 1 deductions of CHF 1.0 billion (securitization exposures
and other deduction items), negative effects relating to share-
based compensation net of tax of CHF 0.9 billion, as well as
currency effects of CHF 0.6 billion and other effects of CHF
0.5 billion.
Hybrid Tier 1 Capital
These instruments are perpetual and can only be redeemed
if they are called by the issuer after having received regu-
latory approval. The payment of interest is subject to com-
pliance with minimum capital ratios and other requirements.
Any missed payment is non-cumulative. As of 31 December
2010, our hybrid tier 1 instruments amounted to CHF 4.9 bil-
lion, down from CHF 7.2 billion as of 31 December 2009.
Under IFRS, these instruments are accounted for as equity
attributable to non-controlling interests.
Tier 2 Capital
These instruments consist mainly of our subordinated long-
term debt that ranks senior to both our shares and hybrid tier
1 instruments but is subordinated to all our senior obligations.
Tier 2 capital net of tier 2 deductions accounted for CHF 5.2
billion in total capital as of year-end 2010. In 2010, we re-
deemed a floating rate EUR 1.2 billion subordinated bond.
• Refer to the “Shares and capital instruments” section of
this report for more information.
Capital Adequacy
CHF Million, Except Where Indicated 31.12.10 31.12.09
BIS core tier 1 capital 30,420 24,574
BIS tier 1 capital 35,323 31,798
BIS total capital 40,542 40,941
BIS core tier 1 capital ratio (%) 15.3 11.9
BIS tier 1 capital ratio (%) 17.8 15.4
BIS total capital ratio (%) 20.4 19.8
BIS risk-weighted assets 198,875 206,525
of which: credit risk(1) 119,919 140,494
of which: non-counterparty related risk 6,195 7,026
of which: market risk 20,813 12,861
of which: operational risk 51,948 46,144
(1) Includes securitization exposures and equity exposures not part
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Capital Components
CHF Million 31.12.10 31.12.09
BIS core tier 1 capital prior to deductions(1) 46,365 40,144
of which: paid-in share capital 383 356
of which: share premium, retained earnings,
currency translation differences and other
elements 45,982 39,788
Less: treasury shares/deduction for own
shares(2) (2,993) (2,424)
Less: goodwill & intangible assets (9,822) (11,008)
Less: securitization exposures(3) (2,385) (1,506)
Less: other deduction items(4) (744) (632)
BIS core tier 1 capital 30,420 24,574
Hybrid tier 1 capital 4,903 7,224
of which: non-innovative capital instruments 1,523 1,785
of which: innovative capital instruments 3,380 5,438
BIS tier 1 capital 35,323 31,798
Upper tier 2 capital 110 50
Lower tier 2 capital 8,239 11,231
Less: securitization exposures(3) (2,385) (1,506)
Less: other deduction items(4) (744) (632)
BIS total capital 40,542 40,941
(1) “BIS core tier 1 capital prior to deductions” plus “Hybrid tier 1
capital” less “treasury shares/deduction for own shares” equals
“Total equity/gross tier 1 including hybrid tier 1 instruments” in
the “Reconciliation of IFRS equity to BIS tier 1 capital” table.
(2) Consists of: i) net long position in own shares held for trading
purposes; ii) own shares bought for unvested or upcoming share
awards; and iii) accruals built for upcoming share awards.
(3) Includes a 50% deduction of the fair value of UBS’s option to ac-
quire the SNB StabFund’s equity (CHF 1,781 million on 31.12.10
and CHF 1,216 million on 31.12.09).
(4) Positions to be deducted as 50% from tier 1 and 50% from total
capital mainly consist of: i) net long position of non-consolidated
participations in the finance sector; ii) expected loss on advanced
internal ratings-based portfolio less general provisions (if differ-
ence is positive); and iii) expected loss for equities (simple risk
weight method).
Transfer of Capital Within UBS Group
Under Swiss company law, UBS is organized as an “Aktienge-
sellschaft,” a corporation that has issued shares of common
stock to investors. UBS AG is the parent company of the
Group. The legal entity structure of the Group is designed
to support our businesses within an efficient legal, tax, regu-
latory and funding framework. We enter into intragroup trans-
actions in order to provide funding and capital to individual
UBS entities. As of 31 December 2010, we were not aware
of any material restrictions, or other major impediments, con-
cerning the transfer of funds or regulatory capital within the
Group apart from those which apply to these entities by way
of local laws and regulations.
IFRS Equity to BIS Tier 1 Capital
The main differences between IFRS equity attributable to
shareholders and tier 1 capital result from:
• The difference of CHF 0.4 billion in Net income recog-
nized directly in equity, net of tax was due to cash flow
hedge effects, which are reversed for BIS purposes and
thereby reduced the amount by CHF 1.1 billion. This was
partly offset by CHF 0.4 billion of net positive foreign cur-
rency translation effects and the reclassification for BIS
purpose of fair value changes relating to Available-for-
sale securities of CHF 0.3 billion.







Share capital 383 0 383
Share premium 34,393 (8) 34,386
Net income recognized
directly in equity, net
of tax (6,534) (406) (6,940)
Retained earnings 19,285 (857) 18,428
Equity classified as
obligation to purchase
own shares (54) 54 0
Equity attributable to
non-controlling interests 5,043 (33) 5,010
Treasury shares/deduction
for own shares(2) (654) (2,339) (2,993)
Total equity/gross tier 1
including hybrid tier 1




Less: accrual for expected
future dividend payments 0
Eligible tier 1 capital 35,323
(1) International Financial Reporting Standards (IFRS).
(2) Generally, treasury shares are fully deducted from equity under
IFRS, whereas for capital adequacy purposes this position covers
the following: i) net long position in own shares held for trading
purposes; ii) own shares bought for unvested or upcoming share
awards; and iii) accruals built for upcoming share awards.
(3) “Other deduction items” include primarily 50% of the deductions
for net long position of non-consolidated participations in the fi-
nance sector; expected loss on advanced internal ratings-based
approach portfolio less general provisions (if difference is posi-
tive): expected loss for equities (simple risk weight method); and
first loss positions from securitization exposures.
• Retained earnings were lower under the BIS view than
under IFRS by CHF 0.9 billion, primarily due to CHF
0.2 billion of life-to-date IFRS gains on own credit net of
tax which are reversed for BIS purposes and CHF 0.3
billion attributable to differences in the scope of consol-
idation. The remainder is due to multiple factors, e.g.
differences in measurement and recognition principles
between IFRS and BIS, including a deduction for unre-
alized losses on available-for-sale securities.
• A negative adjustment in Treasury shares/deduction for
own shares of CHF 2.3 billion, mainly due to the differ-
ent calculation of the capital deduction relating to share-
based compensation.
FINMA Leverage Ratio
FINMA requires a minimum leverage ratio of 3% at a Group
level and expects that, in normal times, the ratio will be well
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On 31 December 2010, our Group FINMA leverage ratio
improved to 4.45%, compared with the 31 December 2009
ratio of 3.93%. During the year, average total assets prior to
deductions decreased by CHF 27.7 billion to CHF 1,398.5
billion. The average total adjusted assets fell by CHF 15.2
billion to CHF 794.2 billion. The table below shows the FINMA
leverage ratio calculation for the Group.
Equity Attribution Framework
The equity attribution framework reflects our overarching ob-
jectives of maintaining a strong capital base and guiding
businesses toward activities with the best balance of profit
potential, risk and capital usage. In June 2010, the key princi-
ples underlying the equity attribution framework received BoD
approval.
Within this framework, the BoD attributes equity to the busi-
nesses after considering their risk exposure, RWA usage, as-
set size, goodwill and intangible assets.
The design of the equity attribution framework enables us
to:
• Calculate and assess return on attributed equity (RoE)
in each of our business divisions. RoE is disclosed for
all business divisions and units.
• Integrate Group-wide capital management activities
with those at business division and business unit levels.
• Measure current period and historical performance in a
consistent manner across business divisions and busi-
ness units.
• Make better comparisons between our businesses and
those of our competitors.
The framework operates as follows: First, each business is at-
tributed an amount of equity equal to the average book value
of goodwill and intangible assets, as reported for that busi-
ness division or business unit according to IFRS. Second, the
BoD considers a number of factors that drive required capital,
including:
• Equity requirements based on aggregated risk expo-
sure, including the potential for losses exceeding earn-
ings capacity as defined by the firm’s risk-based capital.
At certain other institutions, this factor is sometimes re-
ferred to as “economic capital.”
• RWA usage and a target capital ratio for each business.
• Asset size and a target leverage ratio for each business.
After reviewing the results of this formulaic approach, the
Group ALCO recommends and the BoD makes adjustments
to the final tangible equity attribution to reflect the amount
of equity it believes is appropriate for each business. This
assessment is based on the expectations of the business’s
clients and the business environment, including allowing for
sufficient capital to support the business’s underlying risks
and sustain extreme stress scenarios. The amount of equity
attributed to all the businesses corresponds to the amount
that we believe is required to maintain a strong capital base
and support our businesses adequately. If the total equity at-
tributed to the businesses differs from the Group’s actual eq-
uity during a given period, the surplus or deficit is reflected in
Treasury activities and other corporate items. The BoD cur-
rently makes equity attribution decisions on a quarterly basis.
FINMA Leverage Ratio Calculation





Total assets (IFRS)(1) 1,398.5 1,426.2
Less: netting of replacement values(2) (410.1) (420.9)
Less: loans to Swiss clients (excluding
banks)(3) (161.6) (161.4)
Less: cash and balances with central banks (20.1) (22.1)
Less: other(4) (12.4) (12.4)
Total adjusted assets 794.2 809.4
BIS tier 1 capital (at year-end) 35.3 31.8
FINMA leverage ratio (%) 4.45 3.93
(1) Total assets are calculated as the average of the month-end val-
ues for the three months in the calculation period.
(2) Includes the impact of netting agreements (including cash collat-
eral) in accordance with Swiss Federal Banking law, based on the
IFRS scope of consolidation.
(3) Includes mortgage loans to international clients for properties lo-
cated in Switzerland.
(4) Refer to the “Capital components” table for more information on
deductions of assets from BIS tier 1 capital.
The amount of equity attributed to each division is an impor-
tant input into the calculation of economic profit for that divi-
sion. Broadly speaking, economic profit equals profits minus
the product of attributed equity and the cost of equity.
As outlined in the table “Average attributed equity,” the
amount of average equity attributed to the Investment Bank
and Treasury activities and other corporate items increased
by CHF 3.0 billion and CHF 2.0 billion respectively from the
fourth quarter of 2009 to the fourth quarter of 2010. The In-
vestment Bank increase was influenced by an expected mod-
erate increase in the size of its assets and RWA over time.
In addition, the increases in both the Investment Bank and
in Treasury activities and other corporate items were due to
a refinement of our methodology. Previously, we had not ex-
plicitly taken account of the equity burden related to tier 1
deductions in the equity attribution framework. In the calcu-
lation of the RWA driver, we now convert these tier 1 deduc-
tions to the equivalent amount of tangible equity and add that
to the amount of tangible equity needed to support reported
RWA for each division. Similarly, in the calculation of the asset
driver, we now convert these tier 1 deductions to the equiva-
lent amount of tangible equity and add that to the amount of
tangible equity needed to support the reported leverage ratio
denominator for each division.
We continue to use both internal assessments of risk (as
reflected in the UBS Risk-Based Capital framework) and reg-
ulatory measures of risk as drivers, as we believe that both
play a role in the amount of equity needed to strongly support
each division and UBS as a whole. In addition, we believe it
is useful for top management and the BoD to compare eq-
uity requirements derived from internal risk measures with
equity requirements derived from regulatory capital require-
ments and standards.
Further, the equity attribution framework continues to be
forward-looking. Therefore, with regard to the RWA and as-
set drivers, we will be taking into account during 2011 the
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Average Attributed Equity
CHF Billion 4Q10 4Q09
Wealth Management 4.4 4.4
Retail & Corporate 4.6 4.6
Wealth Management & Swiss Bank 9.0 9.0
Wealth Management Americas 8.0 8.0
Global Asset Management 2.5 2.5
Investment Bank 27.0 24.0
Treasury activities and other corporate items 3.0 1.0
Average equity attributed to the business divisions 49.5 44.5
Surplus/(deficit) (2.2) (4.2)
Average equity attributable to UBS shareholders 47.3 40.3
Shares and Capital Instruments
Shares
UBS Shares and Tier 1 Capital
The majority of our tier 1 capital comprises share premium
and retained earnings attributed to UBS shareholders. As
of 31 December 2010, total IFRS equity attributable to our
shareholders amounted to CHF 46,820 million, and was rep-
resented by a total of 3,830,840,513 shares issued, of which
38,892,031 (1.0%) were held by UBS.
In 2010, the shares issued were increased by a total of
272,727,760 shares due to the conversion of CHF 13 billion
mandatory convertible notes (MCN) on 5 March 2010, leading
to an issuance of 272,651,005 shares from conditional cap-
ital. In addition, the exercise of employee options led to the
issuance of 76,755 shares.
Each share has a par value of CHF 0.10, and generally en-
titles the holder to one vote at the shareholders’ meeting and
to a proportionate share of distributed dividends. There are
no preferential rights for shareholders and no other classes
of shares are issued by the Parent Bank directly.
• Refer to the “Shareholders’ participation rights” section
of this report for more information.
Under Swiss company law, shareholders must approve in a
shareholders’ meeting any increase in the total number of
issued shares, which may arise from an ordinary share capital
increase or the creation of conditional or authorized capital.
The table below lists all shareholder-approved issuances of
shares at year-end 2010. It is our objective not to dilute shares
by the issuance of additional shares unless it is warranted by
stressed financial market conditions or by regulators.
Holding of UBS Shares
UBS holds own shares for two main purposes: in Group Trea-
sury to cover employee share and option programs and in
the Investment Bank, to a limited extent, for trading purposes
where the Investment Bank engages in market-making ac-
tivities in UBS shares and related derivative products. The
holding of treasury shares on 31 December 2010 increased
to 38,892,031 or 1.0% of shares issued, from 37,553,872 or
1.1% on the same date one year prior.
As of 31 December 2010, employee options and stock ap-
preciation rights to receive 5.2 million shares were exercis-
able. Shares held in treasury or newly shares issued are de-
livered to the employee at exercise. On 31 December 2010,
25.8 million shares were available for this purpose, and an
additional 149.9 million unissued shares in conditional share
capital were assigned to cover future employee option ex-
ercises. At year-end 2010, the shares available covered all
exercisable employee obligations.
The presentation in the table “Treasury share activities”
shows the purchase of our shares by Group Treasury and
does not include the activities of the Investment Bank.
Treasury Shares Held by the Investment Bank
The Investment Bank, acting as liquidity provider to the equity
index futures market and as a market-maker in our shares and
derivatives, has issued derivatives linked to UBS stock. Most
of these instruments are classified as cash-settled derivatives
and are primarily issued to meet client demand and for trading
purposes. To hedge the economic exposure, a limited number




Number of Shares 31.12.10
Balance at the beginning of the year 3,558,112,753
Issue of shares for capital increase (conversion
of MCN in March 2010) 272,651,005
Issue of shares for employee options 76,755
Balance at the end of the year 3,830,840,513
















SNB warrants 100,000,000 2009 2.61
Employee equity
participation plans of
UBS AG 149,920,712 2006 3.91
Conversion rights/
warrants granted in
connection with bonds 380,000,000 2010 9.92
Total 629,920,712 16.44
Capital Instruments
In order to improve the quality of capital, regulators are
proposing new requirements for capital instruments and cre-
ating a new category of capital instruments: contingent con-
vertible bonds (CoCo). The changes proposed are designed
to increase the resilience against a financial crisis and are
expected to maintain the banks in crisis as going concerns.
Regulators view these instruments as additional protection
against systemic risks of large banks.
• Refer to the “Regulatory developments” section of this
report for more information.
Mandatory Convertible Notes
As part of the measures taken to strengthen our capital base
in 2008, we issued two MCN. The first had a principal amount
IFRS ATT 1.78
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of CHF 13 billion and consisted of private placements with
two financial investors. The second was placed with the Swiss
Confederation and had a principal amount of CHF 6 billion.
The CHF 6 billion MCN was converted on 25 August 2009.
The CHF 13 billion MCN expired on 5 March 2010, and was
mandatorily converted into 273 million of newly issued shares,
representing 7.7% of our then issued share capital.
Hybrid Tier 1 Capital
Hybrid tier 1 instruments represent innovative and non-
innovative perpetual instruments. They are accounted for un-
der non-controlling interests in the IFRS equity. Hybrid tier 1
instruments are perpetual instruments which can only be re-
deemed if they are called by the issuer after having received
regulatory approval. If such a call is not exercised at the call
date, the terms might include a change from fixed to floating
coupon payments and, in the case of innovative instruments
only, a limited step-up of the interest rate. Non-innovative in-
struments do not have a step-up of the interest rate and are
therefore viewed as having a higher equity characteristic for
regulatory capital purposes. The instruments are issued ei-
ther through trusts or our subsidiaries and rank senior to our
shares in dissolution. Payments under the instruments are
subject to adherence to our minimum capital ratios and other
requirements. Any missed payment is non-cumulative. We did
not issue hybrid tier 1 instruments in 2010 but redeemed USD
1.5 billion of trust preferred securities. As of 31 December
2010, we had CHF 4,903 million of such instruments in vari-
ous currencies outstanding.
Treasury Share Activities
Treasury Shares Purchased for Employee
Share and Option Participation Plans and
Acquisitions(1) Total Number of Shares







January 2010 0 0.00 0 0.00
February 2010 45,000,000 14.20 45,000,000 14.20
March 2010 33,580,113 15.13 78,580,113 14.60
April 2010 0 0.00 78,580,113 14.60
May 2010 0 0.00 78,580,113 14.60
June 2010 0 0.00 78,580,113 14.60
July 2010 0 0.00 78,580,113 14.60
August 2010 900,000 16.93 79,480,113 14.63
September 2010 0 0.00 79,480,113 14.63
October 2010 0 0.00 79,480,113 14.63
November 2010 3,110,000 15.72 82,590,113 14.67
December 2010 670,000 15.70 83,260,113 14.68
(1) This table excludes market-making and related hedging purchases by UBS. The table also excludes UBS shares purchased by investment
funds managed by UBS for clients in accordance with specified investment strategies that are established by each fund manager acting
independently of UBS; and also excludes UBS shares purchased by pension and retirement benefit plans for UBS employees, which are
managed by a board of UBS management and employee representatives in accordance with Swiss law guidelines. UBS’s pension and
retirement benefit plans purchased 53,000 UBS shares during the year and held 1,638,000 UBS shares as of 31 December 2010.







Per UBS Share (CHF)
Conversion Into
Number of UBS Shares
MCN 9% 13 5 March 2008 6 September 2008 5 March 2010 47.68(1) 272,651,005
(1) Adjusted for dilution effects of the capital increase.
Treasury Management (in part)
Tier 2 Capital
The major element in tier 2 capital consists of subordinated
long-term debt. Tier 2 instruments have been issued in vari-
ous currencies and with a range of maturities across capital
markets globally. They accounted for CHF 8,239 million in
total eligible capital as of year-end 2010. Tier 2 instruments
rank senior to both our shares and to hybrid tier 1 instruments
but are subordinated to all our senior obligations. In 2010, we
redeemed EUR 1.2 billion floating rate subordinated notes.
Distributions to Shareholders
The decision whether to pay a dividend, and the level of the
dividend, are dependent on our targeted capital ratios and
cash flow generation. The decision on dividend payments is
proposed by the BoD to the shareholders and is subject to
their approval at the Annual General Meeting. The BoD has
decided to further bolster capital and has therefore not pro-
posed any dividend for the financial year 2010.
IFRS ATT 1.78
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Dividends Declared and Not Recognized
as a Liability
1.79
TAM S.A. (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
The principal accounting policies applied in the preparation
of these consolidated financial statements are set out below.
These policies have been consistently applied to all the years
presented, unless otherwise stated.
The preparation of financial statements requires the use
of certain critical accounting estimates. It also requires man-
agement to exercise its judgment in the process of applying
the group’s accounting policies. The areas involving a higher
degree of judgment or complexity, or areas where assump-
tions and estimates are significant to the consolidated finan-
cial statements are disclosed in Note 3.
2.1 Basis of Preparation
The consolidated financial statements have been prepared in
accordance with International Financial Reporting Standards
(“IFRSs”) issued by the International Accounting Standards
Board—(IASB) and International Financial Reporting Inter-
pretations Committee (IFRIC).
The consolidated financial statements were prepared un-
der the historical cost model and the fair value measurement
model for derivative financial instruments.
The first IFRS consolidated financial statements were pre-
pared by the Company for the year ended December 31, 2008,
in anticipation of the requirements in Brazilian Exchange
Comission (CVM) Instruction 457/07, which established the
preparation, by Brazilian listed companies, of consolidated
financial statements in conformity with the pronouncements
issued by the IASB. At that moment, the Company elected to
adopt certain accounting policies, selected among those per-
mitted by international accounting standards, including the
policy of periodic revaluation of the carrying amount of its
flight equipment. In its individual parent company financial
statements, prepared in accordance with accounting prac-
tices adopted in Brazil, the revaluation of flight equipment
was not considered, since this option is not legally provided
for. As a result, the profit and equity presented in its individ-
ual financial statements were not equivalent to those in the
consolidated financial statements.
Among the accounting policies adopted by Accounting
Pronouncements Committee (CPC) for local purposes in its
pronouncements, the option for measurement of assets at
revalued cost is not included, considering the prohibition con-
tained in the Brazilian Corporate Law.
On December 2, 2010, CVM issued CVM Resolution 647,
approving Technical Pronouncement CPC 37 (R1)—First-
time Adoption of International Accounting Standards. CPC
37 (R1) defines that, should the entity have disclosed its IFRS
consolidated financial statements related to any year ended
before January 1, 2009 in disagreement with the Brazilian ac-
counting practices defined by CPC, it should restrict its diver-
gences of accounting practices to those adopted when CPC
37(R1) was approved and requires that new diverging pro-
nouncements shall not be adopted. Nevertheless, in such res-
olution, CVM included the requirement that listed companies
that have already published their IFRS consolidated financial
statements in disagreement with the accounting practices de-
fined by CPC shall present detailed information supporting
the maintenance of these differences, and CVM can accept
or restrict them or determine their elimination.
On December 16, 2010, CVM issued CVM Resolution 651,
approving Technical Pronouncement CPC 43(R1)—First-time
Adoption of Technical Pronouncements CPC 15 to 41. One of
the purposes of CPC 43(R1) is of, together with CPC 37(R1),
permitting the presentation of equal net profit or loss and eq-
uity in the individual and in the consolidated financial state-
ments of Brazilian entities. In it’s introduction, CPC 43(R1)
reaffirms the CPC’s vision that it its fully undesirable to have
two sets of statements with distinct accounting criteria and
with different net profit or loss and equity. Thus, CPC 43(R1)
permits adjustments in the individual financial statements of
Brazilian companies, so that they may produce, when con-
solidated, the same amounts of assets, liabilities, equity, and
profit or loss that the consolidation prepared under IFRSs and
Technical Pronouncement CPC 37(R1). The Company under-
stands that the difference presented between its individual
and consolidated financial statements, due to the recognition
of flight equipment revaluation, is in accordance with the ac-
counting practice issued by the CPCs and IFRSs issued by
IASB until now.
Since the recognition of the effects of flight equipment reval-
uation in the Company’s individual financial statements, basis
for payment of dividends, is prohibited by law, and consider-
ing the purposes of CPC 43(R1) and CVM that preferably no
differences exist between profit or loss and equity in the indi-
vidual and consolidated financial statements, the Company’s
management elected to change its accounting policy related
to measurement of its flight equipment in the preparation of its
consolidated financial statements for consistency with its indi-
vidual financial statements. Such change in accounting policy
has effects on the consolidated financial statements prepared
in accordance with IFRS previously issued for the years ended
December 31, 2009, 2008 and 2007. Therefore these con-
solidated financial statements prepared in accordance with
IFRS and the accounting practices adopted in Brazil differ
from IFRS financial statements previously issued as detailed
in Note 4.
4. Adjustments Retroactive to the Financial
Statements Consolidated for the Prior Period
As mentioned in note 2.1, at December 31, 2010, the Com-
pany decided to change the accounting policy related to
recognition of flight equipment revaluation in its consolidated
financial statements, in order that the consolidated profit and
equity may be equivalent to those presented in the parent
company’s individual financial statements since the Brazilian
corporate law does not permit the revaluation of assets. This
change in accounting policy has effects on the consolidated
financial statements presented for comparative purposes for
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The effects of retroactive adjustments at December 31,
2009, 2008 and 2007 are as follows:
December 31, 2009
As Originally Presented Retrospective Adjustment Adjusted
Effects on Balance Sheet
Property, plant and equipment 6,910,496 1,223,532 8,134,028
Deferred income tax and social contribution asset 621,788 (427,912) 193,876
Total 7,532,284 795,620 8,327,904
Revaluation reserve 116,504 (116,504)
Retained earnings (accumulated deficit) and other reserves (296,993) 912,124 615,131
Total (180,489) 795,620 615,131
December 31, 2008
As Originally Presented Retrospective Adjustment Adjusted
Effects on Balance Sheet
Property, plant and equipment 9,663,452 (1,566,101) 8,097,351
Deferred income tax and social contribution asset 306,969 532,474 839,443
Total 9,970,421 (1,033,627) 8,936,794
Revaluation reserve 1,146,829 (1,146,829)
Accumulated deficit and other reserves (499,433) 113,202 (386,231)
Total 647,396 (1,033,627) (386,231)
December 31, 2007
As Originally Presented Retrospective Adjustment Adjusted
Effects on Balance Sheet
Property, plant and equipment 5,781,076 83 5,781,159
Deferred income tax and social contribution asset 4,770 (19) 4,751
Total 5,785,846 64 5,785,910
Revaluation reserve 284,465 (284,465)
Accumulated deficit and other reserves 946,125 284,529 1,230,654
Total 1,230,590 64 1,230,654
December 31, 2009
As Originally Presented Retrospective Adjustment Adjusted
Effects on Profit or Loss
Operating expenses (9,595,826) 40,194 (9,555,632)
Gains (losses) on revaluation of aircraft (1,207,608) 1,207,608
Operating profit (loss) before income tax and social contribution 650,196 1,247,802 1,897,998
Income tax and social contribution (212,781) (436,758) (649,539)
Profit for the year 437,415 811,044 1,248,459
Earnings per share—basic 2.90 8.30
Earnings per share—diluted 2.90 8.29
Effects on Comprehensive Income (Loss) for the Year
Revaluation of property, plant and equipment (1,017,255) 1,017,255
Profit for the year 437,415 811,044 1,248,459
Total comprehensive income (loss) for the year (599,944) 1,828,299 1,228,356
December 31, 2008
As Originally Presented Retrospective Adjustment Adjusted
Effects on Profit or Loss
Operating expenses (9,954,107) 18,670 (9,935,437)
Gains (losses) on revaluation of aircraft 242,370 (242,370)
Operating profit (loss) before income tax and social contribution (2,068,013) (223,700) (2,291,713)
Income tax and social contribution 634,243 75,931 710,174
Profit for the year (1,433,770) (147,769) (1,581,539)
Earnings per share—basic (9.54) (10.52)
Earnings per share—diluted (9.54) (10.52)
Effects on Comprehensive Income (Loss) for the Year
Revaluation of property, plant and equipment 885,921 (885,921)
Profit for the year (1,433,770) (147,769) (1,581,539)
Total comprehensive income (loss) for the year (534,697) (1,033,690) (1,568,387)
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December 31, 2007
As Originally Presented Retrospective Adjustment Adjusted
Effects on Profit or Loss
Operating expenses (7,698,478) (11,009) (7,709,487)
Gains (losses) on revaluation of aircraft (224,701) 224,701
Operating profit (loss) before income tax and social contribution 477,720 213,692 691,412
Income tax and social contribution (145,941) (67,808) (213,749)
Profit for the year 331,779 145,884 477,663
Earnings per share—basic 2.20 3.17
Earnings per share—diluted 2.19 3.15
Effects on Comprehensive Income (Loss) for the Year
Revaluation of property, plant and equipment (17,370) 17,370
Profit for the year 331,779 145,884 477,663
Total comprehensive income (loss) for the year 310,872 163,254 474,126
Change in Accounting Estimate
1.80
Absa Group Limited (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
24. Policyholder Liabilities Under Insurance Contracts
(in part)







Balance at the beginning of the year 1,402 1,493
Reinsurance liability 16 (31)
Transfer from statement of comprehensive income
(refer to note 34) 45 (60)
Increase in retrospective liabilities 165 152
Unwind of discount rate 34 32
New business 59 33
Change in methodology (34) 39
Change in economic assumptions 37 (86)
Changes in non-economic assumptions (154) (158)
Expected cash flow 354 259
Expected release of margins (411) (337)
Experience variances (5) 6
Balance at the end of the year (refer to note 24) 1,463 1,402
Recoverable from reinsurers 58 41
Net liabilities 1,405 1,361
Unit-linked liabilities 1,049 898
Non-linked liabilities 356 463
1,463 1,402
Change in Accounting Estimate—Changes in
Non-Economic Assumptions
One of the margins established in terms of the Group’s
accounting policy, is that future investment management
charges on unit-linked business are not recognised when de-
termining the value of policyholder liabilities under insurance
contracts. The Group earns investment management fees on
the investment balances held in respect of unit-linked busi-
ness. PGN 104 allows for the inclusion of expected future
investment management fees when determining the best es-
timate of future cash flows. The best estimate of future cash
flows is used in the calculation of the policyholder liabilities.
Allowing for the future investment management charges in
the best estimate of future cash flows will reduce the policy-
holder liability. Management previously considered it appro-
priate not to provide for this margin as asset-based fees are
more appropriately accounted for as and when they are re-
ceived. However, the emergence of investment management
charges in the Group’s financial statements have been con-
sistent and can be expected to continue into the future. Fur-
thermore, PGN 104 allows for the explicit recognition in the
liabilities of factors that are expected to be received in terms of
the policy contracts. During the current reporting period man-
agement has reassessed the margin held in respect of future
investment management fees. Management considered it ap-
propriate to revise the margin to take full account of the future
investment management charges expected to be received on
unit-linked business, based on additional experience of the
emergence of investment management fees.
This has resulted in a decrease in policyholder liabilities and
an increase in profit before taxation of R117 million (a reduced
lapse margin was previously held on certain regular premium
business against the uncertainty and inherent volatility asso-
ciated with future lapses, which resulted in a release of R162
million in 2009). This amount is taxed in the corporate fund at
28%, amounting to R32,8 million, as it represents a transfer
from the individual policyholders fund to the corporate fund.
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Correction of an Error
1.81
Alumina Limited (Dec 2010)
CONSOLIDATED BALANCE SHEETS AS AT
31 DECEMBER 2010
US$ Million
Notes 2010 2009 1 January 2009(∗)
Current Assets
Cash and cash equivalents 10 112.1 305.6 46.3
Derivative financial instruments 5.0 — 4.6
Receivables 11 0.2 0.1 50.4
Other assets 9.4 8.6 1.1
Total current assets 126.7 314.3 102.4
Non-Current Assets
Investments accounted for using the equity method 12 3,415.6 3,189.7 2,597.0
Property, plant and equipment 13 0.2 0.2 0.1
Deferred tax assets 17 — — 1.5
Total non-current assets 3,415.8 3,189.9 2,598.6
Total assets 3,542.5 3,504.2 2,701.0
Current Liabilities
Payables 14 5.9 5.3 38.5
Interest-bearing liabilities 15 217.7 — 250.0
Derivative financial instruments — 1.4 —
Current tax liabilities — — 0.3
Provisions 16 0.2 0.2 0.1
Other 0.6 0.8 1.1
Total current liabilities 224.4 7.7 290.0
Non-Current Liabilities
Interest-bearing liabilities 15 246.2 577.9 475.9
Provisions 18 0.4 0.3 0.2
Total non-current liabilities 246.6 578.2 476.1
Total liabilities 471.0 585.9 766.1
Net assets 3,071.5 2,918.3 1,934.9
Equity
Contributed equity 19 2,154.1 2,154.1 1,000.8
Treasury shares 21(e) (1.5) (1.0) (0.6)
Reserves:
—Group 21 4.3 (205.6) 172.4
—Associates 21 2.5 1.7 1.3
Retained profits:
—Group 21(d) 903.6 803.0 515.2
—Associates 12(c) 8.5 166.1 245.8
Total equity 3,071.5 2,918.3 1,934.9
(∗) See note 1(a) for details regarding the change in accounting policy.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
22. Revision of Financial Statements for
31 December 2008
We have revised our consolidated financial statements as of
and for the comparative years ended 31 December 2008 and
2009.
In May 2011 the Company identified an error related to the
2008 financial statements which resulted from differences be-
tween US GAAP and IFRS accounting regarding the joint ven-
ture’s defined benefit plans. The impact of the error resulted
in an overstatement of share of net profit of associates for the
year 2008 of $23.9 million. The error also understated equity
reserves for the year ended 31 December 2008 by $23.9 mil-
lion. The opening balances for certain 2009 equity accounts
have been adjusted to reflect the revised 2008 numbers.
As the errors were of a non-cash nature which did not impact
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the Company’s cash position, business activities or prospects,
the Company after having assessed the materiality of this
misstatement in accordance with the SEC’s Staff Accounting
Bulletin (SAB) No. 99 concluded that these errors were not
material to our previously issued consolidated financial state-
ments for 2008.
TABLE 1-8: COMMITMENTS AND CONTINGENCIES
2010 2009
Commitments
Business combinations.............................................. 9 9
Capital expenditures.................................................. 107 108
Collaboration and licensing arrangements................ 14 14
Commitments to associates and joint ventures........ 21 19
Commitments to extend credit................................... 12 12
Commitments to purchase goods and services........ 45 42
Commitments to purchase investments.................... 15 9
Compensation agreements ....................................... 1 1
Environmental matters............................................... 23 18
Leases........................................................................ 142 140
Pensions and other employee benefits..................... 10 8
Total ........................................................................... 399 380
Contingencies
Contractual disputes, including arbitration................ 10 9
Debt obligations......................................................... 17 14
Guarantees................................................................ 106 104
Letters of credit.......................................................... 25 19
Litigations................................................................... 122 111
Related to government grants................................... 3 5
Taxation..................................................................... 30 27
Total ........................................................................... 313 307
Other commitments or contingencies........................ 66 62
Accordingly, by reference to SAB No. 108, our previously
issued consolidated financial statements have been revised
as shown in the tables below. Effective in 2010, the Company
has changed to US presentation currency retrospectively and
accordingly the 2008 figures are presented in US dollars.
Revision to Consolidated Statements of Comprehensive
Income
Year Ended and as of 31 December 2008
(In US$ Millions, Except Per Share Amounts)
As Previously
Reported Revision As Revised
Share of net profits of associates accounted for using the equity method 206.7 (23.9) 182.8
Profit/(loss) before income tax 145.3 (23.9) 121.4
Profit/(loss) for the year 143.1 (23.9) 119.2
Foreign exchange translation difference (115.5) 23.9 (91.6)
Other comprehensive income/(loss) for the year, net of tax (115.5) 23.9 (91.6)
Basic earnings per share 9.6¢ (1.6¢) 8.0¢
Diluted earnings per share 9.6¢ (1.6¢) 8.0¢
Revision to Consolidated Balance Sheets
Year Ended and as of 31 December 2009 Year Ended and as of 31 December 2008










Reserves-Group (229.5) 23.9 (205.6) 148.5 23.9 172.4
Retained profits-Associates 190.0 (23.9) 166.1 269.7 (23.9) 245.8
1.82
AstraZeneca plc (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)








Contracts placed for future capital expenditure
on property, plant and equipment and
software development costs not provided for
in these accounts 259 368 178
Guarantees and contingencies arising in the ordinary course
of business, for which no security has been given, are not
expected to result in any material financial loss.
Research and Development Collaboration Payments
The Group has various ongoing collaborations including in-
licensing and similar arrangements with development part-
ners. Such collaborations may require the Group to make
payments on achievement of stages of development, launch
or revenue milestones although the Group generally has
the right to terminate these agreements at no cost. The
Group recognises research and development milestones as
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intangible assets once it is committed to payment, which is
generally when the Group reaches set trigger points in the de-
velopment cycle. Revenue-related milestones are recognised
as intangible assets on product launch at a value based on the
Group’s long-term revenue forecasts for the related product.
The table below indicates potential development and revenue-






Years 1 and 2
$m





Future potential research and development
milestone payments 3,106 115 711 646 1,634
Future potential revenue milestone payments 3,234 – 2 70 3,162
The table includes all potential payments for achievement
of milestones under ongoing research and development ar-
rangements. Revenue-related milestone payments represent
the maximum possible amount payable on achievement of
specified levels of revenue as set out in individual contract
agreements, but exclude variable payments that are based
on unit sales (eg royalty-type payments) which are recog-
nised as the associated sale is recognised in the compre-
hensive income statement. The table excludes any payments
already capitalised in the financial statements for the year
ended 31 December 2010 and excludes payments under the
Merck agreements (detailed below).
The future payments we disclose represent contracted pay-
ments and, as such, are not discounted and are not risk ad-
justed. As detailed in the Principal risks and uncertainties
section from page 96, the development of any pharmaceu-
tical product candidate is a complex and risky process that
may fail at any stage in the development process due to a
number of factors (including items such as failure to obtain
regulatory approval, unfavourable data from key studies, ad-
verse reactions to the product candidate or indications of other
safety concerns). The timing of the payments is based on the




In 1982, Astra AB set up a joint venture with Merck & Co.,
Inc. (now Merck Sharp & Dohme Corp., a subsidiary of the
new Merck & Co., Inc. that resulted from the merger with
Schering-Plough) (Merck) for the purposes of selling, market-
ing and distributing certain Astra products in the US. In 1998,
this joint venture was restructured (Restructuring). Under the
agreements relating to the Restructuring (Agreements), a US
limited partnership (Partnership) was formed, in which Merck
is the limited partner and AstraZeneca is the general partner,
and AstraZeneca obtained control of the joint venture’s busi-
ness subject to certain limited partner and other rights held
by Merck and its affiliates. These rights provide Merck with
safeguards over the activities of the Partnership and place
limitations on AstraZeneca’s commercial freedom to operate.
The Agreements provided for:
• A payment to Merck in the event of a business combina-
tion between Astra and a third party in order for Merck
to relinquish certain claims to that third party’s products.
• Annual contingent payments.
• Termination arrangements which cause Merck to relin-
quish its interests in AstraZeneca’s products and activi-
ties in stages, some of which are mandatory and others
optional.
These elements are discussed in further detail below, together
with a summary of their accounting treatments.
Payment in the Event of a Business Combination
On the merger of Astra and Zeneca, a one-time lump sum
payment of $809m was triggered. As a result of this payment,
Merck relinquished any claims it may have had to Zeneca
products.
This payment was expensed at the point of merger since it
caused no incremental benefits over the prior years’ aggre-
gate Astra and Zeneca performance to accrue to the merged
AstraZeneca entity.
Annual Contingent Payments
AstraZeneca makes ongoing payments to Merck based on
sales of certain of its products in the US (the ‘contingent
payments’ on the ‘agreement products’). AstraZeneca will
continue to make contingent payments to Merck until at
least 2012. Contingent payments (excluding those in respect
of Prilosec, Nexium and the authorised generic version of
felodipine) ceased in 2010 as AstraZeneca exercised the First
Option (as discussed under First Option below); contingent
payments in respect of Prilosec and Nexium will cease in late
2012 if AstraZeneca exercises the Second Option that year
(as discussed under Second Option below); contingent pay-
ments in respect of the authorised generic version of felodip-
ine will continue at least until June 2011.
The annual contingent payments on agreement products
are expensed as incurred.
Termination Arrangements
The Agreements provided for arrangements and payments
under which, subject to the exercise of certain options, the
rights and interests in AstraZeneca’s activities and products
held by Merck immediately prior to the merger would be ter-
minated, including details of:
• the Advance Payment
• the Partial Retirement
• the True-Up
• the Loan Note Receivable
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Advance Payment
The merger between Astra and Zeneca in 1999 triggered the
first step in the termination arrangements. Merck relinquished
all rights, including contingent payments on future sales, to po-
tential Astra products with no existing or pending US patents
at the time of the merger. As a result, AstraZeneca now has
rights to such products and is relieved of potential obligations
to Merck and restrictions in respect of those products (in-
cluding annual contingent payments), affording AstraZeneca
substantial freedom to exploit the products as it sees fit.
At the time of the merger, the Advance Payment was paid.
It was calculated as the then net present value of $2.8bn dis-
counted from 2008 to the date of merger at a rate of 13% per
annum and amounted to $967m. It was subject to a true-up
in 2008 (as discussed under True-Up below).
Partial Retirement
In March 2008, there was a partial retirement of Merck’s lim-
ited partnership interest by payment to Merck of an amount
calculated as a multiple of the average annual contingent
payments from 2005 to 2007 on the relevant products, plus
$750m. The payment was $4,271m.
Upon the Partial Retirement, Merck’s rights in respect of
certain of the agreement products ended. The products cov-
ered by the Partial Retirement include Toprol-XL, Pulmicort,
Rhinocort and Symbicort.
True-Up
In 2008, in accordance with the Agreements, there was a True-
Up of the Advance Payment. The True-Up amount was based
on a multiple of the average annual contingent payments from
2005 to 2007 in respect of all the agreement products with
the exception of Prilosec and Nexium (subject to a minimum
of $6.6bn), plus other defined amounts (totalling $912m). In
accordance with the Agreements, the calculated amount was
then reduced by the Appraised Value (as discussed under
‘First Option’ below), the Partial Retirement and the Advance
Payment (at its undiscounted amount of $2.8bn). This True-
Up amount was settled in an amount equal to $241m owed
by Merck to AstraZeneca.
Loan Note Receivable
Included in the assets and liabilities covered by the Restruc-
turing was a loan note receivable by AstraZeneca from Merck
with a face value of $1.38bn. In 2008, at the same time as
the settlement of the Partial Retirement and the True-Up,
Merck settled the loan note receivable by paying AstraZeneca
$1.38bn.
If Merck had exercised the First Option in 2008, the net
minimum payment that would have been made to Merck would
have been $3.3bn, being the minimum combined payments of
$4.7bn specified in the Agreements on the Partial Retirement,
the True-Up and First Option, less the repayment of the loan
note of $1.38bn. In accounting for the Restructuring in 1998,
the loan note was included in the determination of the fair
values of the assets and liabilities to be acquired. At that time,
the loan note was ascribed a fair value of zero on acquisition
and on the balance sheet, because it was estimated that the
net minimum payment of $3.3bn equated to the fair value of
the rights to be acquired under the Partial Retirement, True-
Up and First Option.
First Option
In accordance with the Agreements, in 2008 a calculation was
made of the Appraised Value, being the net present value of
the future contingent payments in respect of all agreement
products not covered by the Partial Retirement, other than
Prilosec and Nexium. The Appraised Value was calculated in
2008 as $647m.
Payment of the Appraised Value to Merck in March 2008
would have taken place only if Merck had exercised the First
Option in 2008. Merck did not exercise this option. Under the
Agreements AstraZeneca could exercise the First Option in
the first two months of 2010 for a sum equal to the 2008
Appraised Value.
In 2010, AstraZeneca gave Merck an irrevocable notice of
its intention to exercise the First Option. Payment of $647m to
Merck was made on 30 April 2010. This payment resulted in
AstraZeneca acquiring Merck’s interests in products covered
by the First Option including Entocort, Atacand, Plendil and
the authorised generic version of felodipine, and certain prod-
ucts still in development (principally Brilinta and lesogaberan
(AZD3355)). On 30 April 2010, contingent payments on these
products ceased with respect to periods after this date (except
for contingent payments on the authorised generic version of
felodipine, which will continue at least until June 2011) and As-
traZeneca obtained the ability to exploit these products and
other opportunities in the Cardiovascular and Neuroscience
therapy areas. As detailed in Note 9, the intangible asset re-
lating to lesogaberan (AZD3355) of $128m was subsequently
impaired to a value of nil following a decision to terminate fur-
ther development of this compound.
Second Option
AstraZeneca may exercise a Second Option to repurchase
Merck’s interests in Prilosec and Nexium in the US. This op-
tion is exercisable by AstraZeneca in 2012, or in 2017, or
if combined annual sales of the two products fall below a
minimum amount. AstraZeneca’s consummation of the Sec-
ond Option will end the contingent payments in respect of
Prilosec and Nexium and will effectively end AstraZeneca’s
relationship with, and obligations to, Merck (other than some
residual manufacturing arrangements). In September 2010,
AstraZeneca and Merck reached an agreement with respect
to the treatment of Vimovo under the Agreements, pursuant
to which AstraZeneca will pay Merck certain amounts with re-
spect to Vimovo only if it exercises the Second Option and as
part of the exercise price for the Second Option.
The exercise price for the Second Option is the net present
value of the future annual contingent payments on Nexium
and Prilosec as determined at the time of exercise and the net
present value of up to 5 percent of future US sales of Vimovo,
with the precise amount dependent on the level of annual
sales and the timing of the option exercise. The exercise price
of the Second Option cannot be determined at this time.
Accounting Treatment of Termination Arrangements
AstraZeneca considers that the termination arrangements de-
scribed above represent the acquisition, in stages, of Merck’s
interests in the Partnership and agreement products (includ-
ing Merck’s rights to contingent payments) and depend, in
part, on the exercise of the First and Second Options. The
effects will only be reflected in the financial statements as
these stages are reached. If and when all such payments are
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made, AstraZeneca will have unencumbered discretion in its
operations in the US market.
AstraZeneca anticipates that the benefits that accrue under
all of the termination arrangements arise:
• Currently, from the substantial freedom over products
acquired or discovered post-merger.
• On occurrence of each stage of such arrangements,
from enhanced contributions from, and substantial free-
dom over, those products that have already been
launched (for example, Pulmicort, Symbicort, Rhinocort
and Atacand), and those that are in development.
Economic benefits include relief from contingent payments,
anticipated cost savings from cessation of manufacturing ar-
rangements and other cost efficiencies, together with the
strategic advantages of increased freedom to operate.
The Advance Payment has been accounted for as an in-
tangible asset and is being amortised over 20 years. This
approach reflects the fact that, under the Agreements, As-
traZeneca has acquired rights relieving it of potential obli-
gations and restrictions in respect of Astra products with no
existing or pending patents at the time of merger. Although
these rights apply in perpetuity, the period of amortisation of
20 years has been chosen to reflect the typical timescale of
development and marketing of a product.
The net payment made in 2008, consisting of the Partial
Retirement of $4.271bn less the True-Up of $241m and loan
note receivable of $1.38bn, in total $2.6bn, has been capi-
talised as intangible assets.
Part of the net payment made in 2008 resulted in As-
traZeneca acquiring Merck’s interests in certain AstraZeneca
products, including Pulmicort, Rhinocort, Symbicort and
Toprol-XL. Consequently AstraZeneca no longer has to make
contingent payments on these products to Merck and has ob-
tained the ability to fully exploit these products and to fully
exploit other opportunities in the respiratory therapy area that
AstraZeneca was previously prevented from doing by Merck’s
interests in these products. Intangible assets aggregating
$994m have been recognised in respect of these acquired
product rights and these are being amortised over various
periods, giving rise to an annual expense of approximately
$60m going forward.
The balance of the net payment made in 2008 ($1,656m)
represented ‘non-refundable deposits’ for future product
rights associated with the First and Second Options. In 2010,
$647m was recognised as an intangible asset as a result
of payment of the Appraised Value for the First Option (see
above). Together with the $1,656m non-refundable deposits
recognised in 2008, the total sum of $2,303m was allocated
as follows: $689m to contingent payment relief, $1,140m to
intangible assets reflecting the ability to fully exploit the prod-
ucts in the cardiovascular and neuroscience therapy areas,
and $474m as non-refundable deposits associated with the
Second Option. The intangible assets recognised on exer-
cise of the First Option give rise to an additional amortisation
expense in the range of $20m to $50m per annum charged
to cost of sales in respect of contingent payment relief, the
precise amount dependent upon the launch status of the cov-
ered pipeline compounds, and an additional charge to SG&A
of around $60m per annum. Amortisation on these intangible
assets began when the $647m payment was made on 30 April
2010. The remaining $474m relating to the non-refundable
deposits will not be subject to amortisation until the Second
Option is exercised and the related product rights are ac-
quired. If the Second Option is exercised then amortisation
related to the ability to exploit opportunities in the gastroin-
testinal therapy area will commence, in the amount of around
$25m per annum (charged to SG&A), as well as an as yet
indeterminable amount of amortisation related to relief from
contingent payments.
The intangible assets relating to purchased product rights
and the intangible assets relating to non-refundable deposits
are subject to impairment testing and would be partially or
wholly impaired if a product is withdrawn or if activity in any
of the affected therapy areas is significantly curtailed. Con-
sequently, following the discontinuation of the development
of lesogaberan (AZD3355) in the third quarter of 2010, an
impairment of $128m was recognised. If it becomes proba-
ble that the Second Option will not be exercised, the non-
refundable deposits for the product rights to be acquired un-
der the Second Option will be expensed immediately.
Environmental Costs and Liabilities
The Group’s expenditure on environmental protection, includ-
ing both capital and revenue items, relates to costs which
are necessary for implementing internal systems and pro-
grammes, and meeting legal and regulatory requirements for
processes and products.
They are an integral part of normal ongoing expenditure for
carrying out the Group’s research, manufacturing and com-
mercial operations and are not separated from overall oper-
ating and development costs. There are no known changes
in legal, regulatory or other requirements resulting in material
changes to the levels of expenditure for 2008, 2009 or 2010.
In addition to expenditure for meeting current and foreseen
environmental protection requirements, the Group incurs
costs in investigating and cleaning up land and groundwater
contamination. In particular, AstraZeneca has environmental
liabilities at some currently or formerly owned, leased and
third party sites.
In the US, Zeneca Inc., and/or its indemnitees, have been
named as potentially responsible parties (PRPs) or defen-
dants at approximately 19 sites where Zeneca Inc. is likely to
incur future environmental investigation, remediation, opera-
tion and maintenance costs under federal or state, statutory
or common law environmental liability allocation schemes (to-
gether, US Environmental Consequences). Similarly, Stauffer
Management Company LLC (SMC), which was established
in 1987 to own and manage certain assets of Stauffer Chemi-
cal Company acquired that year, and/or its indemnitees, have
been named as PRPs or defendants at approximately 31
sites where SMC is likely to incur US Environmental Con-
sequences. Outside the US, AstraZeneca has given indemni-
ties to third parties in respect of approximately 22 sites. These
environmental liabilities arise from legacy operations that are
not part of the Group’s current pharmaceutical business and,
at most of these sites, remediation, where required, is either
completed or nearing completion.
AstraZeneca has made provisions for the estimated costs
of future environmental investigation, remediation, operation
and maintenance activity beyond normal ongoing expenditure
for maintaining the Group’s R&D and manufacturing capac-
ity and product ranges. Where a present obligation exists,
it is probable that such costs will be incurred and they can
be estimated reliably. With respect to such estimated future
costs, there were provisions at 31 December 2010 in the ag-
gregate of $106m, which mainly relate to the US. These pro-
visions do not include possible additional costs that are not
currently probable. Where we are jointly liable or otherwise
have cost sharing agreements with third parties, we reflect
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only our share of the obligation. Where the liability is insured
in part or in whole by insurance or other arrangements for
reimbursement, an asset is recognised to the extent that this
recovery is virtually certain.
It is possible that AstraZeneca could incur future environ-
mental costs beyond the extent of our current provisions. The
extent of such possible additional costs is inherently difficult
to estimate due to a number of factors, including: (1) the na-
ture and extent of claims that may be asserted in the future;
(2) whether AstraZeneca has or will have any legal obligation
with respect to asserted or unasserted claims; (3) the type of
remedial action, if any, that may be selected at sites where
the remedy is presently not known; (4) the potential for recov-
eries from or allocation of liability to third parties; and (5) the
length of time that the environmental investigation, remedia-
tion and liability allocation process can take. Notwithstanding
and subject to the foregoing, it is estimated that potential addi-
tional loss for future environmental investigation, remediation
and remedial operation and maintenance activity above and
beyond our provisions could be, in aggregate, in the order of
$20m to $40m, which relates solely to the US.
Legal Proceedings
AstraZeneca is involved in various legal proceedings consid-
ered typical to its business, including actual or threatened liti-
gation and/or actual or potential government investigations re-
lating to employment matters, product liability, commercial dis-
putes, pricing, sales and marketing practices, infringement of
intellectual property rights, the validity of certain patents and
anti-trust laws. The more significant matters are discussed
below.
Most of the claims involve highly complex issues. Often
these issues are subject to substantial uncertainties and
therefore the probability of a loss, if any, being sustained and
an estimate of the amount of any loss is difficult to ascertain.
Consequently, for a majority of these claims, it is not possi-
ble to make a reasonable estimate of the expected financial
effect, if any, that will result from ultimate resolution of the pro-
ceedings. In these cases, AstraZeneca discloses information
with respect to the nature and facts of the cases.
With respect to each of the legal proceedings described
below, other than those for which provision has been made,
we are unable to make estimates of the possible loss or range
of possible losses at this stage, other than as set forth herein.
We also do not believe that disclosure of the amount sought
by plaintiffs, if that is known, would be meaningful with respect
to those legal proceedings. This is due to a number of factors,
including (1) the stage of the proceedings (in many cases trial
dates have not been set) and the overall length and extent of
pre-trial discovery; (2) the entitlement of the parties to an ac-
tion to appeal a decision; (3) clarity as to theories of liability,
damages and governing law; (4) uncertainties in timing of liti-
gation; and (5) the possible need for further legal proceedings
to establish the appropriate amount of damages, if any.
However, although there can be no assurance regarding the
outcome of any of the legal proceedings referred to in this Note
25, based on management’s current and considered view of
each situation, we do not currently expect them to have a
material adverse effect on our financial position. This position
could of course change over time, not least because of the
factors referred to above.
In cases that have been settled or adjudicated, or where
quantifiable fines and penalties have been assessed and
which are not subject to appeal (or other similar forms of re-
lief), or where a loss is probable and we are able to make a
reasonable estimate of the loss, we indicate the loss absorbed
or the amount of the provision accrued.
Where it is considered that the Group is more likely than
not to prevail, legal costs involved in defending the claim are
charged to profit as they are incurred.
Where it is considered that the Group has a valid contract
which provides the right to reimbursement (from insurance or
otherwise) of legal costs and/or all or part of any loss incurred
or for which a provision has been established, and we con-
sider recovery to be virtually certain, the best estimate of the
amount expected to be received is recognised as an asset.
Assessments as to whether or not to recognise provisions
or assets, and of the amounts concerned, usually involve a
series of complex judgements about future events and can
rely heavily on estimates and assumptions. AstraZeneca be-
lieves that the provisions recorded are adequate based on cur-
rently available information and that the insurance recoveries
recorded will be received. However, given the inherent uncer-
tainties involved in assessing the outcomes of these cases,
and in estimating the amount of the potential losses and the
associated insurance recoveries, we could in future periods
incur judgments or insurance settlements that could have a
material adverse effect on our results in any particular period.
Intellectual property claims include challenges to the
Group’s patents on various products or processes and as-
sertions of non-infringement of patents. A loss in any of these
cases could result in loss of patent protection on the related
product. The consequences of any such loss could be a sig-
nificant decrease in sales of the product, which could have a
materially adverse effect on our future results. The lawsuits
pending against companies that have filed ANDAs in the US,
seeking to market generic forms of products sold by the Group
prior to the expiry of the applicable patents covering these
products, typically include allegations of non-infringement, in-
validity and unenforceability of these patents. In the event that
the Group is not successful in these actions or the statutory
30-month stay expires before a ruling is obtained, the compa-
nies involved will also have the ability, subject to FDA approval,
to introduce generic versions of the product concerned.
AstraZeneca has full confidence in, and will vigorously de-
fend and enforce, its intellectual property.
Accolate (zafirlukast)
Patent Litigation—US
As previously reported, in June 2008, AstraZeneca com-
menced patent infringement litigation against Dr. Reddy’s
Laboratories, Ltd and Dr. Reddy’s Laboratories, Inc. (together,
DRL) in the US District Court for the District of New Jersey for
infringement of US Patent Nos. 5,319,097 (the ’097 patent),
5,482,963 (the ’963 patent) and 6,143,775 (the ’775 patent).
In 2009, the parties agreed to dismiss without prejudice all
claims and counterclaims based on the ’097 and ’775 patents.
In February 2010, DRL filed a motion for summary judgment
based on prosecution history estoppel. AstraZeneca applied
for summary judgment in response. In November 2010, the
US District Court for the District of New Jersey denied As-
traZeneca’s motion and granted DRL a summary judgment
that DRL’s zafirlukast tablets did not infringe the ’963 patent.
In December 2010, AstraZeneca filed a Notice of Appeal to
the US Court of Appeals for the Federal Circuit. In January
2011, AstraZeneca and DRL entered into a settlement agree-
ment under which AstraZeneca will dismiss its appeal and
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In 2009, AstraZeneca received a Notice of Allegation from
Mylan Pharmaceuticals ULC (Mylan) in respect of Canadian
Patent No. 1,337,420 (the ’420 patent) listed on the Cana-
dian Patent Register for Arimidex. AstraZeneca filed a Notice
of Application in federal court seeking an order prohibiting
the Minister of Health from issuing a Notice of Compliance
to Mylan for its anastrozole tablets until the expiration of the
’420 patent. In October 2010, the hearing in this matter was
scheduled for three days commencing on 31 May 2011.
Atacand (candesartan cilexetil)
Patent Litigation—US
In November 2010, AstraZeneca received a Paragraph IV
Certification notice-letter from Apotex Inc. (Apotex) informing
AstraZeneca that Apotex was seeking approval to market a
generic version of Atacand prior to the expiration of US Patent
No. 5,534,534 (the ’534 patent). Apotex alleged that its prod-
uct did not infringe the ’534 patent. AstraZeneca did not file
suit in response to Apotex’s letter.
Patent Litigation—Canada
In April 2009, AstraZeneca received a Notice of Allegation
from Sandoz Canada Inc. (Sandoz) in respect of Canadian
Patent Nos. 2,040,955 (the ’955 patent) and 2,083,305 (the
’305 patent) listed on the Canadian Patent Register for Ata-
cand. Sandoz indicated it would await the expiry of the ’955
patent, but alleged that the ’305 patent was not infringed and
was not properly listed on the Canadian Patent Register.
In May 2009, AstraZeneca filed a Notice of Application
in federal court seeking an order prohibiting the Minister of
Health from issuing a Notice of Compliance to Sandoz for its
4, 8 and 16mg candesartan cilexetil tablets until the expiration
of the ’305 patent. In December 2009, AstraZeneca discon-
tinued the proceeding.
In March 2010, AstraZeneca received a Notice of Allegation
from Cobalt Pharmaceuticals Inc. (Cobalt) in respect of the
’955 and ’305 patents listed on the Canadian Patent Register
for Atacand. Cobalt has confirmed it will await the expiry of the
’955 patent. For the ’305 patent, Cobalt alleges that the patent
is not infringed, is invalid, irrelevant and not properly listed.
AstraZeneca did not commence an application in response.
In April 2010, AstraZeneca received a Notice of Allegation
from Pharmascience Inc. (PMS) in respect of the ’305 patent
listed on the Canadian Patent Register for Atacand. PMS al-
leges that the formulation patent is not infringed. PMS has
not addressed the ’955 patent and must await its expiry in
April 2011 before it may receive its marketing authorisation.
AstraZeneca did not commence an application in response.
In May 2010, AstraZeneca received a Notice of Allegation
from Mylan Pharmaceuticals ULC (Mylan) in respect of the
’955 and ’305 patents listed on the Canadian Patent Regis-
ter for Atacand. Mylan has confirmed it will await the expiry
of the ’955 patent. Mylan alleged that the ’305 patent is not
infringed, is improperly listed and is invalid. AstraZeneca did
not commence an application in response.
In June 2010, AstraZeneca received a Notice of Allegation
from Sandoz in respect of the ’305 patent and relating to the
32mg strength of Atacand, not previously addressed by San-
doz. Sandoz alleges that the ’305 patent is not infringed and
is improperly listed. Sandoz does not address the ’955 patent
and must await its expiry before it may receive its marketing
authorisation. AstraZeneca did not commence an application
in response.
In August 2010, AstraZeneca received a Notice of Allega-
tion from Teva Canada Limited (Teva) in respect of the ’955
patent and the ’305 patent listed on the Canadian Patent Reg-
ister for Atacand. AstraZeneca did not commence an applica-
tion in response. In December 2010, AstraZeneca received
another Notice of Allegation from Teva in respect of the ’955
and ’305 patents listed on the Canadian Patent Register for
Atacand. Teva has confirmed it will await the expiry of the ’955
patent. AstraZeneca is evaluating the allegations.
None of Sandoz, Cobalt, PMS, Mylan or Teva may receive
a marketing authorisation before April 2011.
Patent Litigation—Brazil
In October 2010, an infringement action with a request for an
interlocutory injunction was filed against Sandoz do Brasil In-
dustria Farmaceutica Ltda (Sandoz) in the Central Court of
Săo Paolo. The Court denied the request for an interlocutory
injunction on 22 October 2010. Takeda Pharmaceutical Com-
pany Ltd. and AstraZeneca have filed a joint appeal. Sandoz
has responded and a decision is expected in the first quarter
of 2011.
Patent Litigation—EU
In Portugal, a request was filed with the Lisbon Administrative
Court of First Instance in December 2009 seeking a prelim-
inary injunction in the administrative courts in order to sus-
pend the effect of decisions taken by administrative bodies
in Portugal to grant Sandoz Farmacêutica Limitada market-
ing authorisations for generic candesartan cilexetil. The Court
denied the preliminary injunction. The decision has been ap-
pealed. A similar preliminary injunction request was filed in
April 2010 with respect to PTR Pharma Consulting Lda as an
interested party. Other similar preliminary injunction requests
were filed in October 2010, with respect to Laboratórios
Azevedos—Industria Farmacêutica (Laboratórios Azevedos),
S.A. Ceamed, Servico e Consultadoria Farmacêutica Lda
(Ceamed) and Teva Pharma—Produtos Farmacêuticos Lda,
as interested parties regarding candesartan cilexetil and also
in combination with hydrochlorothiazide. Corresponding main
actions have been initiated regarding all the above mentioned
matters.
In addition to the previously reported cases, a preliminary
injunction request was filed in December 2010, with respect to
Laboratórios Azevedos and Ceamed as interested parties, in
the capacity of owners of the marketing authorisations, and of
applicants of the retail prices regarding candesartan cilexetil
containing generics. The corresponding main action was filed
in the administrative courts also in December 2010, with the
aim of declaring null, or to annul, the decisions taken by ad-
ministrative bodies in Portugal granting Laboratórios Azeve-
dos and Ceamed marketing authorisations for generic can-
desartan cilexetil, or to defer the effects of the said decision,
and to prevent the decision being taken by administrative bod-
ies regarding the retail prices of the generic products. A pre-
liminary injunction request was filed in December 2010, with
respect to Labesfal—Laboratorios Almiro, S.A. (Labesfal) as
an interested party, in the capacity of owner of the marketing
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authorisations and of applicants of the retail prices regarding
candesartan cilexetil and a combination of candesartan cilex-
etil and hydrochlorothiazide containing generics. The corre-
sponding main action was filed in the administrative courts
in December 2010, with the aim of declaring null, or to an-
nul, the decisions taken by administrative bodies in Portugal
granting Labesfal marketing authorisations for generic can-
desartan cilexetil and a combination of candesartan cilexetil
and hydrochlorothiazide, or to defer the effects of the said de-
cision, and to prevent the decision being taken by administra-
tive bodies regarding the retail prices of the generic products.
Atacand HCT/Atacand Plus (candesartan
cilexetil/hydrochlorothiazide)
Patent Litigation—US
As previously reported, in 2008 and 2009, AstraZeneca and
Takeda Pharmaceutical Company Limited (Takeda) received
Paragraph IV Certification notice-letters from Matrix Laborato-
ries Limited (Matrix) and Sandoz Inc. (Sandoz) notifying the
parties that ANDAs had been submitted to the FDA seek-
ing approval to market generic versions of Atacand HCT in
32/12.5, 32/25 and 16/12.5mg dose forms. Matrix is a sub-
sidiary of Mylan, Inc.
Neither Matrix nor Sandoz challenged the two listed com-
pound patents, US Patent Nos. 5,705,517 and 5,196,444,
the latest of which expires in June 2012. As a result,
neither generic filer can market its candesartan cilex-
etil/hydrochlorothiazide (HCT) combination product before
December 2012, when the six-month Paediatric Exclusivity
period expires. Matrix and Sandoz have alleged that the re-
maining Orange Book patents listed for Atacand HCT, US
Patent Nos. 5,534,534, 5,721,263, 5,958,961 and 7,538,133
are invalid, unenforceable or not infringed. AstraZeneca and
Takeda did not file a complaint for patent infringement in re-
sponse to either notice-letter.
Patent Litigation—Canada
In 2009, AstraZeneca received a Notice of Allegation from
Sandoz Canada Inc. (Sandoz) in respect of Canadian Patent
Nos. 2,040,955 (the ’955 patent), 2,083,305 (the ’305 patent)
and 2,125,251 (the ’251 patent) listed on the Canadian Patent
Register for Atacand Plus. Sandoz has confirmed that it will
await the expiry of the ’955 patent, but alleges that the ’305
patent is not infringed and is not properly listed on the Cana-
dian Patent Register, and that the ’251 patent is not infringed,
is invalid and not properly listed. In September 2009, As-
traZeneca filed a Notice of Application in federal court seeking
an order prohibiting the Minister of Health from issuing a No-
tice of Compliance to Sandoz for its 16/12.5mg candesartan
cilexetil-HCT tablets until the expiration of the ’305 and ’251
patents. In January 2010, the court scheduled a hearing in
the Sandoz matter for four days beginning on 9 May 2011.
In January 2010, AstraZeneca received a Notice of Allega-
tion from Mylan Pharmaceuticals ULC (Mylan) in respect of
the ’955, ’305 and ’251 patents. On 12 January 2011, Mylan
withdrew its Notice of Allegation and AstraZeneca discontin-
ued its application on 17 January 2011.
In April 2010, AstraZeneca received two Notices of Alle-
gation from Cobalt Pharmaceuticals Inc. (Cobalt) in respect
of the ’305 and ’251 patents listed on the Canadian Patent
Register for Atacand Plus. Cobalt alleges that the ’305 patent
is not infringed, is invalid, and is irrelevant and not properly
listed. Cobalt alleges that the ’251 patent is not infringed and
is invalid. Cobalt has indicated that it is prepared to await its
marketing approval until after the ’955 patent expires in April
2011. AstraZeneca commenced a proceeding in response in
June 2010.
In April 2010, AstraZeneca received a Notice of Allegation
from Pharmascience Inc. (PMS) in respect of the ’305 patent
listed on the Canadian Patent Register for Atacand Plus. PMS
alleges that the ’305 patent is not infringed. AstraZeneca com-
menced a proceeding in response on 17 June 2010. On 20
December 2010, AstraZeneca received a Notice of Allega-
tion from PMS in respect of the ’251 patent. AstraZeneca is
evaluating the allegations. PMS has not addressed the ’955
patent.
In September 2010, AstraZeneca received a Notice of Alle-
gation from Teva Canada Limited (Teva) in respect of the ’305
patent listed on the Canadian Patent Register for Atacand
Plus. Teva withdrew its Notice of Allegation on 17 November
2010, and in response, on 30 November 2010, AstraZeneca




US Patent No. RE 37,314 (the ’314 patent)
As previously reported, in 2007 and 2008, AstraZeneca and
AstraZeneca’s licensor, Shionogi Seiyaku Kabushiki Kaisha
(Shionogi) (together, the Plaintiffs), filed lawsuits in the US
District Court for the District of Delaware, against various par-
ents or subsidiaries of eight generic ANDA filers for infringe-
ment of the ’314 patent, the patent covering rosuvastatin cal-
cium, the active ingredient in Crestor tablets.
On 3 March 2010, Judge Joseph Farnan, in the US Dis-
trict Court for the District of Delaware, completed the trial of
the consolidated matter. Following the trial, on 26 March 2010,
the Court approved and signed the stipulation and consent or-
der of the Plaintiffs and co-defendants, Aurobindo Pharma Ltd
and Aurobindo Pharma USA Inc., whereby Aurobindo Pharma
Ltd consented to jurisdiction and venue. Aurobindo Pharma
USA Inc. agreed to be bound by any judgment against Au-
robindo Pharma Ltd and the Plaintiffs agreed in exchange to
dismiss the action against Aurobindo Pharma USA Inc.
In June 2010, the Court issued a decision finding infringe-
ment and rejecting the defendants’ arguments of invalidity and
unenforceability with respect to the ’314 patent. In August
2010, the defendants filed Notices of Appeal to the US Court
of Appeals for the Federal Circuit. The defendants filed their
opening briefs with the appellate court in December 2010.
For trial, the Court retained jurisdiction over Apotex Corp.,
which participated in the trial. However, the Court transferred
the infringement matter as it pertained to co-defendant, Apo-
tex Inc. to the US District Court for the Southern District of
Florida. The Florida Court stayed the Apotex Inc. case pend-
ing the outcome of the appeal to the Federal Circuit.
In May 2010, AstraZeneca received a Paragraph IV Certifi-
cation notice-letter from Glenmark Generics Inc., USA (for-
merly, Glenmark Pharmaceuticals, Inc., USA) (Glenmark),
challenging the ’314 patent. In June 2010, the Plaintiffs filed a
patent infringement action against Glenmark in the US District
Court for the District of Delaware. On 15 November 2010, the
Court approved the parties’ stipulation and proposed order
requesting the Court to enter judgment in favour of the Plain-
tiffs and to stay the Glenmark action in its entirety. As part of
the stipulation, Glenmark conceded infringement of the ’314
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patent and agreed to be bound by the Court’s June 2010 de-
cision. The parties also agree to be bound by the results of
any subsequent appeal in the Plaintiffs’ other Crestor ANDA
litigation, which found the ’314 patent valid and enforceable.
505(b)(2) NDA for Rosuvastatin zinc Tablets (the ’314
Patent)
In September 2010, AstraZeneca received a Paragraph IV
Certification notice-letter from Watson Laboratories, Inc. in-
forming AstraZeneca of the filing of its section 505(b)(2) NDA
for rosuvastatin zinc tablets, and challenging the ’314 patent
and the Crestor formulation patent (US Patent No. 6,316,460
(the ’460 patent)). On 26 October 2010, AstraZeneca and Sh-
ionogi (together, the Plaintiffs) commenced a patent infringe-
ment action in the US District Court for the District of Delaware
(the Delaware Action) against Watson Pharmaceuticals, Inc.,
Watson Pharma, Inc., Watson Laboratories, Inc. and other
related entities for infringement of the ’314 patent. On 10
November 2010, for jurisdictional reasons, the Plaintiffs filed
a duplicate protective lawsuit in the US District Court for the
District of Nevada (the Nevada Action) against Watson Phar-
maceuticals, Inc., Watson Pharma Inc. and Watson Laborato-
ries, Inc. On 23 December 2010, pursuant to the parties’ joint
stipulation in the Delaware Action setting forth the agreement
of Watson Laboratories, Inc. to personal jurisdiction in the Dis-
trict of Delaware and other admissions, conditions, and agree-
ments, the Court dismissed all of the Watson co-defendants
without prejudice, except Watson Laboratories, Inc. Watson
Pharmaceuticals, Inc., Watson Pharma, Inc., Watson Labora-
tories, Inc. and other named Watson entities were dismissed
without prejudice from the Delaware action. In January 2011,
AstraZeneca dismissed the Nevada Action.
US Patent Nos. 6,858,618 (the ’618 Patent) and 7,030,152
(the ’152 Patent)
In April 2010, AstraZeneca commenced new patent infringe-
ment actions involving Crestor in the US District Court for the
District of Delaware, based on the ’618 and ’152 patents. Later
in April 2010, AstraZeneca amended nine complaints, adding
a co-plaintiff, The Brighams & Women’s Hospital (BWH), As-
traZeneca’s licensor of the ’152 patent, to the suits. In these
new infringement actions, AstraZeneca and BWH (together,
the Plaintiffs) allege that the defendants’ original filings or
amendments of ANDAs seeking approval to market generic
rosuvastatin calcium tablets prior to the expiration of these
patents, infringe the ’618 and ’152 patents under 35 USC
§271(e)(2). The ’618 and ’152 patents, which AstraZeneca
lists in the FDA’s Orange Book, relate respectively to the use
of rosuvastatin calcium for primary prevention of cardiovas-
cular disease and the treatment of heterozygous familial hy-
percholesterolemia (HeFH). AstraZeneca obtained FDA ap-
proval for the use of Crestor tablets for primary prevention of
cardiovascular disease in February 2010 and for paediatric
treatment of HeFH in October 2009. The new infringement
actions were brought against: (a) Aurobindo Pharma Ltd, Au-
robindo Pharma USA Inc. (together, Aurobindo) (b) Apotex
Corp., (c) Cobalt Pharmaceuticals Inc., Cobalt Laboratories,
Inc. (together, Cobalt) (d) Par Pharmaceuticals, Inc. (e) San-
doz Inc. (Sandoz), (f) Mylan Pharmaceuticals, Inc. (g) Sun
Pharmaceutical Industries Ltd., Sun Pharmaceutical Indus-
tries Inc., Caraco Pharmaceutical Laboratories Ltd. (together,
Sun) and (h) Teva Pharmaceuticals USA, Inc. These eight de-
fendant groups were also defendants in the ’314 patent litiga-
tion described above. In addition, AstraZeneca commenced
a first patent infringement action against Glenmark Generics
Inc. USA.
In May 2010, AstraZeneca received a Paragraph IV Cer-
tification notice-letter from Torrent Pharmaceuticals Limited
(Torrent Pharmaceuticals), challenging the ’460 patent (the
formulation patent). In July 2010, the Plaintiffs filed a patent
infringement action against Torrent Pharmaceuticals and Tor-
rent Pharma Inc. (together, Torrent) in the US District Court for
the District of Delaware, based on the ’618 and ’152 patents.
Torrent did not challenge the ’314 patent in its Paragraph IV
notice-letter.
In July and August 2010, all of the defendants, except San-
doz, filed Motions to Dismiss for lack of subject matter juris-
diction and failure to state a claim.
In November 2010, the Court approved a stipulation and
proposed order of the Plaintiffs and Torrent jointly requesting
the Court to stay the Torrent action. As part of the stipulation,
Torrent agrees to be bound by the results of the first final
decision and any appeals of that decision, as prosecuted by
the remaining defendants.
In December 2010, the Court granted the Motions to Dis-
miss and dismissed the infringement actions for lack of sub-
ject matter jurisdiction. The Court also ordered the Plaintiffs
to show cause why the claims against Sandoz, the sole non-
movant, should not also be dismissed. In 2011, the Plaintiffs
filed Notices of Appeal to the US Court of Appeals for the Fed-
eral Circuit. In January 2011, the Plaintiffs and Sandoz also
filed a joint response to the show cause order, requesting that
the Sandoz action be stayed until after the Federal Circuit ren-
ders its decision on the appeals or, alternatively, dismisses it
without prejudice.
Patent Litigation—Canada
In 2008, AstraZeneca received Notices of Allegation from
Novopharm Limited (now, Teva Canada Limited) (Teva) and
Apotex Inc. (Apotex), respectively, regarding Canadian Patent
Nos. 2,072,945 (the ’945 patent) and 2,313,783 (the ’783
patent) listed on the Canadian Patent Register for Crestor. As-
traZeneca commenced proceedings in response. The Cana-
dian Federal Court conducted consecutive hearings on the
two matters beginning on 22 March 2010 and 29 March 2010
respectively. In July 2010, AstraZeneca reached comprehen-
sive settlement agreements with each of Teva and Apotex to
resolve litigation between them. As part of the agreements,
Teva and Apotex may enter the Canadian market in April 2012,
or earlier, in certain circumstances. The Canadian substance
patent expires in July 2012.
In 2009, AstraZeneca received a Notice of Allegation from
Cobalt Pharmaceuticals, Inc. (Cobalt) in respect of the ’945
and ’783 patents. In November 2010, AstraZeneca reached a
comprehensive settlement agreement with Cobalt, resolving
the litigation, and as part of the agreement, Cobalt may enter
the Canadian market in April 2012, or earlier, in certain cir-
cumstances. The Canadian substance patent expires in July
2012.
Also in 2009, AstraZeneca received a Notice of Allegation
from Sandoz Canada Inc. (Sandoz) in respect of the ’945
and ’783 patents. In January 2011, AstraZeneca reached a
comprehensive settlement agreement resolving the litigation,
and as part of the agreement, Sandoz may enter the Canadian
market in April 2012, or earlier, in certain circumstances.
In August 2009, AstraZeneca received a Notice of Allega-
tion from ratiopharm Inc. (ratiopharm) with respect to the ’945
and ’783 patents. AstraZeneca commenced an application
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in response. In August 2010, AstraZeneca discontinued the
application as a result of Teva’s acquisition of ratiopharm.
In February 2010, AstraZeneca received a Notice of Alle-
gation from Pharmascience Inc. (Pharmascience) in respect
of the ’945 and ’783 patents. Pharmascience alleges that
the ’945 and ’783 patents are not infringed and are invalid.
AstraZeneca commenced an application in response in April
2010.
In July 2010, AstraZeneca received a Notice of Allegation
from Ranbaxy Pharmaceuticals Canada Inc. (Ranbaxy) re-
garding the ’945 patent, the ’783 patent and Canadian Patent
No. 2,315,141 (the ’141 patent). Ranbaxy alleges certain of
the claims of the ’945, ’783 and ’141 patents are not infringed
and that the patents are invalid. AstraZeneca commenced an
application in response in August 2010.
In August 2010, AstraZeneca received a Notice of Alle-
gation from Mylan Pharmaceuticals ULC (Mylan) regarding
the ’945, ’783 and ’141 patents. Mylan alleges certain of the
claims of the ’945, ’783 and ’141 patents are not infringed
and that the patents are invalid. AstraZeneca commenced an
application in response in September 2010.
Patent Litigation—EU
In Portugal, a preliminary injunction request was filed with
the Lisbon Administrative Court of First Instance in May 2010
seeking a suspension of the effect of decisions taken by ad-
ministrative bodies in Portugal to grant Teva Pharma Lda
(Teva) marketing authorisations for generic rosuvastatin cal-
cium, and to prevent the approval of the retail price. A similar
preliminary injunction request was filed with respect to San-
doz Farmaceutica Lda in June 2010. In October 2010, the
Court granted the preliminary injunction request to suspend
the effect of the decisions taken by the administrative bodies
in Portugal to grant Teva marketing authorisation for generic
rosuvastatin. The decision has been appealed by the admin-
istrative body, Infarmed, and by Teva. In November 2010, the
Court granted the preliminary injunction request to suspend
the marketing authorisations for generic rosuvastatin granted
to Sandoz Farmaceutica Lda. The decision has been ap-
pealed by Infarmed. In November 2010, the Court granted
the preliminary injunction request to suspend the marketing
authorisations for generic rosuvastatin granted to Hexal AG.
The decision has been appealed by Infarmed. Correspond-
ing main actions have been initiated regarding all the above
mentioned matters.
Patent Litigation—Brazil
Torrent do Brasil (Torrent) launched its generic versions of
Crestor in early October 2010 and AstraZeneca filed a request
for a preliminary injunction. On 13 October 2010, the court
of first instance granted the requested injunction and ordered
Torrent to discontinue the sale and marketing of these generic
products in Brazil and to recall products already on the market.
Torrent appealed the decision. The effects of the preliminary
injunction were suspended by the court of first instance until
the decision by the Court of Appeal. The Court of Appeal is
likely to make its decision in the first quarter of 2011.
Other US Patent Litigation
In October 2010, in the Teva Pharmaceuticals Industries Ltd.
(Teva) patent infringement lawsuit against AstraZeneca, with
regard to Crestor, the US District Court for the Eastern District
of Pennsylvania granted AstraZeneca’s motion for summary
judgment invalidating Teva’s patent based on prior inventor-
ship. AstraZeneca thereafter filed a motion for attorneys’ fees,
which was denied by the Court without prejudice pending
Teva’s appeal, which it filed in November 2010.
Entocort EC (Budesonide)
In 2008, AstraZeneca initiated patent infringement actions
against Barr Laboratories, Inc. (Barr) and Mylan Pharma-
ceuticals, Inc. (Mylan) for infringement of US Patent Nos.
6,423,340 (the ’340 patent) and 5,643,602 (the ’602 patent)
in the US District Court for the District of Delaware.
In May 2010, AstraZeneca entered into a settlement agree-
ment with Barr (acquired by Teva Pharmaceutical Industries
Ltd. in 2009, now, Teva). Under the terms of the agreement,
AstraZeneca has granted Teva a licence to enter the US mar-
ket with its generic version of oral budesonide on 15 Febru-
ary 2012, subject to regulatory approval. Also in May 2010,
AstraZeneca proceeded to trial against Mylan before Judge
Gregory Sleet on the sole issue of infringement of the ’602
patent. The Court has reserved judgment.
Faslodex (Fulvestrant)
Patent Litigation—US
In 2009, AstraZeneca received a Paragraph IV Certification
notice-letter from Teva Parenteral Medicines, Inc. (Teva Par-
enteral), informing AstraZeneca that it had filed an ANDA to
market a generic form of Faslodex before the expiration of
the Orange Book listed patents covering Faslodex. In Jan-
uary 2010, AstraZeneca filed a patent infringement lawsuit
against Teva Parenteral, Teva Pharmaceuticals USA, Inc. and
Teva Pharmaceutical Industries Ltd (together, Teva) in the US
District Court for the District of Delaware for infringement of
US Patent Nos. 6,774,122 and 7,456,160. The case was as-
signed to Judge Joel Pisano, sitting by designation due to
judicial vacancy in the District of Delaware. On 24 December
2010, Teva advised AstraZeneca that it had requested the
FDA to withdraw its ANDA without prejudice to refile. The
Court has stayed the litigation to permit the parties to re-
solve the matter pending the FDA’s acknowledgement of the
withdrawal.
Iressa (Gefitinib)
Between 2004 and 2008, seven claims were filed against As-
traZeneca in Japan, in the Osaka and Tokyo District Courts. In
these claims, it is alleged that Iressa caused a fatal incidence
of interstitial lung disease in a Japanese patient. AstraZeneca
believes the claims are without merit and has defended all




As previously reported, by 2006, AstraZeneca had initiated
patent infringement actions in the US District Court for the
Southern District of New York against several generic com-
panies and their suppliers, all alleging infringement of As-
traZeneca’s patents relating to omeprazole. As previously re-
ported, following trials against numerous defendants, in 2007,
the District Court upheld both formulation patents covering
the Prilosec omeprazole product and ruled that the generic
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omeprazole formulations of Impax Laboratories Inc. (Impax)
(manufacturers of the generic product distributed in the US by
Teva Pharma Ltd (Teva)) and Apotex Corp. and Apotex Inc.
(together, Apotex Group) infringed AstraZeneca’s patents.
The Court found that the generic products sold by Lek Phar-
maceutical and Chemical Company d.d. and Lek Services
USA, Inc. (together, Lek), Mylan Pharmaceuticals, Inc. and
Mylan, Inc. (together, Mylan) and Laboratorios Esteve, S.A.
and Esteve Quimica, S.A. (together, Esteve) did not infringe
AstraZeneca’s patents. In 2008, the US Court of Appeals for
the Federal Circuit upheld the rulings that Mylan and Es-
teve did not infringe. The Federal Circuit also upheld that
the generic omeprazole formulations of Impax and Apotex
Group infringed AstraZeneca’s patents. In January 2010, As-
traZeneca settled with Impax and Teva for their infringing com-
mercial sales, obtaining a one-time payment for past infringe-
ment. In 2010, AstraZeneca continued efforts to recover in-
fringement damages and other remedies against Andrx Phar-
maceuticals, Inc. and Apotex Group.
Patent Litigation—Canada
AstraZeneca continues to be involved in proceedings in
Canada involving various patents relating to omeprazole
capsules and omeprazole magnesium tablets. Apotex Inc.
launched a generic omeprazole capsule product in Canada
in January 2004.
In 2006, AstraZeneca was served with a claim in the Federal
Court of Canada for payment of an undetermined sum based
on damages allegedly suffered by Apotex Inc. due to the delay
from January 2002 to January 2004 in the issuance to Apotex
Inc. of a Notice of Compliance for its 20mg omeprazole cap-
sule product. AstraZeneca believes the claim is without merit
and is defending it, as well as continuing to vigorously pursue
its already pending patent infringement action against Apotex
Inc.
In May 2010, the Federal Court scheduled the trial for the
pending matters to be heard concurrently commencing in
March 2012.
European Commission Case
In July 2010, the General Court of the European Union (the
General Court) handed down its judgment in AstraZeneca’s
appeal against the European Commission’s 2005 Decision
fining AstraZeneca €60m for abuse of a dominant position
regarding omeprazole. The General Court upheld most of the
European Commission’s arguments but reduced the fine to
€52.5m as it said that the European Commission’s case had
not been proven in relation to Denmark and Norway. The fine
was paid in 2005 in accordance with the original Decision
and €7.5m plus interest has been repaid to AstraZeneca.
AstraZeneca was ordered to pay 90% of the European Com-
mission’s costs and the European Commission was ordered
to pay 10% of AstraZeneca’s costs. AstraZeneca has ap-
pealed the General Court’s judgment in relation to market
definition, that AstraZeneca’s behaviour was abusive (even if
AstraZeneca was dominant at the time) and the level of fine.
The European Commission has cross appealed the General
Court’s judgment regarding Denmark and Norway. It is possi-
ble that third parties could seek damages for alleged losses
arising from this matter. Any such claims would be vigorously
resisted.
Nexium (Esomeprazole Magnesium)
Sales and Marketing Practices
AstraZeneca entities have been sued in various state and fed-
eral courts in the US in purported representative class actions
involving the marketing of Nexium. These actions generally al-
lege that AstraZeneca’s promotion and advertising of Nexium
to physicians, consumers and third party payers was unfair,
unlawful and deceptive, particularly as the promotion relates
to comparisons of Nexium with Prilosec. Some of the cases
also allege that AstraZeneca’s conduct relating to the pricing
of Nexium was unfair, unlawful and deceptive. The plaintiffs
allege claims under various state consumer protection, unfair
practices and false advertising laws. The plaintiffs in these
cases seek remedies that include restitution, disgorgement
of profits, damages, punitive damages, injunctive relief, attor-
neys’ fees and costs of suit.
The first action was brought in 2004 in California State
Court on behalf of a class of Californian consumers and
third-party payers. Lawsuits making substantially similar al-
legations were later filed in 2004 and 2005 in state courts in
Arkansas, Florida, Massachusetts and Delaware, and in the
Delaware Federal Court.
The Florida and Arkansas cases have been dismissed at
the trial court level. Both of those dismissals were affirmed
on appeal and no further appeal is possible. Similarly, in May
2010, the Delaware Federal Court dismissed the complaint
for failure to state a claim and the plaintiffs did not appeal.
In March 2009, the California trial court granted Astra-
Zeneca’s motions for summary judgment and denied plaintiffs’
motion for class certification. That decision was appealed. In
August 2010, the California Court of Appeal affirmed the trial
court’s orders denying class certification and granting sum-
mary judgment in favour of AstraZeneca in an unpublished
decision. The time for further appeals has lapsed.
In July 2010, the Massachusetts trial court entered an order
granting plaintiffs’ motion to certify a class of Massachusetts
purchasers of Nexium denying AstraZeneca’s motion for sum-
mary judgment as to two plaintiffs, and granting AstraZeneca’s
motion for summary judgment as to one plaintiff. AstraZeneca
filed a petition for discretionary interlocutory review of those
rulings, which was denied by a single justice of the Mas-
sachusetts Appeals Court in September 2010.
The Delaware state case in Superior Court has been stayed
since May 2005 in favour of the Delaware federal court case. In
August 2010, the plaintiffs filed a request to lift the stay based
on the final resolution of the Delaware federal case and to en-
ter a scheduling order setting deadlines for the plaintiffs to file
an amended complaint and for the briefing of AstraZeneca’s
expected motion to dismiss. The Delaware Superior Court has
not yet acted on the plaintiffs’ request and the case remains
stayed.
Patent Litigation—US
In 2008, AstraZeneca entered into a settlement agreement
and consent judgment with Ranbaxy Pharmaceuticals, Inc.
and Ranbaxy Laboratories Limited (together, Ranbaxy) to set-
tle the Ranbaxy ANDA patent litigation. Ranbaxy was the first
to file a Paragraph IV Certification notice-letter in respect of
Nexium patents listed in the FDA’s Orange Book. The set-
tlement agreement allows Ranbaxy to commence sales of a
generic version of Nexium under a licence from AstraZeneca
on 27 May 2014.
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In 2006, in response to a Paragraph IV Certification notice-
letter from IVAX Pharmaceuticals Inc. stating that IVAX Cor-
poration (together, IVAX Group) had submitted an ANDA for
approval to market 20 and 40mg esomeprazole magnesium
delayed-release capsules, AstraZeneca commenced patent
infringement litigation in the US District Court for the District
of New Jersey against IVAX Group, its parent, Teva Phar-
maceutical Industries Ltd, and their affiliates (together, Teva
Group). In 2008, the Court granted AstraZeneca’s motion to
add Cipla, Ltd. as a defendant in the IVAX Group/Teva Group
litigation.
In 2007, AstraZeneca received a Paragraph IV Certifica-
tion notice-letter from Dr. Reddy’s Laboratories, Ltd and Dr.
Reddy’s Laboratories, Inc (together, DRL) stating that DRL
had submitted an ANDA for 20 and 40mg esomeprazole
magnesium delayed-release capsules. In 2008, AstraZeneca
commenced patent infringement litigation in the US District
Court for the District of New Jersey against DRL in response
to DRL’s ANDA and Paragraph IV Certifications regarding
Nexium.
In 2008, AstraZeneca, IVAX Group and DRL filed declara-
tory judgment suits in the US District Court for the District of
New Jersey for patents that were not previously included in
the ongoing Nexium patent infringement litigations.
In January 2010, AstraZeneca entered into an agreement
to settle the IVAX Group/Teva Group litigation. Teva Group
conceded that all patents-at-issue in its US Nexium patent
litigations are valid and enforceable. Teva Group also con-
ceded that its ANDA product would infringe six of the Nexium
patents-in-suit. AstraZeneca granted Teva Group a licence for
its ANDA product to enter the US market, subject to regulatory
approval, on 27 May 2014. This market entry date, and the
settlement, are consistent with AstraZeneca’s prior settlement
with Ranbaxy. As a result of settlement and entry of a consent
judgment, the litigation against IVAX Group/Teva Group and
Cipla, Ltd. has been dismissed. In January 2010, as part of the
settlement between AstraZeneca and IVAX Group, the 2008
declaratory judgment actions involving IVAX Group were also
dismissed.
In January 2011, AstraZeneca entered into an agreement
to settle the DRL litigation. DRL conceded that the patents-
at-issue in its US Nexium patent litigations are valid and en-
forceable with reference to DRL’s US esomeprazole magne-
sium ANDA product. DRL also conceded that its ANDA prod-
uct would infringe three Nexium patents-in-suit. AstraZeneca
granted DRL a licence for its ANDA product to enter the US
market, subject to regulatory approval, on 27 May 2014. This
market entry date, and the settlement, are consistent with
AstraZeneca’s settlement with Ranbaxy and the January set-
tlement with the IVAX Group, Teva Pharmaceutical Ltd., and
their affiliates. As a result of the DRL settlement and entry of a
consent judgment, the DRL litigation was dismissed. As part
of the settlement, DRL’s declaratory judgment actions were
also dismissed.
In January 2010, AstraZeneca received a Paragraph IV
Certification notice-letter from Sun Pharma Global FZE and
its affiliates (together, Sun) stating that Sun had filed an ANDA
and notifying of Sun’s challenge to patents listed in the FDA’s
Orange Book in reference to Nexium i.v. In February 2010, As-
traZeneca filed suit against Sun in the US District Court for the
District of New Jersey. In August 2010, upon AstraZeneca’s
motion, Magistrate Judge Bongiovanni stayed the Sun liti-
gation. In December 2010, among other actions, the Court
vacated the stay and referred the matter back to Magistrate
Judge Bongiovanni for a scheduling conference. No trial date
has been set in the Sun patent litigation.
In 2008, AstraZeneca received a Paragraph IV Certifi-
cation notice-letter from Sandoz Inc. (Sandoz) stating that
Sandoz had submitted an ANDA for approval to market 20
and 40mg esomeprazole magnesium delayed-release cap-
sules. In 2009, AstraZeneca commenced patent infringement
litigation in the US District Court for the District of New Jersey.
In July 2009, the Court stayed the Sandoz patent infringement
litigation until after trial in the above referenced DRL Nexium
patent infringement litigation. No trial date has been set in the
Sandoz patent infringement litigation.
In September 2009, AstraZeneca received a Paragraph IV
Certification notice-letter from Lupin Limited (Lupin) stating
that Lupin had submitted an ANDA for approval to market 20
and 40mg esomeprazole magnesium delayed-release cap-
sules relating to patents listed in the FDA’s Orange Book
with reference to Nexium. In October 2009, AstraZeneca com-
menced patent infringement litigation against Lupin in the US
District Court for the District of New Jersey. In March 2010,
the Court stayed the Lupin patent infringement litigation until
after trial in the DRL Nexium patent infringement litigation. No
trial date has been set in the Lupin patent litigation.
In December 2010, AstraZeneca received a Paragraph IV
Certification notice-letter from Hanmi USA Inc. (Hanmi) stat-
ing that it had submitted an NDA under section 505(b)(2) for
FDA approval to market 20 and 40mg esomeprazole stron-
tium capsules. Hanmi alleges non-infringement or invalidity
of 11 patents listed in the FDA’s Orange Book with refer-
ence to Nexium. AstraZeneca is evaluating Hanmi’s notice
and certifications.
Patent Litigation—Canada
AstraZeneca received several Notices of Allegation from Apo-
tex Inc. (Apotex) in 2007 in respect of patents listed on
the Canadian Patent Register for Nexium. AstraZeneca re-
sponded by commencing seven applications in 2008 under
the Patented Medicines (Notice of Compliance) Regulations.
In June 2010, after a hearing, the Federal Court of Canada
dismissed AstraZeneca’s application to prohibit the Minister
of Health from issuing a Notice of Compliance (marketing au-
thorisation) for generic esomeprazole magnesium to Apotex,
and Apotex received its marketing authorisation in June 2010.
In October 2010, AstraZeneca commenced a patent infringe-
ment action against Apotex alleging infringement of five Cana-
dian patents related to Nexium.
As previously reported, in 2009, AstraZeneca received a
Notice of Allegation from Mylan Pharmaceuticals ULC. As-
traZeneca commenced an application in response in January
2010. A hearing has been set for 24 October 2011.
In September 2010, AstraZeneca received several No-
tices of Allegation from Pharmascience Inc. in respect of the
patents listed on the Canadian Patent Register for Nexium.
AstraZeneca commenced applications in response in Octo-
ber 2010.
In October 2010, AstraZeneca received a Notice of Allega-
tion from Ranbaxy Pharmaceuticals Canada Inc. (Ranbaxy)
in respect of the patents listed on the Canadian Patent Reg-
ister for Nexium. AstraZeneca commenced a proceeding in
response in December 2010.
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Patent Litigation—Brazil
AstraZeneca has filed two law suits before the Federal Courts
of Brasilia seeking judicial declaration to confirm that all condi-
tions established in the Trade-Related Aspects of Intellectual
Property Rights Agreement have been satisfied and thereby
entitling AstraZeneca to exclusive marketing rights for Nex-
ium to July 2012. The Court rejected one suit in 2008 and the
other one on 1 May 2010. AstraZeneca has appealed both
decisions and the Federal Court of Appeals is expected to
issue decisions on the merits by the middle of 2011.
Patent Litigation—EU
Most major European markets (Belgium, France, Italy, Luxem-
bourg, the Netherlands, Germany, Sweden and the UK) had
regulatory data protection for Nexium until 10 March 2010
and other markets had six years regulatory data protection.
To date, there are generic products in several 6-year coun-
tries and in Germany, Sweden and the Netherlands among
the 10-year countries.
Patent Litigation—EU: 10-Year Countries
In July 2010, Consilient Health Limited (Consilient) was
granted marketing approval in the UK for a generic esomepra-
zole product manufactured by Krka, d.d., Novo Mesto (Krka)
in Slovenia. AstraZeneca initiated infringement proceedings
against Consilient and Krka on 8 September 2010. Consilient
and Krka agreed not to launch their generic esomeprazole
product pending the outcome of the main infringement case.
AstraZeneca has undertaken to be liable for losses of the de-
fendants and third parties if the injunction is lifted at a later
date. The trial will not be held before 3 October 2011.
In October 2010, AstraZeneca was served an invalidity
case in which Ranbaxy (UK) Ltd claimed that the Nexium
esomeprazole magnesium patent (EP 1020461) and the es-
omeprazole magnesium trihydrate patent (EP 0984957) are
invalid in the UK. Ranbaxy (UK) Ltd further requested the
Court to confirm that its generic esomeprazole product does
not infringe either patent if launched in the UK. The trial of the
non-infringement part will not be held before May 2011. The
invalidity part has been stayed pending the non-infringement
trial.
In Germany, Krka, d.d., Novo Mesto, TAD Pharma GmbH,
Abz-Pharma GmbH, CT Arzneimittel GmbH, ratiopharm
GmbH and Teva GmbH launched generic esomeprazole mag-
nesium products during September and October 2010. In Oc-
tober 2010, AstraZeneca filed requests for preliminary injunc-
tions to restrain said companies from marketing and selling
these products in Germany. In November 2010, AstraZeneca
added Hexal AG and Sandoz Pharmaceuticals GmbH as de-
fendants. The trial was held on 10 December 2010, and the
court rejected the request for preliminary injunctions on 17
December 2010. The decision has not yet been published. As-
traZeneca has four weeks from the date of publication to deter-
mine whether it will appeal. In November 2010, AstraZeneca
was served with a law suit filed by Ethypharm S.A. claiming
that the two Nexium cloud point patents (EP 0984773 and EP
1124539) are invalid in Germany.
In Sweden, AstraZeneca filed a request for an interlocutory
injunction on 26 October 2010 against Krka Sverige AB to re-
strain this company from marketing and selling its generic
esomeprazole magnesium product in Sweden. In January
2011, AstraZeneca was served with a lawsuit filed by ratio-
pharm GmbH and ratiopharm AB claiming that the Nexium
esomeprazole magnesium patent (EP 1020461) is invalid in
Sweden.
In the Netherlands, Sandoz B.V. and Hexal AG (both in the
Sandoz group) and Stada Arzneimittel AG and Centrafarm
Services B.V. (both in the Stada group) filed lawsuits in June
2010, in accelerated proceedings, claiming that the Nexium
esomeprazole magnesium patent (EP 1020461) is invalid in
the Netherlands. The trials were held on 14 January 2011.
The decision has not yet been published.
In Italy, EG s.p.a. (a company in the Stada group) filed a
law suit in June 2010 claiming that the Nexium esomepra-
zole magnesium patent (EP 1020461) is invalid in Italy. Astra-
Zeneca has added a counterclaim of infringement. An initial
hearing was held on 23 November 2010.
In France, ratiopharm GmbH and Laboratoire ratiopharm
S.A. filed a law suit against AstraZeneca on 18 August 2010
claiming that the Nexium esomeprazole magnesium patent
(EP 1020461) is invalid in France. Ethypharm S.A. filed a law
suit against AstraZeneca in August 2010 claiming that the
Nexium esomeprazole magnesium patent (EP 1020461) and
the cloud point patent (EP 1124539) are invalid in France. The
next hearing in these cases will be on 17 March 2011.
In Belgium, AstraZeneca was served in October 2010 with
a revocation action by Teva Pharmaceutical Industries Ltd
and Teva Pharma Belgium NV claiming that the Nexium es-
omeprazole magnesium patent (EP 1020461) is invalid in Bel-
gium. The next hearing is scheduled for 23 September 2011.
Patent Litigation—EU: 6-Year Countries
In Denmark, Sandoz A/S (Sandoz) launched its generic prod-
uct in June 2009 and AstraZeneca filed a request for a pre-
liminary injunction in the same month. In January 2010, the
court granted AstraZeneca a preliminary injunction prevent-
ing Sandoz from continuing to sell the products based on an
infringement of a Nexium esomeprazole magnesium patent
(EP 1020461). Sandoz appealed this decision and the appeal
will be heard on 22 to 25 February 2011. In March 2010, the
court granted a preliminary injunction based on infringement
of a Nexium process patent (EP 0773940). Sandoz appealed
this decision and the appeal was heard on 17 to 24 January
2011. The decision will be announced on 28 February 2011.
In July 2010, AstraZeneca filed an application with the Dis-
trict Court of Copenhagen, seeking an interlocutory injunc-
tion to restrain Krka Sverige AB from selling and marketing
its generic esomeprazole magnesium products in Denmark.
The hearing took place in November 2010. On 10 December
2010, the court denied AstraZeneca’s request for a prelimi-
nary injunction. AstraZeneca has appealed this decision.
In Austria, Hexal Pharma GmbH and 1A Pharma GmbH
(both in the Sandoz group) launched generic products in Oc-
tober 2009. Requests for preliminary injunctions were filed in
December 2009. Preliminary injunctions have been granted
by the Vienna Commercial Court against Hexal Pharma
GmbH on 10 March 2010 and against 1A Pharma GmbH on
11 March 2010. The decisions were appealed by the San-
doz companies. The Higher Regional Court of Vienna upheld
the injunction against 1A Pharma GmbH in July 2010 and
against Hexal Pharma GmbH in September 2010. In Decem-
ber 2010, the Supreme Court rejected 1A Pharma GmbH’s
request for extraordinary appeal. In July 2010, AstraZeneca
filed an application for a preliminary injunction to be granted
against Krka Pharma GmbH and Krka, d.d., Novo Mesto. In
October 2010, the Vienna Commercial Court granted the pre-
liminary injunction against Krka Pharma GmbH. This decision
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has been appealed by Krka Pharma GmbH. The case is
still pending against Krka, d.d., Novo Mesto. On 29 Novem-
ber 2010, a similar request for a preliminary injunction was
filed with the Vienna Commercial Court against ratiopharm
Arzneimittel Vertriebs-GmbH.
In July 2008, AstraZeneca initiated a declaratory action in
Finland requesting the District Court of Helsinki to confirm that
Sandoz AS and Sandoz A/S would infringe a patent relating
to esomeprazole if they were to commercialise their generic
esomeprazole product in Finland. In September 2008, Hexal
AG, Sandoz Oy Ab and Sandoz A/S (all in the Sandoz group)
initiated an invalidity case requesting the Court to invalidate
the same patent. These cases will be heard jointly and were
scheduled to be heard in September 2010. The hearing has
been postponed to a date to be determined later.
AstraZeneca initiated similar declaratory actions in Finland
at the District Court of Helsinki against Ranbaxy (UK) Limited
in December 2009, against Mylan AB in March 2010, against
Stada Arzneimittel AG in April 2010 and against Teva Swe-
den AB on 17 January 2011, requesting an order that these
companies would infringe a patent relating to esomeprazole if
they were to commercialise their generic products in Finland.
In Portugal, AstraZeneca filed a request in August 2009
with the Lisbon Administrative Court of First Instance seek-
ing a preliminary injunction and initiating a main action in the
administrative courts. AstraZeneca has filed the request to
seek a suspension of the effect of decisions taken by ad-
ministrative bodies in Portugal to grant Sandoz Farmacêutica
Limitada marketing authorisations for generic esomeprazole
magnesium products. In October 2009, the Court granted As-
traZeneca a preliminary injunction suspending the efficacy of
the marketing authorisations and the price approvals for San-
doz Farmacêutica Limitada’s generic esomeprazole magne-
sium products. The decision was appealed by the Portuguese
authorities. In a decision on 22 December 2010, the court
upheld the preliminary injunction. In January 2010, Mepha
AG and Mepha Investigacao Fabricacao Farmacêutica, Limi-
tada filed a nullity action to revoke the esomeprazole magne-
sium patent (EP 1020461) for Nexium. In February 2010, As-
traZeneca filed a similar request for a preliminary injunction
regarding the marketing approval for Mepha Farmacêutica
Limitada. The preliminary request was denied by the Court in
June 2010. AstraZeneca has appealed this decision.
During 2009, Lek Farmacevtska Druzba d.d. (a company
within the Sandoz group), (Lek) initiated an invalidity case
regarding two esomeprazole related patents in Slovenia. As-
traZeneca filed a request for an interlocutory injunction in Jan-
uary 2010 against Lek to restrain this company from com-
mercialising, manufacturing and selling products containing
esomeprazole magnesium in Slovenia. The interlocutory in-
junction was granted in June 2010. Lek appealed in July 2010,
and in September 2010 the Appeal Court upheld the injunc-
tion. In July 2010, AstraZeneca filed an application with the
District Court of Ljublijana in Slovenia seeking an interlocutory
injunction to restrain Krka, d.d., Novo Mesto from manufactur-
ing and selling generic esomeprazole magnesium products.
On 20 October 2010, the court rejected the request for an in-
junction. AstraZeneca appealed this decision on 28 October
2010.
In Spain, AstraZeneca filed a request for a prelimi-
nary injunction in April 2010 against Sandoz Farmacéutica
S.A., Bexal Farmacéutica S.A., and Acost Comercial Gener-
icpharma, S.L. (all in the Sandoz group) to restrain the com-
panies from selling their generic esomeprazole magnesium
products in Spain. In May 2010, the Court of Barcelona
granted AstraZeneca a preliminary injunction against these
Sandoz companies. A hearing in court took place in July 2010.
Six days later, the court revoked the preliminary injunction.
AstraZeneca has appealed.
In Poland, AstraZeneca filed in May 2010 a request for an in-
terlocutory injunction against Lek Farmacevtska Druzba d.d.
and Sandoz GmbH (both in the Sandoz group) to restrain
them from manufacturing, using and selling their generic es-
omeprazole magnesium product in Poland. In June 2010, the
application was granted regarding commercialising the prod-
uct. AstraZeneca has appealed to have the injunction ex-
tended to manufacturing and Lek and Sandoz appealed in Au-
gust 2010. In November 2010, the Appeal Court denied both
appeals and thereby confirmed the interlocutory injunction.
In Ireland, AstraZeneca initiated a main action in August
2010 against Krka, d.d., Novo Mesto and Pinewood Labora-
tories Ltd claiming that the sale and marketing of their generic
esomeprazole magnesium products infringes the Nexium es-
omeprazole magnesium patent (EP 1020461).
In Estonia, AstraZeneca filed a request for an interlocu-
tory injunction in June 2010 against Krka, d.d., Novo Mesto
(Krka) to restrain this company from commercialising its mag-
nesium esomeprazole product in Estonia. In July 2010, the
court granted the requested interlocutory injunction. Krka ap-
pealed. In September 2010, the Appeal Court rejected the ap-
peal and upheld the injunction. Krka, d.d., Novo Mesto filed an
appeal with the Supreme Court, which denied leave to appeal.
In July 2010, AstraZeneca filed a similar request for an inter-
locutory injunction against Krka in Lithuania. In July 2010, the
injunction was granted. In September 2010, Krka appealed.
Krka and Zentiva k.s. have challenged Nexium esomeprazole
magnesium patents in courts in Estonia, Latvia and Lithua-
nia. In January 2011, Zentiva k.s. waived its invalidity claim in
Lithuania.
Patent Litigation—Norway
In Norway, Hexal AG, Sandoz AS and Sandoz A/S (together,
Sandoz) initiated an invalidity case regarding two esomepra-
zole related patents in July 2008. In December 2009, the
Court of Oslo invalidated a formulation patent while it upheld a
substance patent related to esomeprazole. Both parties have
appealed and the case was heard by the Appeal Court in
January 2011. In September 2010, AstraZeneca filed a re-
quest for an interlocutory injunction against Krka Sverige AB
to restrain the company from marketing and selling its generic
esomeprazole magnesium product in Norway. In December
2010, the Court granted AstraZeneca’s application, thereby
prohibiting Krka Sverige AB’s commercialisation of its generic
esomeprazole product in Norway. Krka Sverige AB has ap-
pealed this decision.
Patent Proceedings
In July 2009, the European Patent Office (EPO) published the
grant of two patents that relate to Nexium (EP 1020461) and
Nexium i.v. (EP 1020460). These two patents were granted on
the basis of two divisional applications of European Patent No.
0652872 (the Parent Patent). The Parent Patent, a substance
patent covering Nexium, was revoked by the EPO Board of
Appeal in December 2006 following post-grant opposition and
appeal proceedings. The claims of EP 1020461 are different
and narrower than the Parent Patent.
The divisional applications were supported by new evi-
dence that was not available at the time the EPO Board of
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Appeal made its decision to revoke the Parent Patent. The
new patents are due to remain in force until May 2014. The
claims of the esomeprazole magnesium divisional application
are limited to preparations and uses thereof having a very high
optical purity, namely esomeprazole magnesium with an op-
tical purity of equal to or greater than 99.8% enantiomeric
excess.
The period for filing Notices of Opposition to the grant of
these patents expired in April 2010. Thirteen Notices of Op-
position have been filed in relation to EP 1020461 and six
Notices of Opposition in relation to EP 1020460. No hearing
date has been set.
European Commission Investigation
On 30 November 2010, the European Commission com-
menced an investigation relating to certain alleged prac-
tices regarding Nexium and dawn raided several AstraZeneca
sites. The European Commission is investigating whether
AstraZeneca may have acted individually or jointly to de-
lay generic entry, in alleged breach of Articles 101 and/or
102 of the Treaty on the Functioning of the European Union,
which prohibit anti-competitive practices between third parties
and abuse of a dominant position. Dawn raids are a prelim-
inary step in investigating suspected anti-competitive prac-
tices. The European Commission is continuing its investiga-
tion. AstraZeneca remains of the view that the investigation is
unfounded and that it has complied with all relevant competi-
tion laws. AstraZeneca has, in accordance with its corporate
policy, co-operated with the European Commission’s investi-
gation. AstraZeneca will continue to co-operate with the Euro-
pean Commission should it decide to take the matter further.
Dutch Competition Authority Nexium Investigation
On 30 November 2010, the Dutch Competition Authority
(NMa) commenced an investigation relating to alleged breach
of Article 24 of Dutch competition law and Article 102 of the
Treaty on the Functioning of the European Union. The NMa’s
investigation relates to alleged foreclosure of generic versions
of certain proton pump inhibitors (PPIs). The NMa is continu-
ing its investigation. AstraZeneca remains of the view that the
investigation is unfounded and that it has complied with all rel-
evant competition laws. AstraZeneca has, in accordance with
its corporate policy, co-operated with the NMa’s investigation.
AstraZeneca will continue to co-operate with the NMa should
it decide to take the matter further.
Federal Trade Commission (FTC) Inquiry
In July 2008, AstraZeneca received a Civil Investigative De-
mand from the FTC seeking information regarding the Nex-
ium patent litigation settlement with Ranbaxy (UK) Limited.
AstraZeneca is co-operating fully with the request.
Pulmicort Respules (Budesonide Inhalation Suspension)
In 2008, AstraZeneca filed a lawsuit in the US District Court
for the District of New Jersey against Breath Ltd. (now owned
by Watson Pharmaceuticals) (Watson) for patent infringement
resulting from an ANDA filed by Watson seeking approval to
market generic copies of Pulmicort Respules in the US prior
to the expiration of AstraZeneca’s patents.
In 2009, AstraZeneca filed a patent infringement lawsuit in
the US District Court for the District of New Jersey against
Apotex Inc. and Apotex Corp. (together, Apotex Group) seek-
ing declaratory judgments and injunctive relief following the
FDA’s approval of Apotex Group’s ANDA for a generic ver-
sion of Pulmicort Respules in the US prior to the expiration of
AstraZeneca’s patents. In May 2009, due to concerns about
Apotex Group’s intent to market its generic ANDA product,
AstraZeneca obtained a preliminary injunction barring Apo-
tex Group from launching its generic version of Pulmicort Re-
spules until further order of the Court. In November 2010,
the Court of Appeals for the Federal Circuit affirmed the Dis-
trict Court’s decision to issue a preliminary injunction. Apotex
Group has filed a petition in the Court of Appeals for rehearing
en banc.
In April 2009, AstraZeneca listed in the FDA’s Orange Book
a newly issued US patent directed to sterile formulations of
budesonide inhalation suspensions. AstraZeneca listed the
new patent in the FDA’s Orange Book, referencing Pulmi-
cort Respules. AstraZeneca amended its pleadings against
Apotex Group and Watson alleging infringement of the newly
issued patent. The litigation involving Apotex Group and Wat-
son has been consolidated under a common scheduling or-
der. In December 2010, the Court scheduled a claim con-
struction hearing to commence on 9 May 2011.
In September 2010, AstraZeneca received a Paragraph
IV Certification notice-letter from Sandoz Inc. notifying As-
traZeneca that it was seeking approval to market a generic
version of 0.25, 0.50 and 1mg doses of Pulmicort Respules
prior to expiration of the patents covering Pulmicort Respules.
In November 2010, AstraZeneca commenced patent infringe-
ment litigation against Sandoz Inc. in the US District Court for
the District of New Jersey.
Seroquel (Quetiapine Fumarate)
AstraZeneca has made provisions in the year totalling $592m
in respect of the ongoing Seroquel product liability litigation
and state attorney general investigations into sales and mar-
keting practices in the aggregate.
Sales and Marketing Practices
As previously reported, AstraZeneca reached a civil settle-
ment with the US Attorney’s Office (Department of Justice)
and the state Attorneys General National Medicaid Fraud
Control Unit (NMFCU) to resolve an investigation relating to
the marketing of Seroquel, pursuant to which AstraZeneca
paid to the United States Federal Government a fine of $302m
plus accrued interest and to participating states a proportional
share of up to $218m plus accrued interest. In September
2010, AstraZeneca entered into individual settlement agree-
ments with 41 states and Washington, D.C. for an aggregate
amount of approximately $210m.
There are also a number of additional active investiga-
tions involving Seroquel sales and marketing practices led by
state Attorneys General which include investigations relating
to Seroquel off-label issues and which purport to cover issues
in addition to the respective states’ participation in NMFCU.
AstraZeneca has reached an agreement in principle to set-
tle Seroquel -related state consumer protection and deceptive
trade practice claims under state law with 37 states and Wash-
ington, D.C., as part of the National Association of Attorneys
General and has recorded a provision for the agreed amount.
Some states may also be conducting individual investigations.
Some states are separately suing AstraZeneca. As previ-
ously reported, the Commonwealth of Pennsylvania and the
states of Arkansas, Montana, New Mexico, South Carolina,
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Mississippi and Utah have sued AstraZeneca under various
state laws generally alleging that AstraZeneca made false
and/or misleading statements in connection with the market-
ing and promotion of Seroquel. In December 2010, the State
of Alaska also sued AstraZeneca, making similar allegations.
In September 2010, the Commonwealth of Pennsylvania vol-
untarily dismissed its lawsuit, and in December 2010, a fed-
eral judge dismissed Utah’s suit in its entirety and gave the
State until 2 February 2011 to amend its complaint and refile.
AstraZeneca believes that the remaining claims, which are in
various stages of litigation, are without merit and intends to
vigorously defend them.
In May 2007, the New Jersey Ironworkers Local Union No.
68 filed a class action suit against AstraZeneca on behalf
of all individuals and non-governmental entities that paid for
Seroquel from January 2000 to date. The lawsuit was filed
in the federal District Court in New Jersey and alleged that
AstraZeneca promoted Seroquel for off-label uses and mis-
led class members into believing that Seroquel was superior
to other, lower-cost alternative medicines. Two similar class
action lawsuits were filed in June and July 2007 in the New Jer-
sey and Pennsylvania federal courts. In December 2007, the
three lawsuits were transferred to the Middle District of Florida
by the US Judicial Panel on Multi-District Litigation (MDL). In
November 2008, the MDL Court granted AstraZeneca’s mo-
tion and dismissed these cases in their entirety with preju-
dice. The plaintiffs have appealed this decision. AstraZeneca
intends to vigorously defend the appeal, which was heard by
the Eleventh Circuit Court of Appeals in February 2010 and
remains pending.
In September 2008, the Pennsylvania Employees Benefit
Trust Fund (PEBTF) served AstraZeneca with a complaint
filed in the Pennsylvania Court of Common Pleas of Philadel-
phia County seeking economic damages stemming from al-
legedly improper marketing practices that caused the PEBTF
to reimburse for allegedly overpriced Seroquel prescriptions
and the medical care of PEBTF members allegedly injured
from Seroquel use. In October 2008, AstraZeneca removed
this lawsuit to the federal court and immediately requested
that it be transferred to the Seroquel MDL. In July 2009,
the MDL Court dismissed PEBTF’s complaint with prejudice.
PEBTF elected to forego a federal appeal of that decision,
and instead pursued an appeal in the Pennsylvania Superior
Court on the dismissal of an earlier-filed state court action. In
August 2010, PEBTF voluntarily dismissed its appeal to the
Pennsylvania Superior Court.
Product Liability
AstraZeneca, either alone or in conjunction with one or more
affiliates, has been sued in numerous individual personal in-
jury actions involving Seroquel. In most of these cases, the
nature of the plaintiffs’ alleged injuries is not clear from the
complaint and, in most cases, little or no factual information re-
garding the alleged injury has been provided in the complaint.
However, the plaintiffs generally contend that they developed
diabetes and/or other related injuries as a result of taking
Seroquel and/or other atypical anti-psychotic medications.
AstraZeneca has defended Seroquel product liability liti-
gation in federal courts, including a Multi-District Litigation
(MDL) in the Middle District of Florida, as well as in multiple
state courts, including Delaware, New York and New Jersey
courts, where cases were consolidated in order to manage
the large volume of claims pending in those jurisdictions.
As of 31 December 2010, AstraZeneca was aware of ap-
proximately 3,950 Seroquel US product liability claims that
have not been settled in principle (see below). The major-
ity of these remaining claims are pending in New Jersey and
New York state courts, although some claims are pending in a
handful of other state courts and in the federal MDL. Some of
the cases pending against AstraZeneca also include claims
against other pharmaceutical manufacturers such as Eli Lilly
& Company, Janssen Pharmaceutica, Inc. and/or BMS. At
present, trial dates remain pending in multiple jurisdictions,
including New Jersey and New York, beginning mid 2011 and
continuing through 2012.
There are four additional putative Canadian class actions
raising allegations that AstraZeneca failed to provide ade-
quate warnings in connection with an alleged association be-
tween Seroquel and the onset of diabetes. These actions have
been filed in the Canadian provinces of British Columbia, Al-
berta, Ontario and Quebec. The Quebec court dismissed the
action, and the petitioner’s appeal of that decision is sched-
uled for hearing in April 2011. A class certification hearing has
been set in the Ontario action for the week of 21 November
2011.
In September 2010, the court presiding over the Delaware
Seroquel litigation issued an opinion dismissing three cases
on the basis that the claims were time-barred under the statute
of limitations.
The only case that has gone to trial resulted in a defence
verdict in favour of AstraZeneca. The plaintiffs have appealed
that verdict, and the appeal is pending before the New Jersey
appellate court.
In November 2009, Judge Anne Conway, who is presiding
over the Seroquel federal MDL, ordered the parties to medi-
ate their claims with a court-appointed mediator. AstraZeneca
remains committed to a strong defence effort, but will also con-
tinue to participate in good faith in the court-ordered mediation
process.
As of 31 December 2010, the mediation process has re-
sulted in agreements in principle on monetary terms, sub-
ject to various subsequent conditions, approvals and agree-
ment on non-monetary terms, with the attorneys representing
24,591 claimants. The claims that have settled in principle in-
clude both claims that have been filed in the courts as well as
claims that had not yet been filed. The specific terms of those
conditional agreements in principle are by agreement, and at
the request of the mediator, confidential at this time. Written
settlement agreements have been finalised in connection with
18,072 claims and payments have been made in connection
with certain of those claims. The parties are finalising written
settlement agreements in respect of the other claims that have
been resolved in principle. The mediation process is ongoing
with regard to other currently unsettled claims.
A provision has been established in respect of the Seroquel
product liability claims regarding both current and anticipated
future settlement costs as well as anticipated future defence
costs associated with resolving all or substantially all remain-
ing claims.
The amount of this provision remains subject to a number of
significant uncertainties and is based on AstraZeneca’s best
estimate of (1) the number of claims that are outstanding and
may be subject to mediation, (2) the financial terms of any
future agreements to settle claims not subject to settlement
agreements in principle at the balance sheet date, and (3) the
likely cost of defending those claims and finalising settlement
agreements through to substantial completion. Each of these
estimates is subject to future adjustment based on multiple
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variables, such as the number of asserted claims, the suc-
cess of future mediations, and further developments in the
litigation. It is therefore not possible at this time to provide any
reasonable indication as to when remaining claims may be
settled. Furthermore, it is possible that the actual cost of ul-
timately settling or adjudicating the Seroquel product liability
claims may differ significantly from the total amount provided.
As of 31 December 2010, legal defence costs of ap-
proximately $738m have been incurred in connection with
Seroquel-related product liability claims.
AstraZeneca has product liability insurance dating from
2003 that is considered to respond to the vast majority of
the Seroquel-related product liability claims. This insurance
provides cover for legal defence costs and potential dam-
ages amounts. The insurers that issued the applicable policies
for 2003 have disputed coverage for Seroquel-related prod-
uct liability claims on various grounds. In April 2010, Astra-
Zeneca settled its claims against several of its insurers for
legal costs incurred defending the Seroquel-related product
liability claims immediately in excess of AstraZeneca’s self-
insured retention of $39m for an amount approximately equal
to the receivable that had been recorded at 31 December
2009.
Disputes continue with insurers about the availability of cov-
erage under additional insurance policies. As of 31 December
2010, legal costs of approximately $123m have been incurred
in connection with Seroquel-related product liability claims
which AstraZeneca believes to be covered by these additional
insurance policies. However, the combined amount charged
to the income statement to date in respect of legal costs and
settlements which AstraZeneca believes to be covered by
these additional policies, including the provisions taken in the
third and fourth quarters of 2010, now significantly exceeds
the total stated upper limits of these insurance policies.
While no insurance receivable can be recognised under
applicable accounting standards at this time, AstraZeneca
believes that it is more likely than not that further insurance
recoveries will be secured under the additional policies, but
there can be no assurance of this or the amount of any po-
tential future recovery.
Patent Litigation—Brazil
In January 2006, AstraZeneca filed a lawsuit before the Fed-
eral Courts of Rio de Janeiro seeking judicial declaration ex-
tending the term of one of its patents from 2006 to 2012. A
preliminary order was granted shortly thereafter. At the end of
July 2010, Pró Genéricos and the Brazilian Patent Trademark
Office (Brazilian PTO) appealed the preliminary order granted
in favour of AstraZeneca. The judge decided in favour of Pró
Genéricos and the Brazilian PTO. AstraZeneca appealed this
decision. In November 2010, the Court of Appeal decided in
favour of Pró Genéricos and the Brazilian PTO and revoked
the prelimary order previously granted to AstraZeneca. The
main action continues.
Patent Litigation—EU
Since 2007, AstraZeneca has filed requests with the Por-
tuguese courts seeking suspension of the effect of decisions
taken by administrative bodies in Portugal to grant other com-
panies marketing authorisations for generic quetiapine fu-
marate. Many preliminary injunctions and main actions are
pending before the courts. The courts have generally agreed
with AstraZeneca’s position and suspended the marketing au-
thorisations in the preliminary injunction actions until a defini-
tive decision on the merits in the main actions (or until Astra-
Zeneca’s patent rights expire, in March 2012, if this occurs
first). Only in one case did the administrative courts not sus-
pend the grant of the marketing authorisation (decision of De-
cember 2009, confirmed in July 2010). Accordingly, the Por-
tuguese administrative bodies have granted the retail price in
respect of that product. In July and November 2010, Astra-
Zeneca filed preliminary injunction proceedings with the aim
of suspending the effect of the retail price decision. Astra-
Zeneca has filed corresponding main actions.
Seroquel XR
Patent Litigation—US
AstraZeneca lists two patents in the FDA’s Orange Book ref-
erencing Seroquel XR, US Patent No. 4,879,288 (the ’288
patent) covering quetiapine fumarate, the active ingredient,
and US Patent No. 5,948,437 (the ’437 patent) covering
extended-release formulations, processes and methods in re-
spect of quetiapine fumarate.
As previously reported, in 2008 and 2009, AstraZeneca
filed patent infringement actions in the US District Court for
the District of New Jersey against various entities of Handa
Pharmaceuticals, LLC (Handa), Accord Healthcare Inc. (Ac-
cord), and Biovail Laboratories International SRL (Biovail) for
ANDAs seeking approval to market generic copies of Sero-
quel XR tablets.
In March 2010, AstraZeneca received a Paragraph IV Certi-
fication notice-letter from Anchen Pharmaceuticals, Inc. (An-
chen) seeking approval to market generic versions of 150,
200, 300 and 400mg Seroquel XR tablets before the expira-
tion of the ’437 patent. In its Certification notice-letter, Anchen
claims that certain of the claims of the ’437 patent will not be
infringed by its proposed ANDA products and that the ’437
patent is invalid. In April 2010, AstraZeneca filed a lawsuit in
the US District Court for the District of New Jersey against
Anchen and Anchen, Inc. alleging infringement of the ’437
patent.
In July 2010, AstraZeneca received a Paragraph IV Certi-
fication notice-letter from Torrent Pharmaceuticals Ltd. (Tor-
rent) indicating that it was seeking approval to market generic
versions of 150, 200, 300 and 400mg Seroquel XR tablets
before the expiration of the ’437 patent. Torrent claims that
certain of the claims of the ’437 patent will not be infringed
by its proposed ANDA products and that the ’437 patent is
invalid. In August 2010, AstraZeneca filed a lawsuit in the US
District Court for the District of New Jersey against Torrent
alleging infringement of the ’437 patent. In September 2010,
AstraZeneca received another Certification notice-letter sim-
ilar to that described above from Torrent with respect to the
50mg Seroquel XR tablets. In September 2010, AstraZeneca
filed another lawsuit in the US District Court for the District
of New Jersey against Torrent for patent infringement alleg-
ing infringement of the ’437 patent with respect to the 50mg
tablet.
In July 2010, AstraZeneca received a Paragraph IV Cer-
tification notice-letter from Osmotica Pharmaceutical Corpo-
ration (Osmotica) indicating that it was seeking approval to
market generic versions of 200, 300 and 400mg Seroquel XR
tablets before the expiration of the ’437 patent. In its Certifica-
tion notice-letter, Osmotica claims that certain of the claims
of the ’437 patent will not be infringed by its proposed ANDA
products and that the ’437 patent is invalid. In August 2010,
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AstraZeneca filed a lawsuit in the US District Court for the
District of New Jersey against Osmotica.
In October 2010, AstraZeneca received a Paragraph IV
Certification notice-letter from Mylan Pharmaceuticals Inc.
(Mylan) indicating that it was seeking approval to market a
generic version of 200mg Seroquel XR tablets before the ex-
piration of the ’437 patent. In its Certification notice-letter, My-
lan claims that certain of the claims of the ’437 patent will not
be infringed by its proposed ANDA products and that the ’437
patent is invalid. In October 2010, AstraZeneca filed a patent
infringement action in the US District Court for the District of
New Jersey against Mylan and Mylan Inc.
The patent infringement actions against all seven ANDA
filers proceed in discovery before US District Court Judge
Joel Pisano.
On 22 November 2010, the Court conducted a claim con-
struction hearing, and on 30 November 2010, Judge Pisano
issued a decision interpreting claims of the ’437 patent. In
December 2010, Torrent filed a Motion for Clarification and
Reconsideration of the Court’s decision in response.
In December 2010, Handa and Accord reported that they
have received tentative FDA approval of their ANDAs.
On 8 January 2011, AstraZeneca and Handa submitted
a joint stipulation and proposed order concerning the ’288
patent staying litigation between the parties until and includ-
ing 26 March 2012. Upon expiration of the stay, AstraZeneca’s
infringement claims against Handa relating to the ’288 patent,
and Handa’s related counterclaims, will be dismissed as moot.
Under the stipulation, Handa agrees not to engage in the
commercial sale of the extended release quetiapine fumarate
products that are the subject of its ANDA before the 26 March
2012 expiration of AstraZeneca’s Paediatric Exclusivity relat-
ing to the ’288 patent. The Court entered the consent order
described above on 10 January 2011. The Court has set a
pre-trial schedule and trial to begin on 3 October 2011.
Patent Litigation—EU
In the UK, Teva UK Limited and Teva Pharmaceuticals Limited
(Teva) issued revocation proceedings against AstraZeneca in
December 2010. Teva claims that the patent EP (UK) 0907364
is invalid.
In Hungary, AstraZeneca was notified in late 2010 that
Teva Pharmaceuticals Limited and Teva Gyógyszergyár Zrt
(together, Teva) had filed a request for nullity of the Hungar-
ian formulation patent for Seroquel XR with the Hungarian
Patent Office. Teva claims that Hungarian Patent No. 225 152
should be declared null and void. AstraZeneca is considering
its response.
Synagis (Palivizumab)
In December 2008, MedImmune initiated patent litigation
against PDL BioPharma, Inc. (PDL) in the US District Court
for the Northern District of California. MedImmune sought a
declaratory judgment that the Queen patents (owned by PDL)
are invalid and/or not infringed by either Synagis and/or mo-
tavizumab, and that no further royalties are owed under a
patent licence MedImmune and PDL signed in 1997 (1997
Agreement). MedImmune has paid royalties on Synagis since
1998 under the 1997 Agreement. In February 2009, MedIm-
mune amended its complaint to add a separate claim assert-
ing that MedImmune is entitled, under the 1997 Agreement’s
‘most favoured licensee’ provision, to the more favourable roy-
alty terms that MedImmune contends PDL has granted to
other Queen patent licensees. PDL has taken the position in
the case that both Synagis and motavizumab infringe a single
claim of the Queen patents, and on that basis, that MedIm-
mune owes royalties for both products. With respect to the
‘most favoured licensee’ dispute, PDL contends that MedIm-
mune’s rights under that provision have not been triggered by
PDL’s licensing activities with third parties. In December 2009,
PDL purported to cancel the 1997 Agreement, an action PDL
later explained was based on an allegation that MedImmune
had underpaid royalties on ex-US sales of Synagis by Abbott
International, Inc. (Abbott), and that MedImmune failed to co-
operate in a royalty audit. After the purported termination,
PDL amended its answer to add counterclaims for breach of
contract and patent infringement. PDL’s claims seek actual
and exemplary damages and an injunction. MedImmune re-
sponded to the new claims by adding its own claims for dam-
ages and recoupment of past royalties. In December 2010,
the Court heard motions for summary judgment that could re-
solve certain issues, including patent invalidity, without a trial.
On 7 January 2011, the Court granted some of those motions.
The Court held that the single patent claim asserted by PDL
as a basis for MedImmune’s royalty obligation is invalid, and
also that MedImmune properly paid royalties on ex-US sales
by Abbott. On 12 January 2011, the Court held a case man-
agement conference and scheduled the remaining claims for
trial on 4 March 2011 with a further hearing scheduled on 4
February 2011 to finalise the trial date.
As at 31 December 2010, MedImmune had provided for
$38m in respect of accrued royalties not paid to PDL for the
period from December 2009 to the end of 2010.
Symbicort (Budesonide/Formoterol)
Symbicort Maintenance and Reliever Therapy (Symbicort
SMART)
In December 2008, oppositions were filed against patent EP
1 085 877 B1 covering the use of Symbicort for the as needed
symptomatic relief of asthma in addition to regular mainte-
nance treatment of chronic asthma. The opponents are Vec-
tura Limited, ratiopharm GmbH, Generics (UK) Limited and
Norton Healthcare Limited. A hearing date has not yet been
set by the European Patent Office Opposition Division.
US Patent Term Extension
In June 2008, the US Patent and Trademark Office issued
a final determination that US Patent No. 5,674,860 was not
eligible for patent term extension. AstraZeneca filed a request
for reconsideration and the matter continues.
Toprol-XL (Metoprolol Succinate)
In the first quarter of 2006, AstraZeneca was served with 14
complaints filed in the US District Court for the Districts of
Delaware, Massachusetts and Florida against AstraZeneca
and Aktiebolaget Hässle. The complaints were putative class
actions filed on behalf of both direct purchasers and indi-
rect purchasers that allege that AstraZeneca attempted to
illegally maintain monopoly power in the US over Toprol-XL
in violation of the Sherman Act through the listing of invalid
and unenforceable patents in the FDA’s Orange Book and
the enforcement of such patents through litigation against
generic manufacturers seeking to market metoprolol succi-
nate. The complaints seek treble damages based on alleged
overcharges to the putative classes of plaintiffs. These 14
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complaints were consolidated into two amended complaints
in the US District Court for the District of Delaware, one on
behalf of direct purchasers, and one on behalf of indirect pur-
chasers. The lawsuits are based upon a 2006 ruling by the US
District Court for the Eastern District of Missouri in the con-
solidated patent litigation against KV Pharmaceuticals Co.,
Andrx Pharmaceuticals, LLC and Eon Labs, Inc. that the As-
traZeneca patents relating to Toprol-XL are invalid and un-
enforceable. In 2006, AstraZeneca filed a motion seeking to
dismiss or, in the alternative, stay the consolidated complaint
in both anti-trust cases. In March 2010, the court ordered the
parties to begin discovery and in April 2010 issued an order
denying AstraZeneca’s motions to dismiss.
In July 2010, a non-class action anti-trust complaint was
filed in federal court in Delaware against AstraZeneca by Wal-
green Co., The Kroger Co., Safeway Inc., HEB Grocery Com-
pany LLP and Supervalu Inc. In October 2010, a similar com-
plaint was filed in Delaware by CVS Pharmacy Inc., Caremark
LLC, Rite Aid Corp, Rite Aid Headquarters Corp, JCG (PJC)
USA LLC, Maxi Drug, Inc. (doing business as, Brooks Phar-
macy) and Eckerd Corp. These two complaints are based
on the same anti-trust allegations that were already alleged
in the direct purchaser actions and, if upheld, would reduce
the damages available to the plaintiffs in the direct purchaser
actions.
Zestril (Lisinopril)
In 1996, two of AstraZeneca’s predecessor companies,
Zeneca Limited and Zeneca Pharma Inc. (as licensees),
Merck & Co., Inc. and Merck Frosst Canada Inc. (together,
Merck Group) commenced a patent infringement action in
the Federal Court of Canada against Apotex Inc. (Apotex), al-
leging infringement of Merck Group’s lisinopril patent. Astra-
Zeneca and the Merck Group were ultimately successful. In
March 2010, AstraZeneca and the Merck Group filed State-
ments of Issues to commence the reference to quantify the
damages related to Apotex’s infringement. The damages mat-
ter proceeds.
Other Product Liability Litigation
Pain Pump Litigation
Since February 2008, AstraZeneca has been named among
other defendants in approximately 300 lawsuits, involving
approximately 489 plaintiffs, filed in various US jurisdic-
tions, alleging injuries caused by third party pain pumps.
The complaints in these cases generally allege that the use
of Marcaine, Sensorcaine, Xylocaine and/or Naropin, with
or without epinephrine, in pain pumps that were implanted
into patients in connection with arthroscopic surgery, caused
chondrolysis. As of the end of 2010, AstraZeneca has been
dismissed from all but two of these cases, each with only one
plaintiff.
It was previously reported that AstraZeneca was among 20
defendants named in a putative class action lawsuit pending
in Federal District Court in Texas that was brought by a single
plaintiff on behalf of ‘several hundred’ class members who
received local anaesthetics intra-articularly for up to 72 hours
or more via a pain pump. In April 2010, the District Court
dismissed AstraZeneca from this lawsuit, and no appeal was
taken.




In May 2009, Verus Pharmaceuticals Inc. (Verus) filed a law-
suit in the New York State Supreme Court, New York County
against AstraZeneca and its subsidiary, Tika Läkemedel AB
(Tika), alleging breaches of several related collaboration
agreements to develop novel paediatric asthma treatments.
The complaint purported to state claims for fraud, breach of
contract, unjust enrichment and conversion. AstraZeneca and
Tika removed the lawsuit to the US District Court for the South-
ern District of New York and moved to dismiss the complaint.
In August 2010, the federal district court granted the defen-
dants’ motion to dismiss in its entirety. In September 2010,
Verus filed a Notice of Appeal from that decision with the US
Court of Appeals for the Second Circuit.
Dr. George Pieczenik v. AstraZeneca Pharmaceuticals LP,
AstraZeneca LP, et al.
In May 2010, Dr. George Pieczenik (the Plaintiff) filed a lawsuit
against AstraZeneca and numerous other companies in the
US District Court for the District of New Jersey alleging that
defendants’ ‘research, commercial and licensing activities’ in-
fringe US Patent No. 5,866,363 (the ’363 patent), purportedly
owned by the Plaintiff. The Plaintiff also alleged violations of
the Racketeering Institution and Corrupt Organization Act. In
June 2010, the Court, sua sponte, dismissed without preju-
dice the Plaintiff’s suit, determining that the asserted claims
failed to meet federal pleading requirements. In July 2010, the
Plaintiff filed an amended complaint again claiming infringe-
ment of the ’363 patent as well as other legal theories. In
October 2010, defendants filed a motion to dismiss the law-
suit asserting that the Plaintiff had failed to state a legally
cognisable cause of action. The Plaintiff opposed the motion
in November 2010 and filed several unsuccessful ancillary
motions, which the Plaintiff has improperly appealed to the
Federal Circuit Court. The Court has not yet ruled on the mo-
tion to dismiss the amended complaint.
Other Pricing Litigation
Average Wholesale Price Litigation
AstraZeneca is a defendant, along with many other pharma-
ceutical manufacturers, in several sets of cases involving al-
legations that, by causing the publication of allegedly inflated
wholesale list prices, defendants caused entities to overpay
for prescription drugs.
The first set of cases was filed in December 2001 in
the US District Court in Boston, Massachusetts on be-
half of a putative class of plaintiffs and related only to the
physician-administered Zoladex medication. Following the
Massachusetts complaint, nearly identical class action suits
were filed in two other states, which were consolidated with
the Massachusetts action for pre-trial purposes, pursuant to
federal Multi-District Litigation (MDL) procedures. As previ-
ously reported, AstraZeneca and other manufacturers were
later sued in similar lawsuits filed by the State Attorneys Gen-
eral of Alabama, Alaska, Arizona, Hawaii, Idaho, Illinois, Iowa,
Kansas, Kentucky, Mississippi, Montana, Nevada, Pennsyl-
vania, Utah, and Wisconsin, as well as by multiple individual
counties in the State of New York. In September and Novem-
ber 2010 respectively, AstraZeneca was separately served
with two new such cases brought by the Attorneys General
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of Oklahoma and Louisiana. The Attorneys General lawsuits
seek to recover alleged overpayments under Medicaid and
other state-funded healthcare programmes for substantially
all of AstraZeneca’s medications. In several cases, the states
are also suing to recover alleged overpayments by state resi-
dents. Several of these suits were consolidated with the Mas-
sachusetts action for pre-trial purposes, pursuant to federal
MDL procedures. Private insurers and consumers filed puta-
tive state-wide class actions in Arizona and New Jersey alleg-
ing damages relating to private reimbursement of prescription
drugs.
In the MDL action in January 2006, the District Court certi-
fied three classes of plaintiffs against AstraZeneca: a nation-
wide class of consumers who made co-payments for Zoladex
reimbursed under the Medicare Part B programme (Class
1); a Massachusetts-only class of third party payers, includ-
ing insurance companies, union health and welfare benefit
plans, and self-insured employers, who covered consumer
co-payments for Zoladex (Class 2); and a Massachusetts-
only class of third party payers and consumers who paid
for Zoladex outside of the Medicare programme (Class 3).
In September 2008, the MDL Court also provisionally certi-
fied multi-state versions of Class 2 and Class 3 relating to
Zoladex. For all of these classes, the only AstraZeneca drug
at issue is Zoladex.
As previously reported, in December 2008, the MDL Court
approved a settlement to resolve the Class 1 claims for up
to $24m to reimburse individual class members submitting
claims, plus attorneys’ fees of $8.58m, with any unclaimed
settlement amounts being donated to charitable organisations
that fund cancer patient care and research. A portion of this
settlement was paid in June 2010, but the administration of
claims continues.
In June 2007 and November 2007, the MDL Court issued
decisions, after a bench trial, on liability and damages on
the Massachusetts Classes 2 and 3. The Court found As-
traZeneca liable in connection with the pricing of Zoladex dur-
ing the period 1998 to 2003 and awarded double damages
(with pre-judgment interest) of $5.5m for Class 2, and single
damages (with pre-judgment interest) of $7.4m for Class 3, for
a total of $12.9m. On 18 June 2010, AstraZeneca executed a
settlement agreement to resolve, inclusive of pre- and post-
judgment interest, administration fees and plaintiffs’ attorney
fees, the Massachusetts Class 2 and Class 3 claims for a to-
tal of $13m. The Court granted preliminary approval of the
settlement on 12 August 2010 and a hearing regarding final
approval is scheduled to take place on 2 February 2011.
In June 2010, AstraZeneca executed a settlement agree-
ment to resolve, inclusive of pre- and post-judgment interest,
administration fees and plaintiffs’ attorney fees, both the Zo-
ladex claims of the provisionally certified multi-state class and
the Zoladex claims in the lawsuit but not certified for class ac-
tion treatment for a total of $90m. The Court granted prelim-
inary approval of the settlement on 12 August 2010. A hear-
ing regarding final approval is scheduled to take place on 2
February 2011.
With regard to the above-referenced MDL class settle-
ments, AstraZeneca had already taken provisions, prior to
2010, in the aggregate amount of approximately $130m.
Many of the multiple attorney general and state putative
class action lawsuits pending against AstraZeneca and other
manufacturers nationwide, which involve numerous drugs in
addition to Zoladex, remain pending and are in various stages
of discovery. Those matters with significant developments are
noted below.
In October 2009, a Kentucky jury found AstraZeneca liable
under the Commonwealth of Kentucky’s Consumer Protection
statute and Medicaid Fraud statute, and awarded $14.72m in
compensatory damages and $100 in punitive damages for
drugs reimbursed by the Commonwealth of Kentucky Medi-
caid Agency and the trial court subsequently awarded statu-
tory penalties of $5.4m. AstraZeneca filed a motion for a new
trial and a motion for judgment notwithstanding the verdict,
both of which were denied on 19 January 2011. AstraZeneca
believes the verdict and the Court’s order are in error and
intends to appeal.
As previously reported, the cases brought by the Attorneys
General of Nevada, Montana, Hawaii, and Pennsylvania have
been resolved through settlements. In the fourth quarter of
2010, AstraZeneca finalised agreements to settle the law-
suits brought by Arizona, Iowa, and the New York Counties. In
September 2010, AstraZeneca also finalised an agreement
to settle the claims of the three named plaintiffs in the pu-
tative New Jersey consumer class action case. All of these
settlements, the aggregate amount of which is approximately
$19m, have been paid in full and AstraZeneca consequently
owes no further obligations as a result of those underlying law-
suits.
As previously reported, in 2009 AstraZeneca prevailed in
the Alabama Attorney General lawsuit and the Arizona con-
sumer class action.
AstraZeneca remains in litigation with 10 state attorney
generals.
AstraZeneca continues to vigorously defend the lawsuits
brought by the Attorneys General of Alaska, Idaho, Illinois,
Kansas, Kentucky, Louisiana, Mississippi, Oklahoma, Utah
and Wisconsin, and denies the allegations therein.
340B Class Action Litigation
In August 2005, AstraZeneca was named as a defendant,
along with multiple other pharmaceutical manufacturers, in a
putative class action suit filed by the County of Santa Clara
on behalf of similarly situated California counties and cities
that allegedly overpaid for drugs covered by federal section
340B of the drug pricing programme (42 USC §256b). The
340B programme entitles hospitals and clinics that treat a
substantial portion of uninsured patients to preferential drug
pricing for outpatient drugs.
On 28 September 2010, the US Supreme Court granted
the defendants’ petition for certiorari from a decision of the
US Court of Appeals for the Ninth Circuit. The issue before the
Supreme Court is whether covered entities under the 340B
programme have enforceable rights to sue as third party ben-
eficiaries of the Pharmaceutical Pricing Agreement that im-
plements the statute. Following the grant of certiorari, the trial
court stayed all proceedings in the matter pending a decision
by the US Supreme Court.
The case was argued on 19 January 2011. A decision is
expected by the end of June 2011.
AstraZeneca intends to vigorously defend these claims.
Other Anti-Trust Litigation and Investigations
Drug Importation Anti-Trust Litigation
In August 2004, Californian retail pharmacy plaintiffs filed an
action in the Superior Court of California alleging a conspiracy
by AstraZeneca and approximately 15 other pharmaceutical
manufacturer defendants to set the price of drugs sold in Cal-
ifornia at or above the Canadian sales price for those same
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drugs and otherwise restrict the importation of pharmaceuti-
cals into the US. In July 2005, the Court overruled in part and
sustained in part, without leave to amend, the defendants’
motion to dismiss the plaintiffs’ third amended complaint in
these proceedings. The Court overruled the defendants’ mo-
tion in respect of conspiracy claims but sustained the motion
in respect of the California Unfair Competition Law claims.
In December 2006, the Court granted the defendants’ mo-
tion for summary judgment determining that any alleged dam-
ages suffered by plaintiffs were ‘passed-on’ to their customers
and the case was subsequently dismissed. The plaintiffs ap-
pealed that decision and the Court of Appeal of the State
of California affirmed the lower Court’s decision. The plain-
tiffs appealed to the California Supreme Court. In July 2010,
the California Supreme Court reversed the decisions by the
lower courts, rejecting the ‘pass-on’ defence and remanded
the case back to the lower court for further proceedings.
As previously reported, in September 2006, the defendants
filed a motion for summary judgment arguing that the plaintiffs
have failed to prove their allegations of a conspiracy and that
the defendants are entitled to judgment as a matter of law.
The Superior Court will hear argument on that motion on 17
February 2011. The Court has scheduled a trial of the matter
to commence on 1 August 2011.
AstraZeneca denies the material allegations in the Califor-
nia action and is vigorously defending this matter.
US Secondary Wholesalers
In July 2006, AstraZeneca was named as a defendant, along
with a number of other pharmaceutical manufacturers and
wholesalers, in a complaint filed by RxUSA Wholesale, Inc.
(RxUSA) in the US District Court for the Eastern District of
New York. The complaint alleges that the defendants violated
federal and state anti-trust laws. In August 2010, the Court of
Appeal for the Second Circuit affirmed the dismissal and the
time period for RxUSA to seek review by the Supreme Court
expired, rendering the matter concluded.
European Commission Patent Settlements Monitoring
In January 2010, the European Commission requested copies
of settlement agreements entered into between July 2008 and
December 2009 from a number of companies, including As-
traZeneca. AstraZeneca co-operated fully with the request.
The European Commission published its First Report on Mon-
itoring of Patent Settlements in July 2010. The report noted
a decrease in the number of settlement agreements which
might be problematic (pursuant to EU competition laws) in
the relevant period, compared to the period covered by the
European Commission’s sector inquiry into the pharmaceuti-
cal industry (January 2000-June 2008). In January 2011, the
European Commission requested copies of settlement agree-
ments which were entered into or amended in 2010 from a
number of companies, including AstraZeneca. AstraZeneca
will co-operate fully with the request.
Other
For a description of other anti trust-related litigation involv-
ing AstraZeneca, see the subsections entitled Losec/Prilosec
(omeprazole), Nexium (esomeprazole) and Toprol-XL (meto-
prolol succinate) in this Note 25 to the Financial Statements.
Other Actual and Threatened Government Investigations
and Related Litigation
AstraZeneca is involved in various governmental investiga-
tions considered typical to its business. The more significant
matters are discussed below.
Foreign Corrupt Practices Act
In connection with an investigation into Foreign Corrupt Prac-
tices Act issues in the pharmaceutical industry, AstraZeneca
has received inquiries from the US Department of Justice
and the SEC regarding, among other things, sales prac-
tices, internal controls, certain distributors and interactions
with healthcare providers in several countries. AstraZeneca is
co-operating with these inquiries. AstraZeneca is investigat-
ing indications of inappropriate conduct in certain countries,
including China. These investigations are ongoing, and it is
not currently possible to predict the scope, duration or out-
come of these matters, including the extent to which, if at all,
they will result in any liability to AstraZeneca.
Medco qui tam Litigation (Schumann)
AstraZeneca has been named as a defendant in a lawsuit
filed in Federal Court in Philadelphia by a former Medco
Health Systems employee, Karl Schumann, under the qui
tam (whistleblower) provisions of the federal and certain state
False Claims Acts. The action was initially filed in September
2003 but remained under seal until July 2009, at which time
AstraZeneca was served with a copy of the amended com-
plaint following the government’s decision not to intervene
in the case. The lawsuit seeks to recover, inter alia, alleged
overpayments by federal and state governments for Prilosec
and Nexium from 1996 to 2007. These overpayments are al-
leged to be the result of improper payments intended to influ-
ence the formulary status of Prilosec and Nexium at Medco
and its customers. In October 2010, the district court denied
AstraZeneca’s motion to dismiss the amended complaint. In
November 2010, AstraZeneca filed a separate motion to dis-
miss for lack of jurisdiction under the False Claims Act. Brief-
ing is complete and this motion remains pending before the
district court.
Additional Government Investigations into Drug Marketing
Practices
As is true for most, if not all, major prescription pharmaceuti-
cal companies operating in the US, AstraZeneca is currently
involved in multiple US federal and state investigations into
drug marketing and pricing practices. The US Attorney’s Of-
fices for the Districts of Delaware, Texas and Alabama are
conducting investigations related to sales and marketing ac-
tivities potentially involving more than one product, including
Crestor and Seroquel XR, and likely in response to the filing
of qui tam (whistleblower) lawsuits. The precise parameters of
these inquiries are unknown, and AstraZeneca is not in a po-
sition at this time to predict the scope, duration or outcome of
these matters, including whether they will result in any liability
to AstraZeneca.
In addition to the investigations described above, and as
previously reported, various federal and state law enforce-
ment offices have requested information relating to con-
tracting and disease management programmes, a leading
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provider of pharmacy services to long-term care facilities,
prior interactions with physicians in the State of Delaware, and
nominal pricing under the Medicaid rebate program respec-




In September 2006, Marc Brody filed a putative class ac-
tion lawsuit against AstraZeneca on behalf of himself and
a class of approximately 844 pharmaceutical sales special-
ists employed by the Group in California during the period 19
September 2002 to the present. The plaintiff alleged he and
the proposed class members were unlawfully classified as
exempt employees and denied overtime compensation and
meal breaks in violation of the California Labor Code. As-
traZeneca removed this action to the US District Court for
the Central District of California in October 2006. The plaintiff
filed a first amended complaint in March 2007, seeking civil
penalties and adding claims for alleged failure to provide meal
and rest periods, failure to pay all wages earned each pay pe-
riod, failure to provide accurate wage statements, failure to
pay wages in a timely manner upon termination of employ-
ment and unfair competition. AstraZeneca denied the allega-
tions made by the plaintiff, asserting that the sales specialists
are properly classified under various exemptions to the wage
laws. The plaintiff’s lawyers are also pursuing similar claims
in lawsuits against most of the major pharmaceutical compa-
nies. The US District Court for the Central District of California
granted summary judgment in favour of AstraZeneca in the
Brody lawsuit, dismissing all claims by the plaintiff and finding
the motion for class certification to be moot. The plaintiff has
filed a Notice of Appeal with the Ninth Circuit Court of Appeals
in California. Briefing in that appeal is currently on hold.
In separate lawsuits against AstraZeneca, the firms repre-
senting the Brody plaintiff filed additional state and wage-and-
hour class actions. One case captioned Baum v. AstraZeneca,
LP was filed under the Pennsylvania Minimum Wage Act and
Wage Payment Collection Law in the US District Court for the
Western District of Pennsylvania on behalf of a putative class
of approximately 473 sales specialists working in Pennsylva-
nia from March 2004. The Court, however, granted summary
judgment in favour of AstraZeneca, dismissing all claims filed
by plaintiff Baum and finding the motion for class certification
to be moot. The plaintiff filed an appeal with the Third Circuit
Court of Appeals, but that appeal was denied. On 4 October
2010, the US Supreme Court denied the plaintiff’s certiorari
petition, which denied certiorari, preserving the favourable de-
cision for AstraZeneca. The Baum lawsuit is now concluded.
Additionally, in June 2007, the firms representing the Brody
plaintiff filed a nationwide collective action based on federal
wage-and-hour law in the US District Court for the District
of Delaware, seeking unpaid overtime compensation and liq-
uidated damages. The lawsuit had a potential class size of
8,300 current and former sales specialists employed by the
Group in the US from June 2004. The parties have negoti-
ated a stipulation of dismissal of this lawsuit and the action
was dismissed.
In November 2010, a separate group of plaintiffs’ coun-
sel filed a new nationwide collective action in the US District
Court for the Southern District of Indiana. In this case, Shatto
v. AstraZeneca PLP, the plaintiffs allege violations of fed-
eral wage-and-hour law for non-payment of overtime wages.
AstraZeneca denies the allegations made by the plaintiff and
intends to defend the litigation vigorously.
Bildman v. Astra USA
In March 2010, Bildman filed a petition for a writ of certio-
rari with the US Supreme Court, seeking appeal of the Mas-
sachusetts Supreme Judicial Court’s dismissal of his defama-
tion claim against AstraZeneca. In May 2010, the US Supreme
Court denied Bildman’s petition for a writ of certiorari, de-
clining to review the lower court’s decision and preserving a
favourable outcome for AstraZeneca.
Tax
Where tax exposures can be quantified, an accrual is made
based on best estimates and management’s judgement. De-
tails of the movements in relation to material tax exposures
are discussed below.
Transfer Pricing and Other International Tax Contingencies
AstraZeneca faces a number of transfer pricing audits in ju-
risdictions around the world and, in some cases, is in dispute
with the tax authorities. The issues under discussion are of-
ten complex and can require many years to resolve. Accruals
for tax contingencies require management to make estimates
and judgements with respect to the ultimate outcome of a
tax audit, and actual results could vary from these estimates.
The international tax environment presents increasingly chal-
lenging dynamics for the resolution of transfer pricing dis-
putes. These disputes usually result in taxable profits being
increased in one territory and correspondingly decreased in
another. Our balance sheet positions for these matters reflect
appropriate corresponding relief in the territories affected.
Management considers that at present such corresponding
relief will be available, but given the challenges in the inter-
national tax environment will keep this aspect under careful
review. The total net accrual included in the Group Finan-
cial Statements to cover the worldwide exposure to transfer
pricing audits is $2,310m, a decrease of $17m due to nego-
tiated settlements offset by the impact of an additional year
of transactions relating to contingencies for which accruals
had already been established, revisions of estimates relat-
ing to existing audits, a number of new tax contingencies and
exchange rate effects.
Tax accruals have been made in respect of two individually
significant exposures:
• The tax accrual at 31 December 2008 and 2009 in-
cluded amounts in relation to a long running transfer
pricing dispute between AstraZeneca and HM Revenue
& Customs (HMRC) covering all periods from 1996 on-
wards. In February 2010, AstraZeneca announced that
the company had entered into an agreement with HMRC
in the UK to settle this dispute. As a consequence of the
settlement, AstraZeneca and HMRC have withdrawn the
joint referral of this issue to the UK Tax Court. The agree-
ment will result in AstraZeneca paying £505m to HMRC
to resolve all claims made by HMRC in relation to this is-
sue for the 15-year period from 1996 to the end of 2010.
The £505m settlement is payable in two instalments of
which the first instalment of £350m ($562m) was paid in
February 2010. A second final instalment of £155m is
due to be paid in March 2011 and is included in ordinary
tax payable at 31 December 2010.
IFRS ATT 1.82
P1: gudu
ACPA210-01D AICPA AICPA-IFRS-ATT.cls January 5, 1970 10:0
66 IFRS Accounting Trends & Techniques
• AstraZeneca has applied for an advance pricing agree-
ment in relation to intra-group transactions between the
UK and the US which is being progressed through com-
petent authority proceedings under the relevant double
tax treaty.
Management continues to believe that AstraZeneca’s posi-
tions on all its transfer pricing audits and disputes are robust
and that AstraZeneca is appropriately provided.
For transfer pricing audits where AstraZeneca and the tax
authorities are in dispute, AstraZeneca estimates the poten-
tial for reasonably possible additional losses above and be-
yond the amount provided to be up to $565m (2009: $575m);
however, management believes that it is unlikely that these
additional losses will arise. It is possible that some of these
contingencies may reduce in the future to the extent that any
tax authority challenge is unsuccessful, or matters lapse fol-
lowing expiry of the relevant statutes of limitation resulting in
a reduction in the tax charge in future periods.
Other Tax Contingencies
Included in the tax accrual is $1,429m relating to a number
of other tax contingencies, an increase of $468m mainly due
to the impact of an additional year of transactions relating
to contingencies for which accruals had already been estab-
lished and exchange rate effects. For these tax exposures,
AstraZeneca does not expect material additional losses. It is,
however, possible that some of these contingencies may re-
duce in the future if any tax authority challenge is unsuccess-
ful or matters lapse following expiry of the relevant statutes
of limitation resulting in a reduction in the tax charge in future
periods.
Timing of Cash Flows and Interest
It is not possible to estimate the timing of tax cash flows in rela-
tion to each outcome, however, it is anticipated that a number
of significant disputes may be resolved over the next one to
two years. Included in the provision is an amount of interest of
$608m (2009: $565m). Interest is accrued as a tax expense.




IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
In May 2011, the IASB issued IFRS 10, Consolidated
Financial Statements, and a revised IAS 27, Separate
Financial Statements. IFRS 10 establishes the princi-
ples for presentation and preparation of consolidated fi-
nancial statements and supersedes the requirements of
IAS 27, Consolidated and Separate Financial State-
ments, and SIC 12 Consolidation—Special Purpose
Entities. IFRS 10 and IAS 27 (revised 2011) are effec-
tive for annual periods beginning on or after 1 January
2013. Earlier application is permitted.
Because the new and revised standards would not
apply to the companies in this sample, the commen-
tary that follows describes the requirements of IAS 27
(2008) and SIC 12.
1.83 IAS 27 (2008) establishes the requirements that an en-
tity should apply in preparing and presenting consolidated
financial statements for a group of entities under control of
a parent. Consolidated financial statements are those of a
group of entities presented as those of a single economic en-
tity. A parent is an entity with one or more subsidiaries that
it controls.
1.84 An entity should also apply IAS 27 in accounting for its
investments in associates and joint ventures when preparing
separate financial statements, regardless of whether separate
statements are required by a regulatory authority or issued
voluntarily. Separate financial statements are those presented
by a parent, an investor in an associate, or an investor in a
jointly controlled entity, in which the investments are ac-
counted for on the basis of a direct equity interest rather than
on the basis of the investees’ reported results and net assets.
Author’s Note
In November 2009, the IASB issued IFRS 9, Financial
Instruments, which amends IAS 27 and other IFRSs,
and is effective for annual periods beginning on or af-
ter 1 January 2013, with early application permitted.
Specifically, IFRS 9 applies when an entity is per-
mitted and elects to account for its interest in a sub-
sidiary in accordance with IAS 39, Financial Instru-
ments: Recognition and Measurement, and IFRS 9. An
entity is also required to apply IFRS 9 in accounting
for any derivatives linked to its interest in a subsidiary,
unless the derivative meets the definition of an equity
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Recognition and Measurement
IFRSs
1.85 Unless it meets the criteria for exemption, a parent
should present consolidated financial statements that include
its investments in subsidiaries (controlled entities) in accor-
dance with the requirements of IAS 27. A parent controls
another entity (a subsidiary) when the parent has the power
to govern the financial and operating policies of the subsidiary
so as to obtain benefits from the subsidiary’s activities.
1.86 A parent is only exempt from preparing consolidated
financial statements in accordance with IAS 27 if all of the
following criteria are met:
• The parent is itself a wholly-owned or partially-owned
subsidiary of another entity and other owners, if any,
and all owners, including those not entitled to vote,
have been informed and do not object to the parent not
preparing consolidated financial statements.
• Neither the parent’s debt nor equity instruments are
traded in a public market, whether the public market is
domestic or foreign, an exchange or over-the-counter,
or local or regional.
• The parent has neither filed nor is in the process of filing
its financial statements with a regulatory authority for
the purpose of listing any class of securities in a public
market.
• The ultimate or any intermediate parent of the parent
prepares and issues for public use a complete set of
consolidated financial statements in compliance with
IFRSs.
1.87 If an entity is exempt from preparing consolidated fi-
nancial statements and elects to present separate financial
statements, the entity should prepare the separate statements
in accordance with IAS 27.
1.88 An entity should include all subsidiaries in its con-
solidated financial statements. In order to determine which
investments it should consider subsidiaries, an entity should
apply the guidance in IAS 27 to determine whether it has
control over another entity. An entity should presume that it
has control when it owns, directly or indirectly, more than
50 percent of the voting power, unless, in exceptional cir-
cumstances, it can clearly demonstrate that such ownership
does not constitute control. However, an entity may still have
control even if such ownership interests are less than 50 per-
cent. IAS 27 requires an entity to assess the substance of the
relationship with the investee to determine whether control
exists. IAS 27 does not permit an entity to exclude an invest-
ment from consolidation as a subsidiary for any other reason
except the absence of control.
1.89 IAS 27 provides guidance to an entity with respect to
the consolidation process and requires the entity to elimi-
nate fully any intragroup balances, transactions, income, and
expenses in the consolidation process.
1.90 All financial statements, whether of the parent or sub-
sidiaries, included in the consolidated financial statements
should be prepared as of the same date. When the financial
statements of one or more subsidiaries are prepared as of
a different date than the parent’s reporting date, these sub-
sidiaries should prepare additional financial statements as of
the reporting date of the parent, unless impracticable. When
the financial statements of one or more subsidiaries are not
prepared as of the same date as the parent’s financial state-
ments, the parent should make adjustments for the effects of
significant transactions that occurred between the date of the
subsidiary’s financial statements and its own reporting date.
In any event, IAS 27 does not permit a difference in the re-
porting dates of a parent and its subsidiaries of more than
three months.
1.91 IAS 27 requires an entity to apply uniform account-
ing policies for like transactions and other events in similar
circumstances in all financial statements included in the con-
solidated financial statements. When one or more entities in
the group use different accounting policies in their separate
financial statements, the parent should make adjustments to
conform accounting policies in consolidation.
1.92 A parent should present any noncontrolling interest
(that is, other equity owners of subsidiaries) in the equity
section of the consolidated balance sheet separate from its
own equity accounts.
1.93 A parent accounts for changes in its ownership interest
that do not result in loss of control as equity transactions.
However, if a parent loses control of a subsidiary, it should
account for this event as follows:
a. Derecognize the carrying amounts of the following:
i. Subsidiary’s assets, including goodwill, and liabil-
ities as of the date the parent lost control
ii. Noncontrolling interest, including any components
of other comprehensive income
b. Recognize the following when resulting from loss of
control:
i. Fair value of consideration received, if any
ii. Distribution, if any, of the subsidiary’s shares to
owners, in their capacity as owners
iii. Any retained investment in the former subsidiary at
fair value as of the date it lost control
c. Reclassify to profit or loss or transfer directly to retained
earnings, if required by an IFRS, all amounts previously
recognized in other comprehensive income
d. Recognize as a gain or loss in profit or loss attributable
to the parent, any resulting difference from the re-
quired derecognition, recognition, and reclassification
of amounts previously recognized in other comprehen-
sive income
1.94 When an entity loses control of a subsidiary and re-
measures any retained investment at fair value, it should sub-
sequently account for that retained investment in accordance
with other applicable IFRSs. For example, if the entity re-
tained significant influence, it should account for the invest-
ment in accordance with IAS 28, Investments in Associates.
1.95 In any separate (company- or parent-only) financial
statements that it prepares, an entity should account for its
investment in a subsidiary, associate, or jointly controlled
entity either at cost or in accordance with IAS 39. When an
investment is classified as held for sale or discontinued op-
erations, an entity should apply the requirements of IFRS 5,
Non-current Assets Held for Sale and Discontinued Opera-
tions. An entity recognizes any dividends declared by these
investees in profit and loss.
1.96 When an entity accounts for its investment in an asso-
ciate or jointly controlled entity in its consolidated financial
statements in accordance with IAS 39 rather than IAS 28 or
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IAS 31, Interests in Joint Ventures, it should also apply IAS
39 in its separate financial statements.
1.97 Standing Interpretations Committee (SIC) Interpreta-
tion 12, Consolidation—Special Purpose Entities, requires
an entity to consolidate an other entity that is created for a
narrow and well-defined objective (namely a special purpose
entity), regardless of its form, when the substance of the re-
lationship between the entity and the special purpose entity
indicates that the special purpose entity is controlled by that
entity. SIC 12 refers to situations in IAS 27 that indicate an
entity controls another entity, even when it has less than 50
percent of the voting power. SIC 12 also provides examples
of situations that indicate an entity controls a special pur-
pose entity and, consequently, should consolidate the special
purpose entity in its financial statements.
U.S. GAAP
Author’s Note
In general, FASB ASC includes considerably more
guidance on consolidation than IFRSs. The follow-
ing discussion only addresses issues directly related
to those addressed in IAS 27 or SIC 12.
1.98 Like IFRSs, FASB ASC 810-10-15-8 considers own-
ership by the reporting entity, directly or indirectly, of more
than 50 percent of the outstanding voting shares of another
entity to be the usual condition indicating that the reporting
entity should consolidate. Also, like IFRSs, this FASB ASC
paragraph indicates that the power to control may also exist
with a lesser percentage of ownership. However, FASB ASC
810, Consolidation, contains considerably more guidance on
consolidation and includes exemptions from consolidation
not included in IAS 27. For example, FASB ASC 810-10-
15-10 and “Pending Content” in FASB ASC 810-10-15-12
include the following scope exclusions to consolidation under
this topic:
• A majority-owned subsidiary should not be consoli-
dated if control does not rest with the majority owner.
For instance, if any of the following are present:
— The subsidiary is in legal reorganization.
— The subsidiary is in bankruptcy.
— The subsidiary operates under foreign exchange re-
strictions, controls, or other governmentally im-
posed uncertainties so severe that they cast signif-
icant doubt on the parent’s ability to control the
subsidiary.
— In some instances, the powers of a shareholder with
a majority voting interest to control the operations or
assets of the investee are restricted in certain respects
by approval or veto rights granted to the noncontrol-
ling shareholder (hereafter referred to as noncontrol-
ling rights). In paragraphs 2–14 of FASB ASC 810-
10-25, the term noncontrolling shareholder refers
to one or more noncontrolling shareholders. Those
noncontrolling rights may have little or no impact on
the ability of a shareholder with a majority voting in-
terest to control the investee’s operations or assets,
or alternatively, those rights may be so restrictive
to call into question whether control rests with the
majority owner.
— Control exists through means other than through
ownership of a majority voting interest.
• A broker-dealer parent within the scope of FASB ASC
940, Financial Services—Broker and Dealers, should
not consolidate a majority-owned subsidiary in which
it has a controlling financial interest if the control is
likely to be temporary.
• Except as discussed in FASB ASC 946-810-45-3, an in-
vestment company within the scope of FASB ASC 946,
Financial Services—Investment Companies, should not
consolidate a noninvestment company investee.
• An employer should not consolidate an employee ben-
efit plan subject to the provisions of FASB ASC 712,
Compensation—Nonretirement Postemployment Bene-
fits, or 715, Compensation—Retirement Benefits.
• An entity should not consolidate investments accounted
for at fair value in accordance with specialized guidance
in FASB ASC 946.
• An entity should not consolidate either a governmental
entity or a financing entity established by a governmen-
tal entity, unless certain conditions are met.
FASB ASC 810-10-15-10 also requires an entity to consider
additional guidance to determine whether consolidation is
appropriate for a limited partnership, a research and devel-
opment arrangement, or an entity controlled by contract.
1.99 FASB ASC 810 also includes more specific and de-
tailed guidance than IFRSs for determining when a variable
interest entity (VIE) (broadly comparable to a special pur-
pose entity in SIC 12) should be consolidated. FASB ASC
810-10-05-8 explains that a VIE is a legal entity in which eq-
uity investors do not have the characteristics of a controlling
financial interest or sufficient equity at risk for the legal entity
to finance its activities without additional subordinated finan-
cial support. When applying this guidance, an entity should
first determine whether the entity under consideration is a
legal entity within the scope of the guidance on consolida-
tion of VIEs, as discussed in FASB ASC 810-10-15-14. The
specific design of the legal entity is important for making this
determination.
1.100 Like IFRSs, it is preferable under FASB ASC that the
subsidiary’s financial statements have the same or nearly the
same fiscal period as the parent. However, FASB ASC 810-
10-45-12 states that for consolidation purposes, it is usually
acceptable to use the subsidiary’s financial statements if the
difference in fiscal period is not more than approximately
three months. In addition, when a difference in the fiscal pe-
riods exists, FASB ASC does not require adjustments to be
made for the effects of significant transactions that occurred
between the parents’ and subsidiaries’ fiscal year-ends. How-
ever, FASB ASC 810-10-45-12 requires recognition by dis-
closure or otherwise of the effect of intervening events that
materially affect the financial position or results of opera-
tions. FASB ASC does not state what qualifies as an other-
wise acceptable means of recognition besides disclosures or
adjustments to reported amounts. In contrast, IAS 27 requires
both the parents’ and subsidiaries’ financial statements used
in the consolidated financial statements to be prepared as of
the same date, unless impracticable. When it is impracticable
for a subsidiary to prepare financial statements as of the date
of the parent’s financial statements, IAS 27 requires an entity
to adjust the financial statements for the effects of significant
transactions or events that occurred between the two dates,
with the proviso that the difference between the end of the
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1.101 Like IFRSs, “Pending Content” in FASB ASC 810-
10-45-16 requires the entity to present any noncontrolling
interest within the “Equity” or “Net Assets” section of the
consolidated statement of financial position separately from
the parent’s equity or net assets.
1.102 Like IFRSs, with some exceptions, “Pending Con-
tent” in FASB ASC 810-10-40-4 requires an entity to decon-
solidate a subsidiary or derecognize a group of assets as of
the date it ceases to have a controlling financial interest in
the subsidiary or group of assets. The process that an entity
should follow when it deconsolidates a subsidiary is similar
under both IFRSs and FASB ASC, except when an entity
deconsolidates a subsidiary through a nonreciprocal transfer
to owners (such as a spinoff). According to “Pending Con-
tent” in FASB ASC 810-10-40-5, if a parent deconsolidates
a subsidiary through a nonreciprocal transfer to owners, the
guidance in FASB ASC 845-10 applies. Otherwise, an entity
should recognize a gain or loss in net income measured as
the difference between the following amounts:
a. Carrying amount of the assets and liabilities of the for-
mer subsidiary or the carrying amount of the group of
assets
b. Sum of the following amounts:
i. Fair value of any consideration received
ii. Fair value of any retained noncontrolling investment
in the former subsidiary or group of assets at the date
that the subsidiary is deconsolidated or the group of
assets is derecognized
iii. Carrying amount of any noncontrolling interest in
the former subsidiary (including any accumulated
other comprehensive income attributable to the non-
controlling interest) at the date the subsidiary is
deconsolidated
1.103 Like IFRSs, FASB ASC 810-10-45-11 recognizes
that an entity may need to prepare parent-entity (separate) fi-
nancial statements, in addition to consolidated financial state-
ments. Unlike IFRSs, this paragraph provides guidance on
how an entity may choose to present these statements (for
example, consolidating financial statements, in which one
column is used for the parent and other columns for particu-
lar subsidiaries or groups of subsidiaries, which is an effective
means of presenting the pertinent information).
Disclosure
IFRSs
1.104 In consolidated financial statements, IAS 27 requires
an entity to disclose the following, when applicable:
• Nature of the relationship between the parent and sub-
sidiary if control exists at less than 50 percent of the
direct or indirect voting power
• Reasons why control does not exist if the parent has
more than 50 percent of the direct or indirect voting
power
• Reasons why the parent and subsidiary have different
reporting dates
• Nature and extent of significant restrictions on the abil-
ity to transfer funds to the parent in the form of divi-
dends, loans, or cash advances
• Schedule of effects of changes in ownership interests
that did not result in loss of control
• Gain or loss, if any, recognized in profit or loss when
the entity loses control and a disaggregation of the net
gain or loss into the following amounts:
—portion of gain or loss attributable to recognition of
retained investment at fair value
—line item(s) in statement of comprehensive income
in which the gain or loss is recognized, if not shown
separately on the face of the statement
1.105 IAS 27 requires the separate financial statements of
a parent, venturer in a jointly controlled entity, or an investor
in an associate to include disclosures of the following:
• Statement that the financial statements are separate and
the reasons why separate statements are prepared, if not
by law
• List of significant investments in subsidiaries, jointly
controlled entities, and associates, including the name;
country of incorporation or residence; proportion of
ownership interest; and, if different, proportion of vot-
ing power held
• Description of the method used to account for the in-
vestments listed under the previous bullet item
1.106 When a parent prepares separate financial statements
because it is exempt from preparing consolidated financial
statements in accordance with IAS 27, it should (a) disclose
the fact that it is exempt and the name and country of domicile
or incorporation of the parent that prepares consolidated fi-
nancial statements in compliance with IFRSs and (b) address
where such statements may be obtained.
1.107 SIC 12 does not include additional disclosure require-
ments.
U.S. GAAP
1.108 FASB ASC 810-10-50-1 requires an entity to dis-
close the consolidation policy that is being followed. IFRSs
require an entity to disclose whether the financial statements
are consolidated or separate.
1.109 Like IFRSs, “Pending Content” in FASB ASC 810-
10-50-1B requires a parent to disclose all of the following
when a subsidiary is deconsolidated or a group of assets is
derecognized in accordance with “Pending Content” in FASB
ASC 810-10-40-3A:
• Amount of any gain or loss recognized in accordance
with “Pending Content” in FASB ASC 810-10-40-5
• Portion of any gain or loss related to the remeasurement
of any retained investment in the former subsidiary or
group of assets to its fair value
• Line item in which the gain or loss is recognized, unless
separately presented on the face of the income statement
In addition, unlike IFRSs, a parent must also disclose the
following:
• A description of the valuation technique(s) used to mea-
sure the fair value of any direct or indirect retained in-
vestment in the former subsidiary or group of assets
• Information that enables users of the parent’s financial
statements to assess the inputs used to develop the fair
value in item (d)
• The nature of the continuing involvement with the sub-
sidiary or entity acquiring the group of assets after it
has been deconsolidated or derecognized
• Whether the transaction that resulted in the deconsoli-
dation or derecognition was with a related party
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• Whether the former subsidiary or entity acquiring
a group of assets will be a related party after
deconsolidation
Unlike IAS 27, FASB ASC 810-10-50-1A requires addi-
tional disclosures about less-than-wholly-owned subsidiaries
for each reporting period.
1.110 Unlike IFRSs, FASB ASC does not have any spe-
cific disclosure requirements for parent-entity-only financial
statements.
Author’s Note
The IASB revised IAS 27 in 2008 at the same time it re-
vised IFRS 3, Business Combinations. These revisions
are effective for annual periods beginning on or after
1 July 2009, with early application permitted if the en-
tity also early adopts the revisions to IFRS 3 at the same
time.
Additionally, all survey companies in this edition
have listed securities and have filed with regulatory
authorities and, therefore, are required by IAS 27 to
present consolidated financial statements.
Presentation and Disclosure Excerpts
Change in Accounting Policy—Revaluation
of Previously Held Interests
1.111
Millicom International Cellular S.A. (Dec 2010)
CONSOLIDATED INCOME STATEMENTS (in part)








Revenues 9 3,920,249 3,372,727 3,150,559
Cost of sales (1,331,003) (1,202,902) (1,114,822)
Gross profit 2,589,246 2,169,825 2,035,737
Sales and marketing (737,691) (647,009) (657,480)
General and administrative expenses (738,779) (606,213) (498,597)
Other operating expenses, net (71,046) (65,580) (61,438)
Operating profit 9,10 1,041,730 851,023 818,222
Interest expense (214,810) (173,475) (135,932)
Interest and other financial income 14,748 11,573 32,277
Revaluation of previously held interests 4 1,060,014 32,319 —
Other non operating expenses, net 12 (29,702) (32,181) (52,265)
(Loss) profit from associates 17 (1,817) 2,329 8,706
Profit before tax from continuing operations 1,870,163 691,588 671,008
Charge for taxes 13 (227,096) (187,998) (268,813)
Profit for the year from continuing operations 1,643,067 503,590 402,195
Profit for the year from discontinued operations, net of tax 6 11,857 300,342 2,246
Net profit for the year 1,654,924 803,932 404,441
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)







Intangible assets, net 15 2,282,845 1,044,837
Property, plant and equipment, net 16 2,767,667 2,710,641
Investments in associates 17 18,120 872
Pledged deposits 18, 26 49,963 53,333
Deferred taxation 13 23,959 19,930
Other non-current assets 17,754 7,965
Total non-current assets 5,160,308 3,837,578
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CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)








Profit before tax from continuing operations 1,870,163 691,588 671,008
Adjustments for non-operating items:
Interest expense 214,810 173,475 135,932
Interest and other financial income (14,748) (11,573) (32,277)
Revaluation of previously held interests (1,060,014) (32,319) —
Profit from associates 1,817 (2,329) (8,706)
Other non operating expenses, net 29,702 32,181 52,265
Adjustments for non-cash items:
Depreciation and amortization 9,10,15,16 676,986 611,435 463,720
Loss on disposal and impairment of property, plant and equipment 9,10 16,257 7,246 9,166
Share-based compensation 24 30,718 10,175 13,619
1,765,691 1,479,879 1,304,727
Decrease (increase) in trade receivables, prepayments and other current assets (31,282) 73,380 5,077
Decrease (increase) in inventories (12,606) 8,812 24,700
(Decrease) increase in trade and other payables 44,773 (4,669) 29,235
Changes to working capital 885 77,523 59,012
Interest expense paid (170,604) (148,038) (137,301)
Interest received 14,639 11,316 32,535
Taxes paid (238,723) (195,851) (201,235)
Net cash provided by operating activities 1,371,888 1,224,829 1,057,738
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Consolidation and Accounting Policies
(in part)
2.28 Changes in Accounting Policies (in part)
The consolidated financial statements as of December 31,
2010 are prepared in accordance with consolidation and ac-
counting policies consistent with those of the previous finan-
cial years, with the exception of the early adoption as of Jan-
uary 1, 2009 of IFRS 3R, ‘Business combinations,’ and IAS
27R, ‘Consolidated and separate financial statements.’
The following new standards and amendments to stan-
dards, which affect the presentation of the consolidated fi-
nancial statements, which were mandatory for the first time
for the financial year beginning January 1, 2010 were early
adopted by the Group in 2009.
IFRS 3 (revised) (‘IFRS 3R’), ‘Business combinations’ and
consequential; amendments to IAS 27, ‘Consolidated and
separate financial statements,’ IAS 28, ‘Investments in as-
sociates,’ and IAS 31, ‘Interests in joint ventures’ are effective
prospectively to business combinations for which the acqui-
sition date is on or after the beginning of the first annual re-
porting period beginning on or after July 1, 2009.
The revised standard continues to apply the acquisition
method to business combinations but with some significant
changes compared with IFRS 3. For example, all payments
to purchase a business are recorded at fair value at the ac-
quisition date, with contingent payments classified as debt
subsequently re-measured through the statement of compre-
hensive income. There is a choice on an acquisition by ac-
quisition basis to measure the non-controlling interest in the
acquiree either at fair value or at the non-controlling interest’s
proportionate share of the acquiree’s net assets. All acquisi-
tion costs are expensed.
The Group early adopted IFRS 3R, ‘Business combina-
tions,’ in 2009 for the step-up acquisition of Navega.com S.A.
(see note 4). Millicom revalued its previously held interests in
Navega.com S.A. at fair value, recognising the resulting gain
in the consolidated income statement.
IAS 27 (revised) (‘IAS 27R’) requires the effects of all trans-
actions with non-controlling interests to be recorded in equity
if there is no change in control and these transactions will
no longer result in goodwill or gains and losses. The stan-
dard also specifies the accounting treatment when control is
lost. Any remaining interest in the entity is re-measured to fair
value, and a gain or loss is recognized in profit or loss.
As the Group early adopted IFRS 3R, it was required to
early adopt IAS 27R, ‘Consolidated and separate financial
statements,’ at the same time.
IFRS ATT 1.111
P1: gudu
ACPA210-01D AICPA AICPA-IFRS-ATT.cls January 5, 1970 10:0
72 IFRS Accounting Trends & Techniques
4. Acquisitions of Subsidiaries, Joint Ventures and
Non-Controlling Interests (in part)
Millicom completed the allocation of the purchase price to the
assets acquired, liabilities assumed and contingent liabilities
during the year ended December 31, 2010. The recognized
amounts of identified assets acquired and liabilities assumed







US$ ’000 US$ ’000
Intangible assets, net(1) 435,174 22,602
Other investments 20,653 13,769
Property, plant and equipment, net 339,082 226,055
Trade receivables 13,876 9,251
Prepayments and accrued income 6,681 4,454
Other current assets 34,485 22,990
Cash and cash equivalents 24,654 16,436
874,605 315,557
Other non-current liabilities(2) 264,590 100,492
Current debt and other financing 74,943 49,962
Trade payables 6,117 4,078
Accrued interests and other expenses 12,756 8,504
Current income tax liabilities 17,465 11,643
Other current liabilities 51,890 35,871
427,761 210,550
Non-controlling interests 147,121
Fair value of the net assets acquired and
contingent liabilities 299,723
Goodwill arising on change of control 854,572
Previously held interests in Celtel (105,007)
Revaluation of the previously held interests
in Celtel 1,049,288
Cost of change of control —
(1) Intangible assets not previously recognized are trademarks for an
amount of $40 million, with estimated useful life of 10 years, cus-
tomers’ list for an amount of $335 million, with estimated useful
life of 8-9 years, and telecommunications license for an amount
of $21 million, with estimated useful life of 11 years.
(2) Deferred tax liabilities, related to the differences between the tax
base and the fair value of the identifiable assets acquired amount
to $114 million.
The goodwill, which is not expected to be tax deductible, is
attributable to the profitability potential of Celtel and the syner-
gies expected to arise. The fair value of the customers’ list was
ascertained using the discounted excess earnings method,
the fair value of the trademark was ascertained using the re-
lief from royalty approach, and the fair value of the telecom-
munications license against comparable transactions.
The change of control contributed revenues of $100 million
and net profit of $1,049 million (including gain on revaluation)
for the period from acquisition to December 31, 2010. If the
change of control had occurred on January 1, 2010, unaudited
pro forma Group revenues from continuing operations for the
year ended December 31, 2010 would have been $4,018 mil-
lion, and the unaudited pro forma net profit from continuing
operations for the same period would have been $1,665 mil-
lion. These amounts have been calculated using the Group
accounting policies.
Millicom revalued at fair value its previously held 66.7% in-
terest in Celtel recognizing a gain of $1,044 million, recorded
under the caption “Revaluation of previously held interests.”
The fair value of the previously held interests was determined
based on a discounted cash flow. The cash flow projections
used (adjusted operating profit margins, income tax, working
capital and capital expenditure) were estimated by manage-
ment covering 6 years. Cash flows beyond this period were
extrapolated using a perpetual growth rate of 2%. The valua-
tion was determined using a discount rate of 14.3%.
Navega S.A. DE CV
As part of a regional shareholding alignment agreement
with its local partner in Honduras, on August 20, 2010 Mil-
licom reached agreement with its local partner in Honduras
whereby Millicom acquired a further 6% of Navega S.A. DE
CV (“Navega Honduras”) (formerly Metrored S.A.). As a re-
sult of this agreement Millicom has the right to control Navega
Honduras, which has been fully consolidated into the Millicom
Group financial statements from August 20, 2010. Previously,
the results of Navega Honduras were proportionately consoli-
dated. The agreement is expected to facilitate further integra-
tion of the cable business and to create synergies.
Millicom completed the allocation of the purchase price to
the assets acquired, liabilities assumed and contingent lia-
bilities during the year ended December 31, 2010. The rec-
ognized amounts of identified assets acquired and liabilities







US$ ’000 US$ ’000
Intangible assets, net 19,563 11,879
Property, plant and equipment, net 22,875 13,890
Other non-current assets 180 109
Trade receivables 1,988 1,207
Prepayments and accrued income 40 25
Current income tax assets 0
Other current assets 482 293
Cash and cash equivalents 3,050 1,852
48,178 29,255
Other non-current liabilities 3,178 1,930
Current debt and other financing 1,152 699
Trade payables 357 217
Accrued interests and other expenses 1,135 689
Current income tax liabilities 1,035 628
Other current liabilities 2,211 1,343
9,068 5,506
Non controlling interests 13,037
Fair value of the net assets acquired and
contingent liabilities 26,073
Goodwill arising on change of control 13,866
Previously held interests in Navega
Honduras (23,748)
Revaluation of the previously held interests
in Navega Honduras 10,726
Cost of change of control 5,465
The goodwill, which is not expected to be tax deductible, is
attributable to the profitability potential of Navega Honduras
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and the synergies expected to arise. The fair value of the
customers’ list was ascertained using the discounted excess
earnings method, and the fair value of the trademark was
ascertained using the relief from royalty approach.
Navega Honduras contributed revenues of $1 million and
net profit of $20 million (including gain on revaluation) for the
period from acquisition to December 31, 2010. If the acquisi-
tion had occurred on January 1, 2010, unaudited pro forma
Group revenues from continuing operations for the year ended
December 31, 2010 would have been $3,924 million, and
the unaudited pro forma net profit from continuing operations
for the same period would have been $1,644 million. These
amounts have been calculated using the Group accounting
policies.
Millicom revalued at fair value its previously held 60% in-
terest in Navega Honduras recognizing a gain of $11 million,
recorded under the caption “Revaluation of previously held
interests.”
Restrictions on Dividend Payments
to Shareholders by Subsidiaries
1.112
National Westminster Bank Plc (Dec 2010)
















Dated loan capital 5,605 6,403 6,560 4,113 4,695 4,518
Undated loan capital 1,681 2,271 3,194 1,500 2,085 2,997
Preference shares 297 325 345 297 325 345
7,583 8,999 10,099 5,910 7,105 7,860
In May 2010, the Group redeemed certain subordinated debt
securities in exchange for cash or senior debt. The exchanges
involving instruments classified as liabilities all met the criteria
in IFRS for treatment as the extinguishment of the original li-
ability and the recognition of a new financial liability. Gains on
these exchanges and on the redemption of securities classi-
fied as liabilities for cash, totalling £145 million were credited
to profit or loss.
A similar series of exchange and tender offers concluded
in April 2009 resulted in a gain of £381 million.
The RBS Group has undertaken that, unless otherwise
agreed with the European Commission, neither the ultimate
holding company nor any of its direct or indirect subsidiaries
(excluding companies in the RBS Holdings N.V. Group, which
are subject to different restrictions) will pay external investors
any dividends or coupons on existing hybrid capital instru-
ments (including preference shares, B shares and upper and
lower tier 2 instruments) from 30 April 2010 for a period of
two years thereafter (“the deferral period”), or exercise any
call rights in relation to these capital instruments between 24
November 2009 and the end of the deferral period, unless
there is a legal obligation to do so. Hybrid capital instruments
issued after 24 November 2009 will generally not be subject to
the restriction on dividend or coupon payments or call options.
Certain preference shares issued by the company are clas-
sified as liabilities; these securities remain subject to the cap-
ital maintenance rules of the Companies Act 2006.
Additional Parent Company Information
Disclosed in a Note to the Consolidated
Financial Statements
1.113
Ashtead Group plc (Apr 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
30. Parent Company Information







Prepayments and accrued income 0.2 0.1
Non-Current Assets
Investments in Group companies (g) 363.7 363.7
Deferred tax asset 0.2 —
363.9 363.7
Total assets 364.1 363.8
Current Liabilities
Amounts due to subsidiary undertakings (f) 82.7 72.0
Accruals and deferred income 3.1 1.2
Total liabilities 85.8 73.2
Equity
Share capital (b) 55.3 55.3
Share premium account (b) 3.6 3.6
Capital redemption reserve (b) 0.9 0.9
Non-distributable reserve (b) 90.7 90.7
Own shares held by the Company (b) (33.1) (33.1)
Own shares held through the ESOT (b) (6.3) (6.3)
Retained reserves (b) 167.2 179.5
Equity attributable to equity holders
of the Company 278.3 290.6
Total liabilities and equity 364.1 363.8
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Parent’s Separate Financial Statements
Presented Side-by-Side With Related




Almost every note disclosure in Alesco Corporation
Limited’s 2010 financial statements provides informa-
tion about both the group and the company. Only a
subset of these notes in the disclosure examples from
Alesco that follow.
Alesco Corporation Limited (May 2010)
INCOME STATEMENTS












Sale of goods 747,858 828,526 — —
Rendering services 23,300 25,970 12,335 10,569
Other revenue 2,038 1,613 25,407 177
Total revenue 773,196 856,109 37,742 10,746
Cost of sales (503,033) (553,750) — —
Gross profit 270,163 302,359 37,742 10,746
Other income 3 244 459 — —
Selling expenses (92,492) (97,593) — —
Marketing expenses (11,427) (12,739) — —
Customer service expenses (20,324) (22,157) — —
Purchasing and inventory management (2,005) (2,256) — —
Distribution expenses (48,113) (49,053) — —
Administration and general expenses (60,086) (65,703) (16,895) (15,480)
Restructuring and other expenses 6 — (28,327) — (3,720)
Impairment of assets 6 (133,100) (70,000) (133,100) (70,000)
Termination payment 6 (1,700) — (1,700) —
Share loan plan expense 6 (5,120) — (5,120) —
Results from operating activities (103,960) (45,010) (119,073) (78,454)
Financial income 5 250 449 14,956 9,761
Financial expenses 5 (15,656) (40,782) (79) (133)
Net financing (costs)/income 5 (15,406) (40,333) 14,877 9,628
Share of associates’ equity accounted net profit 30 — 22 — —
(Loss)/profit from continuing operations before income tax (119,366) (85,321) (104,196) (68,826)
Income tax (expense)/benefit 7 (4,935) 1,813 8 396
(Loss)/profit from continuing operations (124,301) (83,508) (104,188) (68,430)
Discontinued operation
Profit from discontinued operation, net of income tax 32 — 70,719 — 28,248
(Loss)/profit for the period after income tax 23 (124,301) (12,789) (104,188) (40,182)
Earnings Per Share
Basic earnings per share 2 (132.84)¢ (13.94)¢
Diluted earnings per share 2 (132.84)¢ (13.94)¢
Continuing operations
Basic earnings per share 2 (132.84)¢ (91.05)¢
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(Loss)/profit for the period 23 (124,301) (12,789) (104,188) (40,182)
Other comprehensive income
Foreign currency translation differences on translating foreign subsidiaries 22 22 1,363 — —
Effective portion of changes in fair value of cash flow hedges 1,313 (9,345) — —
Net change in fair value of cash flow hedges transferred to profit or loss 4,371 762 — —
Income tax (expense)/benefit on other comprehensive income (1,706) 2,575 — —
Other comprehensive income/(loss) for the period, net of income tax 4,000 (4,645) — —
Total comprehensive income for the period (120,301) (17,434) (104,188) (40,182)
The notes on pages 69 to 142 are an integral part of these
consolidated financial statements.
STATEMENTS OF FINANCIAL POSITION












Cash and cash equivalents 36(a) — 6,106 — 471
Trade and other receivables 8 111,663 128,672 — 6,905
Inventories 9 120,614 122,009 — —
Current tax assets 19 3,901 — 3,901 —
Other 10 6,143 5,022 470 520
Total current assets 242,321 261,809 4,371 7,896
Non-current assets
Trade and other receivables 8 5,764 6,869 291,795 310,602
Other investments 11 — 89 358,395 358,391
Property, plant and equipment 12 55,158 67,521 1,181 2,183
Intangible assets 13 371,413 506,094 401 371
Deferred tax assets 14 17,204 19,648 3,889 3,621
Other 15 62 638 62 638
Total non-current assets 449,601 600,859 655,723 675,806
Total assets 691,922 862,668 660,094 683,702
Liabilities
Bank overdraft 17 3,881 — 8,479 —
Trade and other payables 16 96,319 92,586 4,781 6,304
Loans and borrowings 17 — 85,262 — —
Current tax liabilities 19 5,126 3,969 — 887
Provisions 20 27,871 38,149 3,665 4,178
Other 18 — 3,992 — —
Total current liabilities 133,197 223,958 16,925 11,369
Non-current liabilities
Loans and borrowings 17 125,000 80,500 221,257 142,777
Provisions 20 6,185 6,773 364 224
Total non-current liabilities 131,185 87,273 221,621 143,001
Total liabilities 264,382 311,231 238,546 154,370
Net assets 427,540 551,437 421,548 529,332
Equity
Share capital 21 520,407 513,262 520,407 513,262
Reserves 22 10,734 4,376 2,997 639
Retained earnings 23 (103,601) 33,799 (101,856) 15,431
Total equity 427,540 551,437 421,548 529,332




ACPA210-01E AICPA AICPA-IFRS-ATT.cls November 8, 2011 13:33
76 IFRS Accounting Trends & Techniques















Note $000 $000 $000 $000 $000 $000
Balance at 1 June 2009 513,262 3,196 (2,794) 3,974 33,799 551,437
Total comprehensive income for the period
(Loss)/profit for the period 2 — — — — (124,301) (124,301)
Other comprehensive income
Foreign exchange translation differences on
translating foreign subsidiaries 22 — 22 — — — 22
Effective portion of changes in fair value of cash flow
hedges, net of tax — — 919 — — 919
Net change in fair value of cash flow hedges
transferred to profit or loss, net of tax — — 3,059 — — 3,059
Total other comprehensive income — 22 3,978 — — 4,000
Total comprehensive income for the period — 22 3,978 — (124,301) (120,301)
Transactions with owners, recorded directly in equity
contributions by and distributions to owners
Issue of ordinary shares 21 3,405 — — — — 3,405
Shares granted as part of Total Eden McCracken’s
deferred consideration 21 3,740 — — — — 3,740
Equity settled share-based payments 22 — — — 693 — 693
Senior executive share loan plan adjustment 22 — — — 1,665 — 1,665
Dividends to equity holders 24 — — — — (13,099) (13,099)
Total transactions with owners 7,145 — — 2,358 (13,099) (3,596)
Balance at 31 May 2010 520,407 3,218 1,184 6,332 (103,601) 427,540











Note $000 $000 $000 $000
Balance at 1 June 2009 513,262 639 15,431 529,332
Total comprehensive income for the period
(Loss)/profit for the period — — (104,188) (104,188)
Transactions with owners, recorded directly in equity contributions
by and distributions to owners
Issue of ordinary shares 21 3,405 — — 3,405
Shares granted as part of Total Eden McCracken’s deferred
consideration 21 3,740 — — 3,740
Equity settled share-based payments 22 — 693 — 693
Senior executive share loan plan adjustment 22 — 1,665 — 1,665
Dividends to equity holders 24 — — (13,099) (13,099)
Total transactions with owners 7,145 2,358 (13,099) (3,596)
Balance at 31 May 2010 520,407 2,997 (101,856) 421,548
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Cash Flows From Operating Activities
Cash receipts in the course of operations 861,524 1,136,319 522 195
Cash payments in the course of operations (797,213) (1,046,561) (17,974) (20,665)
Income taxes paid (7,268) (12,673) (6,818) (14,773)
Net cash provided by/(used in) operating activities 36(b) 57,043 77,085 (24,270) (35,243)
Cash Flows from Investing Activities
Proceeds from sale of property, plant and equipment 819 1,900 — —
Payments for property, plant and equipment and capitalised
development expenditure (8,871) (16,992) (579) (2,417)
Proceeds from sale of investments 200 — — —
Receipt of deferred consideration on disposal of entity 6,905 — 6,905 —
Disposal of discontinued operation, net of cash disposed of 32 — 173,248 — 67,417
Proceeds from sale of equity accounted investees 30 — 342 — —
Payments of deferred consideration on acquisitions — (1,791) — —
Payments for assets on acquisition of business 29(c) — (5,542) — —
Interest received 250 514 162 206
Net cash (used in)/provided by investing activities (697) 151,679 6,488 65,206
Cash Flows from Financing Activities
Proceeds from issue of shares — 761 — 761
Dividends paid (10,875) (28,830) (10,875) (28,830)
Finance lease payments (262) (536) — —
Proceeds from borrowings, net of transaction costs 262,000 177,207 — —
Repayment of borrowings (302,500) (330,130) — —
Net proceeds from loans with controlled entities — — 19,786 3,508
Payments related to interest rate hedge restructure — (14,842) — —
Interest paid (14,704) (28,158) (79) (133)
Net cash (used in)/provided by financing activities (66,341) (224,528) 8,832 (24,694)
Net increase/(decrease) in cash held (9,995) 4,236 (8,950) 5,269
Cash and cash equivalents at the beginning of the
financial year 6,106 1,910 471 (4,798)
Effects of exchange rate fluctuations on the balances of cash
held in foreign currencies 8 (40) — —
Cash and cash equivalents at the end of the financial year 36(a) (3,881) 6,106 (8,479) 471
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1: Statement of Significant Accounting Policies
(in part)
The significant policies which have been adopted in the prepa-
ration of this financial report are:
(b) Basis of Preparation
These consolidated financial statements are presented in
Australian dollars, which is the Company’s functional currency
and the functional currency of the majority of the Group. The
consolidated financial statements have been prepared on the
historical cost basis except for derivative financial instruments
that are stated at fair value.
The Company is of a kind referred to in ASIC Class Order
98/100 dated 10 July 1998 and, in accordance with the Class
Order, all financial information presented in Australian dollars
has been rounded to the nearest thousand unless otherwise
stated.
(d) Going Concern
Whilst the Company’s current liabilities exceed its current as-
sets by $12,554,000 (2009: $3,473,000), the directors are sat-
isfied that the Company’s financial report be prepared on a
going concern basis as the Company has access to cash
generated by the Group via the Deed of Cross Guarantee.
On this basis, the directors believe that it is appropriate
to prepare the Company’s financial statements on a going
concern basis.
(e) Basis of Consolidation
Subsidiaries
Subsidiaries are entities controlled by the Company. Control
exists when the Company has the power, directly or indirectly,
to govern the financial and operating policies of an entity so
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as to obtain benefits from its activities. In assessing control,
potential voting rights that presently are exercisable or con-
vertible are taken into account. The financial statements of
subsidiaries are included in the financial report from the date
that control commences until the date that control ceases.
Investments in subsidiaries are carried at their cost of acqui-
sition, less any impairment losses, in the Company’s financial
statements.
(s) Income Tax
Income tax expense comprises current and deferred tax. In-
come tax is recognised in the income statement except to the
extent that it relates to items recognised directly in equity, in
which case it is recognised in equity.
Current tax is the expected tax payable on the taxable in-
come for the year, using tax rates enacted or substantially
enacted at the balance sheet date, and any adjustment to tax
payable in respect of previous years.
Deferred tax is provided using the balance sheet liability
method, providing for temporary differences between the car-
rying amounts of assets and liabilities for financial reporting
purposes and the amounts used for taxation purposes. The
following temporary differences are not provided for: the ini-
tial recognition of goodwill, the initial recognition of assets or
liabilities in a transaction that is not a business combination
and that affect neither accounting nor taxable profit and dif-
ferences relating to investments in subsidiaries to the extent
that they will probably not reverse in the foreseeable future.
The amount of deferred tax provided is based on the expected
manner of realisation or settlement of the carrying amount of
assets and liabilities, using tax rates enacted or substantively
enacted by the reporting date.
A deferred tax asset is recognised only to the extent that it
is probable that future taxable profits will be available against
which the asset can be utilised. Deferred tax assets are re-
duced to the extent that it is no longer probable that the related
tax benefit will be realised.
Additional income taxes that arise from the distribution of
dividends are recognised at the same time as the liability to
pay the related dividend.
Tax Consolidation
The Company and its wholly-owned Australian resident en-
tities have formed a tax-consolidated group with effect from
1 June 2004 and are therefore taxed as a single entity from
that date. The Company is the head entity within the tax-
consolidated group.
Current tax expense/income, deferred tax liabilities and de-
ferred tax assets arising from temporary differences of the
members of the tax-consolidated group are recognised in
the separate financial statements of the members of the tax-
consolidated group using the “separate taxpayer within group”
approach by reference to the carrying amounts of assets and
liabilities in the separate financial statements of each entity
and the tax values applying under tax consolidation.
Any current tax liabilities (or assets) and deferred tax as-
sets arising from unused tax losses of the subsidiaries are
assumed by the head entity in the tax-consolidated group
and are recognised as amounts payable (receivable) to (from)
other entities in the tax-consolidated group in conjunction with
any tax-funding arrangement amounts (refer below). Any dif-
ference between these amounts is recognised by the Com-
pany as an equity contribution or distribution.
The Company recognises deferred tax assets arising from
unused tax losses of the tax-consolidated group to the ex-
tent that it is probable that future taxable profits of the tax-
consolidated group will be available against which the asset
can be utilised.
Any subsequent period adjustments to deferred tax assets
arising from unused tax losses as a result of revised assess-
ments of the probability of recoverability is recognised by the
head entity only.
Nature of Tax-Funding Arrangements and Tax-Sharing
Agreements
The head entity, in conjunction with other members of the tax-
consolidated group, has entered into a tax-funding arrange-
ment which sets out the funding obligations of members of
the tax-consolidated group in respect of tax amounts. The
tax-funding arrangements require payments to/from the head
entity equal to the current tax liability (asset) assumed by the
head entity and any tax-loss deferred tax asset assumed by
the head entity, resulting in the head entity recognising an
inter-entity receivable (payable) equal in amount to the tax li-
ability (asset) assumed. The inter-entity receivable (payable)
is at call.
Contributions to fund the current tax liabilities are payable
as per the tax-funding arrangement and reflect the timing of
the head entity’s obligation to make payments for tax liabilities
to the relevant tax authorities.
The head entity, in conjunction with other members of the
tax-consolidated group, has also entered into a tax-sharing
agreement. The tax-sharing agreement provides for the de-
termination of the allocation of income tax liabilities between
the entities should the head entity default on its tax payment
obligations. No amounts have been recognised in the finan-
cial statements in respect of this agreement as payment of
any amounts under the tax-sharing agreement is considered
remote.










Gain on disposal of property,
plant and equipment 126 459 — —
Gain on sale of investments 118 — — —
Total other income 244 459 — —
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Buildings 12 390 391 — —
Leasehold improvements 12 1,014 1,105 37 42
Motor vehicles 12 1,241 1,514 — —
Plant and equipment 12 7,766 12,734 338 526
Leased plant and equipment 12 1 — — —
10,412 15,744 375 568
Amortisation of identifiable intangibles:
Brand names 13 965 3,188 — —
Patents and trademarks 13 462 460 — —
Customer relationships 13 4,399 6,847 — —
Development costs 13 4,960 3,521 235 56
Lease premium 13 — 750 — —
Other 13 54 883 — —
10,840 15,649 235 56
Total depreciation and amortisation 21,252 31,393 610 624
Personnel expenses:
Wages and salaries 122,860 150,897 6,933 7,020
Employee benefits 37,532 45,938 3,381 2,668
Equity-settled share-based payments 693 (1,752) 693 (892)
Senior executive share loan adjustments 6 5,120 — 5,120 —
166,205 195,083 16,127 8,796
Impairment loss on trade receivables 1,588 1,689 — —
Operating lease rental expense 20,021 23,332 559 419
Research and development expenditure 41 100 — —
Gain on disposal of property, plant and equipment 126 459 — —
Loss on disposal of property, plant and equipment (1,325) (1,098) — (42)
Net loss on disposal of property, plant and equipment (1,199) (639) — (42)
Note 5: Net Financing Income/(Costs)











Cash and cash equivalents 250 449 162 206
Related parties — — 14,794 9,555
Financial income 250 449 14,956 9,761
Interest expense:
Bank loans and overdraft (15,656) (25,940) (79) (133)
Interest rate hedging restructure — (14,842) — —
Financial expenses (15,656) (40,782) (79) (133)
Net financing (costs)/income (15,406) (40,333) 14,877 9,628
Recognised in Other Comprehensive Income
Foreign currency translation differences on translating foreign subsidiaries 22 1,363 — —
Effective portion of changes in fair value of cash flow hedges 1,313 (9,345) — —
Net change in fair value of cash flow hedges transferred to profit or loss 4,371 762 — —
Income tax (expense)/benefit on other comprehensive income (1,706) 2,575 — —
Finance income/(costs) recognised in other comprehensive income,
net of income tax (4,000) (4,645) — —
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Impairment loss on goodwill (116,341) (59,980) — —
Impairment loss on brand names — (10,020) — —
Impairment loss on capitalised software development costs (1,688) — — —
Impairment loss on customer relationships (12,705) — — —
Impairment loss on property, plant and equipment (2,366) — — —
Impairment loss on loans to controlled entities — — (133,100) (70,000)
Impairment of assets (133,100) (70,000) (133,100) (70,000)
Related income tax benefit 1,216 — — —
(131,884) (70,000) (133,100) (70,000)
Termination Payment
Termination payment (1,700) — (1,700) —
Related income tax benefit 510 — 510 —
(1,190) — (1,190) —
Senior Executive Share Loan Plan Expense
Senior executive share loan plan expense (5,120) — (5,120) —
Related income tax benefit 1,536 — 1,536 —
(3,584) — (3,584) —
Sale of Scientific & Medical Division
Proceeds on sale of Scientific & Medical division — 181,537 — 73,953
Carrying value of net assets sold, associated costs incurred and net
impact of foreign exchange — (115,162) — (38,951)
Gain on sale — 66,375 — 35,002
Related income tax expense — (6,754) — (6,754)
— 59,621 — 28,248
Business Restructuring
Rationalisation of business operations — (16,834) — (530)
Related income tax benefit — 5,050 — 159
— (11,784) — (371)
Inventory
Write-down of inventory to net realisable value — (7,920) — —
Related income tax benefit — 2,376 — —
— (5,544) — —
Sale of Investment
Loss on sale of equity accounted investment — (165) — —
Related income tax expense — — — —
— (165) — —
Occupational Health and Safety (OH&S)
Provision for costs associated with OH&S — (3,408) — (3,190)
Related income tax benefit — 573 — 507
— (2,835) — (2,683)
Interest Rate Hedge Restructure(1)
Costs associated with revaluation and settlement of interest rate swaps — (14,842) — —
Related income tax benefit — 4,453 — —
— (10,389) — —
Total significant items before income tax expense (139,920) (46,794) (139,920) (38,718)
Related income tax benefit/(expense) on significant items 3,262 5,698 2,046 (6,088)
Total significant items after income tax (136,658) (41,096) (137,874) (44,806)
(1) Interest rate hedge restructuring included in net financing costs.
(2) For continuing operations only.
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Recognised in the Income Statement
Current tax expense:
Current year 5,758 2,929 1,334 (390)
Adjustments for prior year (1,506) 588 (246) (193)
4,252 3,517 1,088 (583)
Deferred tax expense:
Origination and reversal of temporary differences 683 (881) (1,096) 187
Total income tax expense/(benefit) excluding gain on sale of
discontinued operation 4,935 2,636 (8) (396)
Income tax expense/(benefit) from continuing operations 4,935 (1,813) (8) (396)
Income tax expense from discontinued operation (excluding gain on sale) — 4,449 — —
4,935 2,636 (8) (396)
Income tax expense on gain on sale of discontinued operation — 6,754 — 6,754






























Foreign currency translation differences on
translating foreign subsidiaries 22 — 22 1,363 — 1,363
Effective portion of changes in fair value of cash
flow hedges 1,313 (394) 919 (9,345) 2,804 (6,541)
Net change in fair value of cash flow hedges
transferred to profit or loss 4,371 (1,312) 3,059 762 (229) 533
5,706 (1,706) 4,000 (7,220) 2,575 (4,645)
There were no amounts recognised in other comprehensive
income for the Company for the financial year ended 31 May
2010 (31 May 2009: Nil).
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(Loss)/profit for the period (124,301) (12,789) (104,188) (40,182)
Total income tax expense/(benefit) 4,935 9,390 (8) 6,358
(Loss)/profit excluding income tax expense (119,366) (3,399) (104,196) (33,824)
Prima facie income tax (benefit)/expense calculated at 30% (2009: 30%)
on (loss)/profit before tax (35,810) (1,020) (31,259) (10,147)
Increase/(decrease) in income tax expense due to:
Non-deductible amortisation of intangibles 1,958 3,921 — —
Non-deductible expenses 307 548 7 479
Non-deductible foreign exchange losses 216 1,890 216 —
Derecognition of foreign tax loss benefit 1,241 — — —
Non-deductible impairment expenses 38,714 21,000 39,930 21,000
Non-deductible set up cost — 298 — —
Overseas tax rate differential (88) (35) — —
Research and development — (589) — —
Recovery of tax benefits not previously brought to account — (3,181) — (3,181)
Non-assessable dividend income — — (7,465) —
Non-assessable capital gains (194) (10,377) (158) (566)
Non-assessable foreign exchange gains — (3,234) — —
Non-assessable interest income — — (1,033) (926)
Sundry items 97 (419) — (108)
Income tax expense on (loss)/profit 6,441 8,802 238 6,551
Income tax (over)/under provided in prior year (1,506) 588 (246) (193)
Income tax expense/(benefit) attributable to pre-tax (loss)/profit 4,935 9,390 (8) 6,358
In February 2009, the New Zealand Inland Revenue De-
partment issued amended assessment notices to Alesco NZ
group entities in relation to an ongoing dispute regarding
the tax deductibility of interest on Optional Convertible Notes
(“OCNs”) issued by Alesco NZ Limited in 2003. On the basis
of external legal and tax advice, Alesco has commenced pro-
ceedings in the New Zealand High Court in relation to this
matter. If Alesco is unsuccessful, the accounting value of in-
terest deductions claimed since the inception of this financing
arrangement in 2003 to 31 May 2010 would be $NZ7,065,000
(2009: $NZ5,964,000). This amount has been fully provided
for (progressively since 2004). No provision has been made
in respect of interest or potential penalty that could be levied
should Alesco be unsuccessful in its New Zealand High Court
action.
If Alesco NZ Limited is successful in the proceedings, any
provision held at that time in relation to the OCNs will be
written back to profit.
The Group will continue to fully provide for any future tax
deductions in relation to the interest on the OCNs.
Note 21: Share Capital










Ordinary shares, fully paid 94,193,403 92,115,140 520,407 513,262
Ordinary Shares—Movements During the Year
Balance at beginning of year 92,115,140 90,577,876 513,262 504,664
Shares issued:
• as part of dividend reinvestment plan 521,068 587,892 2,233 3,787
Associated transaction costs — — (9) (9)
• shares granted as part of Total Eden McCracken’s deferred consideration 1,078,609 48,114 3,740 616
• shares granted for no consideration under the employee and management
share plans — 315,043 — 1,026
• shares issued for consideration under the employee share plans — 90,673 — 613
• shares issued for consideration under the management share plans — 21,726 — 148
• shares issued under the senior executive share acquisition plan 478,586 473,816 1,181 2,417
Balance at end of year 94,193,403 92,115,140 520,407 513,262
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Terms and Conditions
The Company does not have authorised capital or par value
in respect of its issued shares. All issued shares are fully paid.
Holders of ordinary shares are entitled to receive dividends
as declared from time to time and are entitled to one vote per
share at shareholders’ meetings. In the event of winding up of
the Company, ordinary shareholders rank after creditors and
are fully entitled to any proceeds of liquidation.
At reporting date, there were 136,422 (2009: 67,984)
shares forfeited under the employee share plans held by a
third party plan trustee.
Capital Management
The consolidated entity’s and the parent entity’s overall strate-
gic capital management objective is to:
• safeguard the consolidated entity’s ability to continue as
a going concern so that it can continue to provide returns
for shareholders and benefits for other stakeholders;
• provide optimal capital structure to reduce the cost of
capital;
• maintain a strong/conservative capital base so as to
maintain creditor and market confidence and to sustain
future development of the business;
• maintain a conservative funding structure which pro-
vides sufficient flexibility to fund the operational de-
mands of the business and to underwrite any strategic
opportunities; and
• manage capital to ensure sufficient buffer over and be-
yond any banking covenants.
The consolidated entity monitors the return on capital, which
the consolidated entity defines as net operating income di-
vided by total shareholders’ equity. The consolidated entity’s
target is for all divisions to achieve a return on average net op-
erating assets over the medium-term which is greater than the
Group’s cost of capital. During the year, the return on average
net operating assets was 6.9% (2009: 9.8%).
Returns on capital fluctuate according to prevailing eco-
nomic circumstances and, in particular, the level of merger
and acquisition activity the consolidated entity undertakes and
the mix of debt and equity used to fund the consolidated entity.
The consolidated entity monitors capital with reference to
having an optimal level of gearing. The level of gearing is
measured by reference to the net debt gearing ratio which is
calculated as net debt divided by total capital. Net debt is cal-
culated at total interest-bearing financial assets and liabilities
less cash and cash equivalents. Total capital is calculated as
equity as shown in the statement of financial position plus net
debt.
The consolidated entity’s net debt gearing ratio at the end






Net debt 128,881 159,656
Total equity 427,540 551,437
Net debt 128,881 159,656
Total capital 556,421 711,093
Net debt gearing ratio at 31 May 23.2% 22.5%
The consolidated entity also monitors the level of dividends
to ordinary shareholders.
In order to maintain or adjust the capital structure, the con-
solidated entity may adjust the amount of dividends paid to
the shareholders, return capital to shareholders or issue new
shares.
The consolidated entity’s capital management objectives
will be effected through:
• an ongoing flow of fully franked dividends, which subject
to the consolidated entity’s franking ability and ongoing
profitability will be on an annually progressive basis; and
• from time to time, on-market purchases mitigate the dilu-
tionary impact of share issues which would be otherwise
necessary to satisfy obligations under employee share-
based remuneration plans as they crystallise.
The consolidated entity expects to continue the payment of
fully franked dividends on an ongoing basis subject to its
overall earnings performance, prevailing economic circum-
stances, alternative demands on funds or alternative more ef-
fective capital management opportunities becoming available.
The Board of directors and management review the Cap-
ital Management Policy on a periodic basis and implement
initiatives which are deemed appropriate in the environment
existing at that time. External consultants and advisers are
used as required to determine the appropriate capital struc-
ture for the consolidated entity and advise on other capital
management related items.
Neither the Company nor any of its subsidiaries are subject
to externally imposed capital requirements.
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Foreign currency translation reserve 3,218 3,196 — —
Hedging reserve 1,184 (2,794) — —
Share equity reserve 6,332 3,974 2,997 639
10,734 4,376 2,997 639
Movements During the Year:
Foreign currency translation reserve
Balance at beginning of year 3,196 1,833 — —
Decrease through disposal of entities and businesses — 6,333 — —
Net translation adjustment 22 (4,970) — —
Balance at end of year 3,218 3,196 — —
Hedging Reserve
Balance at beginning of year (2,794) 3,214 — —
Net gain/(loss) transferred to/from hedging reserve 3,978 (6,008) — —
Balance at end of year 1,184 (2,794) — —
Share Equity Reserve
Balance at beginning of year 3,974 4,725 639 774
Employee share-based payments 693 1,068 693 1,068
Reversal of employee share-based expenses — (1,203) — (1,203)
Senior executive share loan plan expense 1,665 — 1,665 —
Deferred earn-out — (616) — —
Balance at end of year 6,332 3,974 2,997 639
Nature and Purpose of Reserves
Foreign Currency Translation
The foreign currency translation reserve comprises all foreign
exchange differences arising from the translation of the finan-
cial statements of foreign operations where their functional
currency is different to the presentation currency of the re-
porting entity as well as from the translation of liabilities that
hedge the Company’s net investment in a foreign subsidiary.
Refer to accounting policy Note 1(f).
Hedging Reserve
The hedging reserve comprises the effective portion of the
cumulative net change in the fair value of cash flow hedging
instruments related to hedged transactions that have not yet
occurred.
Share Equity
The share equity reserve relates to shares issued, and held
on trust, associated with the Group’s equity compensation
plans that have not vested at the reporting date as well as an
amount in relation to potential deferred consideration associ-
ated with previous acquisitions. The fair value of the shares
is expensed over the vesting period and credited to this re-
serve. The reserve will reverse against share capital when the
underlying shares vest in the employee.











Balance at beginning of year 33,799 79,196 15,431 88,221
Net loss attributable to members of the parent entity (124,301) (12,789) (104,188) (40,182)
Dividends 24 (13,099) (32,608) (13,099) (32,608)
Balance at end of year (103,601) 33,799 (101,856) 15,431
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IAS 10, EVENTS AFTER THE
REPORTING PERIOD
IFRSs Overview and Comparison
to U.S. GAAP
1.115 IAS 10, Events After the Reporting Period, estab-
lishes recognition and disclosure requirements for certain
events that occur after the balance sheet date. The events
within the scope of IAS 10 may be favorable or unfavorable
and occur between the balance sheet date and the date the
entity authorizes the financial statements for issue.
Recognition and Measurement
IFRSs
1.116 An entity should adjust the financial statements for
those events that provide evidence of conditions existing at
the balance sheet date (that is, adjusting events) and should
not adjust for those events that indicate conditions arising
after the balance sheet date (that is, nonadjusting events).
1.117 IAS 10 provides several examples of adjusting events
for conditions that existed at the balance sheet date, including
the following:
• Settlement of a lawsuit confirming a present obligation
• Confirming information of an asset impairment
• Determination of costs of assets purchased or proceeds
of assets sold
• Discovery of fraud or errors
1.118 Examples of nonadjusting events include the follow-
ing:
• Declines in market values
• Filing of lawsuits
• Issue of new debt or equity securities
• Declaration of dividends
1.119 IAS 10 prohibits an entity from preparing its finan-
cial statements on a going concern basis if management deter-
mines after the end of the reporting period that it will liquidate
the entity or cease operations and has no alternatives to doing
so.
U.S. GAAP
1.120 Like IFRSs, FASB ASC 855, Subsequent Events, in-
cludes general guidance applicable to all entities on account-
ing for, and disclosure of, events after the reporting period
(subsequent events) that are not addressed specifically in
other topics within FASB ASC.
1.121 Like IFRSs, paragraphs 1 and 3 of FASB ASC 855-
10-25 require an entity to recognize only the effects of events
that provide evidence of conditions that existed at the bal-
ance sheet date, including accounting estimates, and prohibit
an entity from recognizing events that provide evidence about
conditions that arose after the balance sheet date. However,
unlike IFRS, no exception exists when the going concern as-
sumption is no longer appropriate. Also unlike IFRSs, FASB
ASC 855-10-25-1A extends the period over which an SEC
filer or a conduit bond obligor for conduit debt securities that
are traded in a public market (a domestic or foreign stock
exchange or an over-the-counter market, including local or
regional markets) should evaluate subsequent events until the
date the financial statements are issued, rather than the date
of authorization. In addition, FASB ASC 855-10-25-2 re-
quires all other entities that do not meet the criteria outlined
in FASB ASC 855-10-25-1A to evaluate such events through
the date the financial statements are available to be issued.
As defined in the FASB ASC glossary, financial statements
are considered available to be issued when they are com-
plete in a form and format that complies with U.S. GAAP,
and all approvals necessary for issuance have been obtained,
for example, from management, the board of directors, or
significant shareholders.
1.122 Like IFRSs, FASB ASC 855-10-25-3 prohibits an
entity from recognizing subsequent events that provide ev-
idence about conditions that did not exist at the date of the
balance sheet but arose after that date and before the financial
statements are issued or are available to be issued.
1.123 Unlike IFRSs, FASB ASC 855-10-25-4 also ad-
dresses the potential for reissue of the financial statements in
reports filed with regulatory agencies. In this circumstance,
an entity should not recognize events occurring between the
time the financial statements were originally issued or were
available to be issued and the time the financial statements
were reissued, unless U.S. GAAP or regulatory requirements
require the adjustment. Similarly, an entity should not rec-
ognize events or transactions occurring after the financial
statements were issued or available to be issued in financial
statements that are later reissued in comparative form along
with financial statements of subsequent periods, unless the
adjustment meets the criteria previously stated.
1.124 FASB ASC provides specific guidance on the
following:
• Like IFRSs, FASB ASC 740-10-25-15 requires an en-
tity to recognize changes in judgment after the balance
sheet date that result in subsequent recognition, dere-
cognition, or a change in measurement of an income
tax position taken in a prior annual period as a discrete
item when the change occurs.
Author’s Note
See the related discussion of income taxes in section
3, “Statement of Comprehensive Income and Related
Disclosures.”
• Like IFRSs, FASB ASC 260-10-55-12 requires an en-
tity to adjust earnings per share amounts for changes
in common stock resulting from stock dividends, stock
splits, or reverse stock splits that occur after the close of
the period. In addition, if per share computations reflect
such changes in the number of shares, that fact should
be disclosed. Unlike IFRSs, the period of evaluation for
such events is extended to the date before the date that
the financial statements are issued or available to be is-
sued, rather than the date of authorization. Also unlike
IFRSs, SEC registrants are required to make retroactive
adjustments, as previously noted, upon declaration of a
stock dividend, stock split, or reverse stock split, even
if the actual date of the event is subsequent to financial
statement issuance, but the event is declared prior to the
issuance of the financial statements.
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Author’s Note
See the related discussion of earnings per share in sec-
tion 3, “Statement of Comprehensive Income and Re-
lated Disclosures.”
• Similar to the treatment of contingent assets in IFRSs,
FASB ASC 450-30-25-1 generally prohibits recogni-
tion of gain contingencies in the financial statements
because to do so might be to recognize revenue before
its realization. Comparable to the definition of a contin-
gent asset in IFRSs, the FASB ASC glossary defines a
gain contingency as an existing condition, situation, or
set of circumstances involving uncertainty about pos-
sible gain to an entity that will ultimately be resolved
when one or more future events occur or fail to occur.
Unlike IFRSs, FASB ASC does not address recognition
when the realization of contingent income is virtually
certain.
Author’s Note
See the related discussion of provisions, contingent li-
abilities, and contingent assets in section 2, “Statement
of Financial Position and Related Disclosures.”
• Like IFRSs, generally, the classification of liabilities as
current or noncurrent reflects circumstances at the re-
porting date. However, unlike IFRSs, paragraphs 14–15
of FASB ASC 470-10-45 address refinancing consider-




1.125 IFRSs do not include specific presentation require-
ments for events after the reporting date.
U.S. GAAP
1.126 Unlike IFRSs, FASB ASC 855-10-50-3 requires an
entity to consider supplementing the historical financial state-
ments with pro forma financial data when an unrecognized
subsequent event occurs. An entity should present pro forma
financial data when an unrecognized subsequent event is suf-
ficiently significant that pro forma information provides the
best disclosure. In preparing pro forma data, an entity should
include the event as if it had occurred on the balance sheet
date. An entity should also consider presenting pro forma
statements, usually a statement of financial position only, in
columnar form on the face of the historical statements.
Disclosure
IFRSs
1.127 An entity should disclose who authorized the issuance
of the financial statements and the authorization date. When
applicable, an entity should also disclose the fact that the en-
tity’s owners or others have the power to amend the financial
statements after issue.
1.128 Even when an entity does not adjust the financial
statements for new information about conditions existing at
the balance sheet date, it should update disclosures relating
to those conditions.
1.129 For material, nonadjusting events, an entity should
disclose the following information by category of event:
• Nature of the event
• Estimate of the financial effect or a statement that an
estimate cannot be made
U.S. GAAP
1.130 Paragraphs 1 and 4 of FASB ASC 855-10-50 state
that an entity, except an SEC registrant, should disclose the
date through which subsequent events have been evaluated,
as well as whether that date is the date the financial statements
were issued or the date the financial statements were available
to be issued. An entity, except an SEC registrant, should also
disclose in the revised financial statements the date through
which subsequent events have been evaluated in both the orig-
inally issued financial statements and the reissued financial
statements. The aforementioned guidance is similar to IFRSs
in that both require disclosure of issuance or authorization,
so that the users of the financial statements will know that the
financial statements do not reflect events after the date(s) dis-
closed. Unlike IFRSs, FASB ASC does not explicitly discuss
the circumstances when an entity’s owners or others have the
power to amend financial statements after issue.
1.131 FASB ASC 855-10-S99 provides guidance to SEC
registrants on recognition or disclosure, or both, of signif-
icant events that occur after the date of the financial state-
ments. FASB ASC 855-10-S99-2 explains that a registrant
may widely distribute its financial statements, but before fil-
ing them with the SEC, the registrant or its auditor may then
become aware of an event or a transaction that existed at the
date of the financial statements that causes those financial
statements to be materially misleading. If a registrant does
not amend those financial statements, so that they are free
of material misstatement or omissions when they are filed
with the SEC, the registrant will be knowingly filing a false
and misleading document. In addition, SEC registrants are
reminded of their responsibility to, at a minimum, disclose
subsequent events, and independent auditors are reminded of
their responsibility to assess subsequent events and evaluate
the impact of the events or transactions on their audit report.
1.132 Like IFRSs, FASB ASC 855-10-50-2 requires an en-
tity to disclose the following information about unrecognized
subsequent events when failure to disclose would result in
misleading financial statements:
• Nature of the event
• Estimate of the event’s financial effect or a statement
that such an estimate cannot be made
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Presentation and Disclosure Excerpts
Cash Dividend Declaration and Distribution
1.133
Companhia de Bebidas das Américas (American
Beverage Company)—Ambev (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
33. Events After the Balance Sheet Date
a) Dividend and Interest on Equity
On February 28, 2011, the Company approved the distribution
of (i) dividends, to be deducted from the reserve and attributed
to the minimum mandatory dividends for 2010, at R$ 0.56
per Common share and R$ 0.61 per Preferred share, without
withholding income tax, pursuant to applicable law.
The payments were made on March 22, 2011 (conditioned
to approval of the Annual General Meeting which will approve
the 2010 financial statements). The record date was March 3,
2011 for BM&FBOVESPA shareholders and March 8, 2011 for
ADR holders. Shares and ADRs shall be traded ex-dividends
as from March 4, 2011.
Binding Offer to Acquire Another Company
and Extension of Credit Lines
1.134
Pargesa Holding AG (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 25—Important Events After the Balance
Sheet Date
On 23 February 2011, Imerys announced that it had entered
into exclusive negotiations with Rio Tinto and had made a
binding offer for the acquisition of 100% of the Luzenac group,
one of the leading players in the talc industry, for an enterprise
value of USD 340 million.
At the start of 2011, GBL extended part of its confirmed
credit lines. GBL will therefore be able to take advantage of
facilities amounting to EUR 1.8 billion up to 2013/2014 and
EUR 900 million from then until 2016.
Initial Public Offering and Private Placement
1.135
Adecoagro S.A (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
34. Events After the Date of the Statement of Financial
Position
Initial Public Offering (IPO) and Private Placement
On January 28, 2011 the Company successfully completed
an initial public offering of its shares in the New York Stock Ex-
change. The Company issued 28,405,925 shares, at a price
of US$ 11 per share. In addition, on February 11, 2010, the
Company issued 4,285,714 shares as a consequence of the
over-alloment option exercised by the underwriters of the ini-
tial public offering, raising an overall amount of approximately
US$ 359 million.
On January 28, 2011, Adecoagro issued and sold to Al
Gharrafa 7,377,598 common shares at a purchase price per
share of US$ 10,65, which is equal to the price per common
share paid by the underwriters acting in the initial public offer-
ing of the Group. This transaction was conditioned upon, and
close immediately after, the closing of the initial public offer-
ing of the Company. Consequently the company raised US$
79 million.
The Company intend to use these funds to finance part of
the construction costs of Ivinhema (sugar and ethanol mill
in Brazil) and for potential investments in the acquisition of
farmland and capital expenditures required in the expansion
of the farming business.
Tender Offer
1.136
InterContinental Hotels Group plc (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1—Accounting Policies (in part)
General Information
The consolidated financial statements of InterContinental Ho-
tels Group PLC (the “Group” or “IHG”) for the year ended De-
cember 31, 2010 were authorized for issue to the UK listing
authorities in accordance with a resolution of the Directors on
February 14, 2011. InterContinental Hotels Group PLC (the
“Company”) is incorporated in Great Britain and registered in
England and Wales.
On February 23, 2011, the Group received an unfavor-
able court judgment in respect of a prior year litigation claim.
As required by IAS 37 “Provisions, Contingent Liabilities and
Contingent Assets” and IAS 10 “Events after the Reporting
Period,” the Consolidated Financial Statements for the year
ended December 31, 2010, authorized by the Directors on
April 11, 2011, for issue on Form 20-F include a litigation
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provision of $22 million ($13 million net of tax) to reflect this
adjusting post balance sheet event.
The impact of the above adjusting post balance sheet event
is summarized as follows:
Consolidated Financial
Statements Authorized on
February 14, 2011 April 11, 2011
Profit before tax ($ million) 397 375
Profit for the year ($ million) 293 280
Net assets ($ million) 291 278
Basic earnings per share (cents) 101.7 97.2
Diluted earnings per share (cents) 99.0 94.6
As the provision has been recorded as an exceptional item,
there was no impact on results before exceptional items and
adjusted earnings per share.
Financial Statements Subject to Approval
of Shareholders
1.137
A.G. Barr plc (January 2011)











Paid final dividend 16.85p 15.20p 6,450 5,837
Paid interim dividend 6.75p 6.25p 2,595 2,413
23.60p 21.45p 9,045 8,250
The directors have proposed a final dividend in respect of the
year ended 29 January 2011 of 18.66p per share, amounting
to a dividend of £7,263,000. It will be paid on 3 June 2011 to
shareholders who are on the Register of Members on 6 May
2011.
This dividend is subject to approval by shareholders at the
annual general meeting and has not been included as a liabil-
ity in these financial statements in line with the requirements
of IAS 10 Events after the Balance Sheet Date.
Issue of Court Opinion in Litigation and
Agreement to Acquire Credit Card Assets
1.138
Barclays plc (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
26. Legal Proceedings (in part)
Lehman Brothers Holdings Inc.
On 15th September 2009, motions were filed in the United
States Bankruptcy Court for the Southern District of New York
(the Court) by Lehman Brothers Holdings Inc. (LBHI), the
SIPA Trustee for Lehman Brothers Inc. (the Trustee) and the
Official Committee of Unsecured Creditors of Lehman Broth-
ers Holdings Inc. (the Committee). All three motions challenge
certain aspects of the transaction pursuant to which Barclays
Capital Inc. (BCI) and other companies in the Group acquired
most of the assets of Lehman Brothers Inc. (LBI) in September
2008 and the court order approving such sale. The claimants
seek an order voiding the transfer of certain assets to BCI;
requiring BCI to return to the LBI estate alleged excess value
BCI received; and declaring that BCI is not entitled to certain
assets that it claims pursuant to the sale documents and or-
der approving the sale. On 16th November 2009, LBHI, the
Trustee and the Committee filed separate complaints in the
Court asserting claims against BCI based on the same un-
derlying allegations as the pending motions and seeking re-
lief similar to that which is requested in the motions. On 29th
January 2010, BCI filed its response to the motions. Barclays
considers that the motions and claims against BCI are with-
out merit and BCI is vigorously defending its position. On 29th
January 2010, BCI also filed a motion seeking delivery of cer-
tain assets that LBHI and LBI have failed to deliver as re-
quired by the sale documents and the court order approving
the sale. Approximately £2.6bn of the assets acquired as part
of the acquisition had not been received by 31st December
2010, approximately £2.0bn of which were recognised as part
of the accounting for the acquisition and are included in the
balance sheet as at 31st December 2010. This results in an
effective provision of £0.6bn against the uncertainty inherent
in the litigation.
On 22nd February 2011, the Court issued its Opinion in
relation to these matters. The Opinion calls for the parties
to submit proposed Orders that will implement the Opinion,
and anticipates a possible status conference to resolve any
potential differences between the parties regarding the final
Order that should be entered. Any such Order should clarify
the precise impact of the Opinion, and may include specific
guidance regarding the treatment of specific types of assets.
Such an Order may be the subject of further proceedings or
appeals by one or more of the parties.
Barclays has considered the Opinion and the decisions con-
tained therein and its possible actions with respect thereto. If
the Opinion were to be unaffected by future proceedings, Bar-
clays estimates that its maximum possible loss, based on its
worst case reading of the Opinion, would be approximately
£2.6bn, after taking into account the effective provision of
£0.6bn. Any such loss, however, is not considered probable
and Barclays is satisfied with the current level of provision.
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46 Events After the Balance Sheet Date
On 22 February 2011, the US Bankruptcy Court for the South-
ern District of New York issued its opinion in relation to
Lehman Brothers Holdings Inc.. Further information is pro-
vided on page 226.
On 1st March 2011, Barclays agreed to acquire Egg’s UK
credit card assets. Under the terms of the transaction, Bar-
clays will purchase Egg’s UK credit card accounts, consisting
of approximately 1.15 million credit card accounts with ap-
proximately £2.3bn of gross receivables. Completion is sub-
ject to competition clearance, and is expected to occur during
the first half of 2011.
Business Combinations
1.139
Galenica Ltd. (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
35. Events After the Reporting Period
Several business combinations occurred between 31 Decem-
ber 2010 and the date the annual accounts of Galencia were
released.
Retail Acquisitions
Galenica purchased several pharmacies. The assets and lia-
bilities of these acquisitions will be consolidated for financial
year 2011 as of the date control was obtained. The purchase
consideration was CHF 1.8 million, the fair value of the net
assets resulting from these additions was estimated at CHF
0.5 million on the acquisition date. The difference is reflected
in the purchased goodwill due to the locations and the ex-
isting customer base of these businesses. Since the trans-
actions were concluded shortly before the annual accounts
were prepared and released, it was not possible to publish
the additional information required by IFRS.
There are no further significant events after the reporting
period.
Property Sales and Capital Contribution
by Swiss Federal Tax Authorities
1.140
PSP Swiss Property Ltd (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
30. Subsequent Events
After the balance sheet date of 31 December 2010, the
following properties were, respectively will be, transferred
(transfer of benefit and risk): i) as at 1 February 2011:
Rösslimatte 6/6A/6C (depot), Thun, and ii) as at 20 June 2011:
Schützengasse 32, Zurich. The total sales price for the two
properties amounts to CHF 12.1 million.
In early February 2011, the Swiss Federal Tax Authorities
approved for PSP Swiss Property Ltd an amount of CHF 659.2
million of capital contributions. The Company discloses such
amount already in the 2010 financial statements (holding bal-
ance sheet) in the new legal reserves account “capital con-
tribution reserves.” This required (apart from bookings within
the legal reserves) a booking of CHF 89.6 million of free re-
serves into legal reserves; therefore, the Board of Directors
proposes to the Annual General Meeting of 1 April 2011 to
approve this booking together with the 2010 financial state-
ments. The capital contribution reserves may be used for tax
exempt repayments to the shareholders in future business
years.
There are no other significant subsequent events to report.
Withdrawal of Tax Reduction by Hungarian
Government
1.141
Magyar Telekom plc (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
37. Events After the Reporting Period
37.1 Announcement of the Hungarian Government on
Intended Withdrawal of Tax Reduction from 2013
On March 1, 2011 the Hungarian Government announced that
as part of its long-term effort to reduce the Hungarian budget
deficit it intends to amend existing law that provides for a re-
duction in corporate tax rates from the current 19% to 10%
starting in 2013. When the law reducing future corporate tax
rates was enacted in 2010, the Group recalculated its deferred
tax balances, resulting in the reversal of net deferred tax lia-
bilities of HUF 14.5 billion (see Note 9.3) in the 2010 income
statement of comprehensive income. The recent announce-
ment of the intended cancellation of the scheduled reduction
of the tax rate from 2013 is expected to cause the recognition
of a substantially higher amount of net deferred tax liabilities
in 2011 and result in a negative impact on deferred tax ex-
pense in 2011 equivalent in magnitude to the positive impact
on net deferred tax expense in 2010.
IFRS ATT 1.141
P1: xxx
ACPA210-01F AICPA AICPA-IFRS-ATT.cls November 8, 2011 13:36
90 IFRS Accounting Trends & Techniques
Early Repayment of Bonds and Declaration of
Taxable Bonus Share Issue to Shareholders
1.142
Silver Fern Farms Limited (Sep 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
32. Events After the Balance Sheet Date
Early Repayment of SFF030 Bond
The SFF030 bond principal of $75m was repaid effective 15
November 2010. This was one month earlier than originally
anticipated given the successful renegotiation of banking fa-
cilities. As a result of repayment of the Bond, the Group delists
from the NZ Debt Exchange.
Taxable Bonus Issue
On 23 November 2010, the Board of Directors resolved to
declare a one for five taxable bonus issue to the New ordi-
nary shareholders. The number of New ordinary shares to be
issued is calculated on all New ordinary shares on issue at
balance date, both fully and partly paid. The issue price is
$1.00 per share and the taxable bonus issue is fully imputed.
Divestiture of Controlling Interest in
Subsidiary, Announcement of Share Buy
Back Program, Received Binding Offer
to Buy Talc Business
1.143
Rio Tinto Limited and Rio Tinto plc (Dec 2010)
NOTES TO THE STATEMENT OF FINANCIAL
POSITION (in part)
48. Events After the Statement of Financial
Position Date
On 4 January 2011, Rio Tinto completed the divestment of
61 per cent of Alcan Engineered Products (AEP) to certain
investment funds affiliated with Apollo Global Management,
LLC (Apollo) and the Fonds Stratégique d’Investissement
(FSI). The terms of the transaction are confidential.
Apollo is now the majority shareholder in AEP with a 51 per
cent stake in a new holding company for AEP, with the FSI
holding 10 per cent. Rio Tinto holds a 39 per cent stake and
will treat its interest in AEP as an equity accounted unit.
On 3 February, Rio Tinto acquired an additional 34,387,776
additional shares in Ivanhoe Mines Ltd. (“Ivanhoe”), by partic-
ipating fully in Ivanhoe’s strategic rights offering, paying a total
of US$477 million and maintaining the Group’s interest in Ivan-
hoe. On 3 February, Rio Tinto also completed the purchase
of ten million shares in Ivanhoe, together with the rights (1.5
million shares) associated with these shares from Citibank,
in accordance with the announcement made on 15 Decem-
ber 2010, paying a total of US$274 million. The transaction
increased Rio Tinto’s ownership of Ivanhoe to 42.1 per cent.
On 10 February 2011, as part of its capital management
programme, the Group announced a share buy back of US$5
billion which, subject to market conditions, is planned for com-
pletion by the end of 2012. At 21 February 2011, 1.725 million
Rio Tinto plc shares had been repurchased and held in trea-
sury at an average price of £45.02 per share, resulting in total
consideration paid of US$125.5 million. No Rio Tinto Limited
shares had been repurchased at 21 February 2011.
On 23 February 2011, Rio Tinto has received a binding
offer from Imerys to acquire its talc business for an enterprise
value of US$340 million. A period of exclusivity with Imerys
has been agreed, and Rio Tinto will respond to this binding
offer following consultation with the relevant European works
councils.
Announcement of Quarterly Dividend
and Bond Issue
1.144
Unilever N.V. and Unilever plc (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
32. Events After the Balance Sheet Date
On 3 February 2011 Unilever announced a quarterly dividend
with the 2010 fourth quarter results of €0.2080 per NV ordi-
nary share and £0.1775 per PLC ordinary share.
On 10 February 2011 Unilever issued a bond composed
of two senior notes: (i) US $500 million 2.75% fixed rate note
which will mature in five years and (ii) US $1,000 million 4.25%
fixed rate note which will mature in ten years.
Increase in Shareholding in Associate, Sale
and Leaseback, and Sale of Building
1.145
China Yuchai International Limited (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
38. Events After the Balance Sheet Date (in part)
(c) Changes in Shareholding of HLGE
With the conversion of 17,234,000 Existing HLGE RCPS
B into HLGE ordinary shares on the Mandatory Conver-
sion Date, the Company’s shareholding interest in HLGE in-
creased from 47.4% to 48.4% with effect from March 24, 2011
upon receipt of regulatory approval.
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(e) Sale and Leaseback Agreement
On January 2011, Yuchai terminated the sale and lease-
back agreement signed with CDB Leasing Company Limited
(“CDB”) in 2009. YAMC repaid approximately RMB28 million
in a lump sum to CDB for redemption of the full ownership of
the finance lease assets.
(f) Sale of Guilin Office Building
On April 27, 2011, Guangxi Yulin Hotel Company Limited en-
tered into a sale and purchase agreement with a third party
to sell its office building located in Guilin, Guangxi province
for a total consideration of Rmb 120 million, where Rmb 60
million of down payment will be paid within 15 working days
from the contract date, and the remaining Rmb 60 million will
be paid by November 30, 2011.
IAS 21, THE EFFECTS OF CHANGES
IN FOREIGN EXCHANGE RATES
IFRSs Overview and Comparison
to U.S. GAAP
1.146 IAS 21, The Effects of Changes in Foreign Exchange
Rates, establishes the accounting for transactions and carry-
ing amounts in foreign currencies, except derivative trans-
actions and carrying amounts within the scope of IAS 39.
An entity should also apply IAS 21 in translating the results
and financial position of foreign operations that an entity
includes in its financial statements by consolidation, propor-
tionate consolidation, or the equity method.
1.147 IAS 21 includes the following definitions relevant to
understanding the required accounting:
Functional currency. Currency of the primary economic
environment in which an entity operates.
Presentation currency. Currency in which the financial
statements are presented. (The presentation currency is
sometimes referred to as the reporting currency.)
Monetary items. Units of currency that an entity holds or
assets or liabilities that an entity expects to receive or
pay in fixed or determinable units of currency.
Foreign operation. Subsidiary, associate, jointly con-
trolled entity, or branch of the entity preparing financial
statements. The foreign operation bases or conducts its
activities in a country or currency different from that of
the reporting entity.
Net investment in a foreign operation. Reporting entity’s
interest in the foreign operation’s net assets.
1.148 IAS 21 does not apply to either the presentation of
foreign currency transactions in the statement of cash flows
or the translation of cash flows of a foreign operation. An
entity should apply the requirements of IAS 7, Statement of
Cash Flows, to these issues.
Recognition and Measurement
IFRSs
1.149 On initial recognition, IAS 21 requires an entity to
measure a foreign currency transaction in its functional cur-
rency by applying the spot exchange rate between the foreign
and functional currencies at the date the transaction qualifies
for recognition under IFRSs (transaction date).
1.150 At subsequent balance sheet dates, when the entity
keeps its books and records in its functional currency, it
should translate any foreign currency monetary items into
the functional currency at the closing rate. The method an
entity should use to translate nonmonetary items depends on
its measurement basis. When the item is carried at histori-
cal cost, an entity should translate the carrying value at the
exchange rate on the date of the original transaction. When
the item is carried at fair value, an entity should translate the
carrying value at the date it determined fair value. IAS 21
includes additional guidance for situations in which multiple
exchange rates prevailed or no exchange rate is available.
1.151 When an entity keeps its books and records in a cur-
rency other than its functional currency, IAS 21 requires the
entity to translate all amounts into the functional currency
when preparing its financial statements (that is, monetary
items are translated at the closing rate and nonmonetary items
are translated at either the historical exchange rate at the date
of recognition [if measured at historical cost] or the exchange
rate at the date when the fair value was determined [if mea-
sured at fair value]).
1.152 On translation or settlement of a monetary item, an
entity should recognize in profit or loss in the period in which
they arise any exchange differences arising from differences
in exchange rates from those used previously, except those
that form part of the entity’s net investment in a foreign op-
eration. An entity should recognize the latter type of foreign
exchange difference in its consolidated financial statements in
other comprehensive income and then should reclassify these
differences to profit and loss on disposal of the net invest-
ment. Such differences are recognized either in the separate
financial statements of the entity or the individual financial
statements of the foreign operation.
1.153 Individual IFRSs may require a gain or loss on a par-
ticular nonmonetary item is to be recognized in other com-
prehensive income rather than profit or loss (for example,
revaluations of property, plant, and equipment carried at a
revalued amount). In these cases, an entity should also record
the effect of any foreign exchange difference in other com-
prehensive income. However, when an entity recognizes a
gain or loss on a nonmonetary item in profit or loss, it should
also recognize any foreign exchange difference in profit or
loss.
1.154 When an entity’s functional currency changes, an en-
tity should apply the requirements of IAS 21 prospectively
from the date of change.
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1.155 When an entity uses a presentation currency different
from its functional currency, IAS 21 requires it to apply the
following translation procedures:
a. Translate all assets and liabilities for each statement
of financial position presented (including comparative
items) at the closing rate on the balance sheet date.
b. Translate all income and expenses for each statement
of comprehensive income or separate income statement
presented (including comparatives) at the exchange rate
on the transaction date (or a rate that approximates these
rates).
c. Recognize resulting exchange differences in other com-
prehensive income.
An entity that does not apply this translation method to these
statements is not in compliance with IFRSs.
1.156 When exchange differences relate to a partially-
owned foreign operation, the entity should allocate the ap-
plicable proportion of these differences to the noncontrolling
interest.
1.157 IAS 21 requires different procedures for translating
the financial statements of an entity whose functional cur-
rency is that of a hyperinflationary economy.
Author’s Note
See section 10, “Reporting in Hyperinflationary Eco-
nomies,” for a discussion of the requirements applica-
ble to hyperinflationary economies, including illustra-
tive examples.
1.158 With respect to acquisition of a foreign operation, an
entity should account for any goodwill or fair value adjust-
ments as assets or liabilities of the operation measured in
the operation’s functional currency. An entity should use the
closing rate to translate these assets and liabilities into its
presentation currency. On disposal of the foreign operation,
an entity should reclassify the cumulative foreign exchange
differences from equity to profit or loss at the same time it
recognizes any gain or loss on disposal. IAS 21 also requires
an entity to account for loss of control; significant influence;
and joint control of subsidiaries, associates, and jointly con-
trolled entities, respectively, even when the entity retains an
interest, as disposals for the purpose of reclassification of the
related cumulative foreign exchange difference.
U.S. GAAP
1.159 Like IFRSs, FASB ASC 830-10-15-3 requires an en-
tity to apply the functional currency approach to all foreign
currency transactions in its financial statements and to trans-
late all foreign currency (a currency different from its report-
ing currency) financial statements that are incorporated in
the entity’s financial statements, whether by consolidation,
combination, or the equity method of accounting.
1.160 Like IFRSs, the FASB ASC glossary defines an en-
tity’s functional currency as the currency of the primary eco-
nomic environment in which the entity operates; normally,
that is the currency of the environment in which an entity pri-
marily generates and expends cash. Paragraphs 3–6 of FASB
ASC 830-10-45 and paragraphs 3–7 of FASB ASC 830-10-
55 provide similar guidance as that provided in IFRSs for
determining an entity’s functional currency.
1.161 For foreign currency transactions, FASB ASC 830-
20-30-1, like IFRSs, requires an entity to recognize the assets,
liabilities, revenue, expenses, gains, and losses arising from
the transaction in the entity’s functional currency by trans-
lating each transaction into the functional currency at the
exchange rate in effect on the recognition date. FASB ASC
830-20-30-2 contains guidance similar to IAS 21 when no
exchange rate exists. FASB ASC 830-10-55 also provides
implementation guidance, including the use of averages and
methods of approximation. FASB ASC 830-30-S99-1 pro-
vides guidance to SEC registrants when multiple foreign cur-
rency exchange rates exist.
1.162 Like IFRSs, FASB ASC 830-20-35-1 requires an en-
tity to include a change in exchange rates between the func-
tional currency and the currency in which the transaction is
denominated in income for the period of the change. Like
IFRSs, FASB ASC 830-10 distinguishes between monetary
and nonmonetary items. However, unlike IFRSs, FASB ASC
830-10-45-18 provides specific nonmonetary balance sheet
items and related revenue, expenses, gain, and loss accounts
that an entity should remeasure at historical rates.
1.163 Like IFRSs, paragraphs 1–2 of FASB ASC 830-20-35
require that an entity adjust the carrying amounts of foreign
currency balances to reflect the current exchange rate at the
date of the financial statements and should generally recog-
nize these gains or losses in net income. However, FASB ASC
830-20-35-3 denotes that an entity should not recognize in
net income gains and losses on foreign currency transactions
that are designated and effective hedges of a net investment
in a foreign entity or intra-entity transactions in which settle-
ment is not planned or anticipated in the foreseeable future
(net investment) and the entities that are parties to the trans-
action are included in the consolidated financial statements
of the reporting entity by consolidation, combination, or the
equity method.
1.164 Like IFRSs, FASB ASC 830-30-45-3 requires an en-
tity to translate all financial statement items using a current
exchange rate, as follows:
• Assets and liabilities should be translated at the ex-
change rate at the balance sheet date.
• Revenues, expenses, gains, and losses should be trans-
lated at the exchange rate at the dates on which those
items were recognized.
Like IFRSs, FASB ASC 830-30-45-12 requires an entity
to include translation adjustments in other comprehensive
income.
1.165 Unlike IFRSs, the guidance in FASB ASC 830-30-
45-3 also applies to accounting allocations (for example, de-
preciation, cost of goods sold) and requires translation at the
current exchange rates applicable to the dates those alloca-
tions are included in revenues and expenses (that is, not the
rates on the dates the related items originated). Like IFRSs,
paragraphs 10–11 of FASB ASC 830-10-55 permit the use
of an average rate, but provide more guidance than IAS 21
on how an entity should determine the average.
1.166 Like IFRSs, FASB ASC 830-10-45-17 also requires
that, when the entity does not maintain its books and records
in its functional currency, it should remeasure the transaction
in the functional currency before translating to the report-
ing currency. Although IFRSs do not use the term remea-
sure, both IFRSs and FASB ASC require this process so as
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to produce financial statements as if the entity had always
accounted for its transactions in the functional currency.
1.167 FASB ASC 830-10 has specific guidance for an en-
tity whose functional currency is that of a hyperinflationary
economy. However, this guidance is significantly different
than that required by IFRSs.
1.168 Like IFRSs, FASB ASC 830-10-15-7 permits the
translation of financial statements from one currency to an-
other for purposes other than consolidation, combination, or
the equity method but does not provide guidance on the ap-




1.169 An entity should disclose the amount of foreign ex-
change differences recognized in profit or loss, except those
from financial instruments carried at fair value through profit
or loss, in accordance with IAS 39, and any net foreign ex-
change differences recognized in other comprehensive in-
come. An entity should also disclose a reconciliation of the
beginning and ending balances in the related component of
equity in which such differences are accumulated.
1.170 When an entity’s presentation currency is different
from its functional currency, it should disclose this fact, its
functional currency, and the reason for using a different pre-
sentation currency.
1.171 When an entity changes its own functional currency
or the functional currency of a significant foreign operation,
it should disclose this fact and the reason for the change.
1.172 An entity sometimes chooses to display its financial
statements or other financial statement information in a cur-
rency that differs from either the presentation or functional
currency for the convenience of readers. In this case, an entity
should clearly identify that this is supplemental information
to distinguish it from the information presented in compli-
ance with IFRSs and should disclose both the display and
functional currencies and translation method used to achieve
the display amounts.
U.S. GAAP
1.173 Unlike IFRSs, FASB ASC 830-20-45-1 requires an
entity to disclose the aggregate transaction gain or loss in-
cluded in net income, either in the statements or the notes.
1.174 Like IFRSs, paragraphs 18–20 of FASB ASC 830-
30-45 require an entity to provide an analysis (reconciliation)
of the changes in the cumulative translation adjustment ac-
count (equity), either in a statement or the notes, and provide
guidance to the entity on the content of this analysis. Unlike
IFRSs, FASB ASC 830-30-45-20 provides a list of the mini-
mum line items that an entity should disclose in this analysis,
including the following:
• Beginning and ending amounts of cumulative transla-
tion adjustments
• Aggregate adjustment for the period resulting from
translation adjustments and gains and losses from cer-
tain hedges and intraentity balances
• Amount of income taxes for the period allocated to
translation adjustments
• Amounts transferred from cumulative translation ad-
justments and included in determining net income for
the period as a result of the sale or complete or substan-
tially complete liquidation of an investment in a foreign
entity
1.175 Unlike IFRSs, FASB ASC 830-20-50-2, with respect
to foreign currency transactions, and FASB ASC 830-30-50-
2, with respect to foreign currency translation, advise that
disclosure of (a) a rate change that occurs after the balance
sheet date of the reporting entity’s financial statements or,
after the date of the foreign currency statements of a foreign
entity, if consolidated, combined, or accounted for by the eq-
uity method in the financial statements of the reporting entity,
and (b) the effects of the rate change on any unsettled foreign
currency transactions may be necessary if these effects are
significant. FASB ASC 830-20-50-2 further explains that in
some cases, it may not be practicable for the entity to de-
termine the changes to unsettled transactions, and the entity
should state that fact. FASB ASC 830-20-50-3 also explicitly
encourages entities to supplement the required disclosures
with discussion of the potential effects of rate changes on
their operating results.
Presentation and Disclosure Excerpts
Author’s Note
In the excerpts that follow, the statements of recognized
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Accounting Policy Disclosure
1.176
Alesco Corporation Limited (May 2010)
STATEMENTS OF COMPREHENSIVE INCOME (in part)











(Loss)/profit for the period 23 (124,301) (12,789) (104,188) (40,182)
Other comprehensive income
Foreign currency translation differences on translating foreign subsidiaries 22 22 1,363 — —














Note $000 $000 $000 $000 $000 $000
Balance at 1 June 2009 513,262 3,196 (2,794) 3,974 33,799 551,437
Total comprehensive income for the period
(Loss)/profit for the period 2 — — — — (124,301) (124,301)
Other comprehensive income
Foreign exchange translation differences on
translating foreign subsidiaries 22 — 22 — — — 22
Effective portion of changes in fair value of cash
flow hedges, net of tax — — 919 — — 919
Net change in fair value of cash flow hedges
transferred to profit or loss, net of tax — — 3,059 — — 3,059
Total other comprehensive income — 22 3,978 — — 4,000
Total comprehensive income for the period — 22 3,978 — (124,301) (120,301)
Transactions with owners, recorded directly in
equity contributions by and distributions to owners
Issue of ordinary shares 21 3,405 — — — — 3,405
Shares granted as part of Total Eden McCracken’s
deferred consideration 21 3,740 — — — — 3,740
Equity settled share-based payments 22 — — — 693 — 693
Senior executive share loan plan adjustment 22 — — — 1,665 — 1,665
Dividends to equity holders 24 — — — — (13,099) (13,099)
Total transactions with owners 7,145 — — 2,358 (13,099) (3,596)
Balance at 31 May 2010 520,407 3,218 1,184 6,332 (103,601) 427,540
The notes on pages 69 to 142 are an integral part of these
consolidated financial statements.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)




Transactions in foreign currencies are translated to the func-
tional currency of the Group at the foreign exchange rate ruling
at the date of the transaction. Monetary assets and liabilities
denominated in foreign currencies at the reporting date are
translated to the functional currency at the foreign exchange
rate at that date. The foreign currency gain or loss on mon-
etary items is the difference between amortised cost in the
functional currency at the beginning of the period, adjusted
for effective interest and payments during the period, and the
amortised cost in foreign currency translated at the exchange
rate at the end of the period. Non-monetary assets and lia-
bilities denominated in foreign currencies that are measured
at fair value are translated to the functional currency at the
exchange rate at the date that the fair value was determined.
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Change in Functional Currency
1.177
Deutsche Bank Aktiengesellschaft (Dec 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME
In € m 2010 2009 2008
Net income (loss) recognized in the income statement 2,330 4,958 (3,896)
Actuarial gains (losses) related to defined benefit plans, net of tax 106 (679) (1)
Other comprehensive income
Unrealized net gains (losses) on financial assets available for sale:(1)
Unrealized net gains (losses) arising during the period, before tax 83 523 (4,516)
Net (gains) losses reclassified to profit or loss, before tax 39 556 (666)
Unrealized net gains (losses) on derivatives hedging variability of cash flows:(1)
Unrealized net gains (losses) arising during the period, before tax (78) 118 (263)
Net (gains) losses reclassified to profit or loss, before tax 4 6 2
Unrealized net gains (losses) on assets classified as held for sale, before tax(2) (25) – –
Foreign currency translation:(1)
Unrealized net gains (losses) arising during the period, before tax 920 40 (1,144)
Net (gains) losses reclassified to profit or loss, before tax (6) 11 (3)
Unrealized net gains (losses) from equity method investments(1) (26) 85 (15)
Tax on net gains (losses) in other comprehensive income 240 (254) 731
Other comprehensive income, net of tax 1,151(3) 1,085(4) (5,874)(5)
Total comprehensive income, net of tax 3,587 5,364 (9,771)
Attributable to:
Noncontrolling interests 4 (1) (37)
Deutsche Bank shareholders 3,583 5,365 (9,734)









Common shares (no par value) 1,1589 —
Additional paid-in capital 14,830 —
Retained earnings(1) 24,056 2,310
Common shares in treasury, at cost (48) —
Equity classified as obligation to
purchase common shares — —
Unrealized net gains (losses) on
financial assets available for sale,
net of applicable tax and other(3) (186) 73
Unrealized net gains (losses) on
derivatives hedging variability of
cash flows, net of tax(3) (134) (45)
Unrealized net gains (losses) on
assets classified as held for sale,
net of tax — (11)
Foreign currency translation, net
of tax(3,4) (3,521) 1,188
Unrealized net gains (losses) from
equity method investments 61 (26)
Accumulated other comprehensive
income, net of tax (3,780) 1,179
Total shareholders’ equity 36,647 3,489
Noncontrolling interests 1,322 (8)
Total equity 37,969 3,481
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
01—Significant Accounting Policies (in part)
Change in the Functional Currency of a Significant Operation
On January 1, 2010, the functional currency of Deutsche
Bank Aktiengesellschaft London Branch (‘London Branch’)
and certain other London-based subsidiaries was changed
from pound sterling to euro.
These entities’ functional currency had previously been de-
termined to be pound sterling on the basis that the currency
of their primary economic environment was based on pound
sterling. However during 2009 it was determined that the Lon-
don Branch’s operating environment, mix of business and bal-
ance sheet composition had gradually changed over time.
To better reflect this change, London Branch management
undertook to manage their operations in euro from January
1, 2010. To implement this decision, procedures were put in
place for London Branch to hedge all non-euro exposures,
sell profits into euro and report internally in euro.
The effect of the change in functional currency to euro was
applied prospectively in these consolidated financial state-
ments. The Group translated all items into the new functional
currency using the exchange rate as at January 1, 2010. Ex-
change differences arising from the translation of the foreign
operation previously recorded in other comprehensive income
were not reclassified to profit or loss and remain in other com-
prehensive income until the entities are disposed of or sold.
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IAS 21 Disclosures With Convenience
Translation
1.178
Sterlite Industries (India) Limited (Mar 2010)
CONSOLIDATED STATEMENTS OF INCOME
(Indian Rupees in millions except share or per share amounts
unless otherwise stated)
For the Year Ended March 31
2009 2010 2010
Notes (Rs. in Millions) (Rs. in Millions)
(US Dollars in
Millions) (Note 2)
Revenue 5 212,192 244,903 5,448.3
Cost of sales (165,097) (181,928) (4,047.3)
Gross profit 47,095 62,975 1,401.0
Other operating income 3,750 1,907 42.4
Distribution expenses (3,388) (3,022) (67.2)
Administration expenses (4,367) (8,026) (178.6)
Operating profit 43,090 53,834 1,197.6
Investment and other income 6 18,772 13,811 307.3
Finance and other costs 7 (6,244) 214 4.8
Share in Consolidated (loss)/profit of associate 10 (3,160) 2,051 45.6
Profit before tax 52,458 69,910 1,555.3
Income tax expense 8 (7,782) (13,247) (294.7)
Profit for the year 44,676 56,663 1,260.6
Profit attributable to:
Equity holders of the parent 32,228 39,263 873.5
Minority interest 12,448 17,400 387.1
Earnings per share 29
Basic 11.37 12.27 0.3
Diluted 11.37 12.03 0.3
Weighted average number of equity shares used in
computing earnings per share
Basic 2,833,583,490 3,199,826,061 3,199,826,061
Diluted 2,833,583,490 3,236,000,281 3,236,000,281
The accompanying notes are an integral part of these con-
solidated financial statements.
The Company presents the statement of income disclosing
expenses by function. The statement of income disclosing
expenses by nature is presented in Note 34 (c).
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME
(Indian Rupees in millions except share or per share amounts
unless otherwise stated)
For the Year Ended March 31
2009 2010 2010
(Rs. in Millions) (Rs. in Millions)
(US Dollars in
Millions) (Note 2)
Profit for the year 44,676 56,663 1,260.6
Other comprehensive (loss)/income, net of tax:
Exchange differences on translation of foreign operations (327) 1,295 28.8
(Loss)/gain on available-for-sale financial investments (79) 318 7.1
Cash flow hedges(∗) 398 121 2.7
Share in consolidated other comprehensive (loss)/income of associate(∗) (582) 799 17.7
Total other comprehensive (loss)/income for the year, net of tax (590) 2,533 56.3
Total comprehensive income 44,086 59,196 1,316.9
Total comprehensive income attributable to:
Equity holders of the parent 31,708 41,724 928.2
Minority interest 12,378 17,472 388.7
44,086 59,196 1,316.9
(∗) Refer to Note 8 for tax related to each component of other comprehensive (loss)/income
Refer to Note 34(a) for amounts reclassified into profit for the year out of other comprehensive (loss)/income.
IFRS ATT 1.178
P1: xxx
ACPA210-01F AICPA AICPA-IFRS-ATT.cls November 8, 2011 13:36
97Section 1: General Topics and Related Disclosures
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION
(Indian Rupees in millions except share or per share amounts
unless otherwise stated)
As at April 1 As at March 31
2008 2009 2010 2010





Property, plant and equipment 9 121,699 166,528 226,629 5,041.8
Leasehold land prepayments 483 967 1,220 27.1
Investment in associate 10 19,085 15,043 4,621 102.8
Financial assets investments 11 1,123 1,044 1,362 30.3
Other non-current assets 12 1,274 9,651 10,227 227.5
Total non-current assets 143,664 193,233 244,059 5,429.5
Current assets
Inventories 13 33,373 24,608 29,822 663.4
Current tax asset 20 109 660 14.7
Trade and other receivables 14 27,780 32,311 118,907 2,645.3
Short term investments 15 155,964 188,067 211,022 4,694.6
Derivative financial assets 25 1,627 1,538 115 2.6
Restricted cash and cash equivalents 16 59 2,011 60 1.3
Cash and cash equivalents 17 12,363 2,701 2,021 45.0
Total current assets 231,186 251,345 362,607 8,066.9
Assets held for sale 18 — — 188 4.2
Total assets 374,850 444,578 606,854 13,500.6
Liabilities
Current liabilities
Short-term borrowings 19 10,190 20,202 19,121 425.4
Acceptances 20 27,033 35,829 29,901 665.2
Trade and other payables 21 22,831 27,243 35,095 780.8
Derivative financial liabilities 25 638 2,639 669 14.9
Provisions 22 687 737 748 16.7
Current tax liabilities 1,087 676 863 19.1
Total current liabilities 62,466 87,326 86,397 1,922.1
Net current assets 168,720 164,019 276,210 6,144.8
Non-current liabilities
Long-term borrowings 19 9,949 14,384 43,578 969.4
Deferred tax liabilities 8 16,141 15,172 17,955 399.5
Retirement benefits 24 647 711 865 19.2
Provisions 22 322 348 382 8.5
Other non-current liabilities 23 6,332 6,034 5,689 126.6
Total non-current liabilities 33,391 36,649 68,469 1,523.2
Total liabilities 95,857 123,975 154,866 3,445.3
Net assets 278,993 320,603 451,988 10,055.3
Equity
Share capital 27 1,417 1,417 1,681 37.4
Securities premium 106,532 106,532 182,797 4,066.7
Other components of equity (377) 439 2,723 60.6
Retained earnings 113,232 142,145 177,971 3,959.2
Equity attributable to equity holders of the parent 220,804 250,533 365,172 8,123.9
Minority interest 58,189 70,070 86,816 1,931.4
Total equity 278,993 320,603 451,988 10,055.3
IFRS ATT 1.178
P1: xxx
ACPA210-01F AICPA AICPA-IFRS-ATT.cls November 8, 2011 13:36
98 IFRS Accounting Trends & Techniques
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Indian Rupees in millions except share or per share amounts
unless otherwise stated)
For the Year Ended March 31
2009 2010 2010
(Rs. in Millions) (Rs. in Millions)
(US Dollars in
Millions) (Note 2)
Cash Flows From Operating Activities
Profit before taxes 52,458 69,910 1,555.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 8,024 8,061 179.3
Provision for doubtful debts/advances 12 46 1.0
Fair value gain on financial assets held for trading (2,254) (2,741) (61.0)
Profit on sale of fixed asset, net (10) (104) (2.3)
Share in consolidated (profit)/loss of associate 3,160 (2,051) (45.6)
Impairment of guarantees 137 — —
Exchange (gains)/loss, net 2,159 (6,074) (135.1)
Gain on fair valuation of conversion option — (587) (13.0)
Interest and dividend income (13,779) (13,076) (290.9)
Interest expenses 4,688 3,910 87.0
Changes in assets and liabilities:
Decrease in trade and other receivables 12,843 3,008 66.9
Decrease/(Increase) in inventories 8,767 (5,167) (115.0)
(Increase)/decrease in other current and non-current assets (6,629) 1,313 29.2
(Decrease)/increase in trade and other payable (8,520) 3,410 75.9
Increase/(Decrease) in other current and non-current liabilities 1,759 (1,482) (33.0)
Proceeds from short term investments 984,841 1,231,265 27,391.9
Purchases of short term investments (976,457) (1,270,518) (28,265.1)
Cash generation from operation 71,199 19,123 425.5
Interest paid (3,897) (5,597) (124.5)
Interest received 4,420 6,460 143.7
Dividend received 9,030 5,966 132.7
Income tax paid (8,649) (11,703) (260.3)
Net cash from operating activities 72,103 14,249 317.1
Cash Flows from Investing Activities
Purchases of property, plant and equipment (40,623) (61,875) (1,376.5)
Proceeds from sale of property, plant and equipment 66 323 7.1
Redemption of investments in associate — 13,342 296.8
Loans repaid by related parties — 6,850 152.4
Loans to related parties (15,381) (96,848) (2,154.5)
Proceeds from short term deposits 13,354 55,811 1,241.6
Purchases of short term deposits (50,277) (37,136) (826.2)
Net changes in restricted cash and cash equivalents (1,952) 1,951 43.4
Net cash used in investing activities (94,813) (117,582) (2,615.9)
Cash Flows from Financing Activities
Proceeds from issuance of equity shares, net — 76,529 1,702.5
Proceeds from Convertible notes — 23,133 514.6
Proceeds from/(repayment of) working capital loan, net (3,588) (1,194) (26.6)
Proceeds from/(repayment of) acceptances, net 5,454 (1,386) (30.9)
Repayment of other short term borrowings — (4,500) (100.1)
Proceeds from other short-term borrowings 4,500 5,626 125.2
Proceeds from long-term borrowings 14,790 13,380 297.7
Repayment of long-term borrowings (3,902) (5,103) (113.5)
Payment of dividends to equity holders of the parent, including dividend tax (3,315) (3,437) (76.5)
Payment of dividends to minority, including dividend tax (497) (726) (16.1)
Net cash provided by financing activities 13,442 102,322 2,276.3
Effect of exchange rate changes on cash and cash equivalents (394) 331 7.4
Net (decrease) in cash and cash equivalents (9,662) (680) (15.1)
Cash and cash equivalents at the beginning of the year 12,363 2,701 60.1
Cash and cash equivalents at the end of the year 2,701 2,021 45.0
Supplementary disclosure of non-cash investing activities:
Payables for purchase of property, plant and equipment 14,383 18,363 408.5
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CONSOLIDATED STATEMENTS OF CHANGES IN
EQUITY (in part)
(Indian Rupees in millions except share or per share amounts
unless otherwise stated)





















Balance as at March 31, 2009 1,417 106,532 (399) 8 830 142,145 250,533 70,070 320,603
Balance as at April 1, 2009 1,417 106,532 (399) 8 830 142,145 250,533 70,070 320,603
Profit for the year 39,263 39,263 17,400 56,663
Exchange differences on
translation of foreign operations — — 1,295 — — — 1,295 — 1,295
Movement in available for sale
financial investments — — — 318 — — 318 — 318
Net movement in fair value of
cash flow hedges, net of tax(∗) — — — — 49 — 49 72 121
Share of other comprehensive
income of associate, net of
tax(∗) — — — — 799 — 799 — 799
Total comprehensive income
for the year — — 1,295 318 848 39,263 41,724 17,472 59,196
Shares issued 264 76,265 — — — — 76,529 — 76,529
Share in associate towards
adjustment for amount
transferred to initial carrying
amount of property, plant and
equipments — — — — (177) — (177) — (177)
Dividend paid including tax on
dividend (3,437) (3,437) (726) (4,163)
Balance as at March 31, 2010 1,681 182,797 896 326 1,501 177,971 365,172 86,816 451,988
Balance as at March 31, 2010
(in US dollars in millions) 37.4 4,066.7 19.9 7.3 33.4 3,959.2 8,123.9 1,931.4 10,055.3
(∗) Refer to Note 8 for taxes related to each component of the other comprehensive income
Refer to Note 34(a) for amount reclassified to the statement of income from other comprehensive income.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Basis of Preparation of Financial Statements
(in part)
Convenience Translation
The consolidated financial statements are presented in In-
dian Rupee, the functional and presentational currency of the
Company. Solely for the convenience of readers, the consoli-
dated financial statements as at and for the year ended March
31, 2010 have been translated into US dollars (“$”) at the noon
buying rate of $1.00 = Rs. 44.95 in the City of New York for
cable transfers of Indian Rupee as certified for customs pur-
poses by the Federal Reserve Bank of New York on March
31, 2010. No representation is made that the Indian Rupee
amounts represent US dollar amounts or have been, could
have been or could be converted into US dollars at such a
rate or any other rate.
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IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
IAS 20, Accounting for Government Grants and Dis-
closure of Government Assistance, was amended by
IFRS 9. IFRS 9 amends paragraph 10A of IAS 20 af-
fecting recognition and measurement of government
loans at below market rates, requiring such loans to be
measured in accordance with IFRS 9 rather than IAS
39. This change is effective for annual periods begin-
ning on or after 1 January 2013. However, entities that
adopt IFRS 9 would apply the amendment to IAS 20
at the same time.
1.179 IAS 20 establishes the accounting for government
grants and disclosures of government grants and other forms
of government assistance. IAS 20 does not address govern-
ment grants included in the scope of IAS 41, Agriculture;
government participation in ownership of the entity; govern-
ment assistance in the form of tax benefits; or special prob-
lems associated with changing prices.
1.180 IAS 20 defines a government grant to be government
assistance in the form of transfers of resources to an entity
in return for past or future compliance with certain condi-
tions related to the entity’s operating activities, excluding
assistance that cannot reasonably be valued and transactions
that cannot be distinguished from the entity’s ordinary activ-
ities. Government assistance is defined as actions designed
to provide an economic benefit specific to a qualifying en-
tity or entities, excluding benefits provided indirectly through
general governmental actions (such as trading constraints on
competitors). The term governments includes governments,
governmental agencies, and similar entities, whether local,
regional, national, or international.
Recognition and Measurement
IFRSs
1.181 IAS 20 prohibits an entity from recognizing a gov-
ernment grant, including a nonmonetary grant at fair value,
unless the entity is reasonably assured that it will receive the
grant and comply with the required conditions.
1.182 An entity should treat a forgivable loan from a gov-
ernment as a government grant when there is reasonable as-
surance that the entity will meet the terms for forgiveness of
the loan.
1.183 An entity should treat the benefit from receiving a
government loan at a below market rate as a government
grant. An entity should measure the initial carrying value of
the loan in accordance with IAS 39 and the benefit received
as the difference between the initial carrying value and the
loan proceeds. IAS 20 requires the entity to consider any
conditions or obligations it has met or should meet in the
future when determining costs associated with the benefit
received.
1.184 IAS 20 requires an entity to recognize the benefit from
a government grant in profit or loss on a systematic basis over
the periods that it incurs the expected costs related to the ben-
efits from the grant. IAS 20 states that an entity would usually
recognize benefits of grants related to depreciable assets in
proportion to the depreciation expense recorded on these as-
sets. An entity would recognize the benefits of other grants
when it incurs the costs and meets the grant’s conditions.
1.185 IAS 20 requires an entity to recognize in profit or loss
a grant related to costs it incurred in the past or to which no
conditions are attached when that grant is receivable.
1.186 An entity may recognize a nonmonetary grant at ei-
ther fair value or a nominal amount.
1.187 SIC 10, Government Assistance—No Specific Rela-
tion to Operating Activities, clarifies that government assis-
tance can meet the definition of a government grant even
when the government does not place conditions on an en-
tity’s operations beyond a requirement to operate in specific
geographic areas or industry sectors. SIC 10 does not permit
an entity to recognize such grants directly in equity.
1.188 If a government grant becomes repayable, an entity
should account for the change prospectively as a change in
accounting estimate, in accordance with IAS 8. To the extent
the repayment exceeds the carrying value of a related liabil-
ity, or if no liability exists, an entity should recognize the
difference in profit or loss immediately. When the repayment
relates to a depreciable asset, an entity should increase the
carrying value of the asset or the related deferred income by
the amount repayable and recognize immediately in profit or
loss the cumulative additional depreciation that would have
been recognized if it had not received the grant. IAS 20 notes
that such repayment may be an indicator of asset impairment.
U.S. GAAP
1.189 Unlike IFRSs, FASB ASC does not include guidance
on recognition, measurement, presentation, or disclosure of
government grants or assistance, except for those received by
not-for-profit entities and entities in regulated industries.
1.190 Without specific guidance to the contrary, FASB ASC
would require an entity to treat a loan from the government in
the same way as a loan from a private sector entity. Therefore,
like IFRSs, an entity would most likely impute interest on
loans made at below market rates.
1.191 In the specific implementation guidance on nonre-
ciprocal transfers between an entity and counterparties other
than its owners, FASB ASC 845-10-05-5 includes the ex-
ample of a contribution of land by a governmental unit for
construction of productive facilities by an entity. FASB ASC
845-10-30-1 states that for exchanges of nonmonetary assets,
an entity should measure the asset received at its fair value,
unless the fair value of the asset given up is more clearly
evident. In cases of government grants of nonmonetary as-
sets, the asset is transferred in exchange for future services;
hence, it is more likely that the fair value of the asset received
is more clearly evident. Unlike IFRSs, FASB ASC does not
permit an entity to measure a nonmonetary government grant
and related asset at nominal amount.
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Presentation
IFRSs
1.192 An entity may present government grants in the state-
ment of financial position either as deferred income or a re-
duction of the carrying value of the related asset.
1.193 IAS 20 suggests that it would be appropriate for an
entity to show cash flows from government grants separately
in the statement of cash flows even when the grant is presented
in the balance sheet as a reduction of the related asset.
1.194 With respect to the statement of comprehensive in-
come, an entity may recognize the income from the grant in
the line item “other income” either as part of profit or loss or
as a reduction of the related expense.
1.195 IAS 1 does not require an entity to present govern-
ment grants separately in the financial statements, unless the
effect is material to an income or expense item.
U.S. GAAP
1.196 FASB ASC does not include specific presentation re-
quirements for government grants.
Disclosure
IFRSs
1.197 IAS 20 requires an entity to disclose the following
information about government grants and, when appropriate,
government assistance that does not meet the definition of a
grant:
• Accounting policy and presentation methods adopted
• Nature and extent of such grants recognized and an in-
dication of other forms of government assistance that
directly benefit the entity
• Unfulfilled conditions and contingencies related to rec-
ognized grants
1.198 When a grant is recognized in profit or loss when it
is receivable, an entity should disclose the circumstances of
the grant so users understand why immediate recognition was
appropriate.
U.S. GAAP
1.199 FASB ASC does not include any specific disclosure
requirements for government grants.
Presentation and Disclosure Excerpts
Initial Recognition at Nominal Amount
1.200
Straumann Holding AG (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2.4 Summary of Significant Accounting Policies
(in part)
Government Grants
Government grants are recognized where there is a reason-
able assurance that the grant will be received and all attaching
conditions will be complied with. When the grant relates to an
expense item, it is recognized as income over the period nec-
essary to match the grant on a systematic basis to the costs
it is intended to compensate. Where the grant relates to an
asset, it is recognized as deferred income and released to
income in equal annual amounts over the expected useful life
of the related asset.
Where the Group receives non-monetary grants, the assets
and grants are recorded at nominal amounts and released to
profit or loss over the expected useful life of the relevant assets
by equal annual instalments.
14. Other Liabilities (Non-Current)
(In CHF 1,000) 2010 2009
Other long-term employee benefits 1,952 —
Government grants 1,777 2,146
Rent payable 1,054 968
Unpaid purchase price consideration 950 1,517
Other 1,158 1,116
Total other liabilities 6,891 5,747
Government grants relate to grants recognized in Germany in
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Initial Recognition as Reduction of Carrying
Value of Depreciable Assets
1.201
Telecom Corporation of New Zealand Limited
(Jun 2010)
STATEMENT OF FINANCIAL POSITION (in part)
As at 30 June 2010, 2009 and 2008
Group Parent
2010 2009 2008 2010 2009 2008
Restated Restated
As at 30 June Notes NZ$M NZ$M NZ$M NZ$M NZ$M NZ$M
Non-Current Assets
Long-term investments 13 276 267 278 8,791 9,287 9,262
Long-term receivables 11 31 — — — — —
Deferred tax assets 19 — — — — 4 —
Long-term derivative assets 10 51 69 48 — — —
Intangible assets 14 1,106 953 990 — — —
Property, plant and equipment 15 4,274 4,288 3,984 — — —
Total non-current assets 5,738 5,577 5,300 8,791 9,291 9,262
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1. Statement of Accounting Policies
Specific Accounting Policies (in part)
Government Grants
Government grants are recognised in earnings on a system-
atic basis that matches them with the related costs that they
are intended to compensate. To achieve this, grants that were
made for Telecom to purchase assets are netted off against
the cost of that asset.
Initial Recognition at Fair Value, Change in
Accounting Policy for Government Grants
1.202
Guangshen Railway Company Limited (Dec 2010)
CONSOLIDATED BALANCE SHEETS (in part)





RMB Restated 2010 2010
(Amounts in Thousands) Note (Note 5) (Note 5) RMB US$∗
Liabilities
Non-current liabilities
Borrowings 25 3,390,000 — — —
Deferred income related to government grants 24 100,495 97,120 95,093 14,408
Bonds payable 26 — 3,465,801 3,471,994 526,060
Employee benefits obligations 27 237,422 174,767 197,386 29,907
3,727,917 3,737,688 3,764,473 570,375
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Principal Accounting Policies (in part)
2.24 Government Grants
Grants from the government are recognized at their fair value
where there is a reasonable assurance that the grant will
be received and the Group will comply with all attached
conditions.
Government grants relating to costs are deferred and rec-
ognized in the comprehensive income statement over the pe-
riod necessary to match them with the costs that they are
intended to compensate.
Government grants relating to property, plant and equip-
ment are included in non-current liabilities as deferred govern-
ment grants and are credited to the comprehensive income
statement on a straight-line basis over the expected lives of
the related assets.
The Group changed the accounting policy in respect of gov-
ernment grants relating to property, plant and equipment from
January 1, 2010. Please refer to Note 5 for more details.
5. Changes in Accounting Policies
During the current year, the Group changed its accounting
policies in respect of fixed assets and government grants
to enhance the comparability of the Group’s financial state-
ments with those of the other listed companies with similar
background, as well as to eliminate the differences between
the Group’s financial statements under IFRS and its PRC
Generally Accepted Accounting Principles (“GAAP”) financial
statements.
a) Change in Accounting Policy for Fixed Assets
The Group’s first financial statements prepared under IFRS
were for the year ended December 31,1996, with the start of
the earliest comparative period being January 1,1994. During
the period from January 1,1994 to December 31, 1996, the
Group was required, due to the Restructuring, by the applica-
ble laws and regulations of the PRC to undertake a valuation
of the to-be-listed fixed assets by an independent appraisal
firm and the values arising from this valuation became the
deemed costs of the related fixed assets included the Group’s
PRC GAAP financial statements.
However, prior to the improvements to IFRSs (2010) issued
in May 2010, IFRS 1 only permitted such valuations to be used
as deemed cost if the event occurred before the date of the
entity’s transition to IFRS. As this valuation was performed as
at a date later than the date of transition to IFRS, the Group
was not permitted at that time to adopt these valuations as
deemed cost for the purposes of its IFRS financial statements.
With the improvements to IFRSs (2010) issued in May 2010,
IFRS 1 was revised and the revalued amounts can become
deemed costs so long as the revaluation takes place at peri-
ods before or during the first-time adopters’ first set of IFRS
financial statements. In addition, the IASB has made a special
provision in this IFRS 1 that existing IFRS preparers may also
be able to retrospectively apply this.
The Group early adopted the aforementioned improved
IFRS 1 from January 1,2010. The impact of the improved
IFRS 1 was applied retrospectively and the comparative fi-
nancial information has also been restated. The effect of the
change is tabulated below:
As at January 1, 2009
RMB’000
As at December 31, 2009
RMB’000
As at December 31, 2010
RMB’000
Increase in fixed assets 918,225 890,636 863,187
Decrease in deferred income tax assets (228,641) (223,123) (217,084)
Increase in share premium 1,270,011 1,270,011 1,270,011
Decrease in retained earnings (580,427) (602,498) (623,908)







Increase in operating expenses 37,106 27,171 27,449
Increase in other expense, net 42 418 —
Decrease in income tax expense (6,687) (5,518) (6,039)
Decrease in profit for the period 30,461 22,071 21,410







Decrease in earnings per share for profit attributable to the
equity holders of the Company during the period—Basic
and diluted — — —
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b) Change in Accounting Policy for Government Grants
Under IAS 20 “Accounting for government grants and disclo-
sure of government assistance,” government grants related
to fixed assets are presented in the financial statements ei-
ther by setting up the grant as deferred income or by deduct-
ing the grant in arriving at the carrying amount of the related
fixed asset. Prior to January 1, 2010, the Group accounted
for government grant related to fixed assets as a deduction
to the carrying amount of the related fixed assets. The grants
are recognized in profit or loss over the lives of the related
fixed assets by way of a reduced depreciation charge. With
the consideration of the following, the Group changed its ac-
counting policy during the current year to account for govern-
ment grants related to fixed assets as deferred income that
is recognized in profit or loss on a systematic basis over the
useful lives of the related fixed assets:
• The practice of other listed companies with similar
background;
• Eliminating the difference between the Group’s finan-
cial statements under IFRS and its PRC GAAP financial
statements; and
• The change will provide reliable and more relevant in-
formation regarding the relevant government grants re-
ceived by the Company.
The change in the accounting policy for government grants
has been accounted for retrospectively.
The effect of the change is tabulated below:
As at January 1, 2009
RMB’000
As at December 31, 2009
RMB’000
As at December 31, 2010
RMB’000
Increase in fixed assets 100,495 97,120 95,093
Increase in deferred government grants 100,495 97,120 95,093







Increase in operating expenses 3,963 3,375 3,388
Decrease in other expense, net (3,963) (3,375) (3,388)
Other than the above stated, the aforementioned accounting
policy changes do not have any impact on other notes to the
financial statements.






Beginning of the year 100,495 97,120
Additions — 1,361
Amortization (3,375) (3,388)
End of the year 97,120 95,093









Interest income from bank 24,321 24,440 41,510
Unwinding of interest accrued on long-term receivable (Note 18) 7,589 4,093 2,893
Write-back of long outstanding payables 21,562 1,932 537
Loss on disposal of fixed assets (31,584) (42,053) (95,849)
Loss on disposal of subsidiaries (188) — —
Amortization of government grants 3,963 3,375 3,388
Dividends income on available-for-sale investments 2,420 3,000 3,853
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36. Cash Flow Generated From Operations
(a) Reconciliation From Profit Attributable to Shareholders









Profit before income tax: 1,464,514 1,684,790 1,925,307
Adjustments for:
Depreciation of fixed assets (Note 7) 1,213,111 1,292,690 1,349,210
Impairment of fixed assets and construction-in-progress — 448 —
Amortization of leasehold land payments (Note 9) 15,603 15,989 15,988
Loss on disposal of fixed assets (Note 31) 31,584 42,053 95,849
Write-down and amortization of deferred employee costs (Note 14) 32,005 20,156 73,911
Recognition of employee benefits obligations (Note 27) 85,988 1,200 100,989
Interest unwound for employee benefit obligations (Note 27) 3,417 6,510 7,609
Share of results of associates (Note 12) (128) (773) (1,361)
Loss on disposal of subsidiaries (Note 31) 188 — —
Dividend income on available-for-sale investment (Note 31) (2,420) (3,000) (3,853)
Provision /(reversal of provision) for doubtful accounts 2,766 414 (1,661)
Write-back of long outstanding of payables (Note 31) (21,562) (1,932) (537)
Amortization of bonds payable (Note 26) — 325 (6,193)
Amortization of government grants (Note 24) (3,963) (3,375) (3,388)
Interest expenses (Note 32) 207,767 227,178 167,650
Interest income (Note 31) (31,910) (28,533) (44,403)
Operating profit before working capital changes 2,996,960 3,254,140 3,675,117
Increase in trade receivables (143,200) (211,176) (107,701)
Increase in materials and supplies (48,249) (29,187) (23,969)
Decrease/(increase) in prepayments and other receivables 51,335 24,117 (6,448)
Decrease in long-term receivable 8,000 8,000 12,000
Increase in trade payables 95,438 150,499 383,289
Decrease in employee benefits obligations (126,179) (64,312) (71,357)
(Decrease)/increase in accrued expenses and other payables (660,420) (23,706) 28,451
Cash generated from operations 2,173,685 3,108,375 3,889,382
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Government Grant Contingencies
1.203
Trinity Biotech plc (Dec 2010)
CONSOLIDATED STATEMENTS OF OPERATIONS
(in part)











Revenues 2 89,635 125,907 140,139
Cost of sales (45,690) (68,891) (77,645)
Gross profit 43,945 57,016 62,494
Other operating income 5 1,616 437 1,173
Research and development expenses (4,603) (7,341) (7,544)
Selling, general and administrative expenses (26,929) (36,013) (47,816)
Selling, general and administrative—impairment charges
and restructuring expenses 28 — — (87,882)
Total selling, general and administrative expenses (26,929) (36,013) (135,698)
Net gain on divestment of business and restructuring expenses 3 46,474 — —
Operating profit/(loss) 60,503 14,099 (79,575)
Financial income 2, 4 1,352 8 65
Financial expenses 2, 4 (495) (1,192) (2,160)
Net financing income/(costs) 857 (1,184) (2,095)
Profit/(loss) before tax 6 61,360 12,915 (81,670)
Total income tax (expense)/credit 2, 9 (942) (1,091) 3,892
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Basis of Preparation and Significant Accounting
Policies (in part)
o) Government Grants
Grants that compensate the Group for expenses incurred
such as research and development, employment and train-
ing are recognised as revenue or income in the statement of
operations on a systematic basis in the same periods in which
the expenses are incurred. Grants that compensate the Group
for the cost of an asset are recognised in the statement of op-
erations as other operating income on a systematic basis over
the useful life of the asset.
(e) Government Grant Contingencies
The Group has received training and employment grant in-
come from Irish development agencies. Subject to existence
of certain conditions specified in the grant agreements, this
income may become repayable. No such conditions existed
as at December 31, 2010. However if the income were to
become repayable, the maximum amounts repayable as at
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IAS 24, RELATED PARTY
DISCLOSURES
IFRSs Overview and Comparison
to U.S. GAAP
1.204 An entity should apply the requirements of IAS 24,
Related Party Disclosures, when identifying related party re-
lationships and transactions; outstanding balances between
the related party and itself; and the circumstances when dis-
closure about these relationships, transactions, and balances
would be required. An entity should also determine the spe-
cific disclosures to provide in accordance with IAS 24.
Author’s Note
In November 2009, the IASB revised IAS 24 by sim-
plifying the definition of a related party, clarifying
its intended meaning, and eliminating inconsistencies
with the definition. The revisions also provide a par-
tial exemption from the disclosure requirements for
government-related entities. The revised IAS 24 is ef-
fective for annual periods beginning on or after 1 Jan-
uary 2011. Early application is permitted. Because the
survey companies selected for this edition generally
have annual periods ending on or before 31 December
2010, the narrative text and illustrative excerpts that
follow may not reflect this newest revision to IAS 24.
Recognition and Measurement
IFRSs
1.205 For the purposes of IAS 24 disclosures, a party is
related to the entity if it has the following characteristics:
• Controls, is controlled by, or is under common con-
trol with the entity, directly or indirectly through an
intermediary
• Either has an interest in the entity that gives it either
significant influence or joint control over the entity, di-
rectly or indirectly through an intermediary, or is an
associate or joint venture of the entity
• Is a member of the key management personnel of the
entity or its parent
• Is a close family member of an individual who is a mem-
ber of the key management personnel or other related
party with control, significant influence, or joint control
over the entity (close family member)
• Is an entity that a close family member controls, jointly
controls, or has significant influence over or with whom
significant voting power resides
• Is a postemployment benefit plan for the benefit of the
employees of the entity or any related party to the entity
1.206 Key management personnel are those persons hav-
ing authority and responsibility for planning, directing, and
controlling the activities of the entity, either directly or in-
directly. This includes directors of the entity, regardless of
whether they are an executive. A close family member is one
who would be expected to influence or be influenced by the
individual in the family member’s interactions with the en-
tity. An entity may consider the following to be close family
members under IAS 24:
• Domestic partners
• Own and domestic partner’s children
• Other dependents
U.S. GAAP
1.207 The FASB ASC definition of related parties is sim-
ilar, but not identical, to that in IAS 24. In the FASB ASC
glossary definition, related parties include the following:
• Entity’s affiliates (according to the FASB ASC glossary,
an affiliate is a party that, directly or indirectly through
one or more intermediaries, controls, is controlled by,
or is under common control with an entity)
• Entities for which investments in their equity securities
would be required to be accounted for by the equity
method by the investing entity, absent the election of the
fair value option under the “Fair Value Option” sections
of FASB ASC 825-10-15
• Trusts for the benefit of employees, such as pension and
profit-sharing trusts that are managed by or under the
trusteeship of management
Author’s Note
The requirements of the previous bullet points are likely
a lower threshold for meeting the definition of related
parties than those in IAS 24 included in its guidance
related to close family members.
• Principal owners of the entity and members of their
immediate families
• Entity’s management (according to the FASB ASC
glossary, management is defined as persons who are
responsible for achieving an entity’s objectives and
who have the authority to establish policies and make
decisions in pursuit of these objectives, regardless of
whether those persons have a formal title) and mem-
bers of their immediate families
Author’s Note
Unlike IFRSs, directors are not specifically scoped into
the FASB ASC glossary definition of management.
However, directors have both the responsibility and au-
thority to set and pursue an entity’s objectives.
• Other parties with which the entity may deal if one party
controls or can significantly influence the management
or operating policies of the other to an extent that one
of the transacting parties might be prevented from fully
pursuing its own separate interests
• Other parties that can significantly influence the man-
agement or operating policies of the transacting parties
or that have an ownership interest in one of the trans-
acting parties and can significantly influence the other
to an extent that one or more of the transacting parties
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Presentation
IFRSs
1.208 IAS 24 does not require a particular presentation of
related party information. IAS 1 requires separate presen-
tation when the transactions or balances are material. If an
entity does not include receivables and payables for key man-
agement personnel separately on the balance sheet, it should
present in a note disclosure a disaggregation of the balance
sheet amounts in which such receivables or payables are
included.
U.S. GAAP
1.209 Unlike IFRSs, FASB ASC 850-10-50-2 requires sep-
arate presentation of notes or accounts receivable from of-
ficers, employees, or affiliated entities on the balance sheet
and prohibits an entity from including these accounts with
other notes receivable or accounts receivable. IFRSs permit
an entity to provide this disaggregation in a note disclosure.
Disclosure
IFRSs
1.210 An entity should disclose relationships between par-
ents and subsidiaries, regardless of whether there are trans-
actions between the related party and the entity, including the
name of the entity’s parent and, if different, the ultimate con-
trolling party. When neither the parent nor ultimate control-
ling party prepares publicly available financial statements, an
entity should disclose the name of the next most senior parent
that does prepare such statements.
1.211 An entity should disclose information about (a) the
compensation of key management personnel, both in total
and separately for each of the categories described in IAS
19, Employee Benefits (that is, short-term benefits, postem-
ployment benefits, other long-term employee benefits, and
termination benefits), and (b) share-based payments, as de-
scribed in IFRS 2, Share-based Payment.
1.212 In addition, when the entity has transactions with re-
lated parties, it should disclose the nature of the related party
relationship. At a minimum, an entity should also disclose
the following:
• Amounts of transactions
• Amounts of, and other information about, outstanding
balances, including the following:
— Terms and conditions
— Whether the balances are secured
• Details of any guarantees given or received
• Provision for uncollectible amounts and any bad debt
expense recognized during the period
IAS 24 does not require an entity to disclose this informa-
tion for the comparative periods presented in the financial
statements.
1.213 IAS 24 requires an entity to make these disclosures
separately for each of the following: parent, entities with joint
control or significant influence over the entity, subsidiaries,
associates, joint ventures, key management personnel of the
entity and its parent, and other related parties. IAS 24 provides
examples of transactions that an entity would be expected to
disclose, including, for example, purchases or sales of goods;
property, plant, and equipment; and financing arrangements.
1.214 IAS 24 permits an entity to aggregate items of a simi-
lar nature, unless disaggregation is necessary for understand-
ing the effects of the transactions in the entity’s financial
statements.
U.S. GAAP
1.215 Like IFRSs, FASB ASC 850-10-50-6 requires an en-
tity to disclose the nature of any control relationship even
when there are no transactions between the entities.
1.216 Like IFRSs, FASB ASC 850-10-50-1 requires an en-
tity to disclose material related party transactions. Also like
IFRSs, an entity is not required to disclose transactions that
are eliminated in consolidation. Unlike IFRSs, FASB ASC
850-10-50-1 exempts compensation arrangements, expense
allowances, and other similar items in the ordinary course
of business from disclosure requirements. However, Item
402 “Executive Compensation” of SEC Regulation S-K re-
quires SEC registrants to provide compensation information
outside the financial statements for specified members of
management.
1.217 Like IFRSs, FASB ASC 850-10-50-1 requires an en-
tity to disclose the following:
• Nature of the relationships
• Description of the transactions and other information
necessary for understanding of the effects of the trans-
actions on the financial statements
• Amounts of the transactions
• Outstanding balances and, if not otherwise apparent, the
terms and manner of settlement
However, unlike IFRS, FASB ASC does not have a require-
ment for such disclosures to be combined by related party
category.
1.218 Unlike IFRSs, FASB ASC 850-10-50-1 requires an
entity to disclose the amount of transactions for each period
for which the entity presents an income statement and to dis-
close the effects of any change in the method of establishing
the terms from that used in the preceding period. For out-
standing balances, an entity should disclose the amount at
each balance sheet date presented.
1.219 Unlike IFRSs, FASB ASC 740-10-50-17 also in-
cludes guidance for disclosures about the tax effects of trans-
actions between an entity and its affiliates when the entity
prepares separate (unconsolidated) financial statements.
1.220 Like IFRSs, FASB ASC 850-10-50-3 permits aggre-
gation of similar transactions by type of related party in cer-
tain circumstances.
Presentation and Disclosure Excerpts
Author’s Note
None of the excerpts that follow reflect the revisions to
IAS 24 that are effective for annual periods beginning
on or after 1 January 2011.
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Disaggregation by Category of Related Party
1.221
Barry Callebaut AG (Aug 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
12. Trade Receivables and Other Current Assets (in part)
As of August 31 2010 2009
In thousands of CHF
Trade receivables 314,636 349,416
Fair values of hedged firm commitments 98,651 42,534
Prepayments 72,063 28,713
Other current assets 7,915 8,966
Accrued income 4,123 2,760
Receivables from related parties 2 192
Other taxes and receivables from government 55,990 62,710
Loans and other receivables 34,000 29,556
Total trade receivables and other current assets 587,380 524,847
27. Related Parties
The following shareholders hold a participation of more than
3% of the issued share capital of the Group’s ultimate parent
Barry Callebaut AG:
As of August 31 2010 2009
Jacobs Holding AG, Zurich, Switzerland 50.11% 50.21%
Renata Jacobs 8.48% 8.48%
Nicolas and Philippe Jacobs(1) 6.14% 6.14%
Nathalie Jacobs 3.07% 3.07%
(1) Form a group of shareholders according to Swiss Stock exchange
regulations as published in the Swiss Official Gazette of Com-
merce of February 4, 2008.
Significant transactions and balances between the Group and
related parties are as follows:
In Thousands of CHF Nature of Cost/Revenue 2009/10 2008/09
Sales to related parties 173 476
Pastelerı́a Totel, S.L Revenue from sales and services 173 476
Purchases from related parties (11,424) (9,554)
African Organic Produce AG Cost of goods sold (11,424) (9,554)
Operating expenses charged by related parties (7,692) (8,746)
Jacobs Holding AG Management services (1,650) (1,678)
Adecco Group Human resources services (5,940) (6,886)
Pastelerı́a Totel, S.L. Management services (13)
Biolands International Ltd Management services (67)
Other (102) (102)
Trade receivables from related parties 2 192
Jacobs Holding AG 2 2
Adecco Group — 4
Pastelerı́a Totel, S.L. — 186
Trade payables to related parties 3,531 2,609
Jacobs Holding AG 310 316
Adecco Group 1,282 1,144
African Organic Produce AG 1,882 1,097
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Transactions with related parties were carried out on com-
mercial terms and conditions at market prices. All receivables
from related parties are non-interest bearing and their collec-
tion is expected within the next twelve months.
Compensation of Key Management Personnel
The key management personnel are defined as the Board
of Directors and the Executive Committee. Key management
compensation consists of the following:
In Million of CHF 2009/10 2008/09
Short-term employee benefits 8.2 7.1
Post-employment benefits 1.5 0.6
Share-based payments 4.2 8.5
Total 13.9 16.2
Further details related to the requirements of the Swiss Trans-
parency law (Art. 663bbis and 663c Swiss Code of Obligations)




Vodafone Group plc (Mar 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
29. Directors and Key Management Compensation
Directors








Salaries and fees 5 5 4
Incentive schemes 3 3 2
Other benefits(1) 1 1 1(2)
9 9 7
Notes:
(1) Includes the value of the cash allowance taken by some individ-
uals in lieu of pension contributions.
(2) Includes the value of payments in respect of loss of office and
relocation to the US.
The aggregate gross pre-tax gain made on the exercise of
share options in the year ended 31 March 2011 by directors
who served during the year was £nil (2010: £1 million, 2009:
£nil).
Further details of directors’ emoluments can be found in
“Directors’ remuneration” on pages 62 to 73.
Key Management Compensation
Aggregate compensation for key management, being the di-








Short-term employee benefits 18 21 17
Post-employment benefits—defined
contribution schemes 1 1 1
Share-based payments 22 20 14
41 42 32
30. Related Party Transactions
The Group’s related parties are its joint ventures (see note
13), associates (see note 14), pension schemes, directors
and Executive Committee members. Group contributions to
pension schemes are disclosed in note 23. Compensation
paid to the Company’s Board and members of the Executive
Committee is disclosed in note 29.
Transactions With Joint Ventures and Associates
Related party transactions with the Group’s joint ventures and
associates primarily comprise fees for the use of products and
services including network airtime and access charges, and
cash pooling arrangements.
No related party transactions have been entered into during
the year which might reasonably affect any decisions made by
the users of these consolidated financial statements except
as disclosed below. Transactions between the Company and
its joint ventures are not material to the extent that they have








Sales of goods and services to associates 327 281 205
Purchase of goods and services from
associates 171 159 223
Purchase of goods and services from joint
ventures 206 194 57
Net interest receivable from joint ventures(1) (14) (44) (18)
Trade balances owed:
by associates 52 24 50
to associates 23 17 18
by joint ventures 27 27 10
to joint ventures 67 40 33
Other balances owed by joint ventures(1) 176 751 311
Note:
(1) Amounts arise primarily through Vodafone Italy, Vodafone Hutchi-
son Australia and Indus Towers and represent amounts not elim-
inated on consolidation. Interest is paid in line with market rates.
Amounts owed by and owed to associates are disclosed within
notes 17 and 25. Dividends received from associates are dis-
closed in the consolidated statement of cash flows.
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Transactions With Directors Other Than Compensation
During the three years ended 31 March 2011, and as of 16
May 2011, neither any director nor any other executive officer,
nor any associate of any director or any other executive officer,
was indebted to the Company.
During the three years ended 31 March 2011, and as of
16 May 2011, the Company has not been a party to any
other material transaction, or proposed transactions, in which
any member of the key management personnel (including
directors, any other executive officer, senior manager, any
spouse or relative of any of the foregoing or any relative of
such spouse) had or was to have a direct or indirect material
interest.
IFRIC 13, CUSTOMER LOYALTY
PROGRAMMES
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
Improvements to IFRSs, issued May 2010, amended
International Financial Reporting Interpretations Com-
mittee (IFRIC) 13, Customer Loyalty Programmes.
This amendment clarifies the wording in paragraph
AG2 that the IASB believed could have been misinter-
preted, leading to diversity in application. The amend-
ment clarifies that when the fair value of award credits
is measured on the basis of the value of the awards for
which they could be redeemed, the fair value of the
award credits should take account of expected forfei-
tures, as well as the discounts or incentives that would
otherwise be offered to customers who have not earned
award credits from an initial sale. The amendment is
effective for annual periods beginning on or after 1
January 2011, and permits early application with dis-
closure of that fact.
1.223 IFRIC 13 addresses recognition and measurement of
revenues and liabilities related to programs that provide in-
centives to customers to buy an entity’s products or services.
Although not formally defined in IFRIC 13, such programs
usually grant points or credits (award credits) that a customer
can accumulate to become eligible for awards that provide
free or discounted products or services. The entity may pro-
vide the products or services directly or through a third-party
entity. In addition, rather than operating a program itself, an
entity may participate in a program operated by another entity.
Awards may also be linked to continued purchases or inter-
action with the company over time or to specific purchases.
1.224 IFRIC 13 applies to award credits that meet the fol-
lowing criteria:
• Entity grants the award credits to the customer as part
of a sales transaction.
• Customers, when qualified, can use the award credits in
the future to acquire other goods or services.
1.225 IFRIC 13 is effective for annual periods beginning
on or after 1 July 2008. Early application is permitted with
disclosure of that fact.
Recognition and Measurement
IFRSs
1.226 Paragraph 13 of IAS 18, Revenue, requires an entity
to apply the revenue recognition criteria separately to iden-
tifiable components of a single transaction in order to reflect
the substance of the transaction. IFRIC 13 requires an entity
to account for award credits as an identifiable component of
the sale transaction in which they are awarded to the cus-
tomer. Therefore, an entity should allocate the consideration
received or receivable in these transactions among the award
credits and other goods or services received. An entity should
measure the amount allocated as the fair value of the amount
for which the award credits could be sold.
1.227 When an entity itself provides the awards, it should
recognize revenue when the award credits are redeemed and
it delivers the products or services awarded. The entity mea-
sures the amount of revenue based on the percentage of actual
award credits redeemed relative to the total award credits ex-
pected to be redeemed.
1.228 When a third party provides the awards, an entity
should determine whether, in giving award credits to cus-
tomers, it is acting on its own account or as an agent for the
third party. When the entity collects consideration as an agent
for a third party, it should measure revenue only at the net
amount it retains, rather than the amount it collects, recog-
nized only when the third party is entitled to the consideration
and obligated to provide the awards. The facts and circum-
stances of the arrangement should determine when this obli-
gating event occurs, and it may not occur until the customer
redeems award credits. When an entity receives consideration
on its own account, it should recognize revenue when it pro-
vides the awards, measured as the amount of consideration
allocated to the redeemed award credits.
1.229 Obligations under award credit contracts may lead
to an onerous contract—one in which the costs to fulfill the
contract exceed the consideration received or receivable. If
the contractual obligation under an award credit contract be-
comes onerous, an entity should recognize a liability for the
excess, measured in accordance with IAS 37, Provisions,
Contingent Liabilities and Contingent Assets. IFRIC 13 ex-
plains that one circumstance in which an entity might need
to recognize a liability is when the entity revises its estimate
of award credits to be redeemed.
U.S. GAAP
1.230 FASB ASC does not include specific guidance on ac-
counting for the type of award credits or customer loyalty
programs covered by IFRIC 13. FASB ASC 605-25-15-2A
explicitly scopes out award credits by broad-based loyalty
program operators from the guidance on revenue recogni-
tion for multiple element arrangements. Therefore, an entity
should evaluate other appropriate guidance in FASB ASC to
determine the most relevant guidance for its specific situa-
tion and apply those requirements by analogy. Some entities
may apply the guidance for multiple element arrangements
and recognize revenue in a manner similar to that required
by IFRIC 13. Unlike IFRIC 13, other entities may apply an
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Author’s Note
FASB and the IASB are currently working on a joint
project on revenue that includes guidance on customer
loyalty programs. In June 2010, FASB and the IASB
jointly published an exposure draft, Revenue from Con-
tracts with Customers, which includes requirements on
accounting for the issues covered by IFRIC 13. A final




1.231 Application of IFRIC 13 does not affect presenta-
tion. IAS 1 requires separate presentation or disclosure if the
amounts are material.
U.S. GAAP
1.232 FASB ASC does not provide specific presentation
guidance on this issue.
Disclosure
IFRSs
1.233 IFRIC 13 does not include disclosure require-
ments but does state that an entity should apply any nec-
essary change in accounting policy retrospectively and
to provide the relevant disclosures in accordance with
IAS 8.
U.S. GAAP
1.234 Disclosure requirements would depend on the partic-
ular section of FASB ASC that an entity uses to recognize
and measure revenue for these award credits.
Presentation and Disclosure Excerpts
Frequent Flyer Program
1.235
Lan Airlines S.A. (Dec 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME








Revenue 27 4,390,502 3,519,162 4,140,245
Cost of sales (3,012,698) (2,522,778) (2,893,944)
Gross margin 1,377,804 996,384 1,246,301
Other income 30 132,826 136,351 142,942
Distribution costs (383,517) (326,964) (366,652)
Administrative expenses (331,831) (269,588) (274,950)
Other expenses (172,428) (100,483) (127,864)
Other gains/(losses) 5,438 (11,728) (134,731)
Financial income 14,946 18,183 18,480
Financial costs 28 (155,279) (153,109) (125,488)
Equity accounted earnings 15 132 315 696
Foreign exchange gains/(losses) 31 13,792 (11,237) 23,443
Result of indexation units 149 (605) 1,229
Income before taxes 502,032 277,519 403,406
Income tax expense 19 (81,107) (44,487) (65,094)
Net income for the period 420,925 233,032 338,312
Income attributable to owners of the parent 419,702 231,126 336,480
Income attributable to non-controlling interests 1,223 1,906 1,832
Net income for the period 420,925 233,032 338,312
Earnings Per Share
Basic earnings per share (US$) 1.23882 0.68221 0.99318
Diluted earnings per share (US$) 1.23534 0.68221 0.99318
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Cash and cash equivalents 6–7 631,052 731,497
Other financial assets 7–11 245,451 110,667
Other non-financial assets 12 18,820 17,128
Trade and other accounts receivable 7–8 481,350 423,739
Accounts receivable from related entities 7–9 50 38
Inventories 10 53,193 46,563
Tax assets 97,656 68,420
Total current assets other than non-current assets (or disposal
groups) classified as held for sale 1,527,572 1,398,052
Non-current assets (or disposal groups) classified as held for sale 13 5,497 10,919
Total current assets 1,533,069 1,408,971
Non-current Assets
Other financial assets 7–11 21,587 20,024
Other non-financial assets 12 32,508 28,736
Rights receivable 7–8 7,883 7,190
Equity accounted investments 15 593 1,236
Intangible assets other than goodwill 16 45,749 34,814
Goodwill 17 157,994 63,793
Property, plant and equipment 18 4,948,430 4,196,556
Deferred tax assets 19 38,084 10,652
Total non-current assets 5,252,828 4,363,001
Total assets 6,785,897 5,771,972
For the Year Ended December 31







Other financial liabilities 7–20 542,624 417,932
Trade and other accounts payable 7–21 645,571 476,597
Accounts payable to related entities 7–9 184 297
Other provisions 22 753 970
Tax liabilities 15,736 11,287
Other non-financial liabilities 23 939,151 616,256
Total current liabilities 2,144,019 1,523,339
Non-current liabilities
Other financial liabilities 7–20 2,562,348 2,443,178
Other accounts payable 7–25 425,681 426,521
Other provisions 22 32,120 26,834
Deferred tax liabilities 19 312,012 240,619
Employee benefits 24 9,657 5,555
Total non-current liabilities 3,341,818 3,142,707
Total liabilities 5,485,837 4,666,046
Equity
Share capital 26 453,444 453,444
Retained earnings 26 949,214 740,047
Other equity interests 26 5,463 2,490
Other reserves 26 (111,307) (97,154)
Equity attributable to owners of parent 1,296,814 1,098,827
Non-controlling interest 3,246 7,099
Total equity 1,300,060 1,105,926
Total liabilities and equity 6,785,897 5,771,972
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2—Summary of Significant Accounting Policies
(in part)
The following describes the principal accounting policies
adopted in the preparation of these consolidated financial
statements.
2.20. Revenue Recognition (in part)
Revenues include the fair value of the proceeds received or to
be received on sales of goods and rendering services in the
ordinary course of the Company’s business. Revenues are
shown net of refunds, rebates and discounts.
(a) Rendering of Services
a.1 Passenger and Cargo Transport
The Company shows revenue from the transportation of pas-
sengers and cargo once the service has been provided.
a.2 Frequent Flyer Program
The Company currently has a frequent flyer program called
Lan Pass, whose objective is customer loyalty through the
delivery of kilometers every time that members fly with the
Company or its alliance partners, use the services of entities
registered with the program or make purchases with an asso-
ciated credit card. The kilometers earned can be exchanged
for flights tickets or other services of associated entities. The
consolidated financial statements include liabilities for this
concept (deferred income), according to the estimate of the
valuation established for the kilometers accumulated pend-




SECTION 2: STATEMENT OF FINANCIAL POSITION
AND RELATED DISCLOSURES∗
IAS 1, PRESENTATION OF FINANCIAL
STATEMENTS





Several items that readers may associate with a state-
ment of financial position are covered in other sections
within this publication more specific to that topic:
• Government grants and customer loyalty pro-
grams (see section 1, “General Topics and Related
Disclosures”)
• Income, expenses, gains, losses, and changes in
fair value associated with balance sheet items (see
section 3, “Statement of Comprehensive Income
and Related Disclosures”)
• Cash and cash equivalents (see section 5, “State-
ment of Cash Flows and Related Disclosures”)
• Construction contracts, assets held for sale, liabil-
ities held for sale, and share-based payments (see
section 6, “Non-current Assets Held for Sale and
Discontinued Operations”)
• Financial instruments and related disclosures,
loans and receivables, available for sale finan-
cial assets, held to maturity investments, financial
assets or financial liabilities held for trading, fi-
nancial assets or financial liabilities designated as
fair value through profit or loss, accounts payable,
and financial liabilities held at amortized cost (see
section 8, “Financial Instruments and Related Dis-
closures”).
IFRS Overview and Comparison
to U.S. GAAP
Author’s Note
In September 2010, the International Accounting Stan-
dards Board (IASB) issued the Conceptual Framework
for Financial Reporting 2010 (IFRS Conceptual
Framework), which supersedes the Framework for the
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
applicable as of 1 January 2011.
Preparation and Presentation of Financial State-
ments. However, the IFRS Conceptual Framework
retains the definitions of the elements of financial
statements (that is, assets, liabilities, equity, income,
and expenses) from the previous Framework for the
Preparation and Presentation of Financial Statements.
Author’s Note
In May 2011, the IASB issued International Financial
Reporting Standard (IFRS) 10, Consolidated Finan-
cial Statements, which supersedes the requirements of
International Accounting Standard (IAS) 27, Consoli-
dated and Separate Financial Statements, with respect
to consolidation, and Standing Interpretations Com-
mittee (SIC) 12, Consolidation—Special Purpose En-
tities. IFRS 10 requires an entity to consolidate all
entities that it controls. IFRS 10 defines the prin-
ciple of control and establishes control as the ba-
sis for determining which entities an entity should
consolidate. IFRS 10 also prescribes the accounting
requirements for the preparation of consolidated finan-
cial statements. Therefore, IAS 27, Separate Finan-
cial Statements (as amended in 2011), retains only the
requirements for accounting and disclosure of invest-
ments in subsidiaries, joint ventures, and associates
when an entity prepares separate (or company-only)
financial statements. IAS 27 (2011) requires an entity
preparing separate financial statements to account for
those investments at cost or in accordance with IFRS
9, Financial Instruments. Both IFRS 10 and IAS 27
(2011) are effective for annual reporting periods begin-
ning on or after 1 January 2013, with early application
permitted.
Because IFRS 10 and IAS 27 (2011) were not issued
until May 2011, no survey entity could apply the new
requirements in its 2010 financial statements. There-
fore, the following commentary only describes the re-
quirements in IAS 27 (2011) that are applicable to 2010
financial statements.
2.01 IAS 1, Presentation of Financial Statements, requires
a statement of financial position (that is, a balance sheet)
at the end of the period as part of a complete set of finan-
cial statements, but does not prescribe a particular title for
the statement. IAS 27 (2011) requires an entity to present a
balance sheet that includes all entities (subsidiaries) that it
controls, except in certain circumstances.
2.02 A complete set of financial statements should include
two balance sheets: one for the end of the current period and
one for the comparable previous period, except when IFRSs
permit or require otherwise. For example, when an entity
applies a change in accounting principle retrospectively, it
should include a restated balance sheet as at the beginning of
the earliest period presented.
2.03 When an entity changes the presentation or classi-
fication of balance sheet items, it should also reclassify
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comparative period information, unless it is impracticable
to do so.
2.04 The IFRS Conceptual Framework establishes the con-
cepts that underlie the preparation and presentation of finan-
cial statements for external users and contains definitions of
the elements of financial statements (that is, assets, liabilities,
equity, income, and expenses). Among other purposes, the
IFRS Conceptual Framework assists preparers of financial
statements in applying IFRSs and in dealing with topics that
have yet to form the subject of a specific standard or interpre-
tation. IAS 8, Accounting Policies, Changes in Accounting
Estimates and Errors, states that an entity’s management
should first refer to, and first consider the applicability of,
the requirements in IFRSs dealing with similar and related
issues and then to the definitions, recognition criteria, and
measurement concepts in the IFRS Conceptual Framework.
Although the IFRS Conceptual Framework is not a standard,
the requirements of IAS 8 essentially establish the IFRS
Conceptual Framework as part of the IFRS hierarchy of ac-
counting and reporting requirements.
Presentation
IFRSs
2.05 At a minimum, IAS 1 requires a balance sheet to include
the following line items:
• Financial assets, such as the following:
— Cash and cash equivalents
— Trade and other receivables
— Investments accounted for using the equity method
(for example, associates and some joint ventures)
— Other financial assets (excluding the amounts in-
cluded in the preceding line items)
• Inventories




• Assets and related liabilities classified as held for sale or
included in disposal groups classified as held for sale
under IFRS 5, Non-current Assets Held for Sale and
Discontinued Operations, such as the following:
— Total of assets held for sale and assets included in
disposal groups
— Liabilities included in disposal groups
• Income tax assets and liabilities as defined in IAS 12,
Income Taxes, such as the following:
— Assets and liabilities for current tax
— Deferred tax assets and liabilities
• Financial liabilities, such as the following:
— Trade and other payables
— Other financial liabilities (excluding amounts shown
in the preceding line items)
• Provisions
• Noncontrolling interest presented within equity
• Issued capital and reserves attributable to owners of the
parent
• Additional line items, headings, and subtotals when
presentation of these is relevant to understanding the
entity’s financial position
2.06 IAS 1 requires an entity to present a classified balance
sheet, except when a presentation based on liquidity provides
reliable, but more relevant information. A classified balance
sheet presents current and noncurrent assets and liabilities
separately. However, IAS 1 does not prescribe a particular
organization of information (for example, either an increas-
ing or a decreasing order of liquidity).
2.07 A current asset is one that the entity expects to realize,
intends to sell or consume in its normal operating cycle or 12
months after the reporting date, or holds for trading, or is a
cash or cash equivalent whose exchange or use is unrestricted
for at least 12 months after the reporting date. Similarly, a
current liability is one that the entity intends to settle within
its normal operating cycle or 12 months after the reporting
date. In addition, an entity also classifies as current a liability
for which it has no unconditional right to defer settlement for
at least 12 months after the reporting date, including those
with terms that could, at the option of the counterparty, result
in settlement by issue of equity instruments. An entity should
classify all other assets and liabilities as noncurrent.
2.08 IAS 1 permits a liquidity order balance sheet when it
provides more relevant information to users of the financial
statements, which may be true for financial institutions (in-
cluding banks and insurance companies). IAS 1 also permits
a mixed presentation (that is, some assets and liabilities in
the classified format and others in liquidity order) when it
provides more relevant information to users. A mixed pre-
sentation may be more relevant when an entity has diverse
operations (for example, an entity with both manufacturing
and finance subsidiaries).
2.09 Regardless of the method of organization selected, an
entity should distinguish amounts it expects to realize or
settle within 12 months after the reporting date from those it
expects to realize or settle later when combined in a single
line item on the balance sheet.
2.10 Specific IFRSs may require additional disclosures
about balance sheet items. For example, IAS 39, Financial
Instruments: Recognition and Measurement, requires entities
to present treasury stock as a contraequity account (reduc-
tion) within stockholders’ equity.
U.S. GAAP
2.11 The Financial Accounting Standards Board (FASB)
Accounting Standards CodificationTM (ASC) requires an
entity to present a balance sheet, although a comparative
balance sheet is preferred. U.S. Securities and Exchange
Commission (SEC) Regulation S-X, together with Financial
Reporting Releases, prescribe the form and content of, and re-
quirements for, financial statements filed with the SEC. Rule
3A-02 of SEC Regulation S-X generally requires consoli-
dated financial statements, although it does allow combined
financial statements in some circumstances. Rule 3-01(a) of
SEC Regulation S-X also requires an entity to present a con-
solidated balance sheet for the current period and one com-
parative period, unless the registrant has been in existence
for less than one year. SEC regulations are more prescriptive
in terms of formats than IFRSs.
2.12 FASB ASC does not require an entity to present a
classified balance sheet or mandate any particular ordering
of balance sheet accounts. However, FASB ASC 210-10-05-
4 states that companies usually present a classified balance
sheet to facilitate calculation of working capital. The FASB
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ASC glossary includes definitions of current assets and li-
abilities, similar to those in IFRSs, if an entity chooses to
use this classification. FASB ASC 210-10-45 provides addi-
tional guidance for determining these classifications. FASB
ASC provides additional guidance with respect to specific as-
sets and liabilities. For example, IFRSs are more prescriptive
with respect to required line items.
Disclosure
IFRSs
2.13 As appropriate to its operations, entities should disclose
additional subclassifications of the required line items, either
on the face of the balance sheet or in the notes. For each
class of share capital, however, entities should disclose the
following:
• Number of shares authorized
• Number of shares issued and fully paid
• Number of shares issued and not fully paid
• Par value or that shares have no par
• Reconciliation of the number of shares outstanding at
the beginning and end of the period
• Rights, preferences, and restrictions, including restric-
tions on dividend distributions or repayment of capital
• Shares reserved for issue under share-based payment
or sale contracts, including terms and amounts
2.14 Entities should also describe the nature and purpose
of each reserve. Entities without share capital (for example,
trusts) should disclose information similar to the require-
ments previously mentioned.
2.15 Specific IFRSs may require additional disclosures
about balance sheet items.
U.S. GAAP
2.16 FASB ASC also sets forth disclosure guidelines regard-
ing capital structure and other balance sheet items. Depend-
ing upon the specific asset, liability, or capital account, FASB
ASC may be more or less prescriptive than IFRSs. SEC reg-
ulations also contain additional requirements for disclosures
that registrants should provide outside the financial state-
ments.




Current assets, noncurrent assets, current
liabilities, noncurrent liabilities, equity............... 51 43 16
Noncurrent assets, current assets, equity,
noncurrent liabilities, current liabilities.............. 67 64 —
Noncurrent assets, current assets, current
liabilities, noncurrent liabilities, equity............... 30 32 73
Noncurrent assets, current assets, noncurrent
liabilities, current liabilities, equity..................... 5 4 —
Liquidity Order
Most current to least current................................. 14 14 7
Least current to most current ............................... 3 3 4
Total................................................................ 170 160 100




Embotelladora Andina S.A. (Dec 2010)
Author’s Note
Embotelladora Andina S.A. implemented IFRSs ef-
fective December 31, 2010, with a date of transition of
January 1, 2009. The excerpt that follows reflects the
initial application of IAS 1.
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CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION
At December 31, 2010 and 2009 and at January 1, 2009
(Translation of consolidated financial statements originally
issued in Spanish—See Note 2.3)
12/31/2010 12/31/2009 01/01/2009
Assets Note ThCh$ ThCh$ ThCh$
Current Assets:
Cash and cash equivalents 5 48,263,080 62,791,221 89,705,981
Other financial assets 6 48,914,734 72,345,111 39,512,890
Other non-financial assets 7.1 10,712,132 10,086,541 7,270,555
Trade and other accounts receivable, net 8 97,254,597 78,558,590 74,029,537
Accounts receivable from related companies 12.1 248,273 1,051,014 1,726,604
Inventory 9 49,939,194 40,908,937 35,443,903
Current tax assets/Tax accounts receivable 10.1 2,288,725 4,563,058 7,089,181
Total current assets 257,620,735 270,304,472 254,778,651
Non-Current Assets:
Other non-financial, non-current assets 7.2 21,507,754 20,454,935 17,628,504
Trade and other accounts receivable, net 8 7,804,481 5,817,177 8,542
Accounts receivable from related companies, net 12.1 8,847 37,869 34,719
Investments in equity investees accounted for using the
equity method 14 50,754,168 34,731,218 32,822,541
Intangible assets, net 15.1 1,365,595 2,117,333 2,455,762
Goodwill 15.2 57,770,335 61,360,345 65,269,071
Property, plant and equipment, net 11 291,482,180 247,869,091 248,747,764
Deferred tax assets 10.4 6,891,609 6,252,523 6,382,129
Total non-current assets 437,584,969 378,640,491 373,349,032
Total assets 695,205,704 648,944,963 628,127,683
12/31/2010 12/31/2009 01/01/2009
Liabilities and Net Equity Note ThCh$ ThCh$ ThCh$
Current Liabilities:
Other financial liabilities 16 11,996,399 5,799,881 11,504,242
Trade and other accounts payable 17 105,282,335 82,302,124 79,549,681
Accounts payable to related companies 12.2 14,323,473 13,757,847 16,528,635
Provisions 18 60,748 38,879 43,440
Income tax payable 10.2 4,009,389 5,676,913 2,927,434
Other non-financial liabilities 19 31,879,967 30,234,814 31,532,517
Total current liabilities 167,552,311 137,810,458 142,085,949
Non-Current Liabilities:
Other non-current financial liabilities 16 70,449,459 73,149,674 80,247,530
Accounts payable to related companies 12.2 — 2,565,767 3,137,347
Provisions 18 4,267,619 4,457,107 2,887,777
Deferred tax liabilities 10.4 42,492,348 39,435,167 34,578,183
Post-employment benefit liabilities 13.2 7,256,590 8,401,791 8,034,813
Other non-current liabilities 19 8,322,781 9,567,264 10,861,802
Total non-current liabilities 132,788,797 137,576,770 139,747,452
Equity: 20
Issued capital 230,892,178 230,892,178 236,327,716
Retained earnings 180,110,975 147,508,036 109,955,729
Accumulated other comprehensive income and capital reserves (16,146,887) (4,851,620) —
Equity attributable to equityholders of the parent 394,856,266 373,548,594 346,283,445
Non-controlling interests 8,330 9,141 10,837
Total equity 394,864,596 373,557,735 346,294,282
Total liabilities and equity 695,205,704 648,944,963 628,127,683
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2.18
Adecoagro S.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
As of December 31, 2010, 2009 and 2008
(All amounts in US$ thousands, except shares and per
share data and as otherwise indicated)
Note 2010 2009 2008
Assets
Non-Current Assets
Property, plant and equipment, net 6 751,992 682,878 571,419
Investment property 7 21,417 21,246 —
Intangible assets, net 8 28,653 21,859 18,108
Biological assets 9 104,216 170,347 75,701
Investments in joint ventures 10 6,271 6,506 7,508
Deferred income tax assets 21 67,463 45,113 18,713
Trade and other receivables, net 11,12 30,752 22,065 8,612
Other assets 26 34 87
Total non-current assets 1,010,790 970,048 700,148
Current Assets
Biological assets 9 82,541 60,107 50,247
Inventories 13 57,170 57,902 61,221
Trade and other receivables, net 11,12 119,205 106,212 75,928
Derivative financial instruments 11 876 99 2,019
Cash and cash equivalents 11,14 70,269 74,806 93,360
Total current assets 330,061 299,126 282,775
Spin-off assets 15 — — 45,311
Total assets 1,340,851 1,269,174 1,028,234
Shareholders Equity
Capital and Reserves Attributable to Equity Holders of the Parent
Share capital 16 120,000 120,000 108,108
Share premium 563,343 563,343 507,516
Cumulative translation adjustment 11,273 2,516 (87,978)
Equity-settled compensation 13,659 11,914 9,092
Retained earnings 257 44,161 44,421
Equity attributable to equity holders of the parent 708,532 741,934 581,159
Non controlling interest 14,570 15,222 57,269
Total Shareholders Equity 723,102 757,156 638,428
Liabilities
Non-Current Liabilities
Trade and other payables 11,19 11,785 6,822 6,090
Borrowings 11,20 250,672 203,134 4,099
Derivative financial instruments 11 — 280 —
Deferred income tax liabilities 21 111,495 107,045 94,627
Payroll and social liabilities 22 1,178 1,106 834
Provisions for other liabilities 23 4,606 3,326 777
Total non-current liabilities 379,736 321,713 106,427
Current Liabilities
Trade and other payables 11,19 69,236 62,098 46,670
Current income tax liabilities 978 222 1,487
Payroll and social liabilities 22 15,478 10,079 6,025
Borrowings 11,20 138,800 103,647 224,214
Derivative financial instruments 11 8,920 12,607 4,159
Provisions for other liabilities 23 4,601 1,652 824
Total current liabilities 238,013 190,305 283,379
Total liabilities 617,749 512,018 389,806
Total shareholders equity and liabilities 1,340,851 1,269,174 1,028,234
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Brookfield Asset Management, Inc. (Dec 2010)
Author’s Note
Brookfield Asset Management Inc. implemented
IFRSs effective December 31, 2010, with a date of
transition of January 1, 2009. The excerpt that follows
reflects the initial application of IAS 1.
CONSOLIDATED BALANCE SHEETS
(Millions) Note Dec. 31, 2010 Dec. 31, 2009(1) Jan. 1, 2009(1)
Assets
Cash and cash equivalents $ 1,713 $ 1,309 $ 1,169
Other financial assets 5 4,419 5,146 4,506
Accounts receivable and other 6 7,869 4,709 3,803
Inventory 7 5,849 5,560 4,752
Investments 8 6,629 4,466 4,646
Property, plant and equipment 9 18,148 16,723 15,597
Investment properties 10 22,163 19,219 16,719
Timber 11 3,206 2,968 2,839
Intangible assets 12 3,805 1,048 619
Goodwill 13 2,546 2,363 1,992
Deferred income tax asset 14 1,784 1,454 984
$78,131 $64,965 $57,626
Liabilities and Equity
Accounts payable and other 15 $10,334 $ 7,827 $ 6,977
Corporate borrowings 16 2,905 2,593 2,284
Non-recourse borrowings
Property-specific mortgages 17 23,454 19,712 17,808
Subsidiary borrowings 17 4,007 3,800 3,661
Deferred income tax liability 14 4,970 5,232 4,748
Capital securities 18 1,707 1,641 1,425
Interests of others in funds 19 1,562 1,021 548
Equity
Preferred equity 20 1,658 1,144 870
Non-controlling interests 20 14,739 10,186 8,038
Common equity 20 12,795 11,809 11,267
29,192 23,139 20,175
$78,131 $64,965 $57,626
(1) Refer to Note 3 for the effects of the adoption of IFRS.
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2.20
Aviva plc (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION




Goodwill M & 13 3,391 3,381
Acquired value of in-force business and intangible assets M & 14 2,806 2,860
Interests in, and loans to, joint ventures C & 15 1,994 1,701
Interests in, and loans to, associates C & 16 643 1,281
Property and equipment N & 17 750 753
Investment property O & 18 13,064 12,422
Loans T & 20 43,074 41,079
Financial investments Q,R & 22 253,288 238,679
Reinsurance assets L & 39 7,084 7,572
Deferred tax assets AA & 43b 288 218
Current tax assets 43a 198 359
Receivables 23 8,295 9,632
Deferred acquisition costs and other assets V & 24 6,072 5,621
Prepayments and accrued income 24d 3,691 3,604
Cash and cash equivalents W & 51d 25,455 25,176
Assets of operations classified as held for sale AF & 3c 14 53
Total assets 370,107 354,391
Equity
Capital AC
Ordinary share capital 26 705 692
Preference share capital 29 200 200
905 892
Capital reserves
Share premium 26b 1,194 1,207
Merger reserve C & 31 3,271 3,271
4,465 4,478
Shares held by employee trusts 28 (32) (68)
Other reserves 32 2,245 1,829
Retained earnings 33 5,411 3,425
Equity attributable to shareholders of Aviva plc 12,994 10,556
Direct capital instrument 30 990 990
Non-controlling interests 34 3,741 3,540
Total equity 17,725 15,086
Liabilities
Gross insurance liabilities J & 36 177,700 171,092
Gross liabilities for investment contracts K & 37 117,787 110,015
Unallocated divisible surplus J & 41 3,428 3,866
Net asset value attributable to unitholders C 9,032 9,894
Provisions Y, Z & 44 2,943 3,980
Deferred tax liabilities AA & 43b 1,758 1,038
Current tax liabilities 43a 314 192
Borrowings AB & 46 14,949 15,000
Payables and other financial liabilities Q & 47 20,292 20,542
Other liabilities 48 4,179 3,653
Liabilities of operations classified as held for sale AF & 3c — 33
Total liabilities 352,382 339,305
Total equity and liabilities 370,107 354,391
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TABLE 2-2: CAPITAL STRUCTURE
2010 2009
Companies With One Class of Common Stock and:
No other equity instrument.............................................. 110 107
One class of preferred stock........................................... 20 18
Two or more classes of preferred stock......................... 9 9
Total .................................................................. 139 134
Dual-Listed Companies
Each Company has One Class of Common Stock........ 5 5
Other Companies With More Than One Class of
Common Stock and:
No other equity instrument.............................................. 20 18
One class of preferred stock........................................... 4 3
Total .................................................................. 24 21
Companies With Only Another Equity Instrument
(for Example, Units)............................................ 1 0
Total Companies ................................................... 170 160
One Class of Share Capital
2.21
China Xiniya Fashion Limited (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
(Expressed in thousands of Chinese Renminbi Yuan)




Share capital 11 9,843 77
Additional paid-in capital 11 — 529,650
Statutory reserve 12 43,897 69,351
Retained earnings 174,667 403,754
Total equity 228,407 1,002,832
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Organization and Principal Activities
China Xiniya Fashion Limited (the “Company”) and its sub-
sidiaries (collectively, the “Group”) designs, manufactures
and markets business casual apparel to retail customers
through a network of authorized retailers and department
store chains managed and supervised by its authorized dis-
tributors. The Company was incorporated under the laws of
Cayman Islands in June 2010. The address of its registered
office is PO Box 309, Ugland House, Grand Cayman, KY1-
1104, Cayman Islands. In November 2010, the Company
completed a 20,000 for one share split resulting in an au-
thorized share capital of one billion shares with a par value
of US$0.00005. All references to shares and earnings per
share have been retroactively restated to give effect to the
share split for all periods presented.
The Company currently conducts its business through Fu-
jian Xiniya Garments and Weaving Co., Ltd. (“Fujian Xiniya”),
an operating subsidiary in the People’s Republic of China,
established in October 2005 with a registered capital of
HK$10 million (RMB9.8 million) (“Registered Capital”), of
which RMB3.1 million was contributed in 2006 and RMB6.7
million was contributed in 2007. Pursuant to January 2005
and September 2005 agreements between Mr. Hing Tuen
Wong (“Mr. Wong”) and Mr Qiming Xu (“Mr. Xu”), the Com-
pany’s founder and Chief Executive Officer, Mr. Xu was
granted effective control over Fujian Xiniya, including the right
to receive dividends declared and to transfer equity interests
to third parties, and Mr. Wong was registered to be Fujian
Xiniya’s shareholder. Accordingly, Mr. Xu was the controlling
person and beneficial owner of Fujian Xiniya. The Registered
Capital was provided pursuant to a loan agreement executed
by Mr. Xu and three Hong Kong investors (“the Investors”).
The loan agreement provided that Mr. Xu would repay the
HK$10 million, plus interest at 10% per annum, to the In-
vestors if Fujian Xiniya incurred losses in any of the years
ended December 31, 2006, 2007 or 2008, or if Fujian Xiniya
failed to achieve aggregate profits of less than HK$100 mil-
lion for the three years ended December 31, 2008. The loan
agreement also provided that if Fujian Xiniya achieved ag-
gregate profits of more than HK$100 million, the loan would
be satisfied through the transfer of 20% of Mr. Xu’s equity
interests in Fujian Xiniya to the Investors. Mr. Xu and the
Investors further agreed that Mr. Xu would grant protective
rights to the Investors for all dividends distributed by Fujian
Xiniya for the three years ended December 31, 2008, which
rights would not affect the strategic operating and financing
policies of Fujian Xiniya, all of which were retained by Mr. Xu.
In January 2009, Xiniya Holdings Limited (“Xiniya HK”)
(Registration No. 1301502) was incorporated with an au-
thorized share capital of 10,000 ordinary shares, par value
HK$1, of which 100 shares were issued to Mr. Wong, on be-
half of Mr. Xu, at incorporation. Mr. Xu was the controlling
person and beneficial owner of Xiniya Hong Kong. In Jan-
uary 2010, Xiniya HK acquired 100% of the equity interests
of Fujian Xiniya for HK$10 million, which consideration was
subsequently waived.
In June 2010, China Xiniya Fashion Limited was incorpo-
rated in the Cayman Islands with an authorized share cap-
ital of one billion shares, par value US$0.00005, of which
20,000 shares were issued at incorporation. In July 2010,
China Xiniya Fashion Limited acquired 100% of the equity
interests in Xiniya HK for HK$100. In July 2010, an additional
199,980,000 shares were issued, of which 20% were issued
to the Investors in satisfaction of the loan agreement.
At the time of these transactions, Xiniya HK and China
Xiniya Fashion Limited had no other operating activities, and
Fujian Xiniya, Xiniya HK and China Xiniya Fashion Limited
were controlled by Mr. Xu. Accordingly, in 2010 these trans-
actions were accounted for as a common control transaction
in a manner similar to a pooling of interests.
On November 23, 2010, the Company completed its initial
public offering (“IPO”) on the New York Stock Exchange and
8,000,000 American depository shares (“ADSs”), represent-
ing 32,000,000 ordinary shares, were sold at a price of US$11
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per ADS (or US$2.75 per ordinary share). The net proceeds
from the IPO, after deducting commissions and IPO costs,
were approximately RMB519.8 million.
The financial statements for the three conducted from Jin-
jiang City, Fujian Province in the PRC. All of the Group’s
customers are located in the PRC.
2. Summary of Significant Accounting Policies (in part)
(l) Share Capital
The transaction costs of an equity transaction are accounted
for as a deduction from equity (net of any related income tax
benefit) to the extent they are incremental costs directly at-
tributable to the equity transaction that otherwise would have
been avoided. These incremental costs include registration
and other regulatory fees, amounts paid to legal, accounting
and other professional advisors, printing costs and stamp du-
ties, excluding management salaries, items normally included
in general and administrative expenses or other recurring
costs. Specifically, legal and accounting fees do not include
any fees that would have been incurred in the absence of
such issuance.
11. Share Capital and Additional Paid-In Capital
(a) Authorized Share Capital
In June 2010, China Xiniya Fashion Limited was incorporated
in the Cayman Islands with an authorized share capital of
one billion shares, par value of US$0.00005, of which 20,000
shares were issued at incorporation.









At June 24, 2010 — — — —
Proceeds from shares issued 232,000 77 529,650 529,727
At December 31, 2010 232,000 77 529,650 529,727
All ordinary shares with a par value of US$0.00005, issued
by the Company, were fully paid.
Multiple Classes of Common Share Capital
2.22
Embotelladora Andina S.A. (Dec 2010)
Author’s Note
Embotelladora Andina S.A. implemented IFRSs effec-
tive December 31, 2010, with a date of transition of
January 1, 2009. The excerpt that follows reflects the
initial application of IAS 1.
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
At December 31, 2010, at December 31, 2009 and at January
1, 2009
(Translation of consolidated financial statements originally
issued in Spanish—See Note 2.3)
12/31/2010 12/31/2009 01/01/2009
Liabilities and Net Equity Note ThCh$ ThCh$ ThCh$
Equity: 20
Issued capital 230,892,178 230,892,178 236,327,716
Retained earnings 180,110,975 147,508,036 109,955,729
Accumulated other comprehensive income and capital reserves (16,146,887) (4,851,620) —
Equity attributable to equityholders of the parent 394,856,266 373,548,594 346,283,445
Non-controlling interests 8,330 9,141 10,837
Total equity 394,864,596 373,557,735 346,294,282
Total liabilities and equity 695,205,704 648,944,963 628,127,683
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The paid-in capital of the Company totaled
ThCh$230,892,178 as of December 31, 2010, divided
into 760,274,542 Series A and B shares. The distribution
and differentiation of these is detailed as follows:











A 380,137,271 380,137,271 380,137,271










20.1.3 Rights of Each Series:
• Series A: Election of 6 of the 7 directors and their re-
spective alternates.
• Series B: Receipt of 10% more of dividends than what
is received by holders of Series A shares, and election
of 1 of 7 directors.
20.2 Dividend Policy
According to Chilean law, cash dividends must be paid equal
to at least 30% of annual net profits, barring a unanimous
vote by shareholders to the contrary. If there is no net profit
in a given year, the company will not be legally obligated
to pay dividends from retained earnings. At the 2010 annual
shareholders meeting, the shareholders authorized the board
to pay interim dividends during July and October 2010 and
January 2011, at its discretion.
During 2009 and 2010, the shareholders’ meeting ap-
proved an extraordinary dividend payment against the re-
tained earnings fund in light of significant cash generation.
We cannot guarantee that those payments will be repeated
in the future.
Regarding Circular Letter N◦ 1945 of the Chilean Super-
intendence of Securities and Insurance, the Company does
not present any adjustments to be made in order to deter-
mine distributable net earnings to comply with minimum legal
amounts.
Pursuant to Circular Letter N◦ 1945 of the Chilean Super-
intendence of Securities and Insurance dated September 29,
2009, during the session held October 26, 2010, the Com-
pany’s Board of Directors decided to maintain the initial ad-
justments of adopting IFRS as retained earnings for future
distribution.
Retained earnings at the date of IFRS adoption amounted
to ThCh$19,260,703, of which ThCh$935,908 have been re-
alized at December 31, 2010 and are available for distribution











Concept Event Realized ThCh$ ThCh$ ThCh$
Revaluation of non-depreciating assets Sale or deterioration 10,958,958 — 10,958,958
Foreign currency translation differences of
investments in related companies
Sale or deterioration 6,393,518 — 6,393,518
Revaluation of depreciating assets Depreciation 1,579,165 (264,582) 1,314,583
Full absorption cost accounting Sale of products 813,885 (813,885) —
Post-employment benefits actuarial calculation Termination of employees 929,560 (238,543) 691,017
Deferred taxes supplementary accounts Depreciation (1,414,383) 381,102 (1,033,281)
Revaluation of non-depreciating assets 19,260,703 (935,908) 18,324,795
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The dividends declared and paid during 2010 and 2009 are
presented below:










2011 January Interim 2010 8.50 9.35
2010 January Interim 2009 7.00 7.70
April Final 2009 11.70 12.87
May Additional Retained Earnings 50.00 55.00
July Interim 2010 8.50 9.35
October Interim 2010 8.50 9.35
2009 January Interim 2008 7.00 7.70
April Final 2008 14.13 15.543
May Additional Retained Earnings 43.00 47.30
July Interim 2009 7.00 7.70
October Interim 2009 7.00 7.70
Capital Structure—Equalization Agreement
Author’s Note
Five survey companies have a capital structure gov-
erned by an equalization agreement whereby two
parent entities, together with the other entities under
common control, operate as a single reporting unit. The
parent entities have the same directors. The two enti-
ties are domiciled in different countries and the struc-
ture generally has tax advantages for both the compa-
nies and their shareholders. This structure is generally
referred to as a dual listed company structure (DLC
structure). These companies are:
• BHP Billiton Limited (Australia) and BHP Billi-
ton plc (United Kingdom)
• Mondi Limited (South Africa) and Mondi plc
(United Kingdom)
• Reed Elsevier NV (The Netherlands) and Reed
Elsevier PLC (United Kingdom)
• Rio Tinto Limited (Australia) and Rio Tinto PLC
(United Kingdom)
• Unilever N.V. (The Netherlands) and Unilever plc
(United Kingdom)
Although the companies may issue separate annual
reports, the financial statements contained therein are
identical.
2.23
Reed Elsevier NV and Reed Elsevier PLC
(Dec 2010)
Author’s Note
As explained in note 1, Basis of the Financial State-
ments, of the Reed Elsevier plc consolidated financial
statements:
“On January 1, 1993 Reed Elsevier PLC and Reed
Elsevier NV contributed their businesses to two com-
panies, Reed Elsevier Group plc and Elsevier Reed
Finance BV. Reed Elsevier Group plc, which owns all
the publishing and information businesses, is incorpo-
rated in England and Elsevier Reed Finance BV, which
owns the financing and treasury companies, is incorpo-
rated in the Netherlands. Reed Elsevier PLC and Reed
Elsevier NV each hold a 50% interest in Reed Elsevier
Group plc. Reed Elsevier PLC holds a 39% interest
in Elsevier Reed Finance BV with Reed Elsevier NV
holding a 61% interest. Reed Elsevier PLC addition-
ally holds an indirect equity interest in Reed Elsevier
NV, reflecting the arrangements entered into between
Reed Elsevier PLC and Reed Elsevier NV at the time
of the merger, which determined the equalisation ratio
whereby one Reed Elsevier NV ordinary share is, in
broad terms, intended to confer equivalent economic
interests to 1.538 Reed Elsevier PLC ordinary shares.
Under the equalisation arrangements Reed Elsevier
PLC shareholders have a 52.9% economic interest in
the Reed Elsevier combined businesses and Reed Else-
vier NV shareholders (other than Reed Elsevier PLC)
have a 47.1% interest. Holders of ordinary shares in
Reed Elsevier PLC and Reed Elsevier NV enjoy sub-
stantially equivalent dividend and capital rights with
respect to their ordinary shares.”
The excerpts that follow are from the combined fi-
nancial statements of the two entities and from the
separate consolidated financial statements of Reed
Elsevier plc and Reed Elsevier N.V. respectively.
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COMBINED STATEMENT OF FINANCIAL POSITION









Goodwill 16 4,441 4,339 4,901
Intangible assets 17 3,457 3,632 4,404
Investments in joint ventures 18 136 135 145
Other investments 18 48 41 49
Property, plant and equipment 19 291 292 329
Net pension assets 8 55 110 152
Deferred tax assets 21 151 208 353
8,579 8,757 10,333
Current Assets
Inventories and pre-publication costs 22 228 275 348
Trade and other receivables 23 1,475 1,492 1,685
Derivative financial instruments 20 134 71 76
Cash and cash equivalents 13 742 734 375
2,579 2,572 2,484
Assets held for sale 24 — 5 49
Total assets 11,158 11,334 12,866
Current Liabilities
Trade and other payables 25 2,584 2,471 2,769
Derivative financial instruments 20 80 102 258
Borrowings 26 516 678 448
Taxation 646 479 554
Provisions 28 71 134 79
3,897 3,864 4,108
Non-Current Liabilities
Borrowings 26 3,786 4,028 5,694
Deferred tax liabilities 21 1,192 1,272 1,525
Net pension obligations 8 225 345 521
Provisions 28 88 61 35
5,291 5,706 7,775
Liabilities associated with assets held for sale 24 — 5 2
Total liabilities 9,188 9,575 11,885
Net assets 1,970 1,759 981
Capital and Reserves
Combined share capitals 30 224 225 209
Combined share premiums 31 2,754 2,807 2,529
Combined shares held in treasury 32 (677) (698) (783)
Translation reserve 33 29 (100) (14)
Other combined reserves 34 (387) (502) (988)
Combined shareholders’ equity 1,943 1,732 953
Non-controlling interests 27 27 28
Total equity 1,970 1,759 981
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COMBINED STATEMENT OF CHANGES IN EQUITY
(in part)

































Balance at January 1, 2010 225 2,807 (698) (100) (502) 1,732 27 1,759
Total comprehensive
income for the year — — — 94 596 690 6 696
Dividends paid 15 — — — — (483) (483) (8) (491)
Issue of ordinary shares,
net of expenses — 11 — — — 11 — 11
Decrease in share based
remuneration reserve — — — — (7) (7) — (7)
Settlement of share awards — — 9 — (9) — — —
Exchange differences on
translation of capital and
reserves (1) (64) 12 35 18 — 2 2
Balance at December 31,
2010 224 2,754 (677) 29 (387) 1,943 27 1,970
NOTES TO THE COMBINED FINANCIAL
STATEMENTS (in part)
1. Basis of Preparation
The Reed Elsevier combined financial statements are pre-
pared in accordance with International Financial Reporting
Standards (“IFRS”) as issued by the International Account-
ing Standards Board (“IASB”) and IFRS as adopted by the
European Union.
The equalisation agreement between Reed Elsevier PLC
and Reed Elsevier NV has the effect that their sharehold-
ers can be regarded as having the interests of a single eco-
nomic group. The Reed Elsevier combined financial state-
ments (“the combined financial statements”) represent the
combined interests of both sets of shareholders and encom-
pass the businesses of Reed Elsevier Group plc and Elsevier
Reed Finance BV and their respective subsidiaries, asso-
ciates and joint ventures, together with the two parent com-
panies, Reed Elsevier PLC and Reed Elsevier NV (“the com-
bined businesses”).
Reed Elsevier PLC
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION









Investments in joint ventures 12 1,037 927 515
Total assets 1,037 927 515
Current Liabilities
Taxation 9 11 11
Total liabilities 9 11 11
Net assets 1,028 916 504
Capital and Reserves
Called up share capital 13 180 180 164
Share premium account 14 1,168 1,159 1,154
Shares held in treasury (including in joint ventures) 15 (312) (317) (347)
Capital redemption reserve 16 4 4 4
Translation reserve 17 142 92 157
Other reserves 18 (154) (202) (628)
Total equity 1,028 916 504
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CONSOLIDATED STATEMENT OF CHANGES
IN EQUITY

























Balance at January 1, 2010 180 1,159 (317) 4 92 (202) 916
Total comprehensive
income for the year — — — — 50 302 352
Equity dividends paid 9 — — — — — (245) (245)
Issue of ordinary shares,
net of expenses — 9 — — — — 9
Share of joint ventures’
settlement of share
awards by employee
benefit trust — — 5 — — (5) —
Share of joint ventures’
decrease in share based
remuneration reserve — — — — — (4) (4)
Balance at December 31,
2010 180 1,168 (312) 4 142 154 1,028
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS OF Reed Elsevier PLC (in part)
2. Accounting Policies (in part)
Basis of Preparation
These consolidated financial statements report the consol-
idated income statement, cash flow and financial position
of Reed Elsevier PLC, and have been prepared under the
historic cost convention and in accordance with accounting
policies that are in conformity with International Financial Re-
porting Standards (“IFRS”) as issued by the International Ac-
counting Standards Board (“IASB”) and IFRS as adopted by
the European Union (“EU”).
Unless otherwise indicated, all amounts shown in the fi-
nancial statements are in pounds sterling (“£”).
The basis of the merger of the businesses of Reed Elsevier
PLC and Reed Elsevier NV is set out on page 11.
Determination of Profit
The Reed Elsevier PLC share of the Reed Elsevier com-
bined results has been calculated on the basis of the 52.9%
economic interest of the Reed Elsevier PLC shareholders
in the Reed Elsevier combined businesses, after taking ac-
count of results arising in Reed Elsevier PLC and its sub-
sidiaries. Dividends paid to Reed Elsevier PLC and Reed
Elsevier NV shareholders are, other than in special circum-
stances, equalised at the gross level inclusive of the UK tax
credit received by certain Reed Elsevier PLC shareholders.
In Reed Elsevier PLC’s consolidated financial statements, an
adjustment is required to equalise the benefit of the tax credit
between the two sets of shareholders in accordance with the
equalisation agreement. This equalisation adjustment arises
on dividends paid by Reed Elsevier PLC to its shareholders
and reduces the consolidated attributable earnings by 47.1%
of the total amount of the tax credit.
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Reed Elsevier NV
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION









Investments in joint ventures 12 1,198 1,031 551
Current Assets
Amounts due from joint ventures 2 2 4
Cash and cash equivalents 3 3 12
5 5 16
Total assets 1,203 1,036 567
Current Liabilities
Payables 13 11 10 10
Taxation 55 56 66
Total liabilities 66 66 76
Net assets 1,137 970 491
Capital and Reserves
Share capital issued 14 54 53 49
Paid-in surplus 15 2,169 2,168 1,712
Shares held in treasury (including in joint ventures) 16 (433) (434) (477)
Translation reserve 17 (51) (153) (138)
Other reserves 18 (602) (664) (655)
Total equity 1,137 970 491
CONSOLIDATED STATEMENT OF CHANGES
IN EQUITY





















Balance at January 1, 2010 53 2,168 (434) (153) (664) 970
Total comprehensive income for the year — — — 98 349 447
Equity dividends paid 9 — — — — (281) (281)
Issue of ordinary shares, net of expenses 1 1 — — — 2
Share of joint ventures’ settlement of share
awards by employee benefit trust — — 5 — (5) —
Share of joint ventures’ decrease in share
based remuneration reserve — — — — (4) (4)
Equalisation adjustments — — — — 3 3
Exchange translation differences — — (4) 4 — —
Balance at December 31, 2010 54 2,169 (433) (51) (602) 1,137
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS OF Reed Elsevier NV
1. Basis of Financial Statements
These consolidated financial statements report the consoli-
dated income statement, cash flow and financial position of
Reed Elsevier NV and are presented using the equity method.
The consolidated financial statements have been prepared
under the historical cost convention.
Unless otherwise indicated, all amounts shown in the con-
solidated financial statements are stated in euros (“€”). Cer-
tain disclosures required to comply with Dutch statutory re-
porting requirements have been omitted.
The Reed Elsevier combined financial statements on pages
F-3 to F-53 form an integral part of the notes to Reed Elsevier
NV’s consolidated financial statements.
As a consequence of the merger of the company’s busi-
nesses with those of Reed Elsevier PLC, the shareholders of
Reed Elsevier NV and Reed Elsevier PLC can be regarded
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as having the interests of a single economic group, enjoying
substantially equivalent ordinary dividend and capital rights




These consolidated financial statements, which have been
prepared under the historic cost convention, report the con-
solidated statements of income, cash flow and financial po-
sition of Reed Elsevier NV, and have been prepared in ac-
cordance with accounting policies that are in conformity with
International Financial Reporting Standards (IFRS) as issued
by the International Accounting Standards Board (IASB) and
as adopted by the European Union (EU).
Unless otherwise indicated, all amounts shown in the fi-
nancial statements are in euros (“€”).
The basis of the merger of the businesses of Reed Elsevier
PLC and Reed Elsevier NV is set out on page 11.
Reed Elsevier NV’s consolidated financial statements are
presented incorporating Reed Elsevier NV’s investments in
the Reed Elsevier combined businesses accounted for using
the equity method, as adjusted for the effects of the equal-
isation arrangement between Reed Elsevier NV and Reed
Elsevier PLC. The arrangement lays down the distribution of
dividends and net assets in such a way that Reed Elsevier
NV’s share in the profit and net assets of the Reed Elsevier
combined businesses equals 50%, with all settlements ac-
cruing to shareholders from the equalisation arrangements
taken directly to reserves. Further detail is provided in note 3.
Because the dividend paid to shareholders by Reed Else-
vier NV is, other than in special circumstances, equivalent
to the Reed Elsevier PLC dividend plus the UK tax credit
received by certain Reed Elsevier PLC shareholders, Reed
Elsevier NV normally distributes a higher proportion of the
combined profit attributable than Reed Elsevier PLC. Reed
Elsevier PLC’s share in this difference in dividend distribu-
tions is settled with Reed Elsevier NV and is credited directly
to consolidated reserves under equalisation. Reed Elsevier
NV can pay a nominal dividend on its R shares held by a sub-
sidiary of Reed Elsevier PLC that is lower than the dividend
on the ordinary shares. Equally, Reed Elsevier NV has the
possibility to receive dividends directly from Dutch affiliates.
Reed Elsevier PLC is compensated by direct dividend pay-
ments by Reed Elsevier Group plc. The settlements flowing
from these arrangements are also taken directly to consoli-
dated reserves under equalisation.
Convertible Redeemable Preference Shares,
Suppliers’ Investment Shares, Members’
Shares, New Ordinary Shares
2.24
Silver Fern Farms Limited (Sep 2010)
BALANCE SHEET (in part)
As at 30 September 2010
Parent Consolidated
NZD in Thousands ($000) Notes As at 30 Sept 10 As at 31 Aug 09 As at 30 Sept 10 As at 31 Aug 09
Net assets excluding members’ shares 378,004 326,544 367,771 316,261
Convertible redeemable preference shares 19, 22 1,595 1,622 1,595 1,622
Supplier investment shares 22 7,203 24,754 7,203 24,754
Members’ ordinary shares 22 20,360 47,769 20,360 47,769
Total members’ shares 29,158 74,145 29,158 74,145
Net assets 348,846 252,399 338,613 242,116
Equity—equity attributable to equity holders of the parent
New ordinary shares 22 117,560 — 117,560 —
Retained earnings 128,878 197,405 126,251 191,841
Other reserves 23 102,408 54,994 94,802 50,275
Total equity 348,846 252,399 338,613 242,116
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
v Convertible Redeemable Preference Shares
The convertible redeemable preference shares exhibit char-
acteristics of a liability, and are therefore recognised as a
liability in the balance sheet.
The convertible redeemable preference shares are mea-
sured initially at cost, being the fair value of the consideration
received net of issue costs associated with the borrowing.
After initial recognition, these shares are subsequently mea-
sured at amortised cost using the effective interest method
which allocates the cost through the expected life of the loan
or borrowing. Amortised cost is calculated taking into account
any issue costs.
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w Members’ Shares
i Members Ordinary Shares
The Co-operative’s share capital includes the amount of
shares issued to the members of the Co-operative. From
time to time, existing members leave the Co-operative and
new members join the Co-operative. Members who leave the
Co-operative are entitled, after a length of time, to have their
share capital amounts repaid to them. New members are re-
quired to subscribe to shares in the Co-operative.
Silver Fern Farms Limited has two classes of Members’
shares: Members’ ordinary shares which are issued to sup-
pliers who supply stock under the Silver Fern Farms rebate
system and Supplier investment shares, which are issued to
all suppliers of stock to Silver Fern Farms (subject to cer-
tain restrictions). All Members’ shares have a nominal value
of one dollar per share. Supplier investment shares are paid
to ninety cents by the supplier with the balance of ten cents
being paid by way of a dividend from retained earnings.
Members’ ordinary shares carry full voting rights subject to
the shareholder being a Current Supplier (as defined in Silver
Fern Farms constitution) at the time of voting. Supplier invest-
ment shares carry voting rights in relation to director elections
only. Members’ shares participate equally on winding up.
The current maximum shareholdings for Members’ ordi-
nary shares and Supplier investment shares are 17,500 and
15,000 respectively.
Members’ shares are eligible to receive a dividend subject
to profitability, although any such dividend is likely to be re-
stricted to fully paid Supplier investment shares. Members’
ordinary shares shareholders are eligible to receive a rebate
based on the profit earned from stock supplied.
Due to the obligations of the Co-operative set out above,
the Co-operative share capital meets the definition of a finan-
cial liability as per NZ IAS 32: Financial Instruments Disclo-
sure and Presentation, and hence, the issued and paid up
capital is classified as a financial liability.
ii New Ordinary Shares
New ordinary shares are classified as equity. Incremental
costs attributable to the issue of new shares are shown in
equity as a deduction, net of tax, from the proceeds.











Declared and paid during the year:
Dividends on convertible
redeemable preference shares 98 127
Members’ ordinary shares issued — 26
Total members’ distributions paid
and proposed 98 153
22. Convertible Redeemable Preference Shares,
Members’ Shares and New Ordinary Shares
In October 2009 the change in the capital structure was fi-
nalised resulting in the issue of new ordinary shares. These
shares began trading on the Unlisted exchange on 27 Octo-
ber 2009. As the new ordinary shares are not redeemable,
they have been classified as equity. The details of the mem-
bers shares and new ordinary shares movements as a result
of the capital raising are as follows:














Balance as at 1 September 2008 2,654 23,937 47,777 — 74,368
Shares issued during the year — 1,283 1,631 — 2,914
Shares surrendered (1,032) (466) (1,639) — (3,137)
Balance as at 31 August 2009 1,622 24,754 47,769 — 74,145
New ordinary shares issued — — — 4,173 4,173
New ordinary shares issued where settlement is deferred (non-cash) — — — 16,163 16,163
Supplier investment shares exchanged (non-cash) — (17,235) — 17,235 —
Members’ ordinary shares exchanged (non-cash) — — (25,669) 25,669 —
Transaction costs paid on ordinary share issue — — — (901) (901)
Taxable bonus issue of new ordinary shares (non-cash) — — — 55,221 55,221
Total of transactions associated with capital raising — (17,235) (25,669) 117,560 74,656
Shares surrendered (27) (316) (1,740) — (2,083)
Balance as at 30 September 2010 1,595 7,203 20,360 117,560 146,718
Called/uncalled
20.360m Members’ ordinary shares of $1 each — — 20,360 — 20,360
63.419m New ordinary shares—fully paid — — — 91,542 91,542
18.025m New ordinary shares—partly paid — — — 26,018 26,018
Issued and fully paid — — 20,360 117,560 137,920
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a Convertible Redeemable Preference Shares
Convertible redeemable preference shares were issued on
1 December 2002. A dividend of 6% (or as otherwise de-
termined by the board) plus any available imputation cred-
its, is paid on the anniversary of their issue. Convertible re-
deemable preference shares may next be redeemed at the
option of the holder on 1 December 2011 and every three
years thereafter.
Convertible redeemable preference shares are currently
finite and subject to a fixed term with rights of renewal.
b Members Shares
Silver Fern Farms Limited has two classes of Members’
shares: Members’ ordinary shares which are issued to sup-
pliers who supply stock under Silver Fern Farms Limited’s
rebate system and Supplier investment shares, which are is-
sued to all suppliers of stock to Silver Fern Farms (subject
to certain restrictions). All Members’ shares have a nominal
value of one dollar per share. Supplier investment shares are
paid to ninety cents by the supplier with the balance of ten
cents being paid by way of a dividend from retained earnings.
Members’ shares are currently classified as a financial liabil-
ity as Silver Fern Farms does not have the unconditional right
to refuse redemption.
Members’ ordinary shares carry full voting rights subject
to the shareholder being a Current Supplier (as defined in
Silver Fern Farms’ Limited constitution) at the time of voting.
Supplier investment shares carry voting rights in relation to
director elections only. Ordinary Shares participate equally
on winding up.
The maximum shareholding for Members’ ordinary shares
and Supplier investment shares is 17,500 (2009: 17,500) and
15,000 (2009: 15,000) respectively.
Silver Fern Farms Limited’s Members’ shares are eligible
to receive a dividend subject to profitability, although any
such dividend is likely to be restricted to fully paid Supplier
investment shares. Members’ ordinary shares shareholders
are eligible to receive a rebate based on the profit earned
from stock supplied.
c New Ordinary Shares Issued
As part of the change in the capital structure, shareholders
could elect to exchange Members’ ordinary shares and Sup-
plier investment shares for New ordinary shares on a one
for one basis; no cash was payable on exchange. In addi-
tion to the exchange of shares, shareholders could elect to
participate in a two for one rights issue. Under the terms of
the rights issue, shareholders were entitled to subscribe in
cash for two New ordinary shares for every one New ordinary
share issued to them under the exchange offer.
The rights issue price per New ordinary share of $1.00
was payable either in full on application or under a deferred
payment option, over a period of approximately three years
by way of deduction from proceeds of the sale of livestock.
Under the deferred payment option, the New ordinary shares
must be fully paid by February 2013. The deferred payments
due are held at their fair value based on their discounted ex-
pected future cashflows. The discount rate applied is 7.3%.






NZD in Thousands ($000) As at 30 Sept 10 As at 31 Aug 09
Deferred payments due within
12 months 6,486 —
Deferred payments due after
12 months 6,192 —
Total deferred payments 12,678 —
Multiple Classes of Preference Shares,
Treasury Shares, Minority Interest
2.25
Anooraq Resources Corporation (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
As at 31 December 2010 and 2009
(Expressed in Canadian Dollars, unless otherwise stated)
Note 2010 2009
Equity
Share capital 18 71,852,588 71,713,114
Treasury shares 18 (4,991,726) (4,991,726)
Convertible preference shares 18 162,910,000 162,910,000
Foreign currency translation reserve (5,197,843) (9,390,899)
Hedging reserve (4,124,155) (731,293)
Share-based payment reserve 22,032,571 19,770,786
Accumulated loss (163,519,502) (111,798,092)
Total equity attributable to equity holders of the Company 78,961,933 127,481,890
Non-controlling interest 42,404,014 82,025,730
Total equity 121,365,947 209,507,620
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CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
For the years ended 31 December 2010, 2009 and 2008
(Expressed in Canadian Dollars, unless otherwise stated)
Note 2010 2009 2008
Cash flows from financing activities
Long-term borrowings raised 19 41,382,644 125,380,745 3,630,000
Common shares issued 67,809 15,869,148 2,037,558
“A” Preference shares issued 19 — 177,720,000 —
“A” Preference shares repaid 19 — (1,066,320) —
“B” Preference shares issued 18 — 162,910,000 —
Transaction costs paid 19 — (4,857,128) —
Vendor claims settled 34 — (251,770,000) —
Interest-free loan raised 19 599,442 4,267,913 —
Loans repaid 19 (590,537) (16,790,368) —
Cash generated from financing activities 41,459,358 211,663,990 5,667,558
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
4. Accounting Policies (in part)
These consolidated financial statements are presented in (un-
less stated otherwise) Canadian Dollars (“$”), which is also
the Company’s functional currency.
(iv) Share Capital
Common Shares
Common shares are classified as equity. Incremental costs
directly attributable to the issue of common shares and share
options are recognised as a deduction from equity, net of any
tax effects.
Preference Share Capital
Preference share capital is classified as equity if it is non-
redeemable, redeemable for a fixed number of the Com-
pany’s shares, or redeemable only at the Company’s option,
and any dividends are discretionary. Dividends thereon are
recognised as distributions within equity upon approval by the
Company’s Board of Directors.
Preference share capital is classified as a liability if it is
redeemable on a specific date or at the option of the hold-
ers, or if dividend payments are not discretionary. Dividends
thereon are recognised as finance expense in profit or loss
as accrued.
Treasury Shares
Shares issued to subsidiaries or SPE’s are reflected as trea-




Common shares with no par value 201,813,472 201,743,472
B2 Convertible Preference shares
of $0.1481 (ZAR 1) each 115,800 115,800
B3 Convertible Preference shares
of $0.1481 (ZAR 1) each 111,600 111,600
The Company’s authorised share capital consists of an un-
limited number of common shares without par value. Dur-
ing 2009 cumulative convertible redeemable “B” preference




Share capital 74,035,621 73,896,147
Share issue costs (2,183,033) (2,183,033)
71,852,588 71,713,114
The Company issued the following common shares on 1 July
2009:
• Anglo Platinum contributed an amount of $15.4 million
(ZAR 103.8 million) to the Anooraq Community Partic-
ipation Trust. Approximately $10.9 million was used to
acquire shares of the Company. As of 1 July 2009, the
Company issued 9,799,505 common shares at $1.11 to
the Anooraq Community Participation Trust.
• Anglo Platinum contributed approximately $6.8 million
(ZAR 45.6 million) to the Bokoni Platinum Mine ESOP
Trust (“ESOP Trust”), of which $5 million was used to
acquire shares of the Company. As of 1 July 2009, the
Company issued 4,497,062 common shares at $1.11 to
the ESOP Trust. The ESOP Trust is consolidated as a
SPE by the Group (refer below).
Number of Shares
Treasury shares 4,991,726 4,991,726
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Treasury shares relate to shares held by the ESOP Trust in
Anooraq, which is consolidated by the Group.
Preference Shares
2010 2009
B2 Convertible Preference shares 17,150 17,150
B3 Convertible Preference shares 16,528 16,528
Share premium 162,876,322 162,876,322
162,910,000 162,910,000
$162.9 million (ZAR 1.1 billion) was raised through share-
settled financing with the issue of cumulative mandatory con-
vertible “B” preference shares (“B Prefs”) to RPM and a sub-
sidiary of Pelawan to finance the acquisition discussed in
note 34. The final effects of the share settled financing will
result in RPM receiving a fixed number of 115.8 million com-
mon shares of Anooraq and Pelawan, Anooraq’s controlling
shareholder, receiving a fixed number of 111.6 million com-
mon shares.
These preference shares are convertible upon the earlier
of the date of receipt of a conversion notice from RPM and 1
July 2018.
A dividend will be declared on the last business day imme-
diately prior to the conversion date, in terms of a formula set
out in the preference share subscription agreement.
Ordinary and Deferred Shares
2.26
Helical Bar plc (Mar 2010)
GROUP AND COMPANY BALANCE SHEETS
(in part)










Called-up share capital 1,447 1,339 1,447 1,339
Share premium account 98,678 70,828 98,678 70,828
Revaluation reserve 3,495 — — —
Capital redemption reserve 7,478 7,478 7,478 7,478
Other reserves 291 291 1,987 1,987
Retained earnings 143,886 162,547 137,831 152,831
Equity attributable to equity holders of the parent 255,275 242,483 247,421 234,463
Non-controlling interests 122 124 — —
Total equity 255,397 242,607 247,421 234,463
The financial statements were approved by the Board of
Directors on 15 June 2011.









The authorised share capital of the Company is
£39,576,626.60 divided into ordinary shares of 1p each and





Allotted, called up and fully paid
—118,137,522 ordinary shares of 1p each (2010:
107,407,522) 1,182 1,074
—212,145,300 deferred shares of 1/8p each 265 265
1,447 1,339
As at 1 April 2010 the Company had 107,407,522 ordinary 1p
shares in issue. On 8 December 2010 the Company issued
10,730,000 new ordinary 1p shares to shareholders as a part
of the Placing referred to in the Financial Review on page
38. At 31 March 2011 there were 118,137,522 ordinary 1p
shares in issue.
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Shares Share Shares Share
in Issue Capital in Issue Capital
31.3.11 31.3.11 31.3.10 31.3.10
Number £000 Number £000
Ordinary shares
At 1 April 107,407,522 1,074 107,087,012 1,071
New shares issued 10,730,000 108 320,510 3
At 31 March 118,137,522 1,182 107,407,522 1,074
Deferred shares
At 1 April 212,145,300 265 212,145,300 265
At 31 March 212,145,300 265 212,145,300 265
The Group’s capital management objectives are:
• to ensure the Group’s ability to continue as a going
concern; and,
• to provide an adequate return to shareholders.
The Group sets the amount of capital in proportion to its over-
all financing structure. It manages the capital structure and
makes adjustments to it in the light of changes in economic
conditions and the risk characteristics of the underlying as-
sets. In order to maintain or adjust the capital structure, the
Group may adjust the amount of dividends paid to share-
holders, return capital to shareholders, issue new shares, or
sell assets to reduce debt. Capital is defined as being issued
share capital, retained earnings and other reserves. (2011:
247,797,000; 2010: £235,005,000).
The deferred shares were issued on 23 December 2004 to
those shareholders electing to receive a dividend, rather than
a capital repayment or further I shares in the Company, as
part of the Return of Cash approved by shareholders on 20
December 2004. The deferred shares carry no voting rights
and have no right to a dividend or capital payment in the event
of a winding up of the Company.
The Company’s Articles of Association give the Company
irrevocable authority to purchase all or any of the deferred
shares for a maximum aggregate total of 1 penny for all de-




CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)





Cash and cash equivalents 5,919 6,207
Restricted cash 90 82
Trade accounts receivable and other, including
392 and 616 from related parties at December
31, 2009 and 2010, respectively (note 6 and 14) 5,750 5,725
Inventories (note 7) 16,835 19,583
Prepaid expenses and other current assets (note 8) 4,212 4,160
Assets held for sale and distribution (note 5) 1 6,918
Total current assets 32,807 42,675
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 8: Prepaid Expenses and Other Current Assets
Other current assets consist of advance payments to tax-
ing and other public authorities (including value-added tax
(“VAT”)), income tax receivable, revaluation of derivative fi-
nancial instruments, and other, which is made up of advances
to employees, prepayments, accrued interest, dividends re-
ceivable and other miscellaneous receivables.
December 31
2009 2010
VAT recoverable 1,298 1,694
Income tax receivable 983 434
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Inventories and work in progress, net (18) & (19) 3,045 2,295 1,902 2,390 2,465
Trade receivables and other receivables, net (18) & (20) 4,862 3,664 3,519 4,693 4,601
Advances and progress payments (18) 99 75 93 99 110
Other current assets (21) 1,174 885 960 1,395 1,117
Current income taxes 223 168 157 113 60
Marketable securities, net (17) & (26) 861 649 1,993 906 894
Cash and cash equivalents (26) 6,688 5,040 3,577 3,687 4,377
Current assets before assets held for sale 16,952 12,776 12,201 13,283 13,624
Assets held for sale and assets included in disposal
groups held for sale (10) 4 3 51 1,348 35
Total current assets 16,956 12,779 12,252 14,631 13,659
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 18. Operating Working Capital (in part)
Operating Working Capital
(In Millions of Euros) December 31, 2010 December 31, 2009 December 31, 2008
Inventories and work in progress, net 2,295 1,902 2,390
Trade receivables and other receivables, net 3,664 3,519 4,693
Advances and progress payments 75 93 99
Customers’ deposits and advances (803) (639) (993)
Trade payables and other payables (4,325) (3,926) (4,571)
Operating working capital, net 906 949 1,618
As explained in Note 4, the presentation of the working capital
items related to construction contracts was amended from
January 1, 2010 onwards.
(In Millions of Euros) As Published in Reclassification Restated
Operating Working Capital-



















Inventories and work in progress, net 1,624 2,196 2,235 278 194 230 1,902 2,390 2,465
Trade receivables and other
receivables, net 3,221 4,330 4,163 298 363 438 3,519 4,693 4,601
Advances and progress payments 93 99 110 — — — 93 99 110
Customers’ deposits and advances (639) (929) (847) — (64) (224) (639) (993) (1,071)
Trade payables and other payables (3,926) (4,571) (4,514) — — — (3,926) (4,571) (4,514)
Amounts due from customers on
construction contracts 528 495 704 (528) (495) (704) — — —
Amounts due to customers on
construction contracts (66) (188) (407) 66 188 407 — — —
Operating working capital, net 835 1,432 1,444 114 186 147 949 1,618 1,591
(1) Beginning of the earliest comparative period is presented, as requested by IAS 1 § 39 due to the change in presentation described in Note 4.
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The amounts of €114 million as of December 31, 2009, €186
million as of December 31, 2008 and €147 million as of Jan-
uary 1, 2008 represent product sales reserves on construc-
tion contracts. They have been reclassified to Provisions in
the statement of financial position.
Current and Non-Current Assets—Prepaid
Expenses and Prepaid Lease Payments
2.29
China Gold International Resources Corp, Ltd
(formerly, Jinshan Gold Mines Inc.) (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION (in part)







Cash and cash equivalents 13 301,608,717 23,984,660
Restricted cash 14 6,725,129 —
Accounts receivable 15 9,050,490 1,681,880
Prepaid expenses and deposits 16 3,418,499 1,734,181
Prepaid lease payments 17 137,808 —
Inventory 18 34,154,278 10,166,429
355,094,921 37,567,150
Assets classified as held for sale 20 54,696 188,971
355,149,617 37,756,121
Non-current assets
Prepaid expense and deposits 16 2,395,882 —
Prepaid lease payments 17 6,634,081 —
Amount due from a non-controlling shareholder 19 419,768 —
Long-term receivable — 49,689
Inventory 18 17,838,819 18,852,686
Property, plant and equipment 20 297,901,855 117,918,672
Intangible assets 21 975,282,711 —
1,300,473,116 136,821,047
Total assets 1,655,622,733 174,577,168
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Summary of Significant Accounting Policies (in part)
Prepaid Lease Payments
Prepaid lease payments representing land use rights in the
PRC are stated at cost and amortized on a straight-line basis
over the lease terms. Prepaid lease payments which are to
be amortized in the next twelve months or less are classified
as current assets.
Leasehold Land and Building
When a lease includes both land and building elements, the
Group assesses the classification of each element as a fi-
nance or an operating lease separately based on the assess-
ment as to whether substantially all the risks and rewards inci-
dental to ownership of each element have been transferred to
the Group. Specifically, the minimum lease payments (includ-
ing any lump-sum upfront payments) are allocated between
the land and the building elements in proportion to the relative
fair values of the leasehold interests in the land element and
building element of the lease at the inception of the lease.
To the extent the allocation of the lease payments can be
made reliably, interest in leasehold land that is accounted
for as an operating lease is presented as “prepaid lease pay-
ments” in the consolidated statement of financial position and
is amortized over the lease term on a straight-line basis.
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Deposits for mine supplies and services 2,006,484 705,420
Deposits for environmental protection
(note a) 1,640,902 —
Deposits for spare parts 881,343 133,036
Prepayment for the land use rights
(note b) 754,979 —
Insurance 331,621 286,787
Rent deposits 19,272 246,846
Refundable CSH Gold Mine
construction deposits — 192,876
Other 179,780 169,216
Total prepaid expenses and deposits 5,814,381 1,734,181
Less: Amounts that are utilized within one
year shown under current assets (3,418,499) (1,734,181)
Amounts that are utilized for more than
one year shown under non-current
assets 2,395,882 —
Notes:
(a) The amount represents deposits paid to the PRC local land ad-
ministration bureau for undertaking the restoration of land to its
present condition when the lease term is expired that are ex-
pected to be utilized after one year and therefore shown as a
non-current asset.
(b) The amount represents advances to PRC local land administra-
tion bureau for acquisition of properties in Tibet, the PRC. The
Group is still negotiating the terms with the PRC local land admin-
istration bureau as of the date of issue of the financial statements.
The amount is shown as non-current asset.
17. Prepaid Lease Payment
US$
At January 1, 2009, December 31, 2009
and January 1, 2010 —
Acquired on acquisition of subsidiaries
(Note 27) 6,730,498
Release to profit or loss (7,447)
Exchange realignment 48,838





Analyzed for reporting purpose:
Current portion 137,808 —
Non-current portion 6,634,081 —
6,771,889 —
Prepaid lease payments represent payments for medium-
term leasehold land of 50 years located in the PRC. The
prepaid lease payments are released to profit or loss over
the remaining lease terms.
The Group is in the process of obtaining the land use right
certificate of a parcel of land included in prepaid lease pay-
ment with carrying amount of approximately US$2,407,000
at December 31, 2010.
Current Liabilities—Premiums and Discounts
to Suppliers, Sales Commisions, Deferred
Revenue and Advances From Customers
2.30
Luxottica Group S.p.A (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
For the years ended December 31, 2010 and 2009
(Amounts in Thousands of Euro) Note Reference 2010 2009
Liabilities and Stockholders’ Equity
Current liabilities:
Short-term borrowings 14 158,648 148,951
Current portion of long-term debt 15 197,566 166,279
Accounts payable 16 537,742 434,604
Income taxes payable 17 60,067 11,204
Other liabilities 18 549,280 554,136
Total current liabilities 1,503,303 1,315,174
IFRS ATT 2.30
139Section 2: Statement of Financial Position and Related Disclosures
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
18. Other Liabilities
As of December 31
(Amounts in Thousands of Euro) 2010 2009
Premiums and discounts to suppliers 27,507 24,179
Sales commissions 1,135 1,775
Leasing rental 22,370 16,051
Insurance 9,255 9,476
Sales taxes payable 35,994 36,336
Salaries payable 183,559 155,101
Due to social security authorities 26,156 21,483
Sales commissions payable 7,154 3,363
Royalties payable 1,602 1,096
Other financial liabilities 125,858 192,849
Total financial liabilities 440,590 461,709
Deferred income 1,356 1,480
Customers’ right of return 27,744 27,334
Advances from customers 53,835 36,680
Other liabilities 25,755 26,933
Total liabilities 108,690 92,427
Total other current liabilities 549,280 554,136
The decrease of other financial liabilities is primarily due to
the payment in May 2010 of the purchase price of Euro 61.8
million for the acquisition of the non-controlling interest in
the Group’s Turkish subsidiary (Luxottica Gözlük Endüstri ve
Ticaret Anonim Sirketi).
Other liabilities consist of the current portion of funds set
aside for the provision for risks that primarily include:
• provisions for long-term insurance risk of Euro 1.0 mil-
lion as of December 31, 2010 (Euro 1.9 million as of
December 31, 2009);
• provisions for licensing expenses and advertising ex-
penses for licensed designer brands of Euro 6.7 million
as of December 31, 2010 (Euro 7.6 million as of De-
cember 31, 2009), which are based upon advertising
expenses that the Group is required to incur under li-
cense agreements; and
• provisions for various legal disputes which have oc-
curred in the ordinary course of business totaling Euro
5.2 million as of December 31, 2010 (Euro 1.0 million
as of December 31, 2009).
Current and Non-Current Liabilities—Deferred
Income
2.31
British Sky Broadcasting Group plc (Jun 2010)
CONSOLIDATED BALANCE SHEET (in part)








Trade and other payables 20 1,526 1,492
Current tax liabilities 136 173
Provisions 21 27 18
Derivative financial liabilities 23 10 46
1,699 2,194
Non current liabilities
Borrowings 22 2,458 2,279
Trade and other payables 22 52 66
Provisions 21 11 12
Derivative financial liabilities 23 17 82
Deferred tax liability 17 7
2,545 2,439
Total liabilities 4,244 4,633
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Policies (in part)
v. Trade and Other Payables
Trade and other payables are non-derivative financial liabili-
ties and are measured at amortised cost using the effective
interest method. Trade and other payables with no stated in-
terest rate are measured at the original invoice amount if the
effect of discounting is immaterial.





Gross trade receivables 303 297
Less: provision for impairment of receivables (153) (118)
Net trade receivables 150 179
Amounts receivable from joint ventures and
associates 6 5
Amounts receivable from other related parties 3
Prepayments 197 221
Accrued income 135 116
VAT 18 52
Other 29 40
Current trade and other receivables 538 613
Non current prepayments 18 21
Total trade and other receivables 556 634
Included within current trade and other receivables is nil
(2009: £54 million) which is due in more than one year.
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The ageing of the Group’s net trade receivables which are





Up to 30 days past due date 50 56
30 to 60 days past due date 6 11
60 to 120 days past due date 5 7
More than 120 days past due date 4 5
65 79
The Directors consider that the carrying amount of trade and
other receivables approximates to their fair values. The Group
is exposed to credit risk on its trade and other receivables,
however the Group does not have any significant concentra-
tions of credit risk, with exposure spread over a large number
of counterparties and customers. Trade receivables princi-
pally comprise amounts outstanding from subscribers, ad-
vertisers and other customers.





Balance at beginning of year 118 84
Amounts utilised (5) (7)
Income statement charge 40 41
Balance at end of year 153 118





Trade payables(i) 419 407
Amounts owed to joint ventures and associates 4 3
Amounts owed to other related parties 70 69
VAT 105 93
Accruals 609 586
Deferred income 251 269
Other 68 65
1,526 1,492
(i) Included within trade payables are £755 million (2009: £143 mil-
lion) of US dollar denominated programme payables.
The Directors consider that the carrying amount of trade
and other payables approximates to their fair values. Trade
payables principally comprise amounts outstanding for pro-
gramming purchases and ongoing costs.
Liabilities in Liquidity Order—Insurance
Liabilities, Unallocated Divisible Surplus
2.32
Aviva plc (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION (in part)




Gross insurance liabilities J & 36 177,700 171,092
Gross liabilities for investment
contracts K & 37 117,787 110,015
Unallocated divisible surplus J & 41 3,428 3,866
Net asset value attributable to
unitholders C 9,032 9,894
Provisions Y, Z & 44 2,943 3,980
Deferred tax liabilities AA & 43b 1,758 1,038
Current tax liabilities 43a 314 192
Borrowings AB & 46 14,949 15,000
Payables and other financial
liabilities Q & 47 20,292 20,542
Other liabilities 48 4,179 3,653
Liabilities of operations classified
as held for sale AF & 3c — 33
Total liabilities 352,382 339,305
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
36—Insurance Liabilities
This note analyses our insurance contract liabilities by type of
product and describes how we calculate these liabilities and
what assumptions we have used.
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(a) Carrying Amount






















Participating 64,043 — 64,043 64,702 — 64,702
Unit-linked non-participating 21,450 — 21,450 21,268 — 21,268
Other non-participating 75,453 — 75,453 68,088 — 68,088
160,946 — 160,946 154,058 — 154,058
Outstanding claims provisions 1,078 9,528 10,606 921 9,977 10,898
Provision for claims incurred but not reported — 2,735 2,735 — 2,719 2,719
1,078 12,263 13,341 921 12,696 13,617
Provision for unearned premiums — 4,855 4,855 — 4,781 4,781
Provision arising from liability adequacy tests — 2 2 — 7 7
Other technical provisions — 1 1 — — —
Total 162,024 17,121 179,145 154,979 17,484 172,463
Less:
Obligations to staff pension schemes transferred to
provisions (note 44a) (1,445) — (1,445) (1,351) — (1,351)
Amounts classified as held for sale — — — — (20) (20)
160,579 17,121 177,700 153,628 17,464 171,092
During 2010, the Group conducted a review of its classifi-
cation of linked liabilities, following refinement of our policy
which now defines unit-linked liabilities as those where all
risks attached to the assets held to back those liabilities are
borne by the policyholders. The review resulted in a reclas-
sification of £1,890 million of insurance liabilities previously
included as unit-linked non-participating liabilities as at 31 De-
cember 2009 to other non-participating liabilities. As a result
of this reclassification, assets held to cover linked liabilities
have also decreased by £1,890 million (see note 25).
(b) Long-Term Business Liabilities
(i) Business Description
The Group underwrites long-term business in a number of
countries as follows:
• In the UK mainly in:
— New With-Profits sub-fund (NWPSF) of Aviva Life &
Pensions UK (UKLAP), where the with-profit policy-
holders are entitled to at least 90% of the distributed
profits, the shareholders receiving the balance. Any
surplus or deficit emerging in NWPSF that is not dis-
tributed as bonus will be transferred from this sub-
fund to the Reattributed Inherited Estate External
Support Account (RIEESA) (see below).
— Old With-Profits sub-fund (OWPSF), With-Profits
sub-fund (WPSF) and Provident Mutual sub-fund
(PMSF) of UKLAP, where the with-profit policyhold-
ers are entitled to at least 90% of the distributed prof-
its, the shareholders receiving the balance.
— ‘Non-profit’ funds of Aviva Annuity UK and UKLAP,
where shareholders are entitled to 100% of the dis-
tributed profits. Shareholder profits on unitised with-
profit business written by WPSF and on stakeholder
unitised with-profit business are derived from man-
agement fees and policy charges, and emerge in the
non-profit funds.
— The RIEESA of UKLAP, which is a non-profit fund
where shareholders are entitled to 100% of the dis-
tributed profits, but these cannot be distributed until
the ‘lock-in’ criteria set by the Reattribution Scheme
have been met. RIEESA will be used to write non-
profit business and also to provide capital support to
NWPSF.
• In France, where the majority of policyholders’ bene-
fits are determined by investment performance, sub-
ject to certain guarantees, and shareholders’ profits are
derived largely from management fees. In addition, a
substantial number of policies participate in investment
returns, with the balance being attributable to share-
holders.
• In the Netherlands, the balance of profits, after provid-
ing appropriate returns for policyholders and after tax,
accrues for the benefit of the shareholders. The bases
for determining returns for policyholders are complex,
but are consistent with methods and criteria followed
generally in the Netherlands. In addition, a substantial
number of policies provide benefits that are determined
by investment performance, subject to certain guaran-
tees, and shareholders’ profits are derived largely from
management fees.
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• In the United States, there are two main types of
business—protection products and accumulation prod-
ucts. Protection products include interest-sensitive
whole life, term life, universal life and indexed life in-
surance policies. The accumulation product segment
includes traditional fixed and indexed deferred annu-
ities for individuals and funding agreements for business
customers. In addition, there are two closed blocks of
participating contracts arising from demutualisations of
subsidiary companies. All products are classified as in-
surance contracts except for the funding agreements
and term certain immediate annuities, which are classi-
fied as non-participating investment contracts.
• In other overseas operations.
(ii) Group Practice
The long-term business provision is calculated separately for
each of the Group’s life operations. The provisions for over-
seas subsidiaries have generally been included on the basis
of local regulatory requirements, modified where necessary
to reflect the requirements of the UK Companies Act.
Material judgement is required in calculating the provisions
and is exercised particularly through the choice of assump-
tions where discretion is permitted. In turn, the assumptions
used depend on the circumstances prevailing in each of the
life operations. Provisions are most sensitive to assumptions
regarding discount rates and mortality/morbidity rates.
Bonuses paid during the year are reflected in claims paid,
whereas those allocated as part of the bonus declaration
are included in the movements in the long-term business
provision.
(iii) Methodology and Assumptions
There are two main methods of actuarial valuation of liabili-
ties arising under long-term insurance contracts—the net pre-
mium method and the gross premium method—both of which
involve the discounting of projected premiums and claims.
Under the net premium method, the premium taken into
account in calculating the provision is determined actuari-
ally, based on the valuation assumptions regarding discount
rates, mortality and disability. The difference between this
premium and the actual premium payable provides a mar-
gin for expenses. This method does not allow for voluntary
early termination of the contract by the policyholder, and so
no assumption is required for persistency. Explicit provision
is made for vested bonuses (including those vesting follow-
ing the most recent fund valuation), but no such provision
is made for future regular or terminal bonuses. However, this
method makes implicit allowance for future regular or terminal
bonuses already earned, by margins in the valuation discount
rate used.
The gross premium method uses the amount of contractual
premiums payable and includes explicit assumptions for in-
terest and discount rates, mortality and morbidity, persistency
and future expenses. These assumptions can vary by con-
tract type and reflect current and expected future experience.
Explicit provision is made for vested bonuses and explicit




The valuation of with-profit business uses the methodology
developed for the Realistic Balance Sheet, adjusted to re-
move the shareholders’ share of future bonuses. The key
elements of the Realistic Balance Sheet methodology are
the with-profit benefit reserve (WPBR) and the present value
of the expected cost of any payments in excess of the WPBR
(referred to as the cost of future policy-related liabilities). The
realistic liability for any contract is equal to the sum of the
WPBR and the cost of future policy-related liabilities. The
WPBR for an individual contract is generally calculated on a
retrospective basis, and represents the accumulation of the
premiums paid on the contract, allowing for investment re-
turn, taxation, expenses and any other charges levied on the
contract.
For a small proportion of business, a prospective valuation
approach is used, including allowance for anticipated future
regular and final bonuses.
The items included in the cost of future policy-related lia-
bilities include:
• Maturity Guarantees;
• Guaranteed Annuity Options;
• GMP underpin on Section 32 transfers; and
• Expected payments under Mortgage Endowment
Promise.
In the Provident Mutual and With-Profits sub-funds in UKLAP,
this is offset by the expected cost of charges to WPBR to be
made in respect of guarantees.
The cost of future policy-related liabilities is determined us-
ing a market-consistent approach and, in the main, this is
based on a stochastic model calibrated to market conditions
at the end of the reporting period. Non-market-related as-
sumptions (for example, persistency, mortality and expenses)
are based on experience, adjusted to take into account future
trends.
The principal assumptions underlying the cost of future
policy-related liabilities are as follows:
Future Investment Return
A ‘risk-free’ rate equal to the spot yield on UK government
securities, plus a margin of 0.1% is used. The rates vary,
according to the outstanding term of the policy, with a typical
rate as at 31 December 2010 being 3.78% (2009: 4.35%) for
a policy with ten years outstanding.
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Volatility of Investment Return
Volatility assumptions are set with reference to implied volatil-
ity data on traded market instruments, where available, or on
a best estimate basis where not. These are term-dependent,
with specimen values for ten-year terms as follows:
Volatility
2010 2009
Equity returns 26.1% 26.6%
Property returns 15.0% 15.0%
Fixed interest yields 13.2% 14.4%
The table above shows the volatility of fixed interest yields, set
with reference to 20 year at-the-money swaption volatilities.
Future Regular Bonuses
Annual bonus assumptions for 2011 have been set con-
sistently with the year-end 2010 declaration. Future annual
bonus rates reflect the principles and practices of the fund. In
particular, the level is set with regard to the projected margin
for final bonus and the change from one year to the next is
limited to a level consistent with past practice.
Mortality
Mortality assumptions are set with regard to recent Company
experience and general industry trends. The mortality tables























Conventional non-profit contracts, including those written in
the with-profit funds, are valued using gross premium meth-
ods which discount projected future cash flows. The cash
flows are calculated using the amount of contractual premi-
ums payable, together with explicit assumptions for invest-
ment returns, inflation, discount rates, mortality, morbidity,
persistency and future expenses. These assumptions vary
by contract type and reflect current and expected future ex-
perience.
For unit-linked and some unitised with-profit business, the
provisions are valued by adding a prospective non-unit re-
serve to the bid value of units. The prospective non-unit re-
serve is calculated by projecting the future non-unit cash flows
on the assumption that future premiums cease, unless it is
more onerous to assume that they continue. Where appropri-
ate, allowance for persistency is based on actual experience.
Valuation discount rate assumptions are set with regard
to yields on the supporting assets and the general level of
long-term interest rates as measured by gilt yields. An ex-
plicit allowance for risk is included by restricting the yields
for equities and properties with reference to a margin over
long-term interest rates or by making an explicit deduction
from the yields on corporate bonds, mortgages and deposits,
based on historical default experience of each asset class. A
further margin for risk is then deducted for all asset classes.
The provisions held in respect of guaranteed annuity op-
tions are a prudent assessment of the additional liability in-
curred under the option on a basis and method consistent
with that used to value basic policy liabilities, and includes a
prudent assessment of the proportion of policyholders who
will choose to exercise the option.





Life conventional non-profit 2.8% to 3.5% 3.0% to 3.8%
Pensions conventional non-profit 3.5% to 3.7% 3.8% to 4.0%
Deferred annuities
Non-profit—in deferment 3.9% 4.2%
Non-profit—in payment 3.5% to 3.7% 3.8% to 4.0%
Annuities in payment




Mortality assumptions are set with regard to recent Company
experience and general industry trends. The mortality tables
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(b) France
The majority of reserves arise from a single premium sav-
ings product and is based on the accumulated fund value,
adjusted to maintain consistency with the value of the assets
backing the policyholder liabilities. The net premium method
is used for prospective valuations, in accordance with local
regulation, where the valuation assumptions depend on the
date of issue of the contract. The valuation discount rate also
depends on the original duration of the contract and mortality
rates are based on industry tables.
Valuation Discount Mortality Tables
Rates Used
2010 and 2009 2010 and 2009






Annuities 0% to 4.5% TPRV (prospective table)
(c) Netherlands
On transition to IFRS, the valuation of most long-term in-
surance and participating investment contracts was changed
from existing methods that used historic assumptions to an
active basis using current market interest rates. A liability
adequacy test is performed in line with IFRS requirements.
Where liabilities are based on current market interest rates
and assets are valued at market value, the margin in the
liability adequacy test is determined by comparison of the li-
abilities with the present value of best estimate cash flows.
The yield curve is constructed from yields on collateralised
AAA bonds. Annuitant mortality assumptions were revised in
2010.
Valuation Discount Mortality Tables
Rates Used
2010 and 2009 2010 and 2009

























For the major part of our US business, insurance liabilities
are measured in accordance with US GAAP as at the date of
acquisition.
The liability for future policy benefits for traditional life in-
surance is computed using the net level method, based on
guaranteed interest and mortality rates as used in calculating
cash surrender values. Reserve interest assumptions ranged
from 2.00% to 7.50% in 2010 (2009: 2.00% to 7.50%). The
weighted average interest rate for all traditional life policy re-
serves in 2010 was 4.50% (2009: 4.47%).
Future policy benefit reserves for universal life insurance,
deferred annuity products and funding agreements are com-
puted under a retrospective deposit method and represent
policy account balances before applicable surrender charges.
For the indexed products, the liability held is calculated based
on the option budget method and is equal to the host con-
tract and the calculated value of the derivative. The value
of the derivative is based on the present value of the differ-
ence between the projected fund value and the underlying
fund guarantee. The range of interest crediting rates for de-
ferred annuity products, the largest component of the US
business, excluding sales inducement payouts, was 1.00%
to 5.20% in 2010 (2009: 2.00% to 6.00%). An additional lia-
bility is established for universal life contracts with death or
other insurance benefit features, which is determined using
an equally weighted range of scenarios with respect to in-
vestment returns, policyholder lapses, benefit election rates,
premium payout patterns and mortality. The additional liabil-
ity represents the present value of future expected benefits
based on current product assumptions.
The indexed life and annuity products guarantee the return
of principal to the customer, and credit interest based on cer-
tain indices. A portion of the premium from each customer is
invested in fixed income securities and is intended to cover
the minimum guaranteed value. A further portion of the pre-
mium is used to purchase derivatives to hedge the growth
in interest credited to the customer as a direct result of in-
creases in the related indices. Both the derivatives and the
options embedded in the policy are valued at their fair value.
Deferred income reserves are established for fees charged
for insurance benefit features which are assessed in a man-
ner that is expected to result in higher profits in earlier years,
followed by lower profits or losses in subsequent years. The
excess charges are deferred and amortised using the same
assumptions and factors used to amortise deferred acquisi-
tion costs. Shadow adjustments may be made to deferred
acquisition costs, acquired value of in-force business, de-
ferred income reserves and contract liabilities. The shadow
adjustments are recognised directly in other comprehensive
income so that unrealised gains or losses on investments
that are recognised directly in other comprehensive income
affect the measurement of the liability, or related assets, in
the same way as realised gains or losses.
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(e) Other Countries
In all other countries, local generally accepted interest rates
and published standard mortality tables are used for different
categories of business as appropriate. The tables are based
on relevant experience and show mortality rates, by age, for
specific groupings of people.
(iv) Movements
The following movements have occurred in the long-term
business provisions during the year:
2010 2009
£m £m
Carrying amount at 1 January 154,058 156,188
Provisions in respect of new business 12,502 11,105
Expected change in existing business
provisions (9,259) (7,625)
Variance between actual and expected
experience 1,858 2,154
Impact of other operating assumption
changes (520) (121)
Impact of economic assumption changes 1,959 (404)
Exceptional strengthening of longevity
assumptions (see below) 483 —
Other movements (197) 1,112
Change in liability recognised as an expense 6,826 6,221
Effect of portfolio transfers, acquisitions and
disposals 1,117 (67)
Foreign exchange rate movements (1,055) (8,284)
Carrying amount at 31 December 160,946 154,058
The variance between actual and expected experience of
£1.9 billion in 2010 was primarily driven by favourable move-
ments in investment markets, which had a direct or indirect
impact on liability values. Equity markets increased, govern-
ment bond yields fell in major markets and credit spreads on
corporate bonds were broadly unchanged. For many types
of long-term business, including unit-linked and participating
funds, movements in asset values are offset by correspond-
ing changes in liabilities, limiting the net impact on profit.
Minor variances arise from differences between actual and
expected experience for persistency, mortality and other de-
mographic factors.
The impact of assumption changes in the above analysis
shows the resulting movement in the carrying value of in-
surance liabilities. A strengthening of longevity assumptions
was made in the Netherlands, following the publication of new
mortality tables, which is separately identified as an excep-
tional item. The reduction in liabilities from other operating
assumption changes mainly relates to assurance mortality
assumptions in the UK and Ireland, with a corresponding re-
duction made to reassurance assets. The £2.0 billion impact
of economic assumption changes reflects reductions in valu-
ation interest rates. For participating business, a movement
in liabilities is generally offset by a corresponding adjustment
to the unallocated divisible surplus and does not impact on
profit. Where assumption changes do impact on profit, these
are included in the effect of changes in assumptions and es-
timates during the year shown in note 40, together with the
impact of movements in related non-financial assets.
(c) General Insurance and Health Liabilities
(i) Provisions for Outstanding Claims
Delays occur in the notification and settlement of claims and
a substantial measure of experience and judgement is in-
volved in assessing outstanding liabilities, the ultimate cost
of which cannot be known with certainty at the statement of fi-
nancial position date. The reserves for general insurance and
health business are based on information currently available.
However, it is inherent in the nature of the business written
that the ultimate liabilities may vary as a result of subsequent
developments.
Provisions for outstanding claims are established to cover
the outstanding expected ultimate liability for losses and loss
adjustment expenses (LAE) in respect of all claims that have
already occurred. The provisions established cover reported
claims and associated LAE, as well as claims incurred but
not yet reported and associated LAE.
We only establish loss reserves for losses that have al-
ready occurred. We therefore do not establish catastrophe
equalisation reserves that defer a share of income in respect
of certain lines of business from years in which a catastrophe
does not occur to future periods in which catastrophes may
occur. When calculating reserves, we take into account esti-
mated future recoveries from salvage and subrogation, and
a separate asset is recorded for expected future recoveries
from reinsurers after considering their collectability.
The table below shows the split of total general insurance
and health outstanding claim provisions and IBNR provisions,
gross of reinsurance, by major line of business.





















Motor 4,419 924 5,343 4,411 753 5,164
Property 1,669 188 1,857 1,697 196 1,893
Liability 2,388 1,303 3,691 2,707 1,379 4,086
Creditor 77 24 101 170 17 187
Other 975 296 1,271 992 374 1,366
9,528 2,735 12,263 9,977 2,719 12,696
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(ii) Discounting
Outstanding claims provisions are based on undiscounted
estimates of future claim payments, except for the following
classes of business for which discounted provisions are held:
Rate Mean Term of Liabilities
Class 2010 2009 2010 2009
Netherlands Permanent health and injury 3.75% 3.48% 7 years 8 years
Reinsured London Market business 3.30% 4.00% 12 years 10 years
Latent claims 0.88% to 4.18% 0.82% to 4.84% 7 to 15 years 8 to 15 years
Structured settlements 3.20% 3.30% 35 years 35 years
The gross outstanding claims provision before discounting
was £13,179 million (2009: £13,576 million). The period of
time which will elapse before the liabilities are settled has
been estimated by modelling the settlement patterns of the
underlying claims.
The discount rate that has been applied to latent claims
reserves is based on the relevant swap curve in the relevant
currency having regard to the expected settlement dates of
the claims. The range of discount rates used depends on
the duration of the claims and is given in the table above. The
duration of the claims span over 35 years, with the average
duration being between 7 and 15 years depending on the
geographical region.
During 2010, we have continued to experience an increase
in the number of bodily injury claims settled by periodic pay-
ment orders (PPOs) or structured settlements, especially in
the UK, which are reserved for on a discounted basis.
(iii) Assumptions
Outstanding claims provisions are estimated based on known
facts at the date of estimation. Case estimates are generally
set by skilled claims technicians, applying their experience
and knowledge to the circumstances of individual claims.
They take into account all available information and corre-
spondence regarding the circumstances of the claim, such as
medical reports, investigations and inspections. Claims tech-
nicians set case estimates according to documented claims
department policies and specialise in setting estimates for
certain lines of business or types of claim. Claims above cer-
tain limits are referred to senior claims handlers for authori-
sation.
No adjustments are made to the claims technicians’ case
estimates included in booked claim provisions, except for rare
occasions when the estimated ultimate cost of a large or
unusual claim may be adjusted, subject to internal reserve
committee approval, to allow for uncertainty regarding, for
example, the outcome of a court case. The ultimate cost of
outstanding claims is then estimated by using a range of
standard actuarial claims projection techniques, such as the
Chain Ladder and Bornhuetter-Ferguson methods. The main
assumption underlying these techniques is that a company’s
past claims development experience can be used to project
future claims development and hence ultimate claims costs.
As such, these methods extrapolate the development of paid
and incurred losses, average costs per claim and claim num-
bers based on the observed development of earlier years
and expected loss ratios. Historical claims development is
mainly analysed by accident period, although underwriting
or notification period is also used where this is considered
appropriate.
Claim development is separately analysed for each geo-
graphic area, as well as by each line of business. Certain
lines of business are also further analysed by claim type or
type of coverage. In addition, large claims are usually sepa-
rately addressed, either by being reserved at the face value
of loss adjuster estimates or separately projected in order to
reflect their future development.
The assumptions used in most non-life actuarial projection
techniques, including future rates of claims inflation or loss
ratio assumptions, are implicit in the historical claims devel-
opment data on which the projections are based. Additional
qualitative judgement is used to assess the extent to which
past trends may not apply in the future, for example, to reflect
one-off occurrences, changes in external or market factors
such as public attitudes to claiming, economic conditions,
levels of claims inflation, judicial decisions and legislation, as
well as internal factors such as portfolio mix, policy conditions
and claims handling procedures in order to arrive at a point
estimate for the ultimate cost of claims that represents the
likely outcome, from a range of possible outcomes, taking
account of all the uncertainties involved. The range of possi-
ble outcomes does not, however, result in the quantification
of a reserve range.
However, the following explicit assumptions are made
which could materially impact the level of booked net re-
serves:
UK Mesothelioma Claims
The level of uncertainty associated with latent claims is con-
siderable due to the relatively small number of claims and the
long-tail nature of the liabilities. UK mesothelioma claims ac-
count for a large proportion of the Group’s latent claims. The
key assumptions underlying the estimation of these claims
include claim numbers, the base average cost per claim, fu-
ture inflation in the average cost of claims, legal fees and the
life expectancy of potential sufferers.
The best estimate of the liabilities reflects the latest avail-
able market information and studies. Many different scenarios
can be derived by flexing these key assumptions and applying
different combinations of the different assumptions. An upper
and lower scenario can be derived by making reasonably
likely changes to these assumptions, resulting in an estimate
£195 million greater than the best estimate, or £85 million
lower than the best estimate. These scenarios do not, how-
ever, constitute an upper or lower bound on these liabilities.
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Interest Rates Used to Discount Latent Claim Liabilities
The discount rates used in determining our latent claim lia-
bilities are based on the relevant swap curve in the relevant
currency at the reporting date, having regard to the dura-
tion of the expected settlement of latent claims. The range
of discount rates used is shown in section (ii) above and de-
pends on the duration of the claim and the reporting date.
At 31 December 2010, it is estimated that a 1% fall in the
discount rates used would increase net claim reserves by
approximately £70 million, excluding the offsetting effect on
asset values as assets are not hypothecated across classes
of business. The impact of a 1% fall in interest rates across
all assets and liabilities of our general insurance and health
businesses is shown in note 54(i).
Allowance for Risk and Uncertainty
The uncertainties involved in estimating loss reserves are
allowed for in the reserving process and by the estimation
of explicit reserve uncertainty distributions. The reserve es-
timation basis for non-life claims adopted by the Group at
31 December 2010 requires all non-life businesses to cal-
culate booked claim provisions as the best estimate of the
cost of future claim payments, plus an explicit allowance for
risk and uncertainty. The allowance for risk and uncertainty is
calculated by each business unit in accordance with the re-
quirements of the Group non-life reserving policy, taking into
account the risks and uncertainties specific to each line of
business and type of claim in that territory. The requirements
of the Group non-life reserving policy also seek to ensure
that the allowance for risk and uncertainty is set consistently
across both business units and reporting periods.
Changes to claims development patterns can materially im-
pact the results of actuarial projection techniques. However,
allowance for the inherent uncertainty in the assumptions un-
derlying reserving projections is automatically allowed for in
the explicit allowance for risk and uncertainty included when
setting booked reserves.
Lump sum payments in settlement of bodily injury claims
decided by the UK courts are calculated in accordance with
the Ogden Tables. The Ogden Tables contain a discount rate
that is set by the Lord Chancellor and that is applied when
calculating the present value of loss of earnings for claims
settlement purposes.
The Ogden discount rate is currently under review by the
Lord Chancellor. The outcome of this review is expected to be
announced in 2011 but it is still not clear whether or by how
much the rate will change. A reduction in the Ogden discount
rates will increase lump sum payments to UK bodily injury
claimants.
(iv) Movements
The following changes have occurred in the general insur-
ance and health claims provisions during the year:
2010 2009
£m £m
Carrying amount at 1 January 12,696 14,360
Impact of changes in assumptions 26 (106)
Claim losses and expenses incurred in the
current year 6,908 7,328
Decrease in estimated claim losses and
expenses incurred in prior years (358) (541)
Exceptional strengthening of general insurance
latent claims provisions 10 60
Incurred claims losses and expenses 6,586 6,741
Less:
Payments made on claims incurred in the
current year (3,641) (3,922)
Payments made on claims incurred in prior
years (3,803) (3,814)
Recoveries on claim payments 271 298
Claims payments made in the year, net of
recoveries (7,173) (7,438)
Unwind of discounting 64 41
Other movements in the claims provisions (18) —
Change in claims reserve recognised as an
expense (541) (656)
Effect of portfolio transfers, acquisitions and
disposals 4 (649)
Foreign exchange rate movements 102 (359)
Other movements 2 —
Carrying amount at 31 December 12,263 12,696
The exceptional strengthening of reserves is in respect of
several specific discontinued commercial liability risks written
in Canada a significant number of years ago.
The effect of changes in the main assumptions is given in
note 40.
(d) Loss Development Tables
(i) Description of Tables
The tables that follow present the development of claim pay-
ments and the estimated ultimate cost of claims for the acci-
dent years 2001 to 2010. The upper half of the tables shows
the cumulative amounts paid during successive years related
to each accident year. For example, with respect to the acci-
dent year 2002, by the end of 2010 £5,814 million had actually
been paid in settlement of claims. In addition, as reflected in
the lower section of the table, the original estimated ultimate
cost of claims of £6,250 million was re-estimated to be £6,035
million at 31 December 2010.
The original estimates will be increased or decreased, as
more information becomes known about the individual claims
and overall claim frequency and severity.
The Group aims to maintain strong reserves in respect of
its general insurance and health business in order to protect
against adverse future claims experience and development.
As claims develop and the ultimate cost of claims become
more certain, the absence of adverse claims experience will
result in a release of reserves from earlier accident years, as
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shown in the loss development tables and movements table
(c)(iv) above. However, in order to maintain overall reserve
adequacy, the Group establishes strong reserves in respect
of the current accident year (2010) where the development of
claims is less mature and there is much greater uncertainty
attaching to the ultimate cost of claims. Releases from prior
accident year reserves are also due to an improvement in the
estimated cost of claims.
Key elements of the release from prior accident year gen-
eral insurance and health net provisions during 2009 were:
• £230 million from the UK, including group reinsurance
business, mainly due to an improved view of group rein-
surance liabilities, and favourable development on per-
sonal and commercial motor claims, and commercial
property and commercial liability large claims.
• £237 million from Europe mainly due to favourable de-
velopment of personal motor and commercial property,
especially in respect of large claims.
• £79 million from Canada mainly due to favourable ex-
perience on motor and personal property.
Key elements of the release from prior accident year general
insurance and health net provisions during 2010 were:
• £101 million from the UK, including group reinsurance
business, mainly due to an improved view of group
reinsurance liabilities, and favourable development on
personal property claims, and commercial property and
commercial liability large claims.
• £167 million from Europe mainly due to favourable de-
velopment of personal and commercial property.
• £44 million from Canada mainly due to favourable ex-
perience on motor and commercial liability.
(ii) Gross Figures




Years 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Total
Accident Year £m £m £m £m £m £m £m £m £m £m £m £m
Gross cumulative claim payments
At end of accident year (3,029) (2,952) (2,819) (2,971) (3,345) (3,653) (4,393) (4,915) (3,780) (3,502)
One year later (4,766) (4,486) (4,190) (4,561) (5,011) (5,525) (6,676) (7,350) (5,464)
Two years later (5,303) (4,921) (4,613) (4,981) (5,449) (5,971) (7,191) (7,828)
Three years later (5,701) (5,233) (4,972) (5,263) (5,784) (6,272) (7,513)
Four years later (5,966) (5,466) (5,258) (5,448) (6,001) (6,531)
Five years later (6,121) (5,618) (5,409) (5,617) (6,156)
Six years later (6,223) (5,715) (5,527) (5,725)
Seven years later (6,294) (5,767) (5,594)
Eight years later (6,350) (5,814)
Nine years later (6,389)
Estimate of gross ultimate claims
At end of accident year 6,590 6,250 6,385 6,891 7,106 7,533 8,530 9,508 7,364 6,911
One year later 6,770 6,372 6,172 6,557 6,938 7,318 8,468 9,322 7,297
Two years later 6,775 6,287 6,124 6,371 6,813 7,243 8,430 9,277
Three years later 6,798 6,257 6,036 6,178 6,679 7,130 8,438
Four years later 6,754 6,205 5,932 6,008 6,603 7,149
Five years later 6,679 6,122 5,853 6,003 6,605
Six years later 6,630 6,056 5,813 5,953
Seven years later 6,576 6,044 5,792
Eight years later 6,600 6,035
Nine years later 6,577
Estimate of gross ultimate claims 6,577 6,035 5,792 5,953 6,605 7,149 8,438 9,277 7,297 6,911
Cumulative payments (6,389) (5,814) (5,594) (5,725) (6,156) (6,531) (7,513) (7,828) (5,464) (3,502)
3,040 188 221 198 228 449 618 925 1,449 1,833 3,409 12,558
Effect of discounting (747) (6) (11) (29) (7) (28) (27) (9) (11) (24) (17) (916)
Present value 2,293 182 210 169 221 421 591 916 1,438 1,809 3,392 11,642
Cumulative effect of foreign
exchange movements — 29 31 47 52 85 122 111 (16) 17 — 478
Effect of acquisitions — 7 8 50 10 18 15 27 8 — — 143
Present value recognised in the
statement of financial position 2,293 218 249 266 283 524 728 1,054 1,430 1,826 3,392 12,263
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(iii) Net of Reinsurance
After the effect of reinsurance, the loss development table is:
All
Prior
Years 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Total
Accident Year £m £m £m £m £m £m £m £m £m £m £m £m
Net cumulative claim payments
At end of accident year (2,970) (2,913) (2,819) (2,870) (3,281) (3,612) (4,317) (4,808) (3,650) (3,386)
One year later (4,624) (4,369) (4,158) (4,378) (4,925) (5,442) (6,542) (7,165) (5,286)
Two years later (5,088) (4,779) (4,565) (4,712) (5,344) (5,881) (7,052) (7,638)
Three years later (5,436) (5,064) (4,924) (4,986) (5,671) (6,181) (7,356)
Four years later (5,648) (5,297) (5,180) (5,163) (5,892) (6,434)
Five years later (5,763) (5,424) (5,325) (5,327) (6,039)
Six years later (5,841) (5,508) (5,442) (5,430)
Seven years later (5,896) (5,552) (5,502)
Eight years later (5,954) (5,598)
Nine years later (5,979)
Estimate of net ultimate claims
At end of accident year 6,185 6,037 6,218 6,602 6,982 7,430 8,363 9,262 7,115 6,650
One year later 6,333 6,038 6,093 6,266 6,818 7,197 8,302 9,104 7,067
Two years later 6,321 5,997 6,037 6,082 6,688 7,104 8,244 9,028
Three years later 6,329 5,973 5,942 5,882 6,544 6,996 8,249
Four years later 6,286 5,912 5,851 5,709 6,476 6,980
Five years later 6,219 5,855 5,772 5,699 6,448
Six years later 6,173 5,786 5,683 5,639
Seven years later 6,109 5,754 5,663
Eight years later 6,130 5,742
Nine years later 6,090
Estimate of net ultimate claims 6,090 5,742 5,663 5,639 6,448 6,980 8,249 9,028 7,067 6,650
Cumulative payments (5,979) (5,598) (5,502) (5,430) (6,039) (6,434) (7,356) (7,638) (5,286) (3,386)
1,750 111 144 161 209 409 546 893 1,390 1,781 3,264 10,658
Effect of discounting (414) (3) (5) (8) (3) (3) (5) (9) (11) (24) (16) (501)
Present value 1,336 108 139 153 205 406 541 884 1,379 1,757 3,248 10,157
Cumulative effect of foreign
exchange movements — 15 27 42 48 80 116 106 (14) 17 — 437
Effect of acquisitions — 6 7 36 8 13 13 20 8 — — 111
Present value recognised in the
statement of financial position 1,336 129 173 231 262 499 670 1,010 1,373 1,774 3,248 10,705
In the loss development tables shown above, the cumulative
claim payments and estimates of cumulative claims for each
accident year are translated into sterling at the exchange
rates that applied at the end of that accident year. The impact
of using varying exchange rates is shown at the bottom of
each table. Disposals are dealt with by treating all outstanding
and IBNR claims of the disposed entity as ‘paid’ at the date
of disposal.
The loss development tables above include information on
asbestos and environmental pollution claims provisions from
business written before 2001. The undiscounted claim pro-
visions, net of reinsurance, in respect of this business at 31
December 2010 were £939 million (2009: £968 million). The
movement in the year reflects exceptional strengthening of
provisions by £10 million (2009: £60 million) in respect of
several specific discontinued commercial liability risks written
in Canada a significant number of years ago, other strength-
ening of £66 million (2009: £62 million release), claim pay-
ments, reinsurance recoveries and foreign exchange rate
movements.
(e) Provision for Unearned Premiums
Movements
The following changes have occurred in the provision for un-





Carrying amount at 1 January 4,781 5,493
Premiums written during the year 10,469 9,958
Less: Premiums earned during the year (10,424) (10,513)
Change in UPR recognised as income 45 (645)
Gross portfolio transfers and acquisitions (14) —
Foreign exchange rate movements 43 (67)
Carrying amount at 31 December 4,855 4,781
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41—Unallocated Divisible Surplus
An unallocated divisible surplus (UDS) is established where
the nature of policy benefits is such that the division between
shareholder reserves and policyholder liabilities is uncertain.
This note shows the movements in this surplus during the
year.
The following movements have occurred in the year:
2010 2009
£m £m
Carrying amount at 1 January 3,866 2,325
Change in participating contract assets (444) (1,314)
Change in participating contract liabilities 169 3,836
Effect of special bonus to with-profit
policyholders (see note 42a) (58) (69)
Effect of reattribution of inherited estate (see
note 42b) — (881)
Other movements 4 (25)
Change in liability recognised as an expense (329) 1,547
Effect of portfolio transfers, acquisitions and
disposals (3) (4)
Movement in respect of change in pension
scheme deficit (note 45c(i)) 18 (24)
Foreign exchange rate movements (61) 43
Other movements (63) (21)
Carrying amount at 31 December 3,428 3,866
In Italy and Spain, the UDS balances were £435 million neg-
ative in total at 31 December 2010 (2009: Italy £92 million
negative) because of an accounting mismatch between par-
ticipating assets carried at market value and participating lia-
bilities measured using local practice. The negative balance
is considered to be recoverable from margins in the existing
participating business liabilities.
IAS 2, INVENTORIES
IFRS Overview and Comparison
to U.S. GAAP
2.33 IAS 2, Inventories, defines inventories as assets held for
sale in the ordinary course of business, assets in the process
of production for such sale, and materials or supplies to be
consumed in the production or rendering of services.
Recognition and Measurement
IFRSs
2.34 IAS 2 applies to all inventories, except work in pro-
cess under construction contracts (IAS 11, Construction Con-
tracts); financial instruments (IAS 32, Financial Instruments:
Presentation, and IAS 39); and biological assets (IAS 41,
Agriculture).
2.35 IAS 16, Property, Plant and Equipment, requires an
entity to include spare parts and servicing equipment as in-
ventory, except that the entity may include major spare parts
and standby equipment in PPE when it expects to use these
items for more than one period or when the parts and equip-
ment can only be used with an item of PPE. Entities should
classify intangible assets and investment properties as inven-
tory when these items are developed and held for sale in the
ordinary course of business.
2.36 To the extent that inventories are measured according
to standard industry practice at net realizable value, IAS
2 exempts the following industries from its measurement
requirements: producers of agricultural and forest products,
agricultural products after harvest, and minerals and mineral
products. Measurement requirements also do not apply to
commodity broker-dealers who measure their inventories at
fair value less cost to sell. In these cases, an entity should
recognize changes in carrying value in profit or loss.
2.37 An entity should recognize items that meet the defini-
tion of inventory when the items also meet the definition of
an asset and the recognition criteria. To meet the recogni-
tion criteria, the asset should be a probable source of future
economic benefits (probability criteria), and its cost should
be measured reliably (measurement reliability criteria). Cost
includes all costs, including purchase, conversion, and other
incurred costs, necessary to bring the assets to their present
condition and location. An entity should exclude from cost
(a) abnormal waste, storage, and administrative overheads
that do not contribute to bringing inventories to their present
location and condition and (b) selling costs.
2.38 At initial recognition, an entity should measure inven-
tories at cost of production. Production costs consist mainly
of direct labor, including supervisory costs and direct over-
head. They also include a systematic allocation of fixed and
variable production overheads that are incurred. Unallocated
overheads are expensed in the period in which they are in-
curred. Capitalized costs should not include administrative
costs, other nonattributable costs, and profit margins. Enti-
ties should measure agricultural produce at fair value less
cost to sell at the point of harvest, in accordance with IAS
41. Subsequently, unless an entity is exempt as previously
explained, the requirements of IAS 2 apply.
2.39 After initial recognition, an entity should measure in-
ventories at the lower of cost or net realizable value. Conve-
nient techniques for measuring cost, such as standard cost or
retail methods, can be used if the results approximate actual
cost.
2.40 An entity should use one of the following cost flow
assumptions to assign costs to inventories and expense:
• Specific identification for assets that are not inter-
changeable or segregated and produced for specific
projects
• First-in, first-out (FIFO)
• Weighted-average cost
IAS 2 requires an entity to apply the same cost flow assump-
tion to inventories of similar nature and use. IAS 2 prohibits
the use of the last-in, first-out (LIFO) cost flow assumption.
2.41 An entity should not carry an asset at an amount ex-
ceeding the amount it expects to realize from sale or use.
When there are indicators that the cost is not recoverable,
such as damage or decline in selling price, an entity should
write-down inventories to net realizable value. Net realizable
value is the estimated selling price in the ordinary course of
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business less estimated completion costs and costs necessary
to make the sale.
2.42 An entity should recognize the carrying amount of
inventories sold as an expense in profit or loss in the same
period as it recognizes the related revenue.
U.S. GAAP
2.43 As defined in the FASB ASC glossary, inventory is the
aggregate of those items of tangible personal property that
have any of the following characteristics:
• Held for sale in the ordinary course of business
• In process of production for such sale
• To be currently consumed in the production of goods
or services to be available for sale
Similar to IFRSs, the term inventory applies to goods await-
ing sale (the merchandise of a trading concern and the fin-
ished goods of a manufacturer), goods in the course of
production (work in process), and goods to be consumed
directly or indirectly in production (raw materials and sup-
plies). However, this definition specifically excludes from
classification as inventory long-term assets subject to depre-
ciation accounting or goods that, when put into use, will
be classified as long term. Therefore, under U.S. GAAP,
an entity should not classify intangible assets or investment
properties held for sale in the normal course of business as
inventory, but they could be so classified under IFRSs.
2.44 Two key measurement differences between IFRSs and
FASB ASC are the following:
• FASB ASC 330-10-35-1 requires an entity to measure
inventories at the lower of cost or market. Market, as
defined in the FASB ASC glossary, means current re-
placement cost, with the constraint that market should
not exceed net realizable value and should not be lower
than net realizable value less an allowance for an ap-
proximately normal profit margin.
• FASB ASC 330-10-30-9 permits the use of the LIFO
cost flow assumption.
2.45 Unlike IFRSs, FASB ASC 330, Inventory, does not
permit reversals (or recovery) of write-downs of inventory.
A write-down under FASB ASC 330-10-35-14 creates a new
cost basis, with the result that no recoveries should be recog-
nized prior to sale or disposal.
Presentation
IFRSs
2.46 An entity should present inventories as a separate line
item on the balance sheet, classified as current or noncurrent
in accordance with IAS 1.
U.S. GAAP
2.47 Given the scope exclusions noted previously in para-
graph 2.43, in accordance with FASB ASC 210-10-45-1, an
entity should generally classify inventories as current.
Disclosure
IFRSs
2.48 IAS 2 requires the following disclosures:
• Accounting policies for measuring inventories and the
cost flow assumption applied
• Total carrying amount and carrying amounts of classi-
fications appropriate to the entity
• Carrying amount of any inventories held at fair value
less cost to sell
• Amount recognized as an expense during the period
• Amounts recognized as write-downs or reversals of
write-downs during the period and a recognition of the
circumstances that led to the write-down or reversal
• Carrying amount of inventories pledged as security for
liabilities
U.S. GAAP
2.49 Required disclosures under FASB ASC are similar to
those in IAS 1, except that the SEC requires additional dis-
closures by entities that use LIFO. Rule 5-02-6(c) of SEC
Regulation S-X requires an entity to disclose the excess of
replacement or current cost over stated amounts for LIFO in-
ventories, if material. SEC Codification of Staff Accounting
Bulletins topic 11(F), “LIFO Liquidations,” requires disclo-
sures about LIFO liquidations, and topic 5(L), “LIFO Inven-
tory Practices,” directs entities to the AICPA issues paper
Identification and Discussion of Certain Financial Account-
ing and Reporting Issues Concerning LIFO Inventories for
guidance in the absence of authoritative literature.
Presentation and Disclosure Excerpts
First-In, First-Out
2.50
Trinity Biotech plc (Dec 2010)










Inventories 15 17,576 39,198
Trade and other receivables 16 25,529 22,931
Income tax receivable 217 229
Cash and cash equivalents 17 58,002 6,078
Total current assets 101,324 68,436
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Basis of Preparation and Significant Accounting
Policies (in part)
i) Inventories
Inventories are stated at the lower of cost and net realisable
value. Cost is based on the first-in, first-out principle and in-
cludes all expenditure which has been incurred in bringing the
products to their present location and condition, and includes
an appropriate allocation of manufacturing overhead based
on the normal level of operating capacity. Net realisable value
is the estimated selling price of inventory on hand in the or-
dinary course of business less all further costs to completion
and costs expected to be incurred in selling these products.
The Group provides for inventory, based on estimates of
the expected realisability of the Group’s inventory. The esti-
mated realisability is evaluated on a case-by-case basis and
any inventory that is approaching its “use-by” date and for
which no further re-processing can be performed is written
off. Any reversal of an inventory provision is recognised in









Raw materials and consumables 4,516 9,191
Work-in-progress 4,676 10,478
Finished goods 8,384 19,529
17,576 39,198
All inventories are stated at the lower of cost or net realis-
able value. Total inventories for the Group are shown net of
provisions of US$6,400,000 (2009: US$12,566,000). Note 3
outlines the net inventories which were transferred to Diag-
nostica Stago during the year as part of the divestiture of the
Coagulation business.
The movement on the inventory provision for the three year











January 1 12,566 16,461 18,234
Charged during the year 3,006 2,064 1,570
Utilised during the year (8,440) (4,751) (2,182)
Released during the year (732) (1,208) (1,161)
Closing provision at
December 31 6,400 12,566 16,461
Weighted Average Cost and Specific
Identification
2.51
Compagnie Financière Richemont SA (Mar)







Inventories 14 2,260 2,422
Trade and other receivables 15 626 672
Derivative financial instruments 16 13 18
Prepayments and accrued income 84 80
Assets of disposal groups held for sale 28 — 11
Financial assets held at fair value
through profit or loss 12 1,339 —
Cash at bank and on hand 17 1,258 2,032
5,580 5,235
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
2.10. Inventories
Inventories are stated at the lower of cost and net realisable
value. Net realisable value is the estimated selling price in
the ordinary course of business, less applicable variable sell-
ing expenses. Cost is determined using either a weighted
average or specific identification basis depending on the na-
ture of the inventory. The cost of finished goods and work in
progress comprises raw materials, direct labour, related pro-
duction overheads and, where applicable, duties and taxes.






Raw materials and work in progress 740 8,191
Finished goods 1,520 1,603
2,260 2,422
The cost of inventories recognised as an expense and in-
cluded in cost of sales amounted to €1,703 million (2009:
€1,763 million).
The Group reversed €40 million (2009: €68 million) of a
previous inventory write-down during the year as the goods
were sold at an amount in excess of the written down value.
The amount reversed has been credited to cost of sales.
The Group recognised €158 million (2009: €124 million) in
the write-down of inventory as a charge to cost of sales.
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Fair Value Less Cost to Sell—Broker Trader
Exemption From IAS 2
2.52
Barry Callebaut AG (Aug 2010)
CONSOLIDATED BALANCE SHEET (in part)
As of August 31, in
Thousands of CHF Notes 2010 2009
Assets
Current assets
Cash and cash equivalents 17,360 33,993
Short-term deposits 750 2,137
Trade receivables and other
current assets 12 587,380 524,847
Inventories 13 1,186,231 1,294,545
Current income tax assets 2,760 5,489
Derivative financial assets 14 370,580 221,649
Total current assets 2,165,061 2,082,660
ACCOUNTING POLICIES (in part)
Unnumbered Note
Inventories
The Group principally acquires cocoa beans, any semi-
finished products resulting from cocoa beans (such as cocoa
liquor, butter, cake or powder), other raw materials such as
sweeteners, dairy and nuts and has industrial chocolate in-
ventories with the purpose of selling them in the near future
and generating a profit from fluctuations in price or broker-
traders’ margin. The Group therefore acts as a broker-trader
of such commodities and these inventories are measured at
fair value less costs to sell in accordance to the broker-trader
exemption per IAS 2.5 (Inventories).
Other inventories, such as finished consumer products and
other items related to the Price List Business are stated at the
lower of cost and net realizable value. The cost of invento-
ries comprises the costs of materials, direct production costs
including labor costs and an appropriate proportion of pro-
duction overheads and factory depreciation. For movements
in inventories, the average cost method is applied. Net realiz-
able value is defined as the estimated selling price less costs
of completion and direct selling and distribution expenses.
13. Inventories
As of August 31, in Thousands of CHF 2010 2009
Cocoa bean stocks 369,758 436,754
Semi-finished and finished products 698,243 722,986
Other raw materials and packaging
materials 118,230 134,805
Total inventories 1,186,231 1,294,545
Thereof Stocks Carried at Fair Value
Less Costs to Sell
Cocoa bean stocks 351,064 420,179
Semi-finished and finished products 539,752 555,267
Other raw materials 50,998 58,219
Total stocks carried at fair value less
costs to sell 941,814 1,033,665
Barry Callebaut applies the broker-trader exemption in ac-
cordance with IAS 2.5 for the Contract Business and there-
fore measures its Contract Business inventories at fair value
less costs to sell. Barry Callebaut fulfills the requirement of a
broker-trader as it holds inventories with the purpose of gen-
erating a profit from short-term fluctuations in price or dealer’s
margin. All commodities, including industrial chocolate, are
valued based on the raw material prices at the balance sheet
date.
In the Price List Business Barry Callebaut is committed to
sell its products at a fixed price over a certain period of time,
i.e. the period of validity of the respective price list. Inventories
dedicated to the Price List Business are therefore measured
at the lower of cost or net realizable value.
As of August 31, 2010, inventories amounting to CHF 19.1
million (2009: CHF 5.8 million) are pledged as security for
financial liabilities.
In fiscal year 2009/10, inventory write-downs of CHF
4.8 million were recognized as expenses (2008/09: CHF
5.5 million).
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Homburg Invest Inc. (Dec 2010)
CONSOLIDATED BALANCE SHEET (in part)
(CAD $ Thousands Except







Cash and cash equivalents 13,617 32,569
Properties under development
for resale 9 36,932 73,957
Receivables and other 5 36,025 49,639
86,574 156,165
Assets classified as held for
sale 16 144,247 72,957
230,821 229,122
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
4. Summary of Significant Accounting Policies (in part)
Properties Under Development for Resale
Properties being developed for resale are accounted for in
accordance with IAS 2—Inventories and are carried at the
lower of cost and net realizable value. Net realizable value is
the estimated selling price in the ordinary course of business
less selling costs and costs to complete development. To the
extent that there have been write downs to net realizable
value, the reversal of these write downs is recognized in the
subsequent period should net realizable value recover.
9. Properties Under Development for Resale
2010 2009
Balance, beginning of year $73,957 $194,638
Construction and development costs
capitalized 627 80,864
Disposals (Note 23 p) (8,472)
Capitalized interest 5,214
Impairment loss (7,811) (27,779)
Net transfers to investment properties
under development (21,323)
Cost of properties sold (21,369) (157,657)
Balance, end of year $36,932 $ 73,957
The Company classifies its construction properties under de-
velopment for resale as current assets. The Company ex-
pects these properties to be completed within their normal
operating cycle for such properties, which may extend be-
yond one year. The Company’s construction properties under
development for resale include condominium developments
that have yet to fully realize their cash flow from sales of units.
Capitalized interest in the prior year relates to a property clas-
sified as a property under development for resale in the prior
year which has been reclassified to Investment property un-
der development. There was no capitalized interest in the
current year.





Land and buildings................................................. 80 84
Production equipment and machinery................... 105 98
Computer and office equipment............................ 46 41
Construction in progress........................................ 86 82
Exploration and evaluation assets......................... 5 6
Furniture and fixtures (equipment)......................... 57 53
Hardware & parts................................................... 6 6
Leased Assets ....................................................... 28 28
Leasehold Improvements...................................... 25 22
Major overhaul (e.g., drydocking)........................... 1 1
Mineral properties and mining assets ................... 12 13
Motor Vehicles....................................................... 52 41
Network infrastructure ........................................... 12 10
Other Transportation (e.g., Aircraft, Vessels)........ 19 47
Oil & gas properties............................................... 5 4
Oil depots, storage tanks and service stations..... 1 1
Other...................................................................... 70 61
IAS 16
IFRSs Overview and Comparison
to U.S. GAAP
2.54 IAS 16 defines items of PPE as tangible items held
for use in the production or supply of goods or services,
items used for rental or administrative purposes, and items
expected to be used over more than one period.
Recognition and Measurement
Author’s Note
The requirements for depreciation and impairment in
IAS 16 are discussed in section 3.
IFRSs
2.55 IAS 16 applies to all items of PPE, unless another
standard permits or requires another treatment. For example,
IAS 40, Investment Property, prescribes the accounting for
land or buildings held for rental, capital appreciation, or both,
and provides an alternative measurement option. In addition,
the scope of IAS 16 only includes items of PPE used to
develop or maintain mineral rights, mineral reserves, and
other nonregenerative resources, not the rights, reserves, or
resources themselves.
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2.56 An entity recognizes an item of PPE when the following
probability and measurement reliability recognition criteria
are met:
• It is probable that future economic benefits will flow to
the entity, and
• The cost can be measured reliably.
2.57 On initial recognition, an entity should capitalize all
directly attributable costs incurred in order to bring the asset
to its present location and condition and that are necessary
for its intended use. Examples of directly attributable costs
include the purchase price, freight, employee benefits, site
preparation, installation, assembly, and testing costs. IAS 16
specifically excludes the following costs from being cap-
italized: costs of opening a new facility, training, general
administration, overhead, and selling and marketing costs.
As soon as an asset is in the location and condition neces-
sary for it to be capable of operating as intended, the entity
should stop capitalizing costs. An entity should not capitalize
a cost previously expensed and should not capitalize initial
operating losses.
2.58 An entity should include the cost of an asset retirement
obligation in the cost of the related item(s) of PPE (or inven-
tory when the obligation is caused by inventory production),
with measurement of the obligation determined by reference
to IAS 37, Provisions, Contingent Liabilities and Contingent
Assets. An entity should also record changes in the obliga-
tion, except for the effect of unwinding of the discount rate
(accretion), as part of the item of PPE. In accordance with
International Financial Reporting Interpretations Committee
(IFRIC) Interpretation 1, Changes in Existing Decommis-
sioning, Restoration and Similar Liabilities, an entity should
recognize the increase in the obligation from accretion as
interest expense in profit and loss as incurred.
2.59 IAS 16 offers two models for subsequent measurement:
cost and revaluation. An entity should select a model for an
entire class of assets. Both models require an entity to record
depreciation expense and to test and measure individual as-
sets for impairment.
2.60 Under the cost model, an entity should measure the car-
rying amount of an item of PPE at its cost less subsequent ac-
cumulated depreciation and accumulated impairment losses.
Under the revaluation model, an entity should measure the
carrying amount of an item of PPE at revalued amount, be-
cause its fair value can be measured reliably. The revalued
amount is the fair value of the asset at the date of revaluation
less subsequent accumulated depreciation and accumulated
impairment losses.
2.61 If the revaluation model is selected for a class of PPE, an
entity should revalue the asset with sufficient regularity that
its carrying amount at the reporting date is not materially dif-
ferent from fair value. Although an entity should revalue all
items in the class at the same time, it should revalue each item
of PPE individually. An entity should recognize increases in
carrying amount on revaluation in other comprehensive in-
come (accumulated revaluation surplus), unless the increase
reverses a revaluation decrease previously recorded to profit
or loss. Similarly, an entity should recognize decreases in
carrying amount on revaluation in profit or loss, unless the
decrease reduces an existing revaluation surplus.
U.S. GAAP
2.62 The requirements in FASB ASC 360-10 for initial
recognition and measurement are essentially the same as
those in IAS 16. FASB ASC 410-20-25-5 requires an en-
tity to capitalize an asset retirement cost by increasing the
amount of the related long-lived asset by the same amount
as the liability for an asset retirement obligation upon initial
recognition of the liability. However, FASB ASC 360, Prop-
erty, Plant, and Equipment, considers mining rights to be a
separate component of PPE and land and buildings to be PPE
regardless of use, even when held for sale.
2.63 In contrast to IFRSs, FASB ASC 360-10-35 permits
only the use of historical cost less accumulated depreciation
and impairment losses for subsequent measurement of PPE.
2.64 Like IFRSs, FASB ASC 410-20-35-8 requires an entity
to include changes to an asset retirement obligation that result
from subsequent revisions of the timing or amount of the
original estimate of undiscounted cash flows in the cost of the
asset. However, changes to the liability due to the passage of
time are expensed and classified as accretion expense. Unlike
IFRSs, FASB ASC 835-20-15-7 does not consider accretion
to be interest expense in this case.
Presentation
IFRSs
2.65 IAS 1 requires an entity to present PPE as a separate
line item on the balance sheet. An entity should classify PPE
as noncurrent, unless it has been classified as held for sale
or is part of a disposal group classified as held for sale, in
accordance with IFRS 5.
U.S. GAAP
2.66 FASB ASC 210-10-45-4 also requires an entity to ex-
clude land and depreciable assets from classification as a
current asset. Thus, it can be inferred that PPE should be
classified as noncurrent when a classified balance sheet is pre-
sented, except when classified as held for sale. As noted pre-
viously, FASB ASC 805-20-55-37 identifies mineral rights
as tangible assets to be accounted for according to their na-




2.67 IAS 16 requires the following disclosures for each class
of PPE:
• Measurement bases used to determine gross carrying
amount
• Depreciation methods and useful lives or depreciation
rates
• Reconciliation of the following carrying amounts at the
beginning and end of the period:
— Gross carrying amount
— Accumulated depreciation and accumulated impair-
ment losses (may be shown combined)
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2.68 The reconciliation discussed in the preceding paragraph
should show the following line items, if applicable:
• Additions, with separate disclosure of items acquired
in a business combination
• Classifications to held for sale or inclusion in a disposal
group classified as held for sale
• Increases or decreases from revaluation or impairment
losses or reversals recognized in other comprehensive
income
• Impairment losses or reversals recognized in profit or
loss
• Depreciation
• Foreign exchange differences, net
2.69 IAS 16 requires an entity to provide general disclo-
sures, including the existence and amounts of title restric-
tions and pledges of collateral; amounts recognized during
construction; contractual commitments to acquire; and, if not
disclosed separately in the statement of comprehensive in-
come, any compensation from third parties for PPE impaired,
lost, or given up.
2.70 An entity that measures a class of PPE using the revalu-
ation model should provide additional disclosures, including
the effective date of the revaluation, whether the entity used
an independent appraiser, the methods and significant as-
sumptions used to determine fair value, the extent to which
fair value came from observable prices in an active market or
other arm’s length transactions, and the amount of the reval-
uation surplus showing the change during the period and any
restrictions on distributions to shareholders. In addition, for
each class of PPE carried at the revalued amount, an entity
should disclose the amount that would have been recognized
in the balance sheet if the cost model were used.
2.71 IAS 23, Borrowing Costs, requires disclosure of interest
capitalized and the capitalization rate used.
U.S. GAAP
2.72 FASB ASC disclosure requirements are essentially the
same as IFRSs, except that FASB 360-10-50 does not re-
quire a reconciliation by asset class of the beginning and
ending balances of the gross carrying amount, accumulated
depreciation, and accumulated impairment losses.
TABLE 2-4: ALTERNATIVE MODELS FOR
SUBSEQUENT MEASUREMENT OF






Property (land and buildings).............................. 4 4
Other asset class................................................ 1 1
All asset classes................................................. 3 1
Total companies using revaluation for at
least one asset class................................... 11 10
Companies not disclosing a model........................ 3 3
Companies using more than one model ............... (7) (8)
Total Companies ........................................... 170 160
Presentation and Disclosure Excerpts
Cost Model—Buildings and Structures,
Production and Other Equipment
2.73
Abu Dhabi Ship Building PJSC (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION (in part)








Plant and equipment 5 263,404 245,679
Advances paid to suppliers 186,834 113,965
Goodwill 6 — 8,610
Non-current derivatives in effective
hedges 17 4,946 —
455,184 368,254
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2.4 Summary of Significant Accounting Policies
(in part)
Plant and Equipment
Plant and equipment are stated at cost less accumulated
depreciation and accumulated impairment losses. Such cost
includes the cost of replacing part of the plant and equipment
when that cost is incurred, if the recognition criteria are met.
Likewise, when a major inspection is performed, its cost is
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recognised in the carrying amount of the plant and equipment
as a replacement if the recognition criteria are satisfied. All
other repair and maintenance costs are recognised in the
consolidated income statement as incurred.
Depreciation is calculated on a straight-line basis over the
estimated useful life of the assets as follows:
Buildings and structures 5 to 40 years
Production and other equipment 3 to 30 years
The carrying amounts are reviewed for impairment when
events or changes in circumstances indicate the carrying
value may not be recoverable. If any such indication exists
and where the carrying values exceed this estimated recover-
able amount, the assets are written down to their recoverable
amount, being the higher of their fair value less costs to sell
and their value in use.
An item of plant and equipment is derecognised upon dis-
posal or when no future economic benefits are expected from
its use or disposal. Any gain or loss arising on derecognition
of the asset (calculated as the difference between the net
disposal proceeds and the carrying amount of the asset) is
included in the consolidated income statement in the year the
asset is derecognised.
The assets’ residual values, useful lives and methods of de-
preciation are reviewed, and adjusted if appropriate, at each
financial year end and adjusted prospectively if appropriate.
5. Plant and Equipment





Plant and equipment, at net carrying amount 257,274 241,687















At 1 January 2010 218,151 111,861 17,473 347,485
Additions 3,130 3,224 26,849 33,203
Transfers 36,026 5,440 (41,466) —
At 31 December 2010 257,307 120,525 2,856 380,688
Depreciation:
At 1 January 2010 54,387 51,411 — 105,798
Charge for the year 8,060 9,556 — 17,616
At 31 December 2010 62,447 60,967 — 123,414
Net carrying amount:
At 31 December 2010 194,860 59,558 2,856 257,274
2009
Cost:
At 1 January 2009 208,473 105,137 1,741 315,351
Additions 4,060 6,570 21,602 32,232
Disposals — (98) — (98)
Transfers 5,618 252 (5,870) —
At 31 December 2009 218,151 111,861 17,473 347,485
Depreciation:
At 1 January 2009 47,316 42,920 — 90,236
Charge for the year 7,071 8,522 — 15,593
Disposals — (31) — (31)
At 31 December 2009 54,387 51,411 — 105,798
Net carrying amount:
At 31 December 2009 163,764 60,450 17,473 241,687
The land upon which the buildings and structures are situated
has been made available by the Abu Dhabi Municipality at a
nominal fee.
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Revaluation Model—All Property, Plant
and Equipment
2.74
Sasini Limited (Sep 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION (in part)
As at 30 September 2010
2010 2009
Assets Note KShs’000 KShs’000
Non-current assets
Property, plant and equipment 4(a) 2,433,720 2,435,962
Capital work-in-progress 4(c) 6,392 78,573
Goodwill 8 39,403 —
Other intangible assets 5 39,791 718
Biological assets 6(a) 5,327,235 4,416,277
Prepaid leases on leasehold land 7 21,038 21,463
Other investments 9 4,229 4,229
7,871,808 6,957,222
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies
(a) Basis of Preparation
The financial statements are prepared in compliance with
International Financial Reporting Standards (IFRS). The fi-
nancial statements are presented in the functional currency,
Kenya Shillings (KShs) and are prepared under the histori-
cal cost basis of accounting except for biological assets and
financial instruments that have been measured at fair value
and property, plant and equipment that have been carried at
revaluation amounts.
The preparation of financial statements in conformity with
International Financial Reporting Standards requires the
use of estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses dur-
ing the reporting period. It also requires directors to exercise
judgement in the process of applying the Group’s accounting
policies. Although these estimates are based on the directors’
best knowledge of current events and actions, actual results
may differ from those estimates. Accounting policies 1(e) and
1(f) below on ‘critical accounting estimates and assumptions’
and ‘critical accounting judgements’ highlight the areas that
involve a higher level of judgement, or where the estimates or
assumptions used are significant to the financial statements.
(e) Critical Accounting Estimates and Assumptions (in part)
Property, Plant and Equipment
Directors make estimates in determining the depreciation
rates for property, plant and equipment. The rates used are
set out in the accounting policy for property, plant and equip-
ment.
These estimates are continually evaluated and are based
on historical experience and other factors, including expec-
tations of future events that are believed to be reasonable
under the prevailing circumstances.
The Group measures its property, plant and equipment at
revalued amounts with changes in revaluation values being
recognized in equity. The Group engages independent val-
uers to determine fair values of property, plant and equip-
ment. The valuation values are based on the prevailing mar-
ket prices which are sensitive to economic conditions.
(h) Taxation (in part)
Deferred tax relating to revaluation reserves of property, plant
and equipment is recognized in equity.
(k) Property, Plant & Equipment and Depreciation (in part)
A decrease in carrying amount arising out of revaluation is
charged as an expense to the extent that it exceeds the bal-
ance, if any, held in the revaluation reserve relating to a pre-
vious revaluation of that asset.
An annual transfer from the asset revaluation reserve to
retained earnings is made for the difference between depre-
ciation based on the revalued carrying amount of the as-
set original cost. Additionally, accumulated depreciation at
the revaluation date is eliminated against the gross carrying
amount of the asset and the net amount is restated to the
revalued amount of the asset. Upon disposal, any surplus
remaining in the revaluation reserve relating to the particular
asset being sold is transferred to retained earnings.
Revaluations are done every 5 years to ensure that the car-
rying amount does not differ materially from that which would
be determined using fair value at the end of the reporting
period.
No depreciation is provided on freehold land. Work-in-
progress is not depreciated until the assets are completed
and brought to use. Other items of property, plant and equip-
ment are depreciated on the straight line basis to write down
the cost or revalued amount of each asset to its residual value
over its estimated useful life as follows:
Buildings and improvements 12–45 years
Plant, machinery and tools 12.5% p.a
Rolling stock 25.0% p.a
Farm implements and trailers 12.5% p.a
Furniture and fittings 12.5% p.a
Computers 33.3% p.a
Useful life, residual values and depreciation methods are re-
viewed on an annual basis.
An item of property, plant and equipment is de-recognised
upon disposal or when no future economic benefits are ex-
pected to arise from the continued use of the asset. Any
gain or loss on de-recognition of the asset (calculated as
the difference between the net disposal proceeds and the
carrying amount of the item) is included in the Statement of
comprehensive income in the year the item is de-recognised.
The carrying values of the property, plant and equipment are
assessed annually and adjusted for impairment where it is
considered necessary.
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4. Property, Plant and Equipment (in part)
a) The Group






















At start of the year 1,003,000 947,353 424,837 96,752 93,111 2,565,053
Additions and transfers — 81,419 33,844 40,183 11,770 167,216
Disposals — (2,619) 458,681 (7,925) 104,881 (10,544)
At 30 September 2010 1,003,000 1,026,153 — 129,010 — 2,721,725
Comprising:
At cost — 251,635 143,834 63,142 89,800 548,411
At valuation 1,003,000 774,518 314,847 65,868 15,081 2,173,314
1,003,000 1,026,153 458,681 129,010 104,881 2,721,725
Depreciation
At start of the year — 68,740 22,386 6,953 31,012 129,091
Charge for the year — 79,266 39,327 22,322 20,748 161,663
Disposals — (537) — (2,212) — (2,749)
At 30 September 2010 — 147,469 61,713 27,063 51,760 288,005
Net Book Value
At 30 September 2010 1,003,000 878,684 396,968 101,947 53,121 2,433,720
The Group’s property was revalued on 30 September 2008
by Lloyd Masika Limited, registered valuers, on the market
value existing use basis.
The Group’s plant and equipment was revalued on 30
September 2009 by Lloyd Masika registered valuers, on the
market value existing use basis.
The book values of the property, plant and equipment were
adjusted to the revaluations and the resultant surplus and
deferred tax effect, was recognised in equity as at that date.






















At start of the year 843,000 860,892 537,181 195,241 126,422 2,562,736
Additions and transfers — 1,417 4,492 2,074 30,637 38,620
Disposals — — — (3,844) — (3,844)
Revaluation surplus 160,000 85,044 (116,836) (96,719) (63,948) (32,459)
At 30 September 2009 1,003,000 947,353 424,837 96,752 93,111 2,565,053
Comprising:
At cost — 170,216 109,990 22,959 78,030 381,195
At valuation 1,003,000 777,137 314,847 73,793 15,081 2,183,858
1,003,000 947,353 424,837 96,752 93,111 2,565,053
Depreciation
At start of the year — 2,081 384,295 153,954 80,451 620,781
Charge for the year — 66,659 19,499 11,937 17,714 115,809
Disposals — — — (2,822) — (2,822)
Eliminated on revaluation — — (381,408) (156,116) (67,153) (604,677)
At 30 September 2009 — 68,740 22,386 6,953 31,012 129,091
Net Book Value
At 30 September 2009 1,003,000 878,613 402,451 89,799 62,099 2,435,962
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14. Reserves (in part)
Revaluation Reserve
The revaluation reserve relates to increases in the fair value
of property, plant and equipment and decreases to the extent
that such decrease relates to an increase on the same asset
previously recognised in equity.
Revaluation Model—Real Estate Properties
and Ducts Infrastructure
2.75
Portugal Telecom, SGPS, S.A. (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION (in part)
31 December 2010 and 2009 and 1 January 2009







Accounts receivable—trade 1,451,332 2,594,779 3,384,632
Accounts receivable—other 26 17,661,730 8,845,235 4,856,624
Taxes receivable 28 267,622 196,429,460 140,771,497
Investments in group companies 31 361,517,602 597,210,048 613,179,099
Other investments 32 17,680,614 16,885,925 21,111,478
Intangible assets 33 1,111,692,584 4,074,303,198 3,486,237,730
Tangible assets 34 3,874,613,414 4,843,868,200 4,621,486,868
Post retirement benefits 14 1,927,991 67,588,596 1,557,026
Deferred taxes 19 653,075,198 1,019,511,128 1,032,723,979
Other non-current assets 30 274,640,756 314,203,554 478,954,057
Total non-current assets 6,314,528,843 11,141,440,123 10,404,262,990
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Accounting Policies, Judgments and Estimates
(in part)
c) Tangible Assets
In 2008, Portugal Telecom changed the accounting policy re-
garding the measurement of real estate properties and the
ducts infra-structure from the cost model to the revaluation
model, since the Company believes the latter better reflects
the economic value of those asset classes, given the nature
of the assets revalued, which are not subject to technologi-
cal obsolescence. The increase in tangible assets resulting
from the revaluation reserves, which are non-distributable re-
serves, is being amortised in accordance with the criteria
used to amortize the revalued assets. Portugal Telecom has
the policy to revise the revalued amount in every 3 years.
The remaining tangible assets are stated at acquisition
cost, net of accumulated depreciation, investment subsidies
and accumulated impairment losses, if any. Acquisition cost
includes: (1) the amount paid to acquire the asset; (2) direct
expenses related to the acquisition process; and (3) the esti-
mated cost of dismantling or removal of the assets (Notes 3.g
and 39). Under the exception of IFRS 1, revaluation of tan-
gible assets made in accordance with Portuguese legislation
applying monetary indices, prior to 1 January 2004, was not
adjusted and was included as the deemed cost of the asset
for IFRS purposes.
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Tangible assets are depreciated on a straight-line basis
from the month they are available for use, during its ex-
pected useful life. The amount of the asset to be depreci-
ated is reduced by any residual estimated value. The depre-
ciation rates correspond to the following estimated average
economic useful lives:
Years
Buildings and other constructions 3–50
Basic equipment:
Network installations and equipment 7–40
Ducts infra-structure 40
Telephones, switchboards and other 3–10
Submarine cables 15–20
Satellite stations 5–7
Other telecommunications equipment 4–10
Other basic equipment 4–20
Transportation equipment 4–8
Tools and dies 4–8
Administrative equipment 3–10
Other tangible fixed assets 4–8
Estimated losses resulting from the replacement of equip-
ments before the end of their economic useful lives are recog-
nised as a deduction to the corresponding asset’s carrying
value, against results of the period, as well as any impair-
ment of these assets. The cost of recurring maintenance and
repairs is charged to net income as incurred. Costs associ-
ated with significant renewals and betterments are capitalized
if any future economic benefits are expected and those ben-
efits can be reliably measured.
The gain or loss arising on the disposal or retirement of
an asset is determined as the difference between the sales
proceeds and the carrying amount of the assets, and is recog-
nised in the Consolidated Income Statement under the cap-
tion “Gains on disposals of fixed assets, net” when occurred.
f) Impairment of Tangible and Intangible Assets, Excluding
Goodwill (in part)
Tangible assets recognized according to the revaluation
model are subject to periodic remeasurement and Portugal
Telecom intends to revalue these assets at least every three
years. Any impairment loss of these assets is recorded as a
reduction to the revaluation reserve initially recognized un-
der shareholders’ equity. Impairment losses in excess of the
initial revaluation reserve are recognized in the Consolidated
Income Statement.
34. Tangible Assets
During the years ended 31 December 2010 and 2009, move-


















Land 127,806,363 61,325,452 1,825,338 (4,018,787) (21,893,342) 165,045,024
Buildings and other constructions 661,037,717 198,638,310 9,136,606 3,374,353 (66,831,441) 805,355,545
Basic equipment 13,570,504,676 506,051,400 388,281,961 (192,945,229) (4,150,214,502) 10,121,678,306
Transportation equipment 76,106,527 18,550,988 487,067 (10,758,853) (3,433,780) 80,951,949
Tools and dies 28,890,634 1,715,488 999,606 272,302 (6,359,021) 25,519,009
Administrative equipment 1,204,106,756 58,560,167 21,571,543 25,800,934 (247,593,971) 1,062,445,429
Other tangible assets 52,210,185 1,425,664 432,544 219,753 (4,056) 54,284,090
In-progress tangible assets 267,196,605 284,732,803 8,618,833 (266,077,212) (73,047,062) 221,423,967
Advances to suppliers of tangible assets 258,046 286,798 (18,078) (15,641) — 511,125
15,988,117,509 1,131,287,070 431,335,420 (444,148,380) (4,569,377,175) 12,537,214,444
Accumulated Depreciation
Land 9,664,867 — — (171,537) — 9,493,330
Buildings and other constructions 232,518,473 49,285,353 3,549,050 (10,342,185) (21,246,514) 253,764,177
Basic equipment 9,758,891,480 838,494,142 271,546,107 (426,615,587) (3,090,239,667) 7,352,076,475
Transportation equipment 45,159,957 13,048,903 231,781 (8,911,117) (1,976,840) 47,552,684
Tools and dies 23,310,019 1,722,406 494,489 (453,924) (4,612,563) 20,460,427
Administrative equipment 1,031,598,761 86,163,040 14,726,484 (18,115,030) (179,597,951) 934,775,304
Other tangible assets 43,105,752 1,643,302 82,305 (25,854) (326,872) 44,478,633
11,144,249,309 990,357,146 290,630,216 (464,635,234) (3,298,000,407) 8,662,601,030
4,843,868,200 140,929,924 140,705,204 20,486,854 (1,271,376,768) 3,874,613,414
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Land 125,840,884 5,834,493 3,721,771 (7,590,785) 127,806,363
Buildings and other constructions 725,181,974 19,889,743 17,148,489 (101,182,489) 661,037,717
Basic equipment 11,954,096,111 533,612,163 860,281,573 222,514,829 13,570,504,676
Transportation equipment 76,118,355 16,540,246 593,257 (17,145,331) 76,106,527
Tools and dies 25,377,080 1,347,121 1,853,257 313,176 28,890,634
Administrative equipment 1,082,255,636 60,403,058 47,868,464 13,579,598 1,204,106,756
Other tangible assets 52,929,865 2,403,902 (91,144) (3,032,438) 52,210,185
In-progress tangible assets 308,335,009 406,745,683 60,251,812 (508,135,899) 267,196,605
Advances to suppliers of tangible assets 321,739 (3,545) (60,148) — 258,046
14,350,456,653 1,046,772,864 991,567,331 (400,679,339) 15,988,117,509
Accumulated Depreciation
Land 10,775,062 — — (1,110,195) 9,664,867
Buildings and other constructions 251,422,215 46,736,029 5,972,858 (71,612,629) 232,518,473
Basic equipment 8,426,572,350 914,089,945 611,711,852 (193,482,667) 9,758,891,480
Transportation equipment 46,615,120 12,283,538 275,163 (14,013,864) 45,159,957
Tools and dies 20,353,787 2,082,681 994,474 (120,923) 23,310,019
Administrative equipment 925,389,799 89,333,317 32,010,484 (15,134,839) 1,031,598,761
Other tangible assets 47,841,452 1,497,269 28,049 (6,261,018) 43,105,752
9,728,969,785 1,066,022,779 650,992,880 (301,736,135) 11,144,249,309
4,621,486,868 (19,249,915) 340,574,451 (98,943,204) 4,843,868,200




Development costs................................................... 40 43
Acquired in-process research and development..... 5 5
Software................................................................... 74 72
Information systems................................................. 12 6
Future servicing rights.............................................. 3 3
Brands...................................................................... 37 38
Patents, licenses, trademarks, and similar rights.... 57 51
Distribution rights...................................................... 11 9
Water rights.............................................................. 3 2
Customer-related intangibles (e.g., customer lists,
relationships).......................................................... 40 43
Marketing-related intangibles................................... 4 4
Core deposit intangible ............................................ 3 2
Mining interests........................................................ 6 7
Exploration and evaluation expenditures................. 6 6
Concessions............................................................. 9 7
Contract-related intangibles (including favorable
leases).................................................................... 20 18
Value of business acquired and acquired
in-force insurance policies.................................... 6 6
Purchased technology.............................................. 7 6
Order backlog........................................................... 1 2
Deferred acquisition costs........................................ 1 1
Other......................................................................... 89 85
IAS 38, INTANGIBLE ASSETS
IFRS 3, BUSINESS COMBINATIONS
IFRS Overview and Comparison
to U.S. GAAP
2.76 IAS 38, Intangible Assets, establishes accounting and
disclosure requirements for goodwill and other intangible
assets. An intangible asset is an identifiable, nonmonetary
asset without physical substance. An identifiable asset is
separable or arises from contractual or legal rights. IFRSs
require an intangible asset to be identifiable to distinguish it
from goodwill. IAS 38 applies to all intangible assets, ex-
cept those within the scope of another IFRS, financial assets
as defined in IAS 32, exploration and evaluation assets, and
assets arising from expenditures on development and extrac-
tion of minerals, oil, natural gas, and other nonregenerative
resources.
2.77 The revisions to IFRS 3, Business Combinations, in
2008 amended IAS 38. Entities should apply these amend-
ments prospectively for annual periods beginning on or after
July 1, 2009. If an entity adopts IFRS 3 at an earlier date,
the amendments to IAS 38 should also be applied for that
earlier period. IFRS 3 is discussed more fully in section 9,
“Business Combinations.” This section includes illustrations
of the ongoing general disclosures required for goodwill in
reporting periods subsequent to the business combination it-
self. Goodwill recognized in a business combination is an
asset representing the future economic benefits arising from
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other assets acquired in a business combination that are not
individually identified and separately recognized.
2.78 The revisions to IAS 1 in 2007 also amended IAS 38.
These amendments relate primarily to adjustments to an in-
tangible asset’s carrying amount as a result of applying the
revaluation model and impairment losses recognized or re-
versed in other comprehensive income, in accordance with
IAS 36, Impairment of Assets. An entity should apply those
amendments for annual periods beginning on or after 1 Jan-
uary 2009. If an entity applies the amendments to IAS 1 for
an earlier period, the amendments to IAS 38 should also be
applied for that earlier period.
Recognition and Measurement
IFRSs
2.79 An entity should recognize an intangible asset if, and
only if, it is probable that future economic benefits will flow
to the entity and the cost of the asset can be measured reliably.
Probability is assessed based on reasonable and supportable
assumptions representing management’s best estimate of the
economic conditions expected to exist over the asset’s useful
life. The probability recognition criteria are always consid-
ered to be satisfied when an entity acquires goodwill and
other intangible assets in a business combination.
2.80 At initial recognition, an entity should measure intan-
gible assets, acquired separately, at cost (that is, the purchase
price, including duties and taxes, and costs that are directly
attributable to getting the asset ready for its intended use).
Examples of directly attributable costs include employee
benefits arising from getting the asset ready for use, pro-
fessional fees, and the cost of testing. IAS 38 specifically
requires expenditures on advertising and promotional activ-
ities (including mail order catalogs), training to operate the
asset, start-up costs, reorganization and relocation of all or
part of the entity, inefficiencies and operation losses, general
overhead, and administrative costs to be recognized as an
expense. However, IAS 38 does not preclude recognition of
a prepayment as an asset when the entity pays for goods or
services in advance of obtaining them.
2.81 In accordance with IFRS 3, if an intangible asset is
acquired in a business combination, the cost of that intangible
asset is its fair value at the acquisition date. IAS 38 permits the
acquirer to recognize an intangible asset that is separable but
only together with a related contract or liability. In this case,
the entity recognizes the intangible separately from goodwill
but together with the related item. IAS 38 also permits the
acquirer to recognize a group of complementary intangible
assets as a single asset, provided that the individual assets in
the group have similar useful lives.
2.82 IAS 38 also establishes the accounting treatment for
research and development (R&D) costs. An entity can incur
R&D costs by acquiring an in-process R&D project, either
separately or in a business combination, or by incurring these
costs internally, either subsequently for an acquired project
or independently. An entity should recognize acquired in-
process R&D as an intangible asset if it meets the probability
and measurement reliability recognition criteria. An entity
should expense costs incurred in a project’s research phase
(for example, the search for knowledge or the evaluation of
alternatives for new or improved products or processes). An
entity should recognize an intangible asset when it incurs
costs in the development phase only if the entity can demon-
strate all of the following:
• Technical feasibility of completing the intangible asset
so that it will be available for sale
• Intention and ability to both complete and use or sell
the asset
• How the intangible asset will generate probable future
economic benefits (for example, demonstrate the exis-
tence of a market for the asset’s output or the asset’s
usefulness to the entity if for internal use)
• Availability of adequate resources to complete devel-
opment and use or sell the asset
• Ability to measure reliably the expenditures directly at-
tributable to the asset during development (for example,
cost of materials or services used, employee benefits,
fees, and amortization of patents or licenses)
2.83 IAS 38 specifically prohibits recognition of internally
generated brands, mastheads, publishing titles, customer
lists, and similar items as intangible assets.
2.84 An entity should recognize expenditures on intangible
items as an expense in profit and loss, unless the expenditure
is a cost of either an intangible asset meeting the recognition
criteria or an item acquired in a business combination that is
not recognized separately. In the latter case, the cost forms
part of the amount recognized as goodwill, in accordance
with IFRS 3. An entity should not capitalize an expenditure
previously expensed.
2.85 IAS 38 includes two alternative models for subsequent
measurement of intangible assets: cost and revaluation. An
entity should select a model for an entire class of assets,
not for individual assets. However, the revaluation model is
only available for those intangible assets that are traded in an
active market.
2.86 Under the cost model, an entity should measure the
intangible asset at cost less accumulated amortization, if any,
and accumulated impairment losses.
2.87 Under the revaluation model, an entity should mea-
sure an intangible asset at the revalued amount, which is the
fair value as of the date of the revaluation, less subsequent
accumulated amortization and subsequent accumulated im-
pairment losses. An entity should determine fair value of
individual assets by reference to an active market. An en-
tity should conduct revaluations with sufficient regularity so
the carrying value of the asset at the reporting date is not
materially different from its fair value at that date.
2.88 The revaluation model is only available for intangible
assets that are traded in an active market. Therefore, if an
active market for an asset is no longer available, an entity
should measure the asset at cost less accumulated amortiza-
tion and impairments. IAS 38 reminds entities that the fact
that an active market no longer exists may be an indicator of
impairment and that the asset needs to be tested in accordance
with IAS 36.
2.89 An entity should recognize increases in the carrying
amount from revaluation in other comprehensive income and
in equity (accumulated revaluation surplus), but the entity
should recognize the increase in profit or loss to the extent
that the increase reverses a previous decrease. Similarly, an
entity should recognize a decrease in carrying value in profit
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or loss, but the entity should recognize the decrease in equity
to the extent that the decrease reverses a previous increase.
2.90 SIC 32, Intangible Assets—Web Site Costs, specifically
addresses costs incurred in developing and maintaining an
entity’s own website. An entity should treat the development
of the website similarly to development costs of an R&D
project (that is, an entity only capitalizes expenditures when
the criteria for capitalizing development costs are met). How-
ever, SIC 32 requires an entity to expense all costs associated
with website activities for advertising and promotional pur-
poses.
Author’s Note
Amortization and impairment are discussed in
section 3.
U.S. GAAP
2.91 The FASB ASC glossary defines an intangible asset
as an asset (not including a financial asset) without physi-
cal substance. Although this definition is similar to that in
IAS 38, it does not specifically include the requirement that
the asset is identifiable. FASB ASC 350-30-25-1 states that
an entity should recognize intangible assets acquired indi-
vidually or in a group of assets. FASB ASC 805-20-25-10
requires an entity to recognize identifiable intangible assets
acquired in a business combination separately from good-
will. The definition in the FASB ASC glossary explains that
the term intangible asset is used to refer to intangible assets
other than goodwill.
2.92 On initial recognition, FASB ASC 350-30-25-2 re-
quires an entity to allocate cost to intangible assets acquired
in a group of assets in a transaction other than through a
business combination, based on relative fair values, and not
recognize goodwill. However, when an asset is acquired sep-
arately, cost and fair value are likely to be the same. As
discussed in FASB ASC 820, Fair Value Measurements and
Disclosures, an entity should determine fair value based on
assumptions market participants would use in pricing the as-
set. FASB ASC 350-30-05-1 refers entities to FASB ASC
805-20 for guidance on recognition and measurement of in-
tangible assets acquired in a business combination.
2.93 Like IFRSs, FASB ASC 805-20-30-1 requires an entity
to measure identifiable assets, including intangible assets, ac-
quired in a business combination at their acquisition-date fair
value on initial recognition. However, IFRS 3 offers an option
to measure the noncontrolling interest at its proportion of the
fair value of the net identifiable assets acquired, rather than
at fair value. Therefore, an entity could measure goodwill at
a different amount under FASB ASC than under IFRSs if it
elected this option.
2.94 Unlike IFRSs, FASB ASC 805-10-35-1 states, in gen-
eral, that an acquirer should subsequently measure and ac-
count for assets acquired, liabilities assumed or incurred, and
equity instruments issued in a business combination in ac-
cordance with other applicable U.S. GAAP for those items,
depending on their nature. Therefore, as explained by FASB
ASC 350-30-35, an entity should measure an intangible as-
set at cost less accumulated amortization, if applicable, and
accumulated impairment losses. An entity should amortize
intangible assets with finite useful lives, including defensive
intangible assets acquired to prevent others from obtaining
access to the asset, over their expected useful lives. An entity
should not amortize an intangible asset with an indefinite
useful life or goodwill in accordance with FASB ASC 350-
30-35-15 or 350-20-35-1
2.95 The definitions of R&D in the FASB ASC glossary
differ from those under IFRSs. However, with the excep-
tion of certain internally developed software, FASB ASC
350-30-25-3 requires an entity to expense as incurred all
internally developing, maintaining, or restoring intangibles
that are not specifically identifiable, that have indeterminate
lives, or that are inherent in a continuing business activity
and related to an entity as a whole, including R&D costs.
Like IFRSs, and consistent with the measurement principle
in FASB ASC 805-20-30-1, in-process R&D acquired in a
business combination is recognized as an intangible asset and
measured at the acquisition-date fair value. FASB ASC 350-
30-35-17A states that an entity should consider intangible
assets acquired in a business combination or an acquisition
by a not-for-profit entity that are used in R&D activities to
have an indefinite life until the completion or abandonment
of the associated R&D efforts. Therefore, such assets are not
amortized but are subject to impairment testing annually.
2.96 FASB ASC 985-20 and 350-40 contain specific guid-
ance on the treatment of software developed for sale and
internal-use software, respectively, whereas IFRSs do not
treat software differently than any other intangible asset. Un-
like the treatment in SIC 32, FASB ASC 350-40 and 350-50
have separate guidance regarding costs incurred for software
to operate the website, unless the entity has a plan to market
the software externally, and other costs, depending upon the
stage of development of the website.
2.97 Like IFRSs, FASB ASC 720-15 requires an entity to
expense training and start-up costs as incurred. Unlike IFRSs,
paragraphs 2–4 of FASB ASC 340-20-25 contain specific cri-




2.98 An entity should present intangible assets as a sepa-
rate line item on the balance sheet, classified as current or
noncurrent, in accordance with IAS 1. An entity should also
present additional line items, headings, and subtotals when
they are relevant to an understanding of the entity’s financial
position.
U.S. GAAP
2.99 FASB ASC 350-30-45-1 states, at a minimum, that all
intangible assets should be aggregated and presented as a sep-
arate line item in the statement of financial position. Similar
to IFRSs, the requirement does not preclude the presentation
of individual intangible assets or classes of intangible assets
as separate line items.
IFRS ATT 2.90
165Section 2: Statement of Financial Position and Related Disclosures
Disclosure
IFRSs
2.100 An entity should identify major classes of intangible
assets and distinguish, at a minimum, between internally gen-
erated and other intangible assets. For each identified class
of intangible asset, the entity should disclose the following
information:
• Whether the assets in the class have a finite or indefinite
useful life
• Useful lives or amortization rates and amortization
methods for assets with finite lives
• Gross carrying amount and combined accumulated
amortization and impairment losses at the beginning
and end of the period
• Line items of comprehensive income in which amorti-
zation is included
• Reconciliation of the beginning and ending balances in
the gross carrying amount and combined accumulated
amortization and impairment, indentifying reasons for
changes in these accounts (for example, additions, clas-
sification to held for sale, revaluations, disposals, amor-
tization, impairment losses, and foreign exchange ef-
fects)
2.101 For each intangible asset with an indefinite life, an
entity should also disclose the asset’s carrying amount and
reasons why an indefinite life is supported, including factors
that made a significant difference in that decision.
2.102 Like indefinite life intangibles, an entity should not
amortize goodwill. IFRS 3 requires a reconciliation of the
carrying amount of goodwill and accumulated impairment
losses showing the following, separately:
• Additional goodwill, except that goodwill related to a
disposal group immediately classified as held for sale
should be shown separately
• Adjustments due to recognition of deferred tax assets
• Related goodwill derecognized on sale of the disposal
group
• Impairment losses
• Foreign exchange adjustments
2.103 An entity should describe any individually material
intangible asset and disclose its carrying amount and remain-
ing amortization period. For assets acquired by government
grant and initially recognized at fair value, the entity should
disclose the fair value initially recognized, the current car-
rying value, and whether the cost or revaluation model is
used subsequently. The entity should also disclose informa-
tion about carrying amounts of assets with title restrictions or
pledged as collateral and information about impaired assets.
2.104 IAS 38 requires additional disclosures about assets
measured using the revaluation model.
Author’s Note
No survey company selected the revaluation model for
a class of intangible assets.
2.105 An entity should disclose the aggregate amount of
R&D expenditures recognized as an expense in profit or loss.
2.106 IAS 8 requires an entity to disclose the nature and
amount of any change in accounting estimate having a mate-
rial impact in the current period or expected to have a material
impact subsequently.
U.S. GAAP
2.107 FASB ASC requires fewer disclosures than IAS 38.
However, FASB ASC 350-30-50-1 does require an entity
to identify major classes of intangible assets and specifies
required disclosures, including disclosure of any significant
residual value, in total, for each class.
2.108 FASB ASC 350-30-50-1 requires an entity to disclose
the weighted average amortization period, rather than useful
lives or amortization rates, as required by IFRSs, in total and
by asset class.
2.109 FASB ASC 350-20-50-2 requires an entity to dis-
close the gross carrying amount and accumulated amortiza-
tion and amortization expense for the period, not the compre-
hensive reconciliation of these carrying amounts as required
by IFRSs.
2.110 FASB ASC 340-20-50 requires specific disclosures
related to direct response advertising costs, including the
accounting policy (expense or capitalization) selected, a de-
scription of any advertising costs recognized as an asset, and
the amounts charged to expense for each income statement
presented or reported as an asset for each balance sheet pre-
sented.
Presentation and Disclosure Excerpts
Goodwill
2.111
Unilever N.V. and Unilever plc (Dec 2010)
CONSOLIDATED BALANCE SHEET (in part)
As at 31 December
€ Million € Million
2010 2009
Goodwill 9 13,178 12,464
Intangible assets 9 5,100 4,583
Property, plant and equipment 10 7,854 6,644
Pension asset for funded schemes in
surplus 19 910 759
Deferred tax assets 17 607 738
Other non-current assets 11 1,034 1,017
Total non-current assets 28,683 26,205
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1 Accounting Information and Policies (in part)
Goodwill
Goodwill arises on business combinations. It is calculated as
the excess of the total fair value of consideration transferred
plus the amount of any non-controlling interest in the acquiree
plus the acquisition-date fair value of any previous equity in-
terest in the acquiree, less the fair value of the Group’s share
of the identifiable net assets acquired. Goodwill is capitalised
and is not subject to amortisation. It is carried at cost but
subject to impairment testing annually, or more frequently if
events or circumstances indicate this is necessary. Any im-
pairment is charged to the income statement as it arises.
Goodwill acquired in a business combination is allocated
to the Group’s cash generating units, or groups of cash gen-
erating units, that are expected to benefit from the synergies
of the combination. These might not always be precisely the
same as the cash generating units that the assets or liabilities
of the acquired business are assigned to. Each unit or group
of units to which the goodwill is allocated represents the low-
est level within the Group at which the goodwill is monitored
for internal management purposes, and is not larger than an
operating segment.
Critical Accounting Estimates and Judgements (in parts)
Estimates and judgements are continually evaluated and are
based on historical experience and other factors, including
expectations of future events that are believed to be reason-
able under the circumstances.
The preparation of financial statements requires manage-
ment to make estimates and assumptions concerning the
future. The resulting accounting estimates will, by definition,
seldom equal the related actual results. The estimates and
assumptions that have a significant risk of causing a material
adjustment to the carrying amounts of assets and liabilities
within the next financial year are discussed below.
Goodwill and Intangible Assets
The Group recognises goodwill and intangible assets which
have arisen through acquisitions. The most significant bal-
ances of goodwill and intangible assets relate to the regional
savoury and dressings sub-product groups.
These assets are subject to impairment reviews to en-
sure that the assets are not carried above their recoverable
amounts: for goodwill and indefinite-lived intangible assets,
reviews are performed at least annually or more frequently
if events or circumstances indicate that this is necessary; for
other intangible assets, reviews are performed if events or
circumstances indicate that this is necessary.
Impairment reviews are performed by comparing the carry-
ing value of the cash generating unit concerned to that cash
generating unit’s recoverable amount, being the higher of
value in use and fair value less costs to sell. Value in use is
a valuation derived from the discounted future cash flows of
cash generating units. The most important estimates in these
forecast cash flows are the long-term growth rates used to
calculate revenue growth in perpetuity and the discount rates
which are applied to the future cash flows. These estimates
are reviewed at least annually and are believed to be appro-
priate. However, changes in these estimates could change
the outcomes of the impairment reviews and therefore affect
future financial results. The effects would be recognised in
the income statement, through operating profit.
The Group has reviewed the carrying value of the cash
generating units by considering expected future cash flows
based on historical experience and planned growth rates and
margins for the product groups.
Please refer also to note 9 on pages 87 and 88.
9. Goodwill and Intangible Assets
Indefinite-lived intangible assets principally comprise those
trademarks for which there is no foreseeable limit to the pe-
riod over which they are expected to generate net cash in-
flows. These are considered to have an indefinite life, given
the strength and durability of our brands and the level of mar-
keting support. Brands that are classified as indefinite-lived
have been in the market for many years, and the nature of the
industry we operate in is such that brand obsolescence is not
common, if appropriately supported by advertising and mar-
keting spend. Finite-lived intangible assets, which primarily
comprise patented and non-patented technology, know-how,
and software, are capitalised and amortised in operating profit
on a straight-line basis over the period of their expected useful
lives, none of which exceeds ten years. The level of amortisa-
tion for finite-lived intangible assets is not expected to change
materially over the next five years.







Intangible assets: 5,100 4,583
Indefinite-lived intangible assets 4,532 4,050





















1 January 2010 13,408 4,269 611 687 18,975
Acquisitions of group companies 259 256 1 — 516
Disposals of group companies (222) (1) — — (223)
Reclassed to held for disposal (82) — — — (82)
Additions — 1 1 180 182
Disposals (1) (8) — (16) (25)
Currency retranslation 823 250 31 48 1,152
31 December 2010 14,185 4,767 644 899 20,495
Amortisation and Impairment
1 January 2010 (944) (219) (458) (307) (1,928)
Disposal of group companies — — — — —
Amortisation for the year — — (58) (116) (174)
Disposals — — — 6 6
Currency retranslation (63) (16) (24) (18) (121)
31 December 2010 (1,007) (235) (540) (435) (2,217)

















1 January 2009 12,617 4,107 598 580 17,902
Acquisitions of group companies 350 105 1 — 456
Disposals of group companies — (1) — — (1)
Additions — 1 — 149 150
Disposals — — — (72) (72)
Currency retranslation 441 57 12 30 540
31 December 2009 13,408 4,269 611 687 18,975
Amortisation and Impairment
1 January 2009 (952) (221) (392) (246) (1,811)
Disposal of group companies — — — — —
Amortisation for the year — — (58) (110) (168)
Disposals — — — 62 62
Currency retranslation 8 2 (8) (13) (11)
31 December 2009 (944) (219) (458) (307) (1,928)
Net book value 31 December 2009 12,464 4,050 153 380 17,047
There are no significant carrying amounts of goodwill and
intangible assets that are allocated across multiple cash gen-
erating units (CGUs).
Impairments Charge in the Year
There were no material impairments in either 2010 or 2009.
Significant CGUs
The goodwill and indefinite-lived intangible assets (predom-
inantly Knorr and Hellmann’s) held in the regional Savoury,
Dressings and Spreads CGUs are considered significant in
comparison to the total carrying amounts of goodwill and
indefinite-lived intangible assets at 31 December 2010. No
other CGUs are considered significant in this respect.
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The goodwill and indefinite-lived intangible assets held in















Western Europe 5.2 1.4 5.2 1.3
The Americas 4.2 1.5 3.9 1.3
Asia Africa CEE 1.8 0.6 1.9 0.6
During 2010, we conducted an impairment review of the car-
rying value of these assets. Value in use in the regional
Savoury, Dressings and Spreads CGUs has been calculated
as the present value of projected future cash flows. A pre-tax
discount rate of 10% was used.
The following key assumptions were used in the discounted
cash flow projections for the regional Savoury, Dressings and
Spreads CGUs:
• a longer-term sustainable growth rate of 2% to 3% for
Western Europe, 3% to 5% for The Americas and 8%
to 9% for Asia Africa CEE;
• average near-term nominal growth rates for the major
product groups within the CGUs of 2% Western Europe,
4% The Americas, 10% for Asia Africa CEE; and
• average operating margins for the major product groups
within the CGUs ranging from 18% to 21% Western
Europe, 17% to 23% The Americas and 10% to 14%
Asia Africa CEE.
The growth rates and margins used to estimate future perfor-
mance are based on past performance and our experience
of growth rates and margins achievable in our key markets.
We believe that the assumptions used in estimating the future
performance of the regional Savoury, Spreads and Dressings
CGUs are consistent with past performance.
The projections covered a period of ten years as we be-
lieve this to be a suitable timescale over which to review and
consider annual performance before applying a fixed termi-
nal value multiple to the final year cash flows of the detailed
projection. Stopping the detailed projections after five years
and applying a terminal value multiple thereafter would not
result in a value in use that would cause impairment.
The growth rates used to estimate future performance be-
yond the periods covered by our annual planning and strate-
gic planning processes do not exceed the long-term average
rates of growth for similar products.
We have performed sensitivity analyses around the base
case assumptions and have concluded that no reasonable
possible changes in key assumptions would cause the recov-
erable amount of the regional Savoury, Spreads and Dress-
ings CGUs to be less than the carrying amount.
Brand Names and Customer Lists
2.112
Ashtead Group plc (Apr 2010)
CONSOLIDATED BALANCE SHEET (in part)




Property, plant and equipment
—rental equipment 12 969.7 1,140.5
—other assets 12 131.9 153.5
1,101.6 1,294.0
Intangible assets—brand names and
other acquired intangibles 13 3.3 5.9
Goodwill 13 373.6 385.4
Deferred tax asset 18 7.8 12.3
Other financial assets—derivatives 23 5.7 —
Defined benefit pension fund surplus 22 — 0.3
1,492.0 1,697.9
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Policies (in part)
The principal accounting policies adopted in the preparation
of these financial statements are set out below. These policies
have been applied consistently to all the years presented,
unless otherwise stated.
Intangible Assets (in part)
Other Intangible Assets
Other intangible assets acquired as part of a business com-
bination are capitalised at fair value as at the date of ac-
quisition. Internally generated intangible assets are not capi-
talised. Amortisation is charged on a straight-line basis over
the expected useful life of each asset. Contract related intan-
gible assets are amortised over the life of the contract.
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Amortisation rates for other intangible assets are as follows:
Per Annum
Brand names 8.3%
Customer lists 10% to 20%









£m £m £m £m £m £m
Cost or Valuation
At 1 May 2008 291.9 10.7 1.7 9.2 21.6 313.5
Recognised on acquisition — — — 0.2 0.2 0.2
Disposals — — — (1.4) (1.4) (1.4)
Exchange differences 93.5 3.0 — 2.8 5.8 99.3
At 30 April 2009 385.4 13.7 1.7 10.8 26.2 411.6
Recognised on acquisition — 0.1 0.1 0.1
Exchange differences (11.8) (0.4) — (0.3) (0.7) (12.5)
At 30 April 2010 373.6 13.3 1.7 10.6 25.6 399.2
Amortisation
At 1 May 2008 — 9.5 0.3 3.8 13.6 13.6
Charge for the period — 0.1 0.3 3.0 3.4 3.4
Disposals — — — (1.4) (1.4) (1.4)
Exchange differences — 3.0 — 1.7 4.7 4.7
At 30 April 2009 — 12.6 0.6 7.1 20.3 20.3
Charge for the period — 0.1 0.2 2.2 2.5 2.5
Exchange differences — (0.4) — (0.1) (0.5) (0.5)
At 30 April 2010 — 12.3 0.8 9.2 22.3 22.3
Net Book Value
At 30 April 2010 373.6 1.0 0.9 1.4 3.3 376.9
At 30 April 2009 385.4 1.1 1.1 3.7 5.9 391.3
Goodwill acquired in a business combination was allocated,
at acquisition, to the reporting units that benefited from that






For the purposes of determining potential goodwill impair-
ment, recoverable amounts are determined from value in use
calculations using cash flow projections based on financial
plans covering a three year period which were adopted and
approved by the Board in April 2010. The growth rate assump-
tions used in the plans reflect management’s expectations of
market developments and take account of past performance.
The annual growth rate used to determine the cash flows be-
yond the three year period is 2% and does not exceed the
average long-term growth rates for the relevant markets. The
pre-tax rate used to discount the projected cash flows is 9%.
A sensitivity analysis has been undertaken by changing the
key assumptions used for both Sunbelt and A-Plant. Based on
this sensitivity analysis, no reasonably possible change in the
assumptions resulted in the carrying value of the goodwill in
Sunbelt or A-Plant being reduced to the recoverable amount.
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Software Development Costs (Internal
and External) and Software
2.113
British Sky Broadcasting Group plc (Jun 2010)
CONSOLIDATED BALANCE SHEET (in part)







Goodwill 12 852 852
Intangible assets 13 336 345
Property, plant and equipment 14 899 799
Investments in joint ventures
and associates 15 149 135
Available for sale investments 16 182 261
Deferred tax assets 17 17
Trade and other receivables 19 18 21
Derivative financial assets 23 382 202
2,818 2,632
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in parts)
1. Accounting Policies (in part)
e) Intangible Assets and Property, Plant and Equipment
(“PPE”)
i. Intangible Assets
Research expenditure is recognised in operating expense in
the income statement as the expenditure is incurred. Devel-
opment expenditure (relating to the application of research
knowledge to plan or design new or substantially improved
products for sale or use within the business) is recognised
as an intangible asset from the point at which it is probable
that the Group has the intention and ability to generate fu-
ture economic benefits from the development expenditure,
that the development is technically feasible and that the sub-
sequent expenditure can be measured reliably. Any other
development expenditure is recognised in operating expense
as incurred.
Other intangible assets, which are acquired by the Group
separately or through a business combination, are initially
stated at cost or fair value, respectively, less accumulated
amortisation and impairment losses, other than those that
are classified as held for sale, which are stated at the lower
of carrying amount and fair value less costs to sell.
Amortisation of an intangible asset begins when the asset
is available for use, and is charged to the income statement
through operating expense on a straight-line basis over the
intangible asset’s estimated useful life, principally being a pe-
riod between three and ten years, unless the asset life is
judged to be indefinite. If the useful life is indefinite or the
asset is not yet available for use, no amortisation is charged
and an impairment test is carried out at least annually. Other
intangible assets are tested for impairment in line with ac-
counting policy j below.
v) Critical Accounting Policies and the Use of Judgment
(in part)
(iv) lntangible Assets and Property, Plant and Equipment
(See Notes 13 and 14)
• The assessment of the useful economic lives of these
assets requires judgment. Depreciation and amortisa-
tion is charged to the income statement based on the
useful economic life selected. This assessment requires
estimation of the period over which the Group will ben-
efit from the assets.
• Determining whether the carrying amount of these as-
sets has any indication of impairment also requires judg-
ment. If an indication of impairment is identified, further
judgment is required to assess whether the carrying
amount can be supported by the net present value of
future cash flows forecast to be derived from the asset.
This forecast involves cash flow projections and select-
ing the appropriate discount rate.
• Assessing whether assets meet the required criteria for
initial capitalisation requires judgment. This requires a
determination of whether the assets will result in future
benefits to the Group. In particular, internally generated
intangible assets must be assessed during the devel-
opment phase to identify whether the Group has the
ability and intention to complete the development suc-
cessfully.
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At 1 July 2008 91 237 89 41 4 102 564
Foreign exchange movements 1 1
Additions 34 20 19 35 13 39 160
Disposals (5) (5) (8) (5) (23)
Transfers 4 50 1 (55)
At 30 June 2009 124 302 101 72 17 86 702
Foreign exchange movements (1) (1)
Additions 51 12 19 41 18 38 179
Disposals (6) (10) (22) (38)
Transfers 5 1 1 (3) (3) 1
At 30 June 2010 174 305 120 113 32 99 843
Amortisation
At 1 July 2008 35 160 54 12 261
Foreign exchange movements 1 1
Amortisation for the year 27 50 15 25 117
Impairments 1 1
Disposals (5) (5) (8) (5) (23)
At 30 June 2009 58 205 62 32 — — 357
Foreign exchange movements (1) (1)
Amortisation for the year 37 59 20 47 163
Impairments 3 1 22 26
Disposals (6) (10) (22) (38)
At 30 June 2010 92 255 81 79 — — 507
Carrying Amounts
At 1 July 2008 56 77 35 29 4 102 303
At 30 June 2009 66 97 39 40 17 86 345
At 30 June 2010 82 50 39 34 32 99 336
The Group’s internally generated intangible assets relate to
software development associated with our customer man-
agement systems and set-top boxes. The Group’s other in-
tangible assets mainly include copyright licences, customer
lists and relationships, and patents and brands acquired in
business combinations.
The estimated future amortisation charge on intangible as-
sets with finite lives for each of the next five years is set out
below. It is likely that future amortisation will vary from the
figures below as the estimate does not include the impact of











Estimated amortisation charge 112 90 58 31 21
For intangible assets acquired in business combinations the
average amortisation period is 3 years (2009: 3 years).
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Acquired R&D, Trademarks, Technology,
and Brand Name
2.114
Novartis AG (Dec 2010)
CONSOLIDATED BALANCE SHEETS (in part)
(At December 31, 2010 and 2009)
$ Millions Note 2010 2009
Assets
Non-current assets
Property, plant & equipment 10 15,840 14,075
Goodwill 11 29,692 12,039
Intangible assets other than goodwill 11 35,231 10,331
Investments in associated companies 4 8,385 17,791
Deferred tax assets 12 5,240 4,615
Financial assets 13 1,840 2,635
Other non-current non-financial
assets 405 328
Total non-current assets 96,633 61,814
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Policies (in part)
Intangible Assets (in part)
Other Intangible Assets
All identifiable intangible assets acquired in a business com-
bination are recognized at their fair value. Furthermore, all
acquired Research & Development assets, including upfront
and milestone payments on licensed or acquired compounds,
which are deemed to enhance the intellectual property of No-
vartis, are capitalized at cost as intangible assets, when it is
probable that future economic benefits will arise, even though
some uncertainties exist as to whether the R&D projects will
ultimately be successful in producing a commercial product.
All Novartis intangible assets are allocated to cash-
generating units. In-Process Research & Development
(IPR&D) and the Alcon brand name are the only classes of
separately identified intangible assets that are not amortized.
Both are tested for impairment on an annual basis or when
facts and circumstances warrant an impairment test. Any im-
pairment charge is recorded in the consolidated income state-
ment under “Research & Development expenses” for IPR&D
and under “Other Expense” for the Alcon brand name. Once
a project included in IPR&D has been successfully developed
and is available for use, it is amortized over its useful life in
the income statement under “Cost of Goods Sold,” where any
related impairment charges are also recorded.
All other intangible assets are amortized over their esti-
mated useful lives once they are available for use. The useful
lives assigned to acquired intangible assets are based on the
period over which they are expected to generate economic
benefits, commencing in the year in which they first generate
sales or are used in development. Acquired intangible as-
sets are amortized on a straight-line basis over the following
periods:
Trademarks Over their estimated economic or
legal life with a maximum of 20
years
Currently marketed products and
marketing know-how 5 to 20 years
Technology 10 to 30 years
Software 3 to 5 years
Others 3 to 5 years
Alcon brand name Indefinite useful life, not amortized
Amortization of trademarks, product and marketing rights is
charged in the income statement to “Cost of Goods Sold”
over their useful lives. Technology, which represents identi-
fied and separable acquired know-how used in the research,
development and production process, is amortized in the in-
come statement under “Cost of Goods Sold” or “Research &
Development.” Any impairment charges are recorded in the
income statement in the same functional cost lines as the
related amortization charges.
Intangible assets, other than the Alcon brand name and
IPR&D, are reviewed for impairment whenever facts and cir-
cumstances indicate their carrying value may not be recover-
able. When evaluating an intangible asset for a potential im-
pairment, the Group estimates the recoverable amount based
on the intangible asset’s “fair value less costs to sell” using the
estimated future cash flows a market participant could gener-
ate with that asset or, in certain circumstances, the “value in
use” of the intangible asset to the Group, whichever is higher.
If the carrying amount of the asset exceeds the recoverable
amount, an impairment loss for the difference is recognized.
For purposes of assessing impairment, assets are grouped
at the lowest level for which there are separately identifiable
cash-generating units. Considerable management judgment
is necessary to estimate the discounted future cash flows and
appropriate discount rates used to make these calculations.
Accordingly, actual cash flows and values could vary signifi-
cantly from forecasted cash flows and related values derived
using discounting techniques.
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Research & Development
Internal Research & Development (R&D) costs are fully
charged to the consolidated income statement in the period in
which they are incurred. The Group considers that regulatory
and other uncertainties inherent in the development of new
products preclude the capitalization of internal development
expenses as an intangible asset until marketing approval from
a regulatory authority is obtained in a relevant major market
such as for the US, the EU, Switzerland or Japan.
Payments made to third parties in compensation for sub-
contracted R&D that is deemed not to enhance the intellectual
property of Novartis such as contract research and develop-
ment organizations are expensed as internal R&D expenses
in the period in which they are incurred. Such payments are
only capitalized if they meet the criteria for recognition of an
internally generated intangible asset, usually when marketing
approval has been achieved from a regulatory authority in a
major market.
Payments made to third parties in order to in-license or
acquire intellectual property rights, compounds and products
(In-Process Research & Development assets, “IPR&D”), in-
cluding initial upfront and subsequent milestone payments,
are capitalized as are payments for other assets, such as
technologies to be used in R&D activities. If additional pay-
ments are made to the originator company to continue to
perform R&D activities, an evaluation is made as to the na-
ture of the payments. Such additional payments will be ex-
pensed if such additional payments are deemed to be com-
pensation for subcontracted R&D services not resulting in an
additional transfer of intellectual property rights to Novartis.
By contrast, such additional payments will be capitalized if
these additional payments are deemed to be compensation
for the transfer to Novartis of additional intellectual property
developed at the risk of the originator company. Subsequent
internal R&D costs in relation to IPR&D and other assets are
expensed since the technical feasibility of the internal R&D
activity can only be demonstrated by the receipt of marketing
approval for a related product from a regulatory authority in a
major market.
Costs for post-approval studies performed to support the
continued registration of a marketed product are recognized
as marketing expenses. Costs for activities that are required
by regulatory authorities as a condition for obtaining market-
ing approval are charged as development expenses as they
are incurred in cases where it is anticipated that the related
product will be sold over a longer period than the activities
required to be performed to obtain the marketing approval.
In the rare cases where costs related to the conditional ap-
proval need to be incurred over a period beyond that of the
anticipated product sales, then the expected costs of these
activities will be expensed over the shorter period of the an-
ticipated product sales. As a result, all activities necessary as
a condition to maintain a received approval, whether condi-
tional or not, are expensed.
IPR&D assets are amortized once the related project has
been successfully developed and regulatory approval for a
product launch obtained and acquired technologies included
in intangible assets are amortized in the consolidated income
statement over their estimated useful lives.
Laboratory buildings and equipment included in property,
plant & equipment are depreciated in the consolidated income
statement over their estimated useful lives.























January 1 12,624 3,216 1,271 11,737 954 17,178
Impact of business combinations 17,986 1,418 2,980 5,460 16,521 44 26,423
Reclassifications(1) (474) 474
Additions 344 62 89 495
Disposals (24) (184) (13) (221)
Currency translation effects (349) 147 (32) 90 61 266
December 31 30,261 4,627 2,980 6,699 28,700 1,135 44,141
Accumulated Amortization
January 1 (585) (547) (273) (5,395) (632) (6,847)
Reclassifications(1) (16) 16
Amortization charge (91) (970) (74) (1,135)
Amortization on disposals 22 95 12 129
Impairment charge (991) (14) (13) (1,018)
Reversal of impairment charge 2 105 107
Currency translation effects 16 (51) 10 (75) (30) (146)
December 31 (569) (1,565) (370) (6,254) (721) (8,910)
Net book value at December 31 29,692 3,062 2,980 6,329 22,446 414 35,231
(1) Reclassifications between various asset categories as a result of product launches of acquired In-Process Research & Development.
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January 1 11,976 3,028 754 10,599 942 15,323
Impact of business combinations 548 161 427 241 — 829
Reclassifications(1) — (790) 60 724 6 —
Additions 57 758 — 104 48 910
Disposals (128) (21) (1) (52) (59) (133)
Currency translation effects 171 80 31 121 17 249
December 31 12,624 3,216 1,271 11,737 954 17,178
Accumulated Amortization
January 1 (691) (477) (201) (4,561) (550) (5,789)
Reclassifications(1) — — (6) 6 — —
Amortization charge — — (51) (875) (99) (1,025)
Amortization on disposals 122 21 — 34 59 114
Impairment charge — (71) — (33) (28) (132)
Reversal of impairment charge — 6 — 100 — 106
Currency translation effects (16) (26) (15) (66) (14) (121)
December 31 (585) (547) (273) (5,395) (632) (6,847)
Net book value at December 31 12,039 2,669 998 6,342 322 10,331
(1) Reclassifications between various asset categories as a result of product launches of acquired In-Process Research & Development.
Segmentation of Goodwill and Intangible Assets
The net book values at December 31, 2010 of goodwill and





















Pharmaceuticals 2,862 1,812 — — 1,841 181 3,834
Vaccines and Diagnostics 1,111 123 — 238 1,351 150 1,862
Sandoz 7,184 508 — 743 1,878 23 3,152
Consumer Health 605 4 — — 855 1 860
Alcon 17,923 615 2,980 5,348 16,521 46 25,510
Corporate 7 — — — — 13 13
Total 29,692 3,062 2,980 6,329 22,446 414 35,231
Potential impairment charge, if any, if
discounted cash flows fell by 5% 3 8 11
Potential impairment charge, if any, if
discounted cash flows fell by 10% 7 16 23
Goodwill, the Alcon brand name and acquired In-Process
R&D are tested for possible impairment annually and when-
ever events or changes in circumstances indicate the value
may not be fully recoverable. If the initial accounting for an
intangible asset acquired in the reporting period is only pro-
visional, it is not tested for impairment unless an impairment
indicator exists, and not included in the calculation of the
net book values at risk from changes in the amount of dis-
counted cash flows. An impairment is recognized when the
consolidated balance sheet carrying amount is higher than
the greater of “fair value less costs to sell” and “value in use.”
Novartis has adopted a uniform method for assessing
goodwill for impairment and any other intangible asset
indicated as possibly impaired. Under this method, the “fair
value less costs to sell” of the related cash-generating unit
is calculated and only if it is lower than the consolidated bal-
ance sheet carrying amount is the value in use determined.
Novartis uses the Discounted Cash Flow (DCF) method to
determine the “fair value less costs to sell” of a related cash-
generating unit, which starts with a forecast of all expected
future net cash flows. Generally, for intangible assets Novar-
tis uses cash flow projections for the whole useful life of these
assets, and for goodwill cash flow projections for the next five
years are utilized based on a range of management forecasts,
with a terminal value using sales projections in line or lower
than inflation thereafter. Three probability-weighted scenarios
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are typically used. These cash flows, which reflect the risks
and uncertainties associated with the asset, are discounted
at an appropriate rate to net present value. The net present
values involve highly sensitive estimates and assumptions
specific to the nature of the Group’s activities with regard to:
• the amount and timing of projected future cash flows;
• the tax and discount rate selected;
• the outcome of R&D activities (compound efficacy, re-
sults of clinical trials, etc.);
• the amount and timing of projected costs to develop the
IPR&D into commercially viable products;
• the probability of obtaining regulatory approval;
• long-term sales forecasts for periods of up to 20 years;
• sales price erosion rates after the end of patent pro-
tection and timing of the entry of generic competition;
and
• the behavior of competitors (launch of competing prod-
ucts, marketing initiatives, etc.).
Factors that could result in shortened useful lives or impair-
ment include entry into the market of generic or alternative
products, lower than expected sales for acquired products or
for sales associated with patents and trademarks; or lower
than anticipated future sales resulting from acquired IPR&D.
Changes in the discount rates used for these calculations
also could lead to impairments. Additionally, impairments of
IPR&D and product and marketing rights may also result from
events such as the outcome of R&D activity, obtaining regu-
latory approval and the launch of competing products.
The discount rates used are based on the Group’s weighted
average cost of capital which is considered to be a good proxy
for the capital cost of a market participant, which is adjusted
for specific country and currency risks associated with the
cash flow projections.
Due to the above factors, actual cash flows and values
could vary significantly from the forecasted future cash flows
and related values derived using discounting techniques.
The recoverable amount of a cash-generating unit and re-
lated goodwill is based on the higher of fair value less costs












Sales growth rate assumptions after forecast period 0.6 2.0 0 to 2.0 (10.0) to 2.0
Discount rate 7.0 7.0 7.0 7.0
There has been no triggering event concerning Alcon be-
tween the date of acquisition of majority ownership of August
25, 2010 and December 31, 2010 that indicates that an im-
pairment is necessary of any values determined as part of the
final allocation of the purchase price as of August 25, 2010.
In 2010, Novartis recorded impairment charges totaling
$1.0 billion. These relate to impairment charges of $356 mil-
lion for Mycograb, $250 million for PTZ601, $228 million for
albinterferon alfa-2b and $120 million for ASA404 as Novar-
tis decided to discontinue the related development projects.
Additionally, $40 million were recorded for various other im-
pairment charges in the Pharmaceuticals Division. Novartis
also recorded various impairment charges of $24 million in
the Sandoz and Consumer Health Divisions.
In 2009, impairment charges of $132 million were recorded,
mainly for terminated development projects or for where the
anticipated cash flows from future sales no longer supported
the carrying value of the intangible assets. These related to
various impairment charges of $88 million, mainly for upfront
and milestone payments in the Pharmaceuticals Division and
$44 million in the Vaccines and Diagnostics, Sandoz and
Consumer Health Divisions.
Changes in circumstances of products impaired in prior
years led to reversals in 2010 that amounted to $107 million
mainly relating to Famvir product rights (2009: $106 million).
In 2008, Novartis recorded impairment charges totaling
$344 million. These relate to an impairment charge of $223
million for Aurograb and $97 million for various other im-
pairments of upfront and milestone payments and product
rights in the Pharmaceuticals Division. Additionally, Novar-
tis recorded various impairment charges of $24 million for
product rights in the Sandoz and Vaccines and Diagnostics
Divisions.
Core Deposit Intangibles, Other Acquired
Intangibles, and Computer Software
2.115
National Westminster Bank Plc (Dec 2010)
BALANCE SHEETS (in part)
As at 31 December 2010
Group
2010 2009 2008
Note £m £m £m
Assets
Intangible assets 18 683 748 815
Property, plant and
equipment 19 3,191 3,300 1,970
Deferred tax 23 574 568 496
Prepayments,
accrued income
and other assets 20 1,579 1,876 2,018
Total assets 366,532 350,728 321,219
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ACCOUNTING POLICIES (in part)
5. Intangible Assets and Goodwill
Intangible assets that are acquired by the Group are stated at
cost less accumulated amortisation and impairment losses.
Amortisation is charged to profit or loss over the assets’ es-
timated economic lives using methods that best reflect the
pattern of economic benefits and is included in depreciation
and amortisation. The estimated useful economic lives are as
follows:
Core deposit intangibles 6 to 10 years
Other acquired intangibles 5 to 10 years
Computer software 3 to 5 years
Expenditure on internally generated goodwill and brands is
written-off as incurred. Direct costs relating to the develop-
ment of internal-use computer software are capitalised once
technical feasibility and economic viability have been estab-
lished. These costs include payroll, the costs of materials and
services, and directly attributable overheads. Capitalisation of
costs ceases when the software is capable of operating as
intended. During and after development, accumulated costs
are reviewed for impairment against the projected benefits
that the software is expected to generate. Costs incurred prior
to the establishment of technical feasibility and economic vi-
ability are expensed as incurred as are all training costs and
general overheads. The costs of licences to use computer
software that are expected to generate economic benefits
beyond one year are also capitalised.
Acquired goodwill, being the excess of the cost of an ac-
quisition over the Group’s interest in the net fair value of
the identifiable assets, liabilities and contingent liabilities of
the subsidiary, associate or joint venture acquired, is initially
recognised at cost and subsequently at cost less any accu-
mulated impairment losses. Goodwill arising on the acqui-
sition of subsidiaries and joint ventures is included in the
balance sheet category ‘Intangible assets’ and that on asso-
ciates within their carrying amounts. The gain or loss on the
disposal of a subsidiary, associate or joint venture includes
the carrying value of any related goodwill.












£m £m £m £m £m
2010
Cost
At 1 January 2010 901 31 46 2,259 3,237
Currency translation and other adjustments 15 (1) (1) (2) 11
Additions — — — 58 58
Disposal of subsidiaries (78) — — — (78)
At 31 December 2010 838 30 45 2,315 3,228
Accumulated Amortisation and Impairment
At 1 January 2010 538 31 41 1,879 2,489
Currency translation and other adjustments (16) (1) (1) (1) (19)
Charge for the year — — 2 73 75
At 31 December 2010 522 30 42 1,951 2,545
Net book value at 31 December 2010 316 — 3 364 683
2009
Cost
At 1 January 2009 973 35 49 2,195 3,252
Currency translation and other adjustments (72) (2) (3) (6) (83)
Additions — — — 70 70
Disposals and write-off of fully amortised assets — (2) — — (2)
At 31 December 2009 901 31 46 2,259 3,237
Accumulated Amortisation and Impairment
At 1 January 2009 579 24 41 1,793 2,437
Currency translation and other adjustments (41) (2) (2) (5) (50)
Disposals and write-off of fully amortised assets — (1) — — (1)
Charge for the year — 10 2 91 103
At 31 December 2009 538 31 41 1,879 2,489
Net book value at 31 December 2009 363 — 5 380 748
(continued)
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£m £m £m £m £m
2008
Cost
At 1 January 2008 773 27 32 2,028 2,860
Currency translation and other adjustments 247 8 10 8 273
Additions — — 8 159 167
Disposal of subsidiaries (47) — — — (47)
Disposals and write-off of fully amortised assets — — (1) — (1)
At 31 December 2008 973 35 49 2,195 3,252
Accumulated Amortisation and Impairment
At 1 January 2008 — 14 13 1,589 1,616
Currency translation and other adjustments — 7 4 1 12
Disposals and write-off of fully amortised assets — — (1) — (1)
Charge for the year — 3 4 99 106
Write down of goodwill and other intangible assets 579 — 21 104 704
At 31 December 2008 579 24 41 1,793 2,437
Net book value at 31 December 2008 394 11 8 402 815
Impairment Review
The Group’s goodwill acquired in business combinations is
reviewed annually at 30 September for impairment by com-
paring the recoverable amount of each cash generating unit
(CGU) to which goodwill has been allocated with its carrying
value. The CGUs of the Group, where the goodwill is signifi-











Global Banking & Markets Greenwich Fair value less cost to sell 120 117














Global Banking & Markets Greenwich Fair value less cost to sell 128 — 128
Europe & Middle East Retail &
Commercial Banking First Active Value in use 576 (576) —
Asia Retail & Commercial
Banking Bank Von Ernst Value in use 182 — 182
The analysis of goodwill by operating segment is shown in
Note 36.
The Group has adopted value in use test for Wealth based
upon management’s latest five year forecasts. For the value
in use test, the long-term growth rates have been based on
respective country GDP rates adjusted for inflation. The risk
discount rates are based on observable market long-term
government bond yields and average industry betas adjusted
for an appropriate risk premium based on independent anal-
ysis. Fair value less costs to sell test has been adopted for
Global Banking & Markets.
The goodwill in Global Banking & Markets arose from
the Group’s interest in Greenwich Capital. The recoverable
amount exceeds the carrying value by £1.0 billion (2009—
more than 100%). The earnings multiples, validated against
independent analyst information, or the earnings would have
to reduce by a quarter to cause the recoverable amount to
equal the carrying value.
In Wealth there was no impairment recognised in respect
of the goodwill arising on the acquisition of Bank von Ernst.
The recoverable amount, based on a 5% (2009—5%) ter-
minal growth rate and 11.3% (2009—11%) pre-tax discount
rate, exceeded its carrying amount by £120 million (2009—
£1.0 billion). A 1% change in the discount rate or the terminal
growth rate would change the recoverable amount by approx-
imately £200 million (2009—£250 million) and £170 million
(2009—£200 million) respectively. In addition, a 5% change
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in forecast pre-tax earnings would change the recoverable
amount by £70 million (2009—£100 million).
In 2008, a goodwill write down was recorded in Europe &
Middle East Retail & Commercial Banking.
Development Costs
2.116
Trinity Biotech plc (Dec 2010)
CONSOLIDATED BALANCE SHEETS (in part)






equipment 11 5,999 12,174
Goodwill and intangible
assets 12 37,248 44,822
Deferred tax assets 13 4,680 5,801
Other assets 14 11,623 1,212
Total non-current assets 59,550 64,009
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Basis of Preparation and Significant Accounting
Policies (in part)
g) Intangibles, Including Research and Development (Other
than Goodwill)
An intangible asset, which is an identifiable non-monetary
asset without physical substance, is recognised to the extent
that it is probable that the expected future economic benefits
attributable to the asset will flow to the Group and that its
cost can be measured reliably. The asset is deemed to be
identifiable when it is separable (that is, capable of being
divided from the entity and sold, transferred, licensed, rented
or exchanged, either individually or together with a related
contract, asset or liability) or when it arises from contractual
or other legal rights, regardless of whether those rights are
transferable or separable from the Group or from other rights
and obligations.
The technical feasibility of a new product is determined by
a specific feasibility study undertaken at the first stage of any
development project. The majority of our new product devel-
opments involve the transfer of existing product know-how to
a new application. Since the technology is already proven in
an existing product which is being used by customers, this
facilitates the proving of the technical feasibility of that same
technology in a new product. The results of the feasibility
study are reviewed by a design review committee compris-
ing senior managers. The feasibility study occurs in the initial
research phase of a project and costs in this phase are not
capitalized.
The commercial feasibility of a new product is determined
by preparing a discounted cash flow projection. This pro-
jection compares the discounted sales revenues for future
periods with the relevant costs. As part of preparing the
cash flow projection, the size of the relevant market is deter-
mined, feedback is sought from customers and the strength
of the proposed new product is assessed against competi-
tors’ offerings. Once the technical and commercial feasibility
has been established and the project has been approved
for commencement, the project moves into the development
phase.
Intangible assets acquired as part of a business combina-
tion are capitalised separately from goodwill if the intangible
asset meets the definition of an asset and the fair value can
be reliably measured on initial recognition. Subsequent to ini-
tial recognition, these intangible assets are carried at cost
less any accumulated amortisation and any accumulated im-
pairment losses (note 1(h)). Definite lived intangible assets
are reviewed for indicators of impairment annually while in-
definite lived assets and those not yet brought into use are
tested for impairment annually, either individually or at the
cash generating unit level.
Research and Development
Expenditure on research activities, undertaken with the
prospect of gaining new scientific or technical knowledge and
understanding, is recognised in the statement of operations
as an expense as incurred. Expenditure on development ac-
tivities, whereby research findings are applied to a plan or
design for the production of new or substantially improved
products and processes, is capitalised if the product or pro-
cess is technically and commercially feasible and the Group
has sufficient resources to complete the development. The
expenditure capitalised includes the cost of materials, direct
labour and attributable overheads and third party costs. Sub-
sequent expenditure on capitalised intangible assets is cap-
italised only when it increases the future economic benefits
embodied in the specific asset to which it relates. All other de-
velopment expenditure is expensed as incurred. Subsequent
to initial recognition, the capitalised development expenditure
is carried at cost less any accumulated amortisation and any
accumulated impairment losses (note 1(h)).
Expenditure on internally generated goodwill and brands is
recognised in the statement of operations as an expense as
incurred.
Amortisation
Amortisation is charged to the statement of operations on a
straight-line basis over the estimated useful lives of intangi-
ble assets, unless such lives are indefinite. Intangible assets
are amortised from the date they are available for use. The
estimated useful lives are as follows:
• Patents and licences 6-15 years
• Capitalised development costs 15 years
• Other (including acquired customer and supplier lists)
6-15 years
The Group uses a useful economic life of 15 years for cap-
italized development costs. This is a conservative estimate
of the likely life of the products. The Group is confident that
products have a minimum of 15 years life given the inertia
that characterizes the medical diagnostics industry and the
barriers to entry into the industry. The following factors have
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been considered in estimating the useful life of developed
products:
(a) once a diagnostic test becomes established, cus-
tomers are reluctant to change to new technology until
it is fully proven, thus resulting in relatively long prod-
uct life cycles. There is also reluctance in customers
to change to a new product as it can be costly both in
terms of the initial changeover cost and as new tech-
nology is typically more expensive.
(b) demand for the diagnostic tests is enduring and robust
within a wide geographic base. The diseases that the
products diagnose are widely prevalent (HIV, diabetes
and Chlamydia being just three examples) in many
countries. There is a general consensus that these
diseases will continue to be widely prevalent in the
future.
(c) there are significant barriers to new entrants in this in-
dustry. Patents and/or licenses are in place for many of
our products, though this is not the only barrier to en-
try. There is a significant cost and time to develop new
products, it is necessary to obtain regulatory approval
and tests are protected by proprietary know-how, man-
ufacturing techniques and trade secrets.
Certain trade names acquired are deemed to have an indefi-
nite useful life.
Where amortisation is charged on assets with finite lives,
this expense is taken to the statement of operations through
the ‘selling, general and administrative expenses’ line.
Useful lives are examined on an annual basis and adjust-
ments, where applicable, are made on a prospective basis.














At January 1, 2009 79,599 34,212 10,093 26,078 149,982
Additions — 7,845 — 407 8,252
Disposals/retirements — — — (25) (25)
Exchange adjustments — 13 — 4 17
At December 31, 2009 79,599 42,070 10,093 26,464 158,226
At January 1, 2010 79,599 42,070 10,093 26,464 158,226
Additions — 5,887 8 407 6,302
Disposals/retirements (32,345) (20,113) (3,675) (7,169) (63,302)
Exchange adjustments — (13) — (4) (17)
At December 31, 2010 47,254 27,831 6,426 19,698 101,209
Accumulated Amortisation and Impairment Losses
At January 1, 2009 (59,546) (28,874) (8,808) (14,229) (111,457)
Charge for the year — (401) (149) (1,409) (1,959)
Disposals/retirements — — — 25 25
Exchange adjustments — (10) — (3) (13)
At December 31, 2009 (59,546) (29,285) (8,957) (15,616) (113,404)
At January 1, 2010 (59,546) (29,285) (8,957) (15,616) (113,404)
Charge for the year — (297) (86) (1,206) (1,589)
Disposals/retirements 30,120 11,824 3,184 5,904 51,032
Exchange adjustments — — — — —
At December 31, 2010 (29,426) (17,758) (5,859) (10,918) (63,961)
Carrying Amounts
At December 31, 2010 17,828 10,073 567 8,780 37,248
At December 31, 2009 20,053 12,785 1,136 10,848 44,822
Included within disposals/retirements in 2010 are intangible
assets with a net book value of US$12,270,000, which were
disposed of as part of the divestiture of the Coagulation busi-
ness in May 2010 (see Note 3).
Included within development costs are costs of
US$8,682,000 which were not amortised in 2010 (2009:
US$4,564,000). These development costs are not being
amortised as the projects to which the costs relate were not
fully complete at December 31, 2010 or at December 31,
2009. As at December 31, 2010 these projects are expected
to be completed during the period from January 1, 2011 to
December 31, 2013 at an expected further cost of approxi-
mately US$6.5 million.
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The following represents the costs incurred during each pe-
riod presented for each of the principal development projects:
2010 2009
Product Name US$’000 US$’000
Premier Hb 9210 Instrument for Haemoglobin
A1c testing 2,569 1,023
Destiny Max coagulation instrument(∗) 956 3,234
Bordetella Pertussis Western Blot test 337 156
Tristat point of care instrument 318 1,072
Coagulation assays and intermediates(∗) 312 1,010
HIV Ag-Ab rapid test 247 —
Legionella Urinary Antigen 198 —
Syphilis Rapid point-of-care test 185 —
Unigold Recombigen HIV Rapid
enhancement 142 456
Lyme assays — 629
Trinblot Scanner — 72
Other projects with spend less than $150,000 623 193
Total capitalized development costs 5,887 7,845
(∗) Note that these projects ceased in May 2010 following the di-
vestiture of the Coagulation Business.
All of the development projects for which costs have been
capitalized are judged to be technically feasible, commer-
cially viable and likely to produce future economic benefits.
In reaching this conclusion, many factors have been consid-
ered including the following:
(a) The Group only develops products within its field of
expertise. The R&D team is experienced in developing
new products in this field and this experience means
that only products which have a high probability of
technical success are put forward for consideration as
potential new products.
(b) A technical feasibility study is undertaken in advance
of every project. The feasibility study for each project is
reviewed by the R&D team leader, and by other senior
management depending on the size of the project. The
feasibility study occurs in the initial research phase of
the project and costs in this phase are not capitalized.
(c) Nearly all of our new product developments involve
the transfer of our existing product know-how to a new
application. The Group does not engage in pure re-
search. Every development project is undertaken with
the intention of bringing a particular new product to
market for which there is a known demand.
(d) The commercial feasibility of each new product is es-
tablished prior to commencement of a project by en-
suring it is projected to achieve an acceptable income
after applying appropriate discount rates.
Other intangible assets consist primarily of acquired customer
and supplier lists, trade names, website and software costs.
Amortisation is charged to the statement of operations
through the selling, general and administrative expenses line.
Included in other intangibles are the following indefinite
lived assets:
December 31, 2010 December 31, 2009
US$’000 US$’000
Fitzgerald trade name 970 970
RDI trade name 560 560
Primus trade name 670 670
2,200 2,200
The trade name assets purchased as part of the acquisition
of Primus and RDI in 2005 and Fitzgerald in 2004 were val-
ued by an external valuer using the relief from royalty method
and based on factors such as (1) the market and competitive
trends and (2) the expected usage of the name. It was con-
sidered that these trade names will generate net cash inflows
for the Group for an indefinite period.
Impairment Testing for Intangibles Including Goodwill and
Indefinite Lived Assets
Goodwill and other intangibles with indefinite lives are tested
annually for impairment at each balance sheet date at a cash-
generating unit (“CGU”) level, i.e. the individual legal entities.
For the purpose of these annual impairment reviews goodwill
is allocated to the relevant CGU.
The recoverable amount of goodwill and intangible assets
contained in each of the Group’s CGU’s is determined based
on the greater of the fair value less cost to sell and value in
use calculations. The Group operates in one market sector
(namely diagnostics) and accordingly the key assumptions
are similar for all CGU’s. The value in use calculations use
cash flow projections based on the 2011 budget and projec-
tions for a further four years using projected revenue and cost
growth rates of between 3% and 5%. At the end of the five
year forecast period, terminal values for each CGU, based
on a long term growth rate are used in the value in use cal-
culations. The cashflows and terminal values for the CGU’s
are discounted using pre-tax discount rates which range from
18% to 32%.
The value in use calculation is subject to significant estima-
tion, uncertainty and accounting judgements and are partic-
ularly sensitive in the following areas. In the event that there
was a variation of 10% in the assumed level of future growth
in revenues, which would represent a reasonably likely range
of outcomes, the following impairment loss/write back would
be recorded at December 31, 2010:
• No impairment loss or reversal of impairment in the
event of a 10% increase in the growth in revenues.
• No impairment loss or reversal of impairment in the
event of a 10% decrease in the growth in revenues.
Similarly if there was a 10% variation in the discount rate used
to calculate the potential impairment of the carrying values,
which would represent a reasonably likely range of outcomes,
there would be the following impairment loss/write back would
be recorded at December 31, 2010:
• No impairment loss or reversal of impairment in the
event of a 10% decrease in the discount rate
• No impairment loss or reversal of impairment in the
event of a 10% increase in the discount rate
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Domains, Brands, Water Rights, Easement
Rights, IT Programs
2.117
Vina Concha y Toro S.A. (Dec 2010)
Author’s Note
Vina Concha y Toro S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of January
1, 2009. The excerpt that follows reflects the initial
application of IAS 38.















Other non-current financial assets (8) 5,765,933 3,943,612 —
Other non-financial assets, non-current — 2,442,581 2,779,252 3,244,011
Investments accounted for using the equity method (12) 9,627,465 9,626,139 9,121,449
Intangible assets other than goodwill (13) 8,863,353 8,379,752 8,417,493
Property, plant and equipment (14) 225,070,491 229,469,990 226,652,653
Non-current biological assets (15) 53,672,218 52,529,942 50,621,435
Deferred tax assets (21) 5,295,823 4,015,976 3,376,166
Total non-current assets 310,737,864 310,744,663 301,433,207
Total assets 584,915,714 576,773,649 564,466,883
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2. Bases of Preparation and Presentation Used
for These Financial Statements
2.11 Intangible Assets
2.11.1 Industrial Brand Rights
Viña Concha y Toro trade its products through the registration
of its own brands with a finite useful life, duly recorded and
completely in-force. Those brands include Concha y Toro and
sub brands Don Melchor, Amelia, Terrunyo, Trio, Casillero
del Diablo, Sunrise, Frontera, Tocornal and Maipo. The sub-
sidiaries have registered their brands Cono Sur, Isla Negra,
Maycas del Limarı́ and Trivento.
• Registered in Chile.
Viña Concha y Toro, has a portfolio of its own industrial
brands registered in Chile for a ten-year period, renewable.
These are valued at brand registration historic cost. This
value is amortized in the period of time in which the regis-
ter is in-force.
• Registered abroad.
The Company also registers its brands abroad in locations
where it operates in the wine business. Normally, these reg-
istration rights have an in-force period from 5 to 10 years. The
registration amounts are amortized in the in-force period of
the related brand registration certificate pursuant to regula-
tions of each country. These are recorded at historic cost net
of amortization.
Viña Concha y Toro, value the related Industrial Brand
Rights at its registration cost value. Disbursements incurred in
developments of brands are recorded as operating expenses
when incurred.
Brands acquired prior to the date in which Viña Concha y
Toro adopted its transition to IFRS are presented at its value
revalued by inflation and lessen by the related accumulated
amortization.
2.11.2 Domain Rights
Correspond to the use rights for a unique internet address
to which users can access. These domains can be domestic
or foreign, to which its in-force period will correspond to that
indicated by the law of each country and in general not higher
than 5 renewable years.
2.11.3 IT Programs
Licenses for IT programs acquired are recorded at historic
cost net of amortization. These costs are amortized using its
estimated useful lives, generally 3 to 8 years.
Expenses related to the development or maintenance of IT
programs are recognized as expense when incurred.
2.11.4 Research and Development
Research and development expenses are recognized as ex-
penses when incurred. The Company has no significant mate-
rial disbursements for these concepts during the years ended
as of December 31, 2010 and December 31, 2009.
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2.11.5 Water Rights
Water rights acquired by the Company correspond to the ex-
ploitation right of water existing in natural sources associated
to agricultural land which are recorded at historic cost. These
are recognized at its purchase value, and given that they
are perpetual rights, these are not amortizable. However, the
Company evaluates these water rights with respect to impair-
ment on a yearly basis.
Water rights prior to the date in which Viña Concha y Toro,
adopted its transition to IFRS are presented at its value re-
stated by inflation and reduced by the related accumulated
depreciation.
2.11.6 Easement Rights
Rights related to easement correspond to the amounts in
acquisition of rights of way for use of service, between sev-
eral co-owners from the area (access to allotments, aqueduct
transit, and power lines), on agricultural land of Viña Concha
y Toro, in addition to those of its subsidiary Viña Cono Sur
S.A. These rights are indefinite therefore, are not amortized
but subject to “impairment test” on an annual basis, restating
the value in case the related market value were lower, based
on the last transactions performed by the Company.
Rights acquired prior to the date in which Viña Concha y
Toro adopted its transition to IFRS are presented at its value
restated by inflation and reduced by the related accumulated
depreciation.
2.11.7 Identification of Classes of Intangibles With Finite and
Undefined Useful Life




Industrial brands, domestic (acquired) Finite




2.11.8 Minimum and Maximum Useful Lives for Amortization
of Intangibles
Useful Life by Class of Intangible Assets Minimum Maximum
Licenses, Registered brands and other rights 5 10
IT Programs 3 8
Other identifiable intangible assets 3 10
Note 13. Intangible Assets
a) Classes of Intangible Assets
Balances of different classes of intangible assets as of De-
cember 31, 2010, December 31, 2009 and January 1, 2009,
are detailed as follows:
12-31-2010 12-31-2009 01-01-2009
Description of Classes on Intangible Assets Th$ Th$ Th$
Net intangible assets 8,863,353 8,379,752 8,417,493
Net Intangible asset with finite life 3,505,854 3,589,477 3,799,353
Net intangible assets with indefinite life
Water right, net 5,339,431 4,772,631 4,599,713
Easement right, net 18,068 17,644 18,427
Net identifiable intangible assets 8,863,353 8,379,752 8,417,493
Licenses, registered brands and other rights, net 7,112,438 6,727,818 6,283,532
IT programs, net 1,750,915 1,651,934 2,133,961
Gross intangible assets 15,548,474 14,244,316 13,217,510
Gross intangible assets identifiable 15,548,474 14,244,316 13,217,510
Licenses, registered brands and other rights, gross 8,546,719 7,884,591 7,281,414
IT programs, gross 7,001,755 6,359,725 5,936,096
Total, accumulated amortization and value impairment on intangible assets 6,685,121 5,864,564 4,800,017
Accumulated amortization and value impairment on identifiable intangible assets 6,685,121 5,864,564 4,800,017
Licenses, registered brands and other rights 1,434,281 1,156,773 997,882
IT programs 5,250,840 4,707,791 3,802,135
As of December 31, 2010, the Company has no restrictions
on intangible assets and does maintain acquisition commit-
ments.
The book value of intangible with indefinite useful life was
assigned to the cash generating unit (CGU) which corre-
sponds to agricultural land, within the Wines segment.
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Changes of intangible assets as of December 31, 2010 are
detailed as follows:
Changes in Identifiable Intangible Assets
Licenses, Registered





Assets, Net in Th$
Beginning balance 6,727,818 1,651,934 8,379,752
Changes:
Additions 700,483 651,487 1,351,970
Withdrawals (47,812) — (47,812)
Amortization (268,051) (552,507) (820,557)
Total changes 384,621 98,981 483,601
Final balance as of December 31, 2010 7,112,438 1,750,915 8,863,353
The amount due to amortization for the year amounts to
Th$ 820,557 which is reflected in the statement of income
in item “depreciation and amortization,” within the line “ad-
ministrative expenses” and in the line “costs of sales” corre-
sponding to the portion which forms part of the inventories
cost.
Changes of intangibles as of December 31, 2009 are de-
tailed as follows:
Changes in Identifiable Intangible Assets
Licenses, Registered





Assets, Net in Th$
Beginning balance 6,283,532 2,133,961 8,417,493
Changes:
Additions 674,331 423,629 1,097,960
Withdrawals (71,155) — (71,155)
Amortization (158,891) (905,656) (1,064,547)
Total changes 444,286 (482,027) (37,741)
Final balance as of December 31, 2009 6,727,818 1,651,934 8,379,752
IAS 40
IFRSs Overview and Comparison
to U.S. GAAP
2.118 Investment property, as defined in IAS 40, is land or
buildings (in whole or part) held for rental or capital ap-
preciation, or both, and is a separate asset class. An entity
may own an investment property or hold it under a finance
(capital) lease. Under certain circumstances, as described
subsequently, lessees holding property interests under op-
erating leases may also classify the property interest as an
investment property under IAS 40.
2.119 An entity should account for land or buildings held
for sale in the ordinary course of business as inventory and
account for it in accordance with IAS 2. Land or buildings
held for use in the production or supply of goods or services
or for administrative purposes is considered owner occupied
and should be accounted for as PPE, in accordance with
IAS 16; otherwise, accounting for those assets should be in
accordance with IAS 40.
2.120 The scope of IAS 40 includes investment property
under construction and excludes biological assets related to
agricultural activity (see IAS 41) and mineral rights and min-




2.121 On initial recognition, an entity should recognize an
investment property as an asset when, and only when
• it is probable that the future economic benefits that are
associated with the investment property will flow to the
entity, and
• the cost of the investment property can be measured
reliably.
Cost should include transaction costs to acquire the invest-
ment property and costs incurred subsequently to add to,
replace part of, or service the property. An entity should
measure the cost of investment property assets held under a
finance lease at the lower of the property’s fair value and the
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present value of the minimum lease payments and recognize
an equivalent amount as a liability.
2.122 As it would for PPE, an entity should allocate the cost
to the components of the property that it expects to replace
over the asset’s useful life. At the time the component is
replaced, an entity should derecognize any remaining carry-
ing amount. Examples of components of investment property
are interior walls, elevators, and heating and air conditioning
systems.
2.123 IAS 40 has two alternative models for subsequent
measurement: cost and fair value. If the entity chooses the
cost model, it should account for the asset in accordance with
IAS 16 and test the asset for impairment in accordance with
IAS 36. However, investment properties that meet the criteria
to be classified as held for sale (or are included in a disposal
group that is classified as held for sale) should be measured
in accordance with IFRS 5.
Author’s Note
See paragraph 2.60 for a description of the cost model.
2.124 An entity may choose one of the two alternative mod-
els separately for each of the following groups of investment
properties:
• All investment property backing liabilities that pay a
return linked directly to the fair value of, or returns
from, specific assets, including the property
• All other investment property
2.125 Lessees who hold property interests under an oper-
ating lease can also classify and account for such interests
as an investment property if, and only if, the property would
otherwise meet the definition of an investment property and
the entity chooses the fair value model for subsequent mea-
surement.
2.126 Under the fair value model, an entity should measure
all of its investment property at fair value, except in the ex-
ceptional case when fair value cannot be determined reliably.
IAS 38 states that there is a rebuttable presumption that, if an
entity chooses the fair value model, it can reliably determine
fair values for its properties. Fair values should reflect market
conditions at the end of the reporting period and the entity
should report changes in fair value in profit or loss.
2.127 If an entity has previously measured an investment
property at fair value, it should continue to measure that in-
vestment property at fair value until disposal or transfer to
inventory or owner-occupied PPE. For a transfer from in-
vestment property carried at fair value to owner-occupied
property or inventories, the property’s deemed cost for sub-
sequent accounting in accordance with IAS 2 or IAS 16,
should be its fair value at the date of change in use. An en-
tity should consider the change in fair value when the asset
is transferred from PPE to investment property held at fair
value as a revaluation increase or decrease under IAS 16.
2.128 An entity derecognizes an investment property on
disposal or when the property is permanently retired (that is,
no further economic benefits are expected). An entity should
recognize gains or losses on disposal or retirement in profit
or loss.
2.129 Entities should recognize compensation from third
parties for impairments or losses in profit or loss only when
the compensation is receivable.
U.S. GAAP
2.130 FASB ASC does not provide specific guidance on
accounting for investment properties. FASB ASC 360, Prop-
erty, Plant, and Equipment, requires an entity to account for
land and buildings as PPE, even when held for sale in the
ordinary course of business, but the entity should not depre-
ciate a long-lived asset while it is classified as held for sale.
Accordingly, the entity should measure the investment prop-
erty using the cost model. Unlike IFRSs, neither FASB ASC
360 nor FASB ASC 840, Leases, discusses whether a prop-
erty held by a lessee under a lease classified as an operating
lease could be accounted for as PPE (effectively, as a capital
lease) by the lessee.
Author’s Note
FASB ASC does not recognize investment properties
as a separate asset class. Such properties are included
in PPE. See paragraphs 2.52–.70 for a more compre-
hensive comparison between FASB ASC and IFRSs
related to PPE, including presentation and disclosure.
Presentation
IFRSs
2.131 IAS 1 requires an entity to include a line item for
investment properties, and it should present items with dif-
ferent measurement bases separately.
Disclosure
IFRSs
2.132 Regardless of the model chosen, entities should dis-
close the following:
• Accounting policy (cost or fair value)
• If the fair value model is used, whether and under what
circumstances property interests held under operating
leases are classified and accounted for as investment
property
• When classification is difficult, the criteria used to
distinguish investment property from owner-occupied
properties and from property held for sale in the ordi-
nary course of business
• Methods and significant assumptions applied in mea-
suring fair values, including a statement regarding the
relative weight of market-related evidence and other
factors
• Extent to which the fair value of investment property
is based on a valuation by independent valuers, with
recognized credentials and recent experience, or the
fact that no such valuation was done
• Amounts recognized in profit or loss, including rental
income, direct operating expenses (generating and
not generating rental income), and the cumulative
change in fair value recognized in profit or loss when
sales occurred between pools of asset under different
models
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2.133 When an entity applies the fair value model, it should
provide a reconciliation of the beginning and ending balance
in investment properties, disclosing the following:
• Additions disaggregating individual property acquisi-
tions from expenditures on existing properties
• Additions due to business combinations
• Classification to held for sale or as part of a disposal
group classified as held for sale
• Changes in fair value
• Net foreign exchange differences
• Transfers to or from inventory or PPE
• Other changes
2.134 In the exceptional case that fair value can no longer
be measured reliably and the cost model is used, an entity
should present information about the property separately in
the relevant reconciliation disclosure. The entity should also
provide a description of the property and the circumstances
that led to the determination that fair value was not reliable.
2.135 For investment properties held under the cost model,
an entity should provide the same disclosures as required
by IAS 16, including the depreciation methods used and
useful lives or depreciation rates used. At a minimum, an
entity should show investment properties as a separate asset
class when the entity includes the required reconciliation with
other assets using the cost model. The entity should disclose
the aggregated fair value of investment properties measured
at cost, except in the rare case when fair value cannot be
measured reliably.





Fair Value......................................................................... 19 17
Fair value only for investment properties backing
liabilities paying a return linked to the fair value of the
investment property otherwise, cost model................. 1 1
No model disclosed ......................................................... 2 2
Survey companies that do not report investment
properties...................................................................... 13 126
Companies disclosing both models................................. (1) 0
Total Companies.................................................... 170 160
Presentation and Disclosure Excerpts
Investment Property Carried at Cost
2.136
Adecoagro S.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
As of December 31, 2010, 2009 and 2008
(All amounts in US$ thousands, except shares and per
share data and as otherwise indicated)




equipment, net 6 751,992 682,878 571,419
Investment property 7 21,417 21,246 —
Intangible assets, net 8 28,653 21,859 18,108
Biological assets 9 104,216 170,347 75,701
Investments in joint ventures 10 6,271 6,506 7,508
Deferred income tax assets 21 67,463 45,113 18,713
Trade and other receivables,
net 11,12 30,752 22,065 8,612
Other assets 26 34 87
Total non-current assets 1,010,790 970,048 700,148
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
The principal accounting policies applied in the preparation
of these consolidated financial statements are set out below.
These policies have been consistently applied to all the years
presented, unless otherwise stated.
2.7. Investment Property
Investment property consists of farmland held to earn rentals
or for capital appreciation and not used in production or for
administrative purposes. Investment property is measured at
cost less any impairment losses. Rental income from invest-
ment property is recorded in the Group’s net sales.
2.24. Revenue Recognition (in part)
In December 2009, the Group began leasing owned farmland
property to third parties under operating lease agreements.
The leased assets are included within investment property
on the Group’s statement of financial position. Rental income
is recognized on a straight-line basis over the period of the
lease.
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7. Investment Property
Changes in the Group’s investment property in 2010, 2009
and 2008 were as follows:
2010 2009 2008
Beginning of the year 21,246 — —
Acquisition of subsidiary (Note 31) 7,935 — —
Transfers(i), (ii) (6,767) 21,246 —
Exchange difference (997) — —
End of the year 21,417 21,246 —
(i) Transferred from property, plant and equipment in 2009. Relates
to farmland rented out to third parties. See Note 30 for details.
(ii) Transferred to property, plant and equipment in 2010. Relates to
finalization of contracts with third parties.
The following amounts have been recognized in the state-
ment of income in the line “Sales of manufactured products
and services rendered”:
2010 2009 2008
Rental income 3,718 172 —
As of December 31, 2010, the fair value of investment prop-
erty is US$ 96.4 million.
Investment Property Carried at Fair Value
2.137
Homburg Invest Inc. (Dec 2010)
Author’s Note
Homburg Invest Inc. is an investment property (real
estate) company. Only the effects of the use of the fair
value model on the statement of financial position are
illustrated in the excerpt below. The effects of account-
ing for investment property at fair value on Homburg
Invest’s statement of comprehensive income, statement
of shareholder’s equity, and statement of cash flows are
illustrated in the relevant parts of Sections 3, 4, and 5
respectively
CONSOLIDATED BALANCE SHEET (in part)
(CAD $ Thousands Except







Investment properties 10,27 $1,401,727 $2,739,415
Investment properties under
development 10 217,363 245,896
Investments, at fair market
value 6 8,864 27,942
Investment in an associate, at
equity 7 191,702
Restricted cash 8 4,088 23,159
Deferred tax assets 15 8,316 26,715
1,832,060 3,063,127
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
4. Summary of Significant Accounting Policies (in part)
Investment Properties
The Company applies IAS 40—Investment Property and has
chosen the fair value method of presenting its investment
properties in the financial statements. Fair value represents
the amount at which the properties could be exchanged be-
tween a knowledgeable and willing buyer and a knowledge-
able and willing seller in an arm’s length transaction at the
date of valuation. The fair value of investment properties is
based on valuations by a combination of independent ap-
praisers and management estimates plus any capital addi-
tions since the date of the most recent appraisal. Manage-
ment regularly undertakes a review of its investment property
revaluation between appraisal dates to assess the contin-
uing validity of the underlying assumptions such as cash-
flow and capitalization rates. These assumptions are tested
against market information obtained from independent indus-
try experts. Where increases or decreases are warranted, the
Company adjusts the carrying values of its investment prop-
erties. Property interests held under operating leases are not
treated as investment properties.
Investment Properties Under Development
The Company has adopted the amended IAS 40—Investment
Property, which now includes, within its scope, properties
being constructed or developed for future use as an invest-
ment property. Investment properties under development are
carried at fair value, to the extent that fair value is reliably
determinable. To the extent that fair value is not reliably de-
terminable, the property is carried at cost until either the fair
value becomes reliably determinable or construction is com-
pleted, whichever is earlier. Changes to the carrying value
are recognized through the consolidated income statement.
Capitalization of Costs
The Company capitalizes investment property acquisition
costs incurred at the time of purchase. For properties being
developed for future use as an investment property and con-
struction properties being developed for resale, the Company
capitalizes all direct expenditures incurred in connection with
the acquisition, development and construction. These expen-
ditures consist of all direct costs and borrowing costs on debt
directly attributable to a specific property, including borrow-
ing costs incurred on the debt prior to the full utilization of the
debt for the project. Borrowing costs are offset by any interest
earned by the Company on borrowed funds prior to utilization.
The development period commences when expenditures are
being incurred and activities necessary to prepare the asset
for its intended use are in progress. Capitalization ceases
when the asset is ready for its intended use.
Significant Accounting Judgments, Estimates and
Assumptions
The preparation of the Company’s consolidated financial
statements requires management to make judgments, es-
timates and assumptions that affect the reported amounts of
revenues, expenses, assets and liabilities, and the disclosure
of contingent liabilities, at the date of the financial statements.
Uncertainty about these assumptions and estimates could
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result in outcomes that require a material adjustment to the
carrying amount of assets or liabilities in future periods.
Estimates and Assumptions
In the process of applying the Company’s accounting policies,
management has made the following estimates and assump-
tions which have the most significant effect on the amounts
recognised in the consolidated financial statements:
i) Valuation of investment properties. Investment properties
comprises real estate (land or buildings or both) held by
the Company in order to earn rentals or for capital ap-
preciation, or both, rather than for use in the production
or supply of goods or services or for administrative pur-
poses or in the ordinary course of business. Investment
properties are presented at fair value at the reporting date.
Any change in fair value is determined by using a com-
bination of management’s internal valuations and valua-
tions from independent real estate valuation experts, each
in accordance with recognised valuation techniques. The
techniques used comprise both the capitalized net operat-
ing income method and the discounted cash flow method
and include estimating, among other things, capitaliza-
tion rates and future net operating income and discount
rates and future cash flows applicable to investment prop-
erties, respectively. Management’s internal assessments
of fair value are based upon internal financial informa-
tion and are corroborated by capitalization rates obtained
from independent industry experts. Management’s inter-
nal valuations and independent appraisal values obtained
are both subject to significant judgment, estimates and
assumptions about market conditions in effect at the re-
porting date.
ii) Valuation of investment properties under development. In-
vestment properties being constructed or developed are
carried at fair value, to the extent that fair value is reli-
ably determinable, with changes in fair value recognized
in the Consolidated income statement. To the extent that
fair value is not reliably determinable, the property is car-
ried at cost until either the fair value becomes reliably
determinable or construction is completed, whichever is
earlier. Fair value is determined by using a combination
of management’s internal valuations and valuations from
independent real estate valuation experts, each in accor-
dance with recognised valuation techniques. The tech-
niques used comprise both the capitalized net operat-
ing income method and the discounted cash flow method
and include estimating, among other things, capitalization
rates, future net operating income, project costs to com-
plete, discount rates and future cash flows applicable to
investment properties, respectively. The fair value of land
to be developed for future use as an investment property
is based on recent comparable market transactions, plus
costs incurred that enhance the land value.
iii) Valuation of properties under development for resale.
Properties under development for resale are carried at
the lower of cost and net realizable value. Net realizable
value is the estimated selling price in the ordinary course
of business less selling costs and costs to complete devel-






2010 2009 2010 2009
Balance, beginning of year $ 2,739,415 $ 3,549,744 $ 245,896 $ 224,285
Acquisition through purchases 4,150
Capital expenditure 4,948 34,299 27,615 31,857
Capitalized interest 16,953 12,988
Deferred rental receipts 5,286 5,208
Disposals and transfers to assets held for resale (Note 19 & 23p) (1,117,939) (111,297) (56,324)
Currency translation adjustment (198,871) (293,578)
Net transfers from properties under development for resale 21,323
Unrealized fair value adjustment (31,112) (444,961) (16,777) (48,707)
Balance, end of year $ 1,401,727 $ 2,739,415 $ 217,363 $245,896
Investment properties are stated at fair value using the fol-
lowing methods, estimates and key assumptions:
(i) External appraisals
At December 31, 2010 external appraisals were ob-
tained for investment properties with an aggregate fair
value of $1,296 million (2009—$2,281 million) rep-
resenting 92.5% (2009—83.3%) of the fair value at
that date, and for an aggregate fair value of $98 mil-
lion (2009—$186 million) for investment properties un-
der development, representing 45.1% (December 31,
2009—75.6%) of the fair value at that date.
(ii) Discounted Cash Flow Method of Valuation
Under this method, discount rates are applied to the
annual operating cash flow (property revenue less
property operating expenses). The key assumption is
the discount rate for each specific property. The Com-
pany received capitalization rate reports from external
knowledgeable property valuators and discount rates
were derived from these reports. The discounted cash
flow method of valuation was reconciled to the capi-
talized net operating income method using capitaliza-
tion rates to ensure valuation accuracy and reason-
ableness. To the extent that the externally provided
capitalization rates or discount rates change from one
reporting period to the next; or should another rate
within the provided ranges be more appropriate than
the rate previously used, the fair value of the invest-
ment properties would increase or decrease accord-
ingly. The Company utilized the following weighted
average capitalization rates or discount rates and has
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determined that an increase (decrease) in the applied
capitalization rate or discount rate of 0.10% in any of
its geographic segments would result in an increase or
decrease in the fair value of the Investment properties,
as follows:
As at December 31, 2010 As at December 31. 2009
Average Impact of 0.10% Change Average Impact of 0.10% Change
Capitalization Rate Increase Decrease Capitalization Rate Increase Decrease
Germany 6.33% $11,685 $12,061 5.84% $14,673 $15,184
The Netherlands 7.46% 5,221 5,353 7.75% 6,568 6,739
The Baltic States 7.89% 2,607 2,674 8.44% 2,748 2,814
Canada % 7.28% 13,163 13,530
USA 8.61% 251 256 8.56% 1,669 1,709
Overall 7.08% $19,764 $20,344 7.08% $38,821 $39,976
The Company has determined, based on the capitalization
rates used, that an increase (decrease) in the net operat-
ing income of $1,000 in any geographic segment would re-
sult in an increase (decrease) in the fair value for that seg-
ment ranging between $11,614 and $15,809 (December 31,
2009—between $11,683 and $17,112).
Investment properties include one property (December 31,
2009—one property) with a fair value of $592,540 (Decem-
ber 31, 2009—$676,850) where there is a purchase option
exercisable by the tenant in 2020 for EUR €282 million.
2.138
Brookfield Asset Management, Inc. (Dec 2010)
Author’s Note
Brookfield Asset Management, Inc. is an invest-
ment management company. Investments in investment
properties (real estate) comprise only a portion of its
investment portfolio. Only the effects of the use of
the fair value model for investment properties on the
statement of financial position are illustrated in the ex-
cerpt below. The effects of accounting for investment
property at fair value on Brookfield Asset Manage-
ment’s statement of comprehensive income, statement
of shareholder’s equity, and statement of cash flows are
illustrated in the relevant parts of Sections 3, 4, and 5
respectively.
Author’s Note
Brookfield Asset Management implemented IFRSs ef-
fective December 31, 2010, with a date of transition of
January 1, 2009. The excerpt that follows reflects the
initial application of IAS 40.
CONSOLIDATED BALANCE SHEETS (in part)
(Millions) Note Dec. 31, 2010 Dec. 31, 2009(1) Jan. 1, 2009(1)
Assets
Cash and cash equivalents $1,713 $ 1,309 $ 1,169
Other financial assets 5 4,419 5,146 4,506
Accounts receivable and other 6 7,869 4,709 3,803
Inventory 7 5,849 5,560 4,752
Investments 8 6,629 4,466 4,646
Property, plant and equipment 9 18,148 16,723 15,597
Investment properties 10 22,163 19,219 16,719
Timber 11 3,206 2,968 2,839
Intangible assets 12 3,805 1,048 619
Goodwill 13 2,546 2,363 1,992
Deferred income tax asset 14 1,784 1,454 984
$78,131 $64,965 $57,626
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
(f) Operating Assets (in part)
(ii) Investment Properties
The company uses the fair value method to account for real
estate classified as investment property. A property is de-
termined to be an investment property when it is principally
held to earn rental income or for capital appreciation, or both.
Investment property also includes properties that are under
development for future use as investment property. Invest-
ment property is initially measured at cost including trans-
action costs. Subsequent to initial recognition, investment
properties are carried at fair value. Gains or losses arising
from changes in fair value are included in net income dur-
ing the period in which they arise. Fair values are primarily
determined by discounting the expected future cash flows
of each property, generally over a term of 10 years, using a
discount and terminal capitalization rate reflective of the char-
acteristics, location and market of each property. The future
cash flows of each property are based upon, among other
things, rental income from current leases and assumptions
about rental income from future leases reflecting current con-
ditions, less future cash outflows relating to such current and
future leases. The company determines fair value using both
internal and external valuations.
(p) Critical Judgements and Estimates (in part)
The preparation of financial statements requires manage-
ment to make critical judgements, estimates and assump-
tions that affect the carried amounts of certain assets and
liabilities, disclosure of contingent assets and liabilities and
the reported amounts of revenues and expenses recorded
during the period. Actual results could differ from those esti-
mates.
In making estimates and judgements, management relies
on external information and observable conditions where pos-
sible, supplemented by internal analysis as required. These
estimates and judgements have been applied in a manner
consistent with prior periods and there are no known trends,
commitments, events or uncertainties that we believe will ma-
terially affect the methodology or assumptions utilized in mak-
ing these estimates and judgements in these financial state-
ments.
The estimates and judgements used in determining the
recorded amount for assets and liabilities in the financial
statements include the following:
(i) Investment Property
The critical assumptions and estimates used when determin-
ing the fair value of commercial properties are: the timing
of rental income from future leases reflecting current mar-
ket conditions, less assumptions of future cash flows in re-
spect of current and future leases; maintenance and other
capital expenditures; discount rates; terminal capitalization
rates; and terminal valuation dates. Commercial properties
under development are recorded at fair value using a dis-
counted cash flow model which includes estimates in respect
of the timing and cost to complete the development. Further




Fair value at beginning of year $19,219 $16,719
Additions 689 1,480
Acquisitions through business combinations 1,416 321
Disposals (859) (360)
Fair value adjustments 835 (888)
Foreign currency translation 863 1,947
Fair value at end of year $22,163 $19,219
The fair value of investment properties is generally deter-
mined by discounting the expected cash flows of the proper-
ties based upon internal or external valuations. All properties
are externally valued on a three year rotation plan. Certain ad-
justments have been made to external valuations conducted
by third parties as follows:
(Millions) Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Properties where fair value is determined by external valuators $ 5,161 $ 7,177 $ 3,587
Adjustment for straight-line rentals (1) 87 12
5,160 7,264 3,599
Internal appraisals 17,003 11,955 13,120
Fair value recorded in financial statements $22,163 $19,219 $16,719
The key valuation metrics of our commercial office properties
are presented in the following table:
United States Canada Australia
Dec. 31, 2010 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2009
Discount rate 8.1% 8.8% 6.9% 7.4% 9.1% 9.3%
Terminal capitalization rate 6.7% 6.9% 6.3% 6.7% 7.4% 7.8%
Investment horizon (years) 10 10 11 10 10 10
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IAS 28, INVESTMENTS IN
ASSOCIATES
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
IAS 28, Investments in Associates, was revised in May
2011, concurrently with the issuance of IFRS 11, Joint
Arrangements, and IFRS 12, Disclosure of Interests in
Other Entities, and renamed IAS 28, Investments in
Associates and Joint Ventures. IAS 28, as revised in
2011, expands the scope of IAS 28 to include investors
with joint control, as well as significant influence, over
an investee and requires the use of the equity method
to account for such investments, unless the entity is ex-
empt from applying the equity method, in accordance
with the standard. Entities will no longer be permitted
to use proportionate consolidation. The revised stan-
dard is effective for annual periods beginning on or
after 1 January 2013, with early application permitted.
Because the revised IAS 28, IFRS 11, and IFRS
12 were not issued until May 2011, no survey entity
could apply the new requirements in its 2010 financial
statements. Therefore, the following commentary only
describes the requirements in IAS 28 (2011).
2.139 An associate, as defined in IAS 28 (2011), is an entity,
including an unincorporated entity (for example, a partner-
ship), over which the investor has significant influence and
is neither a subsidiary (controlled entity) nor an interest in
a jointly controlled entity (joint venture). An investor has
significant influence over its investee when it has the power
to participate in the investee’s financial and operating policy
decisions but does not have control or joint control over those
policies.
2.140 IAS 28 applies to investments in which the investor has
significant influence. IAS 28 does not apply to the following
investments held by
• venture capital entities, or
• mutual funds, trusts, and other similar entities (includ-
ing investment-linked insurance funds)
that, upon initial recognition, are designated as at fair value
through profit or loss or are classified as held for trading and
accounted for in accordance with IAS 39. IAS 28 states that
these entities are to measure such investments at fair value
in accordance with IAS 39 and to recognize changes in fair
value in profit or loss in the period of the change. However,
IAS 28 does not exempt these entities from some disclosures,
including the nature and extent of any restrictions on the
ability of the associate to transfer funds to the investor in the
form of cash dividends, loan repayments, or advances.
Recognition and Measurement
IFRSs
2.141 IFRSs presume that an investor has significant influ-
ence if it holds 20 percent or more of the voting or potential
voting shares of the associate directly or indirectly and that
it does not have significant influence if it holds less. If the
investor holds 50 percent or more of the voting or potential
voting shares, it must determine whether it has control, in
accordance with IAS 27.
2.142 IAS 28 provides guidance to investors in determining
whether they have significant influence over an investee and
identifies various circumstances that provide evidence that
significant influence exists. These circumstances include the
following:
• The investor is represented on the board of directors
(governing body) of the investee.
• The investor participates in policymaking decisions,
including those concerning dividend and other distri-
butions.
• The investor and investee engage in material transac-
tions.
• The investor provides the investee with essential tech-
nical information.
2.143 An investor should use the equity method to account
for investments in associates, except when the associate is
classified as held for sale in accordance with IFRS 5. IAS
27 exempts an entity from preparing consolidated financial
statements if certain criteria are met. Similarly, IAS 28 ex-
empts an investor from using the equity method for its invest-
ment in an associate if the investor is a parent that is exempt
from consolidated financial statements in accordance with
IAS 27, or the entity itself meets those same criteria.
2.144 The equity method requires the entity to initially rec-
ognize the investment at cost. The investor should include
any difference in the cost and the investor’s proportionate
share of the fair value of the associate’s net identifiable as-
sets (referred to as goodwill) in the carrying value of the
associate. IAS 28 prohibits amortization of this difference.
The investor should also include any excess as income in
determining the investor’s proportionate share of the asso-
ciate’s profit or loss in the period in which the investment is
acquired. Subsequently, the investor should adjust the carry-
ing value of the investment for its share in the net profit or
loss of the associate and should recognize the same amount
in the investor’s profit or loss. The investor should also rec-
ognize its share of changes in the net assets of the associate
recognized in other comprehensive income in its own other
comprehensive income.
2.145 An investor should discontinue the equity method
when it no longer has significant influence. At that point,
the investor should measure any remaining investment at fair
value and recognize the change in the carrying value of the
investment in profit or loss. Subsequent accounting for the
investment should be in accordance with IAS 39.
2.146 An investor should use the most recent financial state-
ments of the associate to apply the equity method. When
the investor’s and associate’s reporting dates differ, the as-
sociate should prepare a set of financial statements as of the
investor’s fiscal year-end for the investors use, unless it is
impracticable. When the associate’s financial statements are
prepared as of a different date, the investor should make ap-
propriate adjustments for the effect of significant transactions
that occur between the two dates. IAS 28 does not permit the
difference in reporting dates to be greater than three months.
2.147 The investor should prepare financial statements based
on application of the same accounting policies for similar
transactions and circumstances. When the associate applies
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different accounting policies for transactions similar to those
of the investor, the investor should make adjustments to the
associate’s financial statements in order to conform to its own
accounting policies.
2.148 An investor’s interest in an associate includes the
carrying value of the equity method investment plus any
other long-term interests that, in substance, form part of
the investment (for example, preference shares, unsecured
loans, and long-term receivables). The investor should rec-
ognize its share of the associate’s losses up to the carrying
value of its interest. After writing its investment in the asso-
ciate to zero, the investor should apply any excess losses to
the other components in the order of reverse seniority. If the
investor’s share in losses of the associate exceeds its interest
in the associate, the investor should discontinue recognizing
further losses. An investor should recognize liabilities only
to the extent that it incurs a legal or constructive obligation
in accordance with IAS 37.
2.149 After applying the equity method, an investor should
test its investment in accordance with the requirements of IAS
39 to determine whether to recognize an impairment loss.
When application of IAS 39 indicates that an impairment
loss should be recognized, an investor should measure the
loss in accordance with IAS 36.
2.150 An investor preparing separate, unconsolidated fi-
nancial statements (for example, parent-only financial state-
ments), either voluntarily or for regulatory purposes, should
account for investments in associates in accordance with
IAS 27.
U.S. GAAP
2.151 Like IFRSs, paragraphs 3–5 of FASB ASC 323-10-15
require an investor to use the equity method to account for
investments in common stock that give the investor the ability
to exercise significant influence over the operating and finan-
cial policies of an investee even when the investor holds 50
percent or less of the common stock or in-substance common
stock (that is, an investment that gives the entities the same
risks and rewards as common stock ownership, as defined
in the FASB ASC glossary) of the investee. However, FASB
ASC 323, Investments—Equity Method and Joint Ventures,
includes a number of scope exceptions exceeding those in
IAS 28. FASB ASC 323-10-15-4 states that following in-
vestments are excluded from the guidance in FASB ASC
323:
• An investment that is accounted for in accordance with
guidance on derivatives and hedging in FASB ASC
815-10.
• An investment in common stock held by an investment
company registered with the SEC under the Investment
Company Act of 1940; one that would be registered
except that it has limited stockholders and the securities
are not offered publicly; or a nonbusiness entity, such
as an estate, trust or individual.
• An investment in common stock consolidated under
FASB ASC 810, Consolidation.
In addition, unlike IFRSs, FASB ASC 323-10-15-5 pro-
vides more targeted guidance to the following investments
that are excluded from the overall guidance in FASB ASC
323-10:
• Partnership or unincorporated joint venture (see FASB
ASC 323-30)
• Limited liability company that maintains specific own-
ership accounts for each investor (see FASB ASC 272-
10)
2.152 FASB ASC 323-10-15-3 also explicitly includes in-
vestments that are in-substance common stock.
2.153 FASB ASC 323-10-15-6 includes indicators similar
to those in IAS 28 of an investor’s ability to exercise sig-
nificant influence, including representation on the board of
directors, participation in the policymaking processes, mate-
rial intra-entity transactions, the interchange of managerial
personnel, technological dependency, and the extent of own-
ership by an investor in relation to the concentration of other
shareholdings.
2.154 Like IFRSs, FASB ASC 323-10-15-8 states that there
is a presumption that, in the absence of predominate evi-
dence to the contrary, an investor has the ability to exercise
significant influence over an investee if the investment (di-
rect or indirect) in an investee’s voting stock is 20 percent
or more. FASB ASC 323-10-15-8 also requires an entity to
demonstrate its ability to exercise significant influence when
its investment is less than 20 percent. Unlike IFRSs, FASB
ASC 323-10-15-9 precludes investors taking into account
potential voting shares when making their assessment of sig-
nificant influence.
2.155 FASB ASC 323-10-35-4 explains that under the eq-
uity method, an investor should recognize its share of the
earnings or losses of the investee in the same period the
investee reports earnings or losses, rather than in the pe-
riod the investee declares a dividend. An investor should
adjust the carrying amount of its investment and recognize
in income its share of the investee’s earnings or losses. Sim-
ilar to IFRSs, FASB ASC 323-10-35-18 also requires an
investor to recognize its proportionate share of the investee’s
equity adjustment for other comprehensive income items as
an adjustment to the carrying amount of the investment, with
a corresponding adjustment in equity. Unlike IFRS, U.S.
GAAP does not explicitly constrain the difference in report-
ing dates of the investor and investee to no more than three
months. When there is a lag in reporting by the investee,
FASB ASC 323-10-35-6 states that the investor would ordi-
narily use the investee’s most recent financial statements and
that the lag in reporting should be consistent from period to
period.
2.156 Like IFRSs, FASB ASC 323-10-35-19 states that an
investor’s share of losses of an investee may equal or exceed
the carrying amount of the investment accounted for by the
equity method plus advances made by the investor. FASB
ASC 323-10-35-19 requires the investor to continue to report
losses up to the carrying amount of its investment, including
any additional financial support provided or committed by
the investor, which may take the form of capital contributions
to the investee, investments in additional common stock of
the investee, investments in preferred stock or debt securities
of the investee, and loans or advances to the investee. See
paragraph 3.208 in section 3 for coverage of impairments of
equity method investments under FASB ASC.
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Presentation
IFRSs
2.157 IAS 28 requires investors to classify investments in
associates as noncurrent assets, unless they are classified as
held for sale, in accordance with IFRS 5.
2.158 IAS 1 requires investors to present investments in
associates as a separate line item on the balance sheet and the
investor’s share in the associates’ profit or loss as a separate
line item on the statement of comprehensive income. An
entity should also present additional line items, headings,
and subtotals when they are relevant to an understanding of
the entity’s financial position.
U.S. GAAP
2.159 Like IFRSs, FASB ASC 323-10-45-1 also requires an
entity to present its equity method investments as a single
amount in a separate line item on the balance sheet and,
consistent with FASB ASC 210-10, classify equity method
investments as noncurrent when a classified balance sheet is
prepared.
2.160 Paragraphs 1–2 of FASB ASC 323-10-45 require an
investor to show its share of the associate’s profit or loss as
a single amount on the income statement, except for the in-
vestor’s share of extraordinary items and accounting changes
reported in the financial statements of the investee, which
should be shown separately, in accordance with income state-
ment presentation guidance under FASB ASC 225-20. IFRSs
do not permit an entity to present extraordinary items. With
respect to the investor’s share of an investee’s items of other
comprehensive income, FASB ASC 323-10-45-3 permits an
entity to combine its proportionate share of those amounts
with its own other comprehensive income items. In contrast,
IFRSs require the investor to present its share of the other
comprehensive income of an associate as a separate line item.
Disclosure
IFRSs
2.161 IAS 28 requires investors to provide the following
disclosures about its equity method investments in associates:
• Fair value of associates when there are published price
quotes
• Summary financial information of associates, including
total assets, total liabilities, total revenues, and profit or
loss
• Share of profit or loss of each investment, including
separate disclosure of its share of discontinued opera-
tions, and the investments’ carrying amounts
• Investor’s share of changes in the net assets of the as-
sociate recognized in other comprehensive income
• Unrecognized share of losses of an associate for the
period and cumulatively if an investor has discontinued
recognition of its share of losses of an associate
• Investor’s share of the contingent liabilities of an asso-
ciate incurred jointly with other investors
• Any contingent liabilities that arise because the investor
is severally liable for all or part of the liabilities of the
associate
2.162 When an investor does not use the equity method, it
should disclose that fact and summary financial information
about the investment, including total assets, total liabilities,
total revenues, and profit or loss.
2.163 When the presumption of significant influence at 20
percent ownership is rebutted, investors should explain the
rationale for overcoming the presumption. When the investor
concludes it has significant influence with less than 20 per-
cent ownership, IAS 28 requires a similar disclosure.
2.164 Investors should also disclose the nature and extent
of significant restrictions on the associate’s ability to transfer
funds to the investor and separately disclose any contingent
liabilities incurred jointly and those for which it is severally
liable.
U.S. GAAP
2.165 The disclosures required by FASB ASC 323 for eq-
uity method investments are less comprehensive than those
required by IFRSs. Like IFRSs, FASB ASC 323-10-50-3
states that investors should usually disclose the aggregate
fair value of equity method investments in common stock
when there are published price quotes.
2.166 Unlike IFRSs, FASB ASC 323-10-50-3 explains that,
for equity method investments in common stock, investors
should disclose, among other things, the name of each in-
vestee; the percentage of ownership of common stock; and
the difference, if any, between the carrying amount of an in-
vestment and the amount of underlying equity in net assets
and how the difference is accounted for. Also unlike IFRSs,
FASB ASC 323-10-50-3(d) states that conversion of out-
standing convertible securities, the exercise of outstanding
options and warrants, and other contingent issuances of an
investee may have a significant effect on an investor’s share
of reported earnings or losses and material effects should be
included in notes to the financial statements of an investor.
Presentation and Disclosure Excerpts
Author’s Note
IAS 28 permits an entity to designate on initial recog-
nition investments in associates and account for them
in accordance with IAS 39 at fair value through profit
and loss. Excerpts illustrating investments in associates
accounted for at fair value through profit and loss are
provided in section 8.
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Significant Influence—Less Than 50%
Voting Power
2.167
Rio Tinto Limited and Rio Tinto plc (Dec 2010)






Goodwill 11 15,296 14,268
Intangible assets 12 5,700 5,730
Property, plant and equipment 13 56,024 45,803
Investments in equity accounted units 14 6,503 6,735
Loans to equity accounted units 227 170
Inventories 16 375 284
Trade and other receivables 17 1,826 1,375
Deferred tax assets 18 1,863 2,231
Tax recoverable 89 85
Other financial assets 20 1,334 841
89,237 77,522
Current assets
Inventories 16 4,756 4,889
Trade and other receivables 17 5,582 4,447
Loans to equity accounted units 110 168
Tax recoverable 542 501
Other financial assets 20 521 694
Cash and cash equivalents 21 9,948 4,233
21,459 14,932
Assets of disposal groups held for sale 19 1,706 4,782
Total assets 112,402 97,236
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
(b) Basis of Consolidation (in part)
Associates: An associate is an entity, that is neither a sub-
sidiary nor a joint venture, over whose operating and financial
policies the Group exercises significant influence. Significant
influence is presumed to exist where the Group has between
20 per cent and 50 per cent of the voting rights, but can
also arise where the Group holds less than 20 per cent if it
has the power to be actively involved and influential in pol-
icy decisions affecting the entity. The Group’s share of the
net assets, post tax results and reserves of associates are
included in the financial statements using the equity account-
ing method. This involves recording the investment initially
at cost to the Group, which therefore includes any goodwill
on acquisition, and then, in subsequent periods, adjusting
the carrying amount of the investment to reflect the Group’s
share of the associates’ post-acquisition profits or losses,
which is recognised in the income statement, and its share of
post-acquisition comprehensive income, which is recognised
within the line item ‘share of other comprehensive income of
equity accounted units’ in the Group statement of compre-
hensive income. Unrealised gains on transactions between
the Group and its associates are eliminated to the extent of
the Group’s interest in the associates.
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7. Interest Receivable and Payable
2010 2009 2008
Note US$m US$m US$m
Interest receivable and similar income from:
—Equity accounted units 33 36 43
—Interest income from bank deposits 81 45 72
—Interest income from other financial assets 21 21 35
135 102 150
Other interest receivable 28 18 54
Total interest receivable and similar income 163 120 204
Interest payable and similar charges(a) (853) (1,127) (1,821)
Net refinancing charge(b) 1 (107) — —
Amounts capitalised 3 182 198 203
Total interest payable and similar charges (778) (929) (1,618)
(a) Interest payable and similar charges relates to interest on bank loans and other borrowings. This includes a fair value gain on interest rate
swaps designated as hedges of US$186 million and an offsetting fair value loss on bank borrowings attributable to interest rate risk of
US$196 million (2009: fair value loss on the interest rate swaps of US$59 million and an offsetting fair value gain on bank borrowings
attributable to interest rate risk of US$59 million; 2008: fair value gain on the interest rate swaps of US$669 million and a US$655 million
fair value loss on bank borrowings attributable to interest rate risk).
(b) Net charge on the refinancing of bonds in October 2010 includes premium of US$252 million, offset by mark to market hedge fair value
adjustments of US$167 million (note 33).














Year Ended 31 December 2009 US$m US$m US$m US$m US$m
Net book value
At 1 January 2009 133 444 5,208 500 6,285
Adjustment on currency translation 10 6 2 71 89
Expenditure during the year 2 — — 53 55
Amortisation for the year — (25) (188) (174) (387)
Impairment charges — (23) (156) — (179)
Subsidiaries now equity accounted — — — (2) (2)
Subsidiaries no longer consolidated — (113) (54) — (167)
Disposals, transfers and other movements — — (10) 46 36
At 31 December 2009 145 289 4,802 494 5,730
—Cost 145 398 5,445 1,062 7,050
—Accumulated amortisation and impairment — (109) (643) (568) (1,320)
(a) Exploration and evaluation: useful life not determined until transferred to property, plant and equipment.
(b) The Group benefits from certain intangible assets acquired with Alcan including power supply contracts, customer contracts and water rights.
The water rights are expected to contribute to the efficiency and cost effectiveness of operations for the foreseeable future: accordingly,
these rights are considered to have indefinite lives and are not subject to amortisation. These water rights constitute the majority of the
amounts in the column of the above table entitled “Contract based intangible assets.” The water rights have been allocated to cash
generating units within Aluminium.
In 2010, the recoverable amount of these cash-generating units was determined based on fair value less costs to sell, using a methodology
and assumptions consistent with those described in note 1(i) and note 11. No impairment of these indefinite-lived intangible assets was
recognised during 2010 (2009: no impairment), as the fair value less costs to sell of the related cash-generating units was in excess of their
carrying amounts.
(c) There are no intangible assets either pledged as security or held under restriction of title.
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14. Investments in Equity Accounted Units
2010 2009
Summary Statement of Financial Position (Rio Tinto Share) US$m US$m
Rio Tinto’s share of assets
—Non-current assets 9,737 9,707
—Current assets 2,576 2,329
12,313 12,036
Rio Tinto’s share of liabilities
—Current liabilities (1,394) (1,089)
—Non-current liabilities (4,416) (4,212)
(5,810) (5,301)
Rio Tinto’s share of net assets(a) 6,503 6,735
(a) Further details of investments in jointly controlled entities and associates are set out in notes 38 and 39.
At 31 December 2010, the quoted value of the Group’s share
in associates having shares listed on recognised stock ex-
changes was US$5,280 million (2009: US$1,230 million).
15. Net Debt of Equity Accounted Units (Excluding
Amounts Due to Rio Tinto)
Group Interest
2010





of Net Debt 2009
% US$m % US$m
Jointly Controlled Entities
Sohar Aluminium Company LLC 20.0 330 20.0 343
Minera Escondida Limitada 30.0 163 30.0 226
Richards Bay Minerals 37.0 94 37.0 199
Halco Mining Inc. 45.0 27 45.0 37
Queensland Alumina Limited (QAL) 80.0 11 80.0 18
Associates
Ivanhoe Mines Ltd.(a) 40.3 (404) 19.7 (58)
Port Waratah Coal Services 27.6 305 27.6 225
Mineraçăo Rio do Norte S.A. 12.0 39 12.0 36
Cloud Peak Energy Resources LLC — — 48.3 170
Other equity accounted units — (86) — (99)
479 1,097
(a) Ivanhoe Mines Ltd. owns 66 per cent of Oyu Tolgoi LLC, which is consolidated by Rio Tinto. Net debt of Ivanhoe Mines Ltd. excludes its
share of the net debt of Oyu Tolgoi LLC. Refer to note 41 for further information relating to the consolidation of Oyu Tolgoi LLC.
In accordance with IAS 28 and IAS 31, the Group includes its
net investment in equity accounted units in its consolidated
statement of financial position. This investment is net of the
Group’s share of the net debt of such units, which is set
out above. Further details of investments in jointly controlled
entities and associates are set out in notes 38 and 39.
Some of the debt of equity accounted units is subject to
financial and general covenants. US$12 million of the debt
shown above is with recourse to Rio Tinto at 31 December
2010 (2009: nil).
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17. Trade and Other Receivables (in part)
Non-Current Current Non-Current Current
2010 2010 2009 2009
US$m US$m US$m US$m
Trade receivables 10 3,939 14 3,442
Provision for doubtful debts(a) — (37) — (62)
Trade receivables—net 10 3,902 14 3,380
Amounts due from equity accounted units 337 217 320 197
Other receivables 300 1,017 247 641
Pension surpluses (note 50) 110 — 15 2
Prepayment of tolling charges to jointly controlled entities(b) 787 — 424 —
Other prepayments 282 446 355 227
1,826 5,582 1,375 4,447
(a) At 31 December 2010, trade and other receivables of US$37 million (2009: US$62 million) were impaired. The majority of these receivables
were more than 90 days overdue.
(b) Rio Tinto Alcan has made certain prepayments to jointly controlled entities for toll processing of bauxite and alumina. These prepayments
will be charged to Group operating costs as processing takes place.
Significant Influence—Between 20% and
50% Voting Power, Contingent Liabilities
2.168
Alumina Limited (Dec 2010)
Author’s Note
One of the Alumina Limited’s associates is an invest-
ment in Alcoa World Alumina and Chemicals (AWAC).
The audited combined financial statements of the en-
tities forming ASWC are prepared in accordance with
US GAAP and are adjusted to convert to Australian
Accounting Standards, which are equivalent to IFRSs.
The excerpt that follows includes details about the prin-
cipal adjustments made.
CONSOLIDATED BALANCE SHEETS (in part)







using the equity method 12 3,415.6 3,189.7 2,597.0
Property, plant and
equipment 13 0.2 0.2 0.1
Deferred tax assets 17 — — 1.5
Total non-current assets 3,415.8 3,189.9 2,598.6
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Summary of Significant Accounting Policies
(in part)
(ii) Associates
Associates are those entities over which the consolidated
entity exercises significant influence but not control over the
financial and operating policies, generally accompanying a
shareholding of between 20% and 50% of the voting rights.
Investments in associates are accounted for using the cost
method and in the consolidated financial statements using the
equity method of accounting, after initially being recognised
at cost. The consolidated entity’s investment in associates
includes goodwill identified on acquisition.
The Group’s share of its associates’ post acquisition prof-
its or losses is recognised in profit or loss, and its share of
other comprehensive income, is recognised in reserves after
aligning back to Group accounting policies. The cumulative
post-acquisition movements are adjusted against the carrying
amount of the investment. Dividends receivable from asso-
ciates reduce the carrying amount of the investment.
When the Group’s share of losses in an associate equals
or exceeds its interest in the associate, including any other
unsecured receivables, the Group does not recognise further
losses, unless it has incurred obligations or made payments
on behalf of the associate.
Unrealised gains on transactions between the Group and
its associates are eliminated to the extent of the Group’s inter-
est in the associates. Unrealised losses are also eliminated
unless the transaction provides evidence of an impairment of
the asset transferred. Accounting policies of associates have
been changed where necessary to ensure consistency with
the policies adopted by the Group.
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3. Critical Accounting Estimates and Judgements
(in part)
Estimated Impairment of Investment in Associates
The Group tests annually whether the investment in as-
sociates has suffered any impairment, in accordance with
the accounting policy stated in note 1(h). The recoverable
amounts of cash-generating units have been determined
based on value-in-use calculations. The key assumptions
used in the calculation were those relating to future aluminium
prices, oil, electricity and gas prices and exchange rates. Ad-
ditionally a discount rate is applied to determine the NPV of
future cashflows.
12. Investments in Associates
(a) Securities Not Quoted on a Prescribed Stock Exchange
Securities in Entities Forming Alcoa World Alumina and
Chemicals (AWAC) With Alcoa Inc.
The investment in AWAC is accounted for in the consolidated






Balance brought forward 3,021.9 2,349.9 1,885.3
Additional funding/
capitalisation in AWAC
entities 161.6 440.6 645.7
Return of capital (13.8) (0.4) —
Foreign currency revaluation 234.9 231.8 (181.1)
Equity accounted cost of
AWAC 3,404.6 3,021.9 2,349.9
Equity in retained profits of
AWAC 12(c) 8.5 166.1 245.8
Equity in reserves of AWAC 2.5 1.7 1.3
Equity accounted carrying
value of AWAC 3,415.6 3,189.7 2,597.0







profits/(losses) before tax 140.4 (7.6) 326.9
Equity share of tax (55.9) 9.2 (144.1)
Equity accounted share of
profit after tax 84.5 1.6 182.8
Dividends
received/receivable by the
Group (242.1) (140.5) (303.3)
Surplus of
dividends/distributions
received over equity share
of profits (157.6) (138.9) (120.5)








received over equity share
of profits (157.6) (138.9) (120.5)
Foreign exchange impact of
change in presentation
currency — 59.2 18.0
Balance brought forward 166.1 245.8 348.3
Total equity share in retained
profits carried forward 8.5 166.1 245.8
(d) Accounting Policies
The audited combined financial statements of the entities
forming AWAC are prepared in accordance with US Generally
Accepted Accounting Principles (US GAAP). Adjustments are
made to convert the accounting policies under US GAAP to
Australian Accounting Standards. The principal adjustments
are to the valuation of inventories from last-in-first-out basis
to a basis equivalent to weighted average cost, create an ad-
ditional asset retirement obligation for dismantling, removal
and restoration of certain refineries, valuation of certain long
term energy purchase contracts which include an aluminium
price component in the energy price and to differences in the
recognition of actuarial gains and losses on certain defined
benefit plans and the reversal of tax credits and fixed asset
uplifts included in Alcoa World Alumina Brasil Ltda.
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(e) Additional Information on Associated Entities
AWAC has a governing strategic council of five members of





(i) Entities Forming AWAC 2010 2009
Alcoa of Australia Ltd Bauxite, alumina & aluminium production Australia 40 40
Alcoa World Alumina LLC Bauxite and alumina production America 40 40
Alumina Espanola S.A. Alumina production Spain 40 40
Alcoa World Alumina Brasil Ltda. Bauxite and alumina production Brazil 40 40
AWA Saudi Ltda. Bauxite and alumina production Hong Kong 40 40
(ii) Equity Accounted Partnerships
Enterprise Partnership(1) Finance lender Australia 40 40
(1) Alcoa Australia Holdings Pty Ltd and Alumina Limited are shareholders of Alcoa of Australia Limited and other Enterprise Companies for
certain activities of AWAC.
(f) Expenditure Commitments and Contingent Liabilities
US$ Million
2010 2009
—other expenditure commitments contracted
for, including long term commitments for
gas and electricity entered into by AWAC 2,214.4 2,431.2
Unascertainable Unsecured Contingent Liabilities
Various lawsuits and claims and proceedings have been, or
may be, instituted or asserted against entities within AWAC,
including those pertaining to environmental, product liability,
and safety and health matters. While the amounts claimed
may be substantial, the ultimate liability cannot now be deter-
mined because of the considerable uncertainties that exist.
Therefore, it is possible that results of operations or liquidity
in a particular period could be materially affected by certain
contingencies. However, based on facts currently available,
management believes that the disposition of matters that are
pending or asserted will not have a materially adverse effect
on the financial position or liquidity of AWAC.
Pursuant to the terms of the AWAC Formation Agreement,
Alcoa and Alumina Limited have agreed to remain liable for
Extraordinary Liabilities (as defined in the agreement) as well
as for certain other pre-formation liabilities, such as existing
environmental conditions, to the extent of their pre-formation
ownership of the company or asset with which the liability is
associated.
On 27 February 2008, Alcoa Inc. received notice that Alu-
minium Bahrain B.S.C. (“Alba”) had filed suit against Alcoa
Inc. and Alcoa World Alumina LLC (collectively, “Alcoa”),
and others, in the U.S. District Court for the Western Dis-
trict of Pennsylvania (the “Court”), Civil Action number 08-
299, styled Aluminium Bahrain B.S.C. v. Alcoa Inc., Alcoa
World Alumina LLC, William Rice, and Victor Dahdaleh. The
complaint alleges that certain Alcoa entities and their agents,
including Victor Phillip Dahdaleh, have engaged in a conspir-
acy over a period of 15 years to defraud Alba. The complaint
further alleges that Alcoa and its employees or agents (1)
illegally bribed officials of the government of Bahrain and (or)
officers of Alba in order to force Alba to purchase alumina
at excessively high prices, (2) illegally bribed officials of the
government of Bahrain and (or) officers of Alba and issued
threats in order to pressure Alba to enter into an agreement by
which Alcoa would purchase an equity interest in Alba, and
(3) assigned portions of existing supply contracts between
Alcoa and Alba for the sole purpose of facilitating alleged
bribes and unlawful commissions. The complaint alleges that
Alcoa and the other defendants violated the Racketeer In-
fluenced and Corrupt Organizations Act (“RICO”) and com-
mitted fraud. Alba’s complaint seeks compensatory, conse-
quential, exemplary, and punitive damages, rescission of the
2005 alumina supply contract, and attorney’s fees and costs.
Alba seeks treble damages with respect to its RICO claims.
No member of the Alumina Group, nor any of its employees,
is a defendant in the litigation.
On February 26, 2008, Alcoa Inc. had advised the U.S.
Department of Justice (the “DOJ”) and the Securities and Ex-
change Commission (the “SEC”) that it had recently become
aware of these claims, had already begun an internal inves-
tigation, and intended to cooperate fully in any investigation
that the DOJ or the SEC may commence. On March 17, 2008,
the DOJ notified Alcoa that it had opened a formal investiga-
tion and Alcoa has been cooperating with the government.
In response to a motion filed by the DOJ on March 27,
2008, the Court ordered the suit filed by Alba to be adminis-
tratively closed and that all discovery be stayed to allow the
DOJ to fully conduct an investigation without the interference
and distraction of ongoing civil litigation. The Court further
ordered that the case will be reopened at the close of the
DOJ’s investigation. Alcoa is unable to reasonably predict an
outcome or to estimate a range of reasonably possible loss.
In September 1998, Hurricane Georges struck the U.S.
Virgin Islands, including the St. Croix Alumina, L.L.C. (SCA)
facility on the island of St. Croix. The wind and rain associ-
ated with the hurricane caused material at the location to be
blown into neighbouring residential areas. Various cleanup
and remediation efforts were undertaken by or on behalf of
SCA. A Notice of Violation was issued by the Division of
Environmental Protection (DEP), of the Department of Plan-
ning and Natural Resources (DPNR) of the Virgin Islands
Government, and has been contested by Alcoa. A civil suit
was commenced in the Territorial Court of the Virgin Islands
by certain residents of St. Croix in February 1999 seeking
compensatory and punitive damages and injunctive relief for
alleged personal injuries and property damages associated
with “bauxite or red dust” from the SCA facility. The company
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is unable to reasonably predict an outcome or to estimate a
range of reasonably possible loss.
In May 2005, Alcoa World Alumina LLC (AWA) and SCA
were among the defendants listed in a lawsuit brought by
the Commissioner of the DPNR, as Trustee for Natural Re-
sources of the Territory of the United States Virgin Islands in
the District Court of the Virgin Islands, Division of St. Croix.
The complaint seeks damages for alleged injuries to natural
resources caused by alleged releases from an alumina re-
finery facility in St. Croix that was owned by SCA from 1995
to 2002. Also listed in the lawsuit are previous and subse-
quent owners of the alumina refinery and the owners of an
adjacent oil refinery. Claims are brought under the Compre-
hensive Environmental Response, Compensation and Liabil-
ity Act (CERCLA), U.S. Virgin Islands law, and common law.
The plaintiff has not specified in the complaint the amount
it seeks in damages. At this stage of the proceeding, the
company is unable to reasonably predict an outcome or to
estimate a range of reasonably possible loss.
In December 2006, SCA was sued by the Commissioner of
DPNR, U.S. Virgin Islands, in the Superior Court of the Virgin
Islands, Division of St. Croix. The plaintiff alleges violations of
the Coastal Zone Management Act and a construction permit
issued thereunder. The complaint seeks civil fine of $10,000
under the Coastal Zone Management Act, civil penalties of
$10,000 per day for alleged intentional and knowing violations
of the Coastal Zone Management Act, exemplary damages,
costs, interest and attorney’s fees, and “other such amounts
as may be just and proper.” At this stage of the proceeding,
the company is unable to reasonably predict an outcome or
to estimate a range of reasonably possible loss.
In December 2006, SCA, along with unaffiliated prior and
subsequent owners, were sued by the Commissioner of the
DPNR, U.S. Virgin Islands, in the Superior Court of Virgin
Islands, Division of St. Croix. This second suit alleges viola-
tions by the defendants of certain permits and environmental
statutes said to apply to the facility. The complaint seeks
the completion of certain actions regarding the facility, a civil
fine from each defendant of $10,000 under the Coastal Zone
Management Act, civil penalties of $50,000 per day for each
alleged violation of the Water Pollution Control Act, $10,000
per day for alleged intentional and knowing violations of the
Coastal Zone Management Act, exemplary damages, costs,
interest and attorney’s fees, and “other such amounts as may
be just and proper.” At this stage of the proceeding, the com-
pany is unable to reasonably predict an outcome or to esti-
mate a range of reasonably possible loss.
DPNR has filled a CERCLA cost recovery suit against
SCRG. SCRG filed a third-party complaint for contribution and
other relief against several third-party defendants. The case
is set for trial in March 2011. At this stage of the proceeding,
the company is unable to reasonably predict an outcome or
to estimate a range of reasonably possible loss.
On January 14, 2010, Alcoa was served with a complaint
involving approximately 2,900 individual persons claimed to
be residents of St. Croix who are alleged to have suffered
personal injury or property damage from Hurricane Georges
or winds blowing material from the property since the time
of the hurricane. This complaint, Abednego, et al. v. Alcoa,
et al. was filed in the Superior Court of the Virgin Islands,
St. Croix Division. The complaint names as defendants the
same entities as were sued in the February 2010, Alcoa and
SCA removed the case to the federal court for the District of
Virgin Islands. Subsequently, plaintiffs have filed a motion to
remand the case to territorial court as well as a third amended
complaint, and defendants have moved to dismiss the case
for failure to state a claim upon which relief can be granted.
The company is unable to reasonably predict an outcome or
to estimate a range of reasonably possible loss.
Refer also to Note 33 for further details in relation to St.
Croix.





Current assets 712.9 687.4 651.3
Non-current assets 3,766.5 3,407.0 2,780.5
Current liabilities (655.5) (611.3) (580.6)
Non-current liabilities (704.6) (591.8) (485.8)
Net assets 3,119.3 2,891.3 2,365.4
Mineral rights and bauxite assets 120.5 122.6 95.9
Goodwill 175.8 175.8 135.7
Carrying value 12(a) 3,415.6 3,189.7 2,597.0
Revenues 2,182.4 1,637.2 2,506.5
Expenses (2,042.0) (1,644.8) (2,179.6)
Profit/(loss) before income tax 140.4 (7.6) 326.9
Income tax (charge)/credit (55.9) 9.2 (144.1)
Profit after income tax 84.5 1.6 182.8
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IAS 31, INTERESTS IN JOINT
VENTURES
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
IFRS 11 and IFRS 12 were issued in May 2011, con-
currently with a revised and renamed IAS 28. IFRS
11 requires all entities that are parties to a joint ar-
rangement to determine the type of joint arrangement
in which they are involved by assessing their rights
and obligations arising from the arrangement. A joint
arrangement is an arrangement of which two or more
parties have joint control. IFRS 11 defines joint con-
trol as the contractually agreed sharing of control of an
arrangement, which exists only when decisions about
the relevant activities (that is, activities that signifi-
cantly affect the returns of the arrangement) require
the unanimous consent of the parties sharing control.
IFRS 11 also requires an entity to classify its joint
arrangements into either joint operations or joint ven-
tures. A joint operation is one in which the parties
that have joint control of the arrangement (joint oper-
ators) have rights to the assets and obligations for the
liabilities of the arrangement. In contrast, a joint ven-
ture is one in which the parties that have joint control
of the arrangement (joint venturers) have rights to the
net assets of the arrangement. Joint operators account
for the assets, liabilities, revenue, and expenses of the
arrangement in accordance with relevant IFRSs.
IFRS 11 provides guidance on distinguishing joint
operations from joint ventures by considering the rights
and obligations it has under the arrangement, assessing
the arrangement’s structure and legal form, the con-
tractual terms of the arrangement, and other relevant
facts and circumstances. Joint venturers account for
their investment in the joint arrangement using the eq-
uity method, in accordance with IAS 28, as revised in
2011. IFRS 11 does not permit an entity to use propor-
tionate consolidation to account for jointly controlled
entities.
IFRS 12 prescribes the disclosure requirements for
all entities that have interests in other entities.
IFRS 11 and IFRS 12 are effective for annual periods
beginning on or after 1 January 2013, with early appli-
cation permitted. Because the revised IAS 28, IFRS
11, and IFRS 12 were not issued until May 2011,
no survey entity could apply the new requirements in
its 2010 financial statements. Therefore, the following
commentary only describes the requirements in IAS
31, Interests in Joint Ventures.
2.169 A joint venture, as defined in IAS 31, is a contractual
arrangement in which two or more parties undertake an eco-
nomic activity that is subject to joint control. Joint control is
the contractually agreed sharing of control over an economic
activity among the parties (investors). Joint control exists
only when the strategic financing and operating decisions re-
lated to the activity require unanimous consent of the parties
sharing control.
2.170 IAS 31 identifies three broad forms of joint ventures:
jointly controlled operations, jointly controlled assets, and
jointly controlled entities. A jointly controlled operation in-
volves the use of the investors’ assets and other resources
without the venturers forming a separate legal entity or finan-
cial structure. A jointly controlled asset involves joint control
or ownership of one or more assets acquired or contributed
to the joint venture and dedicated to its purpose. Investors
share in the output of the asset and obligate themselves to
an agreed upon share of the expenses. A jointly controlled
entity is a separate legal entity (for example, corporation or
partnership) in which the investors have an interest. Jointly
controlled entities operate in the same way as other entities,
except that a contractual arrangement gives the investors joint
control.
2.171 IAS 31 establishes the accounting for interests in a
joint venture, regardless of form, and the reporting of the
joint venture’s assets, liabilities, income, and expenses in
an investor’s financial statements. Investors in joint ventures
should account for these investments in accordance with IAS
31. However, IAS 31 makes an exception for venture capital
organizations and mutual funds, trusts, and similar entities
(including investment-linked insurance funds) whose inter-
ests in jointly controlled entities are, upon initial recognition,
designated as at fair value through profit or loss or are classi-
fied as held for trading and accounted for in accordance with
IAS 39. Such entities should measure these investments at
fair value in accordance with IAS 39, with changes in fair
value recognized in profit or loss in the period of the change.
Venturers with such interests should make certain disclo-
sures required by IAS 31. Investors in joint ventures that do
not have joint control should recognize their investment in
accordance with IAS 28 or IAS 39, as appropriate.
Recognition and Measurement
IFRSs
2.172 IAS 31 requires an investor in jointly controlled oper-
ations to recognize only the assets it controls, liabilities and
expenses it incurs, and its share of income it earns from sales
of goods or services generated by the operations. An investor
in jointly controlled assets should recognize its share of the
jointly controlled assets classified by nature, liabilities and
expenses it incurs, its share of liabilities and expenses in-
curred jointly, and the income from sale or use of its share of
the asset’s output. For both jointly controlled operations and
jointly controlled assets, an investor should recognize only
the assets it controls, the liabilities and expenses it incurs,
and its share of the income. No adjustments or intercompany
eliminations are required in respect of these items when the
venturer presents consolidated financial statements.
2.173 An investor in a jointly controlled entity, however,
should account for its investment using either the propor-
tionate consolidation or equity method. When it loses joint
control, an investor should cease to use the selected method.
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Author’s Note
See paragraphs 2.139–.152 for a discussion of account-
ing for investments using the equity method, including
a comparison with FASB ASC requirements.
2.174 When an investor applies the proportionate consoli-
dation method, it should include its share of the assets and
liabilities of the jointly controlled entity in its balance sheet
and its share of income, expenses, and items of other compre-
hensive income in its statement of comprehensive income.
Investors should apply procedures similar to those for full
consolidation as described in IAS 27.
2.175 An investor who uses the proportionate consolidation
method to account for its interest in a jointly controlled entity
should include its share of the assets, liabilities, income,
and expenses of the jointly controlled entity in its financial
statements using one of two alternative reporting formats:
• Combined on a line-by-line basis with its other assets,
liabilities, income and expenses, or
• Presented in separate line items.
2.176 IAS 31 states that investors should not offset assets
and liabilities or income and expenses unless a legal right of
offset exists and the net presentation represents the expected
realization of the asset or settlement of the liability.
2.177 When the investment in the joint venture is classified
as held for sale in accordance with IFRS 5, IAS 31 exempts
the investor from using the proportionate consolidation or
the equity method. IAS 27 exempts an entity from preparing
consolidated financial statements if certain criteria are met.
IAS 31 exempts an entity from using the proportionate con-
solidation method and equity method for its investment in
joint ventures if the investor is a parent that is exempt from
consolidated financial statements, in accordance with IAS
27, or the investor itself meets those same criteria.
2.178 When an investor ceases to have joint control, it should
account for its interest in a jointly controlled entity in accor-
dance with IAS 39. If the jointly controlled entity becomes a
subsidiary, an investor should apply both the requirements of
IAS 27 and IFRS 3. If the jointly controlled entity becomes
an associate, an investor should apply the requirements of
IAS 28. At the point the investor in a jointly controlled entity
loses joint control, the investor should measure its investment
at fair value and recognize the difference between fair value
and the joint venture’s carrying amount in profit or loss.
U.S. GAAP
2.179 The FASB ASC glossary defines a corporate joint ven-
ture as a corporation owned and operated by a small group
of entities (venturers) as a separate and specific business or
project for the mutual benefit of the members of the group. A
government may also be a member of the group. Frequently,
the purpose of a corporate joint venture is to share risks and
rewards in developing a new market, product, or technology;
to combine complementary technological knowledge; or to
pool resources in developing production or other facilities. A
corporate joint venture also usually provides an arrangement
under which each joint venture may participate, directly or
indirectly, in the overall management of the joint venture.
Thus, joint venturers have an interest or relationship other
than as passive investors. An entity that is a subsidiary of
one of the joint ventures is not itself a corporate joint ven-
ture. Although ownership of a corporate joint venture seldom
changes, and its stock is usually not traded publicly, FASB
ASC does not preclude a corporation from being a corpo-
rate joint venture when there is a minority public ownership.
The guidance in FASB ASC 323 applies to investments in
common or in-substance common stock, or both, including
investments in common stock of corporate joint ventures, ac-
cording to FASB ASC 323-10-15-3. However, in accordance
with FASB ASC 323-10-15-4(c), the guidance in FASB ASC
323-10 does not apply to an investment in common stock
within the scope of FASB ASC 810, which may include vari-
able interest entities (see paragraphs 13–17 of FASB ASC
810-10-15). In contrast, IAS 31 does not exclude joint ven-
tures in the form of variable interest entities from its scope.
2.180 IAS 31 requires joint ventures to be contractual ar-
rangements in which investors have joint control. As illus-
trated by the definition of corporate joint venture in the FASB
ASC glossary, FASB ASC does not require that the agree-
ment among the investors be contractual, but it does include
the concept of joint control. In contrast to a passive invest-
ment, the definition in the FASB ASC glossary states that
investors usually have the ability to participate in the ven-
ture’s decision-making activities.
2.181 FASB ASC 323-30 also requires the entity to use
the equity method to account for partnerships, unincorpo-
rated joint ventures, and limited liability companies. How-
ever, FASB ASC 810-10-45-14 explains that unincorporated
entities in the construction or extractive industries may use a
proportionate consolidation method when its use is industry
practice (see FASB ASC 932-323-45-1 with respect to the
oil and gas industry).
2.182 The FASB ASC glossary does not define jointly con-
trolled operations or assets but does define a collaborative
arrangement as a contractual arrangement that involves a
joint operating activity involving two (or more) parties that
meet both of the following requirements:
• They are active participants in the activity.
• They are exposed to significant risks and rewards de-
pendent on the commercial success of the activity.
FASB ASC 808-10-45 establishes the accounting for such
arrangements. Consistent with the requirements of IAS 31
for jointly controlled assets and operations, FASB ASC 808-
10-45 explains that participants in such arrangements should
account for the costs incurred and revenue generated from
third parties (that is, an entity that is not one of the par-
ties to the arrangement) in each entity’s respective income
statement and should not apply the equity method. FASB
ASC 808-10-45 directs entities to FASB ASC 605-45 for
additional guidance on whether to report revenue gross (as
a principal) or net (as an agent). FASB ASC 970-323 also
provides guidance on real estate projects and joint ventures.
2.183 Unlike IAS 31, which contains criteria for exemption
from its requirements (similar to the exemption in IAS 27
and IAS 28), FASB ASC does not provide any criteria that
could exempt an entity from using the equity method when
required.
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Presentation
IFRSs
2.184 In accordance with IAS 1, an investor should present
investments accounted for under the equity method as a sep-
arate line item on the balance sheet and its share of profit
or loss from the investment separately on the statement of
comprehensive income. In IFRSs, there is no requirement
to distinguish between investments in associates and inter-
ests in joint ventures. However, an entity should also present
additional line items, headings, and subtotals when they are
relevant to an understanding of the entity’s financial position.
U.S. GAAP
2.185 Investors should apply the same presentation require-
ments as for other equity method investments, as discussed
in FASB ASC 323-10-45.
Disclosure
IFRSs
2.186 An investor should disclose a listing and description
of its interests in significant joint ventures, the proportion
of its interest in jointly controlled entities, and the method
used to account for its interests in jointly controlled entities.
If it uses the line-by-line format for proportionate consoli-
dation, the investor should disclose separately the aggregate
amounts of current assets, long-term assets, current liabil-
ities, long-term liabilities, income, and expenses related to
the proportionately consolidated interests.
2.187 An investor should also disclose information about
contingent liabilities and commitments related to its inter-
ests in joint ventures separately from its other contingent
liabilities and commitments. With respect to contingent li-
abilities, an investor should disclose not only its contingent
liabilities but also those shared jointly with other investors,
its share of contingent liabilities of the venture for which it
is contingently liable, and contingent liabilities that arise be-
cause it is contingently liable for liabilities of other investors.
Similar disclosures are required for commitments.
U.S. GAAP
2.188 IFRSs require more disclosures than FASB ASC about
joint ventures, particularly disclosures about contingent li-
abilities and commitments. When the joint venture is ac-
counted for using the equity method, FASB ASC 323 requires
specific equity method disclosures. In particular, FASB ASC
323-10-50-3(c) states that when the equity method invest-
ments of a venturer are, in the aggregate, material in relation
to its financial position or results of operations, it may be
necessary for an investor to disclose summarized informa-
tion about the joint venture’s assets, liabilities, and results of
operations in the notes or separate statements.
TABLE 2-7: ACCOUNTING TREATMENT FOR JOINTLY
CONTROLLED ENTITIES(1)
2010 2009 2008
Survey entities using proportionate consolidation.... 40 38 26
Survey entities using equity method......................... 61 58 43
Survey entities designating an investment “at
fair value through profit or loss”............................. 1 1 0
Survey entities with a jointly controlled entity,
but no method disclosed........................................ 13 13 0
Survey entities with no jointly controlled entities
disclosed................................................................ 56 51 31
Survey entities included in more than one
category ................................................................. (1) (1) 0
Total ................................................................ 170 160 100
(1) IAS 31, Joint Ventures, identifies three broad types of joint
ventures—jointly controlled operations, jointly controlled assets,
and jointly controlled entities. A jointly controlled entity is a joint
venture that involves the establishment of a corporation, partner-
ship, or other entity in which each venturer has an interest. The
entity operates in the same way as other entities, except that a
contractual arrangement between the venturers establishes joint
control over the economic activity of the entity.




As previously explained, in May 2011, the IASB issued
IFRS 11 and IFRS 12. Effective for annual periods
beginning on or after 1 January 2013, entities will no
longer have the option of accounting for interests in
joint ventures by proportionate consolidation.
2.189
Harmony Gold Mining Company Limited
(Jun 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2 Accounting Policies (in part)
2.2 Consolidation (in part)
(iii) Joint venture entities are those entities in which the group
holds an interest and shares joint control over strategic, fi-
nancial and operating decisions with one or more other ven-
tures under a contractual arrangement. The group’s interest
in jointly controlled entities is accounted for by proportion-
ate consolidation. Under this method, the group includes its
share of the joint venture’s individual income and expenses,
assets and liabilities and cash flows on a line-by-line basis
with similar items in the group’s financial statements.
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The group recognises the portion of gains or losses on
the sale of assets by the group to the joint venture that is
attributable to the other ventures. The group does not recog-
nise its share of profits or losses from the joint venture that
result from the purchase of assets by the group from the joint
venture until it resells the assets to an independent party.
However, if a loss on the transaction provides evidence of a
reduction in the net realisable value of current assets or an
impairment loss, the loss is recognised immediately.
Joint venture operations and assets: The group and com-
pany has contractual arrangements with other participants to
engage in joint activities or invest in joint assets other than
through a separate entity. The group and company includes
its assets, liabilities and share of income and expenditure in
such joint venture operations with similar items in its financial
statements.
22 Investment in Joint Venture
Morobe Mining Joint Ventures (MMJV) Partnership
Agreement (50%)
The group has a 50% interest in gold and copper assets
located in the Morobe province, PNG. Newcrest owns the
remaining 50% interest in these assets. This partnership was
formed during the 2009 financial year through a range of
transactions, which are discussed below.
On 22 April 2008, Morobe Consolidated Goldfields Limited
and Wafi Mining Limited, subsidiaries of Harmony Australia,
entered into a Master Purchase and Farm-in Agreement with
Newcrest. This agreement provided for Newcrest to purchase
a 30.01% participating interest (stage 1) and a further farm-in
of an additional 19.99% participating interest in Harmony’s
Morobe gold and copper assets, giving them a 50% interest.
The total value of the transaction was estimated at US$530
million.
On 16 July 2008, the conditions to the Master Purchase and
Farm-in agreement were finalised, which included regulatory
and statutory approvals by the PNG Government. Stage 1
completion took place on 31 July 2008, and a total consider-
ation of R1 792 million (US$229.8 million) was received on
7 August 2008, of which R390 million (US$50.0 million) was
placed in a jointly controlled escrow account. This amount
was subsequently released to Harmony following confirma-
tion of approval of an exploration license during September
2008 by the PNG mining authorities.
Harmony recognised a profit of R416 million (US$58 mil-
lion) on the completion of stage 1, which represented a sale
of a 30.01% undivided interest of Harmony’s Morobe gold
and copper assets and liabilities comprising the joint venture.
During the farm-in period, Harmony agreed to transfer a
further 19.99% interest to Newcrest in consideration for an
agreement by Newcrest to meet certain expenditure which
would otherwise have to be undertaken by Harmony. The
interest to be transferred was conditional on the level of cap-
ital expenditures funded by Newcrest at certain milestones,
and by the end of February 2009, Newcrest acquired another
10% through the farm-in arrangement. The final 9.99% was
acquired by 30 June 2009.
At the date of completion of each party’s obligations under
the farm-in arrangement, Harmony derecognised the propor-
tion of the mining assets and liabilities in the joint venture
that it had sold to Newcrest, and recognised its interest in
the capital expenditure at fair value. The difference between
the net disposal proceeds and the carrying amounts of the
asset disposed of during the farm-in arrangement amounted
to a gain of R515 million (US$54 million), which has been
included in the consolidated income statement for 2009.
The following are the group’s effective share of income,
expenses, assets and liabilities, which are included in the
2010 consolidated financial statements:
SA Rand US Dollar
2009 2010 Figures in Millions 2010 2009
50% 50% 50% 50%
— 79 Revenue 10 —
— (63) Production costs (8) —
— 16 Gross profit 2 —
(108) (302) Other costs (40) (12)
(108) (286) Net loss (38) (12)
1,427 2,910 Non-current assets 382 185
343 364 Current assets 48 44
1,770 3,274 Total assets 430 229
1,241 168 Non-current liabilities 22 161
281 148 Current liabilities 19 36
1,522 316 Total liabilities 41 197
Jointly Controlled Entities—Equity Method,
Jointly Controlled Operations
2.190
Sims Metal Management Limited (Jun 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)




Receivables 9 7.9 17.6
Investments accounted for using the
equity method 29 369.5 400.2
Other financial assets 21.4 —
Property, plant and equipment 12 925.8 947.7
Deferred tax assets 8 74.1 71.6
Goodwill 13 1,151.7 1,146.8
Other intangible assets 14 195.2 238.8
Total non-current assets 2,745.6 2,822.7
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1—Summary of Significant Accounting Policies
(in part)
(C) Principles of Consolidation (in part)
(III) Joint Ventures
A joint venture is a contractual arrangement whereby two or
more parties undertake an economic activity that is subject to
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joint control. Joint control is the contractually agreed sharing
of control such that significant operating and financial deci-
sions require the unanimous consent of the parties sharing
control. In some situations, joint control exists even though
the Group has an ownership interest of more than 50% be-
cause of the veto rights held by joint venture partners. The
Group has two types of joint ventures:
Jointly Controlled Entities
A jointly controlled entity is a joint venture that involves the
establishment of a corporation, partnership or other entity
in which each venture has a long-term interest. Jointly con-
trolled entities are accounted for using the equity method. In
addition, for both associates and jointly controlled entities, the
carrying value will include any long-term debt interests that in
substance form part of the Group’s net investment.
Joint Venture Operations
A joint venture operation is a joint venture in which the ventur-
ers have joint control over assets contributed to or acquired
for the purpose of the joint venture. A joint venture operation
does not involve the establishment of a corporation, partner-
ship or other entity. This includes situations where the partic-
ipants derive benefit from the joint activity through a share of
the production, rather than by receiving a share of the results
of trading. The Group’s proportionate interest in the assets,
liabilities, revenues, expenses and cash flows of joint venture
operations are incorporated into the Group’s financial state-
ments under the appropriate headings.
Note 29—Investments in Associates and Jointly
Controlled Entities (in part)
(A) Carrying Amounts of Associates and Jointly Controlled
Entities
Name of Associate or Jointly Country of Ownership Interest % Carrying Amount
Controlled Entity Incorporation 2010 2009 2010 A$M 2009 A$M
SA Recycling LLC USA 50% 50% 314.3 329.9
Metal Management Nashville LLC USA 50% 50% 14.0 22.4
Rondout Iron & Metal LLC USA 50% 50% 0.9 0.6
Port Albany Ventures LLC(1) USA 100% 50% — 6.6
Richmond Steel Recycling Ltd Canada 50% 50% 19.8 21.6
LMS Generation Pty Ltd Australia 50% 50% 19.9 18.5
Australia Refined Alloys Pty Ltd Australia 50% 50% — —
Extruded Metals Ltd New Zealand 33% 33% 0.6 0.6
369.5 400.2
(1) On 18 November 2009, the Group obtained control of Port Albany by acquiring the remaining 50% of the joint venture. As a result, the
Group’s equity interest in Port Albany increased from 50% to 100%.
(B) Movements in Carrying Amounts
2010 2009
A$M A$M
Balance at 1 July 400.2 332.2
Share of profit before tax 17.5 57.6
Associates share of income tax expense (2.4) (2.6)
Accretion of deferred gain to equity accounted profit 2.7 3.2
Dividends received (19.6) (41.5)
Return of capital from jointly controlled entities (0.4 (3.6)
Purchase of remaining 50% interest in Port Albany (5.6) —
Impairment of investment in Metal Management Nashville LLC (5.7) —
Other — 1.7
Foreign exchange differences (17.2) 53.2
Balance at 30 June 369.5 400.2
(c) Share of associates’ and jointly controlled entities’ profit
Profit before income tax 14.5 60.8
Associates’ share of income tax expense (2.4) (2.6)
Profit after income tax recognised in equity accounted investment 12.1 58.2
Jointly controlled entities income tax(1) (2.4) (19.2)
Associates’ and jointly controlled entities’ profit after tax 9.7 39.0
(1) The jointly controlled entities to which this relates are “pass-through” entities for taxation purposes. As such, the Group incurs the income
tax expense and associated tax liability on its share of the profit and includes this amount as part of its income tax expense. Refer to
Note 8.
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(C) Port Albany
At 30 June 2009, the Group held a 50% interest in Port Al-
bany. This jointly controlled entity was accounted for using the
equity method. On 18 November 2009, the Group purchased
the remaining 50% ownership interest in Port Albany that it
previously did not own. In accordance with the revised AASB
3 (IFRS 3) and AASB 127 (IAS 27), the Group was required
to remeasure its previously held equity interest in Port Albany
at its acquisition-date fair value and recognise the resulting
gain or loss in profit or loss. This transaction resulted in the
recognition of a gain calculated as follows:
A$M
Fair value of 50% interest in Port Albany 14.3
Carrying amount of Port Albany investment (5.6)
Gain recognised on acquisition 8.7
(D) SA Recycling LLC
On 1 September 2007, the Group completed the merger of
its Southern Californian metal recycling assets with those of
Adams Steel LLC. The jointly controlled entity, SA Recycling
LLC, operates within a territory encompassing Southern Cal-
ifornia, Arizona, Southern Nevada and Northern Mexico. In
accordance with AASB 128 (IAS 28) Investments in Asso-
ciates and AASB 131 (IAS 31) Interests in Joint Ventures,
the SA Recycling LLC is a jointly controlled entity accounted
for under the equity method.
The fair values of assets and liabilities contributed to SA











equipment 71.4 79.8 (8.4)
Goodwill and intangible
assets 196.5 265.7 (69.2)
Non-current provisions (3.2) (3.2) —
264.7 342.3 (77.6)
In accordance with UIGI 113 (SIC 13) Jointly Controlled
Entities—Non-Monetary Contributions by Venturers, the por-
tion of the non-cash gain attributable to the equity interest of
the other venturer, in this instance 50%, was recognised im-
mediately on contribution of assets to the SA Recycling LLC
jointly controlled entity. This has been recognised in other
income as disclosed in Note 6. The remaining 50% of the
non-cash gain for intangibles has been allocated to reduce
the cost of the equity accounted investment and will be recog-
nised progressively over the remaining useful life of the as-
sets to which it relates. The remaining 50% of the non-cash
gain for property, plant and equipment has been allocated to
reduce the cost of the equity accounted investment and will
be recognised if the land to which the gain relates is sold.
(E) Summarised Financial Information of Associates and
Jointly Controlled Entities
2010 2009
Group’s Share of Assets and Liabilities A$M A$M
Current assets 104.0 92.1
Non-current assets 289.8 313.4
Total assets 393.8 405.5
Current liabilities 30.0 34.1
Non-current liabilities 100.0 102.2
Total liabilities 130.0 136.3
Net assets 263.8 269.2
Group’s Share of Revenue, 2010 2009 2008
Expenses and Results A$M A$M A$M
Revenues 596.3 814.2 699.9
Expenses (578.8) (756.6) (637.6)
Profit before income tax 17.5 57.6 62.3
(F) Contingent Liabilities and Capital Commitments
The Group’s share of the contingent liabilities of associates
and jointly controlled entities is disclosed in Note 22. The
Group’s share of the capital commitments and other expendi-
ture commitments of associates and jointly controlled entities
is disclosed in Note 23.
(G) Jointly Controlled Operations
The Group accounts for its 50% interest in Sims Pacific Metals
joint venture under the proportionate consolidation method.
Sims Pacific Metals is an unincorporated joint venture based
in New Zealand and its principal activity is metal recycling.
The Group’s interest in the jointly controlled operation is






Current assets 17.0 10.2
Non-current assets 6.9 7.6
Total assets 23.9 17.8
Current liabilities 18.9 10.2
Non-current liabilities 0.1 3.2
Total liabilities 19.0 13.4
Net assets 4.9 4.4
The Group’s share of the jointly controlled operations’ con-
tingent liabilities and capital expenditure commitments is in-
cluded in Notes 22 and 23, respectively.
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Jointly Controlled Assets
2.191
Aquarius Platinum Limited (Jun 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
5. Significant Accounting Policies (in part)
(v) Interest in Jointly Controlled Entities
The Group’s interest in jointly controlled entities is accounted
for by proportionate consolidation, which involves recognising
a proportionate share of the joint venture’s assets, liabilities,
income and expenses with similar items in the consolidated
financial statements on a line-by-line basis.
In respect of the Group’s interest in jointly controlled assets,
the following are recognised in the financial statements:
(i) the Group’s share of the jointly controlled assets, clas-
sified according to the nature of the assets;
(ii) any liabilities that the Group has incurred;
(iii) the Group’s share of any liabilities incurred jointly with
the other venturers in relation to the joint venture;
(iv) any income from the sale or use of the Group’s share
of the output of the joint venture, together with the
Group’s share of any expenses incurred by the joint
venture; and
(v) any expenses that the Group has incurred in respect
of its interest in the joint venture.
IAS 41
IFRSs Overview and Comparison
to U.S. GAAP
2.192 IAS 41 establishes the accounting for biological as-
sets, agricultural produce at the point of harvest, and cer-
tain government grants that relate to agricultural activity.
Examples of biological assets include farm animals, trees,
grapevines, and other plants. After the point of harvest, IAS
2 or another applicable IFRS is applied. Accordingly, IAS 41
does not apply to the processing of agricultural produce after
harvest or to land (found in IAS 16 or IAS 40) or intangible
assets (found in IAS 38) related to agricultural activity.
Recognition and Measurement
IFRSs
2.193 IAS 41 states that an entity should recognize biolog-
ical assets (living animal or plant) or agricultural produce
(harvested product of the biological asset) on the balance
sheet only when the following criteria are met:
• The entity controls the biological asset or agricultural
produce as a result of past events.
• It is probable that future economic benefits from the
asset will flow to the entity.
• The fair value (or cost) of the asset can be measured
reliably.
2.194 On initial recognition and at the end of each reporting
period, an entity should measure both biological assets and
agricultural produce at the point of harvest at fair value less
cost to sell. When there is an active market for the agricultural
produce or biological asset in its present condition and loca-
tion, IAS 41 states that the quoted market price in that market
is the only appropriate basis for determining fair value. When
market-determined prices or values are not available for the
asset in its present condition, the entity should use the present
value of expected future cash flows discounted at a market-
determined rate. In making this calculation, an entity should
include the net cash flows that market participants would
expect the asset to generate in its most relevant market.
2.195 At initial recognition of a biological asset, an entity
can only rebut the presumption that fair value can be mea-
sured reliably when there are no market-determined prices
or values available and alternative estimates of fair value are
clearly unreliable. In this case, an entity should only measure
biological assets at cost less accumulated depreciation and
impairment losses.
2.196 An entity should recognize gains or losses on initial
recognition of biological assets or agricultural produce and
changes in fair value of biological assets less cost to sell in
profit or loss.
2.197 IAS 41 requires an entity to recognize unconditional
government grants related to biological assets that are mea-
sured at fair value less cost to sell in profit or loss when
the grant becomes receivable. When a government grant is
conditional, an entity should recognize the grant only when
these conditions are met.
U.S. GAAP
2.198 FASB ASC 905, Agriculture, contains industry spe-
cific guidance applicable to accounting by agricultural pro-
ducers and agricultural cooperatives, rather than to account-
ing for biological assets by all entities. However, FASB
ASC 905-10-15-4 excludes the following producers from
the scope of this guidance:
• Growers of timber, pineapple, and sugarcane in tropical
regions,
• Raisers of animals for competitive sports, and
• Merchants or noncooperative processors of agricultural
products that purchase commodities from growers, con-
tract harvesters, or others serving agricultural produc-
ers.
2.199 However, unlike IFRSs, FASB ASC 905 does not
require an entity within the scope of this guidance to account
for all types of biological assets in the same way.
2.200 FASB ASC 905-330-25 explains that an entity should
account for growing crops (for example, a field, row, tree,
bush, or vine crop before harvest) as inventory. For growing
crops accounted for as inventory, an entity should capitalize
all direct and indirect costs until the time of harvest. An entity
should defer and allocate some costs incurred before planting
(such as soil preparation) to the cost of the growing crop.
Further, an entity should estimate, accrue, and allocate other
costs (such as clearing residue of harvest) to the harvested
crop (agricultural produce). FASB ASC 905-330-30-1 states
that in exceptional cases, it may be impracticable for an entity
to determine an appropriate cost basis for these inventories.
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FASB ASC 905-330 permits an entity to use realizable value,
calculated on the basis of quoted market prices, less estimated
costs of disposal for these inventories only when all of the
following criteria are met:
• The products have immediate marketability at quoted
market prices that cannot be influenced by the producer.
• The products have characteristics of unit interchange-
ability.
• The products have relatively insignificant costs of dis-
posal.
Subsequently, in accordance with FASB ASC 905-330-35-1,
an entity should measure inventories of growing crops at
the lower of cost or market. FASB ASC 905-330-25-3 ex-
plains that an entity is permitted to classify animals with
short productive lives (for example, poultry) as inventory.
Subsequently, an entity would also measure these animals at
the lower of cost or market.
2.201 Unlike IFRSs and in contrast to FASB ASC 905-
330 for growing crops, paragraphs 2–3 of FASB ASC 905-
360-25 explains that an entity should recognize trees, vines,
orchards, groves, and vineyards as fixed assets (PPE). The
aforementioned FASB ASC guidance also notes that an en-
tity should capitalize limited-life land development costs and
direct and indirect development costs of orchards, groves,
vineyards, and intermediate-life plants (defined in the FASB
ASC glossary as plants having growth and production cycles
of more than one year but less than those of trees and vines)
during the development period. In accordance with FASB
ASC 905-360-25-4, except for animals with short produc-
tive lives classified as inventory, an entity should recognize
breeding animals, livestock, and production animals as fixed
assets. FASB ASC 905-360-35-2 states that when breeding
and production animals reach maturity and are transferred to
a productive function, an entity should depreciate the accu-
mulated development costs, less any estimated salvage value,
over the animals’ estimated productive lives. Unlike IFRSs,
FASB ASC 905-360-30 also contains additional guidance on
other costs to be included as production costs with respect to
the end product from these animals.
2.202 Unlike IFRSs, paragraphs 1–2 of FASB ASC 905-
360-30 explain that for animals raised for sale, an entity
should capitalize all direct and indirect development costs
of developing animals and measure them at the lower of
cost or market until available for sale. Animals available and
held for sale should be measured at the lower of cost or
market or sales price, less estimated costs of disposal, when
there are reliable, readily determinable, and realizable market
prices for the animals; the costs of disposal are relatively




2.203 An entity should present biological assets as a sepa-
rate line item on the balance sheet, classified as current or
noncurrent, in accordance with IAS 1. An entity should also
present additional line items, headings, and subtotals when
they are relevant to an understanding of the entity’s finan-
cial position. This guidance applies to all entities with assets
subject to the requirements of IAS 41, not just those in the
agriculture industry.
U.S. GAAP
2.204 Unlike IFRSs, FASB ASC 905-205, Agriculture—
Presentation of Financial Statements, is applicable only for
entities in the agriculture industry and agricultural coopera-
tives and provides no guidance on the separate presentation
in the statement of financial position of biological assets,
distinguished from other types of inventory or PPE.
Disclosure
IFRSs
2.205 Entities should disclose a description of each group
of biological assets and any aggregate gain or loss from
initial recognition or change in fair value, less cost to sell, of
biological assets and agricultural produce.
2.206 When not disclosed elsewhere in information pub-
lished with the financial statements (that is, the information
may be outside the audited financial statements), an entity
should disclose the following:
• Nature of activities for each group of biological assets
• Nonfinancial measures or estimates of the physical
quantities of each group of biological assets at the end
of the period and the output of agricultural product
during the period
2.207 IAS 41 states that entities should disclose a recon-
ciliation of the beginning and ending balance in biological
assets, including the following changes, if applicable:
• Changes in fair value during the period
• Increases from purchases
• Decreases from sales and classification to held for sale,
whether alone or as part of a disposal group
• Decreases due to harvest
• Increases from business combinations
• Foreign exchange differences
2.208 IAS 41 also requires an entity to disclose the methods
and significant assumptions applied in determining fair value
less cost to sell for each group of agricultural produce and
biological asset during the period.
2.209 An entity should also disclose the following general
information: title restrictions, commitments, and financial
risk strategies. Additional disclosures are required for gov-
ernment grants and when the fair value less cost to sell of
biological assets cannot be measured reliably.
U.S. GAAP
2.210 FASB ASC does not include special disclosure re-
quirements for biological assets or agricultural produce at
the point of harvest. Depending upon the asset category in
which the asset appears on the balance sheet (for example,
inventory), other U.S. GAAP disclosure requirements apply.
However, FASB ASC 905-330-50-1 does state that agricul-
tural cooperatives should disclose the amounts assigned to
members’ products. In addition, FASB ASC 905-360-50-1
also states that an entity should make financial statement dis-
closure of the accumulated costs and estimated useful life of
intermediate-life plants.
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Presentation and Disclosure Excerpts
Current and Non-current Assets—Growing
Crops, Sugarcane, Coffee, Growing Herd,
and Cattle Held for Sale
2.211
Adecoagro S.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
As of December 31, 2010, 2009 and 2008
(All amounts in US$ thousands, except shares and per
share data and as otherwise indicated)
Note 2010 2009 2008
Assets
Non-current assets
Property, plant and equipment, net 6 751,992 682,878 571,419
Investment property 7 21,417 21,246 —
Intangible assets, net 8 28,653 21,859 18,108
Biological assets 9 104,216 170,347 75,701
Investments in joint ventures 10 6,271 6,506 7,508
Deferred income tax assets 21 67,463 45,113 18,713
Trade and other receivables, net 11,12 30,752 22,065 8,612
Other assets 26 34 87
Total non-current assets 1,010,790 970,048 700,148
Current assets
Biological assets 9 82,541 60,107 50,247
Inventories 13 57,170 57,902 61,221
Trade and other receivables, net 11,12 119,205 106,212 75,928
Derivative financial instruments 11 876 99 2,019
Cash and cash equivalents 11,14 70,269 74,806 93,360
Total current assets 330,061 299,126 282,775
Spin-off assets 15 — — 45,311
Total assets 1,340,851 1,269,174 1,028,234
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
The principal accounting policies applied in the preparation
of these consolidated financial statements are set out below.
These policies have been consistently applied to all the years
presented, unless otherwise stated.
2.1. Basis of Preparation (in part)
The consolidated financial statements of the Group have
been prepared in accordance with International Financial
Reporting Standards (IFRS) of the International Account-
ing Standards Board (IASB) and the Interpretations of the
International Financial Reporting Interpretations Committee
(IFRIC). All IFRS issued by the IASB, effective at the time of
preparing these consolidated financial statements have been
applied.
The consolidated financial statements have been prepared
under the historical cost convention as modified by finan-
cial assets and financial liabilities (including derivative instru-
ments) at fair value through profit or loss and biological assets
measured at fair value.
2.13. Biological Assets
Biological assets comprise growing crops (mainly corn,
wheat, soybeans, sunflower and rice), sugarcane and coffee
and livestock (growing herd and cattle for sale).
The Group distinguishes between consumable and bearer
biological assets, and between mature and immature biolog-
ical assets. “Consumable” biological assets are those assets
that may be harvested as agriculture produce or sold as bio-
logical assets, for example livestock intended for the produc-
tion of meat and/or livestock held for sale. “Bearer” biological
assets are those assets capable of producing more than one
harvest, for example sugarcane or livestock from which raw
milk is produced. “Mature” biological assets are those that
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have attained harvestable specifications (for consumable bi-
ological assets) or are able to sustain regular harvests (for
bearer biological assets). “Immature” biological assets are
those assets other than mature biological assets.
Costs are capitalized as biological assets if, and only if,
(a) it is probable that future economic benefits will flow to
the entity, and (b) the cost can be measured reliably. The
Group capitalizes costs such as: planting, harvesting, weed-
ing, seedlings, irrigation, agrochemicals, fertilizers and a sys-
tematic allocation of fixed and variable production overheads
that are directly attributable to the management of biological
assets, among others. Costs that are expensed as incurred
include administration and other general overhead and unal-
located production overhead, among others.
Biological assets, both at initial recognition and at each sub-
sequent reporting date, are measured at fair value less costs
to sell, except where fair value cannot be reliably measured.
Cost approximates fair value, when little biological transfor-
mation has taken place since the costs were originally in-
curred or the impact of biological transformation on price is
not expected to be material.
Gains and losses that arise on measuring biological assets
at fair value less costs to sell and measuring agricultural pro-
duce at the point of harvest at fair value less costs to sell are
recognized in the statement of income in the period in which
they arise.
Where there is an active market for a biological asset
or agricultural produce, quoted market prices in the most
relevant market are used as a basis to determine the fair
value. Otherwise, when there is no active market or market-
determined prices are not available, fair value of biological
assets is determined through the use of valuation techniques.
Therefore, the fair value of biological assets is generally de-
rived from the expected discounted cash flows of the related
agricultural produce. The fair value of our agricultural pro-
duce at the point of harvest is generally derived from market
determined prices. A general description of the determination
of fair values based on the Company’s business segments
follows:
• Growing crops:
Growing crops, for which biological transformation is not sig-
nificant, are measured at cost, which approximates fair value.
Expenditure on growing crops includes land preparation ex-
penses and other direct expenses incurred during the sowing
period including labor, seedlings, agrochemicals and fertiliz-
ers among others.
Otherwise, biological assets are measured at fair value less
estimated point-of-sale costs at initial recognition and at any
subsequent period. Point-of-sale costs include all costs that
would be necessary to sell the assets. Gains and losses aris-
ing from such measurements are included in the statement
of income in the period in which they arise under the line
item “Initial recognition and changes in fair value of biological
assets and agricultural produce.”
The fair value of growing crops excluding sugarcane and
coffee is measured based on a formula, which takes into con-
sideration the estimated crop yields, estimated market prices
and costs, and discount rates. Yields are determined based
on several factors including location of farmland, environmen-
tal conditions and other restrictions and growth at the time of
measurement. Yields are multiplied by sown hectares to de-
termine the estimated tons of crops to be obtained. The tons
are then multiplied by a net cash flow determined as the actual
crop prices less the direct costs to be incurred. This amount
is discounted at a discount rate, which reflects current mar-
ket assessments of the assets involved and the time value of
money.
• Growing herd and cattle:
Livestock are measured at fair value less estimated point-of-
sale costs, with any changes therein recognized in the state-
ment of income, on initial recognition as well as subsequently
at each reporting period. Gains and losses arising from ani-
mal growth and changes in livestock numbers are included in
the statement of income in the period in which they arise, un-
der the line item “Initial recognition and changes in fair value
of biological assets and agricultural produce.” The fair value
of livestock is determined based on the actual selling prices
less estimated point-of-sale costs on the markets where the
Group operates.
• Coffee:
The coffee trees are accounted for as plantations and are
generally felled after their optimum economic age for use has
expired, generally 18 years.
Coffee trees, for which biological growth is not significant,
are valued at cost, which approximates fair value. Expendi-
ture on coffee trees planting includes land preparation ex-
penses and other direct expenses incurred during the sowing
period including labor, seedlings, agrochemicals and fertiliz-
ers among others.
Coffee trees which have attained significant biological
growth are valued through a discounted cash flow model.
Revenues are based on yearly coffee production volumes
and the price is calculated as the average of daily prices for
coffee future contracts (Coffee ICE-NY contracts) for a six
month period. Projected costs include maintenance, pruning,
land leasing, harvesting and coffee treatment.
These projections generate cash flows for each productive
year, which, after being adjusted to present value at an ap-
propriate discount rate, are the basis to determine the fair
value of coffee.
• Sugarcane:
The fair value of sugarcane depends on the variety, location
and maturity of the plantation. The sugarcanes are accounted
for as plantations and are felled after their optimum economic
age for use has expired, generally five years.
Sugarcane, for which biological growth is not significant, is
valued at cost, which approximates fair value. Expenditure on
sugarcane consists mainly in land preparation expenses and
other direct expenses incurred during the sowing period in-
cluding labor, seedlings, agrochemicals and fertilizers among
others.
Sugarcane which has attained significant biological growth
is measured at fair value. The fair value considers estimated
revenues based on yearly production volume (which will be
destined to sugar, ethanol, energy and raw cane production)
and the price is calculated as the average of daily prices for
sugar future contracts (Sugar #11 ICE-NY contracts) for a
six month period. Projected costs include maintenance, land
leasing, harvesting and transportation.
The operating cash flows are discounted at a discount rate,
which reflects current market assessment of the time value
of money and risks involved.
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4. Critical Accounting Estimates and Judgments
(in part)
(c) Biological Assets
The nature of the Group’s biological assets and the basis
of determination of their fair value are explained under Note
2.13. The discounted cash flow model requires the input of
highly subjective assumptions including observable and un-
observable data. Generally the estimation of the fair value of
biological assets is based on models or inputs that are not
observable in the market and the use of unobservable inputs
is significant to the overall valuation of the assets. Unobserv-
able inputs are determined based on the best information
available, for example by reference to historical information
of past practices and results, statistical and agronomical in-
formation, and other analytical techniques. Key assumptions
include future market prices, estimated yields at the point of
harvest, estimated production cycle, future cash flows, future
costs of harvesting and other costs, and estimated discount
rate.
Market prices are generally determined by reference to ob-
servable data in the principal market for the agricultural pro-
duce. Harvesting costs and other costs are estimated based
on historical and statistical data. Yields are estimated based
on several factors including the location of the farmland and
soil type, environmental conditions, infrastructure and other
restrictions and growth at the time of measurement. Yields are
subject to a high degree of uncertainty and may be affected
by several factors out of the Group’s control including but not
limited to extreme or unusual weather conditions, plagues
and other crop diseases, among other factors.
The key assumptions discussed above are highly sensitive.
Reasonable shifts in assumptions including but not limited to
increases or decreases in prices, costs and discount factors
used would result in a significant increase or decrease to the
fair value of biological assets. In addition, cash flows are pro-
jected over a number of years and based on estimated pro-
duction. Estimates of production in themselves are dependent
on various assumptions, in addition to those described above,
including but not limited to several factors such as location,
environmental conditions and other restrictions. Changes in
these estimates could materially impact on estimated produc-
tion, and could therefore affect estimates of future cash flows
used in the assessment of fair value.
The valuation models and their assumptions are reviewed
annually, or quarterly if warranted, and, if necessary, ad-
justed. During the year ended December 31, 2009, the Group
made no changes to the models and assumptions. During the
year ended December 31, 2010, new information has been
gained and accordingly the Group introduced an adjustment
to the valuation model for sugarcane. Projected revenues are
now calculated based on the average of daily prices for sugar
future contracts (Sugar # 11 ICE-NY contract) during the six-
month period ended at period end rather than the single price
for sugar future contracts at year end used during 2009. The
Group determined that the use of 6-month average of daily
prices of future contracts was a more appropriate estimate
for price inputs in the valuation model than the single price
for sugar future contracts at period-end, as it would mitigate
any additional variability that a single-day price may have on
the sugarcane valuation model and was necessary to prop-
erly measure the fair value of the related biological assets
given changes in market conditions in 2010. The effect of this
change in the valuation model recognized in the line item “Ini-
tial recognition and changes in fair value of biological assets
and agricultural produce” was an increase in the loss before
income tax for US$ 90.9 million for the year ended December
31, 2010.
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5. Segment Information (in part)
Segment Analysis for the Year Ended December 31, 2010
Farming







Sales of manufactured products and
services rendered 344 59,280 — 2,709 3,718 66,051 228,478 — — 294,529
Cost of manufactured products sold and
services rendered — (52,017) — (2,546) — (54,563) (164,638) — — (219,201)
Gross profit from manufacturing activities 344 7,263 — 163 3,718 11,488 63,840 — — 75,328
Sales of agricultural produce and
biological assets 107,818 2,305 14,297 4,863 2,407 131,690 48 — — 131,738
Cost of agricultural produce sold and
direct agricultural selling expenses (107,818) (2,305) (14,297) (4,863) (2,407) (131,690) (48) — — (131,738)
Initial recognition and changes in fair
value of biological assets and
agricultural produce 38,879 9,360 9,129 (2,630) 737 55,475 (86,003) — — (30,528)
Gain from changes in net realizable value
of agricultural produce after harvest 7,482 — — 517 — 7,999 — — — 7,999
Gross profit/(loss) from agricultural
activities 46,361 9,360 9,129 (2,113) 737 63,474 (86,003) — — (22,529)
Margin on manufacturing and agricultural
activities before operating expenses 46,705 16,623 9,129 (1,950) 4,455 74,962 (22,163) — — 52,799
General and administrative expenses (7,087) (3,773) (2,910) (983) (350) (15,103) (19,080) — (22,379) (56,562)
Selling expenses (1,522) (8,154) (333) (655) (175) (10,839) (41,689) — — (52,528)
Other operating income, net (6,194) 345 — (2,165) 70 (7,944) 5,305 20,837 26 18,224
Share of loss of joint ventures — — (50) — — (50) — — — (50)
Profit/(loss) from operations before
financing and taxation 31,902 5,041 5,836 (5,753) 4,000 41,026 (77,627) 20,837 (22,353) (38,117)
Depreciation and amortization 1,711 2,080 423 449 333 4,996 32,567 — — 37,563
Initial recognition and changes in fair
value of biological assets (unrealized) 8,719 6,273 3,610 (2,450) (36) 16,116 (96,795) — — (80,679)
Initial recognition and changes in fair
value of agricultural produce
(unrealized) 7,229 742 — (71) — 7,900 405 — — 8,305
Initial recognition and changes in fair
value of biological assets and
agricultural produce (realized) 22,931 2,345 5,519 (109) 773 31,459 10,387 — — 41,846
Gain from changes in net realizable
value of agricultural produce after
harvest (unrealized) 2,050 — — (523) — 1,527 — — — 1,527
Gain from changes in net realizable
value of agricultural produce after
harvest (realized) 5,432 — — 1,040 — 6,472 — — — 6,472
Property, plant and equipment, net 204,454 50,899 4,202 25,265 18,831 303,650 448,342 — — 751,992
Investment property — 1,168 — — 20,249 21,417 — — — 21,417
Goodwill 4,931 7,023 — 1,115 319 13,388 13,106 — — 26,494
Biological assets 31,247 21,555 7,130 21,577 401 81,910 104,847 — — 186,757
Investment in joint ventures — — 6,271 — — 6,271 — — — 6,271
Inventories 22,926 8,422 883 7,023 61 39,315 17,855 — — 57,170
Total segment assets 263,299 89,066 19,063 54,980 39,542 465,950 584,151 — — 1,051,101
Borrowings (59,339) (41,050) (10,262) (13,651) — (124,302) (265,170) — — (389,472)
Total segment liabilities (59,339) (41,050) (10,262) (13,651) — (124,302) (265,170) — — (389,472)
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9. Biological Assets
Changes in the Group’s biological assets in 2010, 2009 and
2008 were as follows:
2010 2009 2008
Beginning of the year 230,454 125,948 102,562
Increase due to purchases 681 296 3,276
Disposal of subsidiary (Note 15) — (86) (376)
Initial recognition and changes in fair value of biological assets(i) (30,528) 71,668 61,000
Decrease due to harvest (237,465) (84,990) (54,709)
Decrease due to sales (2,138) (37,014 (6,382)
Costs incurred during the year 224,969 136,625 49,949
Exchange differences 784 18,007 (29,372)
End of the year 186,757 230,454 125,948
(i) Biological asset with a production cycle of more than one year (that is, sugarcane, coffee, dairy and cattle) generated ‘Initial recognition and
changes in fair value of biological assets’ amounting to US$ (78,767) for the year ended December 31, 2010 (2009: US$ 52,935; 2008: US$
25,141). In 2010, an amount of US$ (60,146) (2009: US$ 29,834; 2008: US$ 29,576) was attributable to price changes, and an amount of
US$ (18,621) (2009: US$ 23,101; 2008: US$ (4,435)) was attributable to physical changes.
Biological assets in 2010, 2009 and 2008 were as follows:
2010 2009 2008
Non-current
Cattle for dairy production(i) 7,130 4,313 4,732
Breeding cattle(i) — — 11,858
Other cattle(ii) 39 66 267
Sown land—coffee(iii) 18,600 18,540 24,763
Sown land—sugarcane(iii) 78,447 147,428 34,081
104,216 170,347 75,701
Current
Breeding cattle(i) — — 3,543
Other cattle(iv) 362 749 3,961
Sown land—coffee(v) 2,977 3,094 690
Sown land—sugarcane(v) 26,400 17,273 14,086
Sown land—crops(ii) 31,247 27,467 21,059
Sown land—rice(ii) 21,555 11,524 6,908
82,541 60,107 50,247
Total biological assets 186,757 230,454 125,948
(i) Classified as bearer and mature biological assets.
(ii) Classified as consumable and immature biological assets.
(iii) Classified as bearer and immature biological assets.
(iv) As of December 31, 2010, an amount of US$ 186 (2009: 493;
2008: 2,718) was classified as consumable and mature biological
assets, and an amount of US$ 176 (2009: 256; 2008: 1,243) was
classified as consumable an immature biological assets.
(v) As of December 31, 2010, and amount of US$ nil (2009: nil;
2008: nil) was classified as bearer and mature biological assets,
and an amount of US$ 29,378 (2009: 20,367; 2008: 14,776) was
classified as bearer and immature biological assets.
The fair value less estimated point of sale costs of agricultural
produce at the point of harvest amounted to US$ 241,762 for
the year ended December 31, 2010 (2009: US$ 88,113; 2008:
US$ 57,457).
Commencing during the middle of 2008 and lasting until
the middle of 2009, the areas in which the Group operates
suffered one of the worst droughts of the last 50 to 70 years,
which resulted in a reduction in its agricultural production per
hectare compared with historical average yields.
As a result of the drought, actual yields for crops in
2008/2009 decreased as compared with historical average
yields, generating a negative impact in ‘Initial recognition and
changes in fair value of biological assets and agricultural pro-
duce’ of U$S nil for the year ended December 31, 2010 (2009:
US$ 16.4; million 2008: US$ 2.0 million). Additionally, actual
yields for rice in 2008/2009 decreased as compared with his-
torical average yields, generating a negative impact in ‘Initial
recognition and changes in fair value of biological assets and
agricultural produce’ of nil for the year ended December 31,
2010 (2009: US$ 4.2 million; 2008: nil).
Current Assets—Biological Assets, No
Reliable Fair Value, Pledged as Guarantee
2.212
Vina Concha y Toro S.A. (Dec 2010)
Author’s Note
Vina Concha y Toro S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of January
1, 2009. The excerpt that follows reflects the initial
application of IAS 41.
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Assets N◦ Th$ Th$ Th$
Current assets
Cash and cash equivalent (7) 16,757,549 6,997,300 3,949,865
Other current financial assets (8) 10,721,894 10,903,083 5,126,520
Other non-financial current assets — 4,616,263 3,703,965 3,380,234
Trade and other accounts receivable, current (9) 108,358,712 102,981,228 110,532,628
Accounts receivable from related parties, current (10) 609,117 220,820 240,155
Inventories (11) 107,233,780 118,196,897 111,600,565
Current biological assets (15) 10,944,784 10,368,684 12,822,074
Current tax assets (22) 14,853,251 12,657,009 15,381,635
Total current assets other than assets or groups of assets for
disposition classified as maintained for sale or as
maintained to distribute to owners 274,095,350 266,028,986 263,033,676
Assets held for sale (16) 82,500 — —
Total current assets 274,177,850 266,028,986 263,033,676
Non-current assets
Other non-current financial assets (8) 5,765,933 3,943,612 —
Other non-financial assets, non-current — 2,442,581 2,779,252 3,244,011
Investments accounted for using the equity method (12) 9,627,465 9,626,139 9,121,449
Intangible assets other than goodwill (13) 8,863,353 8,379,752 8,417,493
Property, plant and equipment (14) 225,070,491 229,469,990 226,652,653
Non-current biological assets (15) 53,672,218 52,529,942 50,621,435
Deferred tax assets (21) 5,295,823 4,015,976 3,376,166
Total non-current assets 310,737,864 310,744,663 301,433,207
Total assets 584,915,714 576,773,649 564,466,883
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2. Bases of Preparation and Presentation Used
for These Financial Statements (in part)
2.13 Biological Assets
Within Biological Assets, Viña Concha y Toro includes all
grapevine plantations. The agricultural product (Grapes) de-
rived from plantations under production is purposed to be a
supply for the wine production process.
In conformity with IAS 41, for those assets for which it is not
possible to reliably determine the fair market value, the Com-
pany has concluded to value the grapevine plantations at its
historic cost less accumulated depreciation and accumulated
losses due to impairment.
The Company depreciates its biological assets following
the straight-line method in function of the estimated useful
lives of grapevines and subjecting the value to impairment
test in each year. Useful lives applied are as follows:
Useful Lives
Plantations vineyard 20–25
For agricultural product (grapes) which are in a growing pro-
cess up to the grape harvest date, costs are accumulated up
to the harvest date and then forms part of the inventory cost
in the following processes.
Note 15. Biological Assets
The Company includes as a part of these assets, the
grapevine plantations, both in the growing stage and in pro-
duction and also the grape product.
As contemplated in IAS 41, biological assets must be mea-
sured at fair value less the estimated costs to sell except
for those in which the fair value cannot be measurable in a
reliable way.
Based on the information and analysis prepared by Viña
Concha y Toro, the biological asset valuation (planted
grapevines in growing/production) at “reasonable value or
fair value” is not feasible to determine in a reliable way in
Chile, given that there is no active market in Chile for planted
grapevines both in growing stage and in production.
Considering the valuation alternatives of IAS 41, which are
summarized in Market Prices Net, Present value of net cash
flows expected of assets and Historic Costs, the main rea-
sons which support this conclusion relate to the fact that
in Chile there is no active market for planted grapevines in
growing/production stage, given that these are not an as-
set commonly traded in our grapevine industry. There is not
enough experience in the market with respect to the num-
ber of transactions on these goods which allow identifying
reference prices for its valuation. Given the high degree of
subjectivity to qualify the quality of grapes associated to the
grapevine, for certain grapes plantations there is no objective
market.
Also it is not possible to apply the cash flow present value,
given that the grapevines in development and productive
stage have no demand, and by itself, do not generate flows.
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Flows must be related with the realization of the agricultural
product (grape) which will generate the biological asset. In
the actual business, the grape coming from vineyards will be
used to produce wine that subsequently will be traded, not
for sale, thus, there is no reference on the grape price in the
market.
In addition, the main variables of all flow models are quan-
tity and price, these variables depend on the efficiency lev-
els of each company when handling its vineyards, which in
turn will depend on: adopted technology and know-how what
makes difficult identifying the proper combination of variables
to be considered (quantity and cost involved) and to be reli-
able.
After analyzing this matter, we may conclude that any
methodology used is not fully reliable due to the fact that
the basic variables which feed these, have no support in ob-
jective information which will finally allow measurable and
reliable results. Consequently, today we have concluded that
the use of flow models does not deliver a reliable fair value
for biological assets.
As per the information and objective indicators analyzed so
far, we have concluded that there are no valuation methods
as appropriate as the cost. Valuation through the cost value
method seems a better estimator on the biological asset value
(grapevines) given the reality of our winegrowing industry and
the market peculiarity as commented above.
The depreciation of grapevines in production is performed
on a linear basis and is based on the production estimated
useful life, which is evaluated on a regular basis. Grapevines
in growing stage are not depreciated until entering into pro-
duction, which occurs the fifth year after planting when the
vines begin to produce commercial grapes for the grapevine
process. Costs incurred in acquisition and plantation of new
grapevines is capitalized.
The agricultural products (grape) coming from grapevines
in production are valued at its harvest value (cost) less the
accumulated losses due to impairment, if any. This valuation
is the best estimate of fair value. Grape acquired from third-
parties, which is present in finished and semi-finished prod-
ucts, is reflected by the Company at the value established in
the purchase contract entered into with third-parties.
15.1 Detail on Groups of Biological Assets
Biological assets maintained by Viña Concha y Toro S.A.
and subsidiaries consist of grapevines in production and
grapevines in growing stage.




Reconciliation of Changes in Biological Assets Th$ Th$
Biological Assets, beginning balance as of December 31, 2009 10,368,684 52,529,942
Biological Assets, gross at beginning of the period — 68,105,195
Biological Assets, accumulated amortization and impairment at beginning of
the period — (15,575,253)
Net Biological Assets at beginning of the period 10,368,684 52,529,942
Increases other than those coming from business combinations, Biological
Assets 17,310,697 4,197,308
Acquisitions performed through business combinations, Biological Assets — —
Increases (decreases) for exchange difference (net), Biological Assets — (392,873)
Depreciation of Biological Assets — (2,388,185)
Profit (loss) of fair value adjustment, Biological Assets — —
Other decreases — (273,974)
Increases (decreases) of transfers and other changes, Biological Assets — —
Decreases due to harvests or pickup, Biological Assets (16,734,597) —
Total Biological Assets as of December 31, 2010 10,944,784 53,672,218
Biological Assets, gross as of December 31, 2010 — 71,635,656
Biological Assets, Amortization and impairment accumulated as of
December 31, 2010 — (17,963,438)
(∗) The other decreases correspond to vine pull ups.
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Reconciliation of Changes in Biological Assets Th$ Th$
Biological Assets, beginning balance as of January 1, 2009 12,822,074 50,621,435
Biological Assets, gross at beginning of the period — 68,416,086
Biological Assets, accumulated amortization and impairment at beginning of the period — (17,794,651)
Net Biological Assets at beginning of the period 12,822,074 50,621,435
Increases other than those coming from business combinations, Biological Assets 10,157,670 5,876,452
Acquisitions performed through business combinations, Biological Assets — —
Increases (decreases) for exchange difference (net), Biological Assets (12,611,060) (1,543,505)
Depreciation of Biological Assets — (2,219,398)
Profit (loss) of fair value adjustment, Biological Assets — —
Other increases (decreases) — —
Increases (decreases) of transfers and other changes, Biological Assets — (205,042)
Decreases due to harvests or pickup, Biological Assets. — —
Total Biological Assets as of December 31, 2009 10,368,684 52,529,942
Biological Assets, gross at beginning of period — 68,105,195
Biological Assets, accumulated amortization and impairment at beginning of the period — (15,575,253)
a) Biological Assets Pledged as Guarantee
The grapevines of Viña Concha y Toro S.A. and subsidiaries,
either in production stage or in growing stage, are not subjet
any restrictions, nor have they been constituted as guaran-
tees of financial liabilities.
b) Government Subsidies Related to the Agricultural Activity
Government subsidies have been received as of December
31, 2010 which amounted to Th$69,845.
c) Commitments to Develop or Acquire Biological Assets
As of December 31, 2010, there are no commitments to de-
velop or acquire biological assets.











Limarı́ 556 340 896 451 113 1,460
Casablanca 384 32 415 11 — 426
Leyda 130 — 130 — — 130
Maipo 892 82 974 22 — 997
Cachapoal 1,054 252 1,306 462 60 1,828
Colchagua 1,327 430 1,757 13 — 1,770
Curicó 466 200 666 45 — 711
Maule 1,812 489 2,300 247 — 2,547
Total Chile 6,621 1,824 8,445 1,251 173 9,870
Argentina
Mendoza 901 167 1,068 142 — 1,210
Total Holding 7,522 1,992 9,513 1,392 173 11,079
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Limarı́ 548 325 873 430 113 1,416
Casablanca 388 27 415 12 — 427
Leyda — 130 130 — — 130
Maipo 945 59 1,004 2 — 1,006
Cachapoal 800 476 1,276 539 71 1,886
Colchagua 1,323 273 1,596 67 — 1,663
Curicó 505 237 742 77 — 819
Maule 1,757 446 2,203 193 — 2,396
Total Chile 6,267 1,973 8,239 1,319 185 9,744
Argentina
Mendoza 780 281 1,061 151 — 1,212
Total Holding 7,047 2,254 9,300 1,470 185 10,956
The total vines planted include certain long-term leases that
the Company has in Valle de Casablanca, del Maipo, and
Colchagua.
The total agricultural area does not include the Company’s
land which are not usable for plantations as hills, roads, etc.
Non-Current Assets—Crops and Nurseries
2.213
REA Vipingo Plantations Limited (Sep 2010)
COMPANY STATEMENT OF FINANCIAL POSITION
(in part)








Property, plant and equipment 13 74,337 123,741
Biological assets 14 41,502 49,446
Prepaid operating lease rentals 15 62,218 17,288
Investment in subsidiaries 16 571,458 575,415
Deferred tax asset 23 53,054 39,495
802,569 805,385
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Accounting Policies (in part)
Biological Assets
Biological assets are measured on initial recognition and at
the end of each reporting period at fair value less estimated
selling costs. Gains and losses arising on the initial recogni-
tion of biological assets and from subsequent changes in fair
value less estimated selling costs are recognised in profit or
loss in the accounting period in which they arise.
All costs of planting, upkeep and maintenance of biological
assets are recognised in profit or loss in the accounting period
in which they are incurred.
3. Critical Accounting Judgements and Key Sources
of Estimation Uncertainty (in part)
(b) Key Sources of Estimation Uncertainty (in part)
Biological Assets
In determining the fair value of biological assets, the group
uses the present value of expected cash flows from the asset
discounted at a current market determined pre tax rate. The
objective of a calculation of the present value of expected net
cash flows is to determine the fair value of a biological asset
in its present location and condition. The group considers this
in determining an appropriate discount rate to be used and
in estimating net cash flows. Management uses estimates
based on historical data relating to yields and market prices.
The methodology and assumptions used for estimating both
the amount and timing of future cash flows are reviewed to
reduce any differences between estimates and actual expe-
rience. The significant assumptions are set out in note 14.
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Crops Shs’000 Total Shs’000
At 1 October 2008
Mature crops 201,203 — 201,203
Immature crops 126,533 — 126,533
327,736 — 327,736
Gain arising from changes in fair value attributable to physical changes 2,243 — 2,243
Gain arising from changes in fair value attributable to price changes 60,643 — 60,643
Gain arising from changes in fair value attributable to changes in exchange rate 26,136 — 26,136
Net fair value gain 89,022 — 89,022
Translation adjustment (15,376) — (15,376)
401,382 — 401,382
At 30 September 2009
Mature crops 294,441 — 294,441






Crops Shs’000 Total Shs’000
At 1 October 2009
Mature crops 294,441 — 294,441
Immature crops 106,941 — 106,941
401,382 — 401,382
Purchases 25,065 — 25,065
(Loss)/gain arising from changes in fair value attributable to physical changes (75,334) 2,522 (72,812)
(Loss) arising from changes in fair value attributable to price changes (9,622) — (9,622)
Gain arising from changes in fair value attributable to changes in exchange and
discount rates 85,259 — 85,259
Net fair value gain 303 2,522 2,825
Translation adjustment (11,823) — (11,823)
414,927 2,522 417,449
At 30 September 2010
Mature crops 317,642 1,651 319,293
Immature crops 97,285 871 98,156
414,927 2,522 417,449
Short-term horticultural crops at the year end comprised
of baby corn, fine beans and chillies. Baby corn and fine
beans are harvested after a period of approximately 12 to 14
weeks. Chillies have three harvesting cycles of approximately
8 weeks each over the lifespan of the plant of approximately
48 weeks.
Significant assumptions made in determining the fair value
of biological assets are:
• Sisal plants will have an average productive life of 8
years.
• Future production and sales estimates are based on
budgets approved by the directors and which are re-
viewed and amended on a regular basis to reflect
changes in operational and market conditions.
• The expected market price of sisal fibre will remain con-
stant based on the average price and exchange rates
realised over a number of years.
• Current market prices are used to determine the fair
value of short-term crop.
• A discount rate of between 14% per annum in Kenya
(2009: 15%) and 15% per annum in Tanzania (2009:
20%) is applied to the anticipated net cash flows arising
from the asset. The costs of production and selling costs
used in the calculation of future cash flows are based
on the latest budgeted costs approved by the directors.
Assumed annual rates of inflation of 5% and 7.5% for
Kenya and Tanzania respectively have been incorpo-
rated for periods beyond the initial budget period of one
year.
• Based on the biological transformation which sisal
plants undergo, 42% of fair value is assigned to the
regeneration of sisal leaf.
• Costs incurred on new plantations in the year approxi-
mate to their fair value.
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Non-Current Assets—Timber
2.214
Brookfield Asset Management, Inc. (Dec 2010)
Author’s Note
Brookfield Asset Management implemented IFRSs ef-
fective December 31, 2010, with a date of transition of
January 1, 2009. The excerpt that follows reflects the
initial application of IAS 41.
CONSOLIDATED BALANCE SHEETS (in part)
(Millions) Note Dec. 31, 2010 Dec. 31, 2009(1) Jan. 1, 2009(1)
Assets
Cash and cash equivalents $ 1,713 $ 1,309 $ 1,169
Other financial assets 5 4,419 5,146 4,506
Accounts receivable and other 6 7,869 4,709 3,803
Inventory 7 5,849 5,560 4,752
Investments 8 6,629 4,466 4,646
Property, plant and equipment 9 18,148 16,723 15,597
Investment properties 10 22,163 19,219 16,719
Timber 11 3,206 2,968 2,839
Intangible assets 12 3,805 1,048 619
Goodwill 13 2,546 2,363 1,992
Deferred income tax asset 14 1,784 1,454 984
$ 78,131 $ 64,965 $ 57,626
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
(f) Operating Assets (in part)
(iii) Timber
Standing timber is measured at fair value after deducting es-
timated selling costs and is recorded as Timber on the Con-
solidated Balance Sheets. Estimated selling costs include
commissions, levies, delivery costs, transfer taxes and du-
ties. The fair value of standing timber is calculated as the
present value of anticipated future cash flows for standing
timber before tax. Fair value is determined based on existing,
sustainable felling plans and assessments regarding growth,
timber prices and felling and silviculture costs. Changes in
fair value are recorded in net income in the period of change.
The company determines fair value using external valuations
on an annual basis.
Harvested timber is included in inventory and is measured
at the lower of fair value less estimated costs to sell at the
time of harvest and net realizable value.
Land under standing timber is accounted for using the
revaluation method and included in property, plant and equip-
ment.
(p) Critical Judgements and Estimates (in part)
(iii) Timber
The fair value of timber is based on the following critical es-
timates and assumptions: the timing of forecasted revenues
and timber prices; estimated selling costs; sustainable felling
plans; growth assumptions; silviculture costs; discount rates;
terminal capitalization rates; and terminal valuation dates.
Further information on estimates used for timber is provided
in Note 11.
11. Timber
(Millions) Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Timber $2,807 $2,610 $2,604
Other agricultural assets 399 358 235
Total $3,206 $2,968 $2,839
The company held 1,447 million acres of consumable free-
hold timber at December 31, 2010 (December 31, 2009—
1,445 million), of which approximately 854 million (December
31, 2009—855 million) acres were classified as mature and
available for harvest.
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The following table presents the change in the balance of
standing timber within the company’s timber business:
(Millions) 2010 2009
Balance at beginning of year $2,610 $2,604
Additions 52 —
Fair value adjustments 282 54
Decrease due to harvest (139) (88)
Foreign currency changes 2 40
Balance at end of year $2,807 $2,610
The carrying values are based on external appraisals that
are completed annually. Key valuation assumptions include
a weighted average discount and terminal capitalization rate
of 6.6% (2009—6.5%) and an average terminal valuation date
of 75 years. Timber prices were based on a combination of
forward prices available in the market and the price forecasts
of each appraisal firm.
IAS 17, LEASES
Author’s Note
In July 2008, the IASB added the project on lease ac-
counting to its agenda as part of its overall convergence
activities with the FASB. In March 2009, the boards
jointly published a discussion paper, Leases: Prelim-
inary Views, with a comment deadline of July 2009.
In August 2010, the boards jointly published an expo-
sure draft on accounting for leases proposing a “right
of use” approach that both lessees and lessors would
apply. This approach would require in entities to rec-
ognize all leases in the statement of financial position
and, therefore, provide consistent, more complete, and
useful information to the users of financial statements.
The comment period on the exposure draft ending De-
cember 2011. The boards began to redeliberate these
proposals in January 2011 and has conducted exten-
sive outreach programs during and after the comment
period.
Some of the IASB’s decisions with respect to the
scope of the leasing standard are the following:
• The boards unanimously agreed that the follow-
ing assets would be within the scope of the new
standard:
— right-of-use assets in a sublease
— leases of non-core assets
— long-term leases of land
• The boards unanimously agreed on the following
scope exclusions:
— Leases for the right to explore for or use
minerals, oil, natural gas and similar non-
regenerative resources
— Leases of biological assets (IFRSs)
— Leases of service concession arrangements
within the scope of IFRIC 12 Service Con-
cession Arrangements
— The boards tentatively agreed to add leases of
intangibles to the scope exclusions.
In June 2011, the IASB staff published a document
showing how the board’s tentative decisions to date
would affect the proposals in the exposure draft. This
document is available on the IASB’s website.
In July 2011, the IASB and FASB announced that
their tentative decisions to date were sufficiently dif-
ferent from the proposals in the exposure draft to war-
rant reexposure of revised proposals. Consequently,
they would aim to complete their redeliberations in the
third quarter of 2011 and publish the revised proposals
shortly thereafter.
Author’s Note
In IFRSs, the term finance lease has the same meaning
as capital lease in FASB ASC. Both terms identify
a lease that transfers substantially all significant risks
and rewards of ownership of an asset to the lessee. The
term finance lease is used in the paragraphs that follow
when discussing accounting under IFRSs, and the term
capital lease is used when discussing accounting under
U.S. GAAP. Similarly, the term finance cost or expense
is interchangeable with interest cost or expense. IFRSs
use both terms.
IFRSs Overview and Comparison
to U.S. GAAP
2.215 A lease, as defined in IAS 17, Leases, is an agreement
whereby the lessor conveys to the lessee the right to use an
asset for an agreed period of time in return for a payment
or series of payments. IAS 17 identifies two types of leases:
finance and operating. A finance lease transfers substantially
all significant risks and rewards incidental to ownership of
the asset to the lessee, although the lessor may or may not
eventually transfer title to the lessee. All other leases are
considered operating leases.
2.216 IAS 17 establishes the accounting and disclosure re-
quirements for leases for both the lessor and lessee. These
recognition and disclosure requirements apply to all leases,
except those to explore for and use nonregenerative resources
(for example, minerals, oil, and gas) and licensing arrange-
ments for films, video recordings, plays, manuscripts, copy-
rights, and patents. IAS 17 measurement requirements also
apply to all lessees and lessors, except the following:
• Lessees who hold property classified as investment
property or lessors who provide investment property
under operating leases should account for the invest-
ment property in accordance with IAS 40.
• Lessees who hold biological assets under finance leases
and lessors who provide biological assets under finance
leases should account for the biological assets in accor-
dance with IAS 41.
Although IAS 17 excludes biological assets from the mea-
surement principles of IAS 17, the recognition and disclosure
requirements of IAS 17 still apply.
2.217 IFRIC 4, Determining Whether an Arrangement Con-
tains a Lease, establishes criteria that an entity should apply
when evaluating whether an arrangement that does not take
the legal form of a lease is in substance a lease and should be,
in whole or in part, accounted for in accordance with IAS 17.
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IFRIC 4 identifies two criteria that indicate an arrangement
contains a lease: fulfillment of the arrangement depends on
the use of one or more specific assets and the arrangement
conveys a right of use.
Recognition and Measurement
IFRSs
2.218 IAS 17 requires both lessors and lessees to clas-
sify lease arrangements as finance leases or operating leases.
When the arrangement transfers substantially all risks and
rewards incidental to ownership of the asset, an entity should
classify the lease as a finance lease. Otherwise, an entity
should classify the lease as an operating lease. Whether the
lease is a finance lease should depend on the substance of the
arrangement. IAS 17 provides both examples and indicators
of circumstances that could lead to classification as a finance
lease. However, the standard also states that the identified
indicators are not conclusive, and if it is clear from other fea-
tures of the lease that the risks and rewards of ownership are
not borne by the lessee, the lessee should classify the lease as
an operating lease. Lessors and lessees should classify leases
in the same way.
2.219 IAS 17 provides the following examples of situations
that, when considered separately or combined, would nor-
mally lead to classifying the lease as a finance lease:
• Agreement transfers ownership of the asset to the lessee
at the end of the lease term
• Lessee has a bargain purchase option to acquire the
asset at an amount sufficiently below its fair value that
the option’s exercise is reasonably certain.
• Lease term is for a major part of the economic life of
the asset, even if title is not transferred.
• Present value of the minimum lease payments amounts
to at least substantially all of the asset’s fair value at the
inception of the lease.
• Assets are of such specialized nature that only the lessee
can use the assets without major modifications.
2.220 Indicators that the agreement is a finance lease include
agreements in which the lessors’ losses are borne by the
lessee if the lease is cancelled, gains or losses from changes
in the fair value of the residual value accrue to the lessee, and
the lessee has the ability to renew the lease for a second term
at a price substantially below market.
2.221 When a lease is classified as a finance lease, a lessee
should recognize a leased asset and a corresponding lease
liability at the inception of the lease, measured at the lower
of the fair value of the leased asset or the present value of
the minimum lease payments. In determining present value,
a lessee should use the discount rate implicit in the lease,
or when the implicit rate is impracticable to determine, the
lessee should use its incremental borrowing rate. The lessee
should include incremental direct costs in the cost of the asset.
2.222 Subsequently, a lessee should allocate the minimum
lease payments to finance cost (interest expense) and a re-
duction of the liability using the effective interest method.
Lessees should charge any contingent rents to expense in the
period they are incurred.
2.223 Lessees should recognize depreciation expense on
the leased asset and select an accounting policy consistent
with its policy for similar owned assets. An entity should
calculate depreciation expense in accordance with IAS 16 or
IAS 38, as appropriate. Unless it is reasonably certain that it
will obtain ownership by the end of the lease term, a lessee
should depreciate the asset fully by the shorter of the lease
term or the asset’s useful life.
2.224 A lessee recognizes operating lease payments as an
expense in profit or loss on a straight-line basis over the
lease term, unless another systematic method is more repre-
sentative of the pattern of benefits received, even when the
amounts of the payments and the expense differ.
2.225 A lessor should recognize and present assets held by
the lessee under finance leases as receivables in the balance
sheet, measured at an amount equal to the net investment in
the lease. A lessor should recognize finance income in profit
or loss using the effective interest method. A lessor should
exclude initial direct costs from the carrying value of the
receivable and expense these costs when the profit on sale is
recognized, normally at the beginning of the lease term.
2.226 A manufacturer or dealer lessor should recognize the
seller’s profit or loss in the period, in accordance with its
policy for regular sales. If artificially low rates of interest are
quoted, IAS 17 restricts the amount of selling profit to an
amount that would apply if normal market interest rates are
charged. The lessor should expense the costs of negotiating
and arranging the lease at the same time as the related profit
or loss is recognized.
2.227 In its balance sheet, a lessor should present assets held
by lessees under operating leases by their nature. Generally,
lessors should recognize lease income on a straight-line basis
over the lease term.
2.228 The timing of income recognition by the lessor on a
sale and leaseback depends on whether the transaction results
in a finance or operating lease. Only when the transaction re-
sults in an operating lease and it is clear that the transaction
is at fair value should the lessor recognize income imme-
diately. When a sale and leaseback transaction results in a
finance lease, IAS 41 establishes criteria for the timing and
amount of gain or loss recognition.
U.S. GAAP
2.229 The FASB ASC glossary defines a lease as an agree-
ment conveying the right to use PPE (land or depreciable as-
sets, or both), usually for a stated period of time. In contrast,
IAS 17 does not restrict to PPE the type of asset that can be
the subject of a lease. Both IFRSs and FASB ASC 840 have
specific scope exclusions, some of which are the same or pro-
duce similar results. For example, FASB ASC 840-10-15-15
excludes lease agreements concerning the rights to explore
for or exploit natural resources, such as oil, gas, minerals,
precious metals, timber, or other natural resources. Similarly,
IFRSs also exclude nonregenerative resources (oil, gas, and
minerals). In addition, both IFRSs and FASB ASC 840-10-
15-15 exclude licensing agreements for items such as motion
picture films, plays, manuscripts, patents, and copyrights.
2.230 Paragraphs 6–15 of FASB ASC 840-10-15 provide
more guidance than IFRSs for determining whether the ar-
rangement does or does not qualify as a lease (that is, conveys
the right to control the use of the underlying PPE). For exam-
ple, FASB ASC 840-10-15-10 excludes contracts for services
that do not transfer the right to use PPE. This paragraph also
states that even when an arrangement identifies a specific
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item of PPE, an entity should not consider the arrangement a
lease unless fulfillment is dependent on the use of that specific
item of PPE. This constraint would exclude most arrange-
ments that call for delivery of an asset with quoted market
prices available in an active market because these arrange-
ments are generally not dependent on using specific PPE.
However, contractual provisions that permit the lessor to sub-
stitute other PPE on or after a specified date do not preclude
application of lease accounting before substitution occurs.
2.231 Like IFRSs, FASB ASC 840-10-15-9 includes agree-
ments that, although not nominally identified as leases, meet
the definition of a lease and, therefore, are within the scope
of the lease standards.
2.232 Like IFRSs, FASB ASC 840-10-15-3 explains that in
determining whether to apply the lease accounting require-
ments of FASB ASC 840, lessors and lessees should evaluate,
at the inception of an arrangement based on the facts and cir-
cumstances, whether that arrangement contains a lease. Both
IFRSs and FASB ASC include criteria for reassessment after
inception.
2.233 Like IFRSs, in accordance with paragraphs 16–19 of
FASB ASC 840-10-15, lessors and lessees should evaluate
arrangements consisting of separate contracts with the same
entity or related parties entered into at or near the same time.
FASB ASC presumes that the entity negotiated such arrange-
ments as a package. FASB ASC refers to these arrangements
as multiple element arrangements. If an arrangement has both
lease and nonlease elements, both the lessor and lessee must
apply the lease accounting requirements of FASB ASC 840
to that lease.
2.234 Like IFRSs, FASB ASC 840-10-5-2 requires the
lessee and lessor to classify a lease as either capital or oper-
ating. FASB ASC 840-10-25-1 has specific criteria, similar
to those in IFRSs, which an entity should apply in evaluating
whether the lease should be accounted for as a capital lease.
FASB ASC 840-10-25-29 states that when any one of the
four criteria is met, both the lessor and lessee should clas-
sify the lease as a capital lease. As described in paragraphs
42–43 of FASB ASC 840-10-25, the lessor should consider
all four lease classification criteria and two additional incre-
mental criteria when classifying the lease. However, only the
following two criteria are identical to those in IAS 17:
• The lease transfers ownership of the property to the
lessee by the end of the lease term.
• The lease contains a bargain purchase option.
In addition, unlike IFRSs, FASB ASC does not address leased
assets of a specialized nature.
2.235 Although the concepts underlying the remaining two
criteria for capital lease classification are the same in both
standards, FASB ASC 840-10-25-1 has explicit quantitative
thresholds to be assessed at the inception of the lease and
IFRSs do not. These thresholds are the following:
• Lease term is equal to 75 percent or more of the esti-
mated economic life of the leased property.
• Present value of the minimum lease payments, ex-
cluding executory costs (including any profit thereon),
equals or exceeds 90 percent of the excess of the fair
value of the leased property to the lessor at lease incep-
tion over any related investment tax credit retained by
the lessor.
Neither of these criteria should be applied if the beginning
of the lease term falls within the last 25 percent of the total
estimated economic life of the leased property.
2.236 Paragraphs 2–27 of FASB ASC 840-10-25 also in-
clude specific criteria and guidance for the following issues:
fiscal funding clauses, minimum lease payments criterion,
guarantees and indemnifications, obligations to retire the
leased asset, classification of leases involving real estate or
between related parties, and classification of a lease acquired
in a business combination.
2.237 Like IFRSs, in accordance with paragraphs 1–4 of
FASB ASC 840-30-30, at the inception of a lease classified
as a capital lease, lessees should recognize a leased asset
and a corresponding lease liability measured at the lower
of the present value of the minimum lease payments and
the fair value of the asset. FASB ASC 840-10-25 includes
more guidance on the payments that should be included in the
present value calculation than IAS 17. Both GAAPs establish
guidance requiring the calculation to include initial direct
costs and exclude indirect (IFRSs) or executory (FASB ASC)
costs.
2.238 Both IFRSs and FASB ASC 840 specify the discount
rate to be used in the present value calculation. IFRSs specify
use of the lessor’s implicit interest rate, unless impracticable
to determine; otherwise, the lessee’s incremental borrowing
rate should be used. FASB ASC 840-10-25-31 imposes an
additional constraint that the lessee should use the lower of
its incremental borrowing rate and the implicit rate, when the
latter is known to the lessee.
2.239 Like IFRSs, FASB ASC 840-20-35-3 requires recog-
nized leased assets to be depreciated using the same account-
ing policy used for owned assets. FASB ASC 840 includes
guidance for, and IFRSs do not address, determining residual
value when there is a guaranteed residual value and the lessee
is entitled to its appreciation.
2.240 In accordance with FASB ASC 840-20-25-1, a lessee
should normally recognize operating lease payments as ex-
pense on a straight-line basis. However, a lessee is permitted
to use another systematic and rational basis if it is more
representative of the benefits derived from use.
2.241 Accounting for capital leases by the lessor is more
complex under FASB ASC 840 than IFRSs. Lessors should
classify leases that do not meet any of the four criteria previ-
ously mentioned as operating leases. Although a lessee need
only meet one of the four criteria mentioned in FASB 840-
10-25-1 for capital lease classification, paragraphs 42–43 of
FASB ASC 840-10-25 require the lessor to meet two ad-
ditional criteria to determine whether it should classify the
capital lease as a sales type, direct financing, or leveraged
lease. These lessor criteria are the following:
• The lessor can reasonably predict collectability of the
minimum lease payments (that is, can estimate uncol-
lectable accounts).
• No important uncertainties surround the amount of un-
reimbursable costs yet to be incurred by the lessor under
the lease.
If the lessor meets both of these additional criteria, FASB
ASC 840-10-25-43 provides additional guidance for select-
ing among the lessor capital lease classifications. The spe-
cific lessor classification determines whether a sale or financ-
ing transaction has occurred and the timing and amounts of
revenue and gains (losses) from sales. Otherwise, FASB ASC
840-10-25-43(d) explains that the lessor should classify the
lease as an operating lease. Therefore, under FASB ASC
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840, unlike IFRSs, a lessor and lessee may have different
classifications for the same lease.
Presentation
IFRSs
2.242 IAS 1 does not require an entity to present leased
assets, lease liabilities, or related revenues or expenses as
separate line items in the relevant financial statement. How-
ever, lessees and lessors should apply the other requirements
of IAS 1 (for example, classify amounts as current or non-
current on the balance sheet). An entity should also present
additional line items, headings, and subtotals when they are
relevant to an understanding of the entity’s financial position.
U.S. GAAP
2.243 Paragraphs 1–2 of FASB ASC 840-30-45 require
lessees to separately identify assets held under capital leases
and the related accumulated depreciation and obligations un-
der capital leases within the balance sheet or footnotes. FASB
ASC further states that capital lease obligations are subject
to the same considerations as other obligations in classifying
them with current and noncurrent liabilities.
2.244 Paragraphs 2–3 of FASB 840-20-45 require lessors
to include leased property classified as an operating lease
within or near PPE in the balance sheet and to deduct accu-
mulated depreciation from their investment in the property.
FASB ASC 840-30-45-4 states that, in sales-type and direct
financing leases, lessors should present lease receivables at
the net investment in the lease and allocate these receivables,
utilizing the same considerations as other assets, between
current and noncurrent classifications when preparing a clas-
sified balance sheet. FASB ASC 840-30-45-5 states that in a
leveraged lease, lessors should present deferred taxes related




2.245 Whether leases are classified as finance or operating,
IAS 17 requires a lessee to disclose a general description
of the lessee’s material leasing arrangements, including the
basis for contingent rent payments, the existence and terms
of renewal or purchase options or escalation clauses, and any
restrictions imposed by the leasing arrangements (for ex-
ample, restrictions on dividends, additional debts, or further
leasing).
2.246 For finance leases, in addition to disclosures required
by IFRS 7, Financial Instruments: Disclosures, a lessee
should disclose the following:
• Net carrying amount at the end of the reporting period
by class of asset
• Reconciliation of the total and present value of future
minimum lease payments at the end of the reporting
period and for each of the following periods: not later
than one year, later than one year but not later than five
years, and later than five years
• Contingent rents recognized as expense
• Total future minimum sublease payments expected to
be received under noncancellable leases at the end of
the reporting period
2.247 Depending on the nature of the leased asset, IAS 17
explains that lessees should disclose all information required
by the related standard for owned assets (for example, IAS
16 for a leased building).
2.248 For operating leases, a lessee should disclose the
following:
• Total future minimum lease payments at the end of the
reporting period and for each of the following periods:
not later than one year, later than one year but not later
than five years, and later than five years
• Total future minimum sublease payments expected to
be received under noncancellable leases at the end of
the reporting period
• Lease and sublease payment recognized as expense
during the period, separately reporting minimum lease
payments, sublease payments, and contingent rents
2.249 All lessors, in addition to providing required IFRS 7
disclosures, should disclose a general description of material
leasing arrangements and contingent rents recognized as in-
come. Lessors recognizing receivables in respect of a finance
lease should disclose a reconciliation of gross investment in
the lease and the present value of the future minimum lease
payments receivable (similar to that required for lessees), un-
earned finance income, the amounts of unguaranteed residual
values accruing to the lessor, and the amount of the accumu-
lated allowance for uncollectible receivables. Lessors with
assets held by lessees under operating leases should disclose
the future minimum lease payments for the same periods as
the lessee.
2.250 IAS 17 requires the same disclosures for lessees and
lessors in sale and leaseback transactions. Sale and lease-
backs may require separate disclosure under IAS 1.
U.S. GAAP
2.251 Unlike IFRSs, FASB ASC 840 does not address
whether entities should also provide any additional disclo-
sures required by FASB ASC about financial instruments for
any recognized lease receivables.
2.252 Like IFRSs, paragraphs 2–3 of FASB ASC 840-10-50
require a lessee to disclose, either in the financial statements
or notes, a description of its leasing arrangements, includ-
ing, but not limited to, the basis on which contingent rental
payments are determined; the existence and terms of renewal
and purchase options and escalation clauses; and restrictions
imposed by lease agreements, such as those on dividend pay-
ments, additional debt, and further leasing. FASB ASC 460,
Guarantees, also requires disclosures about guarantees.
2.253 FASB ASC 840-30-50-1 states that lessees should
disclose the gross carrying amount of assets recorded under
capital leases separately either on the balance sheet or in the
notes. Lessees should separately report related lease liabili-
ties on the balance sheet. FASB ASC 840-30-45-3 explains
that depreciation expense on leased assets is not required to
be shown separately, but if it is not included with other de-
preciation and amortization expense, the charge should be
disclosed either on the face of the income statement or in the
notes.
IFRS ATT 2.242
223Section 2: Statement of Financial Position and Related Disclosures
2.254 Like IFRSs, FASB ASC 840-30-50-1 requires lessees
to disclose the following, either in the financial statements or
notes:
• Gross amount of assets held under capital leases by
major classes (according to nature or function), which
may be combined with the comparable information for
owned assets
• Future minimum lease payments as of the date of the
current balance sheet both in the aggregate and for each
of the five succeeding fiscal years
• Contingent rent expense incurred for each period for
which an income statement is presented
FASB ASC 840-30-50-1 also requires lessees to disclose
separately deductions for executory costs included in the
minimum lease payments, imputed interest, and total future
minimum lease payments from noncancelable subleases.
2.255 In accordance with paragraphs 4–5 of FASB ASC
840-10-50, exclusive of leveraged leasing, lessors should
disclose a description of their leasing arrangements when
leasing is a significant portion of their business activities.
Lessors should also disclose their accounting policy for con-
tingent rental income. If a lessor accrues contingent rental
income before the lessee’s achievement of the specified tar-
get (provided that achievement of that target is probable),
lessors should disclose the impact on rental income.
2.256 For leases classified as operating, FASB ASC 840-20-
50-4 requires lessors to provide disclosures similar to IFRSs.
Lessors should disclose the following:
• Cost and carrying amount, if different, of property on
lease or held for leasing by major classes of property
according to nature or function and the total amount
of accumulated depreciation as of the current balance
sheet date
• Minimum future lease payments on noncancelable
leases as of the balance sheet date, both in the aggregate
and for each of the five succeeding fiscal years
• Total contingent rents included in income for each pe-
riod presented
2.257 Unlike IFRSs, FASB ASC 840-30-50-4 requires spe-
cific disclosures by lessors for sales-type and direct financing
leases, including the components of the net investment in the
lease, minimum lease payments, and contingent rents. Para-
graphs 5–6 of FASB ASC 840-30-50 require disclosure by
lessors of the net investment in leveraged leases when such
leasing is a significant part of the lessor’s business activities.
2.258 With respect to sale and leaseback transactions, FASB
ASC 840-40-50-1 requires similar disclosures to IAS 17 for
the seller-lessee to describe the contract terms, including
future commitments, obligations, provisions, or other cir-
cumstances that would require its continuing involvement.
These disclosures are in addition to general lease disclosures
addressed in FASB ASC 840-10-50, as well as disclosure
requirements addressed under real estate sales in FASB ASC
360-20-50.
Presentation and Disclosure Excerpts
Author’s Note
See paragraphs 3.240–.241 in section 3 for excerpts
of disclosures required by lessees holding assets under
operating leases.
Lessee—Operating and Finance Leases
2.259
Copa Holdings, S.A. (Dec 2010)
Author’s Note
Copa Holdings, S.A. implemented IFRSs effective De-
cember 31, 2010, with a date of transition of January
1, 2009. The excerpt that follows reflects the initial
application of IAS 17.
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
(In US$ thousands)
As of As of As of
December 31, December 31, January 1,
Notes 2010 2009 2009
Assets
Property, plant and equipment:
Flight equipment 11 1,782,070 1,451,312 1,375,042
Other 59,426 45,126 41,415
1,841,496 1,496,438 1,416,457
Less: Accumulated depreciation 11 (274,940) (214,963) (168,802)
1,566,556 1,281,475 1,247,655
Purchase deposits for flight equipment 12 205,972 198,697 84,861
Total property and equipment 1,772,528 1,480,172 1,332,516
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
2.4 Significant Accounting Judgments, Estimates
and Assumptions (in part)
The preparation of the Company’s financial statements re-
quires management to make judgments, estimates and as-
sumptions that affect the reported amounts of revenues, ex-
penses, assets and liabilities, at the reporting date. Actual
results could differ from those estimates. However, uncer-
tainty about these assumptions and estimates could result
in outcomes that could require a material adjustment to the
carrying amount of the related asset or liability in the future.
a) Judgments
In the process of applying the Company’s accounting policies,
management has made judgment, apart from those involving
estimations. The judgments that have the most significant
effect on the amounts recognized in the consolidated financial
statements are operating lease commitments.
The Company has entered into lease contracts on the air-
craft it operates. The Company has determined, based on
the terms and conditions of the arrangements, that all the
significant risks and rewards of ownership of the aircraft it
operates are not transferred, so it accounts for the contracts
as operating leases.
2.10 Property, Plant and Equipment
Property, plant and equipment comprise mainly airframe, en-
gines and other related flight equipments. All property, plant
and equipment is shown at cost, less subsequent deprecia-
tion and impairment, if any. Subsequent costs are included
in the asset’s carrying amount or recognized as a separate
asset, as appropriate, only when it is probable that future
economic benefits associated with the item will flow to the
Company and the cost of the item can be measured reliably.
All other repairs and maintenance expenditures are charged
to the statement of income during the financial period in which
they are incurred.
Depreciation is calculated using the straight-line method to
allocate the cost of each asset to its residual value over its
estimated useful life as follows:
• Airframe and engines 30 years
• Aircraft components 30 years
• Ground equipment 10 years
• Furniture, fixture, equipment and other 5 to 10 years
• Major maintenance events 1 to 8 years
• Leasehold improvements lesser of remaining lease
term or useful life
The assets’ residual values and useful lives are reviewed,
and adjusted if appropriate, at each statement of financial
position date. An asset’s carrying amount is written down
immediately to its recoverable amount if the asset’s carrying
amount is greater than its estimated recoverable amount. The
carrying value of equipment and leasehold improvements are
reviewed for impairment when events or changes in circum-
stances indicate that the carrying value may not be recover-
able.
Gains and losses on disposals are determined by compar-
ing the disposal proceeds with the carrying amount and are
included in the income statement.
2.13 Maintenance Deposit
Under lease agreement with aircraft lessors, Copa pays main-
tenance deposits, for two aircrafts, to lessors to be applied to
future maintenance event costs, calculated based on a per-
formance measure, such as flight hours, and are specifically
to be used to reimburse 3rd-party maintenance providers.
If amounts on deposit are insufficient, Copa must cover the
shortfall since Copa is legally responsible for maintaining the
leased aircraft. If there are excess amounts on deposit at
expiration of the lease, the lessor is entitled to retain any ex-
cess amounts. Maintenance deposits paid under lease agree-
ments do not transfer either the obligation to maintain the
aircraft or cost risk associated with maintenance activities to
lessors.
The Company also makes payments for engine overhauls
under power by the hour agreements (“PBH”). Payments re-
lated to engine overhauls under PBH agreements as well as
the maintenance deposits under aircraft leases are capital-
ized as prepaid assets until the maintenance event occurs
and are then amortized over the expected period until the
next event. Management performs regular reviews of the re-
covery of maintenance deposits and believes that the values
reflected in the consolidated statement of financial position
are recoverable.
2.16 Provisions
For certain operating leases, the Company is contractually
obliged to return aircraft in a defined condition. The Com-
pany accrues for restitution costs related to aircraft held un-
der operating leases at the time the asset does not meet the
return conditions criteria and throughout the remaining dura-
tion of the lease. Provisions for costs, including restitution,
restructuring and legal claims and assessments are recog-
nized when:
• The Company has a present legal or constructive obli-
gation as a result of past events;
• It is more likely than not that an outflow of resources will
be required to settle the obligation; and
• The amount has been reliably estimated.
2.20 Leases
Leases where lessor effectively retains substantially all the
risks and benefits of ownership of the leased item, are classi-
fied as operating leases. Operating lease payments are rec-
ognized as an expense in the consolidated statement of in-
come on a straight-line basis over the lease term.
The determination of whether an arrangement is, or con-
tains a lease is based on the substance of the arrangement
at inception date of whether the fulfillment of the agreement is
dependent on the use of a specific asset or assets or the ar-
rangement conveys a right to use the asset, even if that right
is not explicitly specified in an arrangement. A reassessment
is made after inception of the lease only if one of the following
applies:
• There is a change in contractual terms, other than a
renewal or extension of the arrangement;
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• A renewal option is exercised or extension granted, un-
less the term of the renewal or extension was initially
included in the lease term;
• There is a change in the determination of whether ful-
fillment is dependent on a specified asset; or
• There is a substantial change to the asset.
Where a reassessment is made, lease accounting shall com-
mence or cease from the date when the change in circum-
stances gave rise to the reassessment. When a renewal op-
tion is exercised or extension granted, lease accounting shall
commence or cease at the date of renewal or extension pe-
riod.
10. Other Assets
Other assets as of December 31, 2010, December 31, 2009










Guaranty deposits $ 11,130 $12,149 $10,016
Deposits for litigation 16,347 12,291 6,679
Maintenance deposits 69,475 63,036 48,051
Other assets 8,813 10,855 9,204
$105,765 $98,331 $73,950
Guaranty deposits are amounts paid to fuel suppliers and
lessors of monthly lease payments, as required at the incep-
tion of the agreements.
Deposit for litigation is paid into escrow account until the
related dispute is settled. (see note 25)
Maintenance deposits mainly refer to payments made by
the Company for overhaul covered by power by the hour ar-
rangements to be used in future engines maintenance events,
and for payments to lessors to be applied to future mainte-
nance events cost. Maintenance deposits paid do not transfer
either obligation to maintain aircraft or cost risk associated
with maintenance activities to lessors or providers.
11. Property, Plant and Equipment, Net (in part)
A summary of equipment and leasehold improvements as of















At January 1, 2010, net of
accumulated
depreciation and
amortization $ 62,787 $ 8,009 $ 725,758 $463,697 $ 4,851 $ 8,296 $ 8,077 $1,281,475
Additions 12,008 3,924 196,836 127,687 2,561 54 10,411 353,481
Reclassifications 25 (25) — — — 2,170 (2,170) 0
Disposals (331) (389) 0 0 (488) — (7,215) (8,423)
Disposals depreciation 54 397 — — 351 — — 802
Depreciation and
amortization (2,516) (2,335) (35,422) (16,295) (2,243) (1,968) — (60,779)
At December 31, 2010, net
of accumulated
depreciation and
amortization $ 72,027 $ 9,581 $ 887,172 $575,089 $ 5,032 $ 8,552 $ 9,103 $1,566,556
At January 1, 2010
At cost $ 74,206 $23,746 $ 837,217 $522,507 $ 17,023 $13,662 $ 8,077 $1,496,438
Accumulated depreciation
and amortization (11,419) (15,737) (111,459) (58,810) (12,172) (5,366) — (214,963)
Net carrying amount $ 62,787 $ 8,009 $ 725,758 $463,697 $ 4,851 $ 8,296 $ 8,077 $1,281,475
At December 31, 2010
At cost $ 85,908 $27,256 $1,034,054 $650,194 $ 19,099 $15,882 $ 9,103 $1,841,496
Accumulated depreciation
and amortization (13,881) (17,675) (146,882) (75,105) (14,067) (7,330) — (274,940)
Net carrying amount $ 72,027 $ 9,581 $ 887,172 $575,089 $ 5,032 $ 8,552 $ 9,103 $1,566,556
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20. Operating Leases
The Company leases the aircraft it operates and other assets
under long-term lease arrangements. Other leased assets
include real property, airport and terminal facilities, sales of-
fices, maintenance facilities, training centers and general of-
fices. Most contract leases include renewal options; a few
have escalation clauses, but no purchase options. Non-
aircraft related leases, primarily held with local governments,
generally have renewable terms of one year. In certain cases,
the rental payments during the renewal periods would be
greater than the current payments. Because the lease re-
newals are not considered to be reasonably assured, the
rental payments that would be due during the renewal peri-
ods are not included in the determination of rent expense until
the leases are renewed. Leasehold improvements are amor-
tized over the contractually committed lease term, which does
not include the renewal periods.
At December 31, 2010, the scheduled future minimum
lease rental payments required under aircraft and non-aircraft
operating leases that have initial or remaining non-cancelable




Up to one year $ 55,231 $10,270
One to five years 204,761 19,147
Over five years 100,110 2,640
Total minimum lease rental
payments $360,102 $32,057
Total rent expense was $72.8 million and $61.7 million for the
years ended December 31, 2010 and 2009, respectively.
Lessee and Lessor—Operating and Finance
Leases, Lease Commitments
2.260
Millicom International Cellular S.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)





Intangible assets, net 15 2,282,845 1,044,837
Property, plant and equipment, net 16 2,767,667 2,710,641
Investments in associates 17 18,120 872
Pledged deposits 18, 26 49,963 53,333
Deferred taxation 13 23,959 19,930
Other non-current assets 17,754 7,965
Total non-current assets 5,160,308 3,837,578
Current assets
Inventories 62,132 46,980
Trade receivables, net 19 253,258 224,708
Amounts due from joint venture partners 99,497 52,590
Prepayments and accrued income 89,477 65,064
Current income tax assets 10,748 17,275
Supplier advances for capital expenditure 36,189 49,165
Other current assets 20 72,205 58,159
Time deposit 21 3,106 50,061
Cash and cash equivalents 22 1,023,487 1,511,162
Total current assets 1,650,099 2,075,164
Assets held for sale 6 184,710 78,276
Total assets 6,995,117 5,991,018
(continued)
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10% Senior Notes 26 — 454,477
Other debt and financing 26 1,796,572 1,458,423
Derivative financial instruments 33 18,250 —
Provisions and other non-current liabilities 27 79,767 88,142
Deferred taxation 13 195,919 66,492
Total non-current liabilities 2,090,508 2,067,534
Current liabilities
Other debt and financing 26 555,464 433,987
Payables and accruals for capital expenditure — 278,063 276,809
Other trade payables — 202,707 194,691
Amounts due to joint venture partners — 97,919 52,180
Accrued interest and other expenses — 228,360 173,609
Current income tax liabilities — 79,861 93,364
Dividend payable 28 — 134,747
Provisions and other current liabilities 27 242,457 210,385
Total current liabilities 1,684,831 1,569,772
Liabilities directly associated with assets held for sale 6 60,767 43,582
Total liabilities 3,836,106 3,680,888
Total equity and liabilities 6,995,117 5,991,018
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Consolidation and Accounting Policies
(in part)
2.18 Leases
The determination of whether an arrangement is, or contains,
a lease is based on the substance of the arrangement and
requires an assessment of whether the fulfillment of the ar-
rangement is dependent on the use of a specific asset or
assets and the arrangement conveys a right to use the asset.
Finance leases, which transfer to the Group substantially
all the risks and benefits incidental to ownership of the leased
item, are capitalized at the inception of the lease at the fair
value of the leased property or, if lower, at the present value
of the minimum lease payments. Lease payments are ap-
portioned between the finance charges and reduction of the
lease liability so as to achieve a constant rate of interest on
the remaining balance of the liability. Finance charges are
charged directly against income. Where a finance lease re-
sults from a sale and leaseback transaction, any excess of
sales proceeds over the carrying amount of the assets is de-
ferred and amortised over the lease term.
Capitalized leased assets are depreciated over the shorter
of the estimated useful lives of the assets, or the lease term
if there is no reasonable certainty that the Group will obtain
ownership by the end of the lease term.
Operating lease payments are recognized as expenses in
the consolidated income statement on a straight-line basis
over the lease term.
26. Borrowings (in part)




10% Senior Notes — 454,477
Other debt and financing 2,352,036 1,892,410
Total borrowings 2,352,036 2,346,887
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The following table provides details of net debt change for
the years 2010, 2009 and 2008:
2010 2009 2008
US$’000 US$’000 US$’000
Net debt at the beginning of the year 722,935 1,483,831 659,694
Cash items
Proceeds from issuance of debt and other financing 1,147,585 627,872 1,206,607
Repayment of debt and other financing (1,396,997) (506,588) (664,294)
Net (increase) decrease in cash and cash equivalents 487,675 (836,967) 500,402
(Purchase) disposal of time deposits 46,953 (50,061) —
(Purchase) disposal of pledged deposits 2,462 (45,652) 4,027
Non-cash items
Vendor financing and finance leases (see note 30) 90,779 45,399 48,632
Interest accretion 31,825 20,908 30,532
10% Senior Notes adjustment — — (28,545)
Conversion of the 4% Convertible Notes — — (176,247)
Debt acquired in acquisition of subsidiaries — 25,962 3,387
Other 77,249 (95,637) (19,469)
Exchange movement on debt and other financing 57,753 53,868 (80,895)
Net debt at the end of the year 1,268,219 722,935 1,483,831
(vi) Ghana
In December 2007 Millicom (Ghana) Limited, Millicom’s oper-
ation in Ghana, entered into a $60 million local 5 year Facility.
The loan bears interest at $ LIBOR plus 2%. In parallel a $80
million offshore 7 year DFI (Development Finance Institution)
financing which bears interest at $ LIBOR plus 2.25% was ar-
ranged. As at December 31, 2010, $102 million (2009: $132
million) was outstanding under these facilities.
In December 2009 the operation entered into a 3.5 year $22
million Ericsson arranged financing with EKN and Nordea
priced at $ LIBOR + 0.85% fully guaranteed by the Com-
pany. As at December 31, 2010, $15 million was outstanding
under this facility (2009: $6 million).
In January 2010, the operation signed a sale and lease-
back agreement with Helios Towers Ghana, a direct sub-
sidiary of Helios Towers Africa, for most of its cell sites, to
be transferred to Helios Towers in 2010 and 2011. As at De-
cember 31, 2010, $41 million was outstanding on the finance
lease as part of the lease back agreement.
31. Commitments and Contingencies (in part)
Lease Commitments
Operating Leases:
The Group has the following annual operating lease commit-




Within: one year 63,375 66,223
Between: one to five years 235,195 226,289
After: five years 143,390 139,894
Total 441,960 432,406
Operating leases comprise mainly of lease agreements re-
lating to land and buildings. The operating lease terms and
conditions reflect normal market conditions. Total operating
lease expense from continuing operations was $83 million in
2010 (2009: $73 million, 2008: $59 million—see note 10).
Finance Leases:
The Group’s future minimum payments on finance leases
were $120 million at December 31, 2010 and mainly com-
prised leased towers in Ghana under 12 year leases (see
note 16). Other financial leases are not material and mainly
consist of lease agreements relating to vehicles used by the
Group.
The Group has the following tower finance lease liabilities




Within: one year 6,874 —
Between: one to five years 33,438 —
After: five years 79,430 —
Total 119,742 —
33. Financial Risk Management (in part)
Liquidity Risk
Liquidity risk is defined as the risk that an entity will encounter
difficulty in meeting obligations associated with financial lia-
bilities. The Group has incurred significant indebtedness but
also has significant cash balances. Millicom evaluates its abil-
ity to meet its obligations on an ongoing basis using a recur-
ring liquidity planning tool. This tool considers the operating
net cash flows generated from its operations and the future
cash needs for borrowing and interest payments and capi-
tal and operating expenditures required in maintaining and
developing local business.
The Group manages its liquidity risk through use of bank
overdrafts, bank loans, vendor financing, Export Credit Agen-
cies and Direct Financial Institutions (“DFI”) and finance
leases. Millicom believes that there is sufficient liquidity
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available in our markets to meet ongoing liquidity needs. Ad-
ditionally, Millicom is able to arrange offshore funding through
the use of Export Credit Agency guarantees and DFIs (IFC,
PROPARCO, DEG and FMO), who have been established
specifically to finance development in our markets. Millicom is
diversifying its financing with commercial banks representing
about 70% of its gross financing, Direct Financial Institutions
15%, suppliers 2% and partners 13%. The Group is therefore
not dependent on a few sources of financing but is relying on
various financing opportunities.
IAS 37
IFRSs Overview and Comparison
to U.S. GAAP
2.261 IAS 37 establishes the accounting for most liabilities.
A provision, as stated in IAS 37, is a liability of uncertain
timing or amount. To be recognized as a provision, an obli-
gation must meet the definition of a liability (that is, be a
present obligation resulting from past transactions or events,
settlement of which is probable, and resulting in an outflow
of resources embodying economic benefits) and the entity
should estimate the amount of the obligation reliably. In IAS
37, probable means more likely than not.
2.262 A contingent liability is defined as either a possible
obligation only confirmed by the occurrence or nonoccur-
rence of a future event not wholly in the control of the entity
or a present obligation that fails to meet either the probabil-
ity or measurement reliability criteria. A contingent asset is
a possible asset only confirmed by the occurrence or nonoc-
currence of a future event not wholly in the control of the
entity.
2.263 IAS 37 also establishes the accounting for onerous
contracts and restructuring programs. An onerous contract
is defined as a contract in which the unavoidable costs of
fulfilling the contract terms exceed the expected benefits to
be received. A restructuring program is a program planned
and controlled by management that materially changes either
the scope of an entity’s business activities or the manner in
which it conducts that business.
2.264 Provisions, contingent liabilities, and contingent as-
sets resulting from executory contracts that are not onerous
and those covered by another standard are excluded from
the scope of IAS 37. Examples of provisions covered by an-
other standard are deferred tax liabilities (IAS 12), postem-
ployment benefits (IAS 19, Employee Benefits), construction
contracts (IAS 11), and leases (see IAS 17, with the exception
of operating leases that have become onerous).
2.265 IFRSs require an entity to recognize the cost of a
decommissioning, environmental remediation, and similar
liability as a liability in accordance with IAS 37 and to include
this cost in the cost of the related asset.
2.266 Accounting and disclosure requirements for financial
liabilities are covered in IAS 32, IAS 39, and IFRS 7.
Author’s Note
As evidenced by the findings from a review of the
survey companies, diversity in practice exists in the
use of the term provision. Almost all survey compa-
nies used provision to refer not only to liabilities that
meet the IAS 37 definition but also to such items as
valuation allowances (for example, provision for es-
timated uncollectible receivables) and expenses (for
example, provision for income taxes). The IASB rec-
ognizes this diversity in practice and, in response, ad-
dressed this issue in two exposure drafts, first in 2005
and the second in January 2010. Among other signifi-
cant proposed changes, the exposure draft does not use
provision as a defined term; instead, it proposes to use
the term nonfinancial liability, which includes items
previously described as provisions, as well as other li-
abilities. It would also clarify that IAS 37, except in
specified cases, should be applied to all nonfinancial
liabilities that are not within the scope of other stan-
dards. In November 2010, the IASB and FASB decided
to amend the timetable for some projects that are im-
portant but less urgent than others to allow the boards
to focus on the projects they aim to complete by 30
June, 2011. The project to revise IAS 37, now titled
Liabilities, is one of the projects that the boards do not
expect to readdress until late in 2011.
Recognition and Measurement
IFRSs
2.267 An entity should recognize a provision (liability) only
when it has a present obligation, either legal or constructive,
as a result of a past transaction or event, and the probability
and measurement reliability recognition criteria are met. IAS
37 acknowledges that there may be rare cases when it is
unclear whether a present obligation exists. In these cases,
the entity should recognize a liability if, taking all of the
evidence into account, the existence of a present obligation
is more likely than not.
2.268 An entity should not recognize contingent liabilities
or contingent assets. Once the relevant probability and mea-
surement reliability recognition criteria are met, the asset or
liability is no longer considered contingent.
2.269 In some circumstances (for example, warranty obliga-
tions), an entity should evaluate the probability recognition
criterion with respect to a class of, rather than individual,
obligations. IAS 37 states that the use of estimates is known
to be an essential part of financial statement preparation;
therefore, an entity’s use of estimates does not invalidate
measurement reliability. However, when an entity concludes
that a liability should not be recognized, it should disclose
the obligation as a contingent liability, unless the possibility
of an outflow of resources is remote.
2.270 An entity should measure provisions at the best pre-
tax estimate of the expenditure required to settle the liabil-
ity at the balance sheet date, taking into account the risks
and uncertainties incorporated into that estimate. When no
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estimate in a range is better than another, an entity should
use the midpoint in the range.
2.271 IAS 37 also requires an entity to calculate the present
value of the liability when this would result in a material dif-
ference from the sum of the gross outflows. An entity should
use a pretax interest rate(s) incorporating current market ex-
pectations of the time value of money and risks associated
with this liability. An entity should adjust either future cash
flows or the interest rate for a specific risk, but not both.
2.272 An entity should reflect the effects of expected events
only when there is sufficient evidence that these events will
occur. For example, an entity should only incorporate possi-
ble changes in legislation when it is virtually certain that the
legislation will be passed. An entity should not include any
expected gains from asset disposals in measuring a provision.
2.273 An entity should recognize a reimbursement as a sep-
arate asset, and not a reduction of the liability, only when
receipt of the reimbursement is probable and the amount
can be measured reliably. An entity should not measure a
reimbursement for more than the amount of the related lia-
bility. However, on the statement of comprehensive income,
an entity may show the expense related to the liability net
of the reimbursement income. An entity should review its
provisions at each balance sheet date and adjust them to its
current best estimate of the settlement amount. When it is no
longer probable that a settlement will occur, the entity should
reverse the provision.
2.274 An entity should not use a provision for expenditures,
other than those originally intended.
2.275 IAS 37 includes specific requirements for future op-
erating losses and onerous contracts. An entity should not
recognize a liability for future operating losses. When a con-
tract becomes onerous, an entity should recognize a liability
and measure it in accordance with this standard. However,
before recognizing this liability, the entity should test any
assets related to the contract for impairment and recognize
an impairment loss when necessary.
2.276 IAS 37 requires an entity to satisfy additional criteria
before recognizing provisions for a restructuring program.
An entity should have a detailed formal plan, and the plan
must include, at a minimum, the business concerned, affected
locations, location, function, approximate number of em-
ployees to receive compensation under the plan, planned ex-
penditures, and timing of implementation. The entity should
also have created a valid expectation in the employees af-
fected either by announcing the plan or starting implemen-
tation. An entity should not consider management or board
decisions that occurred before the balance sheet date to be
sufficient by themselves to create a constructive obligation
and, therefore, should not recognize restructuring provisions
under those circumstances.
2.277 Only when there is a binding sales agreement should
an entity recognize a provision for the sale of an operation. In
addition, an entity should recognize provisions only for di-
rect expenditures required by the restructuring and not those
connected to continuing operations. For example, an entity
should not recognize provisions for retraining employees for
other positions in the entity, for marketing, or for acquisition
or development of new systems or technology.
U.S. GAAP
2.278 Unlike IFRSs, FASB ASC does not consolidate its
guidance on accounting for a wide variety of liabilities in
one topic. Recognition, measurement, and disclosure require-
ments are dispersed across many topics. In addition, unlike
IFRSs, FASB ASC provides transaction-specific guidance
on accounting for noncash payments, restructurings, foreclo-
sures, unclaimed wages, deposits on returnable containers,
advance sales, dealer reserves, coupons and similar promo-
tions, and energy trading contracts.
2.279 FASB ASC 405-20-40-1 prescribes the following
criteria for derecognition (extinguishment) of a liability:
• Debtor pays the creditor and is relieved of its obligation.
• Debtor is legally released as the primary obligor under
the liability, either judicially or by the creditor.
Therefore, it can be inferred that like IFRSs, an entity can
only charge against the liability (provision) expenditures re-
lated to its original nature. Netting expenditures against a li-
ability (provision) that was originally recognized for another
purpose would conceal the impact of two different liabilities.
2.280 Although the accounting results may be similar,
the FASB ASC glossary and IFRSs definitions of, and ap-
proaches to, a contingency are different. IFRSs address the
issue from the perspective of asset or liability recognition on
the balance sheet, and FASB ASC 450, Contingencies, ad-
dresses the issue from the perspective of gain or loss recog-
nition in the income statement. As defined by the FASB ASC
glossary, a contingency is an existing condition, situation, or
set of circumstances involving uncertainty concerning pos-
sible gain (gain contingency) or loss (loss contingency) to
an entity that will ultimately be resolved when one or more
future events occur or fail to occur.
2.281 FASB ASC 450-20-25-2 requires an entity to rec-
ognize an estimated loss from a loss contingency in income
only when the following two conditions are met:
• Information is available before the financial statements
are issued or are available to be issued indicating it is
probable (that is, the future event(s) are likely to occur,
as defined in the FASB ASC glossary) that an asset has
been impaired or liability incurred as of the balance
sheet date, with the implicit understanding that it is
probable that a future event(s) will occur to confirm the
loss.
• Amount of the loss can be reasonably estimated.
Despite the similarity in these conditions to those in IAS
37, IFRSs recognize that financial statements deal with the
financial position of an entity at the end of its reporting period
and not its possible position in the future. Therefore, under
IFRSs, a liability should not be recognized for costs that
an entity needs to incur to operate in the future. The only
liabilities that an entity should recognize in its statement
of financial position are those that exist at the end of the
reporting period.
2.282 FASB ASC 450-20-50-5 also expresses a preference
for disclosure when the amount cannot be reasonably es-
timated (see discussion of disclosure requirements starting
with paragraph 2.298).
2.283 In accordance with FASB ASC 450-20-30-1, when
one estimate within a range is better than others, an entity
should measure the loss and liability at that amount. When
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no estimate is better than another, an entity should use the
minimum in the range, whereas IFRSs require the entity to
use the midpoint.
2.284 Unlike IFRSs, FASB ASC 460-10-25-5 considers
warranties a contingency. Therefore, an entity should meet
the two conditions described in paragraph 2.281 before rec-
ognizing a loss and related liability. FASB ASC 460-10 con-
tains additional guidance concerning the items that an entity
should consider in order to meet the probability recognition
criteria, including references to the entity’s own and others’
experience. FASB ASC also provides more specific guidance
for extended warranties and product maintenance contracts,
which are not discussed in IFRSs.
2.285 FASB ASC 450-30-25-1 usually does not permit
recognition of gain contingencies because to do so might be to
recognize revenue before its realization. Unlike IFRSs, FASB
ASC 450-30-50-1 does not contain a probability threshold
that an entity should meet before disclosure.
2.286 FASB ASC 410, Asset Retirement and Environmental
Obligations, contains extensive guidance on accounting for
asset retirement obligations, including scope, recognition and
measurement rules, and disclosures that far exceed those in
IFRSs.
2.287 IAS 37 includes specific conditions that must be met
before an entity can recognize restructuring liabilities. FASB
ASC refers to these liabilities as exit and disposal activities,
and with the exception of one-time liabilities for employee
termination benefits, FASB ASC 420-10-25-1 requires an
entity to recognize a liability for a cost associated with these
activities in the period that the liability is incurred, measured
at fair value. When fair value cannot be reasonably esti-
mated, an entity should defer recognition until it can make a
reasonable estimate. Paragraphs 2–3 of FASB ASC 420-10-
30 express a preference for quoted market prices followed
by present value techniques to make the estimate; however,
it does not preclude the use of other techniques and compu-
tational shortcuts when consistent with fair value measure-
ments.
2.288 However, in the case of one-time employee termi-
nation benefits, paragraphs 4–10 of FASB ASC 420-10-25
explain that such an arrangement exists only when the entity
has communicated the arrangement to the affected employees
and the date of the termination plan meets several conditions,
including management approval. Many are similar to the con-
ditions in IAS 37. However, FASB ASC 420-10-25 contains
additional conditions that affect the timing of measurement
of the termination benefit liability, including a minimum re-
tention period not exceeding the legal notification period or,
in its absence, 60 days. For example, FASB ASC 420-10-25-
9 explains that when an entity requires employees to render
services until termination in order to receive benefits and the
retention period exceeds the minimum, it recognizes the lia-
bility at the communication date but measures fair value as
of the termination date. The entity should then recognize the
termination benefits ratably over the future service period. In
all other cases, the entity recognizes and measures the fair
value of the liability at the communication date. IFRSs do
not include this specific guidance.
2.289 Like IFRSs, FASB ASC 420-10-25-3 does not permit
recognition of anticipated future operating losses because
such losses do not meet the definition of a liability. An entity




2.290 IAS 1 requires entities to present trade and other
payables and provisions as a separate line item on the bal-
ance sheet, disaggregated into their current and noncurrent
components. An entity should also present additional line
items, headings, and subtotals when they are relevant to an
understanding of the entity’s financial position.
2.291 IFRS 5 requires an entity to present separately lia-
bilities associated with disposal groups classified as held for
sale and discontinued operations.
U.S. GAAP
2.292 U.S. GAAP has more specific guidance than IFRSs
on presentation of current liabilities. SEC guidance in Reg-
ulation S-X permits aggregation on the financial statements
and requires more disaggregated disclosures either on the
face of the financial statements or in the notes. (See, for
example, sections 210.5-01 through 210.5-04 of SEC Regu-
lation S-X for guidance relevant to commercial and industrial
companies.)
2.293 FASB ASC 210-20 contains similar criteria to IFRSs
permitting offsetting of assets and liabilities only when the
entity has both a legal right to settle net and the intention




2.294 For each class of provision, IAS 37 requires an en-
tity to disclose a description of the nature of the provision
and the expected timing of settlements. An entity should
also discuss any uncertainties in these estimates, including
major assumptions about future events. An entity should dis-
close the amount of expected reimbursements, including any
amount recognized as an asset.
2.295 An entity should also provide reconciliations of
the beginning and ending balance for each class of provi-
sion. Changes in the provision should include the following
changes to the accounts: additions to, and increases in, provi-
sions; charges against the provision; reversals; and unwind-
ing of the discount rate when provisions have been measured
at present value. Comparative information is not required.
2.296 Unless the possibility of an outflow is remote, an
entity should disclose a brief description of each class of
contingent liability. When practicable, this disclosure should
include an estimate of financial impact, a discussion of un-
certainties relating to possible outflows, and the possibility
of reimbursement. Only when the probability of an inflow
of benefits is probable should an entity disclose information
about contingent assets and, when practicable, an estimate
of the expected financial impact. When the impracticability
exception is used, an entity should disclose that fact.
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2.297 Finally, IAS 37 recognizes that disclosure of some
of the required information on contingent liabilities can have
a prejudicial effect on litigation or other disputes. In those
cases, the entity need not disclose all of the required informa-
tion. However, the general nature of the contingency should
be disclosed and described, together with the reason why the
entity has not provided the remaining information.
U.S. GAAP
2.298 FASB ASC 210-10-45-5 requires an entity to present
the total amounts of current liabilities on a classified balance
sheet. An entity has considerable discretion concerning how
much disaggregation to present on the face of the statement
or in the notes. Regulation S-X contains requirements for dis-
aggregating different types of obligations and classification
as current or noncurrent. As previously noted, Regulation S-
X requires specific disaggregation of balance sheet line items
either on the face of the relevant financial statements or in
the notes.
2.299 Several FASB ASC topics discuss asset retirement
costs and obligations: FASB ASC 360, 410-20, and 450.
With respect to asset retirement obligations, see disclosure
guidance within FASB ASC 410-20-50 and SEC Codification
of Staff Accounting Bulletins topic 5(Y), “Accounting and
Disclosures Related to Loss Contingencies.” For example, an
entity should disclose whether the liability has been measured
at present value and, if so, it should disclose information
about the present value technique used, in accordance with
FASB ASC 820-10-50.
2.300 When the asset retirement obligation is a loss con-
tingency, an entity should disclose the same information that
it would disclose for all loss contingencies, including the
nature of the contingency, the amount of any accruals, and
the reasons why an accrual has not been made, as described
in FASB ASC 450-20-50. As noted previously, FASB ASC
450-30-50-1 does not prohibit disclosure of a contingency
that might result in a gain, but it does state that an entity
should exercise caution so as not to be misleading about the
likelihood of realization.
2.301 Like IFRSs, FASB ASC 420-10-50-1 requires an
entity to disclose a description of exit and disposal activi-
ties. However, although it is likely that a restructuring would
constitute a major class of provision, unlike FASB ASC,
IFRSs do not specifically require separate reconciliations of
the major costs in a restructuring. FASB ASC 420-10-50-1
also requires disclosure of information about these activities
by reportable operating segment and the line item(s) on the
income statement that contains these costs.
Author’s Note
See also the discussion in paragraph 2.350 of the re-
quirement to disclose a reconciliation of liabilities rec-
ognized for termination benefits that are a major part
of exit and disposal activities.
Presentation and Disclosure Excerpts
Warranty, Restructuring, Product
Infringement, Project Loss and Tax
Provisions
2.302
Nokia Corporation (Dec 2010)







Current portion of long-term
loans 16,35 116 44
Short-term borrowings 16,35 921 727
Other financial liabilities 16,17,35 447 245
Accounts payable 16,35 6,101 4,950
Accrued expenses and other
liabilities 26 7,365 6,504
Provisions 27 2,590 2,718
17,540 15,188
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Principles (in part)
Provisions (in part)
Provisions are recognized when the Group has a present le-
gal or constructive obligation as a result of past events, it
is probable that an outflow of resources will be required to
settle the obligation and a reliable estimate of the amount
can be made. Where the Group expects a provision to be
reimbursed, the reimbursement is recognized as an asset
only when the reimbursement is virtually certain. At each bal-
ance sheet date, the Group assesses the adequacy of its
pre-existing provisions and adjusts the amounts as necessary
based on actual experience and changes in future estimates.
Warranty Provisions
The Group provides for the estimated liability to repair or
replace products under warranty at the time revenue is rec-
ognized. The provision is an estimate calculated based on
historical experience of the level of volumes, product mix and
repair and replacement cost.
Intellectual Property Rights (IPR) Provisions
The Group provides for the estimated future settlements re-
lated to asserted and unasserted past alleged IPR infringe-
ments based on the probable outcome of potential infringe-
ment.
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Tax Provisions
The Group recognizes a provision for tax contingencies based
upon the estimated future settlement amount at each balance
sheet date.
Restructuring Provisions
The Group provides for the estimated cost to restructure when
a detailed formal plan of restructuring has been completed
and the restructuring plan has been announced by the Group.
Other Provisions
The Group recognizes the estimated liability for non-
cancellable purchase commitments for inventory in excess
of forecasted requirements at each balance sheet date.
The Group provides for onerous contracts based on the
lower of the expected cost of fulfilling the contract and the
expected cost of terminating the contract.
Use of Estimates and Critical Accounting Judgments
The preparation of financial statements in conformity with
IFRS requires the application of judgment by management
in selecting appropriate assumptions for calculating financial
estimates, which inherently contain some degree of uncer-
tainty. Management bases its estimates on historical experi-
ence, expected outcomes and various other assumptions that
are believed to be reasonable under the circumstances, the
results of which form the basis for making judgments about
the reported carrying values of assets and liabilities and the
reported amounts of revenues and expenses that may not
be readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or
conditions.
Set forth below are areas requiring significant judgment
and estimation that may have an impact on reported results
and the financial position.
Warranty Provisions
The Group provides for the estimated cost of product war-
ranties at the time revenue is recognized. The Group’s war-
ranty provision is established based upon best estimates of
the amounts necessary to settle future and existing claims on
products sold as of each balance sheet date. As new prod-
ucts incorporating complex technologies are continuously in-
troduced, and as local laws, regulations and practices may
change, changes in these estimates could result in addi-
tional allowances or changes to recorded allowances being
required in future periods.
Provision for Intellectual Property Rights, or IPR,
Infringements
The Group provides for the estimated future settlements re-
lated to asserted and unasserted past alleged IPR infringe-
ments based on the probable outcome of potential infringe-
ment. IPR infringement claims can last for varying periods of
time, resulting in irregular movements in the IPR infringement
provision. The ultimate outcome or actual cost of settling an
individual infringement may materially vary from estimates.
Income Taxes
Management judgment is required in determining current tax
expense, tax provisions, deferred tax assets and liabilities
and the extent to which deferred tax assets can be recog-
nized. Each reporting period they are assessed for realizabil-
ity and when circumstances indicate it is no longer probable
that deferred tax assets will be utilized, they are adjusted as
necessary. If the final outcome of these matters differs from
the amounts initially recorded, differences may impact the in-




Warranty Restructuring Infringements Losses Tax Other Total
EURm EURm EURm EURm EURm EURm EURm
At January 1, 2009 1,375 356 343 245 460 813 3,592
Exchange differences (13) — — — — — (13)
Additional provisions 793 268 73 269 139 344 1,886
Change in fair value — — — — — (1) (1)
Changes in estimates (178) (62) (9) (63) (325) (174) (811)
Charged to profit and loss account 615 206 64 206 (186) 169 1,074
Utilized during year (1,006) (378) (17) (254) 0 (280) (1,935)
At December 31, 2009 971 184 390 197 274 702 2,718
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IPR Project
Warranty Restructuring Infringements Losses Tax Other Total
EURm EURm EURm EURm EURm EURm EURm
At January 1, 2010 971 184 390 197 274 702 2,718
Exchange differences 40 — — — — — 40
Additional provisions 888 228 106 239 40 238 1,739
Changes in estimates (43) (44) (15) (52) (13) (87) (254)
Charged to profit and loss account 845 184 91 187 27 151 1,485
Utilized during year (928) (173) (32) (177) (5) (338) (1,653)
At December 31, 2010 928 195 449 207 296 515 2,590
2010 2009
EURm EURm
Analysis of total provisions at December 31:
Non-current 837 841
Current 1,753 1,877
Outflows for the warranty provision are generally expected to
occur within the next 18 months. Timing of outflows related to
tax provisions is inherently uncertain. In 2009, tax provisions
decreased due to the positive development and outcome of
various prior year items.
The restructuring provision is mainly related to restructuring
activities in Devices & Services and Nokia Siemens Networks
segments. The majority of outflows related to the restructuring
is expected to occur during 2011.
In 2010, Devices & Services recognized restructuring provi-
sions of EUR 85 million mainly related to changes in Symbian
Smartphones and Services organizations as well as certain
corporate functions that are expected to result in a reduc-
tion of up to 1,800 employees globally. In 2009, Devices &
Services recognized restructuring provisions of EUR 208 mil-
lion mainly related to measures taken to adjust our business
operations and cost base according to market conditions.
Restructuring and other associated expenses incurred in
Nokia Siemens Networks in 2010 totaled EUR 316 million
(EUR 310 million in 2009) including mainly personnel related
expenses as well as expenses arising from the elimination of
overlapping functions, and the realignment of product port-
folio and related replacement of discontinued products in
customer sites. These expenses included EUR 173 million
(EUR 151 million in 2009) impacting gross profit, EUR 19
million (EUR 30 million in 2009) research and development
expenses, EUR 21 million reversal of provision (EUR 12 mil-
lion in 2009) in selling and marketing expenses, EUR 76 mil-
lion (EUR 103 million in 2009) administrative expenses and
EUR 27 million (EUR 14 million in 2009) other operating ex-
penses. EUR 510 million was paid during 2010 (EUR 514
million during 2009).
Provisions for losses on projects in progress are related
to Nokia Siemens Networks’ onerous contracts. Utilization of
provisions for project losses is generally expected to occur in
the next 18 months.
The IPR provision is based on estimated future settle-
ments for asserted and unasserted past IPR infringements.
Final resolution of IPR claims generally occurs over several
periods.
Other provisions include provisions for non-cancelable pur-
chase commitments, product portfolio provisions for the align-
ment of the product portfolio and related replacement of dis-
continued products in customer sites and provision for pen-
sion and other social security costs on share-based awards.
In 2010, usage of other provisions mainly relates to product
portfolio provisions. Most of those contracts were signed in
2008 and contract fullfillment occurred primarily in 2009 and
2010.
Onerous Contracts, Store Closings,
and Insurance Provisions
2.303
Delhaize Brothers and Co “The Lion” (Delhaize
Group) SA (Dec 2010)
CONSOLIDATED BALANCE SHEET (in part)
Consolidated Liabilities and Equity (in part)
(In Millions of EUR) Note 2010 2009 2008
Long-term debt 18.1 1,966 1,904 1,766
Obligations under finance leases 18.3 684 643 643
Deferred tax liabilities 22 543 227 215
Derivative instruments 19 16 38 —
Provisions 20, 21 233 228 226
Other non-current liabilities 68 57 68
Total non-current liabilities 3,510 3,097 2,918
Short-term borrowings 18.2 16 63 152
Long-term debt—current portion 18.1 40 42 326
Obligations under finance leases 18.3 57 44 44
Derivative instruments 19 — 2 —
Provisions 20, 21 52 52 49
Income tax payable 17 65 98
Accounts payable 1,574 1,436 1,383
Accrued expenses 23 393 397 378
Other current liabilities 174 141 154
2,323 2,242 2,584
Liabilities associated with assets
held for sale 5.2 — — 3
Total current liabilities 2,323 2,242 2,587
Total liabilities 5,833 5,339 5,505
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2.3. Summary of Significant Accounting Policies
(in part)
Provisions (in part)
Provisions are recognized when the Group has a present le-
gal or constructive obligation as a result of past events, it
is more likely than not that an outflow of resources will be
required to settle the obligation, and the amount can be reli-
ably estimated. Provisions are measured at the balance sheet
date using management’s best estimate of the expenditures
expected to be required to settle the obligation, discounted
using a pre-tax discount rate that reflects the current market
assessments of the time value of money and the risk spe-
cific on the liability, if material. Where discounting is used,
the increase in the provision due to the passage of time (“un-
winding of the discount”) is recognized within “Finance costs”
(Note 29.1).
Store closing costs: Delhaize Group regularly reviews its
stores’ operating performance and assesses the Group’s
plans for certain store closures. Closing stores results in a
number of activities required by IFRS in order to appropriately
reflect the value of assets and liabilities and related store clos-
ing costs, such as a review of net realizable value of inventory
or review for impairment of assets or cash-generating units
(for both activities see accounting policies described above).
In addition, Delhaize Group recognizes “Closed store pro-
visions,” which consist primarily of provisions for onerous
contracts and severance (“termination”) costs (for both see
further below). Costs recognized as part of store closings
are included in “Other operating expenses” (Note 28), ex-
cept for inventory write-downs, which are classified as “Cost
of sales” (Note 25). If appropriate (see accounting policy for
“Non-Current Assets/Disposal Groups and Discontinued Op-
erations” above), stores are accounted for in accordance with
IFRS 5 Non-current Assets Held for Sale and Discontinued
Operations.
Onerous contracts: IAS 37 Provisions, Contingent Liabil-
ities and Contingent Assets requires the recognition of a
provision for a present obligation arising under an onerous
contract, which is defined as a contract in which the unavoid-
able costs of meeting the obligations under the contract ex-
ceed the economic benefits expected to be received under
it. Judgment is required in determining if a present obliga-
tion exists, taking into account all available evidence. Once
the existence has been established, at the latest upon actual
closing, Delhaize Group recognizes provisions for the present
value of the amount by which the unavoidable costs to ful-
fill the agreements exceeds the expected benefits from such
agreements, which comprises the estimated non-cancellable
lease payments, including contractually required real estate
taxes, common area maintenance and insurance costs, net
of anticipated subtenant income. The adequacy of the closed
store provision is dependent upon the economic conditions in
which stores are located which will impact the Group’s ability
to realize estimated sublease income. Owned and finance
leased stores that are closed and rented out to third-parties
are reclassified as investment property (Note 9).
When termination costs are incurred in connection with a
store closing, a liability for the termination benefits is recog-
nized in accordance with IAS 19 Employee Benefits, when
the Group is demonstrably committed to the termination for
the estimated settlement amount, which is when the imple-
mentation of a formal plan has started or the main features
have been announced to those affected (see also “Employee
Benefits” below).
Store closing provisions are reviewed regularly to ensure
that accrued amounts appropriately reflect management’s
best estimate of the outstanding commitments and that addi-
tional expenses are provided for or amounts that are no longer
needed for their originally intended purpose are released.
Self-insurance: Delhaize Group is self-insured for work-
ers’ compensation, general liability, vehicle accidents, phar-
macy claims, health care and property insurance in the United
States. The self-insurance liability is determined actuarially,
based on claims filed and an estimate of claims incurred but
not reported. Excess loss protection above certain maximum
retained exposures is provided by external insurance compa-
nies.
Critical Accounting Estimates (in part)
Self Insurance
As explained in Note 20.2 to our consolidated financial state-
ments, included under Item 18 of this document, in the United
States we are self-insured for workers’ compensation, gen-
eral liability, vehicle accident and pharmacy claims up to a
certain retention and we hold excess-insurance contracts with
external insurers for any costs in excess of these retentions.
Our self-insurance liability is determined actuarially, based
on claims filed and an estimate of claims incurred but not
reported (“IBNR”). The significant assumptions used in the
development of the actuarial estimates are based upon our
historical claims data, including the average monthly claims
and the average duration between incurrence and payment.
In addition, our property insurance in the United States
includes self-insured retentions per occurrence of $10 million
for named windstorms, $5 million for Zone A flood losses and
$2.5 million for all other losses.
We are also self-insured in the United States for health care
which includes medical, pharmacy, dental and short-term dis-
ability. The self-insurance liability for IBNR claims is estimated
quarterly by management based on available information and
considers an annual actuarial evaluation based on historical
claims experience, claims processing procedures and medi-
cal cost trends.
Actuarial estimates are subject to a high degree of uncer-
tainty due to, among other things, changes in claim reporting
patterns, claim settlement patterns, judicial decisions, legis-
lation and economic conditions. We believe that the actuarial
estimates are reasonable and represent our best estimate
of the total exposure. However, it lays in the nature of such
estimates that significant differences between actual and es-
timates could materially affect our self-insurance obligations.
Closed Store Provisions
We regularly review the operational performance of our retail
stores and make assessments of the future developments of
the various stores. In some cases, we decide to close stores,
which results in a number of accounting activities in order to
ensure that assets and liabilities resulting from these deci-
sions are appropriately reflected in our financial statements.
This involves testing assets for impairment, see above, but
also the recognition of closed store and severance (“termina-
tion”) provisions.
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The provision for closed stores expenditures is estimated
based on remaining lease obligations, expected sub-lease
income and exit costs associated with store closing commit-
ments. Other exit costs include estimated utilities, real estate
taxes, common area maintenance and insurance costs to be
incurred after the store closes, all of which are contractually
required payments under the lease agreements, over the re-
maining lease term.
The estimates are based on past experience and are re-
viewed regularly to ensure that accrued amounts continue to
reflect our best estimate of the outstanding commitments. It
is in the nature of such estimates that actual amounts differ
from the estimates. Adjustments to closed store provisions
and other exit costs primarily relate to changes in subtenant
income and actual exit costs differing from original estimates.
Such adjustments are made in the period in which the change
becomes known. Any excess store closing provision remain-
ing upon settlement of the obligation is reversed in the period
that such settlement is determined.
Calculating the estimated store closing losses requires sig-
nificant judgments and estimates that could be impacted by
factors such as the extent of interested buyers, the ability
to obtain subleases, the creditworthiness of sublessees, and
our success at negotiating early termination agreements with
lessors. These factors are significantly dependent on gen-
eral economic conditions and resulting demand for commer-
cial property. Finally, applying an appropriate discount rate
on long-term cash flow projection requires the application of
judgment.
Varying the discount rate applied by 200 basis points
would have resulted in an immaterial increase/decrease of
expenses charged to profit or loss for 2010 store closing activ-
ities and increased/decreased the total closed store provision
by €4 million.
20.1. Closed Store Provisions
As explained in Note 2.3, Delhaize Group records closed
store provisions for present obligations in connection with
store closing activities, which consist primarily of provisions
for onerous contracts and severance (“termination”) costs.
The amounts recognized reflect management’s best estimate
of the expected expenditures required to settle the present
obligation at balance sheet date and requires the application
of judgment and estimates that could be impacted by factors
such as the discount rate applied, the ability to sub-lease, the
creditworthiness of the sub-lessee or the success when nego-
tiating any early termination of lease agreements. Most of the
factors are significantly dependent on general economic con-
ditions and the interrelated demand for commercial property.
Consequently, the cash flows projected, and the risk reflected
in those, might change, if applied assumptions change.
Most obligations recognized relate to onerous lease con-
tracts, predominately for stores located in the United States,
with remaining lease terms ranging from one to 18 years.
The average remaining lease term for closed stores was 5.2
years at December 31, 2010. During 2010, 2009 and 2008,
only minor amounts relate to termination benefits.
The following table reflects the activity related to closed
store provisions:
(In Millions of EUR) 2010 2009 2008
Closed store provision at January 1 54 51 51
Additions:
Store closings—lease obligations 1 10 6
Store closings—other exit costs — 2 2
Update of estimates 1 5 1
Interest expense (unwinding of discount) 4 4 4
Utilization:
Lease payments made (14) (14) (11)
Lease terminations (5) (1) (3)
Payments made for other exit costs (2) — (2)
Transfer to other accounts — (1) —
Currency translation effect 5 (2) 3
Closed store provision at December 31 44 54 51
During 2010, 2009 and 2008, Delhaize Group recorded addi-
tions to the closed store provision of EUR 1 million, EUR 12
million and EUR 8 million respectively, primarily related to 7,
32 and 19 store closings, respectively, made in the ordinary
course of business.
The following table presents a reconciliation of the number
of closed stores included in the closed store provision:
Number of
Closed Stores
Balance at January 1, 2008 168
Store closings added 19
Stores sold/lease terminated (38)
Balance at December 31, 2008 149
Store closings added 32
Stores sold/lease terminated (35)
Balance at December 31, 2009 146
Store closings added 7
Stores sold/lease terminated (49)
Balance at December 31, 2010 104
Expenses relating to closed store provisions were recorded
in the income statement as follows:
(In Millions of EUR) Note 2010 2009 2008
Other operating expenses 28 2 17 9
Interest expense included in “Finance
costs” 29.1 4 4 3
Results from discontinued operations 5.3 — — 1
Total 6 21 13
20.2. Self-Insurance Provision
Delhaize Group’s U.S. operations are self-insured for their
workers’ compensation, general liability, vehicle accident and
pharmacy claims up to certain retentions and holds excess-
insurance contracts with external insurers for any costs in
IFRS ATT 2.303
237Section 2: Statement of Financial Position and Related Disclosures
excess of these retentions. The self-insurance liability is de-
termined actuarially, based on claims filed and an estimate
of claims incurred but not reported. The assumptions used in
the development of the actuarial estimates are based upon
historical claims experience, including the average monthly
claims and the average lag time between incurrence and pay-
ment.
The maximum retentions, including defense costs per oc-
currence, are:
• USD 1.0 million per accident for workers’ compensation;
• USD 3.0 million per occurrence for general liability,
• USD 3.0 million per accident for vehicle accident, and
• USD 5.0 million per occurrence for pharmacy claims.
Our property insurance in the United States includes self-
insured retentions per occurrence of USD 10 million for
named windstorms, USD 5 million for Zone A flood losses
and USD 2.5 million for all other losses.
Delhaize Group is also self-insured in the U.S. for health
care, which includes medical, pharmacy, dental and short-
term disability. The self-insurance liability for claims incurred
but not reported is based on available information and con-
siders annual actuarial evaluations of historical claims experi-
ence, claims processing procedures and medical cost trends.
The movements of the self-insurance provision can be
summarized as follows:
(In Millions of EUR) 2010 2009 2008
Self-insurance provision at January 1 108 122 111
Expense charged to earnings 179 158 153
Claims paid (174) (169) (148)
Currency translation effect 8 (3) 6
Self-insurance provision at December 31 121 108 122
Actuarial estimates are judgmental and subject to uncertainty,
due to, among many other things, changes in claim report-
ing patterns, claim settlement patterns or legislation. Man-
agement believes that the assumptions used to estimate the
self-insurance provision are reasonable and represent man-
agement’s best estimate of the expenditures required to settle
the present obligation at the balance sheet date. Nonetheless,
it is in the nature of such estimates that the final resolution
of some of the claims may require making significant expen-
ditures in excess of the existing provisions over an extended





Royal Dutch Shell plc (Dec 2010)








Debt 16 34,381 30,862
Deferred tax 17 13,388 13,838
Retirement benefit obligations 18 5,924 5,923
Other provisions 19 14,285 14,048
Other 20 4,250 4,586
72,228 69,257
Current liabilities
Debt 16 9,951 4,171
Accounts payable and accrued
liabilities 21 76,550 67,161
Taxes payable 17 10,306 9,189
Retirement benefit obligations 18 377 461
Other provisions 19 3,368 3,807
100,552 84,789
Total liabilities 172,780 154,046
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Accounting Policies (in part)
Property, Plant and Equipment and Intangible Assets (in
part)
A—Recognition
Property, plant and equipment, including expenditure on ma-
jor inspections, and intangible assets are initially recognised
in the Consolidated Balance Sheet at cost where it is prob-
able that they will generate future economic benefits. This
includes capitalisation of decommissioning and restoration
costs associated with provisions for asset retirement (see
“Provisions”), certain development costs (see “Research and
development”) and the effects of associated cash flow hedges
(see “Derivative contracts”) as applicable. The accounting for
exploration costs is described separately below (see “Explo-
ration costs”). Intangible assets include goodwill, capitalised
software costs and trademarks. Interest is capitalised, as an
increase in property, plant and equipment, on major capital
projects during construction.
Property, plant and equipment and intangible assets are
subsequently carried at cost less accumulated depreciation,
depletion and amortisation (including any impairment). Gains
and losses on disposals are determined by comparing dis-
posal proceeds with the carrying amounts of assets sold and
recognised in income, within interest and other income.
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Provisions
Provisions are recognised at the balance sheet date at
Shell’s best estimate, using risk-adjusted future cash flows,
of the present value of the expenditure required to settle the
present obligation. Non-current amounts are discounted us-
ing the risk-free rate. Specific details for decommissioning
and restoration costs and environmental remediation are de-
scribed below. The carrying amounts of provisions are regu-
larly reviewed and adjusted for new facts or changes in law
or technology.
Provisions for decommissioning and restoration costs,
which are primarily in respect of hydrocarbon production fa-
cilities, are measured on the basis of current requirements,
technology and price levels; the present value is calculated
using amounts discounted over the useful economic life of
the assets. The liability is recognised (together with a corre-
sponding amount as part of the related property, plant and
equipment) once an obligation crystallises in the period when
a reasonable estimate can be made. The effects of changes
resulting from revisions to the timing or the amount of the
original estimate of the provision are reflected on a prospec-
tive basis, generally by adjustment to the carrying amount of
the related property, plant and equipment.
Provisions for environmental remediation resulting from on-
going or past operations or events are recognised in the pe-
riod in which an obligation arises and the amount can be
reasonably estimated. Provisions are measured based on
current legal requirements and existing technology. Recog-
nition of any joint and several liability is based upon Shell’s
best estimate of the final pro rata share of the liability. Pro-
visions are determined independently of expected insurance
recoveries. Recoveries are recognised and reported as sep-
arate events and brought into account when virtually certain
of realisation.
3. Key Accounting Estimates and Judgements (in part)
Decommissioning and Restoration Costs
Provisions are recognised for the future decommission-
ing and restoration of hydrocarbon production facilities and
pipelines at the end of their economic lives. The estimated
cost is recognised in income over the life of the proved devel-
oped reserves on a unit-of-production basis or on a straight-
line basis, as applicable. Changes in the estimates of costs
to be incurred, proved developed reserves or in the rate of
production will therefore impact income, generally over the
remaining economic life of oil and gas assets.
Estimates of the amounts of provisions recognised are
based on current legal and constructive requirements, tech-
nology and price levels. Because actual outflows can differ
from estimates due to changes in laws, regulations, public ex-
pectations, technology, prices and conditions, and can take
place many years in the future, the carrying amounts of pro-
visions are regularly reviewed and adjusted to take account
of such changes. The interest rate used to discount the risk-
adjusted cash flows is reviewed annually, although it has
been stable in recent years.
Information about decommissioning and restoration provi-
sions is presented in Note 19.
17. Taxation (in part)
C—Deferred Taxation
Movements in deferred tax liabilities and assets during the
year, taking into consideration the offsetting balances within










At January 1, 2010 17,768 1,257 (5,185) (2) 13,838
(Credited)/charged to income (281) 350 (217) (454) (602)
Other movements (1,505) 38 1,764 6 303
Currency translation differences (73) (106) 121 (93) (151)
At December 31, 2010 15,909 1,539 (3,517) (543) 13,388
At January 1, 2009 16,022 1,382 (4,494) (392) 12,518
Charged/(credited) to income 641 (360) (433) (196) (348)
Other movements (304) 109 64 594 463
Currency translation differences 1,409 126 (322) (8) 1,205
At December 31, 2009 17,768 1,257 (5,185) (2) 13,838
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At January 1, 2010 1,360 1,606 (915) 2,482 4,533
(Charged)/credited to income (242) 953 30 171 912
Other movements (131) 1,743 (1,502) (126) (16)
Currency translation differences (8) 9 (76) 7 (68)
At December 31, 2010 979 4,311 (2,463) 2,534 5,361
At January 1, 2009 881 1,145 (808) 2,200 3,418
Credited/(charged) to income 224 307 157 (41) 647
Other movements 200 53 (228) 294 319
Currency translation differences 55 101 (36) 29 149
At December 31, 2009 1,360 1,606 (915) 2,482 4,533
Other movements in deferred tax assets and liabilities relate
mainly to acquisitions, divestments, reclassifications between
assets and liabilities and amounts recognised in other com-
prehensive income and directly in equity (see Note 25).
19. Other Provisions
Current Non-Current Total
($ Million) Dec 31, 2010 Dec 31, 2009 Dec 31, 2010 Dec 31, 2009 Dec 31, 2010 Dec 31, 2009
Decommissioning and restoration 1,006 653 12,011 11,633 13,017 12,286
Environmental 325 365 797 891 1,122 1,256
Redundancy 746 1,492 204 157 950 1,649
Litigation 175 201 382 499 557 700
Other 1,116 1,096 891 868 2,007 1,964
Total 3,368 3,807 14,285 14,048 17,653 17,855
Movements in provisions are as follows:
($ Million)
Decommissioning
and Restoration Environmental Redundancy Litigation Other Total
At January 1, 2010 12,286 1,256 1,649 700 1,964 17,855
Additional provisions 224 89 142 103 662 1,220
Amounts charged against provisions (350) (223) (890) (236) (586) (2,285)
Accretion expense 656 31 — 15 45 747
Reclassifications and other movements 361 (28) 93 (19) (67) 340
Currency translation differences (160) (3) (44) (6) (11) (224)
At December 31, 2010 13,017 1,122 950 557 2,007 17,653
At January 1, 2009 10,496 1,163 310 958 2,094 15,021
Additional provisions 265 192 1,535 196 680 2,868
Amounts charged against provisions (424) (189) (171) (489) (776) (2,049)
Accretion expense 638 26 — 9 55 728
Reclassifications and other movements 488 13 (27) 8 (155) 327
Currency translation differences 823 51 2 18 66 960
At December 31, 2009 12,286 1,256 1,649 700 1,964 17,855
The timing and amounts settled in respect of these provisions
are uncertain and dependent on various factors that are not
always within management’s control.
Of the decommissioning and restoration provision at De-
cember 31, 2010, an estimated $4,082 million is expected to
be utilised within one to five years, $4,059 million within six
to ten years, and the remainder in later periods.
Reviews of estimated decommissioning and restoration
costs are carried out annually, which in 2010 resulted in an
increase of $1,297 million (2009: $477 million) in both the
provision, reported within “Reclassifications and other move-
ments,” and the corresponding property, plant and equipment
assets reported within “Sales, retirements and other move-
ments” in Note 9. Offsetting this increase in 2010 was a re-
duction resulting from disposals of assets, primarily in Norway
and the USA, of $924 million.
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Provisions for environmental remediation costs relate to
a number of events in different locations, none of which is
individually significant.
The amounts charged against provisions for redundancy in
2010 mainly relate to payments made to staff leaving Shell as
a result of the restructuring programme announced in 2009.
Provisions for litigation costs at December 31, 2010, relate
to a number of cases, none of which is individually signifi-
cant. Further information is given in Note 27. In 2009, Shell
concluded the settlement of claims arising from the 2004 re-
categorisation of certain hydrocarbon reserves.
Included in other provisions at December 31, 2010, are
$753 million (2009: $750 million) relating to employee end-
of-service benefits.
Environmental and Litigation Provisions
2.305
ArcelorMittal (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)





Short-term debt and current portion of long-term
debt (note 15) 4,135 6,716
Trade accounts payable and other, including 337
and 465 to related parties at December 31, 2009
and 2010, respectively (note 14) 10,676 13,256
Short-term provisions (note 20) 1,433 1,343
Accrued expenses and other liabilities (note 21) 6,922 6,900
Income tax liabilities 314 471
Liabilities held for sale and distribution (note 5) 11 2,037
Total current liabilities 23,491 30,723
Non-current liabilities:
Long-term debt, net of current portion (note 15) 20,677 19,292
Deferred tax liabilities (note 19) 5,144 4,006
Deferred employee benefits (note 23) 7,583 7,180
Long-term provisions (note 20) 2,121 1,738
Other long-term obligations 3,244 1,865
Total non-current liabilities 38,769 34,081
Total liabilities 62,260 64,804
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2: Summary of Significant Accounting Policies
(in part)
Significant Accounting Policies (in part)
Provisions and Accruals
ArcelorMittal recognizes provisions for liabilities and probable
losses that have been incurred when it has a present legal or
constructive obligation as a result of past events and it is prob-
able that the Company will be required to settle the obligation
and a reliable estimate of the amount of the obligation can
be made. If the effect of the time value of money is material,
provisions are discounted using a current pre-tax rate that
reflects, where appropriate, the risks specific to the liability.
Where discounting is used, the increase in the provision due
to the passage of time is recognized as a financing cost. Pro-
visions for onerous contracts are recorded in the statement
of operations when it becomes known that the unavoidable
costs of meeting the obligations under the contract exceed
the economic benefits expected to be received.
Provisions for restructuring relate to the estimated costs
of initiated reorganizations that have been approved by the
Group Management Board “GMB,” and which involve the re-
alignment of certain parts of the industrial and commercial
organization. When such reorganizations require discontinu-
ance and/or closure of lines or activities, the anticipated costs
of closure or discontinuance are included in restructuring pro-
visions. A liability is recognized for those costs only when the
Company has a detailed formal plan for the restructuring and
has raised a valid expectation with those affected that it will
carry out the restructuring by starting to implement that plan
or announcing its main features to those affected by it.
Environmental Costs
Environmental costs that relate to current operations are ex-
pensed or capitalized as appropriate. Environmental costs
that relate to an existing condition caused by past opera-
tions, and which do not contribute to current or future revenue
generation or cost reduction, are expensed. Liabilities are
recorded when environmental assessments and/or remedial
efforts are probable and the cost can be reasonably estimated
based on ongoing engineering studies, discussions with the
environmental authorities and other assumptions relevant to
the nature and extent of the remediation that may be required.
The ultimate cost to ArcelorMittal is dependent upon factors
beyond its control such as the scope and methodology of the
remedial action requirements to be established by environ-
mental and public health authorities, new laws or government
regulations, rapidly changing technology and the outcome of
any potential related litigation. Environmental liabilities are
discounted if the aggregate amount of the obligation and the
amount and timing of the cash payments are fixed or reliably
determinable.
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Note 20: Provisions













Environmental (see note 24) 769 72 (131) — 33 743
Asset retirement obligations 278 49 (2) — 11 336
Restructuring 566 78 (131) 1 (183) 331
Voluntary separation plans(1) 935 280 (685) — (218) 312
Litigation (see note 24) and other(3) 1,601 296 (803) 2 125 1,221
Tax claims 480 125 (183) — 22 444
Competition/Antitrust claims 640 2 (400) — 26 268
Other legal claims 387 169 (220) 2 77 415
Other unasserted claims 94 — — — — 94
Commercial agreements and
onerous contracts 855 471 (1,150) — (2) 174
Other(2) 631 266 (321) 3 (142) 437
5,635 1,512 (3,223) 6 (376) 3,554
Short-term provisions 3,292 — — — — 1,433
Long-term provisions 2,343 — — — — 2,121













Environmental (see note 24) 743 95 (104) — (4) 730
Asset retirement obligations 336 24 (30) — 12 342
Restructuring 331 92 (118) — (68) 237
Voluntary separation plans(1) 312 69 (268) — (32) 81
Litigation (see note 24) and other(3) 1,221 327 (280) — (197) 1,071
Tax claims 444 41 (52) — (159) 274
Competition/Antitrust claims 268 28 (21) — (41) 234
Other legal claims 415 52 (207) — 3 263
Other unasserted claims 94 206 — — — 300
Commercial agreements and
onerous contracts 174 240 (221) — 20 213
Other(2) 437 238 (143) — (125) 407
3,554 1,085 (1,164) — (394) 3,081
Short-term provisions 1,433 — — — — 1,343
Long-term provisions 2,121 — — — — 1,738
3,554 — — — — 3,081
(∗) A movement of (167) is related to the transfer of provisions to liabilities held for sale and distribution.
(1) Voluntary separation plans were announced at the end of 2008 by the Group Management Board and were largely completed in 2009 and
2010. In 2010, new voluntary separation plans were announced in Mexico, Kazakhstan, Ukraine and France. As of December 2010, the
outstanding provision relates to remaining plans primarily in USA, France, Poland, Germany, Bosnia, Mexico, Romania and Czech Republic.
(2) Other includes provisions for technical warranties, guarantees as well as other disputes.
(3) In previously filed financial statements the caption litigation and other was presented as a single line item. In order to provide further
clarity to the class of provisions for litigation, amounts relating to tax claims, competition/antitrust claims, other legal claims, and other
unasserted claims, have been presented separately in the tabular disclosure. The provision presented as “other unasserted claims” relates
to a commercial dispute in respect of which no legal action has commenced.
There are uncertainties regarding the timing and amount of
the provisions above. Changes in underlying facts and cir-
cumstances for each provision could result in differences in
the amounts provided for and the actual outflows. In general,
provisions are presented on a non-discounted basis due to
the uncertainties regarding the timing or the short period of
their expected consumption.
Environmental provisions have been estimated based on
internal and third-party estimates of contaminations, available
remediation technology, and environmental regulations. Esti-
mates are subject to revision as further information develops
or circumstances change. These provisions are expected to
be consumed over a period of 20 years.
Restructuring provisions are mainly related to reorganiza-
tions in France and are expected to be settled within the next
year.
Provisions for litigation related to probable losses that have
been incurred due to a present legal or constructive obligation
are expected to be settled in a period of one to four years.
Discussion regarding legal matters is provided in note 24.
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Provisions for onerous contracts related to unavoidable
costs of meeting obligations exceeding expected economic
benefits under certain contracts.
In addition to existing labor agreements, voluntary sepa-
ration plans which provide incentives for early retirement or
separation from the Company in exchange for cash benefits,
were announced at the end of 2008 and were largely com-
pleted in 2009. As of December 31, 2010, the outstanding
provision relates to remaining plans primarily in France and
Belgium which are expected to be settled over a period of
one to four years.
Other includes provisions for technical warranties, guaran-
tees as well as other disputes.
Note 24: Contingencies (in part)
ArcelorMittal may be involved in litigation, arbitration or other
legal proceedings. Provisions related to legal and arbitration
proceedings are recorded in accordance with the principles
described in note 2.
Most of these claims involve highly complex issues, actual
damages and other matters. Often these issues are subject
to substantial uncertainties and, therefore, the probability of
loss and an estimation of damages are difficult to ascertain.
Consequently, for a large number of these claims, the Com-
pany is unable to make a reasonable estimate of the expected
financial effect that will result from ultimate resolution of the
proceeding. In those cases, the Company has disclosed in-
formation with respect to the nature of the contingency. The
Company has not accrued a reserve for the potential outcome
of these cases.
In the cases in which quantifiable fines and penalties have
been assessed, the Company has indicated the amount of
such fine or penalty or the amount of provision accrued that
is the estimate of the probable loss.
In a limited number of ongoing cases, the Company is able
to make a reasonable estimate of the expected loss or range
of possible loss and has accrued a provision for such loss,
but believe that publication of this information on a case-by-
case basis would seriously prejudice the Company’s position
in the ongoing legal proceedings or in any related settlement
discussions. Accordingly, in these cases, the Company has
disclosed information with respect to the nature of the con-
tingency, but has not disclosed the estimate of the range of
potential loss.
These assessments can involve a series of complex judg-
ments about future events and can rely heavily on estimates
and assumptions. These assessments are based on esti-
mates and assumptions that have been deemed reasonable
by management. The Company believes that the provisions
recorded for the above matters are adequate based upon cur-
rently available information. However, given the inherent un-
certainties related to these cases and in estimating contingent
liabilities, the Company could, in the future, incur judgments
that could have a material adverse effect on its results of op-
erations in any particular period. The Company considers it
highly unlikely, however, that any such judgments could have
a material adverse effect on its liquidity or financial condition.
Environmental Liabilities
ArcelorMittal’s operations are subject to a broad range of laws
and regulations relating to the protection of human health and
the environment at its multiple locations and operating sub-
sidiaries. As of December 31, 2010, ArcelorMittal had estab-
lished reserves of 730 for environmental remedial activities
and liabilities (see note 20), including 300 in provisions relat-
ing to Europe, 213 in provisions relating to the United States,
185 in provisions relating to South Africa and 26 in provisions
relating to Canada. ArcelorMittal and the previous owners of
its facilities have expended substantial amounts to achieve
or maintain ongoing compliance with applicable environmen-
tal laws and regulations. ArcelorMittal expects to continue




Veolia Environnement (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Principles and Methods (in part)
1.13 Provisions
Pursuant to IAS 37, Provisions, Contingent Liabilities and
Contingent Assets, a provision is recorded when, at the year
end, the Group has a current legal or implicit obligation to
a third party as a result of a past event, it is probable that
an outflow of resources embodying economic benefits will
be required to settle the obligation and the amount of the
obligation can be reliably estimated.
As part of its obligations under public services contracts,
Veolia Environnement generally assumes responsibility for
the maintenance and repair of the installations it manages.
The resulting maintenance and repair costs are analyzed in
accordance with IAS 37 on provisions and, where necessary,
a provision for contractual commitments is recorded where
there is outstanding work to be performed.
In the event of a restructuring, an obligation exists if, prior
to the period end, the restructuring has been announced and
a detailed plan produced or implementation has commenced.
Future operating costs are not provided.
In the case of provisions for rehabilitation of landfill facilities,
Veolia Environnement accounts for the obligation to restore
a site as waste is deposited, recording a non-current asset
component and taking into account inflation and the date on
which expenses will be incurred (discounting). The asset is
amortized based on its depletion.
Provisions giving rise to an outflow after more than one
year are discounted if the impact is material. Discount rates
reflect current assessments of the time value of money and
the risks specific to the liability. The unwinding of the discount
is recorded in the Consolidated Income Statement in “Other
financial income and expenses.”
2. Use of Management Estimates in the Application
of Group Accounting Standards (in part)
Veolia Environnement may be required to make estimates
and assumptions that affect the reported amounts of assets,
liabilities, revenue and expenses, and the disclosures of con-
tingent assets and liabilities. Future results may be different
from these estimates.
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Underlying estimates and assumptions are determined
based on past experience and other factors considered as
reasonable given the circumstances. They act as a basis
for making judgments necessary to the determination of the
carrying amount of assets and liabilities, which cannot be ob-
tained directly from other sources. Future values could differ
from these estimates.
Underlying estimates and assumptions are reviewed on
an ongoing basis. The impact of changes in accounting es-
timates is recognized in the period the change is made if it
affects this period only and in the period the change is made
and prior periods if they are also affected by the change.
All these estimates are based on organized procedures
for the collection of forecast information on future flows, val-
idated by operating management, and on expected market
data based on external indicators and used in accordance
with consistent and documented methodologies.
The calculation methodology for discount rates adopted as
of December 31, 2008 was analyzed with respect to the finan-
cial crisis. Following the stabilization of the financial context
in 2009 and 2010, these rates were analyzed again taking
account of current conditions and using the following proce-
dures:
• Application of IAS 37, Provisions, Contingent Liabilities
and Contingent Assets: the discount rates used consist
of a risk-free interest rate and a risk premium specific
to the underlying assets and liabilities. The adjustment
applied to this risk premium in December 2008 to limit
market volatility in this period, was not considered nec-
essary at the 2010 or 2009 year-ends
37. Contingent Assets and Liabilities
In accordance with IAS 37 criteria, management does not
consider it appropriate to record a provision or recognize de-
ferred income in respect of these legal or arbitration proceed-
ings as of December 31, 2010, due to the uncertain nature of
their outcome.
The main contingent assets and liabilities relating to legal
or arbitration proceedings are presented below:
Veolia Eau Bruxelles
Since 2008, Aquiris, a 99% subsidiary of the Company, holds
a concession pursuant to which it is responsible for operating
the Brussels-North wastewater treatment plant. As a result
of extensive obstruction of the plant’s security chambers fol-
lowing the arrival of abnormal and extraordinary quantities of
rubble and other solid waste through the public sewer lines,
Aquiris decided to suspend operation of the plant from De-
cember 8 to December 19, 2009 due to significant safety
risks to persons and to the plant. This suspension permit-
ted a partial return to normal, but has resulted in several
disputes regarding liability for the disruption and the possi-
ble environmental consequences of the suspension in waste-
water treatment services. An expert’s report on the causes
of the disruption was delivered on January 13, 2011. The re-
port concludes, in error according to Aquiris, that there was
no legitimate reason to suspend operations at the station. In
addition, during the course of 2010, Aquiris instituted legal
proceedings against SBGE, the grantor authority, with a view
to showing that the Brussels-North treatment plant is faced
with sizing issues that are attributable to the grantor authority.
Aquiris is claiming compensation for its loss of business and
requesting confirmation that the significant upgrading costs
that will be required should be borne by the grantor author-
ity. Aquiris and the SBGE have asked a panel of experts to
render a technical opinion concerning these matters. A pre-
liminary report is expected to be delivered in mid-May 2011.
Pending the resolution of this dispute, Aquiris must bear ad-
ditional operating costs. At this point, the Company believes
that these disputes will not have a significant impact on its
financial position, results of operations or liquidity.
Veolia Propreté Italie
On April 16, 2008, Termo Energia Calabria S.p.a. (TEC), a
company specialized in waste incineration and a 98.76% sub-
sidiary of Veolia Servizi Ambientali Tecnitalia S.p.a. (VSAT),
which is in turn a subsidiary of Veolia Propreté, filed a claim
with the administrative court of the region of Calabria in Italy
for the payment of subsidies in an updated amount of €26.9
million, allegedly owed under a concession agreement en-
tered into on October 17, 2000 with the region of Calabria.
On August 11, 2008, the administrative court ordered the re-
gion to respond to this claim. At the end of November 2008,
the region announced its refusal to pay the subsidies claimed.
In addition, on May 16, 2008, TEC filed a claim with an Italian
arbitration tribunal against the Extraordinary Commissioner of
Calabria seeking reimbursement of €62.2 million for various
additional operating fees and costs incurred since 2005 and
claiming breach of the price indexation provision included in
the concession agreement. The arbitration proceedings be-
gan and, on October 24, 2008, the Extraordinary Commis-
sioner of Calabria filed a counterclaim against TEC seeking
the termination of the concession agreement and the pay-
ment of the sum of €62.3 million as compensation for con-
struction delays. The arbitration award, which was filed on
July 26, 2010 with the Arbitration Chamber of Rome, awards
a total amount of €39.8 million to TEC, and fully dismisses the
counterclaim of the Extraordinary Commissioner of Calabria
as well as his application for termination of the concession
agreement. On September 17, 2010, this decision was held
to be enforceable by the Civil Court of Rome. The State and
the Extraordinary Commissioner of Calabria have filed an ap-
peal of this decision with the Court of Appeals of Rome, and
a hearing is scheduled to take place in May 2011.
In addition, VSAT has been accused of manipulating the
software that monitors carbon monoxide emissions in its in-
cineration facilities in Falascaia (Tuscany), Vercelli (Pied-
mont) and Brindisi (Puglia). In all three cases, VSAT filed a
“John Doe” complaint in June 2008, August 2008 and Febru-
ary 2009, respectively, which are currently being investigated.
For all of these reasons, in early 2009 Veolia Propreté de-
cided to initiate negotiations with the Italian company Termo-
meccanica Ecologia S.p.a. pursuant to the seller’s guarantee
granted by Termomeccanica Ecologia S.p.a. in the agree-
ment pursuant to which VSAT was sold to Veolia Propreté
in 2007. In light of the repeated refusal of Termomeccanica
Ecologia S.p.a. to compensate VSAT pursuant to its guar-
antee, on May 19, 2009, Veolia Propreté and Veolia Servizi
Ambientali S.p.a., the parent companies of VSAT, filed a re-
quest for arbitration with the International Chamber of Com-
merce (ICC). The arbitration tribunal was formed in August
2009 and has set a schedule calling for a final hearing in the
end of December 2011 and an award at the end of April 2012
at the earliest.
Moreover, SIEE, which is the 25% shareholder and former
owner of VSAT, filed suit against VSAT’s “Veolia” directors
with a view to their removal on grounds of mismanagement
IFRS ATT 2.306
244 IFRS Accounting Trends & Techniques
and the appointment of an administrator by the court. On
February 17, 2010, the Genoa Court of Appeals fully reversed
the judgment of the Civil Tribunal of La Spezia, removed
the current directors and appointed an ad hoc administrator
whose duties were to manage and direct the company for 6
months from the acceptance of his appointment (that is until
September 4, 2010), to verify, if need be with the assistance of
a technical expert, the discharges from the facilities operated
by VSAT in Falascaia, Vercelli and Brindisi, verify the validity
of the 2008 balance sheet and lastly to issue a report at
the close of this period. The administrator’s appointment was
extended until May 31, 2011.
Finally, following an order issued by the Public Prosecutor’s
Office of Lucca on July 1, 2010, operations at the Falascaia
facility were suspended on the alleged grounds of an im-
proper administrative operating authorization and discharges
of polluted wastewater. A temporary solution was submitted
to the Province of Lucca by the VSAT subsidiary owning the
facility with a view to resumption of operations.
At this point, the Company is not in a position to predict
whether the outcome of these actions will have an additional
significant impact on its financial position, results of opera-
tions or liquidity.
Veolia Transport—Metrolink (USA)
On September 12, 2008, a suburban train operated by Con-
nex Railroad LLC, a Veolia Transport subsidiary, on behalf
of the Southern California Regional Rail Authority (SCRRA),
collided with a Union Pacific freight train in Chatsworth, Cali-
fornia. This accident resulted in 25 fatalities and a significant
number of injuries. The National Transportation Safety Board
(NTSB), a federal agency, with which Connex Railroad LLC
has been cooperating, reached a preliminary conclusion that
the two causes of the accident were, first, lack of attention
by the engineer, who failed to stop for a red light (a fact
that continues to be contested), and, second, the failure of
the SCRRA to have installed an automatic train braking sys-
tem in compliance with prior recommendations of the NTSB.
Lawsuits seeking an undetermined amount of total damages
have been filed by the heirs of the deceased passengers and
by all of the injured passengers, in the courts of the state of
California in Los Angeles, against Connex Railroad LLC, its
parent company, Veolia Transportation LLC, the SCRRA and
the Los Angeles County Metropolitan Transportation Author-
ity (LACMTA). These actions have been consolidated into
a single case. At the same time, Connex Railroad LLC and
the SCRRA brought before the federal courts in California
their disputes concerning their respective contractual liability
in connection with the suits filed as a result of this accident.
A U.S. federal statute limits the total amount of damages that
may be awarded for injuries and property damage arising
from a single passenger rail accident to U.S. $200 million.
In July 2010, the SCRRA and Connex Railroad LLC en-
tered into a settlement agreement concerning their respec-
tive contractual liabilities in connection with the accident, pur-
suant to which the parties made demands upon their insurers
to create a settlement fund for the victims of the accident and
their families up to the $200 million federal damages cap.
As a result of this agreement, the proceeding between Con-
nex Railroad LLC and the SCRRA before the federal courts
in California was stayed. On August 25, 2010, Connex Rail-
road LLC, Veolia Transportation, the SCRRA and LACMTA
filed a federal interpleader action in federal court to create a
settlement fund.
Following respective demands upon insurers, the Inter-
pleader Fund was funded with $200 million and a Final Dis-
charge Order was entered by Judge Wu (the relevant judge
appointed to hear this matter within the federal court) on Jan-
uary 3, 2011. This discharge order released Connex Railroad
LLC, Veolia Transportation, SCRRA from all and any claims
arising out of the collision. The 30 day appeal period in re-
spect of this discharge order expired on February 3, 2011 and
thus Connex (and related affiliates) has no further liability in
respect of this matter. On March 24, 2011, the state court
presiding over the consolidated claims of the heirs of the de-
ceased passengers and the injured passengers entered an
order dismissing all claims against Connex Railroad LLC, Ve-
olia Transportation and the other defendants in accordance
with the judgment and order of the federal court.
Furthermore, the Group is subject to several other litiga-
tions in the normal course of its business (see Item 8). At this
point, the Company considers that these disputes should not
have a significant impact on its financial position or results.
Reimbursement Asset for Environmental
Costs
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BP plc (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Significant Accounting Policies (in part)
Provisions, Contingencies and Reimbursement Assets
Provisions are recognized when the group has a present obli-
gation (legal or constructive) as a result of a past event, it is
probable that an outflow of resources embodying economic
benefits will be required to settle the obligation and a reliable
estimate can be made of the amount of the obligation. Where
appropriate, the future cash flow estimates are adjusted to
reflect risks specific to the liability.
If the effect of the time value of money is material, provi-
sions are determined by discounting the expected future cash
flows at a pre-tax risk-free rate that reflects current market as-
sessments of the time value of money. Where discounting is
used, the increase in the provision due to the passage of
time is recognized within finance costs. Provisions are split
between amounts expected to be settled within 12 months of
the balance sheet date (current) and amounts expected to be
settled later (non-current).
Contingent liabilities are possible obligations whose exis-
tence will only be confirmed by future events not wholly within
the control of the group, or present obligations where it is not
probable that an outflow of resources will be required or the
amount of the obligation cannot be measured with sufficient
reliability. Contingent liabilities are not recognized in the fi-
nancial statements but are disclosed unless the possibility of
an outflow of economic resources is considered remote.
Where the group makes contributions into a separately ad-
ministered fund for restoration, environmental or other obli-
gations, which it does not control, and the group’s right to the
assets in the fund is restricted, the obligation to contribute to
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the fund is recognized as a liability where it is probable that
such additional contributions will be made. The group recog-
nizes a reimbursement asset separately, being the lower of
the amount of the associated restoration, environmental or
other provision and the group’s share of the fair value of the
net assets of the fund available to contributors.
Amounts that BP has a contractual right to recover from
third parties are contingent assets. Such amounts are not
recognized in the accounts unless they are virtually certain to
be received.
2. Significant Event—Gulf of Mexico Oil Spill
As a consequence of the Gulf of Mexico oil spill, as described
on pages 34 to 39, BP has incurred costs during the year and
has recognized liabilities for future costs. Liabilities of uncer-
tain timing or amount and contingent liabilities have been ac-
counted for and/or disclosed in accordance with IAS 37 ‘Pro-
visions, contingent liabilities and contingent assets’. These
are discussed in further detail in Note 37 for provisions and
Note 44 for contingent liabilities. BP’s rights and obligations
in relation to the $20-billion trust fund which was established
during the year have been accounted for in accordance with
IFRIC 5 ‘Rights to interests arising from decommissioning,
restoration and environmental rehabilitation funds’. Key as-
pects of the accounting for the oil spill are summarized below.
The financial impacts of the Gulf of Mexico oil spill on the
income statement, balance sheet and cash flow statement of
the group are shown in the table below. Amounts related to




of Which Amount Related
to the Trust Fund
Income Statement
Production and manufacturing expenses 40,858 7,261
Profit (loss) before interest and taxation (40,858) (7,261)
Finance costs 77 73
Profit (loss) before taxation (40,935) (7,334)
Less: Taxation 12,894 —
Profit (loss) for the period (28,041) (7,334)
Balance Sheet
Current assets
Trade and other receivables 5,943 5,943
Current liabilities
Trade and other payables (6,587) (5,002)
Provisions (7,938) —
Net current liabilities (8,582) 941
Non-current assets
Other receivables 3,601 3,601
Non-current liabilities
Other payables (9,899) (9,899)
Provisions (8,397) —
Deferred tax 11,255 —
Net non-current liabilities (3,440) (6,298)
Net assets (12,022) (5,357)
Cash Flow Statement
Profit (loss) before taxation (40,935) (7,334)
Finance costs 77 73
Net charge for provisions, less payments 19,354 —
Increase in other current and non-current assets (12,567) (12,567)
Increase in other current and non-current liabilities 16,413 14,828
Pre-tax cash flows (17,658) (5,000)
Trust Fund
BP has established the Deepwater Horizon Oil Spill Trust
(the Trust) to be funded in the amount of $20 billion (the trust
fund) over the period to the fourth quarter of 2013, which is
available to satisfy legitimate individual and business claims
administered by the Gulf Coast Claims Facility (GCCF), state
and local government claims resolved by BP, final judgments
and settlements, state and local response costs, and natural
resource damages and related costs. In 2010 BP contributed
$5 billion to the fund, and further quarterly contributions of
$1.25 billion are to be made during 2011 to 2013. The income
statement charge for 2010 includes $20 billion in relation to
the trust fund, adjusted to take account of the time value of
money. Fines, penalties and claims administration costs are
not covered by the trust fund. The establishment of the trust
fund does not represent a cap or floor on BP’s liabilities and
BP does not admit to a liability of this amount.
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Under the terms of the Trust agreement, BP has no right
to access the funds once they have been contributed to the
trust fund and BP has no decision-making role in connection
with the payment by the trust fund of individual and business
claims resolved by the GCCF. BP will receive funds from the
trust fund only upon its expiration, if there are any funds re-
maining at that point. BP has the authority under the Trust
agreement to present certain resolved claims, including nat-
ural resource damages claims and state and local response
claims, to the Trust for payment, by providing the trustees
with all the required documents establishing that such claims
are valid under the Trust agreement. However, any such pay-
ments can only be made on the authority of the Trustee and
any funds distributed are paid directly to the claimants, not
to BP. BP will not settle any such items directly or receive
reimbursement from the trust fund for such items.
BP’s obligation to make contributions to the trust fund was
recognized in full, amounting to $20 billion on an undis-
counted basis as it is committed to making these contribu-
tions. On initial recognition the discounted amount recognized
was $19,580 million. After BP’s contributions of $5 billion to
the trust fund during 2010, and adjustments for discounting,
the remaining liability as at 31 December 2010 was $14,901
million. This liability is recorded within other payables on the
balance sheet, apportioned between current and non-current
elements according to the agreed schedule of contributions.
The table below shows movements in the funding obliga-
tion, recognized within other payables on the balance sheet,
during the period to 31 December 2010.
$ Million
Trust fund liability initially recognized—discounted 19,580
Unwinding of discount 73
Change in discount rate 240
Contributions (5,000)
Other 8
At 31 December 2010 14,901
Of which—current 5,002
—non-current 9,899
An asset has been recognized representing BP’s right to re-
ceive reimbursement from the trust fund. This is the portion
of the estimated future expenditure provided for that will be
settled by payments from the trust fund. We use the term “re-
imbursement asset” to describe this asset. BP will not actually
receive any reimbursements from the trust fund, instead pay-
ments will be made directly to claimants from the trust fund,
and BP will be released from its corresponding obligation.
The portion of the provision recognized during the year for
items that will be covered by the trust fund was $12,567 mil-
lion. Of this amount, payments of $3,023 million were made
during the year from the trust fund. The remaining reimburse-
ment asset as at 31 December 2010 was $9,544 million and is
recorded within other receivables on the balance sheet. The
amount of the reimbursement asset is equal to the amount
of provisions as at 31 December 2010 that will be covered
by the trust fund—see Note 37 in the table under Provisions
relating to the Gulf of Mexico oil spill.
Movements in the reimbursement asset are presented in
the table below:
$ Million
Increase in provision for items covered by the trust fund 12,567
Amounts paid directly by the trust fund (3,023)
At 31 December 2010 9,544
Of which—current 5,943
—non-current 3,601
The amount of the income statement charge related to the
trust fund comprises:
$ Million
Trust fund liability—discounted 19,580
Change in discount rate relating to trust fund liability 240
Recognition of reimbursement asset (12,567)
Other 8
Total charge relating to the trust fund 7,261
As noted above, the obligation to fund the $20-billion trust
fund has been recognized in full. Any increases in the provi-
sion that will be covered by the trust fund (up to the amount
of $20 billion) have no net income statement effect as a re-
imbursement asset is also recognized, as described above.
These charges for provisions, and the associated reimburse-
ment asset, recognized during the year amounted to $12,567
million. Thus, a further $7,433 million could be provided in
subsequent periods for items covered by the trust fund with
no net impact on the income statement. Such future increases
in amounts provided could arise from adjustments to exist-
ing provisions, or from the initial recognition of provisions for
items that currently cannot be estimated reliably, namely final
judgments and settlements and natural resource damages
and related costs.
It is not possible at this time to conclude as to whether the
$20-billion fund will be sufficient to satisfy all claims under
the Oil Pollution Act of 1990 (OPA 90) that will ultimately
be paid. Further information on those items that currently
cannot be reliably estimated is provided under Provisions
and contingencies and in Note 44.
The Trust agreement does not require BP to make further
contributions to the trust fund in excess of the agreed $20
billion should this be insufficient to cover all claims adminis-
tered by the GCCF, or to settle other items that are covered
by the trust fund, as described above. Should the $20-billion
trust fund not be sufficient, BP would commence settling legit-
imate claims and other costs by making payments directly to
claimants. In this case, increases in estimated future expen-
diture above $20 billion would be recognized as provisions
with a corresponding charge in the income statement. The
provisions would be utilized and derecognized at the point
that BP made the payments.
On 30 September 2010, BP pledged certain Gulf of Mexico
assets as collateral for the trust fund funding obligation. The
pledged collateral consists of an overriding royalty interest in
oil and gas production of BP’s Thunder Horse, Atlantis, Mad
Dog, Great White and Mars, Ursa and Na Kika assets in the
Gulf of Mexico. A wholly-owned company called Verano Col-
lateral Holdings LLC (Verano) has been created to hold the
overriding royalty interest, which is capped at $1.25 billion
per quarter and $17 billion in total. Verano has pledged the
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overriding royalty interest to the Trust as collateral for BP’s re-
maining contribution obligations to the Trust. BP contributed
a further $2 billion to the trust fund since this arrangement
was established, thereby reducing the amount of the pledge
to $15 billion at the end of the year. There is no change in op-
eratorship or the marketing of the production from the assets
and there is no effect on the other partners’ interests in the
assets. For financial reporting purposes Verano is a consoli-
dated entity of BP and there is no impact on the consolidated
financial statements from the pledge of the overriding royalty
interest.
Provisions and Contingencies
At 31 December 2010 BP has recorded certain provisions
and disclosed certain contingencies as a consequence of the
Gulf of Mexico oil spill. These are described below under Oil
Pollution Act of 1990 and Other items.
Oil Pollution Act of 1990 (OPA 90)
The claims against BP under the OPA 90 and for personal
injury fall into three categories: (i) claims by individuals and
businesses for removal costs, damage to real or personal
property, lost profits or impairment of earning capacity, loss
of subsistence use of natural resources and for personal in-
jury (“Individual and Business Claims”); (ii)claims by state and
local government entities for removal costs, physical damage
to real or personal property, loss of government revenue and
increased public services costs (“State and Local Claims”);
and (iii)claims by the United States, a State trustee, an Indian
tribe trustee, or a foreign trustee for natural resource dam-
ages (“Natural Resource Damages claims”). In addition, BP
faces civil litigation in which claims for liability under OPA 90
along with other causes of actions, including personal injury
claims, are asserted by individuals, businesses and govern-
ment entities.
A provision has been recorded for Individual and Business
Claims and State and Local Claims. A provision has also been
recorded for claims administration costs and natural resource
damage assessment costs.
BP considers that it is not possible to measure reliably any
obligation in relation to Natural Resource Damages claims
under OPA 90 or litigation for violations of OPA 90. These
items are therefore disclosed as contingent liabilities.
The $20-billion trust fund described above is available to
satisfy the OPA 90 claims and litigation referred to above with
the exception of claims administration costs which are borne
separately by BP. BP’s rights and obligations in relation to the
trust fund have been recognized and $20 billion, adjusted to
take account of the time value of money, was charged to the
income statement. The establishment of the trust fund does
not represent a cap or floor on BP’s liabilities and BP does
not admit liability for this amount.
Other Items
Provisions at 31 December 2010 also include amounts in re-
lation to offshore and onshore oil spill response, BP’s commit-
ment to a 10-year research programme in the Gulf of Mexico,
estimated penalties for liability under Clean Water Act Sec-
tion 311 and legal fees where we have been able to estimate
reliably those which will arise in the next two years. These
are not covered by the trust fund.
The provision does not reflect any amounts in relation to
fines and penalties except for those relating to the Clean
Water Act, as it is not possible to estimate reliably either the
amount or timing of such additional items. BP also considers
that it is not possible to measure reliably any obligation in
relation to litigation or any obligation in relation to legal fees
beyond two years. These items are therefore disclosed as
contingent liabilities.
No amounts have been recognized for recovery of costs
from our co-owners of the Macondo well because under IFRS
recovery must be virtually certain for receivables to be recog-
nized. All of these items are therefore disclosed as contingent
assets.
Further information on provisions is provided below and
in Note 37. Further information on contingent liabilities and
contingent assets is provided in Note 44.
A provision has been recognized for estimated future ex-
penditure relating to the oil spill, for items that can be reliably
measured at this time, in accordance with BP’s accounting
policy for provisions, as set out in Note 1.
The total amount recognized as a provision during the year
was $30,261 million (including $12,567 million for items cov-
ered by the trust fund and $17,694 million for other items).
After deducting amounts utilized during the year totaling
$13,935 million (including payments from the trust fund of
$3,023 million and payments made directly by BP of $10,912
million), and after adjustments for discounting, the remaining
provision as at 31 December 2010 was $16,335 million.
Movements in the provision are presented in the table be-
low.
$ Million
Increase in provision—items not covered by the trust fund 17,694
—items covered by the trust fund 12,567
Unwinding of discount 4
Change in discount rate 5
Utilization—paid by BP (10,912)
—paid by the trust fund (3,023)
At 31 December 2010 16,335
Of which—current 7,938
—non-current 8,397
The total amounts that will ultimately be paid by BP in relation
to all obligations relating to the incident are subject to signif-
icant uncertainty and the ultimate exposure and cost to BP
will be dependent on many factors. Furthermore, the amount
of claims that become payable by BP, the amount of fines
ultimately levied on BP (including any determination of BP’s
negligence), the outcome of litigation, and any costs arising
from any longer-term environmental consequences of the oil
spill, will also impact upon the ultimate cost for BP. Although
the provision recognized is the current best reliable estimate
of expenditures required to settle certain present obligations
at the end of the reporting period, there are future expendi-
tures for which it is not possible to measure the obligation
reliably as noted above.
Impact Upon the Group Income Statement and Cash Flow
Statement
The group income statement for 2010 includes a pre-tax
charge of $40,935 million in relation to the Gulf of Mexico oil
spill. This comprises costs incurred up to 31 December 2010,
estimated obligations for future costs that can be estimated
reliably at this time and rights and obligations relating to the
trust fund. Finance costs of $77 million reflect the unwinding
of discount on the trust fund liability and provisions.
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The amount of the provision recognized during the year
can be reconciled to the income statement charge as follows:
$ Million
Increase in provision 30,261
Change in discount rate relating to provisions 5
Costs charged directly to the income statement 3,339
Trust fund liability—discounted 19,580
Change in discount rate relating to trust fund liability 240
Recognition of reimbursement asset (12,567)
(Profit) loss before interest and taxation 40,858
Costs charged directly to the income statement relate to ex-
penditure incurred prior to the establishment of a provision at
the end of the second quarter and ongoing operating costs of
the GCRO. The accounting associated with the recognition of
the trust fund liability and the expenditure which will be settled
from the trust fund is described above.
The total charge in the income statement is analysed in the
table below. Costs charged directly to the income statement
in relation to spill response, environmental and litigation and
claims are those that arose prior to recording a provision at
the end of the second quarter of the year.
$ Million
Trust fund liability—discounted 19,580
Change in discount rate relating to trust fund liability 240
Recognition of reimbursement asset (12,567)
Other 8
Total charge relating to the trust fund 7,261
Spill response—amount provided 10,883
—costs charged directly to the income
statement 2,745
Total charge relating to spill response 13,628
Environmental—amount provided 929
—change in discount rate relating to
provisions 5
—costs charged directly to the income
statement 70
Total charge relating to environmental 1,004
Litigation and claims—amount provided 14,939
—costs charged directly to the
income statement 184
Total charge relating to litigation and claims 15,123
Clean Water Act penalties—amount provided 3,510
Other costs charged directly to the income statement 332
(Profit) loss before interest and taxation 40,858
Finance costs 77
(Profit) loss before taxation 40,935
The total amounts that will ultimately be paid by BP in relation
to all obligations relating to the incident are subject to signif-
icant uncertainty as described above under Provisions and
contingencies.
Response operations following the Deepwater Horizon in-
cident in April 2010 have been managed by the federal gov-
ernment’s response framework, which transitioned on 17 De-
cember from the Unified Area Command (UAC) to the Gulf
Coast incident management team (GC-IMT). Both the UAC
and now the GC-IMT link the organizations responding to
the incident and provide a forum for those organizations to
make consensus decisions. If consensus cannot be reached
the US Coast Guard co-ordinator carries the final decision on
response related actions deemed necessary. As such, the
activities undertaken by BP and its sub-contractors, and the
associated costs, are not wholly within BP’s control. This will
continue to be the case until control of the response opera-
tions transitions to the Gulf Coast Restoration Organization.
In particular, the centralized approval process established
for the procurement of materials, equipment and personnel
has not been used for all of the procurement activity that has
taken place. The types of activity that fell outside the central-
ized approval process included aspects of the surface and
shoreline response. Numerous personnel and vessels were
involved in activities which included skimming, boom deploy-
ment and shoreline clean up. Due to the scale of the incident
and the need to respond rapidly, procurement authority was
vested with state on-scene co-ordinators, various responsible
parties and various state and local government authorities.
So long as the expenses incurred are found to be consistent
with the National Contingency Plan, the responsible parties
will be expected to pay these costs, regardless of whether or
not they were involved in or approved the decision to procure
the resource. With the large number of parties involved, the
resulting funding flows are complex and resulted in difficulty
maintaining real time monitoring of expenses.
Pre-tax cash flows amounted to $17,658 million and the
impact on net cash provided by operating activities, on a
post-tax basis, amounted to $16,019 million.










Trade receivables 24,255 — 22,604 —
Amounts receivable from
jointly controlled
entities 751 601 1,317 11
Amounts receivable
from associates 448 220 417 298
Other receivables 4,763 1,342 4,949 1,420
30,217 2,163 29,287 1,729
Non-financial assets
Gulf of Mexico oil
spill trust fund
reimbursement
asset(a) 5,943 3,601 — —
Other receivables 389 534 244 —
6,332 4,135 244 —
36,549 6,298 29,531 1,729
(a) See Note 2 for further information.
Trade and other receivables are predominantly non-interest
bearing. See Note 27 for further information.
Receivables with a carrying value of $18 million (2009 nil)
have been pledged as security for certain of the group’s lia-
bilities.
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IAS 19, EMPLOYEE BENEFITS
IFRIC 14, IAS 19—THE LIMIT ON A
DEFINED BENEFIT ASSET, MINIMUM
FUNDING REQUIREMENTS AND
THEIR INTERACTION
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
On 16 June 2011, the IASB issued a revised IAS 19,
which is effective for annual reporting periods begin-
ning on or after 1 January 2013, with early application
permitted. The amendments to IAS 19 finalize propos-
als related to the accounting for termination benefits
and include a revised definition and recognition and
measurement requirements. The key changes are the
following:
• Termination benefits are employee benefits pro-
vided in exchange for the termination of an em-
ployee’s employment as a result of either of the
following:
— An entity’s decision to terminate an em-
ployee’s employment before the normal retire-
ment date
— An employee’s decision to accept an offer of
benefits in exchange for the termination of em-
ployment
• An entity should recognize a liability and expense
for termination benefits at the earlier of the fol-
lowing dates:
— When the entity can no longer withdraw the
offer of those benefits
— When the entity recognizes costs for a restruc-
turing that is within the scope of IAS 37 and
that involves the payment of termination ben-
efits
• An entity should measure the liability for termi-
nation benefits, both initially and subsequently,
according to the nature of the employee benefit,
provided that if the benefit is an enhancement of a
postemployment benefit, the liability is measured
in accordance with the requirements of IAS 19
for those benefits.
None of the survey companies could have adopted these
amendments in their 2010 financial statements. The dis-
cussion of termination benefits in the following commen-
tary reflects the requirements of IAS 19, as applicable in
2010.
2.308 Employee benefits, as defined in IAS 19, are all forms
of consideration given by an entity for services rendered by
its employees. An entity should account for all employee
benefits in accordance with IAS 19, except those to which
IFRS 2, Share-based Payment, applies.
2.309 IAS 19 recognizes that an entity can provide em-
ployee benefits under agreements with individual or groups
of employees, legislative requirements or industry arrange-
ments, or informal arrangements that give rise to constructive
obligations. Constructive obligations are defined as those in
which an entity indicates to other parties by its past actions,
published policy, or current statements that it will accept cer-
tain responsibilities and, hence, creates a valid expectation in
affected parties that those responsibilities will be discharged.
For example, an entity can have a constructive obligation for
an employee benefit when it has always given its employees
a set amount of money as a holiday bonus, even though it has
no legal or contractual obligation to do so.
2.310 IAS 19 establishes separate requirements for four
types of employee benefits: short-term benefits, long-term
benefits, postemployment benefits, and termination benefits.
Employee benefits include those provided directly to em-
ployees, their spouses or dependents, or others (for example,
insurance companies). Employees include personnel provid-
ing services to an entity on a full-time, part-time, permanent,




2.311 Unless another IFRS permits an amount to be included
in the cost of an asset, IAS 19 requires an entity to recognize
a liability for the undiscounted amount of short-term bene-
fits it expects to pay for employee services, after deducting
amounts already paid, and a corresponding expense in profit
or loss. When amounts already paid exceed the undiscounted
amount of the benefits, the entity should recognize an asset
(prepaid expense). Short-term benefits include salaries and
wages; Social Security contributions; paid sick leave or vaca-
tion leave (short-term compensating absences); profit sharing
and bonuses payable within 12 months after the end of the
period that the employee rendered service; and nonmonetary
benefits, such as medical care, cars, and free or subsidized
goods.
2.312 With respect to short-term compensating absences,
an entity should recognize a liability for the expected cost.
When compensating absences can be accumulated (that is,
the employee’s entitlement can be carried forward to future
periods), the entity recognizes the expected cost when ser-
vice increases the employee’s entitlement to the benefit. Oth-
erwise, the entity should recognize the expected cost when
the absence occurs. An entity should measure the expected
cost of accumulating compensating absences as the addi-
tional amount it expects to pay as a result of the entitlement
carried forward to the next period.
2.313 An entity should recognize the expected cost of profit
sharing and bonus plans when it has a present legal or con-
structive obligation to make payments as a result of past
events and it can make a reliable estimate of its liability. An
entity has a present obligation when it has no realistic al-
ternative but to make the payments. Estimates should take
into account the fact that some employees may leave without
receiving a bonus. An entity should include any payments
due beyond 12 months with long-term employee benefits.
2.314 Postemployment benefits include pensions and other
benefits, such as insurance and medical care. IAS 19 estab-
lishes the requirements for accounting for both defined con-
tribution and defined benefit postemployment benefit plans.
Defined contribution plans are defined as those in which
the entity’s legal or constructive obligation is limited to the
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agreed contributions to the plan; therefore, the employee
bears the actuarial risk that benefits will be less than ex-
pected and investment risk that the assets will be insufficient
to meet the expected benefits. All other plans are consid-
ered defined benefit plans for the purposes of accounting in
accordance with IAS 19.
2.315 For defined contribution plans, an entity should rec-
ognize liabilities for contributions payable in exchange for
employee service and a corresponding expense in profit or
loss, unless appropriately included in the cost of another as-
set. When payments exceed the liability, an entity should
recognize an asset (prepaid expense) for the excess. An en-
tity should discount contributions payable beyond 12 months
and, in most circumstances, should use a discount rate deter-
mined by reference to market yields on high-quality corpo-
rate bonds, with consistent currency and estimated maturity.
2.316 Accounting for defined benefit plans under IAS 19
is more complex than that for defined contribution plans.
To determine the amount of a liability and the associated
expense to recognize in the current period, an entity should
take the following steps, separately, for each defined benefit
plan:
a. Use actuarial techniques to reliably estimate the amount
of the benefit earned.
b. Discount the benefit using the projected unit credit
method to determine the present value of the defined
benefit obligation.
c. Determine the fair value of any plan assets.
d. Determine the total amount of actuarial gains and losses
and the amount to be recognized in the current period.
e. Determine any past service cost resulting from the in-
troduction of a new plan or change to an existing plan.
f. Determine the resulting gain or loss from a plan cur-
tailment or settlement.
2.317 An entity should apply the requirements of IAS 19 not
only to its legal obligations but also to its constructive obli-
gations, with the understanding that a constructive obligation
exists when failure to pay benefits would result in unaccept-
able damage to an entity’s relationship with employees.
2.318 An entity should recognize a net defined benefit obli-
gation as the present value of the defined benefit obligation
(calculated as described previously) adjusted by the follow-
ing amounts:
• Net unrecognized actuarial gains (or losses)
• Unrecognized past service cost
• Fair value of the plan assets available to settle the lia-
bility
2.319 An entity should determine the present value of the
defined benefit obligation and fair value of the plan assets
with sufficient regularity so that amounts recognized are not
materially different from those that it would determine at the
balance sheet date.
2.320 An entity should not recognize a defined benefit as-
set at an amount more than the present value of economic
benefits available in the form of refunds or reductions in
future contributions (asset ceiling). IAS 19 includes specific
requirements for recognition of any gains or losses that might
result from application of this constraint. IFRIC 14, IAS 19—
The Limit on a Defined Benefit Asset, Minimum Funding Re-
quirements and their Interaction, provides guidance on the
recognition of an entity’s right to a refund or contribution
reduction, as well as how a minimum funding requirement
affects the availability of reductions in future contributions
and might give rise to a liability.
2.321 Except to the extent that it may be included in the cost
of an asset, an entity should recognize the net total of the
following amounts as an expense in profit or loss:
• Service cost
• Interest cost
• Expected return on plan assets and any reimbursement
rights
• Actuarial gains or losses, if any (subsequently de-
scribed)
• Past service cost
• Effect of any curtailments or settlements
• Effect of the asset ceiling
2.322 IAS 19 gives an entity two alternatives for recognizing
the effects of actuarial gains and losses in profit or loss. An
entity may recognize only a portion of actuarial gains and
losses in profit or loss using the corridor method. An entity
should apply the corridor method separately to each plan to
amortize unrecognized actuarial gains or losses to profit or
loss. To determine the amount to be included in expense using
the corridor method, an entity takes the following steps:
a. Determine the amount by which the net cumulative un-
recognized actuarial gains and losses exceed the greater
of 10 percent of the present value of the defined benefit
obligation and 10 percent of the fair value of the plan
assets. (If this amount is zero or negative, no expense
is recognized.)
b. Divide the excess, if any, by the expected average re-
maining working lives of plan participants and recog-
nize this amount as an expense. (If there is no excess,
no expense is recognized.)
2.323 Alternatively, an entity may use another system-
atic method of amortizing unrecognized actuarial gains and
losses as long as the selected method recognizes these gains
and losses faster than the corridor method. When an entity
chooses to recognize all actuarial gains and losses on all
its defined benefit plans in the period in which they occur,
it should recognize them in other comprehensive income.
When so recognized, these actuarial gains and losses will
never affect profit or loss in the future.
2.324 Multiemployer plans (that is, asset pools from con-
tributions by entities that are not under common control to
be used to provide benefits to employees of more than one
entity) can be either defined contribution or defined benefit
plans. When these plans are defined benefit plans, an entity
should apply defined benefit plan accounting in accordance
with IAS 19, unless insufficient information is available. In
the latter case, the entity should apply defined contribution
accounting and make additional disclosures. An entity should
account for state plans (established by legislation for all en-
tities or all entities in a particular category) as if the plans
were multiemployer plans.
2.325 When the risks of a defined benefit plan are shared
among entities under common control, the plan is not con-
sidered to be a multiemployer plan. An entity participating
in such a plan should not claim it does not have sufficient
information to apply defined benefit plan accounting. IAS
19 provides guidance about how the individual entity should
account for its participation in these plans in its separate fi-
nancial statements. In addition, participation in these plans is
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considered a related party transaction and additional disclo-
sures are required, in accordance with IAS 24, Related Party
Disclosures.
2.326 An entity should treat insured benefits as defined con-
tribution plans, unless it has a remaining legal or constructive
obligation to pay benefits or further amounts if the insurer
does not pay. An entity should account for any remaining
legal or constructive obligation as a defined benefit plan.
2.327 An entity might offer other types of long-term em-
ployee benefits, such as sabbaticals, housing, disability ben-
efits, or deferred compensation. An entity should recognize
and measure the liability and related expense for these ben-
efits in a manner similar to that for postemployment benefit
obligations except that it recognizes any actuarial gains and
losses and past service cost immediately in profit or loss.
2.328 An entity should recognize termination benefits as a
liability and expense when the entity is demonstrably com-
mitted to terminate employment before normal retirement or
to provide such benefits due to an offer encouraging voluntary
termination. IAS 19 states that an entity is only demonstrably
committed when it has a detailed formal plan for termination,
with no realistic possibility of withdrawing. IAS 19 requires
an entity to include specific items in such a plan (for exam-
ple, termination benefits by job category). An entity should
measure termination benefits due within 12 months at the
amount payable and those due beyond 12 months at present
value using a similar interest rate as that required for defined
contribution plans.
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2.329 Accounting for short-term and long-term employee
benefits is similar under FASB ASC and IFRSs, especially
with respect to compensating absences. Consistent with
FASB ASC 710-10-25-1, obligations and corresponding ex-
penses are generally recognized when the settlement of the
obligation is probable and the amount can be measured rea-
sonably (reliably in IFRSs). However, FASB ASC 710-10-
25-4 makes a distinction for certain sabbatical leaves by ex-
plaining that when the purpose of a sabbatical leave is solely
for research or public service expected to enhance the repu-
tation or otherwise benefit the entity in the future, an entity
should not consider the sabbatical a benefit related to the em-
ployee’s past service. Therefore, an entity should not accrue
the liability in advance.
2.330 The FASB ASC glossary defines defined contribution
plan more directly than IFRSs. Such a plan is one that pro-
vides an individual account for each participant and provides
benefits based on amounts contributed to the participant’s
account by the employer or employee, investment experi-
ence, and any forfeitures allocated to the account less any
administrative expenses charged to the plan. The accounting
for such plans is similar to IAS 19, except FASB ASC 715-
70-35-1 states that when a plan requires an entity to make
contributions after the employee terminates or retires, the en-
tity should accrue the estimated cost during the employee’s
service period.
2.331 Like IFRSs, when a plan does not meet the definition
of defined contribution plan, an entity should account for it
as a defined benefit plan.
2.332 Although the accounting for postemployment benefit
plans is similar under both FASB ASC and IFRSs, several
important differences exist, including the following:
• The FASB ASC glossary defines the following two
obligations:
— Projected benefit obligation (PBO) is the actuarial
present value of all benefits attributed by the pension
benefit formula to employee service rendered up to
the date the PBO is calculated. An entity should
measure the PBO using assumptions about future
compensation levels if the pension benefit formula
is based on those future compensation levels (for
example, career-average-pay plans).
— Accumulated postretirement benefit obligation
(APBO) is the actuarial present value of all future
benefits attributed to an employee’s service rendered
to the date the APBO is calculated, based on the as-
sumption that the plan will continue in effect and that
all assumptions about future events are fulfilled. The
APBO generally reflects a pro rata allocation of ex-
pected future benefits to employee service already
rendered in the attribution period. Before an em-
ployee’s full eligibility date, that employee’s APBO
as of a particular date is the portion of the expected
postretirement benefit obligation attributed to that
employee’s service rendered to that date. On and
after the full eligibility date, the accumulated and
expected postretirement benefit obligations for an
employee are the same.
• FASB ASC 715-60-35-79 requires an entity to select a
discount rate to compute the present value of the defined
benefit obligation based on either of the following:
— Interest rate inherent in the amount at which the
postretirement benefit obligation could be settled, if
it is possible to settle the obligation with third-party
insurers
— Yields currently available on high-quality, fixed-rate
investments whose cash flows match the timing and
amount of expected benefit payments (FASB ASC
715-60-35-80 requires the use of rates on high-
quality, fixed-rate investments for other postretire-
ment obligations)
• FASB ASC 715-30-35-36 states that an entity should
use the projected unit credit method to determine the
obligation for pay-related plans, such as final-pay and
career-average-pay plans. Unlike IFRSs, this paragraph
further states that entities should use the benefit-years-
of-service approach when the benefit formula defines
benefits similarly for all years of service.
• An entity should calculate the expected return on plan
assets based on the market-related value of plan assets,
defined in the FASB ASC glossary as either the fair
value or a calculated value that recognizes changes in
fair value in a systematic and rational manner over a
period not longer than five years.
• An entity should accumulate in other comprehensive
income (a) gains and losses not included in pension
expense, including gains and losses resulting from
changes in experience (for example, the difference be-
tween the actual and expected return on plan assets)
and assumptions (for example, actuarial assumptions),
as stated by FASB ASC 715-60-35-25, and (b) prior
service costs, as stated by FASB ASC 715-60-35-16.
(FASB ASC 715-60-35-31 permits an entity to use the
same corridor method used in IAS 19 or another method
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that recognizes gains and losses more quickly if the
method is used consistently and treats gains and losses
in the same way. However, the entity should recognize
the minimum amortization in any period in which it is
greater [reduces the net gain or loss balance by more]
than the amount that the entity would recognize under
the method used.)
2.333 The FASB ASC glossary defines multiemployer plans
similarly to IFRSs. However, FASB ASC 715-80-35-1 ex-
plains that an entity should recognize as net pension cost or
net periodic postretirement benefit cost the required contribu-
tions to multiemployer plans, rather than use defined benefit
accounting, as would generally be required under IFRSs.
2.334 Under FASB ASC, an entity should account for ter-
mination benefits depending upon the type of arrangement.
As noted by FASB ASC 715-30-25-10, when the benefits
are contractual, an entity should recognize a liability and ex-
pense loss when it is probable that employees will be entitled
to benefits and it can reasonably estimate the liability. These
conditions may not be met until the entity acts. When an
employer offers special termination benefits to employees,
the entity recognizes a liability and loss when the employees
accept the offer and it can reasonably estimate the amounts to
be paid. As stated by FASB ASC 715-30-55-189, a plan that
provides termination benefits for virtually all employees is
considered a pension plan. Such plans are either defined con-
tribution or defined benefits plans and should be accounted
for accordingly.
2.335 Under FASB ASC 420-10, an entity that provides
involuntary termination benefits associated with exit or dis-
posal activities (one-time termination benefits) is subject to
similar conditions to those in IFRSs and should account for
these benefits in a similar manner.
Presentation
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2.336 IAS 1 does not require assets and liabilities associated
with postemployment benefit plans to be shown as separate
line items. However, IAS 19 prohibits an entity from off-
setting assets and liabilities related to different plans in the
balance sheet, unless it has a legal right to use a surplus in
one plan to settle a liability in another and it intends to do
so. IAS 19 does not provide guidance on whether an entity
should disaggregate these assets and liabilities into current
and noncurrent portions.
U.S. GAAP
2.337 Paragraphs 2–3 of FASB ASC 715-20-45 contains
guidance for classification of defined benefit retirement plans
on the balance sheet. Otherwise, FASB ASC does not pre-




2.338 IAS 24 requires disclosure of key management per-
sonnel compensation and, together with the general guidance
of IAS 1, specific disclosures of employee benefits. Although
IAS 19 does not require specific disclosures about short-term
or long-term employee benefits, other than the subsequently
discussed disclosures required for defined benefit and de-
fined contribution plans, the requirements of IAS 1 and IAS
24 still apply.
2.339 With respect to defined contribution benefit plans, an
entity should disclose the amount recognized as an expense
during the period.
2.340 With respect to defined benefit plans, an entity should
disclose descriptions of the type(s) of plans and its accounting
policy choice for recognition of actuarial gains and losses.
An entity should disclose a reconciliation of the beginning
and ending balances of the following:
• Present value of the defined benefit obligation
• Fair value of the plan assets
• Reimbursement rights, if any
2.341 In these reconciliations, an entity should disclose,
when applicable, the separate components of expense (for
example, service cost, interest cost, and so on); contributions
to the plan and payments to beneficiaries; effects of business
combinations and disposals; and any foreign currency ad-
justments. An entity should also reconcile the balances in the
net benefit obligation, plan assets, and amounts recognized
in the balance sheet, including any unrecognized amounts
(past service cost, actuarial gains and losses, asset due to
the asset ceiling, and so on), and discuss any links between
reimbursement rights and related obligation.
2.342 An entity should disclose an analysis of its defined
benefit obligation into fully- or partially-funded and un-
funded amounts.
2.343 An entity should disclose the amounts recognized
in the statement of comprehensive income. For the expense
recognized in profit or loss, an entity should disclose the
components of the expense (for example, service cost and
interest cost). For the amount recognized in other compre-
hensive income, an entity should separately disclose actuarial
gains and losses and the effect of the asset ceiling. When the
entity has opted to report all actuarial gains and losses of
the period directly in other comprehensive income, the entity
should disclose the cumulative amount recognized.
2.344 An entity should disclose the following with respect
to defined benefit plans:
• Major categories of plan assets
• Percentage or amount of each major category of the fair
value of plan assets
• Any property occupied or assets used by the entity
• Rate of return on plan assets, including a narrative de-
scribing the method used to determine the expected
return and the effects of major categories
• Actual return on plan assets and recognized reimburse-
ment rights
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2.345 An entity should also disclose the following with
respect to defined benefit plans:
• Information about actuarial assumptions used (for ex-
ample, discount rates, salary increases, and health care
cost trends)
• Effect of one percentage point change in health care
cost trend on the aggregate of service and interest cost
of net postemployment medical costs and net postem-
ployment benefit obligation
• Historical information about the net benefit obligation
and fair value of plan assets, including experience ad-
justments
• Best estimate of expected contributions to the plan in
the next reporting period
2.346 IAS 19 does not require specific disclosure of termi-
nation benefits. However, the requirements of IAS 1 and IAS
24 both apply. In addition, uncertainty about whether, or how
many, employees will accept an offer of voluntary termina-
tion may give rise to a contingent liability. In this case and
with respect to restructuring activities, an entity should rec-
ognize and disclose such a contingency in accordance with
IAS 37.
U.S. GAAP
2.347 Although the principal required disclosures are the
same as those required under IFRSs, FASB ASC 715-20-50
disclosure requirements are more extensive and, for example,
include the following:
• Description of how the entity makes investment alloca-
tion decisions
• Inputs and valuation techniques used to measure the
fair value of plan assets
• Effect of fair value measurements using significant un-
observable inputs (level 3) on changes in plan assets for
the period
• Significant concentrations of risk within plan assets
• Accumulated benefit obligation for defined benefit plan
• Benefits expected to be paid in each of the next five
fiscal years and in the aggregate for the five fiscal years
thereafter
FASB ASC 715-70-50 and 715-80-50 include specific dis-
closure requirements for defined contribution plans and mul-
tiemployer plans, respectively.
2.348 Paragraphs 2–4 of FASB ASC 715-20-50 also include
conditions under which disclosures about plans in different
jurisdictions or plans with different funding statuses can be
combined or should be shown separately.
2.349 With respect to other postemployment benefits, FASB
ASC 715-60-50 requires additional disclosures on the impact
of subsidies from the Medicare Prescription Drug, Improve-
ment, and Modernization Act of 2003.
2.350 Unlike IFRSs, when termination benefits are a major
cost of an exit and disposal activity, FASB ASC 420-10-50-
1 requires an entity to disclose the total expected amount,
amount incurred in the period, and cumulative amount in-
curred to date. An entity should also provide a reconciliation
of beginning and ending balances in the liability showing
adjustments to the liability, amounts incurred and charged
to expense, and costs paid or otherwise settled and should
explain why the entity made such adjustments.
Presentation and Disclosure Excerpts
Current Liabilities: Employee Entitlements
2.351
Rio Tinto Limited and Rio Tinto plc (Dec 2010)









Bank overdrafts repayable on demand 21 (7) (91)
Borrowings 22 (1,057) (756)
Trade and other payables 25 (6,576) (5,759)
Other financial liabilities 26 (265) (412)
Tax payable (2,773) (1,329)
Provisions 27 (1,117) (1,182
(11,795) (9,529)
Non-current liabilities
Borrowings 22 (13,277) (22,155)
Trade and other payables 25 (879) (591)
Other financial liabilities 26 (416) (601)
Tax payable (417) (299)
Deferred tax liabilities 18 (5,175) (4,304)
Provision for post retirement benefits 27 (4,339) (4,993)
Other provisions 27 (9,023) (7,519)
(33,526) (40,462)
Liabilities of disposal groups held
for sale 19 (1,807) (1,320)
Total liabilities (47,128) (51,311)
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)













Trade payables — 2,068 — 1,959
Amounts owed to equity accounted units 505 222 197 205
Other payables(a) 138 865 128 512
Employee entitlements — 681 — 856
Royalties and mining taxes — 594 — 325
Accruals and deferred income 109 2,097 125 1,865
Government grants deferred 127 49 141 37
879 6,576 591 5,759
(a) “Other payables” include deferred consideration of US$108 million (2009: US$119 million) relating to certain assets acquired. The deferred consideration is
included at its net present value. The amortisation of the discount applied in establishing the net present value is treated as a finance cost. All other accounts
payable and accruals are non-interest bearing.
Due to their short term maturities, the fair value of trade and
other payables approximates their carrying value.

















At 1 January 5,150 795 6,916 833 13,694 10,933
Adjustment on currency translation (68) 63 465 1 461 913
Amounts capitalised — — 872 — 872 268
Subsidiaries now equity accounted — — — — — (277)
Charged/(credited) to income statement:
—new provisions — 209 — 20 229 62
—increases to existing provisions 346 124 123 62 655 769
—unused amounts reversed — (25) (48) (1) (74) (82)
—exchange (gains)/losses on provisions — (4) 97 4 97 181
Amortisation of discount — 4 293 2 299 255
Utilised in year (1,110) (272) (102) (133) (1,617) (833)
Actuarial losses recognised in equity 860 — — — 860 693
Transfers (to)/from assets held for sale (718) (21) (19) (71) (829) 774
Transfers and other movements 12 (7) 5 (178) (168) 38
At 31 December 4,472 866 8,602 539 14,479 13,694
Statement of Financial Position Analysis:
Current 133 508 267 209 1,117 1,182
Non-current 4,339 358 8,335 330 13,362 12,512
Total 4,472 866 8,602 539 14,479 13,694
(a) The main assumptions used to determine the provision for pensions and post retirement healthcare, and other information, including the expected level of future
funding payments in respect of those arrangements, are given in note 50.
(b) The provision for other employee entitlements includes a provision for long service leave of US$267 million (2009: US$205 million), based on the relevant
entitlements in certain Group operations and includes US$132 million (2009: US$229 million) of provision for redundancy and severance payments. On 1 July
2010, the Performance Share Plan (formerly the Mining Companies Comparative Plan) was redesignated from cash-settled to equity-settled due to a change in
settlement terms. This resulted in a provision balance of US$57 million being reclassified to reserves, refer to note 30. Further details of the plan’s treatment are
provided in note 49.
(c) The Group’s policy on close down and restoration costs is described in note 1(k). Close down and restoration costs are a normal consequence of mining, and the
majority of close down and restoration expenditure is incurred at the end of the relevant operation. Remaining lives of mines and infrastructure range from one
to over 50 years with an average, weighted by closure provision, of around 21 years (2009: 23 years). Although the ultimate cost to be incurred is uncertain, the
Group’s businesses estimate their respective costs based on feasibility and engineering studies using current restoration standards and techniques. Provisions
of US$8,602 million (2009: US$6,916 million) for close down and restoration costs and environmental clean up obligations include estimates of the effect of
future inflation and have been adjusted to reflect risk. These estimates have been discounted to their present value at an average rate of approximately four per
cent per annum, being an estimate of the long term, risk free, pre-tax cost of borrowing. Excluding the effects of future inflation, and before discounting, this
provision is equivalent to some US$12.3 billion (2009: US$10.1 billion).
(d) Some US$687 million (2009: US$505 million) of environmental clean up expenditure is expected to take place within the next five years. The remainder includes
amounts for the operation and maintenance of remediation facilities in later years. The provision for environmental clean up expenditure includes the issue
described in (e) below.
(e) Includes provision for remediation of contamination of ground water in the vicinity of the Bingham Canyon mine as a result of the agreement between Kennecott
Utah Copper (KUC) with the US Environmental Protection Agency (EPA) and the State of Utah in 1995. In September 2008, the EPA withdrew its proposal to list
the Kennecott South Zone Site on the Superfund National Priorities List. This action recognises that soil clean up work is complete and that groundwater clean
up is adequately initiated and financial assurance is in place to assure completion of the work.
IFRS ATT 2.351
255Section 2: Statement of Financial Position and Related Disclosures
Defined Contribution Benefit Plans, Funded
and Unfunded Defined Benefit Plans,
Immediate Recognition of Actuarial Gains
and Losses in Other Comprehensive Income,
Recognition of Assets
2.352
Companhia de Bebidas das Américas (American
Beverage Company)—Ambev (Dec 2010)
CONSOLIDATED BALANCE SHEETS (in part)
As at December 31, 2010 and 2009




Property, plant and equipment 13 7,032.3 6,595.1
Goodwill 14 17,441.8 17,527.5
Intangible assets 15 1,823.2 1,932.6
Investments in associates 18.5 24.3
Investment securities 16 208.7 246.9
Deferred tax assets 17 1,089.8 1,368.5
Employee benefits 24 20.9 13.7
Trade and other receivables 19 2,132.1 2,089.3
29,767.4 29,797.9
Current assets
Investment securities 16 1,069.3 73.3
Inventories 18 1,905.2 1,488.1
Income tax receivable 181.2 986.2
Trade and other receivables 19 3,794.1 3,652.5
Cash and cash equivalents 20 5,909.3 4,042.9
Assets held for sale 21 51.8 60.2
12,910.9 10,303.1
Total assets 42,678.3 40,101.0
Liabilities
Non-current liabilities
Interest-bearing loans and borrowings 23 4,164.2 6,460.2
Employee benefits 24 966.2 767.9
Deferred tax liabilities 17 548.7 502.2
Trade and other payables 26 1,343.4 663.6
Provisions 27 536.1 919.3
7,558.6 9,313.2
Current liabilities
Bank overdrafts 20 1.0 18.6
Interest-bearing loans and borrowings 23 2,606.2 801.1
Income tax and social contribution
payable 701.6 1,295.9
Trade and other payables 26 7,142.9 6,279.9
Provisions 27 103.0 96.2
10,554.9 8,491.7
Total liabilities 18,113.5 17,804.9
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Summary of Significant Accounting Policies (in part)
(a) Basis of Preparation and Measurement
The consolidated financial statements were prepared in ac-
cordance with IFRS standards and the interpretations of the
International Financial Reporting Interpretations Committee
(“IFRIC”) that were in force on December 31, 2010.
The consolidated financial statements are presented in mil-
lions of Brazilian Reais (R$), rounded to the nearest million
indicated. Depending on the applicable IFRS requirement,
the measurement basis used in preparing the financial state-
ments is cost, net realizable value, fair value or recover-
able amount. Whenever IFRS provides an option between
cost and another measurement basis (e.g., systematic re-
measurement), the cost approach is applied.
The preparation of financial statements in conformity with
IFRS requires management to make judgments, estimates
and assumptions that affect the application of policies and
reported amounts of assets and liabilities, income and ex-
penses. The estimates and associated assumptions are
based on historical experience and various other factors that
are believed to be reasonable under the circumstances, the
results of which form the basis of making the judgments about
carrying values of assets and liabilities that are not readily ev-
ident from other sources. Actual results may differ from these
estimates.
The estimates and underlying assumptions are reviewed
on an ongoing basis. Revisions to accounting estimates are
recognized in the period in which the estimate is revised if the
revision affects only that period or current and future periods
if the revision affects such periods.
The Company believes that the following accounting poli-
cies reflect management´s most critical judgments, estimates
and assumptions that are important to its business opera-
tions and the understanding of its results: business combi-
nations, intangible assets, goodwill, impairment, provisions,
share-based payments, employee benefits and accounting
for current and deferred tax.
The fair value of acquired identifiable intangibles is based
on an assessment of future cash flows. Impairment anal-
yses of goodwill and indefinite-lived intangible assets are
performed annually and whenever a triggering event has oc-
curred, in order to determine whether the carrying value ex-
ceeds the recoverable amount. These calculations are based
on estimates of future cash flows.
Management selects a variety of methods including the dis-
counted cash flow method and option valuation models and
make assumptions about the fair value of financial instru-
ments that are mainly based on market conditions at each
balance sheet date.
Actuarial assumptions are established to anticipate future
events and are used in calculating pension and other postre-
tirement benefit expense and liability. These factors include
assumptions with respect to interest rates, expected return on
plan assets, medical cost trend rates, rates of future salary
increase, turnover rates, and longevity.
(s) Employee Benefits
Post-employment benefits include pensions managed in
Brazil by Instituto Ambev de Previdência Privada—IAPP,
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post-employment dental benefits and post-employment med-
ical benefits managed by Fundaçăo Zerrenner (formerly
Fundaçăo Antônio e Helena Zerrener Instituiçăo Nacional de
Beneficência—FAHZ). Usually, pension plans are funded by
payments made by both the Company and its employees, tak-
ing into account the recommendations of independent actuar-
ies. Post-employment dental benefits and post-employment
medical benefits are maintained by the return on Fundaçăo
Zerrener’s plan assets. If necessary, the Company may con-
tribute some of its profit to the Fundaçăo Zerrener.
The Company manages defined benefit and defined contri-
bution plans for employees of its companies located in Brazil
and in its subsidiaries located in Canada, Dominican Repub-
lic, Argentina and Bolivia.
Ambev maintains funded and unfunded plans.
Defined Contribution Plans
Payments to defined contribution plans are recognized as an
expense in the income statement when incurred. A defined
contribution plan is a pension plan under which Ambev pays
fixed contributions into a fund. Ambev has no legal or con-
structive obligations to pay further contributions if the fund
does not hold sufficient assets to pay all employees for the
benefits relating to employee service in the current and prior
periods.
Defined Benefit Plans
For defined benefit plans, expenses are assessed separately
for each plan using the projected unit credit method. The
projected unit credit method takes into account each period
of service as giving rise to an additional unit of benefit to
measure each unit separately. Under this method, the cost of
providing pensions is charged to the income statement during
the period of service of the employee. The amounts charged
to the income statement consist of current service cost, inter-
est cost, the expected return of the plan assets, past service
costs and the effect of any settlements and curtailments. The
obligations of the plan recognized in the balance sheet are
measured at the present value of the estimated future cash
outflows using a discount rate equivalent to the government´s
bond rates with maturity terms similar to those of the obliga-
tion, less any past service cost not recognized and the fair
value of any plan assets. Past service costs result from the
introduction of a new plan or changes to an existing plan.
They are recognized in the income statement over the pe-
riod the benefit vests. Actuarial gains and losses consist of
the effects of differences between the previous actuarial as-
sumptions and what has actually occurred and the effects of
changes in actuarial assumptions. Actuarial gains and losses
are fully recognized in Other comprehensive income.
Ambev recognizes assets (prepaid expenses) of its defined
benefit plans, to the extent of the economic value of the ben-
efit available to Ambev, from refunds or reductions in future
contributions.
Other Post-Employment Obligations
The Company and its subsidiaries provide post-employment
medical benefits, reimbursement of expenses with drugs and
other benefits to certain retirees through Fundaçăo Zerren-
ner. These benefits are not granted to new retirees. The ex-
pected costs of these benefits are recognized over the period
of employment, using an accounting methodology similar to
that for defined benefit plans.
Bonuses
Bonuses granted to employees and managers are based on
financial performance indicators. The estimated amount of
the bonus is recognized as an expense in the period the
bonus is earned. To the extent that part of the bonus is settled
in shares of the Company, these are accounted for as share-
based payments.
9. Payroll and Related Benefits
2010 2009 2008
Wages and salaries 1,642.7 1,694.8 1,588.3
Social security contributions 400.0 377.8 383.1
Other personnel cost 373.0 371.9 334.9
Increase/(decrease) in liabilities for
defined benefit plans (3.3) 63.2 62.8
Share-based payment 120.3 134.7 57.8
Contributions to defined contribution
plans 6.7 7.4 10.4
2,539.4 2,649.8 2,437.3
Average number of full time
employees (FTE) 44,924 42,573 41,138
Payroll and related benefits by reportable segment:
2010 2009 2008
LAN (Brazil and Hila-ex) 1,482.4 1,467.3 1,291.1
LAS 384.5 401.7 427.9
Canada 672.4 780.9 718.2
2,539.3 2,649.9 2,437.2
24. Employee Benefits
Ambev provides post-employment benefits, including pen-
sion benefits and medical and dental care. Pursuant to IAS
19 Employee Benefits, post-employment benefits are classi-
fied as either defined contribution or defined benefit plans.
Defined Contribution Plans
These plans are funded by the participants and the sponsors,
and are managed by privately administered pension funds.
During 2010, the Company contributed R$6.7 (R$7.4 and
R$7.3 in 2009 and 2008, respectively) to these funds, which
were recorded as an expense. Once the contributions have
been paid, the Company has no further payment obligations.
Defined Benefit Plans
The Company provides pension benefits, health care bene-
fits, reimbursement of expenses for drugs and other benefits
to retirees. Such benefits are not granted to new retirees.
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At December 31, the net liability for long-term and post-
employment benefits consists of the following:
(Expressed in Millions
of Brazilian Reais) 2010 2009 2008
Present value of funded obligations (3,325.9) (2,997.6) (2,942.1)
Fair value of plan assets 3,471.2 3,315.1 3,138.9
Present value of net obligations 145.3 317.5 196.8
Present value of unfunded obligations (515.4) (468.9) (488.3)
Present value of net obligations (370.1) (151.4) (291.5)
Unrecognized past service cost 1.4 2.7 5.8
Unrecognized assets (576.9) (605.2) (466.7)
Net liability (945.6) (753.9) (752.4)
Other long term employee benefits 0.3 (0.3) (12.0)
Total employee benefits (945.3) (754.2) (764.4)
Employee benefits amount in the
balance sheet:
Liabilities (966.2) (767.9) (784.3)
Assets 20.9 13.7 19.9
Net liabilities (945.3) (754.2) (764.4)
The changes in the present value of the defined benefit obli-
gations were as follows:
(Expressed in Millions
of Brazilian Reais) 2010 2009 2008
Defined benefit obligation at January 1 (3,466.5) (3,430.4) (3,771.4)
Service cost (34.0) (48.2) (68.1)
Interest cost (253.3) (252.8) (234.6)
New unvested past service cost (6.4) 5.5 (3.0)
Contributions by plan participants (4.2) — —
Actuarial gains and (losses) (358.1) (374.8) 495.5
Gains/(losses) on settlements or
curtailments — 22.2 —
Reclassifications — 3.0 —
Effects of exchange rate changes (11.9) 343.6 (99.7)
Benefits paid 293.1 265.4 250.9
Defined benefit obligation
at December 31 (3,841.3) (3,466.5) (3,430.4)
The changes in the fair value of plan assets are as follows:
(Expressed in Millions
of Brazilian Reais) 2010 2009 2008
Fair value of plan assets at January 1 3,315.1 3,138.9 3,534.5
Expected return 298.2 268.0 283.2
Actuarial gains and (losses) 25.8 331.0 (645.9)
Contributions by employer 108.8 103.3 136.1
Contributions by plan participants 4.2 4.0 3.7
Effects of exchange rate changes 12.7 (258.1) 78.2
Transfers — (6.6) —
Benefits paid (293.6) (265.4) (251.0)
Fair value of plan assets
at 31 December 3,471.2 3,315.1 3,138.8
Expected return on plan assets generated a gain of R$30.2
(Loss of R$ (15.2) in 2009 and R$ (27.5) in 2008).
The expense recognized in the income statement with re-
gard to defined benefit plans is detailed as follows:
(Expressed in Millions
of Brazilian Reais) 2010 2009 2008
Current service costs (34.0) (28.6) (43.5)
Interest cost (253.3) (252.8) (234.7)
Expected return on plan assets 298.2 268.0 283.2
Amortized past service cost (7.6) (14.4) (0.5)
New vested past service cost — (15.5) (17.7)
(Gains) losses on settlements
or curtailments — 39.6 —
Recognized past service cost — — (3.1)
Asset limitation — (59.5) (46.5)
3.3 (63.2) (62.8)
The employee benefit expenses are included in the following
line items in the income statement:
(Expressed in Millions
of Brazilian Reais) 2010 2009 2008
Cost of sales (17.3) (24.3) (15.7)
Sales and marketing expenses (27.4) (28.9) (25.3)
Administrative expenses 48.1 1.3 (21.8)
Other operating income and expense — (11.3) —
3.4 (63.2) (62.8)
The assumptions used in the calculation of the obligations
are as follows:
2010 2009 2008
Discount rate 7.0% 10.5% 8.1%
Future salary increases 4.2% 3.5% 3.8%
Future pension increases 2.9% 3.5% 2.4%









Dental claims trend rate 4.5% 6.2% 4.6%
Life expectation for an over
65 years old male 84 80 80
Life expectation for an over
65 years old female 87 84 85
The assumptions used in the calculation of the periodic pen-
sion costs are as follows(i):
2010 2009 2008
Discount rate 10.5% 8.1% 6.6%
Expected return on plan
assets 8.8% 13.2% 8.4%
Future salary increases 3.5% 3.8% 3.6%
Future pension increases 3.5% 2.4% 2.3%









Dental claims trend rate 6.2% 4.6% 4.0%
(i) Since the assumptions are nominal rates in different currencies
the Company has converted the foreign rates into Reais equiv-
alents based on the two year forward currency exchange rates.
The weighted average assumptions are calculated based on these
Reais equivalents.
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Assumed medical cost trend rates have a significant effect
on the amounts recognized in profit or loss. A one percentage
point change in the assumed medical cost trend rates would
have the following effects (note that a positive amount refers
to a decrease in the obligations or cost, while a negative
amount refers to an increase in the obligations or cost):
2010 2009 2008
(Expressed in Millions of Brazilian Reais)



















Effect on the aggregate of the service cost and interest
cost and of medical plans (10.6) 11.1 (6.7) 5.8 (7.4) 6.2
Effect on the defined benefit obligation for medical cost (70.5) 69.2 (65.9) 57.6 (57.1) 48.8
The disclosure requirements of IAS 1 Presentation of Finan-
cial Statements on the Company´s sensitivity analysis in rela-
tion to the discount rates, future salary increases and mortality
rates is presented below:
2010 2009 2008




















Effect on the aggregate of the service cost and interest
cost of defined benefit plans 1.5 0.1 1.3 (0.1) 1.4 (1.0)
Effect on the defined benefit obligation 217.5 (234.6) 177.1 (190.5) 156.7 (168.4)
2010 2009 2008




















Effect on the aggregate of the service cost (1.7) 1.7 (0.8) 0.8 (1.1) 1.1
Effect on the defined benefit obligation (12.4) 12.1 5.4 (5.5) (6.3) 6.1
2010 2009 2008














Effect on the aggregate of the service cost and interest
cost of defined benefit plans (5.7) 11.9 (4.1) 4.0 (8.9) 9.0
Effect on the defined benefit obligation (115.6) 114.9 (61.8) 59.7 (89.8) 87.5
The data presented in these tables is purely hypothetical
and are based on changes in individual assumptions hold-
ing all other assumptions constant; economic conditions and
changes therein will often affect multiple assumptions at the
same time and the effects of changes in key assumptions are
not linear. Therefore, the above information is not necessarily
a reasonable representation of future results.
The plan assets at December 31, consist of the following:
2010 2009 2008
Government bonds 78% 27% 47%
Corporate bonds 0% 10% 13%
Equity 17% 60% 39%
Property 5% 3% 2%
The overall expected rate of return is calculated by weight-
ing the individual rates in accordance with the anticipated
share in the total investment portfolio.
Ambev expects to contribute approximately R$84.0 to its
defined benefit plans in 2011.
IFRS ATT 2.352
259Section 2: Statement of Financial Position and Related Disclosures
The historic four-year present value of defined bene-
fit obligations, fair value of plan assets and pension re-
serve/contingency plans, is presented as follows:
2010 2009 2008 2007
Present value of funded
obligation (3,325.9) (2,997.6) (2,942.1) (3,227.4)
Fair value of plan assets 3,471.2 3,315.1 3,138.9 3,534.5
Pension/Contingency
reserves 145.3 317.5 196.8 307.1
Experience adjustments:
(increase)/decrease plan
liabilities (130.5) (374.8) 495.5 43.2
Experience adjustments:
increase/(decrease) plan
assets 14.4 331.0 (645.9) (34.4)
The present value of funded obligations include R$481.2
(R$402.3 in 2009 and R$333.3 in 2008) of two health care
plans for which the benefits are provided directly by Fundaçăo
Zerrenner. Fundaçăo Zerrenner is a legally distinct entity
whose main goal is to provide Ambev’s current and retired
employees and managers with health care and dental assis-
tance, technical and superior education courses, maintain-
ing facilities for assisting and helping elderly people, among
other things, through direct initiatives or through financial as-
sistance agreements with other entities.
Ambev recognizes the assets of that plan (prepaid ex-
penses) to the extent of the value of economic benefit avail-
able to the Company, from refunds or reductions in future
contributions, in this case in an amount equivalent to the cor-
responding actuarial liabilities.
Defined Contribution Plans, Defined Benefit
Plans, Recognition of Actuarial Gains and
Losses Using the Corridor Approach,
Curtailment and Settlement of a Defined
Benefit Plan
2.353
Eni SPA (Dec 2010)
CONSOLIDATED BALANCE SHEET (in part)
(Euro Million)
Dec. 31, 2009 Dec. 31, 2010
Note Total Amount
Of Which With
Related Parties Total Amount
Of Which With
Related Parties
Liabilities and Shareholders’ Equity
Non-current liabilities
Long-term debt (26) 18,064 20,305
Provisions for contingencies (27) 10,319 11,792
Provisions for employee benefits (28) 944 1,032
Deferred tax liabilities (29) 4,907 5,924
Other non-current liabilities (30) 2,480 49 2,194 45
36,714 41,247
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Summary of Significant Accounting Policies (in part)
Employee Benefits
Post-employment benefit plans, including constructive obli-
gations, are classified as either defined contribution plans or
defined benefit plans depending on the economic substance
of the plan as derived from its principal terms and conditions.
In the first case, the company’s obligation, which consists of
making payments to the State or a trust or a fund, is deter-
mined on the basis of contributions due. The liabilities related
to defined benefit plans, net of any plan assets, are deter-
mined on the basis of actuarial assumptions and charged on
an accrual basis during the employment period required to
obtain the benefits.
The actuarial gains and losses of defined benefit plans are
recognized pro-rata on service, in the profit and loss account
using the corridor method, if and to the extent that net cumu-
lative unrecognized actuarial gains and losses at the end of
the previous reporting period exceed the greater of 10% of
the present value of the defined benefit obligation or 10%
of the fair value of the plan assets, over the expected average
remaining working lives of the employees participating in the
plan. Such actuarial gains and losses derive from changes
in the actuarial assumptions used or from a change in the
conditions of the plan. Obligations for long-term benefits are
determined by adopting actuarial assumptions. The effect of
changes in actuarial assumptions or a change in the charac-
teristics of the benefit are taken to the profit or loss in their
entirety.
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5. Use of Accounting Estimates (in part)
Employee Benefits
Defined benefit plans are evaluated with reference to uncer-
tain events and based upon actuarial assumptions including
among others discount rates, expected rates of return on
plan assets, expected rates of salary increases, medical cost
trends, estimated retirement dates and mortality rates. The
significant assumptions used to account for defined bene-
fit plans are determined as follows: (i) discount and inflation
rates reflect the rates at which benefits could be effectively
settled, taking into account the duration of the obligation. In-
dicators used in selecting the discount rate include rates of
annuity contracts and rates of return on high quality fixed-
income investments. The inflation rates reflect market condi-
tions observed country by country; (ii) the future salary levels
of the individual employees are determined including an esti-
mate of future changes attributed to general price levels (con-
sistent with inflation rate assumptions), productivity, seniority
and promotion; (iii) healthcare cost trend assumptions reflect
an estimate of the actual future changes in the cost of the
healthcare related benefits provided to the plan participants
and are based on past and current healthcare cost trends in-
cluding healthcare inflation, changes in healthcare utilization
and changes in health status of the participants; (iv) demo-
graphic assumptions such as mortality, disability and turnover
reflect the best estimate of these future events for individual
employees involved, based principally on available actuarial
data; and (v) determination of the expected rates of return
on assets is made through compound averaging. For each
plan, the distribution of investments among bonds, equities
and cash and their specific average expected rate of return is
taken into account. Differences between expected and actual
costs and between the expected return and the actual return
on plan assets routinely occur and are called actuarial gains
and losses.
Eni applies the corridor method to amortize its actuarial
losses and gains. This method amortizes on a pro-rata basis
the net cumulative unrecognized actuarial gains and losses
at the end of the previous reporting period that exceed 10%
of the greater of: (i) the present value of the defined bene-
fit obligation; and (ii) the fair value of plan assets, over the
average expected remaining working lives of the employees
participating in the plan. Additionally, obligations for other
long-term benefits are determined by adopting actuarial as-
sumptions. The effect of changes in actuarial assumptions or
a change in the characteristics of the benefit are taken to the
profit or loss in their entirety.
28. Provisions for Employee Benefits







Foreign pension plans 204 295
Supplementary medical reserve for Eni
managers (FISDE) and other foreign
medical plans 107 108
Other benefits 188 206
944 1,032
Provisions for indemnities upon termination of employment
primarily related to the provisions accrued by Italian com-
panies for employee termination indemnities (“TFR”), deter-
mined using actuarial techniques and regulated by Article
2120 of the Italian Civil Code.
The indemnity is paid upon retirement as a lump sum pay-
ment the amount of which corresponds to the total of the pro-
visions accrued during the employees’ service period based
on payroll costs as revalued until retirement. Following the
changes in regime, starting from January 1, 2007 the amount
already then accrued and future benefits will be put in pension
funds or the treasury fund held by the Italian administration for
post-retirement benefits (INPS). For companies with less than
50 employees, it will be possible to continue the scheme as in
previous years. Therefore, the allocation of future TFR provi-
sions to pension funds or the INPS treasury fund determines
that these amounts will be classified as costs to provide ben-
efits under a defined contribution plan. Past unpaid amounts
accrued before January 1, 2007 for post-retirement indemni-
ties under the Italian TFR regime continue to represent costs
to provide benefits under a defined benefit plan and must be
assessed based on actuarial assumptions.
Pension funds are defined benefit plans provided by for-
eign subsidiaries located mainly in Nigeria and in Germany.
Benefits under these plans consisted of payments based on
seniority and the salary paid in the last year of service, or al-
ternatively, the average annual salary over a defined period
prior to retirement.
Group companies provide healthcare benefits to retired
managers. Liability to these plans (FISDE and other foreign
healthcare plans) and the current cost are limited to the con-
tributions made by the company.
Other benefits primarily consisted of a deferred cash incen-
tive plans, the long-term incentive plan and Jubilee awards.
The provisions for the deferred cash incentive plans are as-
sessed based on the estimated remuneration related to the
probability of the company reaching planned targets that will
be paid to managers reaching individual performance goals.
The long-term incentive plan replaces the previous stock op-
tion assignments and provides for an incentive to be paid
after a period of three years in an amount connected with
the variation of a performance indicator. Jubilee awards are
benefits due following the attainment of a minimum period of
service and, for the Italian companies, consist of an in-kind
remuneration.
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The value of employee benefits, estimated by applying ac-













Current value of benefit liabilities and plan assets at beginning of year 443 802 (453) 94 168 1,054
Current cost — 27 — 2 45 74
Interest cost 26 22 — 6 6 60
Amendments — 81 — 10 — 91
Expected return on plan assets — — (16) — — (16)
Employee contributions — 1 (42) — — (41)
Actuarial gains/losses 18 301 (16) 9 4 316
Benefits paid (41) (45) 22 (7) (39) (110)
Curtailments and settlements — (15) 14 — — (1)
Currency translation differences and other changes 1 (28) (9) 1 4 (31)
Current value of benefit liabilities and plan assets at end of year 447 1,146 (500) 115 188 1,396
2010
Current value of benefit liabilities and plan assets at beginning of year 447 1,146 (500) 115 188 1,396
Current cost — 42 — 2 50 94
Interest cost 22 36 — 6 6 70
Amendments — 9 — — — 9
Expected return on plan assets — — (20) — — (20)
Employee contributions — 1 (30) — — (29)
Actuarial gains/losses 8 (22) (4) 4 6 (8)
Benefits paid (42) (28) 9 (7) (45) (113)
Curtailments and settlements (113) 115 — — 2
Currency translation differences and other changes (2) 38 (38) — 1 (1)
Current value of benefit liabilities and plan assets at end of year 433 1,109 (468) 120 206 1,400
Other benefits of euro 206 million (euro 188 million at De-
cember 31, 2009) primarily concerned the deferred monetary
incentive plan for euro 126 million (euro 119 million at De-
cember 31, 2009), jubilee awards for euro 59 million (euro
52 million at December 31, 2009) and the long-term incentive
plan for euro 2 million.
Curtailments and settlements of foreign pension plans con-
cerned a sale to third parties of obligations related to the pen-
sion plan and the relevant plan assets of Eni Lasmo Plc for
euro 115 million with a net effect equal to zero.
The reconciliation analysis of benefit obligations and plan
























Present value of benefit obligations with plan assets — — 935 874 — — — —
Present value of plan assets — — (500) (468) — — — —
Net present value of benefit obligations with plan assets — — 435 406 — — — —
Present value of benefit obligations without plan assets 447 433 211 235 115 120 188 206
Actuarial gains (losses) not recognized (2) (10) (442) (273) (6) (9) — —
Past service cost not recognized — — — (73) (2) (3) — —
Net liabilities recognized in provisions for employee benefits 445 423 204 295 107 108 188 206
The net liability for foreign employee pension plans of euro
295 million (euro 204 million at December 31, 2009) included
the liabilities related to joint ventures operating in exploration
and production activities for euro 62 million and euro 121 mil-
lion at December 31, 2009 and 2010, respectively. A receiv-
able of an amount equivalent to such liability was recorded.
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Current cost — 27 2 45 74
Interest cost 26 22 6 6 60
Expected return on plan assets — (16) — — (16)
Amortization of actuarial gains (losses) — 10 7 4 21
Effect of curtailments and settlements — 1 — (3) (2)
26 44 15 52 137
2010
Current cost — 42 2 50 94
Interest cost 22 36 6 6 70
Expected return on plan assets — (20) — — (20)
Amortization of actuarial gains (losses) — 8 — 7 15
Effect of curtailments and settlements — 5 — — 5
22 71 8 63 164
The main actuarial assumptions used in the evaluation of
post-retirement benefit obligations at year-end and in the es-










Discount rate 5.0 2.7-11.0 5.0 2.0-5.0
Expected return rate on plan assets — 4.0-13.0 — —
Rate of compensation increase 3.0 2.7-14.0 — —
Rate of price inflation 2.0 0.9-10.0 2.0 2.0
2010
Discount rate 4.8 2.7-14.0 4.8 1.8-4.8
Expected return rate on plan assets — 3.5-14.0 — —
Rate of compensation increase 3.0 2.0-14.0 — —
Rate of price inflation 2.0 0.8-13.0 2.0 2.0
With regards to Italian plans, demographic tables prepared
by Ragioneria Generale dello Stato (RG48) were used. Ex-
pected return rate by plan assets has been determined by
reference to quoted prices expressed in regulated markets.
Plan assets consisted of the following:
(%) Plan Assets Expected Return
Securities 13.0 6.4-7.4
Bonds 36.4 1.8-14.0
Real estate 2.0 6.4
Other 48.6 0.5-14.0
Total 100.0
The effective return of the plan assets amounted to euro 24
million (nil at December 31, 2009).
With reference to healthcare plans, the effects deriving from
a 1% change of the actuarial assumptions of medical costs
were as follows:
(Euro Million) 1% Increase 1% Decrease
Impact on the current costs and
interest costs 1 (1)
Impact on net benefit obligation 14 (12)
The amount expected to be accrued to defined benefit plans
for 2011 amounted to euro 125 million.
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The analysis of changes in the actuarial valuation of the
net liability with respect to prior year deriving from the non-
correspondence of actuarial assumptions with actual values











Impact on net benefit obligation (7) 4 3 2
Impact on plan assets — (16) — —
2010
Impact on net benefit obligation (1) (31) 1 4
Impact on plan assets — 3 — —
Senior Management Remuneration
and Employment Termination Benefits
2.354
Vina Concha y Toro S.A. (Dec 2010)
Author’s Note
Vina Conca y Toro S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of January
1, 2009. The excerpt that follows reflects the initial
application of IAS 19.
CONSOLIDATED CLASSIFIED STATEMENTS OF











Liabilities and Shareholders’ Equity N◦ Th$ Th$ Th$
Liabilities
Current liabilities
Other current financial liabilities (18) 30,732,214 36,891,049 75,069,473
Trade accounts payable and other current accounts payable (20) 56,675,343 63,816,895 62,897,932
Current accounts payable to related companies (10) 2,876,996 2,479,224 3,620,684
Other current provisions (24) 14,687,986 18,621,917 21,530,839
Current tax liabilities (22) 18,022,445 11,154,271 8,539,379
Other current non-financial liabilities — 9,924,689 7,580,233 8,063,787
Total current liabilities 132,919,673 140,543,589 179,722,094
Non-current liabilities
Other non-current financial liabilities (18) 49,959,254 62,772,393 69,746,210
Other non-current accounts payable (20) 2,137,049 2,211,541 2,393,975
Non-current accounts payable to related companies (10) 1,452,471 1,664,255 1,947,240
Non-current liabilities due to deferred taxes (21) 25,930,099 25,003,032 23,225,431
Non-current provisions due to benefits to employees (24) 1,841,740 1,606,683 1,582,919
Total non-current liabilities 81,320,613 93,257,904 98,895,775
Total liabilities 214,240,286 233,801,493 278,617,869
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2. Bases of Preparation and Presentation Used
for These Financial Statements (in part)
2.17 Benefits to Employees
2.17.1 Vacations
Costs associated to personnel contractual benefits and re-
lated to services provided by employees during the year are
charged to income in the related period.
2.17.2 Severance Indemnities
Company’s management use assumptions in order to deter-
mine the best estimate of these benefits. The valuation of
these obligations is performed through an actuarial calcula-
tion. The assumptions used in this calculation include the
pension rotation hypothesis, the mortality rate, the discount
rates the expected rise in remuneration and the future per-
manence, among other.
Actuarial gains or losses that can occur due to variations
of defined pre-established obligations are directly recorded in
income for the year.
Actuarial gains or losses arise from the deviations between
estimates and actuality of the actuarial hypothesis behavior
or in the reformulation of the established actuarial hypothesis.
Note 10. Transactions with Related Parties (in part)
10.4 Senior Management Remuneration
Managers and main executives participate in an annual
bonuses plan through participation on income and goals
achievements. The global remuneration of the Company’s
managers and main executives during the year, ended as of








Short-term benefits to employees 8,146,838 8,818,268
Contract termination benefit 173,632 81,858
Total remuneration 8,320,470 8,900,126
Note 18. Financial Liabilities (in part)
As of December 31, 2010, December 31, 2009 and January
1, 2009, the Company’s financial liabilities are detailed as
follows:
Current Non-Current
Non-Guaranteed 12-31-2010 12-31-2009 01-01-2009 12-31-2010 12-31-2009 01-01-2009
Loans from financial entities 24,261,847 26,490,158 70,321,495 12,261,171 23,352,311 26,968,465
Obligations with the employees(∗) 2,841,237 7,906,714 1,611,528 36,600,644 38,189,958 41,643,224
Financial lease 227,306 224,237 456,801 268,245 554,665 1,134,521
Notes payable — 688,886 — — — —
Derivatives 3,401,824 1,581,054 2,679,649 829,194 675,460 —
Total 30,732,214 36,891,049 75,069,473 49,959,254 62,772,393 69,746,210
(∗) Valued at amortized cost except for obligations with the employees which are valued through the effective rate method.
Note 23. Benefits to Employees
23.1 Employee Benefits and Expenses
The movement in classes of expenses is detailed as follows:
12-31-2010 12-31-2009
Employee Benefits and Expenses Th$ Th$
Participation in profits, bonuses and expenses 40,615,584 37,419,590
Participation in profits and bonuses, current 8,530,953 8,304,437
Personnel expenses 32,084,631 29,115,153
Wages and Salaries 26,167,412 24,057,522
Short-term benefits to employees 3,563,180 2,704,567
Expense for obligation of personnel benefits 346,589 325,366
Other long-term benefits 964,924 1,068,683
Other personnel expenses 1,042,526 959,015
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23.2 Severance Indemnities Obligations
A. General Aspects:
Viña Concha y Toro and some of its subsidiaries located in
Chile provide severance indemnity benefit plans to active em-
ployees which are determined and recorded in the financial
statements following the criterion described in Note 2.23).
These benefits are mainly referred to:
• Severance indemnity:
The beneficiaries receive the equivalent of a determined num-
ber of days per contractual years of service at his/her retire-
ment date and/or due to cease of his/her functions. In case of
dissociation due to a Company decision, beneficiaries receive
the equivalent stipulated by law.
B. Openings, Movements and Presentation in Financial
Statements:









obligation 1,841,740 1,606,683 1,582,919
Total 1,841,740 1,606,683 1,582,919
For the year ended as of December 31, 2010 and 2009 and
as of January 1, 2009
Movement of obligations for employment termination for
the year ended as of December 31, 2010 and December 31,
2009 is detailed as follows:
Severance Indemnity
Employment Termination Benefits Th$
Initial balance 1,582,919
Balance as of January 1, 2009 1,582,919
Current period costs of services 180,694
Cost for interest 68,995
Actuarial (Profits) losses (28,069)
Paid benefits (168,441)
Costs of past services —
Other (29,415)
Balance as of December 31, 2009 1,606,683
Current period costs of services 203,824
Cost for interest 78,291
Actuarial (Profits) losses (6,188)
Paid benefits (43,240)
Costs of past services —
Other 2,370
Balance as of December 31, 2010 1,841,740
The main actuarial hypothesis used for the calculation of sev-
erance indemnity obligations as of December 31, 2010 and








Retirement rate 0.7% 0.7%
Mortality rate RV-2004 RV-2004
Discount rate 5.0% 5.0%
Salary increase rate 3.5% 3.0%
Future permanence (years) 7.2 7.2
During the Company’s Board meeting held on May 28, 2009
it was agreed to offer the balance of shares not subscribed
by shareholders during the preferred option period (with
charge to the Company’s capital contribution agreed dur-
ing the Shareholder’s Board meeting held on December 18,
2008), between all the employees of Viña Concha y Toro S.A.
and subsidiaries who voluntarily wish to participate in this pro-
gram, at prorate of their age in the Company and salary, in
the same price and subject to the same conditions offered
to the shareholders during this period. Unsubscribed shares
in the preferred option period reached a total of 1,674,591,
equivalent to 5.98% of the new issuance (which correspond
to 0.22% of the Company’s total shares). Shares purchases
reached Th$ 1,404,149 as of December 31, 2009.
The purpose of the explanation in the aforementioned para-
graph is to establish a procedure for employees to effectively
participate in the Company’s property, as shareholders, and
concentrate their efforts to achieve a greater value to the
company and for their own investment.
The amounts recorded in the consolidated statement of
comprehensive income by function as of December 31, 2010










Cost of services for current period 203,824 180,694
Interest cost 78,291 68,995
Actuarial (Profits) losses (6,188) (28,069)
Paid benefits 256,958 25,474
Costs of past services — —
Other — —
Total expense recognized in the Consolidated
Statement of Comprehensive Income
by Function 532,885 247,093
IFRS ATT 2.354
266 IFRS Accounting Trends & Techniques
IFRS 2, SHARE-BASED PAYMENT
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
See section 3, beginning with paragraph 3.157, for an
additional discussion of employee share-based pay-
ment transactions (such as, employee stock option
plans) and a comparison to U.S. GAAP recognition
and measurement requirements. Excerpts for equity-
settled employee share-based payment compensation
schemes are also provided in that section.
2.355 The objective of IFRS 2 is to reflect the effects of
share-based payment transactions, whether with employees
or others, on an entity’s profit or loss and financial position
of the reporting period. A share-based payment transaction,
as defined in appendix A of IFRS 2, is a transaction in which
an entity receives goods or services as consideration for the
entity’s equity instruments (including shares or share op-
tions) or acquires goods or services by incurring liabilities
to the supplier of those goods and services for amounts that
are based on the price of the entity’s shares or other equity
instruments. An entity may grant share options or other eq-
uity instruments (for example, contracts giving the holder
the right, but not the obligation, to subscribe to an entity’s
shares at a fixed or determinable price for a specific period of
time) to employees as part of their compensation for services
rendered to the entity.
2.356 Transfers of an entity’s equity instruments by its share-
holders in exchange for supplying goods and services to the
entity are also considered share-based payments within the
scope of IFRS 2, unless the transfer is clearly for some other
purpose than the supply of goods or services to the entity.
Also included within the scope of IFRS 2 are transfers of eq-
uity instruments of the entity’s parent, or equity instruments
of another entity in the same group as the entity, to parties
that have supplied goods or services to the entity. Goods in-
clude inventories, consumables, PPE, intangible assets, and
other nonfinancial assets.
2.357 The revisions to IFRS 3 in 2008 amended the guidance
in IFRS 2 related to share-based payments in a business
combination. An entity should apply those amendments to
annual periods beginning on or after 1 July 2009. If an entity
applies IFRS 3, as revised in 2008, in an earlier period, the




2.358 Under IFRS 2, an entity should recognize goods and
services at the time they are received and either a corre-
sponding decrease in equity for equity-settled transactions
or a liability for cash-settled transactions.
2.359 In the case when the supplier chooses the settlement
option, IFRS 2 considers the entity to have issued a compound
financial instrument. This compound financial instrument in-
cludes both a debt component (that is, the supplier’s right to
demand payment in cash) and an equity component (that is,
the supplier’s right to demand settlement in equity instru-
ments rather than cash). When the fair value of the goods or
services is measured directly, an entity should first measure
the debt component at fair value. Then, the entity measures
the equity component as the difference between the fair val-
ues of the goods and services and the debt component. This
approach is usually referred to as the incremental approach.
2.360 In the case when the entity chooses the settlement op-
tion, the entity should still recognize a liability if the option
to issue equity has no commercial substance (for example,
the entity is prohibited from issuing equity) or it has a past
practice of always settling in cash. Only if no present obli-
gation exists should the entity account for the transaction
as equity-settled. An example of a cash-settled share-based
payment is a stock appreciation right.
U.S. GAAP
2.361 Like IFRSs, FASB ASC 718, Compensation—Stock
Compensation, requires an entity to determine whether to
classify a share-based payment transaction as cash settled
or equity settled. Paragraphs 6–19 of FASB ASC 718-10-25
provide guidance for determining whether certain financial
instruments awarded in share-based payment transactions are
liabilities. FASB ASC 718-10-25-6 further states that in de-
termining whether instruments not specifically discussed in
the preceding paragraphs are classified as a liability or equity,
an entity should apply U.S. GAAP applicable to financial in-
struments issued in transactions not involving share-based
payment.
Presentation
2.362 Neither IFRSs nor FASB ASC 718-30 require separate
presentation of share-based payment liabilities, unless they
are material to the financial statements.
Disclosure
Author’s Note
See section 3, beginning at paragraph 3.179, for a
comparison of disclosure requirements for share-based
payments classified as equity.
IFRSs
2.363 When the entity has recognized liabilities from share-
based payment transactions, IFRS 2 requires the entity to
disclose the following amounts:
• Total carrying amount at the end of the period
• Total intrinsic value at the end of the period of liabilities
for which the counterparty’s right to cash or other assets
had vested by the end of the period (for example, vested
share appreciation rights)
U.S. GAAP
2.364 FASB ASC 718-30 does not prescribe specific disclo-
sures related to share-based payments recognized as liabili-
ties.
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Presentation and Disclosure Excerpts
Cash-Settled Share Appreciation Rights
2.365
AEGON N.V. (Dec 2010)
CONSOLIDATED BALANCE SHEET (in part)
As at December 31
Amounts in EUR Million Note 2010 2009
Trust pass-through securities 18 143 130
Insurance contracts 19 100,506 93,790
Insurance contracts for account of
policyholders 20 77,650 69,760
Investment contracts 21 23,237 27,932
Investment contracts for account of
policyholders 22 69,527 57,421
Derivatives 9 5,971 5,716
Borrowings 23 8,518 7,485
Provisions 24 357 421
Defined benefit liabilities 25 2,152 2,104
Deferred revenue liabilities 26 82 69
Deferred tax liabilities 27 1,824 817
Other liabilities 28 18,495 13,714
Accruals 29 416 392
Total liabilities 308,878 279,751
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
2.22 Assets and Liabilities Relating to Employee Benefits
(in part)
c. Share-Based Payments
The Group has issued share-based plans that entitle em-
ployees to receive equity instruments issued by the Group or
cash payments based on the price of AEGON N.V. common
shares. Some plans provide employees of the Group with the
choice of settlement.
For share option plans that are equity-settled, the expense
recognized is based on the fair value on the grant date of the
share options, which does not reflect any performance condi-
tions other than conditions linked to the price of the Group’s
shares. The cost is recognized in the income statement, to-
gether with a corresponding increase in shareholders’ equity,
as the services are rendered. During this period the cumula-
tive expense recognized at the reporting date reflects man-
agement’s best estimate of the number of shares expected
to vest ultimately.
Share appreciation right plans are initially recognized at
fair value at the grant date, taking into account the terms and
conditions on which the instruments were granted. The fair
value is expensed over the period until vesting, with recog-
nition of a corresponding liability. The liability is remeasured
at each reporting date and at the date of settlement, with any
changes in fair value recognized in the income statement.
Share option plans that can be settled in either shares
or cash at the discretion of the employee are accounted for
as a compound financial instrument, which includes a debt
component and an equity component.
3. Critical Accounting Estimates and Judgment in
Applying Accounting Policies (in part)
Application of the accounting policies in the preparation of
the financial statements requires management to apply judg-
ment involving assumptions and estimates concerning future
results or other developments, including the likelihood, tim-
ing or amount of future transactions or events. There can
be no assurance that actual results will not differ materially
from those estimates. Accounting policies that are critical to
the financial statement presentation and that require com-
plex estimates or significant judgment are described in the
following sections.
Valuation of Share Appreciation Rights and Share Options
Because of the inability to measure the fair value of employee
services directly, fair value is measured by reference to the
fair value of the rights and options granted. This value is
estimated using the binomial option pricing model, taking into
account the respective vesting and exercise periods of the
share appreciation rights and share options.
The volatility is derived from quotations from external mar-
ket sources and the expected dividend yield is derived from
quotations from external market sources and the binomial
option pricing model. Future blackout periods are taken into
account in the model in conformity with current blackout peri-
ods. The expected term is explicitly incorporated in the model
by assuming that early exercise occurs when the share price
is greater than or equal to a certain multiple of the exercise
price. This multiple has been set at two based on empiri-




Payables due to policyholders 980 577
Payables due to brokers and agents 1,015 1,090
Payables out of reinsurance 914 815
Social security and taxes payable 74 55
Income tax payable 385 174
Investment creditors 542 512
Cash collateral 7,664 4,020
Repurchase agreements 5,077 4,867
Share appreciation rights 1 1
Other creditors 1,843 1,603
At December 31 18,495 13,714
Current 15,725 11,718
Non-current 2,770 1,996
The carrying amounts disclosed reasonably approximate the
fair values at year end.
Refer to note 38 for a description of share appreciation
rights and related expenses.
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38. Commissions and Expenses (in part)
2010 2009 2008
Commissions 2,802 2,764 3,072
Employee expenses 2,151 2,035 1,899
Administration expenses 1,182 1,227 1,373
Deferred expenses (1,611) (1,613) (1,792)
Amortization of deferred expenses 1,306 1,212 1,332
Amortization of VOBA and future
servicing rights 204 358 225
Total 6,034 5,983 6,109
Included in administration expenses above is depreciation
amounting to EUR 88 million (2009: EUR 90 million; 2008:
EUR 84 million) that relates to equipment, software and real
estate held for own use. The direct operating expenses relat-
ing to investments in real estate that generated rental income
was EUR 83 million (2009: EUR 72 million; 2008: EUR 59
million). Minimum lease payments recognized as expense
amounted to EUR 7 million (2009: EUR 6 million; 2008: EUR
6 million). Included in employee expenses is EUR 29 mil-
lion (2009: EUR 27 million; 2008: EUR 26 million) regarding
defined contribution expenses.
Included in the amortization of deferred expenses and
VOBA is EUR (27) million (2009: EUR 78 million; 2008: EUR
14 million) that is classified for segment reporting purposes as
non underlying earnings as an offset against realized gains
and losses and impairments on financial investments. In-
cluded in employee expenses is EUR 74 million that is classi-
fied for segment reporting purposes as non underlying earn-
ings (2009 and 2008: nil).
Employee Expenses 2010 2009 2008
Salaries 1,368 1,311 1,285
Post-employment benefit costs 258 281 180
Social security charges 134 150 146
Other personnel costs 390 287 303
Share appreciation rights and share
options 1 6 (15)
Total 2,151 2,035 1,899
Share Appreciation Rights and Share Options
Senior executives of AEGON companies, as well as other
AEGON employees, have been offered both share appre-
ciation rights and share options. These share appreciation
rights and share options have been granted at an exercise
price equal to the market price of the shares at the date of the
grant. The rights and options granted in 2004–2008 vest after
three years and can only be exercised during the four years
after the vesting date. The rights and options granted in 2003
vest after two years and can only be exercised during the five
years after the vesting date. Vesting and exercisability de-
pend on continuing employment of the individual employee
to whom the rights and options have been granted. Option
plans are settled in equity, whilst stock appreciation rights
are settled in cash or provide the employee with the choice
of settlement.
Decisions by the Executive Board to implement share ap-
preciation rights and share option plans are subject to ap-
proval by the Supervisory Board. If, subsequently, the Exec-
utive Board decides to implement such plans, that decision
has to be approved by the Supervisory Board.
In compliance with regulations under Dutch law, share ap-
preciation rights and share options cannot be exercised in
blackout periods.
Long Term Incentive Plan
In 2010, AEGON implemented a new Long Term Incentive
Plan which replaces the option plan, share appreciation plans,
share plans or similar plans relating to AEGON shares. Mem-
bers of the Executive Board and the Management Board, as
well as other senior managers within AEGON, have been
granted the right to receive AEGON shares if certain perfor-
mance indicators are met and depending on continued em-
ployment of the individual employee to whom the rights have
been granted. The shares were granted in May at the average
share price on the NYSE Euronext stock exchange in Ams-
terdam during the period between December 15 preceding a
plan year and January 15 of a plan year. The performance in-
dicators apply over a vesting period of three years and consist
of financial and non-financial targets set by the Supervisory
Board or the local remuneration committees. After the vesting
period, the shares are transferred to the individual employ-
ees. Members of the Executive Board and the Management
Board are not entitled to execute any transactions regarding
the shares for a period of two years following vesting.
In compliance with regulations under Dutch law, no trans-
actions regarding the shares can be exercised in blackout
periods.
In 2010, 4,266,107 shares were granted to participants in
the Long Term Incentive Plan of which 52,314 shares were
subsequently forfeited.
Share Appreciation Rights
The following tables present the movements in number of
share appreciation rights outstanding (SARs), as well as the
breakdown by the year in which they were granted.
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Outstanding at January 1, 2009 18,144,141 15.30 1.71 0
Forfeited (1,168,508) 13.68
Expired (5,643,604) 26.70
Outstanding at January 1, 2010 11,332,029 9.78 1.44 0
Forfeited (992,380) 10.47
Expired (2,443,509) 6.30
Outstanding at December 31, 2010 7,896,140 10.77 0.79 0
Exercisable at December 31, 2010 7,649,840 10.83 0.68 0















2003 11,447,300 2,562,809 — 6.30 until March 11, 2010
2004 11,574,850 4,934,254 4,546,426 10.56 until March 17, 2011
2005 4,575,600 3,183,566 2,778,114 10.86 until March 8, 2012
2006 244,300 183,700 177,100 14.00 until March 14, 2013
2007 309,500 213,600 148,200 14.98 until March 13, 2014
2008 300,300 254,100 246,300 8.93 until March 11, 2015
Total 28,451,850 11,332,029 7,896,140
In 2009 and 2010 no share appreciation rights were granted.
The volatility is derived from quotations from external mar-
ket sources and the expected dividend yield is derived from
quotations from external market sources and the binomial op-
tion pricing model. Refer to note 3 for a further description of
the method used to estimate the fair value and a description
of the significant assumptions.
The liability related to share appreciation rights is valued
at fair value at each balance sheet date. Refer to note 28
for details. The costs related to the share appreciation rights
amount to EUR 4 million (2009: EUR (5) million; 2008: EUR
(34) million) and are recognized in the income statement as
part of ‘Commissions and expenses.’
Share Appreciation Rights and Share Options
No share appreciation rights and share options were granted
in 2009 and 2010. The fair value of a share appreciation right
or share option at the grant date in 2008 amounted to EUR
1.57. This amount is equal to the weighted average fair value
for 2008.
No share options were exercised and no SARs were paid
during 2009 and 2010. The total intrinsic value of share op-
tions exercised and SARs paid during 2008 amounted to EUR
1 million.
At December 31, 2010, the total compensation cost related
to non-vested awards not yet recognized is estimated at EUR
1 million (2009: EUR 5 million). The weighted average period
over which it is expected to be recognized is 0.25 years (2009:
0.8 years).
No cash is received from exercise of share options during
2010, 2009 and 2008. Cash used to settle share appreciation
rights amounts to EUR 0 million in 2010 (2009: EUR 0 million;
2008: EUR 0.4 million).
The exposure from the issued share appreciation rights and
share options is economically hedged by part of the position
in treasury shares.
There have been no modifications to the plans during the
financial year.
No share appreciation rights and share options were
granted in 2009 and 2010. The breakdown of the share appre-
ciation rights and share options granted in 2008 is as follows:
senior executives 4,747,500 and other employees 5,822,700.
Refer to note 52 for detailed information about the SARs/
share options and the shares and options conditionally
granted to the Executive Board.
52. Related Party Transactions (in part)
Related party transactions include, among others, transac-
tions between AEGON N.V. and Vereniging AEGON.
Share options and share appreciation rights and interests
in AEGON N.V. held by active members of the Executive
Board.
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2003 50,000(1) — — 50,000 — — 6.30
2004 50,000 — — — 50,000 50,000 10.56
2005 34,132 — — — 34,132 34,132 9.91
2006 50,842 — — — 50,842 50,842 14.55 44,210
Jan J. Nooitgedagt — — — — — — — —
(1) The share appreciation rights were granted before becoming a member of the Executive Board.
For each of the members of the Executive Board, the shares
held in AEGON as shown in the above table do not exceed
1% of total outstanding share capital at the balance sheet
date.
At the balance sheet date, Mr. Wynaendts had mortgage
loans with AEGON totalling to EUR 1,485,292, with interest
rates of 4.1%, 4.3%, 4.4% and 5.4%. These loans were made
in AEGON’s ordinary course of business, pursuant to a widely
available employee benefit program on terms comparable to
other AEGON employees in the Netherlands and were ap-
proved in advance by the Supervisory Board. In accordance
with the terms of the mortgage loans, no principal repayments
were received on the loans in 2010.
Cash-Settled Phantom Shares
2.366
Gerdau S.A. (Dec 2010)
CONSOLIDATED BALANCE SHEETS (in part)
As of December 31, 2010 and 2009
In thousands of Brazilian reais (R$)
Note 2010 2009
Non-Current Liabilities
Long-term debt 14 12,360,056 12,563,155
Debentures 15 616,902 600,979
Deferred income taxes 9 2,270,849 2,273,759
Unrealized losses on derivatives 16 92,476 90,377
Provision for tax, civil and labor
liabilities 18 645,375 447,171
Environmental liabilities 21 42,902 66,642
Employee benefits 20 834,471 961,300
Put options on non-controlling




NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2—Summary of Significant Accounting Practices
(in part)
2.11—Employee Benefits
The Company has several employee benefit plans includ-
ing pension and retirement plans, health care benefits, profit
sharing, bonus, and share-based payment, as well as other
retirement and termination benefits. The main benefit plans
granted to the Company’s employees are described in notes
20 and 25.
The actuarial obligations related to the pension and re-
tirement benefits and the actuarial obligations related to the
health care plans are recorded based on actuarial calcula-
tions performed every year by independent actuaries, using
the projected unit credit method, net of the assets that fund the
plan, when applicable, and the related costs are recognized
over the employees’ vesting period. Any employee benefit
plan surpluses are also recognized up to the probable amount
of reduction in future contributions of the plans’ sponsor.
The projected unit credit method considers each period
of service as a triggering event of an additional benefit unit,
which is accrued to calculate the total obligation. Other ac-
tuarial assumptions are also used such as estimates of the
increase of healthcare costs, demographical and economic
hypotheses and, also, historical costs and employee contri-
butions.
Actuarial gains and losses arising from adjustments and
changes in actuarial assumptions of the pension and retire-
ment benefit plans and actuarial obligations related to the
health care plan are recognized directly in Equity as described
in Note 20. The Company believes that the recognition of ac-
tuarial gains and losses in comprehensive income provides
a better presentation of these changes in the consolidated
financial statements when considered as a whole.
Note 25—Long-Term Incentive Plans (in part)
II) Gerdau Ameristeel Corporation—(“Gerdau Ameristeel”)
In February 2010, the Board of Directors of the Company ap-
proved the adoption of the Equity Incentive Plan (the “EIP”).
Awards under the EIP may take the form of stock options,
SARs, deferred share units (“DSUs”), restricted share units
(“RSUs”), performance share units (“PSUs”), restricted stock,
and/or other share-based awards. Except for stock options,
which must be settled in common shares, awards may be
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settled in cash or common shares as determined by the Com-
pany at the time of grant.
For the portion of any award which is payable in options
or SARs, the exercise price of the options or SARs will be
no less than the fair market value of a common share on the
date of the award. The vesting period for all awards (including
RSUs, DSUs and PSUs) is determined by the Company at
the time of grant. Options and SARs have a maximum term
of 10 years.
On March 12, 2010, an award of approximately US$11.8
million (R$ 20.81 million) was granted to participants un-
der the EIP for 2010 performance. The Company issued
1,728,689 equity-settled SARs, 277,621 RSUs, and 396,602
PSUs under this plan. This award is being accrued over the
vesting periods.
In connection with the adoption of the EIP, the Company
terminated the existing long-term incentive plan (“LTIP”), and
no further awards will be granted under the LTIP. All outstand-
ing awards under the LTIP will remain outstanding until either
exercised, forfeited or they expire. At December 31, 2010,
there were 2,577,470 cash-settled SARs, 1,397,701 stock
options, and 428,489 phantom shares outstanding under the
LTIP. These awards are being accrued over the vesting pe-
riod.
An award valued at approximately US$10.6 million
(R$24.54 million) was earned by participants pursuant to the
long-term incentive plan in 2008 and was granted 40% in
SARs, 30% in options and 30% in phantom stock. On March
5, 2009, the Company issued 2,002,116 options as part of
this award.
On August 30, 2010, Gerdau S.A. indirectly acquired all
of the outstanding common shares of the Company not al-
ready owned, directly or indirectly, by Gerdau S.A. In con-
nection with the acquisition, all outstanding Options, SARs,
PSUs, RSUs, and Phantom Shares as well as shares un-
der the amended and restated employment agreement of the
Company’s President and Chief Executive (the “Executive”)
were converted to awards in respect of American Depository
Shares of Gerdau S.A. (“ADS”), which represents the right to
receive one preferred share of Gerdau S.A. The conversion
was based on the relative value of a common share of the
Company to an ADS as at the closing of the Arrangement in
order to maintain an equivalent intrinsic value of the award
at the time of the exchange. A conversion factor was applied
of 0.7993 (the “conversion factor”), equal to the final closing
price of a common share of the Company on the New York
Stock Exchange (“NYSE”) divided by the closing price of an
ADS on the NYSE on August 27, 2010, the last trading day
for the Company’s common shares.
All amounts (e.g. grants, exercises, forfeitures, weighted
average fair value, fair value, etc.) disclosed in this footnote
regarding share-based activity prior to August 30, 2010 (the
“modification date”) are on a pre-conversion basis in respect
of the Company’s common shares. All amounts disclosed
related to activity after the modification date are on a post-
conversion basis in respect of ADSs.
Modification expenses for equity-settled awards are rec-
ognized if the effect of the modification increases the total
fair value of the equity-settled awards or is otherwise bene-
ficial to the employee. The incremental fair value granted is
the difference between the fair value of the modified equity
award and that of the original award, both estimated at the
date of modification. If the modification occurs during the vest-
ing period, the incremental fair value granted is recognized
for services received over the remaining vesting period while
the original grant date fair value of the original equity award
continues to be recognized in accordance with the original
vesting period. If the modification occurs after vesting date,
the incremental fair value granted is recognized immediately.
The modification date fair value of all of the Company’s eq-
uity settled awards was less than the fair value of the original
awards at the modification date. As such, no incremental ex-
pense was recognized by the Company. The modification did
not impact the Company’s classification of equity-settled and
cash-settled awards.
Phantom Shares
Phantom Shares provide the holder with the opportunity to
receive a cash payment equal to the fair market value of
the ADSs. Phantom Shares vest 25% each year over a four
year period with the holders receiving payment for vested
shares on each grant anniversary date. The holders of Phan-
tom Shares have no voting rights, but accumulate additional
shares based on notional dividends paid by Gerdau S.A. on its
ADSs at each dividend payment date, which are reinvested
as additional Phantom Shares. Compensation expense re-
lated to Phantom Shares is recognized over the vesting pe-
riod based upon the number of shares that are expected to
vest and remain outstanding at the end of the reporting pe-
riod. On the date of grant, the fair value of a Phantom Share
is equal to the fair value of the underlying reference shares.
For Phantom Shares, the fair value is remeasured at each
balance sheet reporting date.
IAS 12, INCOME TAXES
SIC 21, INCOME TAXES—RECOVERY
OF REVALUED NON-DEPRECIABLE
ASSETS
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
Accounting for income taxes is significantly different
between IFRSs and FASB ASC. Therefore, revising
IAS 12 was originally part of a convergence project
with FASB. However, in 2009, the two boards deter-
mined that revising their respective standards on ac-
counting for income taxes was a larger project than
originally anticipated, and they removed it from that
agenda. In March 2010, the IASB determined to pro-
ceed with more limited amendments to IAS 12 and
planned to issue an exposure draft in late 2010 and
a revised standard in the first half of 2011. The IASB
proposed including the following in a revised standard:
• An initial step in which the entity would consider
whether the recovery of an asset or settlement of
liability will affect taxable profit
• Recognition of a deferred tax asset in full and
an offsetting valuation allowance to the extent
necessary, which is similar to that required in US
GAAP
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• Guidance on assessing the need for a valuation
allowance
• Guidance on substantive enactment
• Allocation of current and deferred taxes within a
group that files a consolidated tax return
The IASB is also considering proposals on the follow-
ing issues:
• Treatment of the tax effect of dividends paid by
entities such as real estate investment trusts and
cooperatives
• Uncertain tax positions, after finalizing the revi-
sion of IAS 37
• Deferred tax on property remeasured at fair value
In December 2010, the IASB issued Deferred Tax: Re-
covery of Underlying Assets: Amendments to IAS 12,
which addressed the last item in the preceding list: de-
ferred tax on property remeasured at fair value. IAS 12
requires an entity to measure the deferred tax relating
to an asset depending on whether the entity expects
to recover the carrying amount of the asset through
use or sale. When the asset is measured using the fair
value model in IAS 40 Investment Property, an entity
might find it difficult and subjective to assess whether
recovery will be through use or sale. This amendment
provides a practical solution to the problem by intro-
ducing a presumption that recovery of the carrying
amount will normally be through sale. As a result of
these amendments, SIC 21, Income Taxes—Recovery
of Revalued Non-Depreciable Assets, would no longer
apply to investment properties carried at fair value. The
amendments also incorporate into IAS 12 the remain-
ing guidance previously contained in SIC 21, which
is accordingly withdrawn. The amendments are effec-
tive for annual periods beginning on or after 1 January
2012, with early application permitted. Given the is-
sue and effective dates, no survey companies would
have applied these amendments to their 2010 financial
statements.
The IASB does not plan to address other issues in the
IAS 12 project until the latter half of 2011.
2.367 IAS 12 establishes the accounting for the current and
future tax consequences of taxes levied on an entity’s income
by taxation authorities. Because the accounting for financial
reporting and tax purposes may be different, an entity can
have current and future tax consequences from the future
recovery of the carrying amount of assets, the future settle-
ment of its liabilities, and transactions and other events in the
current period recognized in its financial statements.
2.368 In IAS 12, income taxes include all domestic and
foreign taxes that are based on taxable profits and also include
taxes, such as withholding taxes, which are payable by a
subsidiary, associate, or joint venture on distributions to the
reporting entity. IAS 12 does not address the accounting
for government grants but does address the accounting for




2.369 Accounting for income taxes in accordance with IAS
12 relies on the following two essential differences between
financial reporting and tax reporting:
• Difference between profit or loss on the statement of
comprehensive income and taxable profit determined
by the rules of the relevant taxation authorities
• Difference between the carrying value of an asset or a
liability in the balance sheet and its tax base, which is
the amount that is attributable to the asset or liability
for tax purposes (temporary difference)
2.370 Temporary differences may be either taxable or de-
ductible. A taxable or deductible temporary difference results
in taxable amounts or deductible amounts, respectively, in a
future period when the carrying amount of the asset is re-
covered or the liability is settled. Deferred tax assets and
deferred tax liabilities are amounts that are recoverable or
taxable, respectively, in future periods as a result of these
temporary differences. Deferred tax liabilities result from
taxable temporary differences. Deferred tax assets can result
not only from deductible temporary differences but also an
unused tax loss or unused tax credit carryforward.
2.371 Tax expense (or income) is defined as the aggregate
amount included in profit or loss for the period in respect of
current and deferred tax. Current tax expense is the amount of
income taxes payable (or recoverable) in respect of taxable
profit (or loss) during the period. Although not explicitly
defined, measurement of deferred tax assets and liabilities
in accordance with IAS 12 determines the measurement of
deferred tax expense.
2.372 An entity should recognize as a liability current tax
and any current tax from prior periods that remains unpaid.
Taxes paid in advance or payments in excess of tax payable in
prior periods are recognized as an asset. When the benefits of
a tax loss can be carried back to prior periods to recover cur-
rent tax paid in prior periods, an entity should also recognize
an asset.
2.373 An entity should recognize a deferred tax liability
for all taxable temporary differences, except when the dif-
ference arises on initial recognition of either goodwill or an
asset or a liability from a transaction that was not a business
combination and at the time of the transaction did not affect
either accounting or taxable profit (or loss). An entity should
recognize a deferred tax asset for all deductible temporary
differences to the extent that future taxable profit will be
available, except when the difference arises on initial recog-
nition of an asset or a liability from a transaction that was not
a business combination and at the time of the transaction did
not affect either accounting or taxable profit (or loss).
2.374 In accordance with the recognition and measurement
requirements of IFRS 3, an entity should measure goodwill
arising in a business combination as either the excess of the
sum of the consideration transferred or the amount of the
noncontrolling interest and the fair value of any previously
held equity interest over the net identifiable assets acquired.
However, many taxation authorities do not permit reductions
in the carrying amount of goodwill to be deductible for tax
purposes; hence, the tax base of goodwill is nil. Although
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the difference between the tax base and its carrying value
is a taxable temporary difference, IAS 12 does not permit
recognition of the deferred tax liability because goodwill is
measured as a residual and its recognition would result in an
increase in the carrying value of goodwill. In contrast, if the
carrying value of goodwill is less than its tax base, the entity
should recognize a deferred tax asset to the extent that future
taxable profit would be available against which the deduction
could be used.
2.375 An entity should recognize a deferred tax asset for
unused tax losses and unused tax credits that can be carried
forward to future years to the extent that future taxable profit
would be available against which the loss or credit could be
used. At the end of each reporting period, an entity should
reassess any unrecognized deferred tax assets. To the extent
that it is probable that future taxable profit would be available,
an entity should recognize a deferred tax asset. An entity
should review the carrying value of deferred tax assets and
liabilities at the end of each reporting period and reduce
deferred tax assets to the extent future taxable profit will not
be available against which to use the asset. This reduction can
be reversed in the future if taxable profit becomes available.
Probable is not specifically defined in IAS 12.
2.376 An entity should not recognize a deferred tax asset
or liability in respect of its investments in subsidiaries, asso-
ciates, and joint ventures when it is probable that the tempo-
rary difference will not reverse in the foreseeable future and
with respect to the following:
• Deferred tax asset. The entity expects future taxable
profit to be available against which to use the deductible
temporary difference.
• Deferred tax liability. The entity can control the timing
of the reversal of the taxable temporary difference.
2.377 Using enacted or substantially enacted tax rates or
laws, an entity should measure current tax liabilities or as-
sets for the current period at the amount they expect to pay
or recover, respectively. An entity should measure deferred
tax assets and liabilities at enacted or substantially enacted
tax rates that are expected to apply in the period of recovery
or payment. Measurement of deferred tax assets or liabili-
ties should reflect that manner in which the entity expects
to recover the asset or settle the liability. For example, when
there are differential tax rates for income generated by oper-
ating activities and income from sales of assets and the entity
intends to recover the asset by its use in operations, the en-
tity should use the rate on operating income to measure the
liability.
2.378 An entity should not discount future cash inflows and
outflows to measure a deferred tax asset or liability.
2.379 IAS 12 notes that a revaluation of an asset may not
always affect taxable profit or loss in the period of the revalu-
ation; consequently, the entity should not adjust the tax base
of the asset as a result of the revaluation. However, if the
future recovery of the asset’s carrying amount will be tax-
able, an entity should recognize any difference between the
carrying amount of the revalued asset and its tax base as a
deferred tax liability or asset in respect of the temporary dif-
ference. SIC 21 requires an entity to recognize the deferred
tax consequences of revaluation of a nondepreciable asset,
such as land, based on its recovery through sale and use of
the tax rate that would apply in that circumstance.
U.S. GAAP
2.380 FASB ASC 740, Income Taxes, provides more exten-
sive requirements and guidance on recognition and measure-
ment of income taxes.
2.381 Like IFRSs, the FASB ASC glossary defines income
taxes as domestic and foreign federal (national), state, and
local (including franchise) taxes based on income. To ac-
complish the objectives of recognizing income tax, FASB
ASC 740-10-05-5 explains that an entity should recognize
the following in its financial statements:
• Amount of estimated taxes payable or refundable on
tax returns for the current year as a tax liability or asset
• Deferred tax liabilities and assets for the estimated fu-
ture tax effects attributable to temporary differences
and carryforwards
2.382 Like IFRSs, FASB ASC 740-10-05-7 applies the con-
cept of temporary differences to incorporate in the financial
statements the differences that exist between financial re-
porting standards and jurisdiction-specific tax regulations or
law. Both sets of principles confront these differences with
an asset-liability approach and, therefore, focus on the dif-
ference between the carrying value of an asset or a liability
in the entity’s financial statements and its tax basis for tax
reporting.
2.383 However, unlike IFRSs, FASB ASC 740-10-10-1 rec-
ognizes that some events do not have tax consequences. Cer-
tain income is not taxable, and certain expenses or losses are
not deductible. For example, in the United States, municipal
bond interest income is generally not taxable but would be
reported as income in the company’s income statements.
2.384 Unlike IFRSs, which permit the use of substantially
enacted tax rates, FASB ASC 740-10-10-3 only permits the
use of enacted tax rates that are expected to apply to tax-
able income in the period in which the deferred tax asset or
liability is expected to be recovered or settled, respectively.
2.385 Like IFRSs, FASB ASC 740-10-05-5 requires an en-
tity to recognize deferred tax assets and liabilities at amounts
recoverable or taxable, respectively, in future periods as a
result of temporary differences. Both deferred tax assets and
liabilities can result from temporary differences and carry-
forwards. FASB ASC 740-10-25-29 explains that an entity
should recognize a deferred tax liability or asset for all tem-
porary differences and operating loss and tax credit carryfor-
wards, in accordance with FASB ASC 740-10-30-5. How-
ever, FASB ASC 740-10-25-3 includes certain exemptions
from these requirements, unless the temporary differences
are expected to reverse in the foreseeable future.
2.386 Although different criteria apply, neither FASB ASC
nor IFRSs requires deferred tax to be recognized on tem-
porary differences arising from investments in foreign sub-
sidiaries or corporate joint ventures until it becomes ap-
parent that those temporary differences will reverse in the
foreseeable future, as discussed in FASB ASC 740-10-25-3.
IFRSs also exempt temporary differences from investments
in associates. FASB ASC 740-10-25-3 includes some ex-
emptions for events that occurred before specific dates (for
example, bad debt reserves for tax purposes of U.S. savings
and loans that arose in tax years beginning before Decem-
ber 31, 1987). Unlike IFRSs, FASB ASC 740-10-25-3 also
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prohibits recognition of deferred tax assets or liabilities for
the following:
• Leveraged leases
• Goodwill when amortization is not tax deductible (sim-
ilar to the IFRSs exception)
• Differences due to the intra-entity difference between
the tax basis of the assets in the buyer’s tax jurisdiction
and their cost as reported in the consolidated financial
statements
• Differences due to remeasurement of assets and liabili-
ties from the local currency into the functional currency,
using historical exchange rates, and differences that re-
sult from changes in exchange rates or indexing for tax
purposes
2.387 Measurement requirements for deferred tax assets and
liabilities under U.S. GAAP are similar to those under IFRSs.
In contrast with the net approach to recognizing deferred
tax assets under IFRSs, the FASB ASC glossary definition
of deferred tax asset explains that an entity is required to
reduce the deferred tax asset balance by a valuation allowance
if, based on the weight of available evidence, it is more
likely than not that some or all of the deferred tax asset
will not be realized. An entity should measure the valuation
allowance at an amount that reduces the carrying value of
the net deferred tax asset to the amount more likely than
not to be recovered. FASB ASC 740-10-25-6 clarifies that
for purposes of applying the more likely than not threshold
in evaluating the potential realization of deferred tax assets,
more likely than not is defined as a likelihood of more than
50 percent.
2.388 Unlike IFRSs, U.S. GAAP includes requirements re-
garding uncertain tax positions. The FASB ASC glossary
defines a tax position as a position in a previously filed tax
return, or a position expected to be taken in a future tax
return, that is reflected in measuring current or deferred in-
come tax assets and liabilities for interim or annual periods.
A tax position can result in a permanent reduction in income
taxes payable, a deferral of income taxes otherwise currently
payable to future years, or a change in the expected real-
izability of deferred tax assets. The term tax position also
encompasses, but is not limited to, a decision not to file a tax
return; an allocation or a shift of income between jurisdic-
tions; the characterization of income or a decision to exclude
reporting taxable income in a tax return; a decision to classify
a transaction, entity, or other position in a tax return as tax
exempt; and an entity’s status, including its status as a pass-
through entity or a tax-exempt not-for-profit entity. FASB
ASC 740-10 includes detailed procedures for recognition,
measurement, and disclosure of uncertain tax positions.
2.389 Unlike IFRSs, FASB ASC 740-20 also includes re-
quirements for intraperiod tax allocation, including compu-
tation of tax expense and treatment of tax carryforwards.
Presentation
IFRSs
2.390 IFRSs require deferred tax assets and liabilities to be
presented separately from current tax receivable and payable
and classified as noncurrent in a classified balance sheet. IAS
12 prohibits the offsetting of tax assets and liabilities, unless
they relate to the same tax authority and the entity has a legal
right and intends to recover or settle net.
U.S. GAAP
2.391 Rule 5-02 of SEC Regulation S-X requires SEC regis-
trants to present deferred credits in the balance, with separate
amounts for deferred income taxes and deferred tax credits,
and also other assets (for example, deferred tax assets) when
they exceed 5 percent of total assets. However, unlike IFRSs,
in a classified statement of financial position, FASB ASC
740-10-45-4 requires deferred tax assets and liabilities to be
classified as either current or noncurrent based on the classi-
fication of the related asset or liability. For example, deferred
tax assets due to temporary differences related to accounts
receivable would be classified as current. Similarly, deferred
tax liabilities due to temporary differences related to PPE
would be classified as noncurrent. FASB ASC 740-10-45-11
requires an entity that presents a classified balance sheet to
classify a liability associated with an unrecognized tax ben-
efit (or the amount of a net operating loss carryforward or
amount refundable that is reduced) as a current liability, to the
extent that the entity expects to pay or receive cash within the
next 12 months (or current operating cycle if longer). FASB
ASC 740-10-45-5 requires an entity to allocate any valuation
allowances for the same tax jurisdictions on a pro rata basis
between current and noncurrent.
2.392 Like IFRSs, FASB ASC 740-10-45-6 prohibits offset-
ting deferred tax assets and liabilities attributable to different
tax-paying components of the entity or different tax jurisdic-
tions. However, an entity should present current deferred tax
assets and liabilities as a single amount and all noncurrent
deferred tax assets and liabilities as a single amount only for
a particular tax-paying component of the entity and within
a particular tax jurisdiction. FASB ASC 740-10-45-13 pro-
hibits the offset of cash or other assets against the tax liability,
unless the general criteria for offsetting, in accordance with
FASB ASC 210-20-45-6, are met.
Disclosure
Author’s Note
Both IAS 12 and FASB ASC 740 require significant
additional disclosures about the effects of accounting
for income taxes on the statement of comprehensive
income. These disclosures are described, and excerpts
are provided, beginning with paragraph 3.322 of sec-
tion 3.
IFRSs
2.393 Under IAS 12, an entity should disclose the amount
of deferred tax assets and liabilities due to each type of tem-
porary difference, unused tax loss, and unused tax credit. An
entity should also disclose the aggregate amount of tempo-
rary differences associated with investments in subsidiaries,
associates, and joint ventures for which deferred tax liabili-
ties have not been recognized. For unused tax losses and tax
credits, an entity should disclose the amount and expiration
date (if any) of deductible temporary differences.
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2.394 An entity should disclose the amount of any deferred
tax asset and the nature of the evidence supporting recogni-
tion when the following two conditions are met:
• Recovery of the asset relies on future taxable profit in
excess of that arising from reversal of existing taxable
temporary differences.
• Entity reported a loss in the current or preceding period
in the relevant tax jurisdiction.
U.S. GAAP
2.395 FASB ASC 740-10-50-2 requires an entity to disclose
the aggregate of all deferred tax liabilities, the aggregate of all
deferred tax assets, and the valuation allowance recognized
for deferred tax assets.
2.396 Like IFRSs, for unrecognized tax loss and tax credit
carryforwards, FASB ASC 740-10-50-3 states that an entity
should disclose the amounts of these carryforwards and their
expiration dates for tax purposes. Unlike IFRSs, an entity
should also disclose the portion of any valuation allowance
for deferred tax assets for which subsequently recognized
tax benefits will be credited directly to contributed capital
rather than income. FASB ASC 740-10-50-6 requires public
entities also to disclose the approximate tax effect of each
type of temporary difference and carryforward that gives rise
to a significant portion of deferred tax assets and deferred tax
liabilities (before allocation of valuation allowances).
Presentation and Disclosure Excerpts
Current and Non-current Tax Payables,
Deferred Tax Liabilities, and Tax Loss
Carryforwards
2.397
Nortel Inversora S.A. (Dec 2010)
Author’s Note
Nortel Inversora S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of Jan-
uary 1, 2009. The excerpt that follows reflects the initial
application of IAS 12.
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION
(In millions of Argentine pesos)
As of December 31 As of January 1
Liabilities Note 2010 2009 2009
Current liabilities
Trade payables 11 2,908 2,212 1,769
Financial debt 12 42 763 1,355
Salaries and social security payables 13 390 300 237
Income tax payables 14 491 431 290
Other taxes payables 15 531 338 336
Other liabilities 16 84 84 73
Provisions 17 64 73 36
Total current liabilities 4,510 4,201 4,096
Non-current liabilities
Trade payables 11 — 24 27
Financial debt 12 121 58 688
Salaries and social security payables 13 110 82 83
Deferred income tax liabilities 14 247 243 266
Income tax payables 14 14 13 —
Other liabilities 16 274 267 231
Provisions 17 536 374 319
Total non-current liabilities 1,302 1,061 1,614
Total liabilities 5,812 5,262 5,710
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 3—Significant Accounting Policies (in part)
n) Taxes Payables
The Company and Telecom Group are subject to different
taxes and levies such as municipal taxes, tax on deposits to
and withdrawals from bank accounts, turnover taxes, regula-
tory fees (including SU) and income taxes, among others, that
represent an expense for the Company and for the Group.
They are also subject to other taxes over their activities that
generally do not represent an expense (internal taxes, VAT,
ENARD tax).
The principal taxes that represent an expense for the Com-
pany and Telecom Group are the following:
• Income taxes
Income taxes are recognized in the consolidated income
statement, except to the extent that they relate to items di-
rectly recognized in Other comprehensive income or directly
in equity. In this case, the tax is also recognized in Other
comprehensive income or directly in equity, respectively. The
tax expense for the period comprises current and deferred
tax.
As per Argentinean Tax Law, income taxes payables have
been computed on a separate return basis (i.e., the Company
is not allowed to prepare a consolidated income tax return). All
income tax payments are made by each of the subsidiaries
as required by the tax laws of the countries in which they
operate. The Company records income taxes in accordance
with IAS 12.
Deferred taxes are recognized using the “liability method.”
Temporary differences arise when the tax base of an asset or
liability differs from their carrying amounts in the consolidated
financial statements. A deferred income tax asset or liability is
recognized on those differences, except for those differences
related to investments in subsidiaries where the timing of
the reversal of the temporary difference is controlled by the
Group and it is probable that the temporary difference will not
reverse in the foreseeable future.
Deferred tax assets relating to unused tax loss carryfor-
wards are recognized to the extent that it is probable that
future taxable income will be available against which they
can be utilized. Current and deferred tax assets and liabili-
ties are offset when the income taxes are levied by the same
tax authority and there is a legally enforceable right of off-
set. Deferred tax assets and liabilities are determined based
on enacted tax rates in the respective jurisdictions in which
the Group operates that are expected to apply to taxable in-
come in the years in which those temporary differences are
expected to be recovered or settled.
The statutory income tax rate in Argentina was 35% for
all years presented. Cash dividends received from a foreign
subsidiary are computed on the statutory income tax rate. As
per Argentinean Tax Law, income taxes paid abroad may be
recognized as tax credits.
The statutory income tax rate in Paraguay was 10% for
all years presented. As per Paraguayan Tax Law, dividends
paid are computed with an additional income tax rate of 5%
(this is the criterion used by Núcleo for the recording of its
deferred tax assets and liabilities, representing an effective
tax rate of 14.75%). However, the effect of the additional
income tax rate according to the Argentine tax law in force on
the undistributed profits of Núcleo is fully recognized as it is
considered probable that those results will flow to Personal
in the form of dividends.
• Tax on minimum presumed income
The Company is subject to a tax on minimum presumed in-
come. This tax is supplementary to income tax. The tax is
calculated by applying the effective tax rate of 1% on the tax
basis of certain assets. The Company’s tax liabilities will be
the higher of income tax or minimum presumed income tax.
However, if the tax on minimum presumed income exceeds
income tax during any fiscal year, such excess may be com-
puted as a prepayment of any income tax excess over the tax
on minimum presumed income that may arise in the next ten
fiscal years.
At December 31, 2009, Nortel had accumulated tax loss
carryforwards. As taxable income for year ended December
31, 2010 is lower than local accumulated tax loss carryfor-
wards, Nortel has recorded the proportional charge for the tax
on minimum presumed income (amounting to $3) which, to-
gether with the previous year charges, was capitalized under
the item line “Other non-current receivables.” These charges
have been estimated as fully recoverable based on the Com-
pany’s tax projections and the 10-year legal expiration term
for use of the related credit.
• Turnover tax
Under Argentine tax law, the Company is subject to a tax
levied on interest from financial investments at a rate of 6%.
Telecom Group is subject to a tax levied on revenues and
other income, net of certain deductible expenses. Rates dif-
fer depending on the jurisdiction where revenues are earned
for tax purposes and on the nature of revenues (services
and equipment). Average rates were approximately 4.6% and
4.4% for the years ended December 31, 2010 and 2009, re-
spectively.
• Other taxes
Since the beginning of 2001, telecommunication services
companies have been required to pay a SU tax to fund SU
requirements. The SU tax is calculated as a percentage of
the total revenues received from the rendering of telecom-
munication services, net of taxes and levies applied on such
revenues, excluding the SU tax and other deductions stated
by regulations. The rate is 1% of total billed revenues (See
Note 2.d)).
Congress passed Law No. 26,539 which amends the ex-
cise tax and establishes that the importation and sale of tech-
nological and computer goods, including mobile phones, will
be subject to the excise tax at a rate of 17%, resulting in an
effective tax rate of up to 20.48%, applicable beginning on
December 1, 2009. Telecom Group has the right to trans-
fer this tax to its customers but this is not always possible.
Such cost is included in the item line “Cost of equipment and
handsets.”
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Note 14—Income Tax Payables and Deferred
Income Tax
Income tax payables as of December 31, 2010 and 2009 and
January 1, 2009 consist of the following:





As of December 31,
2009
As of January 1,
2009
Income tax payables 405 662 4 — 1,071 797 635
Payments in advance of income taxes (212) (367) (5) — (584) (346) (110)
Credit on minimum presumed income tax(∗) — — — — — (23) (235)
Law No. 26,476 Tax Regularization Regime 3 — — — 3 3 —
Current income tax payables (receivables) 196 295 (∗∗)(1) — 490 431 290
Deferred income tax liabilities 101 143 1 2 247 (∗∗∗)242 266
Law No. 26,476 Tax Regularization Regime 14 — — — 14 13 —
Non-current Income tax payables 115 143 1 2 261 255 266
(∗) The Company is subject to a tax on minimum presumed income. This tax is supplementary to income tax. The tax is calculated by applying
the effective tax rate of 1% on the tax basis of certain assets. The Company’s tax liabilities will be the higher of income tax or minimum
presumed income tax. However, if the tax on minimum presumed income exceeds income tax during any financial year, such excess
may be computed as a prepayment of any income tax excess over the tax on minimum presumed income that may arise in the next ten
financial years.
(∗∗) Núcleo’s receivable is included in Current other receivables, net—Tax credits.
(∗∗∗) Núcleo’s deferred income tax assets amounted to $1 and are included in Non-current other receivables, net.
The tax effects of temporary differences that give rise to sig-
nificant portions of the Company’s deferred tax assets and
liabilities are presented below:





As of December 31,
2009
As of January 1,
2009
Tax loss carryforwards — 1 — — 7 8 5 5
Allowance for doubtful accounts 22 26 1 — — 49 55 75
Provisions 173 68 — — — 241 184 155
Inventory (2) 10 — — — 8 18 4
Termination benefits 53 1 — — — 54 41 42
Deferred revenues 34 1 — — — 35 37 37
Other deferred tax assets 44 8 — — (2) 50 40 73
Total deferred tax assets 324 115 1 — 5 445 380 391
PP&E and intangible assets (101) (236) 9 (2) — (330) (227) (215)
Inflation adjustments(i) (319) (6) (11) — — (336) (376) (416)
Other deferred tax liabilities (5) — — — — (5) — (10)
Total deferred tax liabilities (425) (242) (2) (2) — (671) (603) (641)
Subtotal net deferred tax assets (liabilities) (101) (127) (1) (2) 5 (226) (223) (250)
—Valuation allowance — (16) — — (5) (21) (19) (16)
Net deferred tax liabilities (101) (143) (1) (2) — (247) (242) (266)
(i) Mainly related to inflation adjustment on PP&E and intangible assets for financial reporting purposes.
As of December 31, 2010, the Company has accumulated
an operating tax loss carryforward of $8 which expires: $1 in
2010, $2 in 2011 (includes $1 of Personal), $1 in 2012, $1 in
2013, and $3 in 2014.
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Income tax expense for the years ended December 31,
2010 and 2009 consists of the following:





Current tax expense (408) (655) (4) — — (1,067)
Deferred tax benefit (expense) 79 (79) (6) — (1) (7)
Valuation allowance — (3) — — 1 (2)
Income tax expense (329) (737) (10) — — (1,076)





Current tax expense (301) (511) (6) — — (818)
Deferred tax benefit (expense) 29 (6) — (1) 2 24
Valuation allowance — (2) — — (2) (4)
Income tax expense (272) (519) (6) (1) — (798)
Income tax expense for the years ended December 31, 2010
and 2009 differed from the amounts computed by applying
the Company’s statutory income tax rate to pre-tax income
as a result of the following:
For the Years Ended
December 31
2010 2009
Pre-tax income 2,861 2,087
Non taxable items—Other income from investments — (13)
Non taxable items—Series “A” preferred shares 171 117
Non taxable items—Other 39 49
Subtotal 3,071 2,240
Weighted statutory income tax rate(∗) 34.4% 34.3%
Income tax expense at weighted statutory tax rate (1,056) (769)
Changes in deferred assets and liabilities (18) (6)
Law No. 26,476 Tax Regularization Regime — (19)
Changes in valuation allowance (2) (4)
(1,076) (798)
(∗) Effective income tax rate based on weighted statutory income tax rate in the different countries where the Company has operations. The
statutory tax rate in Argentina was 35%, in Paraguay was 10% plus an additional rate of 5% in case of payment of dividends, in the USA
the effective tax rate was 34% and in Uruguay the statutory tax rate was 25%.
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Current Tax Receivables and Payables,
Deferred Tax Assets and Liabilities
2.398
AstraZeneca plc (Dec 2010)




Notes $m $m $m
Assets
Non-current assets
Property, plant and equipment 7 6,957 7,307 7,043
Goodwill 8 9,871 9,889 9,874
Intangible assets 9 12,158 12,226 12,323
Derivative financial instruments 15 324 262 449
Other investments 10 211 184 156
Deferred tax assets 4 1,475 1,292 1,236
30,996 31,160 31,081
Current assets
Inventories 11 1,682 1,750 1,636
Trade and other receivables 12 7,847 7,709 7,261
Other investments 10 1,482 1,484 105
Derivative financial instruments 15 9 24 —
Income tax receivable 3,043 2,875 2,581
Cash and cash equivalents 13 11,068 9,918 4,286
25,131 23,760 15,869
Total assets 56,127 54,920 46,950
Liabilities
Current liabilities
Interest-bearing loans and borrowings 14 (125) (1,926) (993)
Trade and other payables 16 (8,661) (8,687) (7,178)
Derivative financial instruments 15 (8) (90) (95)
Provisions 17 (1,095) (1,209) (600)
Income tax payable (6,898) (5,728) (4,549)
(16,787) (17,640) (13,415)
Non-current liabilities
Interest-bearing loans and borrowings 14 (9,097) (9,137) (10,855)
Derivative financial instruments 15 — — (71)
Deferred tax liabilities 4 (3,145) (3,247) (3,126)
Retirement benefit obligations 18 (2,472) (3,354) (2,732)
Provisions 17 (843) (477) (542)
Other payables 16 (373) (244) (149)
(15,930) (16,459) (17,475)
Total liabilities (32,717) (34,099) (30,890)
Net assets 23,410 20,821 16,060
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Group Accounting Policies (in part)
Estimates and Judgements
The preparation of the financial statements in conformity
with generally accepted accounting principles requires man-
agement to make estimates and judgements that affect
the reported amounts of assets and liabilities at the date of the
financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could
differ from those estimates.
Judgements include classification of transactions between
profit and the consolidated statement of financial position and
the determination of operating segments while estimates fo-
cus on areas such as carrying values and estimated lives.
AstraZeneca’s management considers the following to be
the most important accounting policies in the context of the
Group’s operations.
The accounting policy descriptions set out the areas where
judgements and estimates need exercising, the most signifi-
cant of which are revenue recognition, research and develop-
ment (including impairment reviews of associated intangible
assets), business combinations and goodwill, litigation and
environmental liabilities, employee benefits, taxation and op-
erating segments.
Taxation
The current tax payable is based on taxable profit for the
year. Taxable profit differs from reported profit because it
excludes items that are never taxable or tax deductible. The
Group’s current tax assets and liabilities are calculated using
tax rates that have been enacted or substantively enacted by
the reporting date.
Deferred tax is provided using the balance sheet liability
method, providing for temporary differences between the car-
rying amounts of assets and liabilities for financial reporting
purposes and the amounts used for taxation purposes. De-
ferred tax assets are recognised to the extent that it is prob-
able that taxable profit will be available against which the
asset can be utilised. This requires judgements to be made
in respect of the availability of future taxable income.
4. Taxation
Taxation recognised in the profit for the period in the consol-




Current year 3,065 2,854 2,946
Adjustment for prior years 370 251 130
3,435 3,105 3,076
Deferred Tax Expense
Origination and reversal of
temporary differences (369) 98 (486)
Adjustment to prior years (170) 60 (39)
(539) 158 (525)
Taxation recognised in the profit
for the period 2,896 3,263 2,551
Taxation relating to components of other comprehensive in-
come is as follows:
2010 2009 2008
$m $m $m
Current and Deferred Tax
Foreign exchange arising on
consolidation (29) 16 20
Actuarial loss for the period (18) 158 340
Share-based payments 9 17 9
Deferred tax impact of reduction
in UK tax rate (23) — —
Other — 1 (1)
Taxation relating to components
of other comprehensive income (61) 192 368
Taxation has been provided at current rates on the profits
earned for the periods covered by the Group Financial State-
ments. The 2010 prior period current tax adjustment relates
mainly to an increase in provisions for tax contingencies and
double tax relief partially offset by a benefit of $342m arising
from a number of tax settlements (including the UK matters
described in Note 25) and tax accrual to tax return adjust-
ments. The 2009 and 2008 prior period current tax adjust-
ments relate mainly to tax accrual to tax return adjustments,
an increase in provisions in respect of a number of transfer
pricing audits and double tax relief. The 2010 prior period
deferred tax adjustment relates mainly to tax accrual to tax
return adjustments and a reclassification from deferred tax
to current tax of amounts provided in relation to tax con-
tingencies for prior periods. The 2009 and 2008 prior year
deferred tax adjustments relate to tax accrual to tax return
adjustments and the recognition of previously unrecognised
deferred tax assets. To the extent that dividends remitted from
overseas subsidiaries, joint ventures and associates are ex-
pected to result in additional taxes, appropriate amounts have
been provided for. No deferred tax has been provided for un-
remitted earnings of Group companies overseas as these are
considered permanently employed in the business of these
companies. Unremitted earnings may be liable to overseas
taxes and/or UK taxation (after allowing for double tax relief)
if distributed as dividends. The aggregate amount of tempo-
rary differences associated with investments in subsidiaries
and branches for which deferred tax liabilities have not been
recognised totalled approximately $16,768m at 31 December
2010 (2009: $14,846m; 2008: $8,449m).
Factors Affecting Future Tax Charges
As a group involved in worldwide operations, AstraZeneca is
subject to several factors that may affect future tax charges,
principally the levels and mix of profitability in different jurisdic-
tions, transfer pricing regulations, tax rates imposed and tax
regime reforms. It is the UK Government’s intention to enact
legislation which will reduce the main rate of UK corporation
tax to 24% by 2014. In November 2010, the UK Government
also released a consultation document providing details on a
proposed programme of corporate tax reforms including the
introduction of a patent box regime. Details of material tax
exposures and items currently under audit and negotiation
are set out in Note 25.
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Tax Reconciliation to UK Statutory Rate
The table shown below reconciles the UK statutory tax charge
to the Group’s total tax charge.
2010 2009 2008
$m $m $m
Profit before tax 10,977 10,807 8,681
Notional taxation charge at UK corporation tax rate of 28% (28% for 2009, 28.5% for 2008) 3,074 3,026 2,474
Differences in effective overseas tax rates (333) (212) (8)
Deferred tax credit relating to reduction in Swedish, UK and other tax rates(1,2) (21) — (70)
Unrecognised deferred tax asset — 2 (7)
Items not deductible for tax purposes 12 156 119
Items not chargeable for tax purposes (36) (20) (48)
Adjustments in respect of prior periods 200 311 91
Total tax charge for the year 2,896 3,263 2,551
(1) The 2010 item relates to the reduction in the UK statutory corporation tax rate from 28% to 27% effective from 1 April 2011.
(2) The 2008 item relates to the reduction in the Swedish statutory corporation tax rate from 28% to 26.3% effective from 1 January 2009.
Deferred Tax
Deferred tax assets and liabilities and the movements during










































Deferred tax assets at
1 January 2008 66 59 531 907 — 611 62 — 330 71 2,637
Deferred tax liabilities
at 1 January 2008 (693) (3,653) (3) (21) (1,171) (13) — (88) — (70) (5,712)
Net deferred tax
balance at 1 January
2008 (627) (3,594) 528 886 (1,171) 598 62 (88) 330 1 (3,075)
Taxation expense 122 375 24 55 (119) 37 43 — 12 (24) 525
Other comprehensive
income — — 340 — — — 9 — — (1) 348
Exchange 168 130 (113) (35) 199 (37) (14) 24 (7) (3) 312
Net deferred tax
balance at 31
December 2008 (337) (3,089) 779 906 (1,091) 598 100 (64) 335 (27) (1,890)
Deferred tax assets at
31 December 2008 136 42 786 935 — 598 100 — 335 45 2,977
Deferred tax liabilities
at 31 December 2008 (473) (3,131) (7) (29) (1,091) — — (64) — (72) (4,867)
Net deferred tax
balance at 31
December 2008 (337) (3,089) 779 906 (1,091) 598 100 (64) 335 (27) (1,890)
Taxation expense 175 232 (61) 17 (303) (146) 5 — (100) 23 (158)
Other comprehensive
income — — 140 — — — 17 — — — 157
Exchange (46) (36) 54 29 (80) 18 7 (7) (4) 1 (64)
Net deferred tax
balance at 31
December 2009 (208) (2,893) 912 952 (1,474) 470 129 (71) 231 (3) (1,955)
(continued)
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Deferred tax assets at
31 December 2009 266 47 918 968 — 553 129 — 231 34 3,146
Deferred tax liabilities
at 31 December
2009 (474) (2,940) (6) (16) (1,474) (83) — (71) — (37) (5,101)
Net deferred tax
balance at 31
December 2009 (208) (2,893) 912 952 (1,474) 470 129 (71) 231 (3) (1,955)
Taxation expense 131 465 (178) 3 24 66 (5) 2 50 (19) 539
Other comprehensive
income — — (46) — — — 4 — — 1 (41)
Acquisition of
subsidiary
undertaking(2) — (143) — — — — — — — 2 (141)
Exchange (6) 5 (9) 15 (81) 12 (1) 3 (10) — (72)
Net deferred tax
balance at 31
December 2010 (83) (2,566) 679 970 (1,531) 548 127 (66) 271 (19) (1,670)
Deferred tax assets at
31 December 2010 357 54 686 988 — 558 127 — 271 25 3,066
Deferred tax liabilities
at 31 December
2010 (440) (2,620) (7) (18) (1,531) (10) — (66) — (44) (4,736)
Net deferred tax
balance at 31
December 2010 (83) (2,566) 679 970 (1,531) 548 127 (66) 271 (19) (1,670)







Deferred tax assets 1,475 1,292 1,236
Deferred tax liabilities (3,145) (3,247) (3,126)
Net deferred tax balance (1,670) (1,955) (1,890)
(1) Untaxed reserves relate to taxable profits where the tax liability is deferred to later periods.
(2) The deferred tax liability of $143m relates to the acquisition of Novexel S.A.
Unrecognised Deferred Tax Assets
Deferred tax assets of $128m have not been recognised in
respect of deductible temporary differences (2009: $104m;
2008: $80m) because it is not probable that future taxable
profit will be available against which the Group can utilise the
benefits therefrom.
25. Commitments and Contingent Liabilities (in part)
Tax
Where tax exposures can be quantified, an accrual is made
based on best estimates and management’s judgement. De-
tails of the movements in relation to material tax exposures
are discussed below.
Transfer Pricing and Other International Tax Contingencies
AstraZeneca faces a number of transfer pricing audits in ju-
risdictions around the world and, in some cases, is in dispute
with the tax authorities. The issues under discussion are of-
ten complex and can require many years to resolve. Accruals
for tax contingencies require management to make estimates
and judgements with respect to the ultimate outcome of a tax
audit, and actual results could vary from these estimates.
The international tax environment presents increasingly chal-
lenging dynamics for the resolution of transfer pricing dis-
putes. These disputes usually result in taxable profits being
increased in one territory and correspondingly decreased in
another. Our balance sheet positions for these matters reflect
appropriate corresponding relief in the territories affected.
Management considers that at present such corresponding
relief will be available, but given the challenges in the inter-
national tax environment will keep this aspect under careful
review. The total net accrual included in the Group Finan-
cial Statements to cover the worldwide exposure to transfer
pricing audits is $2,310m, a decrease of $17m due to nego-
tiated settlements offset by the impact of an additional year
of transactions relating to contingencies for which accruals
had already been established, revisions of estimates relating
to existing audits, a number of new tax contingencies and
exchange rate effects.
Tax accruals have been made in respect of two individually
significant exposures:
• The tax accrual at 31 December 2008 and 2009 in-
cluded amounts in relation to a long running transfer
pricing dispute between AstraZeneca and HM Revenue
& Customs (HMRC) covering all periods from 1996 on-
wards. In February 2010, AstraZeneca announced that
the company had entered into an agreement with HMRC
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in the UK to settle this dispute. As a consequence of the
settlement, AstraZeneca and HMRC have withdrawn
the joint referral of this issue to the UK Tax Court. The
agreement will result in AstraZeneca paying £505m to
HMRC to resolve all claims made by HMRC in relation
to this issue for the 15-year period from 1996 to the end
of 2010. The £505m settlement is payable in two instal-
ments of which the first instalment of £350m ($562m)
was paid in February 2010. A second final instalment of
£155m is due to be paid in March 2011 and is included
in ordinary tax payable at 31 December 2010.
• AstraZeneca has applied for an advance pricing agree-
ment in relation to intra-group transactions between the
UK and the US which is being progressed through com-
petent authority proceedings under the relevant double
tax treaty.
Management continues to believe that AstraZeneca’s posi-
tions on all its transfer pricing audits and disputes are robust
and that AstraZeneca is appropriately provided.
For transfer pricing audits where AstraZeneca and the tax
authorities are in dispute, AstraZeneca estimates the poten-
tial for reasonably possible additional losses above and be-
yond the amount provided to be up to $565m (2009: $575m);
however, management believes that it is unlikely that these
additional losses will arise. It is possible that some of these
contingencies may reduce in the future to the extent that any
tax authority challenge is unsuccessful, or matters lapse fol-
lowing expiry of the relevant statutes of limitation resulting in
a reduction in the tax charge in future periods.
Other Tax Contingencies
Included in the tax accrual is $1,429m relating to a number
of other tax contingencies, an increase of $468m mainly due
to the impact of an additional year of transactions relating
to contingencies for which accruals had already been estab-
lished and exchange rate effects. For these tax exposures,
AstraZeneca does not expect material additional losses. It is,
however, possible that some of these contingencies may re-
duce in the future if any tax authority challenge is unsuccess-
ful or matters lapse following expiry of the relevant statutes
of limitation resulting in a reduction in the tax charge in future
periods.
Timing of Cash Flows and Interest
It is not possible to estimate the timing of tax cash flows in
relation to each outcome, however, it is anticipated that a
number of significant disputes may be resolved over the next
one to two years. Included in the provision is an amount of





SECTION 3: STATEMENT OF COMPREHENSIVE INCOME
AND RELATED DISCLOSURES∗
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The following items are covered in the indicated sec-
tions within this publication more specific to that topic:
• Assets and liabilities associated with certain in-
come and expense items (see section 2, “State-
ment of Financial Position and Related Disclo-
sures”).
• Assets held for sale and discontinued operations
(see section 6, “Non-current Assets Held for Sale
and Discontinued Operations”).
• Financial instruments (see section 8, “Financial
Instruments and Related Disclosures”).
IFRS Overview and Comparison
to U.S. GAAP
Author’s Note
In September 2010, the International Accounting
Standards Board (IASB) issued Conceptual Frame-
work for Financial Reporting 2010 (IFRS Conceptual
Framework), which supersedes the Framework for the
Preparation and Presentation of Financial Statements.
However, the IFRS Conceptual Framework retains the
definitions of the elements of financial statements (that
is, assets, liabilities, equity, income, and expenses)
from the previous Framework for the Preparation and
Presentation of Financial Statements.
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
applicable as of 1 January 2011.
Author’s Note
In May 2011, the IASB issued International Financial
Reporting Standard (IFRS) 10, Consolidated Finan-
cial Statements, which supersedes the requirements of
International Accounting Standard (IAS) 27, Consoli-
dated and Separate Financial Statements, with respect
to consolidation, and Standing Interpretations Com-
mittee (SIC) 12, Consolidation—Special Purpose En-
tities. Because IFRS 10 and IAS 27, Separate Financial
Statements (as amended in 2011) were not issued until
May 2011, no survey entity could apply the new re-
quirements in its 2010 financial statements. Therefore,
the following commentary only describes the require-
ments in IAS 27 that are applicable to 2010 financial
statements. See additional discussion before paragraph
2.01 in section 2.
3.01 IAS 1, Presentation of Financial Statements, requires
an entity to include in a complete set of financial statements
a statement of comprehensive income for the period. A state-
ment of comprehensive income should present all income and
expense items recognized in the period. An entity can choose
to present the required income, expense, and other compre-
hensive income items in either a single statement of compre-
hensive income or in two statements presented sequentially.
When an entity chooses the two-statement format, it should
prepare a separate income statement that displays the com-
ponents of profit or loss followed by a second statement that
begins with profit or loss and displays the components of
other comprehensive income.
3.02 IAS 27, Consolidated and Separate Financial State-
ments, requires a statement of comprehensive income to in-
clude the results of all entities (subsidiaries) that the reporting
entity controls, except in certain circumstances, eliminating
intragroup income, expenses, and dividends.
3.03 A complete set of financial statements should include
two statements of comprehensive income: one for the current
period and one for the comparable previous period, except
when IFRSs permit or require otherwise.
3.04 When an entity changes the presentation or classifica-
tion of items in the statement of comprehensive income, it
should also reclassify comparative period information, unless
it is impracticable to do so.
3.05 The IFRS Conceptual Framework establishes the con-
cepts that underlie the preparation and presentation of finan-
cial statements for external users and contains definitions of
the elements of financial statements (that is, assets, liabili-
ties, equity, income, and expenses). Among other purposes,
the IFRS Conceptual Framework assists preparers of finan-
cial statements in applying IFRSs and in dealing with topics
that have yet to form the subject of a specific standard or
interpretation.
3.06 IAS 8, Accounting Policies, Changes in Accounting
Estimates and Errors, states that when making judgments
about an issue not specifically addressed in IFRSs, an entity’s
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management should first refer to and consider the applica-
bility of the requirements in IFRSs dealing with similar and
related issues and then refer to the definitions, recognition
criteria, and measurement concepts in the IFRS Conceptual
Framework. Although the IFRS Conceptual Framework is
not a standard, the requirements of IAS 8 essentially estab-
lish the IFRS Conceptual Framework as part of the IFRS
hierarchy of accounting and reporting requirements.
3.07 The IFRS Conceptual Framework defines income as in-
creases in economic benefits during the accounting period in
the form of inflows or enhancements of assets or decreases
in liabilities that result in increases in equity, other than those
increases relating to contributions from the entity’s owners.
This definition includes both revenue and gains. Revenue is
defined as income that arises in the course of an entity’s or-
dinary activities. Gains, on the other hand, may or may not
arise from ordinary activities of the entity, and IFRSs do not
consider gains to be a separate element of the financial state-
ments. An entity should recognize income when an increase
in future economic benefits related to an increase in an asset
or a decrease in a liability can be measured reliably. How-
ever, an entity should only recognize an increase in an asset
when it is probable that future economic benefits will flow to
the entity.
3.08 The IFRS Conceptual Framework defines an expense as
outflows or depletions of assets or an incurrence of liabilities
that result in a decrease in equity, other than those relating to
distributions to the entity’s owners. Expenses, which include
the concept of losses, may or may not arise in the course of the
ordinary activities of the entity. IFRSs also do not consider
a loss to be a separate element of the financial statements.
An entity should recognize an expense when a decrease in
economic benefits related to a decrease in an asset or an
increase in a liability can be measured reliably. However, an
entity should recognize an increase in a liability only when it
is probable that an outflow of economic benefits will occur.
Author’s Note
Although not specifically discussed in the IFRS Con-
ceptual Framework, changes in fair value meet the def-
inition of income or expense when recognized in either
profit or loss or other comprehensive income.
3.09 The IFRS Conceptual Framework also notes that ex-
penses usually are recognized in profit and loss when directly
associated with a specific item of income, often referred to
as the “matching concept.” However, the IFRS Conceptual
Framework explicitly states that application of this concept
does not permit recognition of items on the balance sheet that
do not meet the definition of an asset or a liability. An entity
should recognize an expense immediately for an expenditure
that does not produce future benefits or to the extent that the
expenditure does not qualify for recognition as an asset. An
entity also recognizes an expense when it incurs a liability
without the recognition of an asset (for example, product
warranty liabilities). Expenses related to the use of assets
over several accounting periods should be allocated to profit
or loss on a rational, systematic basis.
Presentation
IFRSs
3.10 At a minimum, IAS 1 requires the statement of com-
prehensive income to include the following line items:
• Revenues
• Finance costs (interest expense)
• Share of profit or loss of equity-method investments
(for example, associates and jointly controlled entities)
• Tax expense
• Discontinued operations as a single amount consisting
of the sum of any profit or loss from the discontinued
operations and any gain or loss on disposal of related
assets or disposal groups
• Profit or loss (net income)
• Share of the other comprehensive income of equity-
method investments
• Each component of other comprehensive income clas-
sified by nature
• Total comprehensive income
3.11 An entity should also provide separate allocations of
profit or loss and total comprehensive income attributable to
the following:
• Noncontrolling interest
• Owners of the parent entity
3.12 An entity should also present additional line items,
headings, and subtotals when these would be relevant for
understanding its financial performance during the period.
IAS 1 also suggests that an entity should amend descriptions
of line items and consider factors such as materiality and the
nature or function of line items when making these decisions.
3.13 An entity should not offset income and expense items
unless required or permitted by an IFRS.
3.14 IAS 1 prohibits the presentation of any line item as
an extraordinary item in the statement of comprehensive in-
come, a separate income statement (if presented), or in the
notes.
Author’s Note
Despite the prohibition against the presentation of an
extraordinary item (that is, presenting the item net of
income taxes and outside of continuing operations),
IAS 1 does not define exceptional or unusual items.
Except for discontinued operations, all other income
statement income and expense items are considered to
be operating items, regardless of the titles an entity
uses for subtotals it provides in the income statement.
Several survey companies use the terms exceptional
or unusual to differentiate among line items included
in the income statement before income taxes. An en-
tity may also define and disclose its own non-generally
accepted accounting principles (GAAP) performance
metric (for example, underlying earnings is not mea-
sured in accordance with GAAP) as long as it also
provides a reconciliation of that metric to profit or loss
measured in accordance with IFRSs.
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3.15 An entity should present all items of income and ex-
pense in profit or loss, unless IFRSs require or permit other-
wise, and should disclose reclassification adjustments related
to components of other comprehensive income. An entity
should disclose the amount of income tax related to compo-
nents of other comprehensive income and may either show
each component net of related tax or each component at its
pretax amount, with an aggregated amount of tax related to
total other comprehensive income items.
U.S. GAAP
3.16 Financial Accounting Standards Board (FASB) Ac-
counting Standards Codification (ASC) 220-10-45-5 re-
quires an entity to report all components of comprehensive
income in its financial statements in the period in which the
components are recognized and to display a total amount
for comprehensive income in the financial statement where
the components of other comprehensive income are reported.
When the entity has a noncontrolling interest in a subsidiary,
it should present separate amounts for both comprehensive
income attributable to the parent and attributable to the non-
controlling interest in the subsidiary on the face of the rele-
vant financial statement, in addition to presenting total con-
solidated comprehensive income. FASB ASC 220-10-45-13
explains that an entity should classify components of com-
prehensive income based on their nature.
3.17 Like IFRSs, FASB ASC 220-10-45-8 does not require
one format for the statement in which an entity presents com-
prehensive income and its components, as long as the finan-
cial statement is displayed with the same prominence as its
other financial statements and net income is shown as a com-
ponent of comprehensive income in that financial statement.
Additionally, like IFRSs, FASB ASC 220-10-45-9 permits an
entity to include the components of comprehensive income
in the income statement or in a separate statement that begins
with net income and encourages an entity to use one of these
formats. Although FASB ASC 220-10-45-10 states that pre-
senting items of other comprehensive income in an income
statement-like form is superior to presenting these items in
a statement of changes in equity, unlike IFRSs, FASB ASC
220-10-45-14 permits an entity to present the components of
comprehensive income in a statement of changes in equity.
3.18 Like IFRSs, FASB ASC 220-10-45-12 requires an en-
tity to disclose the amount of income tax expense or benefit
allocated to each component of other comprehensive income,
including reclassification adjustments, either on the face of
the relevant statement or in the notes to the financial state-
ments.
3.19 Rule 5-03, “Income Statements,” of Securities and Ex-
change Commission (SEC) Regulation S-X prescribes the
format of the income statement for issuers and requires an
issuer to display net sales and gross revenues, separately dis-
closing the following classes, which are different from those
required by IFRSs:
• Net sales of tangible products (gross sales less dis-
counts, returns, and allowances)
• Operating revenues of public utilities or others
• Income from rentals
• Revenues from services
• Other revenues
3.20 The aforementioned SEC rule permits an entity to com-
bine classes of net sales and gross revenue derived from a
particular class with another class if each is not more than
10 percent of the sum of the classes. When such classes of
income are combined, an entity should also combine the re-
lated costs and expenses. IFRSs do not include a quantitative
threshold for aggregating the prescribed line items on the
statement of comprehensive income.
3.21 Unlike IFRSs, FASB ASC 225-20 provides for the
presentation of extraordinary items in the income statement
when the required conditions are met. Extraordinary items,
as defined in the FASB ASC glossary, are events and transac-
tions that are distinguished by both their unusual nature and
infrequency of occurrence. Additionally, extraordinary items
should be material in relation to income before extraordinary
items, to the trend of annual earnings before extraordinary
items, or material by other appropriate criteria in order to be
classified separately in the income statement in accordance
with FASB ASC 225-20-45-3. Unlike IFRSs, Rule 5-03 of
SEC Regulation S-X includes a long list of cost and expense
line items that an entity should show separately, including
extraordinary items, net of tax. Some of these line items may
be provided in note disclosures. Like IFRSs, an entity should
show material amounts of the preceding items separately.
Disclosure
IFRSs
3.22 IAS 1 requires an entity to present the following addi-
tional information either in the statement or in the notes:
• Nature and amount of material items of income or ex-
pense (for example, inventory write-downs, restructur-
ing activities, disposals of investments, and so on).
• Analysis of expenses by nature or by function (for ex-
ample, cost of sales), whichever provides reliable and
more relevant information, with subclassifications to
highlight differences in components (such as frequency
and potential for gain or loss). When an entity classifies
expenses by function, it should also disclose informa-
tion about the nature of expenses, particularly depreci-
ation and amortization expense and employee benefit
expense.
Author’s Note
IAS 1 encourages entities to provide the analysis of
expenses in the statement of comprehensive income or
the income statement, rather than in the notes. How-
ever, some companies present one line item, “operating
expenses,” in the statement with the disaggregation in
a note disclosure.
U.S. GAAP
3.23 FASB ASC 225-10 does not contain a disclosure re-
quirement comparable to the analysis of expenses. However,
Rule 5-03 of SEC Regulation S-X effectively requires SEC
registrants to provide this analysis by its list of required cost
and expense line items. Paragraphs 9 and 12 of FASB ASC
225-20-45 explain that extraordinary items should be seg-
regated from the results of ordinary operations and shown
separately in the income statement, with disclosure of the
nature and amounts thereof, including earnings per share
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data, presented either on the face of the income statement or
in the related notes.
TABLE 3-1: ANALYSIS OF EXPENSES RECOGNIZED IN
PROFIT AND LOSS
2010 2009 2008
Survey entities reporting expenses by
function................................................... 92 86 54
Survey entities reporting expenses by
nature......................................................
Financial institutions............................... 11 12 6
Insurance entities................................... 8 8 5
Entities in other industries...................... 59 54 35
Total................................................... 170 160 100
TABLE 3-2: ITEMS OF OTHER COMPREHENSIVE
INCOME
2010 2009
Foreign currency translation.............................................. 136 129
Change in fair value of available for sale
financial instrument ........................................................ 106 102
Change in fair value of property plant and equipment
held at revalued amount................................................. 15 13
Change in fair value of intangible assets held at
revalued amount............................................................. 0 0
Cash flow hedges.............................................................. 101 94
Hedge of net investment in a foreign operations.............. 11 11
Other derivatives and hedging transactions...................... 11 20
Actuarial gains and losses on defined benefit plans......... 61 62
Share of other comprehensive income of associates
and joint ventures........................................................... 35 32
Share-based payments ..................................................... 2 4
Revaluation of equity interest............................................ 8 9
Other.................................................................................. 31 20
Disclosure of Income Tax Recognized Directly
in Equity
Tax effect shown in statement....................................... 94 87
Items shown net of tax................................................... 65 64
No items of other comprehensive income..................... 11 9
Total Companies...................................................... 170 160
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Presentation and Disclosure Excerpts
Single Statement—Statement of
Comprehensive Income, Expenses by Nature
3.24
Huaneng Power International Inc. (Dec 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME
For the years ended December 31, 2010, 2009 and 2008
(Prepared in accordance with International Financial Re-
porting Standards)
(Amounts expressed in thousands of RMB or US$, except
per share data)
For the Year Ended December 31
2010 2009 2008
Note RMB US$ RMB RMB
Operating revenue 5 104,318,120 15,751,600 76,862,896 67,835,114
Tax and levies on operations (147,641) (22,293) (151,912) (106,385)
Operating Expenses
Fuel (67,891,547) (10,251,340) (44,861,375) (49,810,275)
Maintenance (2,302,018) (347,595) (2,035,297) (1,702,274)
Depreciation (10,447,021) (1,577,456) (8,572,103) (7,718,773)
Labor (4,067,420) (614,163) (3,595,340) (3,164,613)
Service fees on transmission and transformer facilities of HIPDC 34 (140,771) (21,256) (140,771) —
Purchase of electricity (5,557,219) (839,117) (3,639,440) (2,726,028)
Others 6 (5,135,492) (775,438) (4,692,955) (3,842,992)
Total operating expense (95,541,488) (14,426,365) (67,537,281) (68,964,955)
Profit/(Loss) from operations 8,628,991 1,302,942 9,173,703 (1,236,226)
Interest income 89,026 13,443 60,397 83,522
Financial Expenses, Net
Interest expense (5,282,549) (797,643) (4,260,400) (4,064,779)
Exchange gain and bank charges, net 87,964 13,282 (48,925) 356,836
Total financial expense, net (5,194,585) (784,361) (4,309,325) (3,707,943)
Share of profits of associates 8 568,794 85,886 756,164 72,688
Gain/(Loss) on fair value changes 11,851 1,789 (33,638) (54,658)
Other investment income 60,013 9,061 56,675 51,061
Profit/(Loss) before income tax expense 6 4,164,090 628,760 5,703,976 (4,791,556)
Income tax (expense)/benefit 31 (842,675) (127,240) (593,787) 239,723
Net profit/(loss) 3,321,415 501,520 5,110,189 (4,551,833)
Other Comprehensive Income/(Loss), Net of Tax
Available-for-sale financial asset fair value changes (258,204) (38,988) 773,967 (1,563,388)
Proportionate share of other comprehensive (loss)/income of investees measured
using the equity method of accounting (35,156) (5,308) 8,795 3,096
Hedging instruments for cash flow hedges (112,377) (16,968) 604,645 (476,601)
Currency translation differences 457,670 69,105 173,548 (536,638)
Other comprehensive income/(loss), net of tax 51,933 7,841 1,560,955 (2,573,531)
Total comprehensive income/(loss) 3,373,348 509,361 6,671,144 (7,125,364)
Net Profit/(Loss) Attributable to:
—Equity holders of the Company 3,347,985 505,532 4,929,544 (3,937,688)
—Non-controlling interests (26,570) (4,012) 180,645 (614,145)
3,321,415 501,520 5,110,189 (4,551,833)
Total Comprehensive Income/(Loss) Attributable to:
—Equity holders of the Company 3,397,720 513,042 6,489,317 (6,509,014)
—Non-controlling interests (24,372) (3,681) 181,827 (616,350)
3,373,348 509,361 6,671,144 (7,125,364)
Earnings/(Loss) Per Share for Profit/(Loss) Attributable to the Equity Holders
of the Company (Expressed in RMB or US $ Per Share)
—Basic and diluted 32 0.28 0.04 0.41 (0.33)
Dividends paid 21 2,528,050 381,725 1,241,633 3,570,334
Proposed dividend 21 2,811,077 424,461 2,531,631 1,205,538
Proposed dividend per share (expressed in RMB or US $ per share) 21 0.20 0.03 0.21 0.10
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
5. Revenue and Segment Information (in part)
A reconciliation of revenue from external customers to oper-
ating revenue is provided as follows:
For the Year Ended December 31
2010 2009 2008
Revenue from external customers (PRC GAAP) 104,307,702 79,742,331 72,198,019
Reconciling item:
Impact of business combination under common control(∗) — (2,884,007) (4,372,882)
Impact of IFRS adjustment(∗∗) 10,418 4,572 9,977
Operating revenue per consolidated statement of comprehensive income 104,318,120 76,862,896 67,835,114
(∗) Under PRC GAAP, the business combination under common control is accounted for under merger accounting method; the operating
results for all periods presented are retrospectively restated by combining the financial information of the businesses acquired as if they
had been combined from the date when the combining entities first came under the control of the controlling party. Therefore, the financial
information of business acquired before the acquisition date is shown as the difference between PRC GAAP and IFRS.
(∗∗) The GAAP adjustments above were primarily represented by the classification adjustments and other adjustments, and the GAAP adjust-
ments other than classification were primarily brought forward from prior years. Such differences will be gradually eliminated following
subsequent depreciation and amortization of related assets or the extinguishment of liabilities.
Two Statements—Income Statement and
Statement of Other Comprehensive Income,
Expenses by Function, Disaggregation of
Expenses by Nature in Note Disclosure
3.25
Vina Concha y Toro S.A. (Dec 2010)
Author’s Note
Vina Concha y Toro S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of January
1, 2009. The excerpt that follows reflects the initial
application of IAS 1.
CONSOLIDATED STATEMENTS OF INCOME BY FUNCTION
For the Year Ended December 31
Note 2010 2009
Statement of Income by Function N◦ Th$ Th$
Income from ordinary activities (29) 374,018,545 354,418,905
Cost of sales (30) (241,775,864) (223,443,943)
Gross revenue 132,242,681 130,974,962
Other income by function 886,787 106,046
Distribution costs (30) (68,256,090) (65,807,994)
Administrative expenses (30) (18,850,626) (18,674,326)
Other expenses by function (30) (747,463) (460,452)
Financial income (31) 340,264 734,741
Financial expenses (31) (3,149,276) (5,594,142)
Participation in income (loss) of associates and joint-ventures
recorded using the equity method — 984,406 811,500
Exchange differences (31) 9,057,132 10,837,415
Income/expense by adjustment units (31) (866,507) 1,950,267
Income before tax 51,641,308 54,878,017
(continued)
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For the Year Ended December 31
Note 2010 2009
N◦ Th$ Th$
Income tax expense (22) (9,722,728) (9,599,971)
Income from continued operations 41,918,580 45,278,046
Income 41,918,580 45,278,046
Income (loss) attributable to :
Income attributable to owners of the company 41,918,574 45,278,038
Income attributable to non-controlling interests 6 8
Income 41,918,580 45,278,046
Income per share
Income per basic share
Income per basic share in continued operations 56.12 61.39
Income per basic share 56.12 61.39
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 30. Costs and Expenses by Nature
Costs and expenses by nature as of December 31, 2010 are
disclosed as follows.















Direct cost 236,295,058 — — — 236,295,058
Maintenance 286,222 3,176,573 2,624,377 — 6,087,172
Depreciations and amortizations 439,095 1,438,406 629,261 — 2,506,762
Power 198,553 719,459 33,200 — 951,212
Transportation and distribution 426,876 9,151,547 161,346 — 9,739,769
Remunerations 2,057,177 14,452,667 13,028,678 — 29,538,522
Advertising and promotions 230,670 34,176,365 31,207 — 34,438,242
Leases 1,608,497 1,449,509 480,753 — 3,538,759
Other expenses 233,716 3,691,564 1,861,804 747,463 6,534,547
Total 241,775,864 68,256,090 18,850,626 747,463 329,630,043
The costs distribution and expenses by nature as of Decem-
ber 31, 2009 are disclosed as follows:















Direct cost 215,900,388 — — — 215,900,388
Maintenance 1,190,801 2,768,575 2,242,252 — 6,201,628
Depreciations and amortizations 424,824 1,016,337 607,783 — 2,048,944
Power 158,076 562,482 25,674 — 746,232
Transportation and distribution 842,426 20,894,343 197,683 — 21,934,452
Remunerations 1,921,786 12,053,061 13,426,816 — 27,401,663
Advertising and promotions 273,889 24,779,549 636,169 — 25,689,607
Leases 388,963 1,538,248 241,662 — 2,168,873
Other expenses 2,342,790 2,195,399 1,296,287 460,452 6,294,928
Total 223,443,943 65,807,994 18,674,326 460,452 308,386,715
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Analysis of Expenses by Function,
Disaggregation of Cost of Sales
in Note Disclosure
3.26
Harmony Gold Mining Company Limited
(Jun 2010)
GROUP INCOME STATEMENTS
For the years ended 30 June 2010
SA Rand US Dollar
2009(∗) 2010 Figures in Million Note 2010 2009(∗)
Continuing Operations
11,496 11,284 Revenue 1,489 1,277
(9,659) (10,484) Cost of sales 5 (1,383) (1,083)
(7,657) (8,358) Production costs (1,103) (850)
(1,253) (1,375) Amortisation and depreciation (181) (139)
(546) (331) Impairment of assets (43) (71)
(39) (205) Employment termination and restructuring costs (27) (4)
(164) (215) Other items (29) (19)
1,837 800 Gross profit 106 194
(329) (382) Corporate, administration and other expenditure (50) (36)
(33) (81) Social investment expenditure (11) (4)
(259) (219) Exploration expenditure (29) (29)
947 104 Profit on sale of property, plant and equipment 6 14 114
(101) (58) Other expenses—net 7 (8) (3)
2,062 164 Operating profit 8 22 236
12 56 Profit from associates 21 7 1
1 — Profit on sale of investment in associate — —
(112) — Impairment of investment in associate 21 — (14)
— (24) Loss on sale of investment in subsidiary 9 (3) —
(101) 38 Net gain/(loss) on financial instruments 10 5 (10)
443 187 Investment income 11 25 49
(212) (246) Finance cost 12 (32) (24)
2,093 175 Profit before taxation 24 238
(188) (335) Taxation 13 (44) (22)
1,905 (160) Net (loss)/profit from continuing operations (20) 216
Discontinued Operations
1,022 (32) (Loss)/profit from discontinued operations 14 (4) 95
2,927 (192) Net (loss)/profit (24) 311
Attributable to:
2,927 (192) Owners of the parent (24) 311
— — Non-controlling interest — —
(Loss)/earnings per ordinary share (cents): 15
460 (38) (Loss)/earnings from continuing operations (5) 52
247 (8) (Loss)/earnings from discontinued operations (1) 23
707 (46) Total (loss)/earnings for the period (6) 75
Diluted (loss)/earnings per ordinary share (cents): 15
458 (38) (Loss)/earnings from continuing operations (5) 51
246 (8) (Loss)/earnings from discontinued operations (1) 23
704 (46) Total diluted (loss)/earnings for the period (6) 74
(∗) The comparative periods have been re-presented for a change in discontinued operations. Refer to note 14.
The accompanying notes are an integral part of these con-
solidated financial statements.
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GROUP STATEMENTS OF OTHER
COMPREHENSIVE INCOME
For the years ended 30 June 2010
SA Rand US Dollar
2009 2010 Figures in Million Note 2010 2009
2,927 (192) Net (loss)/profit for the year (24) 311
(450) (131)
Other comprehensive (loss)/income for the year, net
of income tax 25 111
(497) (127) Foreign exchange translation 26 25 105
47 (4) Fair value movement of available-for-sale investments 26 — 6
2,477 (323) Total comprehensive (loss)/income for the year 1 422
Attributable to:
2,477 (323) Owners of the parent 1 422
— — Non-controlling interest — —
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
5. Cost of Sales
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
7,657 8,358 Production costs (a) 1,103 850
1,176 1,326
Amortisation and depreciation of mining properties, mine
development costs and mine plant facilities 175 130
77 49
Amortisation and depreciation of assets other than mining
and mining related assets (b) 6 9
5 29 Rehabilitation expenditure (c) 4 1
44 57 Care and maintenance cost of restructured shafts 8 5
39 205 Employment termination and restructuring costs (d) 27 4
113 148 Share-based payments (e) 20 13
546 331 Impairment of assets (f) 43 71
2 (19) Provision for post retirement benefits (g) (3) —
9,659 10,484 Total cost of sales 1,383 1,083
(a) Production costs include mine production, transport
and refinery costs, applicable general and administra-
tive costs, movement in inventories and ore stockpiles
and ongoing 1 environmental rehabilitation costs as
well as transfers to and from deferred stripping. Ongo-
ing employee termination costs are included, however
employee termination costs associated with major re-
structuring and shaft closures are excluded. Produc-
tion costs, analysed by nature, consist of the following:
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
4,857 5,776 Labour costs, including contractors 762 540
1,937 2,284 Stores and materials 302 215
840 1,212 Water and electricity 160 93
222 178 Insurance 24 25
136 140 Transportation 19 15
(14) (20) Changes in inventory (3) (2)
(953) (1,187) Capitalisation of mine development costs (157) (106)
— 6 Deferred mining 1 —
(25) (35) By-products sales (5) (3)
— 33 Royalty expense 4 —
657 (29) Other (4) 73
7,657 8,358 Total production cost 1,103 850
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(b) Amortisation and depreciation of assets other than
mining and mining related assets
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
8 16 Other non-mining assets 2 1
24 30 Intangible assets 4 3
45 3 Amortisation of issue costs — 5
77 49 Total amortisation and depreciation 6 9
(c) For the assumptions used to calculate the rehabilita-
tion costs, refer to note 3.4.
This expense includes the change in estimate for the
rehabilitation provision as well as ongoing rehabilita-
tion cost.
(d) Employment termination and restructuring costs con-
sist of the following:
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
10 72 Harmony Gold Mining Company Limited (Harmony) 9 1
9 4 Randfontein Estates Limited (Randfontein) 1 1
8 116
Evander Gold Mines Limited (Evander)
ARMGold/Harmony Freegold Joint Venture 15 1
12 12 Company (Proprietary) Limited (Freegold) 2 1
— 1 Avgold Limited (Avgold) — —
During the 2010 financial year, certain shafts in Harmony and
Evander were closed and placed on care and maintenance.
These closures were due to mining no longer being econom-
ically viable as a result of the current economic situation.
The group also engaged in a voluntary retrenchment process
during the year, resulting in retrenchment costs for various
operations.
(e) Refer to note 34 for details on the share-based pay-
ments schemes operated by the group.
(f) Impairment consists of the following:
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
52 249 Virginia(1) 33 7
236 11 Target(1) 1 31
258 70 Evander(1) 9 33
— 1 Australia — —
546 331 Total impairment of assets 43 71
(1) During the 2010 financial year impairments to the value of R300 million (US$40 million) were recognised mainly as a result of the shaft
closures discussed under note 5(d) above. The remaining balance in 2010 and the impairment in 2009 resulted from revised business
(life-of-mine) plans, which are completed in June of each year, and included increases in electricity and labour costs. Included in 2009 for
Evander and Target was additional capital expenditure that was needed to access reserve ounces in areas where geological anomalies have
been discovered.
These adjustments impacted negatively on the recoverable
amount of property, plant and equipment and contributed to
the recognition of the impairments at the shafts. Impairment
tests were performed as required by IAS 36, Impairment of
Assets, and as a result these impairments were recorded. For
assumptions used to calculate the recoverable amount, refer
to note 3.1.
(g) The net credit of R19 million (US$2.5 million) is a result
of curtailments in 124 members’ post employment sub-
sidies due to renegotiation of employment contracts.
These members were transferred from Freegold em-
ployment conditions to Harmony employment condi-
tions.
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In 2002, the IASB and the FASB jointly initiated a
project on revenue recognition with the objective of
developing a single coherent asset and liability model
for revenue recognition. In such a model, revenue is a
function of changes in assets and liabilities and is not
based on the notions of realization and the completion
of an earnings process. Currently, there are significant
differences between IFRSs and U.S. GAAP in how
and when an entity recognizes revenue. In the course
of this project, the boards issued the following due
process documents:
• In December 2008, the boards published for
public comment a discussion paper, Preliminary
Views on Revenue Recognition in Contracts with
Customers, which set out a joint approach for rev-
enue recognition. Comments were due by June
2009.
• In January 2010, the boards published for pub-
lic comment an exposure draft, Revenue from
Contracts with Customers. The proposed standard
would replace IAS 18, Revenue, IAS 11 Con-
struction Contracts, and related interpretations. In
U.S. GAAP, it would supersede most of the guid-
ance on revenue recognition in Topic 605 of the
FASB Accounting Standards Codification. Com-
ments were due by October 2010.
The core principle in the exposure draft is to recognize
revenue so as “to depict the transfer of goods or services
in an amount that reflects the consideration expected to
be received in exchange for those goods or services.”
An entity would take five steps to apply this principle:
1. Identify the customer contract(s).
2. Identify the separate performance obligations.
3. Determine the transaction price for the con-
tract(s).
4. Allocate the transaction price to the performance
obligations.
5. Recognize revenue when the entity settles the per-
formance obligations.
Overall, comment letters supported the project’s ob-
jective to create a single revenue recognition standard
to be used across industries and capital markets. How-
ever, other comments resulted in redeliberations by the
boards on a number of issues including determining
when transfer occurs for services, clarifying what con-
stitutes a “distinct” performance obligation, handling
of contract modifications, reducing complexity of pro-
posed approach to segmenting contracts, determining
whether an entity should expense all contract acquisi-
tion costs, accruing “statutory” warranty costs, deter-
mining how to account for licenses, reducing complex-
ity of measurements, and determining when to apply a
test for an onerous contract.
In June 2011, because of the extent of the changes to
the proposed standard, the boards decided to reexpose
their revised proposals in the third quarter of 2011 with
a target date for a new IFRS of 2012.
IFRS Overview and Comparison
to U.S. GAAP
3.27 The IFRS Conceptual Framework defines income as
increases in economic benefits during the period in the form
of inflows or enhancements of assets or reductions of liabili-
ties that result in an increase in equity other than an increase
from contributions by equity participants. Income includes
both revenues and gains. The IFRS Conceptual Framework
defines revenue as income that results from the entity’s or-
dinary business activities. Gains also meet the definition of
income but may or may not result from the entity’s ordinary
business activities. Because gains represent increases in eco-
nomic benefits, they are no different in nature from revenue.
Whereas the IFRS Conceptual Framework considers revenue
to be a separate element of the financial statements, a gain is
not considered a separate element.
Recognition and Measurement
IFRSs
3.28 IAS 18, Revenue, establishes the accounting and dis-
closure requirements for revenue from the sale of goods,
rendering of services, and the use by others of an entity’s
assets that yield interest, dividends, or royalties. IAS 18 does
not address the accounting for revenue or income generated
by the extraction of mineral ores, changes in value of cur-
rent assets, or assets covered by another IFRS. For example,
IAS 18 does not apply to revenue arising from leases, divi-
dends from equity-method investments, insurance contracts,
change in fair value or disposal of financial instruments,
agricultural produce, and biological assets since other IFRSs
address these issues.
3.29 Revenue includes only gross inflows received or re-
ceivable by an entity on its own account. When amounts are
collected on behalf of third parties (for example, fees and
commissions), an entity should only recognize revenue for
its fee or commission, not the amount collected. Similarly,
amounts collected on behalf of third parties, such as sales
taxes, goods and services taxes, and value-added taxes, are
not economic benefits that flow to the entity and do not result
in increases in equity; therefore, these items are excluded
from revenue.
3.30 IAS 18 requires an entity to segment or combine trans-
actions to arrive at the substance of the arrangement for rev-
enue recognition purposes. Because there is limited guidance
on segmenting and combining in IAS 18, the entity should
refer to and consider the applicability of the guidance on
segmenting and combining transactions included in IAS 11,
Construction Contracts.
Author’s Note
For more information on IAS 11, see paragraph 3.64
in this section.
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3.31 Revenue is measured at the fair value of the consid-
eration received or receivable. The fair value should take
into account any trade discounts or volume rebates. When
a transaction is effectively a financing arrangement, IAS 18
requires an entity to determine the fair value by discounting
future cash flows using an imputed interest rate. The imputed
rate of interest is the more clearly determinable of either the
prevailing rate on similar instruments by issuers with similar
credit ratings or the rate that discounts the nominal amount of
the instrument to the current cash sales price of the goods or
services provided. An entity should recognize the difference
between the present value and the nominal amount as interest
revenue, in accordance with IAS 39, Financial Instruments:
Recognition and Measurement.
3.32 When goods and services are exchanged, an entity
should not recognize revenue when the goods or services
are similar. An entity should only recognize revenue when it
exchanges dissimilar goods or services. In an exchange, an
entity should measure revenue at the fair value of the goods
or services received. Only when this fair value cannot be
measured reliably should the entity recognize revenue at the
fair value of the goods or services given up, adjusted by any
cash or cash equivalent transferred.
3.33 SIC Interpretation 31, Revenue—Barter Transactions
Involving Advertising Services, when entering into a barter
transaction, an entity should recognize revenue only when the
fair value is determined by reference to nonbarter transactions
with certain characteristics.
3.34 IAS 18 requires an entity to meet two conditions before
recognizing revenue on the sale of goods. The entity should
• transfer the significant risks and rewards of ownership
of the goods to the buyer and
• retain neither continuing management involvement as-
sociated with ownership nor effective control over the
goods sold.
3.35 An entity should determine that the economic benefits
from the transfer of the goods are probable and should mea-
sure reliably both the revenue and the costs associated with
the transaction. An entity should recognize a sale when it
retains only an insignificant amount of the risk and rewards
of ownership.
3.36 To meet the probability criteria when an entity does not
receive consideration at the time the goods are transferred and
is uncertain about the consideration’s future collectability, the
entity should measure revenue at the amount expected to be
collected.
3.37 With respect to revenue generated by providing
services, an entity should recognize revenue using the
percentage-of-completion method; that is, the entity recog-
nizes revenue when it is probable that future economic ben-
efits will be received and it can reliably measure all of the
following:
• Amount of revenue
• Stage of completion
• Costs incurred
• Costs to complete the project
IAS 18 does not require an entity to use a particular method
for measuring the stage of completion. Use of surveys of
work performed, services performed to date, and the per-
centage of costs incurred are all acceptable measurement
methodologies.
3.38 When the outcome of a transaction for services cannot
be measured reliably, an entity should recognize revenue only
up to the amount of recoverable costs incurred.
3.39 An entity should recognize revenue from the use of
assets generating interest, dividends, or royalties only when
receipt of the expected economic benefits is probable and it
can measure the amount reliably. IAS 18 requires an entity
to recognize these types of revenue as follows:
• Recognize interest revenue using the effective interest
method
• Recognize royalty revenue using the accrual basis, in
accordance with the substance of the relevant agree-
ment
• Recognize dividend revenue when an entity’s share-
holder rights to dividends are established
U.S. GAAP
3.40 FASB ASC 605, Revenue Recognition, includes exten-
sive requirements and guidance for revenue recognition and
measurement, which exceed that provided in IAS 18. Rev-
enue guidance is contained in both FASB ASC and rules of
the SEC.
3.41 FASB ASC 605-10-25-1 generally permits an entity to
recognize revenue only in the following circumstances:
• The revenue is realized or realizable (that is, when the
goods or services are exchanged for cash or claims to
cash).
• The revenue is being earned (that is, when the entity
has substantially accomplished what it must do to be
entitled to the benefits represented by the revenues).
3.42 However, FASB ASC 605-10-25-4 permits revenue
and gain recognition using the installment or cost-recovery
methods under exceptional circumstances. The cost-recovery
method yields essentially the same results as the requirements
of IAS 18 in circumstances when the outcome of a transaction
cannot be measured reliably. IFRSs do not permit entities to
use the installment method. Unlike IFRSs, for transactions
involving the rendering of services, FASB ASC 605 does not
require an entity to use the percentage-of-completion method
of revenue recognition.
3.43 SEC Codification of Staff Accounting Bulletins topic
13, “Revenue Recognition,” states that revenue generally is
realized or realizable and earned when all of the following
criteria are met:
• Persuasive evidence of an arrangement exists.
• Delivery of the goods has occurred or services have
been rendered.
• The seller’s price to the buyer is fixed or determinable.
• Collectability is reasonably assured.
3.44 In addition, unlike IFRSs, FASB ASC and SEC sources
contain detailed transaction-specific guidance. For example,
these sources provide guidance on revenue recognition for
sales when the title is retained, bill and hold sales, goods
are shipped but not billable or are subject to conditions,
consignment sales, layaway sales, options to buy, special
orders and drop shipments, sale and repurchase agreements,
subscriptions, and points and other items redeemable for
goods or services.
3.45 Despite the detailed guidance on the timing of recogni-
tion, FASB ASC and SEC sources contain little guidance on
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measurement, other than the previously noted requirement
for the seller’s price to be fixed or determinable. Additional
guidance about this condition exists for extended payment
terms, reseller arrangements, customer cancellation privi-
leges, fiscal funding clauses, and software arrangements. If
the fee is not fixed or determinable, an entity should recog-
nize revenue as payments are received.
3.46 FASB ASC 605-25 contains more guidance on seg-
menting of transactions, referred to as multiple element ar-
rangements, for both recognition and measurement. FASB
ASC 605-25-30-2 requires that when there is objective and
reliable evidence of the fair values of different units of ac-
count in an arrangement, the entity should allocate the con-
sideration to these units based on their relative fair values,
except when fair values do not exist for delivered elements.
In the latter case, the residual method is used to allocate the
consideration to the separate elements.
Author’s Note
In October 2009, FASB issued Accounting Stan-
dards Update (ASU) No. 2009-13, Revenue Recog-
nition (Topic 605): Multiple-Deliverable Revenue
Arrangements—a consensus of the FASB Emerging Is-
sues Task Force. This ASU addresses the accounting
for multiple-deliverable arrangements to enable ven-
dors to account for products or services (deliverables)
separately, rather than as a combined unit. This guid-
ance affects accounting and reporting for all vendors
that enter into multiple-deliverable arrangements with
their customers when those arrangements are within
the scope of FASB ASC 605-25. This guidance is la-
beled as “Pending Content” due to the transition and
open effective date information discussed in FASB
ASC 605-25-65-1. The ASU became effective prospec-
tively for revenue arrangements entered into or materi-
ally modified in fiscal years beginning on or after June
15, 2010. See the ASU or “Pending Content” in FASB
ASC 605-25. The fiscal years of all survey companies
included in the sample began before June 15, 2010.
3.47 Like IFRSs, FASB ASC 605-45 requires entities to




3.48 IAS 1 requires an entity to present total revenue sepa-
rately on the statement of comprehensive income. Use of the
term revenue is not required.
Author’s Note
Companies domiciled in the United Kingdom com-
monly use the term “turnover” in place of revenue.
U.S. GAAP
3.49 Rule 5-03 of SEC Regulation S-X requires SEC reg-
istrants to present revenues on a separate line item on the
income statement.
3.50 Unlike IFRSs, FASB ASC 605-45-50-3 explains that
an entity may present taxes collected from customers and
remitted to governmental authorities on either a gross basis
(included in both revenues and costs) or net basis (excluded




3.51 An entity should disclose its accounting policies for
revenue recognition separately for the following categories:
sales of goods, services, interest, dividends, and royalties.
The policies should appear either on the face of the statement
of comprehensive income or in the notes. Entities should also
disclose the amount of revenue recognized from the exchange
of goods or services in each of those categories.
U.S. GAAP
3.52 FASB ASC 235-10-50-3 also requires entities to dis-
close the accounting policy for revenue recognition. FASB
ASC 235 does not require disclosures comparable to those
required by IAS 18 for each type of revenue.
3.53 FASB ASC 605 includes extensive disclosure require-
ments, including those pertaining to multiple element ar-
rangements and specific industry requirements. For example,
FASB ASC 605-25-50-1 requires an entity to provide spe-
cific disclosures regarding multiple element arrangements,
including the accounting policy for such arrangements (for
example, whether deliverables are separable into units of ac-
counting) and the nature of such arrangements (for example,
provisions for performance, termination, or cancellation of
the agreement). “Pending Content” in FASB ASC 605-25-
50-1 explains that the objective of the disclosure guidance
is to provide both qualitative and quantitative information
about a vendor’s revenue arrangements and the significant
judgments made about the application of FASB ASC 605-25,
changes in those judgments, or the application of FASB ASC
605-25 that may significantly affect the timing or amount of
revenue recognition. Therefore, in addition to the required
disclosures, a vendor shall also disclose other qualitative and
quantitative information as necessary to comply with this
objective.
3.54 For SEC registrants, SEC Codification of Staff Account-
ing Bulletins topic 13(B), “Disclosures,” provides SEC staff
views on disclosures pertaining to revenue recognition.
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Presentation and Disclosure Excerpts
Revenue—Sales of Goods and Contracts
to Provide Services
3.55
Ultra Electronics Holdings plc (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)







Revenue 3 710,043 651,036
Cost of sales — (505,425) (462,524)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Statement of Accounting Policies (in part)
In Respect of the Group’s Consolidated Financial
Statements
A summary of the Group’s principal accounting policies, all
of which have been applied consistently across the Group
throughout the current and preceding year, are set out below:
Revenue Recognition
Revenue from the sale of goods is measured at the fair value
of the consideration received or receivable and represents
amounts receivable for goods and services provided in the
normal course of business, net of discounts, VAT and other
sales related taxes. Sales of goods are normally recognised
when goods are delivered and title has passed.
Revenue from contracts to provide services is recognised
by reference to the stage of completion of the contracts in the
same way as for long-term contracts.
Revenue from long-term contracts is recognised in accor-
dance with the Group’s accounting policy on long-term con-
tracts (see accounting policy ‘Long-term contracts’).
Interest income is accrued on a time basis, by reference
to the principal outstanding and at the effective interest rate
applicable.
Long-Term Contracts
Where the outcome of a long-term contract can be estimated
reliably, revenue and costs are recognised by reference to
the stage of completion of the contract activity at the balance
sheet date. This is normally measured by the proportion that
contract costs incurred for work performed to date bear to
the estimated total contract costs, except where this would
not be representative of the stage of completion. Variations
in contract work, claims and incentive payments are included
to the extent that they have been agreed with the customer,
or when it is considered probable that the customer will ap-
prove the variation and the amount of revenue arising from
the variation.
Where the outcome of a long-term contract cannot be esti-
mated reliably, contract revenue is recognised to the extent of
contract costs incurred that it is probable will be recoverable.
Contract costs are recognised as expenses in the period in
which they are incurred.
When it is probable that total contract costs will exceed
total contract revenue, the expected loss is recognised as an
expense immediately.
Revenue—Sales of Services and Barter
Transactions
3.56
City Telecom (H.K.) Limited (Aug 2010)
CONSOLIDATED INCOME STATEMENTS
City Telecom (H.K.) Limited and its subsidiaries
(Expressed in Hong Kong dollars)








Revenue 2 1,574,687 1,478,239 1,302,981
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Significant Accounting Policies (in part)
(s) Revenue Recognition
(i) Revenue for the provision of international telecommu-
nications and fixed telecommunications network ser-
vices is recognized, when an arrangement exists, ser-
vice is rendered, the fee is fixed or determinable, and
collectability is probable.
(ii) Tariff-free period granted to subscribers of fixed
telecommunications network services are recognized
in profit or loss ratably over the term of the service
subscription agreement. Unbilled revenue represents
revenue recognized in accordance with the require-
ment in note 1(s)(i) that has not been billed to the
subscriber.
(iii) Amount received in advance for the provision of fixed
telecommunications network services is deferred and
included under deferred service revenue, and subse-
quently recognized as revenue on a straight-line basis
over the related service period.
(iv) Interest income is recognized as it accrues using the
effective interest method.
(v) Rental income receivable under operating leases is
recognized in profit or loss in equal installments over
the periods covered by the lease term. Lease incen-
tives granted are recognized in profit or loss as an
integral part of the aggregate net lease payments re-
ceivable.
(v) Accounting for Barter Transactions
When goods or services are exchanged for goods or services
which are of a similar nature and value, the exchange is not
regarded as a revenue generating transaction.
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When goods are sold or services are rendered in exchange
for dissimilar goods or services, the exchange is regarded
as a transaction which generates revenue. The revenue is
measured at the fair value of the goods or services received,
adjusted by the amount of any cash or cash equivalents trans-
ferred. When the fair value of the goods or services received
cannot be measured reliably, the revenue is measured at the
fair value of the goods or services rendered, adjusted by the
amount of any cash or cash equivalents transferred.
2. Turnover and Segment Information (in part)
The Group is principally engaged in the provision of inter-
national telecommunications services and fixed telecommu-
nications network services to customers in Hong Kong and










services 218,589 247,359 291,943
Fixed telecommunications
network services (note 2(b)) 1,356,098 1,230,880 1,011,038
1,574,687 1,478,239 1,302,981
28. Barter Transaction
During the year ended August 31, 2010, HKBN entered into
an agreement with a third party (the “Contract Party”). Pur-
suant to the agreement, HKBN would provide network ca-
pacity to the Contract Party for a service term of 10 years
commencing on May 1, 2010 or after the respective activa-
tion of the relevant network capacity, and in exchange, the
Contract Party would provide HKBN the right to use telecom-
munications facilities for a term of 10 years commencing on
May 1, 2010 or after the respective activation of the rele-
vant network capacity. The transaction has been entered into
on a barter basis at no consideration being exchanged. The
agreement expires on April 30, 2020.
The Directors of the Company made an assessment and
determined that since the arrangement above involves ex-
change of services of a similar nature and value, the ex-
change is not regarded as a transaction which generates
revenue. Accordingly, the network capacity of the Contract
Party under the arrangement has not been recognized as an
asset and no revenue or deferred revenue has been recog-
nized in the financial statements of the Group since inception
of the arrangement.
Revenue—Bill and Hold Transactions
3.57
Tenaris S.A. (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)
(All amounts in thousands of U.S. dollars, unless otherwise
stated)
Year Ended December 31
Notes 2010 2009 2008
Continuing Operations
Net sales 1 7,711,598 8,149,320 11,987,760
Cost of sales 1 & 2 (4,700,810) (4,864,922) (6,698,285)
Gross profit 3,010,788 3,284,398 5,289,475
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
S. Revenue Recognition
Revenue comprises the fair value of the consideration re-
ceived or receivable for the sale of goods and services in the
ordinary course of Tenaris’ activities. Revenue is shown net
of value-added tax, returns, rebates and discounts and after
eliminating sales within the group.
Tenaris’ products and services are sold based upon pur-
chase orders, contracts or upon other persuasive evidence of
an arrangement with customers, including that the sales price
is known or determinable. Sales are recognized as revenue
upon delivery, when neither continuing managerial involve-
ment nor effective control over the products is retained by
Tenaris and when collection is reasonably assured. Delivery
is defined by the transfer of risk, provision of sales contracts
and may include delivery to a storage facility located at one
of the Company’s subsidiaries. For bill and hold transactions
revenue is recognized only to the extent (a) it is probable
delivery will be made; (b) the products have been specifically
identified and are ready for delivery; (c) the sales contract
specifically acknowledges the deferred delivery instructions;
(d) the usual payment terms apply.
The percentage of total sales that were generated from
bill and hold arrangements for products located in Tenaris’s
storage facilities that have not been shipped to customers
amounted to 1.2%, 0.7% and 1.7% as of December 31, 2010,
2009 and 2008, respectively. The Company has not experi-
enced any material claims requesting the cancellation of bill
and hold transactions.
Other revenues earned by Tenaris are recognized on the
following bases:
• Interest income: on the effective yield basis.
• Dividend income from investments in other companies:
when Tenaris’ right to receive payment is established.
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Revenue—Software, Support, Subscription,
Consulting Revenues and Multiple Element
Arrangements
3.58
SAP AG (Dec 2010)
CONSOLIDATED INCOME STATEMENTS OF SAP
GROUP (in part)
For the years ended December 31,










Software revenue 4,332 3,265 2,607 3,606
Support revenue 8,138 6,133 5,285 4,602
Subscription and other software-related service revenue 525 396 306 258
Software and software-related service revenue 12,996 9,794 8,198 8,466
Consulting revenue 2,915 2,197 2,074 2,498
Other service revenue 628 473 400 611
Professional services and other service revenue 3,543 2,670 2,474 3,109
Total revenue (5) 16,538 12,464 10,672 11,575
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
(3) Summary of Significant Accounting Policies
(in part)
(3b) Relevant Accounting Policies (in part)
Reclassifications (in part)
We have reclassified and renamed certain revenue items in
our Consolidated Financial Statements: As a result of the
acquisition of Sybase we recognize revenue from messaging
services. This revenue is presented within the other service
revenue line item within the professional services and other
service revenue subsection. In addition, we have merged our
previously-presented Training revenue line item (2009: €273
million; 2008: €434 million) and other revenue line item (2009:
€42 million; 2008: €70 million) into the other service revenue
line item in our income statement. We believe that this change
further improves the clarity of our income statement. Amounts
reported in previous years have been reclassified accordingly
to conform to the current presentation.
Revenue Recognition
We derive our revenue from the sale or license of our soft-
ware products and of support, subscription, consulting, devel-
opment, training, and other services. The vast majority of our
software arrangements include support services, and many
also include professional services and other elements.
Software and software-related service revenue, as shown
in our Consolidated Income Statements, is the sum of our
software revenue, support revenue, and revenue from sub-
scriptions, on-demand services and other software-related
services. Professional services and other service revenue
as shown in our Consolidated Income Statements is the sum
of our consulting revenue and other service revenue. Other
service revenue as shown in our Consolidated Income State-
ments mainly consists of revenue from training services, mes-
saging services, and SAP marketing events. Revenue infor-
mation by segment and geographic region is disclosed in
Note (29).
If, for any of our product or service offerings, we determine
at the outset of an arrangement that the amount of revenue
cannot be measured reliably, we conclude that the inflow
of economic benefits associated with the transaction is not
probable, and we defer revenue until the arrangement fee be-
comes due and payable by the customer. If, at the outset of an
arrangement, we determine that collectability is not probable,
we conclude that the inflow of economic benefits associated
with the transaction is not probable, and we defer revenue
recognition until the earlier of when collectability becomes
probable or payment is received. If collectability becomes un-
likely before all revenue from an arrangement is recognized,
we recognize revenue only to the extent of the fees that are
successfully collected unless collectability becomes reason-
ably assured again. If a customer is specifically identified as a
bad debtor, we stop recognizing revenue except to the extent
of the fees that have already been collected.
We account for out-of-pocket expenses invoiced by SAP
and reimbursed by customers as support, consulting, and
training revenues, depending on the nature of the service for
which the out-of-pocket expenses were incurred.
Software revenue represents fees earned from the sale or
license of software to customers. Revenue from the sale of
perpetual licenses of our standard products is recognized in
line with the requirements for selling goods stated in IAS 18
Revenue (IAS 18) when evidence of an arrangement exists,
delivery has occurred, the risks and rewards of ownership
have been transferred to the customer, the amount of rev-
enue and associated costs can be measured reliably, and
collection of the related receivable is reasonably assured.
The sale is recognized net of returns and allowances, trade
discounts, and volume rebates. We usually sell or license soft-
ware on a perpetual basis. Occasionally, we license software
for a specified time. Revenue from short-term time-based
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licenses, which usually include support services during the
license period, is recognized ratably over the license term.
Revenue from multi-year time-based licenses that include
support services, whether separately priced or not, is rec-
ognized ratably over the license term unless a substantive
support service renewal rate exists; if this is the case, the
amount allocated to the delivered software is recognized as
software revenue based on the residual approach once the
basic criteria described above have been met. In general,
our software license agreements do not include acceptance-
testing provisions. If an arrangement allows for customer ac-
ceptance testing of the software, we defer revenue until the
earlier of customer acceptance or when the acceptance right
lapses. We usually recognize revenue from software arrange-
ments involving resellers on evidence of sell-through by the
reseller to the end-customer, because the inflow of the eco-
nomic benefits associated with the arrangements to us is not
probable before sell-through has occurred.
Sometimes we enter into customer-specific software devel-
opment agreements. We recognize software revenue in con-
junction with these arrangements using the percentage-of-
completion method based on contract costs incurred to-date
as a percentage of total estimated contract costs required to
complete the development work. If we do not have a sufficient
basis to reasonably measure the progress of completion or
to estimate the total contract revenue and costs, revenue is
recognized only to the extent of the contract costs incurred
for which we believe recoverability to be probable. When it
becomes probable that total contract costs exceed total con-
tract revenue in an arrangement, the expected losses are
recognized immediately as an expense based on the costs
attributable to the contract.
Support revenue represents fees earned from providing
customers with unspecified future software updates, up-
grades, and enhancements, and technical product support.
We recognize support revenue for most of our services ratably
over the term of the support arrangement. We do not sepa-
rately sell technical product support or unspecified software
upgrades, updates, and enhancements. Accordingly, we do
not distinguish within software and software-related service
revenue or within cost of software and software-related ser-
vices the amounts attributable to technical support services
and unspecified software upgrades, updates, and enhance-
ments.
Subscription and other software-related service revenue
represents fees earned from subscription and software rental
arrangements, on-demand solutions, and other software-
related services. Subscription contracts combine software
and support service elements, as they provide the customer
with current software products, rights to receive unspecified
future software products, and rights to support services dur-
ing the subscription term. Customers pay an annual fee for a
defined subscription term, and we recognize such fees ratably
over the term of the arrangement beginning with the delivery
of the first product.
Software rental contracts also combine software and sup-
port service elements. Such contracts provide the customer
with current software products and support but not the right
to receive unspecified future software products. Customers
pay a periodic fee over the rental term and we recognize fees
from software rental contracts ratably over the term of the
arrangement.
Revenue from on-demand solutions relates to software
hosting arrangements that provide the customer with the right
to use certain software functionality, but do not include the
right to terminate the hosting contract and take possession
of the software without significant penalty. On-demand so-
lution revenue is generally recognized ratably over the term
of the arrangement. Other software-related service revenue
mainly results from software-related revenue-sharing agree-
ments with other software vendors.
We recognize consulting, and other service revenue when
the respective services are performed. Consulting revenue
primarily results from implementation contracts to install
and configure our software products. Consulting contracts
do not usually involve significant production, modification,
or customization of software and are recognized using the
percentage-of-completion method of accounting as outlined
above.
Other service revenue consists of fees from training ser-
vices, cancelable hosting contracts, application management
services (AMS), messaging services, revenue from SAP mar-
keting events, and referral fees.
Training services provide educational services to cus-
tomers and partners regarding the use of our software prod-
ucts. We recognize training revenue when the respective
services are rendered. Cancelable hosting contracts allow
the customer to terminate a software hosting arrangement
at any time and to take possession of the hosted software
without significant penalty. In these contracts revenue is allo-
cated to the hosting element and to the software element. The
hosting revenue is recognized ratably over the agreed host-
ing period. Our AMS contracts provide post-implementation
application support, optimization, and improvements to a
customer’s IT solution. We recognize revenue from AMS
services when the respective services are rendered. Messag-
ing revenue mainly represents fees earned from transmitting
electronic text messages from one mobile phone provider
to another. We recognize revenue from message services
based upon the number of messages successfully processed
and delivered. Revenue from fixed-price messaging arrange-
ments is recognized ratably over the contractual term of the
arrangement. Revenue from marketing events hosted by
SAP, for which SAP sells tickets to its customers, is rec-
ognized after the marketing event takes place. Fees from
referral services are commissions from partners to which we
have referred customers.
The vast majority of our software arrangements form
multiple-element arrangements, as they include support ser-
vices, and many also include professional services and
other elements. As authorized by IAS 8 Accounting Policies,
Changes in Accounting Estimates and Errors (IAS 8), we
follow the guidance provided by FASB ASC Subtopic 985-
605, Software Revenue Recognition, as amended, in order
to determine the recognizable amount of license revenue
in multiple-element arrangements. Revenue from multiple-
element arrangements is recognized using the residual
method of revenue recognition when company-specific ob-
jective evidence of fair value exists for all of the undelivered
elements (for example, support services, consulting services,
or other services) in the arrangement, but does not exist for
one or more delivered elements (generally software). We de-
termine the fair value of and allocate revenue to each un-
delivered element based on its respective company-specific
objective evidence of fair value, which is the price charged
when that element is sold separately or, for elements not yet
sold separately, the price established by our management if it
is probable that the price will not change before the element is
sold separately. We allocate revenue to undelivered support
services based on the rates charged to renew the support
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services annually after an initial period. Such renewal rates
generally represent a fixed percentage of the discounted soft-
ware license fee charged to the customer. The vast majority
of our customers renew their annual support service contracts
at these rates. We allocate revenue to future incremental dis-
counts whenever customers are granted the right to license
additional software at a higher discount than the one given
within the initial software license arrangement, or to purchase
or renew support or services at rates below company-specific
objective evidence of fair value of the respective service.
We defer revenue for all undelivered elements and recog-
nize the residual amount of the arrangement fee attributable
to the delivered elements, if any, when the revenue recogni-
tion criteria described above have been met and company-
specific objective evidence of fair value for the undelivered
elements exists.
Combining or segmenting multiple-element arrangements
consisting of software and consulting or other professional
services depends on:
• Whether the arrangement involves significant produc-
tion, modification, or customization of the software, and
• Whether the services are not available from third-party
vendors and are therefore deemed essential to the soft-
ware.
If neither of the above is the case, revenue for the software
element and the other element is recognized separately. In
contrast, if one or both of the above is the case, the ele-
ments of the arrangement are combined and accounted for
as a single unit of accounting, and the entire arrangement
fee is recognized using the percentage-of-completion method
as outlined above. If the arrangement includes multiple ele-
ments, we exclude those elements from contract accounting
that meet the criteria for separate recognition (for example
support services or hosting), provided that the elements have
stand-alone value.
Our contributions to resellers that allow our resellers to
execute qualified and approved marketing activities are rec-
ognized as an offset to revenue, unless we obtain a separate
identifiable benefit for the contribution, and the fair value of
the benefit is reasonably estimable.
Deferred Income
Deferred income is recognized as software revenue, support
revenue, professional service revenue, or other revenue, de-
pending on the reasons for the deferral, once the basic ap-
plicable revenue recognition criteria have been met, for ex-
ample, when the related services are performed or when the
discounts are used.
(3c) Management Judgments and Sources of Estimation
Uncertainty
The preparation of the Consolidated Financial Statements
in conformity with IFRS requires management to make judg-
ments, estimates, and assumptions that affect the application
of accounting policies and the reported amounts of assets, li-
abilities, revenues, and expenses, as well as disclosure of
contingent assets and liabilities.
We base our judgments, estimates, and assumptions on
historical and forecast information, as well as regional and in-
dustry economic conditions in which we or our customers op-
erate, changes to which could adversely affect our estimates.
Although we believe we have made reasonable estimates
about the ultimate resolution of the underlying uncertainties,
no assurance can be given that the final outcome of these
matters will be consistent with what is reflected in our assets,
liabilities, revenues, and expenses. Actual results could differ
from original estimates.
The accounting policies that most frequently require us to
make judgments, estimates, and assumptions, and therefore
are critical to understanding our results of operations, are:
• Revenue recognition
• Valuation of trade receivables
• Accounting for share-based compensation
• Accounting for income tax
• Accounting for business combinations
• Subsequent accounting for goodwill and other intangi-
bles
• Accounting for legal contingencies
• Recognition of internally generated intangible assets
from development
Our management periodically discusses these critical ac-
counting policies with the Audit Committee of the Supervisory
Board.
Revenue Recognition
As described in the Revenue Recognition section of Note
(3b), we do not recognize revenue before persuasive evi-
dence of an arrangement exists, delivery has occurred, the
risks and rewards of ownership have been transferred to the
customer, the amount of revenue can be measured reliably,
and collection of the related receivable is reasonably assured.
The determination of whether the amount of revenue can be
measured reliably or whether the fees are collectible is inher-
ently judgmental as it requires estimates as to whether and
to what extent subsequent concessions may be granted to
customers and whether the customer is expected to pay the
contractual fees. The timing and amount of revenue recog-
nition can vary depending on what assessments have been
made.
In most of our revenue-generating arrangements we sell
to the customer more than one product solution or service.
Additionally, we have ongoing relationships with many of our
customers and often enter into several transactions with the
same customer within close proximity in time. We therefore
have to determine:
• Which arrangements with the same customer are to be
accounted for as one arrangement
• Which deliverables under one arrangement are to be
accounted for separately
• How to allocate the total arrangement fee to the individ-
ual elements of one arrangement
The determination of whether different arrangements with the
same customer are to be accounted for as one arrangement
is highly judgmental as it requires us to evaluate whether the
arrangements are negotiated together or linked in any other
way. The timing and amount of revenue recognition can vary
depending on whether two arrangements are accounted for
separately or as one arrangement.
We do not account separately for software and other deliv-
erables under an arrangement if one of the other deliverables
(such as consulting services) is deemed to be essential to the
functionality of the software. The determination whether an
undelivered element is essential to the functionality of the de-
livered element requires the use of judgment. The timing and
amount of revenue recognition can vary depending on how
that judgment is exercised because software revenue which
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may otherwise have been recognized up front is recognized
over the term of providing the essential deliverable.
We also do not account separately for different deliverables
under an arrangement if we have no basis for allocating the
overall arrangement fee to the different elements of the ar-
rangement. We believe that such allocation basis exists if we
can demonstrate for each undelivered element of the arrange-
ment a company-specific objective evidence of fair value as
further defined in the Revenue Recognition section of Note
(3b). Judgment is required in the determination of company-
specific evidence of fair value which may impact the timing
and amount of revenue recognized depending on:
• Whether company-specific evidence of fair value can
be demonstrated for the undelivered elements of a soft-
ware arrangement
• The approaches used to demonstrate company-specific
evidence of fair value
Additionally, our revenue would be significantly different if we
applied a revenue allocation policy other than the residual
method.
Revenue from consulting, other professional services, and
custom software development projects is determined by ap-
plying the percentage of completion method of revenue
recognition. The percentage-of-completion method requires
us to make estimates about total revenue, total cost to com-
plete the project, and the stage of completion. The assump-
tions, estimates, and uncertainties inherent in determining
the stage of completion affect the timing and amounts of rev-
enue recognized and expenses reported. If we do not have
a sufficient basis to measure the progress of completion or
to estimate the total contract revenue and costs, revenue
recognition is limited to the amount of contract costs incurred.
The determination of whether a sufficient basis to measure
the progress of completion exists is judgmental. Changes
in estimates of progress towards completion and of contract
revenue and contract costs are accounted for as cumulative
catch-up adjustments to the reported revenue for the appli-
cable contract.
(5) Revenue
For detailed information about our revenue recognition poli-
cies, see Note (3).
For revenue information by segment and geographic re-
gion, see Note (29).
Revenue from construction-type contracts (contract rev-
enue) is included in software revenue and consulting revenue
depending on the type of project. The status of our construc-
tion projects in progress at the end of the reporting period
accounted for under IAS 11 was as follows:
Construction Projects in Progress
€ Millions 2010 2009 2008
Revenue recognized in the respective year 141 109 80
Aggregate cost recognized (multi-year) 163 106 126
Recognized result ( + profit/ − loss;
multi-year) 17 14 –14
Advance payments received 5 3 0
Gross amounts due from customers 21 8 18
Gross amounts due to customers 35 7 12
Loss provisions 28 1 2
Revenue—Sale of Gold, Copper and Silver;
Gold and Silver Bullion; and Interest Revenue
3.59
Newcrest Mining Limited (June 2010)
INCOME STATEMENT (in part)







Operating sales revenue 3(a) 2,801.8 2,530.8
Cost of sales 3(b) (1,568.7) (1,638.0)
Gross profit 1,233.1 892.8
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
The significant accounting policies adopted in the preparation
of this financial report are:
(v) Revenue Recognition
Revenue from the sale of goods is recognised when there has
been a transfer of risks and rewards to the customer and no
further processing is required by the Group, the quality and
quantity of the goods has been determined with reasonable
accuracy, the price is fixed or determinable, and collectability
is probable. The point at which risk and title passes for the
majority of the Group’s commodity sales is upon receipt of the
bill of lading when the commodity is delivered for shipment.
Revenue is measured at the fair value of the consideration
received or receivable.
Gold and Silver Bullion Sales
Revenue from gold and silver bullion sales is brought to ac-
count when the significant risks and rewards of ownership
have transferred to the buyer and selling prices are known or
can be reasonably estimated.
Gold, Copper and Silver in Concentrate Sales
Contract terms for the Group’s sale of gold, copper and sil-
ver in concentrate (‘metal in concentrate’) allow for a price
adjustment based on final assay results of the metal in con-
centrate by the customer to determine content. Recognition
of sales revenue for these commodities is based on the most
recently determined estimate of metal price in concentrate
with a subsequent adjustment made upon final determination
and presented as part of ‘Other Income’.
The terms of metal in concentrate sales contracts with third
parties contain provisional pricing arrangements whereby the
selling price for metal in concentrate is based on prevailing
spot prices on a specified future date after shipment to the
customer (quotation period). Adjustments to the sales price
occur based on movements in quoted market prices up to
the date of final settlement. The period between provisional
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invoicing and final settlement is typically between one and six
months.
The provisionally priced sales of metal in concentrate con-
tain an embedded derivative that is required to be sepa-
rated from the host contract for accounting purposes. Ac-
cordingly the embedded derivative, which does not qualify
for hedge accounting, is recognised at fair value, with subse-
quent changes in fair value recognised in the Income State-
ment each period until final settlement, and presented as
‘Other Income’. Changes in fair value over the quotation pe-
riod and up until final settlement are estimated by reference
to forward market prices.
Interest Revenue
Interest revenue is recognised as it accrues using the effec-
tive interest method.
3. Revenue and Expenses (in part)
Specific Items
Profit before income tax includes the following revenues, in-
come and expenses whose disclosure is relevant in explain-
ing the performance of the Group:









Total operating sales revenue 2,801.8 2,530.8
Revenue—Rental Revenue, Land and
Home Sales
3.60
Brookfield Office Properties Canada (Dec 2010)
Author’s Note
Brookfield Office Properties Canada implemented
IFRSs effective December 31, 2010, with a date of
transition of January 1, 2009. The excerpt that follows
reflects the initial application of IAS 18.
CONSOLIDATED STATEMENTS OF INCOME
(in part)
December 31 (US Millions, Except
per Share Amounts) Note 2010 2009
Revenue 25 $1,326 $1,156
Net operating income
Commercial property operations 25 729 690
Interest and other income 25 110 38
839 728
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2: Significant Accounting Policies (in part)
(l) Revenue Recognition
(i) Commercial Operations
The company has retained substantially all of the risks and
benefits of ownership of its investment properties and there-
fore accounts for leases with its tenants as operating leases.
Revenue recognition under a lease commences when the
tenant has a right to use the leased asset. Generally, this
occurs on the lease inception date or, where the company is
required to make additions to the property in the form of ten-
ant improvements which enhance the value of the property,
upon substantial completion of those improvements. The to-
tal amount of contractual rent to be received from operating
leases is recognized on a straight-line basis over the term of
the lease; a straight-line rent receivable, which is included in
the carrying amount of investment property, is recorded for
the difference between the rental revenue recorded and the
contractu al amount received.
Rental revenue also includes percentage participating
rents and recoveries of operating expenses, including prop-
erty and capital taxes. Percentage participating rents are rec-
ognized when tenants’ specified sales targets have been met.
Operating expense recoveries are recognized in the period
that recoverable costs are chargeable to tenants.
(ii) Residential Operations
Land sales are recognized at the time that the risks and re-
wards of ownership have been transferred, possession or title
passes to the purchaser, all material conditions of the sales
contract have been met, and a significant cash down payment
or appropriate security is received.
Revenue from the sale of homes is recognized when title
passes to the purchaser upon closing and at which time all
proceeds are received or collectability is ensured.
(iii) Performance and Management Fee Revenue
The company is entitled to management fees and perfor-
mance fees on the management of properties for third par-
ties. The company recognizes management fees as earned.
The company recognizes performance fees in revenue when
the amount receivable from its fund partners is determinable
at the end of a contractually specified term.
(o) Critical Judgments in Applying Accounting Policies
(in part)
The following are the critical judgments that have been made
in applying the company’s accounting policies and that have
the most significant effect on the amounts in the consolidated
financial statements:
(iv) Leases
The company’s policy for revenue recognition on commercial
properties is described in Note 2(l)(i). In applying this policy,
the company makes judgments with respect to whether tenant
improvements provided in connection with a lease enhance
the value of the leased property which determines whether
such amounts are treated as additions to commercial property
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as well as the point in time at which revenue recognition under
the lease commences.
The company also makes judgments in determining
whether certain leases, in particular those tenant leases with
long contractual terms where the lessee is the sole tenant in
a property and long-term ground leases where the company
is lessor, are operating or finance leases. The company has
determined that all of its leases are operating leases.
Note 25: Revenue and Net Operating Income (in part)
(a) Revenue
The components of revenue are as follows:
(Millions) 2010 2009
Revenue from commercial
property operations $1,224 $1,141
Interest and other income(1) 102 15
Total $1,326 $1,156
(1) Excludes foreign exchange gains and losses associated with
translation of the company’s net foreign currency denominated
monetary assets.
(b) Commercial Property Operations
The company’s commercial property net operating income
from continuing operations is as follows:
(Millions) 2010 2009
Revenue $1,224 $1,141
Property operating costs (495) (451)
Commercial property net operating income $ 729 $ 690
The company leases commercial properties under operating
leases generally with lease terms of between 1 and 15 years,
with options to extend up to a further 5 years.
The company also earns fee revenue for property man-
agement, leasing and third party service fees. Fee revenue
included in revenue from commercial property operations was
$58 million for the year ended December 31, 2010 (2009—
$50 million).
Minimum rental commitments on non-cancellable tenant
operating leases are as follows:
(Millions) Dec. 31, 2010 Dec. 31, 2009
Not later than 1 year $ 892 $ 740
Later than 1 year and not longer
than 5 years 2,995 2,415
Later than 5 years 3,745 3,460
Total $7,632 $6,615
Property operating costs for the year ended December 31,
2010 includes $21 million (2009—$22 million) representing
rent expense associated with operating leases for land on
which certain of the company’s commercial properties are
situated. The company does not have an option to purchase
the leased land at the expiry of the lease periods. Future
minimum lease payments under these arrangements are as
follows:
(Millions) Dec. 31, 2010 Dec. 31, 2009
Not later than 1 year $ 22 $ 22
Later than 1 year and not longer
than 5 years 81 85
Later than 5 years 1,093 1,110
Total $1,196 $1,217
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Royalty Income and Dividend Income
3.61
Compagnie Financière Richemont SA (Mar 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME (in part)







Sales 6 5,176 5,418
Cost of sales (1,985) (2,001)
Gross profit 3,191 3,417
Selling and distribution expenses (1,277) (1,235)
Communication expenses (506) (644)
Administrative expenses (545) (542)
Other operating
(expense)/income 24 (33) (28)
Operating profit 830 968
Finance costs 27 (161) (228)
Finance income 27 24 127
Share of post-tax profit of
associated undertakings 10 4 3
Profit before taxation 697 870
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
2.18. Revenue Recognition
(a) Goods
Sales revenue comprises the fair value of the sale of goods,
net of value-added tax, duties, other sales taxes, rebates and
trade discounts and after eliminating sales within the Group.
Revenue is recognised when significant risks and rewards of
ownership of the goods are transferred to the buyer. Where
there is a practice of agreeing to customer returns, accumu-
lated experience is used to estimate and provide for such
returns at the time of sale.
(b) Interest Income
Interest income is recognised on a time-proportion basis us-
ing the effective interest method.
(c) Royalty Income
Royalty income is recognised on the accruals basis in accor-
dance with the substance of the relevant agreements.
(d) Dividend Income
Dividend income is recognised when the right to receive pay-
ment is established.
24. Other Operating (Expense)/Income
2010 2009
€m €m
Royalty income—net 18 16
Amortisation of other intangible assets
acquired on business combinations (15) (13)
Other expenses (36) (31)
(33) (28)







—bank borrowings (26) (37)
—other financial expenses (1) (1)
Net loss in fair value of financial assets at fair
value through profit or loss (2) (18)
Mark-to-market adjustment in respect of hedging
activities — (172)
Net foreign exchange losses on monetary items (132) —
Finance costs (161) (228)
Finance income:
Interest income on bank and other deposits 15 73
Dividend income on financial assets at fair value
through profit or loss 7 1
Net foreign exchange gains on monetary items — 53
Mark-to-market adjustment in respect of hedging
activities 2 —
Finance income 24 127
Net finance (costs)/income (137) (101)
Foreign exchange losses resulting from effective hedge
derivative instruments of €14 million (2009: gains of €12 mil-
lion) were reflected in cost of sales during the year. Gains and
losses on all non-hedge derivatives, as well as the ineffec-
tive portion of hedge derivatives, are included in net finance
(costs)/income.
34. Related-Party Transactions (in part)
Compagnie Financière Rupert, Bellevue, Geneva holds
522,000,000 ‘B’ registered shares representing an interest
in 50 per cent of the voting rights in Compagnie Financière
Richemont SA. In addition, Compagnie Financière Rupert has
advised that parties related to it held a total of 2,811,664
Richemont ‘A’ bearer shares, or the equivalent thereof in the
form of Depository Receipts, as at 31 March 2010, represent-
ing 0.3 per cent of the voting rights of the Company.
The Group has a number of transactions and relationships
with related parties, as defined by IAS 24, Related Party Dis-
closures, all of which are undertaken in the normal course of
business.
Besides Compagnie Financière Rupert, the Board of Direc-
tors of Compagnie Financière Richemont SA and the Group
Management Committee (‘key management’), the Group has
identified the following other related parties:
• Richemont’s associated undertakings (see note 10);
• Richemont’s joint venture interests (see note 36);
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• Reinet Investments SCA, a public company incorpo-
rated in Luxembourg;
• Remgro Limited, a public company incorporated in
South Africa;
• VenFin Limited, a private company incorporated in
South Africa; and
• Richemont foundations (employee and others).
The following transactions were carried out with related
parties giving rise to (expense/payables) and income/
receivables:
(a) Transactions and Balances Between the Richemont





Rouages SA—purchase of watch components (1) —
Sales to Net-a-Porter Limited 1 1
Net-a-Porter Limited—dividend income 1 —
Interest Income, Fees and Commissions,
Insurance Net Premium Income
3.62
The Royal Bank of Scotland Group plc (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)








Interest receivable 22,776 26,311 42,190
Interest payable (8,567) (12,923) (26,708)
Net interest income 1 14,209 13,388 15,482
Fees and commissions receivable 2 8,193 8,738 8,855
Fees and commissions payable 2 (2,211) (2,790) (2,444)
Income/(loss) from trading activities 2 4,517 3,761 (9,025)
Gain on redemption of own debt 2 553 3,790 —
Other operating income (excluding insurance net premium income) 2 1,479 873 2,153
Insurance net premium income 26 5,128 5,266 5,709
Non-interest income 17,659 19,638 5,248
Total income 31,868 33,026 20,730
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Accounting Policies (unnumbered note, in part)
3. Revenue Recognition
Interest income on financial assets that are classified as loans
and receivables, available-for-sale or held-to-maturity and in-
terest expense on financial liabilities other than those at fair
value through profit or loss are determined using the effective
interest method. The effective interest method is a method of
calculating the amortised cost of a financial asset or finan-
cial liability (or group of financial assets or liabilities) and of
allocating the interest income or interest expense over the ex-
pected life of the asset or liability. The effective interest rate
is the rate that exactly discounts estimated future cash flows
to the instrument’s initial carrying amount. Calculation of the
effective interest rate takes into account fees payable or re-
ceivable that are an integral part of the instrument’s yield, pre-
miums or discounts on acquisition or issue, early redemption
fees and transaction costs. All contractual terms of a finan-
cial instrument are considered when estimating future cash
flows.
Financial assets and financial liabilities held-for-trading or
designated as at fair value through profit or loss are recorded
at fair value. Changes in fair value are recognised in profit
or loss together with dividends and interest receivable and
payable.
Commitment and utilisation fees are determined as a per-
centage of the outstanding facility. If it is unlikely that a spe-
cific lending arrangement will be entered into, such fees are
taken to profit or loss over the life of the facility otherwise they
are deferred and included in the effective interest rate on the
advance.
Fees in respect of services are recognised as the right to
consideration accrues through the provision of the service
to the customer. The arrangements are generally contrac-
tual and the cost of providing the service is incurred as the
service is rendered. The price is usually fixed and always
determinable. The application of this policy to significant fee
types is outlined below.
Payment services—this comprises income received for
payment services including cheques cashed, direct debits,
Clearing House Automated Payments (the UK electronic set-
tlement system) and BACS payments (the automated clear-
ing house that processes direct debits and direct credits).
These are generally charged on a per transaction basis.
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The income is earned when the payment or transaction oc-
curs. Charges for payment services are usually debited to the
customer’s account monthly or quarterly in arrears. Income
is accrued at period end for services provided but not yet
charged.
Card related services—fees from credit card business in-
clude:
• Commission received from retailers for processing
credit and debit card transactions: income is accrued
to the income statement as the service is performed;
• Interchange received: as issuer, the Group receives a
fee (interchange) each time a cardholder purchases
goods and services. The Group also receives inter-
change fees from other card issuers for providing cash
advances through its branch and automated teller ma-
chine networks. These fees are accrued once the trans-
action has taken place; and
• An annual fee payable by a credit card holder is deferred
and taken to profit or loss over the period of the service
i.e. 12 months.
Insurance brokerage—this is made up of fees and commis-
sions received from the agency sale of insurance. Commis-
sion on the sale of an insurance contract is earned at the
inception of the policy, as the insurance has been arranged
and placed. However, provision is made where commission
is refundable in the event of policy cancellation in line with
estimated cancellations.
Investment management fees—fees charged for managing
investments are recognised as revenue as the services are
provided. Incremental costs that are directly attributable to se-
curing an investment management contract are deferred and
charged as expense as the related revenue is recognised.
Insurance premiums—see Accounting policy 12.
12. Insurance
General Insurance
General insurance comprises short-duration contracts. Due
to the nature of the products sold—predominantly property,
and motor—the insurance protection is provided on an even
basis throughout the term of the policy. Consequently, writ-
ten premiums are recognised on a straight-line basis over the
period of the policy. Insurance premiums exclude insurance
premium tax. Unearned premiums represent the proportion
of the net premiums that relate to periods of insurance after
the balance sheet date and are calculated over the period of
exposure under the policy, on a daily basis, 24th’s basis or
allowing for the estimated incidence of exposure under poli-
cies which are longer than twelve months. Provision is made
where necessary for the estimated amount of claims over and
above unearned premiums including that in respect of future
written business on discontinued lines under the run-off of
delegated underwriting authority arrangements. The provi-
sion is designed to meet future claims and related expenses
and is calculated across related classes of business on the
basis of a separate carry forward of deferred acquisition ex-
penses after making allowance for investment income.
Acquisition expenses relating to new and renewed busi-
ness for all classes are expensed over the period during which
the premiums are earned. The principal acquisition costs so
deferred are commissions payable, and costs associated with
the telesales and underwriting staff. Claims and the related
reinsurance are recognised in the accounting period in which
the loss occurs. Provision is made for the cost of settling out-
standing claims at the balance sheet date, including claims
estimated to have been incurred but not yet reported at that
date, and claims handling expenses. Provisions are only dis-
counted where claims, principally motor, either have been or
are expected to be settled by periodical payments. Related
reinsurance receivables are recognised on the same basis
and at the same time.
Life Assurance
The Group’s long-term assurance contracts include whole-life
term assurance, endowment assurance, flexible whole-life,
pension and annuity contracts that are expected to remain in
force for an extended period of time. Long-term assurance
contracts under which the Group does not accept significant
insurance risk are classified as financial instruments.
The Group recognises the value of in-force long-term as-
surance contracts as an asset. Cash flows associated with
in-force contracts and related assets, including reinsurance
cash flows, are projected, using appropriate assumptions as
to future mortality, persistency and levels of expenses and
excluding the value of future investment margins, to estimate
future surpluses attributable to the Group. These surpluses,
discounted at a risk-adjusted rate, are recognised as a sepa-
rate asset. Changes in the value of this asset are included in
profit or loss.
Premiums on long-term insurance contracts are recognised
as income when receivable. Claims on long-term insurance
contracts reflect the cost of all claims arising during the year,
including claims handling costs. Claims are recognised when
the Group becomes aware of the claim.
Reinsurance
The Group has reinsurance treaties that transfer significant
insurance risk. Liabilities for reinsured contracts are calcu-
lated gross of reinsurance and a separate reinsurance asset
recorded.
Notes on the Accounts (in part)








Loans and advances to customers 18,889 21,356 34,949
Loans and advances to banks 591 830 2,201
Debt securities 3,296 4,125 5,040
Interest receivable 22,776 26,311 42,190
Customer accounts: demand deposits 1,228 970 3,475
Customer accounts: savings deposits 1,148 1,245 2,261
Customer accounts: other time
deposits 1,345 2,546 7,906
Deposits by banks 1,333 2,898 6,362
Debt securities in issue 3,277 4,482 8,919
Subordinated liabilities 417 1,291 1,959
Internal funding of trading businesses (181) (509) (4,174)
Interest payable 8,567 12,923 26,708
Net interest income 14,209 13,388 15,482
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Fees and commissions receivable 8,193 8,738 8,855
Fees and commissions payable
—Banking (1,892) (2,351) (2,043)
—Insurance related (319) (439) (401)
(2,211) (2,790) (2,444)
Income/(loss) from trading activities(1)
Foreign exchange 1,491 2,340 1,906
Interest rate 1,862 3,883 1,026
Credit 41 (4,147) (12,207)
Other 1,123 1,685 250
4,517 3,761 (9,025)
Gain on redemption of own debt(2) 553 3,790 —
Other operating income (excluding insurance net premium income)
Operating lease and other rental income 1,394 1,323 1,469
Changes in the fair value of own debt attributable to own credit(3) 249 51 977
Changes in the fair value of securities and other financial assets and liabilities (180) 42 (1,266)
Changes in the fair value of investment properties (405) (117) (86)
Profit on sale of securities 496 162 164
Profit on sale of property, plant and equipment 50 40 177
(Loss)/profit on sale of subsidiaries and associates (107) (144) 934
Life business profits/(losses) 90 156 (52)
Dividend income 69 78 276
Share of profits less losses of associated entities 70 (268) 45
Other income(4) (247) (450) (485)
1,479 873 2,153
Notes:
(1) The analysis of trading income/(loss) is based on how the business is organised and the underlying risks managed. Trading income/(loss)
comprises gains and losses on financial instruments held for trading, both realised and unrealised, interest income and dividends and the
related funding costs.
The types of instruments include:
• Foreign exchange: spot foreign exchange contracts, currency swaps and options, emerging markets and related hedges and funding.
• Interest rate: interest rate swaps, forward foreign exchange contracts, forward rate agreements, interest rate options, interest rate
futures and related hedges and funding.
• Credit: asset-backed securities, corporate bonds, credit derivatives and related hedges and funding.
• Other: equities, commodities, equity derivatives, commodity contracts and related hedges and funding.
(2) In May 2010, the Group redeemed certain subordinated debt securities and equity preference shares in exchange for cash or senior debt.
The exchanges involving instruments classified as liabilities all met the criteria in IFRS for treatment as the extinguishment of the original
liability and the recognition of a new financial liability. Gains on these exchanges and on the redemption of securities classified as liabilities
for cash, totalling £553 million were credited to profit or loss. No amounts have been recognised in profit or loss in relation to the redemption
of securities classified as equity in the Group financial statements. The difference between the consideration and the carrying value for
these securities amounting to £651 million has been recorded in equity. A similar series of exchange and tender offers completed in April
2009 and resulted in a gain of £3,790 million being credited to profit or loss and £829 million being recorded in equity.
(3) Measured as the change in fair value from movements in the period in the credit risk premium payable by the Group.
(4) Includes income from activities other than banking and insurance.








Insurance premium income 5,379 5,529 6,009
Reinsurers’ share (251) (263) (300)
Net premium income 5,128 5,266 5,709
Insurance claims 4,932 4,492 4,090
Reinsurers’ share (149) (135) (173)
Net claims 4,783 4,357 3,917
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Income—Emissions Rights
3.63
OAO Gazprom (Dec 2010)
IFRS CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME (in part)
For the year ended 31 December 2010




25 Sales 3,597,054 2,991,001
5 Net gain front trading activity 6,256 4,171
26 Operating expenses (2,440,777) (2,092,832)
Impairment provision and other
provisions (48,711) (45,428)
Operating profit 1,113,822 856,912
NOTES TO THE IFRS CONSOLIDATED FINANCIAL
STATEMENTS (in part)
(In millions of Russian Roubles)
5. Summary of Significant Accounting Policies (in part)
The principal accounting policies followed by the Group are
set out below.
5.18 Revenue Recognition
Revenues are measured at the fair value of the consideration
received or receivable. When the fair value of consideration
received cannot be measured reliably, the revenue is mea-
sured at the fair value of the goods or services given up.
Sales are recognised for financial reporting purposes when
products are delivered to customers and title passes and are
stated net of VAT, excise taxes and other similar compulsory
payments. Gas transportation sales are recognized when
transportation services have been provided, as evidenced
by delivery of gas in accordance with the contract.
Natural gas prices and gas transportation tariffs to the final
consumers in the Russian Federation are established mainly
by the Federal Tariffs Service. Export gas prices for sales
to European countries are indexed to oil products prices, as
stipulated in long-term contracts. Export gas prices for sales
to Former Soviet Union countries are determined in various
ways including using formulas, similar to European.
Promissory Notes
Promissory notes issued by the Group are recorded initially
at the fair value of the consideration received or the fair value
of the note, which is determined using the prevailing market
rate of interest for a similar instrument.
In subsequent periods, promissory notes are stated at
amortised cost using the effective yield method. Any differ-
ence between the fair value of the consideration (net of trans-
action costs) and the redemption amount is recognised as
interest expense over the period of the promissory note.
Trading Activity
Contracts to buy or sell non-financial items entered into for
trading purposes and which do not meet the expected own-
use requirements, such as contracts to sell or purchase com-
modities that can be net settled in cash or settled by entering
into another contract, are recognized at fair value and asso-
ciated gains or losses are recorded as Net gain from trading
activity. These contracts are derivatives in the scope of IAS 39
for both measurement and disclosure. Revenues generated
by trading activities are reported as a net figure, reflecting
realized gross margins. Trading activities are mainly man-
aged by Gazprom Marketing and Trading Ltd. subsidiary of
the Group and relate partly to gas and oil trading and power
and emission rights trading activities.
6. Critical Judgments and Estimates in Applying
Accounting Policies (in part)
The value in use of assets or cash-generating units related
to oil and gas operations are based on the cash flows ex-
pected from oil and gas production volumes, which include
both proved reserves as well as certain volumes of those that
are expected to constitute proved and probable reserves in
the future. Impairment charges are given in Note 12.
6.6 Fair Value Estimation for Financial Instruments (in part)
The fair values of energy trading contracts, commodity futures
and swaps are based on market quotes on measurement date
(Level 1 in accordance with the valuation hierarchy). Custom-
ary valuation models are used to value financial instruments
which are not traded in active markets. The fair values are
based on inputs that are observable either directly or indi-
rectly (Level 2 in accordance with the valuation hierarchy).
The fair values of Emission Reduction Purchase Agreements
(“ERPA”) for the acquisition of post 2012 emission rights gen-
erating from pre-2012 registered Clean Development Mech-
anism (“CDM”) projects are based on the inputs that are not
based on observable market data (Level 3 in accordance with
the valuation hierarchy). Where the valuation technique em-
ployed incorporates significant unobservable input data such
as these long-term price assumptions, contracts have been
categorised as Level 3 in accordance with the valuation hier-
archy (see Note 22).
The assessment of the significance of a particular input to
the fair value measurement requires judgment and may affect
the placement of assets and liabilities within the levels of the
fair value hierarchy.
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IAS 11, CONSTRUCTION CONTRACTS
IFRIC 15, AGREEMENTS FOR THE
CONSTRUCTION OF REAL ESTATE
IFRS Overview and Comparison
to U.S. GAAP
3.64 A construction contract is a contract specifically ne-
gotiated for the construction of an asset or combination of
assets that are closely interrelated or interdependent in terms
of their design, technology, and function or their ultimate
purpose or use. IAS 11 establishes the accounting by con-
tractors for these contracts. In addition to contracts for the
construction of tangible assets, IAS 11 includes contracts
for rendering of services directly related to the construc-
tion of an asset, destruction or restoration of an asset, or
restoration of the environment after destruction of the asset.
International Financial Reporting Interpretations Committee
(IFRIC) Interpretation15, Agreements for the Construction
of Real Estate, provides guidance for determining whether
an agreement for the construction of real estate is a con-
struction contract within the scope of IAS 11 or is a contract
for the sale of goods within the scope of IAS 18. IFRIC 15
was issued in July 2008 and is effective for annual periods
beginning on or after 1 January 2009. Earlier application is
permitted.
3.65 IAS 11 includes the definitions of two types of con-
tracts: cost plus and fixed price. A cost-plus contract is one
in which the contractor is reimbursed for allowable or other-
wise defined costs plus either a percentage of these costs or a
fixed fee. A fixed-price contract is one in which the contrac-
tor agrees to a fixed contract price or a fixed rate per unit of
output, which in some cases is subject to escalation clauses.
Recognition and Measurement
IFRSs
3.66 The requirements of IAS 11 generally apply separately
to each construction contract. However, the standard recog-
nizes that contracts can be written so that there are separately
identifiable components covering the construction of multi-
ple assets. Multiple contracts can be so interrelated that they
are, in effect, part of a single project with an overall profit
margin. Therefore, contractors should assess whether to seg-
ment a particular contract into components or whether to
combine a group of contracts. If the criteria for combining
or segmenting are met, the contracts should be combined or
segmented, as appropriate.
3.67 The guidance in IAS 11 states that contractors should
treat individual assets as separate contracts when the cus-
tomer submitted separate proposals and separately negotiated
for each asset so the customer or contractor, or both, could
accept or reject the parts of the contract relating to each asset
and the contractor is able to identify each asset’s costs and
revenues. In contrast, contractors should combine contracts
when the customer and contractor negotiated a group of as-
sets as a package and the contracts are so interrelated that
they, in substance, form one project with an overall profit
margin and the contractor will perform the contracts either
concurrently or in sequence.
3.68 IAS 11 also specifies that contractors should treat con-
struction of an additional asset as a separate contract when
the asset differs in design, technology, or function from other
assets covered by the original contract or the price for the ad-
ditional asset is negotiated independent of the original con-
tract price.
3.69 IAS 11 defines contract revenue as the sum of the
following amounts:
• Initial amount of revenue agreed in the contract
• Variations in contract work, claims, and incentive pay-
ments to the extent that it is probable that these items
will result in revenue and can be measured reliably
Contractors should measure contract revenue at fair value of
the consideration received or receivable.
3.70 IAS 11 defines contract costs as the sum of the follow-
ing amounts:
• Costs that relate directly to the specific contract
• Costs that are attributable to contract activity in general
and can be allocated to the specific contract
• Other costs specifically chargeable to the customer un-
der the terms of the contract
In addition to providing guidance on cost that can or may
be attributable to the contract, IAS 11 does not permit an
entity to include general administration costs or research
and development costs in contract costs, unless the contract
specifies reimbursement, selling costs, and depreciation of
idle plant and equipment not used on that contract.
3.71 When the outcome of the contract can be estimated
reliably, the contractor should recognize contract revenue
and costs according to the percentage-of-completion method,
with reference to the stage of completion at the end of the
reporting period. When it is probable that total contract costs
will exceed total contract revenues, contractors should im-
mediately recognize expected losses as an expense.
3.72 IAS 11 provides that costs directly related to securing
a contract and other precontract costs are included as part
of contract costs only when it is probable that the contract
will be obtained and the costs can be identified separately
and measured reliably. An entity should not capitalize costs
previously expensed.
3.73 For fixed-price contracts, IAS 11 states that the con-
tractor can estimate the contract outcome reliably when the
following criteria are met:
• The contractor can measure reliably the total contract
revenue, the costs to complete the contract, and the
stage of completion at the end of the reporting period;
• It is probable that future economic benefits will flow to
the contractor from the contract; and
• Attributable contract costs can be clearly identified and
measured reliably so that accrued costs can be com-
pared with prior estimates.
3.74 For cost-plus contracts, IAS 11 states that the con-
tractor can estimate the contract outcome reliably when it
is probable that future economic benefits will flow to the
contractor from the contract and attributable contract costs
can be clearly identified and measured reliably, regardless of
whether they are specifically reimbursable, so that accrued
costs can be compared with prior estimates. Because the
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percentage-of-completion method is applied on a cumulative
basis, changes in the required estimates are accounted for
prospectively as a change in accounting estimate, in accor-
dance with IAS 8.
3.75 When the contract outcome cannot be estimated re-
liably, the contractor should recognize contract costs as an
expense in the period incurred and contract revenue only to
the extent that contract costs were incurred and cost recovery
is probable.
Author’s Note
The method used when the contract outcome cannot
be measured reliably is commonly referred to as either
the cost-recovery-first or zero-profit method, although
IAS 11 does not use these terms.
U.S. GAAP
3.76 FASB ASC 605-35 also includes guidance that an entity
may use for combining contracts for revenue recognition
and loss determination. FASB ASC 605-35-25-5 states that
the presumption in combining contracts is that revenue and
profit are earned and should be reported uniformly over the
performance of the combined contracts. In addition to the
criteria established under IFRSs for combining contracts,
FASB ASC 605-35-25-8 includes the following additional
indicators that a group of contracts may be combined:
• Contracts are, in essence, an agreement to complete a
single project.
• Contracts are, in substance, an agreement with a single
customer.
3.77 Unlike IFRSs, FASB ASC 605-35-25-12 permits an en-
tity to segment a construction contract if all of the following
steps were taken and are documented and verifiable:
a. The contractor submitted bona fide proposals on the
separate components of the project and the entire
project.
b. The customer had the right to accept the proposals on
either basis.
c. The aggregate amount of the proposals on the separate
components approximated the amount of the proposal
on the entire project.
When these restrictive conditions are not met, contractors
may segment contracts only if seven other conditions, dis-
cussed in FASB ASC 605-35-25-13, are met.
3.78 FASB ASC 605-35-25 includes significantly more
guidance than IAS 11 for determining total contract revenue
and contract costs. With respect to revenues, paragraphs 16–
31 of FASB ASC 605-35-25 include specific requirements
for determining the basic contract price for cost-type (cost-
plus) and fixed-price contracts, for incorporating customer-
furnished materials, priced and unpriced change orders, con-
tract options and additions, and for claims.
3.79 With respect to costs, paragraphs 32–44 of FASB ASC
605-35-25 include specific guidance on the costs that con-
tractors should include in construction-in-progress accounts.
Although the accounting for costs incurred to secure a con-
tract and other precontract costs is similar to IFRSs, FASB
ASC 605-35-25 provides more extensive guidance and, un-
like IFRSs, allows for deferral of such costs until receipt of
the anticipated contract in certain circumstances. Paragraphs
42–43 of FASB ASC 605-35-25 specify the accounting treat-
ment for back charges, requiring both adjustments to receiv-
ables and payables for back charges to and from others.
3.80 Like IFRSs, FASB ASC 605-35-25-45 requires an en-
tity to recognize a loss immediately when estimated contract
costs exceed contract revenues. However, unlike IFRSs, para-
graphs 45–50 of FASB ASC 605-35-25 provide considerable
guidance on how contractors should estimate the loss.
3.81 FASB ASC 605-35-05-5 identifies the percentage-of-
completion method and the completed-contract method as
the two accounting methods commonly followed by contrac-
tors. An entity should use one of the two methods in specified
circumstances and should not consider the methods accept-
able alternatives for the same circumstances.
3.82 Paragraphs 56–61 of FASB ASC 605-35-25 describe
the circumstances under which use of the percentage-of-
completion method would be appropriate. Specifically, the
use of the percentage-of-completion method requires an en-
tity to make reasonably dependable estimates of the extent
of progress toward completion, contract revenues, and con-
tract costs. FASB ASC 605-35-25-60 states that normally, a
contractor will be able to estimate total contract revenue and
total contract cost in single amounts. Those amounts should
normally be used as the basis for accounting for contracts
under the percentage-of-completion method. Unlike IFRSs,
guidance on how an entity should apply this method and
allowed alternatives is extensive.
3.83 Paragraphs 88–89 of FASB ASC 605-35-25 state that
under the completed-contract method, an entity recognizes
income only when a contract is completed or substantially
completed. However, in accordance with paragraphs 45–
50 of FASB ASC 605-35-25, an entity should recognize
expected contract losses as soon as they become evident.
Paragraphs 90–93 of FASB ASC 605-35-25 identify ap-
propriate circumstances under which an entity should ap-
ply the completed-contract method. Contractors may use the
completed-contract method as their accounting policy either
when their financial position and operating results would not
be materially different from that which would result from us-
ing the percentage-of-completion method or inherent hazards
and undependable estimates would make the necessary fore-
casts required by the percentage-of-completion method un-
reliable. For example, a contractor with primarily short-term
contracts could use the completed-contract method. In con-
trast, IFRSs do not permit contractors to use the completed-
contract method in any circumstances.
Presentation
IFRSs
3.84 IFRSs contain limited presentation guidance for con-
tract revenues, expenses, or the related assets and liabilities.
Although not required to present these as separate line items
on the balance sheet, an entity should present the following
amounts:
• Gross amount due from customers for contract work as
an asset
• Gross amount due to customers for contract work as a
liability
The gross amount due from customers for contract work is
the net amount of costs incurred plus recognized profits (less
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the sum of recognized losses and progress billings) for all
contracts in progress for which costs incurred plus recognized
profits (less recognized losses) exceed progress billings.
The gross amount due to customers for contract work is
the net amount of costs incurred plus recognized profits (less
the sum of recognized losses and progress billings) for all
contracts in progress for which progress billings exceed costs
incurred plus recognized profits (less recognized losses).
U.S. GAAP
3.85 Like IFRSs, FASB ASC 605-35 contains limited pre-
sentation guidance for contract revenues and expenses, and
related assets and liabilities. FASB ASC 605-35-45-3 states
that, when an entity applies the percentage-of-completion
method, current assets may include costs and recognized
income not yet billed, with respect to certain contracts.
Liabilities—in most cases, current liabilities—may include
billings in excess of costs and recognized income, with re-
spect to other contracts.
3.86 FASB ASC 605-35-45-4 explains that when the
completed-contract method is used, an excess of accumu-
lated costs over related billings should be shown in the bal-
ance sheet as a current asset, and an excess of accumulated
billings over related costs should be shown among the liabil-
ities, in most cases as a current liability. Similar to IFRSs, if
costs exceed billings on some contracts and billings exceed
costs on others, the contracts should ordinarily be segregated
so that the amounts shown as assets include only those con-
tracts on which costs exceed billings and those shown as
liabilities include only those on which billings exceed costs.
FASC 605-35-45-5 recommends that an entity describe the
asset as costs of uncompleted contracts in excess of related
billings, rather than as inventory or work in process. The en-
tity should describe the liability as billings on uncompleted
contracts in excess of related costs.
3.87 Paragraphs 1–2 of FASB ASC 605-35-45 require an
entity to recognize expected contract losses in the income
statement as additional contract costs, not a reduction of
contract revenues. Unless the loss is material in amount or
unusual or infrequent in nature, an entity should not show
the loss contract cost separately in the income statement. If
the loss is shown separately, an entity should present it as a




3.88 Contractors should disclose the amount of revenue rec-
ognized during the period and the methods used to determine
the contract revenue and stage of completion. For contracts in
progress, contractors should disclose the aggregate amount of
costs incurred and recognized net profits, amount of advances
received, and amount of retentions. They should also disclose
any contingencies in accordance with IAS 37, Provisions,
Contingent Liabilities and Contingent Assets (for example,
warranty costs, claims, penalties, and possible losses).
U.S. GAAP
3.89 FASB ASC 605-35-50 requires fewer disclosures than
IFRSs. According to FASB ASC 605-35-50-1, contractors
should disclose their accounting policy (for example, per-
centage of completion or completed contract). In addition,
the guidance in FASB ASC 605-35-50-3 states that if a con-
tractor departs from the percentage-of-completion method
as its basic accounting policy for a single contract or group
of contracts for which the entity cannot make reasonably
dependable estimates or for which inherent hazards make es-
timates doubtful, the entity should disclose that fact and the
reason. Similarly, in accordance with FASB ASC 605-35-50-
5, if an entity departs from the completed-contract method
as its basic accounting policy, it should disclose and explain
that departure.
Presentation and Disclosure Excerpts
Construction Contracts
3.90
Subsea 7 S.A. (formerly, Acergy S.A.) (Nov 2010)
CONSOLIDATED INCOME STATEMENT (in part)
For the fiscal year ended November 30
(In $ Millions, Except per Share Data) Notes 2010 2009 2008
Continuing operations:
Revenue 5 2,369.0 2,208.8 2,522.4
Operating expenses (1,701.0) (1,683.8) (1,874.2)
Gross profit 668.0 525.0 648.2
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Significant Accounting Policies (in part)
Investments in associates and joint ventures are accounted
for using the equity method. Under this method, the in-
vestment is carried in the balance sheet at cost plus post-
acquisition changes in the Group’s share of net assets of
the associate or joint venture, less any provisions for im-
pairment. The Consolidated Income Statement reflects the
Group’s share of the results of operations after tax of the
associate or joint venture. Losses in excess of the Group’s
interest (which includes any long-term interests that, in sub-
stance, form part of the Group’s net investment) are only
recognised to the extent that the Group has incurred legal or
constructive obligations or made payments on behalf of the
associate or joint venture.
Where there has been a change recognised directly in the
equity of the associate or joint venture, the Group recognises
its share in the Consolidated Statement of Comprehensive
Income. Net incomes and losses resulting from transactions
between the Group and the associate or joint venture are
eliminated to the extent of the Group’s interest.
Revenue Recognition
Revenue is measured at the fair value of the consideration
received or receivable and represents amounts receivable
for goods and services provided in the normal course of busi-
ness, net of discounts and sales related taxes.
Revenue from construction contracts is recognised in ac-
cordance with the Group’s accounting policy on construction
contracts (see below). Revenue from rendering of services is
recognised when services are provided.
Service Revenues
Revenues received for the provision of services under char-
ter agreements, day-rate contracts, reimbursable/cost-plus
contracts and similar contracts are recognised on an accrual
basis as services are provided.
Long-Term Contracts
Long-term contracts are accounted for using the percentage-
of-completion method. Revenue and gross profit are recog-
nised each period based upon the advancement of the work-
in-progress.
The percentage-of-completion method is calculated based
on the ratio of costs incurred to date to total estimated costs,
taking into account the level of completion. The percentage-
of-completion method requires the Group to make reliable es-
timates of progress toward completion of contract revenues
and contract costs. Provisions for anticipated losses are made
in full in the period in which they become known. In rare cir-
cumstances where percentage-of-completion based on cost
is not appropriate, the physical proportion of the contract work
performed is used to measure the percentage-of-completion.
If the stage of completion is insufficient to enable a reli-
able estimate of gross profit to be established (typically when
less than 5% completion has been achieved), revenues are
recognised to the extent of contract costs incurred where it is
probable that they will be recoverable.
A major portion of the Group’s revenue is billed under fixed-
price contracts. However, due to the nature of the services
performed, variation orders and claims are commonly billed
to clients in the normal course of business. Additional contract
revenue arising from variation orders is recognised when it
is probable that the client will approve the variation and the
amount of revenue arising from the variation can be reliably
measured. Revenue resulting from claims is recognised in
contract revenue only when negotiations have reached an
advanced stage such that it is probable that the client will ac-
cept the claim and that the amount can be measured reliably.
During the course of multi-year projects the accounting es-
timates may change. The effects of such changes are ac-
counted for in the period of change and the cumulative income
recognised to date is adjusted to reflect the latest estimates.
Such revisions to estimates do not result in restating amounts
in previous periods.
Investment Income
Investment income is recognised when it is probable that the
economic benefits will flow to the Group and the amount of
income can be measured reliably. Interest income is accrued
on a time basis, by reference to the principal outstanding and
at the effective interest rate applicable, which is the rate that
exactly discounts estimated future cash receipts through the
expected life of the financial asset to that asset’s net carrying
amount on initial recognition.
22. Other Accrued Income and Prepaid Expenses
As at November 30 (In $ Millions) 2010 2009
Amounts due from contract clients (see Note 23) 112.1 144.4
Unbilled revenue 96.3 54.7
Prepaid expenses 33.9 13.7
Total 242.3 212.8
Unbilled revenue relates to completed work other than lump-
sum construction contracts, which has not yet been billed to
customers.
Prepaid expenses are incurred in the normal course of
business and represent expenditure which has been deferred
and which will be recognised within the next fiscal year.
23. Construction Contracts
As at November 30 (In $ Millions) 2010 2009
Contracts in progress at balance sheet date:
Amounts due from contract clients included in
other accrued income and prepaid expenses
(see Note 22) 112.1 144.4
Deferred revenue recognised under
construction contracts (see Note 38) (198.4) (241.2)
Total (86.3) (96.8)
Contract costs incurred plus recognised net
profits less recognised losses to date 2,656.8 3,535.0
Less: progress billings (2,743.1) (3,631.8)
Total (86.3) (96.8)
As at November 30, 2010 retentions held by customers for
contract work amounted to $3.1 million (2009: $13.0 mil-
lion). Advances received from customers for contract work
amounted to $19.4 million (2009: $38.6 million) (refer to Note
38 ‘Deferred revenue’).
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As at November 30, 2010 a total of $10.1 million (2009:
$7.9 million) was recorded for losses expected at completion.
38. Deferred Revenue
Revenue deferred relating to the Group’s obligations are as
indicated:
As at November 30 (In $ Millions) 2010 2009
Construction contracts (see Note 22) 198.4 241.2
Advances received from clients (see below) 19.4 38.6
Total 217.8 279.8
Construction contracts are the gross amount due to clients
for contract work billed prior to progress of work performed.
This is adjusted for estimated losses at completion.
Advances received from clients are amounts received be-
fore the related work is performed.
Advances received from clients are recognised as follows:
For the Fiscal Year (In $ Millions) 2010 2009
Balance at December 1 38.6 59.8
Revenue deferred in respect of advances
received 3.6 19.2
Revenue recognised on discharge of obligation (22.8) (32.1)
Less: assets classified as held for sale — (8.3)
Balance at November 30 19.4 38.6
IAS 2, INVENTORIES
TABLE 3-3: INVENTORY COST DETERMINATION
2010 2009
First-in first-out (FIFO)............................................... 52 51
(Weighted) average cost.......................................... 88 78
Specific identification................................................ 10 9
Fair value less cost to sell (broker-dealer
exemption).............................................................. 8 4
Other......................................................................... 3 4
No valuation method disclosed................................ 14 16
No inventory or not-material..................................... 28 27
Total................................................................ 203 189
Less: Companies disclosing at least two
valuation methods................................................. (27) (27)
Companies disclosing at least three
valuation methods............................................. (3) (2)
Total Companies in Sample ............................. 170 160
IFRS Overview and Comparison
to U.S. GAAP
3.91 IAS 2, Inventories, establishes the requirements for
recognition and measurement of cost of sales, write-downs,
and reversals of write-downs of inventory. IAS 1 establishes
the requirements for presentation of this information in the
statement of comprehensive income and note disclosures.
Author’s Note
See paragraphs 2.33–.42 in section 2 for coverage of
accounting for inventories under IFRSs. The discussion
that follows focuses only on the expenses and losses
addressed in IAS 2 that are recognized in the statement
of comprehensive income.
3.92 IAS 2 applies to all inventories except work in process
arising under construction contracts, financial instruments,
biological assets related to agricultural activity, and agricul-
tural produce at the point of harvest.
Recognition and Measurement
IFRSs
3.93 An entity should use one of the following cost flow
assumptions to assign costs to inventories and cost of sales:
• Specific identification for inventory items that are not
interchangeable or segregated and produced for specific
projects
• First in, first out (FIFO)
• Weighted average cost
IAS 2 requires an entity to apply the same cost flow assump-
tion to inventories of similar nature and use. IAS 2 prohibits
the use of the last in, first out (LIFO) cost flow assumption.
3.94 An entity should recognize the carrying amount of
inventories sold as an expense in the same period as the
related revenue is recognized.
3.95 An entity should not carry inventories on the balance
sheet at amounts exceeding those it expects to realize from
sale or use. When there are indicators that the cost is not
recoverable, such as damage or decline in selling price, an
entity should write down inventories to net realizable value.
An entity normally should write down inventories on an
item-by-item basis. However, IAS 2 recognizes that when
an entity tests its inventory for impairment, there may be
circumstances when it is more appropriate to group similar
or related items (for example, items in the same product line
that cannot be evaluated separately).
3.96 Net realizable value is the estimated selling price in
the ordinary course of business less the sum of estimated
costs to complete and costs necessary to make the sale. An
entity should recognize a write-down of inventory in profit
or loss in the period recognized. IAS 2 permits reversals of
inventory write-downs.
U.S. GAAP
3.97 Relative to IFRSs, FASB ASC 330, Inventory, estab-
lishes a more complex process for determining the circum-
stances for, and the amount by, which an entity should record
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inventory write-downs and provides considerably more
guidance for applying this process. FASB ASC 330-10-35-1
requires an entity to value inventories at the lower of cost or
market, in contrast to the IAS 2 requirement to value inven-
tories at the lower of cost or net realizable value. Market, as
defined in the FASB ASC glossary, is generally considered
to be replacement cost not to exceed net realizable value (the
ceiling) and not to be less than net realizable value less an
allowance for an approximately normal profit margin (the
floor). The FASB ASC glossary defines net realizable value
similarly to IFRSs.
3.98 FASB ASC 330-10 explains that the lower of cost or
market rule applies to all inventory cost flow assumptions (for
example, FIFO, weighted average cost, and LIFO). However,
FASB ASC 330-10-35-7 explains that the concept of “mar-
ket” is intended as a guide, not a literal rule, and discusses
application of this concept in the context of the retail inven-
tory method. Because the retail method already incorporates
the concept of lower of cost or market when adequate mark-
downs are taken, FASB ASC explains that an entity is not
required to make additional adjustments since the inventory
method applied already meets the objectives of the lower of
cost or market rule. IFRSs do not discuss the retail method
in the same detail as FASB ASC 330-10 but permit use of
either the standard cost or retail inventory method if the result
approximates cost.
3.99 Both paragraphs 8–10 of FASB ASC 330-10-35 and
IFRSs provide guidance on testing inventory for impair-
ments. Both conclude that an entity should generally test
individual items but recognize that there may be circum-
stances when performing the test on groups of items is more
appropriate.
3.100 Unlike IFRSs, FASB ASC 330-10 does not permit
reversals of inventory write-downs, with the rationale that
inventory written down acquires a new cost basis and recov-
ery of the original cost is only permitted on sale or disposal.
However, as noted in paragraphs 15–16 of FASB ASC 330-
10-35, in exceptional circumstances, certain inventories (for
example, precious metals with a fixed monetary value and no
substantial marketing costs) may be stated above cost.
Presentation
IFRSs
3.101 IAS 1 does not require an entity to present cost of sales
or cost of inventory as a separate line item on the statement
of comprehensive income. IAS 1 does require an entity to
provide an analysis of expenses either on the face of the
income statement or in the notes. An entity may choose from
two formats for this analysis: by function or by nature. The by
function format is often referred to as the cost of sales format.
Unless an entity uses the by function format, an entity should
disclose cost of sales in the notes.
U.S. GAAP
3.102 Rule 5-03 of SEC Regulation S-X states that SEC
registrants should disclose cost of sales or cost of revenues
as a separate line item on the income statement. However,
unlike IFRSs, neither FASB ASC nor SEC rules require a
particular presentation format for this disclosure.
3.103 Unlike IFRSs, paragraphs 2 and 5 of FASB ASC 330-
10-50 respectively require an entity to present substantial
and unusual write-downs and net losses on firm purchase
commitments separately from cost of goods sold.
Disclosure
IFRSs
3.104 IAS 2 requires an entity to disclose the accounting
policies adopted to measure inventories, the cost flow as-
sumptions (formula) used (for example, FIFO), the amount
of inventories recognized as an expense during the period,
and the amounts of any writedowns or reversals of write-
downs recognized in profit or loss. An entity should also
discuss the circumstances or events that led to the reversal of
a writedown of inventories.
U.S. GAAP
3.105 FASB ASC 330-10-50-1 requires an entity reporting
under U.S. GAAP to disclose whether inventories are stated
at the lower of cost or market or another basis and the relevant
cost flow assumption (for example, LIFO).
3.106 When an SEC registrant using the LIFO method liq-
uidates a substantial portion of its LIFO inventory and, as a
result, includes a material amount of income in its income
statement due to the liquidation, the registrant should disclose
the amount of income realized as a result of the liquidation,
either in a note or parenthetically on the face of the income
statement, in accordance with SEC Codification of Staff Ac-
counting Bulletins topic 11(F), “LIFO Liquidations.”
3.107 Unlike IFRSs, when entities recognize inventory
write-downs, FASB ASC 330-10-50-2 only requires disclo-
sure of the amount of any substantial and unusual write-
downs.
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Presentation and Disclosure Excerpts
Analysis of Expenses by Function (Cost
of Sales)—First-In, First-Out Cost Flow
Assumption, Write-Downs and Reversal
of Write-Downs of Inventory
3.108
GlaxoSmithKline plc (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)





















Turnover 6 28,392 — 28,392 28,368 — 28,368
Cost of sales (7,405) (187) (7,592) (7,095) (285) (7,380)
Gross profit 20,987 (187) 20,800 21,273 (285) 20,988
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Accounting Principles and Policies (in part)
Inventories
Inventories are included in the financial statements at the
lower of cost (including raw materials, direct labour, other
direct costs and related production overheads) and net real-
isable value. Cost is generally determined on a first in, first out
basis. Pre-launch inventory is held as an asset when there is
a high probability of regulatory approval for the product. Be-
fore that point a provision is made against the carrying value
to its recoverable amount; the provision is then reversed at
the point when a high probability of regulatory approval is
determined.
9. Operating Profit (in part)







Employee costs (Note 10) 6,994 7,167 6,524
Advertising 971 923 805
Distribution costs 413 363 310
Depreciation of property, plant and equipment 1,146 1,130 920
Impairment of property, plant and equipment, net of reversals 186 149 256
Amortisation of intangible assets 533 432 311
Impairment of intangible assets and goodwill, net of reversals in 2008 160 172 115
Net foreign exchange losses/(gains) 60 163 (145)
Inventories:
Cost of inventories included in cost of sales 7,014 6,743 5,734
Write-down of inventories 305 276 298
Reversal of prior year write-down of inventories (66) (116) (118)
Operating lease rentals:
Minimum lease payments 136 160 143
Contingent rents 14 13 15
Sub-lease payments 7 6 1
Fees payable to the company’s auditor and its associates in relation to the Group (see below) 22.2 24.1 19.2
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The reversals of prior year write-downs of inventories princi-
pally arise from the reassessment of usage or demand ex-






Raw materials and consumables 1,466 1,153
Work in progress 751 1,437
Finished goods 1,620 1,474
3,837 4,064
Analysis of Expenses by Function (Cost of
Sales)—Weighted Average Cost, Inventories
Stated at Net Realizable Value
3.109
Clicks Group Limited (Aug 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME (in part)







Revenue 1 13,912,673 12,754,202
Turnover 1 13,276,277 12,175,312
Cost of merchandise sold (10,372,685) (9,657,930)
Gross profit 2,903,592 2,517,382
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Accounting Policies (unnumbered note, in part)
Significant Accounting Estimates and Assumptions (in part)
Estimates and assumptions that have a significant risk of
causing a material adjustment to the carrying amounts of
assets and liabilities within the next financial year are outlined
below and disclosed in the relevant notes to the financial
statements.
Allowance for Net Realisable Value of Inventories
The group evaluates its inventory to ensure that it is car-
ried at the lower of cost and net realisable value. Provi-
sion is made against slow moving, obsolete and damaged
inventories. Damaged inventories are identified and written
down through the inventory counting procedures conducted
within each business. Allowance for slow moving and ob-
solete inventories is assessed by each business as part of
their ongoing financial reporting. Obsolescence is assessed
based on comparison of the level of inventory holding to the
projected likely future sales using factors existing at the re-
porting date.
Rebates Received From Vendors
The group enters into agreements with many of its ven-
dors providing for inventory purchase rebates based upon
achievement of specified volumes of purchases, with many of
these agreements applying to the calendar year. For certain
agreements, the rebates increase as a proportion of neces-
sary purchases as higher quantities or values of purchases
are made relative to the prior period. The group accrues the
receipt of vendor rebates as part of its cost of sales for prod-
ucts sold, taking into consideration the cumulative purchases
of inventory to date. Rebates are accrued monthly, with an ex-
tensive reassessment of the rebates earned being performed
at the reporting date. Consequently the rebates actually re-
ceived may vary from that accrued in the financial statements.
Inventories
Merchandise for resale is valued on the weighted average
cost basis and is stated at the lower of cost and net realisable
value. The cost of inventories comprises all costs of purchase,
conversion and other costs incurred in bringing the invento-
ries to their present location and condition and is stated net
of purchase incentives. Net realisable value is the estimated
selling price in the ordinary course of business, less the es-
timated costs to complete and sell the product. The cost of
merchandise sold includes normal shrinkage, wastage and
inventory losses. Obsolete, redundant and slow moving in-
ventories are identified on a regular basis and are written
down to their net realisable value. The carrying amount of
inventory is recognised as an expense in the period in which








Goods for resale 1,493,412 1,378,950
Goods in transit 77,836 42,546
1,571,248 1,421,496
Inventories stated at net realisable value 49,458 61,004
The value of inventories stated at net realisable value is de-
termined on management’s best estimate of the likely selling
price at which the inventories in question could be sold in
the ordinary course of business less the directly attributable
selling costs.
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Analysis of Expenses by Function (Cost of
Sales)—Multiple Cost Flow Assumptions,
Provision for Inventory Obsolescence
3.110
Diageo plc (Jun 2010)










Sales 2 12,958 12,283 10,643
Excise duties 3 (3,178) (2,972) (2,553)
Net sales 2 9,780 9,311 8,090
Cost of sales 3, 5 (4,099) (3,893) (3,254)
Gross profit 5,681 5,418 4,836
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Accounting Policies of the Group (unnumbered note,
in part)
Biological Assets
Grape cultivation by the group’s wine business is accounted
for as an agricultural activity. Accordingly, the group’s biolog-
ical assets (grape vines and grapes on the vine) are carried
at fair value which, in the absence of third party valuations,
is computed on the basis of a discounted cash flow compu-
tation. Agricultural produce (harvested grapes) is valued at
market value on transfer into inventory.
Inventories
Inventories are stated at the lower of cost and net realis-
able value. Cost includes raw materials, direct labour and
expenses, an appropriate proportion of production and other
overheads, but not borrowing costs. Cost is calculated on an
actual usage basis for maturing inventories and on a first in,




At 30 June 2008 31
Exchange differences 6
Harvested grapes transferred to inventories (24)
Changes in fair value 24
At 30 June 2009 37
Exchange differences 3
Harvested grapes transferred to inventories (23)
Transfer to assets held for sale (6)
Changes in fair value 19
At 30 June 2010 30
Biological assets comprise grape vines and grapes on the
vine. At 30 June 2010, these assets comprise approximately
1,725 hectares (2009—2,206 hectares) of vineyards, ranging
from newly established vineyards to vineyards that are 91
years old. As part of the restructuring of the US wines oper-
ations, 481 hectares of vineyards are expected to be sold in








Raw materials and consumables 297 270 245
Work in progress 21 25 21
Maturing inventories 2,506 2,274 1,939
Finished goods and goods for resale 457 509 483
3,281 3,078 2,688
Maturing inventories include whisky, rum and wines. The fol-
lowing amounts of inventories are expected to be utilised after
more than one year:
£ Million 2010 2009 2008
Raw materials and consumables 46 42 35
Maturing inventories 2,093 1,875 1,595
2,139 1,917 1,630
Inventories are disclosed net of provisions for obsolescence,
an analysis of which is as follows:
£ Million 2010 2009 2008
Balance at beginning of the year 55 38 43
Exchange differences 3 1 2
Income statement charge 63 22 2
Written off (24) (6) (9)
97 55 38
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Analysis of Expenses by Nature—Multiple
Cost Flow Assumptions, Write-Down and
Reversal of Write-Downs of Inventory
Author’s Note
Barloworld Limited discloses cost of sales in a note
disclosure disaggregating operating profit.
3.111
Barloworld Limited (Sep 2010)
CONSOLIDATED INCOME STATEMENT (in part)











Revenue 19 40,830 45,269 50,107
Operating profit before items
listed below (EBITDA) 3,318 4,061 4,689
Depreciation (1,736) (1,854) (1,833)
Amortisation of intangible
assets (64) (61) (52)
Leasing interest classified as
cost of sales (142) (152) (153)
Operating profit 20 1,376 1,994 2,651
Accounting Policies (unnumbered note, in part)
Definitions
Refer to the web version of the annual report on
www.barloworld.com under Investor centre for a list of fi-
nancial terms used in the annual financial statements of
Barloworld Limited (the company) and consolidated financial
statements.
Basis of Preparation (in part)
1. Accounting Framework (in part)
The financial statements are prepared in accordance with In-
ternational Financial Reporting Standards (IFRS) as issued
by the International Accounting Standards Board using the
historical cost convention except for certain financial instru-
ments that are stated at fair value and adjustments, where
applicable, in respect of hyperinflation accounting.
15. Non-Current Assets Held for Sale (in part)
Rental assets that become available for sale after being re-
moved from rental fleets are transferred to inventories (policy
note 16) at their carrying amount. Sale proceeds from such
rental assets are recognised as revenue in accordance with
policy note 21.
16. Inventories
Inventories are assets held for sale in the ordinary course
of business, in the process of production for such sale or
in the form of materials or supplies to be consumed in the
production process or in the rendering of services.
Inventories are stated at the lower of cost and net realisable
value. Cost includes all costs of purchase, costs of conversion
and other costs incurred in bringing the inventories to their
present location and condition, net of discount and rebates
received. Net realisable value is the estimated selling price
in the ordinary course of business, less the estimated cost of
completion, distribution and selling.
The specific identification basis is used to arrive at the cost
of items that are not interchangeable. Otherwise the first-
in-first-out method or weighted average method for certain
classes of inventory is used to arrive at the cost of items that
are interchangeable.





Work in progress 295 295 291
Finished goods 2,554 3,617 4,219
Merchandise 2,421 3,054 3,219
Consumable stores 11 21 26
Other inventories 37 49 20
Total inventories 5,318 7,036 7,775
Per business segment:
—Equipment 2,623 4,386 5,010
—Automotive 2,097 1,902 2,124
—Handling 595 791 798
—Logistics 3 5 7
—Corporate 3 11
Total group 5,318 7,087 7,950
Amounts classified as held for sale — (51) (175)
Total per statement of financial position 5,318 7,036 7,775
The value of inventories has been
determined on the following bases:
First-in first-out and specific
identification 4,957 6,680 7,361
Weighted average 361 356 414
5,318 7,036 7,775
Inventory pledged as security for
liabilities 107 109 170
The secured liabilities are included
under trade and other payables
(note 17)
Amount of write down of inventory to net
realisable value and losses of
inventory 141 22 13
Amount of reversals of inventory
previously written down 4 7 5
Amounts removed during the year from
cash flow hedge reserve and included
in the initial cost of inventory 8 (55) (2)
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20. Operating Profit
Operating profit is arrived at as follows:
2010 2009 2008
Rm Rm Rm
Revenue 40,830 45,269 50,107
Less: Net expenses 39,454 43,275 47,456
Cost of sales 31,900 35,296 39,778
Distribution costs 984 1,134 2,080
Administrative costs 4,436 4,571 4,349
Other operating costs 2,495 2,359 1,380
Other operating income (361) (85) (131)
Operating profit 1,376 1,994 2,651
Per business segment:
Continuing operations
—Equipment 656 1,293 2,057
—Automotive 772 703 540
—Handling (17) (27) 172
—Logistics 10 77 135
—Corporate (45) (52) (253)
Total continuing operations 1,376 1,994 2,651
Discontinued operations
—Car rental—Scandinavia (89) (135) (10)
—Coatings 78
—Scientific 13
Total discontinued operations (89) (135) 81
Total group 1,287 1,859 2,732
DEPRECIATION AND AMORTIZATION
Author’s Note
The commentary that follows addresses depreciation
and amortization of assets covered by the following
IFRSs:
• IAS 17, Leases
• IAS 16, Property, Plant and Equipment
• IAS 38, Intangible Assets
• IAS 40, Investment Property
TABLE 3-4: DEPRECIATION AND AMORTIZATION
METHODS
2010 2009
Property, Plant and Equipment Investment Properties
Held at Cost
Straight line.............................................................................. 157 148
Declining balance.................................................................... 3 3
Units of production.................................................................. 17 16
Other (e.g., proportion of proven reserves)............................. 9 8
No property, plant and equipment or depreciation method
disclosed.............................................................................. 6 5
Total............................................................................. 192 180
Less: Companies disclosing at least two depreciation
methods............................................................................... (19) (18)
Companies disclosing at least three depreciation methods (3) (2)
Total Companies .......................................................... 170 160
Intangible Assets With Finite Life
Straight line.............................................................................. 124 118
Units of production.................................................................. 8 18
Other (e.g., pattern of consumption)........................................ 28 29
Assets not yet available for use.............................................. 1 0
No finite-life intangible assets or amortization method
disclosed.............................................................................. 31 26
Total............................................................................. 192 181
Less: Companies disclosing at least one amortization
methods............................................................................... (20) (19)
Companies disclosing at least three amortization methods (2) (2)
Total Companies .......................................................... 170 160
IFRS Overview and Comparison
to U.S. GAAP
3.112 Depreciation and amortization are terms describing
the systematic allocation of an asset’s carrying amount less
estimated residual value (depreciable or amortizable amount)
over the asset’s estimated useful life. IFRSs require an entity
to record depreciation or amortization on the following asset
classes for all assets in the class with finite useful lives:
• Property, plant, and equipment (PPE) (measured under
either the cost or revaluation model)
• Intangible assets (measured under the cost or revalua-
tion model)
• Investment property (measured under the cost model)
• Assets held under a finance (capital) lease (those pre-
viously listed)
Author’s Note
Section 2 provides the general recognition and mea-
surement requirements applicable to these asset
classes.
IFRS ATT 3.112
322 IFRS Accounting Trends & Techniques
Recognition and Measurement
IFRSs
3.113 IAS 16 requires an entity to measure items of PPE
initially at cost and to allocate that cost to the item’s signifi-
cant component parts. This allocation of cost is often referred
to as componentization or component accounting. One such
part, or component, to which an entity should allocate cost
is major inspection and overhaul costs. An entity should de-
preciate all significant components separately. To calculate
depreciation, an entity should determine the depreciable base
of assets with finite lives by estimating the asset’s useful life
and residual value. IAS 16 also requires an entity to depre-
ciate separately each component part with an individual cost
that is significant in relation to the total cost of the item.
3.114 IAS 16 requires an entity to begin to depreciate an
asset when it is available for use (that is, when the asset is in
the location and condition necessary for it to be capable of
operating in the manner intended by management). Depreci-
ation of an asset should cease at the earlier of the date that
the asset is classified as held for sale (or included in a dis-
posal group that is classified as held for sale), in accordance
with IFRS 5, Non-current Assets Held for Sale and Discon-
tinued Operations, or the date that the asset is derecognized.
Therefore, an entity does not stop recognizing depreciation
when the asset becomes idle or is retired from active use, un-
less the asset is fully depreciated. However, under methods
of depreciation based on usage or units of production, the
depreciation charge can be zero while there is no production.
3.115 To allocate the asset’s depreciable base over its useful
life on a reasonable and systematic basis, an entity should
select a depreciation method that most closely reflects the
pattern in which economic benefits from the asset will flow
to the entity. Specific methods mentioned in the standard are
straight line, declining balance, and units of production, but
no methods are specifically required or prohibited.
3.116 Depreciation expense should be recognized in profit or
loss in each reporting period, unless included in the carrying
value of another asset (for example, inventory, assets under
construction, and capitalized development costs). An entity
should annually review depreciation methods and estimates
of useful lives and residual values. Changes in estimated use-
ful lives, residual values, and depreciation methods should be
considered a change in accounting estimate, and the change
should be applied prospectively, in accordance with IAS 8.
3.117 When using the revaluation model for subsequent
measurement, an entity continues to recognize depreciation
expense. At each revaluation, the revalued amount becomes
the new cost basis for the asset. At the same time, the entity
should reassess the asset’s useful life and residual value, if
any, and calculate depreciation expense going forward based
on the new cost basis and these estimates. The carrying
value of the asset is the revalued amount less any subsequent
accumulated depreciation and impairment losses.
3.118 An entity should measure depreciation in accordance
with IAS 16 for investment property measured under the cost
model.
3.119 IFRSs require an entity to measure a decommissioning
or restoration obligation (that is, asset retirement obligation)
in accordance with IAS 37 and include the amount in the
cost of the asset that gives rise to the obligation. When that
asset is PPE, including land, an entity should depreciate over
the useful life of the asset the amount of a decommission-
ing or restoration obligation capitalized. Generally, land is
considered to have an indefinite life; therefore, an entity that
capitalizes the obligation as a component of the cost of land
should depreciate the amount over the period that benefits
are expected to flow to the entity, unless the land itself is de-
termined to have a finite life. In the latter case, depreciation
should be recorded over the useful life of the land.
3.120 IAS 38 requires an entity to assess whether an intan-
gible asset’s useful life is indefinite (that is, no foreseeable
limit to the asset’s ability to generate net future cash inflows)
or finite. If its useful life is determined to be finite, the entity
should determine the length of the life in time or units of
production. The useful life of an asset that arises from con-
tractual or other legal rights (for example, a patent) should
not exceed the period of those rights. If the contracts contain
renewal clauses, these clauses should be taken into account
if the entity has the ability to renew without significant cost.
An assessment of the useful life of reacquired rights in a
business combination only considers the remaining original
contract period; renewals are not considered.
3.121 For intangible assets with finite useful lives, the entity
should allocate the asset’s depreciable base (original cost less
residual value) over its useful life to profit or loss. Amorti-
zation begins when the asset is available for use and stops
at the earlier of the date that it is classified as held for sale
or derecognized. The residual value of an intangible asset is
assumed to be zero, unless the entity has a commitment from
a third party to purchase the asset at the end of its useful
life or there is an active market for the asset that the entity
expects to exist at the end of the asset’s useful life and from
which it expects to determine a reliable residual value.
3.122 Like PPE, when measuring an intangible asset using
the revaluation model, an entity records amortization based
on the revalued amount less any residual value over the es-
timated useful life of the asset. The carrying value of the
asset is the revalued amount less subsequent accumulated
amortization and impairment losses.
3.123 Amortization should reflect the pattern of benefits to
be received from the asset’s use. If it cannot determine the
pattern reliably, an entity should use the straight-line method.
An entity should review both the amortization period and
method annually. Changes to either should be considered
changes in accounting estimate and applied prospectively, in
accordance with IAS 8.
3.124 Goodwill acquired in a business combination (see sec-
tion 9, “Business Combinations”) and intangible assets with
indefinite lives should not be amortized. Instead, IAS 38 re-
quires an entity to test goodwill and indefinite-life intangibles
for impairment annually.
3.125 An entity should account for leased assets in accor-
dance with IAS 17. IAS 17 requires leased items of PPE,
investment properties, and intangible assets that an entity
accounts for as a finance lease to be depreciated in a man-
ner consistent with the depreciation policy on similar assets
owned by the entity.
U.S. GAAP
3.126 FASB ASC 350, Intangibles—Goodwill and Other,
and FASB ASC 360, Property, Plant, and Equipment, es-
tablish essentially the same requirements for depreciation
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and amortization of PPE and intangible assets owned or held
under a capital (finance) lease. FASB ASC 360 does not con-
sider investment property to be a separate asset class. FASB
ASC 360 requires an entity to classify as PPE those land and
buildings classified as investment property under IFRSs.
3.127 Consistent with IFRSs and subject to the same condi-
tions, FASB ASC 350-30-35-8 explains that an entity should
assume the residual value of an intangible asset is zero. FASB
ASC 350-30-35-9 states that an entity should review es-
timates of useful lives of intangible assets each reporting
period and amortize these assets prospectively over their re-
maining useful lives.
3.128 In contrast, measuring depreciation of PPE or invest-
ment properties under FASB ASC 360 requires an entity to
estimate both useful lives and residual values (salvage val-
ues). Unlike IFRSs, FASB ASC 360 does not require an
entity to review estimates of the useful lives of these assets
each reporting period. Instead, such a review is required,
in accordance with FASB ASC 360-10-35-22, only when
events or changes in circumstances indicate that the current
estimates are no longer appropriate, as is also the case with
depreciation methods.
Author’s Note
In the process of determining appropriate FASB ASC
references for U.S. GAAP requirements, we found that
FASB ASC 360-10-35-3 states that depreciation ex-
pense in financial statements for an asset shall be de-
termined based on the asset’s useful life. Neither FASB
ASC 360 nor other sections of FASB ASC include the
requirement to estimate residual values for items of
PPE in determining depreciation expense. The FASB
ASC glossary does not include definitions of depre-
ciation, depreciable base, or residual value of PPE.
The existing definition of residual value applies to an
intangible asset. FASB ASC briefly discusses residual
value in the context of leased assets. Notwithstanding
the absence of specific guidance in FASB ASC, it is
generally accepted that an entity should include esti-
mates of useful or depreciable lives and residual or
salvage values in calculating depreciation expense.
3.129 Like IFRSs, an entity should select a depreciation
method. Paragraphs 9–10 of FASB ASC 360-10-35 specify
two methods that are unacceptable for financial reporting:
the accelerated cost recovery system if the number of years
specified by that system does not fall within a reasonable
range of the asset’s useful life (used for tax reporting in
the United States) and the annuity method. Unlike IFRSs,
changes in depreciation method should be considered to be
a change in accounting estimate affected by a change in
accounting principle, in accordance with FASB ASC 250-
10-45-18. Although accounted for prospectively, as stated by
FASB ASC 250-10-45-19, an entity should make this change
only if it is justifiable on the basis that it is preferable.
3.130 Consistent with FASB ASC 360-10-35-4, FASB
ASC 410-20-35-2 states that an entity should depreciate the
costs of asset retirement obligations included in the cost of
the related asset over the useful life of that asset using a
rational and systematic basis.
Presentation
IFRSs
3.131 IAS 1 does not require separate presentation of de-
preciation or amortization expense in the statement of com-
prehensive income.
U.S. GAAP
3.132 FASB ASC 350-30-45 permits an entity to present
amortization expense and impairment losses for intangible
assets in income statement line items within continuing op-
erations, as the entity deems appropriate. However, FASB




Required disclosures about the relevant balance sheet
accounts are discussed in section 2.
IFRSs
3.133 Both IAS 16 and IAS 38 require disclosure of de-
preciation and amortization methods used and estimates of
useful lives (when the intangible asset has a finite life) or
depreciation and amortization rates by asset class are neces-
sary. Both standards require an entity to disclose depreciation
and amortization as line items in the relevant reconciliation
of the beginning and ending balances in the accumulated
depreciation and impairment loss account.
3.134 IAS 1 requires an entity classifying expenses by
function to disclose total depreciation and amortization ex-
pense in the notes. Entities classifying expenses by nature
should present total depreciation and amortization expense
on the face of the statement of comprehensive income.
U.S. GAAP
3.135 FASB ASC does not require an entity to provide
reconciliation disclosures. For PPE, FASB ASC 360-10-50-
1 does require disclosure of depreciation expense for the
period, account balances by major classes of depreciable
assets, accumulated depreciation either by major depreciable
asset classes or in total, and a general description of the
depreciation method(s) used.
3.136 For intangible assets subject to amortization, FASB
ASC 350-30-50-2 requires an entity to disclose the gross car-
rying amount and accumulated amortization, in total and by
major intangible asset class; aggregate amortization expense
for the period; and estimated aggregate amortization expense
for each of the five succeeding fiscal years.
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Presentation and Disclosure Excerpts
Property, Plant, and Equipment—Cost Model,
Straight Line Method
3.137
Empresa Nacional de Electricidad S.A.
(Endesa-Chile) (Dec 2010)
STATEMENT OF COMPREHENSIVE INCOME
(in part)
2010 2009 2008
Note ThCh$ ThCh$ ThCh$
Sales 23 2,397,944,527 2,406,367,778 2,531,561,947
Other operating income 23 37,437,927 12,551,577 4,826,492
Total Revenues 2,435,382,454 2,418,919,355 2,536,388,439
Raw materials and consumable used 24 (1,191,327,819) (976,145,889) (1,304,453,135)
Contribution Margin 1,244,054,635 1,442,773,466 1,231,935,304
Other work performed by entity and capitalized 10,126,628 731,901 500,315
Employee benefits expenses 25 (80,066,349) (75,564,322) (63,799,789)
Depreciation and amortization expense 26 (179,007,900) (196,142,075) (186,604,575)
Reversal of impairment loss (impairment loss) recognized in profit or loss (706,125) (43,999,600) —
Other expenses 27 (103,677,256) (110,868,779) (107,867,715)
Operating income 890,723,633 1,016,930,591 874,163,540
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Basis of Presentation of the Consolidated Financial
Statements (in part)
2.3 Responsibility for the Information and Estimates Made
(in part)
The information contained in these consolidated financial
statements is the responsibility of the Company’s Board,
which expressly states that IFRS principles and standards
have been fully implemented.
In preparing the consolidated financial statements, certain
estimates made by the Company’s Management have been
used in order to quantify some assets, liabilities, income, ex-
penses and commitments recorded in such statements.
These estimates basically refer to:
• The useful life of property, plant and equipment as well
as intangible assets (see Notes 3.a and 3.b).
3. Accounting Principles Applied
The principal accounting principles applied in preparing the
attached consolidated financial statements are detailed as
follows:
a) Property, Plant and Equipment
Property, Plant and Equipment is valued at acquisition cost,
net of accumulated depreciation and any impairment losses
it may have experienced. In addition to the price paid to ac-
quire each item, the cost also includes, where appropriate,
the following concepts:
• Finance expenses accrued during the construction pe-
riod that are directly attributable to the acquisition, con-
struction or production of qualified assets, which re-
quire a substantial period of time before being ready
for use such as, for example, electricity generation or
distribution facilities. The interest rate used is that of
the specific financing or, if none exists, the mean fi-
nancing rate of the company carrying out the invest-
ment. The mean financing rate depends principally on
the geographic area and ranges between 5.19% and
7.46%. The amount capitalized for this concept amounts
to ThCh$ 11,744,123, ThCh$ 4,745,501, and ThCh$
4,331,965 for the years ended December 31, 2010,
2009 and 2008 respectively.
• Personnel expenses directly related to construction in
progress, capitalized for the years ended December 31,
2010, 2009 and 2008, amount to ThCh$ 10,126,628
ThCh$ 731,901 and ThCh$ 500,315, respectively.
• Future disbursements that Endesa Chile and sub-
sidiaries must make to close their facilities are incor-
porated into the value of the asset at present value,
recording the corresponding provision in accounting.
On a yearly basis, Endesa Chile and subsidiaries re-
view their estimate of these future disbursements, in-
creasing or decreasing the value of the asset based on
the results of this estimate. (see Note 20).
• Items acquired before the date on which Endesa Chile
transitioned to IFRS, that is January 1, 2004, include
within the acquisition cost, where appropriate, asset
reappraisals permitted in various countries to adjust the
value of Property, Plant and Equipment for inflation as
of that date. (see Note 22.5I).
The construction in progress are transferred to operating as-
sets once the testing period has been completed, when they
are available for use, at which time depreciation begins.
Expansion, modernization and improvement costs that rep-
resent an increase in productivity, capacity or efficiency or a
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longer useful life are capitalized as a greater cost for the
corresponding assets.
Replacement or overhaul of whole components that in-
crease the asset’s useful life, or its economic capacity, are
recorded as an increase in value for the respective assets,
derecognizing the replaced or overhauled components.
Periodic maintenance, conservation and repair expenses
are recorded directly in income as an expense for the year in
which they are incurred.
The Company, based on the outcome of impairment testing
explained in Note 3.d, believes that the book value of these
assets does not exceed their net recoverable value.
Property, Plant and Equipment, net of its residual value, is
depreciated by distributing the cost of the different items that
compose it on a straight-line basis over its estimated useful
life, which is the period during which the companies expect to
use them. Useful estimated life is periodically reviewed and,
if appropriate, adjusted prospectively.
The following are the main classes of Property, plant and
equipment including their estimated useful lives:
Classes of Property, Plant and
Equipment
Range of Estimated
Useful Lives (In Years)
Buildings 22–100
Plant and equipment (see below) 3–65
IT equipment 3–15
Fixtures and fittings 5–21
Motor vehicles 5–10
Other 2–33
Additionally, and for more information, there is a greater open-
ing of the useful lives for plant and equipment class:
Range of Estimated





Coal/fuel power plants 25–40
Combined-cycle power plants 10–25
Renewable energy 35
Transport and Distribution Facilities:
High voltage network 10–60
Low and medium voltage network 10–60
Measurement and telecontrol equipment 3–50
Other facilities 4–25
The following table shows a detail of the duration period of
those non-indefinite administrative concessions maintained









(Generation) Argentina 30 years 13 years
Endesa Chile’s management evaluated the specific contract
term of each of the aforementioned concession, which vary
by country, business or legal jurisprudence, and concluded
that no determining factors exist to indicate that the grantor,
which in each case is a government entity, controls the infras-
tructure and, at the same time, can continuously set the price
to be charged for services. These requirements are essential
for applying IFRIC 12 “Service Concession Arrangements,”
which establishes how to record and value certain types of
concessions (see Note 3b.1).
Gains or losses that arise from the sale or disposal of items
of Property, Plant and Equipment are recognized in income
for the period and calculated as the difference between the
sale value and the net book value.
14. Property, Plant and Equipment (in part)
a) The following tables detail the balances within this ac-
count as of December 31, 2010 and 2009:
Classes of Property, Plant 12/31/2010 12/31/2009
and Equipment, Net ThCh$ ThCh$
Property, plant and equipment, net 4,253,906,589 4,326,989,360
Construction in progress 608,596,323 536,448,556
Land 78,877,683 60,524,427
Buildings 434,119,630 469,701,385
Plant and equipment 3,069,395,911 3,204,840,870
IT equipment 2,415,894 2,644,074
Fixtures and fittings 2,985,401 6,763,919
Motor vehicles 998,995 813,545
Other 56,516,752 45,252,584
Classes of Property, Plant and 12/31/2010 12/31/2009
Equipment, Gross ThCh$ ThCh$
Property, plant and equipment, net 7,214,012,699 7,180,903,160
Construction in progress 608,596,323 536,448,556
Land 78,877,683 60,524,427
Buildings 603,016,963 636,044,699
Plant and equipment 5,822,980,365 5,856,864,944
IT equipment 12,315,903 12,121,154
Fixtures and fittings 19,289,187 18,887,548









Total accumulated depreciation and
impairment, property, plant and
equipment (2,960,106,110) (2,853,913,800)
Buildings (168,897,333) (166,343,314
Plant and equipment (2,753,584,454) (2,652,024,074)
IT equipment (9,900,009) (9,477,080)
Fixtures and fittings (16,303,786) (12,123,629)
Motor vehicles (2,494,232) (2,557,249)
Other (8,926,296) (11,388,454)
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Movement 2010 ThCh$ ThCh$ ThCh$ ThCh$ ThCh$ ThCh$ ThCh$ ThCh$ ThCh$
Movements
Beginning balance as of
January 1, 2010 536,448,556 60,524,427 469,701,385 3,204,840,870 2,644,074 6,763,919 813,545 45,252,584 4,326,989,360
Additions 181,369,666 — — — — — — — 181,369,666
Retirements (56,851) — — (124,642) (659) (270) (6,727) (7,538) (196,687)
Depreciation expense — — (14,841,057) (156,596,319) (924,609) (1,176,493) (277,595) (1,251,831) (175,067,904)
Impairment losses
recorded on
earnings(∗) — — — (397,857) — — — — (397,857)
Foreign currency
translation (3,456,617) (861,803) (24,307,921) (50,250,877) (68,970) (539,579) (21,615) (1,865,613) (81,372,995)
Other increases
(decreases) (105,708,431) 19,215,059 3,567,223 71,924,736 766,058 (2,062,176) 491,387 14,389,150 2,583,006
Total movements 72,147,767 18,353,256 (35,581,755) (135,444,959) (228,180) (3,778,518) 185,450 11,264,168 (73,082,771)
Ending balance as of
December 31, 2010 608,596,323 78,877,683 434,119,630 3,069,395,911 2,415,894 2,985,401 998,995 56,516,752 4,253,906,589
(∗) See Note 26: Depreciation, amortization and impairment.
26. Depreciation, Amortization and Impairment Losses
This account as presented in the accompanying consolidated
statements of comprehensive income for the 2010, 2009 and




Depreciation (175,067,904) (192,772,740) (182,631,235)
Amortization (3,939,996) (3,369,335) (3,973,340)
Impairment losses
financial assets (308,268) — —
Impairment losses
Fixes assets (397,857) (43,999,600) —
Total (179,714,025) (240,141,675) (186,604,575)
Property, Plant, and Equipment—Cost Model,
Declining Balance Method at Varying Rates
3.138
HGL Limited (Sep 2010)
PROFIT AND LOSS STATEMENT







Sales revenue 2 170,067 164,653
Cost of sales 2 (93,497) (95,089)
Gross profit 76,570 69,564
Other revenue 2 10,887 7,594
Share of associates’ profit 484 397
Sales, marketing and advertising
expenses (25,055) (22,837)
Freight and distribution expenses (7,116) (6,765)
Administration expenses (25,373) (24,800)
Occupancy expenses (4,614) (4,351)
Impairment of available for sale assets — (1,665)
Fair value of interest rate swap — (651)
Finance costs (1,229) (2,502)
Profit before income tax expense 24,554 13,984
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1—Summary of Significant Accounting Policies
(in part)
(g) Property, Plant and Equipment
Land and buildings are measured at fair value. Fair value is
determined on the basis of independent valuation prepared
by external valuation experts. The fair values are recognised
in the financial statements of the consolidated entity and are
reviewed at the end of each reporting period to ensure that the
carrying value of land and buildings is not materially different
from their fair values.
Any revaluation increase arising on the revaluation of land
and buildings is credited to the land and buildings revaluation
reserve, except to the extent that it reverses a revaluation
decrease for the same asset previously recognised as an
expense in profit or loss, in which case the increase is credited
to the profit and loss statement to the extent of the decrease
previously charged. A decrease in the carrying amount arising
on the revaluation of land and buildings is charged as an
expense in profit or loss to the extent that it exceeds the
balance, if any, held in the land and buildings revaluation
reserve relating to a previous revaluation of that asset.
On the subsequent sale, the attributable revaluation sur-
plus remaining in the land and buildings revaluation reserve,
net of any related deferred taxes, is transferred directly to
retained earnings.
Plant and equipment, leasehold improvements and equip-
ment under finance lease are stated at cost less accumulated
depreciation and impairment. Cost includes expenditure that
is directly attributable to the acquisition of the item.
(h) Depreciation
Buildings are depreciated over their estimated useful lives
using the straight line method. Items of plant and equipment
are depreciated over their estimated useful lives using the
reducing balance method. The estimated useful lives and
depreciation method is reviewed at the end of each reporting
period.
The following estimated useful lives are used in the
calculation of depreciation: buildings—40 years; plant and
equipment—3 to 10 years; and leased plant and equipment—
3 to 5 years. The cost of improvements to or on leasehold
properties is depreciated over the lesser of the period of the









Sales revenue 170,067 164,653
Net income from MMC Contrarian Limited — 7
Acquisition discount 25 761 —
Profit on sale of listed securities 9,373 6,120
Dividends from listed securities 230 917
Interest:
Other entities—bank 325 414
Employee Share Scheme:
Key management personnel 198 136
180,954 172,247
b) Profit/(Loss) Before Income Tax
Profit/(Loss) before income tax has been arrived at after cred-







Profit/(Loss) on sale of property, plant
and equipment 50 (56)








Cost of sales 93,497 95,089
Interest:
Associates 49 48
Other entities—bank 1,089 2,364
Fair value of interest rate swap — 651





Leased plant and equipment 294 366
Leasehold improvements 90 81
Plant and equipment 1,682 1,477
2,138 1,999
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Balance at 30 September 2008 5,737 1,105 8,539 2,037 17,418
Additions — 50 2,120 308 2,478
Net revaluation increments 79 — — — 79
Disposals (374) (5) (1,054) (595) (2,028)
Deconsolidation of controlled entity — — (76) — (76)
Net foreign currency exchange difference (29) (5) (16) — (50)
Balance at 30 September 2009 5,413 1,145 9,513 1,750 17,821
Additions — 659 2,851 424 3,934
Disposals — (353) (729) (617) (1,699)
Net foreign currency exchange difference (207) (39) (117) — (363)
Balance at 30 September 2010 5,206 1,412 11,518 1,557 19,693
Accumulated Depreciation
Balance at 30 September 2008 (341) (936) (4,773) (986) (7,036)
Disposals 374 4 829 445 1,652
Deconsolidation of controlled entity — — 74 — 74
Depreciation expense (75) (81) (1,477) (366) (1,999)
Net foreign currency exchange difference 2 3 13 — 18
Balance at 30 September 2009 (40) (1,010) (5,334) (907) (7,291)
Disposals — 348 595 493 1,436
Depreciation expense (72) (90) (1,682) (294) (2,138)
Net foreign currency exchange difference — 34 108 — 142
Balance at 30 September 2010 (112) (718) (6,313) (708) (7,851)
Net Book Value
As at 30 September 2010 5,094 694 5,205 849 11,842
As at 30 September 2009 5,373 135 4,179 843 10,530
The carrying value of the properties are based on market
values provided by independent valuations made in 2009 and
2008. It was determined the carrying value of the land and




The carrying amount of land and buildings had
they been recognised under the cost model 3,939 4,003
Aggregate depreciation allocated during the year is recog-
nised as an expense and disclosed in note 2 to the financial
statements.
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Property, Plant, and Equipment—Cost Model,
Straight Line Method, Capitalization of Major
Overhaul Expenditures
3.139
TAM S.A. (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)
Year ended December 31, 2010












Revenue 24 11,378,691 9,765,506 10,513,044 8,018,819
Operating expenses 25 (10,401,678) (9,555,632) (9,935,437) (7,709,487)
Operating profit before movements in fair value of fuel
derivatives 977,013 209,874 577,607 309,332
Movements in fair value of fuel derivatives 36,585 316,852 (1,273,461) 130,410
Operating profit/(loss) 1,013,598 526,726 (695,854) 439,742
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
The principal accounting policies applied in the preparation
of these consolidated financial statements are set out below.
These policies have been consistently applied to all the years
presented, unless otherwise stated.
The preparation of financial statements requires the use of
certain critical accounting estimates. It also requires manage-
ment to exercise its judgment in the process of applying the
group’s accounting policies. The areas involving a higher de-
gree of judgment or complexity, or areas where assumptions
and estimates are significant to the consolidated financial
statements are disclosed in Note 3.
2.12 Property, Plant and Equipment Including Aircraft
Pre-Delivery Payments
Depending on the type of the asset and the timing of its
acquisition, the cost refers to the historical acquisition cost,
deemed cost, or to the historical acquisition cost adjusted for
the effects of hyperinflation, in the years in which the Brazilian
economy was considered hyperinflationary. Brazil was con-
sidered a hyperinflationary economy for IFRS purposes until
1997.
Land is not subject to depreciation. Depreciation is recog-
nized based on the estimated useful life of each asset under
the straight-line method, so that the cost less its residual value
after its useful life is fully written off. The estimated useful life,
residual values and depreciation methods are reviewed an-
nually and the effect of any changes in estimates is accounted
for prospectively. The estimated useful life of items used in






Machinery and equipment 10
Computers 5
Major overhaul expenditure, including replacement spares
and labor costs, is capitalized and amortized over the aver-
age expected life between major overhauls (the “built-in over-
haul method”). All other replacement spares and other costs
relating to maintenance of flight equipment assets, including
all amounts payable under “power by the hour” maintenance
contracts, are charged to the income statement on consump-
tion or as incurred respectively, as described below in Note
2.25.
The costs of loans attributable to the acquisition of quali-
fying assets, which necessarily take a substantial period of
time to get ready for use, are added to the cost of such assets
until the date when they are ready for their intended use.
The carrying value of property, plant and equipment is re-
viewed for impairment when events or changes in circum-
stances indicate the carrying value is greater than its esti-
mated recoverable amount.
A property, plant and equipment item is written off after
disposal or when there are no future economic benefits as a
result of the continued use of the asset. Any gains or losses
on the sale or disposal of a property, plant and equipment
item are determined by the difference between the amounts
received from the sale and the carrying amount of the asset
and are recognized in profit or loss.
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(a) Pre-Delivery Payments
Pre-delivery Payments (PDPs) paid to aircraft manufacturers
under the terms of purchase agreements for aircraft are de-
nominated in US dollars and are recognized in the financial
statements at the amount paid translated at the exchange
rate ruling at the date of payment. Borrowing costs, including
interest and applicable foreign exchange differences incurred
for the construction of qualifying assets are capitalized during
the period which the aircraft are built.
In the event that a decision is taken that the aircraft will
not be purchased by TAM, but rather it will be leased and
it is agreed that the PDPs will be returned to TAM, then the
related PDPs are reclassified to other receivables and are
remeasured to the present value of the amount expected to
be returned to TAM. This amount will, if it is denominated in
a foreign currency, be translated at the exchange rate ruling
at the reporting date, and any resulting difference recognized
in the income statement.
4. Adjustments Retroactive to the Financial
Statements Consolidated for the Prior Period (in part)
As mentioned in note 2.1, at December 31, 2010, the Com-
pany decided to change the accounting policy related to
recognition of flight equipment revaluation in its consolidated
financial statements, in order that the consolidated profit and
equity may be equivalent to those presented in the parent
company’s individual financial statements since the Brazilian
corporate law does not permit the revaluation of assets. This
change in accounting policy has effects on the consolidated
financial statements presented for comparative purposes for
the years ended December 31, 2009, 2008 and 2007 previ-
ously issued.
The effects of retroactive adjustments at December 31,






Effects on Balance Sheet
Property, plant and equipment 6,910,496 1,223,532 8,134,028
Deferred income tax and social contribution asset 621,788 (427,912) 193,876
Total 7,532,284 795,620 8,327,904
Revaluation reserve 116,504 (116,504)
Retained earnings (accumulated deficit) and other reserves (296,993) 912,124 615,131






Effects on Profit or Loss
Operating expenses (9,595,826) 40,194 (9,555,632)
Gains (losses) on revaluation of aircraft (1,207,608) 1,207,608 —
Operating profit (loss) before income tax and social
contribution 650,196 1,247,802 1,897,998
Income tax and social contribution (212,781) (436,758) (649,539)
Profit for the year 437,415 811,044 1,248,459
Earnings per share—basic 2.90 8.30
Earnings per share—diluted 2.90 8.29
Effects on Comprehensive Income (Loss) for the Year
Revaluation of property, plant and equipment (1,017,255) 1,017,255 —
Profit for the year 437,415 811,044 1,248,459
Total comprehensive income (loss) for the year (599,944) 1,828,299 1,228,356
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Net book amount January 1,
2010—adjusted(∗) 7,179,464 219,970 47,746 77,721 12,154 490,679 106,294 8,134,028
Acquired on acquisition of
Pantanal at fair value(vi) 13,208 — 90 71 — — 612 13,981
Transfers of pre-delivery
payments(v) 155,577 — — — — (306,066) 3 (150,486)
Additions(v) 1,038,528 3,296 3,748 9,385 3,969 282,815 14,899 1,356,640
Transfers (8,628) (5) — 8,633 —
Disposals/write-offs (2,241) (8,633) (996) (522) — (277) (12,669)
Capitalized interest/other 50 (4) 8 3 9,086 9,143
Depreciation (584,088) (5,012) (18,853) (11,779) — — (19,055) (638,787)
Net book amount December 31,
2010 7,800,448 209,671 31,731 66,256 16,121 476,514 111,109 8,711,850
At December 31, 2010
Cost 10,722,269 254,572 152,665 135,873 16,121 476,514 214,138 11,966,415
Accumulated depreciation (2,921,821) (44,901) (120,934) (69,617) — — (103,029) (3,260,302)
Net book amount December 31,
2010 7,800,448 209,671 31,731 66,256 16,121 476,514 111,109 8,711,850
(i) Includes aircraft, engines and spare parts. Aircraft includes aircraft leased under finance leases, according to IAS 17—Leases. As of
December 31, 2010 TAM has 79 aircraft under finance leases (2009—66 aircraft, 2008—64 aircraft and 2007—47 aircraft).
During the year ended December 31, 2010, the Company received 14 aircraft. Twelve aircraft leases were classified as finance leases
and one A320 aircraft and one A319 aircraft were classified as operational leases.
(ii) Mainly composed of improvements carried out at the Săo Carlos Technology Center.
(iii) Amounts disbursed from the aircraft acquisition program are recorded as advances, since upon the disbursement the form of lease
agreement that will be used is not yet defined. The Company’s past experience shows that the refund of prepaid amounts upon the delivery
of aircraft by manufacturers is probable. Note 2.12 (a).
(iv) Basically furniture and vehicles.
(v) Transfers occur when the aircraft are delivered and amounts are either returned to TAM or capitalized within flight equipment as “Additions.”
(vi) Refers to the initial balance of Pantanal. The movements after the date of acquisition are included in the corresponding line items.
The Properties and improvements of TLA are pledged as
collateral for loans in the total amount of R$ 110,499 (2009—
R$ 110,499, 2008—R$ 110,499 and 2007—R$ 110,499).
Other than aircraft, there are no significant amounts of
property, plant and equipment outside of Brazil. Aircraft are
based in Brazil but fly both domestically and internationally.
As described in note 2.12, the Company adopts the policy
of reviewing the estimated useful life of property, plant and
equipment items annually at the end of each year. The Com-
pany analyzed the remaining economic useful life of property,
plant and equipment items. As a consequence of the review
of this accounting estimate that was intended to realign the
useful life and the residual value of assets and, consequently,
the remaining depreciation to the residual life of assets, an
impact was recorded as a credit to the 2010 depreciation re-
sult, in the comparison with the depreciation recorded in the
prior period, of R$ 346.
The depreciation expense is recorded in the statement of









Cost of services rendered 554,127 480,232 376,709 228,583
Selling expenses 1,344 1,262 838 1,443
General and administrative expenses 83,316 78,220 49,783 27,613
638,787 559,714 427,330 257,639
(∗) See note 4.
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Personnel 1,881,905 247,283 191,220 2,320,408 22.3
Directors’ fees 1,895 — 6,125 8,020 0.1
Fuel 3,451,198 — — 3,451,198 33.2
Depreciation and amortization 613,687 1,661 84,421 699,769 6.7
Maintenance and repairs (excluding personnel) 612,262 — — 612,262 5.9
Aircraft insurance 51,982 — — 51,982 0.5
Take-off, landing and navigation aid charges 609,447 — — 609,447 5.9
Leasing of aircraft, engines and equipment under operating leases 447,112 7,252 16,619 470,983 4.5
Third party services 166,691 262,696 343,907 773,294 7.4
Marketing and related expenses — 959,843 — 959,843 9.2
Reversal of additional tariff (Note 20 (b)) — — (364,854) (364,854) (3.5)
Other 353,788 274,966 180,572 809,326 7.8
8,189,967 1,753,701 458,010 10,401,678 100.0
Property, Plant, and Equipment—Revaluation
Model Applied to Multiple Asset Classes
3.140
Sasini Limited (Sep 2010)
CONSOLIDATED INCOME STATEMENT (in part)
For the year ended 30 September 2010
2010 2009
Note KShs’000 KShs’000
Revenue 23 2,297,927 2,182,090
Gains arising from
changes in fair value of
biological assets less
estimated point of sale
costs 6(a) 904,832 568,992
Cost of Sales 24 (1,376,450) (1,471,493)
Gross profit 1,826,309 1,279,589
Other income 25 177,192 48,495
Expenses
Administration and
establishment expenses 26 (563,550) (513,913)
Selling and distribution
costs 27 (13,427) (11,297)
Interest income 28 27,774 28,497
Interest expense 28 (71,923) (71,649)
Profit before tax 28 1,382,375 759,722
CONSOLIDATED STATEMENT OF OTHER
COMPREHENSIVE INCOME (in part)
For the year ended 30 September 2010
2010 2009
KShs’000 KShs’000
Profit for the year 993,729 533,032
Other comprehensive income
Revaluation of property, plant and
equipment 28,818 572,217
Deferred tax on revaluation — (123,122)
Other comprehensive income after tax 28,818 449,095
Total comprehensive income for the year 1,022,547 982,127
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CONSOLIDATED STATEMENT OF CHANGES IN
EQUITY (in part)































At 1 October 2009 228,055 137,933 2,081,483 2,455,567 581,650 45,611 5,530,299 131,523 5,661,822
Total comprehensive
income for the year — — (21,763) 628,354 352,553 — 959,144 63,403 1,022,547
Excess depreciation on
revaluation — — (97,322) — 94,912 — (2,410) 2,410 —
Acquisition of investments — — — — — — — (60,597) (60,597)
Release on disposal of
assets — — (3,168) — — — (3,168) — (3,168)
Final 2009 dividend paid — — — — — (45,611) (45,611) — (45,611)
Interim 2010 dividend paid — — — — (45,611) — (45,611) — (45,611)
Proposed 2010 dividend — — — — (68,417) 68,417 — — —
At 30 September 2010 228,055 137,933 1,959,230 3,083,921 915,087 68,417 6,392,643 136,739 6,529,382
Note 13 Note 14 Note 14 Note 14
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
(e) Critical Accounting Estimates and Assumptions (in part)
Property, Plant and Equipment
Directors make estimates in determining the depreciation
rates for property, plant and equipment. The rates used are
set out in the accounting policy for property, plant and equip-
ment.
These estimates are continually evaluated and are based
on historical experience and other factors, including expec-
tations of future events that are believed to be reasonable
under the prevailing circumstances.
The Group measures its property, plant and equipment at
revalued amounts with changes in revaluation values being
recognized in equity. The Group engages independent val-
uers to determine fair values of property, plant and equip-
ment. The valuation values are based on the prevailing mar-
ket prices which are sensitive to economic conditions.
(k) Property, Plant & Equipment and Depreciation
Property, plant and equipment are stated at cost or revalued
amounts less accumulated depreciation and any impairment
losses. Revaluation increases arising on the revaluations are
credited to a revaluation reserve, except to the extent that
it reverses a revaluation decrease for the same asset previ-
ously recognised as an expense, in which case the increase
is credited to the statement of comprehensive income to the
extent of the decrease previously charged. A decrease in
carrying amount arising out of revaluation is charged as an
expense to the extent that it exceeds the balance, if any, held
in the revaluation reserve relating to a previous revaluation of
that asset.
An annual transfer from the asset revaluation reserve to
retained earnings is made for the difference between depre-
ciation based on the revalued carrying amount of the as-
set original cost. Additionally, accumulated depreciation at
the revaluation date is eliminated against the gross carrying
amount of the asset and the net amount is restated to the
revalued amount of the asset. Upon disposal, any surplus
remaining in the revaluation reserve relating to the particular
asset being sold is transferred to retained earnings.
Revaluations are done every 5 years to ensure that the car-
rying amount does not differ materially from that which would
be determined using fair value at the end of the reporting
period.
No depreciation is provided on freehold land. Work-in-
progress is not depreciated until the assets are completed
and brought to use. Other items of property, plant and equip-
ment are depreciated on the straight line basis to write down
the cost or revalued amount of each asset to its residual value
over its estimated useful life as follows:
Buildings and improvements 12–45 years
Plant, machinery and tools 12.5% p.a
Rolling stock 25.0% p.a
Farm implements and trailers 12.5% p.a
Furniture and fittings 12.5% p.a
Computers 33.3% p.a
Useful life, residual values and depreciation methods are re-
viewed on an annual basis.
An item of property, plant and equipment is de-recognised
upon disposal or when no future economic benefits are ex-
pected to arise from the continued use of the asset. Any
gain or loss on de-recognition of the asset (calculated as
the difference between the net disposal proceeds and the
carrying amount of the item) is included in the Statement of
comprehensive income in the year the item is de-recognised.
The carrying values of the property, plant and equipment are
assessed annually and adjusted for impairment where it is
considered necessary.
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4. Property, Plant and Equipment (in part)
a) The Group















KShs’000 KShs’000 KShs’000 KShs’000 KShs’000 KShs’000
Cost or Valuation
At start of the year 1,003,000 947,353 424,837 96,752 93,111 2,565,053
Additions and transfers — 81,419 33,844 40,183 11,770 167,216
Disposals — (2,619) — (7,925) — (10,544)
At 30 September 2010 1,003,000 1,026,153 458,681 129,010 104,881 2,721,725
Comprising:
At cost — 251,635 143,834 63,142 89,800 548,411
At valuation 1,003,000 774,518 314,847 65,868 15,081 2,173,314
1,003,000 1,026,153 458,681 129,010 104,881 2,721,725
Depreciation
At start of the year — 68,740 22,386 6,953 31,012 129,091
Charge for the year — 79,266 39,327 22,322 20,748 161,663
Disposals — (537) — (2,212) — (2,749)
At 30 September 2010 — 147,469 61,713 27,063 51,760 288,005
Net Book Value
At 30 September 2010 1,003,000 878,684 396,968 101,947 53,121 2,433,720
The Group’s property was revalued on 30 September 2008
by Lloyd Masika Limited, registered valuers, on the market
value existing use basis.
The Group’s plant and equipment was revalued on 30
September 2009 by Lloyd Masika registered valuers, on the
market value existing use basis.
The book values of the property, plant and equipment were
adjusted to the revaluations and the resultant surplus and
deferred tax effect, was recognised in equity as at that date.
26. Administration and Establishment Expenses









Staff costs (note 32) 159,100 144,263 78,041 71,652
Insurance and medical costs 21,719 16,592 1,169 402
Depreciation of property, plant and equipment 161,663 115,809 48,096 31,075
Amortisation of intangible assets 10,092 1,991 3,486 —
Amortisation of leasehold land 239 135 125 121
Auditors’ remuneration 3,400 2,830 1,050 870
Directors’ emoluments 9,972 10,286 9,972 10,286
Legal and professional fees 7,110 9,912 2,687 2,362
Secretarial costs 3,000 3,000 — —
Travelling and accommodation 2,795 3,443 2,269 2,657
Coffee house overheads 34,523 25,450 — —
Office expenses 43,152 18,335 6,950 17,680
Administration costs 102,544 142,595 100,144 99,646
Bank charges 2,034 3,251 231 1,681
Sundry expenses 2,207 16,021 — 11,747
563,550 513,913 254,220 250,179
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28. Profit Before Taxation
The profit before taxation is arrived at after charging:









Depreciation 161,663 115,809 48,096 31,075
Amortisation of intangible assets 10,092 1,991 3,486 —
Amortisation of leasehold land 239 135 125 121
Directors’ emoluments:
Fees 2,601 2,915 2,601 2,915
Other remuneration 7,371 7,371 7,371 7,371
Pension scheme contributions 6,843 5,608 3,409 2,721
Auditors’ remuneration 3,400 2,830 1,050 870
Interest expense 71,923 71,649 56,923 67,374
And after crediting:
Interest income 27,774 28,497 8,846 26,129
Foreign exchange gain 38,419 20,761 37,217 23,648
Gain on disposal of property, plant and equipment 79,407 101 79 101
Intangible Assets
3.141
Koninklijke Philips Electronics NV (Dec 2010)
CONSOLIDATED STATEMENTS OF INCOME
(in part)
In millions of euros unless otherwise stated
Consolidated statements of income (including earnings per
share) of the Philips Group for the years ended December 31
2008 2009 2010
Sales 26,385 23,189 25,419
Cost of sales (17,938) (15,110) (15,873)
Gross margin 8,447 8,079 9,546
Selling expenses (5,518) (5,159) (5,246)
General and administrative
expenses (972) (734) (735)
Research and development
expenses (1,777) (1,631) (1,576)
Impairment of goodwill (301) — —
Other business income 261 97 100
Other business expenses (86) (38) (24)
Income from operations 54 614 2,065
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Significant Accounting Policies (in part)
The Consolidated financial statements in this section have
been prepared in accordance with International Financial Re-
porting Standards (IFRS) as endorsed by the European Union
(EU). All standards and interpretations issued by the Inter-
national Accounting Standards Board (IASB) and the IFRS
Interpretations Committee effective year-end 2010 have been
endorsed by the EU, except that the EU did not adopt some
paragraphs of IAS 39 applicable to certain hedge transac-
tions. Philips has no hedge transactions to which these para-
graphs are applicable. Consequently, the accounting policies
applied by Philips also comply fully with IFRS as issued by
the IASB.
The Consolidated financial statements have been prepared
under the historical cost convention, unless otherwise indi-
cated.
Intangible Assets Other Than Goodwill
Acquired definite-lived intangible assets are amortized us-
ing the straight-line method over their estimated useful life.
The useful lives are evaluated every year. Patents and trade-
marks with a definite useful live acquired from third parties
either separately or as part of the business combination are
capitalized at cost and amortized over their remaining useful
lives. Intangible assets acquired as part of a business com-
bination are capitalized at their acquisition-date fair value.
The Company expenses all research costs as incurred. Ex-
penditure on development activities, whereby research find-
ings are applied to a plan or design for the production of new
or substantially improved products and processes, is capi-
talized as an intangible asset if the product or process is
technically and commercially feasible and the Company has
sufficient resources and the intention to complete develop-
ment.
The development expenditure capitalized includes the cost
of materials, direct labor and an appropriate proportion of
overheads. Other development expenditures and expendi-
tures on research activities are recognized in the State-
ment of income. Capitalized development expenditure is
stated at cost less accumulated amortization and impairment
losses. Amortization of capitalized development expenditure
is charged to the Statement of income on a straight-line basis
over the estimated useful lives of the intangible assets.
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Costs relating to the development and purchase of software
for both internal use and software intended to be sold are
capitalized and subsequently amortized over the estimated
useful life.
9. Intangible Assets Excluding Goodwill (in part)






Balance as of January 1, 2010:
Cost 5,040 820 606 6,466
Accumulated amortization (1,484) (436) (385) (2,305)
Book value 3,556 384 221 4,161
Changes in book value:
Additions 64 219 76 359
Acquisitions and purchase price allocation adjustments 131 (13) 1 119
Amortization/deductions (484) (155) (89) (728)
Impairment losses (3) (13) — (16)
Translation differences 268 17 11 296
Other (2) 20 (11) 7
Total changes (26) 75 (12) 37
Balance as of December 31, 2010:
Cost 5,486 1,046 665 7,197
Accumulated amortization (1,956) (587) (456) (2,999)






Balance as of January 1, 2009:
Cost 5,021 805 702 6,528
Accumulated amortization (1,137) (448) (466) (2,051)
Book value 3,884 357 236 4,477
Changes in book value:
Additions 14 188 91 293
Acquisitions and purchase price allocation adjustments 102 25 — 127
Amortization/deductions (433) (165) (103) (701)
Impairment losses (3) (16) (3) (22)
Translation differences (18) (4) — (22)
Other 10 (1) — 9
Total changes (328) 27 (15) (316)
Balance as of December 31, 2009:
Cost 5,040 820 606 6,466
Accumulated amortization (1,484) (436) (385) (2,305)
Book value 3,556 384 221 4,161
The additions for 2010 contain internally generated assets of
EUR 219 million and EUR 70 million for product development
and software, respectively (2009: EUR 188 million, EUR 76
million).
The acquisitions through business combinations in 2010
consist of the acquired intangible assets of Discus Hold-
ings, Inc. for EUR 67 million and several other smaller ac-
quisitions. The acquisitions through business combinations
in 2009 mainly consist of the acquired intangible assets of
Saeco for EUR 74 million.
The amortization of Intangible assets is specified in note 1.
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Other intangible assets consist of:
December 31, 2009 December 31, 2010
Accumulated Accumulated
Gross Amortization Gross Amortization
Brand names 939 (212) 843 (206)
Customer relationships 2,581 (534) 2,839 (762)
Technology 1,472 (712) 1,743 (948)
Other 48 (26) 61 (40)
5,040 (1,484) 5,486 (1,956)
The estimated amortization expense for other intangible as-






The expected useful lives of the intangible assets excluding
goodwill are as follows:
Brand names 2–20 years





The expected weighted average remaining life of other intan-
gible assets is 9.1 years as of December 31, 2010 (2009:
11.3 years).
The Group assessed the useful life of intangible assets with
indefinite lives and reviewed the amortization period for intan-
gible assets with definite lives. This assessment resulted in
the following changes in amortization expense, mainly recog-
nized in cost of sales, for 2010 and future years:
In Thousands of Euros 2010 2011 2012 2013 2014 Later
Increase in amortization
expense 16 15 15 15 15 196
The unamortized costs of computer software to be sold,
leased or otherwise marketed amounted to EUR 82 million
(2009: EUR 95 million). The amounts charged to the Consoli-
dated statements of income for amortization or impairment of
these capitalized computer software costs amounted to EUR
25 million (2009: EUR 38 million).
Depreciation and Depletion
3.142
BP plc (Dec 2010)
GROUP INCOME STATEMENT (in part)
$ Million
For the Year Ended 31 December Note 2010 2009 2008
Sales and other operating revenues 7 297,107 239,272 361,143
Earnings from jointly controlled entities—after interest and tax 1,175 1,286 3,023
Earnings from associates—after interest and tax 3,582 2,615 798
Interest and other income 8 681 792 736
Gains on sale of businesses and fixed assets 5 6,383 2,173 1,353
Total revenues and other income 308,928 246,138 367,053
Purchases 216,211 163,772 266,982
Production and manufacturing expenses(a) 64,615 23,202 26,756
Production and similar taxes 9 5,244 3,752 8,953
Depreciation, depletion and amortization 10 11,164 12,106 10,985
Impairment and losses on sale of businesses and fixed assets 5 1,689 2,333 1,733
Exploration expense 16 843 1,116 882
Distribution and administration expenses 12 12,555 14,038 15,412
Fair value (gain) loss on embedded derivatives 34 309 (607) 111
Profit (loss) before interest and taxation (3,702) 26,426 35,239
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Significant Accounting Policies (in part)
Oil and Natural Gas Exploration, Appraisal and
Development Expenditure
Oil and natural gas exploration, appraisal and development
expenditure is accounted for using the principles of the suc-
cessful efforts method of accounting.
Licence and Property Acquisition Costs
Exploration licence and leasehold property acquisition costs
are capitalized within intangible assets and are reviewed at
each reporting date to confirm that there is no indication that
the carrying amount exceeds the recoverable amount. This
review includes confirming that exploration drilling is still un-
der way or firmly planned or that it has been determined, or
work is under way to determine, that the discovery is eco-
nomically viable based on a range of technical and commer-
cial considerations and sufficient progress is being made on
establishing development plans and timing. If no future ac-
tivity is planned, the remaining balance of the licence and
property acquisition costs is written off. Lower value licences
are pooled and amortized on a straight-line basis over the
estimated period of exploration. Upon recognition of proved
reserves and internal approval for development, the relevant
expenditure is transferred to property, plant and equipment.
Exploration and Appraisal Expenditure
Geological and geophysical exploration costs are charged
against income as incurred. Costs directly associated with
an exploration well are initially capitalized as an intangible
asset until the drilling of the well is complete and the results
have been evaluated. These costs include employee remu-
neration, materials and fuel used, rig costs and payments
made to contractors. If potentially commercial quantities of
hydrocarbons are not found, the exploration well is written off
as a dry hole. If hydrocarbons are found and, subject to fur-
ther appraisal activity, are likely to be capable of commercial
development, the costs continue to be carried as an asset.
Costs directly associated with appraisal activity, under-
taken to determine the size, characteristics and commer-
cial potential of a reservoir following the initial discovery of
hydrocarbons, including the costs of appraisal wells where
hydrocarbons were not found, are initially capitalized as an
intangible asset.
All such carried costs are subject to technical, commercial
and management review at least once a year to confirm the
continued intent to develop or otherwise extract value from
the discovery. When this is no longer the case, the costs are
written off. When proved reserves of oil and natural gas are
determined and development is approved by management,
the relevant expenditure is transferred to property, plant and
equipment.
Development Expenditure
Expenditure on the construction, installation and completion
of infrastructure facilities such as platforms, pipelines and the
drilling of development wells, including service and unsuc-
cessful development or delineation wells, is capitalized within
property, plant and equipment and is depreciated from the
commencement of production as described below in the ac-
counting policy for property, plant and equipment.
Property, Plant and Equipment
Property, plant and equipment is stated at cost, less accumu-
lated depreciation and accumulated impairment losses.
The initial cost of an asset comprises its purchase price
or construction cost, any costs directly attributable to bringing
the asset into operation, the initial estimate of any decommis-
sioning obligation, if any, and, for qualifying assets, borrowing
costs. The purchase price or construction cost is the aggre-
gate amount paid and the fair value of any other consideration
given to acquire the asset. The capitalized value of a finance
lease is also included within property, plant and equipment.
Exchanges of assets are measured at fair value unless the
exchange transaction lacks commercial substance or the fair
value of neither the asset received nor the asset given up is
reliably measurable. The cost of the acquired asset is mea-
sured at the fair value of the asset given up, unless the fair
value of the asset received is more clearly evident. Where fair
value is not used, the cost of the acquired asset is measured
at the carrying amount of the asset given up. The gain or loss
on derecognition of the asset given up is recognized in profit
or loss.
Expenditure on major maintenance refits or repairs com-
prises the cost of replacement assets or parts of assets, in-
spection costs and overhaul costs. Where an asset or part
of an asset that was separately depreciated is replaced and
it is probable that future economic benefits associated with
the item will flow to the group, the expenditure is capitalized
and the carrying amount of the replaced asset is derecog-
nized. Inspection costs associated with major maintenance
programmes are capitalized and amortized over the period
to the next inspection. Overhaul costs for major maintenance
programmes, and all other maintenance costs are expensed
as incurred.
Oil and natural gas properties, including related pipelines,
are depreciated using a unit-of-production method. The cost
of producing wells is amortized over proved developed re-
serves. Licence acquisition, common facilities and future de-
commissioning costs are amortized over total proved re-
serves. The unit-of-production rate for the amortization of
common facilities costs takes into account expenditures in-
curred to date, together with the future capital expenditure
expected to be incurred in relation to these common facilities
and excluding future drilling costs.
Other property, plant and equipment is depreciated on a
straight line basis over its expected useful life. The useful
lives of the group’s other property, plant and equipment are
as follows:
Land improvements 15 to 25 years
Buildings 20 to 50 years
Refineries 20 to 30 years
Petrochemicals 20 to 30 years
Pipelines 10 to 50 years
Service stations 15 years
Office equipment 3 to 7 years
Fixtures and fittings 5 to 15 years
The expected useful lives of property, plant and equipment
are reviewed on an annual basis and, if necessary, changes
in useful lives are accounted for prospectively.
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The carrying value of property, plant and equipment is re-
viewed for impairment whenever events or changes in circum-
stances indicate the carrying value may not be recoverable.
An item of property, plant and equipment is derecognized
upon disposal or when no future economic benefits are ex-
pected to arise from the continued use of the asset. Any gain
or loss arising on derecognition of the asset (calculated as the
difference between the net disposal proceeds and the carry-
ing amount of the item) is included in the income statement
in the period in which the item is derecognized.
10. Depreciation, Depletion and Amortization
$ Million
By Business 2010 2009 2008
Exploration and Production
US 3,751 4,150 3,012
Non-US 4,865 5,407 5,428
8,616 9,557 8,440
Refining and Marketing
US 955 919 825
Non-US(a) 1,303 1,317 1,383
2,258 2,236 2,208
Other Businesses and Corporate
US 140 136 132
Non-US 150 177 205
290 313 337
By Geographical Area
US 4,846 5,205 3,969
Non-US(a) 6,318 6,901 7,016
11,164 12,106 10,985
(a) Non-US area includes the UK-based international activities of
Refining and Marketing.






















At 1 January 2010 3,786 2,918 157,197 41,599 3,022 12,441 10,295 231,258
Exchange adjustments (85) (68) 3 35 (41) 28 (72) (200)
Additions 39 96 11,980 3,354 279 152 610 16,510
Acquisitions 2 3 1,931 41 5 15 — 1,997
Transfers — — 2,633 — — — — 2,633
Reclassified as assets held for sale (6) (10) (6,610) (1,083) (87) (212) — (8,008)
Deletions (176) (104) (6,950) (1,119) (213) (208) (1,181) (9,951)
At 31 December 2010 3,560 2,835 160,184 42,827 2,965 12,216 9,652 234,239
Depreciation
At 1 January 2010 571 1,389 86,975 18,903 1,893 7,852 5,400 122,983
Exchange adjustments 1 (46) — (19) (25) 16 (13) (86)
Charge for the year 34 82 8,024 1,492 291 268 606 10,797
Impairment losses 57 5 918 117 1 — 21 1,119
Reclassified as assets held for sale — (8) (4,342) (514) (76) (97) — (5,037)
Deletions (91) (38) (3,528) (796) (208) (99) (940) (5,700)
At 31 December 2010 572 1,384 88,047 19,183 1,876 7,940 5,074 124,076
Net book amount at 31 December
2010 2,988 1,451 72,137 23,644 1,089 4,276 4,578 110,163
(continued)
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At 1 January 2009 3,964 2,742 146,813 37,905 3,045 12,295 10,345 217,109
Exchange adjustments 148 85 2 877 83 66 546 1,807
Additions 59 313 11,928 3,743 145 115 739 17,042
Transfers — — 745 — — — — 745
Deletions (385) (222) (2,291) (926) (251) (35) (1,335) (5,445)
At 31 December 2009 3,786 2,918 157,197 41,599 3,022 12,441 10,295 231,258
Depreciation
At 1 January 2009 598 1,313 79,955 17,298 1,696 7,542 5,507 113,909
Exchange adjustments 19 38 — 446 54 30 272 859
Charge for the year 31 102 8,951 1,372 302 289 618 11,665
Impairment losses 88 53 10 185 10 8 52 406
Deletions (165) (117) (1,941) (398) (169) (17) (1,049) (3,856)
At 31 December 2009 571 1,389 86,975 18,903 1,893 7,852 5,400 122,983
Net book amount at 31 December 2009 3,215 1,529 70,222 22,696 1,129 4,589 4,895 108,275
Net book amount at 1 January 2009 3,366 1,429 66,858 20,607 1,349 4,753 4,838 103,200
Assets Held Under Finance Leases at
Net Book Amount Included Above
At 31 December 2010 — 14 236 386 — 7 18 661
At 31 December 2009 — 14 225 110 — 7 19 375
Decommissioning Asset at Net Book
Amount Included Above Cost Depreciation Net
At 31 December 2010 9,237 4,585 4,652
At 31 December 2009 7,968 4,129 3,839
Assets Under Construction
Included Above
At 31 December 2010 23,055
At 31 December 2009 19,120
IAS 19, EMPLOYEE BENEFITS
IFRS Overview and Comparison
to U.S. GAAP
Author’s Note
On 16 June 2011, the IASB issued a revised IAS 19,
Employee Benefits, which is effective for annual re-
porting periods beginning on or after 1 January 2013,
with early application permitted. See the author’s note
preceding paragraph 2.308 in section 2 for a discussion
of the amendments to this standard.
3.143 Employee benefits are all forms of consideration given
by an entity for services rendered by its employees. IAS 19
establishes the requirement of accounting for four general
categories of employee benefits within its scope: short term
(for example, wages and compensating absences); postem-
ployment (for example, pensions); other long term (for ex-
ample, long-term disability); and termination benefits (for
example, severance pay). An entity should account for all
employee benefits, except those to which IFRS 2, Share-
based Payment, applies, in accordance with IAS 19.
Author’s Note
See section 2, beginning with paragraph 2.308, for a
more comprehensive discussion of recognition, mea-
surement, presentation, and disclosure requirements
set forth in IAS 19. This subsection only provides a
brief overview of the effects of IAS 19 on the state-
ment of comprehensive income.
Recognition and Measurement
IFRSs
3.144 For most employee benefits, IAS 19 requires an entity
to recognize both a liability and related expense in profit or
loss when it is probable that settlement of the obligation will
IFRS ATT 3.143
341Section 3: Statement of Comprehensive Income and Related Disclosures
result in an outflow of economic benefits and the cost can be
estimated reliably, except to the extent that the cost may be
included in the cost of an asset.
3.145 An entity should recognize termination benefits as a
liability and expense when the entity is demonstrably com-
mitted to terminate employment before normal retirement or
provide such benefits due to an offer encouraging voluntary
termination.
3.146 With respect to postemployment benefits, IAS 19 re-
quires an entity to recognize the net total of the following
amounts as an expense in profit or loss, except as otherwise
required or permitted to be included in the cost of an asset:
• Service cost
• Interest cost
• Expected return on plan assets and any reimbursement
rights
• Actuarial gains or losses, if any (see the following para-
graph)
• Past service cost
• Effect of any curtailments or settlements
• Effect of the limit on recognition of a defined benefit
asset, unless recognized in other comprehensive income
3.147 For defined benefit plans, IAS 19 provides an entity
with alternatives for recognizing the effects of actuarial gains
and losses. An entity can recognize only a portion of actuarial
gains and losses in profit or loss using the corridor method.
An entity should apply the corridor method to each defined
benefit plan separately. An entity using the corridor method
should determine the amount, if any, of unrecognized ac-
tuarial gains or losses to be recognized in profit or loss as
follows:
a. Determine the amount by which the net cumulative un-
recognized actuarial gains and losses exceed the greater
of 10 percent of the present value of the defined benefit
obligation and 10 percent of the fair value of the plan
assets. (If this amount is zero or negative, no expense
is recognized.)
b. Divide the excess, if any, by the expected average re-
maining working lives of plan participants and recog-
nize this amount as an expense. (If there is no excess,
no expense is recognized.)
Alternatively, IAS 19 states that an entity may use a system-
atic method that recognizes actuarial gains or losses more
quickly, as long as the method treats gains and losses the
same and is applied consistently from period to period. If the
entity chooses to recognize all actuarial gains and losses on
all its defined benefit plans in the period in which they occur,
it can recognize them in other comprehensive income, rather
than profit or loss.
U.S. GAAP
3.148 Like IFRSs, U.S. GAAP requires an entity to rec-
ognize obligations and corresponding expenses when settle-
ment of the obligation is probable and the amount can be mea-
sured reasonably. FASB ASC 710, Compensation—General
addresses general employee compensation (such as salaries,
wages, and compensating absences); deferred compensation;
and lump sum payments under union contracts. FASB ASC
712, Compensation—Nonretirement Postemployment Bene-
fits, FASB ASC 715, Compensation—Retirement Benefits,
and FASB ASC 718, Compensation—Stock Compensation,
address postemployment nonretirement benefits; pensions
and other retirement benefits; and stock compensation re-
spectively.
3.149 With respect to defined benefit postemployment ben-
efit plans, FASB ASC 715 requires an entity to recognize
essentially the same components on the income statement as
IAS 19, except that FASB ASC 220-10-55-2(h)–(j) requires
an entity to report in other comprehensive income the follow-
ing items associated with pensions and other postretirement
benefits:
• Gains and losses and transition assets or obligations to
the extent these items are not recognized immediately
as a component of net periodic pension cost, and
• Prior service costs or credits.
Presentation
3.150 Neither IAS 19 nor FASB ASC requires an entity to
present employee benefits as a separate line item(s) in the
statement of comprehensive income. An entity may disag-
gregate information either on the statement or in the notes.
However, it is common in practice for actuarial gains and




3.151 IAS 19 requires an entity to disclose amounts rec-
ognized in the statement of comprehensive income. For the
expense recognized in profit or loss, an entity should dis-
close the components of the expense (for example, service
cost and interest cost). For the amount recognized in other
comprehensive income, an entity should separately disclose
actuarial gains and losses and the effect of the asset ceiling.
When the entity has opted to report all actuarial gains and
losses of the period directly in other comprehensive income,
the entity should disclose the cumulative amount recognized.
U.S. GAAP
3.152 FASB ASC 715 requires similar disclosures for items
reported on the income statement and in other comprehensive
income.
Presentation and Disclosure Excerpts
Author’s Note
When using the two-statement format for the Statement
of Comprehensive Income, several survey companies
use the title “Statement of Recognized Income and
Expense” as the title for the statement that includes
the information recognized in other comprehensive in-
come.
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Short-Term Benefits
3.153
Reckitt Benckiser Group plc (Dec 2010)
GROUP INCOME STATEMENT (in part)
2010 2009
For the Year Ended 31 December Notes £m £m
Net revenues 2 8,453 7,753
Cost of sales 3 (3,332) (3,089)
Gross profit 5,121 4,664
Net operating expenses 3 (2,991) (2,773)
Operating profit 2 2,130 1,891
Operating profit before exceptional items 2,231 1,891
Exceptional items 3 (101) —
Operating profit 2,130 1,891
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
5. Employees (in part)
(a) Staff Costs
The total employment costs, including Directors, were
2010 2009
£m £m
Wages and salaries 815 749
Social security costs 145 141
Net pension costs 56 52
Share based payments 62 59
1,078 1,001
Details of Directors’ emoluments are included in the Directors’
Remuneration Report on pages 22 to 28, which forms part of
the financial statements.






Salaries and short-term employee
benefits 12 14
Post-employment benefits 1 1
Share based payments 21 23
34 38
There were no other long-term benefits (2009: £nil) or termi-
nation benefits (2009: £nil) paid to key management in 2010.
(b) Staff Numbers
The average number of people employed by the Group, in-




North America and Australia 3.7 3.6
Developing Markets 10.8 9.2
RBP 0.4 0.4
27.2 24.9
(∗) Included in Europe are 2,700 (2009: 2,500) UK employees.
Postemployment Benefits—Actuarial Gains
and Losses Recognized Immediately in
Equity, Effect of the Asset Ceiling, Special
Contributions
3.154
Thomson Reuters Corporation (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)
Year Ended
December 31
(Millions of U.S. Dollars, Except per
Share Amounts) Notes 2010 2009
Revenues 13,070 12,997
Operating expenses 5 (10,061) (9,875)
Depreciation (457) (509)
Amortization of computer software (572) (548)
Amortization of other identifiable
intangible assets (545) (499)
Other operating (losses) gains, net 6 (16) 9
Operating profit 1,419 1,575
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME (in part)
Year Ended
December 31
(Millions of U.S. Dollars) Notes 2010 2009
Net earnings 933 867
Other comprehensive (loss) income:
Net gain on cash flow hedges 113 296
Net (gain) on cash flow hedges
transferred to earnings 19 (123) (350)
Foreign currency translation
adjustments to equity 9 678
Foreign currency translation
adjustments to earnings (8) 173
Net actuarial losses on defined
benefit pension plans, net of tax(1) 26 (108) (4)
Other comprehensive (loss) income (117) 793
Total comprehensive income 816 1,660
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
(Unless otherwise stated, all amounts are in millions of U.S.
dollars)
Note 1: Summary of Business and Significant
Accounting Policies (in part)
Employee Future Benefits
For defined benefit pension plans and other post-employment
benefits, the net periodic pension expense is actuarially de-
termined on an annual basis by independent actuaries using
the projected unit credit method. The determination of benefit
expense requires assumptions such as the expected return
on assets available to fund pension obligations, the discount
rate to measure obligations, expected mortality, the expected
rate of future compensation and the expected healthcare cost
trend rate. For the purpose of calculating the expected return
on plan assets, the assets are valued at fair value. Actual
results will differ from results which are estimated based on
assumptions. The vested portion of past service cost aris-
ing from plan amendments is recognized immediately in the
income statement. The unvested portion is amortized on a
straight-line basis over the average remaining period until the
benefits become vested.
The asset or liability recognized in the statement of financial
position is the present value of the defined benefit obligation
at the end of the reporting period less the fair value of plan
assets, together with adjustments for unrecognized past ser-
vice costs. The present value of the defined benefit obligation
is determined by discounting the estimated future cash out-
flows using interest rates of high-quality corporate bonds that
are denominated in the currency in which the benefits will
be paid and that have terms to maturity approximating the
terms of the related pension liability. All actuarial gains and
losses that arise in calculating the present value of the de-
fined benefit obligation and the fair value of plan assets are
recognized immediately in retained earnings and included in
the statement of comprehensive income. For funded plans,
surpluses are recognized only to the extent that the surplus
is considered recoverable. Recoverability is primarily based
on the extent to which the Company can unilaterally reduce
future contributions to the plan.
Payments to defined contribution plans are expensed as in-
curred, which is as the related employee service is rendered.
Note 26: Employee Benefit Plans
Retirement Benefits
The Company sponsors both defined benefit and defined con-
tribution employee future benefit plans covering substantially
all employees. Costs for all future employee benefits are ac-
crued over the periods in which employees earn the bene-
fits. Defined benefit plans provide pension and other post-
employment benefits (“OPEB”) to covered employees. Sig-
nificant plans are valued under IAS 19, Employee Benefits,
by independently qualified actuaries using the projected unit
credit method. The largest defined benefit plans are Thom-
son Reuters Group Pension Plan and the Reuters Pension
Fund.
Net Defined Benefit Plan Obligations
The movement on net defined benefit plan obligations was
as follows:
Pension Plans(1) OPEB(1) Total(1)
2010 2009 2010 2009 2010 2009
As of January 1 (590) (588) (179) (174) (769) (762)
Plan expense recognized in income statement (71) (78) (15) (13) (86) (91)
Actuarial losses (155) (7) (11) (4) (166) (11)
Exchange differences (16) 3 — 1 (16) 4
Contributions paid 76 75 11 11 87 86
Other (26) 5 (2) — (28) 5
Net plan obligations as of December 31 (782) (590) (196) (179) (978) (769)
Net plan surpluses recognized in non-current assets — — — — 48 64
Net plan obligations recognized in non-current liabilities — — — — (1,026) (833)
(1) Includes amounts for immaterial defined benefit and OPEB plans that are not included in the detailed analysis below.
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Analysis of Material Defined Benefit Plans
The net defined benefit surpluses (obligations) of the material
defined benefit plans recognized in the statement of financial
position were as follows:
Funded Unfunded(1) OPEB Total
As of December 31 2010 2009 2010 2009 2010 2009 2010 2009
Present value of plan obligations (4,883) (4,436) (281) (263) (186) (172) (5,350) (4,871)
Fair value of plan assets 4,586 4,261 — — — — 4,586 4,261
(297) (175) (281) (263) (186) (172) (764) (610)
Unrecognized plan assets(2) (172) (127) — — — — (172) (127)
Net plan obligations (469) (302) (281) (263) (186) (172) (936) (737)
Net plan surpluses 48 64 — — — — 48 64
Net plan obligations (517) (366) (281) (263) (186) (172) (984) (801)
(1) The unfunded pension plans referred to above consist primarily of supplemental executive retirement plans (“SERPs”) for eligible employees.
(2) Unrecognized plan assets represent the plan surpluses deemed not recoverable as the Company cannot unilaterally reduce future contri-
butions in order to utilize the surplus. These amounts are not included in the statement of financial position.
The following summarizes the activity in material defined ben-
efit pension and OPEB plans:
Present Value of Defined Benefit Funded Unfunded OPEB Total
Obligation 2010 2009 2010 2009 2010 2009 2010 2009
Opening defined benefit obligation (4,436) (3,922) (263) (253) (172) (166) (4,871) (4,341)
Current service cost (80) (75) (4) (5) (2) (2) (86) (82)
Interest cost (247) (234) (15) (15) (10) (10) (272) (259)
Actuarial losses (357) (113) (13) (3) (11) (4) (381) (120)
Contributions by employees (8) (9) — — — — (8) (9)
Benefits paid 164 155 15 15 10 11 189 181
Exchange differences 104 (237) 1 (7) (1) (1) 104 (245)
Other (23) (1) (2) 5 — — (25) 4
Closing defined benefit obligation (4,883) (4,436) (281) (263) (186) (172) (5,350) (4,871)
Funded Unfunded OPEB Total
Fair Value of Plan Assets 2010 2009 2010 2009 2010 2009 2010 2009
Opening fair value of plan assets 4,261 3,698 — — — — 4,261 3,698
Expected return(1) 279 257 — — — — 279 257
Actuarial gains(1) 271 135 — — — — 271 135
Contributions by employer 59 57 15 15 10 11 84 83
Contributions by employees 8 9 — — — — 8 9
Benefits paid (164) (155) (15) (15) (10) (11) (189) (181)
Exchange differences (127) 260 — — — — (127) 260
Other (1) — — — — — (1) —
Closing fair value of plan assets 4,586 4,261 — — — — 4,586 4,261
(1) Actuarial gains and losses include the difference between the expected and actual return on plan assets. The expected return on assets
represents the projected increase in the fair value of plan assets due to investment returns. The actual return on plan assets for the year
ended December 31, 2010 was a gain of $550 million (2009: gain of $392 million).
The weighted average duration of the plan obligations were
17 years (2009: 17) and 22 years (2009: 20) for the Thomson
Reuters Group Pension Plan and the Reuters Pension Fund,
respectively.
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For funded plans, the major categories of plan assets as a
percentage of total plan assets were as follows:







Plan assets are invested to satisfy the fiduciary obligation to
adequately secure benefits and to minimize the Company’s
long-term contributions to the plans. As of December 31, 2010
and 2009, there were no Thomson Reuters securities held in
the Company’s pension plans’ assets.
The following summarizes the history of plan obligations,
plan assets and experience adjustments:
As of 2010 2009 2008
December 31 Funded Unfunded OPEB Total Funded Unfunded OPEB Total Funded Unfunded OPEB Total
Present value of
plan
obligations (4,883) (281) (186) (5,350) (4,436) (263) (172) (4,871) (3,922) (253) (166) (4,341)
Fair value of
plan assets 4,586 — — 4,586 4,261 — — 4,261 3,698 — — 3,698
Deficit (297) (281) (186) (764) (175) (263) (172) (610) (224) (253) (166) (643)
Year Ended 2010 2009 2008
December 31 Funded Unfunded OPEB Total Funded Unfunded OPEB Total Funded Unfunded OPEB Total
Experience gains
(losses) on plan
obligations (22) 1 — (21) (2) 5 4 7 (50) 3 10 (37)
Experience gains
(losses) on plan
assets 271 — — 271 135 — — 135 (578) — — (578)
Contributions
In 2010, the Company made special contributions of $12 mil-
lion (2009: $7 million) to the Reuters Supplementary Pension
Plan (“SPS”) following discussion with plan Trustees. In 2009,
the Company also made special contributions of $4 million to
the Reuters Pension Fund. In 2011, the Company expects
to contribute approximately $77 million to all its plans in ac-
cordance with normal funding policy, of which $50 million
relates to the normal funding policy of funded plans, and the
remainder relates to claims arising under unfunded plans. Ad-
ditionally, the Company does not anticipate having to make
material special contributions to its pension plans in 2011.
From time to time, the Company may elect to make volun-
tary contributions in order to improve the funded status of
the plans. Relative to certain plans, the Trustees have the
right to call for special valuations, which could result in an
unexpected contribution. No such valuation has been called
for as of this date. Because of the ability of the trustees to
call for interim valuations for certain plans, as well as market
driven changes that the Company cannot predict, the Com-
pany could be required to make contributions in the future
that differ significantly from its estimates.
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Actuarial Assumptions
The weighted average actuarial assumptions were as follows:
Funded Unfunded OPEB
As of December 31 2010 2009 2010 2009 2010 2009
Discount rate 5.32% 5.72% 5.41% 5.94% 5.05% 5.65%
Inflation assumption 3.33% 3.03% 2.73% 2.73% — —
Rate of increase in salaries 3.91% 3.86% 3.60% 4.78% 3.50% 3.50%
Rate of increase in pensions in payment 3.25% 3.17% 3.40% 3.30% — —
Medical cost trend — — — — 7.53% 8.01%
Expected rate of return on assets 6.82% 6.81% — — — —
Discount Rate
The discount rate was selected based on a review of current
market interest rates of high-quality, fixed-rate debt securities
adjusted to reflect the duration of expected future cash out-
flows for pension benefit payments. Because the Company
has a relatively young workforce, the expected future cash
outflows for its plans tend to be of longer duration than the
bond indices reviewed. Therefore, the discount rate used for
the Company’s plans tends to be higher than these bench-
mark rates. To estimate the discount rate, the Company’s ac-
tuary constructed a hypothetical yield curve that represented
yields on high quality zero-coupon bonds with durations that
mirrored the expected payment stream of the benefit obli-
gation. For the Thomson Reuters Group Pension Plan and
Reuters Pension Fund, a 0.25% increase or decrease in the
discount rate would have decreased or increased the defined
benefit obligation by approximately $155 million as of Decem-
ber 31, 2010.
Expected Rate of Return on Assets
The Company must make assumptions about the expected
long-term rate of return on plan assets, but there is no as-
surance that a plan will be able to earn the assumed rate of
return. In determining the long-term rate of return assumption,
the Company considers historical returns, input from invest-
ment advisors and its actuary’s simulation model of expected
long-term rates of return assuming the Company’s targeted
investment portfolio mix. For the Thomson Reuters Group
Pension Plan and Reuters Pension Fund, a 0.25% increase
or decrease in the expected rate of return on assets would
decrease or increase pension expense by approximately $8
million in 2011.
Medical Cost Trend
The medical cost trend is based on the Company’s actuarial
medical claims experience and future projections of medical
costs. The average medical cost trend rate used was 7.5%
for 2010, which is reduced ratably to 5% in 2016. A 1% in-
crease or decrease in the trend rate would have resulted in
an increase or decrease in the benefit obligation for post-
retirement benefits of approximately $17 million at December
31, 2010 and an increase or decrease in the service and
interest costs of approximately $1 million in 2010.
Mortality Assumptions
The mortality assumptions used to assess the defined ben-
efit obligation for the Thomson Reuters Group Pension Plan
and the Reuters Pension Fund as of December 31, 2010
are based on the UP94 Generational Table and the 00 Se-
ries Tables issued by the Continuous Mortality Investigation
Bureau with allowance for projected longevity improvements
and adjustment for the medium cohort effect, respectively.
The following table illustrates the life expectation in years of
an average plan participant retiring at age 65 as of December
31, 2010 and 2009 and a plan participant at age 40 as of
December 31, 2010 and 2009 retiring 25 years later at age
65 under the mortality assumptions used.
Life Expectation in Years
December 31, 2010 Male Female
Employee retiring as of December 31,
2010 at age 65 21 23
Employee age 40 as of December 31,
2010 retiring at age 65 22 24
Life Expectation in Years
December 31, 2009 Male Female
Employee retiring as of December 31,
2009 at age 65 21 23
Employee age 40 as of December 31,
2009 retiring at age 65 22 23
For the Thomson Reuters Group Pension Plan and the
Reuters Pension Fund, an increase in life expectancy of one
year across all age groups would result in a $65 million in-
crease in the defined benefit obligation as of December 31,
2010.
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Analysis of Income and Expense
The following summarizes income and expense activity for
material defined benefit plans:
Income Statement Funded Unfunded OPEB Total
Year Ended December 31 2010 2009 2010 2009 2010 2009 2010 2009
Current service cost 80 75 4 5 2 2 86 82
Interest cost 247 234 15 15 10 10 272 259
Expected gain on plan assets (279) (257) — — — — (279) (257)
Defined benefit plan expense 48 52 19 20 12 12 79 84
Statement of Comprehensive Income Funded Unfunded OPEB Total
Year Ended December 31 2010 2009 2010 2009 2010 2009 2010 2009
Actuarial losses (gains) 86 (22) 13 3 11 4 110 (15)
Effect of asset ceiling 52 25 — — — — 52 25
Total recognized in other comprehensive income before
taxation 138 3 13 3 11 4 162 10
Funded Unfunded OPEB Total
Accumulated Comprehensive Income 2010 2009 2010 2009 2010 2009 2010 2009
Balance of actuarial losses (gains) at January 1 542 564 1 (2) (13) (17) 530 545
Net actuarial losses (gains) recognized in the year 86 (22) 13 3 11 4 110 (15)
Balance of actuarial losses (gains) at December 31 628 542 14 1 (2) (13) 640 530
Balance of asset ceiling at January 1 46 21 — — — — 46 21
Effects of the asset ceiling in the year 52 25 — — — — 52 25
Balance of asset ceiling at December 31 98 46 — — — — 98 46
Total accumulated comprehensive income at December 31 726 588 14 1 (2) (13) 738 576
Defined Contribution Plans
The Company sponsors various defined contribution savings
plans that provide for company-matching contributions. To-
tal expense related to defined contribution plans was $132
million in 2010 (2009: $128 million), which approximates the
cash outlays related to the plans.
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Postemployment Benefits—Change in
Accounting Policy for Actuarial Gains
and Losses, Termination Benefits
3.155
Luxottica Group S.p.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF INCOME
(in part)
For the years ended December 31, 2010, 2009 and 2008(∗)
(Amounts in Thousands of Euro Except Share Data) Note Reference 2010 2009 2008
Net sales 4 5,798,035 5,094,318 5,201,611
Cost of sales (1,990,205) (1,762,591) (1,748,628)
Gross profit 3,807,831 3,331,727 3,452,983
Selling and Advertising (2,367,979) (2,104,362) (2,144,989)
General and administrative (727,693) (656,280) (576,355)
Total operating expenses (3,095,672) (2,760,642) (2,721,344)
Income from operations 712,159 571,085 731,639
(∗) In accordance with IFRS.
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (in part)
For the years ended December 31, 2010, 2009 and 2008(∗)
(Amounts in Thousands of Euro) 2010 2009 2008
Net income 407,258 304,896 397,872
Other comprehensive income:
Cash flow hedge—net of tax (3,223) 10,429 (41,287)
Currency translation differences 233,518 24,827 (63,900)
Actuarial gain/(loss) on defined benefit plans—net of tax (8,744) 14,951 (50,208)
Total other comprehensive income—net of tax 221,552 50,207 (155,395)
Total comprehensive income for the period 628,810 355,103 242,477
(∗) In accordance with IFRS.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Consolidation Principles, Consolidation Area and
Significant Accounting Policies (in part)
Employee Benefits
The Group has both defined benefit and defined contribution
plans.
A defined contribution plan is a pension plan under which
the Group pays fixed contributions into a separate entity. The
Group has no legal or constructive obligations to pay further
contributions if the fund does not hold sufficient assets to pay
all employees the benefits relating to employee service in the
current and prior periods.
A defined benefit plan is a pension plan that is not a de-
fined contribution plan. Typically, defined benefit plans define
an amount of pension benefit that an employee will receive
upon retirement, usually dependent on one or more factors
such as age, years of service and compensation. The liability
recognized in the consolidated statement of financial posi-
tion in respect of defined benefit pension plans is the present
value of the defined benefit obligation at the end of the re-
porting period less the fair value of plan assets, together with
adjustments for unrecognized past-service costs. The defined
benefit obligation is calculated annually by independent ac-
tuaries using the projected unit credit method. The present
value of the defined benefit obligation is determined by dis-
counting the estimated future cash outflows using interest
rates of high-quality corporate bonds that are denominated
in the currency in which the benefits will be paid and that
have terms to maturity approximating the terms of the related
pension obligation.
Actuarial gains and losses due to changes in actuarial as-
sumptions or to changes in the plan’s conditions are recog-
nized as incurred in the consolidated statement of compre-
hensive income.
For defined contribution plans, the Group pays contribu-
tions to publicly or privately administered pension insurance
plans on a mandatory, contractual or voluntary basis. The
Group has no further payment obligations once the contri-
butions have been paid. The contributions are recognized
as employee benefit expenses when they are due. Prepaid
contributions are recognized as an asset to the extent that a
cash refund or a reduction in the future payments is available.
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Use of Estimates (in part)
The preparation of financial statements in conformity with
IFRS requires the use of certain critical accounting estimates
and assumptions which influence the value of assets and
liabilities as well as revenues and costs reported in the con-
solidated statement of financial position and in the consoli-
dated statement of income, respectively, or the disclosures
included in the notes to the consolidated financial statements,
in relation to potential assets and liabilities existing as of the
date the consolidated financial statements were authorized
for issue.
Estimates are based on historical experience and other
factors. The resulting accounting estimates could differ from
the related actual results. Estimates are periodically reviewed
and the effects of each change are reflected in the consoli-
dated statement of income in the period in which the change
occurs.
The current economic and financial crisis has resulted in
the need to make assumptions on future trends that are char-
acterized by a significant degree of uncertainty and, therefore,
the actual results in future years may significantly differ from
the estimate.
The most significant accounting principles which require a
higher degree of judgment from management are illustrated
below.
f) Benefit plans. The Group participates in benefit plans
in various countries. The present value of pension li-
abilities is determined using actuarial techniques and
certain assumptions. These assumptions include the
discount rate, the expected return on plan assets, the
rates of future compensation increases and rates rel-
ative to mortality and resignations. Any change in the
abovementioned assumptions could result in signifi-
cant effects on the employee benefit liabilities.
2. New Accounting Principles (in part)
Changes to Previously Applied Accounting Principles
During 2009, the Group changed the accounting principle on
to the recognition of actuarial gains and losses on defined
benefit plans. Actuarial gains and losses comprise (i) the ef-
fects of differences between the previous actuarial assump-
tions and what has actually occurred and (ii), the effect of
changes in actuarial assumptions. Up to December 31, 2008,
actuarial gains and losses were recognized based on the “cor-
ridor” method. Starting from January 1, 2009, the Company
recognizes actuarial gains and losses in other comprehensive
income, as incurred.
The above change was implemented in order to reduce
volatility and improve comparability of the consolidated state-
ments of income presented.
In accordance with IAS 8, the change in the account-
ing principle was applied retrospectively. The effects of the
change on stockholders’ equity, deferred tax assets, termina-
tion indemnities and other long-term payables, as of January
1, 2008 and January 1, 2009, are reported below (amounts
in thousands of Euro):
January 1, 2008
Reported
Effect Due to Change in
Accounting Principle Restated
Retained earnings 2,604,274 (2,760) 2,601,514
Currency translation difference (367,421) 431 (366,990)
Liability for termination indemnities 48,344 (3,034) 45,310
Other non-current liabilities 232,185 7,942 240,127
Deferred tax assets 314,026 4,831 318,857
Deferred tax liabilities 372,350 2,252 374,602
January 1, 2009
Reported
Effect Due to Change in
Accounting Principle Restated
Retained earnings 2,729,519 (52,968) 2,676,551
Currency translation difference (428,093) (2,454) (430,547)
Liability for termination indemnities 47,355 (1,789) 45,566
Other non-current liabilities 326,681 92,602 419,283
Deferred tax assets 355,470 35,883 391,353
Deferred tax liabilities 415,778 492 416,270
In September 2007, the IASB issued a revised IAS 1—
Presentation of Financial Statements requiring to present,
in a statement of changes in equity, all owner changes in
equity. All non-owner changes in equity (i.e. comprehensive
income) are required to be presented in one statement of
comprehensive income or in two separate statements (an in-
come statement and a statement of comprehensive income).
Components of comprehensive income are not permitted
to be presented in the statement of changes in equity. The
Company has applied the revised standard retrospectively
from January 1, 2009, electing to present both the income
statement and the statement of comprehensive income, and
has consequently amended the presentation of changes in
stockholders’ equity. The provisions of the new guidance
have been applied to all periods presented in the accom-
panying consolidated financial statements.
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20. Liability for Termination Indemnities
Liabilities for termination indemnity were equal to Euro 45.4
million (Euro 44.6 million as of December 31, 2009).
This item primarily includes the liabilities related to the post-
employment benefits of the Italian companies’ employees
(hereinafter “TFR”), accounted for in accordance with Article
2120 of the Italian Civil Code.
Effective January 1, 2007, the TFR system was reformed,
and under the new law, employees are given the ability to
choose where the TFR compensation is invested, whereas
such compensation otherwise would be directed to the Na-
tional Social Security Institute or Pension Funds. As a result,
contributions under the reformed TFR system are accounted
for as a defined contribution plan. The liability accrued un-
til December 31, 2006 continues to be considered a defined
benefit plan. Therefore, each year, the Group adjusts its ac-
crual based upon headcount and inflation, excluding changes
in compensation level.
The liabilities as of December 31, 2010 amounted to Euro
37.8 million (Euro 37.8 million as of December 31, 2009).
Contribution expense was Euro 16.2 million, Euro 15.0 mil-
lion and Euro 14.9 million for the years 2010, 2009 and 2008,
respectively.
In application of Accounting Principle IAS 19, the valua-
tion of TFR liability accrued as of December 31, 2006 was
based on the Projected Unit Credit Cost method. The main
assumptions utilized are reported below:
Economic
Assumptions 2010 2009
Discount rate 4.60% 5.10%
Annual TFR
increase rate 3.00% 3.00%
Death
probability:


























Movements in liabilities during the course of the year are
detailed in the following table:
(Amounts in Thousands of Euro) 2010 2009 2008
Liabilities at the beginning of the period 37,829 39,712 34,409
Expenses for interests 1,929 2,090 2,223
Actuarial loss (income) 1,575 (819) 1,246
Benefits paid (3,495) (3,154) (4,163)
Liabilities at the end of the period 37,838 37,829 39,712
22. Other Non-Current Liabilities
As of December 31
(Amounts in Thousands of Euro) 2010 2009
Provision for risk 82,855 99,050
Other liabilities 113,077 113,517
Other financial liabilities 114,658 137,461
Total other non-current liabilities 310,590 350,028
The provision for risks primarily includes:
(1) accruals for “self-insurance” covering specific risks,
amounting to Euro 26.9 million (Euro 25.2 million as of
December 31, 2009);
(2) accruals for various legal disputes arising from normal
business activities, totaling Euro 6.0 million (Euro 3.0
million as of December 31, 2009); and
(3) accruals for tax liabilities of Euro 37.5 million (Euro
51.3 million as of December 31, 2009). The decrease is
primarily related to certain contingent tax liabilities for
Euro 19.9 million originally recorded as part of the 2006
sale of our Things Remembered retail business, which
either settled or expired. The release of the provision
has been recorded in the discontinued operations line
within the consolidated statement of income as of De-
cember 31, 2010. The entire discontinued operations
relate to release of the tax reserve noted above.
Other liabilities primarily include the liabilities for U.S. pension
funds.
The decrease of other financial liabilities as of December
31, 2010 as compared to December 31, 2009 was mainly
due to the payment of the financial liabilities relating to the
purchase of the remaining non-controlling interests in our sub-
sidiary SGH UK Ltd., which occurred on July 30, 2010 (the
financial liabilities were Euro 31.2 million at December 31,
2009).
Information regarding post-employment employee benefits
is provided below.
Pension Funds
Qualified Pension Plans—US Holdings sponsors a qualified
noncontributory defined benefit pension plan, the Luxottica
Group Pension Plan (“Lux Pension Plan”), which provides
for the payment of benefits to eligible past and present em-
ployees of US Holdings upon retirement. Pension benefits
are gradually accrued based on length of service and annual
compensation under a cash balance formula. Participants be-
come vested in the Lux Pension Plan after three years of
vesting service as defined by the Lux Pension Plan.
Nonqualified Pension Plans and Agreements—US Hold-
ings also maintains a nonqualified, unfunded supplemental
executive retirement plan (“Lux SERP”) for participants of
its qualified pension plan to provide benefits in excess of
amounts permitted under the provisions of prevailing tax law.
The pension liability and expense associated with this plan
are accrued using the same actuarial methods and assump-
tions as those used for the qualified pension plan. This plan’s
benefit provisions mirror those of the Lux Pension Plan.
US Holdings also sponsors the Cole National Group, Inc.
Supplemental Pension Plan. This plan is a nonqualified un-
funded SERP for certain participants of the former Cole pen-
sion plan who were designated by the Board of Directors of
Cole on the recommendation of Cole’s chief executive officer
at such time. This plan provides benefits in excess of amounts
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permitted under the provisions of the prevailing tax law. The
pension liability and expense associated with this plan are
accrued using the same actuarial methods and assumptions
as those used for the qualified pension plan.
The following tables provide key information pertaining to
the Lux Plan and SERPs (amounts in thousands of Euro):
Obligations and Funded Status
Pension Plan SERPs
2010 2009 2008 2010 2009 2008
Change in benefit obligations:
Benefit obligation—beginning of period 334,015 313,520 272,611 11,299 12,014 10,361
Service cost 18,640 18,443 17,344 367 466 552
Interest cost 21,700 19,476 17,476 627 664 718
Actuarial (gain)/loss 26,417 1,952 359 455 (1,142) 102
Settlement loss — — — 81 — —
Benefits paid (14,152) (9,545) (9,142) (23) (367) (289)
Settlements — — — (2,293) — —
Translation difference 22,696 (9,831) 14,872 827 (336) 570
Benefit obligation—end of period 409,316 334,015 313,520 11,340 11,299 12,014
Pension Plan SERPs
2010 2009 2008 2010 2009 2008
Change in plan assets:
Fair value of plan assets—beginning of period 238,168 184,379 224,534 — — —
Expected return on plan assets 21,185 15,205 17,720 — — —
Actuarial gain/(loss) on plan assets 14,462 23,790 (73,341 — — —
Employer contribution 39,164 31,267 16,318 2,316 367 289
Benefits paid (14,152) (9,546) (9,142) (23) (367) (289)
Translation difference 15,675 (6,927) 8,290 (2,293) — —
Fair value of plan assets—end of period 314,501 238,168 184,379 — — —
Unfunded status—end of period 94,815 95,847 129,141 11,340 11,299 12,014
Amounts to be recognized in the statement of financial posi-
tion and profit or loss along with actual return on assets were
as follows (amounts in thousands of Euro):
Pension Plan SERPs
2010 2009 2008 2010 2009 2008
Amounts recognized in the statement of financial position:
Liabilities:
Present value of the obligation 409,316 334,015 313,520 11,340 11,299 12,014
Fair value of plan assets 314,501 238,168 184,379 — — —
Liability recognized in statement of financial position 94,815 95,847 129,141 11,340 11,299 12,014
Accumulated other comprehensive income:
Net gain/(loss), beginning of year (63,659) (87,429) (9,107) (2,627) (3,849) (3,545)
Asset gain/(loss) 14,462 23,790 (73,341 — — —
Liability experience gain/(loss) 1,744 (1,761) (4,380) 421 1,228 (948)
Liability assumption change gain/(loss) (28,161) (191) 4,020 (875) (86) 825
Translation difference (4,527) 1,932 (4,621) (187) 80 (181)
Accumulated other comprehensive income, end of year (80,141) (63,659) (87,429) (3,268) (2,627) (3,849)
Service cost 18,640 18,443 17,344 367 466 552
Interest cost 21,700 19,476 17,476 628 663 718
Expected return on plan assets (21,185) (15,204) (17,720) — — —
Settlement loss — — — 81 — —
Expense recognized in profit or loss 19,156 22,715 17,100 1,076 1,129 1,270
Actual return on assets:
Expected return on assets 21,185 15,205 17,720 — — —
Actuarial gain/(loss) on plan assets 14,462 23,790 (73,341) — — —
Actual return on assets 35,646 38,995 (55,621) — — —
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During 2010, the Lux SERP plan settled a portion of its benefit
obligations through lump sum cash payments to certain plan
participants. As a result of this action, the projected benefit
obligation was re-measured as of July 1, 2010. US Holdings
recognized an actuarial loss of Euro 81 thousand in earnings
at the time of re-measurement.
The following tables show the main assumptions used to
determine the period benefit cost and the benefit obligation.
Pension Plan SERPs
2010 2009 2010 2009
Weighted-average assumptions used to determine benefit obligations:
Discount rate 5.50% 6.15% 5.50% 6.15%
Rate of compensation increase 5%/3%/2% 4%/3%/1% 5%/3%/2% 4%/3%/1%
Expected long-term return on plan assets 8.00% 8.00% N/A N/A
Pension Plan
2010 2009 2008
Weighted-average assumptions used to determine
net periodic benefit cost:
Discount rate 5.50% 6.15% 6.30%
Expected long-term return on plan assets 8.00% 8.00% 8.00%
Rate of compensation increase 5%/3%/2% 4%/3%/1% 6%/5%/4%
Mortality table RP-2000 RP-2000 RP-2000
SERPs
2010 2009 2008
Weighted-average assumptions used to determine net periodic benefit cost:
Discount rate:
For the year ended December 31 N/A 6.15% 6.30%
For the period prior to re-measurement 6.15% N/A N/A
For the period after re-measurement 5.50% N/A N/A
Expected long-term return on plan assets 8.00% 8.00% 8.00%
Rate of compensation increase 5%/3%/2% 4%/3%/1% 6%/5%/4%
Mortality table RP-2000 RP-2000 RP-2000
Defined benefit plan data for the current and previous four
annual periods are as follows:
(Amounts in Thousands of Euro) 2010 2009 2008 2007 2006
Pension Plans:
Defined benefit obligation 409,316 334,015 313,520 272,611 277,468
Fair value of plan assets 314,501 238,168 184,379 224,533 224,262
Plan surplus/(deficit) 94,815 95,847 129,141 48,078 53,206
Plan liabilities experience gain/(loss) 1,744 (1,761) (4,379) (5,212) (6,414)
Plan assets experience gain/(loss) 14,462 23,790 (73,341) (2,619) 3,698
SERPs:
Defined benefit obligation 11,340 11,299 12,015 10,361 8,512
Fair value of plan assets — — — — —
Plan surplus/(deficit) (11,340) (11,299) (12,015) (10,361) (8,512)
Plan liabilities experience gain/(loss) 421 1,228 (927) 2,039) (1,799)
Plan assets experience gain/(loss) — — — — —
The Group’s discount rate is developed using a third party
yield curve derived from non-callable bonds of at least an Aa
rating by Moody’s Investor Services or at least an AA rating
by Standard & Poor’s. Each bond issue is required to have
at least U.S. $250 million par outstanding. The yield curve
compares the future expected benefit payments of the Lux
Pension Plan to these bond yields to determine an equivalent
discount rate.
The Group uses an assumption for salary increases based
on a graduated approach of historical experience. The
Group’s experience shows salary increases that typically vary
by age.
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In developing the long-term rate of return assumption, the
Group considers its asset allocation. The Group analyzed his-
torical rates of return being earned for each asset category
over various periods of time. Additionally, the Group con-
sidered input from its third-party pension asset managers,
investment consultants and plan actuaries, including their re-
view of asset class return expectations and long-term inflation
assumptions.
Plan Assets—The Lux Pension Plan’s investment policy is
to invest plan assets in a manner to ensure over a long-term
investment horizon that the plan is adequately funded; maxi-
mize investment return within reasonable and prudent levels
of risk; and maintain sufficient liquidity to make timely ben-
efit and administrative expense payments. This investment
policy was developed to provide the framework within which
the fiduciary’s investment decisions are made, establish stan-
dards to measure the investment manager’s and investment
consultant’s performance, outline the roles and responsibili-
ties of the various parties involved, and describe the ongoing
review process. The investment policy identifies target asset
allocations for the plan’s assets at 40 percent Large Cap U.S.
Equity, 10 percent Small Cap U.S. Equity, 15 percent Inter-
national Equity, and 35 percent Fixed Income Securities, but
an allowance is provided for a range of allocations to these
categories as described in the table below.
Asset Class as a Percent
of Total Assets
Asset Category Minimum Maximum
Large Cap U.S. Equity 37% 43%
Small Cap U.S. Equity 8% 12%
International Equity 13% 17%
Fixed Income Securities 32% 38%
Cash and Equivalents — 5%
The actual allocation percentages at any given time may vary
from the targeted amounts due to changes in stock and bond
valuations as well as timing of contributions to, and bene-
fit payments from, the pension plan trusts. The Lux Pension
Plan’s investment policy intends that any divergence from
the targeted allocations should be of a short duration, but
the appropriate duration of the divergence will be determined
by the Investment Subcommittee of the Luxottica Group Em-
ployee Retirement Income Security Act of 1974 (“ERISA”)
Plans Compliance and Investment Committee with the advice
of investment managers and/or investment consultants based
on current market conditions. During 2010, the Committee re-
viewed the Lux Pension Plan’s asset allocation monthly and
if the allocation was not within the above ranges, the Com-
mittee re-balanced the allocations if appropriate based on
current market conditions.
Plan assets are invested in diversified portfolios consisting
of an array of asset classes within the above target alloca-
tions and using a combination of active and passive strate-
gies. Passive strategies involve investment in an exchange-
traded fund that closely tracks an index fund. Active strate-
gies employ multiple investment management firms. Risk is
controlled through diversification among asset classes, man-
agers, styles, market capitalization (equity investments) and
individual securities. Certain transactions and securities are
prohibited from being held in the Lux Pension Plan’s trusts,
such as ownership of real estate other than real estate invest-
ment trusts, commodity contracts, and American Depositary
Receipts (“ADR”) or common stock of the Group. Risk is fur-
ther controlled both at the asset class and manager level by
assigning benchmarks and excess return targets. The invest-
ment managers are monitored on an ongoing basis to evalu-
ate performance against the established market benchmarks
and return targets.
Quoted market prices are used to measure the fair value of
plan assets, when available. If quoted market prices are not
available, the inputs utilized by the fund manager to derive net
asset value are observable and no significant adjustments to
net asset value are necessary.
Contributions—US Holdings expects to contribute Euro
48,104 thousand to its pension plan and Euro 421 thousand
to the SERP in 2011.
Other Benefits—US Holdings provides certain post-
employment medical, disability and life insurance benefits.
The Group’s accrued liability related to this obligation as of
December 31, 2010 and 2009 was Euro 1,880 thousand and
Euro 1,360 thousand, respectively, and is included in other
long-term liabilities in the consolidated statement of financial
position.
US Holdings sponsors the following additional benefit
plans, which cover certain present and past employees of
some of its U.S. subsidiaries:
(a) US Holdings provides, under individual agreements,
post-employment benefits for continuation of health
care benefits and life insurance coverage to former
employees after employment. As of December 31,
2010 and 2009, the accrued liability related to these
benefits was Euro 582 thousand and Euro 627 thou-
sand, respectively, and is included in other long-term
liabilities in the consolidated statement of financial po-
sition.
(b) US Holdings established and maintains the Cole Na-
tional Group, Inc. Supplemental Retirement Benefit
Plan, which provides supplemental retirement bene-
fits for certain highly compensated and management
employees who were previously designated by the for-
mer Board of Directors of Cole as participants. This
is an unfunded noncontributory defined contribution
plan. Each participant’s account is credited with inter-
est earned on the average balance during the year.
This plan was frozen as to future salary credits on the
effective date of the Cole acquisition in 2004. The plan
liability of Euro 848 thousand and Euro 869 thousand
at December 31, 2010 and 2009, respectively, is in-
cluded in other long-term liabilities in the consolidated
statement of financial position.
The Group continues to participate in superannuation plans
in Australia and Hong Kong. The plans provide benefits on
a defined contribution basis for employees upon retirement,
resignation, disablement or death. Contributions to defined
contribution superannuation plans are recognized as an ex-
pense as the contributions are paid or become payable to the
fund. Contributions are accrued based on legislated rates and
annual compensation. The Group’s accrued liability related to
this obligation as of December 31, 2010 and 2009 was Euro
3,642 thousand and Euro 3,045 thousand, respectively, and
is included in other long-term liabilities in the consolidated
statement of financial position.
Health Benefit Plans—US Holdings partially subsidizes
health care benefits for eligible retirees. Employees gener-
ally become eligible for retiree health care benefits when they
retire from active service between the ages of 55 and 65. Ben-
efits are discontinued at age 65. During 2009, US Holdings
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provided for a one-time special election of early retirement to
certain associates age 50 or older with 5 or more years of
service. Benefits for this group are also discontinued at age
65 and the resulting special termination benefit is immaterial.
The plan liability of Euro 3,277 thousand and Euro 3,482
thousand at December 31, 2010 and 2009, respectively, is in-
cluded in other long-term liabilities on the consolidated state-
ment of financial position.
The cost of this plan in 2010 and 2009 as well as the 2011
expected contributions are immaterial.
For 2011, a 9.5 percent (10.0 percent for 2010) increase
in the cost of covered health care benefits was assumed.
This rate was assumed to decrease gradually to 5 percent for
2020 and remain at that level thereafter. The health care cost
trend rate assumption could have a significant effect on the
amounts reported. A 1.0 percent increase or decrease in the
health care trend rate would not have a material impact on
the consolidated financial statements. The weighted-average
discount rate used in determining the accumulated postre-
tirement benefit obligation was 5.5 percent at December 31,
2010 and 6.15 percent at December 31, 2009.
The weighted-average discount rate used in determining
the net periodic benefit cost for 2010, 2009 and 2008 was
6.15 percent, 6.3 percent and 6.5 percent, respectively.
Demographic (including mortality) assumptions are deter-
mined in the light of local conditions. Mortality assumptions
are reviewed annually to reflect the latest available standard
mortality tables for individual countries concerned, adjusted
where appropriate to reflect the experience of Shell.
The long-term assumptions for pensionable salary in-
creases, used to determine benefit obligations at December
31, 2010, remained at similar levels to those used at Decem-
ber 31, 2009 (2009: 0.75% increase for UK plans and 0.25%
increase for US plans).
The assumptions for discount rates reflected decreases of
AA rated corporate bond yields of 0.40% in the Eurozone
(2009: 0.70%), of 0.40% in the UK (2009: 0.30%) and of
0.50% in the USA (2009: 0.30%).
The effect of a one percentage point increase/(decrease),
at December 31, 2010, in the principal pension benefit as-
sumptions would be to increase/(decrease) the defined ben-





Sensitivity to Changes in Assumptions
Relating to Pension Benefits
Expected rates of increase in pensionable
salaries
Change in defined benefit obligation 2,126 (1,897)
Change in annual pension benefit cost
(pre-tax) 240 (211)
Discount rates
Change in defined benefit obligation (8,390) 10,517
Change in annual pension benefit cost
(pre-tax) (103) 101
Expected rates of return on plan assets
Change in annual pension benefit cost
(pre-tax) (629) 629
The effect of an increase/(decrease) of one year in life ex-
pectancy would be to increase/(decrease) the defined benefit
obligation by approximately $2,069 million/($2,147 million).
The impact on the retirement benefit obligation reflected
in Shell’s Consolidated Balance Sheet and on Shell’s annual
pension benefit cost of changes in assumptions described
above excludes the effects of any amortisation of actuarial
gains and losses resulting from such changes. The amorti-
sation would vary from year to year by fund depending on
whether or not the cumulative unrecognised actuarial gains
and losses exceed the corridor (see Note 2). Any amounts
outside the corridor would be recognised in income over the
expected average remaining working lives of employees for
the relevant plan, the average of which across all pension
plans at December 31, 2010, is 12 years (2009: 12 years).
Other Defined Benefit Plans
The weighted averages for the discount rate and healthcare
cost trend rates applicable for the principal other benefit plans
in Shell are:
Other Benefits Assumptions 2010 2009 2008
Discount rates (used to determine benefit
obligations) 5.4% 5.9% 6.3%
Healthcare cost trend rate in year after
reporting year 7.7% 7.9% 8.2%
Ultimate healthcare cost trend rate 4.3% 4.3% 4.2%
Year ultimate healthcare cost trend rate is
applicable 2027 2027 2027
The effect of a one percentage point increase/(decrease)
at December 31, 2010, in the annual rate of increase in
the assumed healthcare cost trend rates would be to in-
crease/(decrease) the defined benefit obligation by approxi-
mately $523 million/($430 million) and the annual benefit cost
(pre-tax) by approximately $36 million/($29 million).
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Postemployment Benefits—Corridor Method,
Retirement Healthcare and Life Insurance
Benefits
3.156
Royal Dutch Shell plc (Dec 2010)
CONSOLIDATED STATEMENT OF INCOME (in part)
$ Million
Notes 2010 2009 2008
Revenue 368,056 278,188 458,361
Share of profit of equity-accounted investments 10 5,953 4,976 7,446
Interest and other income 4 4,143 1,965 5,133
Total revenue and other income 378,152 285,129 470,940
Purchases 283,176 203,075 359,587
Production and manufacturing expenses 24,458 25,301 25,565
Selling, distribution and administrative expenses 15,528 17,430 16,906
Research and development 1,019 1,125 1,230
Exploration 2,036 2,178 1,995
Depreciation, depletion and amortisation 15,595 14,458 13,656
Interest expense 5 996 542 1,181
Income before taxation 35,344 21,020 50,820
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Accounting Policies (in part)
Employee Benefits (in part)
A—Employee Retirement Plans (Pensions)
Retirement plans that define the amount of pension benefit to
be provided (“defined benefit plans”) generally are funded by
payments to independent trusts. Where a plan is not funded,
a provision is made. Valuations of both funded and unfunded
plans are carried out annually by independent actuaries, us-
ing the projected unit credit method to calculate the defined
benefit obligation. Pension cost primarily represents the in-
crease in the actuarial present value of the obligation for pen-
sion benefits based on employee service during the year and
the interest on this obligation in respect of employee service
in previous years, net of the expected return on plan assets.
Actuarial gains and losses are accounted for using the cor-
ridor method. Under this method, to the extent that any cumu-
lative unrecognised actuarial gain or loss exceeds 10% of the
greater of the present value of the defined benefit obligation
and the fair value of plan assets, that excess is recognised in
income over the expected average remaining working lives
of the employees participating in the plan. Otherwise, the ac-
tuarial gain or loss is not recognised.
For retirement plans where benefits depend solely on the
amount contributed to the employee’s account and the invest-
ment returns earned on these contributions (“defined contri-
bution plans”), pension cost is the amount of employer con-
tributions payable for the period.
B—Retirement Benefits Other than Pensions
Retirement healthcare and life insurance benefits are pro-
vided to certain retirees, the entitlement to which is usually
dependant upon the employee remaining in service up to re-
tirement age and the completion of a minimum service period.
These plans are not funded and a provision is made. Valu-
ations of benefits are carried out annually by independent
actuaries, using the projected unit credit method to calculate
the defined benefit obligation.
The expected costs of retirement benefits other than pen-
sions are accrued over the periods employees render service
to Shell. Actuarial gains and losses are accounted for using
the corridor method, as described above.
18. Retirement Benefits
Retirement plans are provided for employees of major sub-
sidiaries. The nature of such plans varies according to the
legal and fiscal requirements and economic conditions of the
country in which the employees are engaged.
Shell’s obligation in respect of defined benefit pension
plans is based on employees’ years of service and aver-
age/final pensionable remuneration. The calculation of the
obligation depends on actuarial assumptions, as described in
Note 3. Defined benefit plans are typically structured as sep-
arate legal entities managed by trustees, who hold the plan
assets in trust.
For defined contribution plans, pension cost is the amount
of employer contributions payable for the period.
Some subsidiaries have established unfunded defined ben-
efit plans to provide certain other retirement healthcare and
life insurance benefits (other benefits) to their retirees. Entitle-
ment to these other benefits is usually based on the employee
remaining in service up to retirement age and the completion
of a minimum service period.
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$ Million
Pension Benefits Other Benefits
Pension and Other Benefits 2010 2009 2010 2009
Change in defined benefit obligation
Obligations for benefits based on employee service to date at January 1 62,718 52,639 3,825 3,494
Increase in present value of the obligation for benefits based on employee service
during the year 1,141 965 62 57
Interest on the obligation for benefits in respect of employee service in previous years 3,227 3,131 216 222
Benefit payments made (3,079) (2,862) (151) (138)
Actuarial losses/(gains) 4,414 5,472 123 (28)
Other movements (21) 281 6 177
Currency translation differences (2,552) 3,092 (14) 41
Obligations for benefits based on employee service to date at December 31 65,848 62,718 4,067 3,825
Change in plan assets
Plan assets held in trust at fair value at January 1 59,425 44,299 — —
Expected return on plan assets 3,645 3,142 — —
Actuarial gains 3,555 6,256 — —
Employer contributions 2,063 5,216 — —
Plan participants’ contributions 86 88 — —
Benefit payments made (3,079) (2,862) — —
Other movements 89 25 — —
Currency translation differences (2,522) 3,261 — —
Plan assets held in trust at fair value at December 31 63,262 59,425
Plan assets (less than)/in excess of the present value of obligations for benefits at
December 31 (2,586) (3,293) (4,067) (3,825)
Unrecognised net actuarial losses since adoption of IFRS 10,494 10,640 173 43
Unrecognised past service cost 9 12 44 48
Net amount recognised 7,917 7,359 (3,850) (3,734)
$ Million
Total Pension Benefits Other BenefitsAmounts Recognised in the
Consolidated Balance Sheet 2010 2009 2010 2009 2010 2009
Prepaid pension costs 10,368 10,009 10,368 10,009 — —
Retirement benefit obligations:
Non-current (5,924) (5,923) (2,275) (2,387) (3,649) (3,536)
Current (377) (461) (176) (263) (201) (198)
Net amount recognised 4,067 3,625 7,917 7,359 (3,850) (3,734)
$ Million Except Where Otherwise Indicated
Additional Information 2010 2009 2008 2007 2006
Pension Benefits
Obligation for pension benefits in respect of unfunded plans 3,293 3,087 2,684 2,505 1,931
Obligation for pension benefits in respect of funded plans 62,555 59,631 49,955 60,018 58,327
Total defined benefit obligation 65,848 62,718 52,639 62,523 60,258
Experience adjustments as a percentage of the total benefit obligation 0.1% (0.5)% 1.0% 0.7% 0.7%
Plan assets 63,262 59,425 44,299 76,198 67,479
Experience adjustments as a percentage of plan assets 5.6% 10.5% (61.1)% 1.3% 6.1%
Plan (deficit)/surplus (2,586) (3,293) (8,340) 13,675 7,221
Actual return on plan assets 7,200 9,398 (22,087) 5,846 8,133
Other Benefits
Total benefit obligation (unfunded) 4,067 3,825 3,494 3,179 3,163
Experience adjustments as a percentage of the total benefit obligation (3.4)% (1.9)% 0.6% 6.0% 0.7%
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Employer contributions to defined benefit pension plans dur-
ing 2011 are estimated to be $2.0 billion.
$ Million
Pension Benefits Other Benefits
Retirement Benefit Costs 2010 2009 2008 2010 2009 2008
Service cost 1,141 965 1,202 62 57 59
Interest cost 3,227 3,131 3,337 216 222 187
Expected return on plan assets (3,645) (3,142) (4,974)
Other components 641 1,033 (383) 9 144 7
Cost/(income) of defined benefit plans 1,364 1,987 (818) 287 423 253
Payments to defined contribution plans 329 269 263 — — —
Total 1,693 2,256 (555) 287 423 253
Retirement benefit costs are reported principally within pro-
duction and manufacturing expenses in the Consolidated
Statement of Income.
Weighted average plan asset allocations by asset category




Assets at Dec 31
Asset Allocation 2010 2010 2009
Equities 53% 54% 53%
Debt securities 37% 38% 40%
Real estate 5% 2% 2%
Other 5% 6% 5%
Total 100% 100% 100%
Long-term investment strategies of plans are generally de-
termined by the relevant pension fund trustees using a struc-
tured asset liability modelling approach to define the asset
mix that best meets the objectives of optimising returns within
agreed risk levels while maintaining adequate funding levels.
Assumptions and Sensitivities
Defined Benefit Pension Plans
The weighted averages for the principal assumptions appli-
cable for the principal defined benefit pension plans in Shell
are:
Pension Benefits Assumptions 2010 2009 2008
Assumptions used to determine benefit
obligations at December 31
Expected rates of increase in pensionable
salaries 5.5% 5.5% 4.4%
Discount rates 5.1% 5.5% 6.0%
Assumptions used to determine benefit
costs for year ended December 31
Expected rates of increase in pensionable
salaries 5.5% 4.4% 4.0%
Discount rates 5.5% 6.0% 5.7%
Expected rates of return on plan assets 6.6% 6.7% 6.9%
Average life expectancy assumptions for
persons aged 60 at December 31
Men (years) 86 86 85
Women (years) 88 88 87
Demographic (including mortality) assumptions are deter-
mined in the light of local conditions. Mortality assumptions
are reviewed annually to reflect the latest available standard
mortality tables for individual countries concerned, adjusted
where appropriate to reflect the experience of Shell.
The long-term assumptions for pensionable salary in-
creases, used to determine benefit obligations at December
31, 2010, remained at similar levels to those used at Decem-
ber 31, 2009 (2009: 0.75% increase for UK plans and 0.25%
increase for US plans).
The assumptions for discount rates reflected decreases of
AA rated corporate bond yields of 0.40% in the Eurozone
(2009: 0.70%), of 0.40% in the UK (2009: 0.30%) and of
0.50% in the USA (2009: 0.30%).
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The effect of a one percentage point increase/(decrease),
at December 31, 2010, in the principal pension benefit as-
sumptions would be to increase/(decrease) the defined ben-
efit obligation and annual pension benefit cost (pre-tax) as
follows:
$ Million
One Percentage PointSensitivity to Changes in Assumptions
Relating to Pension Benefits Increase Decrease
Expected rates of increase in pensionable
salaries
Change in defined benefit obligation 2,126 (1,897)
Change in annual pension benefit
cost (pre-tax) 240 (211)
Discount rates
Change in defined benefit obligation (8,390) 10,517
Change in annual pension benefit
cost (pre-tax) (103) 101
Expected rates of return on plan assets
Change in annual pension benefit
cost (pre-tax) (629) 629
The effect of an increase/(decrease) of one year in life ex-
pectancy would be to increase/(decrease) the defined benefit
obligation by approximately $2,069 million/($2,147 million).
The impact on the retirement benefit obligation reflected
in Shell’s Consolidated Balance Sheet and on Shell’s annual
pension benefit cost of changes in assumptions described
above excludes the effects of any amortisation of actuarial
gains and losses resulting from such changes. The amorti-
sation would vary from year to year by fund depending on
whether or not the cumulative unrecognised actuarial gains
and losses exceed the corridor (see Note 2). Any amounts
outside the corridor would be recognised in income over the
expected average remaining working lives of employees for
the relevant plan, the average of which across all pension
plans at December 31, 2010, is 12 years (2009: 12 years).
Other Defined Benefit Plans
The weighted averages for the discount rate and healthcare
cost trend rates applicable for the principal other benefit plans
in Shell are:
Other Benefits Assumptions 2010 2009 2008
Discount rates (used to determine
benefit obligations) 5.4% 5.9% 6.3%
Healthcare cost trend rate in year
after reporting year 7.7% 7.9% 8.2%
Ultimate healthcare cost trend rate 4.3% 4.3% 4.2%
Year ultimate healthcare cost
trend rate is applicable 2027 2027 2027
The effect of a one percentage point increase/(decrease)
at December 31, 2010, in the annual rate of increase in
the assumed healthcare cost trend rates would be to in-
crease/(decrease) the defined benefit obligation by approxi-
mately $523 million/($430 million) and the annual benefit cost
(pre-tax) by approximately $36 million/($29 million).
IFRS 2, SHARE-BASED PAYMENT
IFRS Overview and Comparison
to U.S. GAAP
3.157 The objective of IFRS 2 is to reflect the effects of
share-based payment transactions, whether with employees
or others, in an entity’s profit or loss and financial position
for the reporting period. IFRS 2 defines share-based payment
transactions as transfers of an entity’s equity instruments
by its shareholders to parties that have supplied goods or
services to the entity, including employees, unless the transfer
is clearly for a purpose other than payment for goods or
services supplied to the entity. Included in this definition
are transfers of equity instruments of the entity’s parent, or
equity instruments of another entity in the same group as
the reporting entity, to parties that have supplied goods or
services to the entity. The term goods includes inventories,
consumables, PPE, intangible assets, and other nonfinancial
assets.
3.158 Also within the scope of IFRS 2 are share options
(for example, contracts giving the holder the right, but not
the obligation, to subscribe to an entity’s shares at a fixed or
determinable price for a specific period of time) and other
equity instruments granted to employees as part of their com-
pensation for services rendered to the entity.
3.159 The revisions to IFRS 3, Business Combinations, in
2008 amended the guidance in IFRS 2 related to business
combinations. An entity should apply those amendments for
annual periods beginning on or after 1 July 2009. If an entity
applies IFRS 3 (revised 2008) in an earlier period, the entity
should apply the amendments to IFRS 2 from that earlier
period.
Author’s Note
See section 2, beginning with paragraph 2.355, for fur-
ther discussion of accounting for share-based payments
and comparison to U.S. GAAP.
Recognition and Measurement
IFRSs
3.160 An entity should apply the accounting for share-based
payments in IFRS 2 to equity-settled, cash-settled, and other
transactions in which it receives or acquires goods or ser-
vices in exchange for its equity instruments (equity-settled),
amounts based on the price or value of these instruments
(cash settled), or when either the entity can settle with or the
supplier (employee) can choose to receive the entity’s equity
instruments.
3.161 In the case in which the supplier chooses the settle-
ment option, IFRS 2 considers the entity to have issued a
compound financial instrument. This compound instrument
includes both a debt component (that is, the supplier’s right
to demand payment in cash) and an equity component (that
is, the supplier’s right to demand settlement in equity instru-
ments rather than in cash). When the fair value of the goods
or services is measured directly, the entity should measure
the debt component (that is, the right to receive cash) first
and then measure the equity component as the difference
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between the fair values of the goods and services and the
debt component. In the case the entity chooses the settlement
option, the entity may still recognize a liability if the option
to issue equity has no commercial substance (for example,
the entity is prohibited from issuing equity) or it has a past
practice of always settling in cash. Only if no present obli-
gation exists should the entity account for the transaction as
equity-settled.
3.162 Under IFRS 2, at the time the entity receives goods or
services, it should recognize the goods and services received
and either a corresponding decrease in equity for equity-
settled transactions or a liability for cash-settled transactions.
When such transactions do not result in recognition of an
asset, the entity recognizes an expense in profit or loss.
3.163 The entity should measure equity-settled transactions
at the fair value of the goods and services received, unless
the fair value cannot be measured reliably. Otherwise, the
entity measures the transaction at the fair value of the equity
instruments granted. The latter measurement is generally the
case for services received from employees. In contrast, when
goods or services are received from nonemployees, IFRS 2
states that there is a rebuttable presumption that transactions
with others can be measured directly by reference to the fair
value of the goods or services received.
3.164 An important issue with respect to share-based pay-
ments is whether the supplier is vested (entitled to the pay-
ment) at the time of the grant. When suppliers are vested
immediately, the entity recognizes the transaction as if the
services have been received in full. When the entity requires
suppliers to complete an additional period of service before
vesting, it should recognize the services received over the
vesting period.
3.165 When share-based payment transactions are mea-
sured by reference to the fair value of the equity instru-
ments granted, IFRS 2 requires an entity to measure the
transaction at the grant date for transactions with employees
and at the date the entity receives the goods or services for
other suppliers. Only when market prices are not available
should the entity estimate the fair value of the equity instru-
ments using a valuation technique consistent with generally
accepted valuation methodologies for financial instruments.
An entity should incorporate in the formula the factors and
assumptions that knowledgeable and willing parties to the
transaction would incorporate.
3.166 An entity should incorporate market-vesting and non-
vesting conditions into the fair value estimation process but
not performance-vesting conditions or reload features.
3.167 An entity should not make subsequent adjustments
to either the goods or services rendered or equity after the
vesting date, even when employees forfeit the instruments
granted.
3.168 In the rare case that the fair value of neither the goods
and services nor the equity instruments can be measured
reliably, the entity should measure the equity instruments
at intrinsic value at the date the entity receives the goods
or services. Subsequently, the entity should remeasure the
intrinsic value of the equity instruments at each reporting
date and the final settlement date and recognize the change
in intrinsic value in profit or loss. The entity should also
recognize the goods or services received based on the number
of equity instruments that ultimately vest or are exercised.
3.169 An entity should only recognize the effects of modi-
fications to the terms or conditions on which equity instru-
ments are granted when the modifications increase the total
fair value of the share-based payment transaction. When a
grant is cancelled or settled during the vesting period, other
than by forfeiture, the entity should consider this action to
be an acceleration of vesting and recognize the remaining
amount immediately. An entity should account for any pay-
ments to employees from such cancellation or modification
as a return of equity. An entity should consider grants of new
equity instruments as replacements of those cancelled and
account for them as if they were modifications.
3.170 An entity should measure cash-settled transactions
(for example, share appreciation rights) at the fair value of
the liability incurred. Until the liability is settled, the entity
remeasures the liability at the end of each reporting period
and at settlement and recognizes the change in the liability
in profit or loss for the period.
U.S. GAAP
3.171 FASB ASC provides guidance on equity-based pay-
ments in different sections. FASB ASC 718, Compensation—
Stock Compensation, includes guidance on share-based pay-
ments to employees, whether classified as equity or liabilities,
and FASB ASC 505, Equity, includes guidance on equity-
based payments to nonemployees. The guidance in these
sections differs in some respects. FASB ASC 505-50-30-6
requires measurement of share-based payments to nonem-
ployees at either the fair value of the goods or services re-
ceived or the fair value of the equity instruments, whichever
is more reliably measurable. In contrast, when the fair value
of the goods or services can be measured reliably, IFRS 2 re-
quires an entity to use that measure. However, as expressed in
SEC Codification of Staff Accounting Bulletins topic 14(A),
“Share-Based Payment Transactions with Nonemployees,”
the SEC staff believes that, generally, an entity should ap-
ply by analogy the U.S. guidance for employee share-based
payments to share-based payment transactions with nonem-
ployees, unless other authoritative accounting literature more
clearly addresses the appropriate accounting or the applica-
tion of this guidance would be inconsistent with the terms
of the instrument issued. Therefore, the remainder of this
section only compares IFRS 2 with the requirements for em-
ployee share-based payments in FASB ASC 718.
3.172 Like IFRS 2, FASB ASC 718 prescribes different ac-
counting treatments for equity-settled and cash-settled share-
based payment transactions because this classification deter-
mines whether the entity recognizes a change in equity or a
liability. Paragraphs 6–19 of FASB ASC 718-10-25 provide
more extensive guidance to an entity in making this classifi-
cation and addresses the following instruments specifically:
• Puttable or callable shares that do not meet certain con-
ditions
• Options or similar instruments related to shares that the
entity either has recognized as a liability or could be
required to settle in cash or other assets
• Awards indexed to another factor besides the entity’s
share price
• Awards with substantive terms that differ from the writ-
ten terms
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• Awards with a provision permitting broker-assisted
cashless exercise
• Awards with a provision related to the entity’s minimum
statutory withholding requirements
For all other instruments, FASB ASC 718-10-25-6 directs the
entity to the general requirements of U.S. GAAP for distin-
guishing liabilities from equity. IFRS 2 does not specifically
address the preceding instruments.
3.173 For employee share-based payments, FASB ASC 718-
10-30-2 generally requires an entity to measure the transac-
tion at the fair value of the equity instruments at the grant
date, except as previously noted in FASB ASC 718-10-30-4
when a reasonable estimate of fair value is not possible. As
stated by paragraphs 6–7 of FASB ASC 718-10-30, an en-
tity should measure these instruments based on observable
market prices for options or other instruments with similar
features and conditions and include factors such as volatility.
3.174 Like IFRSs, FASB ASC 718-10-30 includes specific
requirements for whether and how to incorporate vesting
conditions, nontransferability, performance or services con-
ditions, market conditions, and reload and contingency fea-
tures, among others, into the measurement of the transaction.
3.175 Like IFRSs, FASB ASC 718-10-30-22 requires an
entity to use intrinsic value when the entity cannot reasonably
estimate the fair value of the equity instrument, and FASB
ASC 718-10-55-9 requires an entity to remeasure liabilities
to their fair values at each reporting date until the liability is
settled.
3.176 FASB ASC 718-40 and 718-50 also provide separate
guidance on accounting for employee stock ownership plans
and employee share purchase plans.
Presentation
IFRSs
3.177 For each class of share capital, IAS 1 requires an entity
to present shares reserved for share issue under options and
contracts for the sale of shares, including terms and amounts,
either in the balance sheet, statement of changes in equity, or
in the notes.
U.S. GAAP
3.178 FASB ASC 718 does not provide specific guidance on
stock compensation presentation. Like other compensation,
stock compensation could be included in cost of goods sold
or administrative expenses as appropriate. See the discussion
over presentation of related liabilities in paragraph 2.361 of
section 2. However, for SEC registrants, SEC Codification
of Staff Accounting Bulletins topic 14(F), “Classification of
Compensation Expense Associated with Share-Based Pay-
ment Arrangements,” requires this expense to be included in
the same line item as cash compensation to the same em-
ployee. The SEC staff believes that SEC registrants should
consider disclosing the portion of the expense related to the
share-based payment, with appropriate disclosure, in a par-
enthetical note to the respective income statement line item,
on the cash flow statement, in the notes to the financial state-
ments, or in the management discussion and analysis.
Disclosure
IFRSs
3.179 IFRS 2 requires an entity to disclose information that
enables users of its financial statements to understand the
effect of share-based payments on the financial statements.
At a minimum, IFRS 2 requires disclosures about the various
share-based payment arrangements in existence during the
period, including the following:
• Detailed descriptions, including general terms and con-
ditions
• Number and weighted average exercise prices of share
options outstanding at the beginning of the period; op-
tions granted, exercised, forfeited, and expired during
the period; and options exercisable and outstanding at
the end of the period
• For options exercised, weighted average share price on
exercise dates
• For options outstanding at the end of the period, range
of exercise prices and weighted average remaining lives
3.180 IFRS 2 also requires disclosures about the methods
used to determine the fair value of the goods or services or
the equity instruments granted. For share options, these dis-
closures include option pricing models used, inputs to those
models, assumptions required, information about volatility,
and how other features of the arrangement have been incor-
porated into the model. For other instruments, these disclo-
sures include whether the entity used observable market data,
how that data was determined, and whether the model took
dividends into account. An entity should also disclose infor-
mation about any modifications made to these arrangements.
3.181 With respect to the effects of share-based payment
transactions on profit or loss, an entity should disclose the
total expense recognized immediately in profit or loss during
the period, with separate disclosure of the amount associated
with equity-settled transactions. When the entity has rec-
ognized liabilities, the entity should disclose end of period
amounts of the total carrying amount and total intrinsic value
of liabilities for which the suppliers’ rights are vested.
3.182 IAS 24, Related Party Transactions, also requires
disclosures about share-based payments.
U.S. GAAP
3.183 U.S. GAAP disclosure requirements are very similar
to those in IFRS 2. IFRSs rely more heavily on the principle
that an entity should disclose information that enables users
to understand the effects of share-based payment transactions
on the balance sheet and the statement of comprehensive
income. In contrast, FASB ASC 718-10-50 specifies more
items that an entity should disclose (for example, cash flow
effects and amount capitalized as part of the cost of an asset).
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Presentation and Disclosure Excerpts
Author’s Note
For completeness, related excerpts from the statement
of changes in equity are provided for each of the pro-
vided disclosure excerpts.
Stock Option Plan—Cash Settled
and Equity Settled
3.184
Siemens Aktiengesellschaft (Sep 2010)
CONSOLIDATED STATEMENTS OF INCOME
(in part)
For the fiscal years ended September 30, 2010, 2009 and
2008
(In millions of €, per share amounts in €)
Note 2010 2009 2008
Revenue 75,978 76,651 77,327
Cost of goods sold and services rendered (54,331) (55,941) (56,284)
Gross profit 21,647 20,710 21,043
Research and development expenses (3,846) (3,900) (3,784)
Marketing, selling and general administrative expenses (11,130) (10,896) (13,586)
Other operating income 6 856 1,065 1,047
Other operating expense 7 (1,611) (632) (2,228)
Income (loss) from investments accounted for using the equity method, net 8 (40) (1,946) 260
Interest income 9 2,161 2,136 2,404
Interest expense 9 (1,890) (2,213) (2,208)
Other financial income (expense), net 9 (336) (433) (74)
Income from continuing operations before income taxes 5,811 3,891 2,874
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies
(in part)
The accounting policies set out below have been applied
consistently to all periods presented in these Consolidated
Financial Statements.
Share-based payment—IFRS 2 distinguishes between
cash-settled and equity-settled share-based payment trans-
actions. For both types, the fair value is measured at grant
date and compensation expense is recognized over the vest-
ing period during which the employees become uncondition-
ally entitled to the awards granted. Cash-settled awards are
re-measured at fair value at the end of each reporting period
and upon settlement. Siemens uses an option pricing model
to determine the fair value of stock options. The fair value of
other share-based awards, such as stock awards, matching
shares, and shares granted under the Jubilee Share Program,
is determined as the market price of Siemens shares, consid-
ering dividends during the vesting period the grantees are not
entitled to and certain non-vesting conditions, if applicable.
See Note 34 for further information on share-based awards.
Treasury Stock
The Company is authorized by its shareholders to acquire up
to 91,420,342 Siemens shares. The authorization became ef-
fective on March 1, 2010 and remains in force through July 25,
2011. The previous authorization to acquire up to 91,420,342
Siemens shares was superseded as of the effective date of
the new resolution. The previous authorization was adopted
on January 27, 2009 and valid until July 26, 2010. According
to the current resolution, repurchased shares may be (i) sold
via a stock exchange or through a public sales offer made
to all shareholders: (ii) retired, (iii) used to meet the obliga-
tions under the 2001 Siemens Stock Option Plan (iv) offered
for purchase to individuals currently or formerly employed by
the Company or any of its subsidiaries or granted and trans-
ferred to such individuals with a holding period of at least two
years: (v) offered and transferred with the approval of the Su-
pervisory Board to third parties against contributions in kind,
particularly in connection with business combinations or the
acquisition of companies or interests therein: (vi) with the ap-
proval of the Supervisory Board sold to third parties against
payment in cash if the price (excluding incidental transac-
tion costs) at which such Siemens shares are to be sold is
not significantly lower than the market price of the Siemens
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stock on the trading day, as determined during the opening
auction of the Xetra trading platform (or a comparable suc-
cessor system); or (vii) used to service convertible bonds or
warrants granted by the Company or any of its subsidiaries.
In addition, the Supervisory Board is authorized to offer re-
purchased shares to the members of the Managing Board
of the Company for purchase as stock-based compensation
under the same terms and conditions as those offered to em-
ployees of the Company or to grant and transfer such shares
to members of the Managing Board with a holding period of
at least two years.
The authorization to acquire up to 91,420,342 Siemens
shares is supplemented by an authorization to repurchase up
to half of those shares by using equity derivatives, such as
put and call options and a combination of put and call options.
As in fiscal 2008 and 2009, the term of such options must be
chosen in a way that any repurchase of the Company’s own
shares upon the exercise of the option will take place no later
than on the expiration date of the supplemented authorization.
In November 2007, the Company announced a share buy
back program. Under the program, the Company originally
expected to conduct share repurchases with a total volume
of up to €10 billion by 2010 for the purpose of cancella-
tion and reduction of capital stock and, to a lesser extent,
to fulfill obligations arising out of stock based compensation
programs. As of September 30, 2010, 56,201,421 Treasury
shares amounting to €4,350 have been repurchased.
In fiscal 2010, 3,411,245 Treasury Shares were re-issued
in connection with share-based payment plans. As of Septem-
ber 30, 2010, 44,366,416 shares remained in treasury with a
carrying amount of €3,373.
In fiscal 2009, 189 shares were re-deposited to the Com-
pany’s Treasury Stock and 4,868,193 of Treasury Shares
were re-issued in connection with share-based payment
plans. As of September 30, 2009, 47,777,661 shares re-
mained in treasury with a carrying amount of €3,632.
In fiscal 2008, the Company repurchased a total of
56,201,421 shares at an average price of €77.41 per share.
In fiscal 2008, a total of 3,556,139 shares of treasury stock
were sold. Thereof, 2,829,239 shares were issued to share-
based compensation plan participants to accommodate the
exercise of stock options and 720,292 shares were issued to
employees under the employee share purchase program with
compensation character, see Note 34 for additional informa-
tion. As of September 30, 2008, 52,645,665 shares remained
in treasury with a carrying amount of €4,002.
28. Additional Capital Disclosures (in part)
As of September 30, 2010 and 2009, our capital structure
was as follows:
September 30
2010 2009 % Change
Total equity attributable to
shareholders of Siemens AG 28,346 26,646 6.4%
As percentage of total capital 59% 58% —
Short-term debt 2,416 698 —
Long-term debt 17,497 18,940 —
Total debt 19,913 19,638 1.4%
As percentage of total capital 41% 42% —
Total capital (total debt, as stated
above, and total equity) 48,259 46,284 4.3%
In fiscal 2010, total equity attributable to shareholders of
Siemens AG increased by 6 percent compared to fiscal 2009.
Total debt increased by 1 percent in fiscal 2010, resulting in
an increase in total equity as a percentage of total capital to
59 percent compared to 58 percent in fiscal 2009. Accord-
ingly, total debt as a percentage of total capital decreased
to 41 percent from 42 percent in the prior year. For further
information on changes in total equity see Note 27 and on
issuance and repayment of debt see Note 23.
Siemens has commitments to sell or otherwise issue com-
mon shares in connection with share-based compensation
plans. In fiscal 2010, commitments arising from share-based
compensation were met by re-issuing treasury shares. In fis-
cal 2011, we may again fulfill our commitments arising from
share-based compensation by re-issuing treasury shares.
For additional information on share-based compensation see
Note 34 and on treasury shares see Note 27.
34. Share-Based Payment
Share-based payment awards at Siemens, including Stock
Awards, Stock Options, the Share Matching Program and
its underlying plans, the Monthly Investment Plan as well as
the Jubilee Share Program are predominately designed as
equity-settled plans and to a certain extent as cash-settled
plans. Total pre-tax expense for share-based payment recog-
nized in net income amounted to €132, €212 and €91 for the
years ended September 30, 2010, 2009 and 2008, respec-
tively, and refers primarily to equity-settled awards, including
the Company’s employee share purchase program.
I. Equity-Settled Awards
Stock Awards
The Company grants stock awards and phantom stock as
another means for providing share-based compensation to
members of the Managing Board and other eligible employ-
ees. Stock awards are subject to a four year vesting period
for awards granted up to fiscal 2007 and a three year vesting
period for awards granted thereafter. Upon expiration of the
vesting period, the recipient receives Siemens shares with-
out payment of consideration. Stock awards are forfeited if
the grantee’s employment with the Company terminates prior
to the expiration of the vesting period. During the vesting
period, grantees are not entitled to dividends. Stock awards
may not be transferred, sold, pledged or otherwise encum-
bered. Stock awards may be settled in newly issued shares
of common stock of Siemens AG, treasury stock or in cash.
The settlement method will be determined by the Managing
Board and the Supervisory Board.
Each fiscal year, the Company decides whether or not to
grant Siemens stock awards. Siemens stock awards may
be granted only once a year within thirty days following the
date of publication of the business results for the previous
fiscal year. The Supervisory Board decides annually after
the end of each fiscal year how many stock awards to grant
to the Managing Board and the Managing Board decides
annually how many stock awards to grant to members of the
top management of domestic and foreign subsidiaries and
eligible employees.
In fiscal 2010, the Company granted 1,361,586 stock
awards: 1,207,360 awards were granted to 4,305 employees
and 154,226 awards were granted to members of the Man-
aging Board. In fiscal 2009, the Company granted 1,992,392
IFRS ATT 3.184
363Section 3: Statement of Comprehensive Income and Related Disclosures
stock awards: 1,740,063 awards were granted to 4,156 em-
ployees and 252,329 awards were granted to members of
the Managing Board. In fiscal 2008, the Company granted
737,621 stock awards to 4,357 employees and members of
the Managing Board, of which 79,133 awards were granted
to the Managing Board. Details on stock award activity and
weighted average grant-date fair value are summarized in the
table below:
Year Ended Year Ended Year Ended














Non-vested, beginning of period 4,438,303 €57.22 3,489,768 €67.56 3,270,910 €60.58
Granted 1,361,586 €60.79 1,992,392 €37.65 737,621 €97.94
Vested (824,694) €57.28 (881,097) €55.63 (79,068) €79.03
Forfeited/settled (187,877)(1) €61.50(1) (162,760) €48.01 (439,695) €64.50
Non-vested, end of period 4,787,318 €58.06 4,438,303 €57.22 3,489,768 €67.56
(1) Consists of 153,020 forfeited and 34,857 settled awards with weighted average grant-date fair values of €57.43 and €79.34, respectively,
in fiscal 2010.
Fair value was determined as the market price of Siemens
shares less the present value of dividends expected during
the four year and three year vesting period, respectively, as
stock awards do not carry dividend rights during the vesting
period, which resulted in a fair value of €60.79, €37.65 and
€97.94, respectively, per stock award granted in fiscal 2010,
2009 and 2008. Total fair value of stock awards granted in
fiscal 2010, 2009 and 2008 amounted to €83, €75 and €72,
respectively.
Forfeited/settled in fiscal 2010, includes rights to stock
awards granted to former Managing and Supervisory Board
members, who used their stock award rights to net their obli-
gations towards the Company, which resulted from settlement
agreements in connection with compliance matters. For fur-
ther information see Note 30.
Share Matching Program and Its Underlying Plans
a) Base Share Program
Under the Base Share Program, members of the Manag-
ing Board and employees of Siemens AG and participating
Siemens companies can purchase Siemens shares under fa-
vorable conditions once a year. The Base Share Program is
measured at fair value at grant-date. Shares purchased under
the Base Share Program grant the right to receive matching
shares under the same conditions described below at Share
Matching Plan.
In fiscal 2010, the Base Share Program allowed members
of the Managing Board and employees of Siemens AG and
participating Siemens companies to make an investment of
a fixed amount of their compensation into Siemens shares,
which is sponsored by Siemens with a tax beneficial al-
lowance per plan participant. Shares were bought at market
price at a predetermined date in the second quarter. In fiscal
2010, the Company incurred pre-tax expense of €27. In fis-
cal 2009, members of the Managing Board and employees
of Siemens AG and participating Siemens companies could
purchase a limited number of Siemens shares at a prefer-
ential price. Up to a stipulated date in the first quarter of
the fiscal year, employees were allowed to order the shares,
which were issued in the second quarter of the fiscal year. In
fiscal 2009, the Company incurred pre-tax expense of €42,
based on a preferential share price of €22 per share and a
grant-date fair value of the equity instrument of €25.56 per
share.
Fair value is determined as the market price of Siemens
shares less the present value of expected dividends as in-
vestment shares of the Base Share Program do not carry
dividend rights until they are issued in the second quarter,
less the share price paid by the participating employee.
The previous employee share purchase program was su-
perseded by the Base Share Program in fiscal 2009. In fiscal
2008, under the previous program, the Company incurred
pre-tax compensation expense of €27, based on a preferen-
tial share price of €69.19 per share and a grant-date fair value
of €37.20. Shares purchased in fiscal 2008, under the em-
ployee share purchase program were not eligible for matching
shares under the Share Matching Plan.
b) Share Matching Plan
In the first quarter of fiscal 2010, Siemens issued a new Share
Matching Plan (Share Matching Plan 2010). In contrast to
the Share Matching Plan 2009 (described below), the Share
Matching Plan 2010 is restricted to senior managers only.
Senior managers of Siemens AG and participating Siemens
companies may invest a certain amount of their compensa-
tion in Siemens shares. While for the Share Matching Plan
2009, the price of the investment shares was fixed at the res-
olution date, for the Share Matching Plan 2010 the shares
are purchased at the market price at a predetermined date
in the second quarter. Up to the stipulated grant-dates in the
first quarter of each fiscal year, senior managers have to de-
cide on their investment amount for which investment shares
are purchased. The investment shares are then issued in the
second quarter of the fiscal year. In exchange, plan partic-
ipants receive the right to one free share (matching share)
for every three investment shares continuously held over a
period of three years (vesting period) provided the plan par-
ticipant has been continuously employed by Siemens AG or
another Siemens company until the end of the vesting period.
During the vesting period, matching shares are not entitled to
dividends. The right to receive matching shares forfeits if the
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underlying investment shares are transferred, sold, pledged
or otherwise encumbered. The Managing Board and the Su-
pervisory Board of the Company will decide, each fiscal year,
whether a new Share Matching Plan will be issued. The fair
value at grant date of investment shares resulting from the
Share Matching Plan 2010 is €—as the investment shares
are offered at market price.
In the first quarter of fiscal 2009, the Company introduced
the Share Matching Plan 2009 to members of the Managing
Board and to employees of Siemens AG and participating
Siemens companies. Plan participants could invest a certain
percentage of their compensation in Siemens shares at a
predetermined price set at the resolution date (investment
shares). In exchange, plan participants receive the right to
one free share (matching share) for every three investment
shares continuously held over a period of three years (vest-
ing period) provided the plan participant has been continu-
ously employed by Siemens AG or another Siemens com-
pany until the end of the vesting period. Up to the stipulated
grant-dates in the first quarter of fiscal year 2009 employees
could order the investment shares, which were issued in the
second quarter of the fiscal year. During the vesting period,
matching shares are not entitled to dividends. The right to
receive matching shares forfeits if the underlying investment
shares are transferred, sold, pledged or otherwise encum-
bered. Investment Shares resulting from the Share Matching
Plan 2009 are measured at fair value at grant-date, which is
determined as the market price of Siemens shares less the
present value of expected dividends as investment shares do
not carry dividend rights until they are issued in the second
quarter, less the share price paid by the participating em-
ployee. Depending on the grant-date being either November
30, 2008 or December 17, 2008, the fair values amount to
€3.47 and €5.56, respectively, per instrument. The weighted
average grant-date fair value amounts to €5.39 per instru-
ment, based on the number of instruments granted.
c) Monthly Investment Plan
In the first quarter of fiscal 2010, the Company introduced the
Monthly Investment Plan as a further component of the Share
Matching Plan. The Monthly Investment Plan is available for
employees—other than senior managers—of Siemens AG
and participating Siemens companies. Plan participants may
invest a certain percentage of their compensation in Siemens
shares on a monthly basis. The Managing Board of the Com-
pany will decide annually, whether shares acquired under the
Monthly Investment Plan (investment shares) may be trans-
ferred to the Share Matching Plan the following year. If man-
agement decides that shares acquired under the Monthly In-
vestment Plan are transferred to the Share Matching Plan,
plan participants will receive the right to one free share
(matching share) for every three investment shares contin-
uously held over a period of three years (vesting period) pro-
vided the plan participant had been continuously employed
by Siemens AG or another Siemens company until the end of
the vesting period. Up to the stipulated grant-dates in the first
quarter of each fiscal year, employees may decide their par-
ticipation in the Monthly Investment Plan and consequently
the Share Matching Plan. The Managing Board will decide,
each fiscal year, whether a new Monthly Investment Plan will
be issued.
d) Resulting Matching Shares













Outstanding, end of period 1,614,729 1,266,444
(1) Thereof 6,837 and 25,962 to the Managing Board in fiscal 2010
and 2009.
Fair value was determined as the market price of Siemens
shares less the present value of expected dividends during
the vesting period as matching shares do not carry dividend
rights during the vesting period. Non-vesting conditions, i.e.
the condition neither to transfer, sell, pledge nor otherwise en-
cumber the underlying shares, were considered in determin-
ing the fair values. The fair value of matching shares granted
on December 17, 2009, amounts to €47.18 per share. The
fair values of matching shares granted amounted to €20.32
and €21.34, per share, respectively, depending on the grant
date being either November 30, 2008 or December 17, 2008.
In fiscal 2010 and 2009, the weighted average grant-date fair
value of the resulting matching shares is €47.18 and €21.29
per share respectively, based on the number of instruments
granted. Total fair value of matching shares granted in fiscal
2010 and 2009 amounted to €21 and €28, respectively.
Jubilee Share Program
In fiscal 2009, Siemens changed its jubilee benefit program,
which applies to a number of Siemens companies, from cash
to share-based compensation. Under the Jubilee Share Pro-
gram, eligible employees are granted jubilee shares after hav-
ing been continuously employed by the Company for 25 and
40 years (vesting period), respectively. Settlement of jubilee
grants is in shares. Jubilee shares are measured at fair value
considering biometrical factors. The fair value is determined
as the market price of Siemens shares at grant date less
the present value of dividends expected to be paid during
the vesting period for which the employees are not entitled
to. The weighted average fair value of each jubilee share
granted in fiscal 2010 for the 25th and the 40th anniversary
is €43.41 and €39.54 respectively, based on the number of
shares granted. The weighted average fair value of each ju-
bilee share granted adjusted by biometrical factors (consid-
ering fluctuation) is €29.40 and €26.28, respectively, in fiscal
2010. The weighted average fair value of each jubilee share
granted in fiscal 2009 for the 25th and the 40th anniversary
is €34.46 and €29.01, respectively, based on the number
of shares granted. The weighted average fair value of each
jubilee share granted adjusted by biometrical factors (consid-
ering fluctuation) is €25.18 and €20.56, respectively, in fiscal
2009.
In fiscal 2010 and 2009, 0.45 million and 4.87 million jubilee
shares were granted. 0.06 million and none were transferred,
0.18 million and 0.08 million forfeited, resulting in an out-
standing balance of 5.0 million and 4.8 million jubilee shares
as of September 30, 2010 and 2009. Considering biometrical
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factors, 3.69 million and 3.52 million jubilee shares are ex-
pected to vest as of September 30, 2010 and 2009.
Stock Option Plan
2001 Siemens Stock Option Plan
At the Annual Shareholders’ Meeting on February 22, 2001,
shareholders authorized Siemens AG to establish the 2001
Siemens Stock Option Plan, making available up to 55 million
options. The option grants are subject to a two-year vesting
period, after which they may be exercised for a period of up
to three years. The exercise price is equal to 120 percent of
the reference price, which corresponds to the average open-
ing market price of Siemens AG during the five trading days
preceding the date of the stock option grant. However, an
option may only be exercised if the trading price of the Com-
pany’s shares reaches a performance target which is equal
to the exercise price at least once during the life of the option.
The terms of the plan allow the Company, at its discretion
upon exercise of the option, to offer optionees settlement of
the options in either newly issued shares of common stock
of Siemens AG from the Conditional Capital reserved for this
purpose, treasury stock or cash. The alternatives offered to
optionees are determined by the Managing Board in each
case as approved by the Supervisory Board. Compensation
in cash shall be equal to the difference between the exercise
price and the opening market price of the Company’s stock
on the day of exercising the stock options.
The issuance of stock options to members of the Man-
aging Board on or after October 1, 2003, has been sub-
ject to the proviso that the Supervisory Board may restrict
the stock option exercise in the event of extraordinary, un-
foreseen changes in the market price of the Siemens share.
Those restrictions may reduce the number of options exercis-
able by each Board Member, provide for an exercise in cash
for a constricted amount only, or suspend the exercise of the
option until the extraordinary effects on the share price have
ceased. The fair value of the options has not been adjusted
for effects resulting from such restrictions. Reasonable esti-
mates cannot be made until it is probable that such adverse
events will occur. Since it is not possible to reliably estimate
the fair value of those options at the grant date, compensa-
tion costs are determined based on the current intrinsic value
of the option until the date at which the number of shares to
which a Board member is entitled to and the exercise price are
determinable. Upon that date, fair value will be determined in
accordance with the fair value recognition provisions of IFRS
2, Share-Based Payment, based on an appropriate fair value
option pricing model.
The authority to distribute options under the 2001 Siemens
Stock Option Plan expired on December 13, 2006. Accord-
ingly, no further options will be granted under this plan.
Details on option exercise activity and weighted average
exercise prices for the years ended September 30, 2010,
2009 and 2008 are as follows:
Year Ended Year Ended Year Ended























period 2,627,742 €73.89 5,097,083 €73.60 8,606,272 €72.13
Granted — — — — — —
Options exercised (687,605) €74.59 — — (2,832,839) €69.91
Options expired (888,210) €72.54 (2,213,111) €73.25 (232,582) €86.52
Options forfeited (116,495) €74.42 (152,015) €73.81 (234,660) €74.43
Options settled — — (104,215) €73.39 (209,108) €73.64
Outstanding, end of period 935,432 €74.59 0.13 3 2,627,742 €73.89 5,097,083 €73.60
Exercisable, end of period 935,432 €74.59 0.13 3 2,627,742 €73.89 5,097,083 €73.60
As of September 30, 2009 and 2008, for Options outstand-
ing the weighted average remaining contractual term was
0.8 years and 1.1 years, respectively; the aggregate intrinsic
value amounted to €—and €—, respectively.
The following table summarizes information on stock op-
tions outstanding at September 30, 2010 and 2009:
















€72.54 — — 898,050 0.1
€74.59 935,432 0.1 1,729,692 1.1
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Fair Value Information
The Company’s determination of the fair value of stock option
grants is based on an option pricing model which was devel-
oped for use in estimating the fair values of options that have
no vesting restrictions. Option valuation models require the
input of highly subjective assumptions including the expected
stock price volatility. The fair value per option outstanding as
of September 30, 2010 amounts to €4.06 for grants made in
fiscal 2006.
II. Cash-Settled Awards
Stock Appreciation Rights (SARs)
Where local regulations restrict the grant of stock options
in certain jurisdictions, the Company grants SARs to em-
ployees under the same conditions as the 2001 Siemens
Stock Option Plan except that SARs are exercisable in cash
only.
Details on SARs activity and weighted average exercise
prices are summarized in the table below:
Year Ended Year Ended Year Ended














Outstanding, beginning of period 54,945 €73.85 138,485 €73.58 198,280 €73.63
Granted — — — — — —
SARs exercised — — — — (40,555) €73.72
SARs forfeited/settled/expired (21,500)(1) €72.69 (83,540) €73.41 (19,240) €73.79
Outstanding, end of period 33,445 €74.59 54,945 €73.85 138,485 €73.58
Exercisable, end of period 33,445 €74.59 54,945 €73.85 138,485 €73.58
(1) Consists of 19,890 expired SARs with a weighted average exercise price of €72.54 and 1,610 settled SARs with a weighted average exercise
price of €74.59 in fiscal 2010.
For purposes of determining the fair value of SARs in fiscal
2010, 2009 and 2008, the expected volatility is based on his-
torical volatility of Siemens shares, implied volatility for traded
Siemens options with similar terms and features, and certain
other factors. The expected term is derived by applying the
simplified method and is determined as the average of the
vesting term and the contractual term. The risk-free interest
rate is based on applicable governmental bonds. Changes in
subjective assumptions can materially affect the fair value of
the SARs.
Phantom Stock
Where local regulations restrict the grants of stock awards
in certain jurisdictions, the Company grants phantom stock
to employees under the same conditions as the Siemens
stock awards, except that grantees receive the share prices’
equivalent value in cash only at the end of the four, respec-
tively, three year vesting period. In fiscal 2008, 24,303 phan-
tom stock rights were granted, 6,517 phantom stock rights
forfeited and 12,952 phantom stock rights were settled, re-
sulting in a balance of 93,294 phantom stock rights as of
September 30, 2008. In fiscal 2009, 159,787 phantom stock
rights were granted, 18,460 were vested and transferred,
14,327 phantom stock rights forfeited and 12,604 phantom
stock rights were settled, resulting in a balance of 207,690
non-vested phantom stock rights as of September 30, 2009.
In fiscal 2010, 11,372 phantom stock rights were granted,
18,768 vested and were transferred 14,478 phantom stock
rights forfeited and 17,476 phantom stock rights were set-
tled, resulting in a balance of 168,340 non-vested phantom
stock rights as of September 30, 2010.
IAS 23, BORROWING COSTS
IFRS Overview and Comparison
to U.S. GAAP
3.185 IAS 23, Borrowing Costs (revised 2007), establishes
the accounting for interest and other costs that an entity incurs
in borrowing funds. It does not cover the actual or imputed
cost of equity, including the cost of preferred capital that
is not classified as a liability. IAS 23 is also not applicable
to borrowing costs in connection with an asset measured at
fair value or inventories that are manufactured, or otherwise
produced, in large quantities on a repetitive basis. The revised
IAS 23 is effective for annual periods beginning on or after
1 January 2009. The 2007 revision to IAS 23 removed the
option to expense all borrowing costs, and given the cost and
difficulties associated with retrospective application in this




3.186 IAS 23 requires an entity to account for borrowing
costs as follows:
a. Capitalize borrowing costs that are directly attributable
to the acquisition, construction, or production of a qual-
ifying asset (that is, an asset that necessarily takes a
substantial period of time to get ready for its intended
use or sale)
b. Expense all other borrowing costs incurred during the
period
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3.187 Borrowing costs include interest cost measured us-
ing the effective interest method, finance charges related to
finance leases, and foreign exchange differences from for-
eign currency borrowings to the extent they are interest cost
adjustments.
3.188 Qualifying assets may be inventories, except as previ-
ously described, (for example, investment properties held for
trading), PPE, intangibles assets, or investment properties.
3.189 An entity should calculate the amount of borrowing
costs to be capitalized as follows:
a. To the extent that the entity borrowed funds specifically
for the qualifying asset, it should capitalize the actual
borrowing costs incurred less any investment income
on any amount of the borrowing that it temporarily
invested.
b. To the extent that the entity borrows funds generally
and uses these funds to obtain the qualifying asset, it
should apply a capitalization rate to its expenditures on
the asset to determine the amount of borrowing costs
to be capitalized.
3.190 An entity determines the capitalization rate as the
weighted average interest rate applicable to borrowings out-
standing during the period, not including any borrowings
specifically for the qualifying asset.
3.191 An entity should not capitalize more than the actual
amount of borrowing costs incurred during the period. An
entity should continue to capitalize borrowing costs even
when there are indicators that the qualifying asset is impaired.
Depending upon the nature of the qualifying asset, an entity
then should test that asset for impairment in accordance with
the relevant standard. For example, an entity should test and
measure any impairment losses for inventory in accordance
with IAS 2 and for an item of PPE in accordance with IAS
36, Impairment of Assets.
3.192 IAS 23 requires an entity to begin capitalization when
the following three conditions are met:
• The entity incurs expenditures for the asset.
• The entity incurs borrowing costs.
• The entity has begun activities necessary to get the asset
ready for its intended use or sale.
An entity should suspend capitalization during extended pe-
riods of inactivity on development of the asset and stop capi-
talization when it completes substantially all of the activities
necessary to get the asset ready for its intended use or sale.
U.S. GAAP
3.193 Despite the fact that IAS 23 and the corresponding
U.S. GAAP guidance resulted from a convergence project,
several differences between FASB ASC 835, Interest, and
IFRSs remain.
3.194 U.S. GAAP uses the term interest cost, rather than
the broader term borrowing costs used in IAS 23, which en-
compasses other costs such as foreign exchange differences
considered interest cost adjustments. FASB ASC 835-20-30-
7 explains that gains and losses on the effective portion of a
fair value hedge are part of capitalized interest cost. IAS 23
does not discuss the treatment of gains and losses on hedging
transactions.
3.195 A comparison of IFRSs to paragraphs 5–6 of FASB
ASC 835-20-15 reveals the following differences in the types
of assets (qualifying assets) for which interest can be capi-
talized:
• FASB ASC 835 only requires the asset to take a period
of time for the activities necessary to get it ready for
use or sale, not the substantial period of time required
by IAS 23.
• FASB ASC 835 does not address assets held at fair
value, which are excluded from the scope of IAS 23.
• FASB ASC 835 permits equity-method investments to
be qualifying assets (while the investee has activities
in progress necessary to begin its planned principal
operations, and the investee’s activities include the use
of funds to acquire qualifying assets for its operations),
but IAS 23 does not.
• FASB ASC 835 does not permit interest to be capital-
ized on assets acquired with gifts or grants. IAS 23 does
not address such circumstances.
3.196 Rather than requiring an entity to capitalize the ac-
tual interest less investment income on temporarily invested
funds, FASB ASC 835-20-30-3 requires an entity to deter-
mine the amount capitalized in an accounting period by ap-
plying a capitalization rate to the average amount of accumu-
lated expenditures for the asset during the period. An entity
should base the capitalization rates it uses on the rates ap-
plicable to borrowings outstanding during the period. If an
entity’s financing plans associate a specific new borrowing
with a qualifying asset, this paragraph permits the entity to
use the rate on that borrowing as the capitalization rate to
be applied to that portion of the average accumulated expen-
ditures for the asset up to the amount of that borrowing. If
average accumulated expenditures for the asset exceed the
amounts of specific new borrowings associated with the as-
set, the entity should determine the weighted average of the
rates applicable to other borrowings of the entity and use that
rate as the capitalization rate. In contrast to IAS 23, FASB
ASC 835 does not permit an entity to reduce the amount
of interest capitalized for investment income on temporary
investment of the borrowed funds.
Presentation
IFRSs
3.197 IAS 1 requires an entity to present a separate line item
for finance costs. IFRSs do not explicitly define finance costs,
but they are generally understood to be interest costs and
other finance charges that are included in the term borrowing
costs. An entity should present separate line items for finance
cost and finance income.
U.S. GAAP
3.198 Rule 5-03(b) of Regulation S-X requires SEC regis-
trants to present interest expense, including amortization of
debt premiums or discounts, as a separate line item on the
income statement.
Author’s Note
Companies reporting under U.S. GAAP generally off-
set interest income and interest expense on the face of
the income statement.
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Disclosure
IFRSs
3.199 IAS 1 requires disclosure of total finance costs during
the period. IAS 23 requires an entity to disclose the amount of
borrowing costs capitalized and the capitalization rate used.
U.S. GAAP
3.200 FASB ASC 835-20-50 does not require disclosure
of the capitalization rate. However, FASB ASC 835-20-50-
1 states that an entity should disclose total interest costs
incurred, the amount capitalized, and the amount expensed
during the period.
Presentation and Disclosure Excerpts
Finance Costs
3.201
GlaxoSmithKline plc (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)












Turnover 6 28,392 — 28,392
Cost of sales (7,405) (187) (7,592)
Gross profit 20,987 (187) 20,800
Selling, general and administration (12,388) (665) (13,053)
Research and development (3,964) (493) (4,457)
Other operating income 8 493 — 493
Operating profit 9 5,128 (1,345) 3,783
Finance income 11 116 — 116
Finance costs 12 (828) (3) (831)
Profit on disposal of interest in associates 8 — 8
Share of after tax profits of associates and joint ventures 13 81 — 81
Profit before taxation 4,505 (1,348) 3,157
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Accounting Principles and Policies (in part)
Discounting
Where the time effect of money is material, balances are dis-
counted to current values using appropriate rates of interest.
The unwinding of the discounts is recorded in finance income
and finance costs.
6. Segment Information (in part)
During 2010, US pharmaceuticals and ViiV Healthcare made
sales to three wholesalers of approximately £2,561 mil-
lion (2009—£2,760 million; 2008—£2,460 million), £2,412
million (2009—£2,710 million; 2008—£2,710 million) and
£1,642 million (2009—£1,680 million; 2008—£1,980 million)
respectively, after allocating final-customer discounts to the
wholesalers.
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2009 2008
2010 (Restated) (Restated)
Segment Profit £m £m £m
US Pharmaceuticals 5,043 5,933 5,461
Europe Pharmaceuticals 3,744 3,993 3,229
Emerging Markets pharmaceuticals 1,271 948 837
Asia Pacific/Japan pharmaceuticals 1,730 1,352 1,016
ViiV Healthcare 851 1,071 1,005
Pharmaceuticals R&D (3,105) (3,082) (2,840)
Other trading and unallocated pharmaceuticals costs (783) (705) (110)
Pharmaceuticals operating profit 8,751 9,510 8,598
Consumer Healthcare operating profit 1,043 931 881
Segment profit 9,794 10,441 9,479
Corporate and other unallocated costs and disposal profits (4,666) (1,184) (1,220)
Operating profit before major restructuring 5,128 9,257 8,259
Major restructuring (1,345) (832) (1,118)
Total operating profit 3,783 8,425 7,141
Finance income 116 70 313
Finance costs (831) (783) (843)
Profit on disposal of interest in associate 8 115 —
Share of after tax profits of associates and joint ventures 81 64 48
Profit before taxation 3,157 7,891 6,659
Taxation (1,304) (2,222) (1,947)




Interest expense arising on:
Financial liabilities at amortised cost (767) (790) (664)
Derivatives at fair value through profit or loss — 20 (165)
Fair value hedges:
Fair value movements on derivatives designated as hedging instruments 26 (37) 92
Fair value adjustments on hedged items (27) 38 (90)
Fair value movements on other derivatives at fair value through profit or loss (16) (2) —
Reclassification of cash flow hedge from other comprehensive income (3) (1) —
Unwinding of discounts on provisions (18) (11) (16)
Net investment hedge ineffectiveness (1) — —
Other finance expense (25) — —
(831) (783) (843)
All derivatives at fair value through profit or loss except des-
ignated and effective hedging instruments are classified as
held-for-trading financial instruments under IAS 39.
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Profit after tax 1,853 5,669 4,712
Tax on profits 1,304 2,222 1,947
Share of after tax profits of associates
and joint ventures (81) (64) (48)
Finance income net of finance costs 715 713 530
Depreciation 1,146 1,130 920
Amortisation of intangible assets 533 432 311
Impairment and assets written off 411 445 436
Profit on sale of intangible assets (118) (835) (170)
Profit on sale of investments in associates (8) (115) —
Profit on sale of equity investments (17) (40) (33)
Changes in working capital:
Decrease/(increase) in inventories 238 (132) (411)
Decrease/(increase) in trade receivables 905 (473) 519
Decrease/(increase) in other receivables 6 (134) 22
Increase/(decrease) in trade payables 154 499 (39)
(Decrease)/increase in other payables (179) 409 (162)
Increase/(decrease) in pension and
other provisions 1,653 (320) 548
Share-based incentive plans 179 179 241
Other (63) (40) (268)
6,778 3,876 4,343
Cash generated from operations 8,631 9,545 9,055
The increase in pension and other provisions primarily re-
flects the charge for legal costs in the year of £4.0 billion,
partly offset by legal settlements of £2.0 billion and further
contributions to the defined benefit pension schemes.
41. Financial Instruments and Related Disclosures
(in part)
Fair Value Hedges
The Group has designated a series of interest rate swaps as a
fair value hedge. The risk being hedged is the variability of the
fair value of the bond arising from interest rate fluctuations.




Anooraq Resources Corporation (Dec 2010)
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (in part)
For the years ended 31 December 2010, 2009 and 2008
(Expressed in Canadian Dollars, unless otherwise stated)
Note 2010 2009 2008
Revenue 24 148,286,833 62,627,868 —
Cost of sales 25 (173,151,188) (80,966,467) —
Gross loss (24,864,355) (18,338,599) —
Administrative
expenses (18,291,753) (11,781,689) (12,071,398)
Transaction costs (1,811,294) (10,401,725) —
Other income 426,617 1,138,850 5,779
Operating loss (44,540,785) (39,383,163) (12,065,619)
Finance income 26 1,113,642 529,285 179,119
Finance expense 27 (67,521,703) (20,340,287) (1,848,574)
Net finance
expense (66,408,061) (19,811,002) (1,669,455)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
4. Accounting Policies (in part)
These consolidated financial statements are presented in (un-
less stated otherwise) Canadian Dollars (“$”), which is also
the Company’s functional currency.
The accounting policies set out below are applied consis-
tently to all years presented in these consolidated financial
statements and have been applied consistently by Group en-
tities.
4.4 Accounting for Borrowing Costs
In respect of borrowing costs relating to qualifying assets the
Group capitalises borrowing costs that are directly attributable
to the acquisition, construction or production of a qualifying
asset as part of the cost of that asset. The Group has cap-
italised borrowing costs with respect to property, plant and
equipment under construction.
4.5 Property, Plant and Equipment
Mining assets, including mine development cost and infras-
tructure costs, mine plant facilities and buildings are mea-
sured at historical cost less accumulated depreciation and
impairment losses.
Mining assets are capitalised to capital work-in-progress
and transferred to mining property, plant and equipment when
the mining venture reaches commercial production.
Capitalised mine development and infrastructure costs in-
clude expenditure incurred to develop new mining operations
and to expand the capacity of the mine to the extent that it
gives rise to future economic benefit. Costs include borrowing
costs capitalised during the construction period where qual-
ifying expenditure is financed by borrowings. Items of mine
property, plant and equipment, excluding capitalised mine
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development and infrastructure costs, are depreciated on a
straight-line basis over their expected useful life. Capitalised
mine development and infrastructure are depreciated on a
units of production basis. Depreciation is charged on mining
assets from the date on which they are available for use.
When parts of an item of property, plant and equipment
have different useful lives, they are accounted for as separate
items (major components) of property, plant and equipment.
Property, plant and equipment are depreciated over their
estimated useful lives as follows:
Mine Development and Infrastructure
Units of
Production
Plant and equipment 1–30 years
Buildings 5–30 years
Motor vehicles 1–5 years
Furniture and fittings 1–10 years
Items of property, plant and equipment that are withdrawn
from use, or have no reasonable prospect of being recovered
through use or sale, are regularly identified and written off.
The assets’ residual values, depreciation methods and use-
ful lives are reviewed, and adjusted if appropriate, at each
reporting date.
Non-mining assets are measured at historical cost less ac-
cumulated depreciation and impairment losses. Depreciation
is charged on the straight-line basis over the useful lives of
these assets.
Subsequent expenditure relating to an item of property,
plant and equipment is capitalised when it is probable that
future economic benefits from the use of the assets will be
increased.
Repairs and maintenance are recognised in profit or loss
during the period in which they are incurred.
Gains and losses on disposal of property, plant and equip-
ment are determined by comparing the proceeds from dis-
posal with the carrying amount of the asset and are recog-
nised net within profit or loss.
27. Finance Expenses
2010 2009 2008
Financial Liabilities at Amortised Cost
Bank and short-term facilities 13,617 72,158 —
“A” Preference shares (related party) 39,661,792 19,560,689 —
OCSF and funding facilities (related party) 22,779,618 8,439,108 1,848,574
Senior Term Loan Facility 11,512,806 5,028,432 —
Interest on fair value of interest rate swap (195,702) 189,173 —
Other 563,219 324 —
74,335,350 33,289,884 1,848,574
Non-Financial Liabilities
Notional interest—rehabilitation provision 515,626 181,813 —
Commitment fees on OCSF 310,177 38,091 —
Transaction fees 631,929 411,058 —
1,457,732 630,962 —
Total finance costs before interest capitalised 75,793,082 33,920,846 1,848,574
Interest capitalised (8,271,379) (13,580,559) —
Total finance costs 67,521,703 20,340,287 1,848,574
The capitalisation rate used to determine the amount of bor-
rowing costs eligible for capitalisation during the year is 13.2%
(2009: 12.95%).
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IAS 28, INVESTMENTS IN
ASSOCIATES
IAS 31, INTERESTS IN JOINT
VENTURES
IFRS Overview and Comparison
to U.S. GAAP
Author’s Note
In May 2011, the IASB issued a revised IAS 28, In-
vestments in Associates, renamed IAS 28, Investments
in Associates and Joint Ventures. At the same time,
the IASB issued IFRS 11, Joint Arrangements, which
replaces IAS 31, Interests in Joint Ventures, and IFRS
12, Disclosures of Interests in Other Entities. These
new and revised standards are effective for annual re-
porting periods beginning on or after 1 January 2013,
with early application permitted. See the author’s note
preceding paragraphs 2.139 and 2.169 in section 2 for
a discussion of these standards.
Because the revised IAS 28, IFRS 11, and IFRS 12
were not issued until 2011, no survey entity could apply
the new requirements in its 2010 financial statements.
Therefore, the following commentary only describes
the requirements in IAS 28 and IAS 3 that are applica-
ble for 2010 financial statements.
3.203 When accounting for its investments in either asso-
ciates or jointly controlled entities using the equity method, in
accordance with IAS 28 or IAS 31, an investor-entity should
recognize the following items in profit and loss:
• Investor’s share of the profit or loss of the investee,
• Impairment loss or reversal of an impairment loss on
the equity-method investment, and
• Difference between the carrying value of the investment
and the fair value of any retained investment when it
discontinues the equity method (which may be a gain
or loss on disposal).
3.204 An investor-entity should recognize in other compre-
hensive income its share of items recognized by the investee
in other comprehensive income.
Author’s Note
The requirements of these standards with respect to
recognition, measurement, presentation, and disclo-
sure on the balance sheet are discussed in section 2,
beginning with paragraph 2.139.
Recognition and Measurement
IFRSs
3.205 IAS 28 and IAS 31 require an entity that accounts
for its investments in associates and joint ventures using
the equity method to recognize in profit or loss its share of
the profit of loss of its investee and to recognize in other
comprehensive income its share of the investee’s items of
other comprehensive income.
3.206 In addition, IAS 28 requires an entity to stop applying
the equity method when it no longer has significant influence.
An entity should remeasure any retained investment at fair
value and recognize in profit or loss the difference between
this fair value and the carrying value before remeasurement.
3.207 With respect to impairment, IAS 28 requires an entity
to recognize its share of the associate’s losses and then apply
the requirements of IAS 39 to determine whether it should
recognize an additional impairment loss with respect to its
net investment. If an entity recognizes this impairment loss,
it should also assess whether an additional impairment loss is
necessary for its interest in the associate that may exceed the
carrying value of its net investment. Whenever application of
the requirements of IAS 39 indicates that the investment may
be impaired, an entity should then measure the impairment
loss in accordance with IAS 36 in order to recognize any
impairment on goodwill embedded in the carrying amount
of the investment.
Author’s Note
The requirements of IAS 36, are discussed in detail in
this section, beginning with paragraph 3.243.
U.S. GAAP
3.208 Like IFRSs, FASB ASC 323-10-35-4 requires an en-
tity to recognize in income its share of the earnings or losses
of an equity-method investee in the same period the investee
reports them in its financial statements. As stated by FASB
ASC 323-10-35-5, the amount recognized in income should
reflect adjustments similar to those for consolidation, includ-
ing the following:
• Adjustments to eliminate intra-entity profits and losses
• Adjustments to amortize, if appropriate, any difference
between investor cost and underlying equity in net as-
sets of the investee at the date of investment
• Adjustments to reflect the investor’s share of changes
in the investee’s capital
• Adjustments to other comprehensive income
3.209 With respect to recognition of the investees’ losses,
like IFRSs, FASB ASC 323-10-35-4 requires an entity to
recognize its share of losses of an investee. As explained in
FASB ASC 323-10-35-19, when these losses equal or exceed
the carrying amount of an investment accounted for by the
equity method plus advances by the entity, the entity should
continue to report losses up to the carrying amount of the
entity’s investment, including any additional financial sup-
port, which may include capital contributions to the investee,
investments in additional common stock or preferred stock,
and loans or debt securities.
3.210 Like IFRSs, FASB ASC 323-10-35-35 requires an
entity to recognize gains and losses on the sales of stock of
an investee equal to the difference at the time of sale between
the selling price and the carrying amount of the stock sold.
3.211 As discussed in FASB ASC 323-10-35-36, when an
entity no longer has significant influence over its investee, it
should discontinue use of the equity method. Unlike IFRSs,
an entity is not required to immediately remeasure the in-
vestment to fair value. An entity is required to include any
earnings or losses that relate to a retained investment as part
of its carrying amount. Unlike IFRSs, an entity must reduce
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the carrying value of the retained investment by any dividends
it receives in a subsequent period that exceed its share of the
investee’s earnings, rather than recognize these dividends as
income. FASB ASC 323-10-35-37 also provides guidance
on the treatment of items recognized in other comprehen-
sive income when an entity discontinues use of the equity
method. Unless it elects the fair value option, in accordance
with FASB ASC 320, Investments—Debt and Equity Securi-
ties, the entity should classify an investment with a readily
determinable fair value as either trading or available for sale,
as appropriate, with subsequent measurement based on the
selected classification.
3.212 Paragraphs 31–32A of FASB ASC 323-10-35 also
provide guidance to an entity when a series of operating
losses or other factors may indicate that there has been an
other than temporary decline in the investment exceeding
that required by the equity method and the entity should
recognize this additional impairment loss. Several factors
are provided that the entity should consider when making
this determination, including the absence of an ability to
recover the investment’s carrying amount, the inability of
the investee to sustain an earnings capacity to justify the
carrying amount, or a current fair value that is less than the
carrying amount. However, an entity is required to evaluate
all factors in making this determination. An equity method
investor should not separately test an investee’s underlying
asset(s) for impairment. However, an equity investor should
recognize its share of any impairment charge recorded by an
investee and consider the effect, if any, of the impairment on
the investor’s basis difference in the assets that give rise to
the investee’s impairment charge.
Presentation
IFRSs
3.213 IAS 1 requires an entity to present its share of the
profit or loss of an associate or jointly controlled entity as a
separate line item in the income statement and its share of the
associate’s or jointly controlled entity’s other comprehensive
income in other comprehensive income.
U.S. GAAP
3.214 Like IFRSs, paragraphs 1–2 of FASB ASC 323-10-45
require an entity to show its share of earnings or losses from
its investment in its income statement as a single amount.
Unlike IFRSs, an entity should separately show its share
of extraordinary items and its share of accounting changes
reported in the financial statements of the investee.
3.215 Like IFRSs, FASB ASC 323-10-45-3 states that an
entity may combine its proportionate share of the amounts of
the investee’s other comprehensive income items with its own




3.216 IAS 28 requires an entity to disclose the amount of
any unrecognized share of losses of an associate, both for the
reporting period and cumulatively, if it has discontinued loss
recognition. IAS 36 disclosures would also apply when an
entity recognizes an impairment loss. However, IAS 31 does
not include this requirement.
U.S. GAAP
3.217 Unlike IFRSs, FASB ASC 323-10 does not require
additional disclosure about the effect of items recognized in
the statement of comprehensive income. FASB ASC 323-10-
50-3 requires disclosure of the difference between the carry-
ing value of the investment and its share of the underlying
net assets of the investee. Although not specifically stated,
this disclosure requirement appears to require disclosure of
unrecognized losses, if any.
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Presentation and Disclosure Excerpts
Share of Post-Tax Profit or Loss of
Associates and Joint Ventures Included in
Pre-Tax Operating Profit, Associates and
Joint Ventures Designated at Fair Value
Through Profit or Loss, Impairment Losses
3.218
Absa Group Limited (Dec 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME (in part)




Net interest income 23,340 21,854
Interest and similar income 29 54,241 65,247
Interest expense and similar charges 30 (30,901) (43,393)
Impairment losses on loans and advances 9.1 (6,005) (8,967)
Net interest income after impairment losses on loans and advances 17,335 12,887
Non-interest income 19,474 20,232
Net fee and commission income 14,391 14,289
Fee and commission income 31 16,454 16,301
Fee and commission expense 31 (2,063) (2,012)
Net insurance premium income 32 4,602 3,787
Net insurance claims and benefits paid 33 (2,405) (2,215)
Changes in investment and insurance liabilities 34 (1,059) (560)
Gains and losses from banking and trading activities 35 2,349 2,575
Gains and losses from investment activities 36 884 1,464
Other operating income 37 712 892
Operating profit before operating expenditure 36,809 33,119
Operating expenditure (24,949) (23,227)
Operating expenses 38 (24,070) (20,857)
Other impairments 39 (108) (1,457)
Indirect taxation 40 (771) (913)
Share of post-tax results of associates and joint ventures 12.1 (9) (50)
Operating profit before income tax 11,851 9,842
Taxation expense 41 (3,262) (2,340)
Profit for the year 8,589 7,502
Other comprehensive income
Exchange differences on translation of foreign operations (371) (668)
Movement in cash flow hedging reserve 1,152 (665)
Fair value gains/(losses) arising during the year 3,421 (148)
Amount removed from other comprehensive income and recognised in the profit and loss
component of the statement of comprehensive income (1,820) (776)
Deferred tax 16 (449) 259
Movement in available-for-sale reserve 166 (326)
Fair value gains/(losses) arising during the year 146 (306)
Amount removed from other comprehensive income and recognised in the profit and loss
component of the statement of comprehensive income — (205)
Amortisation of government bonds—release to the profit and loss component of the
statement of comprehensive income 92 104
Deferred tax 16 (72) 81
Movement in retirement benefit asset and liabilities 21 52
Increase in retirement benefit surplus 27 104
Decrease/(increase) in retirement benefit deficit 2 (33)
Deferred tax 16 (8) (19)
Total comprehensive income for the year 9,557 5,895
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Accounting Policies (in Part)
For the year ended 31 December
1. Summary of Significant Accounting Policies (in part)
1.2.5 Impairment of Investments in Associates and Joint
Ventures
When indications exist that the carrying amount of the invest-
ment in associates and joint ventures would not be recover-
able, an impairment is recognised. The recoverable amount
is the higher of value in use and fair value less cost to sell
and is based on the Group’s best estimate of the price the
Group would achieve in a sale transaction of the investment.
1.3.2 Investments in Associates and Joint Ventures
Associates are those companies which are not subsidiaries
and in which the Group exercises significant influence on
the financial and operating policies. Significant influence is
normally evident when the Group owns between 20% and
50% of a company’s voting rights.
A joint venture is a contractual agreement between two or
more parties to undertake an economic activity that is under
joint control.
Investments in associates and joint ventures that are not
deemed to be part of the Group’s venture capital activities are
held at cost plus equity-accounted earnings less any accu-
mulated impairment. The Group’s investment cost includes
goodwill. Impairment of an associate or joint venture is ev-
idenced by a significant or prolonged decline in fair value
below cost and when the recoverable amount is the highest
of value-in-use and fair value less cost to sell.
The results of associates and joint ventures are accounted
for according to the equity method, based on their most re-
cent audited financial statements. If the most recent available
audited financial statements are for an accounting period that
ended no more than three months prior to the Group’s year
end, these are adjusted in respect of material adjustments
between their reporting date and the Group’s reporting date.
The Group’s share of its post-acquisition profits or losses is
recognised in the statement of comprehensive income and
the Group’s interest in the post-acquisition reserves of asso-
ciates and joint ventures is treated as distributable reserves in
the Group’s financial statements. When the Group’s share of
losses exceeds its interest in an equity-accounted investee,
the carrying amount of that interest (including any long-term
investments) is reduced to nil and the recognition of further
losses is discontinued except to the extent that the Group has
an obligation or has made payments on behalf of the investee.
After application of the equity method, the Group deter-
mines whether it is necessary to recognise an additional im-
pairment loss on the Group’s investment in its associates and
joint ventures. The Group determines at each reporting date
whether there is objective evidence that the investment in as-
sociate or joint venture is impaired. The primary indicators of
potential impairment are considered to be adverse fair value
movements, the disappearance of an active market for the
investments, or adverse changes in the technological, eco-
nomic, legal or tax environment that the entity operates in. If
this is the case, the Group calculates the amount of impair-
ment as the difference between the recoverable amount (the
higher of the asset’s fair value less costs to sell and value in
use) of the associate or joint venture and its carrying value
and recognises the amount in the profit and loss component
of the statement of comprehensive income.
Unrealised gains on transactions between the Group and
its associates and joint ventures are eliminated to the extent
of the Group’s interest in the entities.
Investments in entities that form part of venture capital
activities of the Group have been designated at fair value
through profit or loss and disclosed under ‘Investment securi-
ties’. The designation has been made in accordance with IAS
39, based on the scope exclusion that is provided in IAS 28.
Venture capital associated investments are distinguished
from other investments by considering the nature of the in-
vestments, expected returns and the manner in which they
are managed by the Group. These are private equity invest-
ments. Private equity is medium- to long-term finance that
is provided in return for an equity stake in potentially high-
growth unquoted entities. The fair value of these investments
is determined in accordance with international private equity
and venture capital valuation guidelines.




Listed investments 41 100
Unlisted investments 375 387
416 487




Balance at the beginning of the year 487 2,144
Share of current year’s post-tax results (9) (50)
Share of current year’s results before taxation 52 (7)
Taxation on current year’s results (16) 2
Dividends received (45) (45)
Net movement resulting from acquisitions, disposals
and transfers (refer to note 12.4) (32) (291)
(Decrease)/increase in loans (4) 4
Impairment charge (refer to note 39) (29) (1,328)
Movement in amount recognised in other liabilities
for the Group’s share of losses 3 8
Balance at the end of the year 416 487
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Shares at book value 51 112
Shares at cost 57 1,440
Impairments (6) (1,328)
Share of post-acquisition reserves (10) (12)
41 100
Unlisted Investments
Shares at cost 114 133
Share of post-acquisition reserves 250 240
Share of non-distributable reserves 250 201
Amount recognised in other liabilities for the
Group’s share of losses — 39
Loans and receivables 11 14
375 387





Cash paid 95 61
Purchase as part of business combination — 39
Transfer from investment securities — 390
95 490
A register of investments in associates and joint ventures is
available for inspection at the registered office of the Com-
pany.




Directors’ valuation of unlisted
investments’(1) 375 387
Market value of listed
investments 55 188
430 575
(1) The directors’ valuation of unlisted investments is measured at
fair value.




Effective Movement Effective Movement
Holding (%) Rm Holding (%) Rm
Acquired during the current year, at cost:
One Commercial Investment Holdings (Proprietary) Limited 49,0 0 — —
Pinnacle Point Group Limited — 95 27,5 —
Acquired during the previous year, at cost:
Kilkishen Investments (Proprietary) Limited 50,0 — 50,0 31
Meadowood Investments 8 (Proprietary) Limited 50,0 — 50,0 —
Stand 1135 Houghton (Proprietary) Limited 50,0 — 50,0 8
Disposed during the current year:
Pinnacle Point Group Limited — (95) 27,5 —
Virgin Money South Africa (Proprietary) Limited — (0) 50,0 —
Disposed during the previous year:
Ambit Properties Limited — — — (718)
Banco Commercial Angolano — — — (63)
Transferred to subsidiaries during the current year:
Sanlam Home Loans (Proprietary) Limited 100,0 — 50,0 —
Transferred (to)/from investment securities during the current
and previous year:
Blue Financial Services Limited 6,7 (32) 20,2 451
(32) (291)





Cash consideration (95) (78)
Consideration in shares — (660)
Total consideration (95) (738)
Loss on disposal (0) (43)
Transfer to investment securities (32) —
(127) (781)
Refer to note 48 for the full disclosure of the Group’s invest-
ments in associates and joint ventures.
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27. Other Reserves (in part)
Associates’ and Joint Ventures’ Reserve
The associates’ and joint ventures’ reserve comprises the






Financial instruments 37 38
Amortised cost instruments 12 2
Available-for-sale instruments (refer to note 11.1) 25 36
Other 71 1,419
Computer software development costs (refer to
note 13) 4 19
Equipment (refer to note 15) 13 9
Goodwill (refer to note 13) — 37
Investments in associates and joint ventures
(refer to note 12.1) 29 1,328
Repossessed properties 25 26
108 1,457
The current year’s impairment losses are reported in the fol-
lowing segments:
• Impairments on investments in associates and joint ven-
tures are reported in the ‘Absa Capital’ and ‘ABB’ seg-
ments.
• Impairments on available-for-sale financial instruments
are reported in the ‘Absa Capital’ segment.
• Impairments on amortised cost financial instruments are
reported in the ‘Other’ segment.
• Impairments on computer software development costs
are reported in the ‘Other’ segment.
• Impairments on equipment are reported in the ‘Absa
Capital’ segment.
• Impairments on repossessed properties are reported in
the ‘Retail Banking’ segment.
The previous year’s impairment losses are reported in the
following segments:
• Impairments on available-for-sale financial instruments
are reported in the ‘Absa Capital’ segment.
• Impairments on amortised cost financial instruments are
reported in the ‘Financial Services’ segment.
• Impairments on computer software development costs
are reported in the ‘Financial Services’ segment.
• Impairments on equipment are reported in the ‘ABB’
segment.
• Impairments on goodwill are reported in the ‘Other’ seg-
ment.
• Impairments on investments in associates and joint ven-
tures are reported in the ‘Absa Capital’ and ‘ABB’ seg-
ments.
• Impairments on repossessed properties are reported in
the ‘Retail Banking’ segments.
During the previous year, the Group sold contractual rights it
had generated in Ambit Management Services (Proprietary)
Limited. The company is now dormant and consequently the
goodwill previously recognised on this investment was written
off.
During the previous year, indications existed that the carry-
ing amount of the investments in associates, that arose as a
result of customer defaults on single stock futures within Absa
Capital, would not be recoverable. The recoverable amount is
the fair value less costs to sell and was based on the Group’s
best estimate of the price the Group would achieve in a sale
of these investments. These investments were consequently
impaired.
48. Related Parties (in part)
48.5 Associates, Joint Ventures and Retirement Benefit Fund
The Group provides certain banking and financial services
to associates and joint ventures. The Group also provides
a number of current and interest-bearing cash accounts to
the Absa Group Pension Fund. These transactions are con-
ducted on the same terms as third-party transactions and are
not individually material.
In aggregate, the amounts included in the Group’s financial












Value of Absa Group Pension Fund investments managed by the Group — 7,193 7,193
Value of Absa Group Limited ordinary shares held by the Absa Group Pension Fund — 116 116
Value of other Absa Bank Limited securities held by the Absa Group Pension Fund — 1,582 1,582
Statement of financial position
Loans and advances 7,275 — 7,275
Other assets 17 — 17
Deposits (0) (30) (30)
Other liabilities (47) — (47)
Derivative transactions 4 — 4
Statement of comprehensive income
Interest and similar income (617) — (617)
Interest expense and similar charges 8 1 9
Fees received (106) (17) (123)
Fees paid 173 — 173
Current service costs — 635 635
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Value of Absa Group Pension Fund investments managed by the Group — 7,047 7,047
Value of Absa Group Limited ordinary shares held by the Absa Group Pension Fund — 69 69
Value of other Absa Bank Limited securities held by the Absa Group Pension Fund — 1,444 1,444
Statement of financial position
Loans and advances 8,411 — 8,411
Other assets 2,218 — 2,218
Deposits (177) (45) (222)
Other liabilities (127) — (127)
Statement of comprehensive income
Interest and similar income (1,026) — (1,026)
Interest expense and similar charges 41 1 42
Fees received (117) (17) (134)
Fees paid 4 — 4
Current service costs — 551 551
Details on investments in associates and joint ventures are
as follows:




Blue Financial Services Limited(1,2) Financial services provider, specifically micro-finance
in Africa. South Africa
Pinnacle Point Group Limited(1,3) Property development. South Africa
Sekunjalo Investments Limited(1) Investment holding company. South Africa
Spring Valley Investments (Proprietary) Limited Property development. South Africa
Equity-Accounted Joint Ventures
FFS Finance South Africa (Proprietary) Limited Provides financing solutions to Ford Motor Company
customers. South Africa
Integrated Processing Solutions (Proprietary) Limited Joint venture with Standard Bank Group Limited involved in
cheque processing activities. South Africa
Kilkishen Investments (Proprietary) Limited(1) Property development. South Africa
MAN Financial Services (S.A.) (Proprietary) Limited Joint venture with MAN Financial Services GmbH for
financing of trucks and buses. South Africa
Meadowood Investments 8 (Proprietary) Limited(1) SPE. South Africa
One Commercial Investment Holdings (Proprietary) Limited(4) Cell captive. South Africa
Sanlam Home Loans (Proprietary) Limited(4) Manages and administers the granting of loans as well as
secure funding for these loans. South Africa
Stand 1135 Houghton (Proprietary) Limited(1) Property development. South Africa
Virgin Money South Africa (Proprietary) Limited(3) Joint venture with Virgin Money Group Limited to provide
retail financial services products under the Virgin brand. South Africa
Associates and Joint Ventures Designated at Fair Value Through Profit or Loss
Absa Corob Trust Joint Venture(1) Property investment. South Africa
African Spirit Trading 309 (Proprietary) Limited(1) Property development. South Africa
Agrista (Proprietary) Limited(1,3) Agriculture consulting. South Africa
Amrichprop 49 Properties (Proprietary) Limited(1,5) Property development. South Africa
Barrie Island Property Investments (Proprietary) Limited(1) Investment in mixed use property. South Africa
Birchacres Mall (Proprietary) Limited (previously
Tembisa Mall) (Proprietary) Limited(1) Property development. South Africa
Cherry Vanilla Investments (Proprietary) Limited Retirement village development. South Africa
Culemborg Investment Properties (Proprietary) Limited(1) Residential property development. South Africa
Mall on 14th Avenue (Proprietary) Limited(1) Property development. South Africa
Maxcity Homes (Proprietary) Limited(1) Property development. South Africa
Maxcity Properties (Proprietary) Limited(1,3) Investment in mixed use property. South Africa
(continued)
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Name Nature of Business
Country of
Incorporation
Mogale City Mall (Proprietary) Limited(1) Investment in commercial property. South Africa
Northern Lights Trading 197 (Proprietary) Limited(1) Investment in commercial property. South Africa
Pacific Heights Investments 196 (Proprietary) Limited(1) Property development. South Africa
Palm Hill Property Investments (Proprietary) Limited(1,3) Property development. South Africa
Parsons Vlei Development (Proprietary) Limited(1) Investment in residential property. South Africa
Persistent Properties (Proprietary) Limited(1) Investment in residential property. South Africa
Retail Africa Wingspan Investments (Proprietary) Limited(1) Property fund. South Africa
Royal Bafokeng Nations Administration (Proprietary)
Limited(6) Consulting services. South Africa
Somerset West Autopark (Proprietary) Limited(11) Investment in auto dealers and fitment centres. South Africa
Sovereign Seekers (Proprietary) Limited(1,6) Oil and gas. South Africa
Supreme Cylinders (Proprietary) Limited(1,6) Engineering. South Africa
The Racing Investment Trust(3) Property development. South Africa
Tropical Mushrooms (Proprietary) Limited(1,6) Agriculture consulting. South Africa
(1) The financial statements have different reporting dates to that of the Group, as these were the financial reporting dates established when
the entities were incorporated. The impact is not considered to be material.
(2) Transferred to investment securities during the year.
(3) Disposed of during the year.
(4) Became a subsidiary during the year.
(5) Acquired during the year.
(6) Transferred from investment securities during the year.
Share of Income From Associates Not
Included in Operating Profit and Share of
Other Comprehensive Income of Associates
3.219
Eni S.p.A. (Dec 2010)
CONSOLIDATED PROFIT AND LOSS ACCOUNT
(in part)
















Net sales from operations (35) 108,082 5,048 83,227 3,300 98,523 3,274
Other income and revenues 728 39 1,118 26 956 58
108,810 84,345 99,479
Operating Expenses (36)
Purchases, services and other 76,350 6,298 58,351 4,999 69,135 5,825
—of which non-recurring charge (income) (21) 250 (246)
Payroll and related costs 4,004 4,181 4,785
Other Operating (Expense) Income (124) 58 55 44 131 41
Depreciation, Depletion, Amortization and Impairments 9,815 9,813 9,579
Operating profit 18,517 12,055 16,111
Finance Income (Expense) (37)
Finance income 7,985 42 5,950 27 6,117 41
Finance expense (8,198) (17) (6,497 (4) (6,713)
Derivative financial instruments (427) (4) (131)
(640) (551) (727)
Income (Expense) From Investments (38)
Share of profit (loss) of equity-accounted investments 640 393 537
Other gain (loss) from investments 733 176 619
1,373 569 1,156
Profit before income taxes 19,250 12,073 16,540
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CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (in part)
(Euro million)
Note 2008 2009 2010
Net profit 9,558 5,317 7,383
Other items of comprehensive income
Foreign currency translation differences 1,077 (869) 2,169
Change in the fair value of cash flow hedging derivatives (32) 1,969 (481) 443
Change in the fair value of available-for-sale securities (32) 3 1 (9)
Share of “Other comprehensive income” on equity-accounted entities — — 2 (10)
Taxation (32) (767) 202 (175)
— 2,282 (1,145) 2,418
Total comprehensive income 11,840 4,172 9,801
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Summary of Significant Accounting Policies (in part)
Non-Current Assets (in part)
Financial Fixed Assets
Investments
Investments in subsidiaries excluded from consolidation,
jointly controlled entities and associates are accounted for
using the equity method. (In the case of step acquisition of a
significant influence (or joint control), the investment is recog-
nized at the acquisition date of significant influence (joint con-
trol) at the amount deriving from the use of the equity method
assuming the adoption of this method since initial acquisition;
the “step-up” of the carrying amount of interests owned before
the acquisition of significant influence (joint control) is taken to
equity.) When there is objective evidence of impairment (see
also section “Current assets”), the recoverability is tested by
comparing the carrying amount and the related recoverable
amount determined by adopting the criteria indicated in the
section “Property, plant and equipment.”
Subsidiaries, joint ventures and associates excluded from
consolidation are accounted for at cost, adjusted for impair-
ment losses if this does not result in a misrepresentation of
the company’s financial condition. When the reasons for their
impairment cease to exist, investments accounted for at cost
are re-valued within the limit of the impairment made and
their effects are included in “Other income (expense) from
investments.”
Other investments, included in non-current assets, are rec-
ognized at their fair value and their effects are included in
the equity reserve related to other comprehensive income;
the changes in fair value recognized in equity are charged
to the profit and loss account when it is impaired or real-
ized. When investments are not traded in a public market
and fair value cannot be reasonably determined, investments
are accounted for at cost, adjusted for impairment losses;
impairment losses may not be reversed.
The risk deriving from losses exceeding shareholders’ eq-
uity is recognized in a specific provision to the extent the par-
ent company is required to fulfill legal or implicit obligations
towards the subsidiary or to cover its losses.
17. Investments
Investments Accounted for Using the Equity Method


































entities controlled by Eni 177 1 (14) 42 (4) (8) (3) 26 217
Joint ventures 3,257 25 (111) 478 (81) (254) (54) 67 3,327
Associates 2,037 200 (24) 173 (156) (122) (31) 207 2,284
5,471 226 (149) 693 (241) (384) (88) 300 5,828
Dec. 31, 2010
Investments in unconsolidated
entities controlled by Eni 217 32 (3) 75 (18) (38) 9 (18) 256
Joint ventures 3,327 44 (526) 379 (124) (312) 124 (177) 2,735
Associates 2,284 187 (33) 263 (7) (130) 81 32 2,677
5,828 263 (562) 717 (149) (480) 214 (163) 5,668
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Acquisitions and subscriptions for euro 263 million related to
the subscription of capital increase, of which euro 183 million
related to Angola LNG Ltd.
Sales and reimbursements of equity-accounted invest-
ments of euro 562 million mainly pertained to the capital re-
imbursement of Artic Russia BV (euro 526 million) following
the divestment of a 51% stake in the Eni-Enel joint venture
OOO “SeverEnergia” as Gazprom exercised a call option on
September 23, 2009. On March 31, 2010, Eni collected a
second installment of the transaction amounting to euro 526
million (as converted at the EUR/USD exchange rate of 1.35
as of the transaction date, corresponding to approximately
$710 million).
Share of profit of equity-accounted investments and the
decrease following the distribution of the dividends pertained
to the following companies:
Dec. 31, 2009 Dec. 31, 2010
(Euro Million)














Galp Energia SGPS SA 116 64 33.34 147 55 33.34
Unión Fenosa Gas SA 108 138 50.00 116 126 50.00
Trans Austria Gasleitung GmbH 84 22 89.00 98 67 89.00
United Gas Derivatives Co 24 40 24.55(∗) 47 44 24.55(∗)
Eni BTC Ltd 35 — 100.00 37 35 100.00
Blue Stream Pipeline Co BV 33 — 50.00 36 — 50.00
Other investments 293 120 — 236 153 —
693 384 — 717 480 —
(∗) Equity ratio 33.33.
Share of losses of equity-accounted investments of euro 149
million primarily related to CARDÓN IV SA (euro 40 million)
and Super Octanos CA (euro 36 million).
Other changes of euro 163 million included: (i) reclassifica-
tion to assets held for sale of the carrying amounts relating to
Trans Austria Gasleitung GmbH (euro 203 million), Transit-
gas AG (euro 40 million) and Trans Europa Naturgas Pipeline
Gesellschaft mbH & Co KG (euro 8 million). More information
is included in Note 31—Assets held for sale and liabilities di-
rectly associated with assets held for sale; (ii) the exclusion
from joint ventures and the inclusion in the scope of consol-
idation following the acquisition of the controlling interest of
Altergaz SA (euro 67 million); and (iii) as an increase the ex-
clusion from the scope of consolidation and the inclusion in
equity-accounted investments of GreenStream BV (euro 149
million) following the sale of 25% of its share capital.
The following table sets out the net carrying amount relating
to equity-accounted investments:










Investments in Unconsolidated Entities Controlled by Eni:
—Eni BTC Ltd 93 100.00 104 100.00
—Eni BBI Ltd 3 100.00 28 100.00
—other investments(1) 121 — 124 —
217 — 256 —
Joint Ventures:
—Unión Fenosa Gas SA 473 50.00 468 50.00
—Artic Russia BV 918 60.00 445 60.00
—Blue Stream Pipeline Co BV 371 50.00 435 50.00
—EnBW Eni Verwaltungsgesellschaft mbH 284 50.00 285 50.00
—Azienda Energia e Servizi Torino SpA 170 49.00 172 49.00
—Eteria Parohis Aeriou Thessalonikis AE 161 49.00 160 49.00
—Toscana Energia SpA 143 49.38 155 48.13
—GreenStream BV — — 147 50.00
—Raffineria di Milazzo ScpA 128 50.00 128 50.00
(continued)
IFRS ATT 3.219
382 IFRS Accounting Trends & Techniques










—Unimar Llc 72 50.00 74 50.00
—Supermetanol CA 80 34.51 66 34.51
—Eteria Parohis Aeriou Thessalias AE 43 49.00 43 49.00
—Starstroi Llc 31 50.00 19 50.00
—Trans Austria Gasleitung GmbH 170 89.00 — —
—Super Octanos CA 66 49.00 — —
—Transitgas AG 33 46.00 — —
—Altergaz SA 28 41.62 — —
—other investments(1) 156 — 138 —
3,327 — 2,735 —
Associates:
—Galp Energia SGPS SA 914 33.34 1,005 33.34
—Angola LNG Ltd 612 13.60 841 13.60
—PetroSucre SA 176 26.00 198 26.00
—Ceska Rafinerska AS 184 32.44 189 32.44
—United Gas Derivatives Co 84 24.55(2) 94 24.55(2)
—Fertilizantes Nitrogenados de Oriente CEC 68 20.00 68 20.00
—ACAM Gas SpA 47 49.00 48 49.00
—Termica Milazzo Srl 23 40.00 40 40.00
—Distribuidora de Gas del Centro SA 29 31.35 32 31.35
—Gaz de Bordeaux SAS 13 17.00 27 34.00
—other investments(1) 134 — 135 —
2,284 — 2,677 —
5,828 — 5,668 —
(1) Each individual amount included herein did not exceed euro 25 million.
(2) Equity ratio 33.33.
Carrying amounts of investments in unconsolidated entities,
including entities controlled by Eni, joint ventures and asso-
ciates, comprised differences between the purchase price of
relevant shareholdings and the corresponding Eni’s share in
the net equity of each entities amounting to euro 511 mil-
lion, of which euro 347 million referred to goodwill. Such
differences primarily related to Unión Fenosa Gas SA (euro
195 million of goodwill), EnBW—Eni Verwaltungsgesellschaft
mbH (euro 181 million, of which euro 18 million of goodwill)
and Galp Energia SGPS SA (euro 106 million of goodwill).








Galp Energia SGPS SA 276,472,161 33.34 14.34 3,965
The table below sets out the provisions for losses included
in the provisions for contingencies of euro 124 million (euro
170 million at December 31, 2009), primarily related to the
following equity-accounted investments:
(Euro Million) Dec. 31, 2009 Dec. 31, 2010
Industria Siciliana Acido Fosforico—ISAF—SpA (under liquidation) 64 59
Southern Gas Constructors Ltd 13 31
Charville—Consultores e Serviços Lda 21 12
Other investments 72 22
170 124
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Other Investments
























Investments in unconsolidated entities
controlled by Eni 30 — (1) 15 44 55 11
Associates 4 — — 4 8 8 —
Other investments 376 4 (7) (9) 364 371 7
410 4 (8) 10 416 434 18
Dec. 31, 2010
Investments in unconsolidated entities
controlled by Eni 44 — 2 (17) 29 29 —
Associates 8 — 1 1 10 18 8
Other investments 364 4 16 (1) 383 390 7
416 4 19 (17) 422 437 15
Investments in unconsolidated entities controlled by Eni and
associates are stated at cost net of impairment losses. Other
investments, for which fair value cannot be reliably deter-
mined, were recognized at cost and adjusted for impairment
losses.
The net carrying amount of other investments of euro 422
million (euro 416 million at December 31, 2009) was related
to the following entities:










Investments in unconsolidated entities controlled by Eni(∗) 44 — 29 —
Associates 8 — 10 —
Other investments: — — — —
—Interconnector (UK) Ltd 134 16.06 136 16.07
—Nigeria LNG Ltd 82 10.40 89 10.40
—Darwin LNG Pty Ltd 78 10.99 79 10.99
—Other(∗) 70 — 79 —
364 383 —
416 422 —
(∗) Each individual amount included herein did not exceed euro 25 million.
Provisions for losses related to other investments, included
within the provisions for contingencies, amounted to euro 76
million (euro 41 million at December 31, 2009) and were pri-
marily in relation to the following entities:
(Euro Million) Dec. 31, 2009 Dec. 31, 2010
Eni BB Ltd — 28
Burren Energy Shipping & Transportation (Samara) Ltd 25 25
Caspian Pipeline Consortium R—Closed Joint Stock Co 15 19
Other investments 1 4
41 76
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Other Information About Investments
The following table summarizes key financial data of uncon-
solidated entities controlled by Eni, joint ventures and as-
sociates prepared in accordance with accounting policies
adopted in the preparation of Eni’s Consolidated Financial
Statements and reflecting Eni’s interest in such entities:














Total assets 2,215 6,981 4,218 2,383 5,711 5,087
Total liabilities 2,081 3,721 1,929 2,193 3,022 2,410
Net sales from operations 65 3,936 5,718 113 3,497 5,134
Operating profit (48) 564 141 (9) 434 323
Net profit (9) 474 101 32 252 225
The total assets and liabilities of unconsolidated controlled
entities of euro 2,383 million and euro 2,193 million, respec-
tively (euro 2,215 million and euro 2,081 million at December
31, 2009) pertained to entities acting as sole-operator in the
management of oil and gas contracts for euro 2,172 million
and euro 2,054 million (euro 1,873 million and euro 1,860 mil-
lion at December 31, 2009). The residual amount pertained
to not significant entities. More information is included in Note
1—Basis of presentation.
18. Other Financial Assets






Receivables for financing operating activities 1,112 1,488
Securities held for operating purposes 36 35
1,148 1,523
Receivables for financing operating activities are presented
net of the allowance for impairment losses of euro 32 million
(euro 29 million at December 31, 2009).
Operating financing receivables of euro 1,488 million (euro
1,112 million at December 31, 2009) primarily pertained to
loans made by the Exploration & Production segment (euro
716 million), Gas & Power segment (euro 559 million) and
Refining & Marketing segment (euro 96 million) to certain
equity-accounted or cost-accounted entities which executed
capital projects on behalf of Eni’s Group companies. Financ-
ing receivables due from unconsolidated subsidiaries, joint
ventures and associates amounted to euro 656 million. Re-
ceivables for financial leasing amounted to euro 78 million
(euro 97 million at December 31, 2009) and pertained to the
disposal of the Belgian gas network by Finpipe GIE.
42. Transactions With Related Parties (in part)
In the ordinary course of its business Eni enters into transac-
tions regarding:
a. the exchange of goods, provision of services and financ-
ing with joint ventures, associates and non-consolidated
subsidiaries;
b. the exchange of goods and provision of services with
entities directly and indirectly owned or controlled by the
Government;
c. transactions with the Gruppo Cosmi related to Eni
through a member of the Board of Directors related
to certain acquisition of engineering, construction and
maintenance services. Relevant transactions which
were executed on an arm’s length basis, consisted of
costs amounting to approximately euro 13 million, euro
21 million and euro 23 million in 2008, 2009 and 2010,
respectively. At December 31, 2010 receivables for euro
1 million and payables for euro 8 million were outstand-
ing (euro 4 million and euro 9 million at December 31,
2009, respectively); and
d. contributions to entities, controlled by Eni with the aim
to develop solidarity, culture and research initiatives.
In particular these related to: (i) Eni Foundation estab-
lished by Eni as a non-profit entity with the aim of pursu-
ing exclusively solidarity initiatives in the fields of social
assistance, health, education, culture and environment
as well as research and development. In 2010, transac-
tions with Eni Foundation were not material; and (ii) En-
rico Mattei Foundation established by Eni with the aim
of enhancing, through studies, research and training ini-
tiatives, knowledge in the fields of economics, energy
and environment, both at the national and international
level. Transactions with Enrico Mattei Foundation were
not material.
Transactions with related parties were conducted in the inter-
est of Eni companies and, with exception of those with entities
with the aim to develop solidarity, culture and research initia-
tives, on an arm’s length basis.
Trade and other transactions with joint ventures, associates
and non-consolidated subsidiaries as well as with entities
directly and indirectly owned or controlled by the Government
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in the 2008, 2009 and 2010, respectively, consisted of the
following:





















Joint Ventures and Associates
ACAM Clienti SpA 14 2 — 1 5 — 56 — — —
Agiba Petroleum Co 2 5 — — 95 — — — — —
Altergaz SA — — — — — — 262 — — —
Azienda Energia e Servizi Torino
SpA 1 65 — — 78 — — 1 — —
Bayernoil Raffineriegesellschaft
mbH — 32 1 19 51 — 2 — — —
Bernhard Rosa Inh. Ingeborg
Plöchinger GmbH 7 — — — — — 50 — — —
Blue Stream Pipeline Co BV 13 14 37 — 152 — — 2 — —
Bronberger & Kessler undGilg &
Schweiger GmbH 20 — — — — — 121 — — —
CEPAV (Consorzio Eni per l’Alta
Velocità) Uno 28 12 6,054 — 5 — — 37 — —
CEPAV (Consorzio Eni per l’Alta
Velocità) Due 6 3 76 — 3 — — 6 — —
Gasversorgung Süddeutschland
GmbH 3 — — — — — 62 — — —
GreenStream BV 4 13 — — 95 — 1 2 — —
Karachaganak Petroleum
Operating BV 39 253 — 821 346 28 8 7 — —
Kwanda Suporto Logistico Lda 51 1 — — — — — 17 — —
Mellitah Oil & Gas BV 30 137 — — 225 — — 33 — —
Petrobel Belayim Petroleum Co 8 34 — — 714 — — 3 2 —
Raffineria di Milazzo ScpA 21 20 — — 266 — 157 7 1 —
Saipon Snc 2 — 53 — — — — 29 — —
Super Octanos CA — 23 — 58 — — 2 — — —
Supermetanol CA — 13 — 57 — — — — 1 —
Trans Austria Gasleitung GmbH 8 69 — 32 149 — 1 37 — —
Transitgas AG — 8 — — 70 — — — — —
Unión Fenosa Gas SA 11 — 58 — — — 60 — 1 —
Other(∗) 138 51 11 27 232 50 35 91 12 —
406 755 6,290 1,015 2,486 78 817 272 17 —
Unconsolidated Entities Controlled by Eni
Agip Kazakhstan North Caspian
Operating Co NV 177 285 — 2 894 5 — 917 7 —
Eni BTC Ltd — — 152 — — — — — — —
Other(∗) 22 22 3 4 48 2 5 23 4 —
199 307 155 6 942 7 5 940 11 —
605 1,062 6,445 1,021 3,428 85 822 1,212 28 —
Entities Owned or Controlled by the Government
Gruppo Enel 83 44 — 20 318 1 128 471 — —
Gruppo Finmeccanica 44 44 — 50 37 — 22 9 — —
GSE—Gestore Servizi Elettrici 94 104 — 466 — 81 462 16 — 3
Terna SpA 35 41 — 115 71 31 55 28 9 38
Other(∗) 62 44 — — 74 4 44 5 21 —
318 277 — 651 500 117 711 529 30 41
923 1,339 6,445 1,672 3,928 202 1,533 1,741 58 41
(∗) Each individual amount included herein does not exceed euro 50 million.
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Most significant transactions with joint ventures, associates
and non-consolidated subsidiaries concerned:
• sale of natural gas to ACAM Clienti SpA, Altergaz SA
and Gasversorgung Süddeutschland GmbH;
• provisions of specialized services in upstream activi-
ties and Eni’s share of expenses incurred to develop oil
fields from Agiba Petroleum Co, Agip Kazakhstan North
Caspian Operating Co NV, Karachaganak Petroleum
Operating BV, Mellitah Oil & Gas BV, Petrobel Belayim
Petroleum Co and, only for Karachaganak Petroleum
Operating BV, purchase of oil products and to Agip
Kazakhstan North Caspian Operating Co NV, provi-
sions of services by the Engineering & Constuction seg-
ment; services charged to Eni’s associates are invoiced
on the basis of incurred costs;
• gas transportation and distribution services in behalf of
Azienda Energia e Servizi Torino SpA;
• payments of refining services to Bayernoil Raffineriege-
sellschaft mbH and Raffineria di Milazzo ScpA in rela-
tion to incurred costs;
• supply of oil products to Bernhard Rosa Inh. Ingeborg
Plöchinger GmbH, Bronberger & Kessler und Gilg &
Schweiger GmbH and Raffineria di Milazzo ScpA on
the basis of prices referred to the quotations on interna-
tional markets of the main oil products, as they would
be conducted on an arm’s length basis;
• acquisition of natural gas transport services outside Italy
from Blue Stream Pipeline Co BV, GreenStream BV,
Trans Austria Gasleitung GmbH and Transitgas AG, the
issuing of guarantees on behalf of Blue Stream Pipeline
Co BV and charges of fuel gas, used as drive gas, to
Trans Austria Gasleitung GmbH;
• transactions related to the planning and the construction
of the tracks for high speed/high capacity trains from
Milan to Bologna with CEPAV (Consorzio Eni per l’Alta
Velocità) Uno and related guarantees;
• guarantees issued on behalf of CEPAV (Consorzio Eni
per l’Alta Velocità) Due and Saipon Snc in relation to
contractual commitments related to the execution of
project planning and realization;
• planning, construction and technical assistance to
Kwanda Suporto Logistico Lda;
• acquisition of petrochemical products from Super Oc-
tanos CA and Supermetanol CA on the basis of prices
referred to the quotations on international markets of
the main products;
• performance guarantees given on behalf of Unión
Fenosa Gas SA in relation to contractual commitments
related to the results of operations and sales of LNG;
and
• guarantees issued in relation to the construction of an
oil pipeline on behalf of Eni BTC Ltd.
Most significant transactions with entities owned or controlled
by the Government concerned:
• sale and transportation service of natural gas, the sale
of fuel oil and the sale and purchase of electricity and
the acquisition of electricity transmission service with
Gruppo Enel;
• a long-term contract for the maintenance of new com-
bined cycle power plants with Gruppo Finmeccanica;
• sale and purchase of electricity, green certificates and
the fair value of derivative financial instruments included
in prices of electricity related to sale/purchase transac-
tions with GSE—Gestore Servizi Elettrici; and
• sale and purchase of electricity, the acquisition of do-
mestic electricity transmission service and the fair value
of derivative financial instruments included in prices
of electricity related to sale/purchase transactions with
Terna SpA.
Financing transactions with joint ventures, associates and
non-consolidated subsidiaries as well as with entities directly
and indirectly owned or controlled by the Government in the
2008, 2009 and 2010, respectively, consisted of the following:
(Euro 000 Million) Dec. 31, 2010 2010
Name Receivables Payables Guarantees Charges Gains
Joint Ventures and Associates
Artic Russia BV 104 3 — — 1
Bayernoil Raffineriegesellschaft mbH 119 — — — —
Blue Stream Pipeline Co BV — 8 648 — 9
GreenStream BV 459 2 — — 19
Raffineria di Milazzo ScpA — — 120 — —
Trans Austria Gasleitung GmbH 144 — — — 6
Transmediterranean Pipeline Co Ltd 141 — — — 5
Other(∗) 105 75 24 — —
1,072 88 792 — 40
Unconsolidated Entities Controlled by Eni
Other(∗) 53 39 1 — 1
53 39 1 — 1
1,125 127 793 — 41
(∗) Each individual amount included herein does not exceed euro 50 million.
Most significant transactions with joint ventures, associates
and non-consolidated subsidiaries concerned:
• bank debt guarantee issued on behalf of Blue Stream
Pipeline Co BV and Raffineria di Milazzo ScpA;
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• financing loans and cash deposit at Eni’s financial com-
panies on behalf of Artic Russia BV and a loan to Bayer-
noil Raffineriegesellschaft mbH for expenditures in re-
fining plants; and
• the financing of the Austrian section of the gasline from
the Russian Federation to Italy and the construction of
natural gas transmission facilities and transport services
with Trans Austria Gasleitung GmbH, GreenStream BV
and Transmediterranean Pipeline Co Ltd, respectively.
The impact of transactions with related parties on the profit















Net sales from operations 108,082 5,048 4.67 83,227 3,300 3.97 98,523 3,274 3.32
Other income and revenues 728 39 5.36 1,118 26 2.33 956 58 6.07
Purchases, services and other 76,350 6,298 8.25 58,351 4,999 8.57 69,135 5,825 8.43
Other operating income (expense) (124) 58 — 55 44 80.00 131 41 31.30
Financial income 7,985 42 0.53 5,950 27 0.45 6,117 41 0.67
Financial expense (8,198) (17) 0.21 (6,497) (4) 0.06 (6,713) — —
Transactions with related parties concerned the ordinary
course of Eni’s business and were mainly conducted at an
arm’s length basis.
IAS 17, LEASES
IFRS Overview and Comparison
to U.S. GAAP
Author’s Note
In August 2010, the IASB and FASB published an
exposure draft on accounting for leases as part of their
convergence agenda. An author’s note in Section 2
under the subsection IAS 17, Leases provides brief
update on the status of this project.
The discussion in this subsection addresses only the
effect of IAS 17 on the statement of comprehensive
income. Recognition, measurement, presentation, and
disclosures related to leasehold assets and liabilities
shown on the balance sheet are discussed in section 2.
3.220 IAS 17 establishes the criteria for revenue and ex-
pense recognition for both lessees and lessors, regardless of
whether the entity accounts for the lease as an operating or
finance lease. A finance lease is one that transfers substan-
tially all of the risks and rewards of ownership to the lessee.
Classification as a finance lease requires a lessee to recog-
nize an asset and related liability on its balance sheet and a
lessor to remove the leased asset from its balance sheet and
recognize a receivable for the lease payments. When a lease
does not meet the criteria for classification as a finance lease,




3.221 Lessees holding assets under finance leases should
recognize depreciation expense on the leasehold asset and a
finance charge (interest expense) on the leasehold liability
using the effective interest method of amortization. A lessee
should recognize contingent rents as an expense of the period
in which they are incurred.
3.222 A lessee should test and measure impairment losses
on leased assets in accordance with IAS 36.
3.223 A lessee holding leased assets under operating leases
should recognize expense on a straight-line basis over the
lease term, unless another systematic basis better represents
the pattern of benefits it expects to receive from the asset’s
use.
3.224 At the inception of a finance lease, a lessor should
recognize a receivable measured at its net investment in the
leased asset. A lessor should treat the lease payment as a
return of principal and finance income and recognize the lat-
ter based on the effective interest method. A manufacturer or
dealer lessor should recognize selling profit or loss during the
period in accordance with its policy for regular sales. How-
ever, if artificially low rates of interest are quoted, the entity
should restrict its selling profit to what would be earned if
it charged a market rate of interest. Manufacturer and dealer
lessors should recognize costs incurred to negotiate or con-
clude the lease as an expense in the same period as they
recognize selling profit or loss.
3.225 A lessor should recognize lease income on operat-
ing leases on a straight-line basis over the lease term, unless
another systematic basis better represents the pattern of ben-
efits it expects to receive from the asset’s use. A lessor should
recognize other costs, such as depreciation expense on the
leased asset, as an expense. A lessor should add any initial
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indirect costs of negotiating and concluding the lease agree-
ment to the carrying value of the asset and recognize an ex-
pense over the lease term on the same basis as it recognizes
income.
U.S. GAAP
3.226 Like IFRSs, FASB ASC 840-10-25 contains guidance
for assessing whether a lessee holds an asset under an op-
erating lease or a capital (finance) lease. These criteria are
similar to those in IFRSs. Like IFRSs, when the lessee holds
an asset under an operating lease, FASB ASC 840-20-25-1
requires the lessee to recognize operating lease payments as
expense on a straight-line basis over the lease term, unless
another systematic and rational basis is more representative
of the time pattern in which use benefit is derived from the
leased property. In the latter case, the entity should use that
basis.
3.227 Like IFRSs, FASB ASC 840-30-25-1 requires a lessee
that holds an asset under a capital lease to record a leased
asset and a corresponding lease liability. In accordance with
paragraphs 1 and 6 of FASB ASC 840-30-35, when the as-
set is depreciable, the lessee should recognize depreciation
expense on the asset and recognize interest expense on the
liability using the effective interest method.
3.228 Unlike IFRSs, when the lessee recognizes a capital
lease, paragraphs 41–45 of FASB ASC 840-10-25 provide
additional criteria that lessors should meet before recognizing
a capital lease, and removing the asset from their balance
sheet. Once a lessor meets those criteria, like IFRSs, FASB
ASC 840-30 requires the entity to recognize a receivable
measured at its net investment in the lease. The lessor should
then recognize interest income using the effective interest
method. Similar to the requirements for lessee recognition
of rent expense, FASB ASC 840-20-25-1 explains that if
the lessor has an operating lease, it should recognize lease
income on a straight-line basis over the lease term, unless
another systematic and rational basis is more representative
of the time pattern in which use benefit is derived from the




3.229 Unless an item of income or expense is material,
neither IAS 1 nor IAS 17 require an entity to present income
or expense items associated with lease agreements separately
in the statement of comprehensive income.
U.S. GAAP
3.230 FASB ASC 840-30-45-3 does not require a lessee
to classify interest expense or amortization of leased assets
as separate items in the income statement. However, when
the lessee includes amortization of assets held under capital
leases in depreciation expense and discloses that fact, the
lessee should separately disclose the amount of the amorti-
zation in either the financial statements or notes. FASB ASC
840-30-45 does not address any lessor income statement pre-
sentation matters.
3.231 FASB ASC 840-20-45-1 states that lessees should
include rental costs associated with an operating lease in
income from continuing operations. However, like IFRSs,
this paragraph does not require rental costs to be identified
separately on the income statement. FASB ASC 840-20-45
does not address income statement presentation by a lessor.
Disclosure
IFRSs
3.232 A lessee holding assets under finance leases should
disclose any contingent rents recognized as an expense dur-
ing the period. A lessee holding assets under operating leases
should disclose lease and sublease payments recognized as an
expense during the period, separately disclosing the amounts
of minimum lease payments, sublease payments, and contin-
gent rents.
3.233 If an impairment loss is recognized or reversed with
respect to leased assets, an entity should make the required
disclosures, in accordance with IAS 36.
3.234 Leases are included within the scope of IFRS 7, Fi-
nancial Instruments: Disclosures, the requirements of which
are applicable to lessors. In addition, for a finance lease, a
lessor should disclose a reconciliation of its gross investment
in the lease and present value of the lease receivable and any
unearned finance income and contingent rents recognized as
income during the period. For an operating lease, a lessor
should disclose the amounts of future minimum lease pay-
ments and contingent rents recognized as income during the
period.
U.S. GAAP
3.235 Like IFRSs, FASB ASC 840-20-50-1 requires a lessee
holding assets under an operating lease to disclose rental
expense for each period for which an income statement is
presented, with separate amounts for minimum rentals, con-
tingent rentals, and sublease rentals. An entity need not in-
clude rental payments under leases with terms of one month
or less that were not renewed. For operating leases having
initial or remaining noncancelable lease terms of more than
one year, FASB ASC 840-20-50-2 requires a lessee to dis-
close the following, as of the date of the latest balance sheet
presented:
• Required future minimum rental payments (in the ag-
gregate and for each of the five succeeding fiscal years)
• Total future minimum rentals to be received under non-
cancelable subleases
3.236 Like IFRSs, FASB ASC 840-30-50-1 requires a lessee
holding assets under a capital lease to disclose the following:
• As of the date of the latest balance sheet presented,
future minimum lease payments (in the aggregate and
for each of the five succeeding fiscal years) and total
future minimum sublease rentals to be received
• For each period for which an income statement is pre-
sented, contingent rentals payments actually incurred
3.237 Like IFRSs, FASB ASC 235-10-50-1 requires dis-
closures of accounting policies. However, paragraphs 4–5
of FASB ASC 840-10-50 include more specific guidance
with respect to accounting policy disclosures when leasing
is a significant part of the lessor’s income and also require
IFRS ATT 3.226
389Section 3: Statement of Comprehensive Income and Related Disclosures
disclosure of its policy on contingent rents. See paragraph
2.252 in section 2 for a discussion of lessors’ disclosure
requirements.
3.238 Like IFRSs, FASB ASC 840-20-50-4 requires lessors
with operating leases to disclose future minimum lease pay-
ments and contingent rental income recognized during the
period.
3.239 Unlike IFRSs, U.S. GAAP does not generally require
reconciliation disclosures previously explained. Also, FASB
ASC 840-30 does not direct an entity to the guidance on
financial liabilities as IAS 17 directs lessees that are contrac-
tually obligated under finance leases to IFRS 7. FASB ASC
825-10-50-8 exempts an entity from providing the required
fair value disclosures for its lease contracts. However, like
IFRSs, paragraphs 20–23 of FASB ASC 825-10-50 require
an entity to provide the required disclosures about concen-
trations of credit risk and market risk for its lease liabilities.
Presentation and Disclosure Excerpts
Lessee—Finance and Operating Leases,
Lessor—Operating Leases
3.240
Delhaize Brothers and Co. “The Lion” (Delhaize
Group) SA (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)
(In Millions of EUR) Note 2010 2009 2008
Revenues — 20,850 19,938 19,024
Cost of sales 24, 25 (15,497) (14,813) (14,204)
Gross profit — 5,353 5,125 4,820
Gross margin — 25.7% 25.7% 25.3%
Other operating income 27 85 78 96
Selling, general and
administrative expenses 24 (4,394) (4,192) (3,962)
Other operating expenses 28 (20) (69) (50)
Operating profit — 1,024 942 904
Operating margin — 4.9% 4.7% 4.8%
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
2.3. Summary of Significant Accounting Policies (in part)
Intangible Assets
Intangible assets include trade names and favorable lease
rights that have been acquired in business combinations (un-
favorable lease rights are recognized as “Other liabilities”
and released in analogy with SIC 15 Operating Leases—
Incentives), computer software, various licenses and pre-
scription files separately acquired. Separately acquired in-
tangible assets are initially recognized at cost, while intan-
gible assets acquired as part of a business combination are
measured initially at fair value (see “Business Combinations
and Goodwill”). Intangible assets acquired as part of a busi-
ness combination that are held to prevent others from us-
ing them (“defensive assets”)—often being trade names with
no intended future usage—are recognized separately from
goodwill.
Expenditures on advertising or promotional activities, train-
ing activities and start-up activities, and on relocating or reor-
ganizing part or all of an entity are recognized as an expense
as incurred, i.e., when Delhaize Group has access to the
goods or has received the services in accordance with the
underlying contract.
Intangible assets are subsequently carried at cost less ac-
cumulated amortization and accumulated impairment losses.
Amortization begins when the asset is available for use, as in-
tended by management. Residual values of intangible assets
are assumed to be zero and are reviewed at each financial
year-end.
Costs associated with maintaining computer software pro-
grams are recognized as an expense as incurred. Develop-
ment costs that are directly attributable to the design and
testing of identifiable and unique “for-own-use software” con-
trolled by the Group are recognized as intangible assets when
the following criteria are met:
• it is technically feasible to complete the software product
so that it will be available for use;
• management intends to complete the software product
and use it;
• there is an ability to use the software product;
• it can be demonstrated how the software product will
generate probable future economic benefits;
• adequate technical, financial and other resources to
complete the development and to use the software
product are available; and
• the expenditure attributable to the software product dur-
ing its development can be reliably measured.
Directly attributable costs capitalized as part of the software
product include software development employee costs and
directly attributable overhead costs. Other development ex-
penditures that do not meet these criteria are recognized as
an expense as incurred. Development costs recognized in a
previous reporting period as an expense are not recognized
as an asset in a subsequent period.
Intangible assets with finite lives are amortized on a
straight-line basis over their estimated useful lives. The useful
lives of intangible assets with finite lives are reviewed annu-
ally and are as follows:
• Prescription files 15 years
• Favorable lease rights Remaining lease term
• Computer software 3 to 5 years
• Other intangible assets 3 to 15 years
Intangible assets with indefinite useful lives are not amortized,
but are annually tested for impairment and when there is an
indication that the asset may be impaired. The Group believes
that acquired and used trade names have indefinite lives be-
cause they contribute directly to the Group’s cash flows as a
result of recognition by the customer of each banner’s char-
acteristics in the marketplace. There are no legal, regulatory,
contractual, competitive, economic or other factors that limit
the useful life of the trade names. The assessment of in-
definite life is reviewed annually to determine whether the
indefinite life assumption continues to be supportable.
Changes, if any, would result in prospective amortization.
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Property, Plant and Equipment
Property, plant and equipment is stated at cost less accumu-
lated depreciation and impairment, if any. Acquisition costs
include expenditures that are directly attributable to the ac-
quisition of the asset. Such costs include the cost of replacing
part of the asset and dismantling and restoring the site of an
asset if there is a legal or constructive obligation and borrow-
ing costs for long-term construction projects if the recognition
criteria are met. Subsequent costs are included in the asset’s
carrying amount or recognized as a separate asset, as appro-
priate, only when it is probable that future economic benefits
associated with the item will flow to the Group and the cost
of the item can be measured reliably. Costs of day-to-day
servicing of property, plant and equipment are recognized in
the income statement as incurred.
Depreciation is calculated using the straight-line method
based on the estimated useful lives of the related assets and
starts when the asset is available for use as intended by
management. When parts of an item of property, plant and
equipment have different useful lives, they are accounted for
as separate components of property, plant and equipment.
Land is not depreciated. The useful lives of tangible fixed
assets are as follows:
• Buildings 33 to 40 years
• Permanent installations 3 to 25 years
• Machinery and equipment 3 to 14 years
•
Furniture, fixtures, equipment
and vehicles 5 to 10 years
Gains and losses on disposals are determined by comparing
the proceeds with the carrying amount and are recognized
within “Other operating income” (Note 27) or “Other operating
expenses” (Note 28) in the income statement.
Residual values, useful lives and methods of deprecia-
tion are reviewed at each financial year-end, and adjusted
prospectively, if appropriate.
Investment Property
Investment property is defined as property (land or building—
or part of a building—or both) held by Delhaize Group to
earn rentals or for capital appreciation or both, but not for
sale in the ordinary course of business or for use in sup-
ply of goods or services or for administrative purposes and
includes investment property under construction. Delhaize
Group recognizes any part of an owned (or leased under a
finance lease) property that is leased to third-party retailers
as investment property, unless it represents an insignificant
portion of the property.
Investment property is measured initially at cost includ-
ing transaction costs. Subsequent to initial recognition, Del-
haize Group elected to measure investment property at cost,
less accumulated depreciation and accumulated impairment
losses, if any (i.e., applying the same accounting policies as
for property, plant and equipment). The fair values, which
reflect the market conditions at the balance sheet date, are
disclosed in Note 9.
Leases
The determination of whether an agreement is, or contains
a lease, is based on the substance of the agreement at in-
ception date. Leases are classified as finance leases when
the terms of the lease agreement transfer substantially all the
risks and rewards incidental to ownership to the Group. All
other leases are classified as operating leases.
Assets held under finance leases are recognized as assets
at the lower of fair value or present value of the minimum lease
payments at the inception of the lease. The corresponding lia-
bility to the lessor is included in the balance sheet as a finance
lease obligation. Lease payments are allocated between fi-
nance costs and a reduction of the lease obligation to achieve
a constant rate of interest over the lease term. Finance lease
assets and leasehold improvements are depreciated over the
shorter of the expected useful life of similar owned assets or
the relevant lease term.
Rents paid on operating leases are charged to income on a
straight-line basis over the lease term. Benefits received and
receivable as an incentive to enter into an operating lease are
spread over the relevant lease term on a straight-line basis
as a reduction of rent expense.
In connection with investment property, where the Group
is the lessor, leases where the Group does not transfer sub-
stantially all the risk and rewards incident to the ownership
of the investment property are classified as operating leases
and are generating rental income. Contingent rents are rec-
ognized as other operating income (Note 27) in the period in
which they are earned.
Provisions
Provisions are recognized when the Group has a present le-
gal or constructive obligation as a result of past events, it
is more likely than not that an outflow of resources will be
required to settle the obligation, and the amount can be reli-
ably estimated. Provisions are measured at the balance sheet
date using management’s best estimate of the expenditures
expected to be required to settle the obligation, discounted
using a pre-tax discount rate that reflects the current market
assessments of the time value of money and the risk spe-
cific on the liability, if material. Where discounting is used,
the increase in the provision due to the passage of time (“un-
winding of the discount”) is recognized within “Finance costs”
(Note 29.1).
• Store closing costs: Delhaize Group regularly reviews
its stores’ operating performance and assesses the
Group’s plans for certain store closures. Closing stores
results in a number of activities required by IFRS in
order to appropriately reflect the value of assets and
liabilities and related store closing costs, such as a re-
view of net realizable value of inventory or review for
impairment of assets or cash-generating units (for both
activities see accounting policies described above). In
addition, Delhaize Group recognizes “Closed store pro-
visions,” which consist primarily of provisions for oner-
ous contracts and severance (“termination”) costs (for
both see further below). Costs recognized as part of
store closings are included in “Other operating ex-
penses” (Note 28), except for inventory write-downs,
which are classified as “Cost of sales” (Note 25). If
appropriate (see accounting policy for “Non-Current
Assets/Disposal Groups and Discontinued Operations”
above), stores are accounted for in accordance with
IFRS 5 Non-current Assets Held for Sale and Discon-
tinued Operations.
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Onerous contracts: IAS 37 Provisions, Contingent Liabilities
and Contingent Assets requires the recognition of a provi-
sion for a present obligation arising under an onerous con-
tract, which is defined as a contract in which the unavoid-
able costs of meeting the obligations under the contract ex-
ceed the economic benefits expected to be received under
it. Judgment is required in determining if a present obliga-
tion exists, taking into account all available evidence. Once
the existence has been established, at the latest upon actual
closing, Delhaize Group recognizes provisions for the present
value of the amount by which the unavoidable costs to ful-
fill the agreements exceeds the expected benefits from such
agreements, which comprises the estimated non-cancellable
lease payments, including contractually required real estate
taxes, common area maintenance and insurance costs, net
of anticipated subtenant income. The adequacy of the closed
store provision is dependent upon the economic conditions in
which stores are located which will impact the Group’s ability
to realize estimated sublease income. Owned and finance
leased stores that are closed and rented out to third-parties
are reclassified as investment property (Note 9).
When termination costs are incurred in connection with a
store closing, a liability for the termination benefits is recog-
nized in accordance with IAS 19 Employee Benefits , when
the Group is demonstrably committed to the termination for
the estimated settlement amount, which is when the imple-
mentation of a formal plan has started or the main features
have been announced to those affected (see also “Employee
Benefits” below).
Store closing provisions are reviewed regularly to ensure
that accrued amounts appropriately reflect management’s
best estimate of the outstanding commitments and that addi-
tional expenses are provided for or amounts that are no longer
needed for their originally intended purpose are released.
2.4. Significant Use of Estimates, Assumptions
and Judgment
The preparation of financial statements in conformity with
IFRS requires Delhaize Group to make judgments, estimates
and assumptions that affect the application of accounting poli-
cies and the reported amounts of assets, liabilities and in-
come and expenses, which inherently contain some degree
of uncertainty. These estimates are based on experience and
assumptions Delhaize Group believes to be reasonable under
the circumstances. By definition, actual results could and will
often differ from these estimates. In the past, the Group’s es-
timates generally have not deviated significantly from actual
results. Revisions to accounting estimates are recognized in
the period in which the estimates are revised and in any future
periods affected.
Information about significant areas of estimation uncer-
tainty and critical judgments in applying accounting policies
that have the most significant effect on the amounts in the
consolidated financial statements is included in, but not lim-
ited to, the following notes:
• Note 3—Identification and aggregation of operating
segments;
• Notes 5.2, 5.3—Disposal Group Classified as Held for
Sale and Discontinued Operations;
• Notes 6, 7, 8, 11, 14, 19—Assessing assets for impair-
ment and fair values of financial instruments;
• Notes 13, 25—Accounting for vendor allowances;
• Note 18.3—Classification of leases;
• Note 20—Provisions;
• Note 21—Employee Benefits;
• Note 22—Income Taxes.
7. Intangible Assets (in part)
Intangible assets consist primarily of trade names, purchased
and developed software, favorable lease rights, prescription
files and other licenses.
Delhaize Group has determined that its trade names have
an indefinite useful life and are not amortized, but are tested
annually for impairment and whenever events or circum-
stances indicate that impairment may have occurred. Trade
names are tested for impairment by comparing their recov-
erable amount, being their value in use, with their carrying
amount. The value in use is estimated using revenue projec-
tions of each operating entity (see Note 6) and applying an
estimated royalty rate of 0.45% and 0.70% for Food Lion and
Hannaford, respectively. No impairment loss of trade names
was recorded or reversed in 2010, 2009 or 2008.
See Note 8 for a description of the impairment test for
assets with finite lives. During 2009, Delhaize Group impaired
various software solutions that related to projects that the
Group abandoned during the year.










Cost at January 1, 2010 362 151 175 201 49 938
Additions — 43 43 — 6 92
Sales and disposals — (4) (2) (22) — (28)
Transfers to/from other accounts — (4) 5 — (2) (1)
Currency translation effect 28 6 9 16 3 62
Cost at December 31, 2010 390 192 230 195 56 1,063
Accumulated amortization at January 1, 2010 — (71) (103) (123) (24) (321)
Accumulated impairment at January 1, 2010 (33) (3) (2) (5) — (43)
Amortization expense — (21) (32) (12) (4) (69)
Sales and disposals — 4 1 22 — 27
Transfers to/from other accounts — (1) 1 (1) 2 1
Currency translation effect (2) (4) (6) (10) (2) (24)
Accumulated amortization at December 31, 2010 — (94) (138) (129) (28) (389)
Accumulated impairment at December 31, 2010 (35) (2) (3) — — (40)
Net carrying amount at December 31, 2010 355 96 89 66 28 634
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8. Property, Plant and Equipment (in part)





















Cost at January 1, 2010 1,764 1,652 2,891 62 845 7,214
Additions 59 82 228 184 54 607
Sales and disposals (11) (29) (124) — (27) (191)
Acquisitions through business combinations 1 1 2 — — 4
Transfers to/from other accounts 45 58 55 (154) — 4
Currency translation effect 72 97 165 2 58 394
Balance at December 31, 2010 1,930 1,861 3,217 94 930 8,032
Accumulated depreciation at January 1, 2010 (503) (899) (1,633) — (330) (3,365)
Accumulated impairment at January 1, 2010 — (14) (34) — (16) (64)
Depreciation expense (71) (127) (254) — (51) (503)
Impairment loss — (2) (5) — (5) (12)
Sales and disposals 8 29 115 — 27 179
Transfers to/from other accounts (1) (2) 1 — — (2)
Currency translation effect (20) (52) (94) — (24) (190)
Accumulated depreciation at December 31, 2010 (587) (1,055) (1,881) — (380) (3,903)
Accumulated impairment at December 31, 2010 — (12) (23) — (19) (54)
Net carrying amount at December 31, 2010 1,343 794 1,313 94 531 4,075
In accordance with the accounting policy summarized in Note
2.3, Delhaize Group tests assets with finite lives for impair-
ment whenever events or circumstances indicate that impair-
ment may exist. The Group monitors the carrying value of its
retail stores, the lowest level asset group for which identifiable
cash flows are independent of other (groups of) assets (“cash-
generating unit” or CGU), for potential impairment based on
historical and projected cash flows. The recoverable value
is estimated using projected discounted cash flows based
on past experience and knowledge of the markets in which
the stores are located, adjusted for various factors, such as
inflation and general economic conditions. Independent third-
party appraisals are obtained in certain situations to help es-
timate fair values based on the location and condition of the
stores.
Management believes that the assumptions applied when
testing for impairment are reasonable estimates of the eco-
nomic conditions and operating performance of the different
CGUs. Changes in these conditions or performance will have
an impact on the projected cash flows used to determine the
recoverable amount of the CGUs and might result in addi-
tional stores identified as being possibly impaired and/or on
the impairment amount calculated.
Impairment losses of property, plant and equipment,
recorded in other operating expenses, amounted to EUR 12
million, EUR 13 million and EUR 24 million in 2010, 2009
and 2008, respectively. Impairment losses recognized in dis-
continued operations (related to assets classified as held for
sale, see Note 5.3) were EUR 5 million in 2008.
The impairment losses of EUR 12 million recognized in
2010, relate to underperforming stores (2009: EUR 6 million),
mainly in the United States, with only insignificant amounts
incurred in connection with store closings (2009: EUR 5 mil-
lion). In accordance with the Group’s policy, closed stores
held under finance lease agreements are reclassified to in-
vestment property (see Note 9). In 2009, the Group recorded
on such closed stores additional impairment losses of EUR 4
million as other operating expenses. In 2008, the Group rec-
ognized an impairment loss of EUR 24 million mainly relating
to Sweetbay stores (EUR 19 million) and stores operated in
Germany (EUR 5 million).
The impairment charges can be summarized by property,
plant and equipment categories as follows:
December 31
(In Millions of EUR) 2010 2009 2008
Leasehold improvements 2 5 9
Furniture, fixtures, equipment and vehicles 5 7 7
Buildings — 1 —
Property under finance leases 5 — 8
Total 12 13 24
Property under finance leases consists mainly of buildings.
The number of owned versus leased stores by segment at






Affiliated and Franchised Stores Owned
by Their Operators or Directly Leased
by Their Operators From a Third Party Total
United States 144 671 812 — 1,627
Belgium 131 34 240 400 805
Greece 41 — 145 37 223
Rest of the World 15 — 130 — 145
Total 331 705 1,327 437 2,800
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9. Investment Property (in part)
Investment property, principally comprised of owned rental
space attached to supermarket buildings and excess real es-
tate, is held for long-term rental yields or appreciation and is
not occupied by the Group.
In accordance with the Group’s accounting policy explained
in Note 2.3, investment property is accounted for at cost,
less accumulated depreciation and accumulated impairment
losses, if any. When stores held under finance lease agree-
ments are closed (see Note 20.1), they are reclassified to
investment property and in 2009 the Group reclassified EUR
14 million, net of accumulated depreciation, of closed store
related assets in the United States and recognized simul-
taneously an impairment loss of EUR 4 million (see also
Note 8).
10. Financial Instruments by Category (in part)
10.2. Financial Liabilities
Financial Liabilities by Class and Measurement Category
December 31, 2010
Financial Liabilities Measured at Fair Value








Part of a Fair Value Hedge
Relationship
Financial Liabilities
at Amortized Cost Total
Non-Current
Long-term debt 18.1 — — 544 1,422 1,966
Obligations under finance leases 18.3 — — — 684 684
Derivative instruments 19 3 13 — — 16
Current
Short-term borrowings 18.2 — — — 16 16
Long-term debt—current portion 18.1 — — — 40 40
Obligations under finance leases 18.3 — — — 57 57
Derivative instruments 19 — — — — —
Accounts payable — — — — 1,574 1,574
Total financial liabilities 3 13 544 3,793 4,353
15. Cash and Cash Equivalents
(In Millions of EUR) 2010 2009 2008
Term deposits with original maturity of three
months or less 491 166 25
Cash at banks 203 200 249
Cash on hand 64 73 46
Cash and cash equivalents at December 31 758 439 320(1)
(1) Amount excludes EUR 1 million, which is classified as asset held
for sale as of December 31, 2008.
Supplemental Cash Flow information:
(In Millions of EUR) 2010 2009 2008
Non-cash investing and financing activities:
Finance lease obligations incurred for store
properties and equipment 54 66 53
18. Financial Liabilities (in part)
18.3. Leases
As explained in Note 2.3, the classification of a lease agree-
ment depends on the allocation of risk and rewards inciden-
tal to the ownership of the leased item. When assessing the
classification of a lease agreement, certain estimates and as-
sumptions need to be made and applied, which include, but
are not limited to, the determination of the expected lease
term and minimum lease payments, the assessment of the
likelihood of exercising options and estimation of the fair value
of the lease property.
Delhaize Group as Lessee—Finance and Operating
Lease Commitments
As detailed in Note 8, Delhaize Group operates a significant
number of its stores under finance and operating lease ar-
rangements. Various properties leased are (partially or fully)
subleased to third parties, where the Group is therefore act-
ing as a lessor (see further below). Lease terms (including
reasonably certain renewal options) generally range from 1
to 40 years with renewal options ranging from 3 to 36 years.
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The schedule below provides the future minimum lease
payments, which have not been reduced by expected mini-
mum sublease income of EUR 50 million, due over the term
of non-cancellable subleases, as of December 31, 2010:
(In Millions of EUR) 2011 2012 2013 2014 2015 Thereafter Total
Finance Leases
Future minimum lease payments 134 122 118 113 110 937 1,534
Less amount representing interest (77) (75) (69) (63) (58) (451) (793)
Present value of minimum lease payments 57 47 49 50 52 486 741
Of which related to closed store lease obligations 3 3 3 2 3 15 29
Operating Leases
Future minimum lease payments (for non-cancellable leases) 269 233 207 182 157 831 1,879
Of which related to closed store lease obligations 13 11 10 8 7 23 72
The average effective interest rate for finance leases was
12.0%, 11.8% and 11.9% at December 31, 2010, 2009 and
2008, respectively. The fair value of the Group’s finance lease
obligations using an average market rate of 5.1% at Decem-
ber 31, 2010 was EUR 994 million (2009: 6.1%, EUR 887
million; 2008: 8.3%, EUR 817 million).
The Group’s obligation under finance leases is secured by
the lessors’ title to the leased assets.
Rent payments, including scheduled rent increases, are
recognized on a straight-line basis over the minimum lease
term. Total rent expense under operating leases was EUR
295 million, EUR 270 million and EUR 245 million in 2010,
2009 and 2008, respectively, being included predominately in
“Selling, general and administrative expenses.” Certain lease
agreements also include contingent rent requirements which
are generally based on store sales and were insignificant in
2010, 2009 and 2008.
Sublease payments received and recognized into income
for 2010, 2009 and 2008 were EUR 22 million, EUR 22 million
and EUR 19 million, respectively.
Delhaize Group signed lease agreements for additional
store facilities under construction at December 31, 2010. The
corresponding lease terms as well as the renewal options
generally range from 15 to 25 years. Total future minimum
lease payments for these agreements relating to stores un-
der construction were approximately EUR 208 million.
Provisions for EUR 44 million, EUR 53 million and EUR 51
million at December 31, 2010, 2009 and 2008, respectively,
representing the discounted value of remaining lease pay-
ments, net of expected sublease income, for closed stores,
were included in “Closed Store Provisions” (see Note 20.1).
The discount rate is based on the incremental borrowing rate
for debt with similar terms to the lease at the time of the store
closing.
Delhaize Group as Lessor—Finance and Operating
Expected Lease Income
As noted above, occasionally, Delhaize Group acts as a
lessor for certain owned or leased property, mainly in con-
nection with closed stores that have been sub-leased to other
parties, retail units in Delhaize Group shopping centers or
within a Delhaize Group store. Currently the Group did not en-
ter into any lease arrangements with independent third party
lessees that would qualify as finance leases. Rental income
is included in “Other Operating Income” in the income state-
ment.
The undiscounted expected future minimum lease pay-
ments to be received under non-cancellable operating leases
as at December 31, 2010 can be summarized as follows:
(In Millions of EUR) 2011 2012 2013 2014 2015 Thereafter Total
Future minimum lease payments to be received 38 33 26 13 3 15 128
Of which related to sub-lease agreements 16 13 8 3 2 8 50
The total amount of EUR 128 million represents expected
future lease income to be recognized as such in the income
statement and excludes expected future sub-lease payments
to receive in relation to stores being part of the “Closed Store
Provision” (see Note 20.1).
Contracts including contingent rent clauses are insignifi-
cant to the Group.
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3.241
Silver Fern Farms Limited (Sep 2010)
STATEMENT OF COMPREHENSIVE INCOME
(in part)
For the 13 months ended 30 September 2010
Parent Consolidated










Sale of goods 1,780,190 1,962,057 1,831,682 2,001,614
Other revenue 5 2,052 850 1,512 320
Revenue 1,782,242 1,962,907 1,833,194 2,001,934
Other income 6 49,623 10,258 45,536 12,656
Total income 1,831,865 1,973,165 1,878,730 2,014,590
Raw materials and consumables used 1,275,184 1,352,884 1,304,687 1,365,931
Employee benefits expense 7 271,544 274,863 274,971 283,104
Depreciation and amortisation 25,320 24,197 25,469 24,679
Finance costs 7 22,322 32,703 22,845 32,776
Other operational expenses 7 252,632 291,707 260,574 304,091
Share of profits of associate 29 — — (1,397) (1,105)
Profit/(loss) from continuing operations before member
distributions, income tax and non-recurring items (15,137) (3,189) (8,419) 5,114
Member distributions 10 98 153 98 153
Profit/loss) before income tax and non-recurring items (15,235) (3,342) (8,517) 4,961
Non-recurring items—income 8 11,341 48,476 11,378 48,476
Non-recurring items—costs 8 (15,028) (9,851) (18,276) (10,078)
Total non-recurring items (3,687) 38,625 (6,898) 38,398
Profit/(loss) before income tax (18,922) 35,283 (15,415) 43,359
Income tax expense/(benefit) 9 (1,966) 66 (1,396) (238)
Net profit/loss) for the period (16,956) 35,217 (14,019) 43,597
Profit/loss) attributable to shareholders of the parent (16,956) 35,217 (14,019) 43,597
NOTES TO THE FINANCIAL STATEMENTS (in part)
For the 13 months ended 30 September 2010
2. Summary of Significant Accounting Policies (in part)
p. Leases
The determination of whether an arrangement is or contains
a lease is based on the substance of the arrangement and
requires an assessment of whether the fulfilment of the ar-
rangement is dependent on the use of a specific asset or
assets and the arrangement conveys a right to use the asset.
Group as Lessee
Finance leases, which transfer to the Group substantially all
the risks and benefits incidental to ownership of the leased
item, are capitalised at the inception of the lease at the fair
value of the leased property or, if lower, at the present value
of the minimum lease payments.
Lease payments are apportioned between the finance
charges and reduction of the lease liability so as to achieve
a constant rate of interest on the remaining balance of the
liability. Finance charges are included in the statement of
comprehensive income as finance costs.
Capitalised leased assets are depreciated over the shorter
of the estimated useful life of the asset and the lease term.
These assets are measured at cost.
Leases where the lessor retains substantially all the risks
and benefits of ownership of the asset are classified as oper-
ating leases.
Operating lease payments are recognised as an expense
in the statement of comprehensive income on a straight-line
basis over the lease term.
Group as Lessor
Leases in which the Group retains substantial all the risks
and benefits of ownership of the leased assets are classified
as operating leases. Rental income is recognised over the
life of the lease.
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ii Significant Accounting Estimates and Assumptions (in part)
Estimate of Useful Lives of Assets
The estimation of useful lives of assets has been based on
historical experience as well as manufacturer’s warranties (for
plant and equipment), lease terms (for leased equipment)
and turnover policies (for motor vehicles). In addition, the
condition of the assets is assessed at least once a year and
considered against the remaining useful life. Adjustments to
useful life are made when considered necessary.
17. Property, Plant and Equipment (in part)
b. Reconciliation of the Carrying Amounts at the Beginning
and End of the Period
Consolidated





13 months ended 30 Sept 2010
At 1 September 2009, net of accumulated depreciation 43,434 123,352 103,460 664 6,853 277,763
Additions 3,539 4,530 12,189 134 2,026 22,418
Disposals (1,165) (5,255) (15,947) (511) (276) (23,154)
Revaluations 18,458 51,770 — — — 70,228
Impairment of assets — — (102) — — (102)
Reclassification of assets (1,499) 2,032 (537) 2 — (2)
Transfers (to)/from assets held for sale (1,076) (447) (22) — — (1,545)
Depreciation charge for the year (95) (6,015) (17,169) (160) (196) (23,635)
Depreciation on disposals 90 1,685 13,430 489 — 15,694
Exchange adjustment — (25) (24) (8) — (57)
At 30 Sept 2010, net of accumulated depreciation 61,686 171,627 95,278 610 8,407 337,608
Cost or fair value 61,686 172,124 367,437 6,834 8,603 616,684
Accumulated depreciation and impairment — (497) (272,159) (6,224) (196) (279,076)
Net carrying value 61,686 171,627 95,278 610 8,407 337,608
g. Carrying Value of Plant and Equipment Under
Finance Leases
The carrying value of plant and equipment held under finance
leases and hire purchase contracts at 30 September 2010 is
$1,166,000 (2009: $531,000).
19. Interest Bearing Loans and Borrowings (in part)
Parent Consolidated
NZD in Thousands ($000)
Average Effective










NZ bank overdraft (9.5m) 10.73% On demand 860 437 860 437
GBP bank overdraft (GBP 1.5m) 2.12% On demand — — 1,987 15
Total overdrafts 860 437 2,847 452
Obligations under finance leases 10.01% Current 348 146 348 146
Secured loan 4.94% Current 49 542 49 542
Total interest bearing loans and borrowings—current 397 688 397 688
Non-Current
Obligations under finance leases 10.01% 832 183 832 183
Secured loan 4.94% Sep-12 41,000 108,000 41,000 108,000
Total interest bearing loans and borrowings—non-current 41,832 108,183 41,832 108,183
Convertible redeemable preference shares
Convertible redeemable preference shares 8.95% Dec-11 1,595 1,622 1,595 1,622
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Silver Fern Farms Limited has renewed its banking facilities
effective 29 September 2010. The two year facility has an
expiry date of September 2012 and is on similar terms to the
previous arrangements. The renewed facilities include spe-
cific funding to repay the $75 m SFF030 Bond in November
2010.
27. Commitments and Contingencies (in part)
Operating Lease Commitments—Group as Lessee
The Group has entered into commercial leases on certain mo-
tor vehicles and items of machinery, office space, processing
and coolstore facilities where it is not in the best interest of
the Group to purchase these assets. These leases have an
average life of between 4 and 15 years with renewal terms
included in the contracts. Renewals are at the option of the
specific entity that holds the lease. There are no restrictions
placed upon the lessee by entering into these leases. Future
minimum rentals payable under non-cancellable operating
leases at balance date are as follows:
Parent Consolidated










Within one year 7,486 7,402 7,578 7,501
After one year but not more than five years 13,822 14,015 13,947 14,521
More than five years 10,152 10,789 10,250 10,896
Total operating lease commitments 31,460 32,206 31,775 32,918
Finance Lease and Hire Purchase Commitments
The Group has finance leases for various items of plant and
machinery, these leases have no terms of renewal or pur-
chase options and escalation clauses. Future minimum lease
payments under finance leases and hire purchase contracts
together with the present value of the net minimum lease
payments are as follows:
Parent and Consolidated As at 30 Sept 10 As at 31 Aug 09
NZD in Thousands ($000) Minimum Payments Minimum Payments
Finance lease and hire purchase commitments
Within one year 424 146
After one year but not more than five years 907 215
Total minimum lease payments 1,331 361
Less amounts representing finance charges (151) (32)
Present value of minimum payments 1,180 329
Operating Lease Commitments—Group as Lessor
The Group has entered into commercial property leases of the
Group’s surplus office and manufacturing buildings. These
properties held under operating leases are measured un-
der the fair value model as the properties are held to earn
rentals. These non-cancellable leases have remaining non-
cancellable lease terms of between one and six years. Future
minimum rentals receivable under non-cancellable operating
leases at balance date are as follows:
Parent Consolidated









Within one year 44 185 44 185
After one year but not more than five years — 58 — 58
More than five years — — — —
Total operating lease commitments (as lessor) 44 243 44 243
IFRS ATT 3.241
398 IFRS Accounting Trends & Techniques
Lessor—Finance Leases
3.242
Telecom Corporation of New Zealand Limited
(Jun 2010)
INCOME STATEMENT (in part)
For the years ended 30 June 2010, 2009 and 2008
Group Parent
Year Ended 30 June











Operating revenues and other gains 3
Local service 1,022 1,049 1,061 — —
Calling 4 1,003 1,239 1,291 — —
Interconnection 178 177 178 — —
Mobile 826 822 875 — —
Data 642 652 638 — —
Broadband and internet 574 582 547 — —
IT services 480 486 439 — —
Resale 274 333 370 — —
Other operating revenues 4 245 286 309 1,289 359
Other gains 6 27 12 7 367 —
5,271 5,638 5,715 1,656 359
Operating expenses 5
Labour (893) (909) (886) — —
Intercarrier costs (957) (1,239) (1,243) — —
Other operating expenses 5 (1,657) (1,710) (1,695) (1) (13)
Asset impairments 6 — (101) — (300) (107)
Other expenses 6 — — — — (66)
Depreciation (757) (683) (574) — —
Amortisation (275) (234) (187) — —
(4,539) (4,876) (4,585) (301) (186)
Finance income 7 22 41 119 306 297
Finance expense 7 (202) (242) (271) (453) (467)
Share of associates’ net profits/(losses) 1 (1) (3) — —
(179) (202) (155) (147) (170)
Net earnings before income tax 553 560 975 1,208 3
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1. Statement of Accounting Policies (in part)
Specific Accounting Policies (in part)
As described below, these accounting policies have been
applied consistently to all periods presented in these financial
statements.
Leased Assets
Telecom is a lessor of equipment. Such leases are consid-
ered operating leases where substantially all the risks and
rewards incidental to ownership remain with Telecom. Rental
income is taken to revenue on a straight-line basis over the
lease term. Leases are classified as finance leases where
substantially all the risks and rewards of ownership transfer
from Telecom to the lessee. Amounts due from lessees under
finance leases are recorded as receivables at Telecom’s net
investment in the leases. Finance lease income is allocated
to accounting periods so as to reflect a constant periodic rate
of return on the net investment outstanding in respect of the
leases.
Telecom is a lessee of certain plant, equipment, land
and buildings under both operating and finance leases.
Lease costs relating to operating leases are recognised on a
straight-line basis over the life of the lease. Finance leases,
which effectively transfer to Telecom substantially all the risks
and benefits of ownership of the leased assets, are capi-
talised at the lower of the leased asset’s fair value or the
present value of the minimum lease payments at inception of
the lease. The leased assets and corresponding liabilities are
recognised and the leased assets are depreciated over their
estimated useful lives.
Financial Instruments (in part)
Telecom has derivative and non-derivative financial in-
struments. Telecom’s non-derivative financial instruments
comprise investments in equity and debt securities, trade
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receivables, other receivables, cash, loans and borrowings,
trade payables and finance lease receivables.
Non-derivative financial instruments are recognised initially
at fair value, plus for instruments not at fair value through
profit and loss, any directly attributable transaction costs.
Subsequent to initial recognition non-derivative financial in-
struments are measured as described below.
A financial instrument is recognised if Telecom becomes a
party to the contractual provisions of the instrument. Finan-
cial assets are de-recognised if Telecom’s contractual rights
to the cash flows from the financial assets expire or if Telecom
transfers the financial asset to another party without retaining
control or substantially all of the risks and rewards of the as-
set. Purchases and sales of financial assets are accounted
for at trade date (i.e., the date Telecom commits itself to pur-
chase or sell the asset). Financial liabilities are de-recognised
if Telecom’s obligations specified in the contract expire or are
discharged or cancelled.
Note 5. Operating Expenses (in part)
Other Operating Expenses
Group








Direct costs 282 360 341
Mobile acquisition, updates and dealer commissions 295 292 322
Procurement and IT services expenses 292 319 264
Computer costs 200 202 197
Advertising costs 98 93 90
Broadband and internet 83 57 78
Accommodation—lease and rental costs 76 72 61
Accommodation—other costs 70 63 66
Outsourcing 36 45 52
Provision for doubtful debts 17 24 29
Equipment—lease and rental costs 10 11 11
Research costs 8 10 9
Movement in provision for inventory obsolescence (3) 9 6
Directors’ fees 1 1 2
Foreign exchange (gains)/losses 10 (9) (1)
(Gain)/loss on disposal of property, plant and equipment — 1 (3)
Other 182 160 171
1,657 1,710 1,695
Telecom has revised the presentation of certain mobile hand-
set revenues and cost of sales as detailed in note 3. Previ-
ously reported other operating expenses were NZ$1,671 mil-
lion for the year ended 30 June 2009 and NZ$1,613 million
for the year ended 30 June 2008.
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Note 7. Finance Income and Expense
Group Parent












Interest income from cash and deposits 8 28 98 — —
Other interest income 13 13 21 — —
Finance lease income 1 — — — —
Interest income on loans to subsidiary companies — — — 306 297
Finance income 22 41 119 306 297
Finance expense:
Finance expense on long-term debt:
—Euro Medium Term Notes (EMTN)(1) 154 187 203 — —
—Capital notes — — 10 — —
—TeleBonds 42 43 36 — —
Revaluation of interest rate derivatives 2 (5) (4) — —
Other interest and finance expenses 24 35 38 — —
Interest expense on loans from subsidiary companies — — — 453 467
222 260 283 453 467
Less interest capitalised (20) (18) (12) — —
Finance expense 202 242 271 453 467
(1) Includes NZ$68 million recycled from the cash flow hedge reserve for the year ended 30 June 2010 (30 June 2009: NZ$665 million, 30 June
2008: NZ$90 million).
Interest is capitalised on property, plant and equipment and
intangible assets under development at an annualised rate of
7.8% (30 June 2009: 8.0%; 30 June 2008: 8.0%).
Note 11. Receivables and Prepayments
Group Parent









Short-Term Receivables and Prepayments:
Trade receivables 481 510 — —
Less allowance for doubtful accounts receivable (24) (29) — —
457 481 — —
Unbilled rentals and tolls 132 182 — —
Finance lease receivable (see note 25) 12 — — —
Prepaid expenses and other receivables 101 118 — —
Due from subsidiaries — — 1,626 485
702 781 1,626 485
Long-Term Receivables and Prepayments:
Finance lease receivable (see note 25) 21 — — —
Other receivables 10 — — —
31 — — —
Bad debts of NZ$22 million (30 June 2009: NZ$27 million)
were written off against the allowance for doubtful accounts
during the year.
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Balance as at 1 July 2009 10,752 94 612 517 454 12,429
Acquisitions 144 — 39 93 479 755
Transfers 456 — — (2) (454) —
Disposals (218) — (5) (4) — (227)
Currency movements (20) — (2) (1) — (23)
Balance as at 30 June 2010 11,114 94 644 603 479 12,934
Accumulated depreciation and impairment losses
Balance as at 1 July 2009 (7,463) — (336) (342) — (8,141)
Depreciation charge (646) — (31) (80) — (757)
Disposals 214 — 4 4 — 222
Currency movements 17 — (2) 1 — 16
Balance as at 30 June 2010 (7,878) — (365) (417) — (8,660)
Net book value at 30 June 2010 3,236 94 279 186 479 4,274
Operating Leases
Included in buildings at 30 June 2010 are buildings on lease-
hold land with a cost of NZ$14 million (30 June 2009: NZ$14
million) together with accumulated depreciation of NZ$6 mil-
lion (30 June 2009: NZ$5 million).
Finance Leases
Telecom has certain eguipment subject to finance lease ar-
rangements.This eguipment is included in the telecommuni-
cations eguipment category of property, plant and eguipment.
As at 30 June 2010 the eguipment capitalised under finance
leases had a cost of NZ$88 million (30 June 2009: NZ$88 mil-
lion) together with accumulated depreciation of NZ$76 million
(30 June 2009: NZ$66 million). Telecom had prepaid all its
minimum lease payments under these finance leases and as
a result has no outstanding finance lease liability.













Balance at 1 July 2009 11 9 17 24 61
Provisions made during the year — 14 5 9 28
Provisions utilised during the year (2) (12) — (2) (16)
Release of provision (7) — (1) (6) (14)
Currency movements — — (1) — (1)
Balance as at 30 June 2010 2 11 20 25 58
Current 2 11 1 5 19
Non-current — — 19 20 39
2 11 20 25 58
Property
Property provisions relate primarily to make-good reguire-
ments under property leases and onerous leases.
NZ$1 million is expected to be utilised during the year
ended 30 June 2011. The remainder, disclosed as non-
current, is expected to be utilised beyond one year.
Note 24. Financial Instruments and Risk Management
(in part)
Telecom manages its treasury activities through a board-
approved treasury constitution consisting of treasury gover-
nance and policy frameworks.Telecom is exposed to foreign
currency, interest rate, credit, liquidity and equity risks. Each
of these risks, the associated financial instruments and the
management of those risks are detailed in this note.
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Financial Instruments (in part)
Telecom’s financial instruments are classified under IFRS as
follows:
Group




















Cash 360 — — — 360
Short-term derivative assets 1 — 3 — 4
Trade and other receivables — — — 461 461
Finance lease receivables — — — 12 12
361 — 3 473 837
Non-current assets
Long-term derivative assets — — 51 — 51
Other receivables — — — 10 10
Finance lease receivables — — — 21 21
Long-term investments(1) — 273 — 1 274
— 273 51 32 356
Liabilities
Current liabilities
Short-term derivative liabilities (1) — (21) — (22)
Trade accounts payable — — — (809) (809)
Short-term debt — — — (163) (163)
Long-term debt due within one year — — — (21) (21)
(1) — (21) (993) (1,015)
Non-current liabilities
Long-term derivative liabilities (49) — (391) — (440)
Long-term debt due after one year — — — (2,137) (2,137)
(49) — (391) (2,137) (2,577)
(1) Excludes associates.
Adoption of IFRS 9
As described in note 1. Telecom has adopted part 1 of IFRS
9 as at 31 December 2009, being the date of Telecom’s ini-
tial application, resulting in changes in the categories and
measurement of some of Telecom’s financial assets. The ta-
ble below illustrates the classification and carrying amount of
Telecom’s financial assets under IAS 39 and IFRS 9 on the













Cash Held to maturity Fair value through profit or loss 296 296
Forward exchange contracts Fair value designated in
hedging relationships
Fair value designated in
hedging relationships 2 2
Interest rate swaps Fair value designated in
hedging relationships
Fair value designated in
hedging relationships 1 1
Cross-currency interest rate swaps Fair value designated in
hedging relationships
Fair value designated in
hedging relationships 28 28
Trade receivables Loans and receivables Amortised cost 430 430
Finance lease receivables Loans and receivables Amortised cost 21 21
Long-term investments(1) Available for sale Fair value through other
comprehensive income 546 290
Long-term investments in
Government stock
Held to maturity Amortised cost
1 1
(1) Excludes associates and Government stock. The impact of the adoption of IFRS 9 on prior periods is presented in note 13.
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Fair Value of Financial Instruments
Under IFRS, financial instruments are either carried at amor-
tised cost, less any provision for impairment, or fair value.The
only significant variances between instruments held at amor-
tised cost and their fair value relates to long-term debt.
Finance Lease Receivable
The fair value of finance lease receivables is estimated to be
NZ$37 million, using a discount rate based on the three-year
swap rate and adding a credit margin that reflects the credit
quality of the receivables.
Risk Management (in part)
Telecom is exposed to market risk due to foreign currency,
interest rates and price risk, as well as credit risk, liquidity risk
and equity price risk.
Credit Risk
In the normal course of its business, Telecom incurs credit risk
from financial instruments including cash, short-term invest-
ments, advances to associate companies, trade receivables,
other receivables, finance lease receivables and derivative
financial instruments.
Telecom has a credit policy that is used to manage this ex-
posure to credit risk. As part of this policy, limits on exposures
with significant counterparties have been set and approved
by the board of directors and are monitored on a regular ba-
sis. Telecom’s financial instruments do not have significant
concentration of risk with any single party.
Telecom has certain derivative and debt agreements that
are subject to bilateral credit support agreements that require
Telecom or the counterparty to post collateral to support the
value of certain derivatives. As at 30 June 2010, US$15 mil-
lion (NZ$21 million) of collateral was posted (30 June 2009:
nil). In the event of a downgrade of Telecom’s credit rating to
either Baal (Moody’s Investors Service), or BBB + (Standard
& Poor’s) US$194 million (based on rates at 30 June 2010)
of additional collateral would be required to be posted.
Telecom places its cash, short-term investments and
derivative financial instruments with high credit quality finan-
cial institutions and sovereign bodies and limits the amount of
credit exposure to any one financial institution. These limits
are monitored daily. There is no significant concentration of
credit risk with respect to trade receivables.
NZ$1,148 million of Telecom’s assets are subject to credit
risk (30 June 2009: NZ$1,160 million). Telecom holds various
letters of credit and guarantees over some of these amounts.
Telecom does not hold any collateral over these amounts.
Finance lease receivables are secured over the underlying
assets.
Note 25. Commitments (in part)
Operating Lease Commitments—Telecom as Lessee
Telecom has entered into commercial leases on properties,
network infrastructure, motor vehicles and other items of
equipment. Certain leases are subject to Telecom being able
to renew or extend the lease period based on terms that would
then be agreed with the lessor. There are no other significant
lease terms that relate to contingent rents, purchase options
or other restrictions on Telecom.
Future minimum rental commitments for all non-cancellable
operating leases are:
Group





Less than 1 year 86 79
Between 1 and 5 years 253 258
More than 5 years 317 332
656 669
Finance Lease Commitments—Telecom as Lessee
At 30 June 2010 and 2009, Telecom had no remaining mini-
mum lease payments in respect of capitalised finance leases,
as discussed in note 15.
Finance Lease Receivables—Telecom as Lessor
Telecom has entered into commercial finance leases on a
range of information and communication technology equip-
ment for Telecom business customers. The profile of lease
payments is set out below:
Undiscounted Discounted





Less than 1 year 15 12
Between 1 and 5 years 23 20
Total minimum future lease
payments 38 32
Unguaranteed residual value 1 1
Gross finance lease receivable 39 33
Less unearned finance income (6) N/A






Allowance for uncollectable lease
payments 1 1
There are no contingent rents recognised as income in the
year ended 30 June 2010 (2009: nil).
The interest rate inherent in the leases is fixed at the con-
tract date for the entire lease term.
Finance lease receivable balances are secured over the
equipment leased. Telecom is not permitted to sell or re-
pledge the collateral in the absence of a default by the lessee.
The maximum credit risk exposure for finance lease receiv-
ables is the carrying amount of the receivables. The finance
lease receivables at 30 June 2010 are neither past due or
impaired.
Note 26. Contingencies (in part)
Cross Border Lease Guarantees
Telecom has cross border leases in respect of certain
telecommunication assets, which provides certain under-
takings (including letters of credit) in accordance with
guarantees entered into as part of the transactions. The
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maximum exposure under these guarantees is now assessed
as NZ$22 million (30 June 2009: NZ$18 million) and the last
guarantee expires in 2014.
IAS 36, IMPAIRMENT OF ASSETS
IFRS Overview and Comparison
to U.S. GAAP
3.243 IAS 36, Impairment of Assets, establishes the proce-
dures that an entity applies to ensure that an asset is carried at
no more than its recoverable amount. Recoverable amount is
the higher of fair value less costs to sell and value in use. An
entity should apply IAS 36 in testing and measuring impair-
ment losses, or reversals of such losses, for all assets, except
the following:
• Inventories
• Assets arising from construction contracts
• Deferred tax assets
• Assets arising from employee benefits
• Financial assets within the scope of IAS 39
• Investment property measured at fair value
• Biological assets related to agricultural activity mea-
sured at fair value
• Deferred acquisition costs and intangible assets arising
from insurance contracts
• Noncurrent assets or disposal groups classified as held
for sale within the scope of IFRS 5
3.244 Financial assets classified as subsidiaries, associates,
and jointly controlled entities are included in the scope of IAS
36. IAS 36 also applies to assets held at revalued amount in
accordance with IAS 16 and IAS 38.
3.245 IAS 36 also applies to cash generating units (CGU). A
CGU is the smallest identifiable group of assets that generates
cash inflows that are largely independent of the cash inflows
of other assets or groups of assets.
Recognition and Measurement
IFRSs
3.246 At the end of each reporting period, an entity should
assess whether there is any indication that an asset may be
impaired. If any indication exists, the entity should test the
asset for impairment in accordance with the procedures in
IAS 36. IAS 36 provides examples of both internal and ex-
ternal indicators of impairment. An entity should test assets
individually, unless the recoverable amount cannot be de-
termined without other assets. In that case, an entity should
test the CGU to which the asset belongs. An entity should
only include a liability in a CGU when a recoverable amount
cannot be determined without including that liability.
3.247 However, an entity should test the following assets
annually for impairment even when no indicator exists:
• Goodwill
• Indefinite-life intangible asset
• Intangible asset not yet available for use (for example,
development costs)
3.248 An entity can perform the impairment test on these
assets at any time during the year, but it should perform the
test at the same time each year. Different intangible assets
may be tested at different times during the year. Even when an
entity acquired an intangible asset during the year, it should
test the asset for impairment before the end of the reporting
period.
3.249 To perform an impairment test, an entity should de-
termine the following amounts:
• Fair value less cost to sell (FVLCS)
• Value in use (VIU)
3.250 IAS 36 includes a hierarchical procedure for determin-
ing FVLCS. IAS 36 states that the best evidence of FVLCS
is a price in a binding sales agreement in an arm’s length
transaction, adjusted for any incremental costs directly at-
tributable to the asset’s disposal. When there is no binding
sales agreement, an entity should use a price determined in
an active market reduced by costs to sell. When no binding
sales agreement or active market exists, an entity should base
its determination of FVLCS on the best available information
of what the entity would obtain at the end of the reporting
period in an arm’s length transaction between knowledgeable
and willing parties.
3.251 An entity calculates an asset’s VIU on the basis of the
following information:
• Estimates of future cash flows it expects to receive from
the asset
• Expectations about variations in the amounts or timing
of these cash flows
• Current market risk-free interest rate
• Price for bearing the risk inherent in the asset
• Other factors, such as lack of liquidity, which market
participants would use in determining a price for the
asset
An entity then calculates the present value of the estimated
future cash flows, making the adjustment for risk to either
the cash flows or the discount rate.
3.252 An entity should base its estimates of future cash
flows on reasonable and supportable assumptions represent-
ing management’s best estimates of the range of economic
conditions that will exist over the asset’s life. An entity should
give greater weight to external evidence, rather than internal
evidence. An entity should use management cash flow pro-
jections, up to a maximum of five years. Cash flows should
relate to the asset in its current condition and exclude any cash
flows resulting from future restructurings or other actions to
improve the asset’s performance. Cash flows should include
cash flows from continuing use of the asset, other cash flows
necessary to the continued use of the asset that the entity
can directly attribute or allocate on a reasonable and support-
able basis, and net cash flows from the asset’s disposal. IAS
36 explicitly prohibits an entity from including cash flows
relating to financing activities and income tax receipts or
payments. An entity should extrapolate cash flows beyond
the five-year limit for specific projections using a steady or
declining growth rate. This growth rate should not exceed
the long-term growth rate on similar products, industries, or
countries, unless the entity can justify a higher rate.
3.253 An entity should use a pretax discount rate that reflects
current market assessments of both the time value of money
and the risks inherent in the asset itself. An entity may use
surrogates when a market interest rate is not available.
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3.254 The recoverable amount is determined as the higher
of FVLCS and VIU. To test for an impairment loss, an entity
should compare the recoverable amount with the asset’s car-
rying value. Except for assets carried at a revalued amount,
an entity should record an impairment loss, measured as the
difference between the carrying value and the recoverable
amount, in profit or loss when the recoverable amount is
lower than the carrying value. An entity should recognize
an impairment loss on an asset carried at a revalued amount
as a revaluation decrease, in accordance with the relevant
standard.
3.255 When the amount estimated for an impairment loss is
greater than the carrying amount of the asset(s) to which it
relates, an entity should recognize a liability if, and only if,
recognition is required by another IFRS.
3.256 When an impairment loss is recognized on a depre-
ciable asset, an entity should assess its remaining useful life
and residual value and adjust depreciation or amortization
expense prospectively.
3.257 An entity should test and measure a reversal of an
impairment loss in the same manner as the original impair-
ment test, based on internal and external indicators that the
impairment no longer exists. An entity should reverse an im-
pairment up to the amount that the carrying value would have
been had an impairment loss not been recorded.
3.258 If it is not possible to test an individual asset for im-
pairment, an entity identifies the smallest CGU to which the
asset belongs and tests the CGU for impairment by calculat-
ing the recoverable amount of the CGU and comparing that
amount with its carrying value. An entity should not include
a liability in a CGU unless the recoverable amount cannot be
calculated otherwise. When an active market exists for the
output of an asset or group of assets, an entity should consider
that asset or group of assets to be a CGU, even if some or
all of the output is used internally. An entity should base its
estimates of cash flows on external prices, not transfer prices.
An entity should define its CGUs consistently from period
to period and determine the carrying amount in a manner
consistent with the determination of the recoverable amount.
3.259 An entity should allocate goodwill to the CGUs to
which the goodwill relates. An entity should allocate good-
will acquired in a business combination to CGUs at the ac-
quisition date. This allocation should be at the lowest CGU
expected to benefit from the business combination but should
be no larger than an operating segment defined in accordance
with IFRS 8, Operating Segments. An entity should allocate
goodwill no later than the end of the reporting period follow-
ing the acquisition.
3.260 When an entity changes its reporting structure and, in
consequence, the CGUs to which it had allocated goodwill,
it should reallocate goodwill to the CGUs affected.
3.261 Similar to allocating goodwill, an entity should allo-
cate to CGUs other corporate assets (for example, IT, head-
quarters building, and so on)) that do not generate cash flows
in order to test these assets for impairment.
3.262 When either goodwill or corporate assets cannot be
allocated to CGUs to which the goodwill or corporate assets
relate, an entity should first test the CGU for impairment,
excluding the goodwill or corporate asset, and recognize any
impairment loss. The entity should then identify the small-
est CGU that includes the CGU under review and to which
the entity can allocate goodwill or the corporate asset and
then test this new CGU for impairment and recognize any
impairment loss.
3.263 When an entity recognizes an impairment loss on a
CGU to which it allocated goodwill, the impairment loss is
attributed first to goodwill and then proportionately to the
other assets in the CGU based on their carrying values. In
attributing the impairment loss to the other assets in the CGU,
an entity should not decrease their carrying values below the
highest of FVLCS, VIU, or zero. Any remaining impairment
loss that would otherwise have been allocated to the asset
should be allocated pro rata to the other assets of the CGU
(or group of CGUs).
3.264 An entity should record a reversal of an impairment
loss on a CGU by allocating that reversal on a pro rata basis
to the assets in the CGU. An entity should not recognize a
reversal of an impairment loss for any asset in the CGU above
its recoverable amount or the carrying value that would have
been determined if no impairment loss had been recorded.
An entity should not reverse impairment losses recognized
for goodwill.
U.S. GAAP
3.265 FASB ASC 350 and 360 include guidance on impair-
ment testing and recognition for the same long-lived assets
covered by IAS 36 (that is, PPE, intangible assets, and good-
will), and that guidance applies both to individual assets and
asset groups. Unlike IFRSs, this guidance also applies to
assets held for disposal. Like IFRSs, FASB ASC 350 recog-
nizes that an entity cannot test goodwill for impairment as a
separate asset.
3.266 The FASB ASC glossary defines an asset group as
a unit of accounting for a long-lived asset or assets to be
held and used, which represents the lowest level for which
identifiable cash flows are largely independent of the cash
flows of other groups of assets and liabilities. Although an
asset group is similar to a CGU, unlike IFRSs, FASB ASC
360-10-35-25, in limited circumstances, permits an entity to
include liabilities in an asset group without the constraint
in IFRSs that an entity should only include liabilities neces-
sary for conducting the impairment test. Therefore, an asset
group may include all the assets and liabilities of the en-
tity. For example, a corporate headquarters facility may not
have identifiable cash flows that are largely independent of
the cash flows of other assets and liabilities and other asset
groups, and the entity would only test it for impairment at
the reporting entity level.
3.267 FASB ASC 350-20-35-1 requires an entity to test
goodwill for impairment at a level of reporting referred to
as a reporting unit. As defined in the FASB ASC glossary, a
reporting unit is an operating segment or one level below an
operating segment (also known as a component). However,
IFRSs do not permit a CGU to be larger than a reportable
operating segment, and an entity should allocate corporate
assets, such as a headquarters facility, to the CGUs to which
these assets relate.
3.268 In contrast, like IFRSs, FASB ASC 360-10-35-21
requires an entity to test for recoverability an individual long-
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lived asset or asset group that does not include goodwill
whenever events or changes in circumstances indicate that
its carrying amount may not be recoverable. However, IFRSs
specifically require an entity to assess at each reporting date
whether such events or circumstances exist, whereas FASB
ASC 360 does not require this assessment.
3.269 Unlike IFRSs, FASB ASC 360-10-35-17 requires an
entity to determine recoverability by comparing the carrying
amount of a long-lived asset or asset group that does not
include goodwill with the sum of the undiscounted cash flows
expected to result from the use and eventual disposition of the
asset or asset group. When the asset or asset group’s carrying
value exceeds the sum of the undiscounted cash flows, an
entity should recognize an impairment loss as the amount by
which the carrying amount exceeds its fair value.
3.270 Like IFRSs, FASB ASC 360-10-35-20 requires an
entity to recognize the impairment loss by adjusting the as-
set’s carrying amount by the loss, with the adjusted carry-
ing amount becoming the new cost basis. When the asset
is subject to depreciation or amortization, an entity should
depreciate or amortize the new cost basis over the remaining
useful life of the asset. Like IFRSs, FASB ASC 360-10-35-22
suggests that when an asset or asset group is tested for recov-
erability, an entity may also need to review its depreciation
estimates and method or the amortization period.
3.271 Unlike IFRSs, for assets other than goodwill, FASB
ASC 360-10-35-20 prohibits an entity from reversing a pre-
viously recognized impairment loss.
3.272 To test goodwill for impairment, IFRSs require an
entity to allocate goodwill to the CGUs or groups of CGUs
expected to benefit from the synergies from the business
combination. An entity should allocate the goodwill to the
lowest level at which goodwill is monitored, which should
not be larger than an operating segment. In contrast, FASB
ASC 360-10-35-26 requires an entity to include goodwill in
an asset group only if the asset group is or includes a reporting
unit and does not permit an entity to include goodwill in a
lower-level asset group that includes only part of a reporting
unit.
3.273 IFRSs require an entity to test a CGU with allo-
cated goodwill by comparing the carrying amount of the
unit, including the goodwill, with the recoverable amount
of the CGU. An entity should only record an impairment
loss when the carrying amount of the unit exceeds the recov-
erable amount. Paragraphs 4–19 of FASB ASC 350-20-35
delineate a more complicated, two-step approach to impair-
ment testing of a reporting unit that includes goodwill. First,
the goodwill impairment test compares the fair value of a
reporting unit with its carrying value, including goodwill.
When the carrying value exceeds fair value, an entity should
proceed to step two to measure the loss by comparing the
implied fair value of the goodwill with its carrying value.
An entity should determine implied fair value in the same
way goodwill is measured in a business combination by as-
signing the fair value of a reporting unit to all the assets and
liabilities of that unit (including any unrecognized intangible
assets). An entity should then recognize the impairment loss
by reducing the carrying value of goodwill.
Author’s Note
In December 2010, FASB issued ASU No. 2010-28,
Intangibles—Goodwill and Other (Topic 350): When
to Perform Step 2 of the Goodwill Test for Report-
ing Units with Zero or Negative Carrying Amounts (a
consensus of the FASB Emerging Issues Task Force).
This guidance is labeled as “Pending Content” due to
the transition and open effective date information dis-
cussed in FASB ASC 350-10-65-2. This guidance is
effective for a public entity for fiscal years, and interim
periods within those years, beginning after December
15, 2010, and December 15, 2011, for nonpublic enti-
ties. Public entities are prohibited from early adopting
this guidance; however, nonpublic entities may elect to
early adopt using the effective date for public entities.
Upon adoption, an entity should assess whether it is
more likely than not that a goodwill impairment exists
for each reporting unit with a zero or negative carrying
amount. If it is more likely than not that a goodwill
impairment exists, the entity should perform the sec-
ond step of the goodwill impairment test to measure
the amount of impairment loss, if any. In the period
of adoption, an entity should record a cumulative ef-
fect adjustment to beginning retained earnings. Given
the effective dates of this ASU, no survey entity will
have adopted these requirements in its 2010 financial
statements.
3.274 Like IFRSs, FASB ASC 360-10-35-28 requires an
entity to reduce only the carrying amounts of a long-lived
asset or assets of the group on a pro rata basis using the
relative carrying amounts of those assets, except that the loss
allocated to an individual long-lived asset of the group shall
not reduce the carrying amount of that asset below its fair
value whenever that fair value is determinable without undue
cost and effort. However, unlike IFRSs, there is no need
to allocate an impairment loss for a CGU first to goodwill
because an entity recognizes an impairment loss on goodwill
directly (as previously described).
Presentation
IFRSs
3.275 IAS 36 has no specific requirements for presenta-
tion of impairment losses. IAS 1 requires material items of
expense to be presented separately. Otherwise, impairment
losses can be included in various line items in profit or loss
on the statement of comprehensive income.
U.S. GAAP
3.276 Paragraphs 2–3 of FASB ASC 350-20-45 require an
entity to present the aggregate amount of goodwill impair-
ment losses as a separate line item in the income statement
within continuing operations, except when the goodwill im-
pairment loss is associated with a discontinued operation.
A goodwill impairment loss associated with a discontinued
operation should be included (net of tax) within the results
of discontinued operations. FASB ASC 350 and 360 allow
for other impairment losses, including impairment losses on
PPE and other intangibles, to be included in other line items
on the income statement that the entity deems appropriate.
SEC registrants should comply with the requirements of Rule
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5-03 of Regulation S-X, which also does not include separate
presentation of other impairment losses.
Disclosure
IFRSs
3.277 For each class of assets, an entity should disclose
the amount of impairment losses recognized in profit or loss
and the amount of reversals of impairment losses. An entity
should also disclose the line item on the statement of com-
prehensive income in which the loss or reversal is presented.
For revalued assets, an entity should disclose the amounts
recorded in other comprehensive income either as an im-
pairment loss or a reversal. An entity usually discloses these
amounts in the reconciliation disclosure for the asset class to
which the asset(s) belongs.
3.278 An entity should also disclose impairment losses and
reversals in its operating segment disclosures in accordance
with IFRS 8.
3.279 For each material impairment loss or reversal recog-
nized during the period, an entity should discuss the facts
and circumstances that led to the loss or reversal, includ-
ing whether the recoverable amount was determined to be
FVLCS or VIU, and disclose the amount of the reversal.
When the recoverable amount is FVLCS or VIU, an entity
should disclose the basis it used to determine FVLCS or the
discount rates used in the current and previous estimate of
VIU, respectively.
3.280 If the loss or reversal is related to an individual asset,
an entity should disclose the nature of the asset and, if ap-
propriate, the reportable segment to which the asset belongs.
If the loss or reversal is related to a CGU, an entity should
disclose a description of the CGU, the amount, and a descrip-
tion of any changes to the composition of the CGU since the
entity’s previous estimate of the recoverable amount.
3.281 For the aggregate impairment losses or reversals rec-
ognized during the period, excluding individually material
losses or reversals, an entity should disclose the main asset
classes affected by losses and reversals, respectively, and the
main events or circumstances that led to their recognition.
3.282 For each CGU or group of CGUs with significant
allocations of goodwill or indefinite-life intangible assets in
comparison with the total amount of an entity’s goodwill and
indefinite-life intangible assets, an entity should disclose the
following:
• Carrying amount of allocated goodwill
• Carrying amount of allocated indefinite-life intangible
assets
• Basis for the recoverable amount
3.283 If the basis for the recoverable amount is VIU, the dis-
closures should include descriptions of key assumptions in
the entity’s cash flow projections, identifying those to which
the recoverable amount is most sensitive. If the basis for
the recoverable amount is FVLCS, the disclosures should
include descriptions of key assumptions in the entity’s esti-
mate of FVLCS, identifying those to which the recoverable
amount is most sensitive. In both cases, an entity should
disclose management’s approach to determining the values
assigned to these assumptions (for example, past experience
and external sources), the period over which management
has projected cash flows based on the financial budgets or
forecasts, the growth rate used for extrapolating beyond the
forecast, and the discount rate used to calculate present value.
If FVLCS is determined based on discounted cash flows, an
entity should disclose the period over which cash flow pro-
jections were made, the growth rate used to extrapolate the
cash flows, and discount rate used to calculate present value.
Additional disclosure is required so that users of the finan-
cial statements understand the effects of reasonably possible
changes in these key assumptions.
3.284 Similar disclosures are required, in the aggregate, for
allocated goodwill or intangible assets with indefinite useful
lives when the amount allocated to a CGU or group of CGUs
is not significant in comparison with the entity’s total carrying
amount of goodwill or intangible assets with indefinite useful
lives.
U.S. GAAP
3.285 U.S. GAAP disclosures are less extensive than those
required by IFRSs. FASB ASC 360-10-50-2 requires an en-
tity to disclose all of the following information in the period
when an impairment loss is recognized for PPE classified as
held and used:
• Description of the impaired long-lived asset or asset
group and the facts and circumstances leading to the
impairment
• Amount of the impairment loss and the income state-
ment line item that includes the loss, if not separately
presented on the face of the statement
• Method or methods for determining fair value (for ex-
ample, whether based on a quoted market price, prices
for similar assets, or another valuation technique)
• Segment in which the impaired long-lived asset (asset
group) is reported, if applicable
3.286 Similarly, for each impairment loss recognized related
to an intangible asset, FASB ASC 350-30-50-3 requires an
entity to disclose the following in the notes to financial state-
ments that include the period in which the impairment loss
is recognized:
• Description of the impaired intangible asset and the
facts and circumstances leading to the impairment
• Amount of the impairment loss and the method for
determining fair value
• Caption in the income statement or the statement of
activities in which the impairment loss is aggregated
• Segment in which the impaired intangible asset is re-
ported, if applicable
3.287 FASB ASC 350-20-50-1 requires an entity to disclose
a reconciliation of goodwill showing a separate line item for
impairment losses. FASB ASC 350-20-50-2 requires that for
each goodwill impairment loss recognized during the period,
an entity should also disclose all of the following:
• Description of the facts and circumstances leading to
the impairment.
• Amount of the impairment loss and the method used
to determine the fair value of the associated reporting
unit (for example, whether the fair value was based on
quoted market prices, prices of comparable businesses
or nonprofit activities, a present value or other valuation
technique, or a combination of methods).
• If the recognized impairment loss was an initial esti-
mate, an entity should disclose the fact and reasons that
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the amount is not final and, in subsequent periods, the
nature and amount of any significant adjustments made
to the initial estimate of the impairment loss.
Presentation and Disclosure Excerpts
Impairment—Losses on Property, Plant, and
Equipment, Goodwill and Other Intangible
Assets
3.288
Alesco Corporation Limited (May 2010)
INCOME STATEMENTS












Sale of goods 747,858 828,526 — —
Rendering services 23,300 25,970 12,335 10,569
Other revenue 2,038 1,613 25,407 177
Total revenue 773,196 856,109 37,742 10,746
Cost of sales (503,033) (553,750) — —
Gross profit 270,163 302,359 37,742 10,746
Other income 3 244 459 — —
Selling expenses (92,492) (97,593) — —
Marketing expenses (11,427) (12,739) — —
Customer service
expenses (20,324) (22,157) — —
Purchasing and inventory
management (2,005) (2,256) — —
Distribution expenses (48,113) (49,053) — —
Administration and
general expenses (60,086) (65,703) (16,895) (15,480)
Restructuring and other
expenses 6 — (28,327) — (3,720)
Impairment of assets 6 (133,100) (70,000) (133,100) (70,000)
Termination payment 6 (1,700) — (1,700) —
Share loan plan expense 6 (5,120) — (5,120) —
Results from operating
activities (103,960) (45,010) (119,073) (78,454)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1: Statement of Significant Accounting Policies
(in part)
(h) Property, Plant and Equipment (in part)
Recognition and Measurement
Items of property, plant and equipment are measured at cost
or deemed cost less accumulated depreciation and impair-
ment losses. The cost of property, plant and equipment at 1
July 2004, the date of transition to AASBs, was determined
by reference to its fair value at that date.
(i) Intangible Assets
Goodwill
Goodwill arises on the acquisition of subsidiaries and joint
ventures.
Acquisitions Prior to 1 June 2004
As part of its transition to AASBs, the Group elected to restate
only those business combinations that occurred on or after
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1 June 2004. In respect of acquisitions prior to 1 June 2004,
goodwill represents the amount recognised under the Group’s
previous accounting framework, Australian GAAP.
Acquisitions on or After 1 June 2004
For acquisitions on or after 1 June 2004, goodwill represents
the excess of the cost of the acquisition over the Group’s
interest in the net fair value of the identifiable assets, liabilities
and contingent liabilities of the acquiree.
Subsequent Measurement
Goodwill is measured at cost less accumulated impairment
losses. In respect of equity accounted investees, the carrying
amount of goodwill is included in the carrying amount of the
investment.
Brand Names
Brand names represent the value of brands owned by con-
trolled entities determined at acquisition that maintain a strong
presence in the marketplace.
Patents and Trademarks
Patents and trademarks represent the value of patents, trade-
marks and registered designs owned by controlled entities
determined at acquisition which provide the entity with a mar-
ket advantage.
Agency Agreements
Agency agreements represent the value of agreements held
by controlled entities with various agents which provide the
entity with a market advantage due to the presence of these
agents in the respective industry.
Lease Premium
Lease premium represents the value of leases assigned by
the vendor to a controlled entity in the acquisition of the busi-
ness of Robinson Industries Limited on 30 April 2003.
Development Costs
Information technology development includes systems re-
engineering costs comprising development expenditure and
associated implementation costs.
Expenditure on research activities, undertaken with the
prospect of gaining new technical knowledge and under-
standing, is recognised in the income statement as an ex-
pense as incurred.
Expenditure on development activities, whereby research
findings are applied to a plan or design for the production
of new or substantially improved products and processes, is
capitalised if the product or process is technically and com-
mercially feasible, future economic benefits are probable, and
the Group has sufficient resources to complete development.
The expenditure capitalised includes the cost of materials,
direct labour and an appropriate proportion of overheads.
Other development expenditure is recognised in the income
statement as an expense as incurred. Capitalised develop-
ment expenditure is stated at cost less accumulated amorti-
sation and impairment losses.
Customer Relationships
Customer relationship intangible assets were acquired by the
Group, have finite useful lives, are measured at cost less ac-
cumulated amortisation and accumulated impairment losses.
Other Intangible Assets
Other intangible assets that are acquired by the Group are
stated at cost less accumulated amortisation and impairment
losses.
Subsequent Expenditure
Subsequent expenditure on capitalised intangible assets is
capitalised only when it increases the future economic bene-
fits embodied in the specific asset to which it relates. All other
expenditure is recognised in profit or loss when incurred.
Amortisation
Amortisation is calculated over the cost of the asset, or other
amounts substituted for cost, less its residual value.
Amortisation is recognised in profit or loss on a straight-
line basis from the date they are available for use over the
estimated useful lives of intangible assets, unless such lives
are indefinite.
Amortisation methods, useful lives and residual values are
reviewed at each financial year end and adjusted if appropri-
ate.
The estimated useful lives for the current and comparative





Technologies, Lincoln Sentry Indefinite
Brands—others 5 to 20 years
Patents and trademarks 5 to 15 years
Lease premium 6 years
Development costs 3 to 7 years
Customer relationships 3 to 10 years
(I) Impairment
Financial Assets
A financial asset is assessed at each reporting date to de-
termine whether there is any objective evidence that it is
impaired. A financial asset is considered to be impaired if
objective evidence indicates that one or more events have
had a negative effect on the estimated future cash flows of
that asset that can be measured reliably.
Non-Financial Assets
The carrying amounts of the Group’s non-financial assets,
other than inventories and deferred tax assets are reviewed
at each reporting date to determine whether there is any in-
dication of impairment. If any such indication exists, then the
asset’s recoverable amount is estimated. For goodwill, as-
sets that have an indefinite useful life and intangible assets
that are not yet available-for-use, the recoverable amount is
estimated at each reporting date.
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An impairment loss is recognised if the carrying amount of
an asset or its cash-generating unit exceeds its recoverable
amount. A cash-generating unit is the smallest identifiable
asset group that generates cash flows that are largely inde-
pendent from other assets and groups. Impairment losses are
recognised in profit or loss. Impairment losses recognised in
respect of cash-generating units are allocated first to reduce
the carrying amount of any goodwill allocated to units and
then to reduce the carrying amount of the other assets in the
unit (group of units) on a pro-rata basis.
The recoverable amount of an asset or cash-generating
unit is the greater of its value in use and its fair value less
costs to sell. In assessing value-in-use, the estimated future
cash flows are discounted to their present value using a pre-
tax discount rate that reflects current market assessments of
the time value of money and the risks specific to the asset.
An impairment loss in respect of goodwill is not reversed.
In respect of other assets, impairment losses recognised in
prior periods are assessed at each reporting date for any in-
dications that the loss has decreased or no longer exists. An
impairment loss is reversed only to the extent that the asset’s
carrying amount does not exceed the carrying amount that
would have been determined, net of depreciation or amorti-
sation, if no impairment loss had been recognised.











Impairment loss on goodwill (116,341) (59,980) — —
Impairment loss on brand names — (10,020) — —
Impairment loss on capitalised software development costs (1,688) — — —
Impairment loss on customer relationships (12,705) — — —
Impairment loss on property, plant and equipment (2,366) — — —
Impairment loss on loans to controlled entities — — (133,100) (70,000)
Impairment of assets (1,33,100) (70,000) (133,100) (70,000)
Related income tax benefit 1,216 — — —
(131,884) (70,000) (133,100) (70,000)












At cost 20,302 20,286 — —
Accumulated depreciation (3,776) (3,386) — —
16,526 16,900 — —
Leasehold improvements:
At cost 8,528 8,433 239 239
Accumulated amortisation and impairment losses (5,085) (4,047) (143) (106)
3,443 4,386 96 133
Motor vehicles:
At cost 13,339 13,935 — —
Accumulated depreciation and impairment losses (11,456) (10,572) — —
1,883 3,363 — —
Plant and equipment:
At cost 99,802 105,443 3,541 3,336
Accumulated depreciation and impairment losses (67,845) (67,285) (2,606) (2,270)
31,957 38,158 935 1,066
Leased plant and equipment:
At cost 28 336 — —
Accumulated amortisation (20) (235) — —
8 101 — —
Capital works in progress at cost 1,341 4,613 150 984
Total property, plant and equipment net book value 55,158 67,521 1,181 2,183
IFRS ATT 3.288
411
Reconciliations-Accumulated Depreciation and Impairment
Losses
Reconciliations of the movement in accumulated depreciation













Accumulated depreciation at beginning of year (3,386) (3,025) — —
Depreciation expense 4 (390) (391) — —
Disposals — 30 — —
Accumulated depreciation at end of year (3,776) (3,386) — —
Leasehold Improvements
Accumulated depreciation at beginning of year (4,047) (4,010) (106) (95)
Disposals 314 152 — 31
Disposals of companies/businesses — 913 — —
Depreciation 4 (1,014) (1,105) (37) (42)
Impairment write-down 6 (336) — — —
Transfers to/(from) capital work in progress and other asset categories 9 (48) — —
Translation differences (11) 51 — —
Accumulated depreciation and impairment losses at end of year (5,085) (4,047) (143) (106)
Motor Vehicles
Accumulated depreciation at beginning of year (10,572) (10,601) — —
Disposals 910 1,503 — —
Disposals of companies/businesses — 277 — —
Depreciation 4 (1,241) (1,514) — —
Impairment write down 6 (624) — — —
Transfers to/(from) capital work in progress and other asset categories 84 (258) — —
Translation differences (13) 21 — —
Accumulated depreciation and impairment losses at end of year (11,456) (10,572) — —
Plant and Equipment
Accumulated depreciation at beginning of year (67,285) (85,913) (2,270) (2,186)
Disposals 4,450 17,385 — 11
Disposals of companies/businesses — 11,175 — —
Depreciation 4 (7,766) (12,734) (338) (526)
Impairment write down 6 (1,406) — — —
Transfers to capital work in progress and other asset categories 3,712 2,464 2 365
Intragroup transfers — — — 66
Translation differences 450 338 — —
Accumulated depreciation and impairment losses at end of year (67,845) (67,285) (2,606) (2,270)
Leased Plant and Equipment
Accumulated amortisation at beginning of year (235) (2,931) — —
Disposals 76 6 — —
Disposals of companies/businesses — 2,527 — —
Amortisation 4 (1) — — —
Transfers to capital work in progress and other asset categories 140 145 — —
Translation differences — 18 — —
Accumulated amortisation at end of year (20) (235) — —
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At cost 419,416 419,033 — —
Accumulated impairment losses (176,321) (59,980) — —
243,095 359,053 — —
Brand names:
At cost 117,669 117,607 — —
Accumulated amortisation and impairment losses (26,120) (25,140) — —
91,549 92,467 — —
Patents and trademarks:
At cost 6,719 6,717 — —
Accumulated amortisation (2,562) (2,099) — —
4,157 4,618 — —
Agency agreements:
At cost — — — —
Customer relationships: — —
At cost 43,337 43,337 — —
Accumulated amortisation and impairment losses (26,117) (9,013) — —
17,220 34,324 — —
Development costs:
At cost 34,917 28,364 1,681 1,414
Accumulated amortisation and impairment losses (19,589) (12,790) (1,280) (1,043)
15,328 15,574 401 371
Lease premium:
At cost 4,827 4,774 — —
Accumulated amortisation (4,827) (4,774) — —
— — — —
Other intangibles:
At cost 190 130 — —
Accumulated amortisation (126) (72) — —
64 58 — —
371,413 506,094 401 371
Reconciliations—Accumulated Amortisation and Impairment
Losses
Reconciliations of the movement in accumulated amortisation













Accumulated impairment at beginning of year (59,980) — — —
Impairment write down 6 (116,341) (59,980) — —
Accumulated impairment losses at end of year (176,321) (59,980) — —
Brand Names
Accumulated amortisation at beginning of year (25,140) (11,952) — —
Amortisation 4 (965) (3,188) — —
Impairment write down 6 — (10,020) — —
Transfers to other asset categories — (17) — —
Translation differences (15) 37 — —















Accumulated amortisation at beginning of year (2,099) (1,640) — —
Amortisation 4 (462) (460) — —
Translation differences (1) 1 — —
Accumulated amortisation at end of year (2,562) (2,099) — —
Customer Relationships
Accumulated amortisation at beginning of year (9,013) (2,789) — —
Disposal of companies/businesses — 391 — —
Amortisation 4 (4,399) (6,847) — —
Impairment write down 6 (12,705) — — —
Transfers to/(from) other asset categories — 232 — —
Accumulated amortisation and impairment losses at end of year (26,117) (9,013) — —
Development Costs
Accumulated amortisation at beginning of year (12,790) (6,299) (1,043) (621)
Disposals — 66 — —
Amortisation 4 (4,960) (3,521) (235) (56)
Impairment writedown(1) 6 (1,750) — — —
Transfers to/(from) other asset categories (65) (3,074) (2) (366)
Translation differences (24) 38 — —
Accumulated amortisation and impairment losses at end of year (19,589) (12,790) (1,280) (1,043)
(1) This balance includes a $62,000 impairment charge against assets in the ordinary course of business which is not classifed as a significant
item as at 31 May 2010.
Impairment Tests for Cash-Generating Units Containing
Intangibles with Indefinite Useful Lives
At 31 May 2010, the carrying amounts of intangible assets
with indefinite useful lives and all other intangibles with finite
useful lives are allocated to cash-generating units (“CGUs”)
as follows:













Construction 51,220 9,500 60,720 3,345 64,065
Functional & Decorative Products 71,823 16,175 87,998 7,113 95,111
Garage Door & Openers 120,052 53,500 173,552 26,859 200,411
Water Products & Services — — — 11,425 11,425
243,095 79,175 322,270 48,742 371,012
Multiple units without significant goodwill — — — 401 401
243,095 79,175 322,270 49,143 371,413
2009
Construction 51,170 9,500 60,670 3,959 64,629
Functional & Decorative Products 71,721 16,175 87,896 8,678 96,574
Garage Door & Openers 119,882 53,500 173,382 28,828 202,210
Water Products & Services 116,337 — 116,337 25,974 142,311
359,110 79,175 438,285 67,439 505,724
Multiple units without significant goodwill — — — 370 370
359,110 79,175 438,285 67,809 506,094
Certain brand names have been determined as maintaining
an indefinite useful life as they operate in markets where they
are positioned as premium brands, command high margins
and hold a strong market presence. Brands include B&D,
Concrete Technologies, Flextool and other brands within
Functional & Decorative Products.
Finite useful life intangible assets primarily include certain
other patents, trademarks, customer relationships and devel-
opment costs.
IFRS ATT 3.288
Section 3: Statement of Comprehensive Income and Related Disclosures
414 IFRS Accounting Trends & Techniques
For Functional & Decorative Products, Water Products &
Services and Garage Doors & Openers, the divisional level is
viewed as the appropriate level of CGU to assess impairment
as the Australian and New Zealand business units are viewed
and managed as one operation. For Construction & Mining,
the assessment is performed at a lower level where the Con-
struction and Mining businesses are analysed separately.
In the financial years ended 31 May 2009 and 31 May
2010, the recoverable amounts of all the Group’s CGUs were
determined based upon a value-in-use basis.
Key Assumptions Used for Value-in-Use Calculations
Value-in-Use
The cash-generating unit impairment tests are based on
value-in-use calculations, whereby the net present value of
the future cash flows of each CGU is compared against the
carrying amount of net operating assets of that CGU. The
value-in-use methodology used is consistent with the prior
year. Cash flow projections are based on the latest financial
forecasts for 2011 and the latest management estimates of
financial forecasts for the 2012–2014 financial years. A termi-
nal value growth rate is then used for subsequent years (see
table below) as the appropriate period to value these CGUs
is assessed as an indefinite life since the primary assets held
by these CGUs are indefinite life intangible assets. Manage-
ment has based the assumptions in the models on current
market conditions, past performance and future expectations
and forecast growth rates found in industry reports.
Growth Rates
Growth rates used were generally determined by factors such
as industry sector, the market to which the CGU is dedicated,
the size of the business, geographic location, past perfor-















Construction 5.7 6.4 5.7
Functional & Decorative Products 8.3 5.8 5.8
Garage Doors & Openers 7.6 8.4 4.8
Water Products & Services 2.0 2.0 2.0
The growth rates used to extrapolate cash flows beyond the
2014 financial year were 3.0% and do not exceed the long-
















Construction 3.0 3.0 3.0
Functional & Decorative Products 5.0 5.0 5.0
Garage Doors & Openers 8.5 10.2 5.5
Water Products & Services 6.8 8.5 5.6
The growth rates used to extrapolate cash flows beyond
the 2013 financial year were 3.0% and do not exceed the
long-term average growth rates for the markets to which the
assets are dedicated.
Discount Rate
A pre-tax discount rate determined by reference to the
Group’s weighted average cost of capital has been used in











Functional & Decorative Products 14.8 14.7
Garage Doors & Openers 14.5 14.6
Water Products & Services 14.7 15.9
Impairment
During the year ended 31 May 2010, an impairment charge of
$133.1 million was incurred in relation to the Water Products
& Services division. The impairment was caused by the dete-
rioration in the CGU’s actual performance for the year to 31
May 2010 and decline in future year forecasts. An impairment
charge of $116.3 million was taken against goodwill. A further
impairment charge of $16.8 million was taken against other
assets of the CGU on a prorata basis. Impairment charges
were made against customer relationships ($12.7 million),
fixed assets ($2.4 million) and software development ($1.7
million).
During the year ended 31 May 2009, an impairment charge
of $70.0 million was incurred in relation to the Water Prod-
ucts & Services division. The impairment was caused by the
deterioration in the CGU’s actual performance for the year
to 31 May 2009 and decline in future year forecasts. The
impairment testing as at May 2009 used a higher pre-tax dis-
count rate of 15.9% reflecting the increased pricing of risk. An
impairment charge of $10.0 million was taken against brands
subsequent to a reassessment of the useful lives of the CGU’s
brands. A further $60.0 million impairment charge was made
against goodwill.
The Group determined that there is no impairment of any
of its other cash-generating units containing goodwill or in-
tangible assets with indefinite useful lives.
Impact of Possible Change in Assumptions
With regard to the assessment of the value-in-use of the
CGUs, a sensitivity analysis (refer to table below) has been
conducted on the effect of a change in the respective key
assumptions on the carrying value of each CGU.
For the Construction, Functional & Decorative and Garage
Doors & Openers CGUs, the excess of the recoverable
amount over the carrying amount of net operating assets
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(“headroom”) was significant. The aggregate amount of that
excess is $180.5 million.
Consolidated
















+ / − 0.5%
$M
Impact of




Construction 30.8 14.5 5.7 3.0 3.7 11.1
Functional & Decorative Products 88.2 14.8 10.8 3.0 8.3 23.9
Garage Doors & Openers 61.5 14.5 13.2 3.0 10.2 31.9
Water Products & Services Nil 14.7 1.1 3.0 0.8 2.7
Consolidated
















+ / − 0.5%
$M
Impact of




Construction 32.4 14.8 5.1 3.0 3.5 13.5
Functional & Decorative Products 136.2 14.7 11.5 3.0 7.9 29.0
Garage Doors & Openers 23.6 14.4 11.8 3.0 9.0 28.5
Water Products & Services Nil 15.9 5.7 3.0 4.2 17.2
All sensitivities shown in the above table are on a pre-tax basis.
(1) Sensitivity has been applied to net present value of the cash flows over the forecast period including the terminal year.
For the Water Products & Services CGU, subsequent to the
impairment charge discussed above, there is no excess of the
recoverable amount over the carrying amount of net operating
assets.
Impairment—Reversals of Losses on
Property, Plant and Equipment Held
at Revalued Amount
Author’s Note
IAS 36 applies to assets carried at revalued amount
(i.e., fair value). When an entity uses market value
to determine fair value, the only difference between
fair and FVLCS fair is any direct incremental costs to
dispose of the asset. When such costs to dispose of the
asset are not negligible, then FVLCS fair is necessarily
less than revalued amount. After the entity revalues the
assets, an entity applies IAS 36 to determine whether
the asset is impaired. When an entity uses a basis other
than market value to determine fair value, then revalued
amount may be higher or lower than its recoverable
amount and the entity applies IAS 36 to determine
whether the asset is impaired.
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Silver Fern Farms Limited (Sep 2010)
STATEMENT OF COMPREHENSIVE INCOME
For the 13 months ended 30 September 2010
Parent Consolidated










Sale of goods 1,780,190 1,962,057 1,831,682 2,001,614
Other revenue 5 2,052 850 1,512 320
Revenue 1,782,242 1,962,907 1,833,194 2,001,934
Other income 6 49,623 10,258 45,536 12,656
Total income 1,831,865 1,973,165 1,878,730 2,014,590
Raw materials and consumables used 1,275,184 1,352,884 1,304,687 1,365,931
Employee benefits expense 7 271,544 274,863 274,971 283,104
Depreciation and amortisation 25,320 24,197 25,469 24,679
Finance costs 7 22,322 32,703 22,845 32,776
Other operational expenses 7 252,632 291,707 260,574 304,091
Share of profits of associate 29 — — (1,397) (1,105)
Profit/(loss) from continuing operations before member
distributions, income tax and non-recurring items (15,137) (31,89) (8,419) 5,114
Member distributions 10 98 153 98 153
Profit/(loss) before income tax and non-recurring items (15,235) (3,342) (8,517) 4,961
Non-recurring items—income 8 11,341 48,476 11,378 48,476
Non-recurring items—costs 8 (15,028) (9,851) (18,276) (10,078)
Total non-recurring items (3,687) 38,625 (6,898) 38,398
Profit/(loss) before income tax (18,922) 35,283 (15,415) 43,359
Income tax expense/(benefit) 9 (1,966) 66 (1,396) (238)
Net profit/(loss) for the period (16,956) 35,217 (14,019) 43,597
Profit/(loss) attributable to shareholders of the parent (16,956) 35,217 (14,019) 43,597
Other comprehensive income
Foreign currency translation gain/(loss) — — (4,454) (3,501)
Revaluation gain on land and buildings 62,184 — 64,361 —
Income tax on items of other comprehensive
income—(charged)/credited 9 (11,119) 267 (11,729) 267
Other comprehensive income for the period, net of tax 51,065 267 48,178 (3,234)
Total comprehensive income for the period attributable to
shareholders of the parent 34,109 35,484 34,159 40,363
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
l. Non-Current Assets Held for Sale
Non-current assets and disposal groups are classified as held
for sale and measured at the lower of their carrying amount
and fair value less costs to sell if their carrying amount will
be recovered principally through a sale transaction. They are
not depreciated or amortised. For an asset or disposal group
to be classified as held for sale, it must be available for imme-
diate sale in its present condition and its sale must be highly
probable.
An impairment loss is recognised for any initial or subse-
quent write-down of the asset (or disposal group) to fair value
less costs to sell. A gain is recognised for any subsequent in-
creases in fair value less costs to sell of an asset (or disposal
group), but not in excess of any cumulative impairment loss
previously recognised. A gain or loss not previously recog-
nised by the date of the sale of the non-current asset (or
disposal group) is recognised at the date of derecognition.
o. Property, Plant and Equipment
Plant and equipment is stated at historical cost less accumu-
lated depreciation and any accumulated impairment losses.
Such cost includes the cost of replacing parts that are eli-
gible for capitalisation when the cost of replacing the parts
is incurred. Similarly, when each major inspection is per-
formed, its cost is recognised in the carrying amount of the
plant and equipment as a replacement only if it is eligible for
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capitalisation. All other repairs and maintenance are recog-
nised in profit or loss as incurred.
Operational land and buildings are measured at fair value,
based on periodic but at least five yearly valuations by ex-
ternal independent valuers who apply the International Val-
uations Standards Committee International Valuation Stan-
dards, less accumulated depreciation on buildings and less
any impairment losses recognised after the date of the reval-
uation.
Depreciation is calculated on a straight-line basis over the
estimated useful life of the specific assets as follows:
• Land Improvements—5 to 50 years
• Buildings—5 to 50 years
• Plant and equipment—4 to 20 years
• Motor Vehicles—5 to 8 years
Certain assets are depreciated on a diminishing value basis.
Revaluations
Following initial recognition at cost, operational land and
buildings are carried at a revalued amount which is the fair
value at the date of the revaluation less any subsequent accu-
mulated depreciation on buildings and accumulated impair-
ment losses.
Revaluations are performed on a periodic but at least five
yearly cycle. Therefore land and buildings purchased inside
the revaluation cycle are recognised at cost until they are
subsequently revalued.
Any revaluation increment is credited to the asset revalua-
tion reserve included in other comprehensive income, except
to the extent that it reverses a revaluation decrement for the
same asset previously recognised in profit or loss, in which
case the increment is recognised in profit or loss.
Any revaluation decrement is recognised in profit or loss,
except to the extent that it offsets a previous revaluation in-
crement for the same asset, in which case the decrement is
debited directly to the asset revaluation reserve to the extent
of the credit balance existing in the revaluation reserve for
that asset.
Any accumulated depreciation as at the revaluation date is
eliminated against the gross carrying amounts of the assets
and the net amounts are restated to the revalued amounts of
the assets.
Gains and losses on disposals are determined by compar-
ing proceeds with the carrying amount. These are included in
the statement of comprehensive income.
Upon disposal or derecognition, any revaluation reserve
relating to the particular asset being sold is transferred to
retained earnings.
Fair value is determined by reference to market-based ev-
idence, which is the amount for which the assets could be
exchanged between a knowledgeable willing buyer and a
knowledgeable willing seller in an arm’s length transaction as
at the valuation date.
Disposals
An item of property, plant and equipment is derecognised
upon disposal or when no future economic benefits are ex-
pected to arise from the continued use of the asset.
Any gain or loss arising on de-recognition of the asset (cal-
culated as the difference between the net disposal proceeds
and the carrying amount of the item) is included in profit or
loss in the year the item is derecognised.
q. Impairment
At each balance sheet date, the group reviews the carrying
amounts of its assets to determine whether there is any in-
dication that those assets have suffered an impairment loss.
If any such indication exists, the recoverable amount of the
asset is estimated in order to determine the extent of the
impairment loss (if any).
For an asset that does not generate largely independent
cash inflows, the recoverable amount is determined for the
cash-generating unit to which the asset belongs.
The recoverable amount is the greater of fair value less
costs to sell and value in use. In assessing value in use, the
estimated future cash flows are discounted to their present
value using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific
to the asset.
If the recoverable amount of an asset (cash-generating
unit) is estimated to be less than its carrying amount, the car-
rying amount of the asset (cash-generating unit) is reduced
to its recoverable amount. An impairment loss is recognised
as an expense immediately.
3. Significant Accounting Judgements, Estimates
and Assumptions (in part)
In applying the Group’s accounting policies, management
continually evaluates judgements, estimates and assump-
tions based on experience and other factors, including ex-
pectations of future events that may have an impact on the
Group. All judgements, estimates and assumptions made are
believed to be reasonable based on the most current set
of circumstances available to management. Actual results
may differ from the judgements, estimates and assumptions.
Significant judgements, estimates and assumptions made by
management in the preparation of these financial statements
are outlined below:
Land and Buildings Revaluation
Operational land and buildings are periodically revalued to fair
value by an independent valuer. As there is no active market
for the buildings held by the Group, Depreciated Replacement
Cost (DRC) is used to establish a fair value; this fair value is
then optimised via economic adjustments. Certain economic
adjustments are applied to a building’s DRC to allow for any
idle capacity included in the operation of the building. If any
economic adjustments are required, these are completed by
the independent valuer and included in the final valuation.
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8. Non-Recurring Items
Parent Consolidated









Gains on disposal 97 4,976 97 4,976
Settlement received from PGG Wrightson Ltd — 42,000 — 42,000
Reversal of previous impairment on land and buildings 10,991 — 10,991 —
Other income 253 1,500 290 1,500
Total income 11,341 48,476 11,378 48,476
Restructuring costs 3,304 767 3,518 767
Plant closure costs 7,411 — 10,445 527
Impairment of investments — 4,800 — 4,800
Loss on disposal — 3,984 — 3,984
Assets written down in value 4,313 300 4,313 —
Total expenses 15,028 9,851 18,276 10,078
Total non-recurring items income/(expense) (3,687) 38,625 (6,898) 38,398
Settlement of PGG Wrightson Limited Liability
On 24 April 2009 Silver Fern Farms and PGG Wrightson
Limited (PGW) agreed terms of a full and final settlement
following PGW’s default on the equity transaction agreed in
2008. PGW paid the Company $30m in cash and issued the
Company ten million ordinary shares in PGW (fully paid and
ranking equally with all other PGW shares on issue).
At 31 August 2009, the ten million ordinary shares in PGW
were recorded at market value. An impairment of $4,800,000
was recognised within impairment of investments, reflecting
the fall in value of the shares from $1.20 per share issue price
to $0.72 per share market value.
17. Property, Plant and Equipment
a. Reconciliation of the Carrying Amounts at the Beginning
and End of the Period
Parent





13 months ended 30 Sept 2010
At 1 September 2009, net of accumulated depreciation 41,514 124,326 102,294 592 6,853 275,579
Additions 3,459 4,578 12,188 132 2,026 22,383
Disposals (1,165) (5,177) (10,824) (442) (276) (17,884)
Revaluations 18,441 49,610 — — — 68,051
Impairment of assets — — (102) — — (102)
Transfers (to)/from assets held for sale (1,076) (447) (22) — — (1,545)
Depreciation charge for the year (95) (5,954) (16,929) (136) (196) (23,310)
Depreciation on disposals 90 1,668 8,415 438 — 10,611
At 30 Sept 2010, net of accumulated depreciation 61,168 168,604 95,020 584 8,407 333,783
Cost or fair value 61,168 169,101 366,422 6,751 8,603 612,045
Accumulated depreciation and impairment — (497) (271,402) (6,167) (196) (278,262)
Net carrying value 61,168 168,604 95,020 584 8,407 333,783
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b. Reconciliation of the Carrying Amounts at the Beginning
and End of the Period
Consolidated





13 months ended 30 Sept 2010
At 1 September 2009, net of accumulated depreciation 43,434 123,352 103,460 664 6,853 277,763
Additions 3,539 4,530 12,189 134 2,026 22,418
Disposals (1,165) (5,255) (15,947) (511) (276) (23,154)
Revaluations 18,458 51,770 — — — 70,228
Impairment of assets — — (102) — — (102)
Reclassification of assets (1,499) 2,032 (537) 2 — (2)
Transfers (to)/from assets held for sale (1,076) (447) (22) — — (1,545)
Depreciation charge for the year (95) (6,015) (17,169) (160) (196) (23,635)
Depreciation on disposals 90 1,685 13,430 489 — 15,694
Exchange adjustment — (25) (24) (8) — (57)
At 30 Sept 2010, net of accumulated depreciation 61,686 171,627 95,278 610 8,407 337,608
Cost or fair value 61,686 172,124 367,437 6,834 8,603 616,684
Accumulated depreciation and impairment — (497) (272,159) (6,224) (196) (279,076)
Net carrying value 61,686 171,627 95,278 610 8,407 337,608
c. Reconciliation of the Carrying Amounts at the Beginning
and End of the Period
Parent





12 months ended 31 Aug 2009
At 1 September 2008, net of accumulated depreciation 39,461 119,807 97,157 707 12,563 269,695
Additions 1,083 10,408 24,032 189 — 35,712
Disposals (38) (531) (12,845) (1,328) — (14,742)
Assets capitalised during the year — — — — (5,622) (5,622)
Transfers (to)/from assets held for sale 1,072 — — — — 1,072
Depreciation charge for the year (74) (5,538) (17,108) (272) (88) (23,080)
Depreciation on disposals 10 180 11,058 1,296 — 12,544
At 31 Aug 2009, net of accumulated depreciation 41,514 124,326 102,294 592 6,853 275,579
Cost or fair value 51,680 225,464 365,079 7,061 6,853 656,137
Accumulated depreciation and impairment (10,166) (101,138) (262,785) (6,469) — (380,558)
Net carrying value 41,514 124,326 102,294 592 6,853 275,579
d. Reconciliation of the Carrying Amounts at the Beginning
and End of the Period
Consolidated





12 months ended 31 Aug 2009
At 1 September 2008, net of accumulated depreciation 39,124 120,693 99,061 943 12,563 272,384
Additions 3,340 8,606 23,654 251 — 35,851
Disposals (38) (639) (13,624) (1,774) — (16,075)
Transfers (to)/from assets held for sale — — — — (5,622) (5,622)
Impairment 1,072 — — — — 1,072
Depreciation charge for the year (74) (5,599) (17,391) (329) (88) (23,481)
Depreciation on disposals 10 311 11,807 1,588 — 13,716
Exchange adjustment — (20) (47) (15) — (82)
At 31 Aug 2009, net of accumulated depreciation 43,434 123,352 103,460 664 6,853 277,763
Cost or fair value 53,831 224,240 372,532 7,226 6,853 664,682
Accumulated depreciation and impairment (10,397) (100,888) (269,072) (6,562) — (386,919)
Net carrying value 43,434 123,352 103,460 664 6,853 277,763
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e. Revaluation of Operational Land and Buildings
The Group engages Darroch Limited, an accredited indepen-
dent valuer that uses the International Valuation Standards
Committee, International Valuation Standards as a reference,
to determine the fair value of its operational land and build-
ings.
Fair value is the amount for which the assets could be
exchanged between a knowledgeable willing buyer and a
knowledgeable willing seller in an arm’s length transaction as
at the valuation date. Fair value is determined by direct refer-
ence to recent market transactions on arm’s length terms for
land and buildings comparable in size and location to those
held by the Group, and to market based yields for compa-
rable properties. Where there is limited information available
relating to specialised assets that are rarely, if ever, sold on
the open market, the Depreciated Replacement Cost (DRC)
method is normally applied. DRC is based on an estimate
of current gross replacement (or reproduction) cost less al-
lowances for physical deterioration and all relevant forms of
obsolescence.
The effective date of the revaluation was 30 September
2010.
If operational land and buildings were measured using the
cost model the carrying amounts would be as follows:
Parent Consolidated









Cost 225,613 222,471 227,054 223,913
Accumulated depreciation (115,594) (111,303) (116,172) (111,841)
Net carrying amount 110,019 111,168 110,882 112,072
f. Assets Held for Sale
Parent/Consolidated Parent/Consolidated
As at 30 Sept 10 As at 31 Aug 09








Deprec. Writedown Book Value
Freehold land (at valuation) 1,102 — — 1,102 191 — — 191
Freehold buildings (at valuation) 447 — — 447 — — — —
Plant and equipment 714 (691) — 23 — — — —
Vehicles — — — — — — — —
Total assets held for sale 2,263 (691) — 1,572 191 — — 191
The Group intends to dispose of its Vital Petfood business,
classified as non-core. All land, buildings, plant and equip-
ment and vehicles associated with Vital are likely to be sold
with the business. The sale is expected to be completed
within 3 months of balance date. No impairment loss was
recognised on reclassification of the assets held for sale at
30 September 2010.
g. Carrying Value of Plant and Equipment Under Finance
Leases
The carrying value of plant and equipment held under finance
leases and hire purchase contracts at 30 September 2010 is
$1,166,000 (2009: $531,000).
h. Expenditure Recognised in the Course of Construction
Included in Work in Progress at 30 September 2010 is an
amount of $1,178,000 (2009: $4,158,000) relating to buildings





Harmony Gold Mining Company Limited
(Jun 2010)
GROUP INCOME STATEMENTS (in part)
For the years ended 30 June 2010
SA Rand US Dollar
2009(*) 2010 Figures in Million Note 2010 2009*
Continuing Operations
11,496 11,284 Revenue 1,489 1,277
(9,659) (10 484) Cost of sales 5 (1,383) (1,083)
(7,657) (8,358) Production costs (1,103) (850)
(1,253) (1,375) Amortisation and depreciation (181) (139)
(546) (331) Impairment of assets (43) (71)
(39) (205) Employment termination and restructuring costs (27) (4)
(164) (215) Other items (29) (19)
1,837 800 Gross profit 106 194
(329) (382) Corporate, administration and other expenditure (50) (36)
(33) (81) Social investment expenditure (11) (4)
(259) (219) Exploration expenditure (29) (29)
947 104 Profit on sale of property, plant and equipment 6 14 114
(101) (58) Other expenses—net 7 (8) (3)
2,062 164 Operating profit 8 22 236
12 56 Profit from associates 21 7 1
1 — Profit on sale of investment in associate — —
(112) — Impairment of investment in associate 21 — (14)
— (24) Loss on sale of investment in subsidiary 9 (3) —
(101) 38 Net gain/(loss) on financial instruments 10 5 (10)
443 187 Investment income 11 25 49
(212) (246) Finance cost 12 (32) (24)
2,093 175 Profit before taxation 24 238
(188) (335) Taxation 13 (44) (22)
1,905 (160) Net (loss)/profit from continuing operations (20) 216
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Accounting Policies (in part)
2.2. Consolidation (in part)
The consolidated financial information includes the financial
statements of the company, its subsidiaries, its proportionate
interest in joint ventures, special purpose entities (SPEs) and
its interests in associates.
(ii) Associates are those entities over which the group
has significant influence, but not control over operational and
financial policies, generally accompanying a shareholding of
between 20% and 50% of the voting rights.
Investments in associates are accounted for by using the
equity method of accounting, and are initially recognised at
cost. The cost of an acquisition is measured as the fair value
of the assets given, shares issued or liabilities assumed at
the date of exchange plus costs directly attributable to the
acquisition.
The group’s share of the associates’ post-acquisition prof-
its or losses is recognised in the income statement, and its
share of post-acquisition movement in reserves is recognised
in other reserves. Cumulative post-acquisition movements
are adjusted against the carrying amount of the investment.
When the group’s share of losses in an associate equals or
exceeds its interest in the associate, including any other un-
secured receivables, the group does not recognise further
losses, unless it has incurred obligations or made payments
on behalf of the associate.
The group’s investment in associates includes goodwill
identified on acquisition, net of any accumulated impairment
losses.
The carrying value of an associate is reviewed on a regular
basis and, if an impairment in the carrying value has occurred,
it is written off in the period in which such impairment is iden-
tified.
Unrealised gains on transactions between the group and
its associates are eliminated to the extent of the group’s inter-
est in the associates. Unrealised losses are also eliminated
unless the transaction provides evidence of an impairment
that should be recognised.
Accounting policies of associates have been reviewed to
ensure consistency with the policies adopted by the group.
Investments in associates are accounted for at cost and are
adjusted for impairments where appropriate in the company’s
separate financial statements.
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3. Critical Accounting Estimates and Judgements (in part)
3.2. Impairment of Investments in Associates
Investments in associates are evaluated annually for impair-
ment by comparing the entire carrying value of the investment
to the recoverable amount, which is the higher of value in use
or fair value less costs to sell.
21. Investment in Associates
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
145 329 Balance at beginning of year 43 19
284 — Subsidiary becoming associate — 25
12 56 Share of profit after tax 7 1
(112) — Impairment of share in associate — (14)
— — Translation — 12
329 385 Balance at end of year 50 43
The carrying amount consists of:
— — Pamodzi Gold Limited (a) — —
329 385 Rand Uranium (Proprietary) Limited (b) 50 43
329 385 Total investment in associates 50 43
(a) On 27 February 2008, Pamodzi Gold Limited (Pamodzi)
bought the Orkney operations from the group for a consider-
ation of 30 million Pamodzi shares. This resulted in Harmony
owning 32.4% of Pamodzi valued at R345 million (US$46.5
million) being R11.50 (US$1.54) per share on acquisition
date. Pamodzi was listed on the JSE and had interests in
operating gold mines in South Africa.
On 30 September 2008, an impairment test was performed
and an impairment of R112 million (US$13.5 million) was
recorded, bringing the total impairment recorded on the in-
vestment to date to R207 million (US$25.8 million). After tak-
ing into account the group’s share of losses of R33 million
(US$3.7 million), the carrying value at 31 December 2008 was
R0. Total share in losses to date was R110 million (US$14.3
million). Subsequently, the group has not recognised its share
of any further losses.
Pamodzi was placed in liquidation and the trading of its
shares on the JSE was suspended.
At the time of this report being finalised no audited fi-
nancial statements were available for years ending 31 De-
cember 2009 and 2008. The extract below represents unau-
dited information for the nine months ended 31 March 2009.
No financial information subsequent to this date is available
and therefore no information has been disclosed for 2010.
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
100% 100%
623 Revenue 69
(801) Production costs (89)
(178) Operating loss (20)
(361) Net loss (40)
The financial position as at 31 March 2009 is disclosed below:
SA Rand US Dollar
2009 2010 Figures in Million 2010 2009
2,005 Non-current assets 260
145 Current assets 18
2,150 Total assets 278
1,863 Current liabilities 241
478 Non-current liabilities 62
2,341 Total liabilities 303
(b) The group owns a 40% share of Rand Uranium, which
is an unlisted company registered in South Africa, with gold
mining operations in the Gauteng province of South Africa.




On 21 November 2008, the company’s wholly-owned sub-
sidiary Randfontein Estates Limited disposed of its Rand-
fontein Cooke assets to a newly formed wholly-owned sub-
sidiary Rand Uranium, for a consideration of US$328 million
(R3, 484 million), settled with Rand Uranium shares. In a re-
lated transaction on the same date, 60% of these shares were
sold to PRF for US$197 million (R2, 093 million). US$40 mil-
lion was paid on the effective date and the balance of US$157
million was paid on 20 April 2009. Interest was charged on
the outstanding balance at 5% per annum, resulting in R32
million (US$3.3 million) being recognised in the income state-
ment. The interest was also received on 20 April 2009.
The conditions precedent for the second part of the Rand
Uranium transaction relating to the sale of the Old Rand-
fontein assets to Rand Uranium were fulfilled on 22 April
2009. These assets were valued at US$20 million (R212 mil-
lion). Additional shares were issued in settlement and 60%
of these shares were sold to PRF in terms of the agreement.
PRF paid its portion of the purchase price, US$12 million
(R109 million), in cash on 20 April 2009.
The shareholders’ agreement includes certain restrictions
on the group’s ability to dispose of its shares in Rand Uranium
for a period of up to four years from the effective date, being
21 November 2008. In addition, PRF has the right, for a period
of up to four years after the effective date, to have first claim
on the proceeds, up to a specified amount, in the event of a
disposal of the operations. Harmony has first right of refusal
in such an event. However due to the contingent nature of
the provision, the group has made no adjustments to the
associate’s carrying amount.
The group recognised a profit of R1 786 million (US$171
million) (before tax) on these transactions during the 2009
financial year. This profit is included in the profit from discon-
tinued operations. Refer to note 14.
The group recognised its share of the post-acquisition prof-
its of R56 million (US$7 million) (7 months ending 30 June
2009: R46 million (US$5.1 million)).
Rand Uranium has a year end of 30 June. The audited
financial information of Rand Uranium for the years ended
30 June 2010 and at 30 June 2010 and 30 June 2009 is as
follows:
SA Rand US Dollar
2009 2010 2010 2009
100% 100% 100% 100%
913 1,691 Revenue 223 101
(678) (1,306) Production costs (172) (75)
235 385 Gross profit 51 26
112 137 Net profit 18 12
4,456 4,666 Non-current assets 612 577
222 206 Current assets 27 29
4,678 4,872 Total assets 639 606
183 173 Current liabilities 23 24
699 766 Non-current liabilities 100 91
882 939 Total liabilities 123 115
Impairment—Investment in Jointly Controlled Entities
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Sims Metal Management Limited (Jun 2010)
CONSOLIDATED INCOME STATEMENTS (in part)
For the year ended 30 June 2010
2010 2009 2008
Note A$M A$M A$M
Revenue 5 7,458.5 8,641.0 7,670.5
Other income 6 25.2 33.7 55.7
Raw materials used and changes in inventories 10 (5,344.3) (6,272.6) (5,324.6)
Freight expense (716.0) (919.3) (778.7)
Employee benefits expense (433.0) (592.4) (404.9)
Depreciation and amortisation expense 7 (143.9) (170.8) (95.1)
Repairs and maintenance expense (111.7) (147.8) (126.2)
Other expenses (538.4) (542.2) (363.0)
Finance costs 7 (16.4) (21.5) (34.4)
Goodwill impairment charge 13 — (191.1) (3.3)
Share of pre-tax profit of investments accounted for using the equity method 29 14.5 60.8 64.6
Profit/(loss) before income tax 194.5 (122.2) 660.6
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1—Summary of Significant Accounting Policies
(in part)
(C) Principles of Consolidation (in part)
(III) Joint Ventures (in part)
A joint venture is a contractual arrangement whereby two or
more parties undertake an economic activity that is subject to
joint control. Joint control is the contractually agreed sharing
of control such that significant operating and financial deci-
sions require the unanimous consent of the parties sharing
control. In some situations, joint control exists even though
the Group has an ownership interest of more than 50% be-
cause of the veto rights held by joint venture partners. The
Group has two types of joint ventures:
Jointly Controlled Entities
A jointly controlled entity is a joint venture that involves the
establishment of a corporation, partnership or other entity
in which each venture has a long-term interest. Jointly con-
trolled entities are accounted for using the equity method. In
addition, for both associates and jointly controlled entities, the
carrying value will include any long-term debt interests that in
substance form part of the Group’s net investment.
Note 29—Investments in Associates and Jointly
Controlled Entities (in part)
(A) Carrying Amounts of Associates and Jointly Controlled
Entities
Ownership Interest % Carrying Amount








SA Recycling LLC USA 50% 50% 314.3 329.9
Metal Management Nashville LLC USA 50% 50% 14.0 22.4
Rondout Iron & Metal LLC USA 50% 50% 0.9 0.6
Port Albany Ventures LLC(1) USA 100% 50% — 6.6
Richmond Steel Recycling Ltd Canada 50% 50% 19.8 21.6
LMS Generation Pty Ltd Australia 50% 50% 19.9 18.5
Australia Refined Alloys Pty Ltd Australia 50% 50% — —
Extruded Metals Ltd New Zealand 33% 33% 0.6 0.6
369.5 400.2
(1) On 18 November 2009, the Group obtained control of Port Albany by acquiring the remaining 50% of the joint venture. As a result, the
Group’s equity interest in Port Albany increased from 50% to 100%.
(B) Movements in Carrying Amounts
2010 2009
A$M A$M
Balance at 1 July 400.2 332.2
Share of profit before tax 17.5 57.6
Associates share of income tax expense (2.4) (2.6)
Accretion of deferred gain to equity accounted profit 2.7 3.2
Dividends received (19.6) (41.5)
Return of capital from jointly controlled entities (0.4) (3.6)
Purchase of remaining 50% interest in Port Albany (5.6) —
Impairment of investment in Metal Management Nashville LLC (5.7) —
Other — 1.7
Foreign exchange differences (17.2) 53.2
Balance at 30 June 369.5 400.2
(c) Share of associates’ and jointly controlled entities’ profit
Profit before income tax 14.5 60.8
Associates’ share of income tax expense (2.4) (2.6)
Profit after income tax recognised in equity accounted investment 12.1 58.2
Jointly controlled entities income tax(1) (2.4) (19.2)
Associates’ and jointly controlled entities’ profit after tax 9.7 39.0
(1) The jointly controlled entities to which this relates are “pass-through” entities for taxation purposes. As such, the Group incurs the income




At 30 June 2009, the Group held a 50% interest in Port Al-
bany. This jointly controlled entity was accounted for using the
equity method. On 18 November 2009, the Group purchased
the remaining 50% ownership interest in Port Albany that it
previously did not own. In accordance with the revised AASB
3 (IFRS 3) and AASB 127 (IAS 27), the Group was required
to remeasure its previously held equity interest in Port Albany
at its acquisition-date fair value and recognise the resulting
gain or loss in profit or loss. This transaction resulted in the
recognition of a gain calculated as follows:
A$M
Fair value of 50% interest in Port Albany 14.3
Carrying amount of Port Albany
investment (5.6)
Gain recognised on acquisition 8.7
(D) SA Recycling LLC
On 1 September 2007, the Group completed the merger of
its Southern Californian metal recycling assets with those of
Adams Steel LLC. The jointly controlled entity, SA Recycling
LLC, operates within a territory encompassing Southern Cal-
ifornia, Arizona, Southern Nevada and Northern Mexico. In
accordance with AASB 128 (IAS 28) Investments in Asso-
ciates and AASB 131 (IAS 31) Interests in Joint Ventures,
the SA Recycling LLC is a jointly controlled entity accounted
for under the equity method.
The fair values of assets and liabilities contributed to SA









Property, plant and equipment 71.4 79.8 (8.4)
Goodwill and intangible assets 196.5 265.7 (69.2)
Non-current provisions (3.2) (3.2) —
264.7 342.3 (77.6)
In accordance with UIGI 113 (SIC 13) Jointly Controlled
Entities—Non-Monetary Contributions by Venturers, the por-
tion of the non-cash gain attributable to the equity interest of
the other venturer, in this instance 50%, was recognised im-
mediately on contribution of assets to the SA Recycling LLC
jointly controlled entity. This has been recognised in other
income as disclosed in Note 6. The remaining 50% of the
non-cash gain for intangibles has been allocated to reduce
the cost of the equity accounted investment and will be recog-
nised progressively over the remaining useful life of the as-
sets to which it relates. The remaining 50% of the non-cash
gain for property, plant and equipment has been allocated to
reduce the cost of the equity accounted investment and will
be recognised if the land to which the gain relates is sold.
(E) Summarised Financial Information of Associates and
Jointly Controlled Entities
Group’s Share of Assets 2010 2009
and Liabilities A$M A$M
Current assets 104.0 92.1
Non-current assets 289.8 313.4
Total assets 393.8 405.5
Current liabilities 30.0 34.1
Non-current liabilities 100.0 102.2
Total liabilities 130.0 136.3
Net assets 263.8 269.2








Revenues 596.3 814.2 699.9
Expenses (578.8) (756.6) (637.6)
Profit before income tax 17.5 57.6 62.3
(F) Contingent Liabilities and Capital Commitments
The Group’s share of the contingent liabilities of associates
and jointly controlled entities is disclosed in Note 22. The
Group’s share of the capital commitments and other expendi-
ture commitments of associates and jointly controlled entities
is disclosed in Note 23.
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(A) Profit/(Loss) Before Income Tax Includes the Following Specific Expenses:
Depreciation and amortisation:
Depreciation expense 109.1 120.7 65.8
Amortisation expense 34.8 50.1 29.3
143.9 170.8 95.1
Finance costs 16.4 21.5 34.4
Net loss on disposal of property, plant and equipment — — 1.9
Net loss on held for trading derivatives 15.4 10.3 —
Rental expenses relating to operating leases 60.1 71.7 43.9
Net foreign exchange loss 15.6 — —
Defined contribution superannuation expense 4.1 8.0 6.3
Share-based payments expense 17.0 9.3 13.4
(B) Profit/(Loss) Before Income Tax Includes the Following Expenses Which are
Included Due to Their Size Or Nature:
Write-down of inventory to net realisable value 18.5 119.4 —
Sarbanes-Oxley related professional fees(1) — 9.7 —
Withdrawal liability related to a multi-employer pension plan(2) — 3.4 —
Impairment provisions for trade receivables(3) 1.2 23.7 0.6
Professional fees and other costs incurred in connection with Fairless Iron 8 Metal
acquisition(4) (0.8) 2.5 —
Loss on sale of subsidiaries — 2.6 —
Impairment loss on fire destroyed assets — — 0.1
Impairment of property, plant and equipment and yard closure costs(5) 14.5 13.7 4.6
Intangible asset impairments(6) 0.9 — —
Impairment of jointly controlled entity (Note 29)(7) 5.7 — —
Merger costs(8) — 4.0 1.4
Redundancies 5.7 5.5 5.6
(1) In 2009, the Group was required to implement and comply with Section 404 of the Sarbanes-Oxley Act of 2002 (United States). Professional
fees incurred in the first year of Sarbanes-Oxley implementation are much higher and thus listed above. No amount is provided for 2010 as
the primary professional fees are inseparable and included in the overall statutory audit fee disclosed in Note 26.
(2) Represents a termination liability associated with the withdrawal from a multi-employer pension plan in the United States.
(3) Represents provisions recorded for trade debtors for which the Group believes collectability is in doubt. Refer to Note 1(m).
(4) In 2009, the Group incurred transaction costs associated with the acquisition of Fairless Iron & Metal which was completed in 2010 (3 July
2009).
In 2009, the Group applied the transitional principles consistent with the revised AASB 3 (IFRS 3) whereby transaction costs are expensed
for all acquisitions prospectively from 1 July 2009. The amount in 2010 represents the reversal of accrued costs which were settled for a
lower amount.
(5) In 2010, impairments on property, plant and equipment were recognised for the write-down of processing equipment located in idled yards
(A$15.8 million) offset by the reversal of previously recognised processing equipment impairments (A$1.3 million). In 2009, the impact of the
global financial crisis on the Group resulted in impairment charges for asset rationalisation, asset retirement and idling of certain yards. In
2008, impairments on property, plant and equipment were recognised for assets held by non-core businesses which were being considered
for disposal.
(6) Represents the write-off of permits which the Group determined had no value.
(7) Represents an impairment of the Group’s investment in Metal Management Nashville LLC. The jointly controlled entity operates in a very
competitive market which has impacted its financial performance resulting in the impairment charge.
(8) Merger costs include integration bonuses, retention incentives and other costs associated with the post-merger rationalisation of the Sims
Metal Management Limited and Metal Management businesses.
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Sterlite Industries (India) Limited (Mar 2010)
Author’s Note
Sterlite Industries (India) Limited implemented IFRSs
effective March 31, 2010, with a date of transition of
April 1, 2008. The excerpt that follows reflects the
initial application of IAS 36.
CONSOLIDATED STATEMENTS OF INCOME
(in part)
(Indian Rupees in millions except share or per share amounts
unless otherwise stated)











Revenue 5 212,192 244,903 5,448.3
Cost of sales (165,097) (181,928) (4,047.3)
Gross profit 47,095 62,975 1,401.0
Other operating income 3,750 1,907 42.4
Distribution expenses (3,388) (3,022) (67.2)
Administration expenses (4,367) (8,026) (178.6)
Operating profit 43,090 53,834 1,197.6
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Significant Accounting Policies (in part)
F. Non-Current Assets Held for Sale
Non-current assets and disposal groups are classified as held
for sale if their carrying amount will be recovered through
a sale transaction rather than through continuing use. This
condition is regarded as met only when the sale is highly
probable and the asset (or disposal group) is available for
immediate sale in its present condition. Management must
be committed to the sale which should be expected to qualify
for recognition as a completed sale within one year from the
date of classification.
Non-current assets and disposal groups classified as held
for sale are not depreciated and are measured at the lower of
carrying amount and fair value less costs to sell. Such assets
and disposal groups are presented separately on the face of
the statement of financial position.
J. Impairment (in part)
Non-Financial Assets
The carrying amounts of the Company’s non-financial assets,
other than inventories and deferred tax assets are reviewed
at each reporting date to determine whether there is any in-
dication of impairment. If any such indication exists, then the
asset’s recoverable amount is estimated.
The recoverable amount of an asset or cash-generating
unit is the greater of its value in use and its fair value less
costs to sell. In assessing value in use, the estimated future
cash flows are discounted to their present value using a pre-
tax discount rate that reflects current market assessments of
the time value of money and the risks specific to the asset.
For the purpose of impairment testing, assets are grouped
together into the smallest group of assets that generates cash
inflows from continuing use that are largely independent of the
cash inflows of other assets or groups of assets (the “cash-
generating unit”).
An impairment loss is recognized if the carrying amount
of an asset or its cash-generating unit exceeds its estimated
recoverable amount.
Impairment losses are recognized in the statement of in-
come. Impairment losses recognized in prior periods are as-
sessed at each reporting date for any indications that the
loss has decreased or no longer exists. An impairment loss
is reversed if there has been a change in the estimates used
to determine the recoverable amount. An impairment loss is
reversed only to the extent that the asset’s carrying amount
does not exceed the carrying amount that would have been
determined, net of depreciation or amortization, if no impair-
ment loss had been recognized.
18. Assets Held for Sale
In the year ended March 31, 2010, the Company recognized
assets amounting to Rs. 188 million as assets held for sale.
Such assets related to the Company’s aluminum segment.
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A description of the assets held for sale is as follows:










Building 192 179 13
Plant and machinery 1,254 1,079 175
Total 1,446 1,258 188
The relatively high cost of operation of BALCO’s Plant I
100,000 tpa smelter which used the Vertical Stud Soderberg
(“VSS”) technology at Korba and the steep decline in LME
prices made the existing operations at the smelter unviable.
Consequently, operations at the smelter were being phased
out of production commencing in February 2009 and opera-
tions at the smelter ceased on June 5, 2009.
Consequently, the Company recognised Plant 1 smelter
assets at Korba, the main receiving station and distribution
system used in the above mentioned smelter, Fume treatment
plant (“FTP”), Profile tube shop and Bidhan Bagh Unit under
the head “Assets held for sale.” The Company obtained ap-
proval for dismantling and disposing of these assets from the
appropriate level of management. Part of the assets recog-
nised as held for sale with a carrying value of Rs. 122 million
have been disposed off. The balance disposal is expected to
be completed by December 2010.
The carrying value of FTP is Rs. 343 million and its net
realizable value is Rs. 17 million. Consequently, an impair-
ment loss of Rs. 326 million was recognized in the statement
of income as part of administration expenses. The estimated
fair value less costs to sell of the other assets held for sale is
Rs. 383 million as at March 31, 2010 and the carrying value
is Rs. 171 million. Since the estimated fair value less costs
to sell of these assets is higher than the carrying value, no
impairment was recognized. The carrying value of the as-
sets has been shown separately in the statement of financial
positions.
GAINS AND LOSSES ON
DERECOGNITION OF
NONCURRENT ASSETS
IFRS Overview and Comparison
to U.S. GAAP
3.293 This subsection addresses recognition of gains or
losses on derecognition of noncurrent assets accounted for in
accordance with IAS 16, IAS 17, IAS 38, and IAS 40. The
requirements of these standards with respect to recognition,
measurement, presentation, and disclosure on the statement
of financial position are discussed in section 2. The require-
ments of these standards with respect to depreciation, amorti-
zation, and impairment testing and recognition are discussed
elsewhere in this section.
Recognition and Measurement
IFRSs
3.294 IAS 16 and IAS 38 require an entity to derecognize an
item of PPE on disposal or when no future economic benefits
are expected to flow to the entity from use or disposal. IAS
40 also adds the condition that the property be permanently
withdrawn from use.
3.295 In all cases, an entity should recognize gains or losses
in profit or loss as the difference between the net proceeds
from disposal, if any, and the carrying value of the asset in
the period in which the retirement or disposal occurs, unless
the asset is the subject of a sale and leaseback transaction
under IAS 17.
3.296 In accordance with IAS 17, an entity should recognize
profit or loss immediately when the sale and leaseback results
in an operating lease and either:
• it is clear that the transaction occurred at fair value, or
• the transaction occurred at less than fair value and the
loss is not compensated by future lease payments at
below market price.
Otherwise, an entity defers and amortizes any gain or loss
over the period in which the entity expects to use the asset.
3.297 Both IAS 16 and IAS 38 prohibit an entity from
recognizing gains on disposal or retirement as revenue.
3.298 When an asset is held at revalued amount, an en-
tity transfers any remaining revaluation surplus account to
retained earnings when the asset is derecognized. For the
purpose of transferring the revaluation surplus to retained
earnings, an entity may transfer either part of the revaluation
surplus as the asset is depreciated or the entire revaluation
surplus when it disposes of or retires the asset.
U.S. GAAP
3.299 FASB ASC 360-10-40 provides very little guidance on
derecognition of long-lived assets on disposal or retirement.
General guidance states that an entity should derecognize
long-lived assets when it no longer has rights to the asset. An
entity should recognize a gain or loss on the date of the sale,
in accordance with FASB ASC 360-10-40-5.
3.300 However, FASB ASC 360-10-40 contains more guid-
ance and conditions than IFRSs that must be met before an
entity recognizes gains or losses on sale and leaseback trans-
actions, referencing FASB ASC 840, Leases. Specifically,
paragraphs 1–3 of FASB ASC 840-40-35 contain guidance




3.301 IAS 1 does not require separate presentation of gains





3.302 Like IFRSs, FASB ASC 360-10-45-5 does not require
separate presentation of these transactions. However, this
paragraph further states that if a subtotal, such as income
from operations, is presented, an entity should include the
amounts of gains or losses recognized on the sale of the
noncurrent asset in that subtotal.
Disclosure
IFRSs
3.303 Unless a gain or loss on derecognition is material,
IFRSs do not require an entity to disclose this information.
U.S. GAAP
3.304 Unlike IFRSs, when an entity does not separately
present gains or losses on the sale of a long-lived asset on the
face of the income statement, FASB 205-20-50-1 requires
the entity to disclose in the notes to the relevant financial
statements the caption of the income statement item that
contains that gain or loss.
Presentation and Disclosure Excerpts
Gain on Sale of Property, Plant, and
Equipment, Intangible Assets, and Assets
Held for Sale
3.305
Magyar Telekom plc (Dec 2010)
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (in part)
For the Year Ended December 31
Note 2008 2009 2010
2010
(Note 2.1)
(In HUF Millions, Except per Share Amounts) (Million USD)
Revenue 22 673,056 643,989 609,579 2,922
Expenses directly related to revenues 23 (167,558) (160,576) (157,427) (755)
Employee related expenses 24 (100,320) (101,918) (93,884) (450)
Depreciation and amortization (106,120) (101,920) (100,872) (483)
Other operating expenses 25 (141,049) (135,305) (148,750) (713)
Operating expenses (515,047) (499,719) (500,933) (2,401)
Other operating income 26 4,249 2,863 3,448 17
Operating profit 162,258 147,133 112,094 537
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
26. Other Operating Income
For the Year Ended December 31
(In HUF Millions) 2008 2009 2010
Gain on sale of PPE, Intangible assets and assets held for sale 2,126 326 327
Gain on sale of subsidiaries and associates (a) 1,233 1,371 —
Compensation for renaming (Note 34.1) 676 — —
Other operating income 214 1,166 3,121
4,249 2,863 3,448
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(a) Gain on Sale of Subsidiaries and Associates
All the subsidiaries sold in the reported years conducted non-
core operations and were insignificant to the Group, therefore
they did not constitute discontinued operations. The results
on the disposals of subsidiaries and associates are recog-
nized as Other operating income in the years of disposal.
All disposals impacted the total ownership in the subsidiaries
and associates sold. No income or loss was incurred on the
sale of Orbitel in 2010 after the impairment loss of the Orbitel
goodwill recognized in 2009. The proceeds from the disposal
included in the Consolidated statement of cash flows are dis-
closed net of the cash balances of the subsidiaries at date of
disposal. These cash balances were not significant.
Gain (Loss) on Disposal of Hotels
3.306
InterContinental Hotels Group plc (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)




















Revenue (Note 2) 1,628 — 1,628 1,538 — 1,538 1,897 — 1,897
Cost of sales (753) — (753) (769) (91) (860) (852) — (852)
Administrative expenses (331) (35) (366) (303) (83) (386) (400) (59) (459)
Other operating income and
expenses 8 35 43 6 (2) 4 14 25 39
552 — 552 472 (176) 296 659 (34) 625
Depreciation and amortization
(Note 2) (108) — (108) (109) — (109) (110) (2) (112)
Impairment (Note 2) — (7) (7) — (197) (197) — (96) (96)
Operating profit/(loss) (Note 2) 444 (7) 437 363 (373) (10) 549 (132) 417
Financial income (Note 6) 2 — 2 3 — 3 12 — 12
Financial expenses (Note 6) (64) — (64) (57) — (57) (113) — (113)
Profit/(loss) before tax 382 (7) 375 309 (373) (64) 448 (132) 316
Tax (Note 7) (98) 1 (97) (15) 287 272 (101) 42 (59)
Profit for the year from
continuing operations 284 (6) 278 294 (86) 208 347 (90) 257
Profit for the year from
discontinued operations
(Note 11) — 2 2 — 6 6 — 5 5
Profit for the year 284 (4) 280 294 (80) 214 347 (85) 262
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 5—Exceptional Items
Year Ended December 31




Onerous management contracts(i) — (91) —
Administrative expenses:
Holiday Inn brand relaunch(ii) (9) (19) (35)
Reorganization and related costs(iii) (4) (43) (24)
Litigation provision(iv) (22) — —
Enhanced pension transfer(v) — (21) —
(35) (83) (59)
Other operating income and expenses:
Gain on sale of associate investments — — 13
Gain on sale of other financial assets(vi) 8 — 14
Gain/(loss) on disposal of hotels (Note 11)(∗) 27 (2) (2)
35 (2) 25
Depreciation and amortization:
Reorganization and related costs(iii) — — (2)
Impairment:
Property, plant and equipment (Note 10) (6) (28) (12)
Assets held for sale (Note 11) — (45) —
Goodwill (Note 12) — (78) (63)
Intangible assets (Note 13) — (32) (21)




Tax on exceptional operating items 1 112 17
Exceptional tax credit(vii) — 175 25
(6) 287 42
Discontinued Operations(viii)
Gain on Disposal of Assets (Note 11)
Gain on disposal of hotels(∗∗) — 2 —
Tax credit 2 4 5
2 6 5
(4) (80) (85)
(∗) Relates to hotels classified as continuing operations.
(∗∗) Relates to hotels classified as discontinued operations.
The above items are treated as exceptional by reason of their size or nature.
(i) An onerous contract provision of $65 million was recognized at December 31, 2009 for the future net unavoidable costs under the
performance guarantee related to certain management contracts with one US hotel owner. In addition to the provision, a deposit of $26
million was written off as it is no longer considered recoverable under the terms of the same management contracts.
(ii) Relates to costs incurred in support of the worldwide relaunch of the Holiday Inn brand family that was announced on October 24, 2007.
(iii) Primarily relates to the closure of certain corporate offices together with severance costs arising from a review of the Group’s cost base.
(iv) Estimate of the amount potentially payable in respect of a prior year claim following an unfavorable court judgment on February 23, 2011.
Any final amount will not be known until the court process is complete.
(v) Related to the payment of enhanced pension transfers to those deferred members of the InterContinental Hotels UK Pension Plan who had
accepted an offer to receive the enhancement either as a cash lump sum or as an additional transfer value to an alternative pension plan
provider. The exceptional item in 2009 comprised the lump sum payments ($9 million), the IAS 19 settlement loss arising on the pension
transfers ($11 million) and the costs of the arrangement ($1 million). The payments and transfers were made in January 2009.
(vi) Relates to the gain on sale of an investment in the EMEA region, in both 2010 and 2008.
(vii) Represents the release of provisions of $7 million (2009 $175 million, 2008 $25 million) which are exceptional by reason of their size or
nature relating to tax matters which had been settled or in respect of which the relevant statutory limitation period has expired, together
with, in 2010, a $7 million charge relating to an internal reorganization. This charge comprises the recognition of deferred tax assets of $24
million for capital losses and other deductible amounts, offset by tax charges of $31 million.
(viii) In 2010, relates to tax refunded relating to the sale of a hotel in a prior year. In 2009 and 2008, related to tax arising on disposals together
with the release of provisions no longer required in respect of hotels disposed of in prior years.
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Profit and Loss on Sales of Property, Plant
and Equipment and Waste Products
3.307
Barry Callebaut AG (Aug 2010)
CONSOLIDATED INCOME STATEMENT
For the Fiscal Year Ended August 31,
in Thousands of CHF Notes 2009/10 2008/09
Revenue from sales and services 5,213,779 4,880,177
Cost of goods sold (4,477,608) (4,172,355)
Gross profit 736,171 707,822
Marketing and sales expenses (120,781) (120,324)
General and administration expenses (248,794) (250,608)
Other income 6 20,456 34,357
Other expenses 7 (16,641) (20,494)
Operating profit (EBIT) 370,411 350,753
Financial income 8 2,021 5,904
Financial expenses 9 (83,122) (97,493)
Result from investments in associates and joint ventures 17 (225) 484
Profit before income taxes 289,085 259,648
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
6. Other Income
In Thousands of CHF 2009/10 2008/09
Gain on disposal of property, plant and equipment 6,177 1,615
Group training centers, museums, outlets and rental income 3,799 3,522
Sale of shells of cocoa beans and waste 3,198 3,285
Litigations, claims and insurance 2,902 1,923
Release of unused provisions and accruals 1,678 837
Gain on disposal of subsidiaries (note 2) — 17,950
Recognition of negative goodwill on acquisitions (note 1) — 1,385
Other 2,702 3,840
Total other income 20,456 34,357
7. Other Expenses
In Thousands of CHF 2009/10 2008/09
Restructuring costs (8,916) (9,947)
Loss on sale of waste (2,088) (2,910)
Litigations and claims (1,741) (1,518)
Costs related to chocolate museums (1,022) (696)
Loss on sale of property, plant and equipment (25) (1,585)
Impairment on property, plant and equipment (note 15) — (566)
Other (2,849) (3,272)
Total other expenses (16,641) (20,494)
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CHANGE IN FAIR VALUE OF
NONFINANCIAL ASSETS
IFRS Overview and Comparison
to U.S. GAAP
3.308 When permitted or required by IFRSs, an entity may
measure a nonfinancial asset at fair value subsequent to initial
recognition. When an entity applies this accounting policy,
by electing to apply a fair value model or revaluation model,
as appropriate, the subsequent measurement of these assets
affects its statement of comprehensive income. The following
standards permit or require these models and are addressed
in this subsection:
• IAS 16—revaluation model
• IAS 38—revaluation model
• IAS 40—fair value model
• IAS 41, Agriculture—fair value model
Author’s Note
Recognition, measurement, presentation, and disclo-
sure requirements for the assets within the scope of
these standards are discussed in section 2. This sub-




3.309 IAS 16 permits an entity to remeasure the carrying
value of items of PPE to revalued amount, which is fair value
on the date of revaluation. An entity should revalue all assets
in the relevant class of PPE with sufficient regularity such
that the carrying value of the class is not materially different
from fair value at the balance sheet date. An entity should
recognize an increase in carrying value from revaluation in
other comprehensive income (revaluation surplus), except
that the entity should recognize the increase to profit and loss
to the extent that the increase reverses accumulated prior
decreases. Similarly, an entity should recognize a decrease
in carrying value in profit or loss, except that the entity should
recognize the decrease in other comprehensive income to the
extent it reverses an existing revaluation surplus.
3.310 IAS 38 permits an entity to select the revaluation
model only if the class of intangible assets has an active
market. The effect of a change in carrying value revaluation
on the statement of comprehensive income is the same as
IAS 16.
3.311 IAS 40 permits an entity to remeasure the carrying
value of all investment properties to fair value at the reporting
date. When the fair value model is selected, an entity should
recognize the change in fair value in profit or loss.
3.312 IAS 41 requires an entity to recognize biological assets
initially and in subsequent reporting periods and agricultural
produce initially and at the point of harvest at FVLCS and
recognize the change in fair value in profit or loss. An entity
should recognize any gains or losses on initial recognition at
FVLCS and on remeasurement in profit or loss.
U.S. GAAP
3.313 Unlike IFRSs, FASB ASC does not permit an entity to
remeasure nonfinancial assets to fair value, revalued amount,
or FVLCS, subsequent to initial recognition, except in rare
circumstances. For example, when an entity recognizes an
impairment loss, it remeasures the asset to fair value. (See
the guidance related to the recognition and measurement of
asset impairments starting with paragraph 3.264)
Presentation
IFRSs
3.314 Changes in fair value, revalued amount, or FVLCS are,
by nature, different from other income and expense items. In
contrast to the alternative to present expenses by nature or
function in profit or loss, IAS 1 requires an entity to present
information of other comprehensive income by nature. When
an entity presents information recognized in profit or loss by
function, it should disclose an analysis of expenses by nature
in a note disclosure.
U.S. GAAP
3.315 Because FASB ASC does not permit nonfinancial
assets to be remeasured to fair value, revalued amount, or
FVLCS, there is no guidance to reference here.
Disclosure
IFRSs
3.316 IAS 16 and IAS 38 require an entity to disclose reval-
uation increases or decreases as a separate line in the recon-
ciliation of the gross carrying amount of the relevant asset
class.
3.317 IAS 40 requires an entity to disclose the net gains or
losses from fair value adjustments of investment properties.
3.318 IAS 41 requires an entity to disclose any gains or
losses from changes in FVLCS.
U.S. GAAP
3.319 Because FASB ASC does not permit nonfinancial
assets to be remeasured to fair value, revalued amount, or
FVLCS, there is no guidance to reference here.
Presentation and Disclosure Excerpts
Author’s Note
None of the survey companies selected for this edi-
tion elected the revaluation model for intangible as-
sets. Therefore, no disclosure excerpts were available
for inclusion.
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Changes in Fair Value of Biological Assets
Recognized in Profit and Loss, Change in




Sasini Limited (Sep 2010)
CONSOLIDATED INCOME STATEMENT (in part)






Revenue 23 2,297,927 2,182,090
Gains arising from changes in fair
value of biological assets less
estimated point of sale costs 6(a) 904,832 568,992
Cost of sales 24 (1,376,450) (1,471,493)
Gross profit 1,826,309 1,279,589
Other income 25 177,192 48,495
Expenses
Administration and establishment
expenses 26 (563,550) (513,913)
Selling and distribution costs 27 (13,427) (11,297)
Interest income 28 27,774 28,497
Interest expense 28 (71,923) (71,649)
Profit before tax 28 1,382,375 759,722
CONSOLIDATED STATEMENT OF OTHER
COMPREHENSIVE INCOME (in part)





Profit for the year 993,729 533,032
Other comprehensive income
Revaluation of property, plant and
equipment 28,818 572,217
Deferred tax on revaluation — (123,122)
Other comprehensive income after tax 28,818 449,095
Total comprehensive income for the
year 1,022,547 982,127
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
(e) Critical Accounting Estimates and Assumptions (in part)
In the process of applying the Group’s accounting policies,
directors make certain estimates and assumptions about fu-
ture events. In practice, the estimated and assumed results
would differ from the actual results. Such estimates and as-
sumptions, that have a significant risk of causing a material
adjustment to the carrying amounts of assets and liabilities
within the next financial year, are described below:
Biological Assets
In determining the fair value of biological assets, the Group
uses the present value of expected future cash flows from
the assets discounted at the current market determined pre
tax rate. The objective of calculating the present value of
expected cash flows is to determine the fair value of bio-
logical assets in their present location and condition. The
Group considers this in determining an appropriate discount
rate to be used and in estimating net cash flows. Manage-
ment uses historical data relating to production and market
prices of tea, coffee, livestock and trees. The methodology
and assumptions used for estimating both the amount and
timing of future cash flows are reviewed to reduce any dif-
ferences between estimates and actual experience. The sig-
nificant assumptions are set out in note 5 to the financial
statements.
Property, Plant and Equipment
Directors make estimates in determining the depreciation
rates for property, plant and equipment. The rates used are
set out in the accounting policy for property, plant and equip-
ment.
These estimates are continually evaluated and are based
on historical experience and other factors, including expec-
tations of future events that are believed to be reasonable
under the prevailing circumstances.
The Group measures its property, plant and equipment
at revalued amounts with changes in revaluation values
being recognized in equity. The Group engages indepen-
dent valuers to determine fair values of property, plant
and equipment. The valuation values are based on the
prevailing market prices which are sensitive to economic
conditions.
(k) Property, Plant & Equipment and Depreciation
Property, plant and equipment are stated at cost or revalued
amounts less accumulated depreciation and any impairment
losses. Revaluation increases arising on the revaluations are
credited to a revaluation reserve, except to the extent that
it reverses a revaluation decrease for the same asset previ-
ously recognised as an expense, in which case the increase
is credited to the statement of comprehensive income to the
extent of the decrease previously charged. A decrease in
carrying amount arising out of revaluation is charged as an
expense to the extent that it exceeds the balance, if any, held
in the revaluation reserve relating to a previous revaluation of
that asset.
An annual transfer from the asset revaluation reserve to
retained earnings is made for the difference between de-
preciation based on the revalued carrying amount of the
asset original cost. Additionally, accumulated depreciation
at the revaluation date is eliminated against the gross car-
rying amount of the asset and the net amount is restated
to the revalued amount of the asset. Upon disposal, any
surplus remaining in the revaluation reserve relating to
the particular asset being sold is transferred to retained
earnings.
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Revaluations are done every 5 years to ensure that the car-
rying amount does not differ materially from that which would
be determined using fair value at the end of the reporting
period.
No depreciation is provided on freehold land. Work-in-
progress is not depreciated until the assets are completed
and brought to use. Other items of property, plant and equip-
ment are depreciated on the straight line basis to write down
the cost or revalued amount of each asset to its residual value
over its estimated useful life as follows;
Buildings and improvements 12–45 years
Plant, machinery and tools 12.5% p.a
Rolling stock 25.0% p.a
Farm implements and trailers 12.5% p.a
Furniture and fittings 12.5% p.a
Computers 33.3% p.a
Useful life, residual values and depreciation methods are re-
viewed on an annual basis.
An item of property, plant and equipment is de-recognised
upon disposal or when no future economic benefits are ex-
pected to arise from the continued use of the asset. Any
gain or loss on de-recognition of the asset (calculated as
the difference between the net disposal proceeds and the
carrying amount of the item) is included in the Statement of
comprehensive income in the year the item is de-recognised.
The carrying values of the property, plant and equipment are
assessed annually and adjusted for impairment where it is
considered necessary.
4. Property, Plant and Equipment (in part)
a) The Group






















At start of the year 1,003,000 947,353 424,837 96,752 93,111 2,565,053
Additions and transfers — 81,419 33,844 40,183 11,770 167,216
Disposals — (2,619) — (7,925) — (10,544)
At 30 September 2010 1,003,000 1,026,153 458,681 129,010 104,881 2,721,725
Comprising:
At cost — 251,635 143,834 63,142 89,800 548,411
At valuation 1,003,000 774,518 314,847 65,868 15,081 2,173,314
1,003,000 1,026,153 458,681 129,010 104,881 2,721,725
Depreciation
At start of the year — 68,740 22,386 6,953 31,012 129,091
Charge for the year — 79,266 39,327 22,322 20,748 161,663
Disposals — (537) — (2,212) — (2,749)
At 30 September 2010 — 147,469 61,713 27,063 51,760 288,005
Net book value
At 30 September 2010 1,003,000 878,684 396,968 101,947 53,121 2,433,720
The Group’s property was revalued on 30 September 2008
by Lloyd Masika Limited, registered valuers, on the market
value existing use basis.
The Group’s plant and equipment was revalued on 30
September 2009 by Lloyd Masika registered valuers, on the
market value existing use basis.
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The book values of the property, plant and equipment were
adjusted to the revaluations and the resultant surplus and
deferred tax effect, was recognised in equity as at that date.






















At start of the year 843,000 860,892 537,181 195,241 126,422 2,562,736
Additions and transfers — 1,417 4,492 2,074 30,637 38,620
Disposals — — — (3,844) — (3,844)
Revaluation surplus 160,000 85,044 (116,836) (96,719) (63,948) (32,459)
At 30 September 2009 1,003,000 947,353 424,837 96,752 93,111 2,565,053
Comprising:
At cost — 170,216 109,990 22,959 78,030 381,195
At valuation 1,003,000 777,137 314,847 73,793 15,081 2,183,858
1,003,000 947,353 424,837 96,752 93,111 2,565,053
Depreciation
At start of the year — 2,081 384,295 153,954 80,451 620,781
Charge for the year — 66,659 19,499 11,937 17,714 115,809
Disposals — — — (2,822) — (2,822)
Eliminated on revaluation — — (381,408) (156,116) (67,153) (604,677)
At 30 September 2009 — 68,740 22,386 6,953 31,012 129,091
Net book value











Balance brought forward 78,573 14,013 68,328 6,717
Additions 2,154 64,560 — 61,611
Transfer to property, plant and equipment (25,170) — (50,899) —
Transfer to intangible assets (49,165) — (17,429) —
6,392 78,573 — 68,328
Capital work-in-progress is not depreciated
6. Biological Assets (in part)
(a) The Group













Carrying amount as at 1 October 2009 1,308,501 2,760,689 332,741 1,093 13,253 4,416,277
Gains/(losses) arising from changes in fair value less
estimated point of sale costs 537,661 452,785 (57,946) (1,093) 878 932,285
Increases due to purchases/planting 5,906 — 220 — — 6,126
Decreases due to harvest — — (27,453) — — (27,453)
Carrying amount as at 30 September 2010 1,852,068 3,213,474 247,562 — 14,131 5,327,235
IFRS ATT 3.320
437Section 3: Statement of Comprehensive Income and Related Disclosures
(a) The Group













Carrying amount as at 1 October 2008 1,345,002 2,197,616 278,086 2,980 14,845 3,838,529
Gains/(losses) arising from changes in fair value less
estimated point of sale costs (37,280) 558,470 51,281 (1,887) (1,592) 568,992
Increases due to purchases/planting 779 4,603 3,374 — — 8,756
Carrying amount as at 30 September 2009 1,308,501 2,760,689 332,741 1,093 13,253 4,416,277
The Group is involved in the growing, processing and sell-
ing of coffee and tea and breeding of dairy cattle. At
30 September 2010, the Group had 127 (2009:108) cows
able to produce milk, 131 (2009:82) calves that are raised
to produce milk in the future, 41 (2009:113) bull calves
and 150 (2009:352) sheep. The Group produced 646,832
(2009:649,751) litres of milk with a fair value less esti-
mated point of sale costs of KShs 13,312,340 (2009: KShs
12,555,712) in the year.
The Group has 856 hectares of mature coffee bushes and
55 hectares of young coffee bushes. The Group harvested
1,106,883 (2009: 1,361,323) Kgs of coffee with a fair value
less estimated point of sale costs of KShs 313 million (2009:
KShs 261 million).
The Group has 1,391 (2009: 1,391) hectares of mature
tea bushes and 46 (2009: 46) hectares of young tea bushes.
The Group harvested 28,251,205 (2009: 23,704,270) Kgs of
green tea leaves with a fair value less estimated point of sale
costs of KShs 438 million (2009: KShs 332 million).
Where meaningful market-determined prices do not exist
to assess the fair value of biological assets, the fair value is
determined based on the net present value of the expected
future cash flows from those assets, discounted at appropri-
ate pre-tax rates. The discount rates used reflect the cost of
capital, an assessment of the country risk and the risks as-
sociated with individual crops. Future cash flows have been
discounted at 15%.
In determining the fair value of biological assets where
the discounting of expected cash flows has been used, the
directors have made certain assumptions as follows:-
• Expected lifespan of the plantations (Coffee trees 20
yrs and Tea bushes 30 yrs).
• The climatic conditions will remain constant.
• The selling prices to remain constant.
• The fair value of livestock is determined based on mar-
ket prices of livestock of similar age and sex.
• Production is taken as an average of five years.
• The biological transformation rate will remain at 100%.
The Group does not anticipate that coffee and tea prices will
decline significantly in the foreseeable future and therefore
has not entered into derivative or other contracts to man-
age the risk of a decline in coffee and tea prices. The Group
reviews its outlook for coffee and tea prices regularly in con-
sidering the need for active financial risk management.
25. Other Income
Gain on disposal of property, plant and equipment 79,407 101 79 101
Exchange gain 38,419 20,761 37,217 24,606
Management fees — — 27,300 27,300
Sundry income 59,366 27,633 35,250 19,112
177,192 48,495 99,846 71,119
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Change in Fair Value Recognized in Profit and
Loss—Investment Property and Timber,
Change in Revalued Amount Recognized in
Other Comprehensive Income—Property,
Plant and Equipment, including Renewable
Power Generation and Utilities, Transport,
and Energy Assets
3.321
Brookfield Asset Management, Inc. (Dec 2010)
Author’s Note
Brookfield Asset Management implemented IFRSs ef-
fective December 31, 2010, with a date of transition of
January 1, 2009. The excerpt that follows reflects the
initial application of IFRSs.
CONSOLIDATED STATEMENTS OF OPERATIONS
Years Ended December 31 (Millions, Except per Share Amounts) Note 2010 2009(1)
Total revenues $13,623 $11,218
Asset management and other services 21 365 298
Revenues less direct operating costs
Renewable power generation 21 748 777
Commercial properties 21 1,282 1,059
Infrastructure 21 221 95
Development activities 21 527 156
Private equity and finance 21 281 111
3,424 2,496
Equity accounted income 494 353




Operating costs 417 396
Current income taxes 14 97 (5)
2,168 1,661
Other items
Fair value changes 22 1,865 (2,268)
Depreciation and amortization (795) (656)
Deferred income tax 14 (43) 287
Net income (loss) $ 3,195 $ (976)
(1) Refer to Note 3 for the effects of the adoption of IFRS.
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CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME
Years Ended December 31 (Millions) 2010 2009(1)
Net income (loss) $3,195 $ (976)
Other comprehensive income
Foreign currency translation 653 2,212
Available-for-sale securities 107 142
Derivative instruments designated as cash
flow hedges (49) 99
Revaluations of property, plant and
equipment (948) (236)
Equity accounted investments (16) (130)
Taxes on above items 448 98
195 2,185
Comprehensive income $3,390 $1,209
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
(e) Revaluation Method for Property, Plant and Equipment
For certain classes of property, plant and equipment, as de-
scribed below, the company uses the revaluation method of
accounting. Property, plant and equipment measured using
the revaluation method is initially measured at cost and sub-
sequently carried at its revalued amount, being the fair value
at the date of the revaluation less any subsequent accumu-
lated depreciation and any accumulated impairment losses.
Revaluations are made on an annual basis to ensure that the
carrying amount does not differ significantly from fair value.
Where the carrying amount of an asset is increased as a re-
sult of a revaluation, the increase is recognized in other com-
prehensive income and accumulated in equity in revaluation
surplus, unless the increase reverses a previously recognized
impairment recorded through net income, in which case that
portion of the increase is recognized in net income. Where
the carrying amount of an asset is decreased, the decrease
is recognized in other comprehensive income to the extent of
any balance existing in revaluation surplus in respect of the
asset, with the remainder of the decrease recognized in net
income.
(f) Operating Assets (in part)
(i) Renewable Power Generation
Renewable power generating assets are classified as prop-
erty, plant and equipment and are accounted for using the
revaluation method. The company determines the fair value
of its renewable power generation assets using a discounted
cash flow model, which includes estimates of forecasted rev-
enue, operating costs, maintenance and other capital expen-
ditures. Discount rates are selected for each facility giving
consideration to the expected proportion of contracted to un-
contracted revenue and markets into which power is sold.
Generally, the first twenty years of cash flow are discounted
with a residual value based on the terminal value cash flows.
The fair value and estimated remaining service lives are re-
assessed on an annual basis. The company uses external
appraisers to review fair values of our renewable power gen-
erating assets on a rotating basis every three to five years.
Depreciation on power generating assets is calculated on
a straight-line basis over the estimated service lives of the
assets, which are as follows:
(Years) Useful Lives
Dams Up to 115
Penstocks Up to 60
Powerhouses Up to 115
Generators Up to 115
Other power generation assets Up to 40
Cost is allocated to significant components of power gener-
ating assets and each component is depreciated separately.
Renewable power generating assets under development
are initially recorded at cost, including pre-development ex-
penditures, unless an impairment is identified requiring a
write-down to estimated fair value.
(ii) Investment Properties
The company uses the fair value method to account for real
estate classified as investment property. A property is de-
termined to be an investment property when it is principally
held to earn rental income or for capital appreciation, or both.
Investment property also includes properties that are under
development for future use as investment property. Invest-
ment property is initially measured at cost including trans-
action costs. Subsequent to initial recognition, investment
properties are carried at fair value. Gains or losses arising
from changes in fair value are included in net income dur-
ing the period in which they arise. Fair values are primarily
determined by discounting the expected future cash flows
of each property, generally over a term of 10 years, using a
discount and terminal capitalization rate reflective of the char-
acteristics, location and market of each property. The future
cash flows of each property are based upon, among other
things, rental income from current leases and assumptions
about rental income from future leases reflecting current con-
ditions, less future cash outflows relating to such current and
future leases. The company determines fair value using both
internal and external valuations.
(iii) Timber
Standing timber is measured at fair value after deducting es-
timated selling costs and is recorded as Timber on the Con-
solidated Balance Sheets. Estimated selling costs include
commissions, levies, delivery costs, transfer taxes and du-
ties. The fair value of standing timber is calculated as the
present value of anticipated future cash flows for standing
timber before tax. Fair value is determined based on existing,
sustainable felling plans and assessments regarding growth,
timber prices and felling and silviculture costs. Changes in
fair value are recorded in net income in the period of change.
The company determines fair value using external valuations
on an annual basis.
Harvested timber is included in inventory and is measured
at the lower of fair value less estimated costs to sell at the
time of harvest and net realizable value.
Land under standing timber is accounted for using the
revaluation method and included in property, plant and equip-
ment.
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(iv) Utilities and Transport and Energy
Utilities and transport and energy assets classified as prop-
erty, plant and equipment are accounted for using the reval-
uation method. The company determines the fair value of
its utilities and transport and energy assets at their depreci-
ated replacement cost. Depreciated replacement cost is de-
termined as the current cost of reproduction or replacement
of an asset less deductions for physical deterioration and ob-
solescence. Valuations are performed internally on an annual
basis.
Depreciation on utilities and transport and energy assets is
calculated on a straight-line basis over the estimated service
lives of the components of the assets, which are as follows:
(Years) Useful Lives
Buildings and infrastructure Up to 50
Machinery and equipment Up to 40
Other utilities and transport and energy assets Up to 41
The fair value and the estimated remaining service lives are
reassessed on an annual basis.
(v) Other Property, Plant and Equipment
The company accounts for its property, plant and equipment,
which do not utilize the revaluation method, under the cost
model. These assets are initially recorded at cost and are
subsequently depreciated over the assets’ useful lives, unless
an impairment is identified requiring a write-down to estimated
fair value.
9. Property, Plant and Equipment
(Millions) Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Cost $12,026 $ 8,911 $ 7,534
Accumulated fair value changes 7,417 8,373 8,063
Accumulated depreciation (1,295) (561) —
Total $18,148 $16,723 $15,597
Accumulated fair value changes include unrealized revalua-
tions of property, plant and equipment using the revaluation
method which are recorded in revaluation surplus as a com-
ponent of equity, as well as unrealized impairment losses
recorded in net income.
The company’s property, plant and equipment relates to
our business platforms as shown in the following table:
(Millions) Note Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Renewable power generation (a) $12,443 $13,166 $12,413
Infrastructure
Utilities (b) 723 209 219
Transport and energy (c) 1,727 298 —
Timberlands (d) 688 737 809
Private equity and finance (e) 2,497 2,114 1,940
Other property, plant and equipment (f) 70 199 216
$18,148 $16,723 $15,597
(a) Renewable Power Generation
(Millions) Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Cost $ 5,533 $ 5,035 $ 4,350
Accumulated fair value changes 7,804 8,531 8,063
Accumulated depreciation (894) (400) —
Total $12,443 $13,166 $12,413
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Renewable power generation assets include the cost of the
company’s hydroelectric generating stations, wind energy,
pumped storage and natural gas-fired cogeneration facilities.
The company’s hydroelectric power facilities operate under
various agreements for water rights which extend to or are
renewable over terms through the years up to 2046.
Renewable power generation assets are accounted for un-
der the revaluation model and the most recent date of reval-
uation was December 31, 2010.
The key valuation metrics of our hydro and wind generating
facilities at the end of 2010 and 2009 are summarized below.
The valuations are impacted primarily by the discount rate
and long-term power prices.
United States Canada Brazil
Dec. 31, 2010 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2009
Discount rate 7.7% 8.2% 6.1% 7.2% 10.8% 11.0%
Terminal capitalization
rate 7.9% 8.4% 7.1% 7.9% 11.0% 11.0%
Exit date 2030 2029 2030 2029 2029 2029
The following table presents the changes to the cost of the
company’s renewable power generation assets:
(Millions) 2010 2009
Balance at beginning of year $5,035 $4,350
Additions 335 146
Foreign currency translation 163 539
Balance at end of year $5,533 $5,035
As at December 31, 2010, the cost of generating facilities
under development includes $239 million of capitalized costs
(December 31, 2009—$231 million; January 1, 2009—$253
million).
The following table presents the changes to the accumu-
lated fair value changes of the company’s power generation
assets:
(Millions) 2010 2009
Balance at beginning of year $8,531 $8,063
Accumulated fair value changes (929) (278)
Foreign currency translation 202 746
Balance at end of year $7,804 $8,531
The following table presents the changes to the accumulated
depreciation of the company’s power generation assets:
(Millions) 2010 2009
Balance at beginning of year $(400) $ —
Depreciation expense (488) (379)
Foreign currency translation (6) (21)









Cost $746 $220 $219
Accumulated depreciation (23) (11) —
Total $723 $209 $219
The company’s utilities assets are primarily comprised of
power transmission and distribution networks, and an Aus-
tralian coal terminal, which are operated primarily under reg-
ulated rate base arrangements.
Utilities assets are accounted for under the revaluation
model, and the most recent date of revaluation was Decem-
ber 31, 2010. The company determined fair value to be the
current replacement cost. The Australasian and European
operations were valued based on fair values attributed in
connection with the Prime merger.
The following table presents the changes to the cost of the
company’s utilities assets:
(Millions) 2010 2009
Balance at beginning of year $220 $219
Additions 12 12
Acquisitions through business combinations 513 4
Disposals — (45)
Foreign currency translation 1 30
Balance at end of year $746 $220
The following table presents the changes to the accumulated
depreciation of the company’s utilities assets:
(Millions) 2010 2009
Balance at beginning of year $(11) $ —
Depreciation expense (11) (10)
Foreign currency translation (1) (1)
Balance at end of year $(23) $(11)
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Cost $1,776 $299 $—
Accumulated fair value changes (32) — —
Accumulated depreciation (17) (1) —
Total $1,727 $298 $—
The following table presents the changes to the cost of the
company’s transport and energy assets:
(Millions) 2010 2009
Balance at beginning of year $ 299 $—
Additions 26 —
Acquisitions through business combinations 1,419 297
Foreign currency translation 32 2
Balance at end of year $1,776 $299
The increase in transport and energy assets during 2010
relates primarily to the acquisition of Prime Infrastructure in
December. Further details are included in Note 4.
The following table presents the changes to the accumu-
lated fair value changes of the company’s transport and en-
ergy assets:
(Millions) 2010 2009
Balance at beginning of year $ — $—
Accumulated fair value changes (33) —
Foreign currency translation 1 —
Balance at end of year $(32) $—
The following table presents the changes to the accumulated
depreciation of the company’s transport and energy assets:
(Millions) 2010 2009
Balance at beginning of year $ (1) $—
Depreciation expense (15) (1)
Foreign currency translation (1) —









Cost $922 $861 $809
Accumulated fair value changes (224) (119) —
Accumulated depreciation (10) (5) —
Total $688 $737 $809
The following table presents the change in the balance of
property, plant and equipment within the company’s timber-
lands business.
(Millions) 2010 2009
Balance at beginning of year $861 $809
Additions 40 33
Disposals (3) (11)
Foreign currency translation 24 30
Balance at end of year $922 $861
Timberland assets are accounted for under the revaluation
model and the most recent date of revaluations was Decem-
ber 31, 2010.
The following table presents the changes to the accumu-






Balance at beginning of year $(119) $ —
Accumulated fair value changes (104) (119)
Foreign currency translation (1) —
Balance at end of year $(224) $(119)
The following table presents the changes to the accumulated
depreciation of the property, plant and equipment within the
company’s timberlands business:
(Millions) 2010 2009
Balance at beginning of year $ (5) $—
Depreciation expense (5) (5)
Balance at end of year $(10) $(5)








Cost $2,951 $2,288 $1,940
Accumulated fair value changes (131) (39) —
Accumulated depreciation (323) (135) —
Total $2,497 $2,114 $1,940
Private equity and finance includes capital assets owned by
the company’s investees held directly or consolidated through
funds.
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These assets are accounted for under the cost model,
which requires the asset to be carried at its cost less any
accumulated depreciation and any accumulated impairment
losses. The following table presents the changes to the car-
rying value of the company’s property, plant and equipment
assets included in the company’s private equity and finance
operations:
(Millions) 2010 2009
Balance at beginning of year $ 2,288 $ 1,940
Additions 184 216
Acquisitions through business combinations 538 21
Disposals (123) (70)
Foreign currency translation 64 181
Balance at end of year $ 2,951 $ 2,288
The following table presents the changes to the accumu-
lated fair value changes of the company’s property, plant and
equipment within its private equity and finance operations:
(Millions) 2010 2009
Balance at beginning of year $ (39) $ —
Accumulated fair value changes (92) (39)
Balance at end of year $ (131) $ (39)
The following table presents the changes to the accumu-
lated depreciation of the company’s other property, plant and
equipment within its private equity and finance operations:
(Millions) 2010 2009
Balance at beginning of year $ (135) $ —
Depreciation expense (185) (180)
Disposals — 53
Foreign currency translation (3) (8)
Balance at end of year $ (323) $ (135)
(f) Other Property, Plant and Equipment
Other property, plant and equipment includes construction in
progress and development properties and totalled $70 million
at December 31, 2010 (December 31, 2009—$199 million;
January 1, 2009—$216 million).
10. Investment Properties
(Millions) 2010 2009
Fair value at beginning of year $19,219 $16,719
Additions 689 1,480
Acquisitions through business combinations 1,416 321
Disposals (859) (360)
Fair value adjustments 835 (888)
Foreign currency translation 863 1,947
Fair value at end of year $22,163 $19,219
The fair value of investment properties is generally deter-
mined by discounting the expected cash flows of the proper-
ties based upon internal or external valuations. All properties
are externally valued on a three year rotation plan. Certain ad-
justments have been made to external valuations conducted








Properties where fair value is
determined by external valuators $ 5,161 $7,177 $3,587
Adjustment for straight-line rentals (1) 87 12
5,160 7,264 3,599
Internal appraisals 17,003 11,955 13,120
Fair value recorded in financial
statements $22,163 $19,219 $16,719
The key valuation metrics of our commercial office properties
are presented in the following table:
United States Canada Australia
Dec. 31, 2010 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2009
Discount rate 8.1% 8.8% 6.9% 7.4% 9.1% 9.3%
Terminal capitalization rate 6.7% 6.9% 6.3% 6.7% 7.4% 7.8%
Investment horizon (years) 10 10 11 10 10 10
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Timber $ 2,807 $ 2,610 $ 2,604
Other agricultural assets 399 358 235
Total $ 3,206 $ 2,968 $ 2,839
The company held 1,447 million acres of consumable free-
hold timber at December 31, 2010 (December 31, 2009—
1,445 million), of which approximately 854 million (December
31, 2009—855 million) acres were classified as mature and
available for harvest.
The following table presents the change in the balance of
standing timber within the company’s timber business:
(Millions) 2010 2009
Balance at beginning of year $2,610 $2,604
Additions 52 —
Fair value adjustments 282 54
Decrease due to harvest (139) (88)
Foreign currency changes 2 40
Balance at end of year $2,807 $2,610
The carrying values are based on external appraisals that
are completed annually. Key valuation assumptions include
a weighted average discount and terminal capitalization rate
of 6.6% (2009—6.5%) and an average terminal valuation date
of 75 years. Timber prices were based on a combination of
forward prices available in the market and the price forecasts
of each appraisal firm.
22. Fair Value Changes
Fair value changes consist of mark-to-market gains (losses)
and are comprised of the following:
For the Years Ended December 31 (Millions) 2010 2009
Investment property $ 835 $ (888)
Timber 143 (34)
Infrastructure 405 —
Equity accounted investments 271 (779)
Power contracts 588 3
Redeemable units (159) (244)
Interest rate contracts (58) 74
Other (160) (400)
$1,865 $(2,268)
IAS 12, INCOME TAXES
Author’s Note
In December 2010, the IASB issued Deferred Tax: Re-
covery of Underlying Assets: Proposed amendments to
IAS 12. The amendments are effective for annual pe-
riods beginning on or after 1 January 2012, with early
application permitted. Given the issue and effective
dates, no survey companies would have applied these
amendments to their 2010 financial statements. See
the author’s note preceding paragraph 2.367 in section
2 for a discussion of these amendments and the re-
maining issues in this project. The IASB does not plan
to address other issues in the IAS 12, Income Taxes,
project until the latter half of 2011.
IFRS Overview and Comparison
to U.S. GAAP
3.322 The objective of IAS 12 is to establish accounting
for the current and future tax consequences of taxes levied
on income by taxation authorities. Because accounting for
financial reporting and accounting for tax purposes may be
different, an entity should recognize in its financial state-
ments the current and future tax consequences from the fu-
ture recovery of the carrying amount of assets, the future
settlement of its liabilities, transactions, and other events in
the current period.
Author’s Note
Both IAS 12 and U.S. GAAP use the asset-liability ap-
proach to measuring current and deferred tax expense
and the carrying amounts of current and deferred tax
assets and liabilities. Issues associated with income
taxes not directly related to the effects of these require-
ments on the statement of comprehensive income are
addressed in the “IAS 12” subsection of section 2.
Recognition and Measurement
IFRSs
3.323 IAS 12 generally requires an entity to recognize cur-
rent and deferred tax income or expense in profit or loss for
the period. However, to the extent that the temporary differ-
ence arises from a business combination or a transaction or an
event recognized in other comprehensive income or directly
in equity, an entity should recognize the current or deferred
tax income or expense in other comprehensive income or
directly in equity, respectively.
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3.324 An entity should recognize current or deferred tax
income or expense in other comprehensive income when it
relates to items recognized in other comprehensive income
and directly in equity when it relates to items recognized
directly in equity. Examples of items recognized in other
comprehensive income are changes in the carrying amount
of PPE held under the revaluation method or changes in
fair value of financial assets classified as available for sale.
Examples of items recognized directly in equity include ad-
justments to retained earnings from a change in accounting
policy and amounts arising on initial recognition of the equity
component of a compound financial instrument.
3.325 IAS 12 provides additional specific guidance to en-
tities in accounting for deferred tax arising in a business
combination and share-based payment transactions.
U.S. GAAP
3.326 FASB ASC 740, Income Taxes, establishes standards
for accounting and reporting for income taxes that are cur-
rently payable and for the tax consequences of all of the
following:
• Revenues, expenses, gains, or losses that are included
in taxable income in an earlier or later year than the
year in which they are recognized in financial income
• Other events that create differences between the tax
bases of assets and liabilities and their amounts for
financial reporting
• Operating loss or tax credit carrybacks for refunds of
taxes paid in prior years and carryforwards to reduce
taxes payable in future years
3.327 Like IFRSs, FASB ASC 740-10-30-3 requires an en-
tity to measure the total income tax expense (or benefit) for
the year as the sum of deferred tax expense (or benefit) and
income taxes currently payable or refundable. The measure-
ment of the expense is dependent on an entity’s measurement
of the carrying values of related assets and liabilities. FASB
ASC 740-10-30-2 requires entities to measure current and
deferred tax expense in the following manner:
• Unlike IFRSs, an entity should measure current and
deferred tax liabilities and assets based on provisions
of the enacted tax law. The effects of future changes in
tax laws or rates are not anticipated. IFRSs permit the
use of substantially enacted tax laws.
• Like IFRSs, an entity should reduce the carrying value
of deferred tax assets, if necessary, by the amount of
any tax benefits that, based on available evidence, the
entity does not expect to realize.
FASB ASC glossary defines deferred tax expense (or benefit)
as the change during the year in an entity’s deferred tax
liabilities and assets.
3.328 FASB ASC 740 includes extensive guidance on ac-
counting for income taxes that far exceeds the guidance in
IAS 12 on measurement of current and deferred tax assets
and liabilities and the resultant benefit or expense.
Presentation
IFRSs
3.329 An entity should present tax expense or income from
ordinary activities in the statement of comprehensive income.
When using the two-statement format and presenting the
components of profit and loss in a separate statement, it
should also present tax expense or income from ordinary
activities in that statement.
3.330 IAS 1 permits an entity to show items of other com-
prehensive income either net of related tax effects or before
tax effects, with one amount presented for the total tax effect
of these items.
3.331 IAS 1 requires an entity to disclose separately the
amount of income tax relating to each component of other
comprehensive income. However, IAS 1 allows two alterna-
tive presentations of income tax effects in the statement of
comprehensive income. An entity may present either
• each component of comprehensive income net of re-
lated tax or
• each component of comprehensive income pretax, with
one line item for the aggregate amount of income tax
on all components.
U.S. GAAP
3.332 Paragraphs 14 and 25 of FASB ASC 740-10-45 pro-
vide limited guidance to nonpublic entities on presentation in
the income statement of interest and penalties and the effects
of changes in deferred tax accounts caused by the following
changes:
• In tax laws or rates
• In the tax status of an entity (for example, an entity’s
change from a corporation to a partnership)
• Affecting the valuation allowance for deferred tax as-
sets related to the realizability of the deferred tax asset
in future years
• Related to assets acquired outside of a business combi-
nation.
3.333 For public entities, SEC Regulation S-X and various
SEC Staff Accounting Bulletin topics establish presentation
requirements, including the requirement to separately present
income tax expense on the face of the income statement.
Disclosure
IFRSs
3.334 IAS 12 requires entities to disclose the following ma-
jor components of income tax expense:
• Current tax income or expense
• Adjustments in the period for current tax of other peri-
ods
• Deferred tax income or expense from origination or
reversal of temporary differences
• Deferred tax income or expense from changes in tax
rates or laws
• Benefits from previously unrecognized tax loss or tax
credit carryforwards
• Deferred tax expense (income) from write-downs (or
reversals) of deferred tax assets
• Tax income or expense resulting from a change in ac-
counting policy or errors (when included in profit and
loss because they cannot be accounted for retrospec-
tively)
3.335 Entities should separately disclose the aggregate
amount of current and deferred income tax income or expense
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relating to items charged to other comprehensive income or
directly to equity.
3.336 Entities should explain the relationship between tax
income or expense and accounting profit by disclosing either
or both of the following reconciliations:
• The amount of reported income tax income or expense
to the expected amount based on applicable tax rate(s)
• The average effective tax rate to the applicable tax
rate(s)
3.337 In both cases, entities should disclose the basis on
which the applicable tax rate was computed. Entities should
explain any differences in the applicable tax rate(s) from the
previous period.
3.338 When an entity prepares the reconciliation disclo-
sure, it should use an applicable tax rate that provides the
most meaningful information to financial statement users.
This tax rate is often the domestic tax rate of the country in
which the entity is domiciled, taking into account both na-
tional and local tax rates. However, when an entity operates
in multiple jurisdictions, it may determine that aggregating
separate reconciliations prepared using the domestic rate in
each individual jurisdiction is more meaningful.
3.339 With respect to discontinued operations, entities
should disclose the tax expense or income from gains or
losses on discontinuance and profit or loss of the discontin-
ued operation for all periods presented.
U.S. GAAP
3.340 Like IFRSs, FASB ASC 740-10-50-9 requires entities
to disclose the significant components of income tax expense,
with the following additions:
• Government grants (to the extent recognized as a re-
duction of income tax expense)
• Benefits of operating loss carryforwards
• The tax expense from allocating certain tax benefits
directly to contributed capital
• Adjustments to the deferred tax assets or liabilities as a
result of enacted changes in tax laws or a change in the
entity’s tax status
• Adjustments to the beginning of a valuation allowance
as a result of a change to the assessment of the ability
of the entity to recover the deferred tax asset (IFRSs do
not currently use valuation allowances)
3.341 FASB ASC 740-10-50-10 also requires an entity
to disclose the amount of income tax benefit or expense
allocated to continuing operations and the amounts sepa-
rately allocated to other items (in accordance with the re-
quirements for intraperiod tax allocation) for each year these
items are presented. IAS 12 has no requirements or guidance
on intraperiod tax allocation.
3.342 Like IFRSs, FASB ASC 740-10-50 requires reconcil-
iations from reported to statutory amounts. As required by
FASB ASC 740-10-50-12, a public entity should disclose a
reconciliation of reported income tax benefit or expense to
the expected amount using percentages or dollar amounts of
the reported income tax income or expense attributable to
continuing operations to the amount that would result from
applying domestic federal statutory tax rates to pretax income
from continuing operations. The entity should use the regu-
lar statutory tax rates even if there are alternatives. An entity
should disclose both the estimated amount and the nature
of each significant reconciling item. FASB ASC 740-10-50-
13 states that a nonpublic entity should disclose the nature
of significant reconciling items but may omit a numerical
reconciliation.
Author’s Note
Rule 4.08(h)(2) of SEC Regulation S-X requires SEC
registrants applying U.S. GAAP to provide a reconcil-
iation between the amount of reported total income tax
expense (benefit) and the amount computed by multi-
plying the income (loss) before tax by the applicable
statutory federal income tax rate, showing the esti-
mated dollar amount of each of the underlying causes
for the difference. However, when the reporting person
is a foreign entity (foreign private issuer), the entity
should normally use the income tax rate in that en-
tity’s country of domicile when making the preceding
computation. Different rates should not be used for
subsidiaries or other segments of a reporting entity.
When the rate used by a reporting person is other than
the United States federal corporate income tax rate, an
entity should disclose the rate used and the basis for
using such rate. When such foreign private issuers pre-
pare their financial statements in accordance with U.S.
GAAP, rather than IFRSs, they prepare this reconcil-
iation based on the statutory rate in their country of
domicile, whether they file their financial statements
on Form 10-K or Form 20-F. In contrast, IAS 12 per-
mits an entity to reconcile tax expense reported on the
income statement to tax expense computed at either
the statutory tax rate in the country of domicile or a
weighted average tax rate.
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Presentation and Disclosure Excerpts
Effects of Change in Tax Rate,
Disaggregation of Tax Effects of Items
Recognized in Other Comprehensive Income
3.343
Portugal Telecom, SGPS, S.A. (Dec 2010)
CONSOLIDATED INCOME STATEMENT









Services rendered 6 3,516,023,963 3,491,970,083 3,503,372,062
Sales 6 165,615,850 197,167,935 217,715,279
Other revenues 6 60,614,025 44,266,786 40,107,789
6 3,742,253,838 3,733,404,804 3,761,195,130
Costs, Losses and (Income)
Wages and salaries 8 637,115,622 546,689,537 489,427,809
Direct costs 9 547,559,101 522,353,576 520,813,168
Costs of products sold 10 179,893,915 207,256,041 244,763,139
Marketing and publicity 81,096,858 78,608,913 87,875,463
Supplies and external services 11 724,519,676 733,310,901 695,635,262
Indirect taxes 13 45,418,246 57,816,564 45,932,970
Provisions and adjustments 39 34,951,944 30,505,493 28,960,873
Depreciation and amortization 33 and 34 758,567,813 716,851,789 647,458,683
Net post retirement benefits costs 14 38,209,838 89,630,520 44,759,000
Curtailment and settlement costs 14 145,513,252 14,804,659 99,955,165
Gains on disposal of fixed assets, net (5,542,839) (1,955,803) (18,259,719)
Other costs, net 15 141,194,008 45,609,985 22,559,957
3,328,497,434 3,041,482,175 2,909,881,770
Income before financial results and taxes 413,756,404 691,922,629 851,313,360
Financial Losses and (Gains)
Net interest expenses 16 185,044,935 227,491,155 205,421,137
Net foreign currency exchange losses 6,814,213 212,867 (3,595,745)
Net gains on financial assets and other investments 17 (1,860,287) (8,067,568) (12,102,127)
Equity in earnings of associated companies, net 31 (141,709,104) (456,043,545) (170,975,397)
Net other financial losses 18 33,300,530 35,715,551 13,670,186
81,590,287 (200,691,540) 32,418,054
Income before taxes 332,166,117 892,614,169 818,895,306
Income taxes 19 77,525,848 185,890,157 204,759,627
Net income from continuing operations 254,640,269 706,724,012 614,135,679
Discontinued Operations
Net income from discontinued operations 20 5,565,426,533 82,462,164 81,686,075
Net income 5,820,066,802 789,186,176 695,821,754
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Income and Expenses Recognised Directly in Shareholders’
Equity
Foreign currency translation adjustments
Translation of foreign operations(i) 433,946,646 942,188,037 (764,998,457)
Transferred to profit and loss(ii) (1,166,099,952) (21,603,864) —
Post retirement benefits
Net actuarial gains (losses) 14 (450,674,906) 164,773,415 (594,809,172)
Tax effect(iii) 19 85,748,128 (43,664,955) 157,624,431
Hedge accounting of financial instruments
Change in fair value (3,791,679) (2,407,036) (1,238,300)
Transferred to profit and loss 42 3,859,739 1,633,364 (44,646)
Tax effect 19 (18,037) 205,023 339,983
Other expenses recognised directly in shareholders’ equity, net (11,283,072) (5,901,102) (3,943,124)
(1,108,313,133) 1,035,222,882 (1,207,069,285)
Reserves Recognised Directly in Shareholders’ Equity
Revaluation of real estate and of the wireline’s ducts infrastructure 34 — — 1,075,033,022
Reassessement of the deferred tax liability related to the revaluation
of assets(iv) 19 14,181,908 12,116,738 (284,346,234)
14,181,908 12,116,738 790,686,788
Total earnings and reserves recognised directly in shareholders’ equity (1,094,131,225) 1,047,339,620 (416,382,497)
Income recognised in the income statement 5,820,066,802 789,186,176 695,821,754
Total income recognised 4,725,935,577 1,836,525,796 279,439,257
(i) Gains recorded in the years ended 31 December 2010 and 2009 are mainly related to the appreciation of the Brazilian Real against the Euro,
including primarily gains regarding Portugal Telecom’s investment in Brasilcel amounting to Euro 337 million in 2010, up to the date of sale,
and Euro 882 million in 2009. Losses recorded in the year ended 31 December 2008 are primarily related to the depreciation of the Brazilian
Real against the Euro.
(ii) In 2010, this caption includes an amount of Euro 1,134,159,099 (Note 20) corresponding to the cumulative amount of foreign currency
translation adjustments relating to the investment in Brasilcel, which was reclassified to profit and loss upon the disposal of this investment
in September 2010 (Note 1). In addition, this caption includes the amounts of Euro 31,940,853 and Euro 21,603,864 in 2010 and 2009 (Note
20), respectively, resulting from the transfer of a portion of accumulated foreign currency translation adjustments related to the investment
in Brasilcel, following a repayment of part of this investment through share capital reductions occurred at this company prior to its disposal.
(iii) This caption includes the tax effect related to the net actuarial losses and gains recorded in the years ended 31 December 2010, 2009 and
2008, respectively, and a loss of Euro 26,924,481 recognised in 2010 resulting from a reduction on the applicable tax rate from 26.5% to
25.0%, occurred during the year 2010.
(iv) In 2010, this caption corresponds to the impact on deferred tax liabilities resulting from a reduction on the applicable tax rate. In 2009,
following the decision to transfer certain real estate assets to the pension funds, and in accordance with IAS 12 Income Taxes, the deferred
tax liability related to the revaluation of these assets was adjusted in order to reflect the manner in which Portugal Telecom expected to
recover the carrying amount of these assets.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Accounting Policies, Judgments and Estimates
(in part)
o) Taxation
Income tax is recognised in accordance with IAS 12, income
tax expense represents the sum of the tax currently payable
and deferred tax.
Portugal Telecom has adopted the tax consolidation regime
in Portugal (currently known as the special regime for the tax-
ation of groups of companies). The provision for income taxes
is determined on the basis of the estimated taxable income
for all the companies in which Portugal Telecom holds at least
90% of the share capital and that are domiciled in Portugal
and subject to Corporate Income Tax (IRC). The remaining
Group companies not covered by the tax consolidation regime
of Portugal Telecom are taxed individually based on their re-
spective taxable income, at the applicable tax rates.
The tax currently payable is based on taxable income for
the period, and the deferred tax is based on differences be-
tween the carrying amounts of assets and liabilities of the
financial statements and the corresponding tax bases used
in the computation of taxable profit, and is accounted for using
the liability method.
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Deferred tax liabilities are generally recognised for all tax-
able temporary differences, and deferred tax assets are
recognised to the extent that it is reasonably likely that taxable
income will be available against which deductible temporary
differences can be used, or when there are deferred tax li-
abilities whose reversal is expected in the same period in
which the deferred tax assets reverse. The carrying amount
of deferred tax assets is reviewed at the date of the Con-
solidated Statement of Financial Position and is reduced to
the extent that it is no longer probable that sufficient taxable
income will be available to allow for all or part of the asset to
be recovered.
Deferred tax is charged to net income, except when it re-
lates to items charged or credited directly to shareholders’ eq-
uity, in which case the deferred tax is also recognised directly
in shareholders’ equity. Accordingly, the impact of changes
in tax rate is also charged to net income, except when it re-
lates to items charged or credited directly to shareholders’
equity, in which case that impact is also recognised directly
in shareholders’ equity.
Cash flows are classified in the Consolidated Statement of
Cash Flows according to three main categories, depending
on their nature: (1) operating activities; (2) investing activi-
ties; and (3) financing activities. Cash flows from operating
activities include primarily collections from clients, payments
to suppliers, payments to employees, payments relating to
post retirement benefits and net payments relating to income
taxes and indirect taxes. Cash flows from investing activities
include primarily acquisitions and disposals of investments,
dividends received from associated companies and purchase
and sale of property, plant and equipment. Cash flows from
financing activities include primarily borrowings and repay-
ments of debt, payments of lease rentals, payments relating
to interest and related expenses, acquisition and sale of trea-
sury shares and payments of dividends to shareholders.
19. Income Taxes
Portugal Telecom and its subsidiaries located in Portugal are
subject to Corporate Income Tax at a rate of 25%, which is
increased by a maximum of 1.5% of collectible profit through
a municipal tax and, following a change in tax legislation oc-
curred in 2010, by another 2.5% of collectible profit above
Euro 2 million, leading to a maximum aggregate tax rate of
approximately 29%. In 2009 and 2008, Portugal Telecom and
its subsidiaries located in Portugal were subject to an aggre-
gate tax rate of approximately 26.5%.
Portugal Telecom adopted the tax consolidation regime for
groups of companies, which apply to all companies located
in Portugal in which it holds at least 90% of the capital stock
and that comply with Article 69 of the Portuguese Corporate
Income Tax Law.
Subsidiaries located in Brazil are subject to income taxes
at a nominal rate of 34%.
In accordance with Portuguese tax legislation, income tax
returns are subject to review and adjustment by the tax au-
thorities during a period of four calendar years (five years for
social security, and ten years for the contributions made with
respect to the years before 2001), except when there are tax
losses, tax benefits were granted, or when tax inspections,
claims or appeals are in progress, in which case the time peri-
ods are extended or suspended. In Brazil, income tax returns
are subject to review and adjustment by the tax authorities
during a period of five calendar years. The Board of Directors
of Portugal Telecom, based on information from its tax ad-
visors, believes that any adjustments which may result from
such reviews, as well as other tax contingencies, will not have
a material impact on the consolidated financial statements as
at 31 December 2010, considering the provisions recognised
by the Company (Note 39).
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a) Deferred Taxes
During the years ended 31 December 2010 and 2009, the
movements in deferred tax assets and liabilities were as fol-
lows:































Accrued post-retirement liability 395,049,525 (7,683,306) 112,672,609 (979,097) (26,924,481) — — — 472,135,250
Tax losses carryforward 211,674,665 (29,986,431) — — — 18,238,721 — (199,926,955) —
Provisions and adjustments 123,278,281 8,382,717 — 3,143,037 — 6,786,636 (65,168) (82,680,665) 58,844,838
Additional contribution to pension
funds 124,179,032 (30,611,749) — (1,048,236) — — — — 92,519,047
Financial instruments 1,114,304 3,343,070 (18,037) — — — — — 4,439,337
Other 164,215,321 (7,315,930) — (277,578) — 13,613,254 4,612,194 (149,710,535) 25,136,726
1,019,511,128 (63,871,629) 112,654,572 838,126 (26,924,481) 38,638,611 4,547,026 (432,318,155) 653,075,198
Deferred Tax Liabilities
Revaluation of fixed assets 258,470,817 (15,782,658) — — (14,181,908) — (94,241) — 228,412,010
Gains on disposals of investments 2,050,322 (322,381) — (105,824) — — — — 1,622,117
Financial instruments(v) — — 15,143,542 — — — — — 15,143,542
Other(vi) 222,591,195 (43,609,089) 720,691 508,561 (23,354) 20,008,228 717,527 (134,494,091) 66,419,668
483,112,334 (59,714,128) 15,864,233 402,737 (14,205,262) 20,008,228 623,286 (134,494,091) 311,597,337
(4,157,501) 96,790,339 435,389 (12,719,219) 18,630,383 3,923,740 (297,824,064)
(i) Changes in the consolidation perimeter correspond to 50% of Vivo’s deferred tax assets and liabilities following the completion of the disposal of the 50% stake
in Brasilcel in September 2010.
(ii) The split between continuing and discontinued operations of changes in deferred taxes recorded through net income in 2010 and 2009 is as follows:
Euro 2010 2009
Continuing operations 24,867,108 (74,556,616)
Discontinued operations (28,589,220) (1,683,596)
(3,722,112) (76,240,212)
(iii) The impacts on net income resulting from changes in tax rate correspond primarily to the revision of the tax rate applicable for certain companies located in
Portugal, namely related to the above mentioned increase in the statutory tax rate in Portugal and to the decrease in the tax rate applicable for certain companies
that are expected to present tax losses in the following years.
(iv) Foreign currency translation adjustments are primarily related to the impact of the appreciation of the Brazilian Real against the Euro up to the completion of
the disposal of the 50% stake in Brasilcel.
(v) The increase in this caption corresponds to the tax effect associated with the equity component of the exchangeable bond obtained by Portugal Telecom in
2007 (Note 35), which was recognized as a result of changes occurred in the Portuguese tax legislation in 2010.
(vi) Other deferred tax liabilities correspond primarily to the tax effect on unpaid dividends from associated companies.
Euro
Balance 1 Jan












Accrued post-retirement liability 486,352,878 (47,638,398) (43,664,955) — — 395,049,525
Tax losses carryforward 172,831,198 (9,617,812) — 49,100,037 (638,758) 211,674,665
Provisions and adjustments 91,149,723 17,751,740 — 16,351,942 (1,975,124) 123,278,281
Additional contribution to pension funds 138,567,071 (14,388,039) — — — 124,179,032
Financial instruments 14,380,500 (13,135,260) 205,023 (335,959) — 1,114,304
Other 129,442,609 38,280 — 32,779,871 1,954,561 164,215,321
1,032,723,979 (66,989,489) (43,459,932) 97,895,891 (659,321) 1,019,511,128
Deferred Tax Liabilities
Revaluation of fixed assets(ii) 290,970,684 (18,809,606) (12,116,738) — (1,573,523) 258,470,817
Gains on disposals of investments 2,378,683 (328,361) — — — 2,050,322
Other 168,843,403 28,388,690 — 27,625,503 (2,266,401) 222,591,195
462,192,770 9,250,723 (12,116,738) 27,625,503 (3,839,924) 483,112,334
(76,240,212) (31,343,194) 70,270,388 3,180,603
(i) Foreign currency translation adjustments are primarily related to the impact of the appreciation of the Brazilian Real against the Euro.
(ii) Following the contributions in kind to the pension funds of certain real estate properties made at the end of 2009, as mentioned in Note 14, the ddeferred tax
liability related to the revaluation of these assets was adjusted in order to reflect the manner in which Portugal Telecom expected to recover the carrying
amounts of these assets. This effect, amounting to Euro 12,116,738, was recognised in the Consolidated Statement of Comprehensive Income and,
subsequently, the remaining deferred tax liability related to these assets was recognised in the Consolidated Income Statement.
As at 31 December 2010 and 2009, total deferred tax assets include respectively Euro 19 million and Euro 441 million from foreign countries, and total
deferred tax liabilities include respectively Euro 64 million and Euro 221 million from foreign countries. As at 31 December 2009, deferred tax assets and
liabilities from foreign countries were primarily related to Portugal Telecom’s investment in Vivo.
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b) Reconciliation of Income Tax Provision
The reconciliation between the nominal and the effective in-
come tax expense for the years ended 31 December 2010,
2009 and 2008 is as follows:
Euro 2010 2009 2008
Income before taxes 332,166,117 892,614,169 818,895,306
Statutory tax rate 29.0% 26.5% 26.5%
96,328,174 236,542,755 217,007,256
Gain resulting from a corporate restructuring(i) (59,045,199) — —
Permanent differences(ii) 36,619,875 (56,177,090) (12,890,872)
Increases and reductions in provisions for income tax contingencies (Notes 28 and 39) 13,795,652 (1,434,464) 7,555,841
Difference in tax rates(iii) (8,276,417) 4,846,141 6,648,894
Tax losses from previous periods 4,520,000 (3,823,664) (5,389,597)
Adjustments to the provision for income taxes of the previous year (Note 28) (3,697,527) 6,541,389 (6,431,797)
Change in tax rate (435,389) — —
Other (2,283,321) (604,910) (1,740,098)
77,525,848 185,890,157 204,759,627
Income tax
Income tax-current (Note 28) 102,392,956 111,333,541 141,377,821
Deferred taxes(iv) (24,867,108) 74,556,616 63,381,806
77,525,848 185,890,157 204,759,627
(i) This gain is primarily related to a corporate restructuring of African businesses that resulted in the decrease of deferred tax liabilities related
to unpaid dividends from associated companies, following a reduction in the estimated applicable tax rate from 26.5% to 10%.
(ii) In 2010, this caption is primarily related to the following non-taxable costs: (1) an impairment loss of Euro 28 million relating to the
investment in UOL (Note 31), (2) interest expenses incurred by Portugal Telecom in connection with the acquisition of financial investments;
and (3) expenses incurred in 2010 for services rendered in relation to the acquisition of an investment in Oi Group (Note 47). In 2009, this
caption includes primarily Euro 70,748,542 resulting from the non-taxable gain amounting to Euro 266,975,632 related to the disposal of
the investment in Médi Télécom. In 2008, this caption includes Euro 2,397,005 and Euro 2,304,973 resulting from the non-taxable gains
amounting to Euro 9,045,300 and Euro 8,822,351 related to the disposals of the investments in Banco Best and Africatel, respectively.
(iii) This caption corresponds to the impact related to the difference between the statutory tax rate applicable in Portugal and other tax rates
applicable to Group companies, namely foreign operations.
(iv) The change in this caption is primarily explained by the impact of the corporate restructuring of African businesses (Euro 59 million), as
explained above, and a lower reduction in deferred tax assets related to accrued post-retirement liability as a result of lower payments and
contributions deductible for tax purposes in 2010.
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Tax Effects of Discontinued Operations, Items
Recognized in Other Comprehensive Income
Shown Net of Tax
3.344
China Yuchai International Limited (Dec 2010)
CONSOLIDATED INCOME STATEMENTS (in part)












Sales of goods 8 10,358,124 13,139,578 16,138,580 2,461,500
Rendering of services 8 46,664 36,325 69,604 10,616
Revenue 8 10,404,788 13,175,903 16,208,184 2,472,116
Cost of sales (goods) (8,328,058) (10,612,260) (12,112,215) (1,847,388)
Cost of sales (services) (27,594) (17,825) (87,038) (13,275)
Gross profit 2,049,136 2,545,818 4,008,931 611,453
Other operating income 9.2a 28,465 93,668 129,075 19,687
Other operating expenses 9.2b (9,005) (16,113) (41,447) (6,322)
Research and development costs 9.1, 9.3 (184,794) (297,259) (324,123) (49,436)
Selling, distribution and administrative costs 9.1 (1,268,060) (1,471,857) (1,822,764) (278,013)
Operating profit 615,742 854,257 1,949,672 297,369
Finance costs 9.4 (150,409) (77,493) (130,446) (19,896)
Share of profit of associates 6 2,717 2,954 (121) (18)
Share of results of joint ventures 7 13,692 (16,000) (53,902) (8,221)
Gain on acquisition of Guangxi Yulin Hotel Company in
settlement of past loan 31 — 202,950 — —
Profit before tax from continuing operations 481,742 966,668 1,765,203 269,234
Income tax expense 10 (110,526) (147,223) (327,946) (50,019)
Profit for the year from continuing operations 371,216 819,445 1,437,257 219,215
Discontinued Operations
(Loss)/profit after tax for the year from discontinued
operations 11 (33,985) 13,022 12,655 1,930
Profit for the year 337,231 832,467 1,449,912 221,145
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME










Profit for the year 337,231 832,467 1,449,912 221,145
Other Comprehensive (Loss)/Income
Foreign currency translation 10,343 (11,201) (22,084) (3,369)
Share of other comprehensive (loss)/income of associates (90,265) 21,038 — —
Others 4,740 (647) — —
Other comprehensive (loss)/income for the year, net of tax (75,182) 9,190 (22,084) (3,369)
Total comprehensive income for the year, net of tax 262,049 841,657 1,427,828 217,776
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)




Current income tax assets and liabilities for the current and
prior periods are measured at the amount expected to be
recovered from or paid to the taxation authorities. The tax
rates and tax laws used to compute the amount are those that
are enacted or substantively enacted, at the reporting date
in the countries where the Group operates and generates
taxable income.
Current income tax relating to items recognised directly in
consolidated statement of comprehensive income is recog-
nised in consolidated statement of comprehensive income
and not in the income statement. Management periodically
evaluates positions taken in the tax returns with respect to
situations in which applicable tax regulations are subject to
interpretation and establishes provisions where appropriate.
Deferred Tax
Deferred tax is provided using the liability method on tempo-
rary differences at the reporting date between the tax bases of
assets and liabilities and their carrying amounts for financial
reporting purposes.
Deferred tax liabilities are recognised for all taxable tem-
porary differences, except:
• Where the deferred tax liability arises from the initial
recognition of goodwill or of an asset or liability in a
transaction that is not a business combination and, at
the time of the transaction, affects neither the account-
ing profit nor taxable profit or loss; and
• In respect of taxable temporary differences associated
with investments in subsidiaries, associates and inter-
ests in joint ventures, where the timing of the reversal
of the temporary differences can be controlled and it is
probable that the temporary differences will not reverse
in the foreseeable future.
Deferred tax assets are recognised for all deductible tempo-
rary differences, carry forward of unused tax credits and un-
used tax losses, to the extent that it is probable that taxable
profit will be available against which the deductible temporary
differences, and the carry forward of unused tax credits and
unused tax losses can be utilised, except:
• Where the deferred tax asset relating to the deductible
temporary difference arises from the initial recognition of
an asset or liability in a transaction that is not a business
combination and, at the time of the transaction, affects
neither the accounting profit nor taxable profit or loss;
and
• In respect of deductible temporary differences associ-
ated with investments in subsidiaries, associates and
interests in joint ventures, deferred tax assets are recog-
nised only to the extent that it is probable that the tem-
porary differences will reverse in the foreseeable future
and taxable profit will be available against which the
temporary differences can be utilised.
The carrying amount of deferred tax assets is reviewed at
each reporting date and reduced to the extent that it is no
longer probable that sufficient taxable profit will be available
to allow all or part of the deferred tax asset to be utilised.
Unrecognised deferred tax assets are reassessed at each
reporting date and are recognised to the extent that it has
become probable that future taxable profits will allow the de-
ferred tax asset to be recovered.
Deferred tax assets and liabilities are measured at the tax
rates that are expected to apply in the year when the asset is
realised or the liability is settled, based on tax rates (and tax
laws) that have been enacted or substantively enacted at the
reporting date.
Deferred tax relating to items recognised outside profit
or loss is recognised outside profit or loss. Deferred tax
items are recognised in correlation to the underlying trans-
action either in other comprehensive income or directly in
equity.
Deferred tax assets and deferred tax liabilities are offset,
if a legally enforceable right exists to set off current tax as-
sets against current income tax liabilities and the deferred
taxes relate to the same taxable entity and the same taxation
authority.











Current income tax charge 87,676 222,047 332,524 50,717
Adjustments in respect of current income tax of previous year 4,942 5,999 3,257 497
Deferred Tax:
Relating to origination and reversal of temporary differences 17,908 (79,632) (5,400) (824)
Adjustments in respect of deferred tax of previous year — (1,191) (2,435) (371)
Income tax expense reported in the income statement 110,526 147,223 327,946 50,019
IFRS ATT 3.344
454 IFRS Accounting Trends & Techniques
Income tax expense reported in the consolidated statements
of income differs from the amount computed by applying the
PRC income tax rate of 15% (being tax rate of Yuchai) for










Computed tax expense 72,261 145,000 264,780 40,385
Adjustments resulting from:
Non-deductible expenses 19,326 808 10,432 1,591
Tax-exempt income — (43,143) (2,994) (457)
Utilisation of deferred tax benefits previously not recognised 858 165 (1,792) (273)
Deferred tax benefits not recognised 10,491 4,968 3,381 516
Tax credits for R&D expense (10,169) (14,563) (17,556) (2,678)
Tax rate differential (2,017) 33,516 25,027 3,816
Underprovision in respect of prior years
—Current 4,942 5,999 3,257 497
—Deferred — (1,191) (2,435) (371)
Withholding tax expense 15,282 15,664 45,846 6,993
Others (448) — — —
Total 110,526 147,223 327,946 50,019
Deferred Tax
Deferred tax relates to the following:















Deferred Income Tax Liabilities
Accelerated tax depreciation (354) (42) (6) — — 347 53
Unremitted earnings from overseas
source income (440) (440) (67) — — — —
Expenditure currently deferred for
tax purpose (100) — — — — 100 15
PRC withholding tax on dividend
income (30,946) (76,792) (11,713) (15,282) (15,664) (45,846) (6,993)
(31,840) (77,274) (11,786) (15,282) (15,664) (45,399) (6,925)
Deferred Income Tax Assets
Accelerated accounting depreciation 9,508 8,418 1,284 (22,781) 1,025 (1,090) (166)
Write down of inventory 45,190 36,104 5,507 11,079 14,987 (9,086) (1,386)
Allowance for doubtful debts 15,040 9,872 1,506 (8,431) (5,861) (5,168) (788)
Accruals 120,931 192,173 29,311 7,383 45,526 71,242 10,866
Tax value of loss carried forward 1,191 2,480 378 2,323 (1,132) 1,307 199
Deferred income 41,312 35,669 5,440 7,918 33,395 (5,643) (861)
Others 8,546 10,218 1,558 (117) 8,547 1,672 256
241,718 294,934 44,984 (2,626) 96,487 53,234 8,120
Deferred tax assets and liabilities are recognised for the fu-
ture tax consequences attributable to differences between
the financial statement carrying amounts of existing assets
and liabilities and their respective tax bases and operating
loss and tax credit carry-forwards. Deferred tax assets and
liabilities are measured using enacted or substantially en-
acted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets
and liabilities of a change in tax rates, if any, is recognised in
the statements of operations in the period that includes the
enactment date.
Deferred tax expense related to share of other compre-
hensive income of associates amounted to Rmb nil (US$ nil)
(2009: Rmb nil; 2008: Rmb nil).
The Group has been granted tax credits in relation to ap-
proved research and development costs. According to the
relevant laws and regulations in the PRC prior to the new
CIT law, the amount of credits relating to the purchase of cer-
tain domestic equipment entitled for deduction each year is
limited to the incremental current income tax expense of the
subsidiary for the year compared to the income tax expense
of the subsidiary in the year immediately prior to the year the
credit was approved.
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The CIT law also provides for a tax of 10% to be withheld
from dividends paid to foreign investors of PRC enterprises.
This withholding tax provision does not apply to dividends
paid out of profits earned prior to January 1, 2008. Beginning
on January 1, 2008, a 10% withholding tax will be imposed
on dividends paid to us, as a non-resident enterprise, unless
an applicable tax treaty provides for a lower tax rate and
the Company will recognise a provision for withholding tax
payable for profits accumulated after December 31, 2007 for
the earnings that we do not plan to indefinitely reinvest in the
PRC enterprises. As at December 31, 2010, the provision for
withholding tax payable was Rmb 76,792 (US$11,713) (2009:
Rmb 30,946).
The following table represents the classification of the







Deferred tax assets 241,718 294,934 44,984
Deferred tax liabilities (31,840) (77,274) (11,786)
209,878 217,660 33,198
11. Discontinued Operations
On December 1, 2009, we announced that concurrently with
the capital reduction and cash distribution exercise to be un-
dertaken by TCL, we intended to appoint a broker to sell
550,000,000 shares in TCL at a price of S$0.03 per share
on an ex-distribution basis (“Placement”). As of December
31, 2009, a total of 536,000,000 shares out of 550,000,000
shares available in the Placement have been taken up. The
Placement was conditional upon the completion of the capital
reduction and cash distribution exercise and subject to all the
shares in the Placement being sold, our total shareholding
in TCL would decrease from 34.4% to 13.4%. The Company
equity accounted for the result of TCL for 11 months in 2009.
The investment in TCL was classified as a disposal group held
for sale and as a discontinued operation as at December 31,
2009.
The results of TCL for the year are equity accounted for 11
months ended November 30, 2009 and presented as discon-
tinued operations for the year ended December 31, 2009. The
related reserves of TCL have been classified to “Reserve of
asset classified as held for sale” on the statement of changes
in equity as of December 31, 2009.
On July 7, 2010, TCL made payment of cash distribution
to shareholders pursuant to the Capital Reduction Exercise.
Subsequent to the cash distribution, the Company began to
sell its shares in TCL in the market. As of December 31, 2010,
580,253,000 shares in TCL have been disposed of and the
Company has recognised a gain on disposal of TCL shares
of Rmb 12,655 (US$1,930).
Upon the disposal of TCL shares, the Company’s share-
holding interest in TCL has reduced from 34.4% to 12.2%.
Meanwhile, the Company’s representation in the board of di-
rectors of TCL also reduced to one out of eight directors on
the board of TCL. As of December 31, 2010, the Company
does not exercise significant influence over the operating and
financial policies of TCL. The Company’s investment in TCL
is classified as held for trading (Note 22) as they are held
for the purpose of selling in the near term. The Company’s
investment in TCL is measured at fair value with changes in
fair value recognised in other income in the income statement









Profit from discontinued operations:
—Profit before tax (33,731) 14,321 — —
—Gain on disposal — — 12,655 1,930
—Taxation (254) (1,299) — —










Basic, from discontinued operation (0.91) 0.35 0.34 0.05
Diluted, from discontinued operation (0.91) 0.35 0.34 0.05
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Offsetting of Assets and Liabilities From the
Same Tax Authority, Used and Unused Tax
Loss Carryforwards, Items Recognized in
Other Comprehensive Income Shown Net
of Tax
3.345
Companhia de Bebidas das Américas—AmBev
(Dec 2010)
CONSOLIDATED INCOME STATEMENT
Years ended December 31, 2010, 2009 and 2008
(Expressed in Millions of Brazilian Reais) Note 2010 2009 2008
Net sales 25,233.3 23,194.0 20,713.2
Cost of sales (8,449.0) (7,731.9) (7,217.7)
Gross profit 16,784.3 15,462.1 13,495.5
Sales and marketing expenses (6,038.5) (5,542.0) (4,956.3)
Administrative expenses (1,196.9) (1,478.1) (1,037.0)
Other operating income/(expenses) 7 624.9 539.3 383.5
Special items 8 (150.8) 196.6 (59.2)
Income from operations 10,023.0 9,177.9 7,826.5
Finance cost 11 (1,104.3) (1,348.5) (1,447.6)
Finance income 11 784.9 366.4 256.8
Net finance cost (319.4) (982.1) (1,190.8)
Share of results of associates 0.2 0.7 2.3
Profit before income tax 9,703.7 8,196.5 6,638.0
Income tax expense 12 (2,084.4) (2,208.1) (1,447.2)
Profit 7,619.2 5,988.4 5,190.9
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME
Years ended December 31, 2010, 2009 and 2008
(Expressed in Millions of Brazilian Reais) 2010 2009 2008
Profit 7,619.2 5,988.4 5,190.9
Exchange differences on translation of foreign operations (gains/(losses) (391.1) (1,567.0) 1,192.9
Actuarial gains/(losses) (234.5) (82.6) (26.8)
Cash flow hedges—gains/(losses)
Recognized in equity (cash flow hedges) 96.8 (75.5) 12.5
Removed from equity and included in profit or loss (48.7) (232.4) 194.8
Change in deferred income tax in equity and other changes 95.6 188.1 (140.0)
Net income (charge) recognized directly in equity (481.9) (1,769.4) 1,233.4
Total comprehensive income 7,137.3 4,219.0 6,424.3
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Summary of Significant Accounting Policies (in part)
(w) Income Tax and Social Contribution
Income tax and social contribution for the year comprises cur-
rent tax and deferred tax. Income tax and social contribution
are recognized in the income statement, unless they relate to
items recognized directly in Other comprehensive income or
equity. In these cases the tax effect is also recognized directly
in equity or Other comprehensive income (except interest on
capital, see item (q)).
Current tax is the expectation of payment on the taxable
income for the year, using tax rates enacted, or substantially
enacted, at the balance sheet date, and any adjustment to
tax payable in respect of previous years.
Pursuant to IAS 12 Income Taxes, deferred taxes are rec-
ognized using the balance sheet/ liability method. This means
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that, taking into account the IAS 12 requirements, a deferred
tax liability or asset is recognized for all taxable and tax de-
ductible temporary differences between the tax and account-
ing basis of assets and liabilities. Under this method, a pro-
vision for deferred taxes is also calculated on the differences
between the fair value of assets and liabilities acquired in a
business combination and their tax basis. IAS 12 prescribes
that no deferred tax is recorded: (i) when recognizing good-
will; (ii) at the initial recognition of assets or liabilities arising
from a transaction other than a business combination; and
(iii) on differences related to investments in subsidiaries to
the extent that they are not reversed in the foreseeable fu-
ture. The amount of deferred tax provided is based on the
expectation of the realization or settlement of the temporary
difference, using currently or substantively enacted tax rates.
Deferred tax assets and liabilities are offset if there is a
legally enforceable right to offset current tax liabilities and
assets, and they relate to income taxes levied by the same
tax authority on the same taxable entity, or on different taxable
entities which intend either to settle current tax liabilities and
assets on a net basis, or to realize the assets and settle the
liabilities simultaneously.
12. Income Tax and Social Contribution
Income taxes reported in the income statement are analyzed
as follows:
2010 2009 2008
Income tax expense—current (1,281.6) (1,304.0) (1,374.1)
Deferred tax (expense)/income — —
Temporary differences (644.8) (510.9) (6.8)
Utilization of tax loss carry
forwards in the current period (168.8) (393.2) (66.2)
Constitution of tax loss carry
forwards offset in current period 1.4 — —
Tax loss carry forwards 9.3 — —
(802.9) (904.1) (73.0)
Total income tax expense (2,084.4) (2,208.1) (1,447.2)
The reconciliation from the weighted nominal to the effective
tax rate is summarized as follows:
2010 2009 2008
Profit before tax 9,703.7 8,196.5 6,638.0
Adjustment on taxable basis
Non-taxable net financial and
other income (490.5) (650.9) (355.8)
Government grants (VAT) (361.2) (263.4) (238.3)
Non-taxable intercompany
dividends — — (0.2)
Share of results of associates (0.2) (0.7) (2.3)
Hedging results 0.4 348.0 (34.3)
Expenses not deductible for tax
purposes 213.7 178.2 179.9
9,065.9 7,807.7 6,186.9
Aggregated weighted nominal tax
rate 32.81% 32.54% 32.69%
Taxes—nominal rate (2,974.5) (2,540.6) (2,022.5)
Adjustment on tax expense
Incentives related to income taxes 289.7 198.5 134.7
Tax benefit—Interest on
shareholders’ equity 393.9 346.8 337.4
Tax benefit—amortization on tax
books 125.9 142.8 174.0
Withholding tax and other income (131.0) (130.8) (71.5)
Changes in taxes rate — — 6.1
Non-deductible losses—foreign
operations (11.1) (47.5) (40.7)
Income tax provision reversal 64.7 1.7 —
Other tax adjustments 158,0 (179.0) 35.3
Income tax and social
contribution expense (2,084.4) (2,208.1) (1,447.2)
Effective tax rate 21.48% 26.94% 21.80%
The main events that impacted the effective tax rate in 2010
were: (a) increase in Government grant on income tax; (b)
increase in dividends withholding tax; (c) decrease in the
non-deductible expenses related mainly, to the reduction of
hedging results; and (d) reversal of provisions related mainly
to Canadian and Argentine income tax.
The Company has income tax incentives granted by the
Brazilian Federal Government to encourage economic and
social development in certain areas of the North and North-
east. These incentives are recorded in income on an accrual
basis and directly impact the effective tax rate.
17. Deferred Income Tax and Social Contribution
Income tax and social contribution taxes are calculated on tax
losses, the negative basis of social contribution and the tem-
porary differences between the tax bases for calculating tax
assets and liabilities and the carrying amounts in the finan-
cial statements. The rates of these taxes, currently set for the
determination of deferred taxes, are 25% for income tax and
9% for social contribution in Brazil. For the other subsidiaries,
applied rates are as follow:
HILA-ex from 25% to 27%
Latin America—South from 7% to 35%
Canada Holding 5%
Canada Operational from 30% to 31%
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The amount of deferred income tax and social contribution by
type of temporary difference is detailed as follows:
2010
Assets Liabilities Net
Property, plant and equipment 2.3 (184.4) (182.1)
Intangible assets 7.2 (360.5) (353.3)
Goodwill 115.6 — 115.6
Inventories 12.6 — 12.6
Investment securities 6.0 — 6.0
Trade and other receivables 25.7 — 25.7
Interest-bearing loans and borrowings — (35.8) (35.8)
Employee benefits 329.5 (0.3) 329.2
Provisions 278.3 (0.2) 278.2
Derivatives 142.6 — 142.6
Other items — (171.3) (171.3)
Loss carry forwards 373.6 — 373.6
Gross deferred tax assets/(liabilities) 1,293.5 (752.4) 541.0
Netting by taxable entity (203.7) 203.7 —
Net deferred tax assets/(liabilities) 1,089.8 (548.7) 541.0
2009
Assets Liabilities Net
Property, plant and equipment 3.6 (209.9) (206.4)
Intangible assets 22.1 (399.7) (377.6)
Goodwill 155.1 — 155.1
Inventories 10.2 (2.2) 8.0
Trade and other receivables 23.2 — 23.2
Interest-bearing loans and borrowings 1.8 (97.5) (95.7)
Employee benefits 332.6 (39.8) 292.8
Provisions 426.3 (4.2) 422.1
Derivatives 174.9 — 174.9
Other items 59.7 (116.6) (56.9)
Loss carry forwards 526.9 — 526.9
Gross deferred tax assets/(liabilities) 1,736.2 (869.8) 866.3
Netting by taxable entity (367.6) 367.6 —
Net deferred tax assets/(liabilities) 1,368.5 (502.2) 866.3
Tax losses and negative bases of social contribution and tem-
porary deductible differences in Brazil, on which the deferred
income tax and social contribution were calculated, have no
expiry date.





As of 2014 32.2
373.6
Part of the tax benefit corresponding to the tax loss carry-
forwards and temporary differences of subsidiaries abroad
was not recorded as an asset, as management is unable to
determine whether realization is probable.
The total unrecognized deferred tax assets related to tax
loss carryforwards for these subsidiaries amount to R$154.6
at December 31, 2010 (R$121.9 at December 31, 2009) for
which the expiry term is on average five years. The tax loss
carry forwards related to these unrecognized deferred tax
assets are equivalent to R$673.6 at December 31, 2010
(R$514.7 at December 31, 2009).
Tax Expense Reconciliation Disclosure—Use
of Single Domestic Statutory Tax Rate
3.346
Brookfield Asset Management, Inc. (Dec 2010)
Author’s Note
Brookfield Asset Management implemented IFRSs ef-
fective December 31, 2010, with a date of transition of
January 1, 2009. The excerpt that follows reflects the
initial application of IAS 12.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in part)
Years Ended December 31
(Millions, Except per Share Amounts) Note 2010 2009(1)
Total revenues $13,623 $11,218
Asset management and other services 21 365 298
Revenues less direct operating costs
Renewable power generation 21 748 777
Commercial properties 21 1,282 1,059
Infrastructure 21 221 95
Development activities 21 527 156
Private equity and finance 21 281 111
3,424 2,496
Equity accounted income 494 353




Operating costs 417 396
Current income taxes 14 97 (5)
2,168 1,661
Other items
Fair value changes 22 1,865 (2,268)
Depreciation and amortization (795) (656)
Deferred income tax 14 (43) 287
Net income (loss) $ 3,195 $ (976)
(1) Refer to Note 3 for the effects of the adoption of IFRS.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies (in part)
(m) Income Taxes
Current income tax assets and liabilities are measured at the
amount expected to be paid to tax authorities, net of recover-
ies based on the tax rates and laws enacted or substantively
enacted at the balance sheet date. Current and deferred in-
come tax relating to items recognized directly in equity are
also recognized in equity. Deferred income tax liabilities are
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provided for using the liability method on temporary differ-
ences between the tax bases and carrying amounts of assets
and liabilities. Deferred income tax assets are recognized for
all deductible temporary differences, carry forward of unused
tax credits and unused tax losses, to the extent that it is
probable that deductions, tax credits and tax losses can be
utilized. The carrying amount of deferred income tax assets
is reviewed at each balance sheet date and reduced to the
extent it is no longer probable that the income tax assets will
be recovered. Deferred income tax assets and liabilities are
measured at the tax rates that are expected to apply to the
year when the asset is realized or the liability settled, based
on the tax rates and laws that have been enacted or substan-
tively enacted at the balance sheet date.
14. Income Taxes
The major components of income tax expense for the year
ended December 31, 2010 and December 31, 2009 are set
out below:
For the Years Ended December 31 (Millions) 2010 2009
Total current income tax $ 97 $ (5)
Deferred income tax expense/(recovery)
Origination and reversal of temporary
differences $ 60 $ (292)
Expense/(recovery) arising from previously
unrecognized tax assets (15) 13
Change of tax rates and imposition of new
legislation (2) (8)
Total deferred income tax $ 43 $ (287)
The company’s effective tax rate is different from the com-
pany’s domestic statutory income tax rate due to the differ-
ences set out below:
2010 2009
Statutory income tax rate 31% 33%
Increase (reduction) in rate resulting from:
Portion of income not subject to tax (7) (4)
International operations subject to different
tax rates (14) (3)
Change in tax rates on temporary differences 1 (2)
Derecognition of future tax assets/(liabilities) (6) 2
Non-recognition of the benefit of current
year’s tax losses 1 (5)
Other (1) (2)
Effective income tax rate 5% 19%
The following chart details the expiry date, if applicable, of








2010 $ — $ 5 $ —
2011 — — 5
2012 — — —
2013 — — —
2014 1 29 —
2015 8 15 29
After 2020 284 257 205
Do not expire 519 432 432
Total $812 $738 $671
The dividend payment on certain preferred shares of the com-
pany results in the payment of cash taxes and the company
obtaining a deduction based on the amount of these taxes.
Deferred income tax assets and liabilities as at December









Non-capital losses (Canada) $ 578 $ 433 $ 215
Capital losses (Canada) 171 129 82
Losses (U.S.) 360 165 177
Losses (International) 634 273 237
Difference in basis (4,929) (4,778) (4,475)








Deferred income tax asset $ 1,784 $ 1,454 $ 984
Deferred income tax liability (4,970) (5,232) (4,748)
Total net deferred tax liability $(3,186) $(3,778) $(3,764)
The aggregate amount of temporary differences associated
with investments in subsidiaries for which deferred tax liabil-
ities have not been recognized as at December 31, 2010 is
$4,164 million (December 31, 2009—$2,497 million; January
1, 2009—$5,999 million).
The company regularly assesses the status of open tax
examinations and its historical tax filing positions for the po-
tential for adverse outcomes to determine the adequacy of
the provision for income and other taxes. The company be-
lieves that it has adequately provided for any tax adjustments
that are more likely than not to occur as a result of ongoing
tax examinations or historical filing positions.
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Effective Tax Rate Reconciliation
Disclosure—Use of Weighted Average
Statutory Tax Rate
3.347
Koninklijke Philips Electronics NV (Dec 2010)
CONSOLIDATED STATEMENTS OF INCOME
(INCLUDING EARNINGS PER SHARE) OF THE
PHILIPS GROUP FOR THE YEARS ENDED
DECEMBER 31 (in part)
2008 2009 2010
Sales 26,385 23,189 25,419
Cost of sales (17,938) (15,110) (15,873)
Gross margin 8,447 8,079 9,546
Selling expenses (5,518) (5,159) (5,246)
General and administrative
expenses (972 (734) (735)
Research and development
expenses (1,777) (1,631) (1,576)
Impairment of goodwill (301) — —
Other business income 261 97 100
Other business expenses (86) (38) (24)
Income from operations 54 614 2,065
Financial income 1,594 225 214
Financial expenses (1,506) (391) (336)
Income before taxes 142 448 1,943
Income tax expense (256) (100) (509)
Income (loss) after taxes (114) 348 1,434
Results relating to investments
in associates:
—Company’s participation in
income 81 23 14
—Other results (62) 53 4
Income (loss) from continuing
operations (95) 424 1,452
Discontinued operations—net
of income tax 3 — —
Net income (loss) (92) 424 1,452
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Significant Accounting Policies (in part)
Income Tax
Income tax comprises current and deferred tax. Income tax
is recognized in the Statement of income except to the extent
that it relates to a business combination, or items recognized
directly within equity or in other comprehensive income. Cur-
rent tax is the expected tax payable on the taxable income
for the year, using tax rates enacted or substantially enacted
at the reporting date, and any adjustment to tax payable in
respect of previous years.
Deferred tax assets and liabilities are recognized, using the
balance sheet method, for the expected tax consequences
of temporary differences between the carrying amounts of
assets and liabilities and the amounts used for taxation pur-
poses. Deferred tax is not recognized for the following tempo-
rary differences: the initial recognition of goodwill, the initial
recognition of assets and liabilities in a transaction that is not
a business combination and that affects neither accounting
nor taxable profit, and differences relating to investments in
subsidiaries to the extent that they probably will not reverse
in the foreseeable future. Deferred tax is measured at the tax
rates that are expected to be applied to temporary differences
when they reverse, based on the laws that been enacted or
substantively enacted by the reporting date. Deferred tax as-
sets and liabilities are offset if there is a legally enforceable
right to offset current tax liabilities and assets, and they relate
to income taxes levied by the same tax authority on the same
taxable entity, or on different tax entities, but they intend to
settle current tax liabilities and assets on a net basis or their
tax assets and liabilities will be realized simultaneously.
A deferred tax asset is recognized for unused tax losses,
tax credits and deductible temporary differences, to the extent
that it is probable that future taxable profits will be available
against which they can be utilized.
The ultimate realization of deferred tax assets is dependent
upon the generation of future taxable income in the countries
where the deferred tax assets originated and during the pe-
riods when the deferred tax assets become deductible. Man-
agement considers the scheduled reversal of deferred tax
liabilities, projected future taxable income, and tax planning
strategies in making this assessment.
Deferred tax liabilities for withholding taxes are recognized
for subsidiaries in situations where the income is to be paid
out as dividend in the foreseeable future, and for undis-
tributed earnings of unconsolidated companies to the extent
that these withholding taxes are not expected to be refund-
able or deductible. Changes in tax rates are reflected in the
period when the change has been enacted or substantively
enacted by the reporting date.
3. Income Taxes
The tax expense on income before tax amounted to EUR 509
million (2009: EUR 100 million, 2008: EUR 256 million).
The components of income before taxes and income tax
expense are as follows:
2008 2009 2010
Netherlands 330 175 935
Foreign (188) 273 1,008
Income before taxes 142 448 1,943
Netherlands:
Current taxes 20 (16) (106)
Deferred taxes (120) (72) (144)
(100) (88) (250)
Foreign:
Current taxes (289) (201) (207)
Deferred taxes 133 189 (52)
(156) (12) (259)
Income tax expense (256) (100) (509)
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The components of deferred tax expense are as follows:
2008 2009 2010
Previously unrecognized tax loss
carried forwards realized 21 1 9
Current year tax loss carried
forwards not realized (98) (60) (55)
Temporary differences (not
recognized) recognized (2) 2 (5)
Prior year results (7) 119 (16)
Tax rate changes (1) — (4)
Origination and reversal of
temporary differences 100 55 (125)
Deferred tax income (expense) 13 117 (196)
Philips’ operations are subject to income taxes in various for-
eign jurisdictions. The statutory income tax rates vary from
10.0% to 40.7%, which causes a difference between the
weighted average statutory income tax rate and the Nether-
lands’ statutory income tax rate of 25.5% (2009: 25.5%; 2008:
25.5%).
A reconciliation of the weighted average statutory income
tax rate to the effective income tax rate is as follows:
In % 2008 2009 2010
Weighted average statutory income
tax rate (18.5) 17.4 26.7
Tax rate effect of:
Changes related to:
—Utilization of previously reserved
loss carryforwards (14.5) (0.3) (0.5)
—New loss carryforwards not
expected to be realized 69.3 13.3 2.8
—Addition (releases) 1.6 (0.4) 0.3
Non-tax-deductible impairment
charges 283.1 3.1 —
Non-taxable income (315.0) (25.9) (7.6)
Non-tax-deductible expenses 91.9 26.3 3.9
Withholding and other taxes (5.1) 4.7 1.2
Tax rate changes 1.0 (0.1) 0.2
Tax expenses due to other liabilities 37.2 8.3 (0.4)
Tax incentives and other 49.2 (24.1) (0.4)
Effective tax rate 180.2 22.3 26.2
The weighted average statutory income tax rate increased in
2010 compared to 2009, as a consequence of a change in
the country mix of income tax rates, as well as a change of
the mix of profits and losses in the various countries.
The effective income tax rate is lower than the weighted
average statutory income tax rate in 2010, attributable to non-
taxable gains on the sale of securities and other non-taxable
income, and incidental tax benefits, which were partly offset
by non-tax-deductible costs, new losses carried forward not
expected to be realized, and income tax expenses due to tax
provisions for uncertain tax positions.
Deferred Tax Assets and Liabilities
Net deferred tax assets relate to the following balance sheet
captions and tax loss carryforwards (including tax credit car-
ryforwards), of which the movements during the years 2010











Intangible assets (1,218) 97 — (3) (93) (1,217)
Property, plant and equipment 15 34 — — (9) 40
Inventories 193 44 — — 5 242
Prepaid pension assets (387) (75) 462 — (1) (1)
Other receivables 36 4 — — (2) 38
Other assets 118 (94) — — 4 28
Provisions:
—Pensions 450 (58) 150 — 27 569
—Guarantees 11 — — — — 11
—Termination benefits 100 (34) — — 2 68
—Other postretirement benefits 91 (7) (10) — 5 79
—Other provisions 567 (71) 5 (1) 45 545
Other liabilities (29) 107 — — 4 82
Tax loss carryforwards (including tax
credit carryforwards) 766 (143) (1) 1 73 696
Net deferred tax assets 713 (196) 606 (3) 60 1,180
(1) Primarily includes foreign currency translation differences which were recognized in equity.
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Intangible assets (1,298) 115 — (11) (24) (1,218)
Property, plant and equipment (146) 28 — 7 126 15
Inventories 147 33 — 4 9 193
Prepaid pension costs (510) (80) 160 — 43 (387)
Other receivables 41 2 — 14 (21) 36
Other assets 61 (20) (14) — 91 118
Provisions:
—Pensions 432 (9) 8 — 19 450
—Guarantees 9 1 — 1 — 11
—Termination benefits 61 34 — — 5 100
—Other postretirement benefits 108 (15) 10 — (12) 91
—Other provisions 751 (111) 3 3 (79) 567
Other liabilities 76 1 — 1 (107) (29)
Tax loss carryforwards (including tax credit carryforwards) 615 138 — 12 1 766
Net deferred tax assets 347 117 167 31 51 713
(1) Primarily includes balance sheet changes amounting to EUR 46 million and foreign currency translation differences which were recognized
in equity




Intangible assets 104 (1,321) (1,217)
Property, plant & equipment 106 (66) 40
Inventories 267 (25) 242
Prepaid pension costs 2 (3) (1)
Other receivables 53 (15) 38
Other assets 50 (22) 28
Provisions:
—Pensions 571 (2) 569
—Guarantees 11 — 11
—Termination benefits 70 (2) 68
—Other postretirement 78 1 79
—Other 579 (34) 545
Other liabilities 110 (28) 82
Tax loss carryforwards (including tax credit carryforwards) 696 — 696
2,697 (1,517) 1,180
Set-off of deferred tax positions (1,346) 1,346 —
Net deferred tax assets 1,351 (171) 1,180
2009 Assets Liabilities Net
Intangible assets 172 (1,390) (1,218)
Property, plant & equipment 109 (94) 15
Inventories 206 (13) 193
Prepaid pension costs 3 (390) (387)
Other receivables 45 (9) 36
Other assets 135 (17) 118
Provisions:
—Pensions 452 (2) 450
—Guarantees 11 — 11
—Termination benefits 105 (5) 100
—Other postretirement 91 — 91
—Other 590 (23) 567
Other liabilities 73 (102) (29)
Tax loss carryforwards (including tax credit carryforwards) 766 — 766
2,758 (2,045) 713
Set-off of deferred tax positions (1,515) 1,515 —
Net deferred tax assets 1,243 (530) 713
IFRS ATT 3.347
463Section 3: Statement of Comprehensive Income and Related Disclosures
Deferred tax assets are recognized for temporary differences,
unused tax losses, and unused tax credits to the extent that
realization of the related tax benefits are probable. The ulti-
mate realization of deferred tax assets is dependent upon the
generation of future taxable income in the countries where the
deferred tax assets originated and during the periods when
the deferred tax assets become deductible. Management
considers the scheduled reversal of deferred tax liabilities,
projected future taxable income, and tax planning strategies
in making this assessment.
The net deferred tax assets of EUR 1,180 million (2009:
EUR 713 million) consist of deferred tax assets of EUR 1,351
million (2009: EUR 1,243 million) in countries with a net de-
ferred tax asset position and deferred tax liabilities of EUR
171 million (2009: EUR 530 million) in countries with a net de-
ferred tax liability position. Of the total deferred tax assets of
EUR 1,351 million at December 31, 2010, (2009: EUR 1,243
million), EUR 812 million (2009: EUR 616 million) is recog-
nized in respect of fiscal entities in various countries where
there have been fiscal losses in the current or preceding pe-
riod. Management’s projections support the assumption that
it is probable that the results of future operations will generate
sufficient taxable income to utilize these deferred tax assets.
At December 31, 2010 and 2009, there were no recog-
nized deferred tax liabilities for taxes that would be payable
on the unremitted earnings of certain foreign subsidiaries of
Philips Holding USA (PHUSA) since it has been determined
that undistributed profits of such subsidiaries will not be dis-
tributed in the foreseeable future. The temporary differences
associated with the investments in subsidiaries of PHUSA,
for which a deferred tax liability has not been recognized,
aggregate to EUR 34 million (2009: EUR 29 million).
In the current year one of our acquisitions has recognized
a deferred tax asset of EUR 18 million, which was not recog-
nized at acquisition date. Based on an audit by the local tax
authorities the intercompany loan policy has been reviewed
and adjusted, which has led to a lower intercompany inter-
est rate. As a consequence the related deferred tax asset
became recoverable.
At December 31, 2010, operating loss carryforwards expire
as follows:
Total 2011 2012 2013 2014 2015 2016/2020 Later Unlimited
4,452 14 23 17 38 28 25 949 3,358
The Company also has tax credit carryforwards of EUR 112
million, which are available to offset future tax, if any, and
which expire as follows:
Total 2011 2012 2013 2014 2015 2016/2020 Later Unlimited
112 1 3 1 3 — 24 68 12
At December 31, 2010 , operating loss and tax credit carryfor-
wards for which no deferred tax assets have been recognized
in the balance sheet, expire as follows:
Total 2011 2012 2013 2014 2015 2016/2020 Later Unlimited
1,689 — 2 — 6 5 28 16 1,632
Classification of the income tax payable and receivable is as
follows:
2009 2010
Income tax receivable 81 79
Income tax receivable—under non-current receivables 2 2
Income tax payable (118) (291)
Income tax payable—under non-current liabilities (1) (1)
Fiscal Risks
Philips is exposed to fiscal uncertainties. These uncertainties
include the following:
Transfer Pricing Uncertainties
Philips has issued transfer pricing directives, which are in
accordance with international guidelines such as those of the
Organization for Economic Co-operation and Development.
As transfer pricing has a cross-border effect, the focus of local
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tax authorities on implemented transfer pricing procedures in
a country may have an impact on results in another country. In
order to mitigate the transfer pricing uncertainties, audits are
executed by Corporate Fiscal and Internal Audit on a regular
basis to safeguard the correct implementation of the transfer
pricing directives.
Tax Uncertainties on General Service Agreements and
Specific Allocation Contracts
Due to the centralization of certain activities in a limited num-
ber of countries (such as research and development, cen-
tralized IT, corporate functions and head office), costs are
also centralized. As a consequence, for tax reasons these
costs and/or revenues must be allocated to the beneficiaries,
i.e. the various Philips entities. For that purpose, apart from
specific allocation contracts for costs and revenues, general
service agreements (GSAs) are signed with a large number of
entities. Tax authorities review the implementation of GSAs,
apply benefit tests for particular countries or audit the use of
tax credits attached to GSAs and royalty payments, and may
reject the implemented procedures. Furthermore, buy in/out
situations in the case of (de)mergers could affect the tax allo-
cation of GSAs between countries. The same applies to the
specific allocation contracts.
Tax Uncertainties Due to Disentanglements and Acquisitions
When a subsidiary of Philips is disentangled, or a new com-
pany is acquired, related tax uncertainties arise. Philips cre-
ates merger and acquisition (M&A) teams for these disen-
tanglements or acquisitions. In addition to representatives
from the involved sector, these teams consist of specialists
from various corporate functions and are formed, amongst
other things, to identify hidden tax uncertainties that could
subsequently surface when companies are acquired and to
reduce tax claims related to disentangled entities. These
tax uncertainties are investigated and assessed to mitigate
tax uncertainties in the future as much as possible. Several
tax uncertainties may surface from M&A activities. Examples
of uncertainties are: applicability of the participation exemp-
tion, allocation issues, and non-deductibility of parts of the
purchase price.
Tax Uncertainties Due to Permanent Establishments
In countries where e.g. Philips starts new operations or alters
business models, the issue of permanent establishment may
arise. This is because when operations in a country are led
from another country, there is a risk that tax claims will arise
in the former country as well as in the latter country.
IAS 33, EARNINGS PER SHARE
IFRS Overview and Comparison
to U.S. GAAP
3.348 IAS 33, Earnings per Share, establishes the require-
ments for calculating and presenting earnings per share
(EPS), including basic EPS and diluted EPS. IAS 33 applies
to separate, individual, and consolidated financial statements
of an entity whose ordinary or potential ordinary shares are
traded in a public market or who files, or is in the process of
filing, with a securities commission or other regulatory au-
thority for the purpose of issuing such securities in a public
market. However, any entity that discloses EPS should do so
only in accordance with IAS 33.
Recognition and Measurement
IFRSs
3.349 IAS 33 requires an entity to calculate basic and diluted
EPS, attributable to equity holders of the parent entity, for
profit or loss from continuing operations, if presented, and
profit or loss.
3.350 Basic EPS is calculated by dividing the relevant profit
or loss amount attributable to the equity holders of the parent
by the weighted average number of ordinary shares outstand-
ing during the period. An entity should adjust reported earn-
ings and earnings from continuing operations by subtracting
any posttax dividends declared, and similar effects, on pref-
erence shares (classified as equity) to arrive at the relevant
amounts attributable to the equity holders of the parent.
3.351 An entity should calculate diluted EPS by adjusting
earnings and earnings from continuing operations, if pre-
sented, attributable to the equity holders of the parent for the
posttax effects of the following:
• Dividends or other items related to dilutive potential
ordinary shares deducted in arriving at earnings at-
tributable to equity holders of the parent
• Any interest expense recognized in respect to dilutive
potential ordinary shares
• Any other changes that would result from conversion
of dilutive potential ordinary shares
3.352 An entity should also adjust the weighted average or-
dinary shares outstanding for the weighted average ordinary
shares that would be issued on conversion of dilutive po-
tential ordinary shares into ordinary shares. An entity should
make these adjustments as if conversion of the dilutive poten-
tial ordinary shares occurred at the beginning of the reporting
period or the issue date, if later.
3.353 An entity should consider a potential ordinary share
to be dilutive only if its conversion will decrease EPS or EPS
from continuing operations.
3.354 IAS 33 discusses the dilutive nature of the following
potential ordinary shares: options, warrants and their equiv-
alents, convertible instruments, contingently issuable shares,
contracts that may be settled in ordinary shares or cash, pur-
chased options, and written put options.
3.355 With respect to options, warrants, and similar instru-
ments, an entity should assume exercise. The entity should
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regard the assumed proceeds of these shares to have been
received from the issue of shares at the average market price.
Therefore, the assumed proceeds divided by the average mar-
ket price of ordinary shares during the period will be the
number of shares that would have been issued. The differ-
ence between the number of shares issued on exercise and
the number of shares that would have been issued is the ad-
ditional shares to be added to the weighted average number
of shares outstanding in the diluted EPS calculation. Accord-
ingly, these securities are dilutive when they are issued for
less than the average market price of ordinary shares during
the period and antidilutive if issued for more than the average
price.
3.356 When dilutive, an entity should adjust both earnings
and the weighted average ordinary shares outstanding for the
effects of convertible securities. If the convertible securities
are preferred shares, the entity should no longer deduct pre-
ferred share dividends from earnings and should increase the
weighted average common shares outstanding for the addi-
tional number of ordinary shares issued on conversion. If the
convertible securities are debt securities, the entity should
adjust earnings for the posttax effect of interest expense and
increase the weighted average ordinary shares outstanding
by the additional shares issued on conversion.
3.357 An entity should treat any contingently issuable shares
as outstanding when the specified conditions are satisfied
(that is, the events have occurred on which issuance depends)
and should make the necessary adjustments to the diluted
EPS calculation as of the beginning of the period or the
date of the contingent share agreement, whichever is later.
If the conditions are not satisfied, an entity should base the
adjustment to the diluted EPS calculation on the number of
shares that would be issued if the end of the period were the
end of the contingency period.
3.358 For contracts that may be settled in equity or cash
at the entity’s option, an entity should presume settlement
would be in equity. For those contracts that may be settled
at the holder’s option, the entity should assume the more
dilutive of the two cases.
3.359 An entity should not include contracts such as pur-
chased options in the calculation of diluted EPS because
exercise would be antidilutive.
3.360 An entity should include in the calculation of diluted
EPS contracts that require it to repurchase its own shares
when the effect is dilutive. If such contracts are “in the
money” during the period, the entity should calculate the
potential dilutive effect as follows:
a. Assume that sufficient ordinary shares will be issued at
the beginning of the period at the average market price
to raise the proceeds to fulfill the contract
b. Assume the proceeds are used to repurchase shares
under the contract
c. Adjust the weighted average number of ordinary shares
outstanding for any incremental number of ordinary
shares issued over the number of shares repurchased
3.361 When the number of ordinary shares increases due
to capitalizations, bonuses, stock splits, or dividends that
occur after the balance sheet date but before the financial
statements are issued, the entity should recalculate EPS for
these changes.
U.S. GAAP
3.362 Like IFRSs, paragraphs 10–11 of FASB ASC 260-
10-45 specify that an entity should calculate basic EPS by
dividing income available to common stockholders (the nu-
merator) by the weighted average number of common shares
outstanding (the denominator) during the period. An entity
should compute income available to common stockholders
by deducting both the dividends declared in the period on
preferred stock (regardless of whether they are paid) and
the dividends accumulated for the period on cumulative pre-
ferred stock (regardless of whether they are earned) from
income from continuing operations (if that amount appears
in the income statement) and also from net income. If there
is a loss from continuing operations or a net loss, the amount
of the loss should be increased by those preferred dividends.
3.363 Both IFRSs and FASB ASC 260-10-45-11A require
that, when computing EPS in consolidated financial state-
ments, income from continuing operations and net income
exclude income attributable to any noncontrolling interests.
3.364 Both IFRSs and FASB ASC 260-10-45-12A state that
an entity should include contingently issuable shares in the
EPS calculation only when there is no circumstance under
which those shares would not be issued (that is, the neces-
sary conditions upon which issuance is predicated have been
met). However, paragraphs 12A–14 of FASB ASC 260-10-
45 provide more guidance on what constitutes a contingently
issuable share.
3.365 Like IFRSs, FASB ASC 260-10-45-16 requires an
entity to adjust the numerator for any convertible preferred
dividends and the post-tax amount of interest recognized in
the period associated with any convertible debt in computing
the dilutive effect of convertible securities. An entity should
also adjust the numerator for any other changes in income
or loss that would result from the assumed conversion of
these potential common shares. FASB ASC 260-10-55-38
also provides an illustration of similar adjustments when a
contract provides the issuer or holder with a choice between
settlement methods.
3.366 Like IFRSs, FASB ASC 260-10-45-17 states that an
entity should not include the conversion, exercise, or contin-
gent issuance of any security that would be antidilutive in the
calculation of EPS. An entity should determine whether po-
tential common shares are dilutive or antidilutive separately
for each issue or series of issues of potential common shares.
3.367 Like IFRSs, FASB ASC 260-10-45-21 requires an en-
tity to base the calculation of diluted EPS on the most advan-
tageous conversion rate or exercise price from the standpoint
of the security holder when there is more than one basis for
conversion.
3.368 Like IFRSs, FASB ASC 260-10-45-16 requires an
entity to include in the denominator of the calculation the
number of additional common shares that would have been
outstanding if the dilutive potential common shares had been
issued when calculating diluted EPS. As described in FASB
ASC 260-10-45, calculation of the number of additional
common shares to be included depends upon the type of
potentially dilutive security. FASB ASC 260-10-45 speci-
fies that an entity should use the treasury stock method for
options, warrants, and similar instruments; reverse treasury
stock method for written put options or forward purchase
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contracts; and the if-converted method for convertible secu-
rities to determine the additional amounts.
3.369 Although the requirements are described differently
than in IFRSs, paragraphs 22–27 of FASB ASC 260-10-45
requires an entity to apply what is known as the treasury
stock method to determine the effect of an exercise of op-
tions, warrants, or similar instruments (for example, stock
purchase contracts) on diluted EPS. This method assumes
that the entity would take the entire proceeds from exercise
and repurchase shares at the average market price for the
period. Therefore, the entity should only include any ex-
cess shares issued over those repurchased in the diluted EPS
calculation. Like IFRSs, FASB ASC 260-10-45-37 does not
permit an entity to include purchased put or call options in the
calculation because they are antidilutive. Paragraphs 28–32
of FASB ASC 260-10-45 provide more guidance than IAS 33
on including share-based compensation arrangements in the
calculation, including guidance on how to account for excess
tax benefits associated with these arrangements. IFRSs and
FASB ASC 260-10-45-35 are also consistent in their treat-
ment of written put options and forward purchase contracts,
if dilutive, by assuming that the entity would issue sufficient
shares and use the proceeds to satisfy the contract.
3.370 To determine the effect of convertible securities on
diluted EPS, paragraphs 40–41 of FASB ASC 260-10-45
require an entity to use the if-converted method, which pro-
duces adjustments that are essentially the same as those re-
quired by IFRSs. An entity should adjust the numerator for
the posttax consequences of reversing dividend declarations
on preferred shares and interest expense on debt instruments
with a corresponding increase in weighted average common
shares outstanding. An entity should not include an antidilu-
tive security in the calculation.
3.371 With respect to contracts with a settlement option, in
contrast to IFRSs, paragraphs 45–47 of FASB ASC 260-10-
45 require an entity to presume the most dilutive option, re-
gardless of whether the entity or holder can select the method
of settlement, unless past experience or a stated policy pro-
vides a reasonable basis to believe that the contract will be
paid partially or wholly in cash.
3.372 Both IFRSs and paragraphs 59A–70 of FASB ASC
260-10-45 use the two-class method for calculating the effect
of participating securities and two-class ordinary shares.
Presentation
IFRSs
3.373 For each class of ordinary shares and each period pre-
sented in the statement of comprehensive income, an entity
should present basic and diluted EPS for profit or loss from
continuing operations and profit or loss for the period, at-
tributable to equity holders of the parent, in the statement of
comprehensive income. An entity should present basic and
diluted EPS with equal prominence.
3.374 An entity should disclose basic and diluted EPS even
when the amount is negative. An entity should disclose EPS
from discontinued operations either on the face of the state-
ment or in the notes.
3.375 IAS 33 also constrains the location where EPS can be
presented when the entity presents both separate and consol-
idated financial statements.
3.376 IAS 33 permits an entity to disclose EPS effects for
additional components of the statement of comprehensive in-
come with the caveat that it should calculate these per share
amounts based on the weighted average ordinary shares out-
standing, determined in accordance with IAS 33 and they are
shown with equal prominence as the required EPS amounts.
An entity should disclose the basis for the numerator and
whether the amounts are before or after tax.
U.S. GAAP
3.377 Like IFRSs, FASB ASC 260-10-45-2 requires an en-
tity to present EPS for income from continuing operations
and net income on the face of the income statement. Unlike
IFRSs, U.S. GAAP requires an entity with a simple capital
structure (that is, only common stock outstanding) to present
only basic EPS. Like IFRSs, U.S. GAAP requires all other
entities to present basic and diluted EPS for income from con-
tinuing operations and net income on the face of the income
statement with equal prominence.
3.378 Like IFRSs, FASB ASC 260-10-45-3 requires an en-
tity that reports a discontinued operation to present basic and
diluted EPS for this line item either on the face of the income
statement or in the notes to the financial statements. How-
ever, U.S. GAAP requires an entity to also report basic and
diluted EPS for a reported extraordinary item.
3.379 Like IFRSs, FASB ASC 260-10-45-5 permits an en-
tity to present additional EPS amounts as long as they are
calculated in accordance with FASB ASC 260-10 and only
allows disclosure of these additional EPS amounts in the
notes to financial statements. An entity should also disclose
whether these amounts are calculated before or after tax.
3.380 Like IFRSs, FASB ASC 260-10-45-7 requires EPS
data to be presented for all periods for which an income
statement or summary of earnings is presented. If diluted
EPS is reported for at least one period, an entity should report
diluted EPS data for all periods presented, even if they are the
same amounts as basic EPS. When basic and diluted EPS are
the same amount, this paragraph permits a dual presentation
in one line on the income statement.
Disclosure
IFRSs
3.381 IAS 33 requires an entity to disclose the following:
• Amounts used as the numerator in the basic and diluted
EPS calculations and a reconciliation of the numerator
to the amount reported in profit or loss attributed to the
equity holders of the parent, with separate disclosure
of the effects of each class of instrument included;
• Weighted average number of ordinary shares used as the
denominator in the basic and diluted EPS calculations, a
reconciliation of the amounts used for basic and diluted
EPS, and a reconciliation showing the effects of each
class of instrument included;
• Instruments that could potentially dilute EPS but were
not included in the calculation because they were an-
tidilutive, including any contingently issuable shares;
and
• Description of any transaction (for example, issue of
shares for cash), other than those for which an entity is
required to adjust EPS, that occurred after the balance
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sheet date and would have changed significantly the
number of shares or potential shares outstanding if the
shares had been issued before the balance sheet date.
3.382 If, in addition to the required basic and diluted EPS,
an entity discloses amounts per share based on a component
of the statement of comprehensive income (or a separate
income statement) that is different from that required for
IAS 33 (a non-IFRS EPS), IAS 33 requires the entity to
calculate that non-IFRS EPS using the weighted average
common shares outstanding, determined in accordance with
IAS 33. In addition, an entity should do the following:
• Indicate the basis on which the numerator of the
non-IFRS EPS was determined, including whether the
amounts are pretax or posttax.
• Disclose the non-IFRS EPS with equal prominence to
basic and diluted EPS presented in the notes.
• Reconcile the component used, if it is not a separate
line item in the statement of comprehensive income (or
separate income statement), with the relevant reported
line item.
U.S. GAAP
3.383 Like IFRSs, FASB ASC 260-10-50-1 requires an en-
tity to disclose all of the following for each income statement
presented in the financial statements:
• A reconciliation of the numerators and denominators
of the basic and diluted per-share computations for in-
come from continuing operations, including individual
income and share amounts for the effects of all se-
curities that affect EPS (the entity is encouraged to
refer readers to pertinent information about securities
included in EPS computations addressed in other sec-
tions of the financial statements)
• The effect of preferred dividends on basic EPS
• Information about securities (including those contin-
gently issuable shares) that could potentially dilute ba-
sic EPS in the future and were not included in the com-
putation of diluted EPS because they were antidilutive,
with disclosure of the terms and conditions of the secu-
rities, regardless of their exclusion from the calculation
of diluted EPS in the current period
3.384 FASB ASC 260-10-50-2 also requires the same dis-
closure as IFRSs for any transaction that occurs after the
end of the most recent period but before the financial state-
ments are issued or are available for issue that would have
changed materially the number of common shares or poten-
tial common shares outstanding at the end of the period if
the transaction had occurred before the end of the period.
Presentation and Disclosure Excerpts
Basic and Diluted EPS Reported on One
Line—No Dilutive Potential Shares
3.385
Yanzhou Coal Mining Company Limited (Dec 2010)
CONSOLIDATED INCOME STATEMENTS
Year Ended December 31
2010 2009 2008
Notes RMB’000 RMB’000 RMB’000
Gross sales of coal 7 32,590,911 19,947,748 24,933,349
Railway transportation service income 513,282 267,345 255,713
Gross sales of electricity power 185,542 187,540 59,811
Gross sales of methanol 629,290 258,867 38,550
Gross sales of heat supply 25,227 15,638 —
Total revenue 33,944,252 20,677,138 25,287,423
Transportation costs of coal 7 (1,160,470) (403,311) (508,712)
Cost of sales and service provided 8 (16,801,323) (10,589,991) (12,201,131)
Cost of electricity power (195,536) (190,802) (88,253)
Cost of methanol (716,802) (352,943) (37,834)
Cost of heat supply (12,490) (9,734) —
Gross profit 15,057,631 9,130,357 12,451,493
Selling, general and administrative expenses 9 (5,093,904) (3,820,241) (3,832,031)
Share of income (loss) of associates 28 8,870 109,786 (67,367)
Other income 10 3,108,081 311,019 351,493
Interest expense 11 (603,343) (45,115) (38,360)
Profit before income taxes 12,477,335 5,685,806 8,865,228
Income taxes 12 (3,171,043) (1,553,312) (2,385,617)
Profit for the year 13 9,306,292 4,132,494 6,479,611
Attributable to:
Equity holders of the company 9,281,386 4,117,322 6,488,908
Non-controlling interests 24,906 15,172 (9,297)
9,306,292 4,132,494 6,479,611
Earnings per share, basic 16 RMB 1.89 RMB 0.84 RMB 1.32
Earnings per ads, basic 16 RMB 18.87 RMB 8.37 RMB 13.19
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
16. Earnings Per Share and Per ADS
The calculation of the earnings per share attributable to
the equity holders of the Company for the years ended
December 31, 2010, 2009 and 2008 is based on the
profit attributable to the equity holders of the Company
for the year of RMB9,281,386,000, RMB4,117,322,000 and
RMB6,488,908,000 and on the 4,918,400,000 shares in is-
sue, during each of the three years.
The earnings per ADS have been calculated based on the
profit for the relevant periods and on one ADS, being equiv-
alent to 10 H shares. The equivalent H shares to one ADS
have been changed from 50 to 10 H shares from June 27,
2008. The new ADS were distributed to ADS holders on July
3, 2008.
No diluted earnings per share has been presented as there
are no dilutive potential shares in issue during the years
ended December 31, 2010, 2009 and 2008.
Basic and Diluted EPS—Two Classes of
Ordinary Shares, Disclosure of EPS per
American Depositary Receipt (ADS), Options
and Warrants Anti-dilutive in Prior Year
3.386
Trinity Biotech plc (Dec 2010)
CONSOLIDATED STATEMENTS OF OPERATIONS
Year Ended December 31
2010 2009 2008
Total Total Total
Notes US$’000 US$’000 US$’000
Revenues 2 89,635 125,907 140,139
Cost of sales (45,690) (68,891) (77,645)
Gross profit 43,945 57,016 62,494
Other operating income 5 1,616 437 1,173
Research and development expenses (4,603) (7,341) (7,544)
Selling, general and administrative expenses (26,929) (36,013) (47,816)
Selling, general and administrative—impairment charges and restructuring expenses 28 — — (87,882)
Total selling, general and administrative expenses (26,929) (36,013) (135,698)
Net gain on divestment of business and restructuring expenses 3 46,474 — —
Operating profit/(loss) 60,503 14,099 (79,575)
Financial income 2, 4 1,352 8 65
Financial expenses 2, 4 (495) (1,192) (2,160)
Net financing income/(costs) 857 (1,184) (2,095)
Profit/(loss) before tax 6 61,360 12,915 (81,670)
Total income tax (expense)/credit 2, 9 (942) (1,091) 3,892
Profit/(loss) for the year (all attributable to owners of the parent) 2 60,418 11,824 (77,778)
Basic earnings/(loss) per ordinary share (US Dollars) 10 0.71 0.14 (0.96)
Basic earnings/(loss) per ‘B’ ordinary share (US Dollars) 10 1.43 0.28 (1.91)
Diluted earnings/(loss) per ordinary share (US Dollars) 10 0.70 0.14 (0.96)
Diluted earnings/(loss) per ‘B’ ordinary share (US Dollars) 10 1.39 0.28 (1.91)
Basic earnings/(loss) per ADS (US Dollars) 10 2.85 0.57 (3.82)
Diluted earnings/(loss) per ADS (US Dollars) 10 2.79 0.57 (3.82)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
10. Earnings/(Loss) Per Share
Basic Earnings/(Loss) Per Ordinary Share
Basic earnings/(loss) per ordinary share for the Group is com-
puted by dividing the profit after taxation of US$60,418,000
(2009: profit after tax of US$11,824,000) (2008: loss after
tax of US$77,778,000) for the financial year by the weighted
average number of ‘A’ ordinary and ‘B’ ordinary shares in
issue of 84,734,378 (2009: 83,737,884) (2008: 81,394,075).
1,400,000 of the total weighted average shares used as the
EPS denominator relate to the 700,000 ‘B’ ordinary shares
in issue. In all respects these shares are treated the same
as ‘A’ ordinary shares except for the fact that they have two
voting rights per share, rights to participate in any liquidation
or sale of the Group and to receive dividends as if each Class
‘B’ ordinary share were two Class ‘A’ ordinary shares. Hence
the earnings/(loss) per share for a ‘B’ ordinary share is exactly
twice the earnings/(loss) per share of an ‘A’ ordinary share.
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December 31, December 31, December 31,
2010 2009 2008
‘A’ ordinary shares 83,334,378 82,337,884 79,994,075
‘B’ ordinary shares
(multiplied by 2) 1,400,000 1,400,000 1,400,000
Basic earnings/(loss)
per share





Number of A ordinary
shares at January 1
(note 18) 82,952,037 82,017,581 74,756,765
Number of B ordinary
shares at January 1




year 382,341 320,303 5,237,310
Basic earnings/(loss)
per share
denominator 84,734,378 83,737,884 81,394,075
The weighted average number of shares issued during the
year is calculated by taking the number of shares issued
multiplied by the number of days in the year each share is in
issue divided by 365 days.
Diluted Earnings/(Loss) Per Ordinary Share
Diluted earnings/(loss) per ordinary share is computed
by dividing the profit after tax of US$60,418,000 (2009:
profit after tax of US$11,824,000) (2008: loss after tax of
US$77,778,000) for the financial year by the diluted weighted
average number of ordinary shares in issue of 86,661,535
(2009: 83,772,094) (2008: 81,394,075).
The basic weighted average number of shares for the
Group may be reconciled to the number used in the diluted
earnings/(loss) per ordinary share calculation as follows:





above) 84,734,378 83,737,884 81,394,075
Issuable on exercise
of options and




denominator(∗) 86,661,535 83,772,094 81,394,075
(∗) At December 31, 2010 and December 31, 2009 the number of
shares issuable on the exercise of options and warrants was dilu-
tive. At December 31, 2008, the number of shares issuable on the
exercise of options and warrants was not dilutive.
Earnings per ADS
In June 2005, Trinity Biotech adjusted its ADS ratio from 1
ADS: 1 Ordinary Share to 1 ADS: 4 Ordinary Shares. Earn-
ings per ADS for all periods presented have been restated to
reflect this exchange ratio.
Basic earnings/(loss) per ADS for the Group is com-
puted by dividing the profit after taxation of US$60,418,000
(2009: profit after tax of US$11,824,000) (2008: loss af-
ter tax of US$77,778,000) for the financial year by the
weighted average number of ADS in issue of 21,183,594
(2009: 20,934,471); (2008: 20,348,519).
December 31, December 31, December 31,
2010 2009 2008
‘A’ ordinary
shares—ADS 20,833,594 20,584,471 19,998,519
‘B’ ordinary
shares—ADS 350,000 350,000 350,000
Basic earnings/(loss)
per share
denominator 21,183,594 20,934,471 20,348,519
Diluted earnings/(loss) per ADS for the Group is computed
by dividing the profit after taxation of US$60,418,000 (2009:
profit after taxation of US$11,824,000) (2008: loss after tax
of US$77,778,000) for the financial year, by the diluted
weighted average number of ADS in issue of 21,665,383
(2009: 20,943,024) (2008: 20,348,519).
The basic weighted average number of ADS shares for the
Group may be reconciled to the number used in the diluted
earnings per ADS share calculation as follows:





above) 21,183,594 20,934,471 20,348,519
Issuable on exercise
of options and




denominator(∗) 21,665,383 20,943,024 20,348,519
(∗) At December 31, 2010 and December 31, 2009, the number of
shares issuable on the exercise of options and warrants was dilu-
tive. At December 31, 2008, the number of ADSs issuable on the
exercise of options and warrants was not dilutive.
27. Derivatives and Financial Instruments (in part)
Capital Management
The Group’s policy is to maintain a strong capital base so
as to maintain investor, creditor and market confidence and
to sustain future development of the business. The Board of
Directors monitors earnings per share as a measure of per-
formance, which the Group defines as profit after tax divided
by the weighted average number of shares in issue.
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Millicom International Cellular S.A. (Dec 2010)
CONSOLIDATED INCOME STATEMENTS
For the years ended December 31, 2010, 2009 and 2008
2010 2009 2008
Notes US$’000 US$’000 US$’000
Revenues 9 3,920,249 3,372,727 3,150,559
Cost of sales (1,331,003) (1,202,902) (1,114,822)
Gross profit 2,589,246 2,169,825 2,035,737
Sales and marketing (737,691) (647,009) (657,480)
General and administrative expenses (738,779) (606,213) (498,597)
Other operating expenses, net (71,046) (65,580) (61,438)
Operating profit 9,10 1,041,730 851,023 818,222
Interest expense (214,810) (173,475) (135,932)
Interest and other financial income 14,748 11,573 32,277
Revaluation of previously held interests 4 1,060,014 32,319 —
Other non operating expenses, net 12 (29,702) (32,181) (52,265)
(Loss) profit from associates 17 (1,817) 2,329 8,706
Profit before tax from continuing operations 1,870,163 691,588 671,008
Charge for taxes 13 (227,096) (187,998) (268,813)
Profit for the year from continuing operations 1,643,067 503,590 402,195
Profit for the year from discontinued operations, net of tax 6 11,857 300,342 2,246
Net profit for the year 1,654,924 803,932 404,441
Attributable to:
Equity holders of the company 1,652,233 850,788 517,516
Non-controlling interest 2,691 (46,856) (113,075)
Earnings per share for the year
(expressed in US$ per common share) 14
Basic earnings per share
—From continuing operations attributable to equity holders 15.19 5.09 4.79
—From discontinued operations attributable to equity holders 0.08 2.75 0.01
—For the year attributable to equity holders 15.27 7.84 4.80
Diluted earnings per share
—From continuing operations attributable to equity holders 15.16 5.08 4.76
—From discontinued operations attributable to equity holders 0.08 2.74 0.01
—For the year attributable to equity holders 15.24 7.82 4.77
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
14. Earnings Per Share
Basic earnings per share are calculated by dividing net profit
for the year attributable to equity holders of the Company by
the weighted average number of ordinary shares outstanding
during the year.
Diluted earnings per share are calculated by dividing the
net profit for the year attributable to equity holders of the Com-
pany by the weighted average number of ordinary shares out-
standing during the year plus the weighted average number
of dilutive potential shares.
The following reflects the net profit and share data used in




Net profit attributable to equity holders from continuing operations 1,643,447 551,390 516,316
Net profit attributable to equity holders from discontinued operations 8,786 298,858 1,200
Net profit attributable to equity holders used to determine the basic earnings per share 1,652,233 850,788 517,516
Diluted
Net profit attributable to equity holders from continuing operations 1,643,447 551,390 516,316
Interest expense on convertible debt (note 26) — — 760
Net profit attributable to equity holders from continuing operations used to determine the
diluted earnings per share 1,643,447 551,390 517,076
Net profit attributable to equity holders from discontinued operations 8,786 298,858 1,200
Net profit attributable to equity holders used to determine the diluted earnings per share 1,652,233 850,788 518,276
2010 2009 2008
’000 ’000 ’000
Weighted average number of ordinary shares (excluding treasury shares) for basic earnings
per share 108,219 108,527 107,869
Effect of dilution:
Potential incremental shares as a result of share options 177 223 434
Assumed conversion of convertible debt — — 343
Weighted average number of ordinary shares (excluding treasury shares) adjusted for the
effect of dilution 108,396 108,750 108,646
To calculate earnings per share amounts for the discontinued
operations, the weighted average number of shares for both
basic and diluted amounts is as per the table above.
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Disclosure, Net Loss, All Potentially Dilutive
Shares Anti-Dilutive
3.388
Adecoagro S.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF INCOME
For the years ended December 31, 2010, 2009 and 2008
(All amounts in US$ thousands, except shares and per
share data and as otherwise indicated)
Note 2010 2009 2008
Sales of manufactured products and services rendered 24 294,529 183,386 117,173
Cost of manufactured products sold and services rendered 25 (219,201) (180,083) (105,583)
Gross profit from manufacturing activities 75,328 3,303 11,590
Sales of agricultural produce and biological assets 24 131,738 130,217 127,036
Cost of agricultural produce sold and direct agricultural selling expenses 25 (131,738) (130,217) (127,036)
Initial recognition and changes in fair value of biological assets and agricultural produce (30,528) 71,668 61,000
Changes in net realizable value of agricultural produce after harvest 7,999 12,787 1,261
Gross (loss)/profit from agricultural activities (22,529) 84,455 62,261
Margin on manufacturing and agricultural activities before operating expenses 52,799 87,758 73,851
General and administrative expenses 25 (56,562) (52,393) (45,633)
Selling expenses 25 (52,528) (31,169) (24,496)
Other operating income, net 27 18,224 13,071 17,323
Excess of fair value of net assets acquired over cost 31 — — 1,227
Share of loss of joint ventures 10 (50) (294) (838)
(Loss)/profit from operations before financing and taxation (38,117) 16,973 21,434
Finance income 28 16,559 11,553 2,552
Finance costs 28 (39,496) (34,216) (50,860)
Financial results, net 28 (22,937) (22,663) (48,308)
Loss before income tax (61,054) (5,690) (26,874)
Income tax benefit 21 16,263 5,415 10,449
Loss for the year (44,791) (275) (16,425)
Attributable to:
Equity holders of the parent (43,904) (260) (18,947)
Non controlling interest (887) (15) 2,522
Loss per share attributable to the equity holders of the parent during the year:
Basic 29 (0.361) (0.002) (0.168)
Diluted 29 n/a n/a n/a
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
The principal accounting policies applied in the preparation
of these consolidated financial statements are set out below.
These policies have been consistently applied to all the years
presented, unless otherwise stated.
2.26. Earnings Per Share
Basic loss per share is calculated by dividing the net loss
for the period attributable to equity holders of the parent by
the weighted average number of ordinary shares outstanding
during the year. Diluted net loss per share is computed by
dividing the net loss for the period by the weighted average
number of ordinary shares outstanding, and when dilutive,
adjusted for the effect of all potentially dilutive shares, includ-
ing share options, on an as-if converted basis. For all periods
presented, there were no differences in the weighted-average
number of ordinary shares used for basic and diluted net loss
per share as the effect of all potentially dilutive shares out-
standing was anti-dilutive.
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29. Earnings Per Share
Basic and diluted loss per share is calculated by dividing
the loss attributable to equity holders of the Group by the
weighted average number of shares in issue during the year.
2010 2009 2008
Loss attributable to equity holders of
the Group (43,904) (260) (18,947)
Weighted average number of shares
in issue (thousands) 121,667 120,000 112,420
Basic and diluted losses per share (0.361) (0.002) (0.168)
Diluted net loss per share is computed by dividing the net
loss for the period by the weighted average number of ordi-
nary shares outstanding, and when dilutive, adjusted for the
effect of all potentially dilutive shares, including share options,
on an as-if converted basis. For all periods presented, there
were no differences in the weighted-average number of or-
dinary shares used for basic and diluted net loss per share
as the effect of all potentially dilutive shares outstanding was
anti-dilutive. As of December 31, 2010, there were 6.4 million
(2009: 6.6 million and 2008: 5.6 million) share options out-
standing that could potentially have a dilutive impact in the
future but were antidilutive in all periods presented.
Basic and Diluted EPS—Net Loss Resulting in
Outstanding Convertible Preference Shares,
Convertible Debt, Share Options Anti-dilutive
in Current Year, Dilutive in Prior Years
3.389
Seven Arts Pictures Plc (Jun 2010)
CONSOLIDATED STATEMENTS OF OPERATIONS
AND OTHER COMPREHENSIVE INCOME/(LOSS)
Year Ended Year Ended
Three Months
Ended Year Ended
June 30, June 30, June 30, March 31,
Notes 2010 2009 2008 2008
Revenue:
Film revenues 2 $ 1,974,516 $ 4,217,910 $ 2,792,836 $ 3,265,808
Fee related revenues—related party 2 4,442,919 6,014,313 — —
Total revenues 2 6,417,435 10,232,223 2,792,836 3,265,808
Cost of sales
Amortization and impairment of film costs 10 (1,770,650) (2,559,932) (781,030) (490,239)
Other cost of sales (628,326) (2,103,391) (520,541) (3,597,469)
Cost of sales (2,398,976) (4,663,323) (1,301,571) (4,087,708)
Gross profit 4,018,459 5,568,900 1,491,265 (821,900)
Operating expenses
General & administrative Expenses (2,619,205) (3,582,348) (711,479) (4,015,533)
Bad debt expense (319,344) (542,811) — —
Total operating expenses (2,938,549) (4,125,159) (711,479) (4,015,533)
Profit/(loss) before interest and taxes 1,079,910 1,443,741 779,786 (4,837,433)
Net interest (expense) income
Interest expenses 3 (1,815,970) (10,907,555) (3,696,033) (672,973)
Interest income 3 110,409 8,599,096 3,272,868 466,887
Net interest (expense) 3 (1,705,561) (2,308,459) (423,165) (206,086)
Profit/(loss) before taxes and other income (625,651) (864,718) 356,621 (5,043,519)
Other income 4 150,000 5,601,683 — —
Profit/(loss) before taxes (475,651) 4,736,965 356,621 (5,043,519)
Provision for income tax (benefit) 5 — — — (485,634)
Net Income (Loss) (475,651) 4,736,965 356,621 (4,557,885)
Comprehensive Income(Loss):
Net Income (Loss) $ (475,651) $ 4,736,965 $ 356,621 $ (4,557,885)
Foreign exchange translation gain (loss) 420,963 (1,413,066) 5,249 —
Comprehensive Income (Loss) $ (54,688) $ 3,323,899 $ 361,870 $ (4,557,885)
Basic profit/(loss) per share 6 $ (0.07) $ 0.78 $ 0.07 $ (0.97)
Diluted profit/(loss) per share 6 $ (0.07) $ 0.58 $ 0.04 $ (0.97)
Weighted average number of ordinary shares
used in the profit (loss) per share
calculation:
Basic 7,013,601 6,051,453 4,870,800 4,676,301
Diluted 7,013,601 8,146,953 8,255,855 4,676,301
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
6. Earnings Per Share
The Group calculates net income (loss) per share in accor-
dance with International Accounting Standard 33, Earnings
per Share (“IAS 33”). Basic net income/(loss) per share is
calculated based on the weighted average common shares
outstanding for the period presented and all have been ad-
justed to reflect the Group’s 5:1 reverse stock split which
occurred on December 31, 2008.
The weighted average number of shares outstanding is
calculated by time-apportioning the shares outstanding dur-
ing the year. The diluted earnings per ordinary share are
calculated based on the weighted average number of shares
outstanding plus the weighted average number of potential










Weighted average number of ordinary shares—Basic 7,013,601 6,051,453 4,870,800 4,676,301
Effect of dilutive potential ordinary shares:
—convertible preference shares — 1,138,000 2,400,000 —
—convertible debt — 700,000 700,000 —
—share options — 257,500 285,055 —
Weighted average number of ordinary shares—Diluted 7,013,601 8,146,953 8,255,855 4,676,301
There were 361,644 and 2,400,000 potential ordinary shares
from convertible preference shares, 803,562 and 700,000 po-
tential ordinary shares from convertible debts, and 114,273
and 75,315 potential ordinary shares from options outstand-
ing at June 30, 2010 and March 31, 2008, respectively. These
outstanding potential ordinary shares were not included in the
computation of diluted net loss per share as anti-dilution is not
permitted because the Group incurred losses in these peri-
ods. In accordance with IAS 33, anti-dilutive potential shares
are not included in the diluted loss per share calculation.
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SECTION 4: STATEMENT OF CHANGES IN EQUITY
AND RELATED DISCLOSURES∗
IAS 1, PRESENTATION OF FINANCIAL
STATEMENTS
IFRIC 17, DISTRIBUTIONS OF
NON-CASH ASSETS TO OWNERS
IFRS Overview and Comparison
to U.S. GAAP
4.01 International Accounting Standard (IAS) 1, Presenta-
tion of Financial Statements, establishes the basis for pre-
sentation of general purpose financial statements to ensure
comparability both with the entity’s financial statements of
previous periods and the financial statements of other entities.
This standard establishes overall requirements for the presen-
tation of financial statements, guidelines for their structure,
and minimum requirements for their content. IAS 1 requires
the presentation of both a statement of comprehensive income
and a statement of changes in equity as part of a complete set
of financial statements (see section 3, “Statement of Com-
prehensive Income and Related Disclosures”). All changes
related to owners in their capacity as owners are shown sepa-
rately from nonowner changes. Effective for fiscal years be-
ginning on or after 1 January 2009, an entity should allocate
total comprehensive income to the components of equity. IAS
1 no longer permits components of comprehensive income
to be presented in the statement of changes in equity.
4.02 IAS 1 also requires disclosures about an entity’s capital
and dividends, including dividends per share.
4.03 General purpose financial statements are those in-
tended to meet the needs of users who are not in a position to
require an entity to prepare reports tailored to their particular
information needs. Although referred to numerous times in
U.S. generally accepted accounting principles (GAAP), gen-
eral purpose financial statements are not explicitly defined in
Financial Accounting Standards Board (FASB) Accounting
Standards CodificationTM (ASC).
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
issued as of 1 January 2011.
Presentation
IFRSs
4.04 IAS 1 requires an entity to present a statement of
changes in equity. This statement includes total compre-
hensive income for the period, showing separately the total
amounts attributable to owners of the parent and to noncon-
trolling interests. IAS 1 requires the components of other
comprehensive income to be shown in either a single state-
ment of comprehensive income or in a statement of other
comprehensive income accompanying a statement of income.
IAS 1 does not permit an entity to avoid preparing the state-
ment of other comprehensive income by presenting these
components in the statement of changes in equity. IAS 1 now
requires an entity to allocate total comprehensive income to
the separate components of equity.
4.05 In addition, for each component of equity, the state-
ment should provide a reconciliation of the carrying amount
at the beginning and end of the period. This reconciliation
should disclose separately changes resulting from profit or
loss, each item of other comprehensive income, and transac-
tions with owners in their capacity as owners. Contributions
from and distributions to owners and changes in ownership
interests in subsidiaries that do not result in a loss of control
also should be shown separately. International Financial Re-
porting Interpretations Committee (IFRIC) Interpretation 17,
Distributions of Non-cash Assets to Owners, provides addi-
tional guidance for the following two types of nonreciprocal
distributions of assets by an entity to its owners acting in
their capacity as owners:
• Distributions of noncash assets (for example, items of
property, plant, and equipment, and businesses as de-
fined in International Financial Reporting Standards
(IFRS) 3, Business Combinations, and ownership in-
terests in another entity or disposal groups as defined
in IFRS 5, Non-current Assets Held for Sale and Dis-
continued Operations)
• Distributions that give owners a choice of receiving
either noncash assets or a cash alternative
IFRIC 17 was issued in October 2008 and is effective for
annual periods beginning on or after 1 July 2009. Earlier
application is permitted.
4.06 An entity should also show separately changes from
retrospective application of a change in accounting policy or
a retrospective restatement due to an error correction.
4.07 IAS 1 permits the following items to be presented either
on the face of the statement of changes in equity or in the
notes:
• amount of dividends recognized as distributions to own-
ers during the period, and
• related dividends per share.
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Author’s Note
Under the amendments to Accounting Standards Up-
date (ASU) No. 2011-05, Comprehensive Income
(Topic 220): Presentation of Comprehensive Income,
an entity has the option to present the total of compre-
hensive income, the components of net income, and
the components of other comprehensive income either
in a single continuous statement of comprehensive in-
come or in two separate but consecutive statements.
In both choices, an entity is required to present each
component of net income along with total net income,
each component of other comprehensive income along
with a total for other comprehensive income, and a
total amount for comprehensive income. This ASU
eliminates the option to present the components of
other comprehensive income as part of the statement
of changes in stockholders’ equity. The amendments
in this ASU do not change the items that must be re-
ported in other comprehensive income or when an item
of other comprehensive income must be reclassified to
net income.
The requirements of this ASU are shown as “Pend-
ing Content” in FASB ASC 220-10-4, with a date of
transition of December 31, 2011, for public compa-
nies and December 31, 2012, for nonpublic compa-
nies. Transition guidance is available in FASB ASC
220-10-65-1.
4.08 Unlike IFRSs, which does not allow components of
comprehensive income to only be included in a statement of
changes in equity, FASB ASC 220-10-45-10 allows an en-
tity to present components of comprehensive income in the
statement of changes in equity. However, this paragraph also
states that displaying comprehensive income and its compo-
nents in an income-statement-type format is superior to dis-
play in a statement of changes in equity. In accordance with
FASB 505-10-50-2, an entity may present changes in equity
in either the basic financial statements or notes thereto or a
separate statement. Under Rule 3-04 of Securities and Ex-
change Commission (SEC) Regulation S-X, an entity should
provide an analysis of the changes in each caption of stock-
holders’ equity and noncontrolling interests presented in the
balance sheets either in a note or separate statement, FASB
ASC 220-10-45-14 provides guidance for reporting other
comprehensive income in the “Equity” section of a state-
ment of financial position.
4.09 Under FASB ASC 220-10-45-3, financial statements
should reflect both comprehensive income (total nonowner
changes in equity) and investments by, and distributions to,
owners during the period. Thus, it can be inferred, like IFRSs,
that an entity should present owner-related changes sepa-




4.10 IAS 1 requires disclosure of information to enable users
of the financial statements to evaluate the entity’s objectives,
policies, and processes for managing capital. This disclosure
should include the following:
a. Qualitative information about its objectives, policies,
and processes for managing capital, including the fol-
lowing:
i. A description of what the entity manages as capital
ii. When an entity is subject to externally imposed cap-
ital requirements, the nature of those requirements,
and how an entity incorporates those requirements
into its capital management policies and procedures
iii. How the entity meets its objectives for managing
capital
b. Summary quantitative data about what the entity man-
ages as capital. Some entities regard certain financial
liabilities (for example, some forms of subordinated
debt) as part of capital. Other entities regard capital
as excluding some components of equity (for example,
components arising from cash flow hedges).
c. Any changes in (a) and (b) from the previous period.
d. Whether, during the period, the entity complied with
any externally imposed capital requirements to which
it was subject.
e. When the entity has not complied with such exter-
nally imposed capital requirements, the consequences
of such noncompliance.
The entity should base these disclosures on the information
provided internally to key management personnel.
4.11 Additional dividend disclosures include the following:
• Amount of dividends proposed or declared before the
financial statements were authorized for issue, but not
recognized as a distribution to owners during the period,
and the related amount per share
• Amount of any cumulative preference dividends not
recognized
U.S. GAAP
4.12 Rule 3-04 of SEC Regulation S-X requires an SEC reg-
istrant to disclose an analysis of the changes in each caption
of other stockholders’ equity and noncontrolling interests
presented in the balance sheets in a note or separate state-
ment (see also FASB ASC 505-10-S99-1). With respect to
any dividends, the entity should state the amount per share
and in the aggregate for each class of shares. The entity is
not constrained to provide dividend information in either the
notes or statement of changes in shareholders’ equity but
could provide this information in the statement of financial
position. The latter is an additional option not available in
IFRSs.
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4.13 FASB ASC 810-10-50-1A (d) requires an entity to
provide in a note disclosure a separate schedule that shows
the effects of any changes in a parent’s ownership interest in
a subsidiary on the equity attributable to the parent.
TABLE 4-1: COMPONENTS OF SHAREHOLDERS’
EQUITY
Components Included in the Statement of
Shareholders’ Equity: 2010 2009(1)
Number of shares of common (ordinary) shares........... 31 30
Number of shares of treasury (own) shares.................. 6 6
Common (ordinary) share capital (stock) ...................... 163 140
Preference (preferred) share capital (stock).................. 8 5
Share premium (additional paid-in capital, paid-in
capital in excess of nominal (par) value).................... 117 99
Share capital and share premium combined................. 8 8
Convertible securities..................................................... 21 25
Other equity instruments................................................ 3 2
Treasury (own) shares................................................... 75 66
Shares held by employee benefit trusts
(e.g., ESOPs, etc)....................................................... 6 4
Foreign currency translation reserve............................. 90 78
Revaluation reserve (surplus) (related to revaluation
of tangible assets)....................................................... 16 8
Investment valuation reserve (change in fair value of
available for sale financial assets) ............................. 61 57
Hedging reserve (cash flow and net investment
hedges)....................................................................... 62 52
Share-based compensation reserve.............................. 29 24
Actuarial gains and losses on pensions ........................ 6 5
Retained earnings or deficit (undistributed profits)........ 170 140
Noncontrolling (minority) interest................................... 115 98
Other reserves................................................................ 106 85
(1) Prior to 1 January 2009, IAS 1 did not require entities to present
changes in equity in a separate statement. Of the 160 survey
companies in the 2009 edition of IFRS Accounting Trends & Tech-
niques, only 140 companies presented a statement of changes in
equity. The remaining 20 companies included this information in
a note disclosure. All 170 survey companies in the 2010 edition
presented a statement of changes in equity.
TABLE 4-2: TYPES OF CHANGES IN SHAREHOLDERS’
EQUITY
Companies Presenting a Statement of Changes in
Shareholders’ Equity 2010 2009(1)
Allocation of total comprehensive income only ............. 57 58
Allocation of net income and one or more components
of total comprehensive income................................... 113 82
Total Companies .............................................. 170 140
Changes Resulting From Transactions
With Owners Presented
Cash dividends............................................................... 126 99
Preference share dividends........................................... 8 5
Other dividends and shares issued in lieu
of dividends................................................................. 8 16
Issue of common shares................................................ 72 57
Issue of preference shares............................................ 6 6
Rights issues.................................................................. 3 4
Treasury share transactions.......................................... 86 76
Share-based compensation........................................... 115 89
Shares acquired by employee benefit trusts................. 17 20
Exercise of stock options............................................... 38 27
Transfers from revaluation reserve to retained
earnings...................................................................... 33 30
Share issuance costs..................................................... 4 11
Changes to the scope of consolidation.......................... 15 34
Acquisition and disposal of noncontrolling (minority)
interest ........................................................................ 47 54
Dividends paid to noncontrolling (minority) interests..... 19 19
Government contributions or returns of assets to
government................................................................. 2 3
Adjustment for hyperinflation (with respect to
hyperinflation in subsidiaries)..................................... 2 2
Adjustment to beginning balance due to change in
accounting policy........................................................ 5 8
Adjustment to beginning balances due to error
correction.................................................................... 0 1
Other............................................................................... 102 83
(1) Prior to 1 January 2009, IAS 1 did not require entities to present
changes in equity in a separate statement. Of the 160 survey
companies in the 2009 edition of IFRS Accounting Trends & Tech-
niques, only 140 companies presented a statement of changes in
equity. The remaining 20 companies included this information in
a note disclosure. All 170 survey companies in the 2010 edition
presented a statement of changes in equity.
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Issue of Common and Preferred Shares
4.14
Brookfield Asset Management, Inc. (Dec 2010)
Author’s Note
Brookfield Asset Management, Inc. implemented
IFRSs effective December 31, 2010, with a date of
transition of January 1, 2009. The excerpt that follows
reflects the initial application of IAS 1.
CONSOLIDATED STATEMENTS OF CHANGES
IN EQUITY
Accumulated Other


























December 31, 2009 $1,289 $67 $3,560 $117 $ 5,193 $1,623 $(40) $11,809 $1,144 $10,186 $23,139
Prior to: deferred income
taxes, net — — 295 — 2,352 119 29 2,795 — 983 3,778




gains prior to other
items — — 1,049 414 — — — 1,463 — 1,119 2,582
Depreciation and
amortization — — (693) — — — — (693) — (102) (795)
Fair value changes — — 1,129 — — — — 1,129 — 736 1,865
Less: disposition gains(1) — — — (414) — — — (414) — — (414)
Associated deferred
income taxes — — (31) — — — — (31) — (12) (43)
— — 1,454 — — — — 1,454 — 1,741 3,195
Other comprehensive
income
Fair value changes — — — — (952) — (3) (955) — 49 (906)
Currency translation — — — — — 276 — 276 — 377 653
Associated deferred
income taxes — — — — 439 31 (17) 453 — (5) 448
— — — — (513) 307 (20) (226) — 421 195
Shareholder distributions
Common equity — — (298) — — — — (298) — — (298)
Preferred equity — — (75) — — — — (75) — — (75)
Non-controlling interests — — — — — — — — — (444) (444)
— — (373) — — — — (373) — (444) (817)
Other items
Equity issuances, net of
redemptions 45 — (14) — — — — 31 514 1,121 1,666
Share-based
compensation — 30 — — — — — 30 — 16 46
Acquisitions/dispositions — — — (162) — 75 — (87) — 1,668 1,581
Associated deferred
income taxes — — — 232 — (75) — 157 — 30 187
45 30 (14) 70 — — — 131 514 2,835 3,480
Reversal of in-period
income taxes — — 31 (232) (439) 44 17 (579) — (13) (592)
1,334 97 4,953 (45) 6,593 2,093 (14) 15,011 1,658 15,709 32,378
Less: deferred income
taxes, net
Opening balances — — (295) — (2,352) (119) (29) (2,795) — (983) (3,778)
In-period amounts — — (31) 232 439 (44) (17) 579 — 13 592
Ending balances — — (326) 232 (1,913) (163) (46) (2,216) — (970) (3,186)
Balance as at
December 31, 2010 $1,334 $97 $4,627 $187 $4,680 $1,930 $(60) $12,795 $1,658 $14,739 $29,192
(1) Disposition gains not recognized in net income under IFRS.
(2) Refer to Note 3 for the effects of the adoption of IFRS.
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
20. Equity
Equity is comprised of the following:
(Millions) Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Preferred equity $ 1,658 $ 1,144 $ 870
Non-controlling interests 14,739 10,186 8,038
Common equity 12,795 11,809 11,267
$29,192 $23,139 $20,175
(a) Preferred Equity
Preferred equity represents perpetual preferred shares and
consists of the following:
Issued and Outstanding
(Millions, Except Share Information) Rate 2010 2009 Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Class A preferred shares
Series 2 70% P 10,465,100 10,465,100 $ 169 $ 169 $169
Series 4 70% P/8.5% 2,800,000 2,800,000 45 45 45
Series 8 Variable up to P 1,805,948 1,805,948 29 29 29
Series 9 4.35% 2,194,052 2,194,052 35 35 35
Series 13 70% P 9,297,700 9,297,700 195 195 195
Series 15 B.A. + 40 b.p.(1) 2,000,000 2,000,000 42 42 42
Series 17 4.75% 8,000,000 8,000,000 174 174 174
Series 18 4.75% 8,000,000 8,000,000 181 181 181
Series 22 7.00% 12,000,000 12,000,000 274 274 —
Series 24 5.40% 11,000,000 — 269 — —
Series 26 4.50% 10,000,000 — 245 — —
Total $1,658 $1,144 $870
(1) Rate determined in a quarterly auction.
P—Prime Rate, B.A.—Bankers’ Acceptance Rate, b.p.—Basis Points.
The company is authorized to issue an unlimited number of
Class A preferred shares and an unlimited number of Class
AA preferred shares, issuable in series. No Class AA pre-
ferred shares have been issued.
The Class A preferred shares have preference over the
Class AA preferred shares, which in turn are entitled to pref-
erence over the Class A and Class B common shares on the
declaration of dividends and other distributions to sharehold-
ers. All series of the outstanding preferred shares have a par
value of C$25 per share.
In February 2011, the company issued 9,400,000 Class A
Series 28, 4.6% preferred shares for cash proceeds of C$235
million, and incurred transaction costs of C$7 million.
(b) Non-Controlling Interests
Non-controlling interests represent the common and pre-
ferred equity in consolidated entities that is owned by other
shareholders.
(Millions) Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Common equity $13,802 $ 9,798 $7,916
Preferred equity 937 388 122
Total $14,739 $10,186 $8,038
Non-controlling interests in common and preferred equity in-
creased by $4,553 and $2,148 million during 2010 and 2009
respectively, primarily as a result of equity issuances in the
company’s consolidated subsidiaries, the consolidation of net
assets acquired through business combinations and the non-
controlling interests’ share of comprehensive income.
IFRS ATT 4.14
480 IFRS Accounting Trends & Techniques
(c) Common Equity
The company’s common share capital is comprised of the
following:
(Millions) Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Class A and B common shares $ 1,334 $ 1,289 $ 1,278
Contributed surplus 97 67 49
Retained earnings 4,627 3,560 4,760
Disposition gains 187 117 —
Accumulated other comprehensive income 6,550 6,776 5,180
Common equity $12,795 $11,809 $11,267
The company is authorized to issue an unlimited number of
Class A Limited Voting Shares (“Class A common shares”)
and 85,120 Class B Limited Voting Shares (“Class B common
shares”), together referred to as common shares. The com-
pany’s common shares have no stated par value. The holders
of Class A common shares and Class B common shares rank
on parity with each other with respect to the payment of divi-
dends and the return of capital on the liquidation, dissolution
or winding up of the company or any other distribution of the
assets of the company among its shareholders for the pur-
pose of winding up its affairs. With respect to the Class A and
Class B common shares, there are no dilutive factors, mate-
rial or otherwise, that would result in different diluted earnings
per share between the classes. This relationship holds true
irrespective of the number of dilutive instruments issued in
either one of the respective classes of common stock, as
both classes of common shares participate equally, on a pro
rata basis, in the dividends, earnings and net assets of the
company, whether taken before or after dilutive instruments,
regardless of which class of common shares is diluted.
The number of shares issued and outstanding and unex-
ercised options at December 31, 2010, December 31, 2009
and January 1, 2009 are as follows:
Dec. 31, 2010 Dec. 31, 2009 Jan. 1, 2009
Class A common shares 577,578,573 572,782,819 572,479,652
Class B common shares 85,120 85,120 85,120
577,663,693 572,867,939 572,564,772
Unexercised options 38,401,076 34,883,426 27,761,269
Total diluted common shares 616,064,769 607,751,365 600,326,041
The authorized common share capital consists of an unlimited
number of common voting shares. Common shares issued
and outstanding changed as follows:
Dec. 31, 2010 Dec. 31, 2009
Outstanding at beginning of year
Shares issued (repurchased)
572,867,939 572,564,772
Dividend reinvestment plan 112,876 178,962
Management share option plan 4,681,614 1,622,444
Repurchases — (1,498,249)
Other 1,264 10
Outstanding at end of year 577,663,693 572,867,939
In January 2011, the company issued 27,500,000 Class A
common shares in connection with the $1.7 billion acquisi-
tion of General Growth Properties common shares. In Febru-
ary 2011, the company issued 17,595,000 Class A common
shares for cash proceeds of C$578 million pursuant to a pub-
lic equity offering.
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Rights Issue, Scrip Dividend, Issue of
Treasury Shares, Shares Issued in Lieu
of Dividends, Purchase of Treasury Shares
4.15
National Grid plc (Mar 2010)
CONSOLIDATED STATEMENT OF CHANGES IN
EQUITY (in part)
For the years ended 31 March
Called-Up Share Other Total Non-
Share Premium Retained Equity Shareholders’ Controlling Total
Capital Account Earnings Reserves(i) Equity Interests Equity
£m £m £m £m £m £m £m
At 31 March 2010 298 1,366 7,316 (4,781) 4,199 12 4,211
Total comprehensive income for the year — — 2,549 (89) 2,460 4 2,464
Rights issue 113 — — 3,101 3,214 — 3,214
Transfer between reserves — — 3,101 (3,101) — — —
Equity dividends — — (1,064) — (1,064) — (1,064)
Scrip dividend related share issue 5 (5) 206 — 206 — 206
Issue of treasury shares — — 18 — 18 — 18
Purchase of own shares — — (3) — (3) — (3)
Other movements in non-controlling interests — — — — — (7) (7)
Share-based payment — — 25 — 25 — 25
Tax on share-based payment — — 5 — 5 — 5
At 31 March 2011 416 1,361 12,153 (4,870) 9,060 9 9,069
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Exceptional Items, Remeasurements and Stranded
Cost Recoveries (in part)
Debt redemption costs represent costs arising from our debt
repurchase programme, undertaken primarily in the first half
of the year, to manage our cash resources efficiently following
the rights issue. Debt redemption costs in the year ended 31
March 2010 represented costs relating to the early redemp-
tion of a significant loan.
7. Dividends
The following table shows the actual dividends paid to equity
shareholders:
2011 2010
2011 2011 Settled 2010 2010 Settled 2009 2009
Pence Total via Scrip Pence Total via Scrip Pence Total
per Share £m £m per Share £m £m per Share £m
Interim—year ended 31 March 2011 12.90 451 65 — — — — —
Final—year ended 31 March 2010 24.84 613 141 — — — — —
Interim—year ended 31 March 2010 — — — 13.65 336 68 — —
Final—year ended 31 March 2009 — — — 23.00 557 137 — —
Interim—year ended 31 March 2009 — — — — — — 12.64 307
Final—year ended 31 March 2008 — — — — — — 21.30 531
37.74 1,064 206 36.65 893 205 33.94 838
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For comparability purposes the table below presents re-
based dividends per share after taking account of the impact
of the rights issue:
2011 2011 2011 2010 2010 2010 2009 2009
Pence Impact Pence Pence Impact Pence Pence Pence
per Share of Rights per Share per Share of Rights per Share per Share per Share
(Actual) Issue (Rebased) (Actual) Issue (Rebased) (Actual) (Rebased)
Interim—year ended 31 March 2011 12.90 — 12.90 — — — — —
Final—year ended 31 March 2010 24.84 (3.10) 21.74 — — — — —
Interim—year ended 31 March 2010 — — — 13.65 (1.71) 11.94 — —
Final—year ended 31 March 2009 — — — 23.00 (1.87) 20.13 — —
Interim—year ended 31 March 2009 — — — — — — 12.64 11.06
Final—year ended 31 March 2008 — — — — — — 21.30 18.64
37.74 (3.10) 34.64 36.65 (3.58) 32.07 33.94 29.70
The Directors are proposing a final dividend for 2011 of
23.47p per share that will absorb approximately £824m of
shareholders’ equity (assuming all amounts are settled in
cash). It will be paid on 17 August 2011 to shareholders who
are on the register of members at 3 June 2011 and a scrip
dividend will be offered as an alternative, subject to share-
holders’ approval at the Annual General Meeting.
8. Earnings Per Share
Adjusted earnings per share, excluding exceptional items,
remeasurements and stranded cost recoveries, are provided
to reflect the business performance subtotals used by the
Company. For further details of exceptional items, remea-
surements and stranded cost recoveries, see note 3.
(a) Basic Earnings Per Share (in part)
Earnings Earnings Earnings
Earnings per Share Earnings per Share Earnings per Share
2011 2011 2010 2010(∗) 2009 2009(∗)
£m Pence £m Pence £m Pence
Adjusted earnings—continuing operations 1,747 51.7 1,418 49.5 1,250 43.3
Exceptional items after tax (16) (0.5) (270) (9.4) (247) (8.6)
Remeasurements after tax 219 6.5 17 0.6 (340) (11.8)
Stranded cost recoveries after tax 209 6.2 221 7.7 256 8.9
Earnings—continuing operations 2,159 63.9 1,386 48.4 919 31.8
Earnings—discontinued operations — — — — 25 0.9
Earnings 2,159 63.9 1,386 48.4 944 32.7
2011 2010 2009
Millions Millions Millions
Weighted average number of shares—basic(∗) 3,378 2,864 2,886
(∗) Comparative EPS data have been restated to reflect the impact of the bonus element of the rights issue and as a result of the additional
shares issued as scrip dividends.
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(b) Diluted Earnings Per Share
Earnings Earnings Earnings
Earnings per Share Earnings per Share Earnings per Share
2011 2011 2010 2010(∗) 2009 2009(∗)
£m Pence £m Pence £m Pence
Adjusted diluted earnings—continuing operations 1,747 51.4 1,418 49.3 1,250 43.1
Exceptional items after tax (16) (0.5) (270) (9.4) (247) (8.5)
Remeasurements after tax 219 6.5 17 0.6 (340) (11.7)
Stranded cost recoveries after tax 209 6.2 221 7.7 256 8.8
Diluted earnings—continuing operations 2,159 63.6 1,386 48.2 919 31.7
Diluted earnings—discontinued operations — — — — 25 0.8
Diluted earnings 2,159 63.6 1,386 48.2 944 32.5
2011 2010 2009
Millions Millions Millions
Weighted average number of shares—diluted(∗) 3,397 2,877 2,903
(∗) Comparative EPS data have been restated to reflect the impact of the bonus element of the rights issue and as a result of the additional




Ordinary Shares Millions £m
At 31 March 2009 2,582 294
Issued during the year in lieu of dividends(i) 35 4
At 31 March 2010 2,617 298
Rights issue 990 113
Issued during the year in lieu of dividends(i) 41 5
At 31 March 2011 3,648 416
(i) The issue of shares in lieu of cash dividends is considered to be
a bonus issue under the terms of the Companies Act 2006 and
the nominal value of the shares is charged to the share premium
account.
The share capital of the Company consists of ordinary shares
of 1117/43 pence nominal value each and American Deposi-
tary Shares. The ordinary and American Depositary Shares
allow holders to receive dividends and vote at general meet-
ings of the Company. The Company holds treasury shares
but may not exercise any rights over these shares including
the entitlement to vote or receive dividends. There are no
restrictions on the transfer or sale of ordinary shares.
In line with the provisions of the Companies Act 2006,
National Grid plc has adopted new Articles of Association,
deleted the objects provisions of its Memorandum of Associ-
ation and ceased to have authorised share capital.
Rights Issue
On 14 June 2010, the Company raised £3.2bn (net of ex-
penses of £105m) through a rights issue of 990m new or-
dinary shares at 335 pence each on the basis of two new
ordinary shares for every five existing ordinary shares. The
issue price represented a discount of 44% to the closing ex-
dividend share price on 20 May 2010, the announcement date
of the rights issue.
The structure of the rights issue initially gave rise to a
merger reserve under section 612 of the Companies Act
2006, representing the net proceeds of the rights issue less
the nominal value of the new shares issued. Following the
receipt of the cash proceeds through the structure, the ex-
cess of the net proceeds over the nominal value of the share
capital issued has been transferred from the merger reserve
to retained earnings.
The discount element inherent in the rights issue is treated
as a bonus issue of 353m shares. Earnings per share data
have been restated for all comparative periods presented, by
adjusting the weighted average number of shares to include
the impact of the bonus shares. For comparability, dividends
per share are also presented after taking account of the bonus
element of the rights issue, in note 7.
Treasury Shares
At 31 March 2011, the Company held 140m (2010: 144m) of
its own shares. The market value of these shares as at 31
March 2011 was £833m (2010: £925m).
The maximum number of shares held during the year was
144m ordinary shares (2010: 154m) representing approxi-
mately 3.9% (2010: 5.9%) of the ordinary shares in issue
as at 31 March 2011 and having a nominal value of £16m
(2010: £18m). The shares held in treasury were not entitled
to participate in the rights issue.
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Dividends on Preference Shares (Classified
as Equity), Dividends of Subsidiaries,
Transfer of Revaluation Reserve to Retained
Earnings on Depreciation and Disposal of
Revalued Assets
4.16
JSC Halyk Bank (Dec 2010)
CONSOLIDATED STATEMENTS OF CHANGES IN
EQUITY (in part)
For the years ended 31 December 2010, 2009 and 2008











31 December 2009 83,571 46,891 13,233 1,317
Net income — — — —
Other comprehensive income/(loss) — — — —
Total comprehensive income/(loss) — — — —
Treasury shares purchased 23 — — — (16)
Treasury shares sold 23 — — — 51
Dividends—preferred shares — — — —
Dividends of subsidiaries — — — —
Release of property and equipment revaluation reserve
on depreciation and disposal of previously revalued
assets — — — —
Changes in non-controlling interest share of net assets — — — —
31 December 2010 83,571 46,891 13,233 1,352
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(103) 1,667 (976) 18,121 116,881 280,602 350 280,952
— — — — 35,943 35,943 273 36,216
— (307) 4,858 51 — 4,602 (8) 4,594
— (307) 4,858 51 35,943 40,545 265 40,810
(8) — — — — (24) — (24)
18 — — — — 69 — 69
— — — — (4,494) (4,494) — (4,494)
— — — — — — (69) (69)
— — — (1,197) 1,197 — — —
— — — — — — 640 640
(93) 1,360 3,882 16,975 149,527 316,698 1,186 317,884
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Significant Accounting Policies (in part)
Non-Controlling Interest
Non-controlling interests represent the portion of profit or loss
and net assets of subsidiaries not owned, directly or indirectly,
by the Group.
Non-controlling interests are presented separately in the
consolidated income statement and within equity in the con-
solidated statement of financial position, separately from par-
ent shareholders’ equity.
Changes in the Group’s Ownership Interests in Existing
Subsidiaries
Changes in the Group’s ownership interests in subsidiaries
that do not result in the Group losing control over the sub-
sidiaries are accounted for as equity transactions. The carry-
ing amounts of the Group’s interests and the non-controlling
interests are adjusted to reflect the changes in their rela-
tive interests in the subsidiaries. Any difference between the
amounts by which the non-controlling interests are adjusted
is recognised directly in equity.
When the Group loses control of a subsidiary, the profit or
loss on disposal is calculated as the difference between (i)
the aggregate of the fair value of the consideration received
and the fair value of any retained interest and (ii) the previous
carrying amount of the assets (including goodwill), and liabili-
ties of the subsidiary and any non-controlling interests. When
assets of the subsidiary are carried at revalued amounts or
fair values and the related cumulative gain or loss has been
recognised in other comprehensive income and accumulated
in equity, the amounts previously recognised in other com-
prehensive income and accumulated in equity are accounted
for as if the Group had directly disposed of the relevant as-
sets (i.e. reclassified to profit or loss or transferred directly
to retained earnings as specified by applicable IFRSs).The
fair value of any investment retained in the former subsidiary
at the date when control is lost is regarded as the fair value
on initial recognition for subsequent accounting under IAS 39
“Financial Instruments: Recognition and Measurement" or,
when applicable, the cost on initial recognition of an invest-
ment in an associate or a jointly controlled entity.
Property and Equipment
Property and equipment are carried at cost less accumulated
depreciation and any accumulated impairment except for the
buildings and constructions which are carried at revaluated
amount, being its fair value at the date of the revaluation less
any subsequent accumulated depreciation and subsequent
accumulated impairment losses.
Leasehold improvements are amortized over the life of the
related leased asset. Expenses related to repairs and re-
newals are charged when incurred and included in operating
expenses unless they qualify for capitalization.
The carrying amounts of property and equipment are re-
viewed at each reporting date to assess whether they are
recorded in excess of their recoverable amounts, and where
carrying values exceed this estimated recoverable amount,
assets are written down to their recoverable amount. An im-
pairment loss is recognized in the respective period and is
included in operating expenses.
Depreciation of an asset begins when it is available for
use. Depreciation is calculated on a straight-line basis over
the following estimated useful lives:
Years
Buildings and constructions 20–100
Vehicles 5–7
Computers and banking equipment 5–10
Other 7–10
Buildings and constructions held for use in supply of services,
or for administrative purposes, are stated in the consolidated
statement of financial position at their revalued amounts, be-
ing the fair value at the date of revaluation, determined from
market-based evidence by appraisal undertaken by profes-
sional independent appraisers, less any subsequent accumu-
lated depreciation and subsequent accumulated impairment
losses. Revaluations are performed with sufficient regular-
ity such that the carrying amount does not differ materially
from that which would be determined using fair values at the
reporting date.
Any revaluation increase arising on the revaluation of such
buildings and constructions is credited to the property and
equipment revaluation reserve, except to the extent that it re-
verses a revaluation decrease for the same asset previously
recognized as an expense, in which case the increase is cred-
ited to the consolidated income statement to the extent of the
decrease previously charged. A decrease in carrying amount
arising on the revaluation of such buildings and constructions
is charged as an expense to the extent that it exceeds the bal-
ance, if any, held in the property and equipment revaluation
reserve relating to a previous revaluation of that asset.
Depreciation on revalued buildings and constructions is
charged to the consolidated income statement. On the sub-
sequent sale or retirement of a revalued property, the at-
tributable revaluation surplus remaining in the property and




The Group classifies a financial instrument that it issues as a
financial asset, financial liability or an equity instrument in ac-
cordance with the substance of the contractual arrangement.
An instrument is classified as a liability if it is a contractual
obligation to deliver cash or another financial asset, or to ex-
change financial assets or financial liabilities on potentially
unfavourable terms. An instrument is classified as equity if it
evidences a residual interest in the assets of the Group after
the deduction of liabilities. The components of a compound
financial instrument issued by the Group are classified and
accounted for separately as financial assets, financial liabili-
ties or equity as appropriate.
External costs directly attributable to the issue of new
shares, other than on a business combination, are shown as a
deduction from the proceeds in equity. Prior to 13 May 2003,
any excess of the fair value of consideration received over
the nominal value of shares issued was recognized as share
premium reserve. Effective 13 May 2003, upon change in
law concerning “Joint Stock Companies,” the nominal amount
concept was restricted to placement of shares only between
the founders of an entity. For all other investors, share
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capital is recorded at placement value being the consider-
ation received by an entity for its shares.
Treasury Shares
When the group acquires its own share capital, the amount
of the consideration paid, including directly attributable costs,
net of any related tax benefit, is recognised as a change in
equity. Shares repurchased by the Group are cancelled. Re-
purchased shares are classified as treasury shares and are
held at cost. These shares are treated as a deduction from
the issued and weighted average number of shares, and the
cost price of the shares is presented as a deduction from
total equity. The par value of the shares is presented as a
deduction from ordinary share capital and the remainder of
the cost is presented as a deduction from ordinary share pre-
mium. Dividends received on treasury shares are eliminated
on consolidation.
Dividends
Dividends are recognized as a liability and deducted from eq-
uity on the date they are declared. Dividends are disclosed
when they are proposed before the reporting date or pro-
posed or declared after the reporting date but before the con-
solidated financial statements are authorized for issue.
13. Property and Equipment (in part)








31 December 2009 42,437 1,591 16,566 15,894 76,488
Additions 1,628 279 1,145 5,681 8,733
Disposals (1,393) (287) (627) (2,128) (4,435)
Transfers 4,388 16 698 (5,102) —
Revaluation 82 — — — 82
Impairment (27) — — — (27)
Translation differences (79) (3) (13) (12) (107)
31 December 2010 47,036 1,596 17,769 14,333 80,734
Accumulated depreciation:
31 December 2009 215 961 7,864 4,290 13,330
Charge 494 274 2,911 1,696 5,375
Disposals — (225) (574) (1,103) (1,902)
Transfers — 1 224 (225) —
Write-off at revaluation (67) — — — (67)
Translation differences 7 (1) 9 (5) 10
31 December 2010 649 1,010 10,434 4,653 16,746
Net book value:
31 December 2010 46,387 586 7,335 9,680 63,988
The Group revalued its buildings and constructions as of 1
August 2009. The revaluation procedures were performed by
an independent appraiser “Real Estate” LLP. The indepen-
dent appraiser used three approaches to identify fair value of
the property and equipment: the income approach with the
method of realization as income capitalization, the compara-
tive approach with application of market information, and the
cost approach.
The income approach with the method of realization as
income capitalization and the comparative approach with ap-
plication of market information were used to identify the fair
value of buildings and constructions in terms of active market
for items that were subjects for revaluation. The cost ap-
proach was used when there was no active market for items
that were subjects for revaluation. The total amount of fair
value of buildings and constructions is KZT 24,977 million.
The carrying amount of property and equipment that would
have been recognized had the assets been carried under the
cost model is KZT 33,289 million.
IFRS ATT 4.16
488 IFRS Accounting Trends & Techniques
23. Equity
Authorized, issued and fully paid number of shares as at 31














Common 2,400,000,000 (1,091,584,040) 1,308,415,960 (6,904,953) 1,301,511,007
Non-convertible preferred 600,000,000 (290,140,570) 309,859,430 (23,972,034) 285,887,396














Common 2,400,000,000 (1,091,584,040) 1,308,415,960 (7,899,791) 1,300,516,169
Non-convertible preferred 600,000,000 (290,140,570) 309,859,430 (23,970,179) 285,889,251














Common 1,129,016,660 (145,000,000) 984,016,660 (4,585,603) 979,431,057
Non-convertible preferred 24,742,000 — 24,742,000 (199,321) 24,542,679
Convertible preferred 80,225,222 — 80,225,222 (113,677) 80,111,545
All shares are KZT denominated. Movements of shares out-
standing are as follows:












31 December 2007 979,759,488 24,686,763 80,192,612 49,758 2,474 13,233
Purchase of treasury shares (328,431) (144,084) (81,067) (3) — —
31 December 2008 979,431,057 24,542,679 80,111,545 49,755 2,474 13,233
Capital contributions 324,399,300 285,117,430 — 33,747 48,019 —
Purchase of treasury shares (4,663,879) (24,023,569) (181,344) (47) (3,602) —
Sale of treasury shares 1,349,691 252,711 200 13 — —
31 December 2009 1,300,516,169 285,889,251 79,930,401 83,468 46,891 13,233
Purchase of treasury shares (769,463) (32,964) (200) (8) — —
Sale of treasury shares 1,764,301 31,109 — 18 — —
31 December 2010 1,301,511,007 285,887,396 79,930,201 83,478 46,891 13,233
At 31 December 2010, the Group held 6,904,953 of the
Group’s common shares as treasury shares at KZT 93 mil-
lion (31 December 2009—7,899,791 at KZT 103 million; 31
December 2008—4,585,603 at KZT 69 million).
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Common Shares
Each common share is entitled to one vote and dividends.
Preferred Shares
In accordance with IAS 32 “Financial Instruments: Presen-
tation” both the non-convertible and convertible preferred
shares (together, the “Preferred Shares”) are classified as
compound instruments. On a return of capital on liquidation,
the assets of the Group available for distribution are applied
in priority to any payment to the holders of common shares
in paying to the holders of the Preferred Shares an amount
equal to the nominal capital paid up or credited as paid up.
The terms of the Preferred Shares require that the Group
pay a nominal dividend amount of 0.01 KZT per share in
order to comply with Kazakhstan legislation, which represents
the liability component. This legislation requires joint stock
companies to pay a certain guaranteed amount of dividends
on preferred shares. According to Kazakhstan legislation on
Joint Stock Companies, dividend payments on the preference
shares cannot be less than the dividends paid on common
shares. Furthermore, the dividends on common shares will
not be paid until dividends on preference shares are fully
paid.
The payment of additional dividends on the Preferred
Shares is determined based on a formula specified in the
share prospectus and is based on the Group’s profitability.
Where the Group has net income no greater than KZT 160
times the quantity of issued Preferred Shares, multiplied by a
factor of inflation as published by the NBK plus one per cent,
the dividend per Preferred Share is determined as net income
divided by the quantity of issued Preferred Shares. Where net
income is greater than this, the dividend per Preferred Share
is calculated as KZT 160 multiplied by a factor of inflation as
published by the NBK plus one per cent. Inflation in either
calculation will range between three and nine per cent. Divi-
dends on the Preferred Shares are only paid if declared and
approved by the Board of Directors at the Annual General
Meeting of the Shareholders. The Preferred Shares do not
have any voting rights, unless the payment of preferred div-
idends has been delayed for three months or more from the
date they became due.
Share Premium Reserve
Share premium reserve represents an excess of contributions
received over the nominal value of shares issued.
Convertible Preferred Shares
Each convertible preferred share is convertible to one com-
mon share at the discretion of the Board of Directors. In ad-
dition, the Group will pay a compensation amount to each
convertible preferred shareholder on conversion based on a
formula specified in the share prospectus. This payment is
calculated such that, at the date of conversion, if the value
of the common shares received by the preferred shareholder
is less than KZT 160 per share, the Group will reimburse the
preferred shareholders for the difference in cash at the time
of conversion.
Reduction in Par Value, Reclassification
of Equity Component of Convertible Debt,
Capital Contribution From Non-Controlling
Interests
4.17
Swiss Life Holding Ltd (Dec 2010)
CONSOLIDATED STATEMENT OF CHANGES IN
EQUITY FOR THE YEAR ENDED 31 DECEMBER
2010 (in part)



























Balance as at 1 January 385 1,697 -25 -216 -41 5,408 7,208 37 7,245
Total net comprehensive income 27 — — — -546 250 557 261 -4 257
Reduction in par value 27 -77 0 — — — — -77 — -77
Convertible debt, reclassification of
equity component at maturity — -56 — — — 56 — — —
Equity-settled share-based payments — 3 — — — — 3 — 3
Purchases of treasury shares — — -1 — — — -1 — -1
Sales of treasury shares — 2 8 — — — 10 — 10
Capital contributions from
non-controlling interests — — — — — — — 0 0
Dividends — — — — — — — 0 0
Balance as at end of period 308 1,646 -18 -762 209 6,021 7,404 33 7,437
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
21. Borrowings (in part)
In CHF Million Notes 31.12.2010 31.12.2009
Money market instruments — 23
Hybrid debt 2,141 2,487
Convertible debt — 34
Bank loans — 184
Finance lease obligations 1 3
Total borrowings 33 2,142 2,731
Convertible Debt
On 10 June 2004, Swiss Life Holding issued CHF 317 million
in 0.625% convertible bonds due in 2010. The bonds could
be converted into registered shares of Swiss Life Holding at
any time at the option of the holder. Bondholders exercising
their conversion right were entitled to receive the number of
shares equal to the principal amount of CHF 1,000 divided
by the original conversion price of CHF 209.625 (subject to
adjustments, with effect from 29 July 2008 conversion price
of CHF 200.20).
No convertible bonds were converted in 2010 or in 2009.
On 10 June 2010, the remaining CHF 34 million in convertible




As approved by the shareholders at the General Meeting of
Swiss Life Holding (SLH) on 6 May 2010, a reduction in the
par value of CHF 2.40 per registered SLH share was effected
in 2010 (2009: CHF 5 per registered share). The payout took
place on 29 July 2010 and led to a reduction in the share
capital of SLH of CHF 77 million (2009: CHF 160 million).
On 7 May 2009, the General Meeting of Shareholders au-
thorised the Board of Directors to cancel the 3,003,500 SLH
shares bought back through a second trading line as part of
the share buyback programme. The reduction in share capital
due to the share cancellation amounted to CHF 51 million.
No convertible bonds were converted in 2010 or in 2009.
As at 31 December 2010, the share capital of SLH con-
sisted of 32,081,054 fully-paid shares with a par value of
CHF 9.60 each. In exercising voting rights, no shareholder
can collect more than 10% of the total share capital directly or
indirectly in respect of own shares or shares they represent.
As at 31 December 2009, SLH had 32,081,054 registered
shares with a par value of CHF 12 per share. Conditional
share capital was CHF 22,650,105.60 as at 31 December
2010 (2009: CHF 28,312,632.00).
Share Premium
Share premium comprises additional paid-in capital in excess
of the par value (net of transaction costs), gains/losses on
own equity instruments and equity compensation benefits.
Due to the reduction in the par value of CHF 2.40 per
registered SLH share in 2010 (2009: CHF 5 per registered
SLH share), an amount of CHF 0.4 million was credited to
share premium in respect of treasury shares (2009: CHF 1
million).
In 2009, the reduction in share premium due to the can-
cellation of the SLH shares bought back through a second
trading line amounted to CHF 635 million.
Number of Shares
The following table shows the development of SLH shares
issued and treasury shares held by the Swiss Life Group
during the period:
Number of Shares 2010 2009
Shares Issued
Balance as at 1 January 32,081,054 35,084,554
Cancellation of treasury shares — -3,003,500
Balance as at end of period 32,081,054 32,081,054
Treasury Shares
Balance as at 1 January 232,158 4,619,466
Purchases of treasury shares 11,217 1,965,033
Sales of treasury shares -74,819 -3,348,841
Cancellation of treasury shares — -3,003,500
Balance as at end of period 168,556 232,158
Foreign Currency Translation Differences
Foreign currency translation differences comprise the result-
ing differences arising on the translation of assets, liabilities,
income and expenses of Group entities denominated in for-
eign currencies into Swiss francs.
Gains/Losses Recognised Directly in Equity
Gains/losses recognised directly in equity comprise fair value
changes of available-for-sale investments, revaluation sur-
pluses on the transfer of owner-occupied property to invest-
ment property and the effective portion of the gain or loss
on hedging derivatives in qualifying cash flow hedges. These
amounts are net of certain policyholder bonuses and other
policyholder liabilities and deferred acquisition costs, deferred
income taxes and non-controlling interests.
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Amounts Recognised Directly in Equity for the Year 2010
Gains/Losses Recognised Directly in Equity












Net balance as at 1 January -216 232 — -273 -41
Gains/losses arising during the period -596 917 — — 917
Hedging gains/losses arising during the period 9 44 — 2 — 2
Revaluation surplus on owner-occupied property
transferred to investment property 17 — — — 3 3
Gains/losses transferred to the income statement 8 — -321 — 232 -89
Effects of
policyholder participation — -355 — -133 -488
shadow accounting — -62 — 36 -26
income tax -1 -35 0 -25 -60
disposals of subsidiaries 0 — — — —
foreign currency translation differences — -7 — -2 -9
non-controlling interests 7 0 — 0 0
Net balance as at end of period -762 369 2 -162 209
Amounts Recognised Directly in Equity for the Year 2009
Gains/Losses Recognised Directly in Equity












Net balance as at 1 January -195 -89 — -356 -445
Gains/losses arising during the period -22 1,689 — — 1,689
Share of gains/losses of associates 16 — — — 0 0
Gains/losses transferred to the income statement 8 — -321 — 241 -80
Effects of
policyholder participation — -933 — -54 -987
shadow accounting — 12 — -76 -64
income tax 3 -125 — -28 -153
disposals of subsidiaries 1 — — — —
foreign currency translation differences — -1 — — -1
non-controlling interests -3 0 — 0 0
Net balance as at end of period -216 232 — -273 -41
The gains/losses transferred to the income statement of CHF
232 million in 2010 (2009: CHF 241 million) shown in “Other’’
relate to financial assets reclassified to loans and receivables.
Retained Earnings
Retained earnings comprise accumulated retained earnings
of the Group entities which have not been distributed to the
shareholders. The distribution of profit is subject to restric-
tions in the various jurisdictions where the Group entities are
located.
The Group’s insurance subsidiaries are subject to regula-
tory restrictions on the amount of dividends, cash loans and
advances which can be remitted to the Group. Certain foreign
jurisdictions have restrictions that allow the payment of divi-
dends but may cause a delay in their remittance. Dividends
payable are not accrued until they have been ratified at the
General Meeting.
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Fair Value of Net Assets Acquired in Reverse
Acquisition, Shares Issued in Private
Placement
4.18
Heatherdale Resources Ltd (Oct 2010)
CONSOLIDATED STATEMENTS OF CHANGES
IN EQUITY
(Expressed in United States Dollars)









(Note 4) Total Equity
Balance at November 1, 2008 $ 7,247,276 $ — $ (1,506,514) $5,740,762 $ — $ 5,740,762
Non-controlling interest in Niblack
Project LLC 14,411,765 14,411,765
Total comprehensive loss — — (2,589,449) (2,589,449) — (2,589,449)
Balance at October 31, 2009 $ 7,247,276 $ — $ (4,095,963) $3,151,313 $14,411,765 $17,563,078
Shares issued for cash on private
placement 13,030,771 — — 13,030,771 — 13,030,771
Shares issued for cash on
exercise of options 42,403 — — 42,403 — 42,403
Fair value of net assets acquired
in reverse asset acquisition 2 105,311 — — 105,311 — 105,311
Fair value of share options
allocated to shares issued
on exercise 46,797 (46,797) — — — —
Share-based compensation—
share issue costs 9(d) (69,000) 69,000 — — — —
Share-based compensation — 2,127,511 — 2,127,511 — 2,127,511
Total comprehensive loss — — (15,640,509) (15,640,509) — (15,640,509)
Balance at October 31, 2010 $20,403,558 $2,149,714 $(19,736,472) $2,816,800 $14,411,765 $17,228,565
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Nature of Operations and Continuance
of Operations
Heatherdale Resources Ltd. (formerly Brass Capital Corp.)
(the “Company”) was incorporated under the laws of the
Province of Alberta, Canada on November 6, 2007 and con-
tinued under the laws of the Province of British Columbia,
Canada on November 16, 2009. The Company’s corporate
office is located at Suite 1020,800 West Pender Street, Van-
couver, British Columbia. These consolidated financial state-
ments of the Company as at and for the year ended October
31, 2010 comprises Heatherdale Resources Ltd. and its sub-
sidiaries (together referred to as the “Group” and individually
as “Group entities”). Heatherdale Resources Ltd. is the ulti-
mate parent entity of the Group.
The Group holds a 51% interest in the Niblack copper–gold-
zinc-silver project in southeast Alaska (the “Niblack Project”)
with additional earn-in options to increase its interest to 70%
(note 4). The Group is in the process of exploring the Niblack
Project and has not yet determined whether it contains eco-
nomically recoverable mineral reserves. The Group’s contin-
uing operations and the underlying value and recoverability
of the amount shown for the mineral property interest is en-
tirely dependent upon the existence of economically recover-
able mineral reserves, the ability of the Group to obtain the
necessary financing to complete the exploration and develop-
ment of the Niblack Project, obtaining the necessary permits
to mine, and on future profitable production of the proceeds
from the disposition of the Niblack Project.
These consolidated financial statements have been pre-
pared on a going concern basis. As at October 31, 2010, the
Group has $2.8 million in working capital and accumulated a
deficit of $19.7 million since inception. The Group has not yet
produced any revenue and further funds will be required in
developing the Group’s business plans and its mineral prop-
erty interest. In November 2010, the Group completed a pri-
vate placement equity financing of $7.8 million (note 14) to
fund the exploration and development of the Niblack Project.
While there can be no assurances that the Group’s plans
to raise additional financing in the future will be successful
or at favourable terms, management is of the opinion that
additional financing will be available to continue its planned
activities in the normal course of operations. If the Group
is unable to raise the necessary capital and generate suffi-
cient cash flows to meet obligations as they come due, the
Group may have to reduce or curtail its operations or obtain
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financing at unfavourable terms. Furthermore, failure to con-
tinue as a going concern would require that the Group’s as-
sets and liabilities be restated on a liquidation basis which
would differ significantly from the going concern basis. These
Financial Statements do not include any adjustments to the
amounts and classification of assets and liabilities that may
be necessary should the Group be unable to continue as a
going concern.
2. Qualifying Transaction and Reverse
Asset Acquisition
On November 17, 2009, the Company completed a qualifying
transaction (“QT”) in accordance with TSX Venture Exchange
Inc. (“TSX V”) Policy 2.4 whereby the Company acquired all
the issued shares of Heatherdale Holdings (Canada) Ltd.
(formerly Heatherdale Resources Ltd.) on a one for one
basis. Under the terms of the transaction the Company is-
sued 32,600,001 common shares for 100% of the issued and
outstanding shares of Heatherdale Holdings (Canada) Ltd.
(“Heatherdale Holdings”). As well, the Company as part of
the QT, consolidated its share capital on the basis of 2.5 old
shares for 1 new share.
From the date of incorporation to the transaction date, the
Company performed no significant business activities as its
sole purpose was the identification and evaluation of assets
or businesses with the view to completing a QT. On the date
of the completion of the QT, the fair value of the net assets of
the Company was $105,311 and comprised the following:
Cash and cash equivalents $102,328
Trade and other receivables 25,310
Trade and other payables (22,327)
$105,311
Legally, the Company is the parent of Heatherdale Hold-
ings; however, as a result of the share exchange, control
of the combined companies passed to the former sharehold-
ers of Heatherdale Holdings, which for accounting purposes
is deemed to be the acquirer. For financial reporting pur-
poses the transaction has been treated as a reverse asset
acquisition and therefore these consolidated financial state-
ments have been prepared as a continuation of Heatherdale
Holdings. The following accounting principles have been em-
ployed:
a. the assets and liabilities of Heatherdale Holdings were
recognized and measured at their precombination car-
rying amounts;
b. the deficit and other equity balances are the retained
deficit and other equity balances of Heatherdale Hold-
ings immediately prior to the share exchange transac-
tion;
c. the amount recognized as issued equity instruments is
determined by adding the fair value attributable to the
net assets of the Company (accounting acquiree) to the
issued equity of Heatherdale Holdings (accounting ac-
quirer) immediately prior to the share exchange trans-
action. However, the equity structure appearing in these
consolidated financial statements (the number and type
of equity instruments issued) reflect the equity structure
of the Company, including the equity instruments issued
by the Company to effect the combination; and
d. comparative information presented in these condensed
consolidated financial statements is that of Heatherdale
Holdings.
9. Capital and Reserves (in part)
(a) Authorized Share Capital
As described in Note 2, the equity structure of the Group rep-
resents the equity structure of the legal parent, Heatherdale
Resources Ltd.
At October 31, 2010, the authorized share capital consisted
of an unlimited (2009—unlimited) number of common shares
without par value and an unlimited number (2009—unlimited)
of preferred shares with no par value.





Balance at November 1, 2009 2,050,000
Balance after consolidation of 2.5 old shares for 1
new share (note 2) 820,000
Shares issued for 100% acquisition of Heatherdale
Holdings (note 2) 32,600,001
Shares issued for cash on private placement (d) 14,358,500
Shares issued on exercise of share options (e) 89,960
Balance as at October 31, 2010 47,868,461
The retroactively adjusted number of common shares of the
Company for October 31, 2009 was 33,420,001 (note 2).
(c) Basic and Diluted Loss Per Share
The calculation of basic and diluted loss per share for the
year ended October 31, 2010 was based on the following:
2010 2009
Loss attributable to common
shareholders $15,640,509 $2,589,449
Weighted average number of common
shares outstanding 47,190,101 33,420,001
(d) Private Placement November 2009
The Company issued 14,358,500 common shares at
Cdn$1.00 per common share on completion of a bro-
kered and non-brokered private placement financing con-
current with the QT (note 2) for gross proceeds of
$13,740,191 (Cdn$14,358,500). After share issue costs of
$709,420 (Cdn$741,151) the Group raised net proceeds of
$13,030,771 (Cdn$13,617,349).
In connection with the private placement, the Company is-
sued the agents compensation options to purchase 162,000
common shares at Cdn$1.00 per share until May 17, 2011.
The fair value of these options, determined using the Black-
Scholes option model (using 96% expected volatility, a risk
free rate of 1.31% and expected life of 1.5 years), was
$69,000 or approximately $0.43 per option, and has been
recorded as share issuance costs.
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12. Subsidiaries
Name of Subsidiary Place of Incorporation
Proportion of
Ownership Interest Principal Activity
Heatherdale Holdings (Canada) Ltd. British Columbia, Canada 100% Holds interest in Niblack Holdings (US) Inc.
Niblack Holdings (US) Inc. Nevada, USA 100% Holds interest in Niblack Project LLC
Niblack Project LLC Delaware, USA 51% Exploration of Niblack Project
Proposed Appropriation of Net Income,
Equity Component of Convertible Bonds
4.19
Homburg Invest Inc. (Dec 2010)
Author’s Note
The Homburg Capital Securities A, is a new bond se-
cured by a corporate guarantee that has a 99 year life,
and bears interest at 9.5% for the first five years. Hom-
burg Invest Inc., which has the option to pay the interest
on the Homburg Capital Securities A in either cash or
shares of Homburg Invest Inc., has guaranteed that for
the first two years, the interest payment will be made
in cash. Homburg Invest, has announced that it is the
Company’s intention to have the Homburg Capital Se-
curities A trading on the NYSE Euronext Amsterdam
by June 30, 2010.
Also during 2010, Homburg Invest disposed of its
long-term investment in DIM Vastgoed N.V. At the end
of 2009, Homburg had a remaining obligation of $3.0
million to the shareholders of DIM Vastgoed, which
was fully settled in 2010.
The effects of these two events on the statement
of changes in equity are illustrated in the following
excerpt.
CONSOLIDATED STATEMENT OF CHANGES
IN EQUITY
Year Ended December 31









(Loss) Income Deficit Total
December 31, 2008 11,489 698,535 7,206 649 (106,980) 610,899
Comprehensive income (loss) — — — 18,575 (449,262) (430,687)
Dividend re: DIM Vastgoed N.V. dividend guarantee — — — — (260) (260)
Homburg Capital Securities A (Note 17d) 22,946 — — — (1,627) 21,319
Acquisition & cancellation of own shares — (6,750) 5,404 — — (1,346)
Stock based compensation — — 146 — — 146
December 31, 2009 34,435 691,785 12,756 19,224 (558,129) 200,071
Equity contribution (net of tax) (Note 23j) — — 4,932 — — 4,932
Comprehensive loss — — — (18,034) (88,054) (106,088)
Shares issued re DIM 2010 (11,489) 11,489 — — — —
Acquisition & cancellation of own shares — (2,240) 1,821 — — (419)
Homburg Capital Securities A (Note 17d) 6,225 — — — (3,133) 3,092
Stock based compensation — — 88 — — 88
December 31, 2010 $29,171 $701,034 $19,597 $1,190 $(649,316) $101,676
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Basis of Financial Statement Presentation
Homburg Invest Inc. (the “Company”) is a Canadian resi-
dent corporation which trades on the Toronto Stock Exchange
(“TSX”) as well as the NYSE Euronext Amsterdam (“AEX”).
To comply with TSX and AEX reporting requirements, these
consolidated financial statements have been prepared in ac-
cordance with International Financial Reporting Standards
(“IFRS”) as issued by the International Accounting Standards
Board on a historical cost basis, except for investment proper-
ties, development properties, derivative financial instruments
and certain long term investments which are measured at
fair value as more fully described in Note 4. The Company
applied for and obtained approval of the OSC to file IFRS fi-
nancial statements to meet its Canadian reporting obligations
effective June 30, 2010.
The Company’s reporting currency is Canadian dollars
(“CAD”) and all values are rounded to the nearest thousand
except where otherwise indicated.
The Company has been negatively impacted by continu-
ing global economic conditions which have resulted in a de-
crease in real estate transactions and declining real estate
values. The Company incurred net losses of $88,054 and
$449,262 for the years ended December 31, 2010 and 2009,
respectively, and is highly levered with a debt to equity ratio
of 16.55:1 at December 31, 2010 (Note 22) and an interest
coverage ratio of below 1:1 for the year ended December 31,
2010.
The Company’s liquidity risks are more fully described in
Note 21. Through June 2012, the Company faces maturities
of its mortgage bonds totalling €102,480 ($135,846), in addi-
tion to regularly scheduled principal payments and maturities
related to other mortgage debts.
The Company will seek to extend the maturity or otherwise
refinance amounts due on its mortgage bonds through the
issue of new mortgage bonds. However, there is no certainty
that these efforts will be successful. Subsequent to year end
the Company arranged new thresholds for the interest cover-
age and tangible net worth covenants in respect of its junior
subordinate notes amounting to $53,145 at December 31,
2010. The new interest coverage requirement is 0.8:1 and the
new minimum tangible net worth requirement is $100 million
throughout 2011. These thresholds increase gradually after
December 31, 2011 thru December 31, 2015. The Company
anticipates it will be below these thresholds in the first quar-
ter of 2011 in which case the lender would have the right to
demand repayment.
The Company could meet refinancing shortfalls through the
sale of development assets, income producing properties,
or additional units of Homburg Canada REIT (“HCREIT”).
However, the Company’s liquidity needs may limit its ability
to maximize the price to be realized on such asset sales. The
Company expects that it will be able to refinance its other
mortgage maturities at similar amounts and terms.
The Company successfully completed the initial public of-
fering (“IPO”) of HCREIT, which now holds the Company’s
Canadian income producing real estate assets and related
mortgage debt. As of year end, the Company has a 33.7%
interest in HCREIT, however, subsequent to year end the
Company sold 2.5 million of the units for net consideration of
$26,800 which was used by the Company to reduce debt and
for general operating purposes (Note 29).
As a result of the Company’s limited partnership structure,
with respect to certain debts the recourse of the lender is
generally limited to the specific assets held in or below the
limited partnerships (“ring fenced structure”). However, the
Company’s mortgage bonds and unsecured debts have re-
course to the consolidated assets of the Company.
The consolidated financial statements of the Company
have been prepared on a basis which contemplates the Com-
pany having sufficient liquidity to realize its assets and to dis-
charge its liabilities in the normal course of business for the
foreseeable future and do not give effect to any adjustments
to recorded amounts and their classification should the Com-
pany be unable to realize its assets and discharge its liabilities
in the normal course of business and at the amounts reflected
in these consolidated financial statements.
2. Corporate Information
Homburg Invest Inc., a corporation incorporated under the
laws of Alberta, Canada, is listed on The Toronto Stock Ex-
change (“TSX”) and the NYSE Euronext Amsterdam (“AEX”).
The Class A Subordinate Voting Shares trade under the sym-
bol “HII.A”, and the Class B Multiple Voting Shares trade
as “HII.B” on the TSX and the Class A Subordinate Voting
Shares trade under the symbol “HN” on the AEX. The prin-
cipal place of business is 1741 Brunswick Street, Suite 600,
Halifax, Nova Scotia B3J 3X8, Canada. These consolidated
financial statements were authorized for issue in accordance
with a resolution of the board of directors on March 31, 2011,
and are subject to approval by the shareholders at the Com-
pany’s annual general meeting.
The Company is directly and indirectly controlled by Mr.
Richard Homburg, the former Chairman and Chief Executive
Officer (“CEO”), through holding companies. The Company
and its subsidiaries lease, build and sell commercial and resi-
dential real estate interests located in Canada, Germany, The
Netherlands, the Baltic States (Lithuania, Estonia and Latvia)





income (a) 1,190 19,224
(648,126) (538,905)
Share capital (b) 701,034 691,785
Other paid in capital (d) 29,171 34,435
Contributed surplus (f) 14,665 12,756
$96,744 $200,071
a) Accumulated Other Comprehensive Income
2010 2009
Net unrealized foreign currency
translation gains (loss) $4,597 $23,890
Change in fair value of available for sale
financial assets — 231
Deferred tax expense (3,407) (4,897)
$1,190 $19,224
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Accumulated other comprehensive income represents the
unrecognized exchange adjustment on the net assets of the
Company’s subsidiaries that operate in the United States of
America, Germany, The Netherlands, and the Baltic States.
The change reflects the impact of currency movements dur-
ing the year on these net assets offset by effective hedges in
place.
The deferred income tax amounts recognized directly in
shareholders’ equity are the result of the foreign exchange
translation effects of certain foreign operations with a func-
tional currency other than the Canadian dollar. These foreign
operations are taxed in the relevant foreign jurisdiction; ac-
cordingly, the foreign operation has deferred income tax as-
sets and liabilities determined using the tax and accounting
basis in the foreign jurisdiction, each measured in the func-
tional currency of the foreign operation. These deferred tax
assets and liabilities are converted to Canadian dollars with
the resulting translation effects recorded directly in equity. An
additional Canadian deferred tax liability arises given that the
foreign operation is also subject to certain incremental tax in
Canada. The tax basis of the assets and liabilities for Cana-
dian taxation purposes is determined based on their historical
Canadian dollar costs. As a result, incremental Canadian de-
ferred taxes are measured based on the difference between
such Canadian dollar tax bases and the balance sheet date
accounting carrying value of the assets and liabilities after
translation from the functional currency of the foreign oper-
ation to Canadian dollars. The accounting carrying value is
therefore impacted by translation gains and losses at each
balance sheet date which gives rise to changes in the tem-
porary differences and incremental Canadian deferred tax
balances related to these assets and liabilities. Since the re-
lated foreign currency translation gains and losses giving rise
to these changes in temporary differences are recognized di-
rectly in shareholders’ equity, the resulting incremental Cana-
dian deferred tax benefit or expense effects are also recorded
directly in shareholders’ equity.
The following are rates of exchange in effect:
$1.00 USD €1.00 EUR
December 31, 2010 $1.00020 $1.32560
December 31, 2009 $1.04940 $1.50410
Average rate for 2010 $1.03075 $1.36843
Average rate for 2009 $1.14172 $1.58706
b) Share Capital
The particulars of the issued and outstanding shares of the









Issued and outstanding at December 31, 2008 16,790 3,151 $698,535
Shares acquired under Normal Course Issuer Bid (171) (2) (6,750)
Issued and outstanding at December 31, 2009 16,619 3,149 691,785
Shares acquired under Normal Course Issuer Bid (46) (36) (2,240)
Shares issued re DIM 2010 476 — 11,489
Issued and outstanding at December 31, 2010 17,049 3,113 $701,034
The Company is authorized to issue an unlimited number
of Class A Subordinate Voting Shares (“Class A”), an un-
limited number of Class B Multiple Voting Shares (“Class
B”), an unlimited number of Class A Preferred Shares (“Pre-
ferred”), issuable in series and an unlimited number of Class B
Preferred Shares (“Preferred”), issuable in series. The Com-
pany’s share capital represents amounts received at the time
of issuance. None of the Company’s shares have a par value.
Holders of Class A shares shall be entitled to receive notice
of, to attend, and to vote at, all meetings of the sharehold-
ers of the Company, voting together with holders of Class B
shares, except for meetings at which only holders of a speci-
fied class or series are entitled to vote. Class A shares shall
be entitled to one vote for each Class A share held. Holders of
Class B shares shall be entitled to receive notice of, to attend,
and to vote at, all meetings of the shareholders of the Com-
pany, voting together with holders of Class A shares, except
for meetings at which only holders of a specified class or se-
ries are entitled to vote. Class B shares shall be entitled to 25
votes for each Class B share held. Class A shares will be con-
vertible into Class B shares in certain limited circumstances
involving offers made to all, or substantially all, of the holders
of Class B shares. Dividends are payable on Class A shares
and Class B shares when declared by the Board of Directors.
The Class A and Class B shares rank equally in dividend
eligibility. Preferred shares may be issued from time to time
in one or more series, each series comprising the number of
shares, designations, rights, privileges, restrictions and con-
ditions which the Board of Directors determines by resolution
prior to issuance. Preferred shares are non-voting and rank
in priority to the Class A and Class B shares with respect
to dividends and distribution upon dissolution. No Preferred
shares have been issued.
c) Normal Course Issuer Bid (“NCIB”)
On August 23, 2010, the Company announced plans, under
an approved NCIB, to acquire up to 1,017,201 Class A Sub-
ordinate Voting shares and 157,426 Class B Multiple Voting
shares over a one year period ending August 24, 2011. The
NCIB enabled the Company to acquire up to 1,000 Class A
Shares and up to 1,000 Class B Shares on any given trading
day. Any shares acquired by the Company under the NCIB
were cancelled. During the year ended December 31, 2010,
the Company acquired and cancelled 46,300 Class A Shares
at an average cost of $4.81 per share, and 35,700 Class B
Shares at an average cost of $5.43 per share. Class A and
Class B shares acquired are being cancelled and removed
from share capital at the average issue price at the time of
acquisition. The discount on repurchases made to date of
$1,821 is credited to contributed surplus.
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d) Other Paid in Capital
2010 2009
Balance, beginning of year 34,435 11,489
Issue of shares re DIM 2010 (11,489) —
Homburg Capital Securities A:
Equity component, net of tax 6,350 24,147
Deferred transaction costs (125) (1,201)
Balance, end of year $29,171 $34,435
During the year ended December 31, 2010, the Company is-
sued EUR €3,217 ($4,598) (December 31, 2009—€23,568
($37,116)) Homburg Capital Securities A (“HCSA”). The
HCSA are 99 year securities maturing February 27, 2108,
bearing an annual interest rate of 9.5%, payable quarterly.
The Company has the option to pay any and all of the
quarterly interest payments in cash or through the issuance
of a fixed number of Class A Preferred shares. The principal
amount of HCSA must be paid in cash upon redemption or
maturity. The HCSA are direct unsecured obligations of Hom-
burg Invest Inc. and are subordinate to the Company’s exist-
ing mortgage bonds payable and corporate non-asset backed
bonds, and rank senior to the Company’s Class A Subordi-
nate Voting Shares and Class B Multiple Voting Shares. The
Company will have the right to redeem the HCSA, at a price
equal to 100% of the principal amount of the HCSA to be
redeemed, plus accrued and unpaid interest to the date of
redemption by giving not less than thirty (30) and no more
than sixty (60) days prior notice on account of:
• certain changes in tax legislation or other tax events
subjecting the issuer to additional taxes or other gov-
ernmental charges;
• the termination of equity treatment for accounting pur-
poses of future interest obligations under the HCSA or
of the Class A Preferred Shares, subject to an insignif-
icant amount of Class A Preferred Shares then issued
and outstanding; and
• on February 27, 2014 or any subsequent interest pay-
ment date, in whole or in part.
Any Class A Preferred shares issued will be issued in series
and will have the following terms and conditions: par value
of one (1) Euro each; non-voting; cumulative dividends at the
annual rate of 9.75%, as and when declared by the board
of directors; have an indefinite life. The Class A Preferred
shares will have a mandatory obligation for the Company to
redeem all issued and outstanding Class A Preferred shares
for an amount equal to their par value plus any accrued but
unpaid dividends thereon at the earlier of:
• the next interest payment date on which the Company
elects to pay interest on the HCSA in cash, in whole or
in part; and
• the business day falling immediately prior to the date on
which the Company redeems, purchases or otherwise
acquires any shares or securities in the capital of the
Company ranking junior to or pari passu with the HCSA.
In addition, any Class A Preferred shares issued in respect
of quarterly interest payments prior to April 1, 2011, will be
puttable at the holder’s option back to the Company for cash
equal to one (1) Euro per Class A Preferred share. The put
option with respect to any such Class A Preferred shares
issued will expire 30 days from the date of receipt of the
Class A Preferred shares.
The Company has determined that the expected life of the
HCSA is 50 years through March 31, 2059. The proceeds
received on issuance during the year ended December 31,
2010 have been allocated to three components:
• The Company has recognized a liability of EUR €15
($21) (December 31, 2009—€107 ($162)) equal to the
present value of the HCSA principal that must be repaid
at the end of the expected life of the instrument. This
liability is being accreted using a rate of 11.0% to its full
principal amount over the expected life of the instrument
using the effective interest rate method with accretion
recognized in interest expense.
• The Company has recognized a liability of EUR €309
($442) (December 31, 2009—€2,447 ($3,704)) for the
present value of the interest payments prior to April 1,
2011, given the holder put option with respect to any
Class A Preferred shares received with respect to such
interest payments. This liability has been discounted
and is being accreted using the effective interest rate
method at a rate of 11.0%, with accretion recognized in
interest expense.
• The residual amount of EUR €2,891 ($4,135) (Decem-
ber 31, 2009—€21,014 ($33,250)) represents the future
quarterly interest payments after March 31, 2011, that
can be settled by the issuance of Class A Preferred
shares at the Company’s option. This residual amount
has been included in other paid in capital. This amount is
also being accreted over the expected life of the instru-
ment using the effective interest rate method with ac-
cretion amounts charged directly to retained earnings.
Interest payments made after March 31, 2011, whether
in cash or Class A Preferred shares, will reduce the
other paid in capital amount. The effective interest rate
used results in other paid in capital reducing to nil at the
end of the expected life of the instrument.
Foreign currency gains and losses on the liability compo-
nents, whether realized or unrealized, will impact net income
each quarter. Foreign currency fluctuations on interest pay-
ments made after March 31, 2011, will be charged to re-
tained earnings. Basic and diluted earnings per share are
being reduced by amounts charged directly to retained earn-
ings as such amounts are in preference to earnings available
to common shareholders. In addition, cumulative preferred
dividends whether paid or unpaid on any Class A Preferred
shares that may be outstanding will reduce basic and diluted
earnings per share. Transaction costs related to the HCSA
are being allocated to the liability and equity components in
proportion to the initial allocation of the proceeds received.
The transaction costs related to the liability components are
included in deferred financing fees and are being amortized,
on an effective interest basis, over the estimated life of the
related liability component. The transaction costs related to
the equity component are netted against other paid in capital
and are being amortized to retained earnings, on an effec-
tive interest basis, over the expected life of 50 years for the
HCSA.
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Outstanding at beginning of year 929 $52.50 929 $52.50
Expired (184) 45.82 — —
Outstanding at end of year 745 $54.16 929 $52.50
Date of Grant Expiration Date Exercise Price
Class A Subordinate Voting
Shares Under Option
(000’s)
Class A Subordinate Voting
Shares Fully Vested
(000’s)
July 16, 2007 July 15, 2012 $56.80 643 643
June 27, 2008 June 26, 2013 $37.60 102 77
745 720
Under the Company’s Stock Option Plan (“the Plan”), the
Company may grant options to its directors and officers of
the Company and employees of the management company.
New stock options may not be granted under the Plan on
Class B Multiple Voting Shares of the Company. The maxi-
mum number of Class A Subordinate Voting Shares issuable
pursuant to stock options outstanding under the Plan shall not
exceed 10% of the aggregate number of issued and outstand-
ing Class A Subordinate Voting Shares and Class B Multiple
Voting Shares at the time of grant. Under the Plan, the ex-
ercise price of each option shall not be less than the closing
market price of the Class A Subordinate Voting Shares on
the TSX on the last trading day prior to the date of grant-
ing of the stock option and an option’s maximum term is 10
years. Options are granted and vest at the discretion of the
Board of Directors, and are fully exercisable once vested.
On December 31, 2010, and December 31, 2009 there were
no Class B Multiple Voting Share Options granted and there
were 745 Class A Subordinate Voting Share Options granted
and unexercised (719 fully vested and exercisable).
The fair value of each option grant is estimated on the date
of grant using the Binomial or similar option pricing model.
The fair value of each option granted was estimated us-
ing the exercise price and the following weighted average
assumptions for all outstanding options: Expected volatility
30.0–40.0%; Risk free interest rate 3.31–4.60%; Expected
dividend yield 5.6–13.0%; Expected life 3.5–5 Years. The
compensation cost that has been expensed against income
in 2010 is $88 (December 31, 2009—$146).
f) Contributed Surplus
2010 2009
Balance, beginning of year $12,756 $ 7,206
Acquisition and cancellation of Class A shares 1,821 5,404
Stock based compensation 88 146
Equity contribution (net of tax) (Note 23j) 4,932 —
Balance, end of year $19,597 $12,756
The Company’s contributed surplus balance
applies to:
Class A stock option expense $ 6,186 $ 6,098
Equity contribution (net tax) 4,932 —
Discount on cancellation of Class A Shares 8,479 6,658
$19,597 $12,756
Class A Subordinate Voting Shares and Class B Multiple
Voting Shares acquired by the Company under the Normal
Course Issuer Bid (“NCIB”) (Note 17(c)) are being cancelled
and are removed from share capital at the average issue
price at the time of acquisition. Any discount on acquisition is
credited to contributed surplus.
23. Related Party Transactions
The Company’s direct parent is Homburg Finance A.G., which
is controlled by the former Chairman and Chief Executive
Officer.
a) The Company has entered into agreements with compa-
nies commonly controlled by the former Chairman and Chief
Executive Officer. A summary of the various transactions be-
tween related parties is as follows:
2010 2009
Rental revenue earned $ (482) $ (788)
Interest income (h) $ (574) $ (768)
Management agreement termination fee (o) $21,600 $
Asset and construction management fees (r) $ 8,440 $24,756
Property management fees incurred (r) $ 4,784 $ 6,555
Insurance costs incurred $ 514 $ 1,281
Service fees incurred $ 4,915 $ 6,489
Property acquisition/disposal fees incurred (r) $ 1,302 $ 1,065
Mortgage bond guarantee fees incurred (j) $17,134 $ 2,898
Bond and other debt issue costs incurred $ 209 $ 1,434
Interest costs incurred (g) (h) (k) $ 276 $ 2,798
j) The Company has ended a guarantee arrangement for
the principal and interest amounts of the mortgage bonds
payable, with a company under the control of the former
Chairman and Chief Executive Officer, wherein it was pro-
tected against fluctuations in the Canadian dollar and the
Euro. The cost of this guarantee per annum was 1.6% on
the Series 4, Series 5, Series 6, and Series 7 Bonds. Dur-
ing the year this contract was cancelled, thus eliminating the
Company’s liability for $13,383 representing an approximate
discount of 30% from the book value of the liability.
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Nestlé SA (Dec 2010)
CONSOLIDATED STATEMENT OF CHANGES
IN EQUITY
For the year ended 31 December 2010




















Equity as at 31 December 2008 383 (9,652) (11,103) 71,146 50,774 4,142 54,916
Total comprehensive income — — (72) 9,784 9,712 1,247 10,959
Dividend paid to shareholders of the parent — — — (5,047) (5,047) — (5,047)
Dividends paid to non-controlling interests — — — — — (732) (732)
Movement of treasury shares (net) — (6,891) — 162 (6,729) — (6,729)
Changes in non-controlling interests — — — — — 21 21
Equity compensation plans — 142 — 63 205 38 243
Reduction in share capital (18) 8,390 — (8,372) — — —
Equity as at 31 December 2009 365 (8,011) (11,175) 67,736 48,915 4,716 53,631
Total comprehensive income — — (4,619) 34,456 29,837 941 30,778
Dividend paid to shareholders of the parent — — — (5,443) (5,443) — (5,443)
Dividends paid to non-controlling interests — — — — — (729) (729)
Movement of treasury shares (net) — (11,859) — 77 (11,782) — (11,782)
Changes in non-controlling interests — — — (146) (146) (4,216) (4,362)
Equity compensation plans — 179 — 2 181 19 200
Adjustment for hyperinflation(a) — — — 305 305 — 305
Reduction in share capital (18) 8,583 — (8,565) — — —
Equity as at 31 December 2010 347 (11,108) (15,794) 88,422 61,867 731 62,598
(a) Relates to Venezuela, considered as a hyperinflationary economy.




The functional currency of the Group’s entities is the currency
of their primary economic environment.
In individual companies, transactions in foreign currencies
are recorded at the rate of exchange at the date of the trans-
action. Monetary assets and liabilities in foreign currencies
are translated at year-end rates. Any resulting exchange dif-
ferences are taken to the income statement.
On consolidation, assets and liabilities of Group entities re-
ported in their functional currencies are translated into Swiss
Francs, the Group’s presentation currency, at year-end ex-
change rates. Income and expense items are translated into
Swiss Francs at the annual weighted average rates of ex-
change or at the rate on the date of the transaction for signif-
icant items.
Differences arising from the retranslation of opening net as-
sets of Group entities, together with differences arising from
the restatement of the net results for the year of Group enti-
ties, are recognised in other comprehensive income.
The balance sheet and net results of Group entities op-
erating in hyperinflationary economies are restated for the
changes in the general purchasing power of the local cur-
rency, using official indices at the balance sheet date, before
translation into Swiss Francs at year-end rates.
18. Equity
18.1 Share Capital Issued
The ordinary share capital of Nestlé S.A. authorised, is-
sued and fully paid is composed of 3,465,000,000 regis-
tered shares with a nominal value of CHF 0.10 each (2009:
3,650,000,000 registered shares). Each share confers the
right to one vote. No shareholder may be registered with the
right to vote for shares which it holds, directly or indirectly,
in excess of 5% of the share capital. Shareholders have the
right to receive dividends.
The share capital changed twice in the last two financial
years as a consequence of the Share Buy-Back Programmes.
The cancellation of shares was approved at the Annual Gen-
eral Meetings of 23 April 2009 and 15 April 2010. In 2009, the
share capital was reduced by 180,000,000 shares from CHF
383 million to CHF 365 million. In 2010, the share capital was
further reduced by 185,000,000 shares from CHF 365 million
to CHF 347 million.
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18.2 Conditional Share Capital
The conditional capital of Nestlé S.A. amounts to CHF 10 mil-
lion as in the preceding year. It confers the right to increase
the ordinary share capital, through the exercise of conversion
or option rights in connection with debentures and other fi-
nancial market instruments, by a maximum of CHF 10 million
by the issue of a maximum of 100,000,000 registered shares
with a nominal value of CHF 0.10 each. Thus the Board of
Directors has at its disposal a flexible instrument enabling it,
if necessary, to finance the activities of the Company through
convertible debentures.
18.3 Treasury Shares
Number of Shares in Millions of Units Notes 2010 2009
Purpose of holding
Trading 40 10
Share Buy-Back Programme 149 142
Long-Term Incentive Plans 11 19 26
208 178
At 31 December 2010, the treasury shares held by the Group
represent 6% of the share capital (2009: 4.9%). Their mar-
ket value amounts to CHF 11,393 million (2009: CHF 8,936
million).
18.4 Number of Shares Outstanding







At 1 January 2009 3,830 (214) 3,616
Purchase of treasury shares — (156) (156)
Treasury shares delivered in respect of options exercised — 9 9
Treasury shares delivered in respect of equity compensation plans — 3 3
Treasury shares cancelled (180) 180 —
At 31 December 2009 3,650 (178) 3,472
Purchase of treasury shares — (227) (227)
Treasury shares delivered in respect of options exercised — 9 9
Treasury shares delivered in respect of equity compensation plans — 3 3
Treasury shares cancelled (185) 185 —
At 31 December 2010 3,465 (208) 3,257
18.5 Translation Reserve
The translation reserve comprises the cumulative gains and
losses arising from translating the financial statements of
foreign operations that use functional currencies other than
Swiss francs. It also includes the changes in the fair value
of hedging instruments used for net investments in foreign
operations.
18.6 Retained Earnings and Other Reserves
Retained earnings represent the cumulative profits, share
premium, as well as actuarial gains and losses on defined
benefit plans attributable to shareholders of the parent. Other
reserves comprise the fair value reserve and the hedging
reserve attributable to shareholders of the parent.
The fair value reserve includes the gains and losses on
remeasuring available-for-sale financial instruments. At 31
December 2010, the reserve is positive of CHF 450 million
(2009: positive of CHF 241 million).
The hedging reserve consists of the effective portion of the
gains and losses on hedging instruments related to hedged
transactions that have not yet occurred. At 31 December
2010, the reserve is positive of CHF 30 million (2009: positive
of CHF 82 million).
18.7 Non-controlling Interests
The non-controlling interests comprise the portion of equity
of subsidiaries that are not owned, directly or indirectly, by
Nestle S.A. In 2009, a significant portion of non-controlling
interests relates to Alcon.
18.8 Dividend
The dividend related to 2009 was paid on 22 April 2010 in con-
formity with the decision taken at the Annual General Meeting
on 15 April 2010. Shareholders approved the proposed div-
idend of CHF 1.60 per share, resulting in a total dividend of
CHF 5443 million.
Dividend payable is not accounted for until it has been
ratified at the Annual General Meeting. At the meeting on 14
April 2011, a dividend of CHF 1.85 per share will be proposed,
resulting in a total dividend of CHF 6,128 million. For further
details, refer to the Financial Statements of Nestlé S.A.
The Financial Statements for the year ended 31 December
2010 do not reflect this proposed distribution, which will be




SECTION 5: STATEMENT OF CASH FLOWS
AND RELATED DISCLOSURES∗
IAS 7, STATEMENT OF CASH FLOWS
IFRSs Overview and Comparison
to U.S. GAAP
5.01 International Accounting Standard (IAS) 1, Presenta-
tion of Financial Statements, requires a statement of cash
flows as an integral part of a complete set of financial state-
ments for each period for which financial statements are
presented. IAS 7, Statement of Cash Flows, establishes the
requirements for the preparation and presentation of a state-
ment of cash flows.
Presentation
IFRSs
5.02 The statement of cash flows reports the changes to the
balance sheet account, cash, and cash equivalents (as those
terms are defined in IAS 7). In IAS 7, cash is defined as cash
on hand and demand deposits. Cash equivalents are defined
as short-term, highly liquid investments, readily convertible
to known amounts of cash, and subject to insignificant risk of
changes in value. An investment normally qualifies as short-
term only when it has a maturity date of three months or less
from the date of acquisition.
5.03 Entities that use bank overdrafts repayable on demand
as part of their normal cash management activities may in-
clude those amounts as a component of cash and cash equiv-
alents. IAS 7 does not prohibit an equity instrument from
being included in cash equivalents if it is, in substance, a
cash equivalent (that is, it meets the definition of a cash
equivalent). An example of an equity instrument that could
meet the definition of a cash equivalent is a preferred share
that have a specified redemption date and are acquired within
three months of their maturity.
5.04 Preparation of a statement of cash flows requires an
entity to classify the inflows and outflows of cash and cash
equivalents into three categories: operating activities, invest-
ing activities, and financing activities. An entity should ex-
clude movements within cash and cash equivalents from this
classification exercise because these movements are part of
an entity’s cash management activities rather than its oper-
ating, investing, and financing activities. This treatment is
consistent with the principle set forth in IAS 7 that cash
management includes the investment of excess cash in cash
equivalents.
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
issued as of 1 January 2011.
5.05 Operating activities are primarily derived from an en-
tity’s principal revenue producing activities (for example,
collections from customer and payments to suppliers of
goods or services, payments to employees, and payments
of income taxes). IAS 7 provides entities two alternatives
for presenting cash flows from operating activities—the di-
rect method and the indirect method. However, the standard
encourages, but does not require, entities to use the direct
method. The direct method results in a presentation of gross
cash collections and payments, except to the extent that the
cash inflows and outflows are either with the same customer
and reflect the activities of the customer rather than those of
the entity, or for items with quick turnover, in large amounts,
and with short maturities. Under the indirect method, an en-
tity derives the net cash flow from operating activities by
adjusting profit or loss (either before or after income taxes)
for the effects of the following:
• Noncash income and expense items (for example, de-
preciation and amortization, deferred taxes, provisions,
and share based payment expense)
• Changes in the entity’s working capital balance sheet
accounts (for example, changes in accounts receivable,
inventories, accounts payable, and accrued liabilities)
• Items for which the cash effects are reported as invest-
ing or financing cash flows (for example, purchases
and sales of property, plant, and equipment [PPE] and
proceeds from and repayments of loans)
Entities should report cash flows arising from income taxes
separately as an operating activity unless they can be specif-
ically identified with financing and investing activities. En-
tities should also report cash payments to manufacture or
acquire assets held for rental to others and subsequently held
for sale (as described in paragraph 68A of IAS 16, Property,
Plant and Equipment) in cash flows from operating activities.
An entity should also classify cash receipts from rentals and
subsequent sales of such assets as cash flows from operating
activities.
5.06 Investing activities represent the extent to which the en-
tity has made expenditures to support future income and cash
flows (for example, acquisition and disposal of noncurrent as-
sets, such as PPE, and investments in business combinations,
joint ventures, and associates).
Author’s Note
Improvements to IFRSs, issued in April 2009, clarified
that only expenditures that result in a recognized asset
in the statement of financial position are eligible for
classification as investing activities. This amendment
to IAS 7 is effective for annual reporting periods begin-
ning on or after 1 January 2010, with early application
permitted.
5.07 Financing activities represent sources of funding for
both operations and investing activities and result in changes
in the size and composition of the equity capital and bor-
rowings of the entity (for example, issues and repurchases of
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share capital, and proceeds and repayments of principal on
borrowings).
5.08 Entities should report cash flows from investing and fi-
nancing activities by major class of gross proceeds and gross
cash payments unless an exception permitting net presenta-
tion applies. One exception to separate presentation of the
cash inflows and outflows is the same exception previously
described for operating activities presented under the direct
method. Another exception applies to financial institutions
for cash flows arising from acceptance or repayment of de-
posits with a fixed maturity date, cash flows arising from the
placement or withdrawal of deposits from other financial in-
stitutions, or from cash advances and loans to customers and
the respective repayments.
5.09 An entity should translate cash flows denominated in a
foreign currency and cash flows of a foreign operation into
its functional currency using the relevant exchange rate at the
dates of the cash flows. An entity should report cash flows
denominated in a foreign currency consistent with IAS 21,
The Effects of Changes in Foreign Exchange Rates. Although
its objective is to translate these transactions using the rele-
vant exchange rate between the entity’s functional currency
and foreign currency, IAS 21 permits the use of a weighted-
average exchange rate that approximates the actual rate. IAS
21 does not permit the use of an end-of-period exchange rate
in translating the cash flows of a foreign subsidiary. Gains
and losses arising on translation are not cash flows but IAS
7 requires these translation effects to be presented separately
in the statement of cash flows.
5.10 Entities should disclose separately interest paid, interest
received, dividends paid, and dividends received, and classify
each consistently from period to period as an operating, an
investing, or a financing activity. IAS 7 requires entities to
disclose the total amount of interest paid during the period
whether expensed in the statement of comprehensive income
or capitalized in accordance with IAS 23, Borrowing Costs.
5.11 When accounting for an investment in another entity
using the equity or cost method, an entity should only report
those cash flows between itself and the investee (for exam-
ple, dividends and advances). When using the proportionate
consolidation method of accounting for a jointly controlled
entity, the entity should include its proportionate share of the
jointly controlled entity’s cash flows in the relevant line item
of its own cash flow statement.
5.12 Entities should report separately aggregate cash flows
from gaining and losing control of subsidiaries and other
businesses, classified as an investing activity. International
Financial Reporting Standard (IFRS) 5, Non-current Assets
Held for Sale and Discontinued Operations, requires sep-
arate disclosure of cash flows attributable to the operating,
investing, and financing activities of discontinued operations
either in the statement of cash flows or in the notes.
U.S. GAAP
5.13 The Financial Accounting Standards Board (FASB)
Accounting Standards Codification (ASC) glossary defini-
tions of cash and cash equivalents are similar to those used
in IAS 7, except that the FASB ASC definitions do not ex-
plicitly give entities the ability to include bank overdrafts
in cash and cash equivalents. Paragraphs 5 and 7 of FASB
ASC 230-10-45 explain that gross cash flows are generally
more relevant than net cash flows unless the cash flows are
part of the entity’s cash management activities rather than its
operating, and financing activities. Paragraphs 8–9 of FASB
ASC 230-10-45 discuss the relevance of net cash flows on
demand deposits of a bank or customer accounts payable
of a broker-dealer, as well as investments (other than cash
equivalents), loans receivable, and debt (provided that the
original maturity of the asset or liability is three months or
less). Despite no explicit prohibition in FASB ASC, current
practice dictates that bank overdrafts are not considered cash
or cash equivalents and are classified as a financing activity.
5.14 In addition, IFRSs are more lenient than FASB ASC and
permit an entity to include equity instruments in cash equiv-
alents. According to the FASB ASC glossary, generally, only
investments with original maturities of three months or less
qualify under the definition of cash equivalent, which would
disqualify equity instruments, except for some mandatorily
redeemable equity instruments.
5.15 The basic structure of the cash flow statement is the
same under both IFRSs and U.S. generally accepted account-
ing principles. FASB ASC 230, Statement of Cash Flows,
requires an entity to classify cash flows as operating, financ-
ing, or investing activities, and contains similar examples of
events included in these classifications. However, paragraphs
16–17 of FASB ASC 230-10-45 require entities to classify
interest paid, interest and dividends received (except divi-
dends with long term donor restrictions), and income taxes
paid as operating activities, even when associated with an
investing or financing transaction. According to FASB ASC




5.16 IAS 7 requires entities to disclose the components of
cash and cash equivalents and its policy for determining these
components. An entity should reconcile the amount shown in
the statement of cash flows with the equivalent balance sheet
amount. Entities also should disclose any restricted amounts
of cash and cash equivalents. When its policy for cash and
cash equivalents changes, the entity should account for the
change retrospectively as a change in accounting policy in
accordance with IAS 8, Accounting Policies, Changes in
Accounting Estimates and Errors.
5.17 An entity should not report noncash financing and in-
vesting activities (for example, the acquisition of an asset by
assuming a mortgage or by means of a finance lease) in the
statement of cash flows. However, an entity should disclose
these activities elsewhere in the financial statements in or-
der to provide information relevant to understanding these
significant financing and investing activities.
5.18 When an entity gains or loses control of a subsidiary
(or other business), in addition to reporting cash flows as
previously described, it also should disclose the total con-
sideration paid or received (including the portion consisting
of cash and cash equivalents), the amount of the subsidiary’s
cash and cash equivalents, and the amounts of the subsidiary’s
other assets and liabilities (that is, assets and liabilities other
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than cash or cash equivalents) by major class of asset and
liability.
5.19 IAS 7 encourages entities to report additional informa-
tion about the types of cash flows when relevant to users’
understanding of the financial statements, including the
following:
• Undrawn borrowing facilities
• Aggregate cash flows of proportionately consolidated
joint ventures
• Aggregate amount of cash flows representing increases
in operating capacity
• Operating, investing, and financing cash flows by seg-
ment
U.S. GAAP
5.20 Like IAS 7, FASB ASC 230-10-50-1 requires an entity
to disclose its policy with respect to cash and cash equivalents
and to account for any changes as a change in accounting
principle with retrospective application and restatement of
the comparative periods presented.
5.21 Like IFRSs, entities reporting under FASB ASC 230-
10-45 can present operating activities using either the direct
or indirect method. However, FASB ASC 230-10-45–30 also
requires entities using the direct method to provide a recon-
ciliation of net income to net cash flow from operating ac-
tivities in a separate schedule. Essentially, this requirement
results in an entity disclosing both the direct and indirect
method of presenting its operating activities. IAS 7 does not
require this additional disclosure. FASB ASC 230-10-45-24
states that separate disclosure of cash flows of extraordinary
items or discontinued operations is not required. However,
Securities and Exchange Commission registrants that elect
to separately disclose cash flows of discontinued operations
should classify the related cash receipts and payments as
operating, investing, and financing activities.
5.22 FASB ASC 230-10-45-3 prohibits reporting cash flow
per share in the financial statements. Cash flow per share is
not discussed in IFRSs.
TABLE 5-1: METHOD OF REPORTING CASH FLOWS
FROM OPERATING ACTIVITIES
2010 2009 2008
Survey entities electing the indirect method....... 147 141 91
Survey entities electing the direct method.......... 23 19 9
Total ........................................................ 170 160 100
TABLE 5-2: CLASSIFICATIONS OF REPORTED
INCOME TAX, INTEREST, AND DIVIDEND
CASH FLOWS
2010 2009 2008
Survey Entities Reporting Income Tax Paid
or Received
Operating............................................................... 164 159 99
Investing................................................................. 0 0 0
Financing................................................................ 0 0 0
Presented in both operating and investing............ 0 1 1
No taxes paid or received presented .................... 6 0 0
Total .......................................................... 170 160 100
Survey Entities Reporting Interest Received
Operating............................................................... 91 86 61
Investing(2).............................................................. 53 52 32
Financing................................................................ 2 2 1
Presented in both operating and investing............ 1 0 1
No interest received presented ............................. 23 20 5
Total .......................................................... 170 160 100
Survey Entities Reporting Interest Paid
Operating............................................................... 112 110 70
Investing................................................................. 0 1 0
Financing(3) ............................................................ 48 46 28
Presented in both operating and financing............ 2 1 1
Presented in both operating and investing............ 0 0 1
Presented in both investing and financing............ 1 0 0
No interest paid presented.................................... 7 2 0
Total .......................................................... 170 160 100
Survey Entities Reporting Dividends
Received
Operating............................................................... 55 53 37
Investing................................................................. 38 46 26
Financing................................................................ 0 0 0
Presented in both operating and investing............ 1 — —
No dividends received presented.......................... 76 71 37
Total .......................................................... 170 160 100
Survey Entities Reporting Dividends Paid
Operating............................................................... 2 3 0
Investing................................................................. 0 0 0
Financing................................................................ 142 128 88
Presented in both operating and financing............ 1 0 0
Presented between operating and investing......... 2 2 3
No dividends received presented.......................... 23 27 9
Total .......................................................... 170 160 100
Survey Entities Reporting Dividends Paid
to Minority Interest
Operating............................................................... 3 4 3
Investing................................................................. 1 1 1
Financing................................................................ 47 45 39
No dividends paid to minority interest................... 119 110 57
Total .......................................................... 170 160 100
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Presentation of Operating Activities Using the
Direct Method—Interest Paid/Received
Presented in Operating, Investing, and
Financing Activities
5.23
Lan Airlines S.A. (Dec 2010)
CONSOLIDATED STATEMENT OF CASH FLOWS
DIRECT METHOD








Cash Flows From Operating Activities
Cash collection from operating activities
Proceeds from sales of goods and services 4,831,963 3,871,189 4,648,591
Other cash receipts from operating activities 46,336 40,319 35,457
Payments for operating activities
Payments to suppliers for goods and services (3,058,168) (2,475,716) (3,318,680)
Payments to and on behalf of employees (633,686) (636,603) (614,528)
Other payments for operating activities (18,000) (19,000) —
Interest paid (387) — —
Interest received 11,438 13,542 8,226
Income taxes refunded (paid) (11,098) 10,304 (26,994)
Other cash inflows (outflows) (43,061) 41,792 (100,997)
Net cash flows from operating activities 1,125,337 845,827 631,075
Cash Flows Used in Investing Activities
Cash flows from disposal of subsidiaries 1,491 1,568 6,708
Cash flows used for acquisition of subsidiaries (12,000) (921) (698)
Cash flows used in the purchase of non-controlling interest — (2,439) —
Other cash receipts from sales of equity or debt instruments of other entities 12,915 8,743 14,511
Other payments to acquire equity or debt instruments of other entities (60,000) (58,983) (2,607)
Amounts raised from sale of property, plant and equipment 577 10,777 6,625
Purchases of property, plant and equipment (1,029,158) (538,576) (779,315)
Purchases of intangible assets (19,236) (12,888) (23,388)
Dividends received 111 414 813
Interest received 4,048 2,637 2,743
Other cash inflows (outflows) 812 — 5
Net cash flow used in investing activities (1,100,440) (589,668) (774,603)
Cash Flows From (Used in) Financing Activities
Amounts raised from term loans 687,792 671,425 574,874
Loan payments (554,539) (261,705) (102,644)
Payments of finance lease liabilities (54,034) (62,858) (52,386)
Dividends paid (155,407) (139,937) (222,803)
Interest paid (128,722) (129,323) (81,421)
Other cash inflows 80,181 21,588 (15,210)
Net cash flows from (used in) financing activities (124,729) 99,190 100,410
Net increase (decrease) in cash and cash equivalents before the effect of
changes in the exchange rate (99,832) 355,349 (43,118)
Effects of variation in the exchange rate on cash and cash equivalents (613) (24,824) (1,525)
Net increase (decrease) in cash and cash equivalents (100,445) 330,525 (44,643)
Cash and cash equivalents at beginning of period 6 731,497 400,972 445,615
Cash and cash equivalents at end of period 6 631,052 731,497 400,972
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2—Summary of Significant Accounting Policies
(in part)
2.13. Cash and Cash Equivalents
Cash and cash equivalents include cash and bank balances,
time deposits in financial institutions, and other short-term
and easily-liquidated investments.
Note 3—Financial Risk Management (in part)
3.1. Financial Risk Factors (in part)
(b) Credit Risk (in part)
Credit risk occurs when the counterparty to a financial agree-
ment or instrument fails to discharge an obligation due.
The Company is exposed to credit risk due to its operative
and financial activities, including deposits with banks and fi-
nancial institutions, investments in other kinds of instruments,
exchange-rate transactions and the contracting of derivative
instruments or options.
(i) Financial Activities (in part)
Cash surpluses that remain after the financing of assets nec-
essary for the operation are invested according to credit limits
approved by the Company’s board, mainly in time deposits
with different financial institutions, short-term mutual funds,
and easily-liquidated corporate and sovereign bonds with
short remaining maturities. These investments are booked
as cash and cash equivalents and as investments held to
maturity.
(c) Liquidity Risk
Liquidity risk represents the risk that the Company has no
funds to meet its obligations.
Because of the cyclical nature of the business, the oper-
ation, and its investment and financing needs related to the
acquisition of new aircraft and renewal of its fleet, plus the
financing needs related to market-risk hedges, the Company
requires liquid funds to meet its payment obligations.
The Company therefore manages its cash and cash equiv-
alents and its financial assets, matching the term of invest-
ments with those of its obligations. Its policy is that the av-
erage term of its investments may not exceed the average
term of its obligations. This cash and cash equivalents posi-
tion is invested in highly-liquid short-term instruments through
first-class financial entities.
The Company has future obligations related to financial
leases, operating leases, maturities of other bank borrowings,
derivative contracts and aircraft purchase contracts.










Bank balances 24,432 31,176
Time deposits 406,143 522,077
Others 196,620 175,537
Total 631,052 731,497
Cash and cash equivalents are denominated in the following











US Dollar 194,212 228,879
Chilean peso(∗) 368,360 435,514
Euro 7,844 13,255
Argentine peso 11,230 6,105
Brazilian real 4,759 3,041
Other currencies 44,647 44,703
Total 631,052 731,497
(∗) The Company entered into currency derivative contracts (forward
exchange controls) for ThUS $ 169,357 at December 31, 2010
(ThUS $ 367,412 at December 31, 2009), for conversion into dol-
lars of investments in Chilean pesos and currency derivative con-
tracts (cross currency swaps) for ThUS $ 30,258 at December
31, 2010 (ThUS $ 0 at December 31, 2009), for conversion into
dollars of investment in Unidades de Fomento (“UF”).
In Venezuela, effective 2003, the authorities decreed that
all remittances abroad should be approved by the Cur-
rency Management Commission (CADIVI). Despite having
free availability of bolivars in Venezuela, the Company has
certain restrictions for freely remitting these funds outside
Venezuela. At December 31, 2010 the amount subject to
such restrictions in dollar terms is ThUS$ 26,738 (ThUS$
26,196 at 31 December 2009).
The Company has no significant non-monetary transac-
tions that should be reported.
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Presentation of Operating Activities Using the
Direct Method, Reconciliation of Profit (Loss)
to Net Cash Flows From Operating Activities
Provided in a Note Disclosure
5.24
Sims Metal Management Limited (Jun 2010)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)








Cash Flows From Operating Activities
Receipts from customers (inclusive of goods and services tax) 7,230.3 9,232.8 7,353.9
Payments to suppliers and employees (inclusive of goods and services tax) (7,305.1) (8,475.6) (6,943.1)
Interest received 2.8 2.3 2.9
Interest paid (16.2) (20.9) (34.4)
Dividends from associates and jointly controlled entities 29 19.6 41.5 5.1
Insurance recoveries 1.0 12.3 7.6
Income taxes refunded (paid) 20.1 (238.0) (144.5)
Net cash (outflow)/inflow from operating activities 33 (47.5) 554.4 247.5
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1—Summary of Significant Accounting Policies
(in part)
(L) Cash and Cash Equivalents
For the purpose of presentation in the consolidated statement
of cash flows, cash and cash equivalents includes cash on
hand, deposits held at call with financial institutions and other
short-term, highly liquid investments with original maturities
of three months or less that are readily convertible to known
amounts of cash and which are subject to an insignificant risk
of changes in value.
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Note 33—Cash Flow Information
(A) Reconciliation of Profit/(Loss) for the Year to Net Cash







Profit/(loss) for the year 126.7 (150.3) 440.1
Adjustments for non-cash items:
Depreciation and amortisation 143.9 170.8 95.1
Net gain on contribution of assets to SA Recycling LLC — — (38.8)
Unrealised (gain)/loss on held for trading derivatives (3.7) 10.3 (3.9)
Impairment of goodwill — 191.1 3.3
Impairment of property, plant and equipment 14.5 10.0 0.1
Impairment of intangible assets 0.9 — —
Net (gain)/loss on disposal of non-current assets (3.0) (0.9) 1.9
Loss on sale of subsidiaries — 2.6 —
Share-based payments 16.9 9.3 13.4
Non-cash pension expense 1.5 1.6 0.5
Non-cash compensation — 0.8 —
Negative goodwill recognised on acquisition — (0.4) —
Equity accounted profit net of dividends received 5.1 (16.7) (55.3)
Gain on acquisition of Port Albany Ventures LLC (8.7) — —
Other (0.3) 0.2 0.3
Change in operating assets and liabilities, excluding the effects of acquisitions
and disposals of entities:
(Increase)/decrease in trade and other receivables (240.7) 492.8 (176.6)
(Increase)/decrease in inventories (339.6) 543.4 (407.6)
(Increase)/decrease in prepayments (2.8) 1.7 18.6
(Decrease)/increase in provisions (7.7) (10.2) 24.2
Increase/(decrease) in income taxes 106.8 (194.8) 80.3
(Decrease)/increase in deferred taxes (11.1) 38.8 (11.2)
Increase/(decrease) in trade and other payables 153.8 (545.7) 263.1
Net cash (outflow)/inflow from operating activities (47.5) 554.4 247.5
(B) Reconciliation of Cash
Cash at the end of the Financial year as shown in the state-
ments of cash flows is reconciled to the related items in the





Cash at bank and on hand 132.2 59.1
Short-term deposits 0.1 10.4
Cash and cash equivalents 132.3 69.5
The carrying amount of the Group’s cash and cash equiva-
lents is assumed to approximate their fair value.
(C) Non-Cash Investing and Financing Activities
(i) During the year ended 30 June 2010, dividends of A$9.2
million (2009: A$26.6 million; 2008: A$18.1 million) were
paid via the issue of ordinary shares pursuant to the DRP.
Refer to Note 21.
(ii) On 14 March 2008, the Company acquired 100% of the
share capital of Metal Management Inc for A$1,500.6
million. The consideration given consists of 53,473,817
ordinary shares in Sims Metal Management Limited with
a fair value of A$1,490.1 million and A$10.5 million of
fully vested share options assumed at fair value. Refer to
Note 27.
(iii) On 1 September 2007, the Group completed the merger
of its Southern Californian metal recycling assets with
those of Adams Steel LLC, amounting to an investment
of A$342.3 million. For details of the assets and liabilities
contributed to the SA Recycling joint venture, refer to
Note 29.
Presentation of Operating Activities Using the
Indirect Method—Adjustments to Income
Before Tax, Adjustments for Accretion on
Financial Liabilities, Dividends on Preferred
Stock Subject to Mandatory Redemption
5.25
Philippine Long Distance Telephone Company
(Dec 2010)
Author’s Note
Excerpt at paragraph 5.32 illustrates Cash Flows from
Investing Activities for Philippine Long Distance Tele-
phone Company.
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CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
For the Years Ended December 31, 2010, 2009 and 2008
(In million pesos)
2010 2009 2008
Cash Flows From Operating Activities
Income before income tax (Note 4) 53,685 54,839 54,049
Adjustments for:
Depreciation and amortization (Notes 3, 4 and 9) 26,277 25,607 24,709
Interest on loans and other related items—net (Notes 4, 5, 9, 20 and 28) 5,471 5,317 5,083
Asset impairment (Notes 3, 4, 5, 9, 10, 14, 16, 17 and 28) 2,438 5,061 4,180
Losses (gains) on derivative financial instruments—net (Notes 4 and 28) 1,741 1,006 (3,115)
Incentive plans (Notes 3, 5 and 25) 1,392 1,833 1,281
Accretion on financial liabilities—net (Notes 5, 20 and 28) 1,177 1,062 956
Amortization of intangible assets (Notes 3 and 14) 388 368 377
Pension benefit costs (Notes 3, 5 and 25) 236 1,306 725
Gains on disposal of property, plant and equipment (Note 9) (913) (127) (534)
Interest income (Notes 4, 5 and 15) (1,200) (1,539) (1,668)
Equity share in net losses (earnings) of associates and joint ventures (Notes 4 and 10) (1,408) (2) 176
Foreign exchange losses (gains)—net (Notes 4, 9 and 28) (1,807) (909) 6,170
Dividends on preferred stock subject to mandatory redemption (Notes 5 and 8) — — 4
Others (352) (802) 830
Operating income before changes in assets and liabilities 87,125 93,020 93,223
Decrease (increase) in:
Trade and other receivables (3,132) (1,324) (3,003)
Inventories and supplies 89 (305) (913)
Prepayments (146) (1,333) (877)
Advances and refundable deposits (15) 271 (1,338)
Increase (decrease) in:
Accounts payable 6,407 130 5,244
Accrued expenses and other current liabilities 3,722 8,227 2,084
Pension and other employee benefits (4,603) (9,071) (1,125)
Customers’ deposits 57 32 27
Other noncurrent liabilities 50 (46) 1
Net cash generated from operations 89,554 89,601 93,323
Income taxes paid (12,294) (15,215) (15,021)
Net cash provided by operating activities 77,260 74,386 78,302
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
Significant Accounting Policies (in part)
Financial Assets (in part)
Initial Recognition
Financial assets are classified as financial assets at fair
value through profit or loss, loans and receivables, held-to-
maturity investments, available-for-sale financial assets, or as
derivatives designated as hedging instruments in an effective
hedge, as appropriate. We determine the classification of fi-
nancial assets at initial recognition and, where allowed and
appropriate, re-evaluate the designation of such assets at
each financial year-end.
Financial assets are recognized initially at fair value plus,
in the case of financial assets not at fair value through profit
or loss, directly attributable transaction costs.
Purchases or sales of financial assets that require delivery
of assets within a time frame established by regulation or
convention in the market place (regular way purchases or
sales) are recognized on the trade date, i.e., the date that we
commit to purchase or sell the asset.
Our financial assets include cash and cash equivalents,
short-term investments, trade and other receivables, quoted
and unquoted equity and debt securities, advances and re-
fundable deposits, and derivative financial assets.
Cash and Cash Equivalents
Cash includes cash on hand and in banks. Cash equivalents
are short-term, highly liquid investments that are readily con-
vertible to known amounts of cash with original maturities of
three months or less from the date of acquisition, and for
which there is an insignificant risk of change in value.
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15. Cash and Cash Equivalents
As at December 31, 2010 and 2009, this account consists of:
(In Million Pesos) 2010 2009
Cash on hand and in banks (Note 28) 2,906 3,300
Temporary cash investments (Note 28) 33,772 35,019
36,678 38,319
Cash in banks earns interest at prevailing bank deposit rates.
Temporary cash investments are made for varying periods of
up to three months depending on our immediate cash require-
ments, and earn interest at the prevailing temporary cash
investment rates. Due to the short-term nature of such trans-
actions, the carrying value approximates the fair value of our
temporary cash investments. See Note 28—Financial Assets
and Liabilities.
Interest income earned from cash in banks and temporary
cash investments amounted to Php1,081 million, Php1,185
million and Php1,523 million for the years ended December
31, 2010, 2009 and 2008, respectively.
29. Cash Flow Information
The table below shows non-cash investing activities for the
years ended December 31, 2010, 2009 and 2008:
(In Million Pesos) 2010 2009 2008
Transfer of Meralco shares to Beacon (Note 10) 15,083 — —
Recognition of asset retirement obligations
(Note 21) 49 17 70
Conversion of preferred stock subject to
mandatory redemption — 9 1,077
Operating Activities: Adjustments for
Depreciation, Impairments, Inventory
Writedowns, Labor Agreements, Litigation




CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
(Millions of U.S. dollars, except share and per share data)
Year Ended December 31
2008 2009(1) 2010
Operating Activities:
Net income (including non-controlling interests) 10,498 114 3,005
Discontinued operations (247) 57 330
Net income from continuing operations (including non-controlling interests) 10,251 171 3,335
Adjustments to reconcile net income to net cash provided by operations and payments:
Depreciation 4,722 4,574 4,395
Impairment 1,037 552 525
Net interest 1,501 1,500 1,445
Income tax expense (benefit) 1,104 (4,432) (1,479)
Write-downs of inventories to net realizable value and expense related
to onerous supply contracts(2) 3,287 2,596 1,189
Labor agreements and separation plans 2,503 252 46
Litigation provisions 629 (433) 145
Recycling of deferred gain on raw material hedges — (979) (354)
Change in fair value of conversion options on convertible bonds and call options on ArcelorMittal
shares — 897 (427)
Unrealized foreign exchange effects, provisions and other non-cash operating expenses net (135) (970) (528)
Changes in operating assets, liabilities, provision and other operating cash activities excluding the
effect from acquisitions:
Trade accounts receivable 1,969 1,355 (433)
Inventories (7,818) 5,230 (5,540)
Interest paid and received (1,921) (1,419) (1,320)
Taxes paid (2,682) (340) (197)
Trade accounts payable (2,005) (110) 3,442
Cash received from settlement of hedges not recognized in the statement of operations 2,509 — 43
Cash paid for separation plans — (615) (240)
Other working capital and provisions movements (866) (811) (277)
Net cash flows provided by operating activities from discontinued operations 567 260 245
Net cash provided by operating activities 14,652 7,278 4,015
IFRS ATT 5.26
510 IFRS Accounting Trends & Techniques
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1: Nature of Business, Basis of Presentation
and Consolidation (in part)
Basis of Presentation (in part)
The consolidated financial statements have been prepared
on a historical cost basis, except for available for sale finan-
cial assets, derivative financial instruments and certain non-
current assets held for distribution, which are measured at
fair value, and inventories, which are measured at the lower
of net realizable value or cost. The consolidated financial
statements have been prepared in accordance with Interna-
tional Financial Reporting Standards (“IFRS”) as issued by
the International Accounting Standards Board (“IASB”) and
are presented in U.S. dollars with all amounts rounded to the
nearest million, except for share and per share data.
Following the approval by the board of directors of Arcelor-
Mittal held on December 7, 2010, to spin off the stainless
steel business into a separate company known as Aperam,
the results of the stainless steel operations are presented
as discontinued operations in accordance with IFRS 5 “Non-
current Assets Held for Sale and Discontinued Operations.”
Consequently, the following presentation is applied:
Statements of Cash Flows
• For all periods presented, all line items of the State-
ment of Cash Flows are reclassified into continuing and
discontinued operations. Contributions from discontin-
ued operations are presented in three separate line
items: “Cash flows provided by operating activities from
discontinued operations”, “ Cash flows used in invest-
ing activities from discontinued operations” and “Cash
flows used in financing activities from discontinued op-
erations”
Note 2: Summary of Significant Accounting Policies
(in part)
Significant Accounting Policies (in part)
Cash and Cash Equivalents
Cash and cash equivalents consist of cash and short-term
highly liquid investments that are readily convertible to cash
with original maturities of three months or less at the time of
purchase and are carried at cost plus accrued interest, which
approximates fair value.
Restricted Cash
Restricted cash represents cash and cash equivalents not
readily available to the Company, mainly related to insurance
deposits, escrow accounts created as a result of acquisitions,
and various other deposits or required balance obligations
related to letters of credit and credit arrangements. Changes
in restricted cash are included within other investing activities
(net) in the statement of cash flows.
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Operating Activities: Adjustment for
Repurchase of Bonds and Change in
Estimates Related to Debentures
5.27
Gol Linhas Aéreas Inteligentes S.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
For the years ended December 31, 2010, 2009 and 2008
(In thousands of Brazilian Reais—R$)
12/31/10 12/31/09 12/31/08
Cash Flows From Operating Activities
Net income (loss) for the year 214,197 890,832 (1,239,347)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization 281,604 142,853 125,127
Allowance for doubtful accounts 7,728 7,701 8,329
Litigation 18,842 13,000 (43,354)
Provision (reversion of provision) for onerous contracts (445) 2,080 8,250
Provision for inventory obsolescence 8,402 4,327 (7,739)
Deferred income taxes 118,444 (135,305) (13,033)
Share-based payments 24,743 4,540 5,362
Net foreign exchange fluctuations and interests (46,549) (708,240) 742,636
Interest on loans and other, net 297,256 275,466 —
Net results from financial derivatives instruments 117,022 80,332 (9,417)
Other provision 108,106 13,113 (29,211)
Deferred revenues (106,299) (38,714) (28,297)
Other items 3,037 (8,832) —
Changes in operating assets and liabilities:
Trade and other receivables 208,526 (182,082) 549,805
Inventories (41,433) 45,878 17,151
Deposits 78,369 (124,196) (104,178)
Prepaid expenses, recoverable taxes and other credits 64,950 25,444 (1,829)
Other assets 9,865 47,771 (7,412)
Accounts payable (146,590) 78,663 (42,645)
Advance ticket sales (44,341) (11,226) 99,713
Advances from customers (162,150) 190,146 —
Salaries, wages and benefits (27,168) 86,357 (16,632)
Sales tax and landing fees 8,809 (20,879) 12,891
Tax obligations 16,549 65,249 28,930
Provisions (124,722) (127,191) 10,272
Other liabilities (4,650) (13,250) 143,666
Cash provided by operating activities 882,102 603,837 209,038
Interest paid (123,019) (115,422) —
Income tax paid (35,186) (31,156) (57,338)
Net cash provided by operating activities 723,897 457,259 151,700
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Basis of Preparation and Summary of Significant
Accounting Policies (in part)
2.2 Basis of Preparation (in part)
b) Cash and Cash Equivalents
Consists primarily of cash balances classified as loans
granted and receivables, and short term investments that are
measured at fair value through profit and loss. The short term
investments have maturities of three months or less (or with
no fixed time for redemption) with immediate liquidity, and are
subject to an insignificant risk of changes in value.
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Operating Activities: Note Disclosure of the
Reconciliation of Profit Before Tax to Cash
From Operating Activities, Adjustments for
Fair Value Gains on Forestry Assets, Felling
Costs, and Special Items, Change in Net Debt
5.28
Mondi Limited and Mondi plc (Dec 2010)
COMBINED AND CONSOLIDATED STATEMENT OF
CASH FLOWS (in part)
For the year ended 31 December 2010
€ Million Notes 2010 2009
Cash generated from operations 32a 778 867
Dividends from associates 14 2 2
Dividends from other investments 1 —
Income tax paid (47) (32)
Net cash generated from operating activities 734 837
Cash Flows From Investing Activities
Acquisition of subsidiaries, net of cash and cash equivalents 29 — (2)
Acquisition of associates, net of cash and cash equivalents (2) —
Proceeds from disposal of subsidiaries, net of cash
and cash equivalents 30 100 54
Proceeds from disposal of associates 30 — 3
Investment in property, plant and equipment 2 (394) (517)
Investment in intangible assets 11 (4) (5)
Proceeds from the disposal of property, plant and equipment
and intangible assets 14 11
Investment in forestry assets 13 (46) (40)
Investment in financial asset investments 16 (11) (7)
Proceeds from the sale of financial asset investments 3 —
Loan repayments from related parties 16 1 1
Loan repayments from external parties 16 2 1
Interest received 10 8
Other investing activities (2) 1
Net cash used in investing activities (329) (492)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Policies (in part)
Basis of Consolidation
Dual Listed Structure
The Group has two separate legal parent entities, Mondi Lim-
ited and Mondi plc, which operate under a dual listed com-
pany (DLC) structure. The substance of the DLC structure is
such that Mondi Limited, and its subsidiaries, and Mondi plc
and its subsidiaries, operate together as a single economic
entity through a sharing agreement, with neither parent en-
tity assuming a dominant role. Accordingly, Mondi Limited
and Mondi plc are reported on a combined and consolidated
basis as a single reporting entity under IFRS.
Cash and Cash Equivalents
Cash and cash equivalents comprise cash on hand and de-
mand deposits, together with short-term, highly liquid invest-
ments of a maturity of three months or less from the date of
acquisition that are readily convertible to a known amount of
cash and that are subject to an insignificant risk of changes in
value. Bank overdrafts are shown within short-term borrow-
ings in current liabilities on the combined and consolidated
statement of financial position. Cash and cash equivalents in
the combined and consolidated statement of cash flows and
in the presentation of net debt are reflected net of overdrafts.
Net Debt
Net debt is a non-IFRS measure and consists of short-term,
medium and long-term borrowings, bank overdrafts less cash
and cash equivalents and current financial asset investments.
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32. Consolidated Cash Flow Analysis
(a) Reconciliation of Profit Before Tax to Cash Generated
from Operations
€ Million 2010 2009
Profit before tax 372 49
Depreciation and amortisation 373 351
Share-based payments 8 5
Non-cash effect of special items 11 98
Net finance costs 117 114
Net income from associates (2) (2)
Decrease in provisions and post-employment benefits (2) (16)
(lncrease)/decrease in inventories (104) 80
(lncrease)/decrease in operating receivables (130) 170
lncrease/(decrease) in operating payables 113 (2)
Fair value gains on forestry assets (36) (28)
Felling costs 65 50
Profit on disposal of tangible and intangible assets (1) (4)
Other adjustments (6) 2
Cash generated from operations 778 867
(b) Cash and Cash Equivalents
€ Million 2010 2009
Cash and cash equivalents per combined and consolidated statement of financial position 83 123
Bank overdrafts included in short-term borrowings (59) (86)
Net cash and cash equivalents per combined and consolidated statement of cash flows 24 37
The fair value of cash and cash equivalents approximate the
carrying values presented.
(c) Movement in Net Debt














At 1 January 2009 75 (298) (1,467) (1,690)
Cash flow (19) 288 (38) 231
Business combinations (see note 29) — — 2 2
Disposal of businesses (see note 30) — 8 — 8
Reclassification (19) (119) 153 15
Currency movements — (12) (71) (83)
At 31 December 2009 37 (133) (1,421) (1,517)
Cash flow (4) 51 114 161
Business combinations (see note 29) — (1) — (1)
Disposal of businesses (see note 30) — 23 52 75
Movement in unamortised loan costs — — (4) (4)
Reclassification — (273) 273 —
Currency movements (9) (18) (51) (78)
At 31 December 2010 24 (351) (1,037) (1,364)
Notes:
(1) The Group operates in certain countries (principally South Africa) where the existence of exchange controls may restrict the use of certain
cash balances. These restrictions are not expected to have any material effect on the Group’s ability to meet its ongoing obligations.
(2) Excludes overdrafts, which are included as cash and cash equivalents. As at 31 December 2010, short-term borrowings on the combined
and consolidated statement of financial position of €410 million (2009: €219 million) include €59 million of overdrafts (2009: €86 million).
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Disposal groups—2010 (see note 31) — — — —
Disposal groups—2009 (see note 31) — — — —
Operating Activities: Adjustment for
Provision for Doubtful Debts, Impairment of
Guarantees, Fair Value Gain on Financial
Assets Held for Trading
5.29
Sterlite Industries (India) Limited (Mar 2010)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Indian Rupees in millions except share or per share amounts
unless otherwise stated)








Cash Flows From Operating Activities
Profit before taxes 52,458 69,910 1,555.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 8,024 8,061 179.3
Provision for doubtful debts/advances 12 46 1.0
Fair value gain on financial assets held for trading (2,254) (2,741) (61.0)
Profit on sale of fixed asset, net (10) (104) (2.3)
Share in consolidated (profit)/loss of associate 3,160 (2,051) (45.6)
Impairment of guarantees 137 — —
Exchange (gains)/loss, net 2,159 (6,074) (135.1)
Gain on fair valuation of conversion option — (587) (13.0)
Interest and dividend income (13,779) (13,076) (290.9)
Interest expenses 4,688 3,910 87.0
Changes in assets and liabilities:
Decrease in trade and other receivables 12,843 3,008 66.9
Decrease/(increase) in inventories 8,767 (5,167) (115.0)
(Increase)/decrease in other current and non-current assets (6,629) 1,313 29.2
(Decrease)/increase in trade and other payable (8,520) 3,410 75.9
Increase/(decrease) in other current and non-current liabilities 1,759 (1,482) (33.0)
Proceeds from short term investments 984,841 1,231,265 27,391.9
Purchases of short term investments (976,457) (1,270,518) (28,265.1)
Cash generation from operation 71,199 19,123 425.5
Interest paid (3,897) (5,597) (124.5)
Interest received 4,420 6,460 143.7
Dividend received 9,030 5,966 132.7
Income tax paid (8,649) (11,703) (260.3)
Net cash from operating activities 72,103 14,249 317.1
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Significant Accounting Policies (in part)
G. Financial Instruments (in part)
(c). Cash and Cash Equivalents
Cash and cash equivalents in the statement of financial po-
sition comprise cash at bank and in hand, and short-term
deposits which have a maturity of three months or less from
the date of acquisition.
16. Restricted Cash and Cash Equivalents
Restricted cash and cash equivalents consist of the following:









Cash at banks 59 61 60 1.3
Short-term deposits — 1,950 — —
59 2,011 60 1.3
Cash at banks is restricted in use as it relates to unclaimed
deposits & debentures, dividends and interest on debentures.
Short term deposits have been pledged with banks for
credit facilities.
17. Cash and Cash Equivalents
Cash and cash equivalents consist of the following:









Cash at banks and in hand 2,349 1,222 1,789 39.8
Short-term deposits 10,014 1,479 232 5.2
12,363 2,701 2,021 45.0
Short-term deposits are made for periods of between one day
and three months, depending on the immediate cash require-
ments of the Company, and earn interest at the respective
short-term deposit rates.
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Investing Activities: Purchase and Sale of
Non-Current Assets, Government Subsidies
5.30
Vina Concha y Toro S.A. (Dec 2010)
Author’s Note
Vina Concha y Toro S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of January
1, 2009. The excerpt that follows reflects the initial
application of IAS 7.
CONSOLIDATED STATEMENTS OF DIRECT CASH
FLOWS









Cash Flows Provided by (Used in) Investing Activities
Amounts provided by sale of property, plant and equipment 1,893,167 299,047
Purchases of property, plant and equipment (17,165,492) (33,857,055)
Purchases of intangible assets (1,234,739) (248,653)
Amounts provided by government subsidies 69,845 12,669
Net cash flows provided by (used in) investing activities (16,437,219) (33,793,992)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2. Bases of Preparation and Presentation Used
for These Financial Statements (in part)
2.5 Cash and Cash Equivalents
Cash equivalents correspond to short-term investments
which are of a significant liquidity, that are easily convert-
ible in cash known amounts and subject to a low exchange
risk in its value with maturity no greater than three months.
2.12 Property, Plant and Equipment (in part)
2.12.3 Government Subsidy
The Company has received a government subsidy from the
Chilean State, in conformity with The Law to Encourage
Drainage and Irrigation, Law 18,450 related to the winegrow-
ing activity developed.
These government subsidies in benefit of the Company are
presented within item Plantations, Plants and Equipment, de-
ducted from the construction value in-progress, and irrigation
material.
2.22 Direct Statement of Cash Flow
For the purposes of the statement of cash flows, cash and
cash equivalents relates to cash as defined previously.
The statement of cash flow gathers the cash movements
performed during the year, determined by the direct method.
In these statements of cash flow the following expressions
are used as detailed below:
• Cash Flows: Incomes and egresses of cash or equiva-
lents, including short term investments less than three
months with high liquidity and low risk of value fluctua-
tions.
• Operating activities: activities which constitute the main
source of ordinary income for the Group, as well as
other activities which cannot be classified as investment
or financing.
• Investing activities: activities of acquisition, alienation
or disposal by other means of assets and other invest-
ments not included in cash and its equivalents.
• Financing activities: activities which produce changes
in the volume and composition of the net equity and of
financial liabilities.
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Investing Activities: Collections and
Payments of Forward Agreements, Collection
and Payments of Bank Deposits, Capital
Increases in Associates
5.31
Embotelladora Andina S.A. (Dec 2010)
Author’s Note
Embotelladora Andina S.A. implemented IFRSs ef-
fective December 31, 2010, with a date of transition of
January 1, 2009. The excerpt that follows reflects the
initial application of IAS 7.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
For the years ended December 31, 2010 and 2009
(Translation of consolidated financial statements originally








Cash Flows Provided by (Used in) Investing Activities
Capital increases in equity investees (15,229,291) (937,607)
Proceeds from sale of property, plant and equipment 590,074 435,013
Purchase of property, plant and equipment (95,461,555) (49,482,837)
Collections from forward agreements 5,336,646 1,039,841
Payments derived from forward agreements (2,368,356) (342,213)
Payments of banks deposits (47,156,718) (102,760,277)
Collection of banks deposits 72,746,562 68,999,577
Cash flows provided by (used in) other investing activities 1,038,460 (1,270,238)
Net cash flows used in investing activities (80,504,178) (84,318,741)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2—Basis of Preparation of Consolidated
Financial Statements and Summary of Significant
Accounting Policies (in part)
2.14 Cash and Cash Equivalents
Cash and cash equivalents include cash on hand, time de-
posits in banks and other short-term, highly liquid investments
with purchased maturities of three months or less.
Note 21—Hedge Assets and Liabilities (in part)
The company held the following hedge liabilities at December
31, 2010; December 31 and January 1, 2009.
21.1 Currency Forwards for Highly Probable Expected
Transactions:
At December 31, 2010, the Company had contracts to hedge
the foreign exchange rate in foreign currency purchases of
property, plant and equipment to be made in 2011, for a total
of Th€$ 4,841. They were valued at fair value, resulting in a
net loss of ThCh$913,378. Since the contracts do not meet
the documentation requirements to be considered hedges
under IFRS, they have been valued at fair value and the
effects have been recognized in income.
At December 31, 2010, the Company had contracts to mit-
igate changes in the foreign exchange rate on purchases
of property, plant and equipment in foreign currencies to be
made in 2011, for a total of ThUS$61,815. These were valued
at fair value, resulting in a net loss of ThCh$485,983. Since
the contracts do not meet the documentation requirements
of the IFRS to be considered hedges, they have been mea-
sured at fair value with all changes being recorded through
profit and loss.
During 2009, the Company had contracts to mitigate
changes in the foreign exchange rate on purchases of prop-
erty, plant and equipment in foreign currencies for a to-
tal of ThUS$10,483, which matured during the same year.
They were valued at fair value, resulting in a net loss of
ThCh$342,213. Since the contracts do not meet the IFRS
documentation requirements to be considered hedges, they
have been measured at fair value with all changes being
recorded through profit and loss.
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21.2 Foreign Currency Forward of Items Recognized
in the Accounting:
At January 1, 2009, the Company had contracts to mit-
igate the foreign exchange impact of foreign-currency-
denominated assets totaling ThUS$32,886. Those contracts
expire in the first quarter of 2009. They were valued at fair
value, which resulted in a net profit of ThCh$1,039,841. Since
these contracts do not meet the documentation requirements
of IFRS to be treated as hedging, they have been measured
at fair value with all changes being recorded through profit
and loss.
21.3 Forward of UF (Unidad de Fomento) Adjustment
for Items Recognized in the Accounting:
At December 31, 2009, the Company had contracts to com-
pensate cash flows in Chilean pesos of financial investments
denominated in Unidades de Fomento, amounting to UF
143,115, Those contracts expire in the first quarter of 2010.
They were valued at fair value, which resulted in a net profit
of ThCh$13,083. Since these contracts do not meet the doc-
umentation requirements of IFRS to be treated as hedging,
they have been measured at fair value with all changes being
recorded through profit and loss.
Investing Activities: Interest and Dividends
Received, Interest Paid and Capitalized,
Purchase of Subsidiaries and Noncontrolling
Interest, Decrease (Increase) in Advances and
Refundable Deposits
5.32
Philippine Long Distance Telephone Company
(Dec 2010)
Author’s Note
Excerpt at paragraph 5.25 illustrates Cash Flows from
Operating Activities for Philippine Long Distance
Telephone Company and related note disclosures.
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 2010, 2009 and 2008
(In million pesos)
2010 2009 2008
Cash Flows From Investing Activities
Proceeds from:
Maturity of short-term investments 6,256 9,728 28,476
Disposal of property, plant and equipment (Note 9) 859 932 1,015
Redemption of investment in debt securities 409 4,005 2,676
Disposal of investment properties (Note 12) 89 18 9
Disposal of investments held-for-sale 10 — —
Disposal of available-for-sale financial assets — — 174
Disposal of investment in associates — — 3
Interest received 1,165 1,352 1,461
Dividends received 534 360 —
Payments for:
Available-for-sale financial assets (2) — (206)
Acquisition of intangibles (Notes 13 and 14) (13) (21) (69)
Purchase of subsidiaries and non-controlling interests—net of cash acquired (Note 13) (188) (8,989) (743)
Purchase of investment in debt securities (Note 10) (403) (3,572) (3,457)
Short-term investments (3,114) (6,838) (21,072)
Notes receivable — (80) —
Purchase of investments in associates (Note 10) — (18,070) —
Interest paid—capitalized to property, plant and equipment (Notes 4, 5, 9, 20 and 28) (710) (691) (778)
Additions to property, plant and equipment (Notes 4 and 9) (28,056) (27,378) (24,425)
Decrease (increase) in advances and refundable deposits (119) 112 (78)
Net cash used in investing activities (23,283) (49,132) (17,014)
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Financing Activities: Issue of Share Capital,
Sales and Leaseback of Aircraft, Repayment
of Finance Lease Obligations, Refunds of
Deposits Pledged for Finance Leases, Receipt
and Payment of Restricted Bank Deposits
5.33
China Eastern Airlines Corporation Limited
(Dec 2010)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
For the years ended December 31, 2010, 2009 and 2008
(Amounts in thousands)








Cash Flows From Financing Activities
Proceeds from draw down of short-term bank loans 20,803,369 28,536,703 25,403,301
Proceeds from sales and leaseback of aircraft — 590,253 —
Repayments of short-term bank loans (21,942,900) (39,535,319) (19,986,723)
Proceeds from draw down of long-term bank loans 11,556,258 10,823,185 4,748,071
Repayments of long-term bank loans (6,526,565) (9,522,385) (3,922,593)
Principal repayments of finance lease obligations (2,201,176) (2,005,264) (2,593,656)
Receipts/(payments) of restricted bank deposits 1,174,066 1,347,525 (1,365,116)
Interest paid (1,644,924) (2,161,085) (2,741,980)
Refunds of deposits pledged for finance leases upon maturities — — 419,604
Capital contribution from non-controlling interests of subsidiaries 519,300
Proceeds from issuance of new shares — 14,056,167 —
Dividends paid to non-controlling interests of subsidiaries (41,738) (44,156) (52,700)
Net cash (outflow)/inflow from financing activities (652,442) 2,085,624 (91,792)
Net increase/(decrease) in cash and cash equivalents 1,356,113 (1,721,019) 1,838,860
Cash and cash equivalents at January 1 1,735,248 3,451,010 1,655,244
Exchange adjustments (13,133) 5,257 (43,094)
Cash and cash equivalents at December 31 27 3,078,228 1,735,248 3,451,010
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
(s) Cash and Cash Equivalents
Cash and cash equivalents includes cash in hand, deposits
held at call with banks and other short-term highly liquid in-
vestments with original maturities of three months or less.
27. Cash and Cash Equivalents
The carrying amounts of the Group’s cash and cash equiva-






US Dollars 263,051 253,776
Euro 30,592 43,519
Japanese Yen 12,705 30,889
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42. Note to Consolidated Cash Flow Statement
(a) Cash Generated From Operations







Profit/(loss) before income tax 5,417,812 249,205 (15,256,009)
Adjustments for:
Depreciation of property, plant and equipment and intangible assets 6,726,651 5,177,149 4,755,622
Loss/(gain) on disposals of property, plant and equipment 15,893 — (267,084)
Loss on disposals of investment in associates 1,013 — —
Gain on disposals of investment in subsidiaries (45,147) — —
Share of results of associates (39,228) 46,602 (69,668)
Share of results of jointly controlled entities (28,154) (23,803) (24,050)
Amortization of lease prepayments 31,186 25,686 25,940
Net foreign exchange gains (1,074,796) (95,379) (1,970,990)
Amortization of deferred revenue — 8,138 (19,965)
Gain arising from fair value movements of derivative financial instruments (915,804) (5,333,546) 6,400,992
Consumption of flight equipment spare parts 601,407 351,151 476,282
Impairment provision of trade and other receivables 1,545 8,807 39,338
Provision for post-retirement benefits 479,514 440,878 200,603
Provision for return condition checks for aircraft under operating leases 586,364 588,745 618,556
Impairment loss 405,391 109,417 2,976,678
Interest income (80,588) (109,925) (89,275)
Interest expenses 1,501,900 1,754,640 2,328,147
Gain on disposal of an associate and available-for-sale financial assets — — (13,557)
Operating profit before working capital changes 13,584,959 3,197,765 111,560
Changes in working capital
Flight equipment spare parts (776,736) (465,626) (529,068)
Trade receivables (202,667) (210,188) 922,431
Prepayments, deposits and other receivables 337,365 540,134 (452,548)
Sales in advance of carriage 846,502 406,305 (197,331)
Trade payables and notes payables (3,418,055) 1,021,365 1,792,556
Other payables and accrued expenses 292,530 (481,798) 1,928,495
Other long-term liabilities 569,577 (160,859) (431,956)
Provision for return condition checks for aircraft under operating leases (305,550) (275,008) (41,448)
Staff housing allowances (166,871) (90,514) (100,428)
Post-retirement benefit obligations (131,581) (106,530) (90,145)
Operating lease deposits 110,366 132,644 30,348
(2,845,120) 309,925 2,830,906
Cash generated from operations 10,739,839 3,507,690 2,942,466
(b) Non-Cash Transactions







Financing activities not affecting cash:
Issuances of new shares for acquisition of Shanghai Airlines (Note 43) 9,118,433 — —
Finance lease obligations incurred for acquisition of aircraft 1,455,152 — 7,964,792
10,573,585 — 7,964,792
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Financing Activities: Capital Increase, Issue
and Repayment of Subordinated Long-Term
Debt, Issuances of Preferred Securities,
Issues of Capital Shares Under Share-Based
Compensation Agreements
5.34
Deutsche Bank Aktiengesellschaft (Dec 2010)
CONSOLIDATED STATEMENT OF CASH FLOWS
(in part)
In € M. 2010 2009 2008
Cash Flows From Financing Activities:
Issuances of subordinated long-term debt 1,341 457 523
Repayments and extinguishments of subordinated long-term debt (229) (1,448) (659)
Issuances of trust preferred securities 90 1,303 3,404
Repayments and extinguishments of trust preferred securities (51) — —
Common shares issued under share-based compensation plans — — 19
Capital increase 10,060 — 2,200
Purchases of treasury shares (15,366) (19,238) (21,736)
Sale of treasury shares 13,519 18,111 21,426
Dividends paid to noncontrolling interests (7) (5) (14)
Net change in noncontrolling interests 200 109 331
Cash dividends paid (465) (309) (2,274)
Net cash provided by (used in) financing activities 9,092 (1,020) 3,220
Net effect of exchange rate changes on cash and cash equivalents 1,911 690 (402)
Net increase (decrease) in cash and cash equivalents 14,804 (13,715) 39,166
Cash and cash equivalents at beginning of period 51,549 65,264 26,098
Cash and cash equivalents at end of period 66,353 51,549 65,264
Net cash provided by (used in) operating activities include
Income taxes paid (received), net 784 (520) (2,495)
Interest paid 13,740 15,878 43,724
Interest and dividends received 29,456 28,211 54,549
Cash and cash equivalents comprise
Cash and due from banks 17,157 9,346 9,826
Interest-earning demand deposits with banks (not included: time deposits of €43,181 m. as of
December 31, 2010, and €5,030 m. and €9,301 m. as of December 31, 2009 and 2008) 49,196 42,203 55,438
Total 66,353 51,549 65,264
The acquisition of Deutsche Postbank AG shares, including
the non-cash portion, is described in detail in Note 04 “Acqui-
sitions and Dispositions.” The restructuring of loans the Group
held with the Icelandic generic pharmaceutical group Actavis
Group hF resulted in a non-cash reclassification of the sub-
ordinated financing arrangement from operating to investing
activities for the purposes of the Consolidated Statement of
Cash Flows. The transaction is described in detail in Note 17
“Equity Method Investments.”
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
01—Significant Accounting Policies (in part)
Consolidated Statement of Cash Flows
For purposes of the consolidated statement of cash flows,
the Group’s cash and cash equivalents include highly liquid
investments that are readily convertible into cash and which
are subject to an insignificant risk of change in value. Such
investments include cash and balances at central banks and
demand deposits with banks.
The Group’s assignment of cash flows to the operating, in-
vesting or financing category depends on the business model
(“management approach”). For the Group the primary oper-
ating activity is to manage financial assets and financial liabil-
ities. Therefore, the issuance and management of long-term
borrowings is a core operating activity which is different than
for a non-financial company, where borrowing is not a princi-
pal revenue producing activity and thus is part of the financing
category.
The Group views the issuance of senior long-term debt as
an operating activity. Senior long-term debt comprises struc-
tured notes and asset backed securities, which are designed
and executed by CIB business lines and which are revenue
generating activities. The other component is debt issued
by Treasury, which is considered interchangeable with other
funding sources; all of the funding costs are allocated to busi-
ness activities to establish their profitability.
Cash flows related to subordinated long-term debt and trust
preferred securities are viewed differently than those related
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to senior-long term debt because they are managed as an in-
tegral part of the Group’s capital, primarily to meet regulatory
capital requirements. As a result they are not interchangeable
with other operating liabilities, but can only be interchanged
with equity and thus are considered part of the financing
category.
The amounts shown in the consolidated statement of cash
flows do not precisely match the movements in the consol-
idated balance sheet from one period to the next as they
exclude non-cash items such as movements due to foreign
exchange translation and movements due to changes in the
group of consolidated companies.
Movements in balances carried at fair value through profit
or loss represent all changes affecting the carrying value. This
includes the effects of market movements and cash inflows
and outflows. The movements in balances carried at fair value
are usually presented in operating cash flows.
Financing Activities: Issue of Securities,
Expenditures Paid by Third Party, Exercise
of Stock Options
5.35
U308 Corp. (Dec 2010)
Author’s Note
U308 Corp. implemented IFRSs effective December
31, 2010, with a date of transition of January 1, 2009.
The excerpt that follows reflects the initial application
of IAS 7.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
(Expressed in Canadian Dollars)





Issue of securities, net of transaction costs
(note 11) 6,699,019 —
South American expenditures paid by Mega
Uranium Ltd. (note 20) 242,570 —
Repayment of Mega Uranium Ltd. (note 20) (242,570) —
Exercise of stock options 108,500 —
Net cash provided by financing activities 6,807,519 —
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Significant Accounting Policies (in part)
(f) Financial Assets
The Company’s financial instruments are comprised of the
following:
Financial Assets: Classification:
Cash and cash equivalents Loans and receivables
Guaranteed investment certificates Loans and receivables
Accounts receivable Loans and receivables
Value-added taxes receivable Loans and receivables
Restricted cash Loans and receivables
Financial Liabilities: Classification:
Accounts payable and other liabilities Other financial liabilities
Due to Mega Uranium Ltd. Other financial liabilities
Loans and Receivables:
Loans and receivables are financial assets with fixed or de-
terminable payments that are not quoted in an active market.
Such assets are initially recognized at fair value plus any
directly attributable transaction costs. Subsequent to initial
recognition, loans and receivables are measured at amortized
cost using the effective interest method, less any impairment
losses.
(j) Cash and Cash Equivalents
Cash and cash equivalents in the consolidated statement of
financial position comprise cash at banks and on hand, and
short-term deposits with an original maturity of three months
or less, which are readily convertible into a known amount
of cash. The Company’s cash and cash equivalents are in-
vested with major financial institutions in business accounts
and guaranteed investment certificates which are available
on demand by the Company for its programs.
11. Share Capital
a) Authorized Share Capital
At December 31, 2010, the authorized share capital consisted
of an unlimited number of common shares.
The common shares do not have a par value. All issued
shares are fully paid.
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b) Common Shares Issued
At December 31, 2010, the issued share capital amounted
to $48,564,060. The change in issued share capital for the




Balance, January 1, 2009, December 31,
2009 (i) 23,057,700 $ 30,197,967
Acquisition of South American property
interests, net of issue costs in the
amount of $4,000 (note 20) 30,564,858 13,138,889
Issue of securities, net of transaction
costs (ii) 23,989,100 5,040,969
Stock options exercised 280,000 108,500
Grant date fair value of stock options
exercised — 77,735
Balance, December 31, 2010 77,891,658 $ 48,564,060
(i) U308 Corp. has adopted a shareholder rights plan (the
“Rights Plan”). The Rights Plan is designed to ensure the
fair treatment of U308 Corp’s shareholders in any transaction
involving a change of control of the Company and will provide
U308 Corp’s Board of Directors and its shareholders with
adequate time to evaluate any unsolicited take-over bid and, if
appropriate, to seek out alternatives to maximize shareholder
value.
Until the occurrence of certain specific events, the rights will
trade with the shares of the Company and be represented
by certificates representing the shares. The rights become
exercisable only when a person, including any party related
to it or acting jointly with it, acquires or announces its intention
to acquire 20% or more of the outstanding shares of the
Company without complying with the Permitted Bid provisions
of the Rights Plan. Should a non-Permitted Bid be launched,
each right would entitle each holder of shares (other than the
acquiring person and persons related to it or acting jointly with
it) to purchase additional shares of the Company at a 50%
discount to the market price at the time.
It is not the intention of the Rights Plan to prevent take-
over bids but to ensure their proper evaluation by the market.
Under the Rights Plan, a Permitted Bid is a bid made to all
shareholders for all of their shares on identical terms and
conditions that is open for at least 60 days. If at the end of 60
days at least 50% of the outstanding shares, other than those
owned by the offeror and certain related parties, have been
tendered and not withdrawn, the offeror may take up and pay
for the shares but must extend the bid for a further ten days
to allow all other shareholders to tender.
On February 17, 2011, U308 Corp. announced that it had
renewed its current shareholder rights plan, which was due
to expire on March 4, 2011. The Rights Plan will be submitted
to holders of U308 Corp’s common shares for approval at the
Company’s 2011 annual meeting.
(ii) On October 14, 2010, U308 Corp. closed a fully sub-
scribed brokered private placement (the “Offering). U308
Corp. issued 23,989,100 units (the “Units”) at a price of $0.30
per Unit for gross proceeds of $7,196,730. Insiders of U308
Corp. purchased, directly or indirectly, approximately $2.2
million of the Offering.
Each Unit consists of one common share and one-half of
one transferable common share purchase warrant. Each full
warrant is exercisable into one common share for a period
of two years after October 14, 2010 at a price of $0.45 per
common share. In the event that at any time after February
15, 2011, the closing price for U308 Corp’s common shares
is greater than $0.70 per share for a period of 20 consecutive
trading days, the Company may accelerate the expiry date of
the warrants to the 30th day after notice of the accelerated
expiry date has been given by U308 Corp. In connection with
the Offering, the agents received broker warrants entitling
them to acquire, in the aggregate, up to 1,239,342 common
shares of U308 Corp. at an exercise price of $0.45 per share
until October 14, 2012.
A value of $1,570,000 was estimated for the 11,994,550
warrants on the date of grant using the Black-Scholes option
pricing model with the following assumptions: expected divi-
dend yield of 0%; expected volatility of 116%; risk-free interest
rate of 1.42%; and an expected average life of 2 years.
A value of $251,484 was estimated for the 1,239,342 bro-
ker warrants on the date of grant using the Black-Scholes op-
tion pricing model with the following assumptions: expected
dividend yield of 0%; expected volatility of 116%; risk-free in-
terest rate of 1.42%; and an expected average life of 2 years.
This value charged $196,624 to share capital and $54,860 to
warrants as transaction costs.
Total share issue costs of $497,711 were charged and
allocated $389,137 to share capital and $108,574 to warrants.
20. Acquisition of South American Operations
On April 7, 2010, U308 Corp. completed the acquisition of
Mega’s South American uranium properties, adding assets
in Colombia and Argentina to the Company’s holdings in
Guyana. Under the terms of the acquisition, U308 Corp. is-
sued 30,564,858 common shares of U308 Corp. in exchange
for Mega’s South American properties and $4,060,991 in
cash. The preliminary fair value estimates is provided below.
The transaction did not meet the definition of a business
combination as the primary assets acquired are in the ex-
ploration stage therefore the transaction was recorded as an
IFRS ATT 5.35
524 IFRS Accounting Trends & Techniques
acquisition of assets. The provisional values of assets and
liabilities recognized on acquisition are their estimated fair
values at the date of acquisition. IFRS permits up to twelve
months for provisional acquisition accounting to be finalized
following the acquisition date if any subsequent information





Fair value of common shares issued (30,564,858
common shares) $13,142,889
Transaction costs 469,045
Total cost of acquisition $13,611,934
Fair Value of Assets and Liabilities
Assets
Cash $4,060,991
Total current asset 4,060,991
Non-current assets
Value-added taxes receivable 487,810
Property and equipment 146,243







Amounts payable and other liabilities $178,952
Non-current liability
Due to Mega Uranium Ltd.(b) 487,810
Total current liabilities $666,762
Net identifiable assets $13,611,934
(a) Mega provided bridge financing to the Company in the amount
of $242,570. The amount was non-interest bearing and due on
demand. On September 27, 2010, the amount was repaid in full.
(b) Under the terms of acquisition, if U308 Corp. recovers value-
added taxes in the amount of $487,810 from government au-
thorities in Argentina, the Company will be required to repay this
amount to Mega in full.
Financing Activities: Commercial Property
Debt Issue, Amortization and Repayment,
Trust Unit and Class B Limited Partnership
Distributions
5.36
Brookfield Office Properties Canada (Dec 2010)
Author’s Note
Brookfield Office Properties Canada implemented
IFRSs effective December 31, 2010, with a date of
transition of January 1, 2009. The excerpt that follows
reflects the initial application of IAS 7.
CONSOLIDATED STATEMENTS OF CASH FLOW
December 31 (US Millions) Note 2010 2009(1)
Financing Activities
Commercial property debt arranged 619 296
Commercial property debt
repayments (268) (284)
Corporate credit facilities arranged 168 212
Corporate credit facilities
repayments (268) (439)
Land development debt arranged 388 60
Land development debt repayments (92) (375)
Other debt arranged — 92
Non-controlling interests issued 144 4
Distributions to non-controlling
interests (1) (20)
Common shares issued — 1,016
Preferred shares issued 544 259
Preferred share dividends (39) (7)
Common share dividends (282) (250)
913 564
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2: Significant Accounting Policies (in part)
(m) Financial Instruments and Derivatives (in part)
Derivative instruments are recorded in the consolidated bal-
ance sheets at fair value, including those derivatives that are
embedded in financial or non-financial contracts and which
are not closely related to the host contract.
IFRS ATT 5.36
525Section 5: Statement of Cash Flows and Related Disclosures
The following summarizes the company’s classification and
measurement of financial assets and liabilities:
Classification Measurement
Financial Assets
Participating loan notes Loans and receivables Amortized cost(2)
Non-current financial assets
Equity securities designated as available-for-sale (“AFS”) AFS Fair value
Derivative assets FVTPL(1) Fair value
Loans receivable Loans and receivables Amortized cost
Receivables and other assets
Accounts receivable Loans and receivables Amortized cost
Loan receivable from affiliate Loans and receivables Amortized cost
Equity installment receivable Loans and receivables Amortized cost
Residential receivables Loans and receivables Amortized cost
Restricted cash and deposits Loans and receivables Amortized cost
Cash and cash equivalents Loans and receivables Amortized cost
(n) Cash and Cash Equivalents
Cash and cash equivalents include cash and short-term in-
vestments with original maturities of three months or less.
Note 31: Capital Management and Liquidity
The company employs a broad range of financing strategies
to facilitate growth and manage financial risk. The company’s
objective is to reduce its weighted average cost of capital
and improve common shareholders’ equity returns through
value enhancement initiatives and the consistent monitor-
ing of the balance between debt and equity financing. As at
December 31, 2010, the company’s weighted average cost
of capital, assuming a 12% return on common equity, was
7.95%.
The following schedule details the components of the com-
pany’s capital as at December 31, 2010 and the related costs
thereof:
Cost of Capital(1) Underlying Value(2)
(Millions) Dec. 31, 2010 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2009
Liabilities
Commercial property debt 5.90% 5.94% $ 7,426 $ 5,307
Capital securities—corporate 5.43% 5.42% 1,038 1,009
Shareholders’ Equity
Preferred equity—corporate 4.11% 6.20% 848 304
Common equity(2) 12.00% 12.00% 8,813 6,076
Other Equity
Preferred equity—subsidiaries 1.52% 4.83% 382 363
Non-controlling interests—fund subsidiaries(3) 10.00% 10.00% 375 300
Non-controlling interests—other subsidiaries(4) 12.00% 12.00% 582 169
Total(5) 7.95% 7.95% $19,464 $13,528
(1) As a percentage of average book value unless otherwise noted.
(2) Underlying value of liabilities represents carrying value or the cost to retire on maturity. Underlying value of common equity is based on the
closing stock price of Brookfield’s common shares.
(3) Assuming 10% return on co-invested capital.
(4) Assuming 12% return on co-invested capital.
(5) In calculating the weighted average cost of capital, the cost of debt has been tax-effected.
Commercial property debt—The company’s commercial pro-
perty debt is primarily fixed-rate and non-recourse to the com-
pany. These financings are typically structured on a loan-to-
appraised value basis of between 55% and 65% when the
market permits. In addition, in certain circumstances where a
building is leased almost exclusively to a high-credit quality
tenant, a higher loan-to-value financing, based on the ten-
ant’s credit quality, is put in place at rates commensurate
with the cost of funds for the tenant. This execution reduces
the company’s equity requirement and enhances its equity
returns when financing certain commercial properties. The
company currently has a level of indebtedness of 50% of fair
value of its commercial properties. This level of indebtedness
is considered by the company to be within its target.
Capital securities—corporate, Preferred equity—corporate
and Preferred equity—subsidiaries. These represent sources
of low-cost capital to the company, without dilution to the
common equity base.
Non-controlling interest—fund subsidiaries—The company
invests its liquidity alongside capital from strategic institutional
partners in fund formats to acquire individual assets and port-
folios. Non-controlling interest—fund subsidiaries represents
investments by partners in consolidated fund subsidiaries.
The company is subject to certain covenants on its credit
facilities. The covenants include a total and secured leverage
ratio, an interest and fixed charge ratio, as well as a dividend
payout ratio and a recourse debt requirement. No amount
was drawn on the credit facilities as at December 31, 2010.
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The company’s strategy is to satisfy its liquidity needs us-
ing cash on hand, cashflows generated from operating activ-
ities and provided by financing activities, as well as proceeds
from asset sales. The company also generates liquidity by
accessing capital markets on an opportunistic basis. Rental
revenue, recoveries from tenants, lot and home sale pro-
ceeds, interest and other income, available cash balances,
draws on corporate credit facilities and refinancing of ma-
turing indebtedness are the company’s principal sources of
capital used to pay operating expenses, dividends, debt ser-
vice and recurring capital and leasing costs in its commercial
property portfolio and residential development business. The
company finances its residential development operations and
ongoing working capital requirements with residential devel-
opment debt and accounts payable. Another source of cash-
flow includes third-party fees generated by the company’s
asset management, leasing and development businesses.
The principal liquidity needs for periods beyond the next
twelve months are for scheduled debt maturities, recurring
and non-recurring capital expenditures, development costs
and potential property acquisitions. The company’s strategy
is to meet these needs with one or more of the following:
• cashflows from operations;
• construction loans;
• creation of new funds;
• proceeds from disposition of residential business;
• proceeds from sales of assets;
• proceeds from sale of non-controlling interests in sub-
sidiaries; and
• credit facilities and refinancing opportunities.
The company attempts to match the maturity of its commer-
cial property debt portfolio with the average lease terms of
its properties. At December 31, 2010, the average term to
maturity of the company’s commercial property debt was five
years, compared to its average lease term of seven years.
The following table presents the contractual maturities of
the company’s financial liabilities at December 31, 2010:
Payments Due By Period
(Millions) Total 1 Year 2–3 Years 4–5 Years After 5 Years
Commercial property debt(1)(2) $8,978 $2,273 $2,763 $1,155 $2,787
Capital securities—corporate(2) 1,248 237 285 569 157
Residential development debt(3) 489 126 362 1 —
Other non-current financial liabilities 105 12 — — 93
Equity installment payable(4) 79 79 — — —
(1) Includes $165 million of debt associated with assets held for sale.
(2) Includes repayment of principal and interest.
(3) Debt associated with assets held for sale.
(4) Represents the company’s obligation to reimburse BAM subsidiaries for their share of the equity installment payment relating to Prime.
Note 34: Other Information
(a) Supplemental cashflow information
(Millions) 2010 2009
Acquisitions of real estate $474 $ —
Mortgages and other balances assumed on acquisition (37) —
Net acquisitions $437 $ —
Dispositions of real estate $ 42 $ 69
Mortgages and other balances assumed by purchasers (21) (53)
Net dispositions $ 21 $ 16
Cash taxes paid $ 25 $ 34
Cash interest paid (excluding dividends on capital securities) $371 $352
(b) In the second quarter of 2010, the company acquired an
interest in loan receivables of $367 million through a cash
collateralized total return swap (refer to Note 13(c)) in
exchange for a reduction of loans receivable from affiliate
of a corresponding amount.
(c) The assets and liabilities of certain of the company’s sub-
sidiaries are neither available to pay debts of, nor consti-




SECTION 6: NON-CURRENT ASSETS HELD FOR SALE
AND DISCONTINUED OPERATIONS∗
IFRS 5, NON-CURRENT ASSETS HELD
FOR SALE AND DISCONTINUED
OPERATIONS
IFRSs Overview and Comparison
to U.S. GAAP
6.01 International Financial Reporting Standard (IFRS) 5,
Non-current Assets Held for Sale and Discontinued Oper-
ations, specifically addresses the accounting, classification,
presentation, and disclosure of noncurrent assets and dis-
posal groups held for sale and discontinued operations. IFRS
5 was developed as part of a Financial Accounting Standards
Board (FASB) convergence project and with consideration
of the requirements of FASB Accounting Standards Codifi-
cation (ASC) 360, Property, Plant, and Equipment.
6.02 IFRS 5 applies to all noncurrent assets (assets that are
not expected to be realized within 12 months after the re-
porting period or the entity’s normal operating cycle) and
disposal groups (groups of assets with associated liabilities
expected to be disposed of in a single transaction), with
the following exceptions: deferred tax assets, assets arising
from employee benefits, financial assets within the scope of
International Accounting Standard (IAS) 39, Financial In-
struments: Recognition and Measurement, noncurrent assets
accounted for using the fair value model in IAS 40, Invest-
ment Property, or measured at fair value through profit and
loss in IAS 41, Agriculture, and contractual rights under in-
surance contracts in IFRS 4, Insurance Contracts.
6.03 IFRS 5 requires an entity to test assets within the scope
of IFRSs for impairment in accordance with all applicable
IFRSs immediately prior to classification as held for sale or
discontinued operations. For example, an entity would test
items of property, plant and equipment (PPE) in accordance
with IAS 36, Impairment of Assets, which establishes the
requirements of the impairment test and measurement of
impairment losses and also permits reversals of impairment
losses, recognized at the time of reclassification, that occur
prior to disposal of an asset or disposal group.
Recognition and Measurement
IFRSs
6.04 An entity should classify noncurrent assets or disposal
groups as held for sale if the carrying amount(s) will be
recovered through a sale transaction rather than continued
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
issued as of 1 January 2011.
use. To be eligible for classification as held for sale, IFRS
5 requires that an asset or disposal group be available for
immediate sale in its present condition subject only to the
usual and customary terms for sales of such assets or disposal
groups. Completion of the sale should be highly probable.
6.05 The entity can conclude that sale is highly probable
if the appropriate level of management is committed to a
plan to sell the asset or disposal group and has initiated an
active program to locate a buyer. The entity should actively
market an asset or disposal group at a reasonable price in
relation to its current fair value. The entity should expect
completion of the sale within one year of the classification,
although the standard recognizes and allows for extension of
this period when there is sufficient evidence that the entity
remains committed to the sale. Actions required to complete
the plan should indicate that it is unlikely the plan will be
withdrawn or changed significantly. An entity should not
reclassify as held for sale any assets to be abandoned.
6.06 At initial recognition as held for sale, an entity should
measure assets and disposal groups within the scope of IFRS
5 at the lower of the carrying amount prior to reclassification
and fair value less cost to sell as defined in IAS 36. If the asset
or disposal group was acquired in a business combination, an
entity should measure the asset at fair value less cost to sell
when classified as held for sale. An entity should not record
depreciation and amortization while the asset is classified as
held for sale even if the asset or disposal group continues to
be used in operations.
6.07 Disposal groups may include assets that are outside the
scope of IFRS 5 (for example, investment property held at
fair value in accordance with IAS 40 or financial instruments
within the scope of IAS 39). IFRS 5 requires an entity to
measure such assets in accordance with the relevant standards
before measuring the disposal group as a whole at fair value
less cost to sell.
6.08 An entity should recognize impairment losses for any
write-downs of assets or disposal groups before or after clas-
sification as held for sale. An entity should first allocate
any impairment losses on disposal groups (cash generating
units) to any related goodwill, then to other assets on a pro
rata basis. An entity should recognize reversals of impair-
ment losses for increases in fair value less cost to sell that
may occur after classification as held for sale. However, re-
versals of impairment losses are limited to the cumulative
amount of impairment losses recognized either under IFRS
5 or previously under IAS 36. An entity should not reverse
impairment losses allocated to goodwill.
6.09 Normally, an entity should recognize gains or impair-
ment losses in the income statement (profit and loss) except
when they relate to an asset held under a revaluation model
(for example, in accordance with IAS 16, Property, Plant and
Equipment). Gains or losses recognized on revalued assets
are considered revaluations and an entity should recognize
such gains or losses in the appropriate other comprehensive
income account.
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6.10 A discontinued operation is a component of an entity,
defined as “operations and cash flows that can be clearly
distinguished both operationally and for financial reporting
purposes.” Consequently, IFRS 5 concludes from this defini-
tion that a discontinued operation is a single cash generating
unit or group of cash generating units. To be presented as a
discontinued operation, IFRS 5 also requires the component
to be a major line of business, geographical area of opera-
tions, or a subsidiary acquired solely with a view to resell
(that either is classified as held for sale or has already been
disposed of).
6.11 When an asset or disposal group no longer meets the
IFRS 5 criteria to be classified as held for sale or discontin-
ued operations, an entity should remove the assets or disposal
groups from this classification and measure them at the lower
of the carrying amount before reclassification, less the depre-
ciation and amortization that the entity would otherwise have
recorded, and recoverable amount on the date the decision
to sell was rescinded. An entity should recognize any adjust-
ments to carrying amounts in profit and loss from continuing
operations in the current year.
U.S. GAAP
6.12 For assets classified as held for sale or discontinued
operations, both IFRSs and FASB ASC 360 and 205-20 are
similar with respect to measurement, timing of classifica-
tion, and presentation within the financial statements. Al-
though IFRS 5 narrowed the differences substantially be-
tween IFRSs and FASB ASC with respect to assets held for
sale, some significant differences remain. Specifically, the
FASB ASC glossary defines a component of an entity as one
that comprises operations and cash flows that can be clearly
distinguished, operationally and for financial reporting pur-
poses, from the rest of the entity. A component of an entity
may be a reportable segment or an operating segment, a re-
porting unit, a subsidiary, or an asset group. Although this
definition is similar to the definition in IFRSs, entities may
apply the definitions differently. For example, IFRS 5 does
not prohibit classification as discontinued operations when
the entity retains a noncontrolling interest (for example, by an
equity method investment) (see paragraph 6.19). However,
for Securities and Exchange Commission (SEC) registrants,
SEC Codification of Staff Accounting Bulletins topic 5(Z)(4),
“Disposal of Operation With Significant Interest Retained,”
states that when the entity retains significant influence (equity
method investment), it should not account for the disposal as
a discontinued operation, only as a disposal of a group of
assets classified within continuing operations.
6.13 Similarly, because FASB ASC does not permit mea-
surement at fair value for assets that meet the definition of
an investment property under IFRSs and biological assets, all
items of PPE can be classified as held for sale or discontinued
operations and would be subject to the same impairment and
measurement requirements. FASB ASC 350-20-50-1 permits
an entity to include goodwill in a disposal group classified as
held for sale.
6.14 As noted previously, the definition of a component of
an entity in the FASB ASC glossary is essentially the same
as the definition in IFRS 5. However, FASB ASC 205-20-
45-1 contains the following additional criteria, not included
in IFRS 5, that an entity should meet before reporting a
component as a discontinued operation:
• The entity has or will eliminate the operations and cash
flows of the component from its continuing operations
as a result of the disposal transaction.
• The entity will not have any significant continuing in-
volvement in the operations of the component after the
disposal transaction.
As a result of these criteria, fewer components of a business
held for sale may qualify as discontinued operations under
FASB ASC 205-20.
6.15 The IFRS 5 convergence project does not address im-
pairment recognition and measurement and significant dif-
ferences remain. For example, under FASB ASC 350-20-35-
31, an entity recognizes impairment losses on assets within
disposal groups without first allocating these losses to any
allocated goodwill. An entity should test separately any good-
will allocated to the disposal group for impairment only after
recording impairment losses on individual assets.
Presentation
IFRSs
6.16 An entity should present assets classified as held for
sale separately from other assets as a single line item in the
statement of financial position. Similarly, the entity should
present any liabilities included in disposal groups separately
from other liabilities as a single line item. An entity should
not offset or show assets and liabilities as a single net asset
or liability. IFRS 5 also requires an entity to show separately
any cumulative income and expense recognized directly in
other comprehensive income in respect of assets and disposal
groups classified as held for sale.
6.17 Although further disaggregation is permitted, IFRS 5
requires presentation of a separate line item on the face of the
statement of comprehensive income consisting of the sum of
the following amounts:
• Posttax profit or loss of the discontinued operations
• Posttax gain or loss on measurement to fair value less
cost to sell, or
• Posttax gain or loss on disposal of the relevant assets
or disposal groups
6.18 Comparative information should reflect the new classi-
fication for assets or disposal groups classified as discontin-
ued operations, but not for those classified as held for sale.
6.19 IFRS 5 also requires an entity that is committed to a
sale plan involving loss of control of a subsidiary to clas-
sify all the assets and liabilities of that subsidiary as held for
sale when the relevant criteria are met, regardless of whether
the entity will retain a noncontrolling interest in the former
subsidiary after the sale. In these circumstances, the entity
should provide the same disclosures required for a discontin-
ued operation. This amendment is included in Improvements
to IFRSs, issued in May 2008 and effective for annual report-
ing periods beginning on or after 1 July 2009, and will apply
to most survey companies.
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U.S. GAAP
6.20 For those assets classified as held for sale or discon-
tinued operations under IFRSs or FASB ASC 360-10-45,
respectively, presentation requirements are essentially the
same, except that under FASB ASC 230-10-45-24, an en-
tity that chooses to report separately operating cash flows
of discontinued operations should do so consistently for all
periods affected, which may include periods long after sale
or liquidation of the operations. In addition, unlike IFRS 5,
FASB ASC 205-20-45-3 requires presentation of both pre-
and posttax income from discontinued operations on the face
of the income statement.
Disclosure
IFRSs
6.21 An entity may present the following disclosures either
on the face of the financial statements or in the notes:
• Major classes of assets and liabilities classified as held
for sale, unless the disposal group is a newly acquired
subsidiary classified as held for sale
• Disaggregation of the posttax profit or loss on discon-
tinued operations into the revenue, expenses, pretax
profit and loss, gains or losses on measurement to fair
value less cost to sell or on disposal, and related income
tax effects of these two items respectively
• Net cash flows attributable to operating, financing, and
investing activities of discontinued operations
• Amount of income from continuing operations and
from discontinued operations attributable to the equity
holders of the parent and the noncontrolling interest
When this information is provided in the notes, an entity
should disclose the caption of the relevant line item in the
financial statements.
6.22 When noncurrent assets or disposal groups are clas-
sified as held for sale or discontinued operations, IFRS 5
requires extensive narrative disclosures, including a descrip-
tion of the assets or disposal groups, facts and circumstances
leading to the sale, the sale itself, and the expected manner
and timing of disposal.
6.23 If applicable, an entity should disclose the reportable
segment in which the asset or disposal group was previously
reported and should also present the asset or disposal group
in accordance with IFRS 8, Operating Segments. A disposal
group classified as a discontinued operation often qualifies
as a separate reportable segment under IFRS 8. IFRS 8 also
requires the entity to disclose a reconciliation of the total
profit and loss of reportable segments to the entity’s profit
and loss before tax and discontinued operations.
U.S. GAAP
6.24 Although disclosure requirements are essentially con-
verged with IFRSs, several differences remain, including the
following:
• According to FASB ASC 230-10-45-24, separate pre-
sentation or disclosure of cash flows from discontinued
operations is not required.
• According to FASB ASC 205-20-50-2, an entity should
disclose the major classes of assets and liabilities clas-
sified as held for sale. Unlike IFRS 5, entities are not
exempt from this requirement for newly acquired sub-
sidiaries classified as held for sale.
TABLE 6-1: NONCURRENT ASSETS HELD FOR SALE
2010 2009 2008
Survey entities reporting assets classified as held
for sale .................................................................. 35 31 45
Survey entities reporting assets and associated
liabilities as held for sale....................................... 35 35 —
Total............................................................. 70 66 45
Survey entities not reporting assets classified as
held for sale........................................................... 100 94 55
Total................................................................ 170 160 100
TABLE 6-2: DISCONTINUED OPERATIONS
2010 2009
Survey entities reporting discontinued operations... 45 41
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Presentation and Disclosure Excerpts
Author’s Note
Excerpts from survey companies with annual reporting
periods beginning before 1 July 2009, may not reflect
the amendment to IFRS 5, described in paragraph 6.19,
issued in May 2008 in Improvements to IFRSs.
Noncurrent Assets Held for Sale
6.25
Lan Airlines S.A. (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION (in part)
2010 2009
Assets Note ThUS$ ThUS$
Current Assets
Cash and cash equivalents 6–7 631,052 731,497
Other financial assets 7–11 245,451 110,667
Other non-financial assets 12 18,820 17,128
Trade and other accounts receivable 7–8 481,350 423,739
Accounts receivable from related entities 7–9 50 38
Inventories 10 53,193 46,563
Tax assets 97,656 68,420
Total current assets other than non-current assets (or disposal groups) classified as held for sale 1,527,572 1,398,052
Non-current assets (or disposal groups) classified as held for sale 13 5,497 10,919
Total current assets 1,533,069 1,408,971
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2—Summary of Significant Accounting Policies
(in part)
The following describes the principal accounting policies
adopted in the preparation of these consolidated financial
statements.
2.22. Non-Current Assets (or Disposal Groups) Classified
as Held for Sale
Non-current assets (or disposal groups) are classified as as-
sets held for sale and are shown at the lesser of their book
value and the fair value less costs to sell.
Note 13—Non-Current Assets (or Disposal Groups)
Classified as Held for Sale
Non-current assets and disposal groups held for sale as of









Inventories on consignment 748 2,348
Aircraft 1,537 1,537
Scrapped aircraft 970 880
Rotables 38 551
Total 5,497 10,919
During the financial year 2010 sales were made of rotables,
inventories held on consignment and three engines, all of the
Boeing 737 fleet.
During the same period of 2009 sales were made of rota-
bles, inventories held on consignment, sale of an aircraft and
five engines, all of the Boeing 737 fleet.
The balances have been written down by ThUS$ 5,212
(ThUS$ 4,179 at December 31, 2009) to fair value less costs
to sell.
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The Company has no discontinued operations as of De-
cember 31, 2010.
Note 18—Property, Plant and Equipment (in part)
The movement in the different categories of property, plant












































Opening balance as of
January 01, 2010 264,259 35,538 81,966 3,231,682 15,043 23,659 951 50,286 493,172 4,196,556
Additions 10,229 — 115 571,422 9,516 2,341 420 2,410 6,673 603,126
Acquisitions through
business
combinations 1,006 490 137 335 107 480 2,555





for Sale — — — 2,552 — — — — — 2,552
Retirements — — — (6,633) (536) (2) (12) — (2,550) (9,733)




differences (62) — — (857) 16 (13) (3) — (27) (946)
Other increases
(decreases) 441,177 — (651) 100,470 (360) 4,680 6 8,221 (102,411) 451,132
Changes, total 451,344 — (1,845) 431,454 3,556 3,344 339 (6,166) (130,152) 751,874
Closing balance as of
December 31, 2010 715,603 35,538 80,121 3,663,136 18,599 27,003 1,290 44,120 363,020 4,948,430
Note 29—Gains (Losses) on the Sale of Non-Current
Assets Not Classified as Held for Sale
The gains (losses) on sales of non-current assets not classi-
fied as Held for Sale as of December 31, 2010 and 2009 are
as follows:







Property, plant and equipment 1,413 4,278 2,546
Investments in companies, associates and joint businesses — (2) 3,664
Total 1,413 4,276 6,210
The gain (loss) on sales of the period is presented in other
operating income, by function.
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Discontinued Operations, Withdrawal
of Business from Held for Sale and
Reclassification as Continuing Operations
6.26
Technicolor SA (Dec 2010)
9.1.1 CONSOLIDATED STATEMENTS OF
OPERATIONS (in part)
Year Ended December 31
(In € Millions) Note 2010 2009(1) 2008(1)
Continuing Operations
Revenues 3,574 3,619 4,192
Cost of sales (2,795) (2,804) (3,422)
Gross margin 779 815 770
Selling and administrative expenses (7) (397) (404) (482)
Research and development expenses (8) (148) (155) (171)
Restructuring costs (29) (41) (41) (166)
Net impairment losses on non-current operating assets (9) (183) (128) (700)
Other income (expense) (7) 28 12 (25)
Profit (loss) from continuing operations before tax and net finance costs 38 99 (774)
Interest income (10) 6 8 16
Interest expense (10) (145) (51) (89)
Gain on Technicolor’s debt restructuring on May 26, 2010 (10) 381 — —
Other financial income (expense) (10) (126) (25) (301)
Net finance costs 116 (68) (374)
Share of profit (loss) from associates (15) — — (4)
Income tax (11) 2 (35) (105)
Profit (loss) from continuing operations 156 (4) (1,257)
Discontinued Operations
Net loss from discontinued operations (12) (225) (338) (676)
Net income (loss) (69) (342) (1,933)
9.1.3 CONSOLIDATED STATEMENTS OF
FINANCIAL POSITION (in part)









Inventories (19) 153 97 270
Trade accounts and notes receivable (20) 666 555 968
Current accounts with associates and joint ventures 4 5 4
Derivative financial instruments (25) — 7 85
Income tax receivable 17 15 32
Other current assets (21) 318 316 485
Cash collateral and security deposits (22) 55 82 38
Cash and cash equivalents (22) 332 569 769
Assets classified as held for sale (12) 90 436 33
Total current assets 1,635 2,082 2,684
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Borrowings (26) 47 2,727 2,862
Derivative financial instruments (25) — 4 46
Retirement benefits obligations (28) 46 60 71
Restructuring provisions (29) 49 48 115
Other provisions (29) 69 68 102
Trade accounts and notes payable 528 435 968
Accrued employee expenses 158 128 155
Income tax payable 17 7 32
Other current liabilities (31) 374 345 548
Payables on acquisition of companies (32) — 2 1
Liabilities classified as held for sale (12) 103 257 22
Total current liabilities 1,391 4,081 4,922
Total liabilities 3,429 4,773 5,725
9.1.4 CONSOLIDATED STATEMENTS OF CASH
FLOWS (in part)
Year Ended December 31
(In € Millions) Note 2010 2009 2008
Net income (loss) (69) (342) (1,933)
Loss from discontinued operations (225) (338) (676)
Profit (loss) from continuing operations 156 (4) (1,257)
Net operating cash generated from/(used in) continuing activities 120 195 (143)
Net operating cash used in discontinued operations (12.4) (55) (97) (175)
Net cash from/(used in) operating activities (I) 65 98 (318)
Net investing cash generated/(used) in continuing activities (99) (194) (280)
Net investing cash generated from/(used in) discontinued operations (12.4) (5) (34) (71)
Net cash used in investing activities (II) (104) (228) (351)
Net financing cash generated from/(used in) continuing activities (207) (74) 878
Net financing cash used in discontinued operations (12.4) (2) (1) (8)
Net cash provided by/(used) in financing activities (III) (209) (75) 870
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2. Summary of Significant Accounting Policies
(in part)
2.19 Assets Held for Sale and Discontinued Operations
(a) Assets Held for Sale
A non-current asset (or disposal group) is classified as held
for sale when its carrying amount will be recovered principally
through a sale transaction rather than through continuing use.
This means the asset (or disposal group) is available for im-
mediate sale and its sale is highly probable. A non-current
asset (or disposal group) classified as held for sale is mea-
sured at the lower of its fair value less costs to sell and its
carrying amount. Any impairment loss for write-down of the
asset (or disposal group) to fair value less costs to sell is
recognized in the statement of operations.
(b) Discontinued Operations
A discontinued operation is a component of the Group that
either has been disposed of (by sale or otherwise) or is held
for sale. To be disclosed as discontinued, the operation must
have been stopped or be classified as “asset held for sale.”
The component discontinued is clearly distinguishable oper-
ationally and for reporting purposes. It represents a separate
major line of business (or geographical area of business),
is part of a single major plan of disposal or is a subsidiary
acquired exclusively for resale.
The profit (loss) from discontinued operations is presented
as a separate line item on the face of the statement of op-
erations with a detailed analysis provided in note 12. The
statement of operations data for all prior periods presented
are reclassified to present the results of operations meeting
the criteria of IFRS 5 as discontinued operations (see note 4
for details on this reclassification). In the statement of cash
flows, the amounts related to discontinued operations are
disclosed separately and detailed in note 12.
When a non current asset or disposal group no longer met
the held-for-sale criteria, the asset or disposal group ceases
to be classified as held for sale.
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It is then measured at the lower of:
• its carrying value before the asset (or disposal group)
was classified as held for sale, adjusted for any depre-
ciation, amortization that would have been recognized
had the asset (or disposal group) not been classified as
held for sale; and
• its recoverable amount at the date of the subsequent
decision not to sell. Recoverable value is the higher of
fair value less costs to sell and value in use.
Any adjustment to the carrying amount is included in profit and
loss from continuing operations in which the assets ceased
to be classified as held for sale.
Note 3. Critical Accounting Estimates and Judgments
(in part)
3.4 Valuation of Businesses Held for Sale
Businesses held for sale should be recorded at the lower of
their carrying amount and fair value less costs to sell. Esti-
mating fair value less costs to sell requires management to
make material judgments and estimates.
Technicolor’s management believes its policies relating to
such valuation are critical accounting policies involving critical
accounting estimates because determining the fair value less
costs to sell requires (1) determining the most probable selling
price of the held for sale businesses based on all available
facts and circumstances and (2) estimating the outcomes of
ongoing negotiations with potential buyers.
In 2010 the Group reviewed the value of its held for sale
businesses. This review led to an impairment of €17 million,
impacting discontinued businesses (see notes 12.3 and 14),
reflecting management’s best estimates.
Note 4. Reconciliation with Consolidated Financial
Statements Released as of December 31, 2009
According to IFRS 5, the statement of operations for the com-
parative period has to be restated in order to reflect the effect
of the scope of discontinued operations defined as of Decem-
ber 31, 2010.
For the year 2010, there has been no change in discontin-
ued perimeter compared to 2009 with the exception of PRN.
For PRN Technicolor has decided to end the disposal pro-
cess. Accordingly, PRN which was classified as a discon-
tinued activity in 2009, has been reclassified into continued
activity and withdrawn from Assets Held for Sale classifica-
tion.
Accordingly the consolidated statement of operations of
2008 and 2009 has been restated with this reclassification
in continuing operations. In compliance with IFRS 5, the cu-
mulative impact of adjusting the carrying value of non-current
assets has been recognized entirely in 2010 (mainly for the
depreciation for the year 2009 which was not recognized un-
der IFRS 5).
For the year 2009, Grass Valley, Convergent, Screenvision
and PRN were part of the divestment process announced on
January 28, 2009 in the framework of the new strategy of the
group. Grass Valley supplied content creators with produc-
tion facilities and distributors with video-focused systems and
equipments. PRN, Convergent and Screenvision, provided
networks services to retailers, cinema exhibitors and other en-
terprises that provided their customers/audiences with video
content.
The column “IFRS 5” below represents the statement of op-
erations of PRN which is no more in discontinued operations
compared to the one published in December 31, 2009.










Revenues 3,529 90 3,619
Cost of sales (2,747) (57) (2,804)
Gross margin 782 33 815
Selling and administrative expenses (382) (22) (404)
Research and development expenses (153) (2) (155)
Restructuring costs (41) — (41)
Net impairment losses on non-current operating assets (80) (48) (128)
Other income (expense) 10 2 12
Profit from continuing operations before tax and net finance costs 136 (37) 99
Finance costs—net (68) — (68)
Share of income (loss) from associates — — —
Income tax (35) — (35)
Profit (loss) from continuing operations 33 (37) (4)
Discontinued Operations
Profit (loss) from discontinued operations—net (375) 37 (338)
Net income (loss) (342) — (342)
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Revenues 4,099 93 4,192
Cost of sales (3,355) (67) (3,422)
Gross margin 744 26 770
Selling and administrative expenses (459) (23) (482)
Research and development expenses (169) (2) (171)
Restructuring costs (166) — (166)
Net impairment losses on non-current operating assets (666) (34) (700)
Other income (expense) (25) — (25)
Profit from continuing operations before tax and net finance costs (741) (33) (774)
Finance costs—net (376) 2 (374)
Share of income (loss) from associates (4) — (4)
Income Tax (104) (1) (105)
Profit (loss) from continuing operations (1,225) (32) (1,257)
Discontinued Operations
Profit (loss) from discontinued operations—net (708) 32 (676)
Net Income (Loss) (1,933) — (1,933)
4.3 Reconciliation for December 31, 2009 and 2008
Statements of Cash Flows
The main variations in the statement of cash flows due to the
changes in the scope of discontinued operations compared
to December 31, 2009 are the following:
Year Ended
December 31
(In € Millions) 2009 2008
Loss from discontinued operations (37) (32)
Profit from continuing operations 37 32
Net operating cash generated from continuing activities (16) (15)
Net operating cash used in discontinued operations 16 15
Net cash from operating activities — —
Net investing cash generated from continuing activities 1 7
Net investing cash generated used in discontinued
operations (1) (7)
Net cash used in investing activities — —
Net financing cash generated from continuing activities — —
Net financing cash (used in)/generated from
discontinued operations — —
Net cash (used in)/provided by financing activities — —
4.4 Assets and Liabilities Held for Sale Related
to PRN Activity
As from the December 2010 closing, PRN activity has been
reclassified into continued activity and withdrawn from Assets
Held for Sale classification. The details of PRN assets and
liabilities reclassified into held for sale in the 2009 publication




Goodwill and intangible assets 38
Property, plant and equipment 17
Other assets 5
Inventories —
Accounts receivable and other receivables 16
Total—assets classified as held for sale 76
Provisions 2
Pension provisions —
Accounts payable and other liabilities 28
Total—liabilities directly associated with assets
classified as held for sale 30
Note 5. Significant Changes in the Scope
of Consolidation
For the years ended December 31, 2010, 2009 and 2008,
Technicolor’s consolidated balance sheets and statements
of operations include the accounts of all investments in sub-
sidiaries, jointly controlled entities and associates (the main
ones being listed in note 40). The following is a summary
of the number of companies consolidated and accounted for
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under the full consolidation method, the equity method and
the proportionate consolidation method.
As of December 31
2010 2009 2008
Europe(∗) France US Others Europe(∗) France US Others Europe(∗) France US Others
Number of Companies:
Parent company and
consolidated subsidiaries 49 19 21 42 56 24 24 44 65 25 29 53
Companies consolidated under
the proportionate method 6 2 2 5 6 3 3 3 11 3 2 4
Companies accounted for
under the equity method — 1 1 — — 4 2 1 — 4 2 1
Sub-total by region 55 22 24 47 62 31 29 48 76 32 33 58
Total 148 170 199
(∗) Except France.
5.1 Changes In 2010
Main Disposals
• On October 14, 2010, Technicolor closed a transac-
tion under which it sold the majority of its 50% interest
in Technicolor Cinema Advertising, LLC (“Screenvision
US”) to a newly formed holding company, SV Holdco,
LLC (“SV Holdco”), an affiliate of Shamrock Capital-
Growth Fund II, a leading private equity fund focused
on media, entertainment and communication. The sale
price for the shares was $60 million (€43 million at Octo-
ber 14, 2010 rate), of which $55 million (€39 million) was
paid in cash and $5 million (€4 million) was placed in
escrow to satisfy post closing indemnity claims against
Technicolor, if any. As part of the transaction, Techni-
color also exchanged its remaining interest in Screenvi-
sion US for a minority interest in SV Holdco represented
by Class A Common Units. Simultaneously at closing,
Carmike Cinemas, Inc acquired Class C Common Units
in SV Holdco representing 20% of the voting rights and
20% of profit and loss of SV Holdco, LLC, in exchange
for entering into a Theater Agreement with Screenvision
US. Technicolor’s Class A Common Units represented
an 18.8% interest in SV Holdco.
Under the terms of the transaction, Technicolor will
no longer have joint control of Screenvision US, but
will retain one seat on the Board of SV Holdco and will
continue to be Screenvision US’s provider of both film
and digital services. Accordingly, Technicolor will have
a significant influence and will account for the stake in
Screenvision US under the equity method.
In accordance with IAS 31 paragraph 45, the residual
interest has been accounted for at fair value (€9.1 mil-
lion) after discount for lack of marketability and lack of
control. The net loss recognized in net loss from discon-
tinued operations on the disposal date was €16 million.
The portion of that result attributable to recognizing the
investment retained in the former subsidiary at its fair
value when joint control was lost is €4 million. Techni-
color applied the $60 million proceeds towards repay-
ment of the DPN (see note 1.2).
• On July 26, 2010 Technicolor received a binding offer
from Francisco Partners for the acquisition of the Grass
Valley Broadcast business. This disposal process con-
tributes to the strategic refocus around its content cre-
ators and network service providers customer base, ini-
tiated by the Group in 2009. The transaction was closed
on December 31, 2010.
The transaction with Francisco Partners comprised
the following:
— U.S.$80 million promissory note (€60 million at the
transaction date) issued to Technicolor with a six-
year maturity and bearing a capitalized interest of 5%
per year. The amount of the note represents the value
of the business minus the present value of retirement
liabilities transferred;
— the transfer by Technicolor of a net amount of €27
million of cash required for the ongoing management
of the activity;
— the right for Technicolor to receive additional con-
sideration from the buyer based on the potential fu-
ture remuneration of the new owners of the disposed
entity.
Based on the book value of the assets, the Group reg-
istered a loss for this disposal in its 2010 consolidated
financial statements of €97 million. Given the structure
of the deal, Technicolor did not receive cash proceeds
from this disposal to be applied to its DPN issued in May
2010.
• On January 27, 2010, Technicolor entered into an
agreement with Sony Electronics Inc. for the sale of
Convergent Media System Corporation, specialized in
digital signage and content distribution systems. Con-
vergent lies outside the scope of Technicolor’s strategic
focus on content creators. The terms of this transac-
tion are financially non-material to Technicolor. The im-
pact of the disposal on the Group consolidated financial
statements is a loss of €7 million at the date of transac-
tion (the sale price amounts to €4.6 million at the date
of transaction) recognized in net loss from discontinued
operations. Technicolor applied the cash proceeds to-
wards redemption of the DPN issued on May 26, 2010
(see note 1.2).
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5.2 Changes in 2009
Main Acquisitions and Business Combinations
• In December 2009, the Group acquired the 37% of re-
maining interests in Technicolor India Pvte Ltd (formerly
Paprikaas) for an amount of U.S.$7 million (equivalent
to €5 million at the date of transaction). Technicolor In-
dia Pvte Ltd (formerly Paprikaas) is consolidated in the
Entertainment Services segment. The main impact of
this additional shares’ acquisition was an increase in
goodwill amounting to €3 million.
Main Disposals
• In July 2009, Technicolor sold its Software Technology
Solutions (STS) business to Civolution B.V. The impact
on the Group consolidated financial statements was a
loss of €4 million.
• In December 2009, Technicolor sold its CNS business
to Verdoso. As part of the agreement, Technicolor has
an obligation towards this entity up to a maximum of
€2 million (€0.4 million at December 31, 2010). This
obligation has been recorded in Technicolor 2009 con-
solidated financial statements. The total impact of the
disposal on the Group consolidated financial statements
is a loss of €7 million (of which €2 million impacts re-
structuring costs).
Note 9. Impairment Losses on Non-Current Operating
Assets






Impairment losses on goodwill(1) — (103) (58) — (161)
Impairment losses on customer relationships(1) — — (15) — (15)
Impairment losses on tangible assets(2) — (5) (30) — (35)
Impairment losses on non-current operating assets — (108) (103) — (211)
Reversal of impairment losses on customer relationships — — 25 — 25
Reversal of impairment losses on contracts and up-front prepaid discount — — 3 — 3
Net impairment losses on non-current operating assets — (108) (75) — (183)
2009
Impairment losses on goodwill(1) — — (48) — (48)
Impairment losses on customer relationships(1) — — (18) — (18)
Impairment losses on patents and trademarks(1) (12) — — — (12)
Impairment losses on other intangible assets(1) — (8) — — (8)
Impairment losses on tangible assets(2) — (1) (13) — (14)
Impairment losses on contracts and up-front prepaid discount — — (44) — (44)
Impairment losses on non-current operating assets (12) (9) (123) — (144)
Reversal of impairment losses on patents and trademarks(1) — 1 5 — 6
Reversal of impairment losses on customer relationships(1) — — 10 — 10
Net impairment losses on non-current operating assets (12) (8) (108) — (128)
Impairment losses on activities classified under discontinued operations (230)
Net Impairment losses on non-current operating assets (total group) (358)
2008
Impairment losses on goodwill(1) (15) (94) (286) — (395)
Impairment losses on customer relationships(1) — (24) (119) — (143)
Impairment losses on patents and trademarks(1) (8) — (6) — (14)
Impairment losses on other intangible assets(1) (4) — (7) (1) (12)
Impairment losses on tangible assets(2) — (56) (70) (1) (127)
Impairment losses on contracts and up-front prepaid discount — — (9) — (9)
Impairment Losses on non-current operating assets (27) (174) (497) (2) (700)
Impairment losses on activities classified under discontinued operations — — — — (406)
Impairment losses on non-current operating assets (total group) — — — — (1,106)
(1) For details, see note 14 on Goodwill and intangible assets. For the year 2009, the €48 million impairment relates to PRN which has been
reclassified in continuing operations in 2010 and presented into continuing operations for prior year periods.
(2) For details, see note 13 on Property, Plant and Equipment.
(3) Additional €1 million on tangible assets have been written-off in 2010 in the frame of a restructuring plan, apart from impairment process.
Total impairment of assets amounts therefore to €184 million.
(4) Additional €17 million impairment was booked on current assets in the discontinued perimeter.
(∗) As of June 1, 2010, the Digital Content Delivery Services (previously part of the Entertainment Services segment) and the Connect activities
were integrated into a new segment called Digital Delivery.
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Note 12. Discontinued Operations
12.1 Scope of the Discontinued Operations
Operations Included in Discontinued Operations in 2010
For the year 2010, there has been no change in discontinued
perimeter compared to 2009 with the exception of the PRN
business.
Operations within the discontinued perimeter in 2010 are:
• Disposal of Convergent: On January 27, 2010, Techni-
color entered into an agreement with Sony Electronics
Inc. for the sale of Convergent Corporation, specialized
in digital signal and content distribution systems.
• Disposal of Screenvision US: On October 14, 2010,
Technicolor sold the majority of its 50% interest in Tech-
nicolor Cinema Advertising, LLC (“Screenvision US”) to
a newly formed holding company, SV Holdco, LLC (“SV
Holdco”), an affiliate of Shamrock Capital Growth Fund
II (see note 5 for more details).
• Disposal of Grass Valley businesses: On December 31,
2010 Technicolor sold its Grass Valley Broadcast busi-
ness to Francisco Partners. The remaining Grass Valley
businesses (Transmission and Head-end) are expected
to be sold in the course of the first semester 2011 (see
note 39).
• Regarding the disposal of PRN, the offers received from
potential buyers of this business did not provide satis-
factory conditions for the Group. Taking into consid-
eration a number of factors, including PRN’s business
achievements in 2010, the improvement in the adver-
tising market in general, and the place based media
market specifically, as seen over the past quarters, the
Group believes greater value can be created by devel-
oping the PRN business. As a consequence, the Group
has decided to end the disposal process for PRN, which
will be consolidated as part of its Entertainment Services
segment within continuing operations going forward.
Operations Discontinued in 2009 and Before 2009
• On January 28, 2009, Technicolor announced its de-
cision to exit the Grass Valley and former Media Net-
works (MN) businesses made of Convergent, Screenvi-
sion and PRN. Grass Valley supplies content creators,
production facilities and distributors with video-focused
systems and equipment. MN includes PRN, Conver-
gent and Screenvision and provides network services
to retailers and cinema exhibitors and other enterprises
that provide their customers/audiences with video con-
tent. These businesses were classified as discontinued
operations in these consolidated financial statements
since the IFRS 5 criteria were met at the beginning of
the second quarter of 2009.
• In the first half of 2008, the Board decided to discontinue
the Silicon Solutions business (named Thomson Silicon
Solutions “TSS”). This business included the Group’s
remote control activity which was ceased in the course
of the first half of 2008, the tuner activity which was sold
on September 1, 2008 to a joint venture, NuTune, over
which Technicolor has no control and holds a participa-
tion of 45%, and the integrated circuits design and sales
activity, which was ceased as of June 30, 2008.
• In 2005 Technicolor decided to sell its audio-video, ac-
cessories and consumer marketing and sales activities
(referred to as “AVA business” hereafter). Pursuant to
the disposals which occurred in 2007 and 2008, the
Group has completely exited the AVA business.
12.2 Results of Discontinued Operations
As of December 31, 2010, the results of these discontinued
operations are as follows:












Revenues — 426 68 494
Cost of sales 3 (284) (46) (327)
Gross margin 3 142 22 167
Expenses other than impairment of assets(1) (5) (319) (42) (366)
Profit (loss) from operations before tax and finance cost and before
impairment (2) (177) (20) (199)
Net interest expense — — — —
Other financial expense (1) (3) — (4)
Income tax (1) (2) (2) (5)
Profit (loss) for the year from discontinued operations before
impairment (4) (182) (22) (208)
Loss on impairment of businesses held for sale(2) (17)
Profit (loss) for the year from discontinued operations (225)
(∗) Corresponds mainly to the AVA business.
(1) Includes restructuring costs for €53 million, a net curtailment gain on pension plans for €4 million and net capital losses on the disposal of
Convergent, Screenvision US and Grass Valley activities for €120 million.
(2) Corresponds to an impairment loss to adjust the held for sale businesses at their fair value less costs to sell. See note 12.3 below.
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Revenues 3 376 101 480
Cost of sales 6 (274) (73) (341)
Gross margin 9 102 28 139
Expenses other than impairment of assets (5) (189) (27) (221)
Profit (loss) from operations before tax and finance cost and before
impairment 4 (87) 1 (82)
Net interest expense(1) (4) (21) (1) (26)
Other financial expense 3 1 1 5
Income tax 1 (2) (4) (5)
Profit (loss) for the year from discontinued operations before impairment 4 (109) (3) (108)
Loss on impairment of businesses held for sale(2) — — — (230)
Profit (loss) for the year from discontinued operations — — — (338)
(∗) Corresponds mainly to the AVA business.
(1) Consists of interest expense of €27 million and interest income of €1 million for the year ended December 31, 2009.
(2) Corresponds to an impairment loss to adjust the held for sale businesses at their fair value less costs to sell. See note 12.3 below.













Revenues 63 531 117 711
Cost of sales (46) (388) (94) (528)
Gross margin 17 143 23 183
Expenses other than impairment of assets (118) (248) (36) (402)
Loss from operations before tax and finance cost and before impairment (101) (105) (13) (219)
Net interest expense(2) (2) (16) (1) (19)
Other financial expense (2) (4) — (6)
Income tax — (2) — (2)
Profit (loss) for the year from discontinued operations
before impairment (105) (127) (14) (246)
Loss on impairment of assets (including impairment losses against assets
in the frame of restructuring plans)(1) — — — (430)
Profit (loss) for the year from discontinued operations — — — (676)
(1) 2008 loss from discontinued operations was impacted by a €430 million loss on impairment of assets, related mainly to:
The goodwill in relation to Grass Valley that was impaired by €329 million. This impairment was triggered by the following facts and
circumstances:
• due to the economic crisis, during the second half of 2008, revenues from the Grass Valley business had been strongly impacted by
reduction in the capital expenditure of some key customers. The uncertainties regarding spending in 2009 has led the company to revise
downwards mid-term assumptions about the results of this business;
• significant delay in new key products introduction with significant impact on sales and margin opportunity.
The goodwill and intangible assets in relation to Media Network businesses that were impaired by €27 million.
The impairment of TSS assets in the frame of a restructuring plan.
(2) Consists of interest expense of €20 million less interest income of €1 million for the year ended December 31, 2008.
12.3 Losses on Impairment of Held for Sale Businesses
IFRS 5.15 requires that a disposal group classified as held
for sale be measured at the lower of its carrying amount and
fair value less costs to sell.
Based on the latest information available to the Group re-
garding the potential selling prices of the held for sale busi-
nesses and on the non-current assets carrying values of such
businesses as of December 31, 2010 the Group recognized
an impairment loss of €17 million for the discontinued busi-
nesses.
As of December 31, 2009 the Group recognized an im-
pairment loss of €230 million that impacted goodwill for
€90 million, and intangible and tangible assets for respec-
tively €102 million and €38 million.
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12.4 Net Cash Used in Discontinued Operations
Year Ended December 31
(In € Millions) 2010 2009 2008
Loss from discontinued operations (225) (338) (676)
Summary adjustments to reconcile loss from discontinued operations to cash
used in discontinued operations
Depreciation and Amortization 1 16 78
Impairment of assets 17 230 429
Net changes in provisions 17 (27) 7
(Profit)/loss on asset sales(1) 120 (3) 20
Interest expense — 26 19
Other non cash items (including tax) 3 6 7
Changes in working capital and other assets and liabilities 11 21 (31)
Cash generated used in discontinued operations (56) (69) (147)
Net interest paid 1 (25) (19)
Income tax received/paid — (3) (9)
Net operating cash used in discontinued operations (I) (55) (97) (175)
Acquisition of subsidiaries, associates and investments, net of cash acquired — (2) (7)
Net cash impact from sale of investments 3 (2) (24)
Purchases of property, plant and equipment (PPE) — (6) (15)
Proceeds from sale of PPE — 1 4
Purchases of intangible assets including capitalization of development costs — (6) (30)
Cash collateral and security deposits granted to third parties (13) (19) 1
Cash collateral and security deposits reimbursed by third parties 5 — —
Net investing cash used in discontinued operations (II) (5) (34) (71)
Repayments of borrowings (2) (1) (8)
Net financing cash used in discontinued operations (III) (2) (1) (8)
Net decrease in cash and cash equivalents (I + II + III) (62) (132) (254)
(1) Corresponds to the capital loss on the disposal of Convergent for €7 million, Screenvision US for €16 million and Grass Valley activities for
€97 million.
12.5 Assets and Liabilities Held for Sale
The assets and liabilities attributable to the operations dis-
continued and not yet sold as of December 31, 2010 and
December 31, 2009 have been classified as held for sale in
the Group consolidated balance sheets and presented sepa-
rately from other assets.
As of December 31, 2010 two main businesses are classi-
fied as held for sale: Grass Valley (Transmission and Head-
end) and MN (Screenvision Europe).
The major classes of assets and liabilities comprising the








Goodwill and intangible assets — 72 4
Property, plant and equipment — 31 2
Other assets 25 65 13
Inventories 23 93 1
Accounts receivable and other receivables 42 175 13
Total—assets classified as held for sale 90 436 33
Provisions 29 20 4
Pension provisions 8 40 —
Accounts payable and other liabilities 66 197 18
Total—liabilities directly associated with assets classified as held for sale 103 257 22
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Note 16. Interest in Joint Ventures
As Screenvision US has been sold in the course of 2010,
the remaining main interests of the Group in jointly controlled
entities for 2010 closing are Screenvision Europe and Con-
tentguard. For the 2010, 2009 and 2008 periods, Screenvi-
sion Europe and Screenvision US activities are discontinued
activities.
The joint ventures’ contribution to the Group’s balance
sheet and statement of operations items is summarized
below:
Year Ended December 31
(In € Millions) 2010 2009 2008
Balance Sheet
Total current assets 38 117 70
Total non-current assets 32 24 83
Total current liabilities 34 68 76
Total non-current liabilities 6 15 21
Statement of Operations
Revenues 17 9 24
Expenses(1) (23) (64) (54)
Contribution to the group’s income for the period (6) (55) (30)
(1) In 2010, includes for €3 million the net loss from joint ventures classified in discontinued operations.
In 2009, includes for €56 million the net loss from joint ventures classified in discontinued operations, including €59 million of impairment of
non-current operating assets.
In 2008, includes for €34 million the net loss from joint ventures classified in discontinued operations.










Opening provisions 64 132 100
Current year expense(1) 55 60 266
Release of provision(1) (11) (27) (11)
Usage during the period (54) (100) (124)
Currency translation adjustment 2 1 —
Change in held for sale provision 1 (3) —
Other movements(2) (1) 1 (99)
Closing Provisions 56 64 132
Of which current 49 48 115
Of which non-current 7 16 17








Profit (loss) from continuing operations
Termination costs (40) (37) (105)
Impairment of assets (part of a restructuring plan)(2) (1) (2) (45)
Other costs related to disposal of activities(2) — (2) (16)
Continuing restructuring expenses (41) (41) (166)
Profit (loss) from discontinued operations(2)(3) (53) 8 (89)
Total restructuring expenses (94) (33) (255)
(2) These restructuring costs are reclassified in the balance sheet against assets prior to disposals and appeared therefore in the line “other
movements” within the restructuring provision variation. The related reclassification for discontinued operations amounts to 0, 0 and
€40 million for years ended December 31, 2010, 2009 and 2008, respectively.
(3) Restructuring costs related to activities discontinued and classified as held for sale since December 2009 closing represent €50 million.
These are not presented in the variation of restructuring provision.
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Note 35. Acquisitions, Disposals and Other Cash
Operations Impacting the Consolidated Statements
of Cash Flows (in part)








Disposals on Continuing Activities
Videocon 40 28 8
Other disposal and cash of companies disposed of (3) (5) (3)
Net cash impact in continuing activities 37 23 5
Disposals of Discontinued Activities
Grass Valley activities(1) (32) — —
Screenvision US 43 — —
Convergent Media System Corporation 5 — —
Other disposal and cash of companies disposed of (13) (2) (24)
Net cash impact of discontinued activities 3 (2) (24)
Total cash impact of disposals 40 21 (19)
(1) Cash out on disposal of Grass Valley activities of which €5 million will be cash back in 2011.
Spinoff, Discontinued Operations, Assets
and Associated Liabilities Classified as Held
for Sale
6.27
Homburg Invest Inc. (Dec)
Author’s Note
As explained in its Management’s Discussion and
Analysis, in December 2009, Homburg Invest Inc.
“outlined a strategy to spin off assets into four geo-
graphically based companies and a development com-
pany . . . On May 25, 2010, [Homburg] completed
the first step in accomplishing this strategy by sell-
ing its portfolio of Canadian income producing in-
vestment properties to Homburg Canada Real Estate
Investment Trust (“HCREIT”) . . . The investment in
HCREIT, in which [Homburg] retained a 33.7% eq-
uity interest as of December 31, 2010, is now valued at
more than the market capitalization of Homburg Invest
itself.”
CONSOLIDATED BALANCE SHEET (in part)







Cash and cash equivalents 13,617 32,569
Properties under development for resale 9 36,932 73,957
Receivables and other 5 36,025 49,639
86,574 156,165




Accounts payable and other liabilities 11 102,783 195,891
Income taxes payable 15 8,243 13,760
Construction financing 13 40,231 94,999
Current portion of long term debt 14 185,168 624,284
Provisions 12 16,922 16,965
353,347 945,899
Liabilities associated with assets classified
as held for sale 16 91,989 43,358
445,336 989,257
Total liabilities 1,961,205 3,092,178
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CONSOLIDATED STATEMENT OF LOSS (in part)
Year Ended December 31
(CAD $ Thousands Except Per Share Amounts) Note 2010 2009
Net income (loss) from continuing operations 18,323 (361,877)
Net loss from discontinued operations after tax 16 (106,377) (87,385)
Net loss $ (88,054) $(449,262)
CONSOLIDATED STATEMENT OF CASH FLOWS
Year Ended December 31
(CAD $ Thousands Except Per Share Amounts) Note 2010 2009
Cash obtained from (used in)
Operating Activities
Net income (loss) from continuing operations $ 18,323 $ (361,877)
Items not affecting cash:
Gain on sale of subsidiary (107,164)
Gain on sale of investments (3,600) (2,239)
Fair market value changes on:
investment properties 31,112 312,227
development properties 16,777 48,707
Impairment loss on properties under development 7,811 27,779
Change in provisions 12 (5,161) 34,089
Loss on derivative instruments 677 7,486
Distribution income from associate 8,188
Amortization of financing fees 4,703 3,920
Loss from associate 12,628
Deferred rental income (4,849) (6,722)
Deferred income taxes 42,794 (79,106)
Stock based compensation 88 146
Fair value change in financial assets (88) 1,187
Accretion of discounted liabilities 1,453
Foreign exchange gain (20,147) (24,201)
2,092 (37,151)
Change in non-cash working capital and other 20 (22,354) 91,311
Net cash (used in) from continuing operations (20,262) 54,160
Net cash from discontinued operations 16 3,744 3,522
Net cash (used in) from operating activities (16,518) 57,682
Investing Activities
Investment in investment properties (1,908) (1,951)
Decrease in restricted cash 639 2,576
Proceeds on sale of investments 10,340 13,946
Purchase of long term investments (1,079)
Investment in development properties (44,644) (42,618)
Discontinued operations 16 103,332 (24,969)
Net cash used in investing activities 66,680 (53,016)
Financing Activities
Decrease in demand loans (41,648) (10,468)
Increase (decrease) in mortgages payable 1,307 (23,373)
Proceeds (repayment) from bonds (51,429) 11,043
Increase (decrease) in related party receivable 10,220 (10,220)
Increase (decrease) in deferred financing charges 2,499 (2,318)
Repurchase of common shares and issue costs (419) (1,346)
Decrease in related party payable (3,556) (14,180)
Increase (decrease) in construction financing 3,925 (7,434)
Homburg Capital Securities A proceeds 17d 4,598 37,116
Discontinued operations 16 5,389 32,724
Net cash from financing activities (69,114) 11,544
Increase (decrease) in cash (18,952) 16,210
Cash, beginning of year 32,569 16,359
Cash, end of year $ 13,617 $ 32,569
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
16. Discontinued Operations
During 2009, the Company outlined a strategy to spin off as-
sets into four geographically based companies and a devel-
opment company. On May 25, 2010 the Company completed
the first step in accomplishing this strategy by selling its port-
folio of Canadian income producing investment properties to
HCREIT for cash proceeds of $114,511, units in HCREIT
at a fair value of $143,139 plus a bargain purchase gain of
$69,380 resulting in a pre-tax loss of $150,962. The following
represents the income statement amounts associated with
the sale plus certain other Canadian investment properties




Property revenue $ 57,773 $147,203
Property operating expenses 30,072 67,246
Gross income from operations 27,701 79,957
Other income 700 93
Interest expense (13,000) (36,356)
General and administrative (3,526) (9,846)
Fair value adjustment on investment
properties 17,241 (132,734)
Loss on sale of assets (775) (6,739)
Net income (loss) from discontinued
operations before income taxes 28,341 (105,625)
Current income tax recovery (1,788)
Deferred income tax expense (recovery) 7,477 (16,452)
20,864 (87,385)
Loss on disposal of discontinued operations (158,943) —
Deferred tax recovery (31,702) —
Net loss from discontinued operations after tax $(106,377) $(87,385)
The assets held for sale include an investment property in
Canada and 9 Limited Partnerships in the United States
2010 2009
Assets and Liabilities Held for Sale
Investment properties $139,434 $ 66,365
Restricted cash 485 5,324
Cash 2,067
Deferred income tax asset 1,565
Receivable and others 696 1,268
$144,247 $ 72,957
Long term debt $ 90,431 $ 21,030
Deferred income tax liabilities 6,618
Income taxes payable 14,552
Accounts payable 1,558 1,158
$ 91,989 $ 43,358
Statement of Cash Flows
Operating activities $ 3,744 $ 3,522
Investing activities $103,332 $(24,969)
Financing activities $ 5,389 $ 32,724
Included in other comprehensive income is a loss in an
amount of $2,389 relating to the foreign assets held for sale.
29. Subsequent Events (in part)
(a) Subsequent to year end, the Company secured a $10
million operating line secured by units in HCREIT.
(b) Subsequent to year end HCREIT completed a public
offering of Units on a bought deal basis.The HCREIT
issued 8,597,500 units, including 1,447,500 units is-
sued through the exercise of the full over allotment
option by the underwriters. Concurrent with the issue
of 8,597,500 units by the REIT, the Company also sold
2,500,000 units for gross proceeds of $28.5 million.
The issue by the HCREIT, and the sale by the Com-
pany will reduce the voting interest of the Company
from 33.7% to approximately 23.1% which will result
in a loss of approximately $11,500. The net proceeds
will be utilized to repay the $10 million outlined in Note
a) above, and for general corporate purposes.
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SECTION 7: OPERATING SEGMENTS∗
IFRS 8, OPERATING SEGMENTS
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
In April 2009, the International Accounting Stan-
dards Board (IASB) issued Improvements to IFRSs,
which revised International Financial Reporting Stan-
dard (IFRS) 8, Operating Segments, by clarifying that
IFRS 8 requires an entity to disclose a measure of seg-
ment assets only if that amount is reviewed by the chief
operating decision maker (CODM). This clarification
also removed an unintended difference with U.S. gen-
erally accepted accounting principles (GAAP). This
amendment is effective for annual reporting periods
beginning on or after 1 July 2009, with early applica-
tion permitted.
In November 2009, the IASB issued a revised IAS
24, Related Party Disclosures, which further revised
IFRS 8. This amendment clarifies that an entity uses
judgment to assess whether it should consider a gov-
ernment, including governmental agencies and sim-
ilar bodies, whether local, national, or international,
and other entities known by the reporting entity to be
under the control of that government to be a single
customer. In making this assessment, the reporting en-
tity should consider the extent of economic integration
among these entities. This amendment is effective for
annual reporting periods beginning on or after 1 Jan-
uary 2011; however, if the reporting entity applies the
revised IAS 24 in an earlier period, as permitted, it
should also apply this amendment to IFRS 8.
Not all survey entities will have applied these two
amendments. An author’s note indicating whether the
survey company has applied either or both of these
amendments will be provided with the excerpts.
7.01 IFRS 8 establishes requirements for disclosures about
an entity’s operating segments, its products and services, the
geographic areas where it operates, and its major customers.
Although IFRS 8 is the result of a short-term convergence
project to reduce the differences between International Ac-
counting Standard (IAS) 14, Segment Reporting, and Finan-
cial Accounting Standards Board (FASB) Accounting Stan-
dards Codification (ASC) 280, Segment Reporting, several
minor differences between IFRS 8 and FASB ASC remain.
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
applicable as of 1 January 2011.
7.02 IFRS 8 applies to the financial statements, whether
consolidated or separate, of a parent entity whose debt or
equity is traded in a public market or who files, or is in
the process of filing, with a regulatory organization for the
purpose of issuing any class of instruments in a public market.
A public market includes domestic or foreign exchanges and
both local and regional over-the-counter markets. Entities not
required to apply IFRS 8 can voluntarily provide information
labeled as segment information, only if that information fully
complies with IFRS 8.
7.03 An operating segment is a component of the entity with
the following characteristics:
• It engages in business activities that may earn revenues
and incur expenses. These revenues and expenses need
not be generated externally but may be solely generated
through transactions with other components of the same
entity.
• The entity’s CODM regularly reviews its operating re-
sults when making resource allocation and performance
assessment decisions (the CODM is a function within
the entity, not necessarily an individual).
• Discrete financial information is available about the
component’s activities.
Note that the term component of an entity is not a defined term
in IFRS 8. It is defined in IFRS 5, Non-current Assets Held
for Sale and Discontinued Operations, and in the glossary
of the IFRS 2011 bound volume, where its definition reflects
the meaning as used in IFRS 5.
Recognition and Measurement
Author’s Note
IFRS 8 is a disclosure standard. Its requirements do
not affect recognition and measurement of items in the
financial statements themselves. However, the standard
does contain criteria for identifying the components
of the entity to be shown in the required disclosures
and for measuring the financial information provided.
These criteria are described in this section.
IFRSs
7.04 IFRS 8 requires disclosure of information about re-
portable segments. Reportable segments are operating seg-
ments or aggregations of operating segments that meet cer-
tain specified criteria. The standard takes the management
approach to identifying reportable segments and for measur-
ing the required financial information to be disclosed.
7.05 Entities should identify operating segments based on
information in internal reports reviewed by the CODM when
making resource allocation and performance assessment de-
cisions. An operating segment is not required to have rev-
enues from external customers. Therefore, an entity can con-
sider different stages of a vertically integrated operation to
be separate operating segments if they meet the definition.
Start-up operations that have not yet earned revenues, but are
incurring expenses, also can be an operating segment.
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7.06 However, not every part of an entity is necessarily
an operating segment or part of an operating segment. For
example, corporate headquarters or certain functional depart-
ments, such as human resources or accounting, may not earn
revenues or may earn revenues that are only incidental to the
activities of the entity and would not meet the definition of
an operating segment. IFRS 8 specifically excludes an en-
tity’s postemployment benefit plan from identification as a
separate operating segment.
7.07 In matrix and similar forms of organization, managers
are held responsible for two or more overlapping sets of
components of an entity. For example, some managers are
responsible for specific products or services, and other man-
agers are responsible for specific geographic areas where
the products and services are offered. Therefore, the CODM
reviews financial reports for both types of components and
discrete information is available for both. In this situation,
IFRS 8 permits the entity to determine the identifying char-
acteristics of the operating segments in accordance with the
objective of the standard rather than providing more prescrip-
tive guidance.
7.08 A reportable segment is either an individual operating
segment or an aggregation of operating segments that meets
or exceeds the following quantitative thresholds:
• Revenue threshold. The reported revenue, whether gen-
erated from sales to external customers or intersegment
transactions, meets or exceeds 10 percent of the com-
bined revenue (internal and external) of all operating
segments.
• Profit and loss threshold. The absolute amount of profit
and loss meets or exceeds 10 percent of the greater of
the absolute amount of combined reported profit of all
segments that did not report a loss and the combined
reported loss of all segments that did not report a profit.
• Asset threshold. The assets meet or exceed 10 percent
of the combined assets of all operating segments.
7.09 Entities can aggregate operating segments in order to
meet the criteria for a reportable segment if the segments
have similar economic characteristics with respect to the
nature of segment products or services; the nature of the
production process; the type or class of customer; distribution
methods; and, when applicable, the nature of the regulatory
environment.
7.10 Two circumstances exist in which entities should iden-
tify additional reportable segments, even if the operating
segments do not meet the preceding thresholds:
• Total external revenue from reportable segments should
meet or exceed 75 percent of the entity’s reported rev-
enue. An entity should identify additional operating
segments as reportable until this criterion is met.
• If management believes that users of the financial state-
ments would find information about an operating seg-
ment useful, the entity can choose to identify that op-
erating segment as reportable.
7.11 Despite these criteria for identifying reportable seg-
ments, IFRS 8 also recognizes that there may be a practical
limit (more than 10) to the number of reportable segments,
after which the information disclosed is likely to be too de-
tailed to be useful.
7.12 With respect to measurement of the financial informa-
tion disclosed, the entity should use the same measurement
bases that are reported internally to the CODM. Therefore,
the measurements in the required disclosures are not neces-
sarily based on the accounting policies used in the preparation
of the consolidated financial statements.
U.S. GAAP
7.13 FASB ASC 280 normally requires more entities to
provide segment disclosures than IFRS 8. Under FASB ASC
280-10-15, segment disclosures are required for all public
entities, with certain exceptions noted in FASB 280-10-15-
3 (such as not-for-profit entities, regardless of whether the
entity meets the definition of a public entity, as defined within
the FASB ASC glossary). The FASB ASC glossary defines
public entities as business entities or not-for-profit entities
that (a) have debt or equity securities or are a conduit bond
obligor for conduit debt securities that are traded in a public
market, (b) are required to file financial statements with a
regulatory organization, or (c) provide financial statements
for the purpose of issuing securities in a public market. The
FASB ASC definition is similar to IFRSs, except that IFRSs
do not apply to not-for-profit entities or specifically address
conduit bond obligors for conduit debt securities. Conduit
debt securities are issued by state or local governments on
behalf of the obligor, not itself a governmental entity. The
issuer itself has no obligation beyond resources provided by
a lease or loan agreement with the obligor.
7.14 Like IFRSs, FASB ASC 280 uses the management
approach to identify operating segments and measure the fi-
nancial information disclosed based on information reported
internally to the CODM to make resource allocation and
performance assessment decisions. However, according to
FASB ASC 280-10-50-9, entities that have a matrix organi-
zation should identify operating segments based on products
and services when more than one type of component is re-
viewed by the CODM.
Disclosure
IFRSs
7.15 The core principle underlying IFRS 8 disclosure re-
quirements is that an entity should disclose information to
enable users of the financial statements to evaluate the nature
and financial effects of its business activities and its eco-
nomic environment. IFRS 8 requires the following types of
disclosures:
• General descriptive information about reportable seg-
ments
• Information about profit or loss, assets, and liabilities
• Information about the measurement bases used
• Entity-wide disclosures about revenues from products
and services, geographical areas, and major customers
• Reconciliations to reported financial statement amounts
• Restatements of prior period information
7.16 Required general descriptive information includes a
description about the factors used to identify the entity’s
reportable segments. These factors include the basis of orga-
nization (for example, how segments are organized around
products and services, geographical areas, regulatory en-
vironments, or a combination of these factors). The entity
also should disclose whether operating segments are aggre-
gated to arrive at reportable segments. Additionally, IFRS 8
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requires an entity to describe the types of revenues generated
by each reportable segment. Often this particular disclosure
is included with other accounting policy disclosures.
7.17 IFRS 8 requires disclosure of a measure of segment
profit or loss, total assets and, if reported to the CODM,
liabilities. However, disclosure of the following additional
measures is required only if they are reported to the CODM:
• Revenue, distinguished between external customers
and intersegment transactions
• Interest income and expense
• Depreciation and amortization, and other similar non-
cash items
• Material items of income and expense in accordance
with IAS 1, Presentation of Financial Statements
• Share in the profit or loss of investments accounted for
using the equity method (for example, associates and
joint ventures)
• Income tax expense or income
• Additions to non-current assets, except financial in-
struments, deferred tax assets, postemployment benefit
assets, rights under insurance contracts, and long-term
customer relationships of financial institutions
7.18 IFRS 8 takes the management approach to measure-
ment as well as segment identification. Because the mea-
surement basis for the quantitative disclosures need not be the
entity’s IFRS accounting policies, IFRS 8 requires a descrip-
tion of the measurement basis used and discussion of various
policies that affect those measurements (for example, transfer
pricing policies and differences between segment amounts
and amounts reported in the financial statement). This dis-
cussion includes the accounting policies and any policies
that the entity used to allocate centrally incurred costs that
are necessary for an understanding of the reported segment
information, as well as any asymmetrical allocations.
7.19 An entity should measure the entity-wide disclosures
about revenues based on the accounting policies used in the
consolidated financial statements, rather than the bases used
for internal measurements. Revenue disclosures include rev-
enue from external customers by product or service (or group
of products and services) by geographic area, and by major
customer. Entities also should disclose non-current assets ex-
cept financial instruments, deferred tax assets, postemploy-
ment benefit assets, and rights under insurance contracts by
geographic area.
7.20 IFRS 8 requires a reconciliation of the total amounts of
segment revenues, reported segment profit or loss, segment
assets, segment liabilities, and other material segment items
to the corresponding reported financial statements amounts.
These reconciliations are required for each statement of fi-
nancial position presented.
7.21 IFRS 8 requires an entity to discuss changes in the com-
position of reportable segments and changes in measurement
bases used. An entity should restate comparative informa-
tion when there is a change in the composition of segments
or measurement basis, unless the information is not available
or is excessively costly to develop. If the comparative infor-
mation is not restated, the entity should present the current
period’s information on both the old and new basis, unless
the information is not available or is excessively costly to
develop.
U.S. GAAP
7.22 FASB ASC 280 and IFRS 8 requirements are largely
converged. FASB ASC 280-10-50-22 requires disclosure of
a measure of segment profit or loss and segment assets, but
does not explicitly require disclosure of segment liabilities.
7.23 IFRS 8 requires disclosure of additional material items
whereas FASB ASC 280-10-50-22(f) requires disclosure of
unusual items of income and expense. This difference in
choice of words is likely to lead to a difference in the items
disclosed. FASB ASC 280-10-55-22(i) also requires disclo-
sure of extraordinary items, which are prohibited in IFRSs.
7.24 IFRS 8 and FASB ASC 280 both require disclosure
of additions to non-current assets with certain exclusions.
In addition to the assets excluded from this requirement by
IFRS 8, FASB ASC 280-10-50-25(b) also excludes mortgage
and other servicing rights and certain other non-current as-
sets (e.g., financial instruments, deferred policy acquisition
costs).
TABLE 7-1: NUMBER OF BUSINESS SEGMENTS
2010 2009










Survey entity that is a subsidiary outside the
scope of IFRS 8............................................................ 0 1
Survey Entity’s Chief Operating Decision Maker
Does Not Review Segment Information ................ 1 0
Total....................................................................... 170 160
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TABLE 7-2: NUMBER OF GEOGRAPHIC SEGMENTS
2010 2009










Survey entity that is a subsidiary outside the scope
of IFRS 8....................................................................... 0 1
Survey Entity’s Chief Operating Decision Maker
Does Not Review Segment Information ................ 1 0
Total....................................................................... 170 160
Presentation and Disclosure Excerpts
Operating Segments Defined on the Basis
of Business Activities
7.25
Adecoagro S.A. (Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
2.4. Segment Reporting
According to IFRS 8, operating segments are identified based
on the ‘management approach’. This approach stipulates ex-
ternal segment reporting based on the Group’s internal or-
ganizational and management structure and on internal fi-
nancial reporting to the chief operating decision maker. The
Management Committee of the Group is responsible for mea-
suring and steering the business success of the segments
and is considered the chief operating decision maker within
the meaning of IFRS 8.
5. Segment Information
IFRS 8 “Operating Segments” requires an entity to report
financial and descriptive information about its reportable seg-
ments, which are operating segments or aggregations of op-
erating segments that meet specified criteria. Operating seg-
ments are components of an entity about which separate
financial information is available that is evaluated regularly
by the chief operating decision maker (“CODM”) in deciding
how to allocate resources and in assessing performance. The
CODM evaluates the business based on the differences in the
nature of its operations, products and services. The amount
reported for each segment item is the measure reported to
the chief operating decision maker for these purposes.
The Group operates in three major lines of business,
namely, Farming; Sugar, Ethanol and Energy; and Land
Transformation.
• The Group’s ‘Farming’ is further comprised of five re-
portable segments;
• The Group’s ‘Crops’ Segment consists of planting, har-
vesting and sale of grains, oilseeds and fibers (including
wheat, corn, soybeans, cotton and sunflowers, among
others), and to a lesser extent the provision of grain
warehousing/conditioning and handling and drying ser-
vices to third parties. Each underlying crop in the Crops
segment does not represent a separate operating seg-
ment. Management seeks to maximize the use of the
land through the cultivation of one or more type of crops.
Types and surface amount of crops cultivated may vary
from harvest year to harvest year depending on several
factors, some of them out of the Group’s control. Man-
agement is focused on the long-term performance of
the productive land, and to that extent, the performance
is assessed considering the aggregated combination, if
any, of crops planted in the land. A single manager is
responsible for the management of operating activity of
all crops rather than for each individual crop.
• The Group’s ‘Rice’ Segment consists of planting, har-
vesting, processing and marketing of rice;
• The Group’s ‘Dairy’ Segment consists of the production
of raw milk, which is processed into manufactured prod-
ucts and marketed through the Group’s joint venture La
Lácteo;
• The Group’s ‘Coffee’ Segment consists of cultivating
coffee beans and marketing own and third party’s coffee
production;
• The Group’s ‘Cattle’ Segment consists of purchasing
and fattening of beef cattle for sale to meat proces-
sors and local livestock auction markets. In December
2009, the Group strategically decided to sell a signifi-
cant amount of heads of cattle from owned farmlands
to Quickfood S.A., an international third party meat pro-
cessor. Additionally, the contract provides for the third
party to lease the Group’s farmland under an operating
lease agreement to raise and fatten the purchased cat-
tle. As required by the Antitrust Law, the Group reported
this transaction to the Argentine Antitrust Commission
for formal approval. As of the date of these consolidated
financial statements, the authorization is still pending.
The Group does not have any evidence which may in-
dicate this transaction will not be formally approved.
• The Group’s ‘Sugar, Ethanol and Energy’ Segment con-
sists of cultivating sugarcane which is processed in
owned sugar mills, transformed into ethanol, sugar and
electricity and marketed;
• The Group’s ‘Land Transformation’ Segment comprises
the (i) identification and acquisition of underdeveloped
and undermanaged farmland businesses for which the
Group generally closes a deal for a price lower than
the land’s fair value (generating gains); and (ii) realiza-
tion of value through the strategic disposition of assets
(generating profits).
The measurement principles for the Group’s segment report-
ing structure are based on the IFRS principles adopted in the
consolidated financial statements. Revenue generated and
goods and services exchanged between segments are cal-
culated on the basis of market prices.
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The following table presents information with respect to
the Group’s reportable segments. Certain other activities of
a holding function nature not allocable to the segments are
disclosed in the column ‘Corporate’.
Segment Analysis for the Year Ended December 31, 2010
Farming Sugar, Land







Sales of manufactured products
and services rendered 344 59,280 — 2,709 3,718 66,051 228,478 — — 294,529
Cost of manufactured products sold
and services rendered — (52,017) — (2,546) — (54,563) (164,638) — — (219,201)
Gross profit from manufacturing
activities 344 7,263 — 163 3,718 11,488 63,840 — — 75,328
Sales of agricultural produce and
biological assets 107,818 2,305 14,297 4,863 2,407 131,690 48 — — 131,738
Cost of agricultural produce sold
and direct agricultural selling
expenses (107,818) (2,305) (14,297) (4,863) (2,407) (131,690) (48) — — (131,738)
Initial recognition and changes in
fair value of biological assets and
agricultural produce 38,879 9,360 9,129 (2,630) 737 55,475 (86,003) — — (30,528)
Gain from changes in net realizable
value of agricultural produce after
harvest 7,482 — — 517 — 7,999 — — — 7,999
Gross profit/(loss) from agricultural
activities 46,361 9,360 9,129 (2,113) 737 63,474 (86,003) — — (22,529)
Margin on manufacturing and
agricultural activities before
operating expenses 46,705 16,623 9,129 (1,950) 4,455 74,962 (22,163) — — 52,799
General and administrative
expenses (7,087) (3,773) (2,910) (983) (350) (15,103) (19,080) — (22,379) (56,562)
Selling expenses (1,522) (8,154) (333) (655) (175) (10,839) (41,689) — — (52,528)
Other operating income, net (6,194) 345 — (2,165) 70 (7,944) 5,305 20,837 26 18,224
Share of loss of joint ventures — — (50) — — (50) — — — (50)
Profit/(loss) from operations before
financing and taxation 31,902 5,041 5,836 (5,753) 4,000 41,026 (77,627) 20,837 (22,353) (38,117)
Depreciation and amortization 1,711 2,080 423 449 333 4,996 32,567 — — 37,563
Initial recognition and changes in
fair value of biological assets
(unrealized) 8,719 6,273 3,610 (2,450) (36) 16,116 (96,795) — — (80,679)
Initial recognition and changes in
fair value of agricultural produce
(unrealized) 7,229 742 — (71) — 7,900 405 — — 8,305
Initial recognition and changes in
fair value of biological assets and
agricultural produce (realized) 22,931 2,345 5,519 (109) 773 31,459 10,387 — — 41,846
Gain from changes in net realizable
value of agricultural produce after
harvest (unrealized) 2,050 — — (523) — 1,527 — — — 1,527
Gain from changes in net realizable
value of agricultural produce after
harvest (realized) 5,432 — — 1,040 — 6,472 — — — 6,472
Property, plant and equipment, net 204,454 50,899 4,202 25,265 18,831 303,650 448,342 — — 751,992
Investment property — 1,168 — — 20,249 21,417 — — — 21,417
Goodwill 4,931 7,023 — 1,115 319 13,388 13,106 — — 26,494
Biological assets 31,247 21,555 7,130 21,577 401 81,910 104,847 — — 186,757
Investment in joint ventures — — 6,271 — — 6,271 — — — 6,271
Inventories 22,926 8,422 883 7,023 61 39,315 17,855 — — 57,170
Total segment assets 263,299 89,066 19,063 54,980 39,542 465,950 584,151 — — 1,051,101
Borrowings (59,339) (41,050) (10,262) (13,651) — (124,302) (265,170) — — (389,472)
Total segment liabilities (59,339) (41,050) (10,262) (13,651) — (124,302) (265,170) — — (389,472)
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Segment Analysis for the Year Ended December 31, 2009
Farming Sugar, Land







Sales of manufactured products
and services rendered 9,667 67,317 752 7,984 172 85,892 97,494 — — 183,386
Cost of manufactured products
sold and services rendered (5,447) (56,576) (613) (7,120) — (69,756) (110,327) — — (180,083)
Gross profit/(loss) from
manufacturing activities 4,220 10,741 139 864 172 16,136 (12,833) — — 3,303
Sales of agricultural produce and
biological assets 82,362 2,033 11,142 6,281 28,306 130,124 93 — — 130,217
Cost of agricultural produce sold
and direct agricultural selling
expenses (82,362) (2,033) (11,142) (6,281) (28,306) (130,124) (93) — — (130,217)
Initial recognition and changes in
fair value of biological assets
and agricultural produce 6,563 12,170 3,374 (16,207) 4,704 10,604 61,064 — — 71,668
Gain from changes in net
realizable value of agricultural
produce after harvest 11,362 191 — 1,234 — 12,787 — — — 12,787
Gross profit/(loss) from
agricultural activities 17,925 12,361 3,374 (14,973) 4,704 23,391 61,064 — — 84,455
Margin on manufacturing and
agricultural activities before
operating expenses 22,145 23,102 3,513 (14,109) 4,876 39,527 48,231 — — 87,758
General and administrative
expenses (6,280) (2,883) (2,221) (2,126) (2,909) (16,419) (13,922) — (22,052) (52,393)
Selling expenses (1,587) (7,485) (777) (1,353) (1,045) (12,247) (18,922) — — (31,169)
Other operating income, net 4,776 (942) (108) 806 377 4,909 (10,467) 18,839 (210) 13,071
Share of loss of joint ventures — — (294) — — (294) — — — (294)
Profit/(loss) from operations
before financing and taxation 19,054 11,792 113 (16,782) 1,299 15,476 4,920 18,839 (22,262) 16,973
Depreciation and amortization 2,066 1,452 403 570 353 4,844 25,512 — — 30,356
Initial recognition and changes in
fair value of biological assets
(unrealized) 4,433 6,759 32 (12,662) 127 (1,311) 57,335 — — 56,024
Initial recognition and changes in
fair value of agricultural produce
(unrealized) 1,485 — — (3,043) — (1,558) 1,375 — — (183)
Initial recognition and changes in
fair value of biological assets
and agricultural produce
(realized) 645 5,411 3,342 (502) 4,577 13,473 2,354 — — 15,827
Gain from changes in net
realizable value of agricultural
produce after harvest
(unrealized) 134 — — (7) — 127 — — — 127
Gain from changes in net
realizable value of agricultural
produce after harvest (realized) 11,228 191 — 1,241 — 12,660 — — — 12,660
Property, plant and equipment, net 248,594 31,282 10,652 2,680 767 293,975 388,903 — — 682,878
Investment property — — — — 21,246 21,246 — — — 21,246
Goodwill 6,110 — — 1,067 237 7,414 12,539 — — 19,953
Biological assets 27,467 11,524 4,313 21,634 815 65,753 164,701 — — 230,454
Investment in joint ventures — — 6,506 — — 6,506 — — — 6,506
Inventories 23,832 9,460 1,086 1,992 716 37,086 20,816 — — 57,902
Total segment assets 306,003 52,266 22,557 27,373 23,781 431,980 586,959 — — 1,018,939
Borrowings 63,893 39,850 9,963 3,493 — 117,199 189,582 — — 306,781
Total segment liabilities 63,893 39,850 9,963 3,493 — 117,199 189,582 — — 306,781
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Segment Analysis for the Year Ended December 31, 2008
Farming Sugar, Land







Sales of manufactured products
and services rendered 3,134 53,280 2,171 8,544 164 67,293 49,880 — — 117,173
Cost of manufactured products sold
and services rendered (2,807) (39,862) (1,849) (6,978) — (51,496) (54,087) — — (105,583)
Gross profit/(loss) from
manufacturing activities 327 13,418 322 1,566 164 15,797 (4,207) — — 11,590
Sales of agricultural produce and
biological assets 92,853 3,645 12,650 7,404 9,193 125,745 1,291 — — 127,036
Cost of agricultural produce sold
and direct agricultural selling
expenses (92,853) (3,645) (12,650) (7,404) (9,193) (125,745) (1,291) — — (127,036)
Initial recognition and changes in
fair value of biological assets and
agricultural produce 28,005 7,854 2,633 4,485 3,788 46,765 14,235 — — 61,000
Gain from changes in net realizable
value of agricultural produce after
harvest 2,211 — — (950) — 1,261 — — — 1,261
Gross profit from agricultural
activities 30,216 7,854 2,633 3,535 3,788 48,026 14,235 — — 62,261
Margin on manufacturing and
agricultural activities before
operating expenses 30,543 21,272 2,955 5,101 3,952 63,823 10,028 — — 73,851
General and administrative
expenses (3,885) (398) (1,835) (3,308) (2,206) (11,632) (12,646) — (21,355) (45,633)
Selling expenses (3,959) (7,647) (967) (902) (473) (13,948) (10,548) — — (24,496)
Other operating income, net 4,824 29 18 (27) 16 4,860 211 13,974 (1,722) 17,323
Excess of fair value of net assets
acquired over cost — — — — — — — 1,227 — 1,227
Share of loss of joint ventures — — (838) — — (838) — — — (838)
Profit/(loss) from operations before
financing and taxation 27,523 13,256 (667) 864 1,289 42,265 (12,955) 15,201 (23,077) 21,434
Depreciation and amortization 6,517 710 348 798 517 8,890 19,424 — — 28,314
Initial recognition and changes in
fair value of biological assets
(unrealized) 332 — 1,840 3,355 2,567 8,094 13,448 — — 21,542
Initial recognition and changes in
fair value of agricultural produce
(unrealized) 3,551 — — 931 — 4,482 298 — — 4,780
Initial recognition and changes in
fair value of biological assets and
agricultural produce (realized) 24,122 7,854 793 199 1,221 34,189 489 — — 34,678
Gain from changes in net realizable
value of agricultural produce after
harvest (unrealized) — — — (99) — (99) — — — (99)
Gain from changes in net realizable
value of agricultural produce after
harvest (realized) 2,211 — — (851) — 1,360 — — — 1,360
Property, plant and equipment, net 232,465 50,804 12,069 12,523 33,041 340,902 230,517 — — 571,419
Spin-off assets — — — — — — — 45,311 — 45,311
Goodwill 3,610 — — 794 383 4,787 11,834 — — 16,621
Biological assets 21,059 6,908 4,732 25,453 19,629 77,781 48,167 — — 125,948
Investment in joint ventures — — 7,508 — — 7,508 — — — 7,508
Inventories 21,201 9,212 — 5,326 878 36,617 24,604 — — 61,221
Total segment assets 278,335 66,924 24,309 44,096 53,931 467,595 315,122 45,311 — 828,028
Borrowings 45,322 36,258 9,065 — — 90,645 137,668 — — 228,313
Total segment liabilities 45,322 36,258 9,065 — — 90,645 137,668 — — 228,313
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Total segment assets are measured in a manner consistent
with that of the consolidated financial statements. These as-
sets are allocated based on the operations of the segment
and the physical location of the asset. The Group’s invest-
ment in the joint venture Grupo La Lácteo is allocated to the
‘Dairy’ segment. Therefore, the Group’s share of profit or loss
after income taxes and its carrying amount are reported in this
segment.
Total reportable segments’ assets are reconciled to total
assets as per the statement of financial position as follows:
2010 2009 2008
Total reportable assets as per Segment Information 1,050,101 1,018,939 828,028
Intangible assets (excluding goodwill) 2,159 1,906 1,487
Deferred income tax assets 67,463 45,113 18,713
Trade and other receivables 149,957 128,277 84,540
Other assets 26 34 87
Derivative financial instruments 876 99 2,019
Cash and cash equivalents 70,269 74,806 93,360
Total assets as per the Statement of Financial Position 1,340,851 1,269,174 1,028,234
Total segment liabilities are measured in a manner consistent
with that of the consolidated financial statements. These lia-
bilities are allocated based on the operations of the segment.
Total reportable segments’ liabilities are reconciled to total
liabilities as per the statement of financial position as follows:
2010 2009 2008
Total reportable liabilities as per Segment Information 389,472 306,781 228,313
Trade and other payables 81,021 68,920 52,760
Deferred income tax liabilities 111,495 107,045 94,627
Payroll and social liabilities 16,656 11,185 6,859
Provisions for other liabilities 9,207 4,978 1,601
Current income tax liabilities 978 222 1,487
Derivative financial instruments 8,920 12,887 4,159
Total liabilities as per the Statement of Financial Position 617,749 512,018 389,806
The Group’s non-current assets and net revenue and fair
value gains and losses are shown by geographic region.
These are the regions in which the Group is active: Argentina,
Brazil and Uruguay. Non-current assets are allocated to the
regions according to the location of the assets in question.
Non-current assets encompass intangible assets; property,
plant and equipment; investments accounted for using the
equity method as well as other non-current assets. Net rev-
enue and fair value gains and losses are allocated according
to the location of the respective operations.
As of and for the year ended December 31, 2010:
Argentina Brazil Uruguay Total
Property, plant and equipment 246,602 495,075 10,315 751,992
Investment property 21,417 — — 21,417
Intangible assets 1,115 1,044 — 2,159
Goodwill 12,272 14,222 — 26,494
Investment in joint ventures 6,271 — — 6,271
Non-current portion of biological assets 7,169 97,047 — 104,216
Initial recognition and changes in fair value of biological assets
and agricultural produce 54,226 (86,557) 1,803 (30,528)
Gain from changes in net realizable value of agricultural produce
after harvest 8,157 (123) (35) 7,999
Sales of manufactured products sold and services rendered 62,455 232,074 — 294,529
Sales of agricultural produce and biological assets 109,387 17,158 5,193 131,738
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Operating Segments Defined on the Basis
of Business Activities, Segment Information
Provided in Separate Asset, Liability,
Revenue and Expense Disclosures
7.26
Sasol Limited (Jun 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
A. Accounting Policies and Financial Reporting Terms
(in part)
Sasol Limited is the holding company of the Sasol group
(the group) and is domiciled in the Republic of South Africa.
The following principal accounting policies were applied by
the group for the financial year ended 30 June 2010. Except
as otherwise disclosed, these policies are consistent in all
material respects with those applied in previous years.
Financial Reporting Terms
These definitions of financial reporting terms are provided to
ensure clarity of meaning as certain terms may not always
have the same meaning or interpretation in all countries.
Group Structures (in part)
Business unit: An operation engaged in providing similar
goods or services that are different to those provided by other
operations.
The primary business units are:







• Sasol Synfuels International




• Sasol Olefins & Surfactants





Classified as “Other Businesses” in the Segment Report
• Sasol Technology
• Sasol Financing
• Corporate head office functions
• Alternative energy businesses
In the notes to the financial statements, where items classified
as “other businesses” are material, the amounts attributable
to these businesses have been specified.
Operation: A component of the group:
• that represents a separate major line of business or
geographical area of operation; and




The group has nine main reportable segments that comprise
the structure used by the Group Executive Committee (GEC)
to make key operating decisions and assess performance.
The group’s reportable segments are operating segments
that are differentiated by the activities that each undertakes
and the products they manufacture and market (referred to
as business segments). Each business utilises different tech-
nology, manufacturing and marketing strategies.
The group evaluates the performance of its reportable seg-
ments based on operating profit. The group accounts for inter-
segment sales and transfers as if the sales and transfers were
entered into under the same terms and conditions as would
have been entered into in a market related transaction.
The financial information of the group’s reportable seg-
ments is reported to the GEC for purposes of making de-
cisions about allocating resources to the segment and as-
sessing its performance.
The group has formed significant joint ventures to promote
Sasol technology and products internationally. The group is
promoting and marketing its gas-to-liquids (GTL) technol-
ogy for converting remote or flared natural gas into new-
generation, low-emission GTL diesel, GTL naphtha and other
products. It is envisaged that Sasol Synfuels International
(SSI) through the recent development of the GTL plants in
Qatar and Nigeria will contribute to the growing of a global
GTL business in the future.
Whilst Sasol Petroleum International (SPI), like SSI, does
not meet the quantitative criteria for disclosure as a separate
segment, it is expected to become a significant contributor
to the group’s performance in future years as the upstream
supplier of resources for the group’s GTL and CTL activities.
Consequently, the GEC has chosen to include SSI and SPI
as reportable operating segments even though SSI and SPI
do not meet any of the quantitative thresholds as the GEC
believes that such information would be useful to the users of
the financial statements.
South African Energy Cluster
Sasol Mining
Sasol Mining’s activities include the mining and supply of coal
to other segments including Sasol Synfuels, other entities and
to third parties.
Sasol Mining sells coal under both long-term and short-
term contracts at a price determinable from the agreements.
Turnover is recognised upon delivery of the coal to the cus-
tomer, which, in accordance with the related contract terms is
the point at which the title and risks and rewards of ownership
pass to the customer, prices are fixed or determinable and
collectability is reasonably assured.
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The date of delivery related to Sasol Mining is determined
in accordance with the contractual agreements entered into
with customers which are briefly summarised as follows:
Delivery Terms
Title and Risks and Rewards of
Ownership Pass to the Customer
Free on Board (FOB) When the coal is loaded onto the vessel
at Richards Bay Coal Terminal—
customer is responsible for shipping
and handling costs.
Free on Barge (Amsterdam) When the coal is loaded from Overslag
Bedrijf Amsterdam stockpile onto the
customer vessel—seller is
responsible for shipping and handling
costs, these are however recovered
from the customer.
Cost Insurance Freight (CIF)
and Cost Freight Railage
(CFR)
When the coal is loaded into the
vessel—seller is responsible for
shipping and handling costs which
are included in the selling price.
The related costs of sales are recognised in the same period
as the supply of the coal and include any shipping and han-
dling costs incurred. All inter-segment sales are conducted at
market related prices.
Sasol Gas
Sasol Gas’ activities include the marketing of clean-burning
pipeline gas sourced from Sasol Synfuels and natural gas
from the Mozambican gas fields.
Sasol Gas sells gas under long-term contracts at a price
determinable from the supply agreements. Turnover is recog-
nised at the intake flange of the customer where it is metered,
which is the point at which the title and risks and rewards of
ownership passes to the customer, and where prices are de-
terminable and collectability is reasonably assured. Gas anal-
ysis and tests of the specifications and content are performed
prior to delivery.
Transportation and handling costs are included in turnover
when billed to customers in conjunction with the sale of a
product. The related costs of sales are recognised in the
same period as the turnover.
Sasol Synfuels
Sasol Synfuels’ activities include the production, using nat-
ural gas, from Sasol Gas, and synthesis gas derived from
coal, supplied by Sasol Mining, using in-house technology
to convert this into a wide range of liquid fuels intermedi-
ates and petrochemicals. Sasol Synfuels also provides chem-
ical feedstock to, amongst others Sasol Polymers and Sasol
Solvents.
Sasol Synfuels sells synthetic fuels, chemical feedstock
and industrial pipeline gas under contracts at prices deter-
minable from the agreements. Turnover is recognised for the
liquid fuel intermediates and petrochemicals when the title
and risks and rewards of ownership pass to the customer,
which is when the product has passed over the appropriate
weigh bridge or flow meter, prices are fixed or determinable
and collectability is reasonably assured.
Sasol Oil
Sasol Oil is responsible for the group’s crude oil refining ac-
tivities and for blending and marketing of all liquid fuels and
lubricants.
Sasol Oil sells liquid fuel products under both short-term
and long-term agreements for both retail sales and commer-
cial sales including sales to other oil companies. The prices
are regulated and fixed by South African law for retail sales,
and the prices are fixed and determinable according to the
specific contract with periodic price adjustments for commer-
cial sales and sales to other oil companies. Laboratory tests
of the fuel specifications and content are performed prior to
delivery. Turnover is recognised under the following arrange-
ments:
• Commercial sales transactions and sales to other oil
companies: when product is delivered to the customer
site, which is the point where the risks and rewards of
ownership and title of the product transfer to the cus-
tomer, and collectability is reasonably assured.
• Dealer-owned supply agreements and franchise agree-
ments: upon delivery of the product to the customer,
which is the point where the risks and rewards of own-
ership of the product transfer to the customer. Title un-
der these contracts is retained to enable recovery of the
goods in the event of customer default on payment. The
title to the goods does not enable the group to dispose
of the product or rescind the transaction, and cannot
prevent the customer from selling the product.
Turnover for the supply of fuel is based on measurement
through a flow-meter into customers’ tanks. Shipping and
handling costs are included in turnover when billed to cus-
tomers in conjunction with the sale of a product. The re-
lated costs of sales are recognised in the same period as
the turnover.
Other
This segment currently includes costs related to the pre-
feasibility study for the expansion of our synthetic fuels ca-
pacity in South Africa known as Project Mafutha.
International Energy Cluster
Sasol Synfuels International (SSI)
SSI is responsible for developing, implementing and manag-
ing international business ventures based on Sasol’s Fischer-
Tropsch synthesis technology. SSI is also involved in the
development of GTL fuels and production of other chemical
products from GTL derived feedstock.
SSI is currently involved in the establishment of two GTL
production facilities in Qatar and Nigeria and is conducting
feasibility studies for both GTL and coal-to-liquids (CTL) fa-
cilities at various other locations around the world, including
China, Uzbekistan and India.
Turnover is derived from the sale of goods produced by the
operating facilities and is recognised when, in accordance
with the related contract terms, the title and risks and re-
wards of ownership pass to the customer, prices are fixed or
determinable and collectability is reasonably assured. Ship-
ping and handling costs are included in turnover when billed
to customers in conjunction with the sale of the products.
Turnover is also derived from the rendering of engineering
services to external partners in joint ventures upon the proof
of completion of the service.
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Sasol Petroleum International (SPI)
SPI develops and manages upstream interests in oil and
gas exploration and production in Mozambique, South Africa,
Gabon, Papua New Guinea, Australia and Nigeria. It pro-
duces gas from Mozambique’s Temane and Pande fields
and oil in Gabon through its share in the offshore Etame
and Ebouri fields.
SPI sells natural gas under long-term contracts to Sasol
Gas and oil to customers under long-term contracts at a price
determinable from the agreements. Turnover is recognised at
the intake flange of the customer where it is metered, which is
the point at which the title and risks and rewards of ownership
passes to the customer, and where prices are determinable
and collectability is reasonably assured.
Chemical Cluster
Sasol Polymers
Sasol Polymers focuses on the production of monomers,
polypropylene, polyethylene, vinyls and other chemical prod-
ucts through its respective businesses.
Sasol Solvents
Sasol Solvents primarily manufactures and markets globally
a range of oxygenated solvents, co-monomers and chemical
intermediates to various industries.
Sasol Olefins & Surfactants
Sasol Olefins & Surfactants manufactures and markets glob-
ally a diverse range of surfactants, surfactant intermediates,
alcohols, monomers and inorganic speciality chemicals.
Other Chemical Businesses
Other chemical businesses include Sasol Wax (production
and marketing of wax and wax related products), Sasol Nitro
(production and marketing of ammonia and ammonia deriva-
tive products), Merisol (manufacturing and marketing of phe-
nolics and cresylics) and Sasol Infrachem (manufacturing of
synthesis gas).
The businesses in the chemical cluster sell much of their
products under contracts at prices determinable from such
agreements. Turnover is recognised upon delivery to the cus-
tomer which in accordance with the related contract terms, is
the point at which the title and risks and rewards of ownership
transfer to the customer, prices are determinable and col-
lectability is reasonably assured. Turnover on consignment
sales is recognised on consumption by the customer, when
title and the risks and rewards of ownership pass to the cus-
tomer, prices are determinable and collectability is reason-
ably assured. Product quality is safeguarded through quality
assurance programmes.
The date of delivery related to the above Chemical cluster
is determined in accordance with the contractual agreements
entered into with customers which are briefly summarised as
follows:
Delivery Terms Title and Risks and Rewards of Ownership Pass to the Customer
Ex-tank sales When products are loaded into the customer’s vehicle or unloaded from the seller’s storage tanks.
Ex works (EXW) When products are loaded into the customer’s vehicle or unloaded at the seller’s premises.
Carriage Paid To (CPT) On delivery of products to a specified location (main carriage is paid for by the seller).
Free on Board (FOB) When products are loaded into the transport vehicle—customer is responsible for shipping and handling costs.
Cost Insurance Freight (CIF) and
Cost Freight Railage (CFR)
When products are loaded into the transport vehicle—seller is responsible for shipping and handling costs which
are included in the selling price.
Proof of Delivery (POD) When products are delivered to and signed for by the customer.
Consignment Sales As and when products are consumed by the customer.
Other Businesses
Other businesses include the group’s treasury, research and
development activities and central administration activities as
well as alternative energy activities.
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and Other Non-Current Total Consolidated Non-Current Current Total Consolidated
Intangible Assets Assets(*) Current Assets(*) Assets(*) Liabilities(*) Liabilities(*) Liabilities(*)
2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008
Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm
South African
energy cluster 43,351 36,629 30,299 686 580 610 14,569 12,569 17,895 58,606 49,778 48,804 9,857 8,233 7,007 8,014 7,520 8,135 17,871 15,753 15,142
Mining 6,024 4,930 4,112 457 417 386 1,037 600 776 7,518 5,947 5,274 1,060 844 746 890 792 788 1,950 1,636 1,534
Gas 4,857 5,934 5,421 2 3 16 525 446 533 5,384 6,383 5,970 2,199 2,194 2,285 410 373 404 2,609 2,567 2,689
Synfuels 27,002 20,659 16,486 125 66 111 2,239 2,483 1,675 29,366 23,208 18,272 3,935 2,837 1,874 1,996 1,372 1,472 5,931 4,209 3,346
Oil 5,393 5,031 4,280 102 94 97 10,766 9,031 14,906 16,261 14,156 19,283 2,663 2,358 2,102 4,718 4,983 5,471 7,381 7,341 7,573
Other 75 75 — — — — 2 9 5 77 84 5 — — — — — — — — —
International
energy cluster 10,672 10,000 8,806 2,728 1,510 5 2,261 2,569 6,331 15,661 14,079 15,142 1,173 1,292 3,768 2,090 3,141 1,812 3,263 4,433 5,580
Synfuels
International 5,485 5,091 4,928 2,728 1,510 5 1,778 2,066 5,959 9,991 8,667 10,892 393 366 2,813 1,788 2,645 1,482 2,181 3,011 4,295
Petroleum
International 5,187 4,909 3,878 — — — 483 503 372 5,670 5,412 4,250 780 926 955 302 496 330 1,082 1,422 1,285
Chemical cluster 38,200 36,810 38,201 3,440 3,543 3,565 23,334 20,059 27,935 64,974 60,412 69,701 6,800 6,790 7,567 8,832 8,274 11,735 15,632 15,064 19,302
Polymers 17,413 18,113 19,239 1,600 1,632 1,641 5,836 4,729 4,496 24,849 24,474 25,376 2,343 2,378 2,914 2,112 2,062 2,349 4,455 4,440 5,263
Solvents 9,355 9,294 9,457 338 404 454 5,347 4,223 5,458 15,040 13,921 15,369 851 651 646 1,169 1,148 1,706 2,020 1,799 2,352
Olefins &
Surfactants 5,260 5,321 5,914 869 846 746 7,772 7,038 12,111 13,901 13,205 18,771 1,869 1,948 2,361 3,500 2,891 5,049 5,369 4,839 7,410
Other 6,172 4,082 3,591 633 661 724 4,379 4,069 5,870 11,184 8,812 10,185 1,737 1,813 1,646 2,051 2,173 2,631 3,788 3,986 4,277
Other businesses 2,511 2,495 1,624 74 103 726 13,203 17,787 2,662 15,788 20,385 5,012 8,137 7,923 6,822 3,383 6,605 4,303 11,520 14,528 11,125
Total 94,734 85,934 78,930 6,928 5,736 4,906 53,367 52,984 54,823 155,029 144,654 138,659 25,967 24,238 25,164 22,319 25,540 25,985 48,286 49,778 51,149
( *) Excludes tax and deferred tax.












2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008
Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm
South African
energy cluster 53,493 58,167 58,515 42,045 45,191 46,275 95,538 103,358 104,790 (202) (48) 96 69 141 (116) 17,808 28,684 28,048 11,493 19,628 18,251
Mining 1,696 2,885 2,470 6,167 5,412 5,009 7,863 8,297 7,479 (2) 7 (7) 1 3 (7) 815 1,593 1,393 567 1,163 1,053
Gas 2,986 2,829 2,563 2,385 2,837 2,134 5,371 5,666 4,697 (16) (31) (6) — 4 (104) 2,479 2,424 1,785 1,402 1,344 904
Synfuels 879 1,367 982 33,014 36,334 38,634 33,893 37,701 39,616 (136) (152) (5) 58 137 (25) 13,175 25,188 19,416 8,907 17,643 13,582
Oil 47,932 51,086 52,500 479 608 498 48,411 51,694 52,998 (48) 130 114 10 (3) 20 1,364 (351) 5,507 642 (353) 2,765
Other — — — — — — — — — — (2) — — — — (25) (170) (53) (25) (169) (53)
International
energy cluster 3,198 4,183 3,016 769 983 748 3,967 5,166 3,764 28 194 (2) 112 795 (369) 468 880 383 451 (153) 318
Synfuels
International 2,282 3,027 1,788 — — 5 2,282 3,027 1,793 33 (13) (16) 4 777 (396) 131 (235) (621) 504 (505) (189)
Petroleum
International 916 1,156 1,228 769 983 743 1,685 2,139 1,971 (5) 207 14 108 18 27 337 1,115 1,004 (53) 352 507
Chemical cluster 65,386 75,315 68,187 6,191 6,598 5,509 71,577 81,913 73,696 (672) 190 153 (251) 510 (294) 5,496 (2,244) 6,605 4,476 (2,773) 5,627
Polymers 14,236 15,326 11,162 85 199 142 14,321 15,525 11,304 (553) 44 296 14 (1) 12 958 946 1,511 844 1,016 1,485
Solvents 14,425 16,317 15,585 1,340 1,798 1,597 15,765 18,115 17,182 (132) 1 404 58 158 (104) 1,154 495 2,382 889 191 2,015
Olefins &
Surfactants 24,774 28,867 28,125 509 667 655 25,283 29,534 28,780 37 84 32 (344) 106 27 2,492 (160) 1,512 2,248 (143) 1,279
Other 11,951 14,805 13,315 4,257 3,934 3,115 16,208 18,739 16,430 (24) 61 (579) 21 247 (229) 892 (3,525) 1,200 495 (3,837) 848
Other businesses 179 171 225 5,241 5,038 4,048 5,420 5,209 4,273 (161) (502) 53 24 23 81 165 (2 654) (1,220) (479) (3,054) (1,779)
Total 122,256 137,836 129,943 54,246 57,810 56,580 176,502 195,646 186,523 (1,007) (166) 300 (46) 1,469 (698) 23,937 24,666 33,816 15,941 13,648 22,417
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Assets Number of Employees
2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008
Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Number Number Number
South African
energy cluster 22,166 32,784 30,513 (3,015) (2,289) (2,146) 10,850 8,758 4,531 29,630 18,402 13,575 17 46 12 15,106 14,622 14,525
Mining 1,727 2,437 2,077 (649) (619) (650) 1,699 1,427 997 7,507 4,107 781 — 16 9 7,364 7,139 7,329
Gas 2,793 2,778 2,192 (322) (310) (289) 363 834 466 567 724 1,110 15 26 — 270 263 218
Synfuels 15,754 27,346 20,185 (1,445) (816) (720) 7,843 5,144 2,305 19,438 11,732 10,656 2 4 1 5,347 5,078 4,791
Oil 1,917 393 6,112 (599) (544) (487) 945 1,278 762 2,118 1,839 1,028 — — 2 2,125 2,142 2,187
Other (25) (170) (53) — — — — 75 1 — — — — — — — — —
International energy
cluster 515 2,453 2,401 (699) (706) (537) 1,504 2,432 2,637 2,931 3,105 7,198 15 7 9 744 659 730
Synfuels
International (349) 1,113 1,157 (316) (386) (286) 721 657 1,508 695 798 3,448 2 2 1 449 395 458
Petroleum
International 864 1,340 1,244 (383) (320) (251) 783 1,775 1,129 2,236 2,307 3,750 13 5 8 295 264 272
Chemical cluster 7,937 2,545 9,303 (2,648) (2,993) (2,365) 3,349 3,397 3,168 12,872 3,099 3,398 175 24 33 11,936 12,539 12,842
Polymers 2,056 2,211 2,479 (1,016) (1,205) (783) 335 668 1,001 1,914 504 559 — 12 19 2,191 2,221 2,178
Solvents 1,894 1,348 2,979 (553) (546) (477) 840 666 939 474 706 1,021 72 9 10 1,676 1,762 1,839
Olefins &
Surfactants 2,746 1,020 2,204 (720) (854) (775) 730 862 555 886 604 912 79 3 3 2,824 2,936 3,143
Other 1,241 (2,034) 1,641 (359) (388) (330) 1,444 1,201 673 9,598 1,285 906 24 — 1 5,245 5,620 5,682
Other businesses 144 (588) 341 (350) (257) (164) 405 1,085 519 791 519 782 66 107 41 5,553 5,724 5,831
Total 30,762 37,194 42,558 (6,712) (6,245) (5,212) 16,108 15,672 10,855 46,224 25,125 24,953 273 184 95 33,339 33,544 33,928
Geographic Segment Information













2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008 2010 2009 2008
Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm Rm
South Africa 115,425 125,417 122,533 62,014 68,561 67,632 18,143 25,727 26,877 101,953 93,739 79,511 13,702 11,674 6,914 42,392 21,495 16,850
Rest of Africa 5,653 7,144 7,842 5,613 7,121 7,098 407 (288) 1,044 9,823 8,423 10,067 750 1,790 2,060 2,071 2,144 6,380
Mozambique 271 282 898 233 259 154 186 92 462 5,766 5,300 4,611 620 1,334 909 1,754 1,856 3,439
Nigeria 429 556 456 427 556 456 2 (717) (298) 3,029 1,947 4,350 4 — 1,012 147 153 2,674
Rest of Africa 4,953 6,306 6,488 4,953 6,306 6,488 219 337 880 1,028 1,176 1,106 126 456 139 170 135 267
Europe 27,620 31,901 29,882 26,978 31,230 29,204 3,553 (3,050) 3,263 17,462 17,801 22,115 935 1,158 988 985 974 1,340
Germany 7,649 8,824 8,904 7,022 8,183 8,262 773 (3,504) 114 7,744 7,969 9,917 776 795 469 538 785 940
Italy 2,724 3,567 3,738 2,719 3,563 3,734 283 (155) 115 2,997 2,282 4,105 122 239 145 115 71 232
Rest of Europe 17,247 19,510 17,240 17,237 19,484 17,208 2,497 609 3,034 6,721 7,550 8,093 37 124 374 332 118 168
North America 13,093 14,727 14,148 13,047 14,692 14,094 1,060 329 991 6,843 6,615 8,177 323 439 89 592 301 302
United States of
America 11,692 13,549 12,926 11,650 13,514 12,872 880 258 905 6,498 6,459 8,006 323 439 89 592 301 302
Rest of North
America 1,401 1,178 1,222 1,397 1,178 1,222 180 71 86 345 156 171 — — — — — —
South America 1,443 2,211 2,592 1,445 2,211 2,592 113 668 849 302 192 453 — — — — — —
Southeast Asia
and Australasia 3,066 3,532 2,628 3,022 3,414 2,548 218 186 581 2,246 1,924 2,241 75 22 7 170 190 —
Middle East and
India 5,450 5,838 2,740 5,451 5,818 2,733 537 1,409 (7) 14,642 14,363 14,059 321 566 729 283 199 164
Iran 795 1,934 301 796 1,934 298 252 1,080 (45) 7,521 7,541 8,346 70 263 457 42 104 96
Qatar 13 27 154 13 26 151 (684) (223) (298) 5,239 5,544 5,044 248 301 268 241 95 68
Rest of Middle
East and
India 4,642 3,877 2,285 4,642 3,858 2,284 969 552 336 1,882 1,278 669 3 2 4 — — —
Far East 4,752 4,876 4,158 4,686 4,789 4,042 (94) (315) 218 1,758 1,597 2,036 2 23 68 4 6 12
176,502 195,646 186,523 122,256 137,836 129,943 23,937 24,666 33,816 155,029 144,654 138,659 16,108 15,672 10,855 46,497 25,309 25,048
(*) Excludes tax and deferred tax.
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C. Other Explanatory Notes to the Financial
Statements (in part)




South African energy cluster 28,605 27,314 25,752
Mining 4,744 4,672 3,962
Gas 3,718 5,049 5,097
Synfuels 15,644 13,361 12,853
Oil 4,424 4,157 3,840
Other SA Energy 75 75 —
International energy cluster 7,541 7,909 5,928
Synfuels International 4,584 4,698 4,240
Petroleum International 2,957 3,211 1,688
Chemical cluster 34,414 33,625 33,660
Polymers 16,775 17,465 16,506
Solvents 8,608 8,467 8,922
Olefins & Surfactants 4,582 4,632 5,358
Other 4,449 3,061 2,874
Other businesses 1,963 1,522 933
Total operations 72,523 70,370 66,273
Capital Commitments (in part)
Capital commitments, excluding capitalised interest, include
all projects for which specific board approval has been ob-
tained up to the reporting date. Projects still under investi-
gation for which specific board approvals have not yet been




South African energy cluster 29,630 18,402 13,575
Mining 7,507 4,107 781
Gas 567 724 1,110
Synfuels 19,438 11,732 10,656
Oil 2,118 1,839 1,028
International energy cluster 2,931 3,105 7,198
Synfuels International 695 798 3,448
Petroleum International 2,236 2,307 3,750
Chemical cluster 12,872 3,099 3,398
Polymers 1,914 504 559
Solvents 474 706 1,021
Olefins & Surfactants 886 604 912
Other 9,598 1,285 906
Other businesses 791 519 782
Total operations 46,224 25,125 24,953
4. Assets Under Construction
2010 2009 2008
Note Rm Rm Rm
Business Segmentation
South African energy cluster 14,599 9,152 4,350
Mining 1,274 254 147
Gas 1,108 862 308
Synfuels 11,303 7,224 3,550
Oil 914 812 345
International energy cluster 3,118 2,078 2,845
Synfuels International 899 382 664
Petroleum International 2,219 1,696 2,181
Chemical cluster 3,077 2,464 3,836
Polymers 452 444 2,675
Solvents 562 607 291
Olefins & Surfactants 425 501 287
Other 1,638 912 583
Other businesses 224 802 662
21,018 14,496 11,693
5. Goodwill (in part)
2010 2009 2008
Note Rm Rm Rm
Business Segmentation
Olefins & Surfactants 203 222 250
Solvents 184 220 249
Wax 171 183 195
Nitro 95 95 95
Oil 85 85 85
Total operations 738 805 874
For the purposes of impairment testing, goodwill is allocated
to the smallest cash generating unit. Impairment testing in
respect of goodwill is performed at each reporting date by
comparing the recoverable amount based on the value-in-
use of the cash generating unit to the carrying amount as
described in note 42.
6. Other Intangible Assets (in part)
2010 2009 2008
Rm Rm Rm
Business Segmentation of Emission
Rights
Olefins & Surfactants 165 136 212
Solvents 42 41 69
Wax 8 9 14
Financing 30 31 —
Merisol 3 3 3
248 220 298
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10. Long-Term Receivables and Prepaid Expenses
(in part)
2010 2009 2008
Note Rm Rm Rm
Geographic Segmentation
South Africa 44 23 90
Rest of Africa 9 3 3
Europe 324 362 409
North America 19 39 79
Southeast Asia and Australasia — — 1
Middle East and India 919 1,406 918
Far East 2 2 1
1,317 1,835 1,499




South African energy cluster 6,622 5,548 7,433
Mining 847 508 539
Gas 40 104 93
Synfuels 1,874 1,997 1,303
Oil 3,861 2,939 5,498
International energy cluster 995 866 694
Synfuels International 973 847 666
Petroleum International 22 19 28
Chemical cluster 8,837 8,155 11,942
Polymers 1,498 1,510 1,394
Solvents 2,108 1,628 1,711
Olefins & Surfactants 3,129 2,936 5,824
Other 2,102 2,081 3,013
Other businesses 18 20 19
Total operations 16,472 14,589 20,088
The impact of lower crude oil prices as well as prices of other
energy and chemical products has had a direct impact on
the carrying value of inventory, affecting mainly the Sasol Oil
business unit and the chemical businesses. These decreases
resulted in a net realisable value write-down of R172 million
in 2010 (2009—R965 million; 2008—R105 million).
The reversal of the net realisable value write-down of R54
million in 2010 arises due to the increase in catalyst prices,
which affect mainly the catalyst business.
No inventories are encumbered.
14. Trade Receivables (in part)
Impairment of Trade Receivables
Trade receivables that are not past the due date are not con-
sidered to be impaired, except in situations where they are
part of individually impaired trade receivables. The individu-
ally impaired trade receivables mainly relate to certain cus-
tomers who are trading in difficult economic circumstances.





South African energy cluster 7,038 6,062 8,688
Mining 47 18 192
Gas 379 268 316
Synfuels 176 152 273
Oil 6,434 5,615 7,902
Other 2 9 5
International energy cluster 533 651 1,188
Synfuels International 335 519 992
Petroleum International 198 132 196
Chemical cluster 10,997 8,435 12,948
Polymers 2,543 1,973 2,254
Solvents 2,704 1,925 3,094
Olefins & Surfactants 4,016 2,962 5,371
Other 1,734 1,575 2,229
Other businesses 56 28 14
Total operations 18,624 15,176 22,838
Geographic Segmentation of Trade Receivables
2010 2009 2008
Rm Rm Rm
South Africa 9,443 8,028 11,221
Rest of Africa 281 343 507
Europe 4,455 3,780 6,709
North America 1,695 1,019 1,653
South America 296 187 446
South-East Asia and Australasia 526 495 745
Middle East and India 1,202 678 569
Far East 726 646 988
18,624 15,176 22,838
15. Other Receivables and Prepaid Expenses (in part)




South Africa 489 436 963
Rest of Africa 36 52 102
Europe 379 419 679
North America 179 346 131
South-East Asia and Australasia 11 17 1
Middle East and India 304 566 506
Far East 19 28 25
1,417 1,864 2,407
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18. Long-Term Debt (in part)
2010 2009 2008
Rm Rm Rm
Related Party Long-Term Debt
Included in Long-Term Debt
Third parties 1,566 1,159 134
Joint ventures 78 33 803
1,644 1,192 937
Business Segmentation
South African energy cluster 4,835 4,492 4,422
Mining 99 — —
Gas 2,245 2,271 2,410
Synfuels 2 — —
Oil 2,489 2,221 2,012
International energy cluster 660 814 3,426
Synfuels International 3 3 2,454
Petroleum International 657 811 972
Chemical cluster 2,692 2,486 3,044
Polymers 2,353 2,341 2,861
Solvents 192 — 1
Olefins & Surfactants 117 120 140
Other 30 25 42
Other businesses(*) 7,010 10,095 5,911
Total operations 15,197 17,887 16,803
(*) Other businesses include Sasol Financing which conducts the
group’s treasury activities.




South African energy cluster 4,524 3,299 2,235
Mining 669 567 491
Gas 141 112 77
Synfuels 3,503 2,441 1,515
Oil 211 179 152
International energy cluster 619 591 652
Synfuels International 377 352 535
Petroleum International 242 239 117
Chemical cluster 1,727 1,661 1,518
Polymers 63 50 87
Solvents 144 130 73
Olefins & Surfactants 714 666 794
Other 806 815 564
Other businesses 143 178 86
Total operations 7,013 5,729 4,491
22. Long-Term Deferred Income (in part)
Amounts received in respect of capital investment, to be
recognised in income over the useful lives of the underlying
assets, as well as emission rights received to be recognised




South African energy cluster 42 44 31
Gas 22 25 27
Oil 20 19 4
Chemical cluster 231 253 345
Polymers 168 172 204
Solvents — — 34
Olefins & Surfactants 63 81 107
Total operations 273 297 376




Synfuels International 14 — —
Polymers 300 291 590
Olefins & Surfactants 31 87 17
Financing — — 1,645
Other chemical businesses 111 112 123
456 490 2,375
26. Short-Term Provisions (in part)
2010 2009 2008
Note Rm Rm Rm
Employee provisions 160 173 130
Insurance related provisions 128 238 119
Restructuring provisions 111 78 13
Provision in respect of EGTL 1,274 1,280 —
Other provisions 368 586 454
2,041 2,355 716
Short-term portion of
Long-term provisions 20 574 1,177 1,123
Post-retirement benefit





South African energy cluster 224 161 134
Mining 62 46 47
Gas 1 1 4
Synfuels 141 79 31
Oil 20 35 52
International energy cluster 1,387 2,118 441
Synfuels International 1,326 2,085 419
Petroleum International 61 33 22
Chemical cluster 682 1,004 1,194
Polymers 65 70 62
Solvents 141 144 139
Olefins & Surfactants 275 504 733
Other 201 286 260
Other businesses 354 309 182
Total operations 2,647 3,592 1,951
IFRS ATT 7.26
561Section 7: Operating Segments




South African energy cluster 6,124 5,931 6,737
Mining 592 746 603
Gas 128 104 133
Synfuels 1,426 969 1,113
Oil 3,978 4,112 4,888
International energy cluster 443 803 819
Synfuels International 383 526 698
Petroleum International 60 277 121
Chemical cluster 5,488 4,858 7,246
Polymers 902 1,131 895
Solvents 864 851 1,023
Olefins & Surfactants 2,475 1,711 3,434
Other 1,247 1,165 1,894
Other businesses 1,280 1,329 781
Total operations 13,335 12,921 15,583
30. Other Payables (in part)
2010 2009 2008
Note Rm Rm Rm
Employee related payables 2,950 2,426 2,590
Insurance related payables 196 198 380
Fuel related payables(∗) 169 192 —
Other payables 734 486 486
1.1 4,049 3,302 3,456
(∗) Relates to the overrecovery by Sasol Oil on regulated fuel prices,




South African energy cluster 1,161 717 622
Mining 229 — 126
Gas 41 39 25
Synfuels 428 324 327
Oil 463 354 144
International energy cluster 113 79 70
Synfuels International 65 34 38
Petroleum International 48 45 32
Chemical cluster 1,479 1,293 1,419
Polymers 465 251 375
Solvents 127 124 167
Olefins & Surfactants 423 336 534
Other 464 582 343
Other businesses 1,296 1,213 1,345
Total operations 4,049 3,302 3,456




South African energy cluster 53,493 58,167 58,515
Mining 1,696 2,885 2,470
Gas 2,986 2,829 2,563
Synfuels 879 1,367 982
Oil 47,932 51,086 52,500
International energy cluster 3,198 4,183 3,016
Synfuels International 2,282 3,027 1,788
Petroleum International 916 1,156 1,228
Chemical cluster 65,386 75,315 68,187
Polymers 14,236 15,326 11,162
Solvents 14,425 16,317 15,585
Olefins & Surfactants 24,774 28,867 28,125
Other 11,951 14,805 13,315
Other businesses 179 171 225
Total operations 122,256 137,836 129,943
32. Cost of Sales and Services Rendered
2010 2009 2008
Rm Rm Rm
Cost of sales of products 78,886 87,995 74,160
Cost of services rendered 297 513 474
79,183 88,508 74,634
Business Segmentation
South African energy cluster 39,187 37,727 33,689
Mining 5,833 5,438 4,551
Gas 784 734 796
Synfuels 9,734 6,006 9,515
Oil 22,836 25,549 18,827
International energy cluster 1,371 1,638 1,080
Synfuels International 609 957 608
Petroleum International 762 681 472
Chemical cluster 36,819 47,998 39,072
Polymers 4,346 4,951 2,185
Solvents 4,538 6,651 5,488
Olefins & Surfactants 18,920 24,922 22,625
Other 9,015 11,474 8,774
Other businesses 1,806 1,145 793
Total operations 79,183 88,508 74,634




Synfuels 4 3 3
Polymers 220 273 251
Olefins & Surfactants (1) (9) (1)
Other (6) 3 1
Total operations 217 270 254
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South African energy cluster 5,296 8,395 8,329
Mining 229 416 332
Gas 722 677 547
Synfuels 4,042 7,389 5,905
Oil 303 (87) 1,545
International energy cluster (36) 824 225
Synfuels International (345) 192 (191)
Petroleum International 309 632 416
Chemical cluster 968 433 1,385
Polymers 153 (75) 422
Solvents 291 331 474
Olefins & Surfactants 192 (37) 195
Other 332 214 294
Other businesses 757 828 190
Total operations 6,985 10,480 10,129
42. Remeasurement Items Affecting Operating Profit
2010 2009 2008
Note Rm Rm Rm
Impairment of — (110) (458) (821)
property, plant and equipment 3 (47) (294) (447)
assets under construction 4 (61) (19) (371)
other intangible assets 6 (1) (137) (3)
investments in securities 7 (1) (8) —
Reversal of impairment of — 365 — 381
property, plant and equipment 3 348 — 381
assets under construction — 2 — —
other intangible assets — 15 — —
Profit/(loss) on disposal of — 5 (761) 440
property, plant and equipment — 4 11 79
other intangible assets — (1) (2) 12
investment in associate 56 7 — —
investments in businesses 56 (5) (770) 349
Loss on repurchase of participation rights in GTL project — — — (34)
Scrapping of property, plant and equipment — (124) (133) (96)
Scrapping of assets under construction — (32) (101) (11)
Write off of unsuccessful exploration wells — (58) (16) —
Realisation of foreign currency translation reserve 34 — — (557)
— 46 (1,469) (698)
Tax effect thereon — 19 (35) 229
Non-controlling interests effect thereon — — — (4)
— 65 (1,504) (473)
Business Segmentation
South African energy cluster — (69) (141) (116)
Mining — (1) (3) (7)
Gas — — (4) (104)
Synfuels — (58 (137) (25)
Oil — (10) 3 20
International energy cluster — (112) (794) (369)
Synfuels International — (4) (777) (396)
Petroleum International — (108) (17) 27
Chemical cluster — 251 (510) (294)
Polymers — (14) 1 12
Solvents — (58) (158) (104)
Olefins & Surfactants — 344 (106) 27
Other — (21) (247) (229)
Other businesses — (24) (24) 81
Total operations — 46 (1,469) (698)
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Management determines the expected performance of the
assets based on past performance and its expectations of
market development. The weighted average growth rates
used are consistent with the increase in the geographic seg-
ment long-term Producer Price Index. Estimations are based
on a number of key assumptions such as volume, price, prod-
uct mix which will create a basis for future growth and gross
margin. These assumptions are set in relation to historic fig-
ures and external reports on market growth. If necessary,
these cash flows are then adjusted to take into account any
changes in assumptions or operating conditions that have
been identified subsequent to the preparation of the budgets.




South African energy cluster (3) (4) (4)
International energy cluster (1,050) (932) (337)
Synfuels International (1,070) (959) (399)
Petroleum International 20 27 62
Chemical cluster 1,118 1,192 2,007
Polymers 105 36 398
Solvents 554 830 956
Olefins & Surfactants (189) 189 689
Wax 986 1,012 1,354
Other (338) (875) (1,390)
Other businesses 72 683 1,340
Financing 38 640 1,282
Other 34 43 58
137 939 3,006
50. Cash Flow From Operations (in part)
2010 2009 2008
Note Rm Rm Rm
Business Segmentation
South African energy cluster 22,166 32,784 30,513
Mining 1,727 2,437 2,077
Gas 2,793 2,778 2,192
Synfuels 15,754 27,346 20,185
Oil 1,917 393 6,112
Other (25) (170) (53)
International energy cluster 515 2,453 2,401
Synfuels International (349) 1,113 1,157
Petroleum International 864 1,340 1,244
Chemical cluster 7,937 2,545 9,303
Polymers 2,056 2,211 2,479
Solvents 1,894 1,348 2,979
Olefins & Surfactants 2,746 1,020 2,204
Other 1,241 (2,034) 1,641
Other businesses 144 (588) 341
Total operations 30,762 37,194 42,558
58. Commitments Under Leases (in part)
2010 2009 2008
Rm Rm Rm
Total minimum future lease payments 7,159 7,227 7,516
These leasing arrangements do not impose any significant




Future Operating Lease Payments
South African energy cluster 4,908 4,945 4,909
Mining 1 — 1
Gas 1,412 1,495 1,388
Synfuels 3,188 3,145 3,352
Oil 307 305 168
International energy cluster 720 651 779
Synfuels International 431 372 456
Petroleum International 289 279 323
Chemical cluster 1,227 1,296 1,422
Polymers 198 202 125
Solvents 316 285 387
Olefins & Surfactants 404 459 591
Other 309 350 319
Other businesses 304 335 406
7,159 7,227 7,516
Operating Segments Defined on the Basis of
Geographic Areas, Revised Based on Change
in Organizational Structure
7.27
Vodafone Group plc (Mar 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Segment Analysis
The Group has a single group of related services and prod-
ucts being the supply of communications services and prod-
ucts. Segment information is provided on the basis of geo-
graphic areas, being the basis on which the Group manages
its worldwide interests. Revenue is attributed to a country or
region based on the location of the Group company reporting
the revenue. Inter-segment sales are charged at arm’s length
prices.
During the year ended 31 March 2011 the Group changed
its organisation structure to enable continued improvement
in the delivery of the Group’s strategic goals. The Europe
region now consists of all existing controlled businesses in
Europe plus the Group’s interests in Czech Republic, Hun-
gary, Romania and Turkey. The Africa, Middle East and Asia
Pacific region includes the Group’s interests in Egypt, India,
Ghana, Kenya, Qatar and Vodacom as well as Australia,
New Zealand and Fiji. Non-Controlled Interests and Common
Functions includes Verizon Wireless, SFR and Polkomtel
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as well as central Group functions. The tables below present
segment information on the revised basis, with prior years






Revenue Revenue Revenue Revenue Revenue EBITDA(1)
£m £m £m £m £m £m
31 March 2011
Germany 7,900 (51) 7,849 (2) 7,847 2,952
Italy 5,722 (31) 5,691 (3) 5,688 2,643
Spain 5,133 (62) 5,071 (2) 5,069 1,562
UK 5,271 (50) 5,221 (7) 5,214 1,233
Other Europe 8,253 (70) 8,183 (3) 8,180 2,433
Europe 32,279 (264) 32,015 (17) 31,998 10,823
India 3,855 (1) 3,854 (11) 3,843 985
Vodacom 5,479 — 5,479 (8) 5,471 1,844
Other Africa, Middle East and Asia Pacific 3,971 — 3,971 (27) 3,944 1,170
Africa, Middle East and Asia Pacific 13,305 (1) 13,304 (46) 13,258 3,999
Non-Controlled Interests and Common Functions 659 — 659 (31) 628 (152)
Group 46,243 (265) 45,978 (94) 45,884 14,670
Verizon Wireless 18,711(2) 7,313
31 March 2010
Germany 8,008 (41) 7,967 (8) 7,959 3,122
Italy 6,027 (40) 5,987 (2) 5,985 2,843
Spain 5,713 (81) 5,632 (2) 5,630 1,956
UK 5,025 (47) 4,978 (10) 4,968 1,141
Other Europe 8,357 (88) 8,269 (5) 8,264 2,582
Europe 33,130 (297) 32,833 (27) 32,806 11,644
India 3,114 (1) 3,113 (20) 3,093 807
Vodacom 4,450 — 4,450 (7) 4,443 1,528
Other Africa, Middle East and Asia Pacific 3,526 — 3,526 (30) 3,496 977
Africa, Middle East and Asia Pacific 11,090 (1) 11,089 (57) 11,032 3,312
Non-Controlled Interests and Common Functions 667 — 667 (33) 634 (221)
Group 44,887 (298) 44,589 (117) 44,472 14,735
Verizon Wireless 17,222(2) 6,689
31 March 2009
Germany 7,847 (59) 7,788 (9) 7,779 3,225
Italy 5,547 (39) 5,508 (3) 5,505 2,565
Spain 5,812 (95) 5,717 (2) 5,715 2,034
UK 5,392 (48) 5,344 (8) 5,336 1,368
Other Europe 8,514 (102) 8,412 (3) 8,409 2,920
Europe 33,112 (343) 32,769 (25) 32,744 12,112
India 2,689 (2) 2,687 (18) 2,669 717
Vodacom 1,778 — 1,778 — 1,778 606
Other Africa, Middle East and Asia Pacific 3,258 — 3,258 (32) 3,226 1,072
Africa, Middle East and Asia Pacific 7,725 (2) 7,723 (50) 7,673 2,395
Non-Controlled Interests and Common Functions 614 — 614 (14) 600 (17)
Group 41,451 (345) 41,106 (89) 41,017 14,490
Verizon Wireless 14,085(2) 5,543
Notes:
(1) The Group’s measure of segment profit, adjusted EBITDA, excludes the Group’s share of results in associates. The Group’s share of results
in associates, by segment, for the year ended 31 March 2011 is Other Europe £nil (2010: £nil; 2009 £(3) million), Vodacom £nil (2010: £(2)
million; 2009: £(1) million), Other Africa, Middle East and Asia Pacific £51 million (2010: £56 million; 2009: £31 million) and Non-Controlled
Interests and Common Functions £5,008 million (2010: £4,688 million; 2009: £4,064 million).
(2) Values shown for Verizon Wireless, which is an associate, are not included in the calculation of Group revenue or adjusted EBITDA.
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A reconciliation of adjusted EBITDA to operating profit is
shown below. For a reconciliation of operating profit to profit




Adjusted EBITDA 14,670 14,735 14,490
Depreciation, amortisation and loss on disposal of fixed assets (7,967) (8,011) (6,824)
Share of results in associates 5,059 4,742 4,091
Impairment losses (6,150) (2,100) (5,900)
Other income and expense (16) 114 —
















£m £m £m £m £m
31 March 2011
Germany 20,764 824 1,214 1,361 —
Italy 16,645 590 12 732 1,050
Spain 9,596 517 — 641 2,950
UK 6,665 516 — 874 —
Other Europe 11,438 1,230 59 1,406 2,150
Europe 65,108 3,677 1,285 5,014 6,150
India 9,882 870 1,851 973 —
Vodacom 7,382 572 19 1,013 —
Other Africa, Middle East and Asia Pacific 4,797 754 2 793 —
Africa, Middle East and Asia Pacific 22,061 2,196 1,872 2,779 —
Non-Controlled Interests and Common Functions 1,570 346 9 83 —
Group 88,739 6,219 3,166 7,876 6,150
31 March 2010
Germany 20,211 766 18 1,422 —
Italy 17,941 610 60 732 —
Spain 12,746 543 — 638 —
UK 6,977 494 — 963 —
Other Europe 13,883 1,282 228 1,467 (200)
Europe 71,758 3,695 306 5,222 (200)
India 8,665 853 — 848 2,300
Vodacom 7,783 520 — 1,005 —
Other Africa, Middle East and Asia Pacific 5,062 694 — 683 —
Africa, Middle East and Asia Pacific 21,510 2,067 — 2,536 2,300
Non-Controlled Interests and Common Functions 1,632 430 19 152 —
Group 94,900 6,192 325 7,910 2,100
31 March 2009
Germany 750 16 1,378 —
Italy 521 — 735 —
Spain 632 — 606 3,400
UK 446 — 1,010 —
Other Europe 1,013 21 1,441 2,250
Europe 3,362 37 5,170 5,650
India 1,351 — 746 —
Vodacom 237 — 231 —
Other Africa, Middle East and Asia Pacific 581 1,101 527 250
Africa, Middle East and Asia Pacific 2,169 1,101 1,504 250
Non-Controlled Interests and Common Functions 378 — 140 —
Group 5,909 1,138 6,814 5,900
Notes:
(1) Comprises goodwill, other intangible assets and property, plant and equipment.
(2) Includes additions to property, plant and equipment and computer software, reported within intangible assets.
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Initial Application of IFRSs and IFRS 8,
Reconciliation of Segment Information
Presented Under Argentine GAAP and IFRSs
7.28
Nortel Inversora S.A. (Dec 2010)
Author’s Note
Nortel Inversora S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of Jan-
uary 1, 2009. The excerpt that follows reflects the initial
application of IFRS 8.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1—Description of Business and Basis of
Preparation of the Consolidated Financial Statements
(in part)
b) Segment Reporting
An operating segment is defined as a component of an entity
on which financial information is held separately and which is
evaluated regularly by the CODM.
Operating segments are reported in a manner consistent
with the internal reporting provided to the CODM. The CODM,
who is responsible for allocating resources and assessing
performance of the operating segments, assesses the per-
formance of the operating segments at the net income (loss)
level and under the accounting principles effective at each
time for reporting to the national Regulatory Bodies. There-
fore, the financial information provided to the CODM during
2010 and 2009 was based on Argentine GAAP rather than
IFRS. Reconciliations between segment information amounts
presented under Argentine GAAP and IFRS as of December
31, 2010 and 2009 and for the years then ended are included
in Note 28.
The accounting policies applied for segment information
are the same for all operating segments. Additional informa-
tion regarding segment information under IFRS is included in
Note 30.
Note 3—Significant Accounting Policies (in part)
e) Revenues
Revenues are recognized to the extent that it is considered
probable that economic benefits will flow to the Company and
their amount can be measured reliably. Final outcome may
differ from those estimates.
Revenues are stated net of discounts and returns.
The Company discloses its revenues into two groups: ser-
vices and equipment. Service revenues are the main source
of income for the Company and are disclosed by nature: Voice
services and Data transmission and Internet services. This
classification of revenues is given by different commercial of-
fers and products, type of contracts and kind of customers.
Equipment sales represent a way to increase service rev-
enues; therefore, from time to time, the Management of Per-
sonal and Núcleo decide to sell mobile handsets at prices
lower than their respective costs in order to acquire new con-
tracts with a minimum non-cancelable period of permanence.
Other income mainly includes penalties collected from sup-
pliers and gains (losses) on the sale of PP&E, which are re-
alized in the ordinary course of business but are not the main
business objective.
The Company’s principal sources of revenues by re-
portable segments are:
Fixed Telecommunication Services and Products
Domestic services revenues consist of monthly basic fees,
measured service, long-distance calls and monthly fees for
additional services, including call forwarding, call waiting,
three-way calling, itemized billing and voicemail.
Revenues are recognized when services are rendered. Un-
billed revenues from the billing cycle dating to the end of each
month are calculated based on traffic and are accrued at the
end of the month.
Basic fees are generally billed monthly in advance and are
recognized when services are provided. Billed basic fees for
which the related service has not yet been provided are de-
ducted from corresponding accounts receivable. Revenues
derived from other telecommunications services, principally
network access, long distance and airtime usage, are recog-
nized on a monthly basis as services are provided.
Traffic revenues from interconnection and roaming are re-
ported gross of the amounts due to other telecommunication
operators.
Revenues from the sale of prepaid calling cards are recog-
nized on the basis of the minutes used, at the contract price
per minute, or when the card expires, whichever happens
first. Remaining unused traffic for unexpired calling cards is
shown as “Deferred revenue on prepaid calling cards” under
Trade payables line item in the statement of financial position.
Interconnection charges represent amounts received by
the Company from other local service providers and long-
distance carriers for calls that are originated on their networks
and transit and/or terminate on the Company’s network. Rev-
enue is recognized as services when they are provided.
Non-refundable up-front connection fees for fixed tele-
phony, data and Internet services that are non-separable
from the service are accounted for as a single transaction
and deferred (as well as the related costs not in excess of the
amount of revenues) over the term of the contract or, in the
case of indefinite period contracts, over the average period of
the customer relationship (approximately 9 years in the case
of fixed telephony).
Rehabilitation fees charged to customers when resuming
service after suspension are deferred and recognized ratably
over the average life for those customers who are assessed
a rehabilitation fee. Associated direct expenses are also de-
ferred over the estimated customer relationship period up to
an amount equal to or less than the amount of deferred rev-
enues. Generally, rehabilitation revenues are higher than its
associated direct expenses.
Revenues from sales of goods, such as telephone and
other equipment, are recognized when the significant risks
and rewards of ownership are transferred to the buyer.
Revenues on construction contracts are recognized based
on the stage of completion (percentage of completion
method). When the outcome of a construction contract can
be estimated reliably, contract revenue and contract costs
associated with the construction contract are recognized as
revenue and expenses respectively by reference to the stage
of completion of the contract activity at the end of the report-
ing period. When it is probable that total contract costs will
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exceed total contract revenue, the expected loss is recog-
nized as an expense immediately. When the outcome of a
construction contract cannot be estimated reliably, contract
revenue is recognized only to the extent of contract costs
incurred that are likely to be recoverable.
Contract revenue recognized as revenue in the years
ended December 31, 2010 and 2009 total $14 and $nil, re-
spectively.
International Long-Distance Services
The Company provides international telecommunications
services in Argentina including voice and data services and
international point-to-point leased circuits.
Revenues from international long-distance service reflect
payments under bilateral agreements between the Company
and foreign telecommunications carriers, covering inbound
international long-distance calls.
Revenues are recognized as services when they are
provided.
Data Transmission and Internet Services
Data and Internet revenues mainly consist of fixed monthly
fees received from residential and corporate customers for
data transmission (including private networks, dedicated
lines, broadcasting signal transport and videoconferencing
services) and Internet connectivity services (dial-up and
broadband). These revenues are recognized as services
when they are rendered.
Mobile Telecommunication Services and Products
The Company provides mobile services throughout Argentina
via cellular networks. Cellular fees consist of monthly ba-
sic fees, airtime usage charges, roaming, charges for TLRD,
CPP charges and additional charges for VAS, including call
waiting, call forwarding, three-way calling, voicemail, SMS,
GPRS, Mobile Internet and for other miscellaneous cellular
services. These revenues are recognized as services when
they are rendered.
Basic fees are generally billed monthly in advance and
are recognized when services are provided. Billed basic fees
for which the related service has not yet been provided are
deducted from the corresponding accounts receivable.
Revenues from the sale of prepaid calling cards are recog-
nized on the basis of the minutes used, at the contract price
per minute, or when the card expires, whichever happens
first. Remaining unused traffic for unexpired calling cards is
shown as “Deferred revenue on prepaid calling cards” under
Trade payables line item in the statement of financial position.
Revenues from sales of goods, such as handsets, sim
cards, tablets, smartphones and other equipment are rec-
ognized when the significant risks and rewards of ownership
are transferred to the buyer.
Personal and Núcleo offer to their subscribers a customer
loyalty program. Under such program Personal and Núcleo
grant award credits as part of the sales transactions which
can be subsequently redeemed for goods or services pro-
vided by Personal and Núcleo or third parties. The fair value
of the award credits is accounted for as deferred revenue,
and recognized as revenue when the award credits are re-
deemed or expire, whichever occurs first. Those revenues
are classified as service or goods revenues depending on
the goods or services redeemed by the customers.
Applicable to both fixed telephony and mobile telephony,
for offerings including separately identifiable components (as
equipment and service), the Company recognizes revenues
related to the sale of the equipment when it is delivered to
the final customer whereas service revenues are recorded
when rendered. The total revenue generated by this type of
transactions is allocated to the separately identifiable units of
accounting based on their fair values, provided that the total
amount of revenue to be recognized does not exceed the con-
tract revenue. IFRS does not prescribe a specific method for
such allocation of revenue. However, telecommunications in-
dustry practice generally applies the method known as “resid-
ual method”. The “residual method” requires identifying all the
components that comprise a transaction and allocating its
fair value on an individual basis to each of them. Under this
method, the fair value of a delivered item (which could not
be individually determined) is determined as the difference
between the total arrangement consideration and the sum of
the fair values of those elements for which fair value can be
estimated on a stand-alone basis.
k) Impairment of Intangible Assets and PP&E (in part)
Intangible assets with an indefinite useful life (including intan-
gible assets not ready to use) are not subject to amortization
and are tested at least annually for impairment. The only
intangible asset with an indefinite useful life held by the Com-
pany at December 31, 2010 and 2009 is the PCS license
(Argentina), which is entirely allocated to the Personal Mobile
Service operating segment. Its recoverable amount is deter-
mined based on the value in use, which is estimated using
discounted net cash flows projections.
l) Other Liabilities (in part)
• Deferred revenue on sale of capacity
Under certain network capacity purchase agreements, the
Company sells excess purchased capacity to other carriers.
Revenues are deferred and recognized as services revenues
when they are provided. Those revenues are recorded un-
der the item line “Data and Internet” in the Fixed services
segment.
Note 21—Revenues (in part)
The Company discloses its service revenues in two groups by
nature: Voice and Data and Internet. At December 31, 2010




Fixed customer lines 4,019,000 3,967,000
ADSL subscribers 1,380,000 1,214,000
Personal mobile services customers 16,333,000 14,475,000
Núcleo mobile services customers 1,878,000 1,806,000
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Note 23—Operating Income
Years Ended December 31
2010 2009
Operating Income From Services and Other Income
Revenues and other income 13,563 11,359
Operating expenses (8,578) (7,137)
Operating income before D&A (a) 4,985 4,222
D&A (b) (1,712) (1,545)
Operating income from services 3,273 2,677
Operating Loss From Equipment Sales
Revenues 1,096 845
Cost of equipment and handsets (1,207) (906)
Operating loss before D&A from equipment sales (c) (111) (61)
Total operating income 3,162 2,616
Consolidated Operating Income
Operating income before D&A (a) + (c) 4,874 4,161
D&A (b) (1,712) (1,545)
Total operating income 3,162 2,616
The breakdown of operating income by segment is as follows:
Year Ended December 31, 2010 Fixed Services Mobile Services Total Consolidated
Services and Other Revenues
Third party revenues 4,610 8,953 13,563
Intersegment revenues 739 61 800
Third party operating expenses (3,609) (4,969) (8,578)
Intersegment operating expenses (61) (739) (800)
Operating income before D&A from services (1) 1,679 3,306 4,985
Equipment and Handsets Sales
Third party revenues 70 1,026 1,096
Third party operating expenses (55) (1,152) (1,207)
Operating income (loss) from equipment and handsets sales (2) 15 (126) (111)
Total operating income before D&A (3) = (1) + (2) 1,694 3,180 4,874
D&A (4) (776) (936) (1,712)
Operating income (5) = (3) – (4) 918 2,244 3,162
Net effect of the intersegment eliminations (6) (678) 678 —
Net segment contribution to the Operating income before D&A (7) = (3) + (6) 1,016 3,858 4,874
Net segment contribution to the Operating income (8) = (5) + (6) 240 2,922 3,162
Year Ended December 31, 2009 Fixed Services Mobile Services Total Consolidated
Services and Other Revenues
Third party revenues 4,143 7,216 11,359
Intersegment revenues 687 44 731
Third party operating expenses (3,064) (4,073) (7,137)
Intersegment operating expenses (44) (687) (731)
Operating income before D&A from services (1) 1,722 2,500 4,222
Equipment and Handsets Sales
Third party revenues 43 802 845
Third party operating expenses (46) (860) (906)
Operating loss from equipment and handsets sales (2) (3) (58) (61)
Total operating income before D&A (3) = (1) + (2) 1,719 2,442 4,161
D&A (4) (721) (824) (1,545)
Operating income (5) = (3)–(4) 998 1,618 2,616
Net effect of the intersegment eliminations (6) (643) 643 —
Net segment contribution to the Operating income before D&A (7) = (3) + (6) 1,076 3,085 4,161
Net segment contribution to the Operating income (8) = (5) + (6) 355 2,261 2,616
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Note 28—Segment Information
The Company conducts its business through six legal enti-
ties each one has been identified as an operating segment.
As explained in Note 1.b) the financial information provided
to the CODM during 2010 and 2009 was based on Argen-
tine GAAP. Consequently, the following segment information
was prepared under Argentine GAAP and reconciled to IFRS
in a consolidated basis in accordance with the provisions of
IFRS 8. It is noted that the Management’s policy is to moni-
tor the economic-financial performance of its operations using
GAAP measures in accordance with its statutory books. At the
date of issuance of these consolidated financial statements,
the Company has adapted its systems and accounting pro-
cedures in order to provide segment information under IFRS.
Additional information on segment information under full IFRS
is given in Note 30.
Under Argentine GAAP the Company has combined the
operating segments into two reportable segments (Fixed and
Mobile services) based on the nature of products provided by
the entities as follows:
Reportable Segment Legal Entity
Fixed telecommunication services Telecom Argentina
Telecom USA
Micro Sistemas
Mobile telecommunication services Personal
Springville
Núcleo
However, in assessing the aggregation criteria under IFRS
for combined operating segments in the “mobile services”
reportable segment, the Company determined that Núcleo
(the subsidiary which provides mobile services in Paraguay)
would not be aggregated together with Personal since it op-
erates in a different regulatory and economic framework. As
a result, under IFRS three reportable segments would be de-
termined: “Fixed services,” “Personal Mobile Services” and
“Núcleo Mobile Services.”
Segment financial information specially prepared for these
consolidated financial statements under IFRS was as follows:
For the Year Ended December 31, 2010


























Services 4,584 8,483 530 9,013 13,597 (66) — 13,531
Equipment sales 56 1,018 8 1,026 1,082 14 — 1,096
Other income — — — — — — 32 32
Total revenues 4,640 9,501 538 10,039 14,679 (52) 32 14,659
Employee benefit expenses and severance
payments (1,412) (423) (45) (468) (1,880) 6 (101) (1,975)
Interconnection costs and other
telecommunication charges (418) (887) (85) (972) (1,390) 13 — (1,377)
Fees for services, maintenance, materials and
supplies (712) (604) (55) (659) (1,371) 34 11 (1,326)
Taxes and fees with the Regulatory Authority (308) (934) (19) (953) (1,261) 3 4 (1,254)
Commissions (120) (1,112) (54) (1,166) (1,286) 145 — (1,141)
Cost of equipment and handsets (45) (1,463) (33) (1,496) (1,541) 362 (28) (1,207)
Advertising (142) (270) (39) (309) (451) 10 — (441)
Provisions — — — — — — (130) (130)
Bad debt expenses (24) (92) (3) (95) (119) — — (119)
Other operating expenses (380) (408) (37) (445) (825) 18 (8) (815)
Operating income before D&A 1,079 3,308 168 3,476 4,555 539 (220) 4,874
Depreciation of PP&E and amortization of
intangible assets (719) (530) (105) (635) (1,354) (358) — (1,712)
Operating income 360 2,778 63 2,841 3,201 181 (220) 3,162
Financial results, net 74 (117) 9 (108) (34) (6) (97) (137)
Other expenses, net (213) (103) (1) (104) (317) — 317 —
Net income before income tax and noncontrolling
interest 221 2,558 71 2,629 2,850 175 — 3,025
Income tax expense, net (324) (675) (11) (686) (1,010) (66) — (1,076)
Noncontrolling interest — — (19) (19) (19) 19 — —
Net (loss) income (103) 1,883 41 1,924 1,821 128 — 1,949
Net income attributable to owners of the Parent — — — — — — — 1,935
Net income attributable to noncontrolling interest — — — — — — — 14
— — — — — — — 1,949
(a) Includes net revenues of $48, operating income before D&A of $15, operating income of $11 and net income of $11 corresponding to
Telecom USA.
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PP&E, net 4,411 2,439 629 3,068 7,479 (118) 4 7,365
Intangible assets, net 171 591 7 598 769 464 — 1,233
Capital expenditures 1,048 791 185 976 2,024 534 (24) 2,534
Net financial asset (debt) 874(b) 504 (154) 350 1,224 — — 1,224
(b) In Net financial asset, includes $2 of Cash and cash equivalents from Springville.
For the Year Ended December 31, 2009


























Services 4,114 6,832 435 7,267 11,381 (56) — 11,325
Equipment sales 43 796 6 802 845 — — 845
Other income — — — — — — 34 34
Total revenues 4,157 7,628 441 8,069 12,226 (56) 34 12,204
Employee benefit expenses and severance
payments (1,151) (314) (39) (353) (1,504) 5 (73) (1,572)
Interconnection costs and other
telecommunication charges (415) (873) (84) (957) (1,372) 11 — (1,361)
Fees for services, maintenance, materials and
supplies (622) (435) (40) (475) (1,097) 34 (8) (1,071)
Taxes and fees with the Regulatory Authority (266) (716) (17) (733) (999) 2 (14) (1,011)
Commissions (105) (922) (41) (963) (1,068) 126 — (942)
Cost of equipment and handsets (46) (1,082) (9) (1,091) (1,137) 256 (25) (906)
Advertising (118) (216) (26) (242) (360) 3 — (357)
Provisions — — — — — — (48) (48)
Bad debt expenses (33) (96) (2) (98) (131) — — (131)
Other operating expenses (322) (308) (28) (336) (658) 21 (7) (644)
Operating income before D&A 1,079 2,666 155 2,821 3,900 402 (141) 4,161
Depreciation of PP&E and amortization of
intangible assets (663) (381) (94) (475) (1,138) (407) — (1,545)
Operating income 416 2,285 61 2,346 2,762 (5) (141) 2,616
Other income from investments — 13 — 13 13 — — 13
Financial results, net (172) (150) (7) (157) (329) 3 (88) (414)
Other expenses, net (148) (79) (2) (81) (229) — 229 —
Net income before income tax and
noncontrolling interest 96 2,069 52 2,121 2,217 (2) — 2,215
Income tax, net (271) (519) (7) (526) (797) (1) — (798)
Noncontrolling interest — — (15) (15) (15) 15 — —
Net (loss) income (175) 1,550 30 1,580 1,405 12 — 1,417
Net income attributable to owners of the Parent — — — — — — — 1,405
Net income attributable to noncontrolling interest — — — — — — — 12
— — — — — — — 1,417
(a) Includes net revenues of $42, operating income before D&A of $15, operating income of $11 and net income of $10 corresponding to Telecom USA.
IFRS ATT 7.28
571Section 7: Operating Segments


























PP&E, net 4,176(b) 2,192 471 2,663 6,839 (73) 1 6,767
Intangible assets, net 176 594 3 597 773 299 — 1,072
Capital expenditures 915(b) 790 116 906 1,821 410 (18) 2,213
Net financial asset (debt) 579(b) 4 (114) (110) 469 — — 469
(b) In PP&E, net and Capital expenditures, includes $1 from Springville; in Net financial asset, includes $2 of Cash and cash equivalents from
Springville.
Note 30—Additional Information Regarding Segment
Information
As explained in Notes 1.b) and 28 the financial information
provided to the CODM during 2010 and 2009 was based on
Argentine GAAP rather than IFRS because Telecom Group’s
policy is to monitor the economic-financial performance of
its operations using GAAP measures in accordance with its
statutory books.
As the Company will adopt IFRS for financial reporting mat-
ters, Management has adapted its systems and accounting
procedures in order to prepare these consolidated financial
statements under IFRS. To monitor its operations for the fi-
nancial year 2011 Management will use both Argentine GAAP
and IFRS sets of information. During 2012, as IFRS is manda-
tory for statutory purposes, the Company will use exclusively
IFRS to monitor its operations.
Consequently, the tables below show the information that
would be reported if segment information under IFRS had
been applied instead of Argentine GAAP during financial
years ended December 31, 2010 and 2009:
For the Year Ended December 31, 2010
• Income statement information
Fixed Mobile Services
Services Personal Núcleo Subtotal Eliminations Total
Total revenues(1) 5,419 9,571 469 10,040 (800) 14,659
Employee benefit expenses and severance payments (1,502) (433) (40) (473) — (1,975)
Interconnection costs and other telecommunication charges (456) (1,428) (77) (1,505) 584 (1,377)
Fees for services, maintenance, materials and supplies (679) (691) (52) (743) 96 (1,326)
Taxes and fees with the Regulatory Authority (304) (934) (16) (950) — (1,254)
Commissions (100) (1,051) (45) (1,096) 55 (1,141)
Cost of equipment and handsets (55) (1,139) (13) (1,152) — (1,207)
Advertising (142) (266) (33) (299) — (441)
Provisions (71) (59) — (59) — (130)
Bad debt expenses (24) (92) (3) (95) — (119)
Other operating expenses (392) (456) (32) (488) 65 (815)
Operating income before D&A 1,694 3,022 158 3,180 — 4,874
Depreciation of PP&E (687) (529) (86) (615) — (1,302)
Amortization of SAC and service connection costs (68) (311) (8) (319) — (387)
Amortization of other intangible assets (21) (1) (1) (2) — (23)
Operating income 918 2,181 63 2,244 — 3,162
Financial results, net 3 (129) (11) (140) — (137)
Net income before income tax expense 921 2,052 52 2,104 — 3,025
Income tax expense, net (329) (737) (10) (747) — (1,076)
Net income 592 1,315 42 1,357 — 1,949
Net income attributable to owners of the Parent — — — — — 1,935
Net income attributable to noncontrolling interest — — — — — 14
— — — — — 1,949
(1)
Service revenues 4,590 8,483 458 8,941 — 13,531
Equipment sales 70 1,018 8 1,026 — 1,096
Other income 20 12 — 12 — 32
Subtotal third party revenues 4,680 9,513 466 9,979 — 14,659
Intersegment revenues 739 58 3 61 (800) —
Total revenues 5,419 9,571 469 10,040 (800) 14,659
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• Balance sheet information
Fixed Mobile Services
Services Personal Núcleo Subtotal Eliminations Total
PP&E, net 4,366 2,440 559 2,999 — 7,365
Intangible assets, net 296 921 16 937 — 1,233
Capital expenditures 1,087 1,266 181 1,447 — 2,534
Net financial asset (debt) 874 504 (154) 350 — 1,224
• Geographic information










Argentina 14,145 13,878 8,108
Abroad 514 781 591
Total 14,659 14,659 8,699
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SECTION 8: FINANCIAL INSTRUMENTS AND RELATED
DISCLOSURES∗
IFRS 7, FINANCIAL INSTRUMENTS:
DISCLOSURES
IAS 32, FINANCIAL INSTRUMENTS:
PRESENTATION
IAS 39, FINANCIAL INSTRUMENTS:
RECOGNITION AND MEASUREMENT
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
Accounting for financial instruments is a major con-
vergence project of the International Accounting Stan-
dards Board (IASB) and the Financial Accounting
Standards Board (FASB), although the boards are not
issuing joint exposure drafts and are proceeding with
their respective projects on different schedules. The ob-
jective of this project is to improve the usefulness for
users of financial statements by simplifying the clas-
sification and measurement requirements for financial
instruments.
The following discussion provides a brief overview
of the state of this project as of 1 July 2011. Read-
ers can find more information about decisions to date
and the expected publication of due process documents
for the IASB under the “Standards Development” sec-
tion of its website at www.ifrs.org. The latest informa-
tion about International Financial Reporting Standard
(IFRS) 9, Financial Instruments (replacement of IAS
39), can be found under the “Work Plan for IFRSs”
section of the IASB’s website at www.ifrs.org. Infor-
mation about FASB’s projects can be found under the
“Projects” section of FASB’s website at www.fasb.org.
IASB Project
For the IASB, accomplishing the project’s objective
involves replacing International Accounting Standard
(IAS) 39, Financial Instruments: Recognition and
Measurement, which is to take place in the following
three phases:
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version of
those standards and interpretations included in IFRS 2011 bound volume,
the official printed consolidated text of IASB standards and interpretations,
including revisions, amendments, and supporting documents, issued as of
1 January 2011.
1. Classification and measurement
In November 2009, the IASB issued International
Financial Reporting Standard (IFRS) 9, Financial
Instruments, which only addressed classification
and measurement of financial assets. As the IASB
completes phase 1 and the other phases of the
project, it plans to delete sections of IAS 39 and
replace them with new sections in IFRS 9.
In brief, IFRS 9 originally addressed only the
classification and measurement of financial assets.
IFRS 9 requires an entity to classify all financial
assets on the basis of the entity’s business model
for managing financial assets and the contractual
cash flow characteristics of the particular financial
asset under consideration. The standard reduces the
number of classifications for financial assets and re-
quires an entity to measure a financial asset initially
at fair value, including, in the case of a financial as-
set not at fair value through profit or loss (FVTPL),
particular transaction costs. Subsequently, an entity
should measure the financial asset at either cost or
fair value.
In October 2010, the IASB added requirements
for financial liabilities to IFRS 9. Although the
IASB carried forward most requirements for finan-
cial liabilities from IAS 39 unchanged, the IASB
made some changes to the fair value option for fi-
nancial liabilities to address the issue of an entity’s
own credit risk.
As of July 2011, IFRS 9 was effective for annual
periods beginning on or after 1 January 2013, with
earlier application permitted. The survey companies
selected for this edition have annual periods ending
on or before the effective date of IFRS 9. However,
a few survey companies have early adopted IFRS 9.
Excerpts from some of these companies’ financial
statements are provided under “Initial Adoption” in
this section.
2. Amortized cost and impairment of assets
In November 2009, the IASB published an exposure
draft, Financial Instruments: Amortised Cost and
Impairment, with a comment deadline of 30 June
2010. This document used an expected cash flow
approach. In January 2001, the IASB issued a sup-
plementary document, Financial Instruments: Im-
pairment, with a comment deadline of 1 April 2011.
This supplement is a joint document published by
the IASB and FASB. The scope of the document
is open portfolios of financial assets measured at
amortized cost, excluding short-term trade receiv-
ables. At the June 2011 joint meeting, the IASB and
FASB discussed a “three-bucket” expected loss ap-
proach for the impairment of financial assets. The
IASB expects to re-expose or review a revised draft
standard in late 2011 or early 2012.
3. Hedge accounting
The IASB issued an exposure draft, Hedge Account-
ing, in December 2010, with a comment deadline
of 9 March 2011. As of October 2011, the IASB
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continued to deliberate the issues in this document
with expectations of issuing a review draft on gen-
eral hedge accounting in the fourth quarter of 2011
with a target date for issuing an IFRS in the first half
of 2012. With respect to macro hedge accounting,
the IASB expects to issue an exposure draft in the
fourth quarter of 2011.
4. Effective date of IFRS 9
In August 2011, the IASB issued an exposure draft
that proposed postponing the effective date of IFRS
9 to 1 January 2015.
FASB Project
In May 2010, FASB issued an exposure draft proposing
a new comprehensive Accounting Standards Update,
Accounting for Financial Instruments and Revisions to
the Accounting for Derivative Instruments and Hedg-
ing Activities. This exposure draft addressed the issues
in all phases of the IASB project: classification and
measurement of financial assets and financial liabili-
ties, impairment methodology, and hedge accounting.
The comment period ended September 30, 2010. In
this document, FASB proposed to apply a fair value
measurement model for many financial assets and fi-
nancial liabilities. This model differed from the mixed
measurement model in IFRS 9.
Some of FASB’s decisions during its redeliberations
regarding classification and measurement are as fol-
lows:
• An entity would classify and subsequently mea-
sure financial instruments based on both the char-
acteristics of the financial instrument and the en-
tity’s business strategy for the instrument.
• If certain criteria are met, the entity would classify
a financial asset as fair value through net income
(FVNI), fair value through other comprehensive
income (FV-OCI), or amortized cost.
• Similarly, if certain criteria are met, an entity
would classify financial liabilities as either FVNI
or amortized cost.
• Initial measurement at either fair value or transac-
tion price depends upon the financial instrument’s
classification and subsequent measurement. An
entity initially measures at fair value those finan-
cial instruments that are classified as FVNI. Oth-
erwise, the entity uses the transaction price for the
initial measurement.
• An entity classifies and measures derivatives at
FVNI, except those designated as the hedging in-
strument in a cash flow hedge or a hedge of a net
investment in a foreign operation.
• FASB Accounting Standards Codification (ASC)
815-15 retains the requirement to bifurcate hybrid
financial assets and hybrid financial liabilities. An
entity is required to account separately for embed-
ded derivative features of such instruments.
• An entity would measure equity instruments at
FVNI. However, nonpublic entities would have a
practicability exception for nonmarketable equity
securities. The nonpublic entity would measure
these securities at cost, less any impairment, plus
upward adjustments in fair value, when informa-
tion about a change in price is observable.
In August 2010, FASB held an education meeting to
discuss the comments received on its exposure draft,
but has not started to redeliberate hedge accounting
issues.
Other Changes to IFRSs
The IASB also has a separate project on derecognition
of financial instruments that addresses both the existing
derecognition criteria in IAS 39 and the related disclo-
sures in IFRS 7, Financial Instruments: Disclosures.
In May 2010, the IASB and FASB agreed to focus on
increasing the transparency and comparability of their
standards by improving and converging U.S. generally
accepted accounting principles (GAAP) and IFRSs’
disclosure requirements for financial assets transferred
to another entity. The boards plan to conduct additional
research and analysis, including a post-implementation
review of FASB’s recently amended requirements. Fol-
lowing these activities, which are expected to conclude
by 2012, the boards will assess whether to proceed
with any further improvement and convergence efforts
on this issue.
Because of this change in convergence strategy, the
IASB decided to finalize changes to IFRS 7 disclosure
requirements, with a view to converging with FASB
ASC requirements for transfers of financial assets. In
October 2010, the IASB issued amendments to IFRS
7. The amendments are effective for annual periods be-
ginning on or after 1 July 2011, with earlier application
permitted.
On 13 May 2011, the IASB issued IFRS 13, Fair
Value Measurement. IFRS 13 defines fair value, sets
out in a single IFRS the framework for measuring fair
value, and requires disclosures about fair value mea-
surements. It does not determine when an entity is
required to measure an asset or a liability at fair value.
Because IFRS 13 applies when other IFRSs require
or permit fair value measurements, it will apply to fair
value measurement under IAS 39 and IFRS 9. The new
requirements are effective for annual periods beginning
on or after 1 January 2013, with earlier application per-
mitted. No survey company could have applied IFRS
13 in its 2010 financial statements.
8.01 IFRSs define a financial instrument as a contract that
gives rise to a financial asset of one entity and a financial
liability of another. IFRSs establish the accounting and dis-
closure requirements and application guidance for both the
financial asset and financial liability created by such contracts
in the following three standards:
• IAS 32, Financial Instruments: Presentation, estab-
lishes the principles for distinguishing a liability from
an equity instrument and for presenting financial assets
and liabilities net on the balance (offsetting).
• IAS 39 establishes the principles for recognizing and
measuring financial assets and financial liabilities as
well as for some contracts to buy or sell nonfinan-
cial items. IAS 39 also establishes the principles under
which an entity would have an effective hedging rela-
tionship and be able to apply hedge accounting.
• IFRS 7 establishes the disclosures that an entity should
provide about the significance of financial instruments
to their balance sheet and statement of comprehensive
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income and the risks from these instruments to which
it is exposed.
8.02 In addition, the IASB has issued several interpretations
that are applicable to the financial instruments covered by
the previous standards, including the following:
• International Financial Reporting Interpretations Com-
mittees (IFRIC) Interpretation 2, Members’ Shares in
Co-operative Entities and Similar Instruments
• IFRIC 9, Reassessment of Embedded Derivatives
• IFRIC 10, Interim Financial Reporting and Impairment
• IFRIC 16, Hedges of a Net Investment in a Foreign
Operation
Author’s Note
IFRIC 19, Extinguishing Financial Liabilities with Eq-
uity Instruments, issued November 2009, also amends
IAS 39. IFRIC 19 requires an entity to consider equity
instruments issued to extinguish a financial liability to
be consideration paid and to measure these instruments
initially at their fair value, unless fair value cannot be
measured reliably. In the latter case, the entity should
measure the fair value of the equity instruments to
reflect the fair value of the financial liability extin-
guished, including any demand features. If the entity
does not extinguish the financial liability in its entirety,
it should first assess whether some of the consideration
paid relates to a modification of terms of the remain-
ing liability. If so, the consideration paid is allocated
between the amount of the liability extinguished and
the amount remaining. The entity should recognize
in profit or loss the difference between the carrying
amount of the financial liability extinguished and the
amount of consideration paid to extinguish the liabil-
ity. The interpretation also addresses the circumstances
when modification of terms is so substantial that the
entity should extinguish the original liability and rec-
ognize a new liability. IFRIC 19 is effective for annual
periods beginning on or after 1 July 2010, with early
adoption permitted.
IFRIC 19 was subsequently amended by IFRS 9
to replace references to relevant paragraphs in IAS
39 with those in IFRS 9. The effective date of this
amendment is 1 January 2013, or upon application of
IFRS 9.
Author’s Note
The commentary that follows in this section collec-
tively refers to the aforementioned standards and inter-
pretations as IFRSs for financial instruments. Recog-
nition and measurement of financial instruments is ex-
tremely complex. Therefore, commentary under this
heading primarily focuses on the disclosures that enti-
ties provide in their financial statements and provides
only a brief description of the issues that an entity must
address when accounting for these items. Although dif-
ferences between IFRSs and FASB ASC exist at a high
level, many additional transaction-specific differences
also exist. See the author’s note at the beginning of
this section for information about the IASB and FASB
convergence project on accounting for financial instru-
ments.
8.03 IAS 32 applies to all financial instruments, except the
following:
• Interests in subsidiaries, associates, or joint ventures
accounted for in accordance with IAS 27, Consoli-
dated and Separate Financial Statements; IAS 28, In-
vestments in Associates; and IAS 31, Interests in Joint
Ventures, respectively, unless the entity is permitted to
account for these investments in accordance with IAS
39.
• Rights and obligations under employee benefit plans,
accounted for in accordance with IAS 19, Employee
Benefits.
• Insurance contracts within the scope of IFRS 4, In-
surance Contracts (except when IAS 32 specifically
provides otherwise).
• Financial instruments, contracts, and obligations ac-
counted for in accordance with IFRS 2, Share-based
Payments (except certain requirements of IAS 32 may
continue to apply).
However, IAS 32 does apply to certain contracts to buy or
sell a nonfinancial item when the entity can settle the contract
net in cash or another financial instrument or by exchanging
financial instruments, as if the contracts themselves were
financial instruments.
8.04 IFRSs for financial instruments contain definitions that
are critical for determining the application of the require-
ments of IFRSs for financial instruments to a particular in-
strument, transaction, or circumstance. These definitions are
dispersed among the different standards and interpretations
previously noted. IAS 32 defines the following terms: finan-
cial instrument, financial asset, financial liability, equity in-
strument, fair value, and puttable instrument. IAS 39 defines
the following terms: financial instrument, financial asset, fi-
nancial liability, equity instrument, fair value, and puttable
instrument. IAS 39 defines the following terms: amortized
cost for a financial asset or financial liability; effective inter-
est method; derecognition; derivative; financial guarantee
contract; regular way purchase or sale; transaction costs;
and, in the context of hedge accounting, firm commitment,
forecast transaction, hedged item, and hedging effectiveness.
Recognition and Measurement
IFRSs
8.05 IAS 39 establishes the recognition and measurement
requirements for financial instruments. In addition to the
scope exclusions in IAS 32, IAS 39 includes the following
additional scope exclusions:
• Rights and obligations accounted for in accordance
with IAS 17, Leases, except for certain lease receiv-
ables, finance lease payables, and embedded deriva-
tives,
• Forward contracts to buy or sell an acquiree that will
result in a business combination,
• Certain loan commitments, and
• Reimbursement rights for previously recognized provi-
sions.
However, the scope of IAS 39 includes other loan commit-
ments: those designated at FVTPL, those that can be settled
net in cash and by delivery or exchange of financial instru-
ments (settled net), and commitments to provide a loan at a
below-market rate. Entities should apply IAS 39 to contracts
to buy or sell a nonfinancial item that can be settled net,
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except when the entity enters into and continues to hold such
contracts for receipt or delivery as part of its normal expected
sale, purchase, or usage requirements.
8.06 In addition to the defined terms previously mentioned,
IAS 39 also defines the following six categories that entities
should use to classify financial instruments:
• Financial asset or financial liability at FVTPL, such as
the following:
— Held for trading
— Designated on initial recognition (designated at
FVTPL)
• Held to maturity (HTM)
• Loans and receivables
• Available for sale financial assets (AFS)
An entity should classify its financial instruments in one of
these four categories to determine the appropriate recogni-
tion, initial and subsequent measurements on the balance
sheet, and derecognition, as well as the nature of the effects
on the statement of comprehensive income.
Author’s Note
IFRS 9 reduces the required classifications of financial
assets to: amortized cost or fair value. An entity should
classify a financial asset in one of these two categories
based on its business model for managing financial
assets and the contractual cash flow characteristics of
the specific asset in question.
8.07 IAS 39 requires recognition of a financial asset or fi-
nancial liability in the balance sheet only when the entity
becomes a party to the instrument’s contractual provisions.
However, IAS 39 includes more extensive guidance on dere-
cognition. Entities should evaluate whether to derecognize a
financial asset by first determining whether they should ap-
ply the derecognition criteria to the financial asset, to part of
the financial asset, to a group of financial assets, or to part
of a group based on criteria in IAS 39. After making this
assessment, the entity should derecognize a financial asset
when, and only when, (a) the contractual rights to the asset’s
cash flows expire or (b) the entity transfers the financial asset
and the transfer meets the criteria in IAS 39. IAS 39 requires
the entity to conduct an evaluation of the extent to which
the entity retains the risks and rewards of ownership of the
financial asset as part of this assessment.
8.08 When a transfer of a financial asset qualifies for dere-
cognition and the entity retains servicing rights for a fee,
the entity should recognize either a servicing asset (when
the entity expects the fee to adequately compensate it for its
services) or a servicing liability (when the entity does not
expect the fee to adequately compensate it for its services).
8.09 When an entity derecognizes a financial asset, it should
recognize a gain or loss equal to the difference between the
asset’s carrying amount and the sum of consideration re-
ceived and the cumulative gain or loss, if any, previously rec-
ognized in comprehensive income. When the derecognized
financial asset is a component of a larger financial asset, the
entity should allocate the larger asset’s carrying value be-
tween the derecognized component and the carrying value of
the retained asset.
8.10 Not all transfers of financial assets will qualify for dere-
cognition. When an entity retains substantially all of the risks
and rewards of ownership or, by the extent of its continuing
involvement, is exposed to changes in the value of the trans-
ferred asset, it should not derecognize the asset. In the former
case, the entity should continue to recognize the entire asset
and also recognize a liability for the consideration received.
In the latter case, the entity should recognize an asset to the
extent of its continuing involvement and an associated lia-
bility. IAS 39 provides guidance for measuring the carrying
amount of this retained asset and the liability. IAS 39 also
provides guidance on accounting for any noncash collateral
provided to the transferee.
Author’s Note
The criteria for determining whether a transfer of a
financial asset qualifies for derecognition is complex
and too lengthy to cover comprehensively in this com-
mentary.
8.11 Entities have an option under IAS 39 to recognize reg-
ular way purchases of financial assets or derecognize sales
using either trade date or settlement date accounting, consis-
tently applied.
8.12 An entity should derecognize all or part of a financial
liability when the entity has discharged or cancelled its obli-
gation under the contract or when the obligation expires. The
entity should consider an exchange of financial instruments
as an extinguishment of the original and should consider
recognition of a new liability only if the terms of the instru-
ments are substantially different. Similarly, when the terms
of the original obligation are substantially modified, the en-
tity should account for the modification as an extinguishment
of the existing liability and recognition of a new liability. The
entity should recognize a gain or loss in profit or loss for the
difference between the carrying value of the existing liability
and the sum of the carrying value of the new liability and any
consideration or noncash assets paid or transferred.
8.13 IAS 39 requires entities to recognize a financial asset
or financial liability initially at the sum of its fair value and
transaction costs, except when the instrument is classified
as FVTPL. When instruments are held at FVTPL, an entity
should recognize any transaction costs directly attributable
to acquisition or issue of the instrument in profit or loss when
incurred.
8.14 Subsequent measurement depends on the classification
of the financial instrument on initial recognition. After initial
recognition, unless designated as a hedged item, an entity
should measure its financial assets, including derivatives, at
fair value, excluding transaction costs, with the following
exceptions:
• Loans, receivables, and HTM investments at amortized
cost using the effective interest method.
• Other financial instruments at cost, including the fol-
lowing:
— Investments in equity instruments without a quoted
market price in an active market and whose fair value
cannot be measured reliably.
— Derivatives linked to and with required settlement
by such unquoted instruments.
8.15 Similarly, unless designated as a hedged item, enti-
ties should subsequently measure financial liabilities, includ-
ing derivatives, at amortized cost using the effective interest
method, with the following exceptions:
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• Derivatives linked to, and with required settlement by,
delivery of an unquoted equity instrument whose fair
value cannot be reliably measured should be measured
at cost
• Financial liabilities at FVTPL should be measured at
fair value
• Financial guarantee contracts and commitments to pro-
vide a loan at below fair market value should be mea-
sured at the higher of the following:
— Amount determined in accordance with IAS 37, Pro-
visions, Contingent Liabilities and Contingent As-
sets
— Amount initially recognized, less any cumulative
amortization recognized in accordance with IAS 18,
Revenue
8.16 IAS 39 contains substantive application guidance on
recognition and measurement including fair value measure-
ment. Appendix A, “Application Guidance,” is considered
an integral part of the standard and is mandatory. In contrast,
the implementation guidance that accompanies the standard
is not considered part of the standard and is not mandatory.
8.17 Entities may need to reclassify a financial asset or fi-
nancial liability because the entity’s intention with respect
to the instrument may change or its fair value can no longer
be measured reliably. IAS 39 prohibits entities from reclassi-
fying financial assets or financial liabilities in the following
circumstances:
• Out of the FVTPL category
— Derivatives when held or issued
— Instruments designated at FVTPL at initial recogni-
tion, generally
• Into the FVTPL category
— Any financial instruments after initial recognition
However, in certain circumstances, IAS 39 permits an entity
to reclassify non-derivative financial assets (other than those
designated at FVTPL at initial recognition) out of the FVTPL
category. The standard also permits an entity to transfer a fi-
nancial asset from the available-for-sale category to the loans
and receivables category when the following two criteria are
met: (a) the financial asset would have met the definition
of loans and receivables if the entity had not classified it as
AFS and (b) the entity has the intention and ability to hold
that financial asset for the foreseeable future. However, in
rare circumstances when specific conditions are met, entities
may reclassify a financial asset no longer held for trading
(selling or repurchasing in the near term) out of the FVTPL
category.
8.18 When an entity no longer has the intent or ability
to hold an investment to maturity, it should reclassify an
HTM investment as AFS and remeasure the investment at
fair value. The entity should recognize the difference be-
tween the carrying amount and fair value in other comprehen-
sive income until the entity derecognizes the asset. However,
when an entity reclassifies more than an insignificant amount
of HTM investments, it should reclassify all of its remain-
ing HTM investments and not classify any new investments
as HTM until two years have elapsed.
8.19 Entities should recognize gains or losses from changes
in fair value on instruments that are not part of a hedging re-
lationship depending on their classification. Entities should
recognize such gains or losses in profit or loss when the in-
strument is classified as FVTPL, and in other comprehensive
income when the instrument is classified as AFS. For instru-
ments held at amortized cost, an entity should recognize a
gain or loss in profit or loss when the financial asset or finan-
cial liability is derecognized or impaired, and also through
the amortization process, unless the instrument is part of a
hedging relationship.
Author’s Note
See section 3, “Statement of Comprehensive Income
and Related Disclosures,” for excerpts illustrating
items recognized in profit or loss and recognized in
other comprehensive income.
8.20 At the end of each reporting period, an entity should
review its financial assets or groups of such assets and de-
termine whether objective evidence of impairment exists.
When such evidence exists for financial assets held at amor-
tized cost, the entity should measure the amount of the loss as
the difference between the carrying value of the asset and the
present value of future cash flows discounted at the original
effective interest rate. The entity should recognize this loss
in profit or loss. The entity may reduce the carrying amount
of the asset directly or use a valuation allowance. Entities
should recognize a reversal of this impairment loss if they
can attribute the decrease in the loss to an event that occurred
after the original loss was recognized. Entities should not
increase the carrying amount of the asset above the amount
that would have resulted if the impairment had not been rec-
ognized. When the entity determines that an AFS financial
asset is impaired, it should reclassify the cumulative loss
previously recognized in equity to profit or loss as a reclas-
sification adjustment. An entity should not reverse an im-
pairment loss recognized on equity instruments classified as
AFS. However, the entity should reverse an impairment loss
on an AFS debt instrument subject to the same constraints as
a reversal on an instrument held at amortized cost.
8.21 In accordance with IAS 32, entities should recognize
in profit or loss interest and dividend income and interest
expense on financial instruments within the scope of IFRSs
for financial instruments.
Author’s Note
See section 3 for excerpts illustrating items recognized
in profit or loss and other comprehensive income.
8.22 IAS 39 provides special accounting treatment for
hedged items and hedging instruments in a designated hedg-
ing relationship. Hedge accounting permits the offsetting of
gains or losses from changes in fair value of the hedged
item and hedging instrument. Certain conditions and con-
straints exist for an instrument to qualify as either a hedging
instrument or hedged item and for designation of the hedg-
ing relationship. The hedging relationship should also meet
an effectiveness test in order for the entity to apply hedge
accounting. IAS 39 recognizes two types of hedging rela-
tionships: fair value hedge and cash flow hedge. When the
hedged item is a forecast transaction, only a cash flow hedge
can be designated. An entity that hedges its net investment in
a foreign operation should account for the hedging relation-
ship similar to a cash flow hedge.
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U.S. GAAP
8.23 Unlike IFRSs, in which requirements for most finan-
cial instruments are contained in three standards, guidance
in FASB ASC covering recognition, measurement, presen-
tation, and disclosure requirements is widely dispersed. Al-
though the primary topic is FASB ASC 825, Financial In-
struments, FASB ASC has specific guidance for various
types of receivables, investments in debt and equity in-
struments, payables, debt, financial instruments held under
the fair value option, and derivatives and hedging within
other topics (for example FASB ASC 310, Receivables, or
FASB ASC 320, Investments—Debt and Equity Securities).
In addition, FASB ASC includes many transaction-specific,
circumstance-specific requirements and a significant amount
of industry specific guidance. For example, with respect to
transfers of assets, FASB ASC 860-20 provides guidance
on accounting for transfers of financial assets, including ac-
counting for transfers of receivables in securitization trans-
actions, transfers of receivables with recourse, and factoring
arrangements.
8.24 Definitions in the FASB ASC glossary also differ from
those in IFRSs in subtle ways that may cause differences in
classification and accounting treatments. For example, the
FASB ASC glossary defines a derivative instrument as a
financial instrument or other contract with all of the following
characteristics:
• The instrument has an underlying, and a notional
amount or payment provision, or both. (As defined in
the FASB ASC glossary, an underlying is a specified
interest rate, security price, commodity price, foreign
exchange rate, index of prices or rates, or other vari-
able (including the occurrence or nonoccurrence of a
specified event such as a scheduled payment under a
contract). An underlying may be a price or rate of an
asset or liability but is not the asset or liability itself.
An underlying is a variable that, along with either a no-
tional amount or a payment provision, determines the
settlement of a derivative instrument.)
• The instrument requires no initial net investment or
one smaller than required on other contracts expected
to have a similar response to market factors.
• The entity can settle the instrument net in one of fol-
lowing three specific ways:
— Terms implicitly or explicitly require or permit net
settlement.
— Entity can readily settle by a means outside the con-
tract.
— Delivery of the asset puts the recipient in a position
not substantially different from net settlement.
Derivative instruments also include embedded derivatives
that have been separated from a host contract in accordance
with FASB ASC 815-15-25-1.
8.25 The characteristics of a derivative under IFRSs compare
and contrast with characteristics previously mentioned in the
following ways:
• The instrument’s value changes in response to changes
in a variable (underlying). However, IFRSs do not re-
quire a notional amount or payment provision.
• The instrument requires no initial net investment or
one smaller than required on other contracts expected
to have a similar response to market factors and is the
same as U.S. GAAP.
• The instrument is settled at a future date. IFRSs have
no requirement for net settlement in any form.
8.26 Like IFRSs, derivatives, securities classified as trad-
ing or AFS, and instruments that the entity has elected to
measure at FVTPL are measured initially at fair value. Un-
like IFRSs, investments in equity method investees may be
measured at fair value using the fair value option in FASB
ASC 825-10-15-1. Other financial instruments are measured
initially at cost. Key differences between IFRSs and FASB
ASC guidance also exist for subsequent measurement.
8.27 In addition to the dispersion of guidance on financial
instruments throughout FASB ASC, differences in scope be-
tween items meeting the definition of a financial instrument
under IFRSs and FASB ASC make comparisons between
the two sets of standards difficult. For example, unless the
receivables have been securitized, the FASB ASC glossary
does not consider the following to meet the definition of a
debt security (financial instrument):
• Trade accounts receivable from credit sales by indus-
trial or commercial entities, and
• Loans receivable from consumer, commercial, and real
estate lending activities of financial institutions.
Presentation
Author’s Note
On 28 January 2011, the IASB published for public
comment an exposure draft, Offsetting Financial As-
sets and Financial Liabilities, and FASB published for
public comment a proposed Accounting Standards Up-
date, Balance Sheet Offsetting. The comment period
ended on 28 April 2011, with a target for release of a
final standard in the third quarter of 2011. According
to the joint exposure drafts, the differences in the exist-
ing offsetting requirements in IFRSs and U.S. GAAP
account for the single largest quantitative difference in
the amounts presented in statements of financial po-
sition. Therefore, the IASB and FASB seek to align
the respective guidance in IFRSs and FASB ASC on
the criteria that would determine when offsetting in the
balance sheet is appropriate.
IFRSs
8.28 IAS 32 requires an entity, on initial recognition, to clas-
sify a financial instrument or its components as a financial
asset, a financial liability, or an equity instrument in accor-
dance with the substance of the contractual arrangement and
the definitions applicable to those respective items. When
distinguishing between a financial liability and an equity
instrument, entities should only classify the item as equity
when the following two conditions are met:
• The entity has no contractual obligation to deliver cash
or to exchange financial assets or liabilities under po-
tentially unfavorable conditions.
• If the entity may settle the instrument with its own
shares, the instrument is either a nonderivative with no
contractual obligation to deliver a variable number of
shares or a derivative that will be settled by a fixed
number of shares.
If the instrument does not meet these conditions, the entity
should classify the instrument as a financial liability.
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8.29 A puttable instrument is a financial instrument that
either gives the holder the right to return (put back) the in-
strument to the issuer for cash or another financial asset or
is automatically put back to the issuer on the occurrence of
an uncertain future event or the death or retirement of the
instrument holder. This is an exception to the definition of
a financial liability. Entities should classify this instrument
as equity when it has certain features established in IAS 32,
including the following:
• In the event of liquidation, the holder is entitled to a pro
rata share of the entity’s net assets.
• The instrument is subordinate to all other financial in-
struments (that is, it has, and conversion is unnecessary
for it to have, no priority over other claims).
8.30 Entities should reclassify an instrument as equity or
financial liability as of the date that the necessary condi-
tions for these classifications are met or are no longer met,
respectively. IAS 32 also provides guidance on liability or
equity classification when contingent settlement provisions
and settlement options exist. Certain instruments, known as
compound financial instruments, contain both a liability and
an equity component. Based on the measurement criteria
identified in IAS 32, entities should classify each component
separately as financial assets, financial liabilities, or equity
and account for each component accordingly.
8.31 Entities should account for treasury shares as a reduc-
tion of equity. Entities should not recognize gains or losses
on treasury share transactions in profit or loss. IAS 1, Presen-
tation of Financial Statements, requires entities to disclose
treasury shares separately either on the face of the balance
sheet or in the notes.
8.32 Entities should offset a financial asset and financial lia-
bility only when they have a legally enforceable right to offset
and intend to settle net or simultaneously. When a transferred
financial asset does not qualify for derecognition under IAS
39, an entity should not offset the transferred asset against
any related liabilities. IAS 32 provides examples of situa-
tions, including synthetic instruments, that would generally
not qualify for a net presentation on the balance sheet.
U.S. GAAP
8.33 Like IFRSs, FASB ASC 480, Distinguishing Liabili-
ties from Equity, contains guidance, which all entities should
apply, for determining when an entity should classify a fi-
nancial instrument with characteristics of both liabilities and
equity as a financial liability or an equity instrument. How-
ever, certain instruments are outside the scope of FASB ASC
480 (for example, registration prepayment arrangements or
non-derivative embedded features). In these circumstances,
an entity should also consider the requirements of FASB ASC
405, Liabilities, or FASB ASC 825, to determine proper clas-
sification. In contrast to IFRSs, FASB ASC includes more
guidance for instruments with specific features. Only by ana-
lyzing the respective guidance in both forms of GAAP and the
particular features of the instrument under consideration, can
an entity know whether the classification and, hence, recog-
nition and measurement would be the same under IFRSs and
FASB ASC.
8.34 Like IFRSs, FASB ASC 505-30 notes that treasury
shares are classified as a reduction of equity and an entity
should not recognize in income any gains and losses on resale
of such shares. However, FASB ASC 505-30-25-2 further ex-
plains that the laws of some states govern the circumstances
under which an entity may acquire its own stock, and these
laws may prescribe an accounting treatment. When these
laws conflict with the requirements of certain paragraphs
in FASB ASC 505-30-25 and 505-30-30, the entity should
comply with the state law.
8.35 FASB ASC 210-20-45-1 includes conditions similar
to those in IFRSs that permit entities to offset assets and
liabilities (right of setoff). A right of setoff exists at the
balance sheet date when all of the following conditions are
met:
• Respective counterparties each owe the other deter-
minable amounts.
• Reporting entity has a right to offset the amount owed
with the amount owed by the other party.
• Reporting party intends to offset (settle net).
• Right of setoff is enforceable by law.
Disclosure
IFRSs
8.36 IFRS 7 applies to all financial instruments not excluded
from the scope of IAS 32, except instruments required to
be classified as equity instruments in accordance with para-
graphs 16(A)–16(D) of IAS 32. The standard also applies to
share-based payment contracts that are within the scope of
IAS 39, rather than IFRS 2.
8.37 IFRS 7 requires certain disclosures by class of financial
instrument. A class of instrument is different from the IAS
39 categories previously discussed (for example, HTM or
FVTPL). A class of instrument is a grouping of instruments
that is appropriate to the information disclosed (for exam-
ple, corporate bonds). Instruments in the same class may be
included in different categories depending on the entity’s in-
tentions. For example, an entity may designate a particular
bond at FVTPL and classify all other bond investments as
AFS while considering all bonds to be a class of financial
assets. IFRS 7 requires entities to provide sufficient detail so
users can reconcile the information in the note disclosures to
the amounts on the balance sheet.
8.38 Entities should separately disclose the amounts of fi-
nancial assets and the amounts of financial liabilities in each
IAS 39 category. When financial assets or financial liabilities
are designated at FVTPL, entities should disclose additional
information. When a loan or receivable or financial liability
is classified at FVTPL, an entity should disclose information
about various risks, including changes in fair value due to
changes in credit risk, changes in market conditions that give
rise to market risk (such as, changes in interest rates), and
the methods used to determine these effects.
8.39 Entities should also disclose additional information
about any reclassifications during the period, including the
amounts reclassified, carrying amounts and fair values, and
amounts that would have been recognized in profit or loss if
they had not reclassified the instrument.
8.40 When an entity has transferred financial assets that
did not qualify for derecognition, it should disclose the na-
ture of these assets, the nature of the risks and rewards to
which it remains exposed, the carrying amount of the recog-
nized assets, and the amount of the original assets when the
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remaining balance sheet measurement relates only to its con-
tinuing involvement.
8.41 With respect to the balance sheet, entities should also
disclose information about collateral, allowances for credit
losses, defaults, and breaches.
8.42 With respect to the statement of comprehensive in-
come, entities should separately disclose net gains or losses
recognized for each IAS 39 category of financial assets and
liabilities, total interest income, total interest expense on in-
struments not held at FVTPL, fee income and expense sepa-
rately for instruments not held at FVTPL, trust and fiduciary
activities, interest income on impaired financial assets, and
the amount of any impairment losses for each class of finan-
cial asset.
8.43 Entities should disclose their accounting policies in
accordance with IAS 1, including the measurement bases
applied.
8.44 With respect to hedge accounting, entities should dis-
close descriptions of the hedge and the hedging instruments
used with fair values and the nature of the risks hedged, sep-
arately, for fair value hedges, cash flow hedges, and hedges
of net investments. IAS 39 requires additional disclosures for
each type of hedge. In addition, for each class of financial
asset and financial liability, an entity should disclose the fair
value of the class in such a way that it can be compared with
the carrying amounts of these classes.
8.45 An entity should disclose the fair value of each class
of financial asset and liability and the methods, valuation
techniques (if any), and the assumptions used in determining
fair value, except when the financial instrument:
• has a carrying amount that approximates fair value,
• is held at cost under IAS 39 because its fair value cannot
be measured reliably, or
• contains a discretionary feature and the fair value of
that feature cannot be measured reliably.
In providing these disclosures, the entity should also clas-
sify fair value measurements using the following fair value
hierarchy:
• Level 1: Fair values obtained from quoted prices (un-
adjusted) in active markets for identical assets or liabil-
ities.
• Level 2: Fair values obtained using inputs other than
quoted prices included within level 1 that are observable
for the asset or liability, either directly or indirectly.
• Level 3: Fair values are obtained using inputs for the
asset or liability that are not based on observable market
data.
For fair value measurements disclosed in the balance sheet,
the entity should disclose the relevant level in this hierarchy,
disclose and explain any significant transfers between levels
1 and 2, and reconcile the beginning and ending balances in
the balance sheet account for level 3 measurements. For level
3 measurements, the entity should disclose the sensitivity of
the measurement to changes in inputs and how this change
was calculated.
8.46 Entities should also disclose both qualitative and quan-
titative information about the nature and extent of their risk
exposure arising from financial instruments. These risks in-
clude, but IAS 39 does not limit these risks to, credit risk,
liquidity risk, and market risk. Entities should provide both
qualitative and quantitative disclosures about these risks.
Qualitative disclosures include the entity’s objective, poli-
cies, and processes used to manage that particular risk and
any changes from the prior period. Entities should base quan-
titative disclosures on the information provided internally to
management (for example, the board of directors). Entities
should disclose when the required information is not pro-
vided because the effect is not material and should discuss
concentrations of risk not apparent from the other disclosures
provided. IAS 39 also requires sensitivity analysis for market
risks.
8.47 Entities should also disclose any additional information
required by IAS 1.
U.S. GAAP
8.48 FASB ASC 825-10-50-14 does not require entities
to disclose fair value information for trade receivables and
payables when their carrying amounts approximate fair
value.
8.49 FASB ASC 825-10-50 requires all entities to disclose
the following general information about financial instru-
ments:
• Fair value
• Concentrations of credit risk
• Market risk
In addition, FASB ASC 825-10-50 requires additional dis-
closures about fair values, regardless of whether the entity
recognized the instruments in the statement of financial po-
sition, except for the following exceptions noted in FASB
ASC 825-10-50-8:
• Employer and plan obligations for post-retirement ben-
efits
• Substantively extinguished debt




• Unconditional purchase obligations
• Equity method investments, noncontrolling interests
and equity investments in consolidated subsidiaries
• Equity instruments issued by the entity and classified
as stockholders’ equity
All of these instruments are excluded from the scope of the re-
quired fair value disclosures for financial instruments within
FASB ASC.
8.50 Similar to IFRSs, FASB ASC 825-10-50-10 states that
entities should disclose, either on the face of the relevant
financial statement or in the notes, the following informa-
tion about fair values of financial instruments for which it is
practicable to estimate that value:
• Methods and significant assumptions used to estimate
fair value
• Description of changes in these methods or assump-
tions, if any, during the period
When information is presented in the notes FASB ASC
825-10-50-11 requires entities to include both the carry-
ing amounts and fair values, clearly indicate whether these
amounts represent assets or liabilities, and explain how the
carrying amounts relate to the amounts reported in the bal-
ance sheet. Unlike IFRSs, if information is dispersed in sev-
eral notes, FASB ASC 825-10-50-12 requires an entity to
provide a summary table with the fair values and related
IFRS ATT 8.41
581Section 8: Financial Instruments and Related Disclosures
carrying amounts with cross references to the related notes
where users can find the additional information.
8.51 In disclosing the fair value of a financial instrument,
under FASB ASC 825-10-50-15, an entity should not net that
fair value with the fair value of other financial instruments,
even if those financial instruments are of the same class
or otherwise considered to be related, except to the extent
that the offsetting of carrying amounts in the statement of
financial position is permitted under the general principle
for offsetting (as previously described in paragraph 8.35)
or under the exceptions for master netting arrangements in
FASB ASC 815-10-45-5 and for amounts related to certain
repurchase and reverse repurchase agreements in paragraphs
11–17 of FASB ASC 210-20-45. This contrasts with IFRSs
in which a master netting arrangement is not an exception to
the general prohibition against offsetting and the assets and
liabilities within the agreement should meet the necessary
terms and conditions to be shown net.
8.52 When it is not practicable for an entity to estimate the
fair value, FASB ASC 825-10-50-16 requires an entity to
explain why it is not practicable and to disclose information
pertinent to estimating the fair value of the financial instru-
ment or class (such as the carrying amount, effective interest
rate, and maturity). When it is practicable to estimate fair
value for only a subset of a class of financial instruments,
FASB ASC 825-10-50-19 requires the entity to estimate and
disclose fair value for that subset.
8.53 Like IFRSs, FASB ASC 825-10-50 requires an entity to
disclose information about risk exposures, specifically credit
risk, and to provide certain quantitative and qualitative infor-
mation. FASB ASC 825-10-50-23 encourages, but does not
require, an entity to disclose quantitative information about
the market risk of financial instruments. Like IFRSs, FASB
ASC 815 requires disclosures about the use of derivatives and
hedging activities, with specific disclosure for each type of
hedge. These disclosures are supplemented for Securities and
Exchange Commission (SEC) registrants by those required
by Item 305 of SEC Regulation S-K. However, unlike IFRSs,
Item 305 only requires SEC registrants to provide these dis-
closures outside the financial statements (for example, in the
management discussion and analysis).
TABLE 8-1: TYPE OF FINANCIAL INSTRUMENTS
Categories of Financial Instruments 2010 2009
Cash............................................................................ 170 160
Loans and receivables................................................ 170 160
Available-for-sale financial assets.............................. 114 111
Held-to-maturity financial assets (measured at
amortized cost)......................................................... 36 29
Financial assets measured at fair value through
profit or loss
Derivatives............................................................... 105 101
Non-derivatives (including those classified as
held-for-trading) ................................................... 71 70
Derivatives designated as hedges............................. 90 82
Trade payables........................................................... 158 147
Financial liabilities measured at amortized cost......... 159 150
Financial liabilities measured at fair value through
profit or loss.............................................................
Derivatives............................................................... 35 114
Non-derivatives (including those classified as
held-for-trading) ................................................... 117 37
Derivatives designated as hedges............................. 90 94
Presentation and Disclosure Excerpts
Early Adoption of IFRS 9—First-time
Adoption of IFRS
8.54
Nortel Inversora S.A. (Dec 2010)
Author’s Note
Nortel Inversora S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of Jan-
uary 1, 2009. The excerpt that follows reflects the initial
application IFRSs and early adoption of IFRS 9.
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CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
(In millions of Argentine pesos)
As of December 31 As of January 1
Note 2010 2009 2009(∗)
Assets
Current assets
Cash and cash equivalents 5 1,385 1,273 902
Investments 5 2 16 223
Trade receivables, net 6 1,463 1,163 1,009
Other receivables, net 7 322 241 209
Inventories, net 8 452 250 252
Total current assets 3,624 2,943 2,595
Non-current assets
Other receivables, net 7 100 76 88
Investments 5 1 1 7
Property, plant and equipment, net 9 7,365 6,767 6,119
Intangible assets, net 10 1,233 1,072 1,080
Total non-current assets 8,699 7,916 7,294
Total assets 12,323 10,859 9,889
Liabilities
Current liabilities
Trade payables 11 2,908 2,212 1,769
Financial debt 12 42 763 1,355
Salaries and social security payables 13 390 300 237
Income tax payables 14 491 431 290
Other taxes payables 15 531 338 336
Other liabilities 16 84 84 73
Provisions 17 64 73 36
Total current liabilities 4,510 4,201 4,096
Non-current liabilities
Trade payables 11 — 24 27
Financial debt 12 121 58 688
Salaries and social security payables 13 110 82 83
Deferred income tax liabilities 14 247 243 266
Income tax payables 14 14 13 —
Other liabilities 16 274 267 231
Provisions 17 536 374 319
Total non-current liabilities 1,302 1,061 1,614
Total liabilities 5,812 5,262 5,710
(∗) Opening IFRS statement of financial position, included as required by IFRS 1 (Note 1.c).
CONSOLIDATED INCOME STATEMENTS (in part)
(In millions of Argentine pesos)
For the Years Ended December 31
Note 2010 2009
Operating income 23 3,162 2,616
Other income from investments 27.d — 13
Finance income 24 192 256
Finance expenses 24 (329) (670)
Net income before income tax expense 3,025 2,215
IFRS ATT 8.54
583Section 8: Financial Instruments and Related Disclosures
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (in part)
(In millions of Argentine pesos)
For the Years Ended
December 31
2010 2009
Net income for the year 1,949 1,417
Other components of the Statements of Comprehensive Income
Currency translation adjustments (non-taxable)(i) 18 28
Cash flow hedges — (13)
Income tax effect on cash flow hedges — 5
Other components of the comprehensive income, net of tax 18 20
Total comprehensive income for the year 1,967 1,437
The movements of the components of the Statements of
Comprehensive Income for the years ended December 31,
2010 and 2009 and the corresponding tax effect are the fol-
lowing:







At January 1, 2009 13 (5) 8 —
Increase — — — 41
Reclassification to income statement (13) 5 (8) (13)
At December 31, 2009 — — — 28
Increase — — — 18
At December 31, 2010 — — — 46
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
(In millions of Argentine pesos)
For the Years Ended December 31
Note 2010 2009
Cash Flows From Financing Activities
Financial debt proceeds 5.b 175 342
Payment of financial debt 5.b (878) (1,837)
Payment of interest 5.b (76) (167)
Cash dividends paid 5.b (1,053) (13)
Payment of capital reimbursement of Núcleo to the noncontrolling interest 27.d — (6)
Total cash flows used in financing activities (1,832) (1,681)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 3—Significant Accounting Policies (in part)
f) Financial Instruments
f.1) Financial Assets
Upon acquisition, in accordance with IFRS 9, financial assets
are subsequently measured at either amortized cost, or fair
value, on the basis of both:
(a) the entity’s business model for managing the financial
assets; and
(b) the contractual cash flow characteristics of the finan-
cial asset.
A financial asset shall be measured at amortized cost if both
of the following conditions are met:
(a) the asset is held within a business model whose ob-
jective is to hold assets in order to collect contractual
cash flows, and
(b) the contractual terms of the financial asset give rise
on specified dates to cash flows that are solely pay-
ments of principal and interest on the principal amount
outstanding.
Additionally, for assets that met the abovementioned condi-
tions, IFRS provides for an option to designate, at inception,
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those assets as measured at fair value if doing so eliminates
or significantly reduces a measurement or recognition incon-
sistency (sometimes referred to as an ‘accounting mismatch’)
that would otherwise arise from measuring assets or liabili-
ties or recognizing the gains and losses on them on different
bases.
A financial asset that is not measured at amortized cost
according to the paragraphs above is measured at fair value.
Financial assets include:
Cash and Cash Equivalents
Cash equivalents are short-term and highly liquid investments
that are readily convertible to known amounts of cash, subject
to an insignificant risk of changes in value and their original
maturity or the remaining maturity at the date of purchase
does not exceed 3 months.
Cash and cash equivalents are recorded, according to their
nature, at fair value or amortized cost.
Trade and Other Receivables
Trade and other receivables classified as either current or
non-current assets are initially recognized at fair value and
subsequently measured at amortized cost using the effective
interest method, less allowances for doubtful accounts.
Investments
Time deposits are valued at their amortized cost.
The Company has investments in certain government
bonds. The Company has valued these securities at amor-
tized cost as Management has the intent and ability to hold
those securities to maturity.
Investments in mutual funds are carried at fair value.
Unrealized gains and losses are included in financial in-
come/expenses in the consolidated statements of income.
The 2003 Telecommunications Fund is recorded at fair
value.
Impairment of Financial Assets
At every annual or interim closing date, assessments are
made as to whether there is any objective evidence that a fi-
nancial asset or a group of financial assets may be impaired. If
any such evidence exists, an impairment loss is recognized in
the consolidated income statement for financial assets mea-
sured at cost or amortized cost.
Certain circumstances of impairment of financial assets
that the Group assesses to determine whether there is ob-
jective evidence of an impairment loss could include: delay in
the payments received from customers; customers that enter
bankruptcy; the disappearance of an active market for that
financial asset because of financial difficulties; observable
data indicating that there is a measurable decrease in the es-
timated future cash flows from a portfolio of financial assets,
significant financial difficulty of the obligor, between others.
f.2) Financial Liabilities
Financial liabilities comprise trade payables (excluding De-
ferred revenue on prepaid calling cards—see e) Revenues,
above -), financial debt (excluding Derivatives), salaries and
social security payables (see m) below), income tax payables,
other taxes payables and certain other liabilities.
Financial liabilities other than derivatives are initially rec-
ognized at fair value and subsequently measured at amor-
tized cost. Amortized cost represents the initial amount net of
principal repayments made, adjusted by the amortization of
any differences between the initial amount and the maturity
amount using the effective interest method.
Financial liabilities hedged by derivative instruments de-
signed to manage exposure to changes in fair value of the
liabilities (fair value hedge derivatives) are measured at fair
value in accordance with the hedge accounting principles of
IAS 39. Gains and losses arising from re-measurement at fair
value, to the extent of the hedged component, are recognized
in the consolidated income statement and are offset by the ef-
fective portion of the gain or loss arising from re-measurement
at fair value of the hedging instrument.
f.3) Derivatives
Derivatives are used by the Company to manage its exposure
to exchange rate and sometimes interest rate risks and to
diversify the parameters of debt so that costs and volatility
can be reduced to pre-established operational limits.
All derivative financial instruments are measured at fair
value in accordance with IFRS 9, when they do not qualify for
hedge accounting or in accordance with IAS 39 when they
meet the conditions for hedge accounting.
In accordance with IAS 39, derivative financial instruments
qualify for hedge accounting only when:
(a) at the inception of the hedge, the hedging relationship
is formally designated and documented;
(b) the hedge is expected to be highly effective;
(c) its effectiveness can be reliably measured;
(d) the hedge is highly effective throughout the financial
reporting periods for which it is designated.
When a derivative financial instrument is designated as a
cash flow hedge (the hedge of the exposure to variability in
cash flows of an asset or liability or a highly probable fore-
casted transaction) the effective portion of any gain or loss
on the derivative financial instrument is recognized directly
in OCI. The cumulative gain or loss is removed from OCI
and recognized in the consolidated income statement at the
same time as the hedged transaction affects the consolidated
income statement. The gain or loss associated with the inef-
fective portion of a hedge is recognized in the consolidated
income statement immediately. If the hedged transaction is
no longer probable, the cumulative gains or losses included in
OCI are immediately recognized in the consolidated income
statement.
If hedge accounting is not appropriate, gains or losses aris-
ing from the fair value measurement of derivative financial in-
struments are directly recognized in the consolidated income
statement.
During 2009 and 2010, the Telecom Group entered into
several foreign currency forward agreements (US$ and Euro)
for the coverage of Notes and trade payables, which were val-
ued according to the criteria described above. As of Decem-
ber 31, 2010, Telecom Group has no derivative instruments.
q) Finance Income and Expenses
Finance income and expenses are recognized on an accrual
basis and include:
• interest accrued on the related financial assets and lia-
bilities using the effective interest rate method;
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• changes in fair value of derivatives and other financial
instruments measured at fair value through profit or loss;
• gains and losses on foreign exchange and financial in-
struments (including derivatives);
• other financial results (repurchase of financial debt,
etc.).
Note 5—Cash and Cash Equivalents and
Investments. Additional Information on the
Consolidated Statements of Cash Flows (in part)
a) Cash and Cash Equivalents and Investments (in part)
Cash and cash equivalents consist of the following:
As of December 31 As of January 1
Cash and Cash Equivalents 2010 2009 2009
Cash 8 12 9
Banks 111 50 27
Time deposits 1,266 1,075 718
Mutual funds — 120 144
Mutual funds—Related parties (Note 27.c) — 16 4
Total cash and cash equivalents 1,385 1,273 902
Investments consist of the following:
As of December 31 As of January 1
Current Investments 2010 2009 2009
Government bonds 2 — 223
Time deposits—Related parties (Note 27.c) — 16 —
Total other investments 2 16 223
As of December 31 As of January 1
Non-Current Investments 2010 2009 2009
2003 Telecommunications Fund 1 1 1
Time deposits—Related parties (Note 27.c) — — 6
Total other investments 1 1 7
b) Additional Information on the Consolidated Statements of
Cash Flows
The consolidated statements of cash flows have been pre-
pared using the indirect method.
For purposes of the statements of cash flows, cash and
cash equivalents comprise cash, bank current accounts and
short-term highly liquid investments (with an original maturity
of three months or less) and bank overdrafts (in the consol-
idated statements of financial position, bank overdrafts are
included in current financial debt).
As of December 31 As of January 1
2010 2009 2009
Cash and cash equivalents 1,385 1,273 902
Bank overdrafts (9) — —
Total cash and cash equivalents at year-end 1,376 1,273 902
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• Changes in assets/liabilities components:
Years Ended December 31
2010 2009
Net (increase) decrease in assets
Investments not considered as cash or cash equivalents 1 (33)
Trade receivables, net (476) (314)
Other receivables, net (116) (39)
Inventories, net (236) (37)
(827) (423)
Net (decrease) increase in liabilities
Trade payables 540 242
Salaries and social security payables 91 55
Other taxes payables 193 (17)
Other liabilities 9 23
Provisions (36) (16)
797 287
Income tax paid consists of the following:
Years Ended December 31
2010 2009
Income tax affidavit (451) (321)
Payments in advance (494) (231)
Other payments (62) (78)
Total payments of income tax (1,007) (630)
• Main non-cash operating transactions:
Years Ended December 31
2010 2009
Payment of SAC offset with trade receivables 57 33
Government bonds received from trade receivables 2 —
Credit on minimum presumed income tax offset with income taxes — 7
Legal fee from Tax Regularization Regime (Note 3.l) — 14
• Financing activities components:
The following table presents the financing activities compo-
nents of the consolidated statements of cash flows:
Years Ended December 31
2010 2009
Bank overdrafts—Núcleo and Personal 42 218
Debt proceeds—Núcleo 133 124
Total financial debt proceeds 175 342
Payment of Notes—Personal and Telecom Argentina (683) (1,409)
Purchase of Notes—Personal and Telecom Argentina (35) (108)
Payment of bank overdrafts—Núcleo and Personal (42) (218)
Payment of bank loans—Núcleo (118) (102)
Total payment of financial debt (878) (1,837)
Payment of interest on Notes—Personal and Telecom Argentina (63) (149)
Payment of interest on bank loans—Núcleo (13) (12)
Payment of interest on bank overdrafts—Personal — (6)
Total payment of interest (76) (167)
The Annual General Ordinary and Extraordinary Sharehold-
ers’ Meeting held on April 28, 2010 approved a cash dividend
distribution in the amount of $1,053 payable in two install-
ments: the first was paid on May 5, 2010, amounting to $689
(equivalent to $0.70 per share) and the second was paid on
December 20, 2010, for the balance of $364 (equivalent to
$0.37 per share).
Otherwise, Núcleo paid cash dividends in the amount of
$13 to its noncontrolling shareholders during the year ended
December 31, 2009.
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Note 6—Trade Receivables, Net
Trade receivables, net consist of the following:
As of December 31 As of January 1
2010 2009 2009
Current trade receivables, net
Fixed services 643 621 538
Fixed services—Related parties (Note 27.c) 10 5 —
Personal mobile services 932 657 582
Personal mobile services—Related parties (Note 27.c) 3 5 5
Núcleo mobile services 26 19 20
Subtotal 1,614 1,307 1,145
Allowance for doubtful accounts (151) (144) (136)
Total trade receivables, net 1,463 1,163 1,009
Movements in the allowance for current doubtful accounts are
as follows:
Years Ended December 31
2010 2009
Current allowance for doubtful accounts
At January 1, (144) (136)
Additions—Bad debt expenses (119) (131)
Uses 113 123
Currency translation adjustments (1) —
At December 31, (151) (144)
Note 7—Other Receivables, Net
Other receivables, net consist of the following:
As of December 31 As of January 1
2010 2009 2009
Current other receivables, net
Prepaid expenses 114 80 65
SU credits (Note 2.d) 112 66 36
Tax credits 52 60 48
Restricted funds 15 10 9
Credit on SC Resolution No. 41/07 and IDC (Note 2.g and h) — 4 11
Derivatives — 1 22
Other 42 36 41
Subtotal 335 257 232
Allowance for regulatory matters (Note 2.g and h) — (4) (11)
Allowance for doubtful accounts (13) (12) (12)
322 241 209
Non-current other receivables, net
Credit on SC Resolution No. 41/07 and IDC (Note 2.g and h) 90 87 93
Deferred tax assets of Núcleo — 1 —
Restricted funds 31 24 15
Tax credits 17 21 17
Prepaid expenses 55 20 22
Credit on minimum presumed income tax 6 7 20
Other 8 12 13
Subtotal 207 172 180
Allowance for regulatory matters (Note 2.G and h) (90) (75) (75)
Allowance for doubtful accounts (17) (21) (17)
100 76 88
Total other receivables, net 422 317 297
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Movements in the allowances are as follows:
Years Ended December 31
2010 2009
Current allowance for regulatory proceedings
At January 1, (4) (11)
Uses — 13
Reclassifications(∗) 4 (6)
At December 31, — (4)
Non-current allowance for regulatory proceedings
At January 1, (75) (75)
Additions(∗∗) (13) (6)
Reclassifications (2) 6
At December 31, (90) (75)
(∗) In 2010, includes reclassifications of $2 from Provisions.
(∗∗) Included in Provisions in the consolidated income statements.
Years Ended December 31
2010 2009
Current allowance for doubtful accounts
At January 1, (12) (12)
Additions(∗∗∗) (1) —
At December 31, (13) (12)
Non-current allowance for doubtful accounts
At January 1, (21) (17)
Additions(∗∗∗) — (4)
Reversals(∗∗∗) 4 —
At December 31, (17) (21)
(∗∗∗) Included in Taxes and fees with the Regulatory Authority in the consolidated income statements.
Note 11—Trade Payables
Trade payables consist of the following:
As of December 31 As of January 1
2010 2009 2009
Current trade payables
PP&E suppliers 1,261 1,053 773
Other assets and services suppliers 846 690 607
Inventory suppliers 450 246 157
Deferred revenue on prepaid calling cards 172 135 134
Related parties (Note 27.c) 110 32 62
Agent commissions 58 45 21
SU reimbursement (Note 2.d) 11 11 15
2,908 2,212 1,769
Non-current trade payables
Related parties (Note 27.c) — 24 27
Total trade payables 2,908 2,236 1,796
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Note 12—Financial Debt
Financial debt consists of the following:
As of December 31 As of January 1
2010 2009 2009
Current financial debt
Notes — 686 1,255
Issue discount and underwriting fees — (1) —
Bank loans 31 72 89
Bank overdrafts 9 — —
Accrued interest 2 3 11
Derivatives — 3 —
42 763 1,355
Non-current financial debt
Notes — — 690
Issue discount and underwriting fees — — (2)
Bank loans 121 58 —
121 58 688
Total financial debt 163 821 2,043
The following table segregates the Telecom Group’s financial















Principal 161 161 685 130 815 1,255 688 89 2,032
Accrued interest 2 2 1 2 3 8 1 2 11
Subtotal 163 163 686 132 818 1,263 689 91 2,043
Derivatives — — 3 — 3 — — — —
Total financial debt 163 163 689 132 821 1,263 689 91 2,043
Short-term financial
debt 42 42 689 74 763 1,263 1 91 1,355
Long-term financial debt 121 121 — 58 58 — 688 — 688
(∗) Telecom’s financial debt was fully cancelled on October 15, 2009.
(∗∗) Personal’s financial debt was fully cancelled on December 22, 2010.
Financial Debt of the Subsidiaries
(a) Personal
Notes
On December 22, 2010, Personal fully cancelled its Notes
issued under the Global Program for the Issuance of Notes
for a maximum outstanding amount of U$S 500 million or its
equivalent in other currencies for a term of five years.
At the same date, Personal fully repaid all the derivative
instruments that had been held in relation to the above men-
tioned Notes.
The Shareholders’ Ordinary and Extraordinary Meeting of
Personal held on December 2, 2010, approved the creation
of a Global Program for the Issuance of Notes for a maxi-
mum outstanding amount of U$S 500 million or its equivalent
in other currencies for a term of five years. At the date of
issuance of these financial statements, Personal is prepar-
ing the documentation required by the CNV to approve this
program.
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(b) Núcleo
1. Bank Loans
The following table shows the outstanding loans with local
banks in Paraguay and their main terms as of December 31,
2010:
Book Value (In Millions of $)
Principal Nominal Value





37,500 5 years 1 31 32
39,500 4 years 2 33 35
50,000 4 years 2 41 43
15,680 2 years 14 — 14
32,650 2 years 12 16 28
175,330 31 121 152
The weighted average annual rate of these loans is 9.2% in
Guaranı́es and the weighted average amortization term of
these loans is approximately 4 years.
The terms and conditions of Núcleo’s loans provide for
certain events of default which are considered standard for
these kinds of operations.
2. Bank Overdrafts
At December 31, 2010, Núcleo has bank overdrafts amount-
ing to $9 (equivalent to Guaranı́es 9,933 million). The average
annual rate of these loans is 5.5% in Guaranı́es.
Note 20—Financial Instruments
Categories of Financial Assets and Financial Liabilities
The following tables set out, for financial assets and liabilities
as of December 31, 2010 and 2009 and as of January 1, 2009,
in accordance with the categories established by IFRS 9, the
supplementary disclosures on financial instruments required
by IFRS 7 and the schedules of gains and losses.
Fair Value












Cash and cash equivalents 1,266 119 — 1,385
Investments 2 1 — 3
Trade receivables, net 1,463 — — 1,463
Other receivables, net(1) 207 — — 207
Total 2,938 120 — 3,058
Liabilities
Trade payables 2,736 — — 2,736
Financial debt 163 — — 163
Salaries and social security payables 500 — — 500
Income tax payables 505 — — 505
Other taxes Payables 531 — — 531
Other liabilities(1) 51 — — 51
Total 4,486 — — 4,486
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Fair Value












Cash and cash equivalents 1,075 198 — 1,273
Investments 16 1 — 17
Trade receivables, net 1,163 — — 1,163
Other receivables, net(1) 169 — 1 170
Total 2,423 199 1 2,623
Liabilities
Trade payables 2,098 3 — 2,101
Financial debt 818 — 3 821
Salaries and social security payables 382 — — 382
Income tax payables 444 — — 444
Other taxes Payables 338 — — 338
Other liabilities(1) 53 — — 53
Total 4,133 3 3 4,139
Fair Value












Cash and cash equivalents 718 184 — 902
Investments 229 1 — 230
Trade receivables, net 1,009 — — 1,009
Other receivables, net(1) 146 9 13 168
Total 2,102 194 13 2,309
Liabilities
Trade payables 1,662 — — 1,662
Financial debt 2,043 — — 2,043
Salaries and social security payables 320 — — 320
Income tax payables 290 — — 290
Other taxes Payables 336 — — 336
Other liabilities(1) 43 — — 43
Total 4,694 — — 4,694
(1) Only includes financial assets and liabilities according to the scope of IFRS 7.





Financial assets at amortized cost 183 159
Financial liabilities at amortized cost (181) (121)
Financial assets at fair value through profit or loss 9 —
Financial liabilities at fair value through other comprehensive income (loss) (63) —
Financial liabilities at fair value through profit or loss (5) —
Total (57) 38
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Financial assets at amortized cost 220 122
Financial liabilities at amortized cost (455) (151)
Financial assets at fair value through profit or loss 15 —
Financial liabilities at fair value through profit or loss (110) —
Financial liabilities at fair value through other comprehensive income (loss) (6) —
Total (336) (29)
(2) Includes the effect in OCI.
Fair Value Hierarchy and Other Disclosures
IFRS 7 establishes a hierarchy of fair value, based on the in-
formation used to measure the financial assets and liabilities
and also establishes different valuation techniques. Accord-
ing to IFRS 7, valuation techniques used to measure fair value
shall maximize the use of observable inputs.
The measurement at fair value of the financial instruments
of the Group is classified according to the three levels set out
in IFRS 7. The fair value hierarchy introduces three levels of
input:
• Level 1: Fair value determined by quoted prices (unad-
justed) in active markets for identical assets or liabilities.
• Level 2: Fair value determined based on inputs other
than quoted prices included within Level 1 that are ob-
servable for the asset or liability, either directly (ie as
prices) or indirectly (ie derived from prices).
• Level 3: Fair value determined by unobservable inputs
where the reporting entity is required to develop its own
assumptions.
Financial assets and liabilities recognized at fair value as of
December 31, 2010 and 2009 and as of January 1, 2009,
their inputs, valuation techniques and the level of hierarchy
are listed below:
Cash and banks: its valuation is classified as Level 1 since
it is based on market prices.
Mutual Funds: These funds are included in cash and cash
equivalents. As of December 31, 2010 the Company had no
mutual funds. The amount as of December 31, 2009 and as
of January 1, 2009 is $ 136 and $148, respectively. The fair
value is based on information obtained from active markets
and corresponds to quoted market prices as of year-end;
therefore its valuation is classified as Level 1.
Other receivables—Derivative financial instruments (For-
ward contracts to purchase US dollars at fixed exchange
rates): As of December 31, 2010 the Group had no derivative
financial instruments outstanding.
As of December 31, 2009 these derivative financial instru-
ments were included in current Other receivables, net and in
current financial debt by $1 and $3, respectively. Their fair
value arose from quoted market prices provided by major fi-
nancial institutions; therefore their valuation is classified as
Level 2.
As of January 1, 2009 derivative financial instruments in-
cluded in current Other receivables, net amounted to $22.
Their fair value was determined by information obtained in
the “Open Electronic Market” (the MAE), the most represen-
tative market for this type of instruments in Argentina. As
the MAE determines the values based on actual transactions
and calculations regarding the volatility of the currency, the
derivative financial instruments’ valuation was classified as
Level 2.
During 2010 and 2009 there were no significant transfers
between Level 1 and Level 2 of the fair value hierarchy.
According to IFRS 7, it is also required to disclose fair
value information about financial instruments whether or not
recognized at fair value in the balance sheet, for which it is
practicable to estimate fair value. The financial instruments
which are discussed in this section include, among others,
cash and cash equivalents, accounts receivable, accounts
payable and other instruments.
Derived fair value estimates cannot be substantiated by
comparison to independent markets and, in many cases,
could not be realized in an immediate sale of the instrument.
Also, because of differences in methodologies and assump-
tions used to estimate fair value, the Company’s fair values
should not be compared to those of other companies.
The methods and assumptions used to estimate the fair
values of each class of financial instrument falling under the
scope of IFRS 7 as of December 31, 2010 and 2009 and as
of January 1, 2009 are as follows:
Time Deposits (Included in Cash and Cash Equivalents and
Investments)
The Company considers all short-term and highly liquid in-
vestments that are readily convertible to known amounts of
cash, subject to an insignificant risk of changes in value and
their original maturity or the remaining maturity at the date of
purchase does not exceed 3 months, to be cash and cash
equivalents. The carrying amount reported in the statement
of financial position approximates fair value.
Investments
Carrying amounts approximate its fair value.
Trade Receivables, Net
Carrying amounts are considered to approximate fair value
due to the short term nature of these accounts receivables.
All amounts that are assumed to be uncollectible within a
reasonable period are written off and/or reserved.
Trade Payables
The carrying amount of accounts payable reported in the
statement of financial position approximates its fair value due
to the short term nature of these accounts payable.
Telecom Argentina Notes
Telecom Argentina Notes were measured at amortized cost
according to IFRS 9 as of January 1, 2009. The fair value of
these notes, which are included in current and non-current
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financial debt, was $ 1,009 at that date and the carrying
amount was $1,263. The fair value of these notes was based
on the purchase price of notes bought by the Company in
the last quarter of 2008 or, if the purchase price was not
available, on the average quoted market prices provided by
financial agencies. These notes were cancelled during 2009.
Other Financial Debt (Except for NDF)
As of December 31, 2010, the fair value of the Company’s
financial debt approximates its fair value and it was $163. As
of December 31, 2009, the fair value of the Company’s finan-
cial debt (excluding NDF) was $853 and the related carrying
amount was $818. As of January 1, 2009, the fair value of
the Company’s financial debt (excluding Telecom Argentina
Notes) was $693 and the related carrying amount was $780.
The fair value of the Company’s debt as of December 31,
2009 and as of January 1, 2009 is based on the purchase
price of notes bought by the Company or, if purchase price is
not available, on the average quoted market prices.
Salaries and Social Security Payables
The carrying amount of Salaries and social security payables
reported in the statement of financial position approximates
its fair value.
Income Tax and Other Taxes Payables
The carrying amount of Income tax payables and Other taxes
payables reported in the statement of financial position ap-
proximates its fair value due to their short-term nature.
Other Receivables, Net and Other Liabilities (Except for
NDF)
The carrying amount of other receivables, net and other lia-
bilities reported in the statement of financial position approx-
imates its fair value due to their short-term nature.
Hedge Accounting
For transactions designated and qualifying for hedge ac-
counting, Telecom documents at inception the relationship
between hedging instruments and hedged items, as well as
its risk management objectives and strategy for undertaking
various hedge transactions. The Company also documents
its assessment, both at hedge inception and on an ongoing
basis, of whether the derivatives that are used in hedging
transactions are highly effective in offsetting changes in fair
values or cash flows of hedged items.
As part of its hedging policy, the Telecom Group has en-
tered into the following derivatives:
1) Non-Deliverable Forward (“NDF”) Contracts to Purchase
Foreign Currency and Other Derivatives
Between October 2008 and January 2009, the Company en-
tered into several contracts to purchase a total amount of
US$ 108.5 million and Yen 5,120 million, to hedge its expo-
sure to foreign currency fluctuations with respect to its Notes.
Additionally, in January 2009, the Company entered into a
derivative contract (an Euro “Zero Cost Collar”) as supple-
mentary of those contracts, to hedge its exposure to foreign
currency fluctuations with respect to the Euro-denominated
Notes. These contracts have expired in April 2009 and were
regarded as ineffective.
The Company also entered into several NDF contracts
amounting to US$344 million in order to hedge its exposure
to US dollar fluctuations with respect to its Notes, which were
settled during fiscal year 2009 jointly with Telecom’s Notes.
The Company designated these NDF contracts as ineffective
cash flow hedges. For the year ended December 31, 2009,
the changes in the fair value of these hedges were recognized
in the income statement within Finance expenses, under the
item line “Loss on derivatives” in an amount of $81.
2) NDF Contracts to Purchase Foreign Currency for Notes
and Accounts Payable
a) For Notes
During the last quarter of 2008, Telecom Argentina entered
into several contracts to purchase a total amount of US$
108.5 million for a fixed forward average price of Argentine
peso 3.49 per US dollar maturing in April 2009 in order to
hedge its exposure to foreign currency fluctuations with re-
spect to its Notes denominated in foreign currency. During
January 2009, the Company entered into new supplemen-
tary derivative contracts.
Considering that the Company primarily generates cash
flows in Argentine pesos and the terms of the NDF did not per-
fectly match the terms of the foreign currency-denominated
obligations, these hedges were regarded as ineffective.
During 2009 Personal entered into several contracts to pur-
chase foreign currency which main characteristics as of De-









Personal US$ 25.2 4.384 $/US$ August/December 2009 June 2010—December 2010 (3)
US$ 90.0 4.344 $/US$ December 2009 December 2010 1
115.2 (*) (2)
(*) Includes $1 in Other current receivables and $(3) in Current debt (which corresponds to related parties).
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When entering into these NDF contracts, the management
objective was to reduce its exposure to foreign currency fluc-
tuations and denominate its Notes in Argentine peso. Con-
sequently, as the main terms of the NDF were substantially
similar to the terms of the foreign currency-denominated obli-
gations, these hedges were regarded as effective.
For the year ended December 31, 2009, the changes in the
fair value of these hedges were recognized in OCI and sub-
sequently were reclassified to the income statement within
Finance expenses, under the item line “Loss on derivatives”
in an amount of $2.
During January 2010, and continuing with its Notes’ hedg-
ing policy, Personal entered into several NDF contracts
amounting to US$72 million in order to hedge its exposure
to US dollar fluctuations with respect to its Notes, maturing in
December 2010. Personal designated these NDF contracts
as effective cash flow hedges.
b) For Accounts Payable
In June 2008, Personal entered into several NDF contracts to
purchase a total amount of US$ 39.7 million between Septem-
ber 2008 and December 2009 for fixed forward prices of Ar-
gentine peso 3.0785 through 3.4450 per US dollar in order
to hedge its exposure to US dollar fluctuations related to a
software license service contract to be quarterly cancelled in
US dollars. Some of these contracts matured during the same
year (US$ 7.1 million in September 2008 and US$ 7.1 million
in December 2008) and the outstanding contracts amounted
to US$ 25.4 million as of January 1, 2009.
In July 2008, Telecom also entered into several NDF con-
tracts to purchase a total amount of US$ 4.7 million between
January 2009 and September 2009 for fixed forward prices
of Argentine peso 3.11 through 3.30 per US dollar in order to
hedge its exposure to US dollar fluctuations related to a soft-
ware and hardware service contract to be monthly cancelled
in US dollars.
The critical terms of NDF contracts and service contracts
(amounts and maturities) were the same, allowing a perfect
cash flows matching between both contracts.
Considering Management’s objective and strategy to re-
duce its exposure to US dollar fluctuations and denominate
its obligations in Argentine peso, the currency in which the
Company mainly generates its cash flows, the Company des-
ignated these NDF contracts as effective cash flow hedges of
the software license service contract (an unrecognized firm
commitment). Changes in the fair value of cash flow hedges
were recognized in other comprehensive income, and were
subsequently reclassified into earnings when the hedged item
affected earnings.
During fiscal year 2009, Personal also entered into several
NDF contracts amounting to US$23.5 million, maturing be-
tween September 2009 and August 2010, in order to hedge
its exposure to US dollar fluctuations related to accounts
payable.
However, as the terms of the NDF did not perfectly match
the terms of the foreign currency-denominated obligations,
these hedges were regarded as ineffective. Therefore, the
changes in the fair value of these NDF until the cancellation
date and the subsequent changes were recognized as a gain
(loss) within “Finance income” or “Finance expenses”, as the
case may be. As of December 31, 2009, US$8.5 million were
outstanding, maturing July and August 2010.
For the year ended December 31, 2009, the changes in the
fair value of these hedges were recognized as a loss in the
income statement within “Finance expenses”, under the item
line “Loss on derivatives” in an amount of $6 with counterpart
in “Trade payables”.
During January 2010, Personal entered into several NDF
contracts amounting to US$30.2 million (maturing January
through December 2010), in order to hedge its exposure to
US dollar fluctuations related to accounts payable. The Com-
pany designated these NDF contracts as effective cash flow
hedges.
As of December 31, 2010, the Company had no derivative
instruments.




Interest on cash equivalents 99 69
Interest on investments 1 2
Interest on receivables 58 49
Gains on Mutual Funds 7 10
Foreign currency exchange gains 26 103
Gain on discounting of other liabilities — 21
Other 1 2
Total finance income 192 256
Interest on financial debt (76) (145)
Interest on taxes and accounts payable (11) (19)
Interest on provisions (70) (80)
Interest on termination benefits (27) (8)
Loss on discounting of other liabilities (7) —
Foreign currency exchange losses (64) (310)
Loss on derivatives (68) (103)
Loss on purchase of Notes (2) (2)
Other (4) (3)
Total finance expenses (329) (670)
Total finance expenses, net (137) (414)
The classification of finance income and expenses as gener-




Interest income 158 120
Gains on Mutual Funds 7 10
Foreign currency exchange differences 26 103
Other 1 2
Financial results generated by assets 192 235
Interest expense (191) (231)
Foreign currency exchange differences (64) (310)
Loss on derivatives (68) (103)
Other (6) (5)
Financial results generated by liabilities (329) (649)
Total financial results, net (137) (414)
IFRS ATT 8.54
595Section 8: Financial Instruments and Related Disclosures
Author’s Note
The following excerpts were prepared in accordance
with IAS 32, IAS 39, and IFRS 7. IFRS 7 requires
extensive disclosures about risk exposures, including
market, currency, interest rate, liquidity, and credit
risks. Each excerpt below includes only the parts of
these disclosures that are relevant to the financial asset
or liability illustrated.
Financial Assets—Accounts Receivable and
Accounts Receivable From Related Parties
8.55
Vina Concha y Toro S.A. (Dec 2010)
Author’s Note
Vina Concha y Toro S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of January
1, 2009. The excerpt that follows reflects the initial
application of IFRSs. The company has not yet adopted
IFRS 9.


















Cash and cash equivalent (7) 16,757,549 6,997,300 3,949,865
Other current financial assets (8) 10,721,894 10,903,083 5,126,520
Trade and other accounts receivable, current (9) 108,358,712 102,981,228 110,532,628
Accounts receivable from related parties, current (10) 609,117 220,820 240,155
Non-Current Assets
Other non-current financial assets (8) 5,765,933 3,943,612 —
Current liabilities
Other current financial liabilities (18) 30,732,214 36,891,049 75,069,473
Trade accounts payable and other current accounts payable (20) 56,675,343 63,816,895 62,897,932
Current accounts payable to related companies (10) 2,876,996 2,479,224 3,620,684
Non-current liabilities
Other non-current financial liabilities (18) 49,959,254 62,772,393 69,746,210
Other non-current accounts payable (20) 2,137,049 2,211,541 2,393,975
Non-current accounts payable to related companies (10) 1,452,471 1,664,255 1,947,240
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2. Bases of Preparation and Presentation Used
for These Financial Statements (in part)
2.1. Basis of Preparation
2.1.7. Significant Accounting Policies (in part)
The main critical policies are as follows:
• Bad debt estimate.
• Financial Instruments.
2.6. Financial Instruments (in part)
2.14.3. Financial Assets Impairment
In the case of trading receivable assets, the Company has
defined a policy to record provisions due to impairment based
on the aging.
For its account receivable, the Company has defined age
stratification parameters as well as the percentages to be
applied in the impairment evaluation for these items.
In accordance with the information presented and evalu-
ating if there is any indication of value impairment of some
assets related to the wine’s flow generating unit; we may con-
clude that there is no evidence of indication that support any
impairment in the value of these assets.
The evaluation of possible impairment losses on Property,
Plants and equipment, Intangibles and Investments (in part)
In the case of financial assets with a trading origin, the
Company has defined a policy for the recording of impair-
ment accruals in function of the irrecoverable status for the
overdue balance, which is determined through an analysis
on the age, historic collection and the collection status of
accounts receivable.
Note 6. Financial Risk Management
6.2. Credit Risk (in part)
The Credit Risk relates to the uncertainty with respect to
the compliance of obligations from the Company’s counter-
party, for particular contract, agreement or financial instru-
ment, when this compliance generates a loss in the market
value of any financial asset.
6.2.1. Accounts Receivable
The Company exports to more than 135 foreign countries
through dealers with whom it maintains distribution contracts
for its different companies and brands. In addition, the Com-
pany has formed distributing subsidiaries of its products in
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England, Sweden, Norway, Finland, Argentina, Brazil and
Singapore.
All export sales is performed in terms with direct credit,
except for some punctual cases that operate with export letter
of credit.
In the domestic market the sale is diversified in more than
15,000 customers and after an internal evaluation, they are
granted with a limited credit line.
The main credit risk corresponds to the lack of payment of
a particular customer, although in some cases there are risks
associated to exchange or legal restrictions in the countries
where they are located and they are temporarily restrained to
comply with their payment obligations.
The Company’s policy is to protect all their customers with
credit insurance. This is performed to both, domestic market
customers and export customers either as nominated or non-
nominated. In the cases in which the insurance company re-
jects to insure a particular customer, alternative mechanisms
are considered in order to document the debt as the case
of post-dated checks in the domestic market, export letter of
credits, etc.
The impairment provision of accounts receivable is per-
formed at each financial year-end after a case-by case anal-
ysis for customers with an indication of doubtful collection.
This accrual is recorded in the statement of income.
a) Sales to third-parties from Chile:
In the case of accounts receivable from the domestic mar-
ket, 84% of customers has a credit insurance which covers
90% of the claim. As of December 31, 2010 the main five
customers concentrate 42.13% of accounts receivable for
this market, consequently, 95.3% of this receivable is cov-
ered by the insurance credit. 67.4% of accounts receivable
are concentrated in customers that maintain accounts receiv-
able in amounts higher than M$100, while 23.6% correspond
to customers with a receivable lower than M$10.
For exports performed from Chile to third-parties, 86.8%
has an insurance credit which covers 90% of the claim. As of
December 31, 2010 the twenty main customers concentrate
67.9% of accounts receivable for this market, consequently,
87.39% of this receivable is covered by an insurance credit.
The remaining 32.1% is comprised by almost 199 customers.
b) Sales to third-parties from abroad:
Bodegas y Viñedos Trivento S.A. maintains credit insur-
ances for 88.8% of its domestic accounts receivable, and
85.76% of its export accounts receivable. In both cases, the
insurance covers 90% of the claim. 69.52% of its export ac-
counts receivable are concentrated in the main 20 customers,
from these, 96% of the debt is insured, while the 20 main cus-
tomers of the domestic market, represents 69.77% of total
accounts receivable, from these 96.0% is insured.
The subsidiary Concha y Toro UK maintains 90.24% of its
accounts receivable portfolio hedged by a credit insurance,
which covers 90% of the value. 77.54% of accounts receiv-
able is concentrated in its 20 main customers, from these
93.39% of the debt is insured, while the remaining 22.46%
of accounts receivable is distributed in more than 250 cus-
tomers.
VCT Brazil concentrates 62.84% of its accounts receivable
in its 20 main customers, distributing the remaining 37.16% in
more than 450 customers. 51.01% of its accounts receivable
are subject to a credit insurance, which covers 90% of the
value.
The subsidiaries of Sweden, Norway and Finland, concen-
trates more than 90% of their accounts receivable in sales
performed to state-owned monopolies that do not have credit
insurance due to its low credit risk.
















current 108,358,712 102,981,228 110,532,628
Trade receivable,
net, current 98,473,707 98,544,589 106,275,990
Other accounts
receivable, net,
current 9,885,005 4,436,639 4,256,638
Balances included within this item, in general, do not accrue
interest.
There are no restrictions to the provisions for this type of
accounts receivable of significant amount.
It is important to note that the Company has dealers to sell
its products through the export markets. The largest dealer of
products in the United States is Productos Banfi Corporation
(“Banfi”), whom represented 11.7% and 12.7% of the Com-
pany’s income with respect to total exports as of December
2010 and 2009, respectively. With respect to the Company’s
total income, Banfi represented 8.7% and 10.0% as of De-
cember 2010 and 2009, respectively.
Sales to the Company’s biggest five dealers, including
Banfi, represented 28.5% and 28.8% of total export income
as of December 2010 and 2009, respectively. It is expected
that these five continue to represent a significant portion of
the Company’s income with respect to total exports in the
future.
The Company has signed agreements with the majority of
its dealers. Generally, these agreements are entered for a
two-year period, which are renewable in an automatic man-
ner. The Company’s strategy to increase its sales in the most
significant export markets depends significantly on the Com-
pany’s dealer’s behavior.










1 to 90 days 4,545,554 5,371,608 8,072,025
91 to 180 days 738,729 733,463 289,015
181 to 360 days 318,402 106,717 1,869,189
361 and more 190,697 444,392 175,033
Total 5,793,382 6,656,180 10,405,262
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The bad debt provision is performed at each year-end af-
ter a case-by-case analysis for customers with irrecoverable
indication.
Financial Assets Th$
Beginning balance as of January 1,
2009 920,310
Increase for the period 93,868
Bad debt accrual as of December 31,
2009 1,014,178
Decrease for the period (195,516)
Bad debt accrual as of December 31,
2010 818,662
Note 10. Transactions with Related Parties (in part)
10.1. Information to be Disclosed on Related Parties
At year-end, balances pending are not guaranteed and are
to be settled in cash. There are no guarantees granted or re-
ceived due to accounts receivable or payable to related par-
ties. As of December 31, 2010, the Group has not recorded
any impairment of accounts receivable related to amounts
owed by related parties. This evaluation is performed on an
annual basis through an analysis of the related party’s finan-
cial position in the market in which the related party operates.
10.5. Accounts Receivable from Related Entities, Current
Related Party











76.021.221-0 Agrı́cola Gabriela Ltda. By Director Chilean pesos — 44,483 —
96.512.200-1 Viñedos Emiliana S.A. By Director Chilean pesos 109,427 — —
96.824.300-4 Viña Almaviva S.A. Associate Chilean pesos 58,967 108,921 238,788
90.950.000-1 Industria Corchera S.A. Associate Chilean pesos 353,633 — —
99.562.040-5 Los Boldos de Tapihue S.A. By Director Chilean pesos — 10,170 —
96.512.190-0 Fruticola Viconto S.A. By Director Chilean pesos 1,000 1,901 —
77.486.130-0 Soc. Ag. El Marco Dos Ltda. By Director Chilean pesos — 13,163 —
76.088.641-6 Agricolas Las Pircas Ltda By Director Chilean pesos 4,991 — —
78.335.990-1 Comercial Greenvic S.A. By Director Chilean pesos 80,699 42,182 —
77.486.290-0 Soc. Ag. Orrego Dos Ltda. By Director Chilean pesos 402 — 1,367
Total to date 609,117 220,820 240,155
IFRS ATT 8.55
598 IFRS Accounting Trends & Techniques
10.8. Detail of Transactions With Related Parties, by Entity
Related Party
ID No. Related Party Name
Nature of





96.512.190-0 Fruticola Viconto S.A. By Director Sale of services and other 9,723 9,564
Purchase of Property, plant and equipment — 15,620
Purchase of services and other — 10,741
96.512.200-1 Viñedos Emiliana S.A. By Director Sale of raw material and products 260,651 152,880
Sale of services and other 667,264 799,537
Purchase of raw material and products 507,513 479,352
Purchase of services and other 295,289 248,269
90.950.000-1 Industria Corchera S.A. Associate Purchase of raw material 6,853,216 6,877,970
96.824.300-4 Viña Almaviva S.A. Coligated Sale of raw material and products 118,541 77,958
Sale of services and other 6,389 4,475
Purchase of raw material and products 577,618 409,896
Purchase of services and other 4,987 6,521
76.021.221-0 Agricola Gabriela Ltda. By Director Purchase of raw material 482,576 446,704
90.310.000-1 Gasco GLP S.A. By Director Purchase sale of service and other 913,096 497,528
90.042.000-1 CGE Distribución S.A. By Director Purchase of services and other 1,943,641 2,188,777
85.201.700-7 Agrı́cola Alto Quitralmán Ltda. By Director Sale of raw material and products 1,835 —
Purchase of raw material and products 254,130 10,136
95.097.000-6 Forestal Quivolgo S.A. By Director Purchase of raw material and products 1,792 646
78.335.990-1 Comercial Greenvic S.A. By Director Sale of raw material and products 164,589 213,238
Purchase of raw material and products 29,273 41,423
Purchase of services and other 22,884 37,500
The amounts indicated as transactions in the above chart,
correspond to trade operations with related companies, which
are performed under market conditions with respect to price
involved and payment terms.
There are no bad debt estimates which reduce balances
receivables or guarantees related to this estimates.
Note 17. Financial Instruments (in part)
17.1. Category of Financial Instruments by Nature (in part)
a) Fair values, based on categories of financial instru-
ments, compared against the current and non-current
book value included in the consolidated statements of
financial position as of December 31, 2010
At Amortized Cost Th$ At Fair Value Th$
Classification Group Type Book Value Fair Value Book Value
Financial assets Cash and cash equivalent Balances in banks 6,242,999 6,242,999 —
Short-term deposits 10,514,550 10,514,550 —
Trade receivables and other accounts
receivable Trade receivables, gross 108,358,712 108,358,712 —
Accounts receivable from related
companies Currents 255,484 255,484 —
Non-currents — — —
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Note 27. Effect of Variations in Exchange Rates of
Foreign Currency (in part)





















Trade receivables and other
accounts receivables 108,358,712 — 99,524,546 3,456,682 110,532,628 —
CLP 20,151,585 — 23,333,232 307,892 18,413,222 —
USD 33,011,452 — 27,280,265 2,867,926 40,778,544 —
CAD 2,933,259 — 2,423,301 203,943 2,936,380 —
EUR 7,858,958 — 7,574,903 73,923 16,376,514 —
UF 79,676 — 192,493 2,998 131,603 —
GBP 23,191,515 — 23,620,329 — 28,530,391 —
SEK 4,549,891 — 4,386,547 — — —
NOK 1,111,120 — 1,110,054 — — —
ARS 6,159,719 — 5,828,741 — 2,835,841 —
BRL 9,311,537 — 3,774,681 — 530,133 —
Account receivable from
related entities, current 609,117 — 220,820 — 240,155 —
CLP 609,117 — 220,820 — 240,155 —
Note 34. Contingencies, Restrictions and Lawsuits
(in part)
6) On the occasion of the earthquake which hit a signifi-
cant portion of the Chilean territory on February 21, 2010,
from the total of 11 Company’s warehouses, those located in
Peumo, Pencahue, and Lontué, where affected and experi-
enced losses of wine and production capacity. The Company
quantified the loss of wine in bulk and finished products in
22.8 millions of liters.
The Company maintains Insurance Policies of all Risk
against earthquakes and its effects for all assets affected,
including damages due to disruption.
The recoverable limit for both physical goods and disruption
damage reached a total of UF 20,417,917. These insurances
contemplate a 2% deductible amount for physical goods on
the insured amount by location, with a maximum of UF 10,000
and of 10 days for disruption damage.
As of December 31, 2010, Viña Concha y Toro and sub-
sidiaries have recorded in its financial statements an amount
of Th$20,631,288 which correspond to sinister inventories,
sinister Property, plant and equipment pursuant to its book
value and expenses incurred up to that date, correspond-
ing to cleaning activities, wreckage removal, goods repair-
ing, mitigation expenses of losses due to disruption. Al these
amounts are duly covered by the insurances indicated in prior
paragraphs and are presented within the item Trade receiv-





Sinister Property, plant and equipment 763,629
Expenses incurred 4,589,916
Total 20,631,288
As of December 31, 2010, Viña Concha y Toro and sub-
sidiaries did not record the related deductible as well as the
amounts expected to receive with respect to a higher value
on the book value of inventories of finished products and wine
in bulk which are insured at its sale price. No incomes have
been recorded due to disruption damages.
Company’s management estimates that the values receiv-
able, provide a proper coverage on the amounts correspond-
ing to deductibles.
As of December 2010, the Company received Th$
21,294,138 as an indemnity advance with respect to dam-
ages caused by the earthquake.
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Financial Assets—Held to Maturity
8.56
Eni S.p.A. (Dec 2010)
CONSOLIDATED BALANCE SHEET (in part)
(Euro million)












Cash and cash equivalents (7) 1,608 1,549
Other financial assets held for trading or available for sale (8) 348 382
Trade and other receivables (9) 20,348 1,355 23,636 1,356
Other current assets (13) 1,307 9 1,350 9
31,129 34,911
Non-current assets
Equity-accounted investments (17) 5,828 5,668
Other investments (17) 416 422
Other financial assets (18) 1,148 438 1,523 668
CONSOLIDATED PROFIT AND LOSS ACCOUNT
(in part)


















Finance income (expense) (37)
Finance income 7,985 42 5,950 27 6,117 41
Finance expense (8,198) (17) (6,497) (4) (6,713)
Derivative financial instruments (427) (4) (131)
(640) (551) (727)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
3. Summary of Significant Accounting Policies (in part)
Current Assets
Available-for-sale financial assets include financial assets
other than derivative financial instruments, loans and receiv-
ables, held for trading financial assets and held-to-maturity
financial assets.
Non-Current Assets (in part)
Financial Fixed Assets (in part)
Receivables and Financial Assets to be Held to Maturity
Receivables and financial assets to be held to maturity are
stated at cost represented by the fair value of the initial ex-
changed amount adjusted to take into account direct external
costs related to the transaction (e.g. fees of agents or consul-
tants, etc.). The initial carrying value is then adjusted to take
into account capital repayments, devaluations and amortiza-
tion of the difference between the reimbursement value and
the initial carrying value. Amortization is carried out on the
basis of the effective interest rate of return represented by
the rate that equalizes, at the moment of the initial revalu-
ation, the current value of expected cash flows to the initial
carrying value (so-called “amortized cost method”). Receiv-
ables for finance leases are recognized at an amount equal
to the present value of the lease payments and the purchase
option price or any residual value; the amount is discounted
at the interest rate implicit in the lease.
Any impairment is recognized by comparing the carrying
value with the present value of the expected cash flows dis-
counted at the effective interest rate as defined at initial recog-
nition, or at the moment of its updating to reflect re-pricings
contractually established.
Receivables and financial assets to be held to maturity are
recognized net of the allowance for impairment losses; when
the impairment loss is definite the allowance for impairment
losses is reversed for excess charges. Changes to the carry-
ing amount of receivables or financial assets in accordance
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with the amortized cost method are recognized as “Financial
income (expense)".
18. Other Financial Assets






Receivables for financing operating
activities 1,112 1,488
Securities held for operating purposes 36 35
1,148 1,523
Receivables for financing operating activities are presented
net of the allowance for impairment losses of euro 32 million
(euro 29 million at December 31, 2009).
Operating financing receivables of euro 1,488 million (euro
1,112 million at December 31, 2009) primarily pertained to
loans made by the Exploration & Production segment (euro
716 million), Gas & Power segment (euro 559 million) and
Refining & Marketing segment (euro 96 million) to certain
equity-accounted or cost-accounted entities which executed
capital projects on behalf of Eni’s Group companies. Financ-
ing receivables due from unconsolidated subsidiaries, joint
ventures and associates amounted to euro 656 million. Re-
ceivables for financial leasing amounted to euro 78 million
(euro 97 million at December 31, 2009) and pertained to the
disposal of the Belgian gas network by Finpipe GIE. The
following table shows principal receivable by maturity date,
which was obtained by summing future lease payment re-
ceivables discounted at the effective interest rate, interests






and Five Years Total
Principal receivable 19 78 97
Interests 6 10 16
Undiscounted value of future
lease payments 25 88 113
Receivables with a maturity date within one year is shown
in current assets in the item trade receivables for operat-
ing purposes—current portion of long-term receivables in the
Note 9—Trade and other receivables.
Receivables for financing operating activities in currencies
other than euro amounted to euro 1,128 million (euro 716
million at December 31, 2009).
Receivables for financing operating activities due beyond
five years amounted to euro 823 million (euro 460 million at
December 31, 2009).
Securities of euro 35 million (euro 36 million at December
31, 2009), designated as held-to-maturity investments, are
listed securities, issued by the Italian Government (euro 20
million) and by foreign governments (euro 15 million).
Securities with a maturity beyond five years amounted to
euro 21 million.
Fair value of receivables for financing operating activities
amounted to euro 1,534 million. Securities did not differ signif-
icantly from their carrying amount. The fair value of financing
receivables has been determined based on the present value
of expected future cash flows discounted at rates ranging
from 0.8% to 4.1% (1.0% and 4.5% at December 31, 2009).
The fair value of securities was derived from quoted market
prices.
Receivables with related parties are described in Note 42—
Transactions with related parties.
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Financial Assets and Financial
Liabilities—Held for Trading, Designated
at FVTPL, Available for Sale, Reclassified
to Loans and Receivables, Reclassified
to Available for Sale
8.57
HSBC Holdings plc (Dec 2010)
CONSOLIDATED BALANCE SHEET AT 31







Cash and balances at central banks 57,383 60,655
Items in the course of collection from other banks 6,072 6,395
Hong Kong Government certificates of indebtedness 19,057 17,463
Trading assets 15 385,052 421,381
Financial assets designated at fair value 19 37,011 37,181
Derivatives 20 260,757 250,886
Loans and advances to banks 208,271 179,781
Loans and advances to customers 958,366 896,231
Financial investments 21 400,755 369,158
Liabilities and Equity
Liabilities
Hong Kong currency notes in circulation 19,057 17,463
Deposits by banks 110,584 124,872
Customer accounts 1,227,725 1,159,034
Items in the course of transmission to other banks 6,663 5,734
Trading liabilities 28 300,703 268,130
Financial liabilities designated at fair value 29 88,133 80,092
Derivatives 20 258,665 247,646
Debt securities in issue 30 145,401 146,896
CONSOLIDATED INCOME STATEMENT FOR THE








Interest income 58,345 62,096 91,301
Interest expense (18,904) (21,366) (48,738)
Net interest income 39,441 40,730 42,563
Trading income excluding net interest income 4,680 6,236 847
Net interest income on trading activities 2,530 3,627 5,713
Net trading income 7,210 9,863 6,560
Changes in fair value of long-term debt issued and related derivatives (258) (6,247) 6,679
Net income/(expense) from other financial instruments designated at fair value 1,478 2,716 (2,827)
Net income/(expense) from financial instruments designated at fair value 3 1,220 (3,531) 3,852
Gains less losses from financial investments 968 520 197
Dividend income 112 126 272
Net operating income before loan impairment charges and other credit risk
provisions 68,247 66,181 81,682
Loan impairment charges and other credit risk provisions 6 (14,039) (26,488) (24,937)
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CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME FOR THE YEAR







Profit for the year 14,191 6,694 6,498
Other comprehensive income/(expense)
Available-for-sale investments 5,835 10,817 (21,904)
—Fair value gains/(losses) 6,368 9,821 (23,722)
—Fair value gains transferred to income statement on disposal (1,174) (648) (1,316)
—Amounts transferred to the income statement in respect of impairment losses 1,118 2,391 1,779
—Income taxes (477) (747) 1,355
CONSOLIDATED STATEMENT OF CASH FLOWS









Cash Flows from Financing Activities
Issue of ordinary share capital 180 18,398 467
—Rights issue — 18,326 —
—Other 180 72 467
Issue of other equity instruments 3,718 — 2,133
Net sales/(purchases) of own shares for market-making and investment
purposes 163 (176) (194)
Purchases of own shares to meet share awards and share option awards 11 (51) (808)
On exercise of share options 2 12 27
Subordinated loan capital issued 4,481 2,959 7,094
Subordinated loan capital repaid (2,475) (4,637) (350)
Net cash outflow from change in stake in subsidiaries (229) — —
Dividends paid to shareholders of the parent company (3,441) (4,264) (7,211)
Dividends paid to non-controlling interests (595) (702) (714)
Dividends paid to holders of other equity instruments (413) (269) (92)
Net cash generated from financing activities 1,402 11,270 352
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
(a) Interest Income and Expense
Interest income and expense for all financial instruments ex-
cept for those classified as held for trading or designated at
fair value (other than debt securities issued by HSBC and
derivatives managed in conjunction with such debt securities
issued) are recognised in ‘Interest income’ and ‘Interest ex-
pense’ in the income statement using the effective interest
method. The effective interest method is a way of calculating
the amortised cost of a financial asset or a financial liability
(or groups of financial assets or financial liabilities) and of
allocating the interest income or interest expense over the
relevant period.
The effective interest rate is the rate that exactly discounts
estimated future cash receipts or payments through the ex-
pected life of the financial instrument or, where appropriate, a
shorter period, to the net carrying amount of the financial as-
set or financial liability. When calculating the effective interest
rate, HSBC estimates cash flows considering all contractual
terms of the financial instrument but excluding future credit
losses. The calculation includes all amounts paid or received
by HSBC that are an integral part of the effective interest rate
of a financial instrument, including transaction costs and all
other premiums or discounts.
Interest on impaired financial assets is recognised using
the rate of interest used to discount the future cash flows for
the purpose of measuring the impairment loss.
(b) Non-Interest Income (in part)
Net trading income comprises all gains and losses from
changes in the fair value of financial assets and financial
liabilities held for trading, together with the related interest
income, expense and dividends.
Net income from financial instruments designated at fair
value includes all gains and losses from changes in the fair
value of financial assets and financial liabilities designated
at fair value through profit or loss. Interest income and ex-
pense and dividend income arising on these financial instru-
ments are also included, except for interest arising from debt
securities issued, and derivatives managed in conjunction
with those debt securities, which is recognised in ‘Interest
expense’ (Note 2a).
Dividend income is recognised when the right to receive
payment is established. This is the ex-dividend date for listed
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equity securities, and usually the date when shareholders
have approved the dividend for unlisted equity securities.
(d) Valuation of Financial Instruments
All financial instruments are recognised initially at fair value.
In the normal course of business, the fair value of a financial
instrument on initial recognition is the transaction price (that
is, the fair value of the consideration given or received). In
certain circumstances, however, the fair value will be based
on other observable current market transactions in the same
instrument, without modification or repackaging, or on a val-
uation technique whose variables include only data from ob-
servable markets, such as interest rate yield curves, option
volatilities and currency rates. When such evidence exists,
HSBC recognises a trading gain or loss on inception of the
financial instrument, being the difference between the trans-
action price and the fair value. When unobservable market
data have a significant impact on the valuation of financial
instruments, the entire initial difference in fair value indicated
by the valuation model from the transaction price is not recog-
nised immediately in the income statement but is recognised
over the life of the transaction on an appropriate basis, or
when the inputs become observable, or the transaction ma-
tures or is closed out, or when HSBC enters into an offsetting
transaction.
Subsequent to initial recognition, the fair values of finan-
cial instruments measured at fair value are measured in ac-
cordance with HSBC’s valuation methodologies, which are
described in Note 16.
(e) Reclassification of Financial Assets
Non-derivative financial assets (other than those designated
at fair value through profit or loss upon initial recognition)
may be reclassified out of the fair value through profit or loss
category in the following circumstances:
• financial assets that would have met the definition of
loans and receivables at initial recognition (if the finan-
cial asset had not been required to be classified as
held for trading) may be reclassified out of the fair value
through profit or loss category if there is the intention
and ability to hold the financial asset for the foresee-
able future or until maturity; and
• financial assets (except financial assets that would have
met the definition of loans and receivables at initial
recognition) may be reclassified out of the fair value
through profit or loss category and into another cate-
gory in rare circumstances.
When a financial asset is reclassified as described in the
above circumstances, the financial asset is reclassified at its
fair value on the date of reclassification. Any gain or loss al-
ready recognised in the income statement is not reversed.
The fair value of the financial asset on the date of reclassifi-
cation becomes its new cost or amortised cost, as applicable.
(f) Loans and Advances to Banks and Customers
Loans and advances to banks and customers include loans
and advances originated by HSBC which are not classified
either as held for trading or designated at fair value. Loans
and advances are recognised when cash is advanced to a
borrower. They are derecognised when either the borrower
repays its obligations, or the loans are sold or written off, or
substantially all the risks and rewards of ownership are trans-
ferred. They are initially recorded at fair value plus any directly
attributable transaction costs and are subsequently mea-
sured at amortised cost using the effective interest method,
less any impairment losses. Where exposures are hedged by
derivatives designated and qualifying as fair value hedges,
the carrying value of the loans and advances so hedged in-
cludes a fair value adjustment for the hedged risk only.
HSBC may commit to underwrite loans on fixed contrac-
tual terms for specified periods of time, where the drawdown
of the loan is contingent upon certain future events outside
the control of HSBC. Where the loan arising from the lending
commitment is expected to be held for trading, the commit-
ment to lend is recorded as a derivative and measured at fair
value through profit or loss. On drawdown, the loan is clas-
sified as held for trading and measured at fair value through
profit or loss. Where it is not HSBC’s intention to trade but hold
the loan, a provision on the loan commitment is only recorded
where it is probable that HSBC will incur a loss. This may oc-
cur, for example, where a loss of principal is probable or the
interest rate charged on the loan is lower than the cost of fund-
ing. On inception of the loan, the loan to be held is recorded
at its fair value and subsequently measured at amortised cost
using the effective interest method. For certain transactions,
such as leveraged finance and syndicated lending activities,
the cash advanced is not necessarily the best evidence of the
fair value of the loan. For these loans, where the initial fair
value is lower than the cash amount advanced (for example,
due to the rate of interest charged on the loan being below
the market rate of interest), the write-down is charged to the
income statement. The write-down will be recovered over the
life of the loan, through the recognition of interest income us-
ing the effective interest method, unless the loan becomes
impaired. The write-down is recorded as a reduction to other
operating income.
Financial assets which have been reclassified into the loans
and receivables category are initially recorded at the fair value
at the date of reclassification and are subsequently measured
at amortised cost, using the effective interest rate determined
at the date of reclassification.
(g) Impairment of Loans and Advances
Losses for impaired loans are recognised promptly when
there is objective evidence that impairment of a loan or port-
folio of loans has occurred. Impairment allowances are cal-
culated on individual loans and on groups of loans assessed
collectively. Impairment losses are recorded as charges to the
income statement. The carrying amount of impaired loans on
the balance sheet is reduced through the use of impairment
allowance accounts. Losses expected from future events are
not recognised.
Individually Assessed Loans and Advances
For all loans that are considered individually significant,
HSBC assesses on a case-by-case basis at each balance
sheet date whether there is any objective evidence that a
loan is impaired. The criteria used by HSBC to determine
that there is such objective evidence include:
• known cash flow difficulties experienced by the bor-
rower;
• past due contractual payments of either principal or in-
terest;
• breach of loan covenants or conditions;
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• the probability that the borrower will enter bankruptcy or
other financial realisation; and
• a significant downgrading in credit rating by an external
credit rating agency.
For those loans where objective evidence of impairment ex-
ists, impairment losses are determined considering the fol-
lowing factors:
• HSBC’s aggregate exposure to the customer;
• the viability of the customer’s business model and their
capacity to trade successfully out of financial difficul-
ties and generate sufficient cash flow to service debt
obligations;
• the amount and timing of expected receipts and recov-
eries;
• the likely dividend available on liquidation or bankruptcy;
• the extent of other creditors’ commitments ranking
ahead of, or pari passu with, HSBC and the likelihood
of other creditors continuing to support the company;
• the complexity of determining the aggregate amount
and ranking of all creditor claims and the extent to which
legal and insurance uncertainties are evident;
• the realisable value of security (or other credit mitigants)
and likelihood of successful repossession;
• the likely deduction of any costs involved in recovery of
amounts outstanding;
• the ability of the borrower to obtain, and make payments
in, the currency of the loan if not denominated in local
currency; and
• when available, the secondary market price of the debt.
Impairment losses are calculated by discounting the expected
future cash flows of a loan at its original effective interest rate
and comparing the resultant present value with the loan’s cur-
rent carrying amount. The impairment allowances on individ-
ually significant accounts are reviewed at least quarterly and
more regularly when circumstances require. This normally
encompasses re-assessment of the enforceability of any col-
lateral held and the timing and amount of actual and antici-
pated receipts. Individually assessed impairment allowances
are only released when there is reasonable and objective
evidence of a reduction in the established loss estimate.
Collectively Assessed Loans and Advances
Impairment is assessed on a collective basis in two circum-
stances:
• to cover losses which have been incurred but have not
yet been identified on loans subject to individual as-
sessment; and
• for homogeneous groups of loans that are not consid-
ered individually significant.
Incurred But Not Yet Identified Impairment
Individually assessed loans for which no evidence of loss
has been specifically identified on an individual basis are
grouped together according to their credit risk characteristics
for the purpose of calculating an estimated collective loss.
This reflects impairment losses that HSBC has incurred as
a result of events occurring before the balance sheet date,
which HSBC is not able to identify on an individual loan basis,
and that can be reliably estimated. These losses will only be
individually identified in the future. As soon as information
becomes available which identifies losses on individual loans
within the group, those loans are removed from the group and
assessed on an individual basis for impairment.
The collective impairment allowance is determined after
taking into account:
• historical loss experience in portfolios of similar credit
risk characteristics (for example, by industry sector, loan
grade or product);
• the estimated period between impairment occurring and
the loss being identified and evidenced by the establish-
ment of an appropriate allowance against the individual
loan; and
• management’s experienced judgement as to whether
current economic and credit conditions are such that
the actual level of inherent losses at the balance sheet
date is likely to be greater or less than that suggested
by historical experience.
The period between a loss occurring and its identification is
estimated by local management for each identified portfolio.
Homogeneous Groups of Loans and Advances
Statistical methods are used to determine impairment losses
on a collective basis for homogeneous groups of loans that
are not considered individually significant, because individual
loan assessment is impracticable. Losses in these groups
of loans are recorded on an individual basis when individual
loans are written off, at which point they are removed from
the group. Two alternative methods are used to calculate
allowances on a collective basis:
When appropriate empirical information is available, HSBC
utilises roll rate methodology. This methodology employs sta-
tistical analyses of historical data and experience of delin-
quency and default to estimate the amount of loans that will
eventually be written off as a result of the events occurring
before the balance sheet date which HSBC is not able to
identify on an individual loan basis, and that can be reliably
estimated. Under this methodology, loans are grouped into
ranges according to the number of days past due and statis-
tical analysis is used to estimate the likelihood that loans in
each range will progress through the various stages of delin-
quency, and ultimately prove irrecoverable. Current economic
conditions are also evaluated when calculating the appropri-
ate level of allowance required to cover inherent loss. The
estimated loss is the difference between the present value
of expected future cash flows, discounted at the original ef-
fective interest rate of the portfolio, and the carrying amount
of the portfolio. In certain highly developed markets, sophisti-
cated models also take into account behavioural and account
management trends as revealed in, for example, bankruptcy
and rescheduling statistics.
• When the portfolio size is small or when information
is insufficient or not reliable enough to adopt a roll rate
methodology, HSBC adopts a basic formulaic approach
based on historical loss rate experience.
In normal circumstances, historical experience provides the
most objective and relevant information from which to as-
sess inherent loss within each portfolio, though sometimes
it provides less relevant information about the inherent loss
in a given portfolio at the balance sheet date, for example,
when there have been changes in economic, regulatory or
behavioural conditions which result in the most recent trends
in portfolio risk factors being not fully reflected in the statisti-
cal models. In these circumstances, the risk factors are taken
into account by adjusting the impairment allowances derived
solely from historical loss experience.
These additional portfolio risk factors may include recent
loan portfolio growth and product mix, unemployment rates,
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bankruptcy trends, geographic concentrations, loan product
features (such as the ability of borrowers to repay adjustable-
rate loans where reset interest rates give rise to increases in
interest charges), economic conditions such as national and
local trends in housing markets and interest rates, portfolio
seasoning, account management policies and practices, cur-
rent levels of write-offs, changes in laws and regulations and
other items which can affect customer payment patterns on
outstanding loans, such as natural disasters. These risk fac-
tors, where relevant, are taken into account when calculating
the appropriate level of impairment allowances by adjusting
the impairment allowances derived solely from historical loss
experience.
Roll rates, loss rates and the expected timing of future re-
coveries are regularly benchmarked against actual outcomes
to ensure they remain appropriate.
Write-Off of Loans and Advances
Loans (and the related impairment allowance accounts) are
normally written off, either partially or in full, when there is
no realistic prospect of recovery. Where loans are secured,
this is generally after receipt of any proceeds from the reali-
sation of security. In circumstances where the net realisable
value of any collateral has been determined and there is no
reasonable expectation of further recovery, write off may be
earlier.
Reversals of Impairment
If the amount of an impairment loss decreases in a subse-
quent period, and the decrease can be related objectively to
an event occurring after the impairment was recognised, the
excess is written back by reducing the loan impairment al-
lowance account accordingly. The write-back is recognised
in the income statement.
Reclassified Loans and Advances
Where financial assets have been reclassified out of the fair
value through profit or loss category to the loans and receiv-
ables category, the effective interest rate determined at the
date of reclassification is used to calculate any impairment
losses.
Following reclassification, where there is a subsequent in-
crease in the estimates of future cash receipts as a result of
increased recoverability of those cash receipts, the effect of
that increase is recognised as an adjustment to the effective
interest rate from the date of change in the estimate rather
than as an adjustment to the carrying amount of the asset at
the date of change in the estimate.
Assets Acquired in Exchange for Loans
Non-financial assets acquired in exchange for loans as part
of an orderly realisation are recorded as assets held for sale
and reported in ‘Other assets’ if the carrying amounts of the
assets are recovered principally through sale, the assets are
available for sale in their present condition and their sale is
highly probable. The asset acquired is recorded at the lower
of its fair value less costs to sell and the carrying amount
of the loan (net of impairment allowance) at the date of ex-
change. No depreciation is charged in respect of assets held
for sale. Any subsequent write-down of the acquired asset to
fair value less costs to sell is recognised in the income state-
ment, in ‘Other operating income’. Any subsequent increase
in the fair value less costs to sell, to the extent this does
not exceed the cumulative write-down, is also recognised in
‘Other operating income’, together with any realised gains or
losses on disposal.
Renegotiated Loans
Loans subject to collective impairment assessment whose
terms have been renegotiated are no longer considered past
due, but are treated as up to date loans for measurement pur-
poses once the minimum number of payments required un-
der the new arrangements have been received. These rene-
gotiated loans are segregated from other parts of the loan
portfolio for the purposes of collective impairment assess-
ment, to reflect their risk profile. Loans subject to individual
impairment assessment, whose terms have been renegoti-
ated, are subject to ongoing review to determine whether
they remain impaired or should be considered past due. The
carrying amount of loans that have been classified as renego-
tiated retain this classification until maturity or derecognition.
Interest is recorded on renegotiated loans taking into account
the new contractual terms following renegotiation.
(h) Trading Assets and Trading Liabilities
Treasury bills, debt securities, equity securities, loans, de-
posits, debt securities in issue, and short positions in se-
curities are classified as held for trading if they have been
acquired or incurred principally for the purpose of selling or
repurchasing in the near term, or they form part of a portfolio
of identified financial instruments that are managed together
and for which there is evidence of a recent pattern of short-
term profit-taking. These financial assets or financial liabili-
ties are recognised on trade date, when HSBC enters into
contractual arrangements with counterparties to purchase or
sell the financial instruments, and are normally derecognised
when either sold (assets) or extinguished (liabilities). Mea-
surement is initially at fair value, with transaction costs taken
to the income statement. Subsequently, the fair values are
remeasured, and gains and losses from changes therein are
recognised in the income statement in ‘Net trading income’.
(i) Financial Instruments Designated at Fair Value
Financial instruments, other than those held for trading, are
classified in this category if they meet one or more of the
criteria set out below, and are so designated by management.
HSBC may designate financial instruments at fair value when
the designation:
• eliminates or significantly reduces measurement or
recognition inconsistencies that would otherwise arise
from measuring financial assets or financial liabilities,
or recognising gains and losses on them, on different
bases. Under this criterion, the main classes of financial
instruments designated by HSBC are:
— Long-term debt issues. The interest payable on cer-
tain fixed rate long-term debt securities issued has
been matched with the interest on ‘receive fixed/pay
variable’ interest rate swaps as part of a documented
interest rate risk management strategy. An account-
ing mismatch would arise if the debt securities issued
were accounted for at amortised cost, because the
related derivatives are measured at fair value with
changes in the fair value recognised in the income
statement. By designating the long-term debt at fair
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value, the movement in the fair value of the long-term
debt will also be recognised in the income statement.
— Financial assets and financial liabilities under invest-
ment contracts. Liabilities to customers under linked
contracts are determined based on the fair value of
the assets held in the linked funds, with changes
recognised in the income statement. If no designa-
tion was made for the assets relating to the customer
liabilities they would be classified as available for
sale and the changes in fair value would be recorded
in other comprehensive income. These financial in-
struments are managed on a fair value basis and
management information is also prepared on this ba-
sis. Designation at fair value of the financial assets
and liabilities under investment contracts allows the
changes in fair values to be recorded in the income
statement and presented in the same line.
• applies to groups of financial assets, financial liabilities
or combinations thereof that are managed, and their
performance evaluated, on a fair value basis in accor-
dance with a documented risk management or invest-
ment strategy, and where information about the groups
of financial instruments is reported to management on
that basis. Under this criterion, certain financial assets
held to meet liabilities under insurance contracts are
the main class of financial instrument so designated.
HSBC has documented risk management and invest-
ment strategies designed to manage such assets at fair
value, taking into consideration the relationship of as-
sets to liabilities in a way that mitigates market risks.
Reports are provided to management on the fair value
of the assets. Fair value measurement is also consis-
tent with the regulatory reporting requirements under
the appropriate regulations for these insurance opera-
tions.
• relates to financial instruments containing one or more
embedded derivatives that significantly modify the cash
flows resulting from those financial instruments, includ-
ing certain debt issues and debt securities held.
The fair value designation, once made, is irrevocable. Des-
ignated financial assets and financial liabilities are recognised
when HSBC enters into the contractual provisions of the ar-
rangements with counterparties, which is generally on trade
date, and are normally derecognised when either sold (as-
sets) or extinguished (liabilities). Measurement is initially at
fair value, with transaction costs taken to the income state-
ment. Subsequently, the fair values are remeasured, and
gains and losses from changes therein are recognised in the
income statement in ‘Net income from financial instruments
designated at fair value’.
(j) Financial Investments
Treasury bills, debt securities and equity securities intended
to be held on a continuing basis, other than those desig-
nated at fair value, are classified as available for sale or held
to maturity. Financial investments are recognised on trade
date when HSBC enters into contractual arrangements with
counterparties to purchase securities, and are normally dere-
cognised when either the securities are sold or the borrowers
repay their obligations.
(i) Available-for-sale financial assets are initially measured
at fair value plus direct and incremental transaction costs.
They are subsequently remeasured at fair value, and changes
therein are recognised in other comprehensive income in
‘Available-for-sale investments – fair value gains/(losses)’ un-
til the financial assets are either sold or become impaired.
When available-for-sale financial assets are sold, cumulative
gains or losses previously recognised in other comprehensive
income are recognised in the income statement as ‘Gains less
losses from financial investments’.
Interest income is recognised on available-for-sale debt
securities using the effective interest rate, calculated over the
asset’s expected life. Premiums and/or discounts arising on
the purchase of dated investment securities are included in
the calculation of their effective interest rates. Dividends are
recognised in the income statement when the right to receive
payment has been established.
At each balance sheet date an assessment is made of
whether there is any objective evidence of impairment in the
value of a financial asset. Impairment losses are recognised
if, and only if, there is objective evidence of impairment as
a result of one or more events that occurred after the initial
recognition of the financial asset (a ‘loss event’) and that loss
event (or events) has an impact on the estimated future cash
flows of the financial asset that can be reliably estimated.
If the available-for-sale financial asset is impaired, the dif-
ference between the financial asset’s acquisition cost (net of
any principal repayments and amortisation) and the current
fair value, less any previous impairment loss recognised in
the income statement, is removed from other comprehensive
income and recognised in the income statement.
Impairment losses for available-for-sale debt securities
are recognised within ‘Loan impairment charges and other
credit risk provisions’ in the income statement and impair-
ment losses for available-for-sale equity securities are recog-
nised within ‘Gains less losses from financial investments’
in the income statement. The impairment methodologies for
available-for-sale financial assets are set out in more detail
below.
• Available-for-sale debt securities. When assessing
available-for-sale debt securities for objective evidence
of impairment at the reporting date, HSBC considers all
available evidence, including observable data or infor-
mation about events specifically relating to the securi-
ties which may result in a shortfall in recovery of future
cash flows. These events may include a significant fi-
nancial difficulty of the issuer, a breach of contract such
as a default, bankruptcy or other financial reorganisa-
tion, or the disappearance of an active market for the
debt security because of financial difficulties relating to
the issuer.
These types of specific event and other factors such
as information about the issuers’ liquidity, business and
financial risk exposures, levels of and trends in default
for similar financial assets, national and local economic
trends and conditions, and the fair value of collateral
and guarantees may be considered individually, or in
combination, to determine if there is objective evidence
of impairment of a debt security.
In addition, when assessing available-for-sale asset-
backed securities (‘ABS’s) for objective evidence of im-
pairment, HSBC considers the performance of underly-
ing collateral and the extent and depth of market price
declines. Changes in credit ratings are considered but
a downgrade of a security’s credit rating is not, of it-
self, evidence of impairment. The primary indicators of
potential impairment are considered to be adverse fair
value movements and the disappearance of an active
market for a security. ABS impairment methodologies
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are described in more detail in ‘Securitisation exposures
and other structured products’ on page 128.
• Available-for-sale equity securities. Objective evidence
of impairment for available-for sale equity securities
may include specific information about the issuer as
detailed above, but may also include information about
significant changes in technology, markets, economics
or the law that provides evidence that the cost of the
equity securities may not be recovered.
A significant or prolonged decline in the fair value
of the asset below its cost is also objective evidence
of impairment. In assessing whether it is significant, the
decline in fair value is evaluated against the original cost
of the asset at initial recognition. In assessing whether it
is prolonged, the decline is evaluated against the period
in which the fair value of the asset has been below its
original cost at initial recognition.
Once an impairment loss has been recognised on an
available-for-sale financial asset, the subsequent ac-
counting treatment for changes in the fair value of that
asset differs depending on the nature of the available-
for-sale financial asset concerned:
— for an available-for-sale debt security, a subsequent
decline in the fair value of the instrument is recog-
nised in the income statement when there is further
objective evidence of impairment as a result of further
decreases in the estimated future cash flows of the
financial asset. Where there is no further objective
evidence of impairment, the decline in the fair value
of the financial asset is recognised in other compre-
hensive income. If the fair value of a debt security
increases in a subsequent period, and the increase
can be objectively related to an event occurring after
the impairment loss was recognised in the income
statement, the impairment loss is reversed through
the income statement to the extent of the increase in
fair value;
— for an available-for-sale equity security, all subse-
quent increases in the fair value of the instrument are
treated as a revaluation and are recognised in other
comprehensive income. Impairment losses recog-
nised on the equity security are not reversed through
the income statement. Subsequent decreases in the
fair value of the available-for-sale equity security are
recognised in the income statement, to the extent that
further cumulative impairment losses have been in-
curred in relation to the acquisition cost of the equity
security.
(ii) Held-to-maturity investments are non-derivative financial
assets with fixed or determinable payments and fixed ma-
turities that HSBC positively intends, and is able, to hold to
maturity. Held-to-maturity investments are initially recorded
at fair value plus any directly attributable transaction costs,
and are subsequently measured at amortised cost using the
effective interest rate method, less any impairment losses.
(k) Sale and Repurchase Agreements (including stock
lending and borrowing)
When securities are sold subject to a commitment to repur-
chase them at a predetermined price (‘repos’), they remain
on the balance sheet and a liability is recorded in respect
of the consideration received. Securities purchased under
commitments to sell (‘reverse repos’) are not recognised on
the balance sheet and the consideration paid is recorded in
‘Loans and advances to banks’ or ‘Loans and advances to
customers’ as appropriate. The difference between the sale
and repurchase price is treated as interest and recognised
over the life of the agreement.
Securities lending and borrowing transactions are generally
secured, with collateral taking the form of securities or cash
advanced or received. The transfer of securities to counter-
parties under these agreements is not normally reflected on
the balance sheet. Cash collateral advanced or received is
recorded as an asset or a liability respectively.
Securities borrowed are not recognised on the balance
sheet. If they are sold on to third parties, an obligation to
return the securities is recorded as a trading liability and mea-
sured at fair value, and any gains or losses are included in
‘Net trading income’.
(m) Derecognition of Financial Assets and Liabilities
Financial assets are derecognised when the contractual right
to receive cash flows from the assets has expired; or when
HSBC has transferred its contractual right to receive the cash
flows of the financial assets, and either:
• substantially all the risks and rewards of ownership have
been transferred; or
• HSBC has neither retained nor transferred substantially
all the risks and rewards, but has not retained control.
Financial liabilities are derecognised when they are extin-
guished, that is when the obligation is discharged, cancelled,
or expires.
(n) Offsetting Financial Assets and Financial Liabilities
Financial assets and financial liabilities are offset and the
net amount is reported in the balance sheet when there is
a legally enforceable right to offset the recognised amounts
and there is an intention to settle on a net basis, or realise
the asset and settle the liability simultaneously.
3. Net Income/(Expense) from Financial Instruments
Designated at Fair Value (in part)
Net income/(expense) from financial instruments designated
at fair value includes:
• all gains and losses from changes in the fair value of
financial assets and liabilities designated at fair value,
including liabilities under investment contracts;
• all gains and losses from changes in the fair value of
derivatives that are managed in conjunction with finan-
cial assets and liabilities designated at fair value; and
• interest income, interest expense and dividend income
in respect of:
— financial assets and liabilities designated at fair value;
and
— derivatives managed in conjunction with the above,
except for interest arising from HSBC’s issued debt
securities and derivatives managed in conjunction
with those debt securities, which is recognised in ‘In-
terest expense’.
IFRS ATT 8.57
609Section 8: Financial Instruments and Related Disclosures
Net Income/(Expense) from Financial Instruments







Net income/(expense) arising on:
—Financial assets held to meet liabilities under insurance and investment contracts 2,349 3,793 (5,064)
—Other financial assets designated at fair value 230 2 1,738
—Derivatives managed in conjunction with other financial assets designated at fair value (149) (249) 77
2,430 3,546 (3,249)
—Liabilities to customers under investment contracts (946) (1,329) 1,751
—HSBC’s long-term debt issued and related derivatives (258) (6,247) 6,679
—Changes in own credit spread on long-term debt (63) (6,533) 6,570
—Derivatives managed in conjunction with HSBC’s issued debt securities (275) (1,726) 4,413
—Other changes in fair value 80 2,012 (4,304)
—Other financial liabilities designated at fair value (18) 492 (1,368)
—Derivatives managed in conjunction with other financial liabilities designated at fair value 12 7 39
(1,210) (7,077) 7,101
1,220 (3,531) 3,852
14. Analysis of Financial Assets and Liabilities
by Measurement Basis
Financial assets and financial liabilities are measured on
an ongoing basis either at fair value or at amortised cost.
The summary of significant accounting policies in Note 2 de-
scribes how the classes of financial instruments are mea-
sured, and how income and expenses, including fair value
gains and losses, are recognised. The following table anal-
yses the carrying amounts of the financial assets and liabili-
ties by category as defined in IAS 39 and by balance sheet
heading.





























US$m US$m US$m US$m US$m US$m US$m US$m
Financial Assets
Cash and balances at central banks — — — — 57,383 — — 57,383
Items in the course of collection from
other banks — — — — 6,072 — — 6,072
Hong Kong Government certificates of
indebtedness — — — — 19,057 — — 19,057
Trading assets 385,052 — — — — — — 385,052
Financial assets designated at
fair value — 37,011 — — — — — 37,011
Derivatives 256,689 — — — — 596 3,472 260,757
Loans and advances to banks — — — — 208,271 — — 208,271
Loans and advances to customers — — — — 958,366 — — 958,366
Financial investments — — 19,499 381,256 — — — 400,755
Other assets — — — — 20,097 — — 20,097
Accrued income — — — — 10,274 — — 10,274
Total financial assets 641,741 37,011 19,499 381,256 1,279,520 596 3,472 2,363,095
Financial Liabilities
Hong Kong currency notes in circulation — — — — 19,057 — — 19,057
Deposits by banks — — — — 110,584 — — 110,584
Customer accounts — — — — 1,227,725 — — 1,227,725
Items in the course of transmission to
other banks — — — — 6,663 — — 6,663
Trading liabilities 300,703 — — — — — — 300,703
Financial liabilities designated at fair value — 88,133 — — — — — 88,133
Derivatives 254,416 — — — — 2,226 2,023 258,665
Debt securities in issue — — — — 145,401 — — 145,401
Other liabilities — — — — 25,533 — — 25,533
Accruals — — — — 12,545 — — 12,545
Subordinated liabilities — — — — 33,387 — — 33,387
Total financial liabilities 555,119 88,133 — — 1,580,895 2,226 2,023 2,228,396
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—Not subject to repledge or resale by
counterparties 284,940 320,155
—Which may be repledged or resold by
counterparties 100,112 101,226
385,052 421,381
Treasury and other eligible bills 25,620 22,346
Debt securities 168,268 201,598
Equity securities 41,086 35,311
Trading securities at fair value 234,974 259,255
Loans and advances to banks 70,456 78,126
Loans and advances to customers 79,622 84,000
385,052 421,381




US Treasury and US Government agencies(2) 20,239 17,620
UK Government 17,036 12,113
Hong Kong Government 11,053 10,649
Other government 92,826 94,264
Asset-backed securities(3) 3,998 5,308
Corporate debt and other securities 48,736 83,990
Equity securities 41,086 35,311
234,974 259,255
(1) Included within these figures are debt securities issued by
banks and other financial institutions of US$37,170m (2009:
US$41,466m), of which US$8,330m (2009: US$7,280m) are guar-
anteed by various governments.
(2) Includes securities that are supported by an explicit guarantee
issued by the US Government.
(3) Excludes asset-backed securities included under US Treasury
and US Government agencies.
Trading Securities Listed on a Recognised Exchange
and Unlisted
Treasury
and other Debt Equity
Eligible Bills Securities Securities Total
US$m US$m US$m US$m
Fair value at 31 December 2010
Listed on a recognised exchange(1) 698 113,878 40,098 154,674
Unlisted 24,922 54,390 988 80,300
25,620 168,268 41,086 234,974
Fair value at 31 December 2009
Listed on a recognised exchange(1) 3,107 159,030 33,428 195,565
Unlisted 19,239 42,568 1,883 63,690
22,346 201,598 35,311 259,255
(1) Included within listed investments are US$3,254m (2009: US$3,229m) of investments listed in Hong Kong.
Loans and Advances to Banks Held for Trading
2010 2009
US$m US$m
Reverse repos 45,771 50,357
Settlement accounts 5,226 10,128
Stock borrowing 6,346 4,711
Other 13,113 12,930
70,456 78,126
Loans and Advances to Customers Held for Trading
2010 2009
US$m US$m
Reverse repos 46,366 42,172
Settlement accounts 7,516 12,134
Stock borrowing 11,161 18,042
Other 14,579 11,652
79,622 84,000
16. Fair Values of Financial Instruments Carried
at Fair Value
The classification of financial instruments is determined in
accordance with the accounting policies set out in Note 2.
The use of assumptions and estimation in valuing financial
instruments is described on page 34.
Fair value is the amount for which an asset could be ex-
changed, or a liability settled, between knowledgeable, willing
parties in an arm’s length transaction.
The following table sets out the financial instruments car-
ried at fair value.
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Trading assets 224,613 154,750 5,689 385,052
Financial assets designated at fair value 23,641 12,783 587 37,011
Derivatives 2,078 254,718 3,961 260,757
Financial investments: available for sale 214,276 158,743 8,237 381,256
Liabilities
Trading liabilities 124,874 164,436 11,393 300,703
Financial liabilities designated at fair value 22,193 65,370 570 88,133
Derivatives 1,808 253,051 3,806 258,665
31 December 2009
Assets
Trading assets 272,509 142,452 6,420 421,381
Financial assets designated at fair value 24,184 11,773 1,224 37,181
Derivatives 1,961 244,472 4,453 250,886
Financial investments: available for sale 163,149 178,168 10,214 351,531
Liabilities
Trading liabilities 119,544 139,812 8,774 268,130
Financial liabilities designated at fair value 27,553 52,032 507 80,092
Derivatives 1,843 240,611 5,192 247,646
The reduction of Level 1 trading assets reflects the decon-
solidation of CNAV funds which is discussed further on page
363. The increase in Level 1 available-for-sale instruments
reflects increased investment in government and US agency
securities. The rise in the size of Level 2 trading assets
and liabilities reflects an increase in repo and reverse repo
activity.
There were no material transfers between Level 1 and
Level 2 in the period.
Control Framework
Fair values are subject to a control framework designed to en-
sure that they are either determined or validated by a function
independent of the risk-taker.
For all financial instruments where fair values are deter-
mined by reference to externally quoted prices or observable
pricing inputs to models, independent price determination or
validation is utilised. In inactive markets, direct observation of
a traded price may not be possible. In these circumstances,
HSBC will source alternative market information to validate
the financial instrument’s fair value, with greater weight given
to information that is considered to be more relevant and reli-
able. The factors that are considered in this regard are, inter
alia:
• the extent to which prices may be expected to represent
genuine traded or tradeable prices;
• the degree of similarity between financial instruments;
• the degree of consistency between different sources;
• the process followed by the pricing provider to derive
the data;
• the elapsed time between the date to which the market
data relates and the balance sheet date; and
• the manner in which the data was sourced.
For fair values determined using a valuation model, the con-
trol framework may include, as applicable, independent de-
velopment or validation of (i) the logic within valuation models;
(ii) the inputs to those models; (iii) any adjustments required
outside the valuation models; and (iv) where possible, model
outputs. Valuation models are subject to a process of due dili-
gence and calibration before becoming operational and are
calibrated against external market data on an ongoing basis.
Determination of Fair Value
Fair values are determined according to the following
hierarchy:
Level 1—quoted market price: financial instruments with
quoted prices for identical instruments in active markets.
Level 2—valuation technique using observable inputs: fi-
nancial instruments with quoted prices for similar instru-
ments in active markets or quoted prices for identical
or similar instruments in inactive markets and financial
instruments valued using models where all significant in-
puts are observable.
Level 3—valuation technique with significant unobservable
inputs: financial instruments valued using valuation tech-
niques where one or more significant inputs are unob-
servable.
The best evidence of fair value is a quoted price in an actively
traded market. The fair values of financial instruments that are
quoted in active markets are based on bid prices for assets
held and offer prices for liabilities issued. Where a financial
instrument has a quoted price in an active market and it is
part of a portfolio, the fair value of the portfolio is calculated
as the product of the number of units and quoted price and
no block discounts are applied. In the event that the market
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for a financial instrument is not active, a valuation technique
is used.
The judgement as to whether a market is active may in-
clude, but is not restricted to, the consideration of factors
such as the magnitude and frequency of trading activity, the
availability of prices and the size of bid/offer spreads. The
bid/offer spread represents the difference in prices at which
a market participant would be willing to buy compared with
the price at which they would be willing to sell. In inactive
markets, obtaining assurance that the transaction price pro-
vides evidence of fair value or determining the adjustments
to transaction prices that are necessary to measure the fair
value of the instrument requires additional work during the
valuation process.
Valuation techniques incorporate assumptions about fac-
tors that other market participants would use in their valu-
ations, including interest rate yield curves, exchange rates,
volatilities, and prepayment and default rates. During the
year, as a result of evolving market practice in the pricing
of certain interest rate derivatives, HSBC has, for single cur-
rency swaps with collateralised counterparties and in sig-
nificant major currencies, adopted a discounting curve that
reflects the overnight interest rate (‘OIS discounting’). Pre-
viously, in line with market practice, discount curves did not
reflect this overnight interest rate component but were based
on a term LIBOR rate. The financial effect of this change was
not significant.
The majority of valuation techniques employ only observ-
able market data. However, certain financial instruments are
valued on the basis of valuation techniques that feature one
or more significant market inputs that are unobservable, and
for them, the derivation of fair value is more judgemental. An
instrument in its entirety is classified as valued using signif-
icant unobservable inputs if, in the opinion of management,
a significant proportion of the instrument’s carrying amount
and/or inception profit (‘day 1 gain or loss’) is driven by un-
observable inputs. ‘Unobservable’ in this context means that
there is little or no current market data available from which
to determine the price at which an arm’s length transaction
would be likely to occur. It generally does not mean that there
is no data available at all upon which to base a determination
of fair value (consensus pricing data may, for example, be
used).
In certain circumstances, primarily where debt is hedged
with interest rate derivatives, HSBC records its own debt
in issue at fair value, based on quoted prices in an active
market for the specific instrument concerned, if available.
When quoted market prices are unavailable, the own debt
in issue is valued using valuation techniques, the inputs for
which are either based upon quoted prices in an inactive mar-
ket for the instrument, or are estimated by comparison with
quoted prices in an active market for similar instruments. In
both cases, the fair value includes the effect of applying the
credit spread which is appropriate to HSBC’s liabilities. The
change in fair value of issued debt securities attributable to
the Group’s own credit spread is computed as follows: for
each security at each reporting date, an externally verifiable
price is obtained or a price is derived using credit spreads for
similar securities for the same issuer. Then, using discounted
cash flow, each security is valued using a LIBOR-based dis-
count curve. The difference in the valuations is attributable to
the Group’s own credit spread. This methodology is applied
consistently across all securities.
Structured notes issued and certain other hybrid instru-
ment liabilities are included within trading liabilities and are
measured at fair value. The credit spread applied to these
instruments is derived from the spreads at which HSBC is-
sues structured notes. These market spreads are smaller
than credit spreads observed for plain vanilla debt or in the
credit default swap markets.
Gains and losses arising from changes in the credit spread
of liabilities issued by HSBC reverse over the contractual
life of the debt, provided that the debt is not repaid at a pre-
mium or a discount.
Fair Value Adjustments
Fair value adjustments are adopted when HSBC considers
that there are additional factors that would be considered
by a market participant that are not incorporated within the
valuation model. The magnitude of fair value adjustments
depends upon many entity-specific factors, and therefore fair
value adjustments may not be comparable across the banking
industry.
HSBC classifies fair value adjustments as either ‘risk-
related’ or ‘model-related’. The majority of these adjustments
relate to Global Banking and Markets.
Movements in the level of fair value adjustments do not nec-
essarily result in the recognition of profits or losses within the
income statement. For example, as models are enhanced,
fair value adjustments may no longer be required. Similarly,
fair value adjustments will decrease when the related posi-
tions are unwound, but this may not result in profit or loss.








Credit risk adjustment 1,355 2,172
Other 60 32
Model-related 389 457
Model limitation 383 391
Other 6 66
Inception profit (Day 1 P&L reserves) (Note 20) 250 260
2,810 3,672
The most significant fair value adjustment movement related
to the release of US$490m of credit risk adjustments held for
monoline insurers of which US$336m resulted from commu-
tations. The commutations did not result in a material gain
or loss. The remainder of the decrease in the credit risk ad-
justment derived primarily from commutations or restructures
with non-monoline counterparties and internal credit rating
upgrades of certain counterparties.
Risk-Related Adjustments
Bid-Offer
IAS 39 requires that portfolios are marked at bid or offer,
as appropriate. Valuation models will typically generate mid
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market values. The bid-offer adjustment reflects the cost that
would be incurred if substantially all residual net portfolio mar-
ket risks were closed using available hedging instruments or
by disposing of or unwinding the actual position.
Uncertainty
Certain model inputs may be less readily determinable from
market data, and/or the choice of model itself may be more
subjective. In these circumstances, there exists a range of
possible values that the financial instrument or market pa-
rameter may assume and an adjustment may be necessary
to reflect the likelihood that in estimating the fair value of the
financial instrument, market participants would adopt rather
more conservative values for uncertain parameters and/or
model assumptions than those used in the valuation model.
Credit Risk Adjustment
The credit risk adjustment is an adjustment to the valuation
of OTC derivative contracts to reflect within fair value the
possibility that the counterparty may default and HSBC may
not receive the full market value of the transactions.
Model-Related Adjustments
Model Limitation
Models used for portfolio valuation purposes may be based
upon a simplifying set of assumptions that do not capture all
material market characteristics. Additionally, markets evolve,
and models that were adequate in the past may require de-
velopment to capture all material market characteristics in
current market conditions. In these circumstances, model
limitation adjustments are adopted. As model development
progresses, model limitations are addressed within the valu-
ation models and a model limitation adjustment is no longer
needed.
Inception Profit (Day 1 P&L Reserves)
Inception profit adjustments are adopted where the fair value
estimated by a valuation model is based on one or more
significant unobservable inputs. The accounting for inception
profit adjustments is discussed on page 254. An analysis of
the movement in the deferred Day 1 P&L reserve is provided
on page 324.
Credit Risk Adjustment Methodology
HSBC calculates a separate credit risk adjustment for each
HSBC legal entity, and within each entity for each counter-
party to which the entity has exposure. The calculation of
the monoline credit risk adjustment and sensitivity to differ-
ent assumptions is described on page 137. Of the total credit
risk adjustment at 31 December 2010 of US$1,355m (2009:
US$2,172m), US$836m (2009: US$1,163m) relates to the
credit risk adjustment taken against non-monoline counter-
parties. The methodology for calculating the credit risk ad-
justment for non-monoline counterparties is described below.
HSBC calculates the credit risk adjustment by applying the
probability of default of the counterparty to the expected pos-
itive exposure to the counterparty, and multiplying the result
by the loss expected in the event of default. The calculation
is performed over the life of the potential exposure.
The probability of default is based on HSBC’s internal credit
rating for the counterparty, taking into account how credit
ratings may deteriorate over the duration of the exposure
through the use of historical rating transition matrices. For
most products, to calculate the expected positive exposure
to a counterparty, HSBC uses a simulation methodology to
incorporate the range of potential exposures across the port-
folio of transactions with the counterparty over the life of an
instrument. The simulation methodology includes credit miti-
gants such as counterparty netting agreements and collateral
agreements with the counterparty. A standard loss given de-
fault assumption of 60% is generally adopted. HSBC does
not adjust derivative liabilities for HSBC’s own credit risk,
such an adjustment is often referred to as a ‘debit valuation
adjustment’.
For certain types of exotic derivatives where the products
are not currently supported by the simulation, or for derivative
exposures in smaller trading locations where the simulation
tool is not yet available, HSBC adopts alternative method-
ologies. These may involve mapping to the results for simi-
lar products from the simulation tool or where such a map-
ping approach is not appropriate, a simplified methodology
is used, generally following the same principles as the sim-
ulation methodology. The calculation is applied at a trade
level, with more limited recognition of credit mitigants such
as netting or collateral agreements than used in the simula-
tion methodology described previously.
The methodologies do not, in general, account for ‘wrong-
way risk’. Wrong-way risk arises where the underlying value of
the derivative prior to any credit risk adjustment is positively
correlated to the probability of default of the counterparty.
Where there is significant wrong-way risk, a trade specific
approach is applied to reflect the wrong-way risk within the
valuation.
HSBC includes all third party counterparties in the credit
risk adjustment calculation and does not net credit risk ad-
justments across HSBC Group entities. During 2010, there
were no material changes made by HSBC to the methodolo-
gies used to calculate the credit risk adjustment.
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Fair Value Valuation Bases
Financial Instruments Measured at Fair Value Using a


























At 31 December 2010
Private equity including strategic
investments 4,057 278 120 — — — —
Asset-backed securities 1,949 566 — — — — —
Leveraged finance — — — — — — 11
Loans held for securitisation — 1,043 — — — — —
Structured notes — — — — 10,667 — —
Derivatives with monolines — — — 1,005 — — —
Other derivatives — — — 2,956 — — 3,787
Other portfolios 2,231 3,802 467 — 726 570 8
8,237 5,689 587 3,961 11,393 570 3,806
Private Equity and Strategic Investments
HSBC’s private equity and strategic investments are gener-
ally classified as available for sale and are not traded in active
markets. In the absence of an active market, an investment’s
fair value is estimated on the basis of an analysis of the in-
vestee’s financial position and results, risk profile, prospects
and other factors, as well as by reference to market valua-
tions for similar entities quoted in an active market, or the
price at which similar companies have changed ownership.
Asset-Backed Securities
Illiquidity and a lack of transparency in the market for ABSs
have resulted in less observable data being available. While
quoted market prices are generally used to determine the fair
value of these securities, valuation models are used to sub-
stantiate the reliability of the limited market data available and
to identify whether any adjustments to quoted market prices
are required. For ABSs including residential MBSs, the valu-
ation uses an industry standard model and the assumptions
relating to prepayment speeds, default rates and loss sever-
ity based on collateral type, and performance, as appropriate.
The valuations output is benchmarked for consistency against
observable data for securities of a similar nature.
Loans, Including Leveraged Finance and Loans Held
for Securitisation
Loans held at fair value are valued from broker quotes and/or
market data consensus providers when available. In the ab-
sence of an observable market, the fair value is determined
using valuation techniques. These techniques include dis-
counted cash flow models, which incorporate assumptions
regarding an appropriate credit spread for the loan, derived
from other market instruments issued by the same or compa-
rable entities.
Structured Notes
The fair value of structured notes valued using a valuation
technique is derived from the fair value of the underlying debt
security, and the fair value of the embedded derivative is de-
termined as described in the paragraph below on derivatives.
Derivatives
OTC (i.e. non-exchange traded) derivatives are valued us-
ing valuation models. Valuation models calculate the present
value of expected future cash flows, based upon ‘no-
arbitrage’ principles. For many vanilla derivative products,
such as interest rate swaps and European options, the mod-
elling approaches used are standard across the industry. For
more complex derivative products, there may be some dif-
ferences in market practice. Inputs to valuation models are
determined from observable market data wherever possible,
including prices available from exchanges, dealers, brokers
or providers of consensus pricing. Certain inputs may not
be observable in the market directly, but can be determined
from observable prices via model calibration procedures or
estimated from historical data or other sources. Examples of
inputs that may be unobservable include volatility surfaces,
in whole or in part, for less commonly traded option products,
and correlations between market factors such as foreign ex-
change rates, interest rates and equity prices. The valuation
of derivatives with monolines is discussed on page 137.
Reconciliation of Fair Value Measurements in Level 3 of the
Fair Value Hierarchy
The following table provides a reconciliation of the movement
between opening and closing balances of Level 3 financial in-
struments, measured at fair value using a valuation technique
with significant unobservable inputs:
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At 1 January 10,214 6,420 1,224 4,453 8,774 507 5,192
Total gains/(losses) recognised in profit or loss 345 158 63 (675) 166 (11) (240)
Total gains/(losses) recognised in other
comprehensive income(1) 618 (101) (36) (110) (157) 74 93
Purchases 3,708 858 81 — (356) — —
New issuances — — — — 4,025 — —
Sales (2,461) (1,543) (8) — — — —
Settlements (1,032) 1 (22) 64 (948) — (820)
Transfers out (7,065) (629) (894) (669) (1,750) — (1,003)
Transfers in 3,910 525 179 898 1,639 — 584
At 31 December 8,237 5,689 587 3,961 11,393 570 3,806
Total gains/(losses) recognised in profit or loss
relating to assets and liabilities held on 31
December: 113 116 17 268 180 (14) 361
—Net interest income 89 — — — — — —
—Trading income excluding net interest
income — 98 — 268 198 — 361
—Net interest income on trading activities — 18 — — (18) — —
—Net income/(expense) from other financial
instruments designated at fair value — — 17 — — (14) —
—Dividend income 24 — — — — — —
(1) Included in ‘Available-for-sale investments: Fair value gains/(losses)’ and ‘Exchange differences’ in the consolidated statement of compre-
hensive income.
Available-for-sale securities: Greater pricing certainty of val-
uations in ABS markets (particularly MBS) has resulted in
the transfer of assets out of Level 3 during 2010. Transfers
into Level 3 were primarily related to strategic investments in
Asia.
Trading assets: Greater pricing certainty of valuations in
ABS markets (particularly MBS) and certain corporate bonds
has resulted in the transfer of assets out of Level 3 during
2010. Transfers into Level 3 were driven by certain other
corporate bonds for which pricing certainty decreased. Sales
relate to disposals of whole loans, municipal bonds and vari-
ous ABSs.
Derivative assets: Transfers out of Level 3 were driven by
increased observability of longer-dated equity index volatil-
ity, particularly in Asian markets. Transfers in relate primar-
ily to quanto structured credit transactions. Commutations
of monoline derivatives and the narrowing of credit spreads
have led to an overall reduction in the value of Level 3 assets.
Trading liabilities: Transfers out of and in to Level 3 relate
primarily to increased/decreased observability of structured
notes with embedded equity derivatives. New issuances re-
late to structured notes particularly those with embedded eq-
uity derivatives issued in the US.
Derivative liabilities: The increased observability in certain
OTC equity derivative markets primarily in Asia led to trans-
fers out of Level 3. Transfers in were driven by structured
credit transactions.
Effect of Changes in Significant Unobservable Assumptions
to Reasonably Possible Alternatives
As discussed above, the fair value of financial instruments
are, in certain circumstances, measured using valuation tech-
niques that incorporate assumptions that are not evidenced
by prices from observable current market transactions in the
same instrument and are not based on observable market
data. The following table shows the sensitivity of these fair
values to reasonably possible alternative assumptions:
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Sensitivity of Fair Values to Reasonably Possible Alternative
Assumptions
Reflected in Other
Reflected in Profit or Loss Comprehensive Income
Favourable Unfavourable Favourable Unfavourable
Changes Changes Changes Changes
US$m US$m US$m US$m
At 31 December 2010
Derivatives, trading assets and trading liabilities(1) 554 (444) — —
Financial assets and liabilities designated at fair value 77 (75) — —
Financial investments: available for sale — — 763 (744)
631 (519) 763 (744)
(1) Derivatives, trading assets and trading liabilities are presented as one category to reflect the manner in which these financial instruments
are risk-managed.
The decrease in the effect of changes in significant unobserv-
able inputs in relation to derivatives, trading assets and trad-
ing liabilities during the year primarily reflected the decreased
sensitivity to monoline credit risk adjustment assumptions
as exposures have reduced. The decrease in the effect of
changes in significant unobservable inputs for available-for-
sale assets arose from increased pricing certainty in respect
of ABSs.
Sensitivity of Fair Values to Reasonably Possible Alternative
Assumptions by Level 3 Instrument Type
Reflected in Other
Reflected in Profit or Loss Comprehensive Income
Favourable Unfavourable Favourable Unfavourable
Changes Changes Changes Changes
US$m US$m US$m US$m
At 31 December 2010
Private equity investments 112 (71) 383 (383)
Asset-backed securities 8 (8) 179 (181)
Loans held for securitisation 8 (8) — —
Structured notes 18 (16) — —
Derivatives with monolines 94 (8) — —
Other derivatives 256 (258) — —
Other portfolios 135 (150) 201 (180)
631 (519) 763 (744)
Favourable and unfavourable changes are determined on the
basis of changes in the value of the instrument as a result of
varying the levels of the unobservable parameters using sta-
tistical techniques. When parameters are not amenable to
statistical analysis, quantification of uncertainty is judgemen-
tal.
When the fair value of a financial instrument is affected
by more than one unobservable assumption, the above table
reflects the most favourable or most unfavourable change
from varying the assumptions individually.
In respect of private equity investments, in many of the
methodologies, the principal assumption is the valuation mul-
tiple to be applied to the main financial indicators. This may be
determined with reference to multiples for comparable listed
companies and includes discounts for marketability.
For ABSs, the principal assumptions in the models are
based on benchmark information about prepayment speeds,
default rates, loss severities and the historical performance
of the underlying assets.
For leveraged finance, loans held for securitisation and
derivatives with monolines the principal assumption concerns
the appropriate value to be attributed to the counterparty
credit risk. This requires estimation of exposure at default,
probability of default and recovery in the event of default.
For loan transactions, assessment of exposure at default is
straightforward. For derivative transactions, a future exposure
profile is generated on the basis of current market data. Prob-
abilities of default and recovery levels are estimated using
available evidence, which may include financial information,
historical experience, CDS spreads and consensus recovery
levels.
For structured notes and other derivatives, principal as-
sumptions concern the value to be attributed to future volatil-
ity of asset values and the future correlation between asset
values. These principal assumptions include credit volatili-
ties and correlations used in the valuation of structured credit
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derivatives (including leveraged credit derivatives). For such
unobservable assumptions, estimates are based on available
market data, which may include the use of a proxy method
to derive a volatility or a correlation from comparable assets
for which market data is more readily available, and/or an
examination of historical levels.
17. Fair Values of Financial Instruments Not Carried at
Fair Value
The classification of financial instruments is determined in
accordance with the accounting policies set out in Note 2.
Fair Values of Financial Instruments Which Are Not Carried
at Fair Value on the Balance Sheet
At 31 December 2010 At 31 December 2009
Carrying Fair Carrying Fair
Amount Value Amount Value
US$m US$m US$m US$m
Assets
Loans and advances to banks 208,271 208,311 179,781 179,658
Loans and advances to customers 958,366 934,444 896,231 855,780
Financial investments: debt securities 19,386 20,374 17,526 18,097
Financial investments: treasury and other eligible bills 113 113 101 101
Liabilities
Deposits by banks 110,584 110,563 124,872 124,856
Customer accounts 1,227,725 1,227,428 1,159,034 1,160,036
Debt securities in issue 145,401 145,417 146,896 145,888
Subordinated liabilities 33,387 33,161 30,478 30,307
Fair Values of Financial Instruments Held for Sale Which
Are Not Carried at Fair Value on the Balance Sheet
At 31 December 2010 At 31 December 2009
Carrying Fair Carrying Fair
Amount Value Amount Value
US$m US$m US$m US$m
Assets Classified as Held for Sale
Loans and advances to banks and customers 116 116 1,356 1,316
The following is a list of financial instruments whose carrying
amount is a reasonable approximation of fair value because,
for example, they are short-term in nature or reprice to current
market rates frequently:
Assets
Cash and balances at central banks
Items in the course of collection from other banks
Hong Kong Government certificates of indebtedness
Endorsements and acceptances
Short-term receivables within ‘Other assets’
Accrued income
Liabilities
Hong Kong currency notes in circulation
Items in the course of transmission to other banks
Investment contracts with discretionary participation features
within ‘Liabilities under insurance contracts’
Endorsements and acceptances
Short-term payables within ‘Other liabilities’
Accruals
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Analysis of Loans and Advances to Customers by
Geographical Segment
At 31 December 2010 At 31 December 2009
Carrying Fair Carrying Fair
Amount Value Amount Value
US$m US$m US$m US$m
Loans and Advances to Customers
Europe 435,799 430,333 439,481 431,158
Hong Kong 140,691 140,699 99,381 99,694
Rest of Asia-Pacific 108,731 108,582 80,043 79,972
Middle East 24,626 24,539 22,844 22,538
North America 190,532 172,522 206,853 174,957
Latin America 57,987 57,769 47,629 47,461
958,366 934,444 896,231 855,780
Valuation
The calculation of fair value incorporates HSBC’s estimate
of the amount at which financial assets could be exchanged,
or financial liabilities settled, between knowledgeable, willing
parties in an arm’s length transaction. It does not reflect the
economic benefits and costs that HSBC expects to flow from
the instruments’ cash flows over their expected future lives.
Other reporting entities may use different valuation method-
ologies and assumptions in determining fair values for which
no observable market prices are available, so comparisons
of fair values between entities may not be meaningful and
users are advised to exercise caution when using this data.
Loans and Advances to Banks and Customers
The fair value of loans and advances is based on observ-
able market transactions, where available. In the absence of
observable market transactions, fair value is estimated using
discounted cash flow models.
Performing loans are grouped, as far as possible, into ho-
mogeneous pools segregated by maturity and interest rates
and the contractual cash flows are generally discounted us-
ing HSBC’s estimate of the discount rate that a market partic-
ipant would use in valuing instruments with similar maturity,
re-pricing and credit risk characteristics.
The fair value of a loan portfolio reflects both loan impair-
ments at the balance sheet date and estimates of market
participants’ expectations of credit losses over the life of the
loans. For impaired loans, fair value is estimated by discount-
ing the future cash flows over the time period they are ex-
pected to be recovered.
Financial Investments
The fair values of listed financial investments are determined
using bid market prices. The fair values of unlisted financial
investments are determined using valuation techniques that
take into consideration the prices and future earnings streams
of equivalent quoted securities.
Deposits by Banks and Customer Accounts
For the purpose of estimating fair value, deposits by banks
and customer accounts are grouped by remaining contractual
maturity. Fair values are estimated using discounted cash
flows, applying current rates offered for deposits of similar
remaining maturities. The fair value of a deposit repayable on
demand is assumed to be the amount payable on demand at
the balance sheet date.
Debt Securities in Issue and Subordinated Liabilities
Fair values are determined using quoted market prices at the
balance sheet date where available, or by reference to quoted
market prices for similar instruments.
The fair values in this note are stated at a specific date
and may be significantly different from the amounts which
will actually be paid on the maturity or settlement dates of
the instruments. In many cases, it would not be possible to
realise immediately the estimated fair values given the size of
the portfolios measured. Accordingly, these fair values do not
represent the value of these financial instruments to HSBC
as a going concern.
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HSBC Holdings
The methods used by HSBC Holdings to determine fair values
of financial instruments for the purpose of measurement and
disclosure are described above.
The following table provides an analysis of the fair value of
financial instruments not carried at fair value on the balance
sheet:
Fair Values of HSBC Holdings’ Financial Instruments Not
Carried at Fair Value on the Balance Sheet
At 31 December 2010 At 31 December 2009
Carrying Fair Carrying Fair
Amount Value Amount Value
US$m US$m US$m US$m
Assets
Loans and advances to HSBC undertakings 21,238 21,798 23,212 23,871
Liabilities
Amounts owed to HSBC undertakings 2,932 2,963 3,711 3,827
Debt securities in issue 2,668 2,960 2,839 3,141
Subordinated liabilities 13,313 14,428 14,406 15,666
18. Reclassification of Financial Assets
During the second half of 2008, HSBC reclassified
US$15.3bn and US$2.6bn of financial assets from the
held-for-trading category to the loans and receivables and
available-for-sale classifications, respectively, as permitted
by the relevant amendment to IAS 39 and explained in Note
2(e) on the Financial Statements. No further reclassifications
were undertaken by HSBC in 2010 and 2009.
Reclassification of HSBC’s Financial Assets
At 31 December 2010 At 31 December 2009
Carrying Fair Carrying Fair
Amount Value Amount Value
US$m US$m US$m US$m
Reclassification to loans and receivables
ABSs 5,892 4,977 7,827 6,177
Trading loans—commercial mortgage loans 522 493 553 506
Leveraged finance and syndicated loans 4,533 4,166 5,824 5,434
10,947 9,636 14,204 12,117
Reclassification to available for sale
Corporate debt and other securities 91 91 1,408 1,408
11,038 9,727 15,612 13,525
The following table shows the fair value gains and losses,
income and expense recognised in the income statement in
respect of reclassified assets and the gains and losses that
would have been recognised if no reclassification had taken
place.
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Effect of Reclassifying and not Reclassifying Financial
Assets
Financial Assets Reclassified to:
Loans and Receivables Available for Sale
Trading Loans— Leveraged Corporate
Commercial Finance and Debt and
Mortgage Syndicated Other
ABSs Loans Loans Total Securities Total
US$m US$m US$m US$m US$m US$m
2010
Recorded in the income statement(1) 235 29 346 610 56 666
Assuming no reclassification(2) 908 45 307 1,260 59 1,319
Net effect of reclassification (673) (16) 39 (650) (3) (653)
Attributable to:
Europe (527) (16) (23) (566) (2) (568)
North America (146) — 49 (97) (1) (98)
Middle East — — 13 13 — 13
2009
Recorded in the income statement(1) 511 32 434 977 101 1,078
Assuming no reclassification(2) 767 15 1,494 2,276 301 2,577
2008
Net effect of reclassification (256) 17 (1,060) (1,299) (200) (1,499)
Attributable to:
Europe (212) 17 (566) (761) (170) (931)
North America (44) — (543) (587) (30) (617)
Middle East — — 49 49 — 49
2008
Recorded in the income statement(1) 303 17 192 512 22 534
Assuming no reclassification(2) (1,549) (13) (1,239) (2,801) (202) (3,003)
2008
Net effect of reclassification 1,852 30 1,431 3,313 224 3,537
Attributable to:
Europe 1,537 30 803 2,370 193 2,563
North America 315 — 601 916 31 947
Middle East — — 27 27 — 27
(1) ‘Income and expense’ recorded in the income statement represents the accrual of the effective interest rate and, for 2010, includes US$6m
in respect of impairment (2009: US$163m; 2008: US$26m). The effect on the income statement for 2008 shows the income and expense
post-reclassification. In 2008 pre-reclassification, the assets were held at fair value and a loss of US$1,371m was recorded in the period up
to reclassification.
(2) Effect on the income statement during the year had the reclassification not occurred.
19. Financial Assets Designated at Fair Value
2010 2009
US$m US$m
Financial assets designated at fair value:
—Not subject to repledge or resale by counterparties 36,990 37,166
—Which may be repledged or resold by counterparties 21 15
37,011 37,181
Treasury and other eligible bills 159 223
Debt securities 18,248 20,718
Equity securities 17,418 14,983
Securities designated at fair value 35,825 35,924
Loans and advances to banks 315 354
Loans and advances to customers 871 903
37,011 37,181
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US Treasury and US Government agencies(2) 78 78
UK Government 1,304 4,799
Hong Kong Government 151 177
Other government 4,130 3,491
Asset-backed securities(3) 6,128 6,463
Corporate debt and other securities 6,616 5,933
Equities 17,418 14,983
35,825 35,924
(1) Included within these figures are debt securities issued by
banks and other financial institutions of US$10,185m (2009:
US$13,745m), of which US$48m (2009: US$49m) are guaran-
teed by various governments.
(2) Includes securities that are supported by an explicit guarantee
issued by the US Government.
(3) Excludes asset-backed securities included under US Treasury
and US Government agencies.
Securities Listed on a Recognised Exchange and Unlisted
Treasury and Other Debt Equity
Eligible Bills Securities Securities Total
US$m US$m US$m US$m
Fair value at 31 December 2010
Listed on a recognised exchange(1) 21 4,168 12,548 16,737
Unlisted 138 14,080 4,870 19,088
159 18,248 17,418 35,825
Fair value at 31 December 2009
Listed on a recognised exchange(1) 78 7,168 10,549 17,795
Unlisted 145 13,550 4,434 18,129
223 20,718 14,983 35,924
(1) Included within listed investments are US$756m of investments listed in Hong Kong (2009: US$506m).
Financial Liabilities—Accounts Payable,
Notes Payable, Warranty Liabilities,
Non-current Financial Liabilities
8.58
Philippine Long Distance Telephone Company
(Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
December 31, 2010 and 2009
(In million pesos, except par value and number of shares)
2010 2009
Noncurrent Liabilities
Interest-bearing financial liabilities—net of current portion (Notes 3, 4, 5, 9, 13, 20, 23, 26 and 28) 75,888 86,079
Current Liabilities
Accounts payable (Notes 13, 22, 24, 26, 27 and 28) 25,804 19,601
Current portion of interest-bearing financial liabilities (Notes 3, 4, 5, 9, 13, 20, 23, 26 and 28) 13,801 12,714
Dividends payable (Notes 13, 19, 26 and 28) 2,086 1,749
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CONSOLIDATED INCOME STATEMENTS (in part)
For the Years Ended December 31, 2010, 2009 and 2008




Interest income (Notes 4, 5, 11 and 15) 1,200 1,539 1,668
Financing costs—net (Notes 4, 5, 9, 20 and 28) (6,698) (6,556) (6,104)
(1,871) (3,043) (6,002)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
For the Years Ended December 31, 2010, 2009 and 2008
(In million pesos)
2010 2009 2008
Cash Flows From Financing Activities
Payments of notes payable (Note 20) (2,274) (270) (678)
Interest paid—net of capitalized portion (Notes 5, 20 and 28) (5,580) (5,239) (5,167)
Cash dividends paid (Note 19) (41,080) (39,286) (37,124)
Proceeds from notes payable (Note 20) — 2,000 660
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
Significant Accounting Policies (in part)
Financial Liabilities (in part)
Initial Recognition
Financial liabilities are classified as financial liabilities at fair
value through profit or loss, other financial liabilities, or as
derivatives designated as hedging instruments in an effective
hedge, as appropriate. We determine the classification of our
financial liabilities at initial recognition.
Financial liabilities are recognized initially at fair value and
in the case of other financial liabilities, inclusive of directly
attributable transaction costs.
Our financial liabilities include accounts payable, accrued
expenses and other current liabilities, interest-bearing finan-
cial liabilities, customers’ deposits, derivative financial liabili-
ties, dividends payable, and accrual for long-term capital ex-
penditures included under “Deferred credits and other non-
current liabilities” account.
Subsequent Measurement
The subsequent measurement of financial liabilities depends
on their classification as follows:
Financial Liabilities at Fair Value Through Profit or Loss
Financial liabilities at fair value through profit or loss include
financial liabilities held-for-trading and financial liabilities des-
ignated upon initial recognition at fair value through profit or
loss. Financial liabilities are classified as at fair value through
profit or loss if they are acquired for the purpose of repur-
chasing in the near term. Derivative liabilities, including sepa-
rated embedded derivatives are also classified as at fair value
through profit or loss unless they are designated as effective
hedging instruments. Financial liabilities at fair value through
profit or loss are carried in our consolidated statement of fi-
nancial position at fair value with gains or losses recognized
in our consolidated income statement under “Gains (losses)
on derivative financial instruments—net” for derivative instru-
ments and “Other income” for non-derivative financial liabili-
ties.
Financial liabilities may be designated at initial recognition
as at fair value through profit or loss if any of the following
criteria are met: (i) the designation eliminates or significantly
reduces the inconsistent treatment that would otherwise arise
from measuring the liabilities or recognizing gains or losses
on them on a different basis; (ii) the liabilities are part of a
group of financial liabilities which are managed and their per-
formance is evaluated on a fair value basis, in accordance
with a documented risk management strategy and informa-
tion about the company is provided internally on that basis
to the entity’s key management personnel; or (iii) the finan-
cial liabilities contain one or more embedded derivatives that
would need to be separately recorded.
Other Financial Liabilities
After initial recognition, other financial liabilities are subse-
quently measured at amortized cost using the EIR method.
Gains and losses are recognized in our consolidated in-
come statement when the liabilities are derecognized as well
as through the EIR amortization process. Amortized cost is
calculated by taking into account any discount or premium
on acquisition and fees or costs that are an integral part of
the EIR. The EIR amortization is included under “Financing
costs—net” in our consolidated income statement.
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Offsetting of Financial Instruments
Financial assets and financial liabilities are offset and the net
amount is reported in our consolidated statement of financial
position if, and only if, there is a currently enforceable legal
right to offset the recognized amounts and there is an inten-
tion to settle on a net basis, or to realize the assets and settle
the liabilities simultaneously.
Fair Value of Financial Instruments
The fair value of financial instruments that are actively traded
in organized financial markets is determined by reference to
quoted market prices at the close of business at the end of
the reporting period. For financial instruments where there
is no active market, fair value is determined using valua-
tion techniques. Such techniques may include using recent
arm’s length market transactions; reference to the current fair
value of another instrument that is substantially the same;
discounted cash flow analysis or other valuation models.
Amortized Cost of Financial Instruments
Amortized cost is computed using the EIR method less any al-
lowance for impairment and principal repayment or reduction.
The calculation takes into account any premium or discount
on acquisition and includes transaction costs and fees that
are an integral part of EIR.
“Day 1” Difference
Where the transaction price in a non-active market is differ-
ent from the fair value of other observable current market
transactions in the same instrument or based on a valuation
technique which variables include only data from observable
market, we recognize the difference between the transaction
price and fair value (a “Day 1” difference) in our consolidated
income statement unless it qualifies for recognition as some
other type of asset or liability. In cases where data used are
not observable, the difference between the transaction price
and model value is only recognized in our consolidated in-
come statement when the inputs become observable or when
the instrument is derecognized. For each transaction, we de-
termine the appropriate method of recognizing the “Day 1”
difference amount.
19. Equity (in part)





Class Approved Record Payable Per Share Pesos)
10% Cumulative Convertible Preferred
Stock
Series CC January 26, 2010 February 25, 2010 March 31, 2010 Php1.00 17
Series DD January 26, 2010 February 11, 2010 February 26, 2010 1.00 3
Series EE March 26, 2010 April 23, 2010 May 31, 2010 1.00 —
Series A, I, R, W, AA and BB July 7, 2010 August 5, 2010 August 31, 2010 1.00 128
Series B, F, Q, V and Z August 3, 2010 September 2, 2010 September 30, 2010 1.00 92
Series E, K, O and U August 31, 2010 September 30, 2010 October 29, 2010 1.00 44
Series C, D, J, T and X September 28, 2010 October 28, 2010 November 30, 2010 1.00 57
Series G, N, P and S November 4, 2010 December 2, 2010 December 29, 2010 1.00 26




Series IV(*) January 26, 2010 February 19, 2010 March 15, 2010 Php— 12
May 13, 2010 May 27, 2010 June 15, 2010 — 13
August 3, 2010 August 18, 2010 September 15, 2010 — 12
November 4, 2010 November 19, 2010 December 15, 2010 — 12
49
Common Stock
Regular Dividend March 2, 2010 March 17, 2010 April 20, 2010 Php76.00 14,197
August 3, 2010 August 19, 2010 September 21, 2010 78.00 14,570
Special Dividend March 2, 2010 March 17, 2010 April 20, 2010 65.00 12,142
Charged to retained earnings 41,367
(*) Dividends were declared based on total amount paid up.
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Class Approved Record Payable Per Share Pesos)
Cumulative Non-convertible Redeemable
Preferred Stock
Series IV(*) January 25, 2011 February 18, 2011 March 15, 2011 Php— 12
10% Cumulative Convertible Preferred Stock
Series CC January 25, 2011 February 24, 2011 March 31, 2011 Php1.00 17
Series DD January 25, 2011 February 10, 2011 February 28, 2011 1.00 2
Series FF January 25, 2011 February 10, 2011 February 28, 2011 1.00 —
Series GG January 25, 2011 February 24, 2011 March 31, 2011 1.00 —
Series EE March 29, 2011 April 28, 2011 May 31, 2011 1.00 —
Series HH March 29, 2011 April 28, 2011 May 31, 2011 1.00 —
19
Common Stock
Regular Dividend March 1, 2011 March 16, 2011 April 19, 2011 Php78.00 14,567
Special Dividend March 1, 2011 March 16, 2011 April 19, 2011 66.00 12,326
26,893
26,924
(*) Dividends were declared based on total amount paid up.
20. Interest-Bearing Financial Liabilities (in part)
As at December 31, 2010 and 2009, this account consists of
the following:
(In Million Pesos) 2010 2009
Long-Term Portion of Interest-Bearing
Financial Liabilities:
Long-term debt (Notes 4, 5, 9, 23, 26 and 28) 75,879 86,066
Obligations under finance lease (Notes 3, 4, 5,
23, 26 and 28) 9 13
75,888 86,079
Current Portion of Interest-Bearing Financial
Liabilities:
Long-term debt maturing within one year (Notes
4, 5, 9, 23, 26 and 28) 13,767 10,384
Obligations under finance lease maturing within
one year (Notes 3, 4, 5, 23, 26 and 28) 34 51
Notes payable (Notes 4, 5, 23, 26 and 28) — 2,279
13,801 12,714
Unamortized debt discount, representing debt issuance costs
and any difference between the fair value of consideration
given or received at initial recognition, included in the financial
liabilities as at December 31, 2010 and 2009 are as follows:
(In Million Pesos) 2010 2009
Long-term debt (Note 28) 2,944 3,858
Obligation under finance lease 1 3
Unamortized debt discount at end of year 2,945 3,861
The following table describes all changes to unamortized debt
discount as at December 31, 2010 and 2009.
(In Million Pesos) 2010 2009
Unamortized debt discount at beginning of year 3,861 4,577
Additions during the year 114 182
Revaluations during the year (16) 22
Accretion during the year included as part of
“Financing costs—net—Accretion on financial
liabilities—net” (Note 5) (1,014) (920)
Unamortized debt discount at end of year 2,945 3,861
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Long-Term Debt
As at December 31, 2010 and 2009, long-term debt consists of:
Description Interest Rates 2010 2009
(In Millions)
U.S. Dollar Debts:
Export Credit Agencies-Supported Loans:
Finnvera, Plc, or Finnvera 2.99% and US$ LIBOR + 0.05% to
1.35% in 2010 and US$ LIBOR +
0.05% to 1.35% in 2009 US$82 Php 3,590 US$58 Php 2,681
Exportkreditnamnden, or EKN 3.79% in 2010 and 2009 14 613 18 860
Kreditanstalt für Wiederaufbau, or KfW US$LIBOR + 0.65% to 2.50% in 2010
and 5.65% and US$ LIBOR + 0.65% to
2.50% in 2009 — — 31 1,454
96 4,203 107 4,995
Fixed Rate Notes 8.35% to 11.375% in 2010 and 2009 375 16,450 385 17,876
Term Loans:
Debt Exchange Facility 2.25% in 2010 and 2009 223 9,791 209 9,725
GSM Network Expansion Facilities 4.515% to 4.70% and US$ LIBOR +
0.42% to 1.85% in 2010 and 4.49% to
4.70% and US$ LIBOR + 0.42% to
1.85% in 2009 97 4,230 157 7,274
Others 2.79% + swap rate and US$ LIBOR +
0.42% to 0.50% in 2010 and 6%; 2.79%
+ swap rate and US$ LIBOR + 0.42%
to 0.50% in 2009 85 3,740 118 5,484
US$876 Php 38,414 US$976 Php 45,354
Description Interest Rates 2010 2009
(In Millions)
Philippine Peso Debts:
Corporate Notes 5.625% to 9.1038% and PDST-F + 1.25% in
2010 and 2009 Php 29,677 Php 24,863
Term Loans:
Unsecured Term Loans 6.125% to 8.7792% and PDST-F + 0.30% to
1.50% in 2010 and 6.125% to 8.7792% and
PDST-F + 0.75% to 1.50% in 2009 21,439 26,088
Secured Term Loans PDST-F + 1.375% and AUB’s prime rate in
2010 and PDST-F + 5.70% + Bank’s
cost of funds; PDST-F + 1.375% and
AUB’s prime rate in 2009 116 145
51,232 51,096
Total long-term debt 89,646 96,450
Less portion maturing within one year (Note 28) 13,767 10,384
Noncurrent portion of long-term (Note 28) Php 75,879 Php 86,066
Note: Amounts presented are net of unamortized debt discount and debt issuance costs.
The scheduled maturities of our consolidated outstanding
long-term debt at nominal values as at December 31, 2010
are as follows:
U.S. Dollar Debt Php Debt Total
Year In U.S. Dollar In Php In Php In Php
(In Millions)
2011 104 4,535 9,400 13,935
2012 234 10,273 9,127 19,400
2013 60 2,606 8,528 11,134
2014 305 13,375 6,125 19,500
2015 and onwards 239 10,482 18,139 28,621
942 41,271 51,319 92,590
IFRS ATT 8.58
626 IFRS Accounting Trends & Techniques
U.S. Dollar Debts:
Export Credit Agencies-Supported Loans
In order to acquire imported components for our network in-
frastructure in connection with our expansion and service
improvement programs, we obtained loans extended and/or
guaranteed by various export credit agencies.
Finnvera, Plc, or Finnvera
On February 11, 2005, Smart signed a refinancing facility
with Finnish Export Credit, Plc, as Lender, and ING Bank
N.V., as Arranger and Facility Agent under an export credit
agency-backed facility in connection with Smart’s GSM ex-
pansion program. This facility was covered by a guarantee
from Finnvera, the Finnish Export Credit Agency, for 100%
of the political and commercial risk for the refinancing facility
of GSM Phases 5A and 5B. The principal benefit of refinanc-
ing the Phase 5 loan was the savings from a lower interest
margin on the refinancing facility. The facility was payable in
equal semi-annual payments over five years starting Septem-
ber 1, 2005. The outstanding balance amounted to US$9.98
million, or Php464 million, net of unamortized discount, as at
December 31, 2009 was paid in full on March 1, 2010.
On May 14, 2009, Smart signed a US$50 million five-year
term facility to finance the Phase 10 (Extension) GSM equip-
ment and services contract with Finnish Export Credit, Plc
guaranteed by Finnvera and awarded to Calyon as the Ar-
ranger. The facility was drawn on July 15, 2009. The loan
is payable over five years in ten equal semi-annual pay-
ments. The amounts of US$39 million, or Php1,703 million,
and US$48 million, or Php2,240 million, both net of unamor-
tized debt discount, remained outstanding as at December
31, 2010 and 2009, respectively.
On October 9, 2009, Smart signed a US$50 million five-
year term loan facility to finance GSM equipment and ser-
vices contracts with Finnish Export Credit, Plc guaranteed by
Finnvera, the Finnish Export Credit Agency, for 100% political
and commercial risk cover. The facility was awarded to Citi-
corp as the Arranger. The loan is payable over five years in
ten equal semi-annual payments. As at December 31, 2009,
no amount had been drawn under the facility. The amount
of US$43 million, or Php1,887 million, net of unamortized
debt discount, which was drawn on April 7, 2010, remained
outstanding as at December 31, 2010.
Exportkreditnamnden, or EKN
On November 25, 2008, Smart signed a US$22 million five-
year term loan facility to finance the supply, installation, com-
missioning and testing of Wireless-Code Division Multiple Ac-
cess, or W-CDMA/High Speed Packet Access project with
Nordea Bank AB as Original Lender, Arranger and Facility
Agent and subsequently assigned its rights and obligations
to the Swedish Export Credit Corporation (AB Svensk Ex-
portkredit) supported by EKN on December 10, 2008. The
amounts of US$8 million, US$13 million and US$1 million
were drawn on December 15, 2008, August 5, 2009 and
September 1, 2009, respectively. This facility is payable semi-
annually in ten equal installments commencing six months
from December 10, 2008. The outstanding balance under the
facility amounted to US$14 million, or Php613 million, and
US$18 million, or Php860 million, both net of unamortized
debt discount, as at December 31, 2010 and 2009, respec-
tively.
Kreditanstalt für Wiederaufbau, or KfW
On January 25, 2002, PLDT signed two loan agreements with
KfW, which provided PLDT with a US$149 million facility to
refinance in part the repayment installments under its existing
loans from KfW due from January 2002 to December 2004.
The facility is composed of a nine-year loan, inclusive of a
three-year disbursement period and a two-year grace period
during which no principal is payable. It partly enjoys the guar-
antee of HERMES, the export credit agency of the Federal
Republic of Germany. On various dates from 2002 to 2004,
we had drawn a total of US$140 million under this facility.
PLDT waived further disbursements under this refinancing
facility effective September 1, 2004 and the undrawn portion
of US$9 million was cancelled.
The outstanding balance under the facility amounted to
US$31 million, or Php1,454 million, as at December 31, 2009.
Final repayment was made on October 15, 2010 and there
are no outstanding amounts remaining under the facility as at
December 31, 2010.
Fixed Rate Notes
PLDT has the following non-amortizing fixed rate notes out-
standing as at December 31, 2010 and 2009:
Principal Amount Interest Rate Maturity Date 2010 2009
(In Millions)
US$234,259,000 8.350% March 6, 2017 US$231 Php 10,149 US$242 Php 11,256
US$145,789,000 11.375% May 15, 2012 144 6,301 143 6,620
US$375 Php 16,450 US$385 Php 17,876
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Term Loans
US$283 Million Term Loan Facility, or Debt Exchange
Facility
On July 2, 2004, Smart acquired from PCEV’s creditors
approximately US$289 million, or 69.4%, the aggregate of
PCEV’s outstanding restructured debt at that time, in ex-
change for Smart debt and a cash payment by Smart. In
particular, Smart paid an amount in cash of US$1.5 million,
or Php84 million and issued new debt of US$283.2 million,
or Php15,854 million, at fair value of Php8,390 million, net of
unamortized debt discount amounting to Php7,464 million.
The outstanding balance of the Facility amounted to
US$223 million, or Php9,791 million, and US$209 million,
or Php9,725 million, both net of unamortized debt discount,
as at December 31, 2010 and 2009, respectively. The Facility
will be payable in full on June 30, 2014.
GSM Network Expansion Facilities
On August 8, 2005, Smart signed a US$30 million commer-
cial facility with Nordic Investment Bank to partly finance the
related Phase 8 GSM equipment and services contracts. The
facility is a five-year term loan payable semi-annually in ten
equal installments with final repayment on July 11, 2011.
The facility was drawn on July 11, 2006 for the full amount
of US$30 million. The amounts of US$6 million, or Php263
million, and US$12 million, or Php556 million, both net of
unamortized debt discount, remained outstanding as at De-
cember 31, 2010 and 2009, respectively.
On August 10, 2005, Smart signed a loan facility for its
GSM Phase 8 financing in the amount of US$70 million. The
facility was awarded to the Bank of Tokyo Mitsubishi Ltd.,
Mizuho Corporate Bank Ltd., Standard Chartered Bank and
Sumitomo Mitsui Banking Corporation as the Lead Arrangers,
with Finnish Export Credit, Plc as the Lender. Smart opted to
utilize only a total of US$67 million of which US$10 million and
US$57 million were drawn on February 15, 2006 and March
13, 2006, respectively. The undrawn balance of US$3 million
was cancelled. The facility is a five-year term loan payable
in ten equal semi-annual installments. The amount of US$15
million, or Php678 million, net of unamortized discount, re-
mained outstanding as at December 31, 2009. The facility
was paid in full on September 1, 2010.
On July 31, 2006, Smart signed a U.S. Dollar term loan
facility for US$44.2 million to partly finance the related Phase
9 GSM equipment and services contracts. The Lender is
Finnish Export Credit, Plc with ABN AMRO Bank N.V., Stan-
dard Chartered Bank, Sumitomo Mitsui Banking Corporation
and Mizuho Corporate Bank Ltd. as the Lead Arrangers. The
facility is a five-year term loan payable in ten equal semi-
annual installments with final repayment on July 15, 2011.
The facility was drawn on November 10, 2006 for the full
amount of US$44.2 million. The amounts of US$9 million, or
Php387 million, and US$18 million, or Php819 million, both
net of unamortized debt discount, remained outstanding as
at December 31, 2010 and 2009, respectively.
On October 16, 2006, Smart signed a U.S. Dollar term loan
facility with Metropolitan Bank and Trust Company to finance
the related Phase 9 GSM facility for an amount of US$50
million. The facility is a five-year loan payable in 18 equal
quarterly installments commencing on the third quarter from
initial drawdown date with final repayment on October 10,
2012. The facility was drawn on October 10, 2007 for the full
amount of US$50 million. The amounts of US$22 million, or
Php973 million, and US$33 million, or Php1,547 million, both
net of unamortized debt discount, remained outstanding as
at December 31, 2010 and 2009, respectively.
On October 10, 2007, Smart signed a US$50 million five-
year term loan facility to finance the related Phase 10 GSM
equipment and service contracts. The facility was awarded to
Norddeutsche Landesbank Girozentrale Singapore Branch
as the Original Lender with Standard Chartered Bank (Hong
Kong) Ltd. as the Facility Agent. The full amount of the facil-
ity was drawn on March 10, 2008. The loan is payable over
five years in ten equal semi-annual payments with final re-
payment on March 11, 2013. The amounts of US$25 million,
or Php1,091 million, and US$35 million, or Php1,616 million,
both net of unamortized debt discount, remained outstanding
as at December 31, 2010 and 2009, respectively.
On November 27, 2008, Smart signed a US$50 million five-
year term loan facility to finance the Phase 10 GSM equip-
ment and service contracts with Finnish Export Credit, Plc.
The facility was awarded to ABN AMRO Bank N.V., Aus-
tralia and New Zealand Banking Group Limited, Standard
Chartered Bank, Mizuho Corporate Bank Ltd. as the Lead
Arrangers. The loan is payable over five years in ten equal
semi-annual installments with final repayment on January 23,
2014. The facility was drawn on January 23, 2009 and May
5, 2009 in the amounts of US$5 million and US$45 million,
respectively. The amounts of US$35 million, or Php1,516 mil-
lion, and US$44 million, or Php2,058 million, both net of un-
amortized debt discount, remained outstanding as at Decem-
ber 31, 2010 and 2009, respectively.
Other Term Loans
On January 15, 2008, PLDT signed a US$100 million
term loan facility agreement with Norddeutsche Landesbank
Girozentrale Singapore Branch to be used for the capital ex-
penditure requirements of PLDT. Two separate drawings of
US$50 million each was drawn from the facility on March 27,
2008 and April 10, 2008 and is payable over five years in
ten equal semi-annual installments with final repayment on
March 27, 2013. The amounts of US$50 million, or Php2,191
million, and US$70 million, or Php3,250 million, remained out-
standing as at December 31, 2010 and 2009, respectively.
On July 15, 2008, PLDT signed a loan agreement amount-
ing to US$50 million with the Bank of the Philippine Islands to
refinance its loan obligations which were utilized for service
improvements and expansion programs. The initial drawdown
under this loan was made on July 21, 2008 in the amount of
US$15 million and the balance of US$35 million was drawn
on September 30, 2008. This loan is payable in 17 equal quar-
terly installments commencing on the fourth quarter from ini-
tial drawdown date with final repayment on July 22, 2013. The
amounts of US$32 million, or Php1,417 million, and US$44
million, or Php2,048 million, remained outstanding as at De-
cember 31, 2010 and 2009, respectively.
On September 24, 2008, BOW signed an Islamic finance
facility agreement granted by the Bank of London and the
Middle East for a total of US$19 million, which will mature on
various dates from June 30, 2013 to September 30, 2014. The
amounts of US$3 million, or Php132 million, and US$4 million,
or Php186 million, remained outstanding as at December 31,
2010 and 2009, respectively.
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Philippine Peso Debts:
Corporate Notes
Php5,000 Million Fixed Rate Corporate Notes
On February 15, 2007, Smart issued Php5,000 million fixed
rate corporate notes, comprised of Series A five-year notes
amounting to Php3,800 million and Series B ten-year notes
amounting to Php1,200 million. Proceeds from the issuance
of these notes have been used primarily for Smart’s capital
expenditures for network improvement and expansion. The
amounts of Php4,962 million and Php4,968 million, both net
of unamortized debt discount, remained outstanding as at
December 31, 2010 and 2009, respectively.
Php5,000 Million Fixed Rate Corporate Notes
On December 12, 2008, Smart issued a five-year term unse-
cured fixed rate corporate notes amounting to Php5,000 mil-
lion. The facility has annual amortizations equivalent to 1%
of the principal amount with the balance of 96% payable on
December 13, 2013. Funds raised from the issuance of these
notes were used primarily to finance Smart’s capital expen-
ditures for network upgrade and expansion. The amounts of
Php4,867 million and Php4,907 million, both net of unamor-
tized debt discount, remained outstanding as at December
31, 2010 and 2009, respectively.
Php5,000 Million Fixed Rate Corporate Notes
On February 20, 2009, PLDT issued Php5,000 million fixed
rate corporate notes under a Notes Facility Agreement dated
February 18, 2009, comprised of Series A five-year notes
amounting to Php2,390 million, Series B seven-year notes
amounting to Php100 million, and Series C ten-year notes
amounting to Php2,510 million. Proceeds from the facility
were used to finance capital expenditures of PLDT. The ag-
gregate amounts of Php4,976 million and Php5,000 million
remained outstanding as at December 31, 2010 and 2009,
respectively.
Php3,000 Million Corporate Notes
On June 29, 2009, Smart signed a Notes Facility Agree-
ment with BDO Private Bank, Inc. amounting to Php3,000
million to finance capital expenditures. The facility is com-
prised of Php1,000 million Series A1 note payable in full in
1.5 years and Php1,000 million each for Series B1 and B2
notes payable in full in two years. The aggregate amount of
Php2,000 million of Series A1 and B1 notes were drawn on
July 8, 2009 while the amount of Php1,000 million of Series
B2 notes was drawn on September 1, 2009. The aggregate
amounts of Php2,997 million and Php2,988 million, both net
of unamortized debt discount, remained outstanding as at
December 31, 2010 and 2009, respectively. The Series A1
amounting to Php1,000 million was repaid on January 10,
2011.
Php7,000 Million Fixed Rate Corporate Notes
On December 10, 2009, PLDT issued Php7,000 million fixed
rate corporate notes under a Notes Facility Agreement dated
December 8, 2009, comprised of Series A 5.25-year notes
amounting to Php5,050 million, Series B seven-year notes
amounting to Php850 million, and Series C ten-year
notes amounting to Php1,100 million. Proceeds from the fa-
cility were used to finance capital expenditures and/or to re-
finance its loan obligations which were also used to finance
capital expenditures for network expansion and improvement.
The aggregate amounts of Php6,891 million and Php7,000
million remained outstanding as at December 31, 2010 and
2009, respectively.
Php2,500 Million Fixed Rate Corporate Notes
On July 13, 2010, PLDT issued Php2,500 million five-year
fixed rate corporate notes under a Notes Facility Agreement
dated July 12, 2010. The notes are non-amortizing and will
mature on July 13, 2015. Proceeds from the facility were used
to finance capital expenditures and/or to refinance PLDT’s
loan obligations. The amount of Php2,500 million remained
outstanding as at December 31, 2010.
Php2,500 Million Fixed Rate Corporate Notes
On July 13, 2010, Smart issued Php2,500 million five-year
fixed rate corporate notes under a Notes Facility Agreement
dated July 12, 2010. The notes are non-amortizing and will
mature on July 13, 2015. Proceeds from the facility were used
primarily to finance Smart’s capital expenditures for network
improvement and expansion. The amount of Php2,484 mil-
lion, net of unamortized debt discount, remained outstanding
as at December 31, 2010.
Php2,000 Million Fixed Rate Corporate Notes
On March 9, 2011, Smart signed a Notes Facility Agree-
ment with BDO Private Bank, Inc. amounting to Php2,000
million to finance capital expenditures. Tranche A amount-
ing to Php1,000 million was issued on March 16, 2011 and
Tranche B amounting to Php1,000 million to be issued in
multiple drawdowns of Php250 million each, all of which are
payable in full in five years from their respective issue dates.
As at March 29, 2011, Php1,500 million has been drawn from
this facility.
Php5,000 Million Fixed Rate Corporate Notes
On March 24, 2011, PLDT issued Php5,000 million fixed
rate corporate notes under a Notes Facility Agreement dated
March 22, 2011, comprised of Series A 5-year notes amount-
ing to Php3,435 million, Series B 7-year notes amounting to
Php700 million and Series C ten-year rate notes amounting
to Php865 million. Proceeds from the facilities will be used
to finance capital expenditures and refinance existing debt
obligations which were also used to finance service improve-
ments and expansion programs.
Term Loans
Unsecured Term Loans
Php2,500 Million Term Loan Facility
On August 14, 2006, Smart signed a Philippine Peso term
loan facility with Metropolitan Bank and Trust Company
amounting to Php2,500 million to finance the related Phase
9 GSM facility. The facility is payable over five years in 18
equal quarterly installments commencing on the third quarter
from initial drawdown date with final repayment on Decem-
ber 9, 2011. The facility was drawn on December 11, 2006.
The amounts of Php555 million and Php1,109 million, both
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net of unamortized debt discount, remained outstanding as
at December 31, 2010 and 2009, respectively.
Php400 Million and Php20 Million Refinancing Loans
On May 22, 2007, PLDT signed loan agreements with The
Philippine American Life and General Insurance Company for
Php400 million and The Philam Bond Fund, Inc. for Php20
million to refinance their respective participations in the ten-
year note under the Php1,270 million Fixed Rate Corporate
Notes which were repaid on June 12, 2007. Both refinancing
loans will mature on June 12, 2014. The amounts of Php400
million and Php20 million remained outstanding as at De-
cember 31, 2009 were both prepaid in full on December 13,
2010.
Php2,500 Million Term Loan Facility
On October 21, 2008, Smart signed a Philippine Peso term
loan facility with Metropolitan Bank and Trust Company to fi-
nance capital expenditures for an amount of Php2,500 million,
which was drawn in full on November 13, 2008. The facility
is payable over five years in 16 equal consecutive quarterly
installments commencing on the fifth quarter from the date
of the first drawdown with final repayment on November 13,
2013. The amounts of Php1,870 million and Php2,492 million,
both net of unamortized debt discount, remained outstanding
as at December 31, 2010 and 2009, respectively.
Php2,400 Million Term Loan Facility
On November 21, 2008, PLDT signed a loan agreement with
Land Bank of the Philippines amounting to Php2,400 million to
finance capital expenditures and/or to refinance its loan obli-
gations which were utilized for service improvements and ex-
pansion programs. The initial drawdown under this loan was
made on December 12, 2008 in the amount of Php500 million
and the balance of Php1,900 million was subsequently drawn
on May 20, 2009 and July 31, 2009 in two equal Php500
million tranches and on September 15, 2009 in the amount
of Php900 million. The loan is payable over five years in
ten equal semi-annual installments with final repayment on
December 12, 2013. The amounts of Php1,533 million and
Php2,044 million remained outstanding as at December 31,
2010 and 2009, respectively.
Php3,000 Million Term Loan Facility
On November 26, 2008, PLDT signed a loan agreement with
Union Bank of the Philippines amounting to Php3,000 million
to finance capital expenditures and/or to refinance its loan
obligations which were utilized for service improvements and
expansion programs. The initial drawdown under this loan
was made on December 22, 2008 in the amount of Php500
million and the balance of Php2,500 million was subsequently
drawn on April 14, 2009. The loan is payable over five years in
nine equal semi-annual installments commencing on the sec-
ond semester from initial drawdown date with final repayment
on December 23, 2013. The amounts of Php2,000 million and
Php2,667 million remained outstanding as at December 31,
2010 and 2009, respectively.
Php2,000 Million Term Loan Facility
On November 28, 2008, PLDT signed a loan agreement with
Philippine National Bank amounting to Php2,000 million to be
used for its capital expenditure requirements in connection
with PLDT’s service improvement and expansion programs.
The initial drawdown under this loan was made on December
19, 2008 in the amount of Php500 million and the balance
of Php1,500 million was subsequently drawn on January 30,
2009, February 27, 2009 and March 13, 2009 in three equal
Php500 million tranches. The loan is payable over five years
in 17 equal quarterly installments commencing on the fourth
quarter from initial drawdown date with final repayment on
December 19, 2013. The amounts of Php1,412 million and
Php1,882 million remained outstanding as at December 31,
2010 and 2009, respectively.
Php1,000 Million Term Loan Facility
On February 20, 2009, Smart signed a Philippine Peso term
loan facility with China Trust (Philippines) Commercial Bank
Corporation to finance capital expenditures for an amount of
Php1,000 million, which was drawn in full on April 27, 2009.
The facility is a five-year term loan payable in eight equal
semi-annual installments starting on the eighteenth month
from initial drawdown date. The amount of Php996 million,
net of unamortized debt discount, remained outstanding as
at December 31, 2009 was repaid on October 27, 2010.
Php2,500 Million Term Loan Facility
On March 6, 2009, PLDT signed a loan agreement with Banco
de Oro Unibank, Inc. amounting to Php2,500 million to fi-
nance capital expenditures and/or refinance its loan obliga-
tions which were utilized for service improvements and ex-
pansion programs. The loan is payable in full upon maturity
on April 17, 2014. The amount of Php2,500 million was fully
drawn on April 17, 2009 and remained outstanding as at De-
cember 31, 2010 and 2009.
Php1,500 Million Term Loan Facility
On May 12, 2009, Smart signed a Philippine Peso term
loan facility with Banco de Oro Unibank, Inc. amounting to
Php1,500 million to finance capital expenditures which was
fully drawn on May 20, 2009. The facility is a three-year loan
payable in full upon maturity on May 20, 2012. The amounts of
Php1,494 million and Php1,491 million, both net of unamor-
tized debt discount, remained outstanding as at December
31, 2010 and 2009, respectively.
Php1,000 Million Term Loan Facility
On May 14, 2009, Smart signed a Philippine Peso term loan
facility with Asia United Bank amounting to Php1,000 million
to finance capital expenditures, which was drawn in full on
July 3, 2009. The facility is payable over five years in eight
equal semi-annual installments commencing on the eigh-
teenth month from initial drawdown date with final repayment
on July 3, 2014. The amounts of Php997 million and Php996
million, both net of unamortized debt discount, remained out-
standing as at December 31, 2010 and 2009, respectively.
The debt was paid in full on January 3, 2011.
Php1,000 Million Term Loan Facility
On May 15, 2009, Smart signed a Philippine Peso term loan
facility with Philippine National Bank amounting to Php1,000
million to finance capital expenditures, which was drawn in
full on July 2, 2009. The facility is a seven-year loan, payable
IFRS ATT 8.58
630 IFRS Accounting Trends & Techniques
in full upon maturity on July 2, 2016. The amounts of Php996
million and Php995 million, both net of unamortized debt
discount, remained outstanding as at December 31, 2010
and 2009, respectively. The debt was paid in full on January
3, 2011.
Php2,500 Million Term Loan Facility
On June 8, 2009, PLDT signed a loan agreement with Rizal
Commercial Banking Corporation amounting to Php2,500 mil-
lion to finance capital expenditures and/or refinance its loan
obligations which were utilized for service improvements and
expansion programs. The facility is payable over seven years
with an annual amortization of 1% on the fifth and sixth year
from initial drawdown date and the balance payable upon
maturity on September 28, 2016. The amount of Php2,500
million was fully drawn on September 28, 2009 and remained
outstanding as at December 31, 2010 and 2009.
Php1,500 Million Term Loan Facility
On June 16, 2009, PLDT signed a loan agreement with Al-
lied Banking Corporation amounting to Php1,500 million to
finance capital expenditures and/or refinance its loan obliga-
tions which were utilized for service improvements and ex-
pansion programs. The facility is payable over five years in
17 equal quarterly installments commencing on September
15, 2010 with final repayment on September 15, 2014. The
amount of Php1,500 million was fully drawn on September
15, 2009. The amounts of Php1,324 million and Php1,500
million remained outstanding as at December 31, 2010 and
2009, respectively.
Php500 Million Term Loan Facility
On June 29, 2009, PLDT signed a loan agreement with Insu-
lar Life Assurance Company, Ltd. amounting to Php500 mil-
lion to finance capital expenditures and/or refinance its loan
obligations which were utilized for service improvements and
expansion programs. The loan will mature on July 1, 2016.
The amount of Php500 million was fully drawn on July 1,
2009 and remained outstanding as at December 31, 2010
and 2009.
Php1,000 Million Term Loan Facility
On July 16, 2009, Smart signed a Philippine Peso term loan
facility with Metropolitan Bank and Trust Company to finance
capital expenditures for an amount of Php1,000 million, which
was drawn in full on August 3, 2009. The facility is payable
over five years in 16 equal consecutive quarterly installments
commencing on the fifth quarter from the date of the first draw-
down with final repayment on August 1, 2014. The amounts
of Php935 million and Php996 million, both net of unamor-
tized debt discount, remained outstanding as at December
31, 2010 and 2009, respectively.
Php2,000 Million Term Loan Facility
On September 18, 2009, PLDT signed a loan agreement with
Bank of the Philippine Islands amounting to Php2,000 million
to finance capital expenditures and/or refinance its loan obli-
gations which were utilized for service improvements and
expansion programs. The facility is payable over five years in
17 equal quarterly installments with final repayment on Octo-
ber 27, 2014. The initial drawdown under this loan was made
on October 26, 2009 in the amount of Php1,000 million and
the balance of Php1,000 million was subsequently drawn on
December 4, 2009. The amounts of Php1,882 million and
Php2,000 million remained outstanding as at December 31,
2010 and 2009, respectively.
Php1,000 Million Term Loan Facility
On November 23, 2009, PLDT signed a loan agreement with
Bank of the Philippine Islands amounting to Php1,000 million
to finance capital expenditures and/or refinance its obligations
which were utilized for service improvements and expansion
programs. The facility is payable over five years in 17 equal
quarterly installments with final repayment on December 18,
2014. The amount of Php1,000 million was fully drawn on
December 18, 2009. The amounts of Php941 million and
Php1,000 million remained outstanding as at December 31,
2010 and 2009, respectively.
Php1,500 Million Term Loan Facility
On March 15, 2011, Smart signed a Philippine Peso term loan
facility with Metropolitan Bank and Trust Company to finance
capital expenditures for an amount of Php1,500 million, which
was drawn in full on March 22, 2011. The facility is a five-year
loan, payable in full upon maturity on March 22, 2016.
Php2,000 Million Term Loan Facility
On March 24, 2011, Smart signed a Philippine Peso term
loan facility with Philippine National Bank to finance capital
expenditures for an amount of Php2,000 million, which was
drawn in full on March 29, 2011. The facility is a five-year
loan, payable in full upon maturity on March 29, 2016.
Secured Term Loans
Php150 Million Term Loan Facility
On June 7, 2007, BayanTrade obtained a medium term
loan facility with Bank of the Philippine Islands amounting
to Php150 million, which was fully availed of in December
2007. Each interest period will cover a 90-day period com-
mencing on the initial drawdown date and the interest rate
will be determined at the first day of each interest period and
payable at the end of the interest period. The loan facility
was obtained to facilitate the purchase of a subsidiary and
to support its working capital requirements. The aggregate
loan amount is due as follows: (a) 20% within the third year
from first drawdown date; (b) 20% within the fourth year from
first drawdown date; and (c) 60% within the fifth year from
first drawdown date. BayanTrade is given a right to repay the
principal and the interest accruing thereon on each interest
payment date or interest rate setting date without any prepay-
ment penalty. BayanTrade and the bank have agreed to the
following terms: (a) pledge of BayanTrade’s shares of stock
of the subsidiary purchased at a collateral loan ratio of 2:1;
(b) assignment of receivables at a collateral-to-loan of 2:1;
and (c) negative pledge on other present and future assets
of BayanTrade. The outstanding principal balance of the loan
was Php113 million and Php139 million as at December 31,
2010 and 2009, respectively.
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Php8 Million Term Loan Facility
On March 31, 2009, Level Up! secured a three-year loan facil-
ity with Asia United Bank amounting to Php8 million maturing
on March 30, 2012. Principal is payable in twelve equal suc-
cessive quarterly installments of Php673 thousand starting
June 30, 2009 and every quarter thereafter. This loan has
a floating interest rate payable every 30 days starting April
30, 2009. The loan is secured by the equipment where the
proceeds of the loan were used. The amounts of Php3 million
and Php6 million remained outstanding as at December 31,
2010 and 2009, respectively.
Notes Payable
On April 23, 2009, PLDT signed the notes facility agreement
with BDO Private Bank, Inc. amounting to Php2,000 million
to finance capital expenditures and/or refinance its loan obli-
gations which were utilized for service improvements and ex-
pansion programs. The facility is comprised of a Php1,000
million Tranche A fixed rate note and a Php1,000 million
Tranche B floating rate note, which were fully drawn on April
28, 2009 and were fully paid on April 28, 2010.
SPi had an outstanding balance of short-term notes of
US$6 million, or Php279 million, as at December 31, 2009,
which matured on various dates from April 26, 2010 to June
4, 2010.
Accounts Payable
As at December 31, 2010 and 2009, this account consists of:
2010 2009
(In Million Pesos)
Suppliers and contractors (Notes 26 and 28) 20,957 14,975
Taxes (Notes 27 and 28) 2,114 1,894
Carriers (Notes 26 and 28) 1,866 1,937
Related parties (Notes 24, 26 and 28) 244 233
Others 623 562
25,804 19,601
28. Financial Assets and Liabilities (in part)
We have various financial assets such as trade and non-
trade receivables and cash and short-term deposits, which
arise directly from our operations. Our principal financial li-
abilities, other than derivatives, comprise of bank loans and
overdrafts, finance leases, trade and non-trade payables. The
main purpose of these financial liabilities is to finance our op-
erations. We also enter into derivative transactions, primarily
principal only-currency swap agreements, currency options,
interest rate swaps and forward foreign exchange contracts
to manage the currency and interest rate risks arising from
our operations and sources of financing. Our accounting poli-
cies in relation to derivatives are set out in Note 2—Summary
of Significant Accounting Policies.
The following table sets forth our . . . financial liabilities as



























Liabilities as at December 31, 2010
Noncurrent:
Interest-bearing financial liabilities—
net of current portion — — — — 75,888 75,888 — 75,888
Deferred income tax liabilities—net — — — — — — 1,099 1,099
Derivative financial liabilities — — 3,604 — — 3,604 — 3,604
Pension and other employee
benefits — — — — — — 1,834 1,834
Customers’ deposits — — — — 2,223 2,223 — 2,223
Deferred credits and other
noncurrent liabilities — — — — 12,041 12,041 1,526 13,567
Current:
Accounts payable — — — — 23,673 23,673 2,131 25,804
Accrued expenses and other current
liabilities — — — — 28,822 28,822 7,137 35,959
Provision for assessments — — — — — — 1,555 1,555
Current portion of interest-bearing
financial liabilities — — — — 13,801 13,801 — 13,801
Dividends payable — — — — 2,086 2,086 — 2,086
Income tax payable — — — — — — 3,010 3,010
Total liabilities — — 3,604 — 158,534 162,138 18,292 180,430
Net assets (liabilities) 54,258 484 (2,904) 147 (158,534) (106,549) 203,934 97,385
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The following table sets forth the consolidated carrying values
and estimated fair values of our financial . . . liabilities recog-
nized as at December 31, 2010 and 2009:
Carrying Value Fair Value
(In Million Pesos) 2010 2009 2010 2009
Noncurrent Financial Liabilities
Interest-bearing financial liabilities:
Long-term debt—net of current portion 75,879 86,066 82,244 88,383
Obligations under finance lease 9 13 8 12
Derivative financial liabilities:
Long-term currency swap 3,604 2,751 3,604 2,751
Customers’ deposits 2,223 2,166 1,701 1,375
Deferred credits and other noncurrent liabilities 12,041 13,159 11,457 11,629
Total noncurrent financial liabilities 93,756 104,155 99,014 104,150
Current Financial Liabilities
Accounts payable:
Suppliers and contractors 20,957 14,975 20,957 14,975
Carriers 1,866 1,937 1,866 1,937
Related parties 244 233 244 233
Others 606 553 606 553
Accrued expenses and other current liabilities:
Utilities and related expenses 19,739 17,388 19,739 17,388
Employee benefits 3,852 8,071 3,852 8,071
Interests and other related costs 1,028 1,167 1,028 1,167
Liability arising from purchase of investment — 65 — 65
Others 4,203 2,061 4,203 2,061
Interest-bearing financial liabilities:
Current portion of long-term debt 13,767 10,384 13,767 10,384
Obligations under finance lease 34 51 34 51
Notes payable — 2,279 — 2,279
Dividends payable 2,086 1,749 2,086 1,749
Total current financial liabilities 68,382 60,913 68,382 60,913
Total Financial Liabilities 162,138 165,068 167,396 165,063
Financial Risk Management Objectives and Policies (in part)
Foreign Currency Exchange Risk
The revaluation of our foreign currency-denominated finan-
cial assets and liabilities as a result of the appreciation or
depreciation of the Philippine peso is recognized as foreign
exchange gains or losses as at the end of the reporting pe-
riod. The extent of foreign exchange gains or losses is largely
dependent on the amount of foreign currency debt. While a
certain percentage of our revenues are either linked to or
denominated in U.S. dollars, most of our indebtedness and
related interest expense, a substantial portion of our cap-
ital expenditures and a portion of our operating expenses
are denominated in foreign currencies, mostly in U.S. dol-
lars. As such, a strengthening or weakening of the Philip-
pine peso against the U.S. dollar will decrease or increase
in Philippine peso terms both the principal amount of our
foreign currency-denominated debts and the related interest
expense, our foreign currency-denominated capital expendi-
tures and operating expenses as well as our U.S. dollar-linked
and U.S. dollar-denominated revenues. In addition, many of
our financial ratios and other financial tests are affected by
the movements in the Philippine peso to U.S. dollar exchange
rate.
To manage our foreign exchange risks and to stabilize our
cash flows in order to improve investment and cash flow plan-
ning, we enter into forward foreign exchange contracts, cur-
rency swap contracts, currency option contracts and other
hedging products aimed at reducing and/or managing the
adverse impact of changes in foreign exchange rates on our
operating results and cash flows. We use forward foreign
exchange purchase contracts, currency swap contracts and
foreign currency option contracts to manage the foreign cur-
rency risks associated with our foreign currency-denominated
loans. We also enter into forward foreign exchange sale con-
tracts to manage foreign currency risks associated with our
U.S. dollar-linked and U.S. dollar-denominated revenues. In
order to manage the hedge costs of these contracts, we utilize
structures that include credit-linkage with PLDT as the refer-
ence entity, a combination of foreign currency option con-
tracts, and fixed to floating coupon only swap contracts. We
accounted for these instruments as either cash flow hedges,
wherein changes in the fair value are recognized as cumula-
tive translation adjustments in other comprehensive income
until the hedged transaction affects our consolidated income
statement or when the hedging instrument expires, or trans-
actions not designated as hedges, wherein changes in the
fair value are recognized directly as income or expense for
the year.
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The following table shows our consolidated foreign
currency-denominated monetary financial assets and liabil-
ities and their Philippine peso equivalents as at December
31, 2010 and 2009:
2010 2009
U.S. Dollar Php(1) U.S. Dollar Php(2)
(In Millions)
Noncurrent Financial Liabilities
Interest-bearing financial liabilities—net of current portion 782 34,244 837 38,871
Derivative financial liabilities 82 3,604 59 2,751
Total noncurrent financial liabilities 864 37,848 896 41,622
Current Financial Liabilities
Accounts payable 169 7,415 155 7,180
Accrued expenses and other current liabilities 143 6,267 95 4,409
Current portion of interest-bearing financial liabilities 103 4,537 155 7,220
Total current financial liabilities 415 18,219 405 18,809
Total Financial Liabilities 1,279 56,067 1,301 60,431
(1) The exchange rate used to translate the U.S. dollar amounts into Philippine peso was Php43.81 to US$1.00, the peso-dollar exchange rate
as quoted through the Philippine Dealing System as at December 31, 2010.
(2) The exchange rate used to translate the U.S. dollar amounts into Philippine peso was Php46.43 to US$1.00, the peso-dollar exchange rate
as quoted through the Philippine Dealing System as at December 31, 2009.
As at March 29, 2011, the peso-dollar exchange rate was
Php43.53 to US$1.00. Using this exchange rate, our consol-
idated net foreign currency-denominated financial liabilities
would have decreased in peso terms by Php253 million as at
December 31, 2010.
Approximately 43% and 46% of our total consolidated debts
(net of consolidated debt discount) were denominated in U.S.
dollars as at December 31, 2010 and 2009, respectively. Con-
solidated foreign currency-denominated debt decreased to
Php38,414 million as at December 31, 2010 from Php45,633
million as at December 31, 2009. See Note 20—Interest-
bearing Financial Liabilities. The aggregate notional amount
of PLDT’s outstanding long-term principal only currency swap
contracts were US$262 million and US$391 million as at De-
cember 31, 2010 and 2009, respectively. Consequently, the
unhedged portion of our consolidated debt amounts was ap-
proximately 30% (or 23%, net of our consolidated U.S. dollar
cash balances) and 28% (or 19%, net of our consolidated
U.S. dollar cash balances) as at December 31, 2010 and
2009, respectively.
Approximately 26% of our consolidated service revenues
were denominated in U.S. dollars and/or were linked to U.S.
dollars for the year ended December 31, 2010 as compared
with approximately 28% for each of the years ended Decem-
ber 31, 2009 and 2008. In this respect, the appreciation of
the weighted average exchange rate of the Philippine peso
against the U.S. dollar decreased our revenues, and con-
sequently, our cash flow from operations in Philippine peso
terms.
The Philippine peso had appreciated by 5.64% against the
U.S. dollar to Php43.81 to US$1.00 as at December 31, 2010
from Php46.43 to US$1.00 as at December 31, 2009. As
at December 31, 2009, the Philippine peso had appreciated
by 2.56% against the U.S. dollar to Php46.43 to US$1.00
from Php47.65 to US$1.00 as at December 31, 2008. As
a result of our consolidated foreign exchange movements
as well as the amount of our consolidated outstanding net
foreign currency financial assets and liabilities, we recognized
net consolidated foreign exchange gains of Php1,807 million
and Php909 million in 2010 and 2009, respectively, and net
consolidated foreign exchange losses of Php6,170 million in
2008. See Note 4—Operating Segment Information.
Capital Management Risk
We aim to achieve an optimal capital structure in pursuit of our
business objectives which include maintaining healthy capital
ratios and strong credit ratings, and maximizing shareholder
value.
In recent years, our cash flow from operations has allowed
us to substantially reduce debts and, in 2005, resume pay-
ment of dividends on common shares. Since 2005, our strong
cash flow has enabled us to make investments in new areas
and pay higher dividends.
Our approach to capital management focuses on balanc-
ing the allocation of cash and the incurrence of debt as we
seek new investment opportunities for new businesses and
growth areas. Our current dividend policy is to pay out 70% of
our core income per common share. Further, in the event no
investment opportunities arise, we may consider the option
of returning additional cash to our shareholders in the form
of special dividends or share buybacks. Philippine corporate
regulations prescribe, however, that we can only pay out div-
idends or make capital distribution up to the amount of our
unrestricted retained earnings.
As part of our goal to maximize returns to our sharehold-
ers, we obtained in 2008 an approval from the Board of Di-
rectors to conduct a share buyback program for up to five
million PLDT common shares. We had acquired a total of
approximately 2.72 million shares of PLDT’s common stock
at a weighted average price of Php2,388 per share for a
total consideration of Php6,505 million as at December 31,
2010. We had acquired at total of approximately 2.68 million
shares of PLDT’s common stock at a weighted average price
of Php2,387 per share for a total consideration of Php6,405
million as at December 31, 2009. See Note 8—Earnings Per
Common Share and Note 19—Equity.
Some of our debt instruments contain covenants that im-
pose maximum leverage ratios. In addition, our credit ratings
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from the international credit ratings agencies are based on
our ability to remain within certain leverage ratios.
We monitor capital using several financial leverage mea-
surements calculated in conformity with PFRS, such as net
consolidated debt to equity ratio. Net consolidated debt is
derived by deducting cash and cash equivalents and short-
term investments from total debt (long-term debt and notes
payable). Our objective is to maintain our net consolidated
debt to equity ratio below 100%.
The table below provides information regarding our con-
solidated debt to equity ratio as at December 31, 2010 and
2009:
(In Million Pesos) 2010 2009
Long-term debt, including current portion
(Note 20) 89,646 96,450
Notes payable (Note 20) — 2,279
Total consolidated debt 89,646 98,729
Cash and cash equivalents (Note 15) (36,678) (38,319)
Short-term investments (669) (3,824)
Net consolidated debt 52,299 56,586
Equity attributable to equity holders of PLDT 97,069 98,575
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Long-term borrowings 22 28,375 28,632
Taxation liabilities 350 —
Deferred tax liabilities 6 6,486 7,377
Post employment benefits 23 87 237
Provisions 24 482 497
Trade and other payables 25 804 816
36,584 37,559
Current Liabilities
Short-term borrowings 22 9,906 11,163
Taxation liabilities 1,912 2,874
Provisions 24 559 497
Trade and other payables 25 14,698 14,082
27,075 28,616
CONSOLIDATED INCOME STATEMENT (in part)
For the years ended 31 March
2011 2010 2009
Note £m £m £m
Operating profit 4 5,596 9,480 5,857
Non-operating income and
expense 15 3,022 (10) (44)
Investment income 5 1,309 716 795
Financing costs 5 (429) (1,512) (2,419)
Profit before taxation 9,498 8,674 4,189
CONSOLIDATED STATEMENT OF CASH FLOWS
(in part)
For the years ended 31 March
2011 2010 2009
Note £m £m £m
Cash Flows From Financing
Activities
Issue of ordinary share capital and
reissue of treasury shares 107 70 22
Net movement in short-term
borrowings (573) 227 (25)
Proceeds from issue of long-term
borrowings 4,861 4,217 6,181
Repayment of borrowings (4,064) (5,184) (2,729)
Purchase of treasury shares (2,087) — (963)
B share capital redemption — — (15)
Equity dividends paid (4,468) (4,139) (4,013)
Dividends paid to non-controlling
shareholders in subsidiaries (320) (56) (162)
Contributions from non-controlling
shareholders in subsidiaries — 613 —
Other transactions with
non-controlling shareholders in
subsidiaries (137) — 618
Interest paid (1,578) (1,601) (1,470)
Net cash flow from financing
activities (8,259) (5,853) (2,556)
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)




Items in hedge relationships:
Other loans 746 888 782
Interest rate swaps (338) (464) (180)
Dividends on redeemable preference shares 58 56 53
Fair value hedging instrument (47) 228 (1,458)
Fair value of hedged item 40 (183) 1,475
Cash flow hedges transferred from equity 17 82 —
Other financial liabilities held at amortised cost:
Bank loans and overdrafts(4) 629 591 452
Other loans(5) 121 185 440
Potential interest on settlement of tax issues(6) (826) (178) (81)
Equity put rights and similar arrangements(3) 19 94 627
Finance leases 9 7 1
Fair value through the income statement (held for trading):
Derivatives—forward starting swaps and futures 1 206 308
429 1,512 2,419
Net (investment income)/financing costs (880) 796 1,624
22. Borrowings
Carrying Value and Fair Value Information
2011 2010
Short-Term Long-Term Short-Term Long-Term
Borrowings Borrowings Total Borrowings Borrowings Total
£m £m £m £m £m £m
Financial liabilities measured at amortised cost:
Bank loans 2,070 5,872 7,942 3,460 4,183 7,643
Bank overdrafts 47 — 47 60 — 60
Redeemable preference shares — 1,169 1,169 — 1,242 1,242
Commercial paper 1,660 — 1,660 2,563 — 2,563
Bonds 2,470 16,046 18,516 1,174 12,675 13,849
Other liabilities(1)(2) 3,659 1,023 4,682 3,906 385 4,291
Bonds in fair value hedge relationships — 4,265 4,265 — 10,147 10,147
9,906 28,375 38,281 11,163 28,632 39,795
Notes:
(1) At 31 March 2011 amount includes £531 million (2010: £604 million) in relation to collateral support agreements.
(2) Amounts at 31 March 2011 include £3,190 million (2010: £3,405 million) in relation to the options disclosed in note 12.
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Banks loans include a ZAR 3.5 billion loan borrowed by Voda-
fone Holdings SA Pty Limited (‘VHSA’), which directly and in-
directly owns the Group’s interest in Vodacom Group Limited.
VHSA has pledged its 100% equity shareholding in Voda-
fone Investments SA (‘VISA’), which holds a direct 20.1% eq-
uity shareholding in Vodacom Group Limited, as security for
its loan obligations. The terms and conditions of the pledge
mean that should VHSA not meet all of its loan payment
and performance obligations, the lenders may sell the eq-
uity shareholding in its subsidiary VISA at market value to
recover their losses, with any remaining sales proceeds be-
ing returned to VHSA. Vodafone International Holdings B.V.
has also guaranteed this loan with recourse only to the VHSA
shares it has pledged. The terms and conditions of the secu-
rity arrangement mean the lenders may be able to sell these
respective shares in preference to the VISA shares held by
VHSA. An arrangement has been put in place where the Vo-
dacom Group Limited shares held by VHSA and VISA are
held in an escrow account to ensure the shares cannot be
sold to satisfy the pledge made by the Company. The maxi-
mum collateral provided is ZAR 3.5 billion, being the carrying
value of the bank loan at 31 March 2011 (2010: ZAR 4.85 bil-
lion). Bank loans also include INR 262 billion of loans held by
Vodafone Essar Limited (‘VEL’) and its subsidiaries (the ‘VEL
Group’). The VEL Group has a number of security arrange-
ments supporting certain licences secured under the terms
of tri-party agreements between the relevant borrower, the
department of telecommunications, Government of India and
the agent representing the secured lenders and certain share
pledges of the shares under VEL. The terms and conditions
of the security arrangements mean that should members of
the VEL Group not meet all of their loan payment and perfor-
mance obligations, the lenders may sell the pledged shares
and enforce rights over the certain licences under the terms
of the tri-party agreements to recover their losses, with any
remaining sales proceeds being returned to the VEL Group.
Each of the eight legal entities within the VEL Group provide
cross guarantees to the lenders in respect to debt contracted
by the other seven.
The fair value and carrying value of the Group’s short-term
borrowings is as follows:
Sterling Equivalent
Nominal Value Fair Value Carrying Value
2011 2010 2011 2010 2011 2010
£m £m £m £m £m £m
Financial liabilities measured at amortised cost 7,316 9,910 7,425 10,006 7,436 9,989
Bonds: 2,444 1,113 2,463 1,124 2,470 1,174
5.875% euro 1.25 billion bond due June 2010 — 1,113 — 1,124 — 1,174
US dollar floating rate note due June 2011 171 — 171 — 171 —
5.5% US dollar 750 million bond due June 2011 467 — 471 — 478 —
1% US dollar 100 million bond due August 2011 45 — 45 — 45 —
Euro floating rate note due January 2012 1,144 — 1,146 — 1,148 —
US dollar floating rate note due February 2012 306 — 306 — 306 —
5.35% US dollar 500 million bond due February 2012 311 — 324 — 322 —
Short-term borrowings 9,760 11,023 9,888 11,130 9,906 11,163
IFRS ATT 8.59
637Section 8: Financial Instruments and Related Disclosures
The fair value and carrying value of the Group’s long-term
borrowings is as follows:
Sterling Equivalent
Nominal Value Fair Value Carrying Value
2011 2010 2011 2010 2011 2010
£m £m £m £m £m £m
Financial liabilities measured at amortised cost:
Bank loans 5,728 4,149 5,872 4,183 5,873 4,183
Redeemable preference shares 1,027 1,174 1,054 1,098 1,169 1,242
Other liabilities 1,022 385 1,023 385 1,022 385
Bonds: 14,581 11,455 15,578 11,961 16,046 12,675
US dollar floating rate note due June 2011 — 230 — 230 — 230
5.5% US dollar 750 million bond due June 2011 — 494 — 518 — 524
Euro floating rate note due January 2012 — 1,158 — 1,157 — 1,161
US dollar floating rate note due February 2012 — 329 — 329 — 329
5.35% US dollar 500 million bond due February 2012 — 329 — 351 — 352
3.625% euro 1,250 million bond due November 2012 1,104 1,113 1,125 1,157 1,132 1,149
6.75% Australian dollar 265 million bond due January 2013 171 160 173 161 176 167
Czech krona floating rate note due June 2013 19 19 19 19 19 19
Euro floating rate note due September 2013 751 757 752 756 752 758
5.0% US dollar 1,000 million bond due December 2013 623 658 676 704 667 718
6.875% euro 1,000 million bond due December 2013 883 891 970 1,024 922 936
Euro floating rate note due June 2014 1,104 1,113 1,099 1,099 1,105 1,114
4.15% US dollar 1,250 million bond due June 2014 778 823 826 856 802 852
4.625% sterling 350 million bond due September 2014 350 — 367 — 382 —
4.625% sterling 525 million bond due September 2014 525 — 551 — 544 —
5.125% euro 500 million bond due April 2015 442 445 475 496 470 475
5.0% US dollar 750 million bond due September 2015 467 — 506 — 512 —
3.375% US dollar 500 million bond due November 2015 311 329 317 327 312 330
6.25% euro 1,250 million bond due January 2016 1,104 — 1,230 — 1,139 —
2.875% US dollar 600 million bond due March 2016 374 — 371 — 371 —
5.75% US dollar 750 million bond due March 2016 467 — 523 — 532 —
4.75% euro 500 million bond due June 2016 442 — 463 — 487 —
5.625% US dollar 1,300 million bond due February 2017 809 — 897 — 920 —
5.375% sterling 600 million bond due December 2017 600 — 638 — 629 —
5% euro 750 million bond due June 2018 663 668 697 721 689 694
8.125% sterling 450 million bond due November 2018 450 — 550 — 488 —
4.375% US dollar 500 million bond due March 2021 311 — 307 — 309 —
7.875% US dollar 750 million bond due February 2030 467 494 591 589 759 814
6.25% US dollar 495 million bond due November 2032 308 326 332 328 425 453
6.15% US dollar 1,700 million bond due February 2037 1,058 1,119 1,123 1,139 1,503 1,600
Bonds in fair value hedge relationships: 3,962 9,395 4,199 10,085 4,265 10,147
4.625% sterling 350 million bond due September 2014 — 350 — 367 — 388
4.625% sterling 525 million bond due September 2014 — 525 — 550 — 532
2.15% Japanese yen 3,000 million bond due April 2015 23 21 24 22 23 22
5.375% US dollar 900 million bond due January 2015 560 592 616 636 621 650
5.0% US dollar 750 million bond due September 2015 — 494 — 529 — 543
6.25% euro 1,250 million bond due January 2016 — 1,113 — 1,278 — 1,168
5.75% US dollar 750 million bond due March 2016 — 494 — 536 — 556
4.75% euro 500 million bond due June 2016 — 445 — 477 — 503
5.625% US dollar 1,300 million bond due February 2017 — 856 — 919 — 960
5.375% sterling 600 million bond due December 2017 — 600 — 634 — 628
4.625% US dollar 500 million bond due July 2018 311 329 327 328 338 349
8.125% sterling 450 million bond due November 2018 — 450 — 553 — 487
5.45% US dollar 1,250 million bond due June 2019 778 823 850 857 823 849
4.65% euro 1,250 million bond due January 2022 1,104 1,113 1,115 1,129 1,114 1,145
5.375% euro 500 million bond due June 2022 442 445 470 481 505 525
5.625% sterling 250 million bond due December 2025 250 250 258 254 284 285
6.6324% euro 50 million bond due December 2028 44 45 68 64 57 54
5.9% sterling 450 million bond due November 2032 450 450 471 471 500 503
Long-term borrowings 26,320 26,558 27,726 27,712 28,375 28,632
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During the year ended 31 March 2011 fair value hedge re-
lationships relating to bonds with nominal value US$2,800
million (£1,743 million), €1,750 million (£1,546 million) and
£1,925 million were de-designated.
Fair values are calculated using quoted market prices or
discounted cash flows with a discount rate based upon for-
ward interest rates available to the Group at the reporting
date.
Maturity of Borrowings
The maturity profile of the anticipated future cash flows includ-
ing interest in relation to the Group’s non-derivative financial
liabilities on an undiscounted basis, which, therefore, differs
from both the carrying value and fair value, is as follows:
Redeemable Loans in Fair
Bank Preference Commercial Other Value Hedge
Loans Shares Paper Bonds Liabilities Relationships Total
£m £m £m £m £m £m £m
Within one year 1,881 52 1,670 3,292 3,766 203 10,864
In one to two years 528 52 — 2,009 191 203 2,983
In two to three years 2,510 52 — 2,919 60 203 5,744
In three to four years 321 52 — 3,251 60 763 4,447
In four to five years 885 52 — 3,613 901 195 5,646
In more than five years 1,825 1,240 — 7,725 — 4,752 15,542
7,950 1,500 1,670 22,809 4,978 6,319 45,226
Effect of discount/financing rates (8) (331) (10) (4,293) (249) (2,054) (6,945)
31 March 2011 7,942 1,169 1,660 18,516 4,729 4,265 38,281
Within one year 3,406 93 2,572 1,634 3,983 510 12,198
In one to two years 858 56 — 3,008 145 510 4,577
In two to three years 847 56 — 1,712 156 510 3,281
In three to four years 1,852 56 — 2,671 — 510 5,089
In four to five years 138 56 — 2,152 31 1,977 4,354
In more than five years 598 1,370 — 6,009 68 9,983 18,028
7,699 1,687 2,572 17,186 4,383 14,000 47,527
Effect of discount/financing rates (56) (445) (9) (3,337) (32) (3,853) (7,732)
31 March 2010 7,643 1,242 2,563 13,849 4,351 10,147 39,795
The maturity profile of the Group’s financial derivatives (which
include interest rate and foreign exchange swaps), using
undiscounted cash flows, is as follows:
2011 2010
Payable Receivable Payable Receivable
£m £m £m £m
Within one year 14,840 15,051 13,067 13,154
In one to two years 631 829 929 938
In two to three years 724 882 1,083 974
In three to four years 667 770 1,040 932
In four to five years 619 690 868 816
In more than five years 3,715 4,592 7,607 5,912
21,196 22,814 24,594 22,726
The currency split of the Group’s foreign exchange deriva-
tives, all of which mature in less than one year, is as follows:
2011 2010
Payable Receivable Payable Receivable
£m £m £m £m
Sterling — 10,198 — 8,257
Euro 11,422 2,832 8,650 3,177
US dollar 13 387 1,545 55
Japanese yen 2,164 23 548 21
Other 727 832 1,485 755
14,326 14,272 12,228 12,265
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Payables and receivables are stated separately in the table
above as settlement is on a gross basis. The £54 million
net payable (2010: £37 million net receivable) in relation to
foreign exchange financial instruments in the table above is
split £153 million (2010: £95 million) within trade and other
payables and £99 million (2010: £132 million) within trade
and other receivables.
The present value of minimum lease payments under fi-
nance lease arrangements under which the Group has leased
certain of its equipment is analysed as follows:
2011 2010
£m £m
Within one year 14 21
In two to five years 45 47
In more than five years 6 7
Interest Rate and Currency of Borrowings
Total Floating Rate Fixed Rate Other
Borrowings Borrowings Borrowings(1) Borrowings(2)
Currency £m £m £m £m
Sterling 2,831 906 1,925 —
Euro 12,361 4,198 8,163 —
US dollar 16,030 9,488 3,352 3,190
Japanese yen 807 807 — —
Other 6,252 2,920 3,332 —
31 March 2011 38,281 18,319 16,772 3,190
Sterling 3,022 3,022 — —
Euro 14,244 9,429 4,815 —
US dollar 15,195 7,329 4,461 3,405
Japanese yen 2,605 2,605 — —
Other 4,729 4,105 624 —
31 March 2010 39,795 26,490 9,900 3,405
Notes:
(1) The weighted average interest rate for the Group’s sterling denominated fixed rate borrowings is 5.7% (2010: n/a). The weighted average
time for which these rates are fixed is 5.4 years (2010: n/a). The weighted average interest rate for the Group’s euro denominated fixed
rate borrowings is 4.3% (2010: 5.3%). The weighted average time for which the rates are fixed is 3.8 years (2010: 3.4 years). The weighted
average interest rate for the Group’s US dollar denominated fixed rate borrowings is 5.4% (2010: 5.5%). The weighted average time for
which the rates are fixed is 9.7 years (2010: 12.3 years). The weighted average interest rate for the Group’s other currency fixed rate
borrowings is 9.2% (2010: 10.1%). The weighted average time for which the rates are fixed is 2.0 years (2010: 1.5 years).
(2) Other borrowings of £3,190 million (2010: £3,405 million) are the liabilities arising under options over direct and indirect interests in Vodafone
Essar.
The figures shown in the tables above take into account in-
terest rate swaps used to manage the interest rate profile of
financial liabilities. Interest on floating rate borrowings is gen-
erally based on national LIBOR equivalents or government
bond rates in the relevant currencies.
At 31 March 2011 the Group had entered into foreign ex-
change contracts to decrease its sterling, US dollar and other
currency borrowings above by £10,198 million and amounts
equal to £374 million and £105 million respectively, and to in-
crease its euro and Japanese yen currency borrowings above
by amounts equal to £8,590 million and £2,141 million respec-
tively.
At 31 March 2010 the Group had entered into foreign ex-
change contracts to decrease its sterling currency borrowings
above by £8,257 million and to increase its euro, US dol-
lar, Japanese yen and other currency borrowings above by
amounts equal to £5,473 million, £1,490 million, £527 million
and £730 million respectively.
Further protection from euro and US dollar interest rate
movements is provided by interest rate swaps. At 31 March
2011 the Group had euro denominated interest rate swaps
covering the period March 2011 to September 2015 for an
amount equal to £883 million and US dollar denominated
interest swaps covering the period March 2011 to Septem-
ber 2015 for an amount equal to £641 million. The average
effective rate which has been fixed is 1.23% for euro denom-
inated interest rate swaps and 1.73% in relation to US dollar
denominated interest rate swaps.
The Group has entered into euro and US dollar denom-
inated interest rate futures. The euro denominated interest
rate futures cover the periods September 2011 to December
2011, December 2011 to March 2012, March 2012 to June
2012 and June 2012 to September 2012 for amounts equal
to £2,083 million, £833 million, £7,185 million and £6,811 mil-
lion respectively. Additional cover is provided for the period
March 2013 to March 2014 and March 2015 to March 2016 for
IFRS ATT 8.59
640 IFRS Accounting Trends & Techniques
average amounts for each period equal to £2,006 million and
£2,331 million respectively. The US dollar denominated inter-
est rate futures cover the periods June 2011 to September
2011, June 2013 to September 2013 and September 2013 to
December 2013 for amounts equal to £3,601 million, £1,923
million and £833 million respectively. The average effective
rate which has been fixed is 2.87% for euro denominated
interest rate futures and 1.33% for US dollar denominated
interest rate futures.
The Group has entered into interest rate futures to alter
the level of protection against interest rate movements during
some futures periods. During the period June 2016 to Decem-
ber 2016 euro denominated interest rate swaps will reduce
the level of fixed rate debt in the Group by an amount equal
to £833 million. US dollar denominated futures will reduce
the level of fixed rate debt during the period March 2016 to
March 2019 for an amount equal to £321 million. US dollar
denominated interest rate futures will reduce the level of fixed
rate debt during the periods September 2012 to December
2012 and December 2013 to March 2014 for amounts equal
to £4,487 million and £1,282 million respectively.
At 31 March 2010 the Group had entered into euro and
US dollar denominated interest rate futures. The euro de-
nominated interest rate futures cover the period June 2010
to September 2010, September 2010 to December 2010 and
December 2010 to March 2011 for amounts equal to £7,888
million, £8,461 million and £4,067 million respectively. The
average effective rate which has been fixed is 1.27%. The
US dollar denominated interest rate futures cover the period
June 2010 to September 2010, September 2010 to Decem-
ber 2010 and December 2010 to March 2011 for amounts
equal to £3,197 million, £2,582 million, and £1,119 million re-
spectively. The average effective rate which has been fixed
is 0.86%.
Borrowing Facilities
At 31 March 2011 the Group’s most significant committed
borrowing facilities comprised two bank facilities which re-
mained undrawn throughout the period of €4,150 million
(£3,666 million) and US$4,170 million (£2,596 million) both
expiring between four and five years (2010: two bank facili-
ties of US$4,115 million (£2,709 million) and US$5,025 million
(£3,308 million)), a US$650 million (£405 million) bank facility
which expires in more than five years (2010: US$650 million
(£428 million)), a ¥259 billion (2010: ¥259 billion (£1,821 mil-
lion)) term credit facility expired during the period, two loan
facilities of €400 million (£353 million) and €350 million (£309
million) both expiring between two and five years (2010: two
loan facilities of €400 million (£356 million) and €350 million
(£312 million) and a loan facility of €410 million (£362 million)
which expires in more than five years (2010: €410 million
(£365 million)). The €400 million and €350 million loan facil-
ities were fully drawn on 14 February 2007 and 12 August
2008 respectively and the €410 million facility was drawn on
30 July 2010.
Under the terms and conditions of the €4,150 million and
US$4,170 million bank facilities, lenders have the right, but
not the obligation, to cancel their commitment 30 days from
the date of notification of a change of control of the Company
and have outstanding advances repaid on the last day of the
current interest period.
The facility agreements provide for certain structural
changes that do not affect the obligations of the Company
to be specifically excluded from the definition of a change of
control. This is in addition to the rights of lenders to cancel
their commitment if the Company has committed an event of
default.
The terms and conditions of the €400 million loan facility
are similar to those of the US dollar bank facilities, with the
addition that, should the Group’s Turkish operating company
spend less than the equivalent of US$800 million on capital
expenditure, the Group will be required to repay the drawn
amount of the facility that exceeds 50% of the capital expen-
diture.
The terms and conditions of the €350 million loan facility
are similar to those of the US dollar bank facilities, with the
addition that, should the Group’s Italian operating company
spend less than the equivalent of €1,500 million on capital
expenditure, the Group will be required to repay the drawn
amount of the facility that exceeds 18% of the capital expen-
diture.
The terms and conditions of the €410 million loan facility
are similar to those of the US dollar bank facilities, with the
addition that, should the Group’s German fixed line opera-
tion, spend less than the equivalent of €824 million on capital
expenditure, the Group will be required to repay the drawn
amount of the facility that exceeds 50% of the capital expen-
diture.
In addition to the above, certain of the Group’s subsidiaries
had committed facilities at 31 March 2011 of £7,152 million
(2010: £5,759 million) in aggregate, of which £667 million
(2010: £1,647 million) was undrawn. Of the total committed
facilities £2,137 million (2010: £1,139 million) expires in less
than one year, £3,719 million (2010: £2,880 million) expires
between two and five years, and £1,296 million (2010: £1,740
million) expires in more than five years.
Redeemable Preference Shares
Redeemable preference shares comprise class D and E pre-
ferred shares issued by Vodafone Americas, Inc. An annual
dividend of US$51.43 per class D and E preferred share
is payable quarterly in arrears. The dividend for the year
amounted to £58 million (2010: £56 million). The aggregate
redemption value of the class D and E preferred shares is
US$1.65 billion. The holders of the preferred shares are en-
titled to vote on the election of directors and upon each other
matter coming before any meeting of the shareholders on
which the holders of ordinary shares are entitled to vote. Hold-
ers are entitled to vote on the basis of twelve votes for each
share of class D or E preferred stock held. The maturity date
of the 825,000 class D preferred shares is 6 April 2020. The
825,000 class E preferred shares have a maturity date of 1
April 2020. The class D and E preferred shares have a re-
demption price of US$1,000 per share plus all accrued and
unpaid dividends.
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Compound Financial Instruments—Perpetual
Bonds Redeemable for Shares
8.60
France Telecom (Dec 2010)
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION
(In Millions of Euros) Note At December 31, 2010 At December 31, 2009(1) At December 31, 2008(1)
Non-current trade payables 21 466 411 428
Non-current financial liabilities at amortized cost,
excluding trade payables 21 31,617 30,502 31,326
Non-current financial liabilities at fair value
through profit or loss 21 2,175 614 495
Non-current hedging derivatives liabilities 22 250 693 650
Non-current employee benefits 23 1,826 1,223 652
Non-current provisions 24 1,009 1,009 1,261
Other non-current liabilities 25 528 565 703
Deferred tax liabilities 10 1,265 1,043 1,256
Total non-current liabilities 39,136 36,060 36,771
Current trade payables 21 8,274 7,531 9,279
Current financial liabilities at amortized cost,
excluding trade payables 21 4,525 6,230 8,152
Current financial liabilities at fair value through
profit or loss 21 366 73 913
Current hedging derivatives liabilities 22 18 1 2
Current employee benefits 23 1,816 1,687 1,692
Current provisions 24 1,546 1,217 1,427
Other current liabilities 25 2,105 2,629 1,894
Current tax payables 10 2,353 282 258
Deferred income 25 2,588 2,443 2,721
Total current liabilities 23,591 22,093 26,338
CONSOLIDATED INCOME STATEMENT (in part)
Amounts in Millions of Euros (Except for per Share Data) Note 2010 2009(1) 2008(1)
Cost of gross financial debt 9 (2,117) (2,232) (3,018)
Income and expense on net debt assets 9 120 129 263
Foreign exchange gains (losses) 9 56 (42) (51)
Other financial Income and expense 9 (59) (61) (78)
Finance costs, net (2,000) (2,206) (2,884)
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CONSOLIDATED STATEMENT OF CASH FLOWS
(in part)
(Amounts in Millions of Euros) Note At December 31, 2010 At December 31, 2009 At December 31, 2008
Financing Activities
Issuances
Bonds 21 3,948 4,638 4,047
Other long-term debt 21 405 421 1,311
Redemptions and repayments
Bonds 21 (6,413) (4,963) (6,328)
Other long-term debt 21 (575) (2,248) (708)
Equity portion of hybrid debt 20–21 — (97) (64)
Other changes
Increase (decrease) in bank overdrafts and
short-term borrowings 21 238 (1,253) 966
Decrease (increase) deposits and other debt-linked financial
assets (including cash collateral) 21 778 (590) 672
Exchange rate effect of derivatives, net (149) (360) (377)
Purchase of treasury shares 20 11 (8) (33)
Changes in ownership interests with no gain/loss of control
O/w Orange Botswana (38) — —
O/w FT España — (1,387) (169)
O/w TP S.A. — — (200)
O/w Mobistar — — (175)
O/w others (8) 1 (25)
Capital increase (decrease)—owners of the parent company 20 1 2 11
Capital increase (decrease)—non-controlling interests 20 3 2 (100)
Dividends paid to non-controlling interests 20 (612) (571) (585)
Dividends paid to owners of the parent company 20–29 (3,706) (3,141) (4,949)
Net cash used in financing activities (6,117) (9,554) (6,706)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 2. Accounting Policies
2.17. Financials Assets and Liabilities (in part)
Financial assets and liabilities are recognized initially at fair
value. They are subsequently measured either at fair value
or amortized cost using the effective interest method, in ac-
cordance with the IAS 39 category they belong to.
The effective interest rate is the rate that discounts esti-
mated future cash payments through the expected contrac-
tual term, or the most probable expected term of the financial
instrument, to the net carrying amount of the financial liability.
This calculation includes all fees and points paid or received
between parties to the contract.
Recognition and Measurement of Financial Assets (in part)
Financial Assets at Fair Value Through Profit or Loss
Financial assets at fair value through profit or loss are:
• assets held for trading that the Group acquired princi-
pally for the purpose of selling them in the near term;
• assets that form a part of a portfolio of identified financial
instruments that are managed together and for which
there is evidence of a recent actual pattern of short-
term profit taking;
• derivative assets not qualifying for hedge accounting;
• assets voluntarily classified at inception in this category
because:
— this classification allows to eliminate or to significantly
reduce a measurement or recognition inconsistency
regarding recognition of assets or liabilities linked to-
gether, that would otherwise be assessed differently
(for instance, a financial asset measured at fair value,
linked to a financial liability measured at amortized
cost),
— a group of financial assets, financial liabilities or both
is managed and its performance is valued on a fair
value basis, in accordance with a documented risk
management or investment strategy, and information
about this group of financial instruments is provided
internally on that basis to the Group’s key manage-
ment personnel,
— the Group decides not to separate from the host con-
tract a separable embedded derivative. It should then
assess the entire hybrid instrument at its fair value.
The Group can designate at fair value at inception cash and
cash equivalents with high liquidity and low volatility invest-
ments such as negotiable debt securities, deposits and mu-
tual funds (OPCVM).
The Group classifies as cash equivalents in the statement
of financial position and in the statement of cash flows the in-
vestments which meet the conditions required by IAS 7 (as-
sets easily convertible into a determined cash amount and
subject to a remote risk of change in value) and which have
a maturity shorter than three months from the date of acqui-
sition.
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Recognition and Measurement of Financial Liabilities
(in part)
Compound Instruments
Certain financial instruments comprise both a liability compo-
nent and an equity component. For the Group, they comprise
perpetual bonds redeemable for shares (TDIRA) and bonds
convertible into or exchangeable for new or existing shares
(OCEANE).
On initial recognition, the fair value of the liability com-
ponent is the present value of the contractually determined
stream of future cash flows discounted at the rate of interest
applied at that time by the market to instruments of compa-
rable credit status and providing substantially the same cash
flows, on the same terms, but without the conversion option.
The equity component is assigned to the residual amount
after deducting from the fair value of the instrument as a whole
the amount separately determined for the liability component.
The equity component determined at initial recognition is
not subsequently remeasured.
Financial Liabilities at Fair Value Through Profit or Loss
The abovementioned comments relating to financial assets at
fair value through profit or loss are applicable to the financial
liabilities of identical nature.
Note 21. Financial Liabilities and Net Financial Debt
(in part)
21.2. Net Financial Debt
Net financial debt as defined and used by France Tele-
com corresponds to (a) financial liabilities excluding op-
erating payables (translated at the year-end closing rate),
less (b): (i) all derivative instruments carried in assets, (ii)
cash collateral paid on derivative instruments, (iii) some de-
posits related to financing, (iv) cash, cash equivalents and
financial assets at fair value, and, since 2010 (v) the loan
granted by the Group to the joint venture Everything Every-
where.
Derivatives qualifying as cash flow hedge and net invest-
ment hedge are set up to hedge items that are not in-
cluded in net financial debt (future cash flows, net invest-
ment in foreign currencies). However, as the market value
of these derivatives is included in the calculation of net fi-
nancial debt, the “effective portion of cash flow hedges”
and the “unrealized gain or loss on net investment hedges”
(c) are added to net financial debt to offset this temporary
difference.
Items in the Statement of Financial Position
Included in the Calculation of Net Financial
Debt
December 31, 2010 December 31, 2009 December 31, 2008






















Non-current financial liabilities at amortized cost,
excluding trade payables 31,617 31,397 30,502 30,322 31,326 31,192
Non-current financial liabilities at fair value through profit
or loss 2,175 2,175 614 614 495 495
Non-current hedging derivatives liabilities 250 250 693 693 650 650
Current financial liabilities at amortized cost, excluding
trade payables 4,525 4,525 6,230(1) 6,058 8,152 8,152
Current financial liabilities at fair value through profit or
loss 366 366 73 73 913 913
Current hedging derivatives liabilities 18 18 1 1 2 2
Liabilities included in the calculation of net financial debt (a) 38,731 37,761 41,404
Assets available for sale 119 0 220 87 202 90
Non-current loans and receivables 891 367 2,554(2) 767 1,553 250
Non-current financial assets at fair value through profit or
loss 96 96 199 199 106 106
Non-current hedging derivatives assets 328 328 180 180 625 625
Current loans and other receivables 775 734 1,093 76 67 2
Current financial assets at fair value through profit or loss,
excluding cash equivalents 758 758 91 91 720 720
Current hedging derivatives assets 72 72 18 18 75 75
Cash equivalents 3,201 3,201 2,911 2,911 3,766 3,766
Cash 1,227 1,227 894 894 928 928
Assets included in the calculation of net financial debt (b) 6,783 5,223 6,562
Retained earnings 2,775 (108) 539 (4) 1,247 582
Components of equity included in the calculation of net
financial debt (c) (108) (4) 582
Net financial debt (a) – (b) + (c) 31,840 32,534 35,424
(1) The 172 million euros liability representing cash generated during the second half of 2009 by assets held for sale and invested at France
Telecom S.A. is excluded from the net financial debt.
(2) The 1,407 million euros loan granted to assets held for sale is not included in net financial debt at December 31, 2009. Out of this amount,
625 million pounds sterling were reimbursed on April 1, 2010.
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Analysis of Net Financial Debt
(In Millions of Euros) Note December 31, 2010 December 31, 2009 December 31, 2008
TDIRA 21.3 1,594 1,631 2,860
Bonds, excluding TDIRA 21.4 29,434 31,094 29,932
Bank loans 21.5 2,249 1,543 3,167
Finance lease liabilities 561 664 1,231
Securitization debt 582 807 1,231
Cash collateral received 236 — —
Commercial paper 601 300 603
Bank overdrafts 165 96 97
Commitment to purchase Mobinil-ECMS shares 3 1,880 — —
Other commitments to purchase non-controlling interests 8 23 55
Amena price guarantee 3 — — 810
Other financial liabilities 525 243 223
Derivatives (liabilities) 22 896 1,360 1,195
Liabilities included in the calculation of net financial debt (a) 38,731 37,761 41,404
Derivatives (assets) 22 598 483 915
Gross financial debt after derivatives 38,133 37,278 40,489
Deposits related to QTE leases and similar items (assets
available-for-sale) 15 — 87 90
Cash collateral paid 17 265 758 238
Deposits related to securitization 17 — 73 —
Other deposits related to financing 17 110 11 14
Loan granted to the joint venture Everything Everywhere 17 726 — —
Other financial assets at fair value, excluding derivatives 18 656 6 611
Cash equivalents 18 3,201 2,911 3,766
Cash 17 1,227 894 928
Assets included in the calculation of net financial debt (b) 6,783 5,223 6,562
Effective portion of cash flow hedges (1) 23 608
Unrealized gain (loss) on net investment hedges (107) (27) (26)
Components of equity included in the calculation of net
financial debt (c) (108) (4) 582
Net financial debt (a)-(b) + (c) 31,840 32,534 35,424
Debt maturity schedules are presented in Note 27.3.
21.3. Perpetual Bonds Redeemable for Shares (TDIRA)
On March 3, 2003, under the terms of the MCSA settlement
agreement (see Note 31), France Telecom issued perpetual
bonds redeemable for shares (TDIRA), with a nominal value
of 14,100 euros each, reserved for members of the banking
syndicate (the “Bank Tranche”) and for MobilCom’s suppliers
(the “Supplier Tranche”). The TDIRA are listed on Eurolist by
Euronext Paris (international section) and were approved by
the Commission des Opérations de Bourse (French Securi-
ties Regulator) on February 24, 2003.
The TDIRA are redeemable to new France Telecom or-
dinary shares, at any time at the holders’ request or, under
certain conditions as described in the appropriate information
memorandum, at France Telecom’s initiative based on a ra-
tio of 503.4654 shares to one TDIRA for the Bank Tranche
(i.e. conversion price of 28.006 euros) and 405.7175 shares
to one TDIRA for the Supplier Tranche (i.e. conversion price
of 34.753 euros), as the initial ratio of 300 shares to one
TDIRA has been adjusted several times to protect bondhold-
ers’ rights, and may be further adjusted under the terms and
conditions set out in the information memorandum.
From January 1, 2006 until December 31, 2009, the inter-
est rate on the TDIRA was 5.25%. Since January 1, 2010,
the interest rate on the TDIRA has been 3-month Euribor +
2.5%.
If no dividend payment is voted in the Ordinary Share-
holders’ Meeting or no interim dividend payment is paid by
the Board of Directors during the 12 months preceding the
coupon payment, France Telecom can delay payment of the
coupon. The amount of interest due will itself bear interest
at the 12-month Euribor rate until the deferred payments are
made. This deferred interest must be paid in full—including
the related accrued interest—at the date of payment of the
coupon following any decision to pay a dividend or interim
dividend and before redemption of the TDIRA.
Taking into account redemptions made since their issue,
129,635 TDIRA remained outstanding at December 31, 2010,
including 111,905 for the Bank Tranche and 17,730 for the
Supplier Tranche, for a nominal amount of 1,828 million
euros.
The TDIRA are classified as hybrid instruments, with the
following breakdown at December 31, 2010:
• a liability component of 1,594 million euros recognized
at amortized cost;
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• an equity component, before deferred taxes, of 439
million euros. This component, calculated at inception,
does not vary over the lifetime of the instrument, with
the exception of redemptions.
The difference between the total nominal amount of the
TDIRA and the sum of the liability and equity components
therefore equals the amortized cost adjustment on the liabil-
ity component recognized since inception.
(In Millions of Euros) December 31, 2010 December 31, 2009 December 31, 2008
Number 129,635 129,635 230,382
Equity component, before deferred tax 439 439 780
Original liability component (a) 1,389 1,389 2,468
Nominal amount of TDIRA 1,828 1,828 3,248
Amortized cost adjustment, excluding accrued interest (b) 190 146 221
Accrued interest (c) 15 96 171
Total liability in statement of financial position (a) + (b) + (c) 1,594 1,631 2,860
Effective interest rate on the liability component 7.07% 7.77% 7.51%
Paid interest 140 206 220
Note 27. Other Information on Exposure to
Market Risks
27.3. Liquidity Risk Management (in part)
The France Telecom Group’s policy is that it must be able to
meet its upcoming loan repayments from available cash and
existing credit lines, without recourse to additional financing,
for at least the next 12 months.
Smoothing Debt Maturities
Debt maturities are spread consistently over the next years,
as evidenced by the average maturity of net debt excluding
TDIRAs, which was 8.5 years at the end of 2010 (7.4 years
at the end of 2009 and 7.5 years at the end of 2008).
The following table shows undiscounted future cash flows
for each financial liability shown on the statement of financial
position. The key assumptions used are:
• amounts in foreign currencies are translated at the year-
end closing rate;
• future variable-rate interest is based on the last fixed
coupon, except if a better estimate is available;
• as the perpetual bonds redeemable for shares (TDIRA)
are undated, redemptions of the nominal amount are
not dated. In addition, from January 1, 2010, interest
payable on the bonds switched to a variable rate over
an undetermined period of time (see Note 21.3). Ac-
cordingly, interest from that date other than for the first
period is no longer included, as including interest pay-
ments for the other periods would not provide relevant
information;
• the maturity dates of revolving credit facilities are the
contractual maturity dates.
Transfers of Financial Assets—Securitization
of Receivables
8.61
Sappi Limited (Sep 2010)
GROUP BALANCE SHEET (in part)
At September 2010
(US$ Million) Note 2010 2009
Assets
Current assets 2,531 2,430
Inventories 15 836 792
Trade and other receivables 16 888 858
Financial instruments 29 15 10
Cash and cash equivalents 792 770
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Accounting Policies (in part)
2.2. Summary of Accounting Policies (in part)
2.2.3. Financial Instruments (in part)
(iii) Subsequent Measurement (in part)
• Loans and receivables
Loans and receivables are carried at amortized cost, with
interest revenue recognized in profit and loss for the period
using the effective interest method.
IFRS ATT 8.61
646 IFRS Accounting Trends & Techniques
4.1. Operating Profit
(US$ Million) 2010 2009 2008
Silviculture costs (included within cost of
sales) 67 50 50
Leasing charges for premises 14 16 16
Leasing charges for plant and equipment 48 15 32
Remuneration paid other than to employees
of the company in respect of: 31 27 33
—technical services 12 11 15
—administration services 19 16 18
Auditors’ remuneration: 8 8 10
—audit and related services 7 6 6
—tax planning and tax advice 1 1 1
—acquisition and refinancing related
services(*) — 1 3
Government grants towards environmental
expenditure — (2) (1)
Research and development costs 25 31 34
Amortization 3 2 —
Cost on derecognition of loans and
receivables(**) 14 16 22
Directors’ remuneration
—executive directors—salaries and benefits 1 2 2
—non-executive directors—fees 1 1 1
(*) These costs have been capitalized.
(**) The cost on derecognition of trade receivables relates to the
derecognition of trade receivables related to the securitization
programme in South Africa and to the sale of letters of credit in
Hong Kong.
16. Trade and Other Receivables
(US$ Million) 2010 2009
Trade accounts receivable, gross 754 682
Allowance for credit losses (14) (15)
Trade accounts receivable, net 740 667
Prepayments and other receivables 148 191
888 858
Management rate the quality of the trade and other receiv-
ables, which are neither past due nor impaired, periodically
against its internal credit rating parameters. The quality of
these trade receivables is such that management believe no
impairment provision is necessary, except in situations where
they are part of individually impaired trade receivables.
The carrying amount of US$888 million (2009: US$858
million) represents the group’s maximum credit risk exposure
from trade and other receivables.
Prepayments and other receivables primarily represent
prepaid insurance and other sundry receivables.
2010 2009
Trade receivables (including securitized trade
receivables) to turnover (%) 15% 16%
16.1. Reconciliation of the Allowance for Credit Losses
2010 2009
Balance at beginning of year 15 5
Raised during the year 9 16
Released during the year (9) (6)
Foreign exchange currency translation effect (1) —
Balance at end of year 14 15
An allowance has been made for estimated irrecoverable
amounts from the sale of goods of US$14 million (2009:
US$15 million). This allowance has been determined by ref-
erence to specific customer delinquencies.
16.2. Analysis of Amounts Past Due
September 2010
The following provides an analysis of the amounts that are
past the due contractual maturity dates:
Not Impaired Impaired Total
Less than 7 days overdue 18 — 18
Between 7 and 30 days overdue 18 — 18
Between 30 and 60 days overdue 3 1 4
More than 60 days overdue 15 13 28
54 14 68
September 2009
The following provides an analysis of the amounts that are
past the due contractual maturity dates:
Not Impaired Impaired Total
Less than 7 days overdue 9 — 9
Between 7 and 30 days overdue 29 — 29
Between 30 and 60 days overdue 9 — 9
More than 60 days overdue 19 15 34
66 15 81
All amounts due which are beyond their contractual repay-
ment terms are reported to regional management on a regular
basis. Any provision for impairment is required to be approved
in line with the group limits of authority framework.
The group has a provision of US$14 million (2009: US$15
million) against trade receivables that are past due.
The group holds collateral of US$17 million (2009: US$17
million) against these trade receivables that are past due.
The group has granted facilities to customers to buy on
credit for the following amounts:
2010 2009
Less than US$0.5 million 331 332
Less than US$1 million but equal to or greater than
US$0.5 million 276 275
Less than US$3 million but equal to or greater than
US$1 million 557 495
Less than US$5 million but equal to or greater than
US$3 million 225 212
Equal to or greater than US$5 million 965 951
2,354 2,265
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16.3. Fair Value
The directors consider that the carrying amount of trade and
other receivables approximates their fair value.
16.4. Trade Receivables Pledged as Security
Trade receivables with a value of US$486 million (2009:
US$460 million) have been pledged as collateral for amounts
received from the banks in respect of the securitization pro-
gramme. The value of the associated liabilities at year end
amounted to US$447 million (2009: US$400 million). The
group is restricted from selling and repledging the trade re-
ceivables that have been pledged as collateral for the liability.
16.5. Off Balance Sheet Structures
Letters of Credit Discounting
To improve the group working capital, the group sells cer-
tain Letters of Credit to ABN AMRO Hong Kong and DBS
Bank (London) at the end of each financial month on a non-
recourse basis.
“Scheck-Wechsel”
The Scheck-Wechsel is a financial guarantee supplied by
Sappi to the bank of certain customers (trade receivables)
who wish to obtain a loan to finance early payment of specified
trade receivables (thereby benefiting from an early settlement
discount). By signing the Scheck-Wechsel, Sappi provides a
financial guarantee to the bank of the customer.
This financial guarantee contract is initially recognized at
fair value. At inception, the risk for Sappi having to reimburse
the bank is nil because there is no evidence that the customer
will not reimburse its loan to the bank. There is also no guar-
antee fee due by the bank and the Scheck-Wechsel is a short
term instrument (maximum 90 days). Therefore the fair value
is zero at inception. Subsequently, the financial guarantee
contract is measured at the higher of:
(i) the amount determined in accordance with IAS 37 Pro-
visions, Contingent Liabilities and Contingent Assets;
and
(ii) the amount initially recognized less any cumulative
amortization.
As no event of default has occurred, no provision has been set
up and the fair value at year end remains at zero. However,
according to IAS 37, a contingent liability of US$29 million
(2009: US$25 million) has been disclosed in this respect.
Trade Receivables Securitization
To improve our cash flows in a cost-effective manner, Sappi
Trading, Sappi Fine Paper Europe and Sappi Fine Paper
North America sell all eligible trade receivables on a non-
recourse basis to special purpose entities (SPEs) that are
owned and controlled by third party financial institutions.
These SPEs are funded with us but securitize assets on be-
half of their sponsors for a diverse range of unrelated parties.
We have a servicing agreement with the entities acquiring
our receivables, acting as servicers for the collection of cash
and administration of the trade receivables sold.
Sappi Southern Africa Securitization Facility
Sappi sells the majority of its ZAR receivables to Rand Mer-
chant Bank Limited, which issues commercial paper to fi-
nance the purchase of the receivables. Sappi does not guar-
antee the recoverability of any amounts, but shares propor-
tionately with Rand Merchant Bank Limited the credit risk of
each underlying receivable, after all recoveries, including in-
surance recoveries, with Sappi bearing 15% of such risk (and
Rand Merchant Bank Limited the remainder). Sappi adminis-
ters the collection of all amounts processed on behalf of the
bank that are due from the customer. The purchase price of
these receivables is adjusted dependent on the timing of the
payment received from the client. The rate of discounting that
is charged on the receivables is JIBAR (Johannesburg Inter
Bank Agreed Rate) plus a spread. This structure is currently
treated as an off balance sheet arrangement.
If this securitization facility were to be terminated, we would
discontinue further sales of trade receivables and would not
incur any losses in respect of receivables previously sold in
excess of the 15% mentioned above. There are a number of
events which may trigger termination of the facility, amongst
others, an amount of defaults above a specified level; terms
and conditions of the agreement not being met; or breaches of
various credit insurance ratios. The impact on liquidity varies
according to the terms of the agreement; generally however,
future trade receivables would be recorded on balance sheet
until a replacement agreement was entered into.
The total amount of trade receivables sold at the end
of September 2010 amounted to US$215 million (Septem-
ber 2009: US$171 million). Details of the securitization pro-
gramme at the end of fiscal 2010 and 2009 are disclosed in
the tables below:
Bank Currency Value Facility Discount Charges
2010
Rand Merchant Bank Limited ZAR ZAR 1,510 million Unlimited(*) Linked to 3 month JIBAR
2009
Rand Merchant Bank Limited ZAR ZAR 1,268 million Unlimited(*) Linked to 3 month JIBAR
(*) The facility in respect of the securitization facility is unlimited, but subject to the sale of qualifying receivables to the bank.
Details of the on balance sheet securitization facilities are
described in note 20.
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16.6 Analysis of Customers
A significant portion of the group’s sales and accounts receiv-
able are from major groups of customers. None of the group’s
major customers represented more than 10% of our sales dur-
ing the years ended September 2010 and September 2009.
Where appropriate, credit insurance has been taken out over
the group’s trade receivables.
None of the group’s other receivable financial instruments
represent a high concentration of credit risk because the
group has dealings with a variety of major banks and cus-
tomers world-wide.
The group has the following amounts due from single cus-
tomers:
2010 2009
No. of Customers US$ Million Percentage No. of Customers US$ Million Percentage
Greater than US$10 million 7 131 18% 6 82 12%
Between US$5 million
and US$10 million 13 81 11% 9 55 8%
Less than US$5 million 2,176 528 71% 2,519 530 80%
2,196 740 100% 2,534 667 100%
None of the trade receivables, with balances of equal to or
greater than US$5 million as at year end have breached their
contractual maturity terms. No impairment charges have been
recognized in respect of customers who owe the group more
than US$5 million.
Refer note 29 for further details on credit risk.
20. Interest-Bearing Borrowings
(US$ Million) 2010 2009 2008
Secured borrowings
—Mortgage and pledge over trade
receivables and certain assets (refer
note 24 for details of encumbered
assets) 1,605 1,849 468
—Capitalized lease liabilities (refer note
24 for details of encumbered assets) 50 71 29
Total secured borrowings(*) 1,655 1,920 497
Unsecured borrowings(*) 1,353 1,407 2,156
Total borrowings (refer note 29) 3,008 3,327 2,653
Less: Current portion included in current
liabilities 691 601 821
2,317 2,726 1,832
(*) Our September 2009 disclosure has been amended to correctly
reflect the split between secured and unsecured interest-bearing
borrowings and to reflect the classification set out in the detailed





Secured borrowings(**) 1,350 570 1,920
Unsecured borrowings 1,977 (570) 1,407
Total 3,327 — 3,327
(**) Mortgage and pledge over trade receivables and certain as-
sets of US$1,849 million was previously disclosed as US$1,321
million, and capitalized lease liabilities of US$71 million was pre-
viously disclosed as US$29 million.
The repayment profile of the interest-bearing borrowings is
as follows:






2015 (September 2009: thereafter) 7 342
Thereafter 224 —
3,008 3,327
(*) Included in the US$691 million reflected as payable in 2010
is US$447 million debt relating to securitization funding (2009:
US$400 million included in US$601 million) which has the char-
acter of a short-term revolving facility but is expected to run until
31 December 2011 under the existing contractual arrangements,
and the intention is to renew this arrangement well ahead of ma-
turity.
IFRS ATT 8.61
649Section 8: Financial Instruments and Related Disclosures
Capitalized Lease Liabilities
Finance leases are primarily for plant and equipment. Lease
terms generally range from 5 to 10 years with options to
make early settlements or renew at varying terms. At the time
of entering into capital lease agreements, the commitments
are recorded at their present value using applicable interest
rates. As of September 2010, the aggregate amounts of min-
imum lease payments and the related imputed interest under
capitalized lease contracts payable in each of the next five















Payable in the year ended September:
2010 — — — 23 (4) 19
2011 16 (5) 11 17 (3) 14
2012 17 (3) 14 18 (2) 16
2013 15 (2) 13 15 (2) 13
2014 6 (1) 5 6 (1) 5
2015 (September 2009: thereafter) 7 — 7 7 (1) 6
Total future minimum lease payments 61 (11) 50 86 (13) 73
Set out below are details of the more significant non-current






Outstanding Balance Sheet Value
Security/
Cession Expiry Financial Covenants
Redeemable Bonds







August 2014 No financial covenants







August 2014 No financial covenants
Public bond US$ Fixed US$500 million US$513 million (2,3,6) Unsecured June 2012 No financial covenants
Public bond US$ Fixed US$221 million US$222 million (2,3,6) Unsecured June 2032 No financial covenants
Public bond ZAR Fixed ZAR1,000 million ZAR1,000 million Unsecured June 2013 No financial covenants
Public bond ZAR Fixed ZAR1,000 million ZAR1,000 million Unsecured October 2011 No financial covenants
Public bond ZAR Fixed ZAR498 million ZAR498 million (6) Unsecured June 2012 No financial covenants
Private placement bond ZAR Fixed ZAR134 million ZAR134 million Unsecured November 2012 No financial covenants
Private placement bond ZAR Fixed ZAR133 million ZAR133 million Unsecured January 2013 No financial covenants
Private placement bond ZAR Fixed ZAR33 million ZAR33 million Unsecured March 2013 No financial covenants
Private placement bond ZAR Fixed ZAR61 million ZAR61 million (6) Unsecured December 2013 No financial covenants
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Cession Expiry Financial Covenants
Secured Loans
State Street Bank EUR Variable EUR231 million EUR231 million Trade receivables Revolving facility EBITDA to net interest
and net debt to
EBITDA(5)
State Street Bank US$ Variable US$61 million US$61 million Trade receivables Revolving facility EBITDA to net interest
and net debt to
EBITDA(5)
State Street Bank US$ Variable US$75 million US$75 million Trade receivables Revolving facility EBITDA to net interest










April 2014 EBITDA to net interest










June 2013 EBITDA to net interest
and net debt to
EBITDA(5)
Capitalized Leases
Fortum EUR Variable EUR22 million EUR22 million Plant and
equipment
November 2012 No financial covenants





EUR Variable EUR58 million EUR58 million(1) Unsecured December 2010 No financial covenants
Nedbank ZAR Fixed ZAR350 million ZAR350 million(1) Unsecured January 2011 No financial covenants
Nedbank ZAR Fixed ZAR397 million ZAR397 million Unsecured March 2014 Gearing ratio/interest &
dividend cover(4)
Peritum Trading ZAR Fixed ZAR13 million ZAR13 million(1) Unsecured June 2014 No financial covenants
Royal Bank of Scotland EUR Fixed EUR12 million EUR12 million Unsecured December 2010 No financial covenants
Local Currency Million US$ Million





(1) The value outstanding equals the total facility available.
(2) In terms of the agreement, limitations exist on liens, sale and leaseback transactions and mergers and consolidation. Sappi Limited must
maintain a majority holding in Sappi Papier Holding GmbH Group.
(3) Sappi Papier Holding GmbH, Sappi Limited or Sappi International SA may at any time redeem the June 2012 and 2032 public bonds (the
“Securities”) in whole or in part at a redemption price equal to the greater of (i) 100% of the principal amount of the Securities to be redeemed
and (ii) a make-whole amount based upon the present values of remaining payments at a rate based upon yields of specified US treasury
securities plus 25 basis points, with respect to the 2012 Securities, and 30 basis points, with respect to the 2032 Securities, together with,
in each case, accrued interest on the principal amount of the securities to be redeemed to the date of redemption.
(4) The financial covenant relates to the financial position of Sappi Southern Africa (Pty) Ltd., a wholly owned subsidiary of Sappi Limited.
(5) Financial covenants relate to the Sappi Limited Group.
(6) The principal value of the loans/bonds corresponds to the amount of the facility, however, the outstanding amount has been adjusted by
the discounts paid upfront and the fair value adjustments relating to hedge accounting.
(7) USD Fixed rates have been swapped into EUR fixed rates. These swaps are subject to hedge accounting in order to reduce as far as
possible the foreign exchange exposure.
(8) This amount includes debt of US$300 million that is swapped into Euro.
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A detailed reconciliation of total interest-bearing borrowings
has been performed in note 29.
Other Restrictions
As is the norm for bank loan debt, a portion of Sappi Limited’s
financial indebtedness is subject to cross default provisions.
Breaches in bank covenants in certain subsidiaries, if not
corrected in time, might result in a default in group debt, and
in this case, a portion of Sappi Limited consolidated liabilities
might eventually become payable on demand.
During fiscal 2010 and 2009 we were in compliance with
the financial covenants relating to all loans payable. Regular
monitoring of compliance with applicable covenants occurs. If
there is a possible breach of a financial covenant in the future,
negotiations would commence with the applicable institutions
before such breach occurs.
Borrowing Facilities Secured by Trade Receivables
The group undertakes several trade receivable securitization
programs due to the cost effectiveness of such structures.
These structures, with the exception of the South African
scheme, are accounted as on balance sheet, with a corre-
sponding liability (external loan) being recognized and corre-
sponding interest is recognized as finance cost.
The trade receivables are legally transferred, however most
of the market risk (foreign exchange risk and interest rate risk)
and the credit risk is retained by Sappi. As a consequence,
based on the risks and rewards evaluation, these securitized
receivables do not qualify for de-recognition under IAS 39.
Further detail of the value of trade receivables pledged as
security for these loans is included in note 16.
Sappi Fine Paper North America
Sappi sells the majority of its US$ receivables to Galleon
Capital LLC on a non-recourse basis. Credit enhancement
includes a 3% deferred purchase price plus a letter of credit in
the amount of US$18 million that relates to the uninsured por-
tion of those obligors with concentrations above 3% (Sappi,
as servicer of the receivables, is responsible for the collec-
tion of all amounts that are due from the customer). The rate
of discounting charged on the receivables is LIBOR (London
Inter Bank Offered Rate) plus a margin for receivables to cus-
tomers located in Organization for Economic Co-operation
and Development ("OECD") countries.
Sappi Fine Paper Europe and Sappi Trading
Under a combined securitization arrangement for Sappi Fine
Paper Europe and Sappi Trading, Sappi sells receivables
to Galleon Capital LLC on a non-recourse basis. Credit en-
hancement is calculated by deducting a deferred purchase
price of 14%. Sappi is responsible for the collection of all
amounts that are due from the customer. The rate of dis-
counting that is charged on the receivables is LIBOR (Lon-
don Inter Bank Offered Rate) plus a margin for receivables to
customers located in OECD countries plus a further margin
for receivables to customers located in non-OECD countries.
Unutilized Facilities
The group monitors its availability of funds on a weekly ba-
sis. The group treasury committee determines the amount of
unutilized facilities to determine the headroom which it cur-
rently operates in. The net cash balances included in current
assets and current liabilities are included in the determination
of the headroom available.
Unutilized Committed Facilities
(US$ Million) Currency Interest Rate 2010 2009
Syndicated loan(*) EUR Variable (EURIBOR) 282 307
(*) Syndicated loan with a consortium of banks with JP Morgan Europe Limited as facility agent with a remaining revolving facility available of
EUR209 million, which is subject to financial covenants relating to the Sappi Limited Group and is secured by the same assets as the public
bonds maturing in 2014.
These committed facilities represent amounts that the group
could utilize. The syndicated loan facility matures in May
2012.
We have paid a total commitment fee of US$7 million (2009:
US$0.8 million) in respect of the syndicated loan facility.
Unutilized Uncommitted Facilities
(US$ Million) Currency Interest Rate 2010 2009
Held by:
Southern Africa ZAR Variable (JIBAR) 417 445
Group Treasury—Europe EUR Variable (EURIBOR) — 54
417 499
Total unutilized facilities (committed and
uncommitted) excluding cash 699 806
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Fair Value
The fair value of all interest-bearing borrowings is disclosed
in note 29 on financial instruments.
29. Financial Instruments (in part)
The group’s financial instruments consist mainly of cash and
cash equivalents, accounts receivable, certain investments,
accounts payable, borrowings and derivative instruments.
Sensitivity Analysis: Interest Rate Risk—in Case of a Credit
Rating Downgrade of SAPPI
The following table shows the sensitivity of securitization debt
to changes in the group’s own credit rating. The securitization
agreement stipulates that if the company were downgraded
below our current grading, an additional margin would be
agreed between the bank and the company. In this respect
we assumed a hypothetical increase of 1.5%.
Please note that the change in value of the securitization
debt is included in the sensitivity analysis of floating rate debt
in the table below:
Securitization in Europe
and Hong Kong Notional
Impact on Income Statement
of a One Notch Downgrade
Below BB- Credit Rating
(US$ Million)
Europe 311 5
Hong Kong 75 1
Sub-total 386 6
Impact calculated on total
portfolio amounts to 1.55%
The pricing of the securitization contracts in Europe and Hong
Kong would be impacted as set out in the table above if the
company were to be downgraded below the current rating.
Based on the existing agreement, the US securitization ar-
rangement would not be impacted by a possible downgrade,
as there are sufficient other credit enhancements to mitigate
the co-mingling risk.
The table below shows the sensitivity of certain fixed rate
debt to changes in the group’s own credit rating. The agree-
ments of these specific external loans stipulate that if the
company were downgraded below our current grading, an
additional margin would be added to the contractual funding
rate.










Commitment fee on unused
revolving credit facility 282 1
Interest on utilised bank
syndicated loan 432 3
Interest on utilised bank
loan 34 —
Sub-total 748 4
Impact calculated on total
portfolio amounts to 0.53%
Categories According
to IAS 39
















Interest-bearing borrowings 2,317 — — 2,317 2,317 2,612
Bank loans payable (>1 year)—including syndicated loans — — 103 103 107
Bonds — — 1,796 1,796 2,052
Financial leasing liabilities — — 39 39 34
Secured loans — — 379 379 419
Current Liabilities
Interest-bearing borrowings 691 — — 691 691 732
Bank loans payable (<1 year)—including syndicated loans — — 96 96 96
Current portion of other non-current loans payable — — 62 62 62
Financial leasing liabilities — — 13 13 13
Secured loans (<1 year) — — 148 148 182
Securitization debt — — 372 372 379
Overdraft
Bank overdrafts (<3 months) 5 — — 5 5 5
Derivative financial instruments 3 — 3 — 3 3
Trade and other payables 1,271 280 — 991 991 991
Accruals 278 — 249 249 249
Accounts payable to associates — — 1 1 1
Other accounts payable—current 2 — 741 741 741
(*) This refers to items that are outside the scope of IAS 39.
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Derivatives and Hedging
8.62
Siemens Aktiengesellschaft (Sep 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION (in part)
As of September 30, 2010 and 2009




Cash and cash equivalents 14,108 10,159
Available-for-sale financial assets 11 246 170
Trade and other receivables 12 14,971 14,449
Other current financial assets(1) 13 2,610 2,407
Inventories 14 14,950 14,129
Income tax receivables 790 612
Other current assets 15 1,258 1,191
Assets classified as held for disposal 4 715 517
Total current assets 49,648 43,634
Goodwill 16 15,763 15,821
Other intangible assets 17 4,969 5,026
Property, plant and equipment 18 11,748 11,323
Investments accounted for using the equity method 19 4,724 4,679
Other financial assets(1) 20 11,296 10,525
Deferred tax assets 10 3,940 3,291
Other assets 739 627
Total assets 102,827 94,926
Liabilities and Equity
Current liabilities
Short-term debt and current maturities of long-term debt 23 2,416 698
Trade payables 7,880 7,593
Other current financial liabilities(1) 21 1,401 1,600
Current provisions 25 5,138 4,191
Income tax payables 1,816 1,936
Other current liabilities 22 21,794 20,311
Liabilities associated with assets classified as held for disposal 4 146 157
Total current liabilities 40,591 36,486
Long-term debt 23 17,497 18,940
Pension plans and similar commitments 24 8,464 5,938
Deferred tax liabilities 10 577 776
Provisions 25 3,332 2,771
Other financial liabilities(1) 990 706
Other liabilities 26 2,280 2,022
Total liabilities 73,731 67,639
(1) Due to the retrospective application of an amended accounting pronouncement in fiscal 2010, certain derivatives, not qualifying for hedge
accounting, were reclassified from current to non-current (see Note 2 to the Consolidated Financial Statements).
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CONSOLIDATED STATEMENTS OF INCOME
(in part)
For the fiscal years ended September 30, 2010, 2009 and
2008
(In millions of €, per share amounts in €)
Note 2010 2009 2008
Interest income 9 2,161 2,136 2,404
Interest expense 9 (1,890) (2,213) (2,208)
Other financial income (expense), net 9 (336) (433) (74)
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (in part)
For the fiscal years ended September 30, 2010, 2009 and
2008
(In millions of €)
Note 2010 2009 2008
Derivative financial instruments 31, 32 (149) 329 (237)
(1) Amortization, depreciation and impairments, in fiscal 2010, includes €1,145 related to the goodwill impairment at Healthcare’s Diagnostics
Division. In fiscal 2009, (income) losses from investments include €1,634 related to an impairment of our equity method investment NSN.
Impairments, net of reversals of impairments, on non-current available-for-sale investments are reclassified retrospectively to conform to
the current year presentation.
(2) Pension related interest income (expense) is reclassified retrospectively to conform to the current year presentation.
(3) Investments include equity instruments either classified as non-current available-for-sale financial assets, accounted for using the equity
method or classified as held for disposal. Purchases of investments include certain loans to investments accounted for using the equity
method.
(4) Includes effects from the retrospective application of an amended accounting pronouncement in fiscal 2010, which resulted in the reclas-
sification of certain derivatives, not qualifying for hedge accounting, from current to non-current. In addition, the prior-year presentation
related to derivatives qualifying for cash flow hedge accounting was reclassified to conform to the current year presentation.
(5) In fiscal 2010, the current portion of long-term provisions and accruals was reclassified. Prior-year amounts were adjusted to conform to
the current year presentation.
(6) Following a change in accounting pronouncements with the beginning of fiscal year 2010 additions to assets held for rental in operating
leases, in previous years reported under additions to intangible assets and property, plant and equipment, were retrospectively reclassified
from net cash provided by (used in) investing activities to net cash provided by (used in) operating activities. For further information, see
Notes to the Consolidated Financial Statements.
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CONSOLIDATED STATEMENTS OF CHANGES IN
EQUITY
For the fiscal years ended September 30, 2010, 2009 and
2008
(In millions of €)
Total Comprehensive Income































Balance at October 1, 2009 2,743 5,946 22,646 (1,294) 76 161 21,589 (3,632) 26,646 641 27,287
Net income — — 3,899 — — — 3,899 — 3,899 169 4,068
Other comprehensive
income, net of tax — — (2,053)(1) 1,176 19 (149) (1,007) — (1,007) 43 (964)(2)
Dividends — — (1,388) — — — (1,388) — (1,388) (183) (1,571)
Issuance of common stock
and share-based payment — 60 (19) — — — (19) — 41 — 41
Re-issuance of treasury
stock — (20) — — — — — 259 239 — 239
Other changes in equity — — (87) 3 — — (84) — (84) 80 (4)
Balance at September 30,
2010 2,743 5,986 22,998 (115) 95 12 22,990 (3,373) 28,346 750 29,096
(1) Retained earnings includes actuarial gains and losses on pension plans and similar commitments of €(2,053), €(1,248) and €(1,716), respectively, in the fiscal
years ended September 30, 2010, 2009 and 2008.
(2) In the fiscal year ended September 30, 2010, Other comprehensive income includes non controlling interests of €(1) relating to Actuarial gains and losses on
pension plans and similar commitments, €44 relating to Currency translation differences, €—relating to Available-for-sale financial assets and €—relating to
Derivative financial instruments.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Summary of Significant Accounting Policies (in part)
Financial instruments—A financial instrument is any contract
that gives rise to a financial asset of one entity and a financial
liability or equity instrument of another entity. Financial assets
of the Company mainly include cash and cash equivalents,
available-for-sale financial assets, trade receivables, loans
receivable, finance lease receivables and derivative financial
instruments with a positive fair value. Cash and cash equiv-
alents are not included within the category available-for-sale
financial assets as these financial instruments are not sub-
ject to fluctuations in value. Siemens does not make use of
the category held to maturity. Financial liabilities of the Com-
pany mainly comprise notes and bonds, loans from banks,
commercial paper, trade payables, finance lease payables
and derivative financial instruments with a negative fair value.
Siemens does not make use of the option to designate finan-
cial assets or financial liabilities at fair value through profit or
loss at inception (Fair Value Option). Based on their nature,
financial instruments are classified as financial assets and
financial liabilities measured at cost or amortized cost and
financial assets and financial liabilities measured at fair value
and as receivables from finance leases. See Notes 31 and
32 for further information.
Financial instruments are recognized on the Statement of
Financial Position when Siemens becomes a party to the con-
tractual obligations of the instrument. Regular way purchases
or sales of financial assets, i.e. purchases or sales under a
contract whose terms require delivery of the asset within the
time frame established generally by regulation or convention
in the marketplace concerned, are accounted for at the trade
date.
Initially, financial instruments are recognized at their fair
value. Transaction costs directly attributable to the acqui-
sition or issue of financial instruments are only recognized
in determining the carrying amount, if the financial instru-
ments are not measured at fair value through profit or loss.
Finance lease receivables are recognized at an amount equal
to the net investment in the lease. Subsequently, financial as-
sets and liabilities are measured according to the category—
cash and cash equivalents, available-for-sale financial as-
sets, loans and receivables, financial liabilities measured at
amortized cost or financial assets and liabilities classified as
held for trading—to which they are assigned.
Financial liabilities—Siemens measures financial liabilities,
except for derivative financial instruments, at amortized cost
using the effective interest method.
Derivative financial instruments—Derivative financial in-
struments, such as foreign currency exchange contracts and
interest rate swap contracts, are measured at fair value.
Derivative instruments are classified as held for trading un-
less they are designated as hedging instruments, for which
hedge accounting is applied. Changes in the fair value of
derivative financial instruments are recognized periodically
either in net income or, in the case of a cash flow hedge, in
Other comprehensive income, net of applicable deferred in-
come taxes. Certain derivative instruments embedded in host
contracts are also accounted for separately as derivatives.
Fair value hedges—The carrying amount of the hedged
item is adjusted by the gain or loss attributable to the hedged
risk. Where an unrecognized firm commitment is designated
as the hedged item, the subsequent cumulative change in its
fair value is recognized as a separate financial asset or liability
with corresponding gain or loss recognized in net income.
For hedged items carried at amortized cost, the adjustment
is amortized such that it is fully amortized by maturity of the
hedged item. For hedged firm commitments the initial carrying
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amount of the assets or liabilities that result from meeting
the firm commitments are adjusted to include the cumulative
changes in the fair value that were previously recognized as
separate financial assets or liabilities.
Cash flow hedges—The effective portion of changes in the
fair value of derivative instruments designated as cash flow
hedges are recognized in Other comprehensive income, net
of applicable deferred income taxes, and any ineffective por-
tion is recognized immediately in net income. Amounts ac-
cumulated in equity are reclassified into net income in the
same periods in which the hedged item affects net income,
see Note 32 for further information.
Prior year information—The presentation of certain prior
year information has been reclassified to conform to the cur-
rent year presentation. Specifically, in May 2008, the IASB
issued a standard for improvements to International Finan-
cial Reporting Standards. In the Consolidated Statements of
Cash Flow, according to an amendment of IAS 7, Statement
of Cash Flows, cash flows to manufacture or acquire assets
held for rental and subsequent sale in the course of the or-
dinary activities are presented as cash flows from operating
activities. Previously, cash outflows in the context of operat-
ing leases have been presented as cash flows from investing
activities. The amended IAS 7 is effective for annual periods
beginning on or after January 1, 2009. Siemens applied the
amendment retrospectively in the Statement of Cash Flow
in fiscal year 2010. The amended IAS 1, applied retrospec-
tively in fiscal 2010, resulted in the reclassification of certain
derivative financial instruments, not qualifying for hedge ac-
counting, from current to non-current. As of September 30,
2008, €227 were reclassified from Other current financial as-
sets to Other financial assets and €334 from Other current
financial liabilities to Other financial liabilities. As of Septem-
ber 30, 2009, the reclassification from Other current financial
assets and liabilities to Other financial assets and liabilities
amounted to €507 and €555, respectively. Beginning in fiscal
2010, the Company presents total interest income and ex-
pense separately in the Consolidated Statements of Income
in accordance with Part II of the Annual Improvements Project
2008 of the IASB. Additionally, pension-related interest in-
come (expense) as well as impairments, net of reversals of
impairments, on investments accounted for using the equity
method and non-current available-for-sale investments are
reclassified retrospectively in the Consolidated Statements
of Cash Flow to conform to the current year presentation.
9. Interest Income, Interest Expense and Other
Financial Income (Expense), Net (in part)
Year Ended September 30
2010 2009 2008
Pension related interest income 1,396 1,303 1,510
Interest income, other than pension 765 833 894
Interest income 2,161 2,136 2,404
Pension related interest expense (1,461) (1,530) (1,374)
Interest expense, other than pension (429) (683) (834)
Interest expense (1,890) (2,213) (2,208)
Income (expense) from available-for-sale
financial assets, net 44 (12) 89
Miscellaneous financial income (expense),
net (380) (421) (163)
Other financial income (expense), net (336) (433) (74)
Miscellaneous financial income (expense), net, in fiscal 2010,
2009 and 2008, comprises gains (losses) of €(313), €(200)
and €(81), respectively, as a result of the accretion of pro-
visions and the increase (decrease) in the discount rate, as
well as expenses as a result of allowances and write offs
of finance receivables, net of reversals of €(63), €(162) and
€(55), respectively. It also includes gains and losses related
to derivative financial instruments.
13. Other Current Financial Assets
September 30
2010 2009
Derivative financial instruments 949 782
Loans receivable 740 786
Other 921 839
2,610 2,407
20. Other Financial Assets
September 30
2010 2009
Receivables from finance leases, see
Note 12 3,094 3,147
Loans receivable 3,032 2,949
Derivative financial instruments 2,693 2,089
Trade receivables from sale of goods
and services 531 453
Available-for-sale financial assets 486 391
Other 1,460 1,496
11,296 10,525
Available-for-sale financial assets include interests in other
companies that are recorded at cost or at fair value if reliably
measurable. Regarding Derivative financial instruments see
Note 31 and Note 32. Loans receivable primarily relate to
long-term loan transactions of SFS. Loans receivable include
a shareholder loan to NSN granted in fiscal 2009, see Note
39.
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21. Other Current Financial Liabilities
September 30
2010 2009
Derivative financial instruments, see
Notes 31 and 32 442 454
Accrued interest expense 327 325
Other 632 821
1,401 1,600
27. Equity (in part)
Other Comprehensive Income
The changes in the other comprehensive income including








Pretax Effect Net Pretax Effect Net Pretax Effect Net
Unrealized holding gains (losses) on
available-for-sale financial assets 41 (4) 37 46 (8) 38 (135) 10 (125)
Reclassification adjustments for (gains)
losses included in net income (24) 6 (18) 44 (10) 34 1 2 3
Net unrealized gains (losses) on
available-for-sale financial assets 17 2 19 90 (18) 72 (134) 12 (122)
Unrealized gains (losses) on derivative
financial instruments (163) 39 (124) 335 (101) 234 (124) 33 (91)
Reclassification adjustments for (gains)
losses included in net income (36) 11 (25) 138 (43) 95 (212) 66 (146)
Net unrealized gains (losses) on derivative
financial instruments (199) 50 (149) 473 (144) 329 (336) 99 (237)
Foreign-currency translation differences 1,220 — 1,220 (506) — (506) (313) — (313)
Actuarial gains and losses on pension plans
and similar commitments (2,889) 835 (2,054) (1,692) 443 (1,249) (1,721) 2 (1,719)
Other comprehensive income (1,851) 887 (964) (1,635) 281 (1,354) (2,504) 113 (2,391)
31. Additional Disclosures on Financial Instruments
The following table presents the carrying amounts of each




Loans and receivables 24,749 24,119
Cash and cash equivalents 14,108 10,159
Derivatives designated in a hedge
accounting relationship 2,232 1,895
Financial assets held for trading 1,410 976
Available-for-sale financial assets 732 561
43,231 37,710
Financial liabilities:
Financial liabilities measured at
amortized cost 28,922 28,539
Financial liabilities held for trading 1,098 864
Derivatives designated in a hedge
accounting relationship 164 134
30,184 29,537
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The following table presents the fair values and carrying
amounts of financial assets and financial liabilities measured
at cost or amortized cost:
September 30, 2010 September 30, 2009
Carrying Carrying
Fair Value Amount Fair Value Amount
Financial assets measured at cost or amortized cost
Trade and other receivables(1) 14,111 14,111 13,951 13,951
Receivables from finance leases 4,879 4,879 4,885 4,885
Cash and cash equivalents 14,108 14,108 10,159 10,159
Other non-derivative financial assets 5,759 5,759 5,283 5,283
Available-for-sale financial assets(2) — 410 — 335
Financial liabilities measured at cost or amortized cost
Notes and bonds 17,343 17,300 16,373 16,502
Trade payables 7,899 7,899 7,617 7,617
Loans from banks and other financial indebtedness 2,439 2,442 2,941 2,942
Obligations under finance leases 169 171 191 194
Other non-derivative financial liabilities 1,110 1,110 1,284 1,284
(1) This caption consists of (i) €13,186 and €12,711 short-term trade receivables (except for receivables from finance leases) in fiscal 2010 and
fiscal 2009, respectively, see Note 12, (ii) €531 and €453 trade receivables from sale of goods and services (non current) in fiscal 2010 and
fiscal 2009, respectively, see Note 20 as well as (iii) €394 and €787 receivables included in Other financial assets in fiscal 2010 and fiscal
2009, respectively, see Note 20.
(2) This caption consists of equity instruments classified as available-for-sale, for which a fair value could not be reliably measured and which
are recognized at cost.
The fair values of cash and cash equivalents, current re-
ceivables, trade payables, other current financial liabilities,
commercial paper and borrowings under revolving credit fa-
cilities approximate their carrying amount largely due to the
short-term maturities of these instruments.
Long-term fixed-rate and variable-rate receivables, includ-
ing receivables from finance leases, are evaluated by the
Company based on parameters such as interest rates, spe-
cific country risk factors, individual creditworthiness of the
customer, and the risk characteristics of the financed project.
Based on this evaluation, allowances for these receivables
are taken into account. As of September 30, 2010 and 2009,
the carrying amounts of such receivables, net of allowances,
approximate their fair values.
The fair value of quoted notes and bonds is based on price
quotations at the period-end date. The fair value of unquoted
notes and bonds, loans from banks and other financial in-
debtedness, obligations under finance leases as well as other
non-current financial liabilities is estimated by discounting fu-
ture cash flows using rates currently available for debt of
similar terms and remaining maturities.
Financial instruments categorized as financial assets and




Financial assets measured at fair value
Available-for-sale financial assets 322 226
Derivative financial instruments 3,642 2,871
Not designated in a hedge accounting
relationship 1,314 820
In connection with fair value hedges 1,936 1,474
Foreign currency exchange derivatives 9 10
Interest rate derivatives 1,927 1,464
In connection with cash flow hedges 296 421
Foreign currency exchange derivatives 295 413
Interest rate derivatives — 8
Commodity derivatives 1 —
Embedded derivatives 96 156
Financial liabilities measured at fair value
Derivative financial instruments 1,262 998
Not designated in a hedge accounting
relationship 998 731
In connection with fair value hedges 11 4
Foreign currency exchange derivatives 11 4
Interest rate derivatives — —
In connection with cash flow hedges 153 130
Foreign currency exchange derivatives 137 130
Interest rate derivatives 16 —
Commodity derivatives — —
Embedded derivatives 100 133
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Fair values for available-for-sale financial assets are derived
from quoted market prices in active markets.
The Company limits default risks in derivative instruments
by a careful counterparty selection. Derivative instruments
are principally transacted with financial institutions with in-
vestment grade credit ratings. The fair valuation of derivative
instruments at Siemens incorporates all factors that market
participants would consider, including an adequate consid-
eration of the counterparties’ credit risks. This assures that
the counterparties’ credit risks themselves as well as any
changes in the counterparties’ credit worthiness are included
in the fair valuation of the Company’s derivative instruments
and thus reflected in the Consolidated Financial Statements.
The exact calculation of fair values for derivative financial
instruments depends on the specific type of instruments:
Derivative interest rate contracts—The fair values of deriva-
tive interest rate contracts (e.g. interest rate swap agree-
ments) are estimated by discounting expected future cash
flows using current market interest rates and yield curves
over the remaining term of the instrument. Interest rate op-
tions are valued on the basis of quoted market prices or on
estimates based on option pricing models.
Derivative currency contracts—The fair value of forward
foreign exchange contracts is based on forward exchange
rates. Currency options are valued on the basis of quoted
market prices or on estimates based on option pricing models.
Derivative commodity contracts—The fair value of com-
modity swaps is based on forward commodity prices. Com-
modity options are valued on the basis of quoted market
prices or on estimates based on option pricing models.
Credit default swaps—The fair value of credit default swaps
is calculated by comparing discounted expected future cash
flows using current bank conditions with discounted expected
future cash flows using contracted conditions.
In determining the fair values of the derivative financial
instruments, no compensating effects from underlying trans-
actions (e.g. firm commitments and anticipated transactions)
are taken into consideration.
The following table allocates financial assets and financial
liabilities measured at fair value to the three levels of the fair
value hierarchy, as defined in IFRS 7.
September 30, 2010
Level 1 Level 2 Level 3 Total
Financial assets measured at fair value
Available-for-sale financial assets 322 — — 322
Derivative financial instruments — 3,642 — 3,642
Total 322 3,642 — 3,964
Financial liabilities measured at fair value
Derivative financial instruments — 1,262 — 1,262
September 30, 2009
Level 1 Level 2 Level 3 Total
Financial assets measured at fair value
Available-for-sale financial assets 226 — — 226
Derivative financial instruments — 2,871 — 2,871
Total 226 2,871 — 3,097
Financial liabilities measured at fair value
Derivative financial instruments — 998 — 998
The levels of the fair value hierarchy and its application to our
financial assets and financial liabilities are described below:
Level 1: quoted prices in active markets for identical assets
or liabilities;
Level 2: inputs other than quoted prices that are observable
for the asset or liability, either directly (i.e. as prices) or
indirectly (i.e. derived from prices); and
Level 3: inputs for the asset or liability that are not based
on observable market data.
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Cash and cash equivalents (34) 7
Available-for-sale financial assets 16 (44)
Loans and receivables (87) (419)
Financial liabilities measured at
amortized cost (283) 302
Financial assets and financial liabilities
held for trading (665) 34
Net gains (2009: losses) on available-for-sale financial as-
sets include impairment losses, gains or losses on derecog-
nition and the ineffective portion of fair value hedges. For the
amount of unrealized gains or losses on available-for-sale fi-
nancial assets recognized directly in equity during the fiscal
year and the amount removed from equity and recognized
in net income for the fiscal year see Other Comprehensive
Income in Note 27.
Net losses on loans and receivables contain changes in
valuation allowances, gains or losses on derecognition as
well as recoveries of amounts previously written-off.
Net losses (2009: gains) on financial liabilities measured at
amortized cost are comprised of gains or losses from dere-
cognition and the ineffective portion of fair value hedges.
Net losses (2009: gains) on financial assets and financial
liabilities held for trading consist of changes in the fair value
of derivative financial instruments (including interest income
and expense), for which hedge accounting is not applied.
The amounts presented include foreign currency gains and
losses from the realization and valuation of the financial as-
sets and liabilities mentioned above.
Collateral
Siemens holds securities as collateral on reverse repurchase
agreements and is permitted to sell or re-pledge these securi-
ties. As of September 30, 2010 and 2009 the fair value of the
collateral held amounted to €2,042 and €716, respectively.
As of September 30, 2010, the right to sell or re-pledge the
collateral has not been exercised. As of September 30, 2010
and 2009, the carrying amount of financial assets Siemens
has pledged as collateral amounted to €537 and €482, re-
spectively.
32. Derivative Financial Instruments and Hedging
Activities
As part of the Company’s risk management program, a va-
riety of derivative financial instruments are used to reduce
risks resulting primarily from fluctuations in foreign currency
exchange rates, interest rates and commodity prices, as well
as to reduce credit risks. For additional information on the
Company’s risk management strategies, including the use of
derivative financial instruments to mitigate or eliminate certain
of these risks, see also Note 33.
The fair values of each type of derivative financial instru-
ments are as follows:
September 30, 2010 September 30, 2009
Asset Liability Asset Liability
Foreign currency exchange contracts 858 423 735 462
Interest rate swaps and combined interest/currency swaps 2,317 416 1,764 204
Commodity swaps 78 11 43 23
Embedded derivatives 96 100 156 133
Options 289 308 170 172
Other 4 4 3 4
3,642 1,262 2,871 998
Foreign Currency Exchange Risk Management
As described in Note 33, the Company employs various
derivative financial instruments in order to mitigate or elim-
inate certain foreign-currency exchange risks.
Derivative Financial Instruments not Designated in a Hedging
Relationship
The Company manages its risks associated with fluctua-
tions in foreign-currency-denominated receivables, payables,
debt, firm commitments and anticipated transactions primarily
through a Company-wide portfolio approach. This approach
concentrates the associated Company-wide risks centrally,
and various derivative financial instruments, primarily for-
eign currency exchange contracts and options, are utilized
to minimize such risks. Such a strategy does not qualify for
hedge accounting treatment under IAS 39, Financial Instru-
ments: Recognition and Measurement. Accordingly, all such
derivative financial instruments are recorded at fair value
on the Consolidated Statements of Financial Position, either
as Other current financial assets/liabilities or Other financial
assets/liabilities, and changes in fair values are charged to
net income (loss).
The Company also has foreign-currency derivative instru-
ments, which are embedded in certain sale and purchase
contracts denominated in a currency other than the functional
currency of the significant parties to the contract and other
than a currency which is commonly used in the economic en-
vironment in which the contract takes place. Gains or losses
relating to such embedded foreign-currency derivatives are
reported in Cost of goods sold and services rendered in the
Consolidated Statements of Income.
Hedging Activities
The Company’s operating units applied hedge accounting for
certain significant anticipated transactions and firm commit-
ments denominated in foreign currencies. Specifically, the
Company entered into foreign exchange contracts to reduce
the risk of variability of future cash flows resulting from fore-
casted sales and purchases and firm commitments result-
ing from its business units entering into long-term contracts
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(project business) and standard product business which are
denominated primarily in U.S. dollar.
Cash flow hedges—Changes in fair value of forward ex-
change contracts that were designated as foreign-currency
cash flow hedges are recorded as follows: the portion of the
fair value changes that is determined to be an effective hedge
is recognized in Other comprehensive income, whereas the
ineffective portion of the fair value changes is recognized in
profit or loss. As of September 30, 2010 and 2009, the in-
effective portion that was immediately recorded in profit or
loss amounted to €(15) and €6, respectively. In fiscal 2010,
2009 and 2008, net gains and losses of €1, €(6), and €5,
respectively, were reclassified from Other comprehensive in-
come into Cost of goods sold and services rendered because
the occurrence of the related hedged forecasted transaction
was no longer probable. The development of Other compre-
hensive income resulting from changes in fair value of these
transactions as well as from amounts that were removed and
included in profit or loss is presented in Note 27.
It is expected that €87 of net deferred gains in Other com-
prehensive income will be reclassified into Cost of goods
sold and services rendered in fiscal 2011, when the hedged
forecasted foreign-currency denominated transaction affects
profit or loss.
As of September 30, 2010, the maximum length of time
over which the Company is hedging its future cash flows
associated with foreign-currency forecasted transactions is
195 months.
Fair value hedges—As of September 30, 2010 and 2009,
the Company hedged firm commitments using forward ex-
change contracts that were designated as foreign-currency
fair value hedges of future sales related primarily to the Com-
pany’s project business and, to a lesser extent, purchases. As
of September 30, 2010 and 2009, the hedging transactions
resulted in the recognition of financial assets of €17 and €13,
respectively, and financial liabilities of €14 and €23, respec-
tively, for the hedged firm commitments. Changes in fair value
of forward exchange contracts resulted in losses of €15 and
gains of €2, respectively. These effects relate to gains from
the valuation of firm commitments of €15 and losses of €2,
respectively. Changes in fair value of the forward exchange
contracts as well as of the firm commitments were recorded
in Cost of goods sold and services rendered.
Interest Rate Risk Management
Interest rate risk arises from the sensitivity of financial as-
sets and liabilities to changes in market rates of interest. The
Company seeks to mitigate this risk by entering into inter-
est rate derivative financial instruments such as interest rate
swaps (see also Note 33), options and, to a lesser extent,
cross-currency interest rate swaps and interest rate futures,
as well as forward rate agreements.
Derivative Financial Instruments not Designated in a
Hedging Relationship
Starting with the first quarter of fiscal 2010, the interest rate
risk management relating to the Group excluding SFS busi-
ness has been realigned with the financial market environ-
ment. Under this portfolio-based approach, derivative finan-
cial instruments are used to manage interest risk actively
relative to a benchmark, consisting of medium-term interest
rate swaps and forward rates. Compared to the former in-
terest rate overlay management, the benchmark approach
may result in longer interest periods of derivatives and higher
nominal volumes. The interest rate management relating to
the SFS business remains to be managed separately, consid-
ering the term structure of SFS’ financial assets and liabilities
on a portfolio basis. Both approaches do not qualify for hedge
accounting treatment under IAS 39. Accordingly, all interest
rate derivative instruments used in this relation are recorded
at fair value, either as Other current financial assets/liabilities
or Other financial assets/liabilities, and changes in the fair
values are charged to Financial income (expense), net. Net
cash receipts and payments relating to interest rate swaps
used in offsetting relationships are also recorded in Financial
income (expense), net.
Fair Value Hedges of Fixed-Rate Debt Obligations
Under the interest rate swap agreements outstanding during
the years ended September 30, 2010 and 2009, the Com-
pany agrees to pay a variable rate of interest multiplied by a
notional principle amount, and receives in return an amount
equal to a specified fixed rate of interest multiplied by the
same notional principal amount. These interest rate swap
agreements offset an impact of future changes in interest
rates on the fair value of the underlying fixed-rate debt obli-
gations. The interest rate swap contracts are reflected at fair
value in the Company’s Consolidated Statements of Finan-
cial Position and the related portion of fixed-rate debt being
hedged is reflected at an amount equal to the sum of its car-
rying amount plus an adjustment representing the change in
fair value of the debt obligations attributable to the interest
rate risk being hedged. Changes in the fair value of interest
rate swap contracts and the offsetting changes in the adjusted
carrying amount of the related portion of fixed-rate debt being
hedged are recognized as Financial income (expense), net in
the Consolidated Statements of Income. Adjustments in the
carrying amount of the debt obligations resulted in a loss of
€498 and a loss of €848, respectively. During the same pe-
riod, the related swap agreements resulted in a gain of €521
and a gain of €931, respectively. Therefore, the net effect rec-
ognized in Financial income (expense), net, representing the
ineffective portion of the hedging relationship, amounted to
€23 and €83 in fiscal 2010 and 2009, respectively. Net cash
receipts and payments relating to such interest rate swap
agreements are recorded as interest income and expense,
respectively.
The Company had interest rate swap contracts to pay vari-
able rates of interest of an average of 0.8 percent, 0.9 percent
and 4.5 percent as of September 30, 2010, 2009 and 2008,
respectively and received fixed rates of interest (average rate
of 5.3 percent, 5.4 percent and 5.6 percent as of September
30, 2010, 2009 and 2008, respectively). The notional amount
of indebtedness hedged as of September 30, 2010, 2009 and
2008 was €15,299, €15,565 and €11,766, respectively. This
changed 91 percent, 94 percent and 89 percent of the Com-
pany’s underlying notes and bonds from fixed interest rates
into variable interest rates as of September 30, 2010, 2009
and 2008, respectively. The notional amounts of these con-
tracts mature at varying dates based on the maturity of the
underlying hedged items. The net fair value of interest rate
swap contracts (excluding accrued interest) used to hedge
indebtedness as of September 30, 2010, 2009 and 2008 was
€1,665, €1,224 and €291, respectively.
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Fair Value Hedges of Available-for-Sale Financial Assets
In fiscal 2008, the Company had applied fair value hedge ac-
counting for certain fixed-rate available-for-sale financial as-
sets. However, fair value hedge accounting was terminated at
the beginning of fiscal 2008, since the majority of the hedged
item was derecognized. There was no such hedging relation-
ship in fiscal 2010 and 2009. To offset the impact of future
changes in interest rates on the fair value of the underly-
ing fixed-rate available-for-sale financial assets, interest rate
swap agreements had been entered into. As long as hedge
accounting was applied, the interest rate swap contracts and
the related portion of the available-for-sale financial assets
were reflected at fair value in the Company’s Consolidated
Statements of Financial Position. Changes in the fair value of
interest rate swap contracts and the offsetting changes in fair
value of the available-for-sale financial assets being hedged
attributable to the interest rate risk being hedged were recog-
nized as adjustments to the line item Financial income (ex-
pense), net in the Consolidated Statements of Income. The
net effect recognized in Financial income (expense), net, rep-
resenting the ineffective portion of the hedging relationship,
amounted to €— in fiscal 2010.
Cash Flow Hedges of Revolving Term Deposits
In fiscal, 2010 and 2009, the Company applied cash flow
hedge accounting for a revolving term deposit. To offset the
effect of future changes in interest payments of this revolv-
ing term deposit, the Company had entered into an interest
rate swap agreement to pay a variable rate of interest and
to receive a specified fixed rate of interest. When the swap
contract ended in June 2010, cash flow hedge accounting
was terminated. As long as hedge accounting was applied,
the interest rate swap contract was reflected at fair value and
the effective portion of changes in fair value were recorded
in Other comprehensive income; any ineffective portion of
changes in fair value was recognized in profit or loss. In fiscal
2010 and 2009, the cash flow hedges of revolving term de-
posits did not result in any ineffective portion to be recognized
in profit or loss. Net cash receipts and payments relating to
such interest rate swap agreements were recorded as interest
income and expense, respectively.
Cash Flow Hedges of a Variable-Rate Term Loan
As of September 30, 2010, the Company applied cash flow
hedge accounting for 50 percent of a variable-rate U.S. dollar
term loan. To benefit from the low interest rates in the U.S., the
Company entered into interest rate swap agreements to pay
a fixed rate of interest and to receive in return a variable rate
of interest. These interest rate swap agreements offset the
effect of future changes in interest payments to be made for
the underlying variable-rate term loan. The interest rate swap
contracts are reflected at fair value and the effective portion of
changes in fair value of the interest rate swap contracts that
were designated as cash flow hedges are recorded in Other
comprehensive income; any ineffective portion of changes in
fair value is recognized in profit or loss. In fiscal 2010, the cash
flow hedges of the variable-rate term loan did not lead to any
ineffective portion to be recognized in profit or loss. Net cash
receipts and payments relating to such interest rate swap
agreements are recorded as interest income and expense,
respectively.
Commodity Price Risk Management
As described in Note 33, the Company employs commodity
derivatives in order to mitigate or eliminate price risks from
the procurement of commodities.
Derivative Financial Instruments not Designated in a
Hedging Relationship
The Company partly uses a portfolio approach to manage
the Company-wide risks associated with fluctuations in com-
modity prices from firm commitments and anticipated trans-
actions by entering into commodity swaps and commodity op-
tions. As such, a strategy does not qualify for hedge account-
ing treatment under IAS 39, Financial Instruments: Recog-
nition and Measurement, the derivative financial instruments
are recorded at fair value on the Consolidated Statements
of Financial Position, either as Other current financial as-
sets/liabilites or Other financial assets/liabilities, and changes
in fair values are charged to net income (loss).
Cash Flow Hedging Activities
As of June 2010, the Company’s corporate procurement ap-
plies cash flow hedge accounting for certain firm commit-
ments to purchase copper. Changes in fair value of the swaps
which are used in the hedging relationship are recorded as fol-
lows: the portion of the fair value changes that is determined
to be an effective hedge is recognized in Other comprehen-
sive income, whereas the ineffective portion of the fair value
changes is recognized in profit or loss. As of September 30,
2010, there was no ineffective portion that had to be recorded
in profit or loss. In fiscal 2010, no gains or losses were reclas-
sified from Other comprehensive income into Cost of goods
sold and services rendered because the occurrence of the re-
lated hedged forecasted transaction was no longer probable.
The development of Other comprehensive income resulting
from changes in fair value of these transactions as well as
from amounts that were removed and included in profit or
loss is presented in Note 27.
It is expected that €1 of net deferred gains in Other com-
prehensive income will be reclassified into Cost of goods sold
and services rendered in fiscal 2011, when the consumption
of the hedged commodity purchases is recognized as Cost
of goods sold and services rendered. As of September 30,
2010, the maximum length of time over which the Company
is hedging its future commodity purchases is 12 months.
33. Financial Risk Management (in part)
Market Risks
Siemens’ financial risk management is an integral part of how
to plan and execute its business strategies. Siemens’ finan-
cial risk management policy is set by the Managing Board.
Siemens’ organizational and accountability structure requires
each of the respective managements of Siemens Sectors,
Cross-Sector Businesses, Regional Clusters and Corporate
Units to implement financial risk management programs that
are tailored to their specific industries and responsibilities,
while being consistent with the overall policy established by
the Managing Board.
Increasing market fluctuations may result in significant
cash-flow and profit volatility risk for Siemens. Its worldwide
operating business as well as its investment and financing
activities are affected by changes in foreign exchange rates,
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interest rates, and commodity and equity prices. To optimize
the allocation of the financial resources across the Siemens
segments and entities, as well as to secure an optimal re-
turn for its shareholders, Siemens identifies, analyzes and
proactively manages the associated financial market risks.
The Company seeks to manage and control these risks pri-
marily through its regular operating and financing activities,
and uses derivative instruments when deemed appropriate.
Within the various methodologies to analyze and manage
risk, Siemens implemented a system based on parametric
variance-covariance Value at Risk (VaR). The VaR methodol-
ogy provides a quantification of the market risk based on his-
torical volatilities and correlations of the different risk factors
under the assumptions of the parametric variance-covariance
Value at Risk model. The VaR figures are calculated based
on
• historical volatilities and correlations,
• a ten day holding period and
• a 99.5 percent confidence level
for all defined financial risks.
Actual results that are included in the Consolidated State-
ments of Income may differ substantially from VaR figures
due to fundamental conceptual differences. The Consolidated
Statements of Income are prepared in accordance with IFRS.
The VaR figures result from a pure financial calculation model
which calculates a potential financial loss which does not ex-
ceed stated VaR within ten days with a probability of 99.5
percent. The concept of VaR is used for internal manage-
ment of the Treasury activities.
Although VaR is an important tool for measuring market
risk, the assumptions on which the model is based rise to
some limitations including the following. A 10-day holding pe-
riod assumes that it is possible to dispose of positions within
this period. This is considered to be a realistic assumption
in almost all cases but may not be the case in situations in
which there is severe market illiquidity for a prolonged period.
A 99.5 percent confident level does not reflect losses that may
occur beyond this level. Even within the model used there is
a 0.5 percent statistical probability that losses could exceed
the calculated VaR. The use of historical data as a basis for
estimating the statistic behavior of the relevant markets and
finally determining the possible range of the future outcomes
out of this statistic behavior may not always cover all possible
scenarios, especially those of an exceptional nature.
Any market sensitive instruments, including equity and
interest bearing investments, that our Company’s pension
plans hold are not included in the following quantitative and
qualitative disclosure. For additional information see Note 24.
SFS holds a minor trading portfolio which is subject to tight
limits. As of September 30, 2010, and 2009, respectively, it
had a value at risk (VaR) close to zero.
Foreign Currency Exchange Rate Risk
Transaction Risk and Currency Management
Siemens’ international operations expose the Company to
foreign-currency exchange risks, especially between the U.S.
dollar and the euro, in the ordinary course of business. The
Company employs various strategies discussed below involv-
ing the use of derivative financial instruments to mitigate or
eliminate certain of those exposures.
Foreign exchange rate fluctuations may create unwanted
and unpredictable earnings and cash flow volatility. Each
Siemens unit conducting business with international coun-
terparties that leads to future cash flows denominated in a
currency other than its functional currency is exposed to the
risk from changes in foreign exchange rates.
Foreign currency exposure is partly balanced by purchas-
ing of goods, commodities and services in the respective cur-
rencies as well as production activities and other contributions
along the value chain in the local markets.
Operating units are prohibited from borrowing or investing
in foreign currencies on a speculative basis. Intercompany fi-
nancing or investments of operating units are preferably done
in their functional currency or on a hedged basis.
Siemens has established a foreign exchange risk manage-
ment system that has an established track record for years.
Each Siemens unit is responsible for recording, assessing,
monitoring, reporting and hedging its foreign currency trans-
action exposure. The binding guideline for Siemens Divisions
and entities provides the concept for the identification and
determination of the single net foreign currency position and
commits the units to hedge it in a narrow band: at least 75
percent but no more than 100 percent of their net foreign cur-
rency position. In addition, the guideline provides a framework
of the organizational structure necessary for foreign currency
exchange management, proposes hedging strategies and de-
fines the hedging instruments available to the entities: forward
contracts, currency put and call options and stop-loss orders.
Where it is not contrary to country specific regulations, hedg-
ing activities of the Siemens units are transacted internally
with Corporate Treasury. Hedging transactions with external
counterparties in the global financial markets are carried out
under these limitations by Corporate Treasury. This includes
hedging instruments which qualify for hedge accounting.
Siemens has a Company-wide portfolio approach which
generates a benefit from any potential off-set of divergent
cash flows in the same currency, as well as optimized trans-
action costs. For additional information relating to the effect
of this Company-wide portfolio approach on the Consolidated
Financial Statements, as well as for a discussion of hedging
activities employed to mitigate or reduce foreign currency ex-
change risks, see Note 32.
The VaR for foreign exchange rates is calculated by aggre-
gation of the net foreign exchange rate exposure. The figures
disclosed here are based on the net foreign exchange po-
sitions after hedging. As of September 30, 2010 the foreign
exchange rate risk based on historical volatilities and corre-
lations, a ten day holding period and a confidence level of
99.5 percent resulted in a VaR of €18 compared to a VaR
of €12 in the year before. Changes in euro values of future
cash flows due to volatile exchange rates might influence
the unhedged portion of revenues, but would also affect the
unhedged portion of cost of materials. Future changes in the
foreign exchange rates can impact sales prices and may lead
to margin changes, the extent of which is determined by the
matching of foreign currency revenues and expenses.
Siemens defines foreign exchange rate exposure generally
as items of the Consolidated Statement of Financial Position
in addition to firm commitments which are denominated in
foreign currencies, as well as foreign currency denominated
cash inflows and cash outflows from anticipated transactions
for the following three months. This foreign currency exposure
is determined based on the respective functional currencies
of the exposed Siemens’ entities.
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Effects of Currency Translation
Many Siemens subsidiaries are located outside the euro
zone. Since the financial reporting currency of Siemens is
the euro, the financial statements of these subsidiaries are
translated into euro for the preparation of the Consolidated
Financial Statements of Siemens. To consider the effects of
foreign exchange translation risk in the risk management,
the assumption is that investments in foreign-based oper-
ations are permanent and that reinvestment is continuous.
Effects from currency fluctuations on the translation of net
asset amounts into euro are reflected in the Company’s con-
solidated equity position.
Interest Rate Risk
Siemens’ interest rate risk exposure is mainly related to debt
obligations like bonds, loans, commercial paper programs
and interest-bearing deposits and investments. Siemens
seeks to manage this risk through the use of derivative instru-
ments which allow it to hedge fair value changes by swapping
fixed rates of interest into variable rates of interest. To opti-
mize the Company’s position with regard to interest income
and interest expenses and to manage the overall financial
interest rate risk with respect to valuation risk affecting profit
and loss and economic risk of changing interest rates, Corpo-
rate Treasury performs a comprehensive corporate interest
rate risk management, which manages the interest rate risk
relating to the SFS business and to the remaining group sep-
arately. For additional information see Note 32.
Where it is not contrary to country-specific regulations,
all Siemens segments and entities generally obtain any re-
quired financing through Corporate Treasury in the form of
loans or intercompany clearing accounts. The same concept
is adopted for deposits of cash generated by the units.
Assuming historical volatilities and correlations, a ten day
holding period and a confidence level of 99.5 percent the
interest rate VaR was €107 as of September 30, 2010, in-
creasing from the comparable value of €33 as of September
30, 2009. This interest rate risk results primarily from euro
and U.S. dollar denominated long-term fixed rate debt obliga-
tions and interest-bearing investments. The increase of VaR
is due primarily to the realignment of the interest rate manage-
ment starting with the first quarter of fiscal 2010. Compared to
the former interest rate overlay management, the benchmark
approach resulted in longer interest periods of derivatives
and higher nominal volumes. For additional information see
Note 32.
Commodity Price Risk
Siemens’ production operations expose the Company to vari-
ous commodity price risks in the ordinary course of business.
Especially in the Industry and Energy Sector a continuous
supply of copper is necessary for the operating activities.
Commodity price risk fluctuations may create unwanted and
unpredictable earnings and cash flow volatility. The Company
employs various strategies discussed below involving the use
of derivative financial instruments to mitigate or eliminate cer-
tain of those exposures.
Siemens has established a commodity price risk manage-
ment system to reduce earnings and cash flow volatility. Each
Siemens unit is responsible for recording, assessing, moni-
toring, reporting and hedging its risks from forecasted and
pending commodity purchase transactions (commodity price
risk exposure). The binding guideline for Siemens Divisions
and entities developed by the Corporate Supply Chain Man-
agement department provides the concept for the identifi-
cation and determination of the commodity price risk expo-
sure and commits the units to hedge it in a narrow band: 75
percent—100 percent of the commodity price risk exposure
in the product business for the current and the subsequent
quarter and 95 percent—100 percent of the commodity price
risk exposure in the project business after receipt of order.
The aggregated commodity price risk exposure is hedged
with external counterparties through derivative financial hedg-
ing instruments by Corporate Treasury. Financial hedging in-
struments designated for hedge accounting are directly en-
tered into with external counterparties. Additionally, Siemens
has a Company-wide portfolio approach which generates a
benefit from optimizing the Company’s position of the overall
financial commodity price risk. For additional information re-
lating to the effect of this Company-wide portfolio approach
on the Consolidated Financial Statements, as well as for a
discussion of hedging activities employed to mitigate or re-
duce commodity price risks, see Note 32.
Using historical volatilities and correlations, a ten day hold-
ing period and a confidence level of 99.5 percent, the VaR for
commodity derivatives was €47 as of September 30, 2010,
decreasing from the comparable value of €68 as of Septem-
ber 30, 2009. However, the economic VaR, which comprises
the net position of commodity derivates and the commodity
purchase transactions with price risk, was €8 as of Septem-
ber 30, 2010.
Equity Price Risk
Siemens’ investment portfolio consists of direct and indi-
rect investments in publicly traded companies held for pur-
poses other than trading. These participations result mainly
from strategic partnerships or compensation from M&A-
transactions; indirect investments are mainly transacted for
financial reasons.
The equity investments are monitored based on their cur-
rent market value, affected primarily by the fluctuations in the
volatile technology-related markets worldwide. The market
value of Siemens’ portfolio in publicly traded companies as
of September 30, 2010 was €138 compared to €141 as of
September 30, 2009.
Based on historical volatilities and correlations, a ten day
holding period and a confidence level of 99.5 percent, the VaR
as of September 30, 2010 of Siemens’ equity investments
was €13 compared to €21 the year before, meaning that the
equity price risk has decreased over the last year.
Liquidity Risk
Liquidity risk results from the Company’s potential inability
to meet its financial liabilities, e.g. for the settlement of its
financial debt or for ongoing cash requirements from oper-
ating activities. Beyond effective working capital and cash
management, Siemens mitigates liquidity risk by arranged
borrowing facilities with highly rated financial institutions, via
a medium-term notes program and via an established global
commercial paper program. For further information on short-
and long-term debt see Note 23.
In addition to the above mentioned sources of liquidity,
Siemens constantly monitors funding options available in the
capital markets, as well as trends in the availability and costs
of such funding, with a view to maintaining financial flexibility
and limiting repayment risks.
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The following table reflects all contractually fixed pay-offs
for settlement, repayments and interest resulting from recog-
nized financial liabilities. It includes expected net cash out-
flows from derivative financial liabilities which are in place as
per September 30, 2010. Such expected net cash outflows
are determined based on each particular settlement date of
an instrument. The amounts disclosed are undiscounted net
cash outflows for the respective upcoming fiscal years, based
on the earliest date on which Siemens could be required to
pay. Cash outflows for financial liabilities (including interest)
without fixed amount or timing are based on the conditions
existing at September 30, 2010.
Year Ended September 30
2013 to 2016 and
2011 2012 2015 Thereafter
Non-derivative financial liabilities
Notes and bonds 2,778 3,166 4,588 9,874
Loans from banks 328 46 2,026 13
Other financial indebtedness 27 21 63 38
Obligations under finance leases 57 21 41 73
Trade payables 7,880 12 5 2
Other financial liabilities 499 59 85 9
Derivative financial liabilities 535 296 222 56
The risk implied from the values shown in the table above,
reflects the one-sided scenario of cash outflows only. Obli-
gations under finance leases, trade payables and other fi-
nancial liabilities mainly originate from the financing of as-
sets used in our ongoing operations such as property, plant,
equipment and investments in working capital—e.g. invento-
ries and trade receivables. These assets are considered in
the Company’s overall liquidity risk management. To monitor
existing financial assets and liabilities as well as to enable
an effective controlling of future risks, Siemens has estab-
lished a comprehensive risk reporting covering its worldwide
business units.
The balanced view of liquidity and financial indebtedness
is stated in the calculation of the Net debt. Net debt results
from total debt less total liquidity. Total debt comprises Short-
term debt and current maturities of long-term debt as well
as Long-term debt, as stated on the Consolidated State-
ments of Financial Position. Total debt comprises Notes and
bonds, Loans from banks, Obligations under finance leases
and Other financial indebtedness such as commercial paper.
Total liquidity refers to the liquid financial assets we had avail-
able at the respective period-end dates to fund our business
operations and to pay for near-term obligations. Total liquid-
ity comprises Cash and cash equivalents as well as current
Available-for-sale financial assets, as stated on the Consol-
idated Statements of Financial Position. Management uses
the Net debt measure for internal corporate finance manage-
ment, as well as for external communication with investors,
analysts and rating agencies.
September 30
2010 2009
Short-term debt and current maturities
of long-term debt 2,416 698
Long-term debt 17,497 18,940
Total debt 19,913 19,638
Cash and cash equivalents 14,108 10,159
Available-for-sale financial assets 246 170
Total liquidity 14,354 10,329
Net debt (Total debt less Total liquidity) 5,560 9,309
Siemens’ capital resources consist of a variety of short- and
long-term financial instruments including, but not limited to,
loans from financial institutions, commercial paper, medium-
term notes and bonds. In addition, other capital resources
consist of liquid resources such as Cash and cash equiva-
lents, future cash flows from operating activities and current
Available-for-sale financial assets.
Siemens’ capital requirements include, among others,
scheduled debt service, regular capital spending, ongoing
cash requirements from operating, Corporate Treasury and
SFS financing activities, dividend payments, pension plan





SECTION 9: BUSINESS COMBINATIONS∗
IFRS 3, BUSINESS COMBINATIONS
IFRSs Overview and Comparison
to U.S. GAAP
Author’s Note
Improvements to IFRSs, issued May 2010, amended
International Financial Reporting Standard (IFRS) 3,
Business Combinations, with respect to the following
issues:
• Transition requirements for contingent consider-
ation from a business combination that occurred
before the effective date of the revised IFRS
• Measurement of noncontrolling interests
• Un-replaced and voluntarily replaced share-based
payment awards
These amendments are effective for annual reporting
periods beginning on or after 1 July 2010, with early
application permitted. Given the issue date of these
amendments, it is unlikely than any survey company
would apply these amendments in its 2010 financial
statements. See author’s notes in this section for addi-
tional information about these clarifications.
9.01 As a result of the second phase of the joint project be-
tween the International Accounting Standards Board (IASB)
and the Financial Accounting Standards Board (FASB), the
IASB issued a revised IFRS 3 in January 2008. The first phase
of this project resulted in the issuance of the original IFRS 3 in
2004 and reflected the IASB’s conclusion that most business
combinations should be accounted for using the acquisition
method. The second phase had the objective of reaching the
same conclusions as FASB with respect to the application
of the acquisition method. Although the IASB and FASB
reached similar conclusions on most matters, several signif-
icant differences between the two standards remain.
9.02 IFRS 3 established two important changes in terminol-
ogy, including the following:
• Acquisition method replaced purchase method.
• Noncontrolling interest replaced minority interest.
9.03 IFRS 3 establishes principles for recognition and mea-
surement of identifiable assets acquired, liabilities assumed,
and any noncontrolling interest in the acquired entity, as well
as any goodwill acquired in the business combination or any
gain from a bargain purchase. IFRS 3 also establishes dis-
closure requirements aimed at enabling users of the financial
statements to adequately evaluate the nature and financial
effects of the business combination.
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
issued as of 1 January 2011.
9.04 IFRS 3 is effective for business combinations with an
acquisition date on or after the beginning of the first annual re-
porting period beginning on or after 1 July 2009. Early appli-
cation is permitted. Application of IFRS 3 before 1 July 2009,
requires disclosure of that fact and also requires application
of International Accounting Standard (IAS) 27, Consolidated
and Separate Financial Statements, as amended in 2008, at
the same time. (See section 1, “General Topics and Related
Disclosures,” for more information on IAS 27.) Among other
significant provisions, the amendments previously described
to IFRS 3 replaced the term purchase method, which was
previously used to describe the method of accounting for
business combinations, with the term acquisition method.
The IASB concluded that a business combination should be




9.05 IFRS 3 applies to a transaction or other event that meets
the definition of a business combination, defined in IFRSs as
a transaction or other event in which an acquirer obtains
control of one or more businesses. IFRS 3 requires the use
of the acquisition method and identification of one of the
combining entities as the acquirer. The acquirer is the entity
that obtains control of the other entities (acquirees). IFRS 3
does not apply to any of the following transactions:
• Formation of a joint venture
• Acquisition of an asset or a group of assets that does
not constitute a business
• Combination of entities or businesses under common
control, as it is described in paragraphs B1–B4 of ap-
pendix B, “Application Guidance,” of IFRS 3
9.06 The fundamental difference between the current IFRS 3
and the former IFRS 3 is that the acquiring entity should mea-
sure each identifiable asset acquired and liability assumed at
their acquisition date fair value rather than at an allocated
amount of the cost of the transaction.
9.07 IFRS 3 permits an entity to measure the noncontrolling
interest in the acquiree at either fair value or its proportionate
share of the acquiree’s net identifiable assets. If the noncon-
trolling interest is measured at fair value, its carrying amount
includes its proportionate share of the recognized goodwill.
Author’s Note
Improvements to IFRSs, issued in May 2010 and effec-
tive for annual reporting periods beginning on or after
1 July 2010, clarifies the measurement of the non-
controlling interest. For each business combination, an
acquirer should measure, at the acquisition date, com-
ponents of any noncontrolling interests in the acquiree
that are present ownership interests and that entitle
their holders to a proportionate share of the entity’s net
assets in the event of liquidation at either
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a. fair value or
b. the present ownership instruments’ proportionate
share in the recognized amounts of the acquiree’s
identifiable net assets.
All other components of noncontrolling interests shall
be measured at their acquisition date fair values, unless
another measurement basis is required by IFRSs.
9.08 Limited exceptions exist to these general recognition
and measurement principles for certain assets and liabilities.
These exceptions include the following:
• Classify leases and insurance contracts based on the
contracts’ terms at their inception rather than their ac-
quisition date, as necessary to apply other IFRSs sub-
sequently.
• Recognize contingent liabilities assumed that consti-
tute a present obligation and can be measured reliably,
even if it is not probable that an outflow of resources
embodying economic benefits will be required to settle
the obligation.
• Measure other assets and liabilities that fall within the
scope of IAS 12, Income Taxes; IAS 19, Employee
Benefits; IFRS 2, Share-based Payment; and IFRS 5,
Non-current Assets Held for Sale and Discontinued Op-
erations in accordance with those standards and not at
fair value.
Author’s Note
Improvements to IFRSs, issued May 2010 and effec-
tive for annual reporting periods beginning on or after
1 July 2010, clarifies the measurement of share-based
payment transactions. This amendment requires an ac-
quirer to measure at the acquisition date a liability
or equity instrument related to share-based payment
transactions of the acquiree or the replacement of an
acquiree’s share-based payment awards transactions
with share-based payment awards transactions of the
acquirer, in accordance with the method in IFRS 2.
• Measure reacquired rights based on the remaining con-
tractual term of the related contract and indemnifi-
cation assets on the same basis as the indemnified
item, subject to a valuation allowance for uncollectible
amounts.
9.09 An entity should recognize the difference between the
sum of the fair values of the consideration transferred, the
noncontrolling interest, any previously held equity interest
in the acquiree, and the net identifiable assets acquired, mea-
sured in accordance with this standard, either as goodwill or,
in certain circumstances, as a gain on a bargain purchase.
9.10 IFRS 3 eliminated the concept of negative goodwill.
Prior to these revisions, an entity initially recognized the
identifiable assets acquired and liabilities assumed (net as-
sets acquired) at cost by allocating the consideration paid
using relative fair values. When the consideration paid was
more than the total fair value of the net assets acquired, the
entity recognized the difference as goodwill. When the con-
sideration paid was less than the total fair value, the entity
allocated the difference and proportionately reducing carry-
ing values. IFRS 3 now requires an entity to recognize the
net assets acquired initially at fair value. Therefore, when the
consideration paid is less than the fair value of the net assets,
an entity recognizes this difference in profit or loss on the
acquisition date and refers to this difference as a gain on a
bargain purchase.
9.11 Paragraphs B19–B27 in appendix B of IFRS 3 include
application guidance on accounting for reverse acquisitions
in which the entity that issues securities (the legal acquirer)
is identified as the acquiree for accounting purposes. IFRS
3 requires the accounting acquiree to meet the definition
of a business in order for the business combination to be
accounted for as a reverse acquisition. IFRS 3 requires the
accounting acquirer to measure the acquisition date fair value
of the consideration that it transferred for its interest in the
accounting acquiree based on the number of equity interests
that the legal subsidiary would have had to issue to give
the owners of the legal parent the same percentage equity
interest in the combined entity that results from the reverse
acquisition. The accounting acquirer uses the fair value of
the number of equity interests calculated in this way as the




Although IFRS 3 is the result of a convergence project
between IASB and FASB, differences between IFRS
3 and Financial Accounting Standards Board (FASB)
Accounting Standards Codification (ASC) 805, Busi-
ness Combinations, remain. The text of IFRS 3 in-
cludes a detailed comparison of the differences be-
tween the two standards. This section only describes
several key recognition and measurement differences.
9.12 Unlike IFRS 3, FASB ASC 805-20-30-1 requires an
entity to measure the noncontrolling interest in the acquired
entity at the acquisition date fair value on initial recognition.
No alternative measurement is permitted.
9.13 Additionally, measurement differences exist between
IFRSs and FASB ASC 805-20-30 even when the boards
reached the same conclusions because there are differences in
the measurement requirements of other standards (for exam-
ple, deferred tax assets and employee benefit obligations).
Disclosure requirements also can differ either because the
entities within the scope of IFRS 3 are different from those
entities subject to the comparable guidance under FASB ASC
805 or disclosure requirements are different for the various
types of entities. For example, unlike FASB ASC 805-10-
15-4, IFRS 3 does not provide a scope exception for not-
for-profit entities that elect to prepare financial statements in
accordance with IFRSs.
9.14 Like IFRS 3, an entity should not adjust assets and
liabilities that arose from business combinations whose ac-
quisition dates preceded the application of FASB ASC 805.
9.15 FASB ASC 805-40 provides more guidance than IFRSs
on reverse acquisitions. Like IFRSs, FASB ASC 805-40-
25-1 requires that the accounting acquiree must meet the
definition of a business. FASB ASC 805-40-30-2 prescribes
the identical measurement of the acquisition date fair value
of the consideration transferred, as described in paragraph
9.11.
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Presentation
IFRSs
9.16 IFRS 3 does not contain separate presentation require-
ments for normal business acquisitions beyond those found
in IAS 1, Presentation of Financial Statements. However,
because the consolidated financial statements following a
reverse acquisition are issued under the name of the legal
parent (accounting acquiree), appendix B of IFRS 3 requires
the entity to describe in the notes to the consolidated finan-
cial statements a continuation of the financial statements of
the legal subsidiary (accounting acquirer), with a retroactive
adjustment of the accounting acquirer’s legal capital to re-
flect the legal capital of the accounting acquiree. IFRS 3 also
requires the legal parent to present comparative information,
which is also retroactively adjusted to reflect the legal capital
of the legal parent (accounting acquiree).
U.S. GAAP
9.17 Like IFRSs, FASB ASC 805-10 does not include spe-
cific presentation requirements for normal business acquisi-
tion. Presentation requirements in FASB ASC 8084-40-45




Although an entity should apply IFRS 3 prospectively,
some disclosures regarding changes in accounting poli-
cies required by IAS 8, Accounting Policies, Changes
in Accounting Estimates and Errors, are relevant.
IFRSs
9.18 Prior to the 2008 revision, IFRS 3 had the following
three disclosure objectives:
• Disclose information that permits evaluation of the na-
ture and financial effect of business combinations that
occurred during the reporting period or after the re-
porting date but before the financial statements were
issued.
• Disclose information that permits evaluation of gains,
losses, error corrections, and other adjustments related
to business combinations that were recognized in the
current period.
• Disclose information that permits evaluation of changes
in the carrying amount of goodwill during the period.
9.19 The 2008 revisions to IFRS 3 resulted in the latter two
objectives being combined into one objective to disclose in-
formation that permits evaluation of adjustments related to
business combinations recognized during the current report-
ing period.
9.20 Disclosure requirements that remain unchanged in the
2008 revisions to IFRS 3 include information about the nature
of the combination including the following:
• Name and description of the acquiree
• Acquisition date
• Percentage of voting equity interests acquired
• Primary reasons for the business combination and a
description of how the acquirer obtained control of the
acquiree
9.21 Additional disclosures, including those resulting from
the 2008 revisions to IFRS 3, include the following:
• Acquisition date fair value of the total consideration
transferred.
• Acquisition date fair value of each major class of con-
sideration (for example, cash, other assets, liabilities
assumed, and equity instruments transferred).
• Amounts recognized for each major class of assets ac-
quired and liabilities assumed.
• Information about contingent liabilities recognized and,
if not recognized for lack of measurement reliability,
the reasons why the contingency could not be measured
reliably.
• Goodwill expected to be tax deductible.
• Descriptions for assets and liabilities recognized sepa-
rately from the business combination.
• Amounts of any gains on bargain purchases, the line
item in which gain is reported, and the reasons why
combination resulted in a gain.
• Noncontrolling interest, such as the following:
— Amounts of noncontrolling interest, if any.
— Measurement basis used.
— If the measurement basis is fair value, information
about valuation models used and key model inputs.
• Information about combinations achieved in stages, in-
cluding the amount of equity interest held before the
acquisition date.
• Additional information also is disclosed for each indi-
vidually material combination, such as the following:
— Information about incomplete accounting.
— Changes in rights to contingent consideration.
— Reconciliation of the carrying amount of goodwill.
— Qualitative description of the factors that make up
the goodwill recognized (for example, expected syn-
ergies from combined operations and intangible as-
sets that did not qualify for separate recognition).
• Amounts of revenues and profit or loss of the acquiree
subsequent to the acquisition date that are included in
the acquirer’s consolidated statement of comprehensive
income, unless disclosure is impracticable. If impracti-
cable, disclose this fact and provide an explanation.
• Information in the aggregate for individually immate-
rial business combinations that are material in aggre-
gate, such as the following:
— Information about incomplete accounting.
— Changes in rights to contingent consideration.
— Reconciliation of the carrying amount of goodwill.
• Amounts and explanations of gains or losses recog-
nized during the period related to assets assumed and
liabilities incurred that are relevant to an understanding
of the combined entity’s financial performance.
• Amounts of revenue and profit and loss of the com-
bined entity for all business combinations in total for
the current reporting period as if the acquisition date
was as of the beginning of the reporting period.
• Acquired receivables, including fair values; gross con-
tractual amounts; and estimated uncollectible amounts.
• Contingent consideration arrangements and indemnifi-
cation assets.
IFRS ATT 9.21
670 IFRS Accounting Trends & Techniques
9.22 The revised IFRS 3 retains the disclosure requirements
of IFRS 3 as originally issued with modifications to reflect
the shift from the original cost-based approach to the ac-
quisition date fair value approach of IFRS 3 revised. New
disclosure requirements required by the 2008 revisions were
added either in response to requests from commentators dur-
ing review of the exposure draft or to converge with FASB
ASC 805 disclosures.
U.S. GAAP
9.23 Most of the required disclosures are similar to those
required by IFRS 3. Both IFRSs and FASB ASC 805-10-50
require supplemental pro forma disclosures for the current
period. However, FASB ASC 805-10-50-2 requires these dis-
closures for public entities only, whereas IFRSs require them
for all entities.
Author’s Note
“Pending Content” in FASB ASC 805-10-50-2,
prospectively applicable when an acquisition date is
on or after the beginning of the first annual reporting
period on or after December 15, 2010, adds several
disclosures about business combinations achieved in
stages, including the following:
• Acquisition date fair value of the equity interest
in the acquiree held by the acquirer immediately
before the acquisition
• Amount of any gain or loss recognized as a result
of remeasuring to fair value the equity interest that
the acquirer held immediately before the business
combination
• Line item in the income statement in which that
gain or loss is recognized
• Valuation technique(s) used to measure the acqui-
sition date fair value of the equity interest the ac-
quirer held immediately before the business com-
bination
• Other information helpful to users in assessing
the inputs used to develop the fair value measure-
ment of the equity interest in the acquiree held
by the acquirer immediately before the business
combination.
If an entity presents comparative financial statements,
it should provide pro forma disclosures for the com-
parative prior period for revenue and earnings of the
combined entity. IFRS 3 has no such requirement.
9.24 Paragraphs 5–6 of FASB ASC 805-10-50 require an
acquirer to disclose information about the financial effects
of adjustments recognized in the current period that relate
to business combinations completed in the current or prior
periods. Unlike IFRSs, these paragraphs do not specifically
require the disclosure of gains or losses recognized in the cur-
rent period that relate to the identifiable assets acquired or lia-
bilities assumed in the business combination. However, these
paragraphs, in conjunction of FASB ASC 805-10-25-17, re-
quire an entity to disclose changes to prior measurements.
Both IFRSs and FASB ASC 805-10-50 include a general re-
quirement for acquirers to disclose information that would be
relevant to users’ understanding of the business combination.
9.25 FASB ASC 805-20-50 disclosures about contingencies
differ from those required by IFRS 3 because the recognition
criteria differ.
Presentation and Disclosure Excerpts
Author’s Note
IFRS 3 (2008) is effective for annual periods begin-
ning on or after 1 July 2009. Most, but not all, survey
companies have fiscal year ends beginning on or after
this date. The following excerpts are all in compliance
with IFRS 3 (2008).
Acquisition Financed Through Issue of
Ordinary Shares and Options Over Ordinary
Shares, Gain on Bargain Purchase
9.26
Aquarius Platinum (Jun 2010)
Author’s Note
Aquarius Platinum refers to the gain on a bargain pur-
chase as a “discount on acquisition.” The gain is in-
cluded in the Statement of Comprehensive Income in
transaction and acquisition costs associated with Ridge
Mining.
STATEMENT OF COMPREHENSIVE INCOME
(in part)
For the year ended 30 June 2010
2010 2009
Note $’000 $’000
Revenue 7 472,220 310,556
Cost of sales 7 (352,029) (334,327)
Gross profit/(loss) 120,191 (23,771)
Other income 7 1,588 1,815
Administrative costs 7 (13,468) (9,354)
Fair value movement in derivative
liability 24 6,084 3,829
Loss on early redemption of
convertible note (26,919) —
Impairment reversals/(losses) 7 301 (13,050)
Foreign exchange loss (4,846) (20,328)
Transaction and acquisition costs
associated with Ridge Mining, net
of discount on acquisition 1,248 (565)
Profit/(loss) from operating activities
before finance costs 84,179 (61,424)
Finance costs 7 (25,750) (35,968)
Profit/(loss) before income tax 58,429 (97,392)
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At 1 July 2009 20,751 (2,802) 826,779 (20,782) 466 — (361,826) — 145,584 608,170
Profit for the period — — — — — — — — 27,773 27,773
Other comprehensive
income — — — 3,629 — — — — — 3,629
Total comprehensive




Shares issued 2,403 — 147,946 — — — — — — 150,349
On market purchase of
share plan shares — (677) — — — — — — — (677)
Acquisition of treasury
shares — (10,785) — — — — — — — (10,785)
Replacement options
issued to Ridge
shareholders — — — — — 5,129 — — — 5,129
Reclassification of
reserve on exercise of
Ridge options — — 5,037 — — (5,037) — — — —
Convertible note equity
component — — — — — — — 62,700 — 62,700
Dividends paid — — — — — — — — (9,255) (9,255)
At 30 June 2010 23,154 (14,264) 979,762 (17,153) 466 92 (361,826) 62,700 164,102 837,033
STATEMENT OF CASH FLOWS (in part)
For the year ended 30 June 2010
2010 2009
Note $’000 $’000
Cash Flows From Investing Activities
Payments for property, plant & equipment and mine development costs (93,186) (59,342)
Acquisition of Ridge Mining net of cash acquired 17 13,595 —
Redeemable deposit — (14,038)
Net cash used in investing activities (79,591) (73,380)
NOTES TO THE ANNUAL FINANCIAL
STATEMENTS (in part)
For the year ended 30 June 2010
5. Significant Accounting Policies (in part)
(g) Business Combinations and Goodwill
Business Combinations
Business combinations are accounted for using the acqui-
sition method. The acquisition method requires that the
acquirer recognises, separately from goodwill, the identifi-
able assets acquired, the liabilities assumed and any non-
controlling interest in the acquiree, at acquisition date. Ac-
quisition costs directly attributable to the acquisition are
expensed in the period. Identifiable assets acquired and lia-
bilities and contingent liabilities assumed in a business com-
bination are measured at fair value at the date of acquisition,
irrespective of the extent of any non-controlling interest.
For each business combination, the Group has an option to
measure any non-controlling interests in the acquiree either
at fair value or at the non-controlling interest’s proportionate
share of the acquiree’s identifiable net assets.
Goodwill
Goodwill represents the excess of the cost of an acquisition
over the fair value of the Group’s share of the net identifiable
assets of the acquired subsidiary at the date of acquisition.
Goodwill is not amortised. Instead, goodwill is tested for im-
pairment annually, or more frequently if events or changes
in circumstances indicate that it might be impaired, and is
carried at cost less accumulated impairment losses. Gains
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and losses on the disposal of an entity include the carrying
amount of goodwill relating to the entity sold.
Goodwill is allocated to cash generating units for the pur-
pose of impairment testing (Note 16).
When the recoverable amount of the cash generating unit
(group of cash generating units) is less than the carrying
amount, an impairment loss is recognised. When goodwill
forms part of a cash generating unit (group of cash generating
units) and an operation within that unit is disposed of, the
goodwill associated with the operation disposed of is included
in the carrying amount of the operation when determining the
gain or loss on disposal of the operation. Goodwill disposed
of in this manner is measured based on the relative values of
the operation disposed of and the portion of cash generating
unit retained.
Impairment losses recognised on goodwill are not subse-
quently reversed.
(aa) Intangible Assets
The cost of intangible assets acquired in a business combi-
nation is the fair value at the date of acquisition. Following
initial recognition, intangible assets are carried at cost less
any accumulated amortisation and any accumulated impair-
ment losses.
Intangible assets with finite lives are amortised using the
straight line method over the useful life of the contract and
assessed for impairment whenever there is an indication that
the intangible asset may be impaired. The amortisation pe-
riod and the amortisation method is reviewed at least each
financial year end. Changes in the expected useful life or the
expected pattern of consumption of future economic benefits
embodied in the asset is accounted for by changing the amor-
tisation period or method, as appropriate, and are treated as
changes in accounting estimates.










Beginning carrying value 8,910 221,147 230,057
Additions 992 18,793 19,785
Additions on acquisition of
Ridge Group 885 31,908 32,793
Depreciation (603) (12,965) (13,568)
Foreign exchange variance 139 2,911 3,050
Closing carrying value 10,323 261,794 272,117
At cost 13,648 348,821 362,469
Accumulated depreciation (3,325) (87,027) (90,352)
Closing carrying value 10,323 261,794 272,117
30 June 2009
Beginning carrying value 10,690 203,624 214,314
Additions 471 37,641 38,112
Depreciation (605) (9,519) (10,124)
Transfers to mining assets (1,642) (8,130) (9,772)
Foreign exchange variance (4) (2,469) (2,473)
Closing carrying value 8,910 221,147 230,057
At cost 11,632 294,784 306,416
Accumulated depreciation (2,722) (73,637) (76,359)
Closing carrying value 8,910 221,147 230,057
Refer to Note 27 for security granted over these assets.
14. Mining Assets
Comprising deferred exploration and evaluation costs, min-






Exploration and evaluation costs 9,619 1,110









Reconciliation of mining assets
Opening balance 270,374 274,270
Additions/expenditure incurred during
the year 68,841 29,276
Additions on acquisition of Ridge Group 111,152 —
Provision for rehabilitation decrement (3,908) (2,896)
Impairment of mining assets — (10,082)
Amortisation charges (24,806) (28,356)
Transfers from property, plant &
equipment — 9,772
Foreign exchange variance 4,229 (1,610)
Cosing balance 425,882 270,374
In accordance with the Group’s policy on mining assets, the
Directors have reviewed the carrying value of mineral explo-
ration tenements as at 30 June 2010. The value of the mineral
exploration tenements is carried forward as an asset provided
the rights to tenure of the area of interest is current and either:
• the exploration and evaluation activities are expected
to be recouped through successful development and
exploitation of the area of interest or, alternatively, by
its sale; or
• exploration and evaluation activities in the area of in-
terest have not at the reporting date reached a stage,
which permits a reasonable assessment of the exis-
tence, or otherwise of economically recoverable re-
serves, and active and significant operations in, or re-
lating to, the area of interest are continuing.
Refer to Note 27 for security granted over these assets.
17. Business Combination
On 6 July 2009, pursuant to a Scheme of Arrangement,
Aquarius acquired 100% of the voting shares of Ridge Min-
ing plc (Ridge), a company registered and headquartered in
England and publicly listed on the AIM market of the London
Stock Exchange.
Ridge is a platinum group metal explorer and developer
with two key projects in the eastern limb of South Africa’s
Bushveld Complex—the 50% owned Blue Ridge Mine which
is in production ramp up and shipped its first concentrate in
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April 2009, and the 39% owned Sheba’s Ridge project which
is under feasibility study.
The total cost of the business combination was $112.704
million and comprised the issue of equity instruments—both
ordinary shares and options over ordinary shares. Aquar-
ius issued 33,477,945 ordinary shares with a fair value of
£1.968 each, based on the quoted price of the shares of
Aquarius on 6 July 2009. The ordinary shares have a to-
tal fair value of £65.885 million or $107.574 million. Aquar-
ius granted 14,089,324 replacement options over ordinary
shares to cover the outstanding Ridge employee share op-
tions, shareholder warrants, and options granted to joint ven-
ture partners. The replacement options have a total fair value
of £3.141 million or $5.129 million, based on a binomial option
valuation in accordance with IFRS as at 6 July 2009.
The fair value of the identifiable assets and liabilities of








Cash and cash equivalents 13,595 13,595
Receivables 13,611 23,731
Inventory 5,285 4,175
Property, plant and equipment 32,793 32,667
Mining assets 111,152 104,104
176,436 178,272
Trade and other payables (10,709) (10,606)
Current tax liabilities (2,068) (1,628)
Provisions (1,300) (1,300)
Interest bearing loans and borrowings (36,728) (36,728)
Deferred tax liabilities (7,502) (5,844)
(58,307) (56,106)
Fair value of identifiable net assets 118,129 —
Discount arising on acquisition (5,425) —
112,704 —
Cost of the combination:
Shares issued, at fair value 107,575 —
Replacement options granted,
at fair value 5,129 —
Tota cost of the combination 112,704 —
The cash inflow on acquisition
is as follows:
Net cash acquired with the subsidiary 13,595 —
Net consolidated cash inflow 13,595 —
The fair value of receivables acquired included $10.095 mil-
lion relating to the fair value of joint venture partner receiv-
ables which are non-interest bearing and have been dis-
counted from a gross contractual receivable at acquisition
date of $21.315 million. The gross contractual amount of cash
flows are expected to be received in full.
Direct costs of $4.177 million (2009: $0.565 million) relating
to the acquisition have been recognised in the profit and loss
for the year ended 30 June 2010.
A discount on acquisition has been recorded as the value
of the net assets acquired was greater than the fair value of
the consideration given at the date control was obtained.
From the date of acquisition, the Ridge Group has con-
tributed $nil to the revenue of Aquarius as the Blue Ridge
Mine is still in the development phase and contributed a loss
of $4.596 million (2009: $0.565 million) to the net profit of
Aquarius for the year ended 30 June 2010. This is offset by
the discount on acquisition recorded of $5.425 million.





Provision for mine-site rehabilitation 67,430 62,858
Provision for employee entitlements 148 105
67,578 62,963
Reconciliation of movement
Balance at beginning of the year 62,963 58,618
Additional provision for employee entitlements 36 15
Reduction in mine-site closure costs provided (3,908) (2,896)
Payments for mine-site closure (162) (1,213)
Acquisition of Ridge Mining provisions 1,072 —
Interest adjustment due to accretion in
mine-site rehabilitation liability 5,414 6,472
Net exchange differences 2,163 1,967
Balance at end of year 67,578 62,963
The mines for which the provision has been raised are ex-
pected to have remaining mine lives in the range of 6 to
beyond 30 years.
Provision for Mine-Site Rehabilitation
The provision for rehabilitation represents the cost of restor-
ing site damage following initial disturbance. Increases in the
provision are capitalised to deferred mining assets to the ex-
tent that the future benefits will arise. Costs incurred that
related to an existing condition caused by past operations
and do not have a future economic benefit are expensed.
Provision for Employee Entitlements







Provision for employee entitlements 804 596
Reconciliation of movement
Balance at beginning of the year 596 474
(Utilisation)/additional provision (35) 118
Acquisition of Ridge Mining provisions 228 —
Net exchange differences 15 4
Balance at end of year 804 596
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Provision for Employee Entitlements
The provision for employee entitlements represents accrued
employee leave entitlements.







common shares with a par value
of $0.05 each 79,500 79,500
5 (2009: 5) “A” class shares with a par value
of $2,400 each 12 12
50,000,000 (2009: 50,000,000) preference







463,070,936 (2009: 415,014,680) common
shares of $0.05 each fully paid 23,154 20,751
Movement in issued capital
At 1 July 2008 262,052,778 13,103
Exercise of share options 97,309 5
Share placement 46,330,000 2,316
Rights issue 41,491,737 2,075
Acquisition of interest in AQPSA 65,042,856 3,252
At 30 June 2009 415,014,680 20,751
At 1 July 2009 415,014,680 20,751
Scheme of arrangement—1 AQP share
issued for every Ridge share 33,477,945 1,674
Exercise of share options—AQP 862,683 43
Exercise of share options—Ridge 13,715,628 686
At 30 June 2010 463,070,936 23,154
Terms and Conditions of Issued Capital
Common shares have the right to receive dividends as de-
clared and, in the event of winding up the Company, to par-
ticipate in the proceeds from the sale of all surplus assets in
proportion to the number of and amounts paid up on shares
held. Ordinary shares entitle their holder to one vote, either
in person or by proxy, at a meeting of the Company.
Preference shares, when issued, have rights and restric-
tions attaching to them as determined by the Board, in accor-
dance with the Bye-Laws of the Company.
Options
For information regarding the Company’s Option Plans, refer
Note 36.





Share premium reserve (a) 979,762 826,779
Foreign currency translation reserve (b) (17,153) (20,782)
Equity benefits reserve (c) 466 466
Ridge replacement options reserve (d) 92 —
Equity reserve (e) (361,826) (361,826)
Convertible bond equity component (f) 62,700 —
Available-for-sale investments reserve (g) — —
664,041 444,637
Movement in reserves
a) Share premium reserve
Balance at beginning of year 826,779 550,860
Premium on shares issued on exercise of
share options—AQP 1,205 133
Premium on shares issued on exercise of
share options—Ridge 45,878 —
Acquisition of Ridge Mining plc 105,900 —
Share placement (2009: 46,330,000
shares at £1.80 per share) — 116,199
Fundraising costs — (13,660)
Rights issue (2009: 41,491,737 shares at
£1.15 per share) — 71,403
Acquisition of interest in AQPSA (2009:
65,042,856 shares at $1.57 per share) — 101,844
Balance at end of year 979,762 826,779
The share premium reserve is used to record the premium
arising on the issue of shares calculated as the difference





d) Ridge replacement options reserve
Balance at beginning of year — —
Replacement options issued to Ridge
shareholders 5,129 —
Exercise of Ridge replacement options (5,037) —
Balance at end of year 92 —
The Ridge replacement options reserve is used to record the
fair value of options issued to replace options previously on




Amounts received or due and receivable by
Ernst & Young for:
—An audit or review of the financial report of
the company and any other entity in the
consolidated group 593 414
—Other services in relation to the company
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Fees paid to auditors for other services predominantly com-
prised assurance related services provided in relation to the
acquisition of Ridge Mining.
Prospective Application of IFRS 3 (2008),
Non-Controlling Interest Measured at the
Proportionate Share of the Net Identifiable
Assets of the Acquiree
9.27
Pearson plc (Dec 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME (in part)
Year ended 31 December 2010
All figures in £ millions
Notes 2010 2009 2008
Profit for the year 1,300 462 323
Net exchange differences on translation of foreign operations 173 (388) 1,125
Currency translation adjustment disposed—subsidiaries 13 — 49
Currency translation adjustment disposed—joint venture — — 1
Actuarial gains/(losses) on retirement benefit obligations—Group 25 70 (299) (71)
Actuarial gains/(losses) on retirement benefit obligations—associate 12 1 (3) (3)
Net increase in fair values of proportionate holding arising on
stepped acquisition — 18 —
Tax on items recognised in other comprehensive income 7 (41) 91 9
Other comprehensive income/(expense) for the year 216 (581) 1,110
CONSOLIDATED STATEMENT OF CHANGES IN
EQUITY (in part)
Year ended 31 December 2010
All figures in £ millions















At 1 January 2010 203 2,512 (226) 227 1,629 4,345 291 4,636
Profit for the year — — — — 1,297 1,297 3 1,300
Other comprehensive income — — — 175 30 205 11 216
Equity-settled transactions — — — — 50 50 — 50
Tax on equity-settled transactions — — — — 4 4 — 4
Issue of ordinary shares under share
option schemes — 12 — — — 12 — 12
Purchase of treasury shares — — (77) — — (77) — (77)
Release/cancellation of treasury shares — — 166 — (166) — — —
Changes in non-controlling shareholding — — — — (6) (6) (231) (237)
Dividends — — — — (292) (292) (7) (299)
At 31 December 2010 203 2,524 (137) 402 2,546 5,538 67 5,605
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CONSOLIDATED CASH FLOW STATEMENT
Year ended 31 December 2010
All figures in £ millions
Notes 2010 2009 2008
Cash Flows From Investing Activities
Acquisition of subsidiaries, net of cash acquired 29 (535) (208) (395)
Acquisition of joint ventures and associates (22) (14) (5)
Purchase of investments (7) (10) (1)
Purchase of property, plant and equipment (76) (62) (75)
Proceeds from the sale of investments — — 5
Proceeds from sale of property, plant and equipment 31 — 1 2
Purchase of intangible assets (56) (58) (45)
Disposal of subsidiaries, net of cash disposed 30 984 — 99
Tax paid on disposal of subsidiaries (250) — —
Interest received 10 3 11
Dividends received from joint ventures and associates 23 22 23
Net cash received from/(used in) investing activities 71 (326) (381)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Policies (in part)
The principal accounting policies applied in the preparation
of these consolidated financial statements are set out below.
a. Basis of Preparation (in part)
These consolidated financial statements have been prepared
in accordance with International Financial Reporting Stan-
dards (IFRS) and International Financial Reporting Interpre-
tations Committee (IFRIC) interpretations as adopted by the
European Union (EU) and with those parts of the Compa-
nies Act 2006 applicable to companies reporting under IFRS.
These consolidated financial statements are also prepared
in accordance with IFRS as issued by the International Ac-
counting Standards Board (IASB). In respect of the account-
ing standards applicable to the Group there is no difference
between EU-adopted and IASB-adopted IFRS. The Group
transitioned from UK GAAP to IFRS on 1 January 2003.
These consolidated financial statements have been pre-
pared under the historical cost convention as modified by the
revaluation of financial assets and liabilities (including deriva-
tive financial instruments) to fair value.
1. Interpretations and amendments to published standards
effective in 2010
• IFRS 3 (Revised) ‘Business Combinations’ and amend-
ments to IAS 27 ‘Consolidated and Separate Financial
Statements’, effective for annual reporting periods be-
ginning on or after 1 July 2009. The amendments affect
the accounting for business combinations, including the
requirement to re-measure the fair value of previously
held interests in step acquisitions with any gain or loss
arising being recognised in the income statement, the
requirement to expense acquisition costs and the re-
quirement to recognise adjustments to contingent con-
sideration in the income statement.
b. Consolidation
1. Business combinations—The acquisition method of ac-
counting is used to account for business combinations of the
Group with an acquisition date on or after 1 January 2010.
The consideration transferred for the acquisition of a sub-
sidiary is the fair value of the assets transferred, the liabilities
incurred and the equity interest issued by the Group. The
consideration transferred includes the fair value of any asset
or liability resulting from a contingent consideration arrange-
ment. Acquisition related costs are expensed as incurred.
Identifiable assets and contingent assets acquired and
identifiable liabilities and contingent liabilities assumed in a
business combination are measured initially at their fair val-
ues at the acquisition date. For material acquisitions, the fair
value of the acquired intangible assets is determined by an
external, independent valuer. The excess of the consideration
transferred, the amount of any non-controlling interest in the
acquiree and the acquisition date fair value of any previous
equity interest in the acquiree over the fair value of the iden-
tifiable net assets acquired is recorded as goodwill. See note
1e(1) for the accounting policy on goodwill. If this is less than
the fair value of the net assets of the subsidiary acquired, in
the case of a bargain purchase, the difference is recognised
directly in the income statement.
On an acquisition-by-acquisition basis, the Group recog-
nises any non-controlling interest in the acquiree either at fair
value or at the non-controlling interest’s proportionate share
of the acquiree’s net assets.
e. Intangible Assets (in part)
1. Goodwill—For the acquisition of subsidiaries made on or
after 1 January 2010 goodwill represents the excess of the
consideration transferred, the amount of any non-controlling
interest in the acquiree and the acquisition date fair value of
any previous equity interest in the acquiree over the fair value
of the identifiable net assets acquired. For the acquisition of
subsidiaries made from the date of transition to IFRS to 31
December 2009 goodwill represents the excess of the cost
of an acquisition over the fair value of the Group’s share of
the net identifiable assets acquired. Goodwill on acquisitions
of subsidiaries is included in intangible assets. Goodwill on
acquisition of associates and joint ventures represents the
excess of the cost of an acquisition over the fair value of the
Group’s share of the net identifiable assets acquired. Goodwill
on acquisitions of associates and joint ventures is included in
investments in associates and joint ventures.
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Goodwill is tested annually for impairment and carried at
cost less accumulated impairment losses. An impairment loss
is recognised to the extent that the carrying value of goodwill
exceeds the recoverable amount. The recoverable amount is
the higher of fair value less costs to sell and value in use.
These calculations require the use of estimates and signif-
icant management judgement. A description of the key as-
sumptions and sensitivities is included in note 11. Goodwill is
allocated to cash-generating units for the purpose of impair-
ment testing. The allocation is made to those cash-generating
units that are expected to benefit from the business combi-
nation in which the goodwill arose.
Gains and losses on the disposal of an entity include the
carrying amount of goodwill relating to the entity sold.
IFRS 3 ‘Business Combinations’ has not been applied ret-
rospectively to business combinations before the date of tran-
sition to IFRS. Subject to the transition adjustments to IFRS
required by IFRS 1, the accounting for business combinations
before the date of transition has been grandfathered.
4. Acquired intangible assets—Acquired intangible assets
include customer lists and relationships, trademarks and
brands, publishing rights, content and technology. These as-
sets are capitalised on acquisition at cost and included in
intangible assets. Intangible assets acquired in material busi-
ness combinations are capitalised at their fair value as deter-
mined by an independent valuer. Intangible assets are amor-
tised over their estimated useful lives of between two and 20
years, using an amortisation method that reflects the pattern
of their consumption.
4. Operating Expenses (in part)
During the year the Group obtained the following services
from the Group’s auditors:
All Figures in £ Millions 2010 2009 2008
Fees payable to the company’s auditors for
the audit of parent company and
consolidated financial statements 4 4 3
The audit of the company’s subsidiaries
pursuant to legislation 2 2 2
Tax services 2 2 2
Other services 2 1 1
Total 10 9 8
Reconciliation between audit and non-audit service fees is
shown below:
All Figures in £ Millions 2010 2009 2008
Group audit fees including fees for attestation
under section 404 of the Sarbanes-Oxley
Act 6 6 5
Non-audit fees 4 3 3
Total 10 9 8
Fees for attestation under section 404 of the Sarbanes-Oxley
Act are allocated between fees payable for the audits of con-
solidated and subsidiary accounts.
Tax services include services related to tax planning and
various other tax advisory matters. Other services is mainly
due diligence on acquisitions, notably our Brazilian acqui-
sition, Sistema Educational Brasileiro (SEB), where we as-
sessed that our auditors were best qualified and cost effective
in taking on this role.
10. Property, Plant and Equipment (in part)








At 1 January 2009 355 839 7 1,201
Exchange differences (21) (55) (1) (77)
Additions 14 46 7 67
Disposals (2) (41) — (43)
Acquisition through business combination 1 17 — 18
Reclassifications 1 5 (6) —
At 31 December 2009 348 811 7 1,166
Exchange differences 8 28 — 36
Additions 21 55 12 88
Disposals (4) (58) — (62)
Acquisition through business combination 8 25 — 33
Disposal through business disposal (48) (201) — (249)
Reclassifications 3 5 (8) —
At 31 December 2010 336 665 11 1,012
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At 1 January 2009 (170) (608) — (778)
Exchange differences 11 42 — 53
Charge for the year (17) (68) — (85)
Disposals 2 39 — 41
Acquisition through business combination — (9) — (9)
At 31 December 2009 (174) (604) — (778)
Exchange differences (4) (19) — (23)
Charge for the year (16) (66) — (82)
Disposals 3 58 — 61
Acquisition through business combination (3) (13) — (16)
Disposal through business disposal 28 164 — 192
At 31 December 2010 (166) (480) — (646)
Carrying Amounts
At 1 January 2009 185 231 7 423
At 31 December 2009 174 207 7 388
At 31 December 2010 170 185 11 366
Depreciation expense of £10m (2009: £12m) has been in-
cluded in the income statement in cost of goods sold, £7m
(2009: £7m) in distribution expenses and £52m (2009: £45m)
in administrative and other expenses. In 2010 £13m (2009:
£21m) relates to discontinued operations.
The Group leases certain equipment under a number of fi-
nance lease agreements. The net carrying amount of leased
plant and equipment included within property, plant and
equipment was £12m (2009: £15m).
11. Intangible Assets (in part)















At 1 January 2009 4,570 310 341 128 165 258 5,772
Exchange differences (420) (25) (32) (9) (5) (22) (513)
Additions—internal development — 35 — — — — 35
Additions—purchased — 24 — — — — 24
Disposals (9) (5) — — — — (14)
Acquisition through business combination 205 — 38 24 55 25 347
At 31 December 2009 4,346 339 347 143 215 261 5,651
Exchange differences 140 9 10 4 9 10 182
Additions—internal development — 41 — — — — 41
Additions—purchased — 15 — — — — 15
Disposals (11) (18) — — — — (29)
Acquisition through business combination 288 9 159 40 6 76 578
Disposal through business disposal (195) (43) (85) (1) — (41) (365)
At 31 December 2010 4,568 352 431 186 230 306 6,073
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At 1 January 2009 — (203) (67) (17) (69) (63) (419)
Exchange differences — 19 6 1 6 8 40
Charge for the year — (44) (35) (11) (22) (35) (147)
Disposals — 4 — — — — 4
At 31 December 2009 — (224) (96) (27) (85) (90) (522)
Exchange differences — (5) (3) (2) (2) (1) (13)
Charge for the year — (51) (39) (12) (24) (38) (164)
Disposals — 16 — — — — 16
Acquisition through business combination — (5) — — — — (5)
Disposal through business disposal — 19 35 — — 28 82
At 31 December 2010 — (250) (103) (41) (111) (101) (606)
Carrying Amounts
At 1 January 2009 4,570 107 274 111 96 195 5,353
At 31 December 2009 4,346 115 251 116 130 171 5,129
At 31 December 2010 4,568 102 328 145 119 205 5,467
Goodwill
The goodwill carrying value of £4,568m relates to acquisi-
tions completed after 1 January 1998. Prior to 1 January
1998 all goodwill was written off to reserves on the date of
acquisition. £3,090m of the carrying value relates to acquisi-
tions completed between 1 January 1998 and 31 December
2002 and £1,478m relates to acquisitions completed after 1
January 2003 (the date of transition to IFRS).
For acquisitions completed between 1 January 1998 and
31 December 2002 no value was ascribed to intangibles other
than goodwill and the goodwill on each acquisition was amor-
tised over a period of up to 20 years. On adoption of IFRS
on 1 January 2003, the Group chose not to restate the good-
will balance and at that date the balance was frozen (i.e.
amortisation ceased). If goodwill had been restated then a
significant value would have been ascribed to other intangi-
ble assets, which would be subject to amortisation, and the
carrying value of goodwill would be significantly lower. For
acquisitions completed after 1 January 2003 value has been
ascribed to other intangible assets which are amortised.
20. Intangible Assets—Pre-Publication
All Figures in £ Millions 2010 2009
Cost
At beginning of year 1,727 1,800
Exchange differences 52 (160)
Additions 319 322
Disposals (248) (230)
Acquisition through business combination 13 (1)
Transfer to inventories — (4)
At end of year 1,863 1,727
Amortisation
At beginning of year (1,077) (1,105)
Exchange differences (33) 102
Charge for the year (350) (307)
Disposals 248 230
Acquisition through business combination (4) 3
At end of year (1,216) (1,077)
Carrying amounts
At end of year 647 650
Included in the above are pre-publication assets amounting
to £399m (2009: £398m) which will be realised in more than
one year.
Amortisation is included in the income statement in cost of
goods sold.
22. Trade and Other Receivables (in part)
Trade receivables are stated at fair value, net of provisions for
bad and doubtful debts and anticipated future sales returns.
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The movements on the provision for bad and doubtful debts
are as follows:
All Figures in £ Millions 2010 2009
At beginning of year (76) (72)
Exchange differences (2) 5
Income statement movements (33) (26)
Utilised 26 20
Acquisition through business combination (3) (3)
Disposal through business disposal 5 —
At end of year (83) (76)
Concentrations of credit risk with respect to trade receivables
are limited due to the Group’s large number of customers,
who are internationally dispersed.
23. Provisions for Other Liabilities and Charges
(in part)
All Figures in £ Millions
Deferred
Consideration Leases Other Total
At 1 January 2010 38 9 21 68
Exchange differences 1 1 — 2
Charged to income statement 2 — 5 7
Deferred consideration on
acquisition—current year 8 — — 8
Deferred consideration on
acquisition—prior year
adjustments (10) — — (10)
Acquisition through business
combination—current year 10 — — 10
Utilised (20) — (5) (25)
At 31 December 2010 29 10 21 60
Deferred consideration primarily relates to the acquisition of
Fronter in 2009.
29. Business Combinations
On 17 June 2010 the Group acquired 100% of the shares
of Melorio plc, a vocational training provider. On 19 August
2010 the Group acquired 100% of the shares of Wall Street
Institute Education S.a.r.l (WSI), a group providing spoken
English training for adults. On 1 September 2010 the Group
acquired 69% of the voting equity of Sistema Educacional
Brasileiro’s (SEB) school learning systems division. On 7
September 2010 the Group acquired 100% of the shares
of America’s Choice Inc, a provider of school improvement
services.
Provisional values for the assets and liabilities arising from
these and other acquisitions completed in the year together
with adjustments to prior year acquisitions are as follows:
2010 2009






















Property, plant and equipment 10 4 7 3 — 3 17 9
Intangible assets 11 89 103 32 24 37 285 142
Intangible assets—Pre-publication 20 — 3 — — 6 9 2
Inventories — 5 1 1 (5) 2 14
Trade and other receivables 8 13 8 7 5 41 23
Cash and cash equivalents 3 5 2 12 4 26 29
Financial liabilities—Borrowings (13) — — — — (13) —
Net deferred income tax liabilities 13 (24) — (3) (4) (6) (37) (45)
Retirement benefit obligations — — — — (1) (1) (1)
Provisions for other liabilities and charges 23 (10) — — — — (10) —
Trade and other liabilities (9) (10) (14) (5) 1 (37) (91)
Current income tax liabilities — — (3) — — (3) (4)
Non-controlling interest — (39) — — — (39) (16)
Net assets acquired at fair value 48 87 26 35 44 240 62
Goodwill 11 50 141 39 30 28 288 205
Increase in fair values of proportionate holding
arising on stepped acquisition — — — — — — (23)
Total 98 228 65 65 72 528 244
Satisfied by:
Cash (98) (228) (65) (65) (74) (530) (201)
Other consideration — — — — — — (5)
Deferred consideration — — — — (8) (8) (27)
Net prior year adjustments — — — — 10 10 (11)
Total consideration (98) (228) (65) (65) (72) (528) (244)
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The goodwill arising on these acquisitions results from sub-
stantial cost and revenue synergies and from benefits that
cannot be separately recognised, such as the assembled
workforce.
The fair value of trade and other receivables is £41m and
includes trade receivables with a fair value of £34m. The
gross contractual amount for trade receivables due is £37m
of which £3m is expected to be uncollectable.
A provisional value of £12m of goodwill arising on 2010
acquisitions is expected to be deductible for tax purposes.
The non-controlling interest in SEB was measured using
the non-controlling interest’s proportionate share of the ac-
quiree’s net assets.
All Figures in £ Millions 2010 2009 2008
Cash Flow on Acquisitions
Cash—Current year acquisitions (530) (201) (394)
Cash—Acquisitions yet to complete — (4) (12)
Deferred payments for prior year
acquisitions and other items (20) (32) (5)
Cash and cash equivalents acquired 26 29 16
Acquisition costs paid (11) — —
Net cash outflow (535) (208) (395)
In 2010, acquisitions contributed £84m to sales and £6m to
operating profit before acquisition costs and amortisation of
acquired intangibles from the date of acquisition to the bal-
ance sheet date. Of these amounts, Melorio contributed £38m
of sales and £5m of profit, SEB contributed £11m of sales
and a loss of £2m, WSI contributed £13m of sales and £1m
of profit and America’s Choice contributed £9m of sales and
£nil of profit.
If the acquisitions had completed on 1 January 2010, the
Group estimates that sales for the period would have been
£5,799m and profit before tax would have been £676m.
31. Cash Generated from Operations
All Figures in £ Millions Notes 2010 2009 2008
Profit 1,300 462 323
Adjustments for:
Income tax 480 198 209
Depreciation 10 82 85 80
Amortisation of acquired
intangible assets 11 113 103 86
Amortisation of other intangible
assets 11 51 44 30
Loss on sale of property, plant
and equipment 3 2 1
Net finance costs 3, 6 73 95 91
Share of results of joint ventures
and associates 12 (41) (30) (25)
(Profit)/loss on disposal of
discontinued operations 3 (1,037) — 53
Loss on disposal 10 — —
Acquisition costs 11 — —
Net foreign exchange adjustment
from transactions (3) (14) 105
Share-based payment costs 26 39 37 33
Pre-publication 29 (16) (58)
Inventories 37 32 (12)
Trade and other receivables (82) (14) (81)
Trade and other liabilities 165 103 82
Retirement benefit obligations (64) (72) (14)
Provisions for other liabilities and
charges 3 (3) (9)
Net cash generated from
operations 1,169 1,012 894
Net cash generated from operations is translated at an ex-
change rate approximating to the rate at the date of cash flow.
The difference between this rate and the average rate used
to translate profit gives rise to a currency adjustment in the
reconciliation between net profit and net cash generated from
operations. This adjustment reflects the timing difference be-
tween recognition of profit and the related cash receipts or
payments.
Operating cash flow, operating free cash flow and total free
cash flow are non-GAAP measures and have been disclosed
as they are part of Pearson’s corporate and operating mea-
sures.
35. Events After the Balance Sheet Date (in part)
On 22 November 2010, the Group announced the proposed
acquisition of a 75% stake in CTI Education Group, a leading
South African education company for £31m. As at the end of
December 2010, this acquisition had not been completed but
is expected to complete in the first half of 2011.
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Prospective Application of IFRS 3 (2008),
Revaluation of Previously Held Equity Interest
9.28
France Telecom (Dec 2010)
CONSOLIDATED INCOME STATEMENT (in part)
Amounts in Millions of Euros (Except for per Share Data) Note 2010 2009(1) 2008(1)
Revenues 4 45,503 44,845 46,712
External purchases 5.1 (19,375) (18,748) (19,511)
Other operating Income 5.2 573 568 612
Other operating expense 5.3 (2,532) (2,211) (2,045)
Labor expenses 5.4 (9,214) (9,010) (8,468)
Gains (losses) on disposal of assets 6 62 (3) (27)
Restructuring costs and similar items 7 (680) (213) (442)
General Court of the European Union ruling of November 30, 2009 31 — (964) —
Depreciation and amortization 12–13 (6,461) (6,234) (6,704)
Remeasurement resulting from business combinations 3 336 — —
Impairment of goodwill 8 (509) (449) (270)
Impairment of fixed assets 8 (127) (69) (9)
Share of profits (losses) of associates 14 (14) 138 (94)
Operating income 7,562 7,650 9,754
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1. Description of Business and Basis
of Preparation of the Consolidated Financial
Statements (in part)
1.2. Basis of Preparation of the 2010 Consolidated Financial
Statements (in part)
For the reported periods, the accounting standards and in-
terpretations endorsed by the European Union are similar
to the compulsory standards and interpretations published
by the International Accounting Standards Board (IASB) with
the exception of the carve-out of the IAS 39 standard and
the standards and interpretations currently being endorsed,
which has no effect on the Group accounts. Consequently,
the Group accounts are prepared in accordance with the IFRS
standards and interpretations, as published by the IASB.
The principles applied to prepare financial data relating to
the financial year 2010 are based on:
• the changes in the accounting IFRS alternatives elected
by the Group with respect to the accounting treatment
of:
Standard/Interpretation Consequences for the Group
IFRS 3 (revised in 2008) The concept of control is now the key-criterion in accounting for the Group’s investments.
Business Combinations
and IAS 27 (revised in 2008)
Consolidated and Separate
Financial Statements
Changes in a parent’s ownership interest in a subsidiary that do not result in a change of
control are accounted for as changes in equity, with no effect on the net income and other
comprehensive income.
Step-acquisitions, as well as changes in ownership interests that result in a change of
control, lead to the remeasurement at fair value in operating income of the previously held
equity interest.
IFRS 3R allows for each takeover with ownership interest below 100% to account for
goodwill either on a 100% basis or via the acquired ownership interest percentage (without
any subsequent change in the case of additional purchase of non-controlling interests).
Acquisition-related costs are now directly recognized in operating income.
These revised standards have been applied prospective from January 1, 2010. Their
application to the 2010 transactions are disclosed in note 3.
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Note 2. Accounting Policies (in part)
2.4 Takeovers (Business Combinations)
For Agreements Closed on or After January 1, 2010
Business combinations are accounted for applying the acqui-
sition method:
• the acquisition cost is measured at the acquisition date
at the fair value of the consideration transferred, includ-
ing all contingent consideration. Subsequent changes
in contingent consideration are accounted for either
through profit or loss or through other comprehensive
income in accordance with the applicable standards;
• goodwill is the difference between the consideration
transferred and the fair value of the identifiable assets
and liabilities assumed at the acquisition date and is
recognized as an asset in the statement of financial po-
sition.
For each business combination with ownership interest below
100%, non-controlling interests are measured:
• either at fair value: in this case, goodwill relating to non-
controlling interests is recognized; or
• at the non-controlling interest’s proportionate share of
the acquiree’s identifiable net assets: in this case, good-
will is only recognized for the share acquired.
Acquisition-related costs are directly recognized in operating
income in the period in which they are incurred.
When a business combination is achieved in stages, the
previously held equity interest is remeasured at fair value
at the acquisition date through operating income. The at-
tributable other comprehensive income, if any, is fully reclas-
sified in operating income.
For Agreements Closed Between January 1, 2004 and
December 31, 2009
For business combinations over this period, the main ac-
counting treatment differences compared with the above de-
scribed accounting treatment are:
• acquisition-related costs are accounted for as acquisi-
tion cost;
• non-controlling interests are measured at the non-
controlling interest’s proportionate share of the ac-
quiree’s identifiable net assets, i.e. with no recognition
of goodwill;
• when a business is achieved in stages, the previously
held equity interest is remeasured at fair value against
equity;
• contingent consideration, if any, is recognized against
the acquisition cost at the acquisition date if the adjust-
ment is probable and can be measured reliably. Sub-
sequent changes in contingent consideration are ac-
counted for against goodwill.
2.5. Loss of Control With Residual Equity Interest
For Agreements Closed on or After January 1, 2010
Loss of control while retaining a residual equity interest is
analyzed as a swap of assets, i.e. a disposal of a controlling
interest in exchange for an acquisition of a non-controlling
interest. Hence, the following occurs at the date when control
is lost:
• the recognition of a gain or loss on disposal which com-
prises:
— a gain or loss resulting from the ownership interest
disposed; and
— a gain or loss resulting from the remeasurement at
fair value of the ownership interest retained in the
entity;
• the reclassification in profit or loss of all related other
comprehensive income balances.
For Agreements Closed Before January 1, 2010
Loss of control while retaining a residual equity interest results
in:
• recognizing a gain or loss resulting only from the own-
ership interest actually disposed;
• carrying at historical cost the previously held equity in-
terest.
2.6. Purchases and Disposals of Non-Controlling Interests
For Agreements Closed on or After January 1, 2010
Changes in the Group’s ownership interest in a subsidiary
that do not result in a loss of control are accounted for as
equity transactions, with no effect on profit or loss or on other
comprehensive income.
For Agreements Closed Before January 1, 2010
Accounting for the acquisition of non-controlling interests was
not addressed by IFRSs until 2009. Therefore, the Group
historically applied the French GAAP accounting treatment,
which consists of recognizing as goodwill the difference be-
tween the acquisition cost of non-controlling interests and
the minority interest share in the net equity, with no purchase
price allocation.
A gain or loss on disposal relating to the equity interest
actually disposed is recognized on transactions which do not
result in a loss of control.
IFRSs do not address the accounting treatment for the
transfer of consolidated shares within the Group resulting in
changes in ownership interest. The Group applies the follow-
ing accounting policy:
• the transferred shares are carried at historical cost and
the gain or loss on the transfer is fully eliminated in the
acquirer’s accounts;
• the non-controlling interests are adjusted to reflect the
change in their share in the equity against Group re-
tained earnings, with no impact on profit and loss and
equity.
Commitments to Purchase Non-Controlling Interests
(Put Options)
When the Group grants firm or contingent commitments to
purchase non-controlling interests, the carrying amount of
non-controlling interests within equity is reclassified in finan-
cial debt.
In the absence of any guidance provided by IFRSs, where
the amount of the commitment exceeds the amount of the
non-controlling interests, the difference is recorded as a re-
duction in shareholders’ equity attributable to the owners of
the parent.
Financial debt is remeasured at fair value at the end of
each reporting period against finance income or expense.
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The IFRS Interpretations Committee is expected to pro-
pose to the IASB accounting alternatives for the put options
granted to non-controlling interests.
Note 3. Main Acquisitions, Disposals and Changes
in Scope of Consolidation
Year Ended December 31, 2010 (in part)
Egypt—Agreement With Orascom Telecom on Mobinil
The commitments made under the term of the agreements
are described in Note 30.4.
Until July 13, 2010, the Group’s investment in Mobinil and
ECMS and the related income were accounted for under the
equity method, and the commitments arising from the agree-
ments qualified as unrecognized contractual commitments.
This accounting treatment is due to the change in method
described in Note 1.2 (since January 2010, investments in
jointly controlled entities have been accounted for under the
equity method).
After the agreements came into effect and after the amend-
ment and restatement of the shareholders’ agreement be-
tween France Telecom and Orascom Telecom relating to
Mobinil, the Group’s investment in Mobinil and ECMS was
fully consolidated. As a consequence, it has been proceeded
to, as of July 13, 2010:
• the expense of acquisition-related costs over the period;
• the recognition in the cost of the Mobinil shares of the
300 million US dollars paid and an additional consider-
ation amounting to 218 million euros relating to the put
option granted to Orascom Telecom;
• the recognition of a gain amounting to 336 million euros
resulting from the remeasurement of the previously held
equity interest in Mobinil based on the ECMS quoted
share price at July 13, 2010;
• the recognition of non-controlling interests at fair value
based on the ECMS quoted share price at July 13, 2010,
in accordance with the option provided by IFRS 3R;
• the reclassification of non-controlling interests from eq-
uity to financial debt, in the amount of 1,935 million
euros, due to the put option held by Orascom Telecom
and the triggering of a public tender offer for the ECMS
shares held by minority shareholders that would result
under the current Egyptian securities regulatory law.
The financial debt is remeasured at the end of each reporting
period against finance income, based on the maturity sched-
ule agreed by France Telecom and Orascom Telecom.
Remeasurement of the Previously Held Equity Interest
in Mobinil:
(In Millions of Euros) July 13, 2010
Fair value of previously held equity
interest in Mobinil 843
Transaction costs (5)
Net fair value of interest in mobinil a 838
Carrying value of mobinil and ECMS b 562
Remeasurement a-b 276
Reclassification adjustment of other
comprehensive income in net income
for the period c (60)
Remeasurement of the previously held
equity interest in Mobinil a-b-c 336
The Group determined the value of the identifiable assets
and liabilities of Mobinil and ECMS to perform a preliminary
allocation of the purchase price consideration for Mobinil:









Other intangible assets 627 1,037 1,664
O/w brand 105 105
O/w subscriber base 348 348
O/w licenses 397 584 981
Property, plant and equipment 996 996
Other non-current assets 13 13
Total non-current assets 1,636 1,037 2,673
Total current assets 269 0 269
Non-current financial liabilities at amortized cost excluding
trade payables 783 783
Other non-current liabilities 133 207 340
Total non-current liabilities 916 207 1,123
Total current liabilities 625 0 625
Net assets acquired 364 830 1,194
o/w attributable to owners of France Telecom 435
o/w attributable to non-controlling interests 759
Goodwill 1,582
Purchase price consideration 2,776
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The brand was measured using the relief from royalty method,
based on the present value of royalties that would have been
paid to a third party for the use of the brand had Mobinil not
owned it. It is amortized over 15 years.
Subscriber bases were measured using the future cash
flows generated by existing customers at the closing date.
They are amortized over 6 years.
Licenses were measured based on the present value of fu-
ture cash flows for a new entrant onto a new market (Green-
field method). They are amortized over 12 years.
The fair value of property, plant and equipment was con-
sidered as the same as the historical net carrying value after
applying an adjustment for the expected useful life of the
mobile access network.
The consolidation of Mobinil led to the recognition of 1,582
million euros goodwill, mainly justified by the access to a
rapidly growing Egyptian market and Mobinil’s leadership po-
sition based on number of customers in the Egyptian mobile
market.
As from the effective date of the agreements, Mobinil gen-
erated revenues of 706 million euros in respect of 2010. Con-
solidated net income after tax of France Telecom for the year
ended December 31, 2010 includes Mobinil’s net income for
the year amounting to 40 million euros, this net income ex-
cluding (471) million euros for goodwill impairment (see Note
8), but including (34) million euros for amortization of identi-




SECTION 10: REPORTING IN HYPERINFLATIONARY
ECONOMIES∗
IAS 29, FINANCIAL REPORTING IN
HYPERINFLATIONARY ECONOMIES
Author’s Note
In December 2010, the International Accounting Stan-
dards Board (IASB) issued Severe Hyperinflation and
Removal of Fixed Dates for First-time Adopters:
Amendments to IFRS 1. These amendments define a
currency of a hyperinflationary economy to be subject
to severe hyperinflation if it has both of the following
characteristics:
(a) no reliable general price index available to all
entities with transactions and balances in the cur-
rency, and
(b) no exchangeability between the currency and a
relatively stable foreign currency.
First-time adopters of IFRS with a functional currency
that is subject to severe hyperinflation and that elect to
measure assets and liabilities at fair value and use
that fair value as deemed cost on the date of transi-
tion should disclose the circumstances that supports
its functional currency meeting the characteristics of a
currency subject to severe hyperinflation.
In addition, with respect to derecognition of financial
assets and liabilities, these amendments replaced the
fixed date of 1 January 2004 with the entity’s date of
transition.
These amendments are effective for annual reporting
periods beginning on or after 1 July 2011 and permit
early application.
IFRSs Overview and Comparison
to U.S. GAAP
10.01 A fundamental element of historical cost measure-
ments is the assumption that the money value or purchasing
power associated with these measurements in the entity’s
functional currency is maintained over fairly long periods
of time. In contrast, fair value measurements do not require
an assumption of long-term stability of the entity’s func-
tional currency. As defined in both the Financial Accounting
Standards Board (FASB) Accounting Standards Codification
(ASC) glossary and International Financial Reporting Stan-
dards (IFRSs), an entity’s functional currency is the currency
of the primary economic environment in which the entity op-
erates.
10.02 International Accounting Standard (IAS) 29, Finan-
cial Reporting in Hyperinflationary Economies, recognizes
that the assumption described in the previous paragraph
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
issued as of January 1, 2011.
is violated for measurements denominated in the currency
of hyperinflationary environments. In addition, the standard
recognizes that in a hyperinflationary economy, reporting the
results of an entity’s financial position and results of opera-
tions without restatement is both meaningless and misleading
to the users of financial statements.
10.03 In a hyperinflationary economy, money loses its
purchasing power at such a fast rate that comparisons of
measurements from different periods, even within the same
accounting period, will significantly skew the results. There-
fore, when an entity’s functional currency is that of a hy-
perinflationary economy, it is necessary to restate an entity’s
financial position, results of operations, and other financial
statement information to provide users of the financial state-
ments with useful information.
10.04 Because judgment is required in determining whether
or not an economy is hyperinflationary, IAS 29 provides
the following indicators of the characteristics of such an
economy:
• The general population tends to keep its wealth in non-
monetary assets or a stable currency. In addition, avail-
able funds in the local currency are immediately in-
vested so as to maintain purchasing power.
• The general population does not refer to prices in the
local currency, and prices may actually be quoted in a
more stable currency.
• Prices for credit purchase and credit sale transactions
take into account estimated changes in purchasing
power even when the time between delivery and pay-
ment is short.
• Prices, including interest rates, wages, and so on, may
be linked to a price index.
• The cumulative inflation rate over a three-year period
approaches or exceeds 100 percent.
Recognition and Measurement
IFRSs
10.05 Although there are several potential approaches
to address the challenges that entities face in providing
useful financial reporting information in hyperinflationary
economies, IAS 29 requires the restatement approach. En-
tities whose functional currency is the local currency of a
hyperinflationary economy should restate the local currency
measurements at the end of the reporting period by applying
a general price index. International Financial Reporting In-
terpretations Committee (IFRIC) Interpretation 7, Applying
the Restatement Approach under IAS 29 Financial Reporting
in Hyperinflationary Economies, clarifies the application of
IAS 29 to nonmonetary items measured at historical cost and
those carried in the opening statement of financial position
at amounts current at dates other than those of acquisition
or incurrence. IFRIC 7 also addresses an entity’s accounting
for opening deferred tax items in its restated financial state-
ments. Application of IAS 29 is mandatory for all entities
whose functional currency is hyperinflationary.
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10.06 IAS 21, The Effects of Changes in Foreign Exchange
Rates, is also relevant for most entities applying IAS 29.
Consistent with FASB ASC glossary, IAS 21 defines func-
tional currency to be the currency of the primary economic
environment in which the entity operates. It also establishes
the requirements for translation of foreign operations and
foreign subsidiaries for inclusion in consolidated financial
statements and for translation of either consolidated or sepa-
rate financial statements from a functional currency to a dif-
ferent presentation currency. IAS 21 prohibits entities with
hyperinflationary functional currencies from using a stable
or hard currency as their measurement unit of account.
10.07 An entity undertaking a restatement in accordance
with IAS 29 would normally take the following actions:
a. Identify a general price index.
b. Restate nonmonetary assets and liabilities on the state-
ment of financial position.
c. Restate items on the statement of comprehensive in-
come.
d. Calculate any gain or loss on the change in the net
monetary position.
e. Restate the statement of cash flows.
f. Restate any comparative financial statements by apply-
ing the general price index.
g. Restate comparative information included in note dis-
closures.
10.08 When an entity’s functional currency first becomes
hyperinflationary, IFRSs require the application of IAS 29 to
the financial statements. IAS 29 is applied retrospectively as
if the functional currency has always been hyperinflationary.
Therefore, in accordance with IAS 1, Presentation of Finan-
cial Statements, the entity should present a restated opening
balance sheet for the earliest period presented and a restated
comparative balance sheet(s), as necessary.
10.09 For consolidation purposes, a reporting entity (par-
ent) restates the financial statements of a foreign subsidiary
in accordance with IAS 29 before translation of these state-
ments into the parent’s functional currency. The financial
statements of a foreign operation also are restated in accor-
dance with IAS 29. A foreign operation, as defined in IFRSs,
is an entity that is a subsidiary, associate, joint venture, or
branch of a reporting entity, the activities of which are based
or conducted in a country or currency other than that of the
reporting entity. Similarly, a foreign currency is a currency
other than the functional currency of the entity.
10.10 In accordance with IAS 21, all assets, liabilities, equity
items, income, and expenses are translated at the closing rate
at the reporting date of the most recent statement of financial
position, including comparatives, except when the financial
statements are translated into a stable currency (the currency
of a nonhyperinflationary economy). When the presentation
currency (the currency in which the financial statements are
presented) is a stable currency, the comparative financial
statement amounts are those that were presented previously
as current year amounts in the relevant prior year financial
statements rather than being adjusted for either subsequent
changes in the price level or subsequent changes in exchange
rates.
U.S. GAAP
10.11 FASB ASC 830, Foreign Currency Matters, applies
to reporting entities with a reporting currency other than the
U.S. dollars in financial statements that are prepared in con-
formity with U.S. GAAP. However, FASB ASC 830 does not
address the scenario under which a reporting entity preparing
U.S. GAAP consolidated financial statements would itself
have a reporting and functional currency from a highly infla-
tionary economy. FASB ASC 830-10-45-11 only addresses
the circumstances in which a reporting entity (parent) trans-
lates the financial reporting information of a foreign oper-
ation or subsidiary whose functional currency is that of a
highly inflationary economy into the presentation currency
of the parent in order to prepare consolidated financial state-
ments. Generally, when applying both FASB ASC 830 and
IFRSs, an entity would determine the same economies to
be highly inflationary or hyperinflationary, even though the
criteria for making the determination are more prescriptive
under FASB ASC 830-10-45-12.
10.12 Paragraphs 11–14 of FASB ASC 830-10-45 provide
guidance to entities with a functional currency in highly infla-
tionary economies. FASB ASC 830-10-45 requires an entity
with a functional currency in a highly inflationary economy
to remeasure its financial statements as if the functional cur-
rency was the reporting currency. When the local currency
financial statements of a foreign operation or foreign sub-
sidiary are consolidated in the financial statements of a U.S.
GAAP parent, then the local currency financial statements
are remeasured as if the functional currency were the parent’s
reporting currency, in accordance with FASB ASC 830-10-
45-11. Such remeasurement is prohibited under IFRSs.
10.13 Unlike IFRSs, when an entity’s functional currency
becomes hyperinflationary, FASB ASC 830-10-45-10 estab-
lishes that restatements are to be made prospectively; there-
fore, an entity does not restate either its comparative financial
statements or other comparative information.
Disclosure
IFRSs
10.14 IAS 29 requires disclosure that the financial state-
ments and prior period comparative information are restated
for the changes in the general purchasing power of the func-
tional currency and, as a result, are stated in terms of the
measuring unit at the end of the reporting period. IAS 29
also requires an entity to disclose whether the financial state-
ments are based on a historical cost approach or a current cost
approach. The identity and level of the price index at the end
of the reporting period and the movement in the index during
the current and prior reporting periods also are disclosed.
U.S. GAAP
10.15 FASB ASC 830 does not address the scenario in which
the consolidated financial statements would be presented in
the currency of a hyperinflationary economy. Therefore, this
topic does not require disclosures comparable with those
required by IAS 29 are necessary.
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10.16 However, foreign entities that prepare U.S. GAAP fi-
nancial statements in the currency of the country in which
the reported operations are conducted and that operate in
countries with hyperinflationary economies are included in
the scope of FASB ASC 255, Changing Prices. Entities are
encouraged, but not required, to disclose the following infor-
mation on the effects of changing prices for each of the five
most recent years:
• Net sales and other operating revenues
• Income from continuing operations on a current cost
basis
• Purchasing power gain or loss on net monetary items
• Increase or decrease in the current cost or lower
recoverable amount of inventory and property, plant,
and equipment, net of inflation
• Aggregate foreign currency translation adjustment on
a current cost basis, if applicable
• Net assets at year-end on a current cost basis
• Income per common share from continuing operations
on a current cost basis
• Cash dividends declared per common share
• Market price per common share at year-end
Presentation and Disclosure Excerpts
Elimination of the Price-Level Adjustment
for Subsidiaries on Transition to IFRSs
10.17
Nortel Inversora S.A. (Dec 2010)
Author’s Note
Nortel Inversora S.A. implemented IFRSs effective
December 31, 2010, with a date of transition of Jan-
uary 1, 2009. The excerpt that follows reflects the initial
application of IAS 29.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 4—Transition to IFRS (in part)
These financial statements for the year ended December
31, 2010 are the first annual financial statements that are
fully compliant with IFRS as issued by the IASB. The Com-
pany has adopted the standards effective as of December
31, 2010. Additionally, the Company early adopted IFRS 9
as issued in October 2010.
The mandatory adoption of IFRS for public companies in
Argentina is effective for financial years beginning January
1, 2012, while early adoption is permitted for financial years
beginning January 1, 2011. Therefore, the consolidated finan-
cial statements as of December 31, 2010 for filing with the
CNV were prepared in accordance with Argentine GAAP. Ar-
gentine GAAP differs in certain respects from IFRS. Notwith-
standing the CNV regulations, financial statements under
IFRS for the year 2010 are allowed to be presented as ad-
ditional information to the consolidated financial statements
prepared under Argentine GAAP.
The reconciliations that are presented in this Note recon-
cile the previously published financial statement information
under Argentine GAAP as of and for the year ended Decem-
ber 31, 2009 and as of January 1, 2009 to the corresponding
amounts calculated in accordance with IFRS in compliance
with IFRS 1.
For the purposes of this quantification, Management of the
Company has elected to make use of some of the exemptions
provided for in IFRS 1 with the aim to simplify the first-time
adoption of IFRS. The Company made use of the exemptions
as detailed below:
Optional Exemptions Provided by IFRS 1 Upon First-Time
Adoption of IFRS (in part):
• Cumulative translation differences for foreign opera-
tions: The cumulative translation differences for all for-
eign operations were deemed to be zero at the date of
transition to IFRS. This exemption applies to the finan-
cial statements translations of the subsidiaries Núcleo
and Telecom USA.
a) Impacts of the Application of IFRS On the Opening
Statement of Financial Position at January 1, 2009 and the
Consolidated Financial Statements at December 31, 2009
IFRS provides for alternative criteria for measurement af-
ter initial recognition of each class of PP&E and Intangible
Assets. An entity shall choose either the “cost model” or
the “revaluation model.” Management of Telecom Group has
elected to continue applying the “cost model” for all classes
of PP&E and Intangible Assets.
After considering exemptions elected and the “cost model”
chosen to measure PP&E and Intangible Assets, the main
differences identified between Argentine GAAP and IFRS and
their impact on equity at January 1, 2009 and December 31,
IFRS ATT 10.17
690 IFRS Accounting Trends & Techniques






Net Income for the
Year Ended
December 31, 2009
Total amounts under Argentine GAAP 2,189 2,953 758
IFRS Adjustments:
1. Noncontrolling interest 1,900 2,552 651
Subtotal amounts and noncontrolling interest under Argentine GAAP 4,089 5,505 1,409
2. Classification of Class “A” Preferred shares (1,039) (1,156) (117)
3. Revenue recognition
3.1 Upfront connection fees (106) (105) 1
3.2 Revenues from contracts for the construction of networks and other assets — — —
3.3 Customer loyalty programs (6) (8) (2)
3.4 Revenue recognition on contracts with multiple deliverables — — —
4. Intangible Assets
4.1 Service connection or habilitation costs 121 114 (7)
4.2 Subscriber acquisition costs 188 186 (2)
5. Reversal of the adjustments for the effects of inflation in foreign entities´
financial statements — (17) (11)
6. Borrowing costs that do not qualify for capitalization (67) (57) 10
7. Other adjustments
7.1 Inventories (8) 1 9
7.2 Fixed assets held for sale (2) (2) —
8. Tax effects on IFRS adjustments (42) (43) (1)
Total amounts under IFRS 3,128 4,418 1,289
Equity attributable to the parent 1,192 1,837 642
Equity attributable to noncontrolling interest 1,936 2,581 647
5. Reversal of the Adjustments for the Effects of Inflation in
Foreign Entities’ Financial Statements
Under IFRS financial statements of any entity whose func-
tional currency is the currency of a hyperinflationary econ-
omy shall be stated in terms of the measuring unit current
at the end of the reporting period. Under Argentine GAAP fi-
nancial statements of Núcleo are prepared in guaranı́es—the
local and functional currency of Núcleo—restated in terms of
the measuring unit current at the end of the reporting period.
However, the economic environment where Núcleo performs
its activities does not meet the requirements established by
IFRS to consider the Paraguayan economy as hyperinflation-
ary. The reconciling item reflects the reversal of the inflation
adjustment made under Argentine GAAP, after considering
the IFRS 1 exemption for deemed cost for the measurement
of fixed assets described above.
The impact of reversing the inflation adjustment recorded
under Argentine GAAP is summarized in the table below:
Impact of Reversing the Restatement











Attributable to the parent (7) (4) (3)
Attributable to noncontrolling interest (10) (7) (3)
Total of the reconciling item (17) (11) (6)
c) Impacts of the Application of IFRS on the Consolidated
Income Statement for the Year Ended December 31, 2010
After considering exemptions elected and the “cost model”
chosen to measure PP&E and Intangible Assets, the main
differences identified between Argentine GAAP and IFRS and
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their impact on net income for the year ended December 31,
2010 are described below:
Net Income for
the Year Ended








Total amounts under Argentine GAAP 1,004 — — — — —
IFRS Adjustments:
1. Noncontrolling interest 843 — — — — —
Subtotal amounts and noncontrolling interest under Argentine
GAAP 1,847 — — — — —
2. Classification of Class “A” Preferred shares (171) — — — (171) —
3. Revenue recognition
3.1 Upfront connection fees 5 5 — — — —
3.2 Revenues from contracts for the construction of networks
and other assets 4 14 (10) — — —
3.3 Customer loyalty programs 4 (1) 5 — — —
4. Intangible assets
4.3 Service connection or habilitation costs (7) — 19 (26) — —
4.4 Subscriber acquisition costs 173 — 534 (361) — —
5. Reversal of the adjustments for the effects of inflation in
foreign entities’ financial statements (23) (70) 50 18 (21) —
6. Borrowing costs that do not qualify for capitalization 10 — — 10 — —
7. Other adjustments
7.1 Inventories 8 — (7) — 15 —
7.2 Fixed assets held for sale 1 — — 1 — —
8. Tax effects on IFRS adjustments (66) — — — — (66)
Total amounts under IFRS 1,785 (52) 591 (358) (177) (66)
Equity attributable to the parent 895
Equity attributable to noncontrolling interest 890
Deconsolidation of Foreign Operations
in a Hyperinflationary Economy
10.18
Companhia de Bebidas das Americas—AmBev
(Dec 2010)
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Corporate Information
Companhia de Bebidas das Américas—AmBev (referred to
as “we,” the “Company” or “Ambev”), headquartered in Săo
Paulo, Brazil produces and sells beer, draft beer, soft drinks,
other non-alcoholic beverages and malt, either directly or by
participating in other Brazilian domiciled companies and else-
where in the Americas.
The Company maintains an agreement with PepsiCo Inter-
national, Inc. (“PepsiCo”) to bottle, sell and distribute Pepsi
products in Brazil and in other Latin American countries,
including Pepsi Cola, 7Up, Lipton Ice Tea, Gatorade and
H2OH!.
The Company maintains a licensing agreement with
Anheuser-Busch, Inc., through its subsidiary Labatt Brew-
ing Company Limited (“Labatt Canada”) and Cervecerı́a
Paraguay (“Cervepar”), to produce, bottle, sell and distribute
Budweiser products in Canada and Paraguay. In addition,
the Company and certain of its subsidiaries produce and dis-
tribute Stella Artois under license to Anheuser-Busch InBev
S.A./N.V. (“AB InBev”) in Brazil, Argentina, Canada, and other
countries and, by means of a license granted to AB InBev, it
distributes its Brahma product in certain countries of Europe,
Asia and Africa.
The Company’s shares are traded on the Brazilian Stock
Exchange—BM&FBOVESPA and on the New York Stock
Exchange—NYSE, as American Depositary Receipts—
ADRs.
Main Corporate Event in 2010:
On October 20, 2010, Ambev and Cerveceria Regional
S.A. (“Cerveceria Regional”) executed a transaction pur-
suant to which they combined their businesses in Venezuela,
whereupon Cerveceria Regional assumed an 85% interest
and Ambev the remaining 15% which may be increased to
20% over the next four years.
The measurement at fair value of the retained interest, as
prescribed by Amended IAS 27 Consolidated and separate
financial statements, led to the recognition of an impairment
loss of R$49.6.
The consolidated financial statements were approved by
the Board of Directors on February 28, 2011.
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3. Summary of Significant Accounting Policies (in part)
(c) Foreign Currency Transactions
Foreign currency transactions are accounted for at exchange
rates prevailing at the date of the transactions. Monetary
assets and liabilities denominated in foreign currencies are
translated at the balance sheet date rate. Gains and losses
resulting from the settlement of foreign currency transactions
and from the translation of monetary assets and liabilities de-
nominated in foreign currencies are recognized in the income
statement. Non-monetary assets and liabilities denominated
in foreign currencies are translated at the foreign exchange
rate prevailing at the date of the transaction. Non-monetary
assets and liabilities denominated in foreign currencies that
are stated at fair value are translated to Brazilian Reais (“R$”)
at exchange rates ruling at the dates the fair value was de-
termined. Gains and losses arising from the settlement of
transactions in foreign currencies and resulting from the con-
version of assets and liabilities denominated in foreign cur-
rencies are recognized in income.
The more significant exchange rates that have had an ef-
fect on the financial statements are as follows:
Closing Rate Average Rate
Currency Name Country 2010 2009 2008 2010 2009 2008
CAD Canadian Dollars Canada 1.6712 1.6581 1.9134 1.7114 1.7554 1.6984
DOP Dominican Pesos Dominican Republic 0.0445 0.0485 0.0661 0.0480 0.0558 0.0523
USD US Dollar
Ecuador, Luxembourg and
Argentina and Uruguay Malt
operations 1.6662 1.7412 2.3370 1.7679 2.0152 1.7901
GTQ Quetzal Guatemala 0.2075 0.2102 0.3006 0.2180 0.2460 0.2403
PEN Novo Sol Peru 0.5940 0.6059 0.7438 0.6219 0.6640 0.6118
VEF Bolı́var Forte Venezuela(1) 0.3884 0.8159 1.0883 0.4121 0.9262 0.8500
ARS Argentinean Peso Argentina 0.4191 0.4586 0.6774 0.4481 0.5407 0.5707
BOB Bolivian Peso Bolivia 0.2367 0.2463 0.3306 0.2495 0.2825 0.2493
PYG Guarani Paraguay 0.0004 0.0004 0.0005 0.0004 0.0004 0.0004
UYU Uruguayan Peso Uruguay 0.0829 0.0887 0.0959 0.0876 0.0889 0.0858
CLP Chilean Peso Chile 0.0036 0.0034 0.0037 0.0034 0.0036 0.0035
(1) As described in Note 1 the subsidiary—Brahma Venezuela was incorporated by Cerveceria Regional as part of the restructuring of operations
in that country.
(e) Hyperinflationary Economies
In hyperinflationary economies, the local currency-denomi-
nated non-monetary assets, liabilities, income statement ac-
counts as well as equity accounts are re-measured by apply-
ing a general price index. The financial statements adjusted
for inflation are then translated into the presentation currency
at the closing rate.
As of November 30, 2009, Venezuela was assessed to be a
highly inflationary economy and the Company has price-level
restated the accounts based on the price index announced
by Venezuela’s central bank for the period from December
2009 to October 20, 2010, when the Venezuelan operations
were deconsolidated, following the transaction between Am-
bev and Cerveceria Regional (Note 1).
(cc) Segment Reporting
Under IFRS 8 Operating Segments reporting segments are
identified based on internal reports regularly reviewed by the
chief operating decision maker of the Company for purposes
of evaluating the performance of each segment and allocating
resources to those segments. Based on the standard, the
appropriate segment presentation has been determined to be
geographically based because the Company’s risks and rates
of return are affected predominantly by its regional business
areas. The Company’s management structure and internal
reporting system to the board of directors reflect this basis.
Ambev operates its business through three zones identified
as reportable segments:
• Latin America North, which includes (a) our opera-
tions in Brazil, where we operate two sub business
units: (i) Beer and (ii) Soft drinks; and (b) our Hispanic
Latin America Operations, Excluding Latin America
South (“HILA-Ex”), which includes our operations in the
Dominican Republic, Venezuela, Ecuador, Guatemala
(which also serves El Salvador and Nicaragua) and
Peru. Financial data for Venezeuela was consolidated
until October 20, 2010 when we combined our business
with Cerveceria Regional;
• Latin America South, which includes our operations in
Argentina, Bolivia, Paraguay, Uruguay and Chile; and
• Canada, represented by Labatt’s operations, which in-
cludes domestic sales in Canada.
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5. Acquisition and Disposal of Subsidiaries
Acquisition Disposal
2010 2009 2008 2010 2009 2008
Assets
Non-current assets
Property, plant and equipment — 17.2 — (121.4) — —
Intangible assets — 25.5 — — — —
Investment securities — 0.1 — 125.5 — —
Trade and other receivables — — — (1.0) — —
— 42.8 — 3.1 — —
Current assets
Inventories — 4.0 — (24.3) — —
Trade and other receivables — 1.2 — (18.4) — —
Cash and cash equivalents — 11.4 — (12.3) — —
Assets held for sale — — — — — —
— 16.6 — (55.0) — —
Non-current liabilities
Employee benefits — (2.4) — — — —
Provisions — (1.5) — 0.5 — —
— (3.9) — 0.5 — —
Liabilities
Current liabilities
Interest-bearing loans and borrowings — — — 7.6 — —
Income tax payable — (4.5) — — — —
Trade and other payables — (13.8) — (5.8) — —
— (18.3) — 1.8 — —
Net identifiable assets and liabilities — 37.3 — (49.6) — —
Goodwill on acquisition — 18.7 — — — —
Loss/(gains) on disposal — — — 49.6 — —
Consideration paid/(received), satisfied in cash — — — 6.3 — —
Cash (acquired)/disposed of — (11.4) — 12.3 — —
Net cash outflow/(inflow ) — 44.5 — 18.7 — —
Disposal in 2010
On October 20, 2010, Ambev and Cerveceria Regional ex-
ecuted a transaction pursuant to which they combined their
businesses in Venezuela, whereupon Cerveceria Regional
assumed an 85% interest and Ambev the remaining 15%
which may be increased to 20% over the next four years.
The measurement at fair value of the retained interest, as
prescribed by Amended IAS 27 Consolidated and separate
financial statements, led to the recognition of an impairment
loss of R$49.6.
8. Special Items (in part)
IAS 1 Presentation of financial statements requires material
items of income and expense to be disclosed separately. Spe-
cial items are those that in management’s judgment need to
be disclosed by virtue of their size or incidence. In determin-
ing whether an event or transaction is special, management
considers quantitative as well as qualitative factors such as
the frequency or predictability of occurrence, and the poten-
tial for variation of impact on profit or loss. These items are
disclosed on the face of the consolidated income statement or
separately disclosed in the notes to the financial statements.
Transactions which may give rise to special items are princi-
pally restructuring activities, impairments, and gains or losses
on disposal of assets and investments. The Company consid-
ers these items to be of significance in nature, and accord-
ingly, management has excluded these from their segment
measure of performance (Note 4).
Special items are detailed below:
2010 2009 2008
Restructuring (45.7) (42.8) (20.6)
Labatt brands indemnity — 239.4 —
Impairment disposal Venezuela (55.9) — —
Merger and Acquisition activities — — (17.1)
Labatt Hamilton Brewery closure
expenses (46.2) — —
Disputes — — (21.5)
Others (3.1) — —
Special items (150.9) 196.6 (59.2)
The restructuring expenses in 2010, 2009 and 2008, amount-
ing to R$45.7, R$42.8 and R$20.6, respectively, are related
to the realignment of the structure and processes in all re-
portable segments.
The measurement at fair value of the new investment
resulting from the combination of the Ambev and Cerve-
cerı́a Regional businesses in Venezuela, as prescribed by
Amended IAS 27 Consolidated and separate financial state-
ments, led to the recognition of an impairment loss of R$49.6
and transaction costs of R$6.3, totaling R$55.9 (Note 5).
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Balance at end of previous year 3,152.2 10,081.4 2,020.7 612.1 15,866.3
Effect of movements in foreign exchange (112.1) (471.0) (50.7) (11.5) (645.3)
Acquisitions 4.0 139.7 44.1 2,037.1 2,224.8
Disposals through the sale of subsidiary (98.1) (477.0) (33.5) (1.9) (610.6)
Disposals (4.8) (140.7) (147.9) (0.5) (294.0)
Transfer to other asset categories 49.1 511.5 471.8 (1,235.5) (203.1)
Other(i) 17.1 85.0 6.2 1.6 109.9
Balance at end of year 3,007.3 9,728.9 2,310.5 1,401.4 16,448.1
Depreciation and Impairment
Balance at end of previous year (1,380.6) (6,597.2) (1,293.4) — (9,271.3)
Effect of movements in foreign exchange 54.1 352.9 25.3 — 432.4
Depreciation (100.7) (869.6) (293.5) — (1,263.8)
Impairment losses(ii) — (150.3) (2.6) — (152.9)
Disposals through the sale 65.9 408.7 12.8 — 487.4
Disposals 1.5 75.3 160.0 — 236.8
Transfer to other asset categories 8.5 405.2 (231.1) — 182.6
Other(i) (12.7) (58.4) 4.1 — (67.0)
Balance at end of year (1,364.0) (6,433.3) (1,618.4) — (9,415.8)
Carrying amount: — — — — —
December 31, 2009 1,771.6 3,484.2 727.2 612.1 6,595.1











Balance at end of previous year 3,280.2 9,982.1 1,984.8 796.0 16,043.1
Effect of movements in foreign exchange (355.3) (1,104.2) (141.5) (86.8) (1,687.7)
Acquisition through business combinations 7.2 8.3 1.6 — 17.0
Acquisitions 6.1 209.7 51.5 1,039.8 1,307.1
Disposals (35.0) (100.4) (109.0) (0.7) (245.2)
Transfer to other asset categories 130.9 597.9 199.2 (1,145.0) (217.0)
Other(i) 118.1 488.0 34.1 8.8 649.0
Balance at end of year 3,152.2 10,081.4 2,020.7 612.1 15,866.3
Depreciation and Impairment
Balance at end of previous year (1,283.5) (6,188.3) (1,266.6) — (8,738.5)
Effect of movements in foreign exchange 93.6 590.4 83.8 — 767.8
Depreciation (111.1) (775.1) (222.8) — (1,109.0)
Impairment losses(ii) — (100.9) — — (100.9)
Disposals 4.1 79.9 100.2 — 184.2
Transfer to other asset categories (0.3) 198.0 3.0 — 200.7
Other(i) (83.4) (401.2) 9.0 — (475.6)
Balance at end of year (1,380.6) (6,597.2) (1,293.4) — (9,271.3)
Carrying amount:
December 31, 2008 1,996.7 3,793.8 718.2 796.0 7,304.6
December 31, 2009 1,771.6 3,484.2 727.2 612.1 6,595.1
(i) Includes price-level restatement of our operations in Venezuela of R$4.3 (R$123.8—December 31, 2009), of which R$17.7 (R$551.3—
December 31, 2009) corresponding to the acquisition cost and R$(12.7) (R$(427.5)—December 31, 2009) to depreciation, respectively.
(ii) R$33.9 relates to impairment losses of the Labatt Hamilton Brewery (Note 8) and the balance primarily to losses on returnable packaging.
IFRS ATT 10.18
695Section 10: Reporting in Hyperinflationary Economies
Foreign Subsidiary Adjusted for Inflation
Prior to Translation into Presentation
Currency
10.19
East Asiatic Company Ltd. A/S (Dec 2010)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME
DKK Million 2010 2009
Net profit for the year 761 214
Other Comprehensive Income:
Foreign exchange adjustments etc.:
Foreign currency translation adjustments, foreign entities 274 -13
Foreign currency translation adjustments, transferred to profit from discontinued operations -36
Foreign currency translation adjustments, transferred to gain on disposal of associates 9
Devaluation of the Bolivar (VEF) in EAC Foods, January 2010 -855
Inflation adjustment for the year (and at 1 January) 299 649
Value adjustments:
Value adjustment, hedging instruments -25
Realised exchange gains/losses, where hedging has ceased, transferred to financial income -19
Other adjustments:
Tax on other comprehensive income (primarily deferred tax related to inflation adjustments at 1 January 2009) -2 -82
Other comprehensive income net of tax -311 510
Total comprehensive income 450 724






















Equity at 1 January 2010 960 9 379 938 69 2,355 106 2,461
Comprehensive income for the year
Profit for the year 392 343 735 26 761
Other comprehensive income
Foreign currency translation adjustments, foreign
entities 267 267 7 274
Reclassified -9 9 0 0
Foreign currency translation adjustments, transferred
to profit from discontinued operations -36 -36 -36
Foreign currency translation adjustments, transferred
to gain on disposal of associates 9 9 9
Devaluation of the Bolivar (VEF) in EAC Foods,
January 2010 -808 -808 -47 -855
Inflation adjustment for the year 285 285 14 299
Tax on other comprehensive income -2 -2 -2
Total other comprehensive income 0 -9 -276 0 0 -285 -26 -311
Total comprehensive income for the year 0 -9 -276 392 343 450 0 450
Transactions with the equity holders of the parent
EAC
Ordinary dividends paid to shareholders -67 -67 -11 -78
Dividends, treasury shares 2 -2
Interim dividend paid to shareholders -267 -267 -267
Interim dividend, treasury shares 7 -7
Purchase of treasury shares -119 -119 -119
Share based payments 10 10 10
Total transactions with the equity holders of the
parent EAC 0 0 0 -100 -343 -443 -11 -454
Equity at 31 December 2010 960 0 103 1,230 69 2,362 95 2,457
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At the end of the year proposed dividends of DKK 69m are
included in retained earnings (DKK 5 per share). Total paid
dividend during the year amounts to DKK 25 per share. No
dividend is declared on treasury shares.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Accounting Policies for the Consolidated Financial
Statements (in part)
Hyperinflation
Effective from 2009, Venezuela has been classified as a hy-
perinflationary economy. As a consequence, the accounting
figures for EAC Foods’ activities in Venezuela have been
adjusted for inflation prior to translation to the Group’s pre-
sentation currency. The effect of the inflation adjustment is

































DKK Million 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009
Income Statement




items 425 680 69 60 494 740 -57 -47 437 693 -108 -71 329 622
Depreciation and amortisation 51 80 12 11 63 91 1 1 64 92 60 76 124 168
Reportable segment operating
profit (EBIT) 374 600 57 49 431 649 -58 -48 373 601 -168 -147 205 454
Financials, net -79 -75 -8 -3 -87 -78 -14 -3 -101 -81 56 37 -45 -44
Share of profit from associates — — 1 1 1 1 12 17 13 18 0 0 13 18
Gain on disposal of associates — — 3 — 3 — 194 — 197 0 0 0 197 0
Profit before tax 295 525 53 47 348 572 134 -34 482 538 -112 -110 370 428
Income tax expense 50 153 14 14 64 167 31 29 95 196 61 52 156 248
Reportable segment profit from
continuing operations 245 372 39 33 284 405 103 -63 387 342 -173 -162 214 180
Balance Sheet
Goodwill 0 0 402 74 402 74 0 0 402 74 0 0 402 74
Other intangible assets 0 3 210 2 210 5 0 0 210 5 2 4 212 9
Property, plant and equipment
and livestock 663 900 87 41 750 941 13 15 763 956 440 505 1,203 1,461
Deferred tax asset 108 135 13 2 121 137 1 1 122 138 -107 -131 15 7
Other financial fixed assets 0 0 1 2 1 2 11 10 12 12 0 0 12 12
Investment in associates 0 0 0 4 0 4 25 43 25 47 0 0 25 47
Inventories 489 654 10 5 499 659 0 0 499 659 15 26 514 685
Trade receivables 387 518 208 86 595 604 0 0 595 604 0 0 595 604
Cash 252 320 118 84 370 404 684 148 1,054 552 0 0 1,054 552
Other current assets 93 241 70 35 163 276 21 21 184 297 1 1 185 298
Discontinued operations — — — — — — — — — 723 — — — 723
Total assets 1,992 2,771 1,119 335 3,111 3,106 755 238 3,866 4,067 351 405 4,217 4,472
(continued)
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DKK Million 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009
Non-current liabilities ex. debt 25 55 62 22 87 77 31 29 118 106 14 0 132 106
Current liabilities ex. debt 340 546 307 120 647 666 41 20 688 686 0 0 688 686
Interest bearing debt 784 866 154 24 938 890 2 2 940 892 0 0 940 892
Liabilities 1,149 1,467 523 166 1,672 1,633 74 51 1,746 1,684 14 0 1,760 1,684
Non-controlling interests 41 44 17 12 58 56 1 0 59 56 36 50 95 106
Equity — — — — — — — — — — — — 2,362 2,355
Discontinued operations — — — — — — — — — — — — — 327
Total equity and liabilities — — — — — — — — — — — — 4,217 4,472
Invested capital 1,375 1,850 631 123 2,006 1,973 -38 -13 1,968 1,960 — — 2,305 2,365
Working capital employed 712 915 56 37 768 952 -1 -1 767 951 — — 783 977
Cash Flows
Cash flows from operations 83 207 34 74 — — — — — — — — 185 342
Cash flows from investing
activities -223 -331 -426 -11 — — — — — — — — 477 -337
Cash flows from financing
activities 219 214 415 -43 — — — — — — — — -94 90
Cash flows from discontinued
operations — — — — — — — — — — — — 6 —
Changes in cash & cash
equivalents 79 90 23 20 — — — — — — — — 574 95
Financial Ratios in %
Operating margins:
EBITDA 14.4 15.7 10.8 10.7 — — — — 12.2 14.1 — — 8.6 11.8
EBIT 12.7 13.8 8.9 8.8 — — — — 10.4 12.3 — — 5.3 8.6
Return on average invested
capital (ROIC) including
goodwill 23.2 37.6 15.1 35.6 — — — — 19.0 34.8 — — 8.8 23.6
Return on average invested
capital (ROIC) excluding
goodwill 23.2 37.6 41.0 75.6 — — — — 21.6 36.4 — — 9.8 24.5
The segment reporting is based on the internal management
reporting in which pro forma figures are prepared under the
historical accounting policies without any hyperinflation ad-
justments. Such adjustments are presented separately.
EAC’s operating segments comprise strategic business
units which sell different products and services. The seg-
ments are managed independently of each other and have
different customers. No inter segment sales occur. Each seg-
ment comprises a set of units and none of these are of a
magnitude which requires them to be viewed as a separate
reportable segment.
Consolidated revenue includes sale of goods in the amount
of DKK 3,218m (DKK 4,700m). Remaining revenue is related
to sale of services.
Reconciliation items in “Parent and unallocated items” are
primarily related to corporate costs and corporate assets in-
cluding cash and cash equivalents held by the Parent Com-
pany.
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14. Intangible Assets (in part)
DKK Million Goodwill Trademarks Software Other(1) Total
2010
Cost:
01.01. 104 84 147 42 377
Translation adjustments including devaluation loss 12 -5 -51 4 -40
Inflation adjustments — — 26 — 26
Additions — — 1 — 1
Additions related to discontinued operations 36 — — — 36
Additions due to business combinations 321 167 — 40 528
Disposals, discontinued operations 71 — 9 46 126
Disposals — -9 — — -9
31.12. 402 237 114 40 793
Amortisation:
01.01. 0 84 135 17 236
Translation adjustments including devaluation loss — -5 -49 2 -52
Inflation adjustments — — 25 — 25
Amortisation for the year — — 4 4 8
Disposals, discontinued operations — — 6 23 29
Disposals — -9 — — -9
31.12. 0 70 109 0 179
Carrying amount 31.12. 402 167 5 40 614
















01.01. 1,186 788 337 78 340 2,729
Translation adjustment including devaluation loss -477 -360 -87 -25 -155 -1,104
Inflation adjustment 157 143 6 9 50 365
Additions 1 — 10 1 236 248
Additions due to business combinations 2 — 43 1 — 46
Disposals 2 1 19 1 1 24
Disposals, discontinued operations 72 4 56 12 3 147
Reclassification 122 95 12 15 -244 0
31.12. 917 661 246 66 223 2,113
Depreciation
01.01. 469 492 211 57 0 1,229
Translation adjustment including devaluation loss -185 -226 -54 -17 — -482
Inflation adjustment 62 89 3 6 — 160
Depreciation for the year 37 42 29 8 — 116
Disposals 2 — 16 5 — 23
Disposals, discontinued operations 31 — 34 10 — 75
31.12. 350 397 139 39 0 925
Carrying amount 31.12. 567 264 107 27 223 1,188
Financial leases — — — — — 0
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16. Livestock
DKK Million 2010 2009
Reconciliation of Carrying Amounts of Breeding
Stock
Carrying amount 01.01 21 15
Translation adjustment including devaluation loss -10 0
Inflation adjustment 3 8
Increase due to purchases 16 20
Gain/loss arising from changes in fair value less
estimated point-of-sale costs attributable to
physical changes -11 -15
Decrease due to sales 4 7
Carrying amount 31.12 15 21
The reproducing livestock is presented at the updated acqui-
sition cost net of accumulated amortisation since there is no
available market price and no other reliable alternatives to
determine the fair value. The assets comprise pig herds and
stock of cattle with an amortisation period of 2.5 and 5 years,
respectively.
As of 31 December 2010, Plumrose owns 12,000 repro-
ducing livestock (31 December 2009:12,000).
27. Credit Risk, Currency Risk and Interest Rate Risk
(in part)
Group Policy for Managing Risk and Capital
Given the international scope of EAC’s business activities,
the Group is exposed to financial market risk, i.e. the risk
of losses as a result of adverse movements in currency ex-
change rates, interest rates and/or commodity prices. It also
encompasses financial counterparty credit risk, liquidity and
funding risk.
EAC operates in relatively volatile markets in South Amer-
ica and Asia Pacific where sudden currency and interest
movements can be expected. Consequently, EAC maintains
a conservative debt-equity ratio providing management with
sufficient flexibility to act in support of its businesses, if and
when so required. EAC will continuously strive to achieve an
efficient debt-equity ratio in the operating businesses, while
maintaining a cautious cash position and equity ratio in the
Parent Company.
EAC’s financial risk management activities are decen-
tralised, although co-ordinated by the EAC Group within a
policy framework approved by the Supervisory Board. It is the
EAC Group’s policy not to engage in any active speculation in
financial risks. Therefore, the Group’s financial management
is focused on managing or eliminating financial risks relat-
ing to operations and funding, in particular on reducing the
volatility of the EAC Group’s cash flows in local currencies.
The Group does currently not apply any material financial
derivatives for hedging.
Currency Risk
The EAC Group is exposed to translation risks from cur-
rency translation into the Group reporting currency (DKK).
EAC’s business activities are conducted in different curren-
cies: Venezuelan Bolivar, Asia Pacific currencies and to a mi-
nor extent DKK. In order to minimise the currency risk, EAC
seeks to match the currency denomination of income and ex-
penses and of assets and liabilities on a country-by-country
basis. Consequently, EAC’s functional currency varies from
country to country and is typically different from the reporting
currency in DKK of the listed entity, EAC A/S. The objective
of EAC’s currency management strategies is to minimise cur-
rency risks relating to the functional currencies, i.e. to protect
profit margins in local currency.
Due to the significance of EAC Foods’ activities in
Venezuela, the currency exposure to the Bolivar (VEF) is rel-
atively high. On 8 January 2010, the Venezuelan government
announced a devaluation of the official exchange rate of the
VEF to the USD, which had remained pegged at VEF/USD
2.15 since March 2005 to a new split rate of VEF/USD 2.60 for
the importation of food, pharmaceuticals and other essential
goods and at VEF/USD 4.30 for all other items. The devalu-
ation reduced consolidated assets by DKK 1.6bn and equity
by DKK 0.9bn. Further the devaluation reduced outstanding
royalties from H1 2008 to Q4 2009 by DKK 50m.
On 30 December 2010, the Venezuelan government an-
nounced that it would unify the official exchange rates with
effect from 1 January 2011 and consequently the VEF/USD
2.60 exchange rate has been eliminated, leaving the official
rate of VEF/USD 4.30. In addition to the official exchange
rate system, limited amounts of foreign currency may also be
purchased through the Sistema de Tranacciones con Titulos
en Moneda Extranjera (SITME) at a variable rate currently
VEF/USD 5.30. The devaluation had no impact on outstand-
ing royalties at year end 2010, but created uncertainty re-
garding the rate to be used for outstanding dividends.
From a Group point of view, net assets in EAC Foods are
translated at the official rate of VEF/USD 4.30. Outstanding
dividends from EAC Foods are summarised below including
the impact from applying VEF/USD 4.30 versus VEF/USD
2.60 for dividend repatriation:
Outstanding Dividends from EAC Foods:
Expectation Before Exchange Rate Potential
Exchange Rate Unification Unification Impact Impact
Period Exchange Rate USD’000 Exchange Rate USD’000 USD’000
2007 VEF/USD 2.60 37,816 VEF/USD 4.30 22,866 14,950
2008 VEF/USD 2.60 23,423 VEF/USD 4.30 14,163 9,260
2009 VEF/USD 4.30 152 VEF/USD 4.30 152 0
Total 61,391 37,181 24,210
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Due to uncertainty, the Parent Company only recognises div-
idends from Venezuela upon receipt. Any payment of divi-
dends at the expected exchange rate before unification will
accordingly give rise to an increase of the EAC Group’s equity
reported in DKK.
EAC Parent Company royalty receivables at exchange rate








During 2010, CADIVI approved payment of USD 25.9m of
outstanding royalties for the periods Q3 2008 to Q3 2009 at
the VEF/USD 2,60 exchange rate.
The devaluation in 2010 and the exchange rate unification
is further described in note 37.
The EAC Group has foreign exchange risk on balance
sheet items, partly in terms of translation of debt denomi-
nated in a currency other than the functional currency for the
relevant Group entity, and partly in terms of translation of net
investments in entities with a functional currency other than
DKK. The former risk affects the operating profit.
Developments in exchange rates between DKK and the
functional currencies of subsidiaries had an impact on the
EAC Group’s revenue and operating profit (EBIT) for 2010
reported in DKK. In a number of countries (particularly in Asia
Pacific) where the EAC Group has significant activities, the
currency correlates partly with the USD. In 2010, the average
DKK/USD rate (563.62) was 5.3 per cent higher than in 2009
(DKK/USD 535.44). As a consequence of the appreciation of
a number of key currencies compared to DKK, revenue and
operating profit (EBIT) for 2010 increased in EAC Moving &
Relocation Services by DKK 49m and DKK 6m respectively.
In foreign subsidiaries that operate in hyperinflationary
economies, income and expenses are translated at the ex-
change rate at the balance sheet date which had a positive
impact in EAC Foods due to the appreciation of the exchange
rate from DKK/USD 519.01 end of 2009 to DKK/USD 561.33
end of 2010. The associated impact on revenue and oper-
ating profit (EBIT) was an increase of DKK 243m and DKK
16m respectively, which only to a minor extent offset the ef-
fect of the devaluation effective from 8 January 2010, which
reduced 2010 revenue and operating profit (EBIT) by DKK
3.0bn and DKK 191m respectively, provided all other factors
remain unchanged.
37. Accounting Impact of Venezuela’s Status as a
Hyperinflationary Economy
As described in the accounting policies for the consolidated
financial statements, the assessment as to when an econ-
omy is hyperinflationary is based on qualitative as well as
quantitative factors.
Due to recent years’ rising inflation in Venezuela, the coun-
try was considered a hyperinflationary economy for account-
ing purposes effective from 30 November 2009. This was
based on the fact that the cumulative inflation for the three
years ending 30 November 2009 exceeds 100 per cent and
that the other qualitative characteristics of a hyperinflationary
economy have all been met.
Based on this assessment, the EAC Group has retrospec-
tively from 1 January 2009 onwards applied IAS 29 “Financial
Reporting in Hyperinflationary Economies” for the activities of
EAC Foods as if the economy has always been hyperinfla-
tionary.
IAS 29 requires the financial reporting of EAC Foods to
be restated to reflect the current purchasing power at the
end of the reporting period, and as a result all non-monetary
assets, such as property, plant and equipment and inven-
tories, should be restated to the current purchasing power
as of 31 December using a general price index from the date
when they were first recognised in the accounts (or 1 January
2004 when IFRS was first applied as basis of preparation of
the consolidated financial statements). Monetary assets and
liabilities are by their nature stated at their current purchas-
ing power and accordingly a gain/loss on the monetary net
position from 1 January to 31 December is recognised as
financial income or expense for the year representing the
gain/loss obtained from maintaining a monetary liability or
asset position respectively during an inflationary period. For
the income statement, all items are restated for changes in
the general price index from the date of the transaction to
the reporting date of 31 December except for items related to
non-monetary assets such as depreciation and amortization
and consumption of inventories etc. Deferred tax is adjusted
accordingly.
IAS 29 and IAS 21 require the end-of-period reporting ex-
change rate to be applied when translating both the income
statement and the balance sheet from the hyperinflationary
currency, VEF, into the presentation currency of the EAC
Group, DKK.
At 31 December 2010, the applicable rate for translation
purposes was the official exchange rate of VEF/USD 4.30
(VEF/USD 2,15) as the Group expects to receive future roy-
alties as well as dividends at this exchange rate. The al-
ternative parallel exchange rate in May 2010 (prior to sus-
pension of the parallel exchange market) was in the region of
VEF/USD 7.50. The implied VEF/USD exchange rate through
issuance of bonds by the Venezuelan republic and PDVSA
during 2010 ranged between VEF/USD 5.51–6.62 (based on
bond purchases/sales by EAC Foods during 2010).
Since the EAC Group’s presentation currency, DKK, is non-
inflationary, comparatives are not adjusted for the effects of
inflation in the current period. The net impact from inflation
adjustment of EAC Foods’ net asset is taken directly to the
equity (as part of other comprehensive income for the year).
The inflation adjustment for 2010 is based on available
data for changes in the Consumer Price Index (CPI) for the
Metropolitan Area of Caracas until December 2007 and the
National Consumer Price Index (NCPI) as from January 2008
published by the Central Bank of Venezuela (BCV). Based on
these indices, the inflation for 2010 is 27.2 per cent (25.1 per
cent) and the hyperinflation closing index at 31 December
2010 was 210 (165).
The hyperinflation adjustment during 2010 is not offset by
a corresponding devaluation of the VEF exchange rate as
this, since the devaluation on 8 January 2010, has been fixed
against the USD at the official rate of VEF/USD 4.30. Ac-
cordingly, the hyperinflation adjustment under IAS 29 has
correspondingly increased the consolidated accounting fig-
ures reported in DKK including revenue, non-current assets
and equity.
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The impact from applying IAS 29 on the consolidated finan-
cial statements for 2010 is summarised in a separate column
in note 4, to which reference is made.
The most material inflation accounting adjustments be-
tween the historical accounting policies of EAC Foods (now
applied for internal management reporting) as well as recog-
nition and measurement after IAS 29 can be explained as
follows:
• Revenue increases as it is restated for changes in the
general price index from the date of the transaction until
31 December.
• Gross profit decreases due to higher costs of goods sold
and fixed costs following restatement for changes in the
general price index from the date of the transaction until
31 December.
• Operating profit decreases due to higher depreciation
charges following the restatement of property, plant and
equipment for changes in the general price index from
the date of the transaction until 31 December.
• Profit before income tax is impacted, in addition to as
set out above, by the recognition of a gain on the net
monetary position which is due to the purchasing power
impact resulting from EAC Foods’ having monetary lia-
bilities in excess of monetary assets as of 31 December.
• Net profit is further impacted by changes to deferred
tax following the change in the accounting values of the
non-monetary assets (hyperinflated).
• Total equity increases primarily due to the restatement
of the fixed assets to a higher inflation adjusted level.
• Total assets and equity increase primarily due to re-
statement of non-current assets to a higher inflation-
adjusted level.
For 2010, the gain on the net monetary position amounts to
DKK 60 million (DKK 42 million) which has been recognised
as financial income.
38. Devaluation of the Bolivar
Devaluation in January 2010
On 8 January 2010, the Venezuelan government announced
a devaluation of the official exchange rate of the Bolivar (VEF)
to the USD, which had been pegged at VEF/USD 2.15 since
March 2005, to a new split rate of VEF/USD 2.60 for the im-
portation of food, pharmaceuticals and other essential goods
and VEF/USD 4.30 for all other items. The existence of a
third floating rate—known as the parallel rate—was officially
acknowledged and will onwards be managed through central
bank intervention to avoid excessive speculation with this ini-
tiative. The government aimed to stabilise the parallel rate at
a rate close to VEF/USD 4.30.
As all future royalties and dividends will be received at
VEF/USD 4.30, this exchange rate has consequently been
applied as of 1 January 2010 for translation of the financial
statements of EAC Foods into the reporting currency of the
EAC Group, DKK.
Due to the significance of EAC Foods’ activities in
Venezuela, the devaluation has an adverse effect on the con-
solidated accounting figures as illustrated below:




Rate of VEF/USD 2.15)
Pro Forma 2009 (Translated at




Revenue 6,607 4,257 -2,350
Gross profit 1,872 1,156 -716
Operating profit 510 284 -226
Profit before income tax 475 268 -207
Net profit for the year 214 109 -105
Total equity 2,461 1,606 -855
Non-current assets 1,746 1,038 -708
Total assets 4,472 2,875 -1,597
Suspension of the Parallel Exchange Market and Introduction
of the SITME Allocation System
On 14 May 2010, the Venezuelan government announced
that it would take over management of the VEF/USD parallel
market. As a consequence, purchase of USD could hence-
forth only be made from CADIVI and via the Central Bank of
Venezuela through the SITME allocation system at a rate of
VEF/USD 5.30 and subject to a number of restrictions.
Simplification of the Venezuelan Exchange Rate
System in December
On 30 December 2010, the Venezuelan government an-
nounced the elimination of the preferential VEF/USD 2.60
exchange rate used for importation of certain product cat-
egories including EAC Foods’ imports. The elimination will
primarily impact future import transactions into Venezuela,




SECTION 11: SERVICE CONCESSION ARRANGEMENTS∗
IFRIC 12, SERVICE CONCESSION
ARRANGEMENTS
SIC 29, SERVICE CONCESSION
ARRANGEMENTS: DISCLOSURES
IFRSs Overview and Comparison
to U.S. GAAP
11.01 Service concession arrangements are a mechanism by
which a public sector entity (such as a governmental agency)
or an entity acting as an agent for a public sector entity pro-
cures public services by entering into an arrangement with a
private sector entity. Rather than the public entity developing,
funding, building, operating, and maintaining infrastructure
assets alone, the public sector entity contracts some or all of
these activities to one or more private sector entities. Exam-
ples of service concession arrangements include developing,
funding, building, operating, and maintaining roads, bridges,
tunnels, hospitals, railroads, and prisons, among other ar-
rangements.
11.02 As part of these arrangements, private sector entities
provide one or more, but not necessarily all, of the services
necessary to make the infrastructure asset operational. In
some cases, the private sector entity constructs the infras-
tructure asset (a road, for example). In other cases, the in-
frastructure asset may already exist, such as an airport, and
the public sector entity contracts with a private sector entity
to manage and operate the asset.
11.03 When providing high quality, transparent, and compa-
rable information, the accounting challenge is to reflect the
substance of the arrangement between the public sector entity
(grantor) and private sector entity (operator). International Fi-
nancial Reporting Interpretations Committee (IFRIC) Inter-
pretation 12, Service Concession Arrangements, establishes
the requirements and provides guidance for reporting public-
to-private service concession arrangements on the financial
statements of service concession operators. Standing Inter-
pretations Committee (SIC) Interpretation 29, Service Con-
cession Arrangements: Disclosures, establishes the disclo-
sure requirements.
11.04 IFRIC 12 is effective for annual periods beginning on
or after 1 January 2008. If an entity early adopts IFRIC
12, it should disclose that fact in the relevant financial
statements.
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version
of those standards and interpretations included in the IFRS 2011 bound
volume, the official printed consolidated text of IASB standards and inter-
pretations, including revisions, amendments, and supporting documents,
issued as of 1 January 2011.
Recognition and Measurement
IFRSs
11.05 IFRIC 12 establishes requirements and provides guid-
ance for private sector operators on accounting for public-to-
private service concession arrangements. It does not provide
accounting guidance to the public sector grantor of the ser-
vice concession. This interpretation applies to those arrange-
ments in which the grantor controls (a) the services that the
operator will provide with the infrastructure asset, to whom
those services will be provided, and the price for those ser-
vices and (b) any significant residual interest in the infra-
structure asset at the end of the term of the arrangement. The
grantor’s control of the residual interest in the infrastructure
asset may exist through ownership, beneficial entitlement,
or other means. As long as both conditions are met, IFRIC
12 applies to infrastructure assets used in service concession
arrangements for the entirety of these assets’ economic lives.
11.06 IFRIC 12 addresses recognition and measurement of
the following:
• Operator’s rights over the infrastructure asset
• Arrangement consideration
• Construction or upgrade services
• Operating services
• Borrowing costs
• Subsequent treatment of recognized financial assets and
intangible assets
• Items provided to the operator by the grantor
11.07 When a service concession arrangement meets the
two conditions previously described, IFRIC 12 concludes
that the arrangement only gives the operator a right of ac-
cess to, not a right to use, the infrastructure asset. The right
of access allows the operator to provide services on behalf
of the grantor in accordance with the contractual terms of
the arrangement. This conclusion is significant because the
interpretation does not permit the infrastructure assets to be
recognized as property, plant, and equipment (PPE) under
International Accounting Standard (IAS) 16, Property, Plant
and Equipment, or as a leased asset under IAS 17, Leases.
The infrastructure asset itself does not meet the definition of
PPE in IAS 16, which requires the asset to be held for use,
or the definition of a leased asset in IAS 17, which requires
a lease to convey the right to use an asset.
11.08 Therefore, IFRIC 12 requires the operator to recognize
either a financial asset or an intangible asset. The operator
should recognize a financial asset to the extent that it has
an unconditional right to receive cash or another financial
asset. The operator should recognize an intangible asset to
the extent that consideration is dependent upon the use of
the asset to provide services. In some cases, the operator
might recognize both a financial and an intangible asset. An
entity classifies a financial asset as a loan or receivable, an
available-for-sale financial asset, or designated at fair value
through profit and loss in accordance with IAS 39, Financial
Instruments: Recognition and Measurement.
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Author’s Note
International Financial Reporting Standard (IFRS) 9,
Financial Instruments, issued December 2009 and ef-
fective for annual periods beginning on or after 1 Jan-
uary 2013, amends the classification and measurement
requirements for financial assets recognized in accor-
dance with IFRIC 12. In accordance with IFRS 9, an
entity measures the amount due from, or at the direc-
tion of, the grantor at either amortized cost or fair value
through profit or loss. If the financial asset is carried
at amortized cost, IFRS 9 requires the entity to use
the effective interest method and to recognize interest
income in profit or loss. Early adoption of IFRS 9 is
permitted. See a more extensive discussion of the fi-
nancial instruments convergence project in section 8,
“Financial Instruments and Related Disclosures.”
11.09 In accordance with IAS 11, Construction Contracts,
when the outcome of a construction contract can be measured
reliably, an entity should recognize revenues and contract
costs for construction and upgrade services using the per-
centage of completion method. An entity should recognize
revenue for providing services in accordance with IAS 18,
Revenue. Revenue is measured at the fair value of the consid-
eration received or receivable. If the operator provides more
than one service, then the entity should allocate the consider-
ation to the different services based on the relative fair values
of the delivered services when separately identifiable.
Author’s Note
In June 2010, the International Accounting Standards
Board (IASB) and the Financial Accounting Standards
Board (FASB) issued an exposure draft, Revenue from
Contracts with Customers, proposing to create a single
revenue recognition standard that would replace the re-
quirements of both IAS 18 and FASB Accounting Stan-
dards Codification (ASC) 605, Revenue Recognition.
Entities would apply the new standard across various
industries and capital markets. The boards believe that
“publication of this joint proposal represents a signifi-
cant step forward toward global convergence in one of
the most important and pervasive areas in financial re-
porting.” In June 2011, the boards decided to re-expose
their revised proposals for a common revenue recog-
nition standard to give constituents an opportunity to
comment on the revisions to the draft issued in 2010.
The IASB expects to issue a revised exposure draft in
the third quarter of 2011, analyze comments received
by the first quarter of 2012, and issue a final standard
later that year. See the discussion of the proposals in
section 3, “Statement of Comprehensive Income and
Related Disclosures.”
11.10 To the extent that the infrastructure asset is a qualify-
ing asset under IAS 23, Borrowing Costs, an operator should
capitalize interest in accordance with that standard. Other-
wise, the operator should expense borrowing costs.
11.11 When the grantor provides assets that the operator can,
at his or her sole discretion, retain or dispose of, the operator
should recognize the assets separately and measure them at
fair value on initial recognition, with a corresponding liability
representing the obligations it has assumed in exchange.
11.12 An entity should recognize and measure maintenance
obligations in accordance with IAS 37, Provisions, Contin-
gent Liabilities and Contingent Assets.
U.S. GAAP
11.13 Service concession arrangements are not defined in
the FASB ASC glossary, and FASB ASC does not include
specific guidance on the applicable accounting treatment. As
a result, there is likely to be diversity in practice. For exam-
ple, although service concession arrangements, as defined in
IFRIC 12, are excluded from the scope of IAS 17, some of
these types of arrangements may be accounted for as leases
under FASB ASC 840, Leases.
11.14 As reflected in current practice, operators generally
do not recognize infrastructure assets as PPE under the FASB
ASC. However, if an operator determined that lease account-
ing was appropriate under FASB ASC 840 and concluded that
the lease constituted a finance (capital) lease under FASB
ASC 840-30, the entity effectively accounts for the leased
infrastructure asset as PPE and depreciates the asset accord-
ingly. Operators generally do not recognize intangible assets
in connection with service concessions.
11.15 A potentially significant difference between IFRSs
and FASB ASC affecting revenue and expense recognition
is the requirement under FASB ASC 605-25 to evaluate the
arrangement to determine whether it is a multiple element
arrangement. In a multiple element arrangement, the entity
allocates the consideration received or receivable to indi-
vidual elements and determines the timing of revenue and
expense recognition separately for each element. FASB ASC
605-25-25-2 requires the consideration received or receiv-
able for delivery of multiple services to be allocated to the
identified elements either by reference to relative fair values
(as in IFRSs) or, if fair values are not available for all services
delivered, by using a residual method.
Author’s Note
“Pending Content” in FASB ASC 605-25-25-2,
amends this paragraph to change the words fair val-
ues to selling prices.
11.16 FASB ASC 605-25 requirements for multiple element
arrangements differ from IFRSs in two ways. First, under
FASB ASC 605-25-30-2, consideration is allocated only by
reference to the relative fair values of the individual services
to be delivered. Second, although IAS 18 requires an entity to
separately identify components of a single transaction in or-
der to reflect the substance of the transaction, IFRSs provide
little guidance for this process. Therefore, it is likely that en-
tities would recognize revenue differently under FASB ASC
605-25 and IFRSs.
Author’s Note
“Pending Content” in FASB ASC 605-25-30-2, also
amends this paragraph to change the words fair values
to selling prices.
11.17 Absent specific guidance in FASB ASC, an operator
would generally not recognize as separate assets items pro-
vided by the grantor as part of the consideration for services
to be provided and which the operator has the discretion
to retain or dispose of. Instead, the operator would allocate
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these items in the same manner as other consideration. Sim-
ilarly, an entity would not recognize liabilities unless cash is
received in advance.
11.18 Although not separately defined, a receivable meets
the definition of a financial asset in the FASB ASC glossary
(that is, a contract that conveys to one entity a right to receive
cash or another financial instrument from a second entity).
Therefore, consistent with IFRSs and in the absence of more
specific guidance, it is generally agreed an operator should
recognize a receivable to the extent that it has an uncondi-




11.19 SIC 29 applies not only to all public-to-private service
concession arrangements within the scope of IFRIC 12 but
also to private-to-private service concession arrangements, as
long as the services provided give the public access to major
economic or social infrastructure assets. However, outsourc-
ing of internal services of a public sector entity (for example,
building maintenance and technology) is excluded.
11.20 Arrangements with the following rights and obliga-
tions of the service concession operator are subject to the
disclosures required by SIC 29:
• Rights to provide services that give the public access to
major economic or social facilities
• Rights to use specified tangible assets, intangible assets,
and financial assets (in some cases)
• Obligations to provide services according to the terms
and conditions of the agreement over the concession
period
• Obligations to return any rights received at the end of
the concession period (when applicable)
11.21 Additional disclosures may be required by other stan-
dards and interpretations depending on the nature of the asset
or liability recognized (for example, IAS 38, Intangible As-
sets, or IFRS 7, Financial Instruments: Disclosures).
U.S. GAAP
11.22 Because there is no separate standard or interpretation
for service concession arrangements, disclosures would de-
pend on the specific FASB ASC topic or other U.S. generally
accepted accounting principles guidance applied.
Author’s Note
None of the survey companies whose excerpts are pro-
vided in this section early adopted IFRS 9.




Companhia de Saneamento Basico do Estado de
Sao Paolo—SABESP (Dec 2010)
CONSOLIDATED BALANCE SHEETS (in part)
As of December 31, 2010 and 2009
Amounts in thousands of reais
Assets Note December 31, 2010 December 31, 2009
Noncurrent assets
Customer accounts receivable, net 7 352,839 266,543
Accounts receivable from related party, net 8 231,076 260,365
Indemnities receivable 9 146,213 146,213
Escrow deposits — 43,543 46,365
Deferred income taxes 14 78,440 43,636
Intangible assets, net 10 18,546,836 16,917,417
Property, plant and equipment, net 11 249,606 190,430
Other assets — 111,910 101,032
Total noncurrent assets 19,760,463 17,972,001
Total assets 23,350, 584 20,243,124
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CONSOLIDATED STATEMENTS OF CASH FLOWS
(in part)
Years Ended December 31, 2010, 2009 and 2008
Amounts in thousands of reais unless otherwise indicated
Note 2010 2009 2008
Profit before income tax and social contribution 2,292,756 2,110,352 1,148,224
Adjustments for:
Depreciation and amortization 552,184 562,236 618,198
Losses on disposal of property, plant and equipment and intangible assets 16,385 23,372 176,439
Allowance for doubtful accounts expense 402,694 308,188 336,264
Change in provisions 352,614 596,543 461,654
Interest on loans and financing 450,297 395,897 502,817
Foreign exchange and monetary (gains) losses on loans and financing 21,139 (535,409) 564,095
Interest and inflation adjustment gains (55,804) (14,252) (87,789)
Provision from Săo Paulo agreement 80,368 — —
Provision for defined contribution plan 32,587 — —
Fair value margin on intangible assets arising from concession contracts (49,603) (30,145) (26,367)
Other adjustments 19,331 8,197 7,495
Adjusted net income 4,114,948 3,424,979 3,701,030
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
1. Operations
Companhia de Saneamento Básico do Estado de Săo Paulo
(“SABESP” or the “Company”) is a mixed-capital company
headquartered in Săo Paulo, controlled by the Săo Paulo
State Government. The Company is engaged in the provi-
sion of basic and environmental sanitation services, supplies
treated water on a wholesale basis and provides sewage
treatment services to six other municipalities in the Greater
Săo Paulo Metropolitan Area.
In addition to providing basic sanitation services in the State
of Săo Paulo, SABESP may perform these activities in other
states and countries, and can operate in drainage, urban
cleaning, solid waste handling and energy markets. The ob-
jective set in the new vision of SABESP is to be recognized
as the company that ensured universal access to water and
sewage services in its marketplace, focused on the customer,
and in a sustainable and competitive manner, with excellence
in environmental solutions.
On December 31, 2010, the company operates water and
sewage services in 364 of municipalities of the State of Săo
Paulo, having temporarily discontinued operations in five of
these municipalities, Itapira, Araçoiaba da Serra, Iperó, Ca-
jobi and Tarumă, due to judicial orders under ongoing law-
suits. Most of these municipalities operations are based on
30-year concession agreements. As of December 31, 2010,
119 concessions had expired and are being negotiated. From
2011 to 2030, 44 concessions will expire, and the remaining
concessions operate on rollover basis. These concessions
with indefinite terms and expired concessions under negoti-
ation are amortized over the useful lives of the underlying
assets. By December 31, 2010, 201 concession program
contracts were signed (2009—174 concession program con-
tracts). In February 2011 the Company restarted the opera-
tion in the municipality of Tarumă by judicial order.
Management believes that all concessions expired and not
yet renewed will result in new contracts or contract exten-
sions, disregarding the risk of discontinuity in the provision of
municipal water supply and sewage services. As of Decem-
ber 31, 2010, the carrying amount of the underlying assets
used in the 119 concessions of the municipalities under ne-
gotiation totaled R$ 5,465 million and the related revenue for
the year then ended totaled R$ 2,591 million.
The Company’s operations are concentrated in the mu-
nicipality of Săo Paulo, which accounted for 54.66% of the
gross revenues in 2010. On June 23, 2010, the State of Săo
Paulo, the Municipality of Săo Paulo, the Company and the
regulatory agency “Agência Reguladora de Saneamento e
Energia—ARSESP” signed an agreement to share the re-
sponsibility for water supply and sewage services to the Mu-
nicipality of Săo Paulo based on a 30-year concession agree-
ment. This agreement is extendable for another 30 years.
This agreement sets forth SABESP as the exclusive service
provider and designates ARSESP as regulator, establishing
prices, controlling and monitoring services.
Also, on June 23, 2010, the State of Săo Paulo, the city of
Săo Paulo and SABESP signed the “Public service provision
agreement of water supply and sewage services,” a 30-year
concession agreement which is extendable for another 30
years. This agreement involves the following activities:
(i) protection of the sources of water in collaboration with
other agencies of the State and the City;
(ii) capture, transport and treatment of water;
(iii) collect, transport, treatment and final disposal of sani-
tary sewage; and
(iv) adoption of other actions of basic and environmental
sanitation.
In the municipality of Santos, in the Baixada Santista region,
which has a significant population, the Company operates
under an authorization by public deed, a situation similar to
other municipalities in that region and in the Ribeira valley,
where the Company started to operate after the merger of the
companies that formed it.
On January 5, 2007, Law 11,445 was enacted, establish-
ing the basic sanitation regulatory framework, providing for
the nationwide guidelines and basic principles for the provi-
sion of such services, such as social control, transparency,
the integration authority of sanitation infrastructure, water re-
sources management, and the articulation between industry
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policies and public policies for urban and regional develop-
ment, housing, suppression of poverty, promotion of health
and environmental protection, and other related issues.
The Company’s shares have been listed in the Novo Mer-
cado (New Market) segment of BM&FBOVESPA (the Săo
Paulo Stock Exchange) since April 2002 and on the New
York Stock Exchange (NYSE) as American Depositary Re-
ceipts (“ADRs”) since May 2002.
These financial statements were approved by the Board of
Directors on June 2, 2011.
2. Summary of Significant Accounting Practices
(in part)
2.2. Proportional Consolidation (in part)
The consolidated financial statements include the financial
statements of the Company and its investees: Sesamm—
Serviços de Saneamento de Mogi Mirim S/A, Águas de An-
dradina S.A., Saneaqua Mairinque S.A. e Aquapolo Ambien-
tal S.A., which were proportionally consolidated according to
the equity interest over its investees.
The Company has no majority shares of its investees, but
according to investees’ By-Laws approvals of any subject by
shareholders in general meeting, except for the approval of
any subject mentioned in the investees’ By-Laws, which re-
lates to decisions that affect financial and operational policies,
for example, approval of the business plan, will be made by
a majority vote, and SABESP has power of veto.
For the purposes of calculating the Company’s proportional
share of revenues, expenses, assets and liabilities of its in-
vestees, unrealized gains or transactions between the Com-
pany and its investees were eliminated in proportion to the
Company’s interest; unrealized losses are also eliminated,
unless the transaction presents evidence of impairment of
the transferred asset. The accounting policies applied by the
investees are consistent with the accounting policies adopted
by the Company.
Sesamm
On August 15, 2008, the Company, together with the com-
panies OHL Médio Ambiente, Inima S.A.U. Unipersonal (“In-
ima”), Técnicas y Gestión Medioambiental S.A.U. (“TGM”)
and Estudos Técnicos e Projetos ETEP Ltda. (“ETEP”) in-
corporated the company Serviços de Saneamento de Mogi
Mirim S.A.—SESAMM (“SESAMM”), for a period of 30 years
from the date the concession agreement with the municipal-
ity of Mogi Mirim for the purpose of providing complementary
services to the sewage diversion system and implementing
and operating a sewage treatment system in the municipality
of Mogi Mirim, including the disposal of solid waste.
SESAMM’s capital as of December 31, 2010 and 2009,
totaled R$ 10,669, and was represented by 10,669,549 reg-
istered shares without a par value. SABESP holds 36% of
its equity interest and Inima holds another 36% of its equity
interest. The Company concluded that both, SABESP and In-
ima, have joint control over SESAMM. Accordingly, SABESP
records their interest over SESAMM applying the proportional
consolidation method, equivalent to the 36% of SESAMM’s
assets and liabilities, revenues and expenses.
As of December 31, 2010, SESAMM´s operations had not
been started yet.
2.7. Revenue from Sales and Services
Revenue from water supply and sewage collection are recog-
nized as the water is consumed and services are provided.
Revenues, including the revenues unbilled, are recognized
at the fair value of the consideration received or receivable
for the sale of those services in the ordinary course of the
Company’s activities. Revenue is shown net of value-added
tax, returns, rebates and discounts. Revenues from unbilled
represent incurred revenues in which the services were pro-
vided, but not yet billed until the end of the each period. Water
supply and sewage services are recorded as trade accounts
receivable based on monthly estimates of the completed ser-
vices.
The Company recognizes revenue when: i) products are
delivered or services are rendered; ii) the amount of revenue
can be reliably measured, iii) it is probable that future eco-
nomic benefits will flow to the Company and iv) it is probable
that the amounts will be collected. The amount of revenue is
not considered to be reliably measurable until all conditions
relating to the sale have been satisfied. Amounts in dispute
are recognized as revenue when collected.
Construction Revenue
Revenue from concession construction contracts is recog-
nized in accordance with IAS 11 Construction Contracts using
the percentage-of-completion method, provided that the ap-
plicable conditions for application are fulfilled. The percentage
of completion is calculated from the ratio of the actual costs
incurred on the balance sheet date to the planned total costs
(cost-to-cost method). Revenue from cost plus contracts is
recognized by reference to the construction costs incurred
during the period plus a fee earned. The fee represents the
additional margin related to the work performed by the Com-
pany in relation to such construction contracts and it is added
to the construction costs incurred and the total is recognized
as construction revenue.
2.11 Intangible Assets (in part)
Intangibles are stated at cost combined with the following
aspects:
Valued at acquisition cost and/or construction of the un-
derlying assets, including interest capitalized during the
construction period, where applicable, for the qualifying
assets. Qualifying assets are assets that, necessarily,
take a substantial period to get ready for its intended
use or sale. The Company considers that substantial pe-
riod means a period greater than 12 months. This period
was established by considering the completion period of
the majority of its constructions which is greater than 12
months. The historical cost was adjusted to fair value
in 1991 and 1992, in accordance with former Brazilian
GAAP.
The amortization is calculated when the intangible assets are
available for use in the necessary condition established by
the Company.
The amortization reflects the period over the expected fu-
ture economic benefits generated by the intangible asset and
can be the period of the contract, depending on the contract.
The utilization of the assets is related to its useful life of the
assets constructed by the Company and the amortization of
the intangible assets is considered in the calculation of the
tariff.
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The amortization of the intangible assets finishes when
the underlying asset is totally consumed or is alienated, not
being considered in the calculation of the tariff any longer,
whichever occurs first.
Infrastructure to which the operator is given access by the
grantor of the concession or donation received from third
parties is not recognized in the consolidated balance sheet,
since such donations are controlled by the municipalities.
(a) Concession Arrangements
The infrastructure used by SABESP subject to service con-
cession arrangements is considered to be controlled by the
concession grantor when:
(i) The grantor controls or regulates what services the
operator must provide with the infrastructure, to whom
it most provide them, and at what price; and
(ii) The grantor controls the infrastructure, i.e., retains the
right to take back the infrastructure at the end of the
concession.
SABESP’s rights over infrastructure operated under conces-
sion arrangements are accounted for as an intangible asset
as SABESP has the right to charge for use of the infrastruc-
ture assets, and users (consumers) have the primary respon-
sibility to pay SABESP for the services.
The fair value of construction and other work on the in-
frastructure represents the cost of the intangible asset and is
recognized as revenue when the infrastructure is built, pro-
vided that this work is expected to generate future economic
benefits.
The great majority of the Company’s contracts for ser-
vice concession arrangements entered with each municipality
(grantor) is under service concession agreements in which
the Company has the legal right to receive, at the end of
the contract, a compensation equivalent to the unamortized
asset balance of the underlying physical assets. The conces-
sion intangible assets are, therefore, amortized considering
the useful lives of the underlying physical assets. Thus, at the
end of the contract, the remaining value of the intangible will
be equal to the residual value of the related physical assets.
Concession intangible assets under Concession contracts
and Program contracts, when there is no right to receive the
residual value of the assets at the end of the contract, are
amortized on a straight-line basis over the period of the con-
tract, or the useful life of the underlying asset.
(b) Amortization Rates
The annual amortization rates based on the related underly-
ing assets as of December 31, 2010 are as follows:
Description of the Underlying Asset
Water and sewage infrastructure 2%
Equipment 5%
Transportation equipment 10%
Furniture and fixtures 6.7%
Others 5%
4. Critical Accounting Estimates and Judgments
(in part)
Estimates and judgments are continually evaluated and are
based on historical experience and on other factors, including
expectations of future events that are believed to be reason-
able under the circumstances.
4.1 Critical Accounting Estimates and Assumptions (in part)
(b) Intangible Assets Arising from Concession Contracts
The Company recognizes intangible assets arising from con-
cession contracts under IFRIC 12. The Company estimates
the fair value of construction and other work on the infras-
tructure to recognize the cost of the intangible asset, which is
recognized when the infrastructure is built and provided that
it will generate future economic benefits. The great majority
of the Company’s contracts for service concession arrange-
ments entered with each grantor is under service concession
agreements in which the Company has the right to receive,
at the end of the contract, a payment equivalent to the un-
amortized asset balance of the concession intangible asset,
which in this case, are amortized over the useful life of the
underlying physical assets, thus at the end of the contract,
the remaining value of the intangible would be equal to the
residual value of the related physical asset.
Concession intangible assets under Concession contracts
and Program contracts, in which, at the end of the contract,
the Company has no right to receive a payment equivalent to
the unamortized asset balance of the concession intangible,
are amortized on a straight-line basis over the useful life of
the contract. Additional information on the accounting for in-
tangible assets arising from concession contracts is disclosed
in Note 2.11(a).
The recognition of fair value for the intangible assets aris-
ing on concession contracts is subject to assumptions and
estimates, and the use of different assumptions could af-
fect the balances recorded. The estimated useful lives of the
underlying assets also requires significant assumptions and
estimates, which different assumptions and estimates and
changes in future circumstances, could affect the remaining
useful lives of the intangible assets and can have a significant
impact on the results of operations.
(c) Impairment of Long-Lived Assets
The Company reviews annually long-lived assets for indica-
tors of impairment, primarily intangible assets arising from
concession contracts, which include water and sewage sys-
tem physical assets to be held and used in the business, for
the purpose of determining and measuring impairment when
events or changes in circumstances indicate that the carrying
value of an asset or group of assets may not be recoverable.
The assets include the intangible asset of the concession
contracts related to water and sewage systems.
In evaluating impairment of long-lived assets, the evalua-
tion requires significant assumptions and estimates regarding
matters that are inherently uncertain, including projections of
future operating income and cash flows, future growth rates,
and the remaining useful lives of the assets and/or the period
of the contract, among other factors. In addition, projections
are computed over an extended period of time, which subjects
those assumptions and estimates to an even larger degree of
uncertainty. While the Company believes that the estimates
used are reasonable, the use of different assumptions could
materially affect the recoverable amount.
No impairment provisions were required in 2010, 2009 and
2008.
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9. Indemnities Receivable
Indemnities receivable are a noncurrent asset that represents
amounts receivable from the Municipalities of Diadema and
Mauá as an indemnity for their unilateral termination of the
concessions for water supply and sewage services of the
Company in 1995. As of December 31, 2010 and 2009, this
balance totaled R$ 146,213.
Due to these concession agreements, the Company in-
vested in the construction of water and sewage systems in
those municipalities in order to meet the concession service
commitments. For the unilateral termination of the Diadema
and Mauá concessions, the municipalities assumed the re-
sponsibility of supplying water and sewage services in those
regions. At that time, the Company reclassified the balances
of property, plant and equipment related to the assets used
in those municipalities to noncurrent assets (indemnities re-
ceivable).
As of December 31, 2010, the net book value of property,
plant, and equipment relating to the municipality of Diadema,
reclassified in December 1996, amounted to R$ 75,231 and
the indemnity balance from the municipality amounted to R$
60,295, on December 31, 2010.
As of December 31, 2010, the net book value of prop-
erty, plant, and equipment relating to the municipality of
Mauá, reclassified in December 1999, totaled R$ 103,763
and the indemnities receivables from the municipality totaled
R$ 85,918.
The Company’s right to recover these amounts has been
challenged by the municipalities.
SABESP filed lawsuits to collect the amounts due by the
municipalities. With respect to Diadema, the decision of the
lower court judge was unfavorable to SABESP, which filed
an appeal in November 2000. In December 2005, SABESP’s
appeal to have the agreement entered into with the munici-
pality of Diadema declared valid was partially accepted. Even
though this Municipal Government filed appeals against this
decision, they were all denied and an unappealable decision
was issued in April 2009. In December 2007, the decision that
accepted the execution of the Companhia de Saneamento
the Diadema—Saned was rendered, ordering this company
to be summoned to pay the full amount of the debt within 15
days under the penalty of fine. Saned filed an interlocutory ap-
peal against the decision but the appeal was rejected by the
Court of Justice in June 2008. The judge approved the seizure
of cash from Saned’s bank accounts and short-term invest-
ments (online seizure) of up to 10% of the adjusted debt. An
appeal was filed against this decision, but the Appellate Court
upheld the final and unappealable decision. R$ 2,919 were
seized and withdrawn on March 3, 2009. Subsequently, the
Court of Justice issued an injunction determining the seizure
through weekly deposits by Saned in the amount correspond-
ing to 20% of everything received in its bank accounts and
short-term investments. This injunction was confirmed in the
sentence of the Court of Justice, which can still be appealed.
On December 29, 2008, Saned and the Municipality of Di-
adema entered into a Letter of Intent with the Săo Paulo State
and SABESP for the purpose of preparing studies and con-
ducting negotiations to guide Diadema’s and SABESP’s deci-
sions, aiming to establish SABESP as the exclusive provider
of water supply and sewage services for the City of Diadema.
The parties agree that the settlement of the existing con-
flicts between the companies is indispensable for the proper
development of the public utility services of water supply and
sewage services in the municipality of Diadema.
In January 2009, the parties filed a joint petition requesting
the suspension of new seizures, for a three-month period, try-
ing to enable an agreement. The suspension was confirmed
by the Tax Court. As the settlement on which a possible
agreement will be based was maintained, the suspension re-
quest was last renewed in April 2010.
With respect to Mauá, a lower court decision demanded this
Municipality pay the amount of R$ 153.2 million to SABESP
as a compensation for loss of profits. In April 2005, the Munic-
ipality of Mauá filed an appeal against this decision. In July
2006, the decision was converted into a measure consist-
ing of an expert clarification on the amount of the indemnity
for loss of profits. The clarification was provided in December
2007, and the expert confirmed the amount of the loss of prof-
its determined by the lower court. In August 2008, the Court
of Justice decided for the integral maintenance of the lower
court decision. The Municipality of Mauá filed special and ex-
traordinary appeals against the decision that confirmed the
sentence to indemnify SABESP. Both appeals were denied
by the Court of Justice, which led to the filing of a bill of re-
view with the Superior Court of Justice and Federal Supreme
Court. Based on the opinion of its legal advisors, manage-
ment continues to believe that the Company is entitled to
receive the amounts related to the indemnity and continues
to monitor the status of the lawsuits.
Based on legal opinion, management believes that the
Company has legal rights to receive the indemnities and is
monitoring the judicial lawsuit.
10. Intangible Assets






Intangible Rights Arising From Concession Contracts
Service concession agreements 13,980,141 (3,242,270) 10,737,871 23,074,648 (7,702,533) 15,372,115
Concession contracts 706,423 (189,145) 517,278 669,301 (165,156) 504,145
Program contracts 900,686 (36,302) 864,384 794,561 (21,772) 772,789
Program contracts—commitments 333,942 (22,666) 311,276 271,194 (12,391) 258,803
Service contract—Săo Paulo 6,196,699 (99,837) 6,096,862 — — —
New businesses 12,129 (901) 11,228 — — —
22,130,020 (3,591,121) 18,538,899 24,809,704 (7,901,852) 16,907,852
Software licenses 49,458 (41,521) 7,937 42,679 (33,114) 9,565
Total 22,179,478 (3,632,642) 18,546,836 24,852,383 (7,934,966) 16,917,417
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Intangible Rights Arising on Concession Contracts
Service concession agreements 13,775,366 869,438 (176,340) (396,957) 14,071,507
Concession contracts 507,789 23,444 — (21,509) 509,724
Program contracts 8,704 623,391 — (9,712) 622,383
Program contracts—commitments — 252,770 — (3,131) 249,639
14,291,859 1,769,043 (176,340) (431,309) 15,453,253
Software licenses — 29,725 — (20,123) 9,602







Intangible Rights Arising on Concession Contracts
Service concession agreements 14,071,507 1,849,993 (51,778) (497,607) 15,372,115
Concession contracts 509,724 17,429 — (23,008) 504,145
Program contracts 622,383 162,466 — (12,060) 772,789
Program contracts—commitments 249,639 18,424 — (9,260) 258,803
15,453,253 2,048,312 (51,778) (541,935) 16,907,852
Software licenses 9,602 12,954 — (12,991) 9,565







Intangible Rights on Concession Contracts
Service concession agreements 15,372,115 1,767,747 (6,019,568) (15,857) (366,566) 10,737,871
Concession contracts 504,145 37,122 — — (23,989) 517,278
Program contracts 772,789 106,125 — — (14,530) 864,384
Program contracts—commitments 258,803 62,748 — — (10,275) 311,276
Service contract—Săo Paulo — 177,131 6,019,568 — (99,837) 6,096,862
New businesses — 12,129 — — (901) 11,228
16,907,852 2,163,002 — (15,857) (516,098) 18,538,899
Software licenses 9,565 6,779 — — (8,407) 7,937
16,917,417 2,169,781 — (15,857) (524,505) 18,546,836
The status of our aggregated construction in progress of the
underlying assets of concession contracts at the end of the
year is as follows:





Construction costs incurred 551,655 1,098,848 1,650,503
Recognized profits less recognized losses 560,346 1,116,523 1,676,869





Construction costs incurred 760,706 1,248,957 2,009,663
Recognized profits less recognized losses 772,117 1,267,691 2,039,808





Construction costs incurred 1,028,115 1,052,956 2,081,071
Recognized profits less recognized losses 1,051,419 1,079,256 2,130,675
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There are no contingent assets or liabilities related to the
construction contracts outstanding.
Investments Committed
The estimated amount related to investments is R$ 2,262
million to be spent from 2011 to 2015 (unaudited).
Intangible Rights Arising from Concession Contracts
The Company operates concession contracts as defined by
IFRIC 12 covering the provision of basic and environmen-
tal sanitation services, water supply and sewage services.
These concession arrangements set out rights and obliga-
tions relative to the infrastructure and to the public service
(See Note 2.11(a)). A general obligation also exists to return
the concession infrastructure to the grantor in good working
condition at the end of the concession.
As of December 31, 2010 and 2009, the Company oper-
ates in 364 municipalities in the State of Săo Paulo. In most
of these municipalities operations are based on 30-year con-
cession period. The agreement with the municipality of Săo
Paulo is accounted for as a service concession arrangement.
The services provided by the Company are billed at a price
established by the “Agência Reguladora de Saneamento e
Energia do Estado de Săo Paulo” (“ARSESP”). Intangible
rights arising on concession contracts are comprised of:
(i) Service concession agreements
The concession contracts state that the property will re-
vert to the grantor at the end of the period, through com-
pensation for the residual value or market value of the
underlying physical assets in accordance with the stipu-
lations in each contract and amortization are calculated
using the straight-line method, which consider the physi-
cal assets economic useful lives.
(ii) Concession contracts
From 1999 through 2006, the negotiations for new con-
cessions were conducted on the basis of the economic
and financial profit or loss of the transaction, determined
in a valuation report issued by independent appraisers.
The amount determined in the related contract, after
the transaction is closed with the municipal authorities, re-
alized through the subscription of the Company’s shares
or in cash, is recorded as “concession contract” and amor-
tized over the period of the related concession (usually 30
years). As of December 31, 2010, 2009 and 2008 there
were no amounts pending related to these payments to
the municipalities.
Intangible assets are amortized on a straight line basis
over the term of the concession agreements or for the
useful lives of the underlying assets, which was lower,
entered into with the related municipality.
(iii) Program contracts—Commitments
After the enactment of the regulatory framework in 2007,
renewals of concession agreements are made through
“program contracts.” In some program contracts the Com-
pany committed to financially participate in social and
environmental sanitation actions. These assets built and
commitments assumed are being amortized on a straight
line basis according to the effective period of the program
contract (mostly 30 years).
As of December 31, 2010, the amounts not yet dis-
bursed related to commitments under the program con-
tracts are recorded in “Other obligations” in current lia-
bilities in the amount of R$ 38,427 and R$ 45,584, and
noncurrent liabilities in the amount of R$ 106,696 and R$
93,292, as of December 31, 2010 and 2009, respectively.
(iv) Program contracts
It refers to the renew of contracts formerly denominated
full concession to operation concession, by program
contracts which purpose is the water supply, sewage
and sanitation public service, where the Company has
the control of the assets acquired or constructed dur-
ing the contract period (30 years) or for the useful lives
of the underlying assets, which was lower.
(v) New businesses
In August 2009, the Company and Companhia de Sanea-
mento de Alagoas—CASAL signed 60 month-period
agreement to provide specialized technical services to
implement a program to reduce the losses and retain
revenues in the municipality of Maceio. The construction
started in 2010.
As of December 31, 2010 the total amount was R$
11,228.
(a) Disposals of Concession Intangible Assets
In 2010, 2009 and 2008, the Company wrote off conces-
sion intangible assets items totaling R$ 15,857, R$ 51,778
and R$ 176,340, respectively, due to obsolescence, theft,
misplacements, unproductive wells and projects considered
economically unfeasible.
(b) Capitalization of Interest and Financial Charges
The capitalization occurs during the construction period of the
assets, considering the average interest rate of the loans in
place in the date of the capitalization.
The Company analyzes the loans and financing acquired
in foreign currency and considers if such loans and financing
were obtained in local currency, establishing a limit to capi-
talize interest and exchange rate variation by the amount that
were capitalized if such loans and financing were acquired in
local currency.
In 2010, 2009 and 2008, the Company capitalized inter-
est and inflation adjustment, including related foreign cur-
rency exchange effects, in concession intangible assets dur-
ing the construction period of the qualifying assets totaling
R$ 228,899, R$ 51,625 and R$ 219,430, respectively.
(c) Revenue from Construction
The Company is responsible to construct and install the in-
frastructure related to the concession contract, using its own
resources or contracting third parties to perform the work,
being exposed to its risks and benefits.
The Company recognizes revenue from construction re-
lated to construction costs added by gross margin. In general,
the constructions regarding the concessions are performed
by third parties. In this case the margin is lower and it is to
cover the costs of management and supervision of the con-
struction. Based on the studies and the benchmark with com-
panies in the construction market the margin used in 2010
was 2.6%.
The amount, net of amortization, in December 31, 2010
was 33,485 (R$ 28,828 in 2009).
(d) Expropriations
As a result of the construction of priority projects related to
water and sewage systems, the Company was required to ex-
propriate or establish rights of way in third-parties’ properties,
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and the owners of these properties will be compensated ei-
ther amicably or through courts.
The assets received as a result of expropriations are
recorded as concession intangible assets after the transac-
tion is completed. In 2010, 2009 and 2008, the amount related
to expropriations was R$ 10,779, R$ 6,244 and R$ 11,004,
respectively.
(e) Assets Pledged as Guarantee
As of December 31, 2010 and 2009, the Company had under-
lying physical assets totaling R$ 249,034 offered as guaran-
tee to the request for the PAES (tax debt refinancing program)
(Note 13).
(f) Public-Private-Partnership (PPP)
The Company and CAB-Sistema Produtor Alto Tiete S.A.,
special purpose entity, formed by Galvăo Engenharia S.A.
and Companhia Águas do Brasil—Cab Ambiental, signed in
June 2008 the contract of public-private-partnership of Alto
Tiete production system.
The contract last 15 years which purpose is expand the
capacity of treated water of Taiaçupeba from 10 thousand to
15 thousand of liters per second.
As of December 31, 2010 and 2009 the amount recognized
as intangible asset related to PPP was R$ 353,468 and R$
150,281, respectively.
14. Deferred Income Taxes (in part)
Breakdown of Deferred Taxes
December 31, 2010 December 31, 2009
Deferred Income Tax Assets(i)
Provisions 539,394 541,511
Pension obligations—G1 162,552 177,736
Accounts receivable from related party—G0 85,271 85,271
Donations of underlying assets on concession agreements 38,213 35,334
Other 179,356 87,077
Total deferred tax assets 1,004,786 926,929
Deferred Income Tax Liabilities
Temporary differences of concession intangible assets (711,283) (721,620)
Capitalization of borrowing costs (102,339) (66,507)
Revenue—government entities (72,968) (73,005)
Other (39,756) (22,161)
Total deferred tax liabilities (926,346) (883,293)
Deferred tax asset (liability) in the balance sheet 78,440 43,636
(i) The expectation of the Company’s management is to realize the deferred income tax assets in 2012 in the same portion of 2011, and the
residual amount to be realized in 2013.
The movements in deferred income tax assets and liabilities
in 2010, 2009 and 2008 are as follows:









As of January 1, 2008 334,489 138,681 — 28,989 11,574 513,733
Credited (charged) to income statement 76,986 18,577 85,271 5,258 45,705 231,797
As of December 31, 2008 411,475 157,258 85,271 34,247 57,279 745,530
Credited (charged) to income statement 130,036 20,478 — 1,087 29,798 181,399
As of December 31, 2009 541,511 177,736 85,271 35,334 87,077 926,929
Credit (charged) to income statement (2,117) (15,184) — 2,879 92,279 77,857
As of December 31, 2010 539,394 162,552 85,271 38,213 179,356 1,004,786









As of January 1, 2008 (787,666) — (86,487) (5,142) (879,295)
Credited (charged) to income statement 28,944 — 12,117 (9,763) 31,298
As of December 31, 2008 (758,722) — (74,370) (14,905) (847,997)
Credited (charged) to income statement 37,102 (66,507) 1,365 (7,256) (35,296)
As of December 31, 2009 (721,620) (66,507) (73,005) (22,161) (883,293)
Credit (changed) to income statement 10,337 (35,832) 37 (17,595) (43,053)
As of December 31, 2010 (711,283) (102,339) (72,968) (39,756) (926,346)
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15. Provisions (in part)
(viii) Other Concession-Related Legal Proceedings
(a) On March 25, 2005, the municipality of Itapira revoked
the concession contract and filed an Assets Repos-
session Action against SABESP. The outcome of this
claim was unfavorable to the Company. The Company
appealed the decision, but in view of the compensation
lawsuit filed against the aforementioned municipality,
the Company has waived the appeal.
(b) The municipality of Cajobi has filed a Repossession
Action that seeks the takeover of the water supply and
sewage services, and sentencing the Company to pay
for losses and damages for amounts received as wa-
ter and sewage tariffs not received in view of utilities
explored since the enactment of the Municipal Decree,
and for the use of assets related to the concession. The
court decision confirmed the Municipality’s takeover of
the water and sewage services. On August 25, 2008,
SABESP filed an appeal that awaits judgment. The
Municipality provides water supply and sewage col-
lection services since May 29, 2007 under injunction
granted in the interlocutory appeal.
(c) The City of Araçoiaba da Serra filed a Repossession
Action seeking an authorization to enter concession-
related facilities, including all properties and chattels
linked to the water supply and sewage treatment ser-
vices. The Municipality is now managing and operat-
ing these services in view of the termination of the
concession agreement on September 23, 2006. The
Municipality also claims the definitive takeover of the
services, including due handover of all assets, rights
and privileges previously transferred to SABESP. The
initially granted injunction and confirmed by the appel-
late court maintained the Municipality as the service
provider. The Company has subsequently filed for an
injunction to request the early production of evidence.
The lawsuit is in the fact-finding phase.
(d) On July 2, 2010, the City of Tarumă filed a writ of pre-
vention related to all assets related to the collection,
treatment and water supply and sewage services sys-
tems. On January 19, 2011 the Company restarted its
operation in this municipality by a court decision. By
injuction decision, the assets will be under SABESP´s
custody due to eventual liquidation of the indemnity to
SABESP. SABESP awaits the final decision.
(e) In December 2, 1997, the municipality of Santos en-
acted a law expropriating the Company’s water and
sewerage mains in Santos. The Company requested
an injunction against the expropriation which was de-
nied by the lower court. This decision was subse-
quently reversed by the State of Săo Paulo appellate
court, which then issued an injunction suspending the
law. The Company was granted a favorable decision
at the lower court, and the municipality of Santos ap-
pealed against the decision. Although the decision was
maintained by the Court of Justice, it is not final. De-
spite the pending action, the Company is operating
the water supply and sewage collection systems in the
municipality of Santos.
(f) The municipality of Tuiuti has brought a declaratory
action seeking to recognize the inexistence of any ju-
dicial or legal grounds to justify our permanence as the
provider of water supply and sewage services in the
municipality of Tuiuti, and the subsequent taking over
of these services by the municipality. The Company
responded with a counterclaim against the municipal-
ity seeking a statement corroborating the existence of
a legal relationship between the two parties for subse-
quent compensation for investments made. The lower
court decision was partially unfavorable to SABESP
as it declared that there was no legal relationship be-
tween the Municipality and SABESP relative to the
service concession and confirmed the injunction au-
thorizing the takeover of the services. However, the
court’s decision was favorable to the counterclaim filed
by SABESP and sentenced the Municipality to pay R$
541, restated from March 1996. The Company filed
an appeal on July 22, 2009. On the other hand, the
Municipality also filed an appeal. The State Appellate
Court partially agreed with SABESP to increase the
indemnity to R$ 1.1 million (Dec./1995). SABESP is
not operating in this municipality as required by the
injunction granted to the Municipality.
(g) On January 12, 2001, the Company filed an ordinary
action against the municipality of Presidente Prudente
for the purpose of recognizing the contractual right to
maintain SABESP as the sanitation service until the
legal and formal cancellation of the contract, including
the respective indemnity, which recognizes the abu-
sive and illegal the acts of the municipality. The Com-
pany still provides sanitation service in Presidente Pru-
dente according to the Decree no 21,228/2010, which
extended the concession contract of Presidente Pru-
dente up to March 2011.
As of December 31, 2010, the lawsuits filed by the
Municipalities of Itapira, Cajobi, Araçoiaba da Serra
and Tarumă totaled approximately R$ 12.2 million and,
based on our legal advisors’ assessment, the likeli-
hood of loss in possible. Our legal advisors assessed
the likelihood of loss as probable regarding the munic-
ipalities of Santos, Tuiuti. With regards to Presidente




SECTION 12: FIRST-TIME ADOPTION OF IFRSS∗




U.S. generally accepted accounting principles (GAAP)
have no comparable standard for an entity adopting
U.S. GAAP or transitioning to U.S. GAAP from an-
other set of accounting principles.
IFRSs Overview and Comparison
to U.S. GAAP
12.01 The International Accounting Standards Board
(IASB) issued International Financial Reporting Standard
(IFRS) 1, First-time Adoption of International Financial Re-
porting Standards, to ensure that an entity’s first IFRS finan-
cial statements, as well as any interim statements issued in
the same reporting period, provide a suitable starting point
for accounting in accordance with IFRSs. The objective of
IFRS 1 is for an entity’s first IFRS financial statements to
provide high quality information that is transparent to users
and comparable over all periods presented, subject to the
constraint that cost should not exceed benefits.
Author’s Note
IFRS 1 is not a static standard. As new jurisdictions
permit or require companies to adopt IFRSs, the enti-
ties affected bring additional issues to the IASB. Many
of the significant provisions are discussed in further de-
tail in “Author’s Notes” appearing later in this section.
The IASB has since amended IFRS 1 in the following
documents:
• International Financial Reporting Interpretations
Committee (IFRIC) 18, Transfers of Assets from
Customers (issued January 2009 with an effective
date of 1 July 2009)
• Additional Exemptions for First-time Adopters:
Proposed amendments to IFRS 1 (issued July
2009 with an effective date of 1 January 2010)
• IFRIC 19, Extinguishing Financial Liabilities
with Equity Instruments (issued November 2009
with an effective date of 1 July 2010)
• Limited Exemption from Comparative IFRS 7
Disclosures for First-time Adopters: Amendment
to IFRS 1 (issued January 2010 with an effective
date of 1 January 2010)
• Improvements to IFRSs (issued May 2010 with an
effective date of 1 January 2011)
∗ Unless otherwise indicated, references to International Accounting Stan-
dards Board (IASB) standards and interpretations throughout this 2011
edition of IFRS Accounting Trends & Techniques refer to the version of
those standards and interpretations included in IFRS 2011 bound volume,
the official printed consolidated text of IASB standards and interpretations,
including revisions, amendments, and supporting documents, issued as of
1 January 2011.
• IFRS 9, Financial Instruments (issued November
2009 with an effective date of 1 January 2013)
• Disclosures—Transfers of Financial Assets:
Amendments to IFRS 7 (issued October 2010 with
an effective date of 1 July 2011)
• IFRS 9, Financial Instruments (issued October
2010 with an effective date of 1 January 2013)
• Severe Hyperinflation and Removal of Fixed
Dates for First-time Adopters: Amendments to
IFRS 1 (issued December 2010 with an effective
date of 1 July 2011)
The amendments previously mentioned are effective
for periods beginning on or after the effective dates
noted. Earlier application is permitted. The timing of
the effective dates of these revisions impacts the avail-
ability of illustrative excerpts from survey companies’
financial statements. Accordingly, the excerpts appear-
ing later in the section may not reflect some or all of
these revisions. The following commentary only ad-
dresses the requirements of IFRSs effective on or be-
fore 1 January 2010.
12.02 An entity should apply IFRS 1 in its first IFRS fi-
nancial statements. It should also apply IFRS 1 in any in-
terim financial statements presented in accordance with In-
ternational Accounting Standard (IAS), Interim Financial
Reporting, for part of the period covered by its first IFRS
financial statements. IFRS 1 considers an entity to present
its first IFRS financial statements when these financial state-
ments contain an explicit, unreserved statement of compli-
ance with IFRSs. Unless an entity makes this explicit, un-
reserved statement of compliance, it has not yet presented
its first IFRS financial statements. IFRS 1 identifies several
cases that do not relieve or disqualify an entity from apply-
ing IFRS 1 in the first set of financial statements in which
full compliance is claimed. One such case is a subsidiary that
prepares an IFRS-compliant consolidation package for a par-
ent that issues IFRS-compliant consolidated financial state-
ments. However, the subsidiary only issues financial state-
ments in its national GAAP. Because the subsidiary itself has
not issued a complete set of financial statements as defined in
IAS 1, Presentation of Financial Statements, with an explicit
unreserved statement of compliance, it would still be eligible
to apply IFRS 1 if it chooses, or is required, to adopt IFRSs
in the future.
12.03 A first-time adopter of IFRSs is required to comply
with IFRS 1. However, an entity has one, and only one, op-
portunity to apply IFRS 1 to its financial statements to take
advantage of the various exemptions available to first-time
adopters. Even if an entity fails to provide IFRS-compliant fi-
nancial statements in some period after its first IFRS financial
statements, it should not apply IFRS 1 subsequently.
12.04 An entity already reporting under IFRSs should
only apply the requirements of IAS 8, Accounting Policies,
Changes in Accounting Estimates and Errors, to a change in
accounting policy. IFRS 1 should not be applied.
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Recognition and Measurement
IFRSs
12.05 At the date of transition to IFRSs, IFRS 1 requires
an entity to prepare and present its opening balance sheet in
accordance with IFRSs. Additionally, the entity should ap-
ply the same accounting policies in its opening IFRS balance
sheet and throughout all periods presented in its first IFRS
financial statements. These accounting policies should com-
ply with each IFRS that is effective at the end of its first IFRS
reporting period, except as otherwise permitted by IFRS 1.
The standards effective at the end of the entity’s first IFRS
reporting period may be different from those that were in
effect at the entity’s transition date, which is the date of its
opening IFRS balance sheet.
12.06 Unless a specific exemption or exception is provided
or required by IFRS 1, IAS 8 requires retrospective appli-
cation for all changes in accounting policy. Retrospective
application involves preparation of the financial statements
as if the entity always applied the new accounting policy.
Retrospective application may be costly or impracticable for
an entity to accomplish or may permit an entity to use hind-
sight to achieve an advantageous result. For the benefit of
first-time adopters of IFRSs, IFRS 1 provides both relief (ex-
emptions) and prohibitions (exceptions) from retrospective
application, as explained in more detail subsequently.
12.07 Exemptions from retrospective application are vol-
untary. An entity should explicitly identify, elect, and then
discuss the elected exemptions in disclosures required by
IFRS 1. Exemptions exist for the following:
• Business combinations. An entity may elect to apply
IFRS 3, Business Combinations, prospectively to all
subsequent business combinations either from the date
of transition or a specifically selected earlier date. When
elected, this exemption permits an entity to avoid restat-
ing any business combination that occurred before the
selected date, regardless of the method(s) of account-
ing used at the original dates of prior combinations (for
example, combinations accounted for as a pooling of
interests would not be restated).
• Share-based payments. This exemption relieves a first-
time adopter from applying IFRS 2, Share-based Pay-
ments, to equity instruments granted on or before 7
November 2002. However, if an entity decides to ap-
ply IFRS 2 to instruments granted before this date,
it should disclose the instruments’ fair value. An ad-
ditional exemption relieves a first-time adopter from
applying IFRS 2 to equity instruments granted after 7
November2002, and vested before the later of its date
of transition to IFRSs or 1 January 2005.
• Insurance contracts. An entity may elect the transition
provisions of IFRS 4, Insurance Contracts.
• Deemed cost for property, plant, and equipment (PPE);
investment property; and intangible assets. An entity
may elect to measure at fair value individual assets
of PPE, investment property, and intangible assets that
meet the criteria for revaluation and use the cost model
for subsequent measurement in accordance with the
relevant standard. Alternative measures of fair value
under this exemption are a revaluation under the entity’s
previous GAAP done at or before the date of transition
if that revaluation is broadly comparable to fair value,
and cost or depreciated cost, in accordance with IFRSs,
adjusted to reflect, for example, changes in a general or
specific price index. An entity may also use as deemed
cost an event-driven fair value determined previously
(for example, at the time of a privatization or initial
public offering.)
• Deemed cost for oil and gas assets. When an entity tran-
sitions from a previous GAAP in which exploration and
development costs for oil and gas properties in the de-
velopment or production phases are accounted for in
cost centers that include all properties in a large ge-
ographical area, the entity may elect to measure the
exploration and evaluation assets at the amount deter-
mined under the entity’s previous GAAP and the assets
in the development or production phases at the amount
determined for the cost center under the entity’s pre-
vious GAAP. The entity should allocate the amount to
the cost centre’s underlying assets on a pro rata basis
using reserve volumes or reserve values as of the date
of transition.
• Deemed cost for operations subject to rate regulation.
An entity may hold and use items of PPE or intangi-
ble assets, either currently or previously, in operations
subject to rate regulation. The carrying amount of these
assets may include amounts measured under the pre-
vious GAAP that would not qualify for capitalization
under IFRSs. This exemption permits an entity to use
the previous GAAP carrying amount as deemed cost at
the date of transition on an item-by-item basis. How-
ever, the entity should test each of these items for im-
pairment, in accordance with IAS 36, Impairment of
Assets, as of the date of transition. IFRS 1 describes
operations subject to rate regulation as those that pro-
vide goods or services to customers at prices (that is,
rates) established by an authorized body empowered
to establish rates binding on customers and designed
both to recover the specific costs the entity incurs in
providing the regulated goods or services and to earn a
specified return, which could be a minimum or range
rather than a fixed or guaranteed return.
• Leases. An entity may elect the transitional provisions
in IFRIC Interpretation 4, Determining Whether an Ar-
rangement Contains a Lease, which permits an entity
to apply IFRIC 4 to arrangements existing at the date
of transition based on the facts and circumstances ex-
isting at that date. Under this exemption, an entity is
not required to reassess any arrangements for which it
had made the same assessment required by IFRIC 4 at
some time prior to its date of transition.
• Actuarial gains or losses on defined benefit plans. If an
entity uses the corridor approach to recognize actuarial
gains and losses under IAS 19, Employee Benefits, some
gains and losses remain unrecognized. This exemption
permits an entity to recognize all unrecognized cumu-
lative actuarial gains and losses existing at the date of
transition, even if it will use the corridor approach after
transition.
• Cumulative translation differences. This exemption
permits an entity to set the cumulative translation ad-
justment account to zero at the date of transition. There-
fore, gains or losses on subsequent disposal of a foreign
operation will exclude all foreign currency translation
adjustments that occurred before transition.
• Investments in subsidiaries, associates, and jointly con-
trolled entities. This exemption applies to the sepa-
rate (unconsolidated) financial statements of a parent
entity. Separate financial statements may be required
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by regulatory authorities or issued voluntarily. Some-
times company-only (parent-only) financial statements
are included within consolidated financial statements.
In these separate financial statements, an entity may
measure its investments in subsidiaries, associates, and
jointly controlled entities at cost or in accordance with
IAS 39, Financial Instruments: Recognition and Mea-
surement. This exemption permits cost to be determined
either in accordance with IAS 27, Consolidated and
Separate Financial Statements, or at deemed cost (that
is, either the fair value in accordance with IAS 39 at the
entity’s date of transition to IFRSs in its separate finan-
cial statements or the previous GAAP carrying amount
at that date).
• Assets and liabilities of subsidiaries, associates, and
jointly controlled entities. When a subsidiary, associate,
or jointly controlled entity adopts IFRSs later than its
parent, this exemption permits the subsidiary, associate,
or jointly controlled entity to apply either IFRS 1 in its
first IFRS financial statements or to use the carrying
amounts that would be included in the parent’s con-
solidated IFRSs financial statements. However, when
the parent becomes a first-time adopter later than a
subsidiary, associate, or jointly controlled entity, the
parent should use the carrying amounts reported in that
investment’s IFRS financial statements.
• Compound financial instruments. When the liability
component of a compound financial instrument is no
longer outstanding, an entity is not required to retro-
spectively separate the liability and equity components
to determine the carrying amount of the equity compo-
nent at the date of transition.
• Designation of previously recognized financial instru-
ments. In most cases, IAS 39 limits an entity’s ability
to reclassify financial assets and liabilities after initial
recognition. This exemption permits an entity to desig-
nate, as of the date of transition, a financial instrument
as available-for-sale or as at fair value through profit or
loss, provided that the relevant criteria for designation
are met.
• Fair value measurement of financial assets or financial
liabilities at initial recognition. This exemption permits
an entity to apply the last sentence of paragraphs AG76
and AG76A1 in IAS 39, prospectively, to transactions
entered into after one of two dates:
— 25 October 2002
— 1 January 2004
1 The text of the relevant paragraphs in International Accounting Standard
(IAS) 39, Financial Instruments: Recognition and Measurement, reads as
follows:
AG76 (in part): The best evidence of the fair value of a financial
instrument at initial recognition is the transaction price (that is, the
fair value of the consideration given or received) unless the fair value
of that instrument is evidenced by comparison with other observable
market transactions in the same instrument (without modification or
repackaging) or based on a valuation technique whose variables include
only data from observable markets.
AG76A: The subsequent measurement of the financial asset or finan-
cial liability and the subsequent recognition of gains or losses should be
consistent with the requirements of this Standard or IFRS 9 as appro-
priate. The application of paragraph AG76 may result in no gain or loss
being recognized on the initial recognition of a financial asset or liability.
In such a case, IAS 39 requires that a gain or loss should be recognized
after initial recognition only to the extent that it arises from a change
in a factor (including time) that market participants would consider in
setting a price.
Author’s Note
In August 2010, the IASB issued an exposure draft,
Removal of Fixed Dates for First-time Adopters (pro-
posed amendments to IFRS 1), proposing to replace
these specific dates in IFRS 1 with the date of tran-
sition. On 30 September 2010, the IASB issued an
exposure draft, Severe Hyperinflation, which proposed
guidance on how an entity should resume presenting
financial statements in accordance with IFRSs after
a period when the entity was unable to comply with
IFRSs because its functional currency was subject to
severe hyperinflation. Both proposals were finalized in
December 2010 when the IASB issued Severe Hyper-
inflation and Removal of Fixed Dates for First-time
Adopters: Amendments to IFRS 1. These amendments
are effective for annual reporting periods beginning on
or after 1 July 2011.
• Decommissioning liabilities included in the cost of
PPE. An entity that elects this exemption should mea-
sure the decommissioning liability in accordance with
IAS 37, Provisions, Contingent Liabilities and Contin-
gent Assets. To the extent that the liability is within
the scope of IFRIC 1, Changes in Existing Decommis-
sioning, Restoration and Similar Liabilities, the entity
should estimate the amount that would have been in-
cluded in the carrying value of the asset when the liabil-
ity first arose (using a historical risk-adjusted interest
rate) and calculate a carrying amount of accumulated
depreciation based on its current estimates of the asset’s
useful life and residual value and its chosen deprecia-
tion method. When an entity applies the exemption
described previously with respect to oil and gas assets
accounted for in cost centers that include properties in
a large geographical area, it may elect to apply IFRIC
1 or to measure its decommissioning, restoration, and
similar liabilities at the date of transition, in accordance
with IAS 37 and recognize directly in retained earnings
the difference between that amount and the carrying
amount of those liabilities at the date of transition de-
termined under its previous GAAP.
• Financial assets or intangible assets accounted for in
accordance with IFRIC 12, Service Concession Ar-
rangements. An entity may elect to apply the transi-
tional requirements in IFRIC 12. When retrospective
application is impracticable, these transition require-
ments permit an entity to recognize financial assets
and intangible assets as of the date of transition and
to use the previous carrying amounts of these assets in
the opening balance sheet. The entity should test these
assets for impairment at the date of transition or, if im-
practicable, at the start of the current reporting period.
• Borrowing costs. An entity may elect to apply the tran-
sitional provisions in IAS 23, Borrowing Costs, which
permit the entity to capitalize interest on qualifying as-
sets as of a designated date but not later than the date
of transition.
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Author’s Note
In 2007, the Institute of Chartered Accountants in Eng-
land and Wales published a study, EU Implementation
of IFRS and the Fair Value Directive: A Report for
the European Commission, that it conducted for the
European Commission regarding application of IFRS
1 exemptions and other applications of IFRSs in
European-listed companies’ first IFRSs’ financial
statements. The study of 151 companies reports that
when an exemption was applicable, all companies sur-
veyed used the following exemptions:
• Business combinations
• Deemed cost (for PPE or investment property,
although practice varied over the amounts used
as deemed cost)
• Actuarial gains and losses on defined benefit
plants (when the entity elected to use the corridor
after transition)
• Cumulative translation differences
• Compound financial instruments
• Share-based payments
No first-time adopters used the deemed cost exemption
for intangible assets.
• Transfers of assets from customers. This exemption per-
mits a first-time adopter to apply the transitional pro-
visions in paragraph 22 of IFRIC 18. An entity should
interpret the reference in that paragraph to the effec-
tive date to be the later of 1 July 2009, or the date
of transition to IFRSs. In addition, a first-time adopter
may designate any date before the date of transition
to IFRSs and apply IFRIC 18 to all transfers of assets
from customers received on or after that date.
• Extinguishing financial liabilities with equity instru-
ments. This exemption permits a first-time adopter to
use the transition provisions in IFRIC 19.
12.08 IFRS 1 includes two categories of exceptions to retro-
spective application: estimates and retrospective application
of other IFRSs. Essentially, these exceptions prohibit the use
of hindsight to achieve a potentially preferable accounting
treatment. With respect to estimates, this exception requires
an entity’s estimates at the date of transition to be consis-
tent with those applied under its previous GAAP at the same
date (after adjustments for changes in accounting policy),
unless there is objective evidence that the previous GAAP
estimates were in error. With respect to retrospective appli-
cation in accordance with other IFRSs, IFRS 1 prohibits an
entity from using retrospective application in the following
circumstances:
• Designating hedging relationships.
• Recognizing previously derecognized financial assets
or financial liabilities, unless they would qualify for
recognition as a result of a later transaction or event.
• Applying IFRS 27 at a date earlier than it elects to apply
IFRS 3 to business combinations. Refer to the previous
discussion of the exemption related to IFRS 3.
Presentation
IFRSs
12.09 To comply with IAS 1, IFRS 1 states that a first
time adopter’s financial statements should include at least
three statements of financial position (which includes this
statement as of the date of transition), two statements of
comprehensive income, two separate income statements (if
presented), two statements of cash flows, and two statements
of changes in equity and related notes, including comparative
information.
12.10 IFRS 1 does not require an entity to restate informa-
tion prior to the date of transition when such information is
included in historical summaries of selected data. An entity
should clearly label any information prepared under previous




12.11 An entity should explain how the transition from its
previous GAAP to IFRSs affected its reported financial po-
sition, financial performance, and cash flows. In addition to
narrative discussions, this explanation should include rec-
onciliations of equity in accordance with previous GAAP to
equity in accordance with IFRSs, at both the date of transition
and the date of the most recent financial statements prepared
under the previous GAAP. This explanation also includes a
reconciliation of comprehensive income in accordance with
previous GAAP to comprehensive income in accordance with
IFRSs for the year of the most recent financial statements
prepared under the previous GAAP. These reconciliations
should include sufficient detail to enable users of the finan-
cial statements to understand the material adjustments to the
balance sheet and the statement of comprehensive income.
12.12 If the entity recognized any impairment losses or
reversals in its opening balance sheet, it should provide
disclosures in accordance with IAS 36 or other applicable
IFRSs.
12.13 An entity should clearly distinguish error corrections
from changes in accounting principle.
12.14 An entity should explain the IFRS 1 exemptions that
it elected. Additional disclosures are required when an entity
elects the exemptions for derecognition of financial assets or
financial liabilities and deemed cost.
12.15 Interim reports in the period covered by an entity’s
first IFRS financial statements prepared under IAS 34 should
include reconciliations similar to those required in the first
IFRS financial statements for the current interim period and
comparable interim period of the immediately preceding fi-
nancial year.
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Presentation and Disclosure Excerpts
Author’s Note
The following excerpts illustrating the required disclo-
sures under IFRS 1 are all taken from survey companies
whose 2010 financial statements were the first IFRS fi-
nancial statements, regardless of the date of transition.
At a minimum, the date of transition is two years prior
to a company’s first IFRS financial statements.
Securities regulators in different jurisdiction impose
different requirements on companies to discuss a forth-
coming transition to IFRS. Disclosures required prior
to those in a company’s first IFRS financial statements
are not illustrated.
Transition From Canadian GAAP to
IFRSs—IFRS 1 Exemptions Elected
12.16
Brookfield Asset Management, Inc. (Dec 2010)
CONSOLIDATED BALANCE SHEETS
(Millions) Note Dec. 31, 2010 Dec. 31, 2009(1) Jan. 1, 2009(1)
Assets
Cash and cash equivalents $ 1,713 $ 1,309 $ 1,169
Other financial assets 5 4,419 5,146 4,506
Accounts receivable and other 6 7,869 4,709 3,803
Inventory 7 5,849 5,560 4,752
Investments 8 6,629 4,466 4,646
Property, plant and equipment 9 18,148 16,723 15,597
Investment properties 10 22,163 19,219 16,719
Timber 11 3,206 2,968 2,839
Intangible assets 12 3,805 1,048 619
Goodwill 13 2,546 2,363 1,992
Deferred income tax asset 14 1,784 1,454 984
$78,131 $64,965 $57,626
Liabilities and Equity
Accounts payable and other 15 $10,334 $ 7,827 $ 6,977
Corporate borrowings 16 2,905 2,593 2,284
Non-recourse borrowings
Property-specific mortgages 17 23,454 19,712 17,808
Subsidiary borrowings 17 4,007 3,800 3,661
Deferred income tax liability 14 4,970 5,232 4,748
Capital securities 18 1,707 1,641 1,425
Interests of others in funds 19 1,562 1,021 548
Equity
Preferred equity 20 1,658 1,144 870
Non-controlling interests 20 14,739 10,186 8,038
Common equity 20 12,795 11,809 11,267
29,192 23,139 20,175
$78,131 $64,965 $57,626
(1) Refer to Note 3 for the effects of the adoption of IFRS.
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
2. Significant Accounting Policies
a) Statement of Compliance
These consolidated financial statements represent the first
annual financial statements of the company prepared in ac-
cordance with International Financial Reporting Standards
(“IFRS”) as issued by the International Accounting Standards
Board (“IASB”). The company adopted IFRS in accordance
with IFRS 1, “First-time Adoption of International Financial
Reporting Standards” (“IFRS 1”) as discussed in Note 3.
These financial statements were authorized for issuance
by the Board of Directors of the company on March 23, 2011.
3. Transition to IFRS
The company prepared its financial statements in accor-
dance with Canadian generally accepted accounting princi-
ples (“Canadian GAAP”) for all periods up to and including
December 31, 2009. These financial statements for the year
ending December 31, 2010 are the company’s first annual
financial statements that have been prepared in accordance
with IFRS.
The company adopted IFRS effective January 1, 2010.
The company’s transition date is January 1, 2009 and the
company prepared its opening IFRS balance sheet at that
date. These financial statements have been prepared in ac-
cordance with the accounting policies described in Note 2.
This note explains the impact of the company’s transition to
IFRS.
The company issued its January 1, 2009 and December
31, 2009 transitional IFRS balance sheets and statement of
operations in its March 31, 2010, June 30, 2010, and Septem-
ber 30, 2010 interim reports in anticipation of adopting IFRS.
These financial statements include the final comparative bal-
ance sheets and Statement of Operations which reflect the
correction of certain immaterial differences arising from the
final selection of accounting policies and finalization of certain
estimates and assumptions. These adjustments resulted in: a
$33 million increase in equity as at January 1, 2009, of which
$29 million is attributable to the company’s common share-
holders; a $167 million increase in comprehensive income, of
which a decrease of $127 million is attributable to the com-
pany’s common shareholders; and a $105 million decrease
in equity as at December 31, 2009, of which $58 million is
attributable to the company’s common shareholders.
(a) Elected Exemptions from Full Retrospective Application
These consolidated financial statements have been prepared
in accordance with IFRS 1 First-time Adoption of International
Financial Reporting Standards (“IFRS 1”). In doing so, the
company has applied certain of the optional exemptions from
full retrospective application of IFRS. The optional exemp-
tions applied are described below.
(i) Business Combinations
The company has elected to not apply IFRS 3 retrospectively
to past business combinations. Accordingly, the company has
not restated business combinations that took place prior to the
transition date.
(ii) Fair Value or Revaluation as Deemed Cost
The company has elected to measure certain items of prop-
erty, plant and equipment at fair value as at the transition date
or revaluation amounts previously determined under Cana-
dian GAAP and use that amount as deemed cost as at the
transition date.
(iii) Employee Benefits
The company has elected to recognize all cumulative actu-
arial gains and losses for the company’s employee benefit
plans as at the transition date in opening retained earnings.
(iv) Cumulative Translation Differences
The company has elected to set the previously accumulated
cumulative translation account, which is included in accumu-
lated other comprehensive income in equity, to zero at the
transition date. This exemption has been applied to all sub-
sidiaries.
(v) Share-Based Payment Transactions
IFRS 2 Share-based Payment (“IFRS 2”) only requires recog-
nition of equity instruments in respect of share-based pay-
ment transactions granted by the company prior to the transi-
tion date. The company has elected to apply IFRS 2 to equity
instruments granted after November 7, 2002 that have not
vested by the transition date.
(b) Mandatory Exceptions to Retrospective Application
In preparing these consolidated financial statements in accor-
dance with IFRS 1 the company has applied certain manda-
tory exceptions from full retrospective application of IFRS.
The mandatory exceptions applied from full retrospective ap-
plication of IFRS are described below.
(i) Hedge Accounting
Hedging relationships that satisfied the hedge accounting cri-
teria as of the transition date are reflected as hedges in the
company’s results under IFRS. Any derivative not meeting the
IAS 39 Financial Instruments: Recognition and Measurement
criteria for hedge accounting was recorded as a non-hedging
derivative financial instrument.
(ii) Estimates
Hindsight was not used to create or revise estimates and
accordingly the estimates previously made by the company
under Canadian GAAP are consistent with their application
under IFRS.
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(c) Reconciliation of Equity as Reported Under Canadian
GAAP to IFRS
The following is a reconciliation of the company’s equity re-
ported in accordance with Canadian GAAP to its equity in








As reported under Canadian GAAP—December 31, 2008 $ 4,911 $870 $ — $ 5,781
Reclassification of non-controlling interests to equity under IFRS — — 6,321 6,321
Differences increasing (decreasing) reported amount:
Revaluations:
Revaluation method for property, plant and equipment (i) 8,000 — 580 8,580
Investment property (ii) 1,227 — 2,143 3,370
Agricultural assets (iii) 237 — 122 359
Fair value as deemed cost (iv) 226 — 13 239
Financial instruments (v) 195 — (133) 62
Lease accounting (vi) (216) — (210) (426)
Deferred revenue (vii) (127) — (63) (190)
Unrecognized portion of employee benefits (viii) (168) — (56) (224)
Renewable power generation sales (ix) (327) — (109) (436)
Basis of accounting (x) — — (247 (247)
Deferred income taxes (xi) (2,701) — (312) (3,013)
Other 10 — (11) (1)
6,356 — 1,717 8,073
As reported under IFRS—January 1, 2009 $11,267 $870 $8,038 $20,175
The following is a reconciliation of the company’s equity re-
ported in accordance with Canadian GAAP to its equity in








As reported under Canadian GAAP—December 31, 2009 $ 6,403 $1,144 $ — $ 7,547
Reclassification of non-controlling interests to equity under IFRS — — 8,969 8,969
Differences increasing (decreasing) reported amount:
Revaluations:
Revaluation method for property, plant and equipment (i) 8,052 — 563 8,615
Investment property (ii) 745 — 1,895 2,640
Agricultural assets (iii) 333 — 213 546
Fair value as deemed cost (iv) 237 — (14) 223
Financial instruments (v) (212) — (419) (631)
Lease accounting (vi) (294) — (270) (564)
Deferred revenue (vii) (109) — (147) (256)
Unrecognized portion of employee benefits (viii) (171) — (58) (229)
Renewable power generation sales (ix) (281) — (94) (375)
Basis of accounting (x) — — (248) (248)
Deferred income taxes (xi) (2,862) — (181) (3,043)
Other (32) — (23) (55)
5,406 — 1,217 6,623
As reported under IFRS—December 31, 2009 $11,809 $1,144 $10,186 $23,139
(i) Revaluation Method for Property, Plant and Equipment
Under IFRS the company measures renewable power gener-
ation, utilities, and transport and energy assets at their reval-
ued amount, being the fair value at the date of the revaluation
less any subsequent accumulated depreciation and any ac-
cumulated impairment losses whereas for Canadian GAAP
the company recorded such assets at historic cost less ac-
cumulated depreciation. The increase in equity relates to the
difference in the fair value of renewable power generation,
utilities, and transport and energy assets and their carried
amounts for Canadian GAAP.
(ii) Investment Property
The company measures its commercial property and certain
other assets as investment property and records the assets
at fair value under IFRS whereas for Canadian GAAP the
company recorded such assets at historic cost less any ac-
cumulated amortization. The increase in equity relates to the
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difference in the fair value of investment property and its car-
ried amount for Canadian GAAP.
(iii) Agricultural Assets
The company’s standing timber and other agricultural assets
are measured at fair value less estimated costs to sell for
IFRS whereas for Canadian GAAP the company recorded
such assets at historic cost less accumulated depletion. The
increase in equity relates to the difference in the fair value,
less estimated costs to sell, of the company’s standing tim-
ber and other agricultural assets and its carried amounts for
Canadian GAAP.
(iv) Fair Value as Deemed Cost
The majority of the company’s assets are revalued at least
annually, however a smaller amount is carried at historical
cost under IFRS. The company elected to measure certain of
the assets at fair value that would otherwise not be revalued
and used that amount as deemed cost on transition to IFRS.
The increase in equity relates to the net difference between
the fair value used as deemed cost and the carried amounts
for Canadian GAAP. The established deemed cost amount
will be amortized to net income over the useful lives of the
assets.
The aggregate amount of assets which the company
elected to measure at fair value and use that amount as
deemed cost at the transition date was an increase of $239
million which was recorded in the following account balances
on the transitional Consolidated Balance Sheets: an increase
of $287 million in property, plant and equipment and a de-
crease of $48 million in intangible assets.
(v) Financial Instruments
Certain equity securities that were measured at historical cost
under Canadian GAAP are measured at fair value for IFRS.
Additionally, non-controlling interests of others in the net as-
sets of consolidated subsidiaries held in the form of equity
securities that contain a feature that allows the holder to
redeem the instrument for cash or another financial asset
are presented as a liability under IFRS. These liabilities are
recorded at fair value and are included in Interests of others
in funds on the Consolidated Balance Sheets. For Canadian
GAAP, these interests were presented within non-controlling
interests and measured at the proportionate share of net as-
sets not owned by the company of such consolidated sub-
sidiaries. The effect on equity of these and other differences




(Millions) Equity Interests Equity
As at January 1, 2009
Fair value of equity securities $ 324 $ 25 $ 349
Interests of others in funds (137) (146) (283)
Other 8 (12) (4)
$ 195 $(133) $ 62
As at December 31, 2009
Fair value of equity securities $ 355 $ 51 $ 406
Interests of others in funds (562) (459) (1,021)
Other (5) (11) (16)
$(212) $(419) $(631)
(vi) Lease Accounting
Under Canadian GAAP, the company recognized intangible
assets and liabilities on the acquisition of commercial prop-
erties related to the difference between the fair value and
contracted amounts of in place leases. These intangible as-
sets and liabilities were amortized into revenue over the life
of the underlying leases. As a result of electing to fair value
investment properties under IFRS, as noted in 3(c)(ii), the
company derecognized these intangible assets and liabilities
as they are included as a component of the fair value at-
tributable to investment properties. In addition, rental revenue
from operating leases is recognized on a straight-line basis
over the term of the lease for both Canadian GAAP and IFRS.
Under IFRS however, rental revenue from operating leases
is determined considering all rentals from the inception of the
lease whereas for Canadian GAAP this determination con-
sidered only rental revenues to be received on a prospective
basis subsequent to January 1, 2004, the adoption date of
this accounting policy for Canadian GAAP purposes.
(vii) Revenue Recognition
IFRIC 15 Agreements for the Construction of Real Estate pro-
vides specific guidance to determine whether an agreement
represents a contract for the construction of real estate or
the sale of real property. For both Canadian GAAP and IFRS
construction contracts are measured using the percentage-
of-completion method and sales of real property are recog-
nized in revenue upon completion, when title passes to the
purchaser and the collectibility is reasonably assured. Upon
transition to IFRS certain contracts in the company’s Brazil-
ian development business that were measured for Canadian
GAAP using the percentage-of-completion method were de-
termined to be contracts for the sale of real property under
IFRS. Accordingly these contracts are recognized in revenue
upon completion of construction and title transfers to the pur-
chaser under IFRS.
(viii) Employee Benefits
The company elected to recognize all cumulative actuarial
gains and losses as at January 1, 2009. Cumulative actuarial
gains and losses that existed at the transition date were rec-
ognized in opening retained earnings for all of the company’s
employee benefit plans.
(ix) Renewable Power Generation Sales
Certain power generation sales are recognized on a levelized
basis for Canadian GAAP but are recognized on an accrual
basis for IFRS.
(x) Basis of Accounting
Under Canadian GAAP the conclusion as to whether an en-
tity should be consolidated or not is determined by using two
different frameworks: the variable interest entity framework or
voting control model. Under IFRS an entity is consolidated if
it is controlled by the company. Control under IFRS is defined
as the power to govern the financial and operating policies
of an entity to obtain benefit and is presumed to exist when
the parent controls, directly or indirectly through subsidiaries,
more than one half of an entity’s voting power, but also exists
when the parent owns half or less of the voting power but
has legal or contractual rights to control, or de facto control.
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The decrease represents the effect of deconsolidating certain
of the company’s investments under IFRS that were previ-
ously consolidated under Canadian GAAP, partially offset by
the impact of consolidating certain of the company’s invest-
ments under IFRS that were previously deconsolidated.
(xi) Deferred Taxes
The decrease in equity related to deferred taxes reflects the
change in temporary differences resulting from the effect of
the IFRS and Canadian GAAP adjustments described.
(d) Reconciliation of Net Income (Loss) as Reported Under
Canadian GAAP to IFRS
The following is a reconciliation of the company’s net income
reported in accordance with Canadian GAAP to its net loss
in accordance with IFRS for the year ended December 31,
2009:








Net income as reported under Canadian GAAP $ 454 $ — $ 454
Add back: non-controlling interests (i) — 219 219
Differences increasing (decreasing) reported net income:
Depreciation of fair value adjustments (ii) (140) (30) (170)
Investment property (iii) (596) (415) (1,011)
Agricultural assets (iv) (11) (27) (38)
Financial instruments (v) (314) 155 (159)
Lease accounting (vi) (63) (50) (113)
Revenue recognition (vii) (61) (77) (138)
Deferred gains (viii) (410) (9) (419)
Renewable power generation sales (ix) 61 15 76
Basis of accounting (x) — 10 10
Deferred income taxes (xi) 234 77 311
Other 10 (8) 2
(1,290) (359) (1,649)
Net loss as reported under IFRS $ (836) $(140) $ (976)
(i) Non-Controlling Interests
Non-controlling interests are included in the determination of
net income under IFRS reported by an entity. This adjustment
adds back non-controlling interests expense to net income as
reported under Canadian GAAP.
(ii) Depreciation of Fair Value Adjustments
Certain property, plant and equipment were recorded at
fair value on transition at carried values in excess of their
recorded amount under Canadian GAAP. Accordingly, these
increased carrying values resulted in higher amounts of de-
preciation during the year.
(iii) Investment Property
For IFRS the company measures investment property at fair
value and records any change in fair value in net income dur-
ing the period of change. Under Canadian GAAP commercial
property was recorded at historic cost and depreciated over
its estimated useful life. The effect on net income of these
differences is as follows:







Changes in fair value recorded under IFRS $(1,128) $(579) $(1,707)
Depreciation and amortization recorded under Canadian GAAP 532 164 696
$ (596) $(415) $(1,011)
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(iv) Agricultural Assets
For IFRS the company’s standing timber and other agricul-
tural assets are measured at fair value less estimated cost
to sell, with changes in fair value or costs to sell recorded
in net income during the period of change. Under Canadian
GAAP, the company recorded such assets at historic cost
and charged a depletion amount to net income based upon
harvest levels. Depletion is not recorded under IFRS. The
effect on net income of these differences is as follows:










Changes in fair value recorded
under IFRS $(53) $(90) $(143)
Depletion recorded under
Canadian GAAP 42 63 105
$(11) $(27) $ (38)
(v) Financial Instruments
Under Canadian GAAP, certain equity securities that were
carried at historic cost are recorded at fair value under IFRS.
Furthermore under IFRS, changes in the fair value of the
equity securities and interests of others in funds classified
outside of shareholders’ equity is recorded in net income
in the period of change. Under IFRS changes in fair value
attributable to changes in foreign currency exchange rates
of available-for-sale debt securities denominated in foreign
currencies is recorded in net income whereas for Canadian
GAAP this amount was recorded in other comprehensive in-
come. The following table shows the effect on net income of
these differences:










Fair value of equity securities $ (5) $ 50 $ 45
Investments of others in funds (332) 100 (232)
Foreign exchange on debt
securities 23 5 28
$(314) $155 $(159)
(vi) Lease Accounting
As described in 3(c)(vi), under IFRS the company derecog-
nized intangible assets and liabilities recognized on the acqui-
sition of investment property. Under Canadian GAAP, these
intangible assets and liabilities were amortized into revenue.
In addition, under IFRS, rental revenue from operating leases
is determined considering all rentals from the inception of the
lease whereas for Canadian GAAP this determination consid-
ers only rentals to be received on a prospective basis subse-
quent to the adoption of this accounting policy for Canadian
GAAP purposes.
(vii) Revenue Recognition
As described in 3(c)(vii), upon transition to IFRS certain con-
tracts that were measured using the percentage of completion
method for Canadian GAAP were determined to be contracts
for the sale of real property under IFRS. Accordingly for IFRS,
sales under these contracts are recognized in revenue upon
completion of construction and transfer of title to the pur-
chaser.
(viii) Deferred Gains
In Canadian GAAP, the company recognized gains in net
income resulting from the partial disposition of a subsidiary
when the company retains a controlling interest in the sub-
sidiary after the sale. Under IFRS, gains on the partial dispo-
sition of a subsidiary are recorded in equity.
(ix) Renewable Power Generation Sales
Certain renewable power generation sales are recognized on
a levelized basis for Canadian GAAP but are on an accrual
basis for IFRS.
(x) Basis of Accounting
The company either consolidates or does not consolidate en-
tities under IFRS that were accounted for differently under
Canadian GAAP. Accordingly, where the company has de-
consolidated entities, the results of operations attributable to
the non-controlling interests are excluded from the determi-
nation of net income under IFRS. When the company com-
menced consolidation under IFRS, the results attributable to
non-controlling interests are included in net income under
IFRS.
(xi) Deferred Taxes
Deferred taxes are impacted by the change in temporary dif-
ferences resulting from the effect of the IFRS and Canadian
GAAP reconciling items described above.
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(e) Reconciliation of Comprehensive Income as Reported
Under Canadian GAAP to IFRS
The following is a reconciliation of the company’s comprehen-
sive income reported in accordance with Canadian GAAP to
its comprehensive income in accordance with IFRS for the
year ended December 31, 2009:







Comprehensive income as reported under Canadian GAAP $ 1,829 $ — $ 1,829
Add back: non-controlling interests (i) — 806 806
Differences increasing (decreasing) reported comprehensive income:
Differences in net income (ii) (1,290) (359) (1,649)
Foreign currency translation (iii) 488 60 548
Financial instruments (iv) (58) (8) (66)
Revaluations of property, plant and equipment (v) (228) (8) (236)
Equity accounted investments (vi) (77) (53) (130)
Deferred taxes (vii) 96 11 107
(1,069) (357) (1,426)
Comprehensive income as reported under IFRS $ 760 $ 449 $ 1,209
(i) Non-Controlling Interests
Non-controlling interests are included in the determination
of comprehensive income under IFRS reported by an entity.
This adjustment adds back non-controlling interests expense
as determined under Canadian GAAP.
(ii) Differences in Net Income
Reflects the differences in net income between Canadian
GAAP and IFRS as described in 3(d) for the year ended
December 31, 2009.
(iii) Foreign Currency Translation
Reflects the impact of foreign currency arising from the IFRS
adjustments described above.
(iv) Financial Instruments
The differences primarily relate to securities that are not
traded in an active market and that were measured at cost
for Canadian GAAP whereas for IFRS, these securities are
recorded at fair value, with changes in fair value recorded
in other comprehensive income. In addition, as described in
Note (d)(v), fair value changes related to foreign exchange
translation of available-for-sale debt securities is recorded in
net income under IFRS, whereas it was recorded in other
comprehensive income for Canadian GAAP.
(v) Revaluations of Property, Plant and Equipment
The company measures renewable power generation, utili-
ties, and transport and energy assets at their revalued amount
under IFRS. Revaluations of these assets in excess of their
cost base less accumulated depreciation are recorded in
revaluation surplus as a component of equity.
(vi) Equity Accounted Investments
The difference reflects the impact of various changes in IFRS
to equity accounted investments.
(vii) Deferred Taxes
The difference related to deferred taxes reflects the change
in temporary differences resulting from the effect of the rec-
onciling items described above that are recorded in other
comprehensive income.
(f) Statement of Cash Flow As Reported Under Canadian
GAAP and IFRS
The following items are the differences in cash flow reported
in accordance with Canadian GAAP from cash flow reported
in accordance with IFRS:
(i) Differences in Net Income
Reflects the differences in net income between Canadian
GAAP and IFRS as described in 3(d) for the year ended
December 31, 2009.
(ii) Fair Value Changes
Reflects the adjustment of non-cash fair value changes to in-
vestment properties, agricultural assets, and financial instru-
ments recognized under IFRS as described in 3(d)(iii) and
3(d)(iv) for the year ended December 31, 2009.
(iii) Basis of Accounting
The company either consolidates or does not consolidate
entities under IFRS that were accounted differently under
Canadian GAAP. The results of operations attributable to the
non-controlling interests of entities that were deconsolidated
under IFRS, are excluded from cash flow for the year ended
December 31, 2009. When the company commenced con-
solidation under IFRS, the results of operations attributable
to the non-controlling interests are included in cash flow.
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Transition From Argentine GAAP to
IFRSs—IFRS 1 Exemptions Elected
12.17
Nortel Inversora S.A. (Dec 2010)
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION
(In millions of Argentine pesos)
As of December 31
Note 2010 2009 As of January 1, 2009(∗)
Assets
Current assets
Cash and cash equivalents 5 1,385 1,273 902
Investments 5 2 16 223
Trade receivables, net 6 1,463 1,163 1,009
Other receivables, net 7 322 241 209
Inventories, net 8 452 250 252
Total current assets 3,624 2,943 2,595
Non-current assets
Other receivables, net 7 100 76 88
Investments 5 1 1 7
Property, plant and equipment, net 9 7,365 6,767 6,119
Intangible assets, net 10 1,233 1,072 1,080
Total non-current assets 8,699 7,916 7,294
Total assets 12,323 10,859 9,889
Liabilities
Current liabilities
Trade payables 11 2,908 2,212 1,769
Financial debt 12 42 763 1,355
Salaries and social security payables 13 390 300 237
Income tax payables 14 491 431 290
Other taxes payables 15 531 338 336
Other liabilities 16 84 84 73
Provisions 17 64 73 36
Total current liabilities 4,510 4,201 4,096
Non-current liabilities
Trade payables 11 — 24 27
Financial debt 12 121 58 688
Salaries and social security payables 13 110 82 83
Deferred income tax liabilities 14 247 243 266
Income tax payables 14 14 13 —
Other liabilities 16 274 267 231
Provisions 17 536 374 319
Total non-current liabilities 1,302 1,061 1,614
Total liabilities 5,812 5,262 5,710
Equity
Equity attributable to owners of the Parent 6,404 5,509 4,098
Noncontrolling interest 107 88 81
Total equity 19 6,511 5,597 4,179
Total liabilities and equity 12,323 10,859 9,889
(∗) Opening IFRS statement of financial position, included as required by IFRS 1 (Note 1.c).
The accompanying notes are an integral part of these con-
solidated financial statements.
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NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS (in part)
Note 1—Description of Business and Basis of
Preparation of the Consolidated Financial Statements
(in part)
c) Basis of Preparation
These consolidated financial statements are the first pub-
lished financial statements of the Company in accordance
with IFRS as issued by the International Accounting Stan-
dards Board. Accordingly, IFRS 1 “First-time adoption of In-
ternational Financial Reporting Standards” has been used in
the preparation of these financial statements.
The accounting policies set out in Note 3 have been ap-
plied in preparing the financial statements for the year ended
December 31, 2010, the comparative information presented
in these financial statements for the year ended December
31, 2009 and in the preparation of the opening IFRS state-
ment of financial position at January 1, 2009 (the Company’s
date of transition). In preparing its opening IFRS statement
of financial position (as required by IFRS 1), the Company
has adjusted amounts reported previously in financial state-
ments prepared under Argentine GAAP. An explanation of
how the transition from Argentine GAAP to IFRS has affected
the Company’s financial position, financial performance and
cash flows is set out in Note 4.
Our financial statements (except for cash flow information)
are prepared on an accrual basis of accounting. Under this
basis, the effects of transactions and other events are rec-
ognized when they occur. Therefore income and expenses
are recognized at fair value on an accrual basis regardless
of when they are perceived or paid. When significant, the dif-
ference between the fair value and the nominal amount of
income and expenses is recognized as finance income or ex-
pense using the effective interest method over the relevant
period.
The accompanying consolidated financial statements have
been prepared on a going concern basis (further details are
provided in Note 3) and in accordance with IFRS. IFRS com-
prises all effective IAS together with all the SIC and all inter-
pretations issued by the IFRIC.
The preparation of financial statements in conformity with
IFRS requires the use of certain critical accounting estimates.
It also requires Management to exercise its judgment in the
process of applying the Telecom Group’s accounting policies.
The areas involving a higher degree of judgment or complex-
ity, or areas where assumptions and estimates are signifi-
cant to the consolidated financial statements are disclosed in
Note 3.
Publication of these consolidated financial statements for
the year ended December 31, 2010 was approved by res-
olution of the Board of Directors’ meeting held on June 23,
2011.
Note 4—Transition to IFRS
These financial statements for the year ended December
31, 2010 are the first annual financial statements that are
fully compliant with IFRS as issued by the IASB. The Com-
pany has adopted the standards effective as of December
31, 2010. Additionally, the Company early adopted IFRS 9
as issued in October 2010.
The mandatory adoption of IFRS for public companies
in Argentina is effective for financial years beginning Jan-
uary 1, 2012, while early adoption is permitted for finan-
cial years beginning January 1, 2011. Therefore, the con-
solidated financial statements as of December 31, 2010 for
filing with the CNV were prepared in accordance with Argen-
tine GAAP. Argentine GAAP differs in certain respects from
IFRS. Notwithstanding the CNV regulations, financial state-
ments under IFRS for the year 2010 are allowed to be pre-
sented as additional information to the consolidated financial
statements prepared under Argentine GAAP.
The reconciliations that are presented in this Note recon-
cile the previously published financial statement information
under Argentine GAAP as of and for the year ended Decem-
ber 31, 2009 and as of January 1, 2009 to the corresponding
amounts calculated in accordance with IFRS in compliance
with IFRS 1.
For the purposes of this quantification, Management of the
Company has elected to make use of some of the exemptions
provided for in IFRS 1 with the aim to simplify the first-time
adoption of IFRS. The Company made use of the exemptions
as detailed below:
Optional Exemptions Provided by IFRS 1 Upon First-Time
Adoption of IFRS:
• Deemed cost for fixed assets: Argentine GAAP valua-
tion for fixed assets has been used as deemed cost at
the transition date to IFRS, since it was considered to
be broadly comparable to cost or depreciated cost in
accordance with IFRS, adjusted to reflect changes in a
general or specific price index.
• Cumulative translation differences for foreign opera-
tions: The cumulative translation differences for all for-
eign operations were deemed to be zero at the date of
transition to IFRS. This exemption applies to the finan-
cial statements translations of the subsidiaries Núcleo
and Telecom USA.
• Business combinations: The Company has elected not
to apply IFRS 3 (as revised in 2008) retrospectively to
business combinations that occurred before the date of
transition to IFRS.
• Share-based payment transactions: The Company has
elected not to apply IFRS 2 “Share-based Payment”
to equity instruments that were granted on or before
November 7, 2002. This exemption applies to the Share
Ownership Program described in note 19.
IFRS Mandatory Exceptions Provided by IFRS 1 Upon
First-Time Adoption of IFRS:
• Estimates exception: IFRS estimates as at January 1,
2009, are consistent with the estimates as at the same
date made in conformity with Argentine GAAP.
The other compulsory exceptions of IFRS 1 have not been
applied as these are not relevant to the Company.
a) Impacts of the Application of IFRS on the Opening
Statement of Financial Position at January 1, 2009 and the
Consolidated Financial Statements at December 31, 2009
IFRS provides for alternative criteria for measurement af-
ter initial recognition of each class of PP&E and Intangible
Assets. An entity shall choose either the “cost model” or
the “revaluation model.” Management of Telecom Group has
IFRS ATT 12.17
728 IFRS Accounting Trends & Techniques
elected to continue applying the “cost model” for all classes
of PP&E and Intangible Assets.
After considering exemptions elected and the “cost model”
chosen to measure PP&E and Intangible Assets, the main
differences identified between Argentine GAAP and IFRS and
their impact on equity at January 1, 2009 and December 31,









Total amounts under Argentine GAAP 2,189 2,953 758
IFRS Adjustments:
1. Noncontrolling interest 1,900 2,552 651
Subtotal amounts and noncontrolling interest under Argentine GAAP 4,089 5,505 1,409
2. Classification of Class “A” Preferred shares (1,039) (1,156) (117)
3. Revenue recognition
3.1 Upfront connection fees (106) (105) 1
3.2 Revenues from contracts for the construction of networks and other assets — — —
3.3 Customer loyalty programs (6) (8) (2)
3.4 Revenue recognition on contracts with multiple deliverables — — —
4. Intangible Assets
4.1 Service connection or habilitation costs 121 114 (7)
4.2 Subscriber acquisition costs 188 186 (2)
5. Reversal of the adjustments for the effects of inflation in foreign entities’
financial statements — (17) (11)
6. Borrowing costs that do not qualify for capitalization (67) (57) 10
7. Other adjustments
7.1 Inventories (8) 1 9
7.2 Fixed assets held for sale (2) (2) —
8. Tax effects on IFRS adjustments (42) (43) (1)
Total amounts under IFRS 3,128 4,418 1,289
Equity attributable to the parent 1,192 1,837 642
Equity attributable to noncontrolling interest 1,936 2,581 647
1. Noncontrolling Interest
Under IFRS, the noncontrolling interest in a subsidiary should
be presented within total equity in the consolidated state-
ment of financial position, identifying separately the portion
attributable to the parent (economic rights attributable to the
Company as Parent Company) and the portion attributable
to the noncontrolling interest instead of being presented as
a separate caption between total liabilities and equity as re-
quired by Argentine GAAP.
Likewise, the noncontrolling interest in a subsidiary’s profit
or loss for the year is presented within net income (loss) in the
consolidated statement of income as a gain or loss incurred
by the parent.
Therefore, a reconciling item has been included to present
noncontrolling interest as required by IFRS (although mea-
sured under Argentine GAAP) representing an increase of
$1,900 and $2,552 in total equity as of January 1, 2009 and
December 31, 2009, respectively, and an increase in net in-
come of $651 for the year ended December 31, 2009.
2. Classification of Class “A” Preferred Shares
Pursuant to IFRS, a financial liability is “a contractual obliga-
tion” (i) to deliver money or other financial asset to another
entity, or (ii) to exchange financial assets or liabilities with
another entity under conditions that are potentially unfavor-
able. As described in Note 19, Nortel’s Class “A” preferred
shares provide a mandatory repayment schedule. Although
payments to the holders of such shares become due only to
the extent that the Company has liquid and realized profits,
legally available for distribution under Argentine law, the Com-
pany’s payment obligation does not disappear as a result of
the temporary lack of such profits. Therefore, the Company’s
payment obligations under the terms of issuance of the Class
“A” preferred shares shall be classified as liability and val-
ued at their amortized cost. Under Argentine Corporations
Law, the Class “A” Preferred Shares has to be included in the
Company’s shareholders’ equity.
3. Revenue Recognition
3.1 Upfront Connection Fees
Under IFRS, non-refundable up-front connection fees for
fixed telephony, data and Internet services that are non-
separable from the service are accounted for as a single
transaction and deferred over the term of the contract, or in
the case of indefinite period contracts, over the average pe-
riod of the customer relationship. This approach is consistent
with the recognition of service connection costs described in
3.1 below. This accounting treatment differs from that pro-
vided for under Argentine GAAP, where up-front connection
fees are fully recognized as income when the customer is
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connected to the network or the service is enabled, which
usually occurs at the beginning of the relationship with the
customer.
The impact of the deferral of up-front connection fees under
IFRS, net of the effect of the deferred fees accrued during the
year, represents a decrease of $106 and $105 in total equity
as of January 1, 2009 and December 31, 2009, respectively,
and an increase of $1 in net income for the year ended De-
cember 31, 2009. Such impacts are substantially originated
in Telecom Argentina from the connection of fixed line cus-
tomers, with an estimated deferral period of 9 years.
3.2 Revenues from Contracts for the Construction of
Networks and Other Assets
Revenue from construction contracts are substantially de-
rived from the construction of data networks or other value-
added services assets for large customers of fixed telephony.
Under IFRS, revenues from construction contracts that are
specifically negotiated for the construction of an asset or a
combination of assets that are closely interrelated or inter-
dependent in terms of their design, technology and function
or their ultimate purpose or use, in which the buyer is able
to specify the major structural elements of the design be-
fore construction, should be accounted for by reference to
the stage of completion of the contract activity. Under this
method, contract revenue and contract costs associated with
the construction contract shall be recognized as revenue and
expenses respectively by reference to the stage of completion
of the contract activity at the end of the reporting period, thus
recognizing profit margin of the contract. The stage of com-
pletion of a contract may be determined in a variety of ways.
Telecom Group has used the proportion that contract costs
incurred for work performed to date bear to the estimated total
contract costs. Any expected loss by reason of the contract
should be recognized immediately as an expense.
Under Argentine GAAP revenues for construction contracts
are fully recognized when construction is completed and the
assets are transferred to the buyer together with related risks
and benefits.
There was no impact in revenue for construction contracts
under IFRS for the financial year 2009.
3.3 Customer Loyalty Programs
Personal offers to its customers a loyalty program named
“Club Personal.” Under such program Telecom Group grants
award credits as part of the sales transactions which can
be subsequently redeemed for goods or services. IFRS re-
quires that the fair value of the award credits be accounted
for as deferred revenue, and recognized as revenue when
the award credits are redeemed or expire. Those revenues
are classified as service or goods revenues depending on
the goods or services redeemed by the customers. Under
Argentine GAAP such program is accounted for considering
the cost of the points expected to be redeemed by the cus-
tomers. Such cost is recorded as operating expenses at the
time the points are granted to the customers. Reconciling
item reflects the net effect of (i) deferral of revenues asso-
ciated with unredeemed points valued at exit fair value, net
of income accrued for the year, and (ii) reversal of operat-
ing costs accrued under Argentine GAAP based on points
expected to be effectively redeemed.
The impact of the measurement of the customer loyalty
program under IFRS represents a decrease of $6 and $8 in
total equity as of January 1, 2009 and December 31, 2009,
respectively, and a decrease of $2 in net income for the year
ended December 31, 2009.
3.4 Revenue Recognition on Contracts With Multiple
Deliverables
Under IFRS, total revenue generated by transactions that in-
clude separately identifiable components (as equipment and
service) should be allocated to the separately identifiable
units of accounting based on their fair values, provided that
the total amount of revenue to be recognized does not exceed
the contract revenue.
IFRS does not prescribe a specific method for such alloca-
tion of revenue. However, telecommunications industry prac-
tice generally applies the method known as “residual method.”
The “residual method” requires identifying all the compo-
nents that comprise a transaction and allocating its fair value
on an individual basis to each of them. Under this method,
the fair value of a delivered item (which could not be individu-
ally determined) is determined as the difference between the
total arrangement consideration and the sum of the fair value
of those elements for which fair value can be estimated on a
stand-alone basis.
Telecom Group is engaged in sale transactions including
multiple identifiable components whose fair value determina-
tion becomes more complex and relate to sales of equipment
to customers jointly with contracts with minimum duration,
fixed monthly bills for services and cancellation fees for early
termination. For such transactions, equipment is sold at a
discount compared to selling price of equipment sold without
related service contract. However, the fair value of services
sold is independent of the fact that the customer purchases
a handset together with the service. Therefore the fair value
of equipment sold can be determined as the difference be-
tween the total arrangement consideration and the service
fair value.
Consequently, the allocation of revenues between equip-
ment and services under IFRS is equivalent to the revenues
accounted for under Argentine GAAP, where revenues from
sale of each component of the transaction are recognized by
the amount contractually agreed with the client, recognizing
equipment revenues when the item is delivered to the cus-
tomer and service revenues when rendered.
Therefore, considering the industry accounting practices
currently prevailing under IFRS there is no quantitative impact
for this matter between IFRS and Argentine GAAP.
4. Intangible Assets
4.1 Service Connection or Habilitation Costs
Under IFRS direct costs incurred for connecting customers to
the network are accounted for as assets and then amortized
over the term of the contract with the customer if certain condi-
tions are met. This approach is consistent with the recognition
of up-front connection fees described in 2.1 above. For indef-
inite period contracts, the deferral of these costs is limited
to the amount of non contingent revenue from the customer
and expensed over the average period life of the customer
relationship. Costs exceeding that amount are expensed as
incurred. Connection costs are generated mainly in Telecom
Argentina for the installation of fixed lines whose average
deferral period is 9 years.
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Under Argentine GAAP, connection costs are expensed
as incurred, in order to match these costs with connection
revenues that are fully recognized in the same period.
The effect of deferral of connection costs under IFRS, net
of accumulated depreciation, represents an increase of $121
and $114 in total equity as of January 1, 2009 and December
31, 2009, respectively, and a decrease in net income of $7
for the year ended December 31, 2009.
4.2 Subscriber Acquisition Costs
Under IFRS, direct and incremental costs incurred for the ac-
quisition of new subscribers with minimum contractual dura-
tion are capitalized when the following conditions are met: the
asset is separately identifiable, it is probable that the expected
future economic benefits that are attributable to the asset will
flow to the entity; and the cost of the asset can be measured
reliably. Capitalized SAC is amortized on a straight-line basis
over the term of the contract with the customer.
The cost of acquiring postpaid and “cuentas claras” cus-
tomers in mobile telephony and broadband customers in fixed
telephony meet the conditions established by IFRS for its
recognition as intangible asset, since these contracts estab-
lish a minimum contractual period, include an enforced ter-
mination penalty and fixed monthly bill for services. SAC are
mainly composed of upfront commissions paid to third par-
ties and subsidies on the sale of handsets. Under Argentine
GAAP, these costs are expensed as incurred since there are
no specific criteria for deferral of costs associated with cus-
tomer contracts.
The impact of capitalization of SAC as intangible assets
under IFRS, net of accumulated depreciations, represents an
increase of $188 and $186 in total equity as of January 1,
2009 and December 31, 2009, respectively, and a decrease
of $2 in net income for the year ended December 31, 2009.
5. Reversal of the Adjustments for the Effects of Inflation
in Foreign Entities’ Financial Statements
Under IFRS financial statements of any entity whose func-
tional currency is the currency of a hyperinflationary econ-
omy shall be stated in terms of the measuring unit current
at the end of the reporting period. Under Argentine GAAP fi-
nancial statements of Núcleo are prepared in guaranı́es—the
local and functional currency of Núcleo—restated in terms of
the measuring unit current at the end of the reporting period.
However, the economic environment where Núcleo performs
its activities does not meet the requirements established by
IFRS to consider the Paraguayan economy as hyperinflation-
ary. The reconciling item reflects the reversal of the inflation
adjustment made under Argentine GAAP, after considering
the IFRS 1 exemption for deemed cost for the measurement
of fixed assets described above.
The impact of reversing the inflation adjustment recorded
under Argentine GAAP is summarized in the table below:
Impact of Reversing the Restatement at the
End of the Reporting Period:
Total Equity as of
December 31, 2009








Attributable to the parent (7) (4) (3)
Attributable to noncontrolling interest (10) (7) (3)
Total of the reconciling item (17) (11) (6)
6. Borrowing Costs that do not Qualify for Capitalization
Under IFRS, capitalization of foreign currency exchange dif-
ferences originated in foreign currency denominated debt is
required as part of the cost of a qualifying asset, when they
are considered to be an adjustment to interest costs. A qual-
ifying asset is an asset that necessarily takes a substantial
period of time to get ready for its intended use.
Under Argentine GAAP, foreign currency exchange differ-
ences (gains or losses) generated on or after January 6, 2002
through July 28, 2003, in connection with foreign-currency de-
nominated debts as of such dates were capitalized as part of
the cost of assets acquired or constructed with such financing,
as long as a series of conditions and requirements were met
(the devaluation of the Peso in that period was approximately
180%).
The reconciliation item represents the reversal of the
amounts capitalized under Argentine GAAP that do not com-
ply with the requirements for capitalization under IFRS, net
of accumulated depreciation. Such reversal represents a de-
crease of $67 and $57 in total equity as of January 1, 2009
and December 31, 2009, respectively, and an increase of $10
in net income for the year ended December 31, 2009.
7. Other Adjustments
7.1 Inventories
Under IFRS inventories are measured at the lower of cost
and net realizable value, and “Last in first out” method is
not allowed. Under Argentine GAAP inventories are stated at
replacement cost.
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The reconciliation item for valuation of inventories under
IFRS represents a decrease of $8 and an increase of $1 in
total equity as of January 1, 2009 and December 31, 2009,
respectively, and an increase of $9 in net income for the
year ended December 31, 2009. Such impacts are substan-
tially generated in Personal with a lower impact generated by
Núcleo´s inventories.
7.2 Fixed Assets Held for Sale
According to IFRS non-current assets should be classified as
held for sale if its carrying amount will be recovered principally
through a sale transaction rather than through continuing use.
To meet that definition, the asset must be available for imme-
diate sale in its present condition subject only to terms that
are usual and customary for sales of such assets and its sale
must be highly probable.
Under Argentine GAAP Telecom Group classifies certain
fixed assets as held for sale. Such assets are included under
the caption “Other assets” and measured at the lower of cost
less depreciation at the time of transfer to the Held-for-sale
category or net recoverable value. As far as those assets
do not comply with the requirements stated by IFRS to be
classified as held for sale, they should be classified as PP&E
and measured at cost less accumulated depreciation.
The impact of this reconciling item represents a decrease
of $2 in total equity as of January 1, 2009 and December 31,
2009, respectively, with no impact in net income for the year
ended December 31, 2009. Such impacts are fully generated
in Telecom Argentina.
8. Tax Effects on IFRS Adjustments
This adjustment represents the effect on deferred income
taxes of the foregoing reconciling items, as appropriate, at a
tax rate of 35% (except for Núcleo, for which the tax rate is
10%). The effect of the IFRS adjustments on income taxes
represents a decrease of $42 and $43 in total equity as of
January 1, 2009 and December 31, 2009, respectively, and
a decrease in net income of $1 for the year ended December
31, 2009.
It should be noted that these amounts include the effect of
the additional income tax provided by currently enforceable
Argentine tax law on the undistributed profits of Núcleo as
it is considered probable that those results will flow to Per-
sonal in the form of dividends. Under Argentine GAAP this
additional income tax obligation is recognized at the time a
dividend distribution proposal is submitted to the approval of
the shareholders of Núcleo.
b) Impacts of the Application of IFRS on the Cash Flow
Statements for the Year Ended December 31, 2009
The Company considers as cash equivalents all short-term
and highly liquid investments that are readily convertible to
known amounts of cash, subject to an insignificant risk of
changes in value and their original maturity or the remaining
maturity at the date of purchase does not exceed 3 months.
As a result, no differences exist between the total amount
of the increase or decrease in cash and cash equivalents
reported in the consolidated financial statements under Ar-
gentine GAAP and the same totals that would be reported in
a statement of cash flows prepared based on IFRS amounts.
However, certain differences exist between cash flows from
operating, investing and financing activities reported in the
consolidated financial statements under Argentine GAAP and
the cash flows from operating, investing and financing activi-
ties under IFRS. These differences are mainly related to the
payments of SAC allocated in investing activities instead of
operating activities.
In addition, under Argentine GAAP the effect of exchange
rate changes on cash and cash equivalents was not pre-
sented in a separate cash flow statement category as re-
quired by IFRS.
The following tables set forth the condensed consolidated









Cash flows provided by operating activities 3,280 3,679
Cash flows from investing activities (1,223) (1,688)
Cash flows from financing activities (1,686) (1,681)
Net foreign exchange differences on cash
and cash equivalents — 61
Increase in cash and cash equivalents 371 371
Cash and cash equivalents at the beginning
of year 902 902
Cash and cash equivalents at year end 1,273 1,273
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c) Impacts of the Application of IFRS on the Consolidated
Income Statement for the Year Ended December 31, 2010
After considering exemptions elected and the “cost model”
chosen to measure PP&E and Intangible Assets, the main
differences identified between Argentine GAAP and IFRS and
their impact on net income for the year ended December 31,
2010 are described below:
Net Income for
the Year Ended








Total amounts under Argentine GAAP 1,004 — — — — —
IFRS Adjustments:
1. Noncontrolling interest 843 — — — — —
Subtotal amounts and noncontrolling interest under
Argentine GAAP 1,847 — — — — —
2. Classification of Class “A” Preferred shares (171) — — — (171) —
3. Revenue recognition
3.1 Upfront connection fees 5 5 — — — —
3.2 Revenues from contracts for the construction of
networks and other assets 4 14 (10) — — —
3.3 Customer loyalty programs 4 (1) 5 — — —
4. Intangible assets
4.3 Service connection or habilitation costs (7) — 19 (26) — —
4.4 Subscriber acquisition costs 173 — 534 (361) — —
5. Reversal of the adjustments for the effects of inflation in
foreign entities´ financial statements (23) (70) 50 18 (21) —
6. Borrowing costs that do not qualify for capitalization 10 — — 10 — —
7. Other adjustments
7.1 Inventories 8 — (7) — 15 —
7.2 Fixed assets held for sale 1 — — 1 — —
8. Tax effects on IFRS adjustments (66) — — — — (66)
Total amounts under IFRS 1,785 (52) 591 (358) (177) (66)
Equity attributable to the parent 895




Company Name Accounting Technique Illustration
A.G. Barr plc 1.137
A/S Dampskibsselskabet TORM
Absa Group Limited 1.80, 3.218
Abu Dhabi Aviation
Abu Dhabi National Hotels PJSC
Abu Dhabi Ship Building PJSC 2.73
Adecoagro S.A. 1.135, 2.18, 2.136, 2.211, 3.388, 7.25
AEGON N.V. 2.365
Aixtron SE (formally, Aixtron Aktiengesellschaft)
Alcatel-Lucent 2.28
Alesco Corporation Limited 1.114, 1.176, 3.288
Allied Irish Bank plc
Alumina Limited 1.81, 2.168
Anooraq Resources Corporation 1.72, 2.25, 3.202
Aquarius Platinum Limited 2.191, 9.26
ArcelorMittal 2.27, 2.305, 5.26
ARM Holdings plc
ARYZTA AG
Ashtead Group plc 1.113, 2.112
AstraZeneca plc 1.82, 2.398
Autonomy Corporation plc




Barry Callebaut AG 1.221, 2.52, 3.307
BBA Aviation plc
BHP Billiton plc and BHP Billiton Limited
BP plc 2.307, 3.142
Brewin Dolphin Holdings plc
British Sky Broadcasting Group plc 2.31, 2.113
Brookfield Asset Management, Inc. 2.19, 2.138, 2.214, 3.321, 3.346, 4.14, 12.16
Brookfield Office Properties Canada 3.60, 5.36
BT Group plc
Cellcom Israel Ltd
Centum Investment Company Ltd
China Eastern Airlines Corporation Limited 5.33
China Gold International Resources Corp, Ltd. (formerly,
Jinshan Gold Mines Inc.) 2.29
China Mobile Limited
China Southern Airlines Company Limited
China Telecom Corporation Limited
China Xiniya Fashion Limited 2.21
China Yuchai International Limited 1.145, 3.344
Chocoladefabriken Lindt & Sprüngli AG
City Telecom (H.K.) Limited 3.56
Clariant Ltd.
Clicks Group Limited 3.109
CNOOC Limited
Compagnie Financière Richemont SA 2.51, 3.61
Compagnie Générale de Géophysique-Veritas, S.A.
Companhia de Bebidas das Américas (American Beverage
Company)—Ambev 1.133, 2.352, 3.345, 10.18
Companhia de Saneamento Basico do Estado de Sao
Paolo—SABESP 1.71, 11.23
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Company Name Accounting Technique Illustration
Compañia Cervecerı́as Unidas S.A.
Copa Holdings, S.A. 2.259
Credicorp Ltd
CRH Public Limited Company
CSR plc
Daimler AG
Delhaize Brothers and Co “The Lion” (Delhaize Group) SA 2.303, 3.240





East Asiatic Company Ltd. A/S 10.19
Eastern Platinum Limited
Elbit Imaging Ltd.
Embotelladora Andina S.A. 2.17, 2.22, 5.31
Empresa Nacional de Electricidad S.A. (Endesa-Chile) 3.137
Enersis S.A.
Eni S.p.A 2.353, 3.219, 8.56
Flughafen Zürich AG




GlaxoSmithKline plc 3.108, 3.201
Gol Linhas Aéreas Inteligentes S.A. 5.27
GrainCorp Limited
Guangshen Railway Company Limited 1.202
Harmony Gold Mining Company Limited 2.189, 3.26, 3.290
Heatherdale Resources Ltd 4.18
Helical Bar plc 2.26
HGL Limited 3.138
Hikma Pharmaceuticals PLC
Homburg Invest Inc. 2.53, 2.137, 4.19, 6.27
HSBC Holdings plc 8.57
Huaneng Power International, Inc. 3.24
InterContinental Hotels Group plc 1.136, 3.306
JSC BTA Bank 1.76
JSC Halyk Bank 4.16
Julius Baer Group Ltd
Koninklijke Philips Electronics NV 3.141, 3.347
Lan Airlines S.A. 1.235, 5.23, 6.25
Luxottica Group S.p.A 2.30, 3.155
Magyar Telekom plc 1.141, 3.305
Millicom International Cellular S.A. 1.111, 2.260, 3.387
Mondi Limited and Mondi plc 5.28
N Brown Group plc
National Grid plc 1.73, 4.15
National Westminster Bank Plc 1.112, 2.115
Nestlé SA 4.20
Newcrest Mining Limited 3.59
Nobel Biocare Holding AG
Nokia Corporation 2.302
Nortel Inversora S.A. 2.397, 7.28, 8.54, 10.17, 12.17




Panalpina World Transport (Holding) Ltd
Pargesa Holding AG 1.134




Company Name Accounting Technique Illustration
Philippine Long Distance Telephone Company 5.25, 5.32, 8.58
Portugal Telecom, SGPS, S.A. 2.75, 3.343
Prudential plc
PSP Swiss Property Ltd 1.14
Randgold Resources Limited
REA Vipingo Plantations Limited 2.213
Reckitt Benckiser Group plc 3.153
Reed Elsevier NV and Reed Elsevier PLC 2.23
Repsol YPF, S.A.
Rio Tinto Limited and Rio Tinto plc 1.143, 2.167, 2.351
Roche Holding Ltd
Royal Bank of Scotland Group plc, The 3.62
Royal Dutch Shell plc 2.304, 3.156
Ryanair Holdings plc
sanofi-aventis
SAP AG 1.77, 3.58
Sappi Limited 8.61
Sasini Limited 2.74, 3.140, 3.320
Sasol Limited 7.26
Seven Arts Pictures Plc 3.389
Siemens Aktiengesellschaft 3.184, 8.62
Silver Fern Farms Limited 1.142, 2.24, 3.241, 3.289
Sims Metal Management Limited 2.190, 3.291, 5.24
Smith & Nephew plc
SouthGobi Resources Ltd.
Stagecoach Group plc
Sterlite Industries (India) Limited 1.178, 3.292, 5.29
Straumann Holding AG 1.200
Subsea 7 S.A. (formerly, Acergy S.A.) 3.90 + B174
Swiss Life Holding Ltd 4.17
Swisscom Ltd
Syngenta AG
TAM S.A. 1.79, 3.139
Taylor Wimpey plc
Technicolor SA 6.26










Trinity Biotech plc 1.203, 2.50, 2.116, 3.386
Turkcell Iletisim Hizmetleri AS 1.75
U308 Corp. 5.35
UBS AG 1.78
Ultra Electronics Holdings plc 3.55
Unilever N.V. and Unilever plc 1.144, 2.111
Veolia Environnement 2.306
Vina Concha y Toro S.A. 2.117, 2.212, 2.354, 3.25, 5.30, 8.55
Vodafone Group plc 1.222, 7.27, 8.59
WPP plc





Note that paragraph references ending with “n” refer to an Author’s Note following the numbered paragraph.
No. Title Paragraph
American Institute of Certified Public Accountants (AICPA)
1 Identification and Discussion of Certain Financial Accounting and
Reporting Issues Concerning LIFO Inventories (issues paper) 2.49







































230 Statement of Cash Flows 5.15
230-10-45 5.13, 5.15, 5.21
230-10-45-3 5.22
230-10-45-15 5.15


















250-10-50-1 1.64, 1.64n, 1.65
250-10-50-4 1.67
250-10-50-5 1.67



































320 Investments—Debt and Equity Securities 3.211, 8.23
323 Investments—Equity Method and Joint Ventures 2.151, 2.165, 2.179






































































































































































712 Compensation—Nonretirement Postemployment Benefits 1.98, 3.148































744 IFRS Accounting Trends & Techniques
No. Title Paragraph










































































820 Fair Value Measurements and Disclosures 2.92
820-10-50 2.299
825 Financial Instruments 8.23, 8.33
825-10-15 1.207
825-10-15-1 8.26

































































840-10-50 2.252, 2.255, 2.258,
3.237

























































940 Financial Services—Broker and Dealers 1.98





Financial Accounting Standards Board (FASB) Accounting Standards Updates (ASUs)
n/a Accounting for Financial Instruments and Revisions to the
Accounting for Derivative Instruments and Hedging Activities
(exposure draft) 8.01n
n/a Balance Sheet Offsetting 8.27n
2009-13 Revenue Recognition (Topic 605): Multiple-Deliverable Revenue
Arrangements—a consensus of the FASB Emerging Issues
Task Force 3.46n
2010-28 Intangibles—Goodwill and Other (Topic 350): When to Perform
Step 2 of the Goodwill Test for Reporting Units with Zero or
Negative Carrying Amounts 3.273n






Financial Accounting Standards Board (FASB) Statements
n/a Leases: Preliminary Views (discussion paper) 2.214n
n/a Preliminary Views on Revenue Recognition in Contracts with
Customers (discussion paper) 3.26n
n/a Revenue from Contracts with Customers (exposure draft) 1.230n, 3.26n, 11.09n
International Accounting Standards (IASs)
1 Presentation of Financial Statements 1.011.82, 1.195, 1.208, 1.231,
2.012.32, 2.46, 2.49, 2.65,
2.78, 2.98, 2.131, 2.158,
2.184, 2.203, 2.242, 2.250,
2.290, 2.336, 2.338, 2.346,
3.013.26, 3.48, 3.91, 3.101,
3.131, 3.134, 3.177, 3.197,
3.199, 3.213, 3.229, 3.275,
3.301, 3.3303.331,
4.014.20, 5.01, 8.31, 8.43,
8.47, 9.16, 10.08, 12.02,
12.09
2 Inventories 2.33–2.53, 2.119, 2.127,
2.192, 3.91–3.111
7 Statement of Cash Flows 1.148, 5.01–5.36
8 Accounting Policies, Changes in Accounting Estimates and
Errors
1.01–1.82, 1.188, 1.233, 2.04,
2.106, 3.06, 3.74, 3.116,
3.123, 5.16, 9.17n, 12.04,
12.06
10 Events After the Reporting Period 1.115–1.145
11 Construction Contracts 2.34, 2.264, 3.26n, 3.30,
3.64–3.90, 11.09
12 Income Taxes 2.05, 2.264, 2.367–2.398,
3.322–3.347, 9.08
14 Segment Reporting 7.01
16 Property, Plant and Equipment 1.21, 2.35, 2.54–2.75, 2.119,








18 Revenue 1.226, 3.26n, 3.27–3.64, 8.15,
11.09
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19 Employee Benefits 1.211, 2.264, 2.308–2.354,
3.143–3.156, 8.03, 9.08,
12.07
20 Accounting for Government Grants and Disclosure of Government
Assistance 1.179–1.203
21 The Effects of Changes in Foreign Exchange Rates 1.146–1.178, 5.09, 10.06
23 Borrowing Costs 2.71, 3.185–3.202, 5.10,
11.10, 12.07









27 (2011) Separate Financial Statements 1.82n, 1.109n, 2.01–2.32,
3.01n
28 Investments in Associates 1.94, 1.96, 2.171, 2.178,
2.183, 3.203–3.219, 8.03
28 (2011) Investments in Associates and Joint Ventures 2.139–2.168, 2.168n,
3.202n
29 Financial Reporting in Hyperinflationary Economies 10.1–10.19
31 Interests in Joint Ventures 1.96, 2.169–2.191,
3.203–3.219, 8.03
32 Financial Instruments: Presentation 1.84n, 2.34, 2.76, 2.266,
8.01–8.62
33 Earnings Per Share 3.348–3.389
34 Interim Financial Reporting 12.02, 12.15





37 Provisions, Contingent Liabilities and Contingent Assets 1.229, 2.58, 2.148,
2.261–2.307, 2.307n,
2.346, 2.366n, 3.88,
3.119, 8.15, 11.12, 12.07
38 Intangible Assets 1.21, 2.76, 2.80–2.83, 2.85,






















International Accounting Standards Board (IASB) Statements
n/a Additional Exemptions for First-time Adopters: Proposed
amendments to IFRS 1 12.01n
n/a Deferred Tax: Recovery of Underlying Assets: Amendments to
IAS 12 2.366n
n/a Deferred Tax: Recovery of Underlying Assets: Proposed
amendments to IAS 12 3.321n
n/a Disclosures—Transfers of Financial Assets: Amendments to IFRS 7 12.01n
n/a Financial Instruments: Amortised Cost and Impairment
(exposure draft) 8.01n
n/a Financial Instruments: Impairment 8.01n
n/a Hedge Accounting (exposure draft) 8.01n
n/a Improvements to IFRSs 1.222n, 5.06n, 6.19,
7.01n, 9.01n,
9.07n–9.08n, 12.01n
n/a Leases: Preliminary Views (discussion paper) 2.214n
n/a Limited Exemption from Comparative IFRS 7 Disclosures for
First-time Adopters: (Amendment to IFRS 1) 12.01n
n/a Offsetting Financial Assets and Financial Liabilities (exposure draft) 8.27n
n/a Preliminary Views on Revenue Recognition in Contracts with
Customers (discussion paper) 3.26n
n/a Removal of Fixed Dates for First-time Adopters (proposed
amendments to IFRS 1) (exposure draft) 12.07n
n/a Revenue from Contracts with Customers (exposure draft) 1.230n, 3.26n, 11.09n
n/a Severe Hyperinflation B511 12.07n
n/a Severe Hyperinflation and Removal of Fixed Dates for First-time
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International Financial Reporting Interpretations Committee (IFRICs)
1 Changes in Existing Decommissioning, Restoration and Similar
Liabilities 2.58, 12.07
2 Members’ Shares in Co-operative Entities and Similar Instruments 8.02
4 Determining Whether an Arrangement Contains a Lease 2.217, 12.07
7 Applying the Restatement Approach under IAS 29 Financial
Reporting in Hyperinflationary Economies 10.05
9 Reassessment of Embedded Derivatives 8.02
10 Interim Financial Reporting and Impairment 8.02
12 Service Concession Arrangements 2.214n, 11.01–11.23,
12.07
13 Customer Loyalty Programmes 1.223–1.235
14 IAS 19—The Limit on a Defined Benefit Asset, Minimum Funding
Requirements and Their Interaction 2.308–2.354
15 Agreements for the Construction of Real Estate 3.64–3.90
16 Hedges of a Net Investment in a Foreign Operation 8.02
17 Distributions of Non-cash Assets to Owners 4.01–4.20
18 Transfers of Assets from Customers 12.01n, 12.07
19 Extinguishing Financial Liabilities with Equity Instruments 8.02n, 12.01n, 12.07
International Financial Reporting Standards (IFRS)
1 First-Time Adoption of International Financial Reporting Standards 12.01–12.17
2 Share-based Payments 1.211, 2.308,
2.355–2.366, 3.143,
3.157–3.184, 8.03,
8.36, 9.08, 9.08n, 12.07




4 Insurance Contracts 6.02, 8.03, 12.07





7 Financial Instruments: Disclosures 2.246, 2.249, 2.266,
3.234, 3.239,
8.01–8.62, 11.21
8 Operating Segments 3.259, 6.23, 7.01–7.28






10 Consolidated Financial Statements 1.82n, 2.01n, 3.01n
11 Joint Arrangements 2.138n, 2.168n, 3.202n
12 Disclosure of Interests in Other Entities 2.138n, 2.168n, 3.202n
13 Fair Value Measurement 8.01n
27 Consolidated and Separate Financial Statements 12.08
Laws (U.S.)
Investment Company Act of 1940 2.151
Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 2.349
Other IFRS Guidance







EU Implementation of IFRS and the Fair Value Directive: A Report
for the European Commission 12.07n








Topic 5(L), “LIFO Inventory Practices” 2.49
Topic 5(Y), “Accounting and Disclosures Related to Loss
Contingencies” 2.299
Topic 5(Z)(4), “Disposal of Operation With Significant Interest
Retained” 6.12
Topic 11(F), “LIFO Liquidations” 2.49
Topic 11(F), “LIFO Liquidations,” 3.106
Topic 11(M), “Miscellaneous Disclosure—Disclosure of the Impact
That Recently Issued Accounting Standards Will Have on the
Financial Statements of the Registrant When Adopted in a
Future Period” 1.66
Topic 13, “Revenue Recognition” 3.43
Topic 13(B), “Disclosures” 3.54
Topic 14(A), “Share-Based Payment Transactions with
Nonemployees” 3.171
Topic 14(F), “Classification of Compensation Expense Associated
with Share-Based Payment Arrangements” 3.178
Form 10-K 1.25n, 3.342n
Form 20-F 1.25n, 3.342n
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Item 402, “Executive Compensation” 1.216
Regulation S-X 1.36, 2.11, 2.292,
2.298, 3.333
Rule 3-01(a) 1.36, 2.11
Rule 3-02(a) 1.36





Rule 5-03 3.21, 3.23, 3.49,
3.102, 3.276
Rule 5-03, “Income Statements” 3.19–3.20
Rule 5-03(b) 3.198
Sec. 210.5-01 through 210.5-04 2.292
Standing Interpretations Committee (SICs)
10 Government Assistance—No Specific Relation to Operating
Activities 1.187
12 Consolidation—Special Purpose Entities 1.83–1.114, 2.01n,
3.01n
21 Income Taxes—Recovery of Revalued Non-depreciable Assets 2.367–2.398
29 Service Concession Arrangements: Disclosures 11.01–11.23
31 Revenue—Barter Transactions Involving Advertising Services 3.27–3.63




Note that paragraph references ending with “n” refer to an author’s note following the numbered paragraph.
A
Accelerated cost recovery system method, 3.129
Accounting estimates, Table 1–7. See also Change in
accounting estimates
Accounting policies. See also Change in accounting
policy
basic and diluted EPS, 3.388




disclosure, 1.46–1.47, 1.60, 1.176, 8.43
government grants, 1.197
investments in associates, 2.147
leases, 2.223
multiple element arrangements, 3.53
revenue recognition, 3.51–3.52
Accounts payable, 2.397, 8.58
Accounts receivable, 2.398, 8.55
Accumulated postretirement benefit obligations
(APBOs), 2.332
Acquirers, 9.05
Acquisition method, 9.01, 9.04
Acquisitions, 1.134, 1.138, 1.143
Actuarial gains and losses
defined benefit plans, 3.147
postemployment benefits, 3.151, 3.154–3.155
recognition in other comprehensive income, 2.323,
2.352
recognition using the corridor approach, 2.322,
2.353
Adjusting events after reporting period. See Events
after reporting period
Adjustments for fair value gains on forestry assets,
felling costs, and special items, 5.28




Agricultural activity. See Agriculture
Agricultural cooperatives, 2.210
Agricultural produce, 2.193–2.194, 2.200
Agricultural product producers, 2.36, 2.198
Agricultural products after harvest, 2.36, 2.192
Agriculture. See also Biological assets
overview, 2.192
disclosure, 2.205–2.210
fair value model, 3.312, 3.318
presentation, 2.203–2.204
presentation and disclosure excerpts,
2.211–2.214
recognition and measurement, 2.193–2.202
Aircraft, 5.33
American Depositary Receipts (ADRs), 3.386
Amortization. See Depreciation (amortization)
Animals raised for competitive sports, 2.198
Animals raised for sale, 2.202
Annuity method for depreciation (amortization),
3.129





depreciation (amortization), 3.119, 3.130
PPE, 2.58, 2.64
provisions, contingent liabilities and contingent
assets, 2.286, 2.299–2.300
Assets
biological, see Biological assets
contingent, see Provisions, contingent liabilities
and contingent assets
current, see Current assets
deferred taxes, see Deferred tax assets
defined, 1.07
energy assets, 3.321
financial, see Financial assets
held for sale, see Held for sale assets
held for trading, 5.29, 8.57
held to maturity, 8.56
identifiable, 2.76
impairment, see Impairment of assets
intangible, see Intangible assets
interests in joint ventures, 2.191
jointly controlled, 2.170, 2.172
noncash, distributions to owners, 4.01–4.20
noncurrent, see Noncurrent assets
offsetting, 1.39, 2.176, 2.293, 2.336, 3.345
recognition, defined contribution/benefit plans,
2.352
reportable segment thresholds, 7.08
revalued nondepreciable assets, recovery,
2.367–2.398
service concession arrangements, 11.17
transfer of, 8.61, 12.07
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transfer of revaluation reserve to retained earnings
on depreciation and disposal, 4.16
transportation assets, 3.321
utility assets, 3.321
Associates, 2.139. See also Investments in associates
Audit firms, Table 1–6
Available for sale assets, 8.57
Award credits. See Customer loyalty programmes
B
Balance sheet. See also Statement of financial
position
overview, 2.01–2.03
biological assets, 2.193, 2.203, 2.210
classified balance sheet, 2.06, 2.12
comparative balance sheet, 2.11
disclosure, 2.13–2.16
employee benefits, 2.319, 2.336–2.337, 2.341
intangible assets, 2.98, 2.110
interests in joint ventures, 2.174, 2.184
inventories, 2.46
investment in associates, 2.158–2.159
investment property, 2.131
leases, 2.225, 2.227, 2.242–2.244, 2.253–2.254,
2.256
liquidity order balance sheet, 2.08
PPE, 2.65–2.66, 2.70
presentation, 2.05–2.12
presentation and disclosure excerpts, 2.17–2.20
provisions, contingent liabilities and contingent





collections and payments, 5.31
restricted deposits, receipt and payment, 5.33
Bank overdrafts repayable on demand, 5.03,
5.13
Barter transactions, 3.26n, 3.33, 3.56
Basic earnings per share (EPS)
accounting policy disclosure, net loss, all
potentially dilutive shares anti-dilutive, 3.388
continuing/discontinued operations, 3.387
net loss resulting in outstanding convertible
preference shares, convertible debt, share
options anti-dilutive in current year, dilutive in
prior years, 3.389
reported on one line—no dilutive potential shares,
3.385
two classes of ordinary shares, disclosure of EPS
per ADR, options and warrants anti-dilutive in
prior year, 3.386
Benefit-years-of-service approach, 2.332
Bill and hold transactions, 3.57
Biological assets. See also Agriculture
on balance sheet, 2.193, 2.203, 2.210
change in fair value, 3.320
defined, 2.193
disclosure, 2.205–2.207
fair value model, 3.312
impairment, 3.243
investment property, exclusion, 2.120
leases, exception, 2.216
no reliable fair value, pledged as guarantee, 2.212






perpetual, redeemable for shares, 8.60
repurchase adjustments, 5.27
Borrowing costs. See also Interest costs or expenses
overview, 3.185
capitalized borrowing costs, 2.71, 3.186,
3.189–3.192, 3.195–3.196, 3.199–3.200, 3.202
defined, 3.194, 3.197
disclosure, 3.199–3.200




presentation and disclosure excerpts, 3.201–3.202
recognition and measurement, 3.186–3.196
service concession arrangements, 11.10
Brands and brand names, 2.112, 2.114, 2.117
Breeding animals, 2.201
Broker traders, 2.52
Buildings and other structures as investments. See
Investment property
Business combinations. See also Consolidated




acquisition financed through issue of ordinary
shares and options over ordinary shares, 9.26
acquisition method, 9.01
brands and brand names, 2.112, 2.114, 2.117
comparative financial statements, 9.23n
computer software, 2.113, 2.115
contingencies, 9.25
contingent liabilities, 9.21
core deposit intangibles, 2.115
customer lists, 2.112






exemption from retrospective application of IFRS 1,
12.07
fair value, 9.21
gain on bargain purchase, 9.26
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goodwill, 2.77, 2.111, 9.10, 9.21
intangible assets, see Intangible assets
IT programs, 2.117
noncontrolling interests, measurement, 9.07, 9.07n,
9.12–9.13, 9.21, 9.27
other acquired intangibles, 2.115
presentation, 2.98–2.99, 9.16–9.25
presentation and disclosure excerpts, 1.139,
2.111–2.117, 9.26–9.28
prior period adjustments, 9.24
prospective application of IFRS 3 (2008), 9.27–9.28
recognition and measurement, 2.79–2.97,
9.05–9.15
revaluation of previously held equity interest, 9.28
reverse acquisitions, 9.11, 9.15–9.16










share, see Share capital
working capital, 1.140
Capital leases. See Finance (capital) leases
Capital shares, 5.34
Capital structure, 2.23, Table 2–2
Capitalized borrowing costs. See Borrowing costs
Cash, 5.02, 5.13, 5.16, 5.20. See also Statement of
cash flows
Cash dividends, 1.62, 1.133
Cash equivalents
change in accounting policy, 5.16, 5.20
defined, 5.02, 5.13–5.14
equity instruments, 5.14
Cash flow statement. See Statement of cash flows
Cash flows from operating activities. See also under
Statement of cash flows
classifications of reported income tax, interest, and
dividends, Table 5–2
reporting methods, Table 5–1
Cash generating units (CGUs)
defined, 3.245
goodwill, 3.245–3.263, 3.272–3.273, 3.282, 3.284
impairment, 3.245, 3.248, 3.264, 3.267
Cash-settled transactions, 3.160, 3.162, 3.170, 3.172,
3.184
Cattle held for sale, 2.211
CGUs. See Cash generating units (CGUs)






disclosure, 1.52, 1.55–1.56, 1.67–1.68, 1.69n
events after reporting period, 1.124
intangible assets, 2.106
presentation and disclosure excerpts, 1.80
prospective application, 1.20, 1.29
recognition and measurement, 1.14–1.31
repayable government grants, 1.188
Change in accounting policy
cash and cash equivalents, 5.16, 5.20
customer loyalty programmes, 1.233
disclosure, 1.52, 1.64, 1.64n, 1.65
exceptions, 1.27
first-time adoption of IFRSs, 12.13
government grants and assistance, 1.202
measurement basis changes, 1.21
retrospective application, 1.19, 1.28
revaluation of previously held interests, 1.111
on statement of changes in equity, 4.06
when permitted, 1.26




presentation and disclosure excerpts, 3.320–3.321
recognition and measurement, 3.309–3.313
recognition in other comprehensive income,
3.320–3.321
recognition in profit and loss, 3.320–3.321
Class of instrument, 8.37
Close family members, 1.206




Commitments, categories of, Table 1–8
Commodity broker-dealers, 2.36
Common shares, 2.22, 2.152, 2.166, 4.14





Completed-contract method, 3.81, 3.83, 3.86,
3.89
Component accounting (componentization), 3.113
Component of an entity, 6.10, 6.12, 6.14, 7.03
Compound financial instruments
defined, 8.30
exemption from retrospective application of IFRS 1,
12.07
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presentation and disclosure excerpts, 8.60
share-based payments, 2.359, 3.161
Comprehensive income, reporting. See Statement of
changes in equity
Computer software, 2.113, 2.115, 2.117, 3.58
The Conceptual Framework for Financial Reporting
(IFRS Conceptual Framework)
disclosure, 1.40–1.41
financial statements, generally, 1.01–1.06, 1.01n
presentation, 1.33
presentation and disclosure excerpts, 1.69n
recognition and measurement, 1.07–1.09, 1.12,
1.16
statement of comprehensive income, 3.01n,
3.05–3.09, 3.27
statement of financial position, 2.01n, 2.04
Consolidated financial statements
overview, 1.83–1.84, 2.01–2.04, 3.01–3.09
changes in accounting policy—revaluation of
previously held interests, 1.111
definitions, 1.83–1.84
disclosure, 1.104–1.110, 2.13–2.16, 3.22–3.23
dividends, restrictions on payments to shareholders
by subsidiaries, 1.112
EPS, computation and presentation, 3.363, 3.375
exclusions to consolidation, 1.98
exemption from retrospective application of IFRS 1,
12.08
investments in associates or jointly controlled
entities, 1.96
investments in joint ventures, 2.172
parent company disclosures in notes, 1.113
parent exemption from consolidated presentation,
1.86
parent’s separate statements presented
side-by-side with related parent’s consolidated
statements, 1.114
presentation, 1.32–1.39, 2.05–2.12, 3.10–3.21
presentation and disclosure excerpts, 1.111–1.114,
2.17–2.32, 3.24–3.26







presentation and disclosure excerpts, 3.90
provisions, contingent liabilities, and contingent
assets, exclusion, 2.264
recognition and measurement, 3.30, 3.66–3.83
separate versus combined contracts, 3.66–3.68,
3.76–3.77
service concession arrangements, 11.09
Construction-in-progress accounts, 3.79
Constructive obligations, 2.309
Contingent assets. See Provisions, contingent
liabilities and contingent assets
Contingent liabilities. See Provisions, contingent
liabilities and contingent assets
Contingently issuable shares, 3.364, 3.383
Continuing operations, 3.341, 3.387
Contract costs, 3.70
Contract revenue, 3.69
Contracts. See Construction contracts; Onerous
contracts
Controlling interest in subsidiary, 1.143
Convertible bonds, 4.19




Corporate joint ventures, 2.179–2.180
Corridor method, 2.322, 2.353, 3.147, 3.156
Cost flow assumptions. See under Inventories
Cost model
for measuring investment property, 2.123,
2.134–2.135
for measuring PPE, 2.60, 2.70, 2.73, 3.137–3.139
Cost of sales, 3.26
Cost of sales format, 3.101
Cost-plus contracts, 3.64, 3.74, 3.78




statistical profiles, Table 1–3
Credit lines, 1.134
Critical accounting estimates, 1.60n, Table 1–7
Crops (agricultural), 2.211
Cumulative translation differences, 12.07
Current assets
advances, 2.28
biological assets, no reliable fair value, pledged as
guarantee, 2.212






prepaid expenses, 2.27, 2.29











premiums/discounts to suppliers, 2.30
presentation, 2.292, 2.298
sales commissions, 2.30
taxes not yet paid, 2.372





frequent flyer program, 1.235
presentation, 1.231–1.232
presentation and disclosure excerpts, 1.235













presentation and disclosure excerpts, 2.398
recognition and measurement, 2.373, 2.375, 2.387





presentation and disclosure excerpts, 2.397–2.398
provisions, contingent liabilities and contingent
assets, exclusion, 2.264
recognition and measurement, 2.373, 2.387
Defined benefit plans
disclosure, 2.344–2.345
exemption from retrospective application of IFRS 1,
12.07
presentation and disclosure excerpts, 2.352–2.353




presentation and disclosure excerpts, 2.352–2.353
recognition and measurement, 2.315
Depletion, 3.142




amortized cost for financial assets or financial
liabilities, 8.04, 8.15
commercial property debt issue, amortization and
repayment, trust unit and class B limited
partnership distributions, 5.36
cost model, PPE, 3.137–3.139
depletion, 3.142
disclosure, 3.133–3.136
financial instrument classification and measurement
simplification project (IASB), 8.01n
on income statement, 3.132
intangible assets, 3.141
methods of, Table 3–4
presentation, 3.131–3.132
presentation and disclosure excerpts, 3.137–3.142
recognition and measurement, 3.113–3.130
revaluation model, PPE, 3.140









provisions, contingent liabilities and contingent
assets, 2.279
Derivative instruments (derivatives)




financial instrument classification and measurement
simplification project (FASB), 8.01n
measurement, 8.15
presentation and disclosure excerpts, 8.62
reclassification, 8.17
Designation of previously recognized financial
instruments, 12.07
Development costs, 2.116
Diluted earnings per share (EPS)
accounting policy disclosure, net loss, all
potentially dilutive shares anti-dilutive, 3.388
continuing/discontinued operations, 3.387
net loss resulting in outstanding convertible
preference shares, convertible debt, share
options anti-dilutive in current year, dilutive in
prior years, 3.389
reported on one line—no dilutive potential shares,
3.385
two classes of ordinary shares, disclosure of EPS
per ADR, options and warrants anti-dilutive in
prior year, 3.386
Direct financing leases, 2.241, 2.257
Direct method of reporting cash flows from operating
activities, 5.05, 5.23–5.24
Disclosure. See under specific topics
Discontinued operations. See also under Noncurrent
assets
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basic and diluted EPS, 3.374, 3.378, 3.387
noncurrent assets held for sale and discontinued
operations, 6.26–6.27
reclassification, 6.11
recognition and measurement, 6.10
on statement of cash flows, 5.21
on statement of comprehensive income, 3.10
statistical profiles, Table 6–2




held for sale, 6.04
impairment, 3.243, 6.08
presentation, 2.291, 6.16–6.20
recognition and measurement, 6.04–6.15
Dividends
announcement, 1.144
cash dividends, 1.62, 1.133
declaration, not recognized as a liability, 1.79
income, 3.61
preference dividends, 3.383
preference shares (classified as equity), 4.16
preferred stock, subject to mandatory redemption,
5.25
recognition and measurement, 3.39, 3.51
restrictions on payments to shareholders by
subsidiaries, 1.112
scrip dividend, 4.15
shares issued in lieu of, 4.15





Dual listed company (DLC) structure, 2.22n
E
Earnings per share (EPS). See also Basic earnings per
share (EPS); Diluted earnings per share (EPS)
overview, 3.348
adjustments, events after reporting period, 1.124
disclosure, 3.381–3.384




presentation and disclosure excerpts, 3.385–3.389
recognition and measurement, 3.349–3.372
Easement rights, 2.117
Effective interest method of amortization, 2.222,
2.225, 3.221, 8.04
Elements of financial position, 1.07
Elements of performance, 1.08
Emissions rights, 3.63
Employee benefits. See also Postemployment
benefits; Termination benefits
overview, 2.308–2.310, 3.143
actuarial gains and losses, immediate recognition in
other comprehensive income, 2.352
actuarial gains and losses, recognition using the
corridor approach, 2.353
assets, recognition, 2.352
on balance sheet, 2.319, 2.336–2.337, 2.341
current liabilities, 2.351
defined, 2.308, 3.143
defined benefit plans, 2.352–2.353
defined contribution plans, 2.352–2.353
disclosure, 2.338–2.350, 3.151–3.152
impairment, 3.243
plan obligations, presentation, 8.03
presentation, 2.336–2.337, 3.150
presentation and disclosure excerpts, 2.351–2.354,
3.153–3.156
recognition and measurement, 2.311–2.335,
3.144–3.149
senior management remuneration, 2.354
short-term benefits, 3.153
Employee share purchase plans, 3.176
Employee share-based payments, 3.171, 3.173,
3.178
Employee stock ownership plans, 3.176
Energy assets, 3.321
Environmental costs, 2.305, 2.307
Environmental rehabilitation, 2.265, 2.304
EPS. See Earnings per share (EPS)
Equity, 1.07
Equity components, 2.359. See also Statement of
changes in equity
Equity instruments
as cash equivalents, 5.14
defined, 8.04
derivatives, 1.84n
exemption from retrospective application of IFRS 1,
12.07
extinguishing financial liabilities with, 8.02n
Equity interests, 3.154, 9.28
Equity method
interests in joint ventures, 2.173, 2.177, 2.184,
2.188, 2.190, 3.203, 3.205–3.206, 3.209,
3.211–3.212
investments in associates, 2.143–2.146, 2.149,
2.151, 2.155, 2.161–2.162, 2.165–2.166, 3.203,
3.205–3.206, 3.209, 3.211–3.212
limited liability companies, 2.181
partnerships, 2.181
unincorporated joint ventures, 2.181
Equity-method investments, 2.158–2.159, 3.10
Equity-settled transactions, 3.160–3.163,
3.171–3.172, 3.181, 3.184
Error correction. See Prior period errors
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Events after reporting period
overview, 1.115
adjusting events, 1.116–1.117
binding offer to acquire another company,
1.134
binding offer to buy talc business received,
1.143
bond issue, announcement, 1.144
business combinations, 1.139
capital contribution by Swiss federal tax authorities,
1.140
cash dividend declaration and distribution, 1.133
credit lines extension, 1.134
disclosure, 1.127–1.132
divestiture of controlling interest in subsidiary,
1.143
early repayment of bonds, 1.142
financial statements subject to approval of
shareholders, 1.137
increase in shareholding in associate, 1.145
initial public offering, 1.135
issue of court opinion in litigation, 1.138
nonadjusting events, 1.116, 1.118, 1.129
presentation, 1.125–1.126
presentation and disclosure excerpts, 1.133–1.145
private placement, 1.135
property sales by Swiss federal tax authorities,
1.140
quarterly dividend, announcement, 1.144
recognition and measurement, 1.116–1.124
sale and leaseback, 1.145
sale of building, 1.145
share buy back program, announcement, 1.143
tax reduction withdrawn by Hungarian government,
1.141
taxable bonus share issue to shareholders
declared, 1.142
tender offer, 1.136
unrecognized subsequent events, 1.132
Exceptional items, 3.14n
Exchanges rates. See Foreign exchanges rates
Executory contracts, 2.264
Exit and disposal activities, 2.287
Expenses. See also Depreciation (amortization)
analysis by function, 3.22, 3.22n, 3.23, 3.26,
3.108–3.110, 3.134
analysis by nature, 3.22, 3.22n, 3.23, 3.111




on statement of comprehensive income, 3.22
third party payments, 5.35
Expenses recognized in profit and loss, Table 3–1
Extraordinary items
defined, 3.21
on income statement, 3.21, 3.23
operating segments, 7.23
on statement of cash flows, 5.21




business combinations, 9.07, 9.21
construction contract revenue, 3.69
defined, 8.01n, 8.04
exemption from retrospective application of IFRS 1,
12.07
felling costs, adjustments, 5.28
financial instruments, 8.13–8.14, 8.16, 8.19, 8.26,
8.45, 8.49–8.52
forestry assets, adjustments, 5.28
gain on held for trading assets, 5.29
government grants, initial recognition, 1.202
interests in joint ventures, 3.218
inventories, fair value less cost to sell—broker
trader exemption from IAS 2, 2.52
net assets acquired in reverse acquisition, 4.18
nonfinancial assets, see Change in fair value of
nonfinancial assets
revenues, 3.31
service concession arrangements, 11.11
share-based payments, 3.163, 3.165–3.166, 3.168,
3.170, 3.175, 3.180
special items, adjustments, 5.28
Fair value hierarchy, 8.45
Fair value less cost to sell (FVLCS)
agricultural assets, 2.194, 2.196–2.197, 2.208,
3.312, 3.318
biological assets, 2.194–2.197, 2.208
impairment of assets, 3.249–3.250, 3.254, 3.263,
3.279, 3.283
nonfinancial assets, 3.313–3.315, 3.319
Fair value model, investment property, 2.123,
2.126–2.127, 2.132–2.133
Fair value through profit or loss (FVTPL), 8.57
Faithful representation of financial information, 1.04
Fees and commissions, 3.62
Felling costs, 5.28
FIFO (First-in, first-out). See under Inventories
Films, 2.216, 2.229
Finance costs or expenses
defined, 2.214n, 3.197
disclosure, 3.199
presentation and disclosure excerpts, 3.201
on statement of comprehensive income, 3.10










presentation and disclosure excerpts, 2.259–2.260,
3.240–3.242
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recognition and measurement, 2.218–2.241,
3.221–3.228
refunds of deposit pledges, 5.33
repayment, 5.33
Financial Accounting Standards Board (FASB)
financial instrument classification and
measurement simplification project, 8.01n
IFRS 5 convergence project, 6.01, 6.15
lease accounting project, 2.214n
revenue recognition project, 3.26n
Financial assets
accounts receivable, 8.55
accounts receivable from related parties, 8.55
available for sale, 8.57
defined, 8.04, 11.18
designated at FVTPL, 8.57
disclosure, 8.38
exemption from retrospective application of IFRS 1,
12.07–12.08
held for trading, 8.57
held to maturity, 8.56
offsetting, 8.32, 8.35
reclassified to available for sale, 8.57
reclassified to loans and receivables, 8.57
service concession arrangements, 11.08, 11.08n
transfers, securitization of receivables, 8.61





available for sale, 8.57
classes of, 8.37
classification, 8.28, 8.33
classification and measurement simplification
project (IASB/FASB), 8.01n
compound financial instruments, 8.60
defined, 8.01, 8.04
derecognition project (IASB), 8.01n
derivatives, 8.62
designated at FVTPL, 8.57
disclosure, 8.36–8.53
early adoption of IFRS 9 (first-time adoption of
IFRS), 8.54
fair value, 8.13–8.14, 8.16, 8.19, 8.26, 8.45,
8.49–8.52
hedging, 8.62
held for trading, 8.57
held to maturity, 8.56
impairment, 8.20
notes payable, 8.58
perpetual bonds redeemable for shares, 8.60
preference shares redeemable classified as
liabilities, 8.59
presentation, 8.28–8.35
presentation and disclosure excerpts, 8.54–8.62
reclassification, 8.17–8.18, 8.30, 8.39, 8.57
recognition and measurement, 8.05–8–27
risk exposure, 8.46, 8.53
transfers, securitization of receivables, 8.61




available for sale, 8.57
defined, 8.04, 8.29
designated at FVTPL, 8.57
disclosure, 8.38
exemption from retrospective application of IFRS 1,
12.08
extinguishing with equity instruments, 8.02n
held for trading, 8.57
notes payable, 8.58
offsetting, 8.32, 8.35
reclassified to available for sale, 8.57
reclassified to loans, 8.57
reclassified to receivables, 8.57
warrant liabilities, 8.58
Financial statements. See also specific statements




basis of presentation, 1.72
capital disclosures, 1.77
capital structure—equalization agreement, 2.23
classified presentation—increasing/decreasing
liquidity, 2.17–2.18
complete set, contents, 1.10
comprehensive disclosures, 1.70







deferred tax assets and liabilities, offsetting, 1.73,
2.392
disclosure, 1.40–1.69, 2.13–2.16, 3.22–3.23,
4.10–4.13
dividends declared and not recognized as a liability,
1.79
expenses by function, 3.25–3.26
expenses by nature, 3.24–3.25
first-time adoption of IFRSs, 12.09
going concern assessment, 1.72
insurance liabilities, 2.32
liquidity order presentation, 2.19–2.20, 2.32
minority interests, multiple classes, 2.25
noncurrent assets, 2.29
noncurrent liabilities, 2.31
pension obligations, offsetting, 1.74
premiums/discounts to suppliers, 2.30
prepaid expenses, 2.27, 2.29
prepaid lease payments, 2.29
presentation, 1.32–1.39, 1.75, 2.05–2.12,
3.10–3.21, 4.04–4.09
presentation and disclosure excerpts, 1.70–1.82,
2.17–2.32, 3.24–3.26
reclassifications, 1.76
recognition and measurement, 1.10–1.31
regulatory capital, disclosure, 1.78
regulatory environment information, 1.71







statement of changes in equity
subject to approval of shareholders, 1.137
treasury shares, multiple classes, 2.25
unallocated divisible surplus, 2.32




First-in, first-out (FIFO). See under Inventories
First-time adoption of IFRSs
overview, 12.01–12.04
amendments to IFRS 1, 12.01n
application of IFRS 1, 12.02
disclosure, 1.54, 12.11–12.15
early adoption of IFRS 9, 8.54




presentation and disclosure excerpts, 12.16–12.17
recognition and measurement, 12.05–12.08
transition from Argentine GAAP to IFRSs, IFRS 1
exemptions elected, 12.17
transition from Canadian GAAP to IFRSs, IFRS 1
exemptions elected, 12.16
Fiscal year end, Table 1–5




gains/losses on translation, 2.163
recognition and measurement, 1.149–1.151
reconciliations on translation, 1.174
translation for statement of cash flows, 5.09
Foreign exchanges rates, changes in
overview, 1.146–1.148
disclosure, 1.169–1.176
functional currency, changes in, 1.177
IAS 21 disclosures with convenience translation,
1.178
presentation and disclosure excerpts, 1.176–1.178
recognition and measurement, 1.149–1.168
Foreign operations, 1.147, 10.09, 10.18
Forest product producers, 2.36
Forestry assets, 5.28
Forward agreements, 5.31, 8.05
Frequent flyer program, 1.235
Functional currency
changes in, 1.177
defined, 1.147, 1.160, 10.01, 10.06
hyperinflationary economies, see Hyperinflationary
economies
remeasurements, 1.166, 10.12
Future operating losses, 2.275, 2.289
FVLCS. See Fair value less cost to sell (FVLCS)
FVTPL. See Fair value through profit or loss (FVTPL)
G
Gain contingency, 1.124
Gain on a bargain purchase, 9.10, 9.21
Gains/losses
actuarial, see Actuarial gains and losses
business combinations, gain on bargain purchase,
9.26
on consolidated financial statements, 1.102
defined, 3.07
derecognition of noncurrent assets, see under
Noncurrent assets
employee benefits, 2.320–2.321
foreign currency translations, 2.163
project loss provisions, 2.302
Gas. See Oil and gas assets
General purpose financial statements, 4.03
Geographic segments
statistical profiles, Table 7–2
Going concern assessment
events after reporting period, 1.119, 1.121
presentation and disclosure excerpts, 1.72
uncertainties affecting, disclosure, 1.42, 1.58
Gold, 3.59
Goods, 3.32, 3.157
Goodwill. See also Intangible assets
business combinations, 2.77, 9.10, 9.21
CGUs, see under Cash generating units (CGUs)
defined, 2.76
depreciation (amortization), 2.102, 3.124
foreign operation acquisitions, 2.158
impairment losses, 3.247, 3.266–3.267, 3.272,
3.276, 3.286, 3.288
intangible assets, 2.76
investments in associates, 2.144
negative goodwill, 9.10
presentation and disclosure excerpts, 2.111
recognition and measurement, 2.374
statistical profiles, Table 2–5
Government grants and assistance
overview, 1.179–1.180
biological assets, 2.197





initial recognition as reduction of carrying value of
depreciable assets, 1.201
initial recognition at fair value, 1.202
initial recognition at nominal amount, 1.200
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loans at below market rate, 1.178n, 1.183, 1.190
presentation, 1.192–1.196
presentation and disclosure excerpts, 1.200–1.203
recognition and measurement, 1.181–1.191
subsidies, purchase and sale, 5.30
Gross amount due from/to customers, 3.84
Groves (plants and trees), 2.201






exemption from retrospective application of IFRS 1,
12.08
hedge accounting, IASB/FASB project, 8.01n
hedged items, 8.04
hedging effectiveness, 8.04
presentation and disclosure excerpts, 8.62
recognition and measurement, 8.22
recycling of deferred hedging gains, 5.26
Held for sale assets
defined, 6.04
gains/losses on derecognition, 3.305
impairment, 3.292
interests in joint ventures, 2.177
noncurrent assets, see under Noncurrent assets
presentation and disclosure excerpts, 6.27
withdrawal of business from held for sale and
reclassification as continuing operations,
6.26
Held for sale liabilities, 6.27
Held for trading assets, 5.29, 8.57
Held for trading liabilities, 8.57






functional currency requirements, 1.167, 10.01,






financial statements, translation, 1.157
foreign operations, deconsolidation in
hyperinflationary economy, 10.18
foreign subsidiary, inflation adjustment prior to
translation into presentation currency, 10.19
presentation and disclosure excerpts,
10.17–10.19
price-level adjustment for subsidiaries,
elimination on transition to IFRSs, 10.17
recognition and measurement, 10.05–10.13










financial instrument classification and measurement
simplification project (IASB), 8.01n
financial instruments, 8.20
first-time adoption of IFRSs, 12.12
goodwill, see under Goodwill
held for sale assets, 3.292
intangible assets, losses, 3.288
interests in joint ventures, 3.218
inventories, 3.99
investment in associate, 3.290
investment in jointly controlled entities, 3.291
leases, 3.222, 3.233
noncurrent assets held for sale, 6.03, 6.08–6.09,
6.13, 6.15
PPE, losses and reversal of losses, 3.288–3.289
presentation, 3.275–3.276
presentation and disclosure excerpts, 3.288–3.292
recognition and measurement, 3.246–3.274
reversals of losses on property, plant and
equipment held at revalued amount, 3.289
on statement of comprehensive income, 3.275
Impracticable, 1.15
Imputed rate of interest, 3.31
“In the money” contracts, 3.360
Income
defined, 1.08, 3.07, 3.27
emissions rights, 3.63
on statement of comprehensive income, 3.22
Income before tax, adjustments, 5.25
Income statement
borrowing costs (interest expense), 3.198
deferred tax accounts, changes, 3.332
depreciation (amortization), 3.132
employee benefits, 3.152
EPS for income from continuing operations, 3.477
expenses by function, 3.25
expenses by nature, 3.25
extraordinary items, 3.21, 3.23
impairment losses, 3.276









assets/liabilities from the same tax authority,
offsetting, 3.345
on balance sheet, 2.390–2.391
current tax payables, 2.397–2.398
current tax receivables, 2.398
deferred tax assets, 2.398
deferred tax liabilities, 2.397–2.398
defined, 2.381
disclosure, 2.393–2.396, 3.334–3.342
items recognized in other comprehensive income,
3.343–3.345
noncurrent tax payables, 2.397
presentation, 2.390–2.392, 3.329–3.333
presentation and disclosure excerpts, 2.397–2.398,
3.343–3.347
recognition and measurement, 2.369–2.389,
3.323–3.328
on statement of comprehensive income, 3.15, 3.18
tax effects of discontinued operations, 3.344
tax expense reconciliation disclosure, single
domestic statutory tax rate, 3.346
tax loss carryforwards, 2.397, 3.345
tax rate changes, 3.343
tax rate reconciliation disclosure, weighted average
statutory tax rate, 3.347
Incremental approach, 2.359
Indemnities receivable, 11.23
Indirect method of reporting cash flows from
operating activities, 5.05, 5.25
Industry classification, Table 1–2
Inflation, 10.19
Initial public offerings (IPOs), 1.135
Installment method (revenue recognition), 3.42
Insurance, 2.303, 3.62
Insurance contracts, 3.243, 8.03, 12.07
Intangible assets. See also Computer software;
Goodwill; Research and development (R&D)
costs
overview, 2.76–2.78
on balance sheet, 2.98, 2.110
core deposit intangibles, 2.115
defined, 2.76, 2.91
depreciation (amortization), 2.108–2.109,
3.120–3.122, 3.124, 3.126–3.127, 3.132, 3.136,
3.141
disclosure, 2.100–2.110
exemption from retrospective application of IFRS 1,
12.07
gains/losses on derecognition, 3.294–3.304
goodwill, 2.76, 2.111
impairment losses, 3.247–3.248, 3.266, 3.286,
3.288
other acquired intangibles, 2.115
presentation, 2.98–2.99
presentation and disclosure excerpts, 2.111–2.117
recognition and measurement, 2.79–2.97
revaluation model, see under Revaluation model
sale, gains/losses on derecognition, 3.305
service concession arrangements, 11.08, 11.14,
11.23
Interest, 5.10, 5.23
Interest cost or expense, 2.214n, 3.10, 3.194, 3.198.
See also Borrowing costs
Interest income, 3.39, 3.51, 3.59, 3.62
Interest paid and capitalized, 5.32
Interest received, 5.32
Interests in associates. See Investments in associates
Interests in joint ventures. See also Jointly controlled
entities or operations
overview, 2.169–2.171, 3.203–3.204
associates and joint ventures designated at fair
value through profit or loss, 3.218
on balance sheet, 2.174, 2.184
definitions, 2.168n, 2.169
disclosure, 2.186–2.188, 3.216–3.217
equity method, jointly controlled operations, 2.190
held for sale investments, 2.177
impairment losses, 3.218
offsetting assets/liabilities, 2.176
presentation, 2.184–2.185, 3.213–3.215, 8.03
presentation and disclosure excerpts, 2.189–2.191,
3.218–3.219
proportionate consolidation, 2.189
recognition and measurement, 2.172–2.183,
3.205–3.212
separate financial statements, 1.84
share of post-tax profit or loss of associates and
joint ventures included in pre-tax operating
profit, 3.218
significant joint ventures, 2.186
Intermediate-life plants, 2.201
International Accounting Standards Board (IASB)
authority to establish IFRSs, 1.24n
financial instrument classification and
measurement simplification project, 8.01n
financial instrument derecognition project, 8.01n
income tax accounting proposals, 2.366n
lease accounting project, 2.214n
revenue recognition project, 3.26n
website, 8.01n
International Financial Reporting Standards (IFRSs)
Conceptual Framework, see The Conceptual
Framework for Financial Reporting (IFRS
Conceptual Framework)
first-time adoption, see First-time adoption of IFRSs
hierarchy, 1.16, 1.16n
IFRSs for financial instruments, 8.02n
Inventories
overview, 2.33, 3.91–3.92
analysis of expenses by function, 3.108–3.110
analysis of expenses by nature, 3.111
on balance sheet, 2.46
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cost determination, Table 3–3
defined, 2.33, 2.43
disclosure, 2.48–2.49, 3.104–3.107
fair value less cost to sell, broker trader exemption
from IAS 2, 2.52
first-in, first-out (FIFO), 2.40, 2.50, 3.93, 3.108
impairment, 3.99, 3.243
on income statement, 3.101–3.102
last-in, first-out (LIFO), 2.40, 2.44, 2.49, 3.93,
3.106
multiple cost flow assumptions, 3.110–3.111
presentation, 2.46–2.47, 3.101–3.103
presentation and disclosure excerpts, 2.50–2.53,
3.108–3.111
provision for inventory obsolescence, 3.110
recognition and measurement, 2.34–2.45,
3.93–3.100
recognition criteria, 2.37
reversal of writedowns, 2.45, 3.100, 3.108, 3.111
specific identification, 2.40, 2.51, 2.53, 3.93
statement at net realizable value, 3.109
on statement of comprehensive income, 3.101
weighted average cost, 2.40, 2.51, 3.93, 3.109
writedowns, 3.95–3.97, 3.107–3.108, 3.111, 5.26




carried at cost, 2.136
carried at fair value, 2.137–2.138
change in fair value, 3.321
defined, 2.118, 2.125
depreciation (amortization), 3.118, 3.128
disclosure, 2.132–2.135
exemption from retrospective application of IFRS 1,
12.07
fair value model, 3.311, 3.317
gains/losses on derecognition, 3.294–3.304
impairment, 3.243
leases, exception, 2.216
measurement models, Table 2–6
presentation, 2.131
presentation and disclosure excerpts, 2.136–2.138




associates and joint ventures designated at fair
value through profit or loss, 3.218
associates’ share of income not included in
operating profit, 3.219
associates’ share of other comprehensive income,
3.219
associates’ share of post-tax profit/loss and joint
ventures included in pre-tax operating profit,
3.218
on balance sheet, 2.158–2.159
capital increases, 5.31
disclosure, 2.161–2.166, 3.216–3.217
exemption from retrospective application of IFRS 1,
12.07
impairment, 3.218, 3.244, 3.290
increase in shareholding, 1.145
presentation, 2.157–2.160, 3.213–3.215, 8.03
presentation and disclosure excerpts, 2.167–2.168,
3.218–3.219
recognition and measurement, 2.141–2.156,
3.205–3.212
separate financial statements, 1.84
significant influence, 2.141–2.142, 2.145, 2.151,
2.153–2.154, 2.163–2.164, 2.167–2.168
on statement of cash flows, 5.11
Involuntary termination benefits, 2.335
IT programs. See Computer software
J
Joint arrangements, 2.168n
Joint control, 2.168n, 2.169
Joint operations, 2.168n
Joint ventures. See Interests in joint ventures
Jointly controlled entities or operations. See also
Interests in joint ventures
accounting treatment, Table 2–7
assets, 2.170, 2.172, 2.191
defined, 2.170
exemption from retrospective application of IFRS 1,
12.07
impairment of investment, 3.244, 3.291
recognition and measurement, 2.172, 2.178
K
Key management personnel
compensation, 1.211, 1.222, 2.338
definitions, 1.206–1.207, 1.207n
disclosures, 1.208, 1.211
as related party, 1.205




Land as investment property. See Investment property
Land sales, 3.60
Last-in, first-out (LIFO). See under Inventories
Leasebacks, 1.145, 2.228, 2.250, 2.258
Leases. See also Finance (capital) leases; Operating
leases
overview, 2.215–2.217, 3.220
accounting project (IASB/FASB), 2.214n
IFRS ATT-SUB
767Subject Index
on balance sheet, 2.225, 2.227, 2.242–2.244,
2.253–2.254, 2.256
defined, 2.215, 2.229
depreciation (amortization), 2.223, 2.239, 2.244
disclosure, 2.245–2.258, 3.232–3.239
exemption from retrospective application of IFRS 1,
12.07




multiple element arrangements, 2.233
presentation, 2.242–2.244, 3.229–3.231
presentation and disclosure excerpts, 2.259–2.260,
3.240–3.242
provisions, contingent liabilities and contingent
assets, exclusion, 2.264
recognition and measurement, 2.218–2.241,
3.221–3.228, 8.05
right of use approach, 2.214n
service concession arrangements, 11.07,
11.13
Leveraged leases, 2.241, 2.244
Liabilities
contingency disclosure, 2.306
contingent, see Provisions, contingent liabilities
and contingent assets
current, see Current liabilities
decommissioning, see Decommissioning
obligations
deferred taxes, see Deferred tax liabilities
defined, 1.07, 2.289
financial, see Financial liabilities
financial liabilities, adjustments for accretion,
5.25
insurance liabilities, 2.32
in liquidity order, 2.32
offsetting, 1.39, 2.176, 2.293, 2.336, 3.345
service concession arrangements, 11.17
unallocated divisible surplus, 2.32
warranty, see Warranty obligations
Life insurance benefits, 3.156
LIFO (Last-in, first-out). See under Inventories
Limited liability companies, 2.181
Limited partnerships, 5.36
Liquidity order presentation, 2.17–2.20




Losses. See Actuarial gains and losses; Impairment
of assets; Profits/losses
Lower of cost or market rule
animals raised for sale, 2.202
growing crops, 2.200
inventories, 2.44, 3.98, 3.105
Lower of cost or net realizable value, 2.39
M
Maintenance obligations, 11.12
Management. See Key management personnel




Market-related value of plan assets, 2.332
Matching concept, 3.09
Material
customer loyalty programmes, 1.231
defined, 1.15
extraordinary items, 3.21
gains/losses on derecognition, 3.303
intangible assets, 2.103
interests in joint ventures, 2.188
nonadjusting events after reporting period, 1.129
related party transactions, 1.208, 1.216
share-based payments, 2.362
on statement of comprehensive income, 3.22
Materiality of financial information, 1.04
Measurement. See under specific topics
Minerals and mineral products, 2.36, 2.120, 2.216,
2.229
Mining rights, 2.62
Minority interests. See Noncontrolling interests
Monetary items, 1.147
“More likely than not,” 2.387









Net defined benefit obligation, 2.318
Net income/loss
basic and diluted EPS, 3.389
proposed appropriation of, 4.19
on statement of changes in equity, 4.07n
on statement of comprehensive income, 3.10
Net investment in a foreign operation, 1.147
Net realizable value, 2.41, 3.96–3.97
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Nonadjusting events after reporting period. See
Events after reporting period
Nonauthoritative accounting and financial reporting
practices, 1.24, 1.24n








on consolidated financial statements, 1.92, 1.101
measurement, 9.07, 9.07n, 9.12–9.13, 9.27
purchase of, 5.32
on statement of comprehensive income, 3.11, 3.16
subsidiaries held for sale, 6.19
Noncontrolling shareholders, 1.98
Noncurrent assets






assets held for sale, 3.305
disclosure, 3.303–3.304
hotels, disposal, 3.306
intangible assets, sales, 3.305
PPE, sales, 3.305, 3.307
presentation, 3.301–3.302
presentation and disclosure excerpts,
3.305–3.307
recognition and measurement, 3.294–3.300
waste products, sales, 3.307
growing crops, 2.211
growing herd, 2.211




impairment, 3.243, 6.03, 6.08–6.09, 6.13, 6.15
presentation, 6.16–6.20
presentation and disclosure excerpts, 6.25–6.27
reclassification, 6.11
recognition and measurement, 6.04–6.15
statistical profiles, Table 6–1
nurseries, 2.213
prepaid expenses, 2.29
prepaid lease payments, 2.29








Notes to financial statements
analysis of expenses by function or nature, 3.22,
3.22n
changes in equity, 4.08
comparative note disclosures, 1.44
cost of sales, disaggregation in note disclosure,
3.26




parent company disclosures, 1.113
reconciliation of net cash flows from operating
activities, 5.24
reconciliation of profit before tax to cash from
operating activities, 5.28
revenue recognition policies, 3.51




deferred tax assets and liabilities, 1.73, 2.392
financial assets and liabilities, 8.32, 8.35
interests in joint ventures, 2.176
pension obligations, 1.74
postemployment benefits, 2.336
provisions, contingent liabilities and contingent
assets, 2.293
when permitted, 1.39
Oil and gas assets, 2.216, 2.229, 12.07
Onerous contracts, 1.229, 2.263, 2.275, 2.303
Operating activities. See under Statement of cash
flows








presentation and disclosure excerpts, 2.259–2.260,
3.240–3.242
recognition and measurement, 2.218–2.241,
3.221–3.228




defined on the basis of business activities,
7.25–7.26




initial application of IFRSs and IFRS 8, 7.28
presentation and disclosure excerpts, 7.25–7.28
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recognition and measurement, 7.04–7.14
reconciliation of segment information presented
under Argentine GAAP and IFRSs, 7.28
restatements, 7.21
revisions based on changes in organizational
structure, 7.27
segment information provided in separate asset,
liability, revenue and expense disclosures, 7.26
statistical profiles, Table 7–1
Operations subject to rate regulation, 12.07
Orchards, 2.201
Other comprehensive income. See also Statement of
other comprehensive income
disaggregation of tax effects, 3.343
employee benefits, 2.332, 2.343, 3.152
foreign exchange differences, 1.153, 1.169
interests in joint ventures, 3.204, 3.213
investments in associates, 3.204, 3.213, 3.219
PPE, changes in revalued amount, 3.320–3.321
shown net of tax, 3.344–3.345
on statement of comprehensive income, 3.10
statistical profiles, Table 3–2
tax income/expense, 3.323–3.324, 3.330–3.331
Owner occupied land/buildings, 2.119
P
Parents
changes in ownership interest, 1.93, 4.13
consolidated financial statements, see
Consolidated financial statements
defined, 1.83
separate financial statements presented
side-by-side with related parent company’s
consolidated financial statements, 1.114
on statement of comprehensive income, 3.11
Partnerships, 2.181
Patents, 2.216, 2.229
PBOs. See Projected benefit obligations (PBOs)
Percentage-of-completion method (revenue
recognition), 3.37, 3.71, 3.81–3.82, 3.85, 3.89
Perpetual bonds redeemable for shares, 8.60
Phantom shares, cash-settled, 2.366
Pineapple growers, 2.198
Plays, 2.216, 2.229
Postemployment benefit plans. See Defined benefit
plans; Defined contribution plans
Postemployment benefits. See also Termination
benefits
actuarial gains and losses recognized immediately
in equity, 3.154
changes in accounting policy for actuarial gains
and losses, 3.155
corridor method, 3.156
effect of the asset ceiling, 3.154
life insurance benefits, 3.156
provisions, contingent liabilities and contingent
assets, exclusion, 2.264




PPE. See Property, plant and equipment (PPE)
Precious metals, 2.229, 3.59
Preference dividends, 3.383
Preference shares
convertible preference shares, 3.389
convertible redeemable preference shares, 2.24
dividends classified as equity, 4.16
dividends subject to mandatory redemption, 5.25
issuance, 4.14, 5.34
multiple classes, 2.25
redeemable, classified as liabilities, 8.59
Presentation currency, 1.147, 1.155, 10.10
Price changes, 10.16
Prior period errors
business combinations, adjustments, 9.24
correction, 1.31, 1.56, 1.69, 1.81–1.82
defined, 1.15
first-time adoption of IFRSs, 12.13
retrospective restatement, 1.22
on statement of changes in equity, 4.06
Private placement, 1.135






change in fair value of nonfinancial assets,
3.320–3.321
construction contracts, 3.80, 3.87
derecognition of noncurrent assets, see under
Noncurrent assets
foreign exchange differences, 1.169
government grants and assistance, 1.185, 1.198
interests in joint ventures, 3.203, 3.218
investments in associates, 2.148, 2.156, 3.203,
3.218
reconciliation of net cash flows from operating
activities provided in a note disclosure, 5.24
reportable segment thresholds, 7.08
on statement of comprehensive income, 3.10
Projected benefit obligations (PBOs), 2.332
Projected unit credit method, 2.332
Property, plant and equipment (PPE)
overview, 2.54
on balance sheet, 2.65–2.66, 2.70
breeding animals, 2.201
classes of, Table 2–3
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cost model for measuring PPE, see under Cost
model
decommissioning provisions, 2.304
depreciation (amortization), 3.112–3.117, 3.126,
3.128, 3.128n, 3.135
disclosure, 2.67–2.72
exemption from retrospective application of IFRS 1,
12.07
gains/losses on derecognition, 3.294–3.304
impairment loss reversal, 3.289
impairment losses, 3.266, 3.288
livestock, 2.201
measurement models, Table 2–4
plants and trees, 2.201
presentation, 2.65–2.66
presentation and disclosure excerpts, 2.73–2.75
production animals, 2.201
recognition and measurement, 2.55–2.64
revaluation model for measuring PPE, see under
Revaluation model
sale of building, 1.145
sales, 1.140
sales, gains/losses on derecognition, 3.305, 3.307
service concession arrangements, 11.07, 11.14
Property, plant and equipment held at revalued
amount, 3.289
Proportionate consolidation method
interests in joint ventures, 2.173–2.175, 2.177,
2.186
unincorporated construction entities, 2.181
unincorporated extractive entities, 2.181
Provision for doubtful debts, 5.29
Provisions, contingent liabilities and contingent assets
overview, 2.261–2.266
on balance sheet, 2.270, 2.273, 2.276,
2.280–2.281, 2.290, 2.298
business combinations, 9.21, 9.25
categories of contingencies, Table 1–8
contingency, defined, 2.280
customer loyalty programmes, 1.229
decommissioning provisions, 2.304
definitions, 2.261–2.262, 2.266n, 2.280
disclosure, 2.294–2.301, 2.306
environmental provisions, 2.305
environmental rehabilitation provisions, 2.304
government grants, 1.197, 1.203
insurance provisions, 2.303





presentation and disclosure excerpts, 2.302–2.307
product infringement, 2.302
project loss provisions, 2.302
provision, defined, 2.261, 2.266n
recognition and measurement, 2.267–2.289





Public entities, 3.273n, 3.333, 7.13
Public utilities, 3.19
Public-to-private service concession arrangements,
11.05, 11.19
Purchase method. See Acquisition method
Puttable instruments, 1.49, 8.04, 8.29
Q
Qualitative characteristics of financial information,
1.04
Qualitative disclosures, 4.10, 8.46
Quantitative disclosures, 4.10, 8.46
R
R&D. See Research and development (R&D) costs




equity component of convertible debt, 4.17
financial instruments, 8.17–8.18, 8.30, 8.39, 8.57
noncurrent assets held for sale and discontinued
operations, 6.11
on statement of comprehensive income, 3.04, 3.15,
3.18
Recognition criteria (inventories), 2.37
Reconciliations





foreign currency translations, 1.174




provisions, contingent liabilities and contingent
assets, 2.295
Recoverable amount, 3.243, 3.269




presentation and disclosure excerpts, 2.397–2.398
recognition and measurement, 2.369–2.389
Refundable deposits, 5.32




Related parties, 1.204n, 1.205, 1.207
Related party disclosures
overview, 1.204






presentation and disclosure excerpts, 1.221–1.222
recognition and measurement, 1.205–1.207
share-based payments, 3.182
Relevance of financial information, 1.04
Renewable power generation, 3.321
Rental revenue, 3.19, 3.60




impairment of assets, 3.280
noncurrent assets held for sale, 6.23
recognition and measurement, 7.08–7.11
Reporting currency. See Presentation currency
Reporting units, 3.267
Research and development (R&D) costs, 2.95, 2.105,
2.114
Residual value of PPE, 3.128n
Restatements
first-time adoption of IFRSs, 12.10
hyperinflationary economies, 10.05, 10.07–10.08,
10.13–10.14
operating segments, 7.21
presentation and disclosure excerpts, 1.76
Restructuring programs, 2.263, 2.276, 2.287, 2.302
Retirement plans. See Defined benefit plans; Defined
contribution plans
Revaluation model
for measuring intangible assets, 2.104, 3.310,
3.316
for measuring PPE, 2.60–2.61, 2.70, 2.74–2.75,
3.117, 3.140, 3.309, 3.316
Revalued amount, 2.60, 2.87, 3.309
Revenue
overview, 3.27
barter transactions, 3.26n, 3.33, 3.56
bill and hold transactions, 3.57
computer software, support, subscription,
consulting revenues and multiple element
arrangements, 3.58
construction contracts, 3.69, 3.71, 3.78
contracts to provide services, 3.55
customer loyalty programmes, 1.226–1.228





fees and commissions, 3.62
home sales, 3.60
on income statement, 3.49
insurance net premium income, 3.62




presentation and disclosure excerpts, 3.55–3.63
recognition and measurement, 3.28–3.47
rental revenue, 3.60
reportable segment thresholds, 7.08
revenue recognition project (IASB/FASB), 3.26n
royalty income, 3.61
sale of gold, copper and silver, 3.59
sale of gold and silver bullion, 3.59
sales of goods, 3.55
sales of services, 3.56
service concession arrangements, 11.09, 11.09n
on statement of comprehensive income, 3.10,
3.48
Reverse acquisitions, 4.18, 9.11, 9.15–9.16
Right of setoff. See Offsetting
Rights issue, 4.15
Risk exposure, 1.61, 8.46
financial instruments, 8.53
Royalty income, 3.39, 3.61




Sales of goods, 3.34–3.35, 3.44, 3.51, 3.55
Sales of services, 3.56




Securitization of receivables, 8.61
Senior management benefits, 2.354




investments in subsidiaries, associates, or jointly
controlled entities, 1.95
parent’s separate statements presented
side-by-side with related parent’s consolidated
statements, 1.114
when permitted, 1.86–1.87, 1.103
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intangible assets, indemnities receivable, 11.23
presentation and disclosure excerpts, 11.23
public-to-private arrangements, 11.05, 11.19
recognition and measurement, 11.05–11.18
Service contracts, 2.230, 3.55
Service revenues
recognition and measurement, 3.32, 3.37–3.38,
3.51
service contracts, 3.55
on statement of comprehensive income, 3.19
Setoff, legal right of. See Offsetting
Share capital





Share compensation, presentation, 3.178
Share options. See also Share-based payments;
Stock options
anti-dilutive in current year, 3.389
anti-dilutive in prior year, 3.386
dilutive in prior years, 3.389
exercise, 5.35





cash-settled phantom shares, 2.366
cash-settled share appreciation rights, 2.365
compound financial instruments, 3.161




exemption from retrospective application of IFRS 1,
12.07
fair value, 3.163, 3.165–3.166, 3.168, 3.170, 3.175,
3.180
measurement, 9.08n
payments to employees, 3.171, 3.173, 3.178
presentation, 2.362, 3.177–3.178, 8.03
presentation and disclosure excerpts, 2.365–2.366,
3.184
recognition and measurement, 2.358–2.361,
3.160–3.176
related party disclosures, 3.182
share-based compensation agreements, 5.34




Shareholders’ equity. See Statement of changes in
equity
Shares. See also Basic earnings per share (EPS);
Diluted earnings per share (EPS); Earnings per
share (EPS); Preference shares; Treasury stock
appreciation rights, cash-settled, 2.365
buy back program announcement, 1.143
capital shares, 5.34
cash flow per share, 5.22
common shares, 2.22, 2.152, 2.166, 4.14
contingently issuable shares, 3.364, 3.383
declaration of taxable bonus share issue to
shareholders, 1.142
deferred shares, 2.26
employee share purchase plans, 3.176
employee stock ownership plans, 3.176
issuance in lieu of dividends, 4.15
members’ shares, 2.24
minority interest, multiple classes, 2.25
new ordinary shares, 2.24
ordinary shares, 2.26, 3.386, 9.26
perpetual bonds redeemable for, 8.60
phantom shares, cash-settled, 2.366
preference, see Preference shares
private placement issuance, 4.18
reduction in par value, 4.17
suppliers’ investment shares, 2.24
Short-term benefits, 2.311, 3.153
Silver and silver bullion, 3.59
Software. See Computer software
Special contributions, 3.154
Special items, 5.28
Special purpose entities, 1.83n, 1.97, 1.99
Specific identification (inventories), 2.40, 2.51, 2.53,
3.93
Stable currency, 10.10





interest paid/received presented in operating,
investing, and financing activities, 5.23
reconciliation of profit (loss) to net cash flows






capital increase, issue and repayment of
subordinated long-term debt, issuances of
preferred securities, issues of capital shares
under share-based compensation agreements,
5.34
characteristics of, 5.07, 5.15
commercial property debt issue, amortization
and repayment, trust unit and class B limited
partnership distributions, 5.36
interest paid/received, 5.23
issue of securities, expenditures paid by third
party, exercise of stock options, 5.35
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issue of share capital, sales and leaseback of
aircraft, repayment of finance lease
obligations, refunds of deposits pledges for
finance leases, receipt and payment of
restricted bank deposits, 5.33
foreign currency translation, 5.09
indirect method
adjustments to income before tax, adjustments
for accretion on financial liabilities, dividends






characteristics of, 5.06, 5.06n
collections and payments of forward agreements,
collection and payments of bank deposits,
capital increases in associates, 5.31
control of subsidiaries, 5.12, 5.18
defined, 5.12
interest and dividends received, interest paid and
capitalized, purchase of subsidiaries and
noncontrolling interest, decrease (increase) in
advances and refundable deposits, 5.32
interest paid/received, 5.23
purchase and sale of noncurrent assets,
government subsidies, 5.30
investments in associates, 5.11
operating activities
adjustment for provision for doubtful debts,
impairment of guarantees, fair value gain on
financial assets held for trading, 5.29
adjustment for repurchase of bonds and changes
in estimates related to debentures, 5.27
adjustments for depreciation, impairments,
inventory writedowns, labor agreements,
litigation provisions, recycling of deferred
hedging gains, 5.26
characteristics of, 5.05, 5.15
interest paid/received, 5.23
note disclosure of the reconciliation of profit
before tax to cash from operating activities,
adjustments for fair value gains on forestry
assets, felling costs, and special items,
changes in net debt, 5.28
presentation, 5.02–5.15
presentation and disclosure excerpts,
5.23–5.36
Statement of changes in equity
overview, 4.01–4.03
changes in shareholders’ equity, Table 4–2
common shares, issuance, 4.14
components of shareholders’ equity, Table 4–1
convertible bonds, equity component, 4.19




net assets acquired in reverse acquisition, fair
value, 4.18
net income, proposed appropriation, 4.19
noncontrolling interests, 4.17
par value, reduction, 4.17
preference shares, dividends classified as equity,
4.16
preferred shares, issuance, 4.14
presentation, 4.04–4.09
presentation and disclosure excerpts, 4.14–4.20
revaluation reserve, transfer to retained earnings on




share capital, reduction, 4.20
shares issued in lieu of dividends, 4.15




Statement of compliance, 1.12, 1.72
Statement of comprehensive income
overview, 3.01–3.09
borrowing costs, 3.185–3.202





earnings per share, 3.348–3.389
employee benefits, 2.343, 3.143–3.156
expenses by function, 3.22, 3.22n, 3.23, 3.134
expenses by nature, 3.22, 3.22n, 3.23–3.24
impairment of assets, 3.243–3.292
income taxes, 3.322–3.347
interests in joint ventures, 3.203–3.219
inventories, 3.91–3.111
investments in associates, 3.203–3.219
leases, 3.220–3.242
noncurrent assets, gains/losses on derecognition,
3.293–3.307
presentation, 3.10–3.21















interests in joint ventures, 2.169–2.191
inventories, 2.33–2.53
investments in associates, 2.139–2.168
leases, 2.215–2.260
presentation, 2.05–2.12
presentation and disclosure excerpts, 2.17–2.32
property, plant and equipment, 2.54–2.75
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Statement of other comprehensive income, 3.25, 4.04
presentation, 4.07n
Statement of recognized income and expense,
3.152n. See also Statement of comprehensive
income
Statistical profiles of surveyed entities. See Tables
Stock. See Shares; Treasury stock
Stock exchanges, Table 1–4
Stock option plans, 3.184
Stock options. See Share options
Store closings, 2.303
Subsequent events. See Events after reporting period
Subsidiaries
cash flows from, on statement of cash flows, 5.12,
5.18
changes in parent ownership interest, 4.13
in consolidated financial statements, 1.88
dividends, 4.16
exemption from retrospective application of IFRS 1,
12.07
foreign subsidiary, inflation adjustment prior to
translation into presentation currency, 10.19
impairment, 3.244
interests in, presentation, 8.03





Surveyed entities, general information, Table 1–1
Systematic method (postemployment benefits), 3.147
T
Tables
audit firms, Table 1–6
business segments, Table 7–1
capital structure, Table 2–2
cash flows from operating activities
classifications of reported income tax, interest,
and dividends, Table 5–2
reporting methods, Table 5–1
commitments and contingencies, Table 1–8
country of incorporation, Table 1–3
critical accounting estimates, Table 1–7
depreciation (amortization) methods, Table 3–4
discontinued operations, Table 6–2
expenses recognized in profit and loss, Table 3–1
financial instruments by type, Table 8–1
fiscal year end, Table 1–5
geographic segments, Table 7–2
goodwill, Table 2–5
industry classification, Table 1–2
inventory cost determination, Table 3–3
investment property, measurement models, Table
2–6
jointly controlled entities, accounting treatment,
Table 2–7
management judgments, Table 1–7
noncurrent assets held for sale, Table 6–1
other comprehensive income, Table 3–2
PPE
classes of, Table 2–3
measurement models, Table 2–4
shareholders’ equity
changes in, Table 4–2
components of, Table 4–1
statement of financial position, format, Table 2–1
stock exchanges, Table 1–4
surveyed entities, general information, Table 1–1
Tangible product sales, 3.19
Tax base, 2.369
Tax credit (loss) carrybacks/carryforwards, 2.385,
2.389, 2.396–2.397, 3.326, 3.345




current tax expense, 2.371
deferred assets, see Deferred tax assets
deferred liabilities, see Deferred tax liabilities
deferred tax expense (benefit), 3.325
income taxes, see Income taxes




Termination benefits. See also Employee benefits
defined, 2.307n
disclosure, 2.346, 2.350
presentation and disclosure excerpts, 3.155
provisions, contingent liabilities and contingent
assets, 2.288
recognition and measurement, 2.307n, 2.328, 2.334
senior management, 2.354
on statement of comprehensive income, 3.145
Third parties, 2.128, 5.35
Timber, 2.198, 2.214, 2.229, 3.321
Timeliness of financial information, 1.04
Total comprehensive income, reporting. See











accounting for, 8.31, 8.34
on balance sheet, 2.10
multiple classes, 2.25
purchase, 4.15
Treasury stock method, 3.369
True and fair view override, 1.12, 1.40–1.41, 1.57




Understandability of financial information, 1.04
Unincorporated construction entities, 2.181
Unincorporated extractive entities, 2.181




Value in use (VIU), 3.249, 3.251, 3.254, 3.263, 3.279,
3.283
Variable interest entities (VIEs), 1.99
Verifiability of financial information, 1.04
Vested suppliers, 3.164
Video recordings, 2.216
VIEs. See Variable interest entities (VIEs)
Vineyards, 2.201
VIU. See Value in use (VIU)
W
Warranty obligations, 2.269, 2.284, 2.302, 8.58
Waste products, 3.307
Water rights, 2.117
Weighted average cost (inventories), 2.40, 2.51, 3.93,
3.109
Working capital, 1.140
Writedowns (inventories), 3.95–3.97, 3.107–3.108,
3.111, 5.26
Z
Zero-profit method, 3.75n
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